PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	SOLOMON, L				SOLOMON, L			HEREDITARY MULTIPLE EXOSTOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYER A, 1814, TRAITE MALADIES CHIR, V3, P594; DIFERRANTE N, 1956, J LAB CLIN MED, V48, P491; Ehrenfried A, 1915, J AMER MED ASSOC, V64, P1642; Ehrenfried A, 1917, J AMER MED ASSOC, V68, P502; HARRIS H., 1948, ANN EUGENICS, V14, P165; KROOTH RS, 1961, AM J HUM GENET, V13, P340; LANGENSKIOLD F, 1925, ACTA CHIR SCAND, V58, P210; LORINCZ AE, 1960, FED PROC, V19, P148; SOLOMON L, 1963, J BONE JT SURG, VB 45, P292; SOLOMON L, 1961, J BONE JT SURG, VB 43, P700; STOCKS P, 1925, TREASURY HUMAN INHER, V3; TELLER WM, 1962, J LAB CLIN MED, V59, P95; Vanzant BT, 1942, J AMER MED ASSOC, V119, P786, DOI 10.1001/jama.1942.02830270022006	13	131	134	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					351	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14207550				2022-12-18	WOS:A19642973A00007
J	Medina-Gomez, C; Kemp, JP; Trajanoska, K; Luan, JA; Chesi, A; Ahluwalia, TS; Mook-Kanamori, DO; Ham, A; Hartwig, FP; Evans, DS; Joro, R; Nedeljkovic, I; Zheng, HF; Zhu, K; Atalay, M; Liu, CT; Nethander, M; Broer, L; Porleifsson, G; Mullin, BH; Handelman, SK; Nalls, MA; Jessen, LE; Heppe, DHM; Richards, JB; Wang, C; Chawes, B; Schraut, KE; Amin, N; Wareham, N; Karasik, D; Van der Velde, N; Ikram, MA; Zemel, BS; Zhou, YH; Carlsson, CJ; Liu, YM; McGuigan, FE; Boer, CG; Bonnelykke, K; Ralston, SH; Robbins, JA; Walsh, JP; Zillikens, MC; Langenberg, C; Li-Gao, R; Williams, FMK; Harris, TB; Akesson, K; Jackson, RD; Sigurdsson, G; den Heijer, M; van der Eerden, BCJ; van de Peppel, J; Spector, TD; Pennell, C; Horta, BL; Felix, JF; Zhao, JH; Wilson, SG; de Mutsert, R; Bisgaard, H; Styrkarsdottir, U; Jaddoe, VW; Orwoll, E; Lakka, TA; Scott, R; Grant, SFA; Lorentzon, M; van Duijn, CM; Wilson, JF; Stefansson, K; Psaty, BM; Kiel, DP; Ohlsson, C; Ntzani, E; van Wijnen, AJ; Forgetta, V; Ghanbari, M; Logan, JG; Williams, GR; Bassett, JHD; Croucher, PI; Evangelou, E; Uitterlinden, AG; Ackert-Bicknell, CL; Tobias, JH; Evans, DM; Rivadeneira, F				Medina-Gomez, Carolina; Kemp, John P.; Trajanoska, Katerina; Luan, Jian'an; Chesi, Alessandra; Ahluwalia, Tarunveer S.; Mook-Kanamori, Dennis O.; Ham, Annelies; Hartwig, Fernando P.; Evans, Daniel S.; Joro, Raimo; Nedeljkovic, Ivana; Zheng, Hou-Feng; Zhu, Kun; Atalay, Mustafa; Liu, Ching-Ti; Nethander, Maria; Broer, Linda; Porleifsson, Gudmar; Mullin, Benjamin H.; Handelman, Samuel K.; Nalls, Mike A.; Jessen, Leon E.; Heppe, Denise H. M.; Richards, J. Brent; Wang, Carol; Chawes, Bo; Schraut, Katharina E.; Amin, Najaf; Wareham, Nick; Karasik, David; Van der Velde, Nathalie; Ikram, M. Arfan; Zemel, Babette S.; Zhou, Yanhua; Carlsson, Christian J.; Liu, Yongmei; McGuigan, Fiona E.; Boer, Cindy G.; Bonnelykke, Klaus; Ralston, Stuart H.; Robbins, John A.; Walsh, John P.; Zillikens, M. Carola; Langenberg, Claudia; Li-Gao, Ruifang; Williams, Frances M. K.; Harris, Tamara B.; Akesson, Kristina; Jackson, Rebecca D.; Sigurdsson, Gunnar; den Heijer, Martin; van der Eerden, Bram C. J.; van de Peppel, Jeroen; Spector, Timothy D.; Pennell, Craig; Horta, Bernardo L.; Felix, Janine F.; Zhao, Jing Hua; Wilson, Scott G.; de Mutsert, Renee; Bisgaard, Hans; Styrkarsdottir, Unnur; Jaddoe, Vincent W.; Orwoll, Eric; Lakka, Timo A.; Scott, Robert; Grant, Struan F. A.; Lorentzon, Mattias; van Duijn, Cornelia M.; Wilson, James F.; Stefansson, Kari; Psaty, Bruce M.; Kiel, Douglas P.; Ohlsson, Claes; Ntzani, Evangelia; van Wijnen, Andre J.; Forgetta, Vincenzo; Ghanbari, Mohsen; Logan, John G.; Williams, Graham R.; Bassett, J. H. Duncan; Croucher, Peter I.; Evangelou, Evangelos; Uitterlinden, Andre G.; Ackert-Bicknell, Cheryl L.; Tobias, Jonathan H.; Evans, David M.; Rivadeneira, Fernando			Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; LD SCORE REGRESSION; ADIPOGENIC DIFFERENTIATION; GENETIC-DETERMINANTS; POSTMENOPAUSAL WOMEN; HUMAN-DISEASES; KNOCKOUT MICE; VARIANTS; EXPRESSION; BINDING	Bone mineral density (BMD) assessed by DXA is used to evaluate bone health. In children, total body (TB) measurements are commonly used; in older individuals, BMD at the lumbar spine (LS) and femoral neck (FN) is used to diagnose osteoporosis. To date, genetic variants in more than 60 loci have been identified as associated with BMD. To investigate the genetic determinants of TB-BMD variation along the life course and test for age-specific effects, we performed a meta-analysis of 30 genome-wide association studies (GWASs) of TB-BMD including 66,628 individuals overall and divided across five age strata, each spanning 15 years. We identified variants associated with TB-BMD at 80 loci, of which 36 have not been previously identified; overall, they explain approximately 10% of the TB-BMD variance when combining all age groups and influence the risk of fracture. Pathway and enrichment analysis of the association signals showed clustering within gene sets implicated in the regulation of cell growth and SMAD proteins, overexpressed in the musculoskeletal system, and enriched in enhancer and promoter regions. These findings reveal TB-BMD as a relevant trait for genetic studies of osteoporosis, enabling the identification of variants and pathways influencing different bone compartments. Only variants in ESR1 and close proximity to RANKL showed a clear effect dependency on age. This most likely indicates that the majority of genetic variants identified influence BMD early in life and that their effect can be captured throughout the life course.	[Medina-Gomez, Carolina; Trajanoska, Katerina; Ham, Annelies; Broer, Linda; Van der Velde, Nathalie; Boer, Cindy G.; Zillikens, M. Carola; van de Peppel, Jeroen; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Medina-Gomez, Carolina; Heppe, Denise H. M.; Felix, Janine F.; Jaddoe, Vincent W.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands; [Medina-Gomez, Carolina; Trajanoska, Katerina; Nedeljkovic, Ivana; Heppe, Denise H. M.; Amin, Najaf; Ikram, M. Arfan; Felix, Janine F.; Jaddoe, Vincent W.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Kemp, John P.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Kemp, John P.; Evans, David M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Luan, Jian'an; Wareham, Nick; Langenberg, Claudia; Zhao, Jing Hua; Scott, Robert] Univ Cambridge, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Chesi, Alessandra; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Ahluwalia, Tarunveer S.; Jessen, Leon E.; Chawes, Bo; Carlsson, Christian J.; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, DK-2820 Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Mook-Kanamori, Dennis O.; Li-Gao, Ruifang; den Heijer, Martin; de Mutsert, Renee] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2333 ZA Leiden, Netherlands; [Hartwig, Fernando P.] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil; [Evans, Daniel S.] Res Inst, Calif Pacif Med Ctr, San Francisco, CA 94107 USA; [Joro, Raimo; Lakka, Timo A.] Univ Eastern Finland, Inst Biomed Physiol, FIN-70211 Kuopio, Finland; [Zheng, Hou-Feng; Richards, J. Brent; Forgetta, Vincenzo] McGill Univ, Dept Med, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Richards, J. Brent; Forgetta, Vincenzo] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Richards, J. Brent; Forgetta, Vincenzo] McGill Univ, Dept Epidemiol, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Richards, J. Brent; Forgetta, Vincenzo] McGill Univ, Dept Biostat, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Richards, J. Brent; Forgetta, Vincenzo] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada; [Zheng, Hou-Feng] Westlake Univ, Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou 100080, Zhejiang, Peoples R China; [Zheng, Hou-Feng] Hangzhou Normal Univ, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China; [Zheng, Hou-Feng] Hangzhou Normal Univ, Affiliated Hosp, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China; [Zhu, Kun; Mullin, Benjamin H.; Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Zhu, Kun; Mullin, Benjamin H.; Walsh, John P.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Liu, Ching-Ti; Zhou, Yanhua] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02131 USA; [Nethander, Maria] Univ Gothenburg, Sahlgrenska Acad, Bioinformat Core Facil, S-41390 Gothenburg, Sweden; [Porleifsson, Gudmar; Styrkarsdottir, Unnur; Stefansson, Kari] DeCODE Genet Amgen, IS-101 Reykjavik, Iceland; [Handelman, Samuel K.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Nalls, Mike A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Nalls, Mike A.] Data Tecn Int, Glen Echo, MD 20812 USA; [Wang, Carol; Pennell, Craig] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA 6009, Australia; [Schraut, Katharina E.; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH16 4UX, Midlothian, Scotland; [Schraut, Katharina E.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Karasik, David; Kiel, Douglas P.] Inst Aging Res, Hebrew SeniorLife, Roslindale, MA 02131 USA; [Karasik, David] Bar Ilan Univ, Fac Med Galilee, IL-1311502 Safed, Israel; [Van der Velde, Nathalie] Acad Med Ctr, Sect Geriatr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Zemel, Babette S.] Childrens Hosp Philadelphia, Div GI Hepatol & Nutr, Philadelphia, PA 19104 USA; [Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [McGuigan, Fiona E.; Akesson, Kristina] Lund Univ, Dept Clin Sci Malmo, Clin & Mol Osteoporosis Res Unit, S-20502 Malmo, Sweden; [Ralston, Stuart H.] Univ Edinburgh, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Robbins, John A.] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA; [Williams, Frances M. K.; Spector, Timothy D.; Wilson, Scott G.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Harris, Tamara B.] NIH, Lab Epidemiol & Populat Sci, NIA, Bethesda, MD 20892 USA; [Akesson, Kristina] Skane Univ Hosp, Dept Orthoped, S-21428 Malmo, Sweden; [Jackson, Rebecca D.] Ohio State Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Sigurdsson, Gunnar; Stefansson, Kari] Natl Univ Hosp Iceland, Landspitali, Dept Endocrinol & Metab, IS-101 Reykjavik, Iceland; [Sigurdsson, Gunnar] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol, NL-1081 HV Amsterdam, Netherlands; [den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands; [Felix, Janine F.; Jaddoe, Vincent W.] Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Orwoll, Eric] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Lakka, Timo A.] Kuopio Res Inst Exercise Med, Kuopio 70100, Finland; [Lakka, Timo A.] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio 70210, Finland; [Grant, Struan F. A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lorentzon, Mattias] Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Geriatr Med, S-40530 Gothenburg, Sweden; [Wilson, James F.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Kiel, Douglas P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Kiel, Douglas P.] Harvard Med Sch, Boston, MA 02215 USA; [Kiel, Douglas P.] Broad Inst MIT & Harvard, Boston, MA 02115 USA; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, S-41345 Gothenburg, Sweden; [Ntzani, Evangelia; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Ghanbari, Mohsen] Mashhad Univ Med Sci, Sch Med, Dept Genet, Mashhad, Iran; [Logan, John G.; Williams, Graham R.; Bassett, J. H. Duncan] Imperial Coll London, Dept Med, Mol Endocrinol Lab, London W12 0NN, England; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Evangelou, Evangelos] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Ackert-Bicknell, Cheryl L.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Tobias, Jonathan H.] Univ Bristol, Sch Clin Sci, Bristol BS10 5NB, Avon, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Queensland; University of Bristol; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Copenhagen; Steno Diabetes Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Federal de Pelotas; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Eastern Finland; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Westlake University; Hangzhou Normal University; Hangzhou Normal University; University of Western Australia; University of Western Australia; Boston University; University of Gothenburg; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Western Australia; University of Edinburgh; University of Edinburgh; Harvard University; Hebrew SeniorLife; Bar Ilan University; University of Amsterdam; Academic Medical Center Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Wake Forest University; Lund University; University of Edinburgh; University of California System; University of California Davis; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Lund University; Skane University Hospital; University System of Ohio; Ohio State University; Landspitali National University Hospital; University of Iceland; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Oregon Health & Science University; Kuopio University Hospital; University of Eastern Finland; University of Pennsylvania; Pennsylvania Medicine; University of Gothenburg; University of Edinburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Gothenburg; University of Ioannina; Mayo Clinic; Mashhad University Medical Science; Imperial College London; University of London; Queen Mary University London; Garvan Institute of Medical Research; Imperial College London; University of Rochester; University of Bristol	Rivadeneira, F (corresponding author), Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands.; Rivadeneira, F (corresponding author), Erasmus MC, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands.; Rivadeneira, F (corresponding author), Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.	f.rivadeneira@erasmusmc.nl	Jessen, Leon/L-7156-2018; Wilson, James F/A-5704-2009; Horta, Bernardo/A-7604-2008; van de Peppel, Jeroen/K-6683-2019; Hartwig, Fernando/AAG-5578-2020; Carlsson, Christian Jakob/AAK-5022-2020; Ackert-Bicknell, Cheryl/AAC-6833-2019; Ohlsson, Claes/AGP-3544-2022; Mullin, Benjamin/H-5493-2014; Langenberg, Claudia/ABG-9067-2021; Kemp, John P./R-3091-2018; Walsh, John/GQI-2785-2022; Li-Gao, Ruifang/B-7172-2018; Ahluwalia, Tarunveer Singh/C-5549-2009; Pennell, Craig/ABD-6902-2020; van der Eerden, Bram CJ/I-7496-2012; Evans, David M/H-6325-2013; Nedeljkovic, Ivana P/B-3815-2013; Lorentzon, Mattias/W-7878-2019; Medina-Gomez, Carolina/I-1725-2019; Ghanbari, Mohsen/AAH-1340-2020; Boer, Cindy Germaine/I-7314-2019; Evangelou, Evangelos/C-3033-2013; Zheng, Houfeng/K-4424-2012; Rivadeneira, Fernando/O-5385-2015; Ikram, M. Arfan/AAM-5225-2021; van Wijnen, Andre J./AAG-3578-2019; Baillie, John Kenneth/F-3124-2011; Richards, J Brent/AAF-4225-2019; Ntzani, Evangelina E./K-1565-2019; Stefansson, Kari/AAE-7187-2019; Zemel, Babette S./D-1117-2009; Bisgaard, Hans/N-4761-2016; Chesi, Alessandra/AAT-8248-2020; Tobias, Jon/E-2832-2014; den Heijer, Martin/J-8036-2015; Chesi, Alessandra/N-7693-2017	Wilson, James F/0000-0001-5751-9178; Horta, Bernardo/0000-0001-9843-412X; van de Peppel, Jeroen/0000-0002-6524-727X; Carlsson, Christian Jakob/0000-0003-2363-173X; Ackert-Bicknell, Cheryl/0000-0003-4253-4775; Ohlsson, Claes/0000-0002-9633-2805; Langenberg, Claudia/0000-0002-5017-7344; Kemp, John P./0000-0002-9105-2249; Li-Gao, Ruifang/0000-0003-0650-1351; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Pennell, Craig/0000-0002-0937-6165; van der Eerden, Bram CJ/0000-0003-4403-6497; Evans, David M/0000-0003-0663-4621; Lorentzon, Mattias/0000-0003-0749-1431; Medina-Gomez, Carolina/0000-0001-7999-5538; Ghanbari, Mohsen/0000-0002-9476-7143; Boer, Cindy Germaine/0000-0003-4809-0044; Evangelou, Evangelos/0000-0002-5488-2999; Zheng, Houfeng/0000-0001-5681-8598; Rivadeneira, Fernando/0000-0001-9435-9441; van Wijnen, Andre J./0000-0002-4458-0946; Baillie, John Kenneth/0000-0001-5258-793X; Richards, J Brent/0000-0002-3746-9086; Zemel, Babette S./0000-0002-6164-7348; Bisgaard, Hans/0000-0003-4131-7592; Van Duijn, Cornelia/0000-0002-2374-9204; Logan, John/0000-0003-2801-700X; Nethander, Maria/0000-0003-3688-906X; Broer, Linda/0000-0003-0011-123X; Prokic (Nedeljkovic), Ivana/0000-0002-0370-1473; Chawes, Bo/0000-0001-6846-6243; van der Velde, Nathalie/0000-0002-6477-6209; Ntzani, Evangelia/0000-0003-3712-4181; Wilson, Scott/0000-0002-0357-1373; Mullin, Benjamin/0000-0003-0743-770X; Tobias, Jon/0000-0002-7475-3932; Liu, Ching-Ti/0000-0002-0703-0742; Handelman, Samuel/0000-0001-6970-2172; den Heijer, Martin/0000-0003-3620-5617; Croucher, Peter/0000-0002-7102-2413; Bonnelykke, Klaus/0000-0003-2003-1018; Williams, Frances/0000-0002-2998-2744; Trajanoska, Katerina/0000-0002-3792-4296; Jessen, Leon Eyrich/0000-0003-2879-2559; Chesi, Alessandra/0000-0002-0954-7446; Styrkarsdottir, Unnur/0000-0001-8146-8278; Wang, Carol/0000-0002-4301-3974; Walsh, John/0000-0002-1766-2612	Johnson Johnson; Data Tecnica; MRC [MR/N003284/1, MC_UU_12015/1, MC_UU_12013/4, MR/M004422/1] Funding Source: UKRI; Lundbeck Foundation [R163-2013-16235] Funding Source: researchfish; Medical Research Council [G1000143, MC_PC_13048, MR/M004422/1, G0401527, MC_UU_12015/1, MC_PC_13046, MC_UU_12013/4, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135, NF-SI-0617-10149, NF-SI-0512-10114] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005785, NNF14OC0010513] Funding Source: researchfish; Steno Diabetes Center Copenhagen (SDCC) [SDCC 3.A Complications] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, U01HL130114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR066160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027574, R01AG005407] Funding Source: NIH RePORTER	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Data Tecnica; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); Steno Diabetes Center Copenhagen (SDCC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	B.M.P. serves on the DSMB of a clinical trial for the manufacturer (Zoll LifeCor) and on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. U.S., G.P., and K.S. are employed be deCODE genetics/Amgen Inc. M.A.N. is supported by Data Tecnica and also consults for Illumina, Inc. and the Michael J. Fox Foundation.	Albagha OME, 2011, NAT GENET, V43, P685, DOI 10.1038/ng.845; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Boudin E, 2017, J BONE MINER RES, V32, P1739, DOI 10.1002/jbmr.3160; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140; da Silva TC, 2016, J STEROID BIOCHEM, V163, P77, DOI 10.1016/j.jsbmb.2016.04.006; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dobbins DE, 2002, BIOCHEM BIOPH RES CO, V294, P1114, DOI 10.1016/S0006-291X(02)00598-3; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Farr JN, 2015, NAT REV ENDOCRINOL, V11, P513, DOI 10.1038/nrendo.2015.89; Freudenthal B, 2016, J ENDOCRINOL, V231, pR31, DOI 10.1530/JOE-16-0258; Ghanbari M, 2015, CIRC-CARDIOVASC GENE, V8, P473, DOI 10.1161/CIRCGENETICS.114.000968; Ghebre MA, 2011, CALCIFIED TISSUE INT, V89, P295, DOI 10.1007/s00223-011-9518-9; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hayer S, 2005, J EXP MED, V201, P903, DOI 10.1084/jem.20040852; Heilmeier U, 2016, J BONE MINER RES, V31, P2173, DOI 10.1002/jbmr.2897; Hendrickx G, 2015, NAT REV RHEUMATOL, V11, P462, DOI 10.1038/nrrheum.2015.48; Iotchkova V., 2016, BIORXIV; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Koek WNH, 2017, BONE, V95, P108, DOI 10.1016/j.bone.2016.11.010; Koller DL, 2013, J BONE MINER RES, V28, P547, DOI 10.1002/jbmr.1796; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li V, 2004, IN VIVO, V18, P517; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; Miyaura C, 2001, BIOCHEM BIOPH RES CO, V280, P1062, DOI 10.1006/bbrc.2001.4246; Moayyeri A, 2014, HUM MOL GENET, V23, P3054, DOI 10.1093/hmg/ddt675; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P3083, DOI 10.1002/art.38787; Nielson CM, 2016, J BONE MINER RES, V31, P2085, DOI 10.1002/jbmr.2913; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; Ousingsawat J, 2015, J BIOL CHEM, V290, P6270, DOI 10.1074/jbc.M114.602979; Paternoster L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003247; Pei YF, 2016, OSTEOPOROSIS INT, V27, P3343, DOI 10.1007/s00198-016-3663-y; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Ryan ZC, 2015, BIOCHEM BIOPH RES CO, V467, P152, DOI 10.1016/j.bbrc.2015.09.087; Sekiya H, 2010, J BONE MINER METAB, V28, P384, DOI 10.1007/s00774-009-0142-y; Shy BR, 2013, CELL REP, V4, P1, DOI 10.1016/j.celrep.2013.06.001; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Soung DY, 2014, MOL ENDOCRINOL, V28, P546, DOI 10.1210/me.2013-1305; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Styrkarsdottir U, 2016, J BONE MINER RES, V31, P173, DOI 10.1002/jbmr.2604; Styrkarsdottir U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10129; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tenne M, 2013, OSTEOPOROSIS INT, V24, P1419, DOI 10.1007/s00198-012-2048-0; Tijchon E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131481; Tsukamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07596; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; van de Peppel J, 2017, STEM CELL REP, V8, P947, DOI 10.1016/j.stemcr.2017.02.018; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Winkler TW, 2015, BIOINFORMATICS, V31, P259, DOI 10.1093/bioinformatics/btu621; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wu QT, 2007, CHEM RES CHINESE U, V23, P297, DOI 10.1016/S1005-9040(07)60063-4; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang TL, 2012, OSTEOPOROSIS INT, V23, P781, DOI 10.1007/s00198-011-1626-x; Zhai GJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002025; Zhang L, 2014, HUM MOL GENET, V23, P1923, DOI 10.1093/hmg/ddt575; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	71	130	135	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					88	102		10.1016/j.ajhg.2017.12.005	http://dx.doi.org/10.1016/j.ajhg.2017.12.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304378	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000419305500007
J	Acuna-Hidalgo, R; Sengul, H; Steehouwer, M; van de Vorst, M; Vermeulen, SH; Kiemeney, LALM; Veltman, JA; Gilissen, C; Hoischen, A				Acuna-Hidalgo, Rocio; Sengul, Hilal; Steehouwer, Marloes; van de Vorst, Maartje; Vermeulen, Sita H.; Kiemeney, Lambertus A. L. M.; Veltman, Joris A.; Gilissen, Christian; Hoischen, Alexander			Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; MOLECULAR INVERSION PROBES; BOHRING-OPITZ SYNDROME; AGE-RELATED MUTATIONS; SOMATIC MUTATIONS; STEM-CELLS; MYELOMONOCYTIC LEUKEMIA; CLINICAL-RELEVANCE; HUMAN-DISEASE; DNA-DAMAGE	Clonal hematopoiesis results from somatic mutations in hematopoietic stem cells, which give an advantage to mutant cells, driving their clonal expansion and potentially leading to leukemia. The acquisition of clonal hematopoiesis-driver mutations (CHDMs) occurs with normal aging and these mutations have been detected in more than 10% of individuals >= 65 years. We aimed to examine the prevalence and characteristics of CHDMs throughout adult life. We developed a targeted re-sequencing assay combining high-throughput with ultra-high sensitivity based on single-molecule molecular inversion probes (smMIPs). Using smMIPs, we screened more than 100 loci for CHDMs in more than 2,000 blood DNA samples from population controls between 20 and 69 years of age. Loci screened included 40 regions known to drive clonal hematopoiesis when mutated and 64 novel candidate loci. We identified 224 somatic mutations throughout our cohort, of which 216 were coding mutations in known driver genes (DNMT3A, JAK2, GNAS, TET2, and ASXL1), including 196 point mutations and 20 indels. Our assay's improved sensitivity allowed us to detect mutations with variant allele frequencies as low as 0.001. CHDMs were identified in more than 20% of individuals 60 to 69 years of age and in 3% of individuals 20 to 29 years of age, approximately double the previously reported prevalence despite screening a limited set of loci. Our findings support the occurrence of clonal hematopoiesis-associated mutations as a widespread mechanism linked with aging, suggesting that mosaicism as a result of clonal evolution of cells harboring somatic mutations is a universal mechanism occurring at all ages in healthy humans.	[Acuna-Hidalgo, Rocio; Sengul, Hilal; Steehouwer, Marloes; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands; [van de Vorst, Maartje; Veltman, Joris A.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Neurosci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands; [Vermeulen, Sita H.; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6500 HB Nijmegen, Netherlands; [Veltman, Joris A.] Newcastle Univ, Int Ctr Life, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Newcastle University - UK; Radboud University Nijmegen; Radboud University Nijmegen	Hoischen, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.; Hoischen, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands.; Hoischen, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6500 HB Nijmegen, Netherlands.	alexander.hoischen@radboudumc.nl	Gilissen, Christian/E-5246-2012; Kiemeney, Lambertus A./D-3357-2009; Vermeulen, Sita H./L-4716-2015; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/AGF-7293-2022; Hoischen, Alexander/D-1282-2013	Gilissen, Christian/0000-0003-1693-9699; Kiemeney, Lambertus A./0000-0002-2368-1326; Vermeulen, Sita H./0000-0003-4913-8601; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476	Netherlands Organisation for Scientific Research [918-15-667]; European Research Council (ERC) [DENOVO 281964]; Radboudumc PhD grant	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Radboudumc PhD grant	The Nijmegen Biomedical Study is a population-based survey conducted at the Department for Health Evidence and the Department of Laboratory Medicine of the Radboud University Medical Center. Principal investigators of the Nijmegen Biomedical Study are L.A.L.M.K., A.L.M. Verbeek, D.W. Swinkels, and B. Franke. We thank the members of the Radboud Genomics Technology Center for their technical support in DNA normalization and sequencing. This work was in part financially supported by grants from the Netherlands Organisation for Scientific Research (918-15-667 to J.A.V.) and the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.). R.A.-H. was supported by a Radboudumc PhD grant.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Akunuru S, 2016, TRENDS MOL MED, V22, P701, DOI 10.1016/j.molmed.2016.06.003; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Carlston CM, 2017, HUM MUTAT, V38, P517, DOI 10.1002/humu.23203; Champion KJ, 2011, CLIN GENET, V79, P468, DOI 10.1111/j.1399-0004.2010.01495.x; Chaudhury SS, 2015, EXP HEMATOL, V43, P745, DOI 10.1016/j.exphem.2015.05.008; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Choi SK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002420; Corces-Zimmerman MR, 2014, LEUKEMIA, V28, P2276, DOI 10.1038/leu.2014.211; Eijkelenboom A, 2016, J MOL DIAGN, V18, P851, DOI 10.1016/j.jmoldx.2016.06.010; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Galesloot TE, 2017, INT J EPIDEMIOL, V46, P1099, DOI 10.1093/ije/dyw268; Gao ZY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002355; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Giannoulatou E, 2013, P NATL ACAD SCI USA, V110, P20152, DOI 10.1073/pnas.1311381110; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kosaki R, 2017, AM J MED GENET A, V173, P250, DOI 10.1002/ajmg.a.37995; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Link DC, 2016, LEUKEMIA, V30, P1633, DOI 10.1038/leu.2016.130; Maher GJ, 2016, P NATL ACAD SCI USA, V113, P2454, DOI 10.1073/pnas.1521325113; Mancini M, 2015, J MOL DIAGN, V17, P179, DOI 10.1016/j.jmoldx.2014.10.003; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Martinelli S, 2010, AM J HUM GENET, V87, P250, DOI 10.1016/j.ajhg.2010.06.015; Mason CC, 2016, LEUKEMIA, V30, P906, DOI 10.1038/leu.2015.337; McKerrell T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4428; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; McRae J. F., 2016, BIORXIV; Moehrle BM, 2016, EXP HEMATOL, V44, P895, DOI 10.1016/j.exphem.2016.06.253; Neveling K, 2017, CLIN CHEM, V63, P503, DOI 10.1373/clinchem.2016.263897; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; RAMSEY MJ, 1995, MUTAT RES-DNAGING G, V338, P95, DOI 10.1016/0921-8734(95)00015-X; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; Shlush LI, 2015, INT J HEMATOL, V102, P513, DOI 10.1007/s12185-015-1870-5; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takahashi K, 2017, LANCET ONCOL, V18, P100, DOI 10.1016/S1470-2045(16)30626-X; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Weren RDA, 2017, HUM MUTAT, V38, P226, DOI 10.1002/humu.23137; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yadav VK, 2016, NUCLEIC ACIDS RES, V44, P2075, DOI 10.1093/nar/gkw086; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yoon SR, 2013, AM J HUM GENET, V92, P917, DOI 10.1016/j.ajhg.2013.05.001; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484	64	130	132	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					50	64		10.1016/j.ajhg.2017.05.013	http://dx.doi.org/10.1016/j.ajhg.2017.05.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28669404	Green Published, Bronze			2022-12-18	WOS:000404886800004
J	Jarvik, GP; Browning, BL				Jarvik, Gail P.; Browning, Brian L.			Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIANTS	The American College of Medical Genetics and Genomics (ACMG) and Association of Molecular Pathology (AMP) recently published important new guidelines aiming to improve and standardize the pathogenicity classification of genomic variants. The Clinical Sequencing Exploratory Research (CSER) consortium evaluated the use of these guidelines across nine laboratories. One identified obstacle to consistent usage of the ACMG-AMP guidelines is the lack of a definition of cosegregation as criteria for pathogenicity classification. Cosegregation data differ from many other types of pathogenicity data in being quantitative. However, the ACMG-AMP guidelines do not define quantitative criteria for use of these data. Here, such quantitative criteria, in an easily implementable form, are proposed.	[Jarvik, Gail P.; Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.; Browning, Brian L.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jarvik, GP (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.; Jarvik, GP (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	pair@u.washington.edu	Browning, Brian L/A-1178-2010	Browning, Brian L/0000-0001-6454-6633	NIH [U01 HG006507, U01 HG007307, U01HG008657, R01 HG008359]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008657, U01HG006507, R01HG008359, U01HG007307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants U01 HG006507, U01 HG007307, U01HG008657, and R01 HG008359. The authors thank the journals Genetics in Medicine and Experimental and Molecular Pathology for permission to reprint and adapt the figures, Dr. Heidi L. Rehm for providing the original figure adapted for Figure 1, and Dr. Adam S. Gordon for helpful comments.	Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Bayrak-Toydemir P, 2008, EXP MOL PATHOL, V85, P45, DOI 10.1016/j.yexmp.2008.03.006; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100	6	130	131	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1077	1081		10.1016/j.ajhg.2016.04.003	http://dx.doi.org/10.1016/j.ajhg.2016.04.003			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236918	Bronze, Green Published			2022-12-18	WOS:000377286000003
J	Riviere, JB; Ramalingam, S; Lavastre, V; Shekarabi, M; Holbert, S; Lafontaine, J; Srour, M; Merner, N; Rochefort, D; Hince, P; Gaudet, R; Mes-Masson, AM; Baets, J; Houlden, H; Brais, B; Nicholson, GA; Van Esch, H; Nafissi, S; De Jonghe, P; Reilly, MM; Timmerman, V; Dion, PA; Rouleau, GA				Riviere, Jean-Baptiste; Ramalingam, Siriram; Lavastre, Valerie; Shekarabi, Masoud; Holbert, Sebastien; Lafontaine, Julie; Srour, Myriam; Merner, Nancy; Rochefort, Daniel; Hince, Pascale; Gaudet, Rebecca; Mes-Masson, Anne-Marie; Baets, Jonathan; Houlden, Henry; Brais, Bernard; Nicholson, Garth A.; Van Esch, Hilde; Nafissi, Shahriar; De Jonghe, Peter; Reilly, Mary M.; Timmerman, Vincent; Dion, Patrick A.; Rouleau, Guy A.			KIF1A, an Axonal Transporter of Synaptic Vesicles, Is Mutated in Hereditary Sensory and Autonomic Neuropathy Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERINE PALMITOYLTRANSFERASE; GENE; MUTATIONS; PROTEIN; KINESIN; BINDING; EXPRESSION; RECEPTOR; SUBUNIT; ELEGANS	Hereditary sensory and autonomic neuropathy type II (HSANII) is a rare autosomal-recessive disorder characterized by peripheral nerve degeneration resulting in a severe distal sensory loss. Although mutations in FAM134B and the HSN2 exon of WNK1 were associated with HSANII, the etiology of a substantial number of cases remains unexplained. In addition, the functions of WNK1/HSN2 and FAM134B and their role in the peripheral nervous system remain poorly understood. Using a yeast two-hybrid screen, we found that KIF1A, an axonal transporter of synaptic vesicles, interacts with the domain encoded by the HSN2 exon. In parallel to this screen, we performed genome-wide homozygosity mapping in a consanguineous Afghan family affected by HSANII and identified a unique region of homozygosity located on chromosome 2q37.3 and spanning the KIF1A gene locus. Sequencing of KIF1A in this family revealed a truncating mutation segregating with the disease phenotype. Subsequent sequencing of KIF1A in a series of 112 unrelated patients with features belonging to the clinical spectrum of ulcero-mutilating sensory neuropathies revealed truncating mutations in three additional families, thus indicating that mutations in KIF1A are a rare cause of HSANII. Similarly to WNK1 mutations, pathogenic mutations in KIF1A were almost exclusively restricted to an alternatively spliced exon. This study provides additional insights into the molecular pathogenesis of HSANII and highlights the potential biological relevance of alternative splicing in the peripheral sensory nervous system.	[Riviere, Jean-Baptiste; Ramalingam, Siriram; Lavastre, Valerie; Shekarabi, Masoud; Holbert, Sebastien; Srour, Myriam; Merner, Nancy; Rochefort, Daniel; Hince, Pascale; Gaudet, Rebecca; Brais, Bernard; Dion, Patrick A.; Rouleau, Guy A.] Ctr Excellence Neurom, Montreal, PQ H2L 2W5, Canada; [Lafontaine, Julie; Mes-Masson, Anne-Marie] Ctr Hosp Univ Montreal, Res Ctr, Inst Canc Montreal, Montreal, PQ H2L 2W5, Canada; [Riviere, Jean-Baptiste; Ramalingam, Siriram; Lavastre, Valerie; Shekarabi, Masoud; Holbert, Sebastien; Srour, Myriam; Merner, Nancy; Rochefort, Daniel; Hince, Pascale; Gaudet, Rebecca; Brais, Bernard; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 2W5, Canada; [Baets, Jonathan; De Jonghe, Peter; Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, B-2650 Edegem, Belgium; [Houlden, Henry; Reilly, Mary M.] UCL, Inst Neurol, Dept Mol Neurosci, Ctr Neuromuscular Dis,MRC, London WC1N 3BG, England; [Nicholson, Garth A.] Concord Hosp, Australian & New Zealand Army Corps Res Inst, Northcott Neurosci Lab, Sydney, NSW 2139, Australia; [Van Esch, Hilde] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Nicholson, Garth A.] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [Nafissi, Shahriar] Univ Tehran Med Sci, Shariati Hosp, Dept Neurol, Tehran 14114, Iran; [Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of London; University College London; Concord Repatriation General Hospital; KU Leuven; University of Sydney; Tehran University of Medical Sciences; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Rouleau, GA (corresponding author), Ctr Excellence Neurom, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	nafissi, shahriar/A-1839-2013; Van+Esch, Hilde/AAU-5688-2020; Nafissi, Shahriar/AAX-9954-2020; Houlden, Henry J/C-1532-2008; Timmerman, Vincent/O-7283-2019; Nafissi, Shahriar/AAS-1597-2020; Brais, Bernard/Y-3910-2019	Nafissi, Shahriar/0000-0003-4763-4310; Houlden, Henry J/0000-0002-2866-7777; Timmerman, Vincent/0000-0002-2162-0933; Reilly, Mary/0000-0003-0686-905X; Nicholson, Garth/0000-0001-9694-066X; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Van Esch, Hilde/0000-0002-9604-5726; Merner, Nancy/0000-0002-8954-0155	Canadian Institutes of Health Research [179251]; Reseau de Medecine Genetique Applique; Association de la Neuropathie Sensorielle et Autonomique Hereditaire de; Fund for Scientific Research (FWO-Flanders); University of Antwerp; Medical Foundation Queen Elisabeth; Association Beige contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office [P6/43]; Medical Research Council [G1001253, G0802760, G108/638, G0601943] Funding Source: researchfish; MRC [G1001253, G0802760, G0601943, G108/638] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique Applique; Association de la Neuropathie Sensorielle et Autonomique Hereditaire de; Fund for Scientific Research (FWO-Flanders)(FWO); University of Antwerp; Medical Foundation Queen Elisabeth; Association Beige contre les Maladies Neuromusculaires; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the patients for their contribution to this study. We thank Dr. R.M. King and Prof. Claus for their assistance with this project. J.-B.R. is the recipient of a Canadian Institutes of Health Research scholarship; V.L. and N.M. are the recipients of a Claude Laberge fellowship from the Reseau de Medecine Genetique Applique; B.B. was funded by the Association de la Neuropathie Sensorielle et Autonomique Hereditaire de Type 2; G.A.R. was funded by a Canadian Institutes of Health Research grant (#179251). J.B. is supported by a PhD fellowship from the Fund for Scientific Research (FWO-Flanders). Granting The work of the Antwerp-Belgian team was in part funded by the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth, the Association Beige contre les Maladies Neuromusculaires, and the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office.	AXELROD FB, 2002, CLIN AUTON RES S1, V12, P12; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; HILZ MJ, 2002, CLIN AUTON RES S1, V12, P133; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Lafreniere RG, 2004, AM J HUM GENET, V74, P1064, DOI 10.1086/420795; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; MURRAY TJ, 1973, BRAIN, V96, P387, DOI 10.1093/brain/96.2.387; OHTA M, 1973, ARCH NEUROL-CHICAGO, V29, P23, DOI 10.1001/archneur.1973.00490250041005; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roddier K, 2005, NEUROLOGY, V64, P1762, DOI 10.1212/01.WNL.0000161849.29944.43; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431	29	130	133	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					219	230		10.1016/j.ajhg.2011.06.013	http://dx.doi.org/10.1016/j.ajhg.2011.06.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21820098	Bronze, Green Published			2022-12-18	WOS:000294148800002
J	Pippucci, T; Savoia, A; Perrotta, S; Pujol-Moix, N; Noris, P; Castegnaro, G; Pecci, A; Gnan, C; Punzo, F; Marconi, C; Gherardi, S; Loffredo, G; De Rocco, D; Scianguetta, S; Barozzi, S; Magini, P; Bozzi, V; Dezzani, L; Di Stazio, M; Ferraro, M; Perini, G; Seri, M; Balduini, CL				Pippucci, Tommaso; Savoia, Anna; Perrotta, Silverio; Pujol-Moix, Nuria; Noris, Patrizia; Castegnaro, Giovanni; Pecci, Alessandro; Gnan, Chiara; Punzo, Francesca; Marconi, Caterina; Gherardi, Samuele; Loffredo, Giuseppe; De Rocco, Daniela; Scianguetta, Saverio; Barozzi, Serena; Magini, Pamela; Bozzi, Valeria; Dezzani, Luca; Di Stazio, Mariateresa; Ferraro, Marcella; Perini, Giovanni; Seri, Marco; Balduini, Carlo L.			Mutations in the 5 ' UTR of ANKRD26, the Ankirin Repeat Domain 26 Gene, Cause an Autosomal-Dominant Form of Inherited Thrombocytopenia, THC2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; MATURATION; PROTEINS; MAPS	THC2, an autosomal-dominant thrombocytopenia described so far in only two families, has been ascribed to mutations in MASTL or ACBD5. Here, we show that ANKRD26, another gene within the THC2 locus, and neither MASTL nor ACBD5, is mutated in eight unrelated families. ANKRD26 was also found to be mutated in the family previously reported to have an ACBD5 mutation. We identified six different ANKRD26 mutations, which were clustered in a highly conserved 19 bp sequence located in the 5' untranslated region. Mutations were not detected in 500 controls and are absent from the 1000 Genomes database. Available data from an animal model and Dr. Watson's genome give evidence against haploinsufficiency as the pathogenetic mechanism for ANKRD26-mediated thrombocytopenia. The luciferase reporter assay suggests that these 5' UTR mutations might enhance ANKRD26 expression. ANKRD26 is the ancestor of a family of primate-specific genes termed POTE, which have been recently identified as a family of proapoptotic proteins. Dysregulation of apoptosis might therefore be the pathogenetic mechanism, as demonstrated for another thrombocytopenia, THC4. Further investigation is needed to provide evidence supporting this hypothesis.	[Pippucci, Tommaso; Castegnaro, Giovanni; Marconi, Caterina; Magini, Pamela; Seri, Marco] Univ Bologna, Med Genet Unit, Dept Gynaecol Obstet & Paediat Sci, I-40138 Bologna, Italy; [Savoia, Anna; Gnan, Chiara; Di Stazio, Mariateresa] Univ Trieste, Dept Reprod & Dev Sci & Publ Med Sci, I-34121 Trieste, Italy; [Savoia, Anna; De Rocco, Daniela] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Genet Lab, Inst Maternal & Child Hlth, I-34121 Trieste, Italy; [Perrotta, Silverio; Punzo, Francesca; Scianguetta, Saverio; Ferraro, Marcella] Univ Naples 2, Dept Paediat, I-80138 Naples, Italy; [Pujol-Moix, Nuria] Univ Autonoma Barcelona, Barcelona 08025, Spain; [Pujol-Moix, Nuria] Hosp Santa Creu & Sant Pau, Platelet Pathol Unit, Barcelona 08025, Spain; [Noris, Patrizia; Pecci, Alessandro; Barozzi, Serena; Bozzi, Valeria; Dezzani, Luca; Balduini, Carlo L.] Univ Pavia, Dept Internal Med, Ist Ricovero & Cura Carattere Sci, Policlin San Matteo Fdn, I-27100 Pavia, Italy; [Punzo, Francesca] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Gherardi, Samuele; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Loffredo, Giuseppe] Pausilipon Hosp, Azienda Santobono Pausilipon, Dept Oncol, I-80122 Naples, Italy	University of Bologna; University of Trieste; IRCCS Burlo Garofolo; Universita della Campania Vanvitelli; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; IRCCS Fondazione San Matteo; University of Pavia; Erasmus University Rotterdam; Erasmus MC; University of Bologna	Seri, M (corresponding author), Univ Bologna, Med Genet Unit, Dept Gynaecol Obstet & Paediat Sci, I-40138 Bologna, Italy.	marco.seri@unibo.it	marconi, caterina/K-8553-2016; Pecci, Alessandro/E-9288-2012; Savoia, Anna/B-6463-2014; marconi, caterina/GSM-9919-2022; Barozzi, Serena/J-4821-2016; Bozzi, Valeria/K-7569-2016; marconi, caterina/B-5385-2014; Savoia, Anna/AIC-4560-2022; Balduini, Carlo L/D-9299-2015; De Rocco, Daniela/K-6753-2016; Pippucci, Tommaso/M-8124-2019; Magini, Pamela/K-4508-2016; Seri, Marco/A-4339-2014	marconi, caterina/0000-0002-1210-3969; Pecci, Alessandro/0000-0001-9202-7013; Savoia, Anna/0000-0002-2407-2696; Barozzi, Serena/0000-0002-5622-739X; Bozzi, Valeria/0000-0002-1054-6491; marconi, caterina/0000-0002-1210-3969; Savoia, Anna/0000-0002-2407-2696; Balduini, Carlo L/0000-0001-6121-9311; De Rocco, Daniela/0000-0002-4536-9798; Magini, Pamela/0000-0002-1752-9977; Perrotta, Silverio/0000-0001-6149-6845; Seri, Marco/0000-0003-2425-2176; Noris, Patrizia/0000-0002-5035-3707	Comitato Telethon Fondazione Onlus [GGP10089]; IRCCS Burlo Garofolo [39/09]; Italian ISS (Istituto Superiore di Sanita); "Francesco Fede" Department of the Second University of Naples	Comitato Telethon Fondazione Onlus(Fondazione Telethon); IRCCS Burlo Garofolo; Italian ISS (Istituto Superiore di Sanita); "Francesco Fede" Department of the Second University of Naples	We thank all patients and their families for participating in the project. We gratefully acknowledge the Comitato Telethon Fondazione Onlus (grant number GGP10089), the IRCCS Burlo Garofolo (Grant Ricerca Corrente 39/09), the Italian ISS (Istituto Superiore di Sanita; Italian/USA Grant on Rare Diseases) and the "Francesco Fede" Department of the Second University of Naples (Grant on Normal and Pathological Hematopoiesis) for financial support of this study. We are grateful to Kerry Rhoden for helpful discussion about the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Balduini CL, 2004, SEMIN THROMB HEMOST, V30, P513, DOI 10.1055/s-2004-835672; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Deutsch V, 2000, BRIT J HAEMATOL, V111, P1180, DOI 10.1046/j.1365-2141.2000.02476.x; Drachman JG, 2000, BLOOD, V96, P118, DOI 10.1182/blood.V96.1.118.013k37_118_125; Gandhi MJ, 2003, HUM HERED, V55, P66, DOI 10.1159/000071812; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Noris P, 2004, HAEMATOLOGICA, V89, P1219; Nurden AT, 2007, HAEMATOLOGICA, V92, P1158, DOI 10.3324/haematol.11256; Punzo F, 2010, J THROMB HAEMOST, V8, P2085, DOI 10.1111/j.1538-7836.2010.03979.x; Savoia A, 1999, AM J HUM GENET, V65, pA101; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; van der Vuurst H, 1998, THROMB HAEMOSTASIS, V79, P1014; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	17	130	131	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					115	120		10.1016/j.ajhg.2010.12.006	http://dx.doi.org/10.1016/j.ajhg.2010.12.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21211618	Green Published, Bronze			2022-12-18	WOS:000286501500012
J	Green, P; Wiseman, M; Crow, YJ; Houlden, H; Riphagen, S; Lin, JP; Raymond, FL; Childs, AM; Sheridan, E; Edwards, S; Josifova, DJ				Green, Peter; Wiseman, Matthew; Crow, Yanick J.; Houlden, Henry; Riphagen, Shelley; Lin, Jean-Pierre; Raymond, F. Lucy; Childs, Anne-Marie; Sheridan, Eamonn; Edwards, Sian; Josifova, Dragana J.			Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VANLAERE SYNDROME; IDENTIFICATION	Brown-Vialetto-Van Laere syndrome is a rare neurological disorder with a variable age at onset and clinical course. The key features are progressive ponto-bulbar palsy and bilateral sensorineural deafness. A complex neurological phenotype with a mixed picture of upper and lower motor neuron involvement reminiscent of amyotrophic lateral sclerosis evolves with disease progression. We identified a candidate gene, C20orf54, by studying a consanguineous family with multiple affected individuals and subsequently demonstrated that mutations in this gene were the cause of disease in other, unrelated families.	[Josifova, Dragana J.] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Green, Peter; Wiseman, Matthew; Edwards, Sian] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Crow, Yanick J.] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Houlden, Henry] Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Riphagen, Shelley] St Thomas Hosp, Evelina Childrens Hosp, Paediat Intens Care Unit, London SE1 7EH, England; [Lin, Jean-Pierre] St Thomas Hosp, Evelina Childrens Hosp, Dept Paediat Neurol, London SE1 7EH, England; [Raymond, F. Lucy] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Childs, Anne-Marie] Gen Infirm, Leeds Teaching Hosp HNS, Dept Paediat Neurol, Leeds LS1 3EX, W Yorkshire, England; [Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Mol Med, Genet Sect, Leeds LS9 7TF, W Yorkshire, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Manchester; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leeds General Infirmary; Saint James's University Hospital; University of Leeds	Josifova, DJ (corresponding author), Guys Hosp, Dept Clin Genet, London SE1 9RT, England.	dragana.josifova@gstt.nhs.uk	Houlden, Henry J/C-1532-2008; Crow, Yanick J/N-6120-2014; Lin, Jean-Pierre/R-3779-2019	Houlden, Henry J/0000-0002-2866-7777; Crow, Yanick J/0000-0001-7211-7564; Lin, Jean-Pierre/0000-0001-9314-2259	Department of Health via the National Institute for Health Research (NIHR); Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Evelina Charity; Medical Research Council [G0802760] Funding Source: researchfish; MRC [G0802760] Funding Source: UKRI	Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Evelina Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We also thank Evelina Charity for funding this research. The authors are extremely grateful to patients and families for the use of genetic samples and clinical information. The authors would like to thank Lucy Feng, Dubowitz Neuromuscular Centre, London, and Gladys Kramer and Alicia Chan, Medical Genetics, Edmonton, Canada, for providing specimens. They Would also like to thank all of file clinicians for contributing samples not included in the current manuscript.	Brown CH, 1894, J NERV MENT DIS, V21, P707, DOI [10.1097/00005053-189411000-00003, DOI 10.1097/00005053-189411000-00003]; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Dipti S, 2005, BRAIN DEV-JPN, V27, P443, DOI 10.1016/j.braindev.2004.10.003; GALLAI V, 1981, J NEUROL SCI, V50, P259, DOI 10.1016/0022-510X(81)90172-6; HAWKINS SA, 1990, J MED GENET, V27, P176, DOI 10.1136/jmg.27.3.176; JORNS MS, 1987, BIOCHEMISTRY-US, V26, P6810, DOI 10.1021/bi00395a034; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Megarbane A, 2000, AM J MED GENET, V92, P117, DOI 10.1002/(SICI)1096-8628(20000515)92:2<117::AID-AJMG7>3.0.CO;2-C; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; VANLAERE J, 1966, REV NEUROL, V115, P289; Vialetto E, 1936, RIV SPER FRENIATR, V40, P1; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181	15	130	136	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					485	489		10.1016/j.ajhg.2010.02.006	http://dx.doi.org/10.1016/j.ajhg.2010.02.006			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206331	Green Published, Bronze			2022-12-18	WOS:000275678800021
J	Tsaousidou, MK; Ouahchi, K; Warner, TT; Yang, Y; Simpson, MA; Laing, NG; Wilkinson, PA; Madrid, RE; Patel, H; Hentati, F; Patton, MA; Hentati, A; Lamont, PJ; Siddique, T; Crosby, AH				Tsaousidou, Maria K.; Ouahchi, Karim; Warner, Tom T.; Yang, Yi; Simpson, Michael A.; Laing, Nigel G.; Wilkinson, Philip A.; Madrid, Ricardo E.; Patel, Heema; Hentati, Faycal; Patton, Michael A.; Hentati, Afif; Lamont, Philippa J.; Siddique, Teepu; Crosby, Andrew H.			Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OXYSTEROL 7-ALPHA-HYDROXYLASE GENE; FAMILIAL SPASTIC PARAPLEGIA; 7 ALPHA-HYDROXYLASE; BILE-ACID; CRITICAL REGION; LOCUS; DISRUPTION; METABOLISM; MICE; DEHYDROEPIANDROSTERONE	The hereditary spastic paraplegias (HSPs) are a genetically and clinically heterogeneous group of upper-motor-neuron degenerative diseases characterized by selective axonal loss in the corticospinal tracts and dorsal columns. Although numerous mechanisms involving defective subcellular transportation, mitochondrial malfunction, and increased oxidative stress have been proposed, the pathogenic basis underlying the neuronal loss is unknown. We have performed linkage analysis to refine the extent of the SPG5 disease locus and conducted sequence analysis of the genes located within this region. This identified sequence alterations in the cytochrome P450-7B1 (CYP7B1) associated with this pure form of HSP. In the liver, CYP7B1 offers an alternative pathway for cholesterol degradation and also provides the primary metabolic route for the modification of dehydroepiandrosterone neurosteroids in the brain. These findings provide the first direct evidence of a pivotal role of altered cholesterol metabolism in the pathogenesis of motor-neuron degenerative disease and identify a potential for therapeutic intervention in this form of HSP.	[Tsaousidou, Maria K.; Simpson, Michael A.; Wilkinson, Philip A.; Patel, Heema; Patton, Michael A.; Crosby, Andrew H.] St Georges Univ London, London SW17 0RE, England; [Ouahchi, Karim; Yang, Yi; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurol Sci, Chicago, IL 60611 USA; [Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Cell & Mol Biol, Chicago, IL 60611 USA; [Warner, Tom T.; Wilkinson, Philip A.] Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Laing, Nigel G.; Lamont, Philippa J.] Univ Western Australia, Med Res Ctr, QEII Med Ctr, Nedlands, WA 6009, Australia; [Madrid, Ricardo E.] New York State Inst Basic Res Dev Disabil, George A Jervis Clin, Staten Isl, NY 10314 USA; [Hentati, Faycal] Inst Natl Neurol, Tunis 1007, Tunisia; [Hentati, Afif] Dept Neurol, Evanston, IL 60201 USA	St Georges University London; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of London; University College London; University of Western Australia; Institute for Basic Research in Developmental Disabilities; Universite de Tunis-El-Manar; Institut National de Neurologie	Crosby, AH (corresponding author), St Georges Univ London, London SW17 0RE, England.	acrosby@sgul.ac.uk	Crosby, Andrew H/E-2218-2015; Siddique, Teepu/AAT-8166-2021; Simpson, Michael/F-4737-2011; Warner, Thomas T/A-1454-2013	Crosby, Andrew H/0000-0003-3667-9054; Simpson, Michael/0000-0002-8539-8753; Warner, Thomas T/0000-0001-6195-6995; Siddique, Teepu/0000-0001-7293-9146; Laing, Nigel/0000-0001-5111-3732	MRC [G0600983] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046535, R01NS050641] Funding Source: NIH RePORTER; Medical Research Council [G0600983] Funding Source: Medline; NIEHS NIH HHS [R01 ES014469, ES014469] Funding Source: Medline; NINDS NIH HHS [R01 NS046535, NS046535, R01 NS050641, NS050641] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Boadu E, 2006, J BIOL CHEM, V281, P37081, DOI 10.1074/jbc.M606890200; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; Clayton PT, 2002, J INHERIT METAB DIS, V25, P501, DOI 10.1023/A:1021211520034; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; HARDING AE, 1983, LANCET, V1, P1151; Heinzlef O, 1998, J MED GENET, V35, P89, DOI 10.1136/jmg.35.2.89; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Klebe S, 2007, AM J MED GENET B, V144B, P854, DOI 10.1002/ajmg.b.30518; Lathe R, 2002, GENETICS STEROID BIO, P405; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Moghadasian MH, 2004, CLIN INVEST MED, V27, P42; Muglia M, 2004, NEUROGENETICS, V5, P49, DOI 10.1007/s10048-003-0167-7; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; Porter FD, 2003, CURR OPIN PEDIATR, V15, P607, DOI 10.1097/00008480-200312000-00011; Pringle AK, 2003, EUR J NEUROSCI, V18, P117, DOI 10.1046/j.1460-9568.2003.02734.x; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Ravindranath V, 1995, TOXICOL LETT, V82-3, P633, DOI 10.1016/0378-4274(95)03508-7; Ribai P, 2006, J NEUROL, V253, P714, DOI 10.1007/s00415-006-0094-2; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Sugama S, 2001, J INHERIT METAB DIS, V24, P379, DOI 10.1023/A:1010564920930; Trap C, 2005, J NEUROIMMUNOL, V159, P41, DOI 10.1016/j.jneuroim.2004.09.019; Wilkinson PA, 2003, NEUROLOGY, V61, P235, DOI 10.1212/01.WNL.0000069920.42968.8D; Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X	35	130	135	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					510	515		10.1016/j.ajhg.2007.10.001	http://dx.doi.org/10.1016/j.ajhg.2007.10.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252231	Green Published, Bronze			2022-12-18	WOS:000253223900023
J	Khateeb, S; Flusser, H; Ofir, R; Shelef, I; Narkis, G; Vardi, G; Shorer, Z; Levy, R; Galil, A; Elbedour, K; Birk, OS				Khateeb, Shareef; Flusser, Hagit; Ofir, Rivka; Shelef, Ilan; Narkis, Ginat; Vardi, Gideon; Shorer, Zamir; Levy, Rachel; Galil, Aharon; Elbedour, Khalil; Birk, Ohad S.			PLA2G6 mutation underlies infantile neuroaxonal dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); BRAIN IRON; NEURODEGENERATION; DEFICIENCY	Infantile neuroaxonal dystrophy ( INAD) is an autosomal recessive progressive neurodegenerative disease that presents within the first 2 years of life and culminates in death by age 10 years. Affected individuals from two unrelated Bedouin Israeli kindreds were studied. Brain imaging demonstrated diffuse cerebellar atrophy and abnormal iron deposition in the medial and lateral globus pallidum. Progressive white-matter disease and reduction of the N-acetyl aspartate: chromium ratio were evident on magnetic resonance spectroscopy, suggesting loss of myelination. The clinical and radiological diagnosis of INAD was verified by sural nerve biopsy. The disease gene was mapped to a 1.17-Mb locus on chromosome 22q13.1 (LOD score 4.7 at recombination fraction 0 for SNP rs139897), and an underlying mutation common to both affected families was identified in PLA2G6, the gene encoding phospholipase A2 group VI ( cytosolic, calcium-independent). These findings highlight a role of phospholipase in neurodegenerative disorders.	Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, Zusman Child Dev Ctr, Beer Sheva, Israel; Soroka Med Ctr, Neuroradiol Unit, Beer Sheva, Israel; Soroka Med Ctr, Pediat Urol Unit, Beer Sheva, Israel; Soroka Med Ctr, Infect Dis Lab, Beer Sheva, Israel; Soroka Med Ctr, Inst Genet, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Soroka Univ, Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel.	obirk@bgu.ac.il		Birk, Ohad/0000-0003-1430-1296; shelef, ilan/0000-0002-8398-6455				AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Bakker HD, 2001, EUR J HUM GENET, V9, P91, DOI 10.1038/sj.ejhg.5200598; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; DORFMAN LJ, 1978, ANN NEUROL, V3, P419, DOI 10.1002/ana.410030511; Farina A, 1999, ELECTRON COMMUN ENG, V11, P41, DOI 10.1049/ecej:19990107; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Hortnagel K, 2004, NEUROLOGY, V63, P922, DOI 10.1212/01.WNL.0000137046.28085.B2; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nardocci N, 1999, NEUROLOGY, V52, P1472, DOI 10.1212/WNL.52.7.1472; SCHINDLER D, 1989, NEW ENGL J MED, V320, P1735, DOI 10.1056/NEJM198906293202606; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x	18	130	135	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					942	948		10.1086/508572	http://dx.doi.org/10.1086/508572			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033970	Bronze, Green Published			2022-12-18	WOS:000241667400015
J	Berg, K; Bonham, V; Boyer, J; Brody, L; Brooks, L; Collins, F; Guttmacher, A; McEwen, J; Muenke, M; Olson, S; Wang, VO; Rodriguez, LL; Vydelingum, N; Warshauer-Baker, E				Berg, K; Bonham, V; Boyer, J; Brody, L; Brooks, L; Collins, F; Guttmacher, A; McEwen, J; Muenke, M; Olson, S; Wang, VO; Rodriguez, LL; Vydelingum, N; Warshauer-Baker, E		Race Ethnicity Genetics Working	The use of racial, ethnic, and ancestral categories in human genetics research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LOW NUCLEOTIDE DIVERSITY; POPULATION STRATIFICATION; DNA-SEQUENCES; HEALTH DISPARITIES; NATURAL-SELECTION; HAPLOTYPE BLOCKS; CRANIAL FORM; HUMAN SKIN; RACE; ADMIXTURE	The global dispersal of anatomically modern humans over the past 100,000 years has produced patterns of phenotypic variation that have exerted-and continue to exert-powerful influences on the lives of individuals and the experiences of groups. The recency of our common ancestry and continued gene flow among populations have resulted in less genetic differentiation among geographically distributed human populations than is observed in many other mammalian species. Nevertheless, differences in appearance have contributed to the development of ideas about "race" and "ethnicity" that often include the belief that significant inherited differences distinguish humans. The use of racial, ethnic, and ancestral categories in genetics research can imply that group differences arise directly through differing allele frequencies, with little influence from socially mediated mechanisms. At the same time, careful investigations of the biological, environmental, social, and psychological attributes associated with these categories will be an essential component of cross-disciplinary research into the origins, prevention, and treatment of common diseases, including those diseases that differ in prevalence among groups.	NHGRI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Olson, S (corresponding author), 7609 Sebago Rd, Bethesda, MD 20817 USA.	solon@nas.edu		Muenke, Maximilian/0000-0002-7719-6545				Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; [Anonymous], 2004, NAT GENET, V36, P541; [Anonymous], 1996, BRIT MED J, V312, P1094; [Anonymous], 1996, AM J PHYS ANTHROPOL, V101, P569; [Anonymous], 2000, NAT GENET, V24, P97; Aoki K, 2002, ANN HUM BIOL, V29, P589, DOI 10.1080/0301446021000019144; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Banton M., 1977, IDEA RACE; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Bonham VL, 2005, AM PSYCHOL, V60, P9, DOI 10.1037/0003-066X.60.1.9; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Braun L, 2002, PERSPECT BIOL MED, V45, P159, DOI 10.1353/pbm.2002.0023; Brodwin P, 2002, ANTHROPOL QUART, V75, P323, DOI 10.1353/anq.2002.0027; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 2003, NAT GENET, V33, P435, DOI 10.1038/ng0403-435; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Chaturvedi N, 2001, INT J EPIDEMIOL, V30, P925, DOI 10.1093/ije/30.5.925; Clark M. E., 2002, SEARCH HUMAN NATURE; Clayton EW, 2002, J LAW MED ETHICS, V30, P290, DOI 10.1111/j.1748-720X.2002.tb00395.x; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; Condit C, 2003, GENET MED, V5, P385, DOI 10.1097/01.GIM.0000087990.30961.72; Condit CM, 2002, PUBLIC UNDERST SCI, V11, P373, DOI 10.1088/0963-6625/11/4/305; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; COOPER RS, 2004, CRIT PERSPECT, P267; Cornell S., 1998, ETHNICITY RACE MAKIN; DAVIS FJ, 2001, WHO BLACK 1 NATIONS; Dikotter Frank, 1992, DISCOURSE RACE MODER; Douglas J G, 1996, J Assoc Acad Minor Phys, V7, P16; Duster T, 2005, SCIENCE, V307, P1050, DOI 10.1126/science.1110303; Duster T., 2003, BACKDOOR EUGENICS, V2nd, P264; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Elliott C, 2002, BRIT MED J, V325, P1469, DOI 10.1136/bmj.325.7378.1469; Eswaran V, 2002, CURR ANTHROPOL, V43, P749, DOI 10.1086/342639; Fang J, 1998, SOC SCI MED, V47, P469, DOI 10.1016/S0277-9536(98)00128-2; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Foster MW, 2004, NAT REV GENET, V5, P790, DOI 10.1038/nrg1452; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Foster MW, 1999, AM J HUM GENET, V64, P1719, DOI 10.1086/302415; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fullilove MT, 1998, AM J PUBLIC HEALTH, V88, P1297, DOI 10.2105/AJPH.88.9.1297; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; GOLDENBERT DM, 2003, CURSE HAM RACE SLAVE; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Goodman AH, 2000, AM J PUBLIC HEALTH, V90, P1699, DOI 10.2105/AJPH.90.11.1699; Gossett T. F, 1997, RACE HIST IDEA AM; Gower BA, 2003, DIABETES, V52, P1047, DOI 10.2337/diabetes.52.4.1047; GUTHRIE RD, 1996, PREHISTORIC MONGOLOI, P172; Hannaford I., 1996, RACE HIST IDEA W; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; HAYESBAUTISTA DE, 1987, AM J PUBLIC HEALTH, V77, P61, DOI 10.2105/AJPH.77.1.61; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoerder Dirk, 2002, CULTURES CONTACT WOR; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Horowitz DL., 2001, DEADLY ETHNIC RIOT; HUMMER RA, 2004, UNDERSTANDING RACIAL; Hutchinson J., 1996, ETHNICITY OXFORD REA; Huxley Julian, 1936, WE EUROPEANS SURVEY; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Isaac Benjamin, 2004, INVENTION RACISM CLA; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; KAPLAN EA, 2003, BLACK LIKE THOUGHT W; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Keita SOY, 1997, AM ANTHROPOL, V99, P534, DOI 10.1525/aa.1997.99.3.534; Kevles D., 1985, NAME EUGENICS; King MC, 2002, SCIENCE, V298, P2342, DOI 10.1126/science.1080373; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laveist Thomas A., 1996, Ethnicity and Disease, V6, P21; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; Lewis Bernard, 1990, RACE SLAVERY MIDDLE; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman L, 2001, CURR ANTHROPOL, V42, P69, DOI 10.1086/318434; Lin SS, 2000, EPIDEMIOL REV, V22, P187, DOI 10.1093/oxfordjournals.epirev.a018032; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Mahoney M C, 1998, Fam Med, V30, P190; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marks J., 1995, HUMAN BIODIVERSITY G; Mays VM, 2003, ANNU REV PUBL HEALTH, V24, P83, DOI 10.1146/annurev.publhealth.24.100901.140927; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Meltzer M., 1993, SLAVERY WORLD HIST; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Morner Magnus, 1967, RACE MIXTURE HIST LA; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; MOSSE GL, 1985, FINAL SOLUTION; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Nobles Melissa., 2000, SHADES CITIZENSHIP R; Nordborg M, 1998, AM J HUM GENET, V63, P1237, DOI 10.1086/302052; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ohno S, 1996, P NATL ACAD SCI USA, V93, P15276, DOI 10.1073/pnas.93.26.15276; Olson S., 2002, MAPPING HUMAN HIST; Oppenheimer GM, 2001, AM J PUBLIC HEALTH, V91, P1049, DOI 10.2105/AJPH.91.7.1049; Ossorio P, 2005, AM PSYCHOL, V60, P115, DOI 10.1037/0003-066X.60.1.115; Paabo S, 2003, NATURE, V421, P409, DOI 10.1038/nature01400; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Platz EA, 2000, JNCI-J NATL CANCER I, V92, P2009, DOI 10.1093/jnci/92.24.2009; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; PROVINE WB, 1986, AM ZOOL, V26, P857; RAWLINGS JS, 1992, AM J DIS CHILD, V146, P313, DOI 10.1001/archpedi.1992.02160150053020; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; RISCH M, 2002, CATEGROIZATION HUMAN; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rivara FP, 2001, ARCH PEDIAT ADOL MED, V155, P119, DOI 10.1001/archpedi.155.2.119; Rohde DLT, 2004, NATURE, V431, P562, DOI 10.1038/nature02842; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; Sallout B, 2003, J Obstet Gynaecol, V23, P555; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Satta Y, 2002, BIOESSAYS, V24, P871, DOI 10.1002/bies.10166; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Shields AE, 2005, AM PSYCHOL, V60, P77, DOI 10.1037/0003-066X.60.1.77; SHIPLER D, 1997, COUNTRY STRANGERS BL; Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smedley A, 1999, RACE N AM ORIGIN EVO; SMELSER N, 2001, AM RACIAL TRENDS THE, V2; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; SNOWDEN FM, 1983, COLOR PREJUDICE ANCE; Spickard P.R., 1992, RACIALLY MIXED PEOPL, P12; STANTON W, 1960, LEOPARDS SPORS SCI A; Stevens J, 2003, J HEALTH POLIT POLIC, V28, P1033, DOI 10.1215/03616878-28-6-1033; STINGER C, 2002, PHILOS T R SOC LON B, V357, P563; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; Takaki Ronald T., 1993, DIFFERENT MIRROR HIS; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; TODOROV T, 1993, HUMAN DIVERSITY; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VEGA WA, 1994, ANNU REV PUBL HEALTH, V15, P39, DOI 10.1146/annurev.pu.15.050194.000351; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wall JD, 2000, GENETICS, V154, P1271; Wallace R, 2004, J NATL MED ASSOC, V96, P609; Wang VO, 2005, AM PSYCHOL, V60, P37, DOI 10.1037/0003-066X.60.1.37; Waters Mary., 1990, ETHNIC OPTIONS CHOOS; Weatherall D, 1999, PHILOS T R SOC B, V354, P1995, DOI 10.1098/rstb.1999.0539; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Weiss KM, 1998, ANNU REV ANTHROPOL, V27, P273, DOI 10.1146/annurev.anthro.27.1.273; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Wiencke JK, 2004, NAT REV CANCER, V4, P79, DOI 10.1038/nrc1257; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wolpoff M. H., 1997, RACE HUMAN EVOLUTION; Wolpoff MH, 2001, SCIENCE, V291, P293, DOI 10.1126/science.291.5502.293; Yu N, 2003, GENETICS, V164, P1511; Yu N, 2002, GENETICS, V161, P269; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	205	130	134	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					519	532						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	967QS	16175499				2022-12-18	WOS:000232106900001
J	Newbury, DF; Cleak, JD; Banfield, E; Marlow, AJ; Fisher, SE; Monaco, AP; Stott, CM; Merricks, MJ; Goodyer, IM; Bolton, PF; Slonims, V; Baird, G; Everitt, A; Hennessy, E; Main, M; Helms, P; Kindley, AD; Hodson, A; Watson, J; O'Hare, A; Cohen, W; Cowie, H; Steel, J; MacLean, A; Seckl, J; Nasir, J; Bishop, DVM; Simkin, Z; Conti-Ramsden, G; Pickles, A				Newbury, DF; Cleak, JD; Banfield, E; Marlow, AJ; Fisher, SE; Monaco, AP; Stott, CM; Merricks, MJ; Goodyer, IM; Bolton, PF; Slonims, V; Baird, G; Everitt, A; Hennessy, E; Main, M; Helms, P; Kindley, AD; Hodson, A; Watson, J; O'Hare, A; Cohen, W; Cowie, H; Steel, J; MacLean, A; Seckl, J; Nasir, J; Bishop, DVM; Simkin, Z; Conti-Ramsden, G; Pickles, A		SLI Consortium	Highly significant linkage to the SLI1 locus in an expanded sample of individuals affected by specific language impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; COMPLEX COGNITIVE TRAIT; DEVELOPMENTAL DYSLEXIA; ATTENTION-DEFICIT/HYPERACTIVITY; LEARNING-DISABILITIES; FAMILIAL AGGREGATION; VARIANCE-COMPONENTS; READING-DISABILITY; GENETIC DISSECTION; CHROMOSOME 6P	Specific language impairment (SLI) is defined as an unexplained failure to acquire normal language skills despite adequate intelligence and opportunity. We have reported elsewhere a full-genome scan in 98 nuclear families affected by this disorder, with the use of three quantitative traits of language ability (the expressive and receptive tests of the Clinical Evaluation of Language Fundamentals and a test of nonsense word repetition). This screen implicated two quantitative trait loci, one on chromosome 16q (SLI1) and a second on chromosome 19q (SLI2). However, a second independent genome screen performed by another group, with the use of parametric linkage analyses in extended pedigrees, found little evidence for the involvement of either of these regions in SLI. To investigate these loci further, we have collected a second sample, consisting of 86 families (367 individuals, 174 independent sib pairs), all with probands whose language skills are greater than or equal to1.5 SD below the mean for their age. Haseman-Elston linkage analysis resulted in a maximum LOD score (MLS) of 2.84 on chromosome 16 and an MLS of 2.31 on chromosome 19, both of which represent significant linkage at the 2% level. Amalgamation of the wave 2 sample with the cohort used for the genome screen generated a total of 184 families (840 individuals, 393 independent sib pairs). Analysis of linkage within this pooled group strengthened the evidence for linkage at SLI1 and yielded a highly significant LOD score (MLS p 7.46, interval empirical P < .0004). Furthermore, linkage at the same locus was also demonstrated to three reading-related measures (basic reading [MLS = 1.49], spelling [MLS = 2.67], and reading comprehension [MLS = 1.99] subtests of the Wechsler Objectives Reading Dimensions).	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Inst Psychiat, MRC, Ctr Social Dev & Genet Psychiat, London, England; Guys Hosp, Newcomen Ctr, London, England; Univ Aberdeen, Dept Child Hlth, Aberdeen AB9 1FX, Scotland; Grampian Univ Hosp Trust, Aberdeen, Scotland; Queen Margaret Univ Coll, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Dept Reprod & Dev Sci, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Edinburgh, Mol Med Ctr, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Sheffield, Sch Med, Acad Unit Neurol, Sheffield S10 2TN, S Yorkshire, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 2JD, England; Univ Manchester, Sch Educ, Manchester M13 9PL, Lancs, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Biostat Grp, Manchester M13 9PL, Lancs, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Aberdeen; University of Aberdeen; Queen Margaret University; University of Edinburgh; University of Edinburgh; University of Sheffield; University of Oxford; University of Manchester; University of Manchester	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Seckl, Jonathan R/C-3555-2013; Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010; Pickles, Andrew/A-9625-2011	Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Pickles, Andrew/0000-0003-1283-0346; Cohen, Wendy/0000-0002-1271-9229				AMOS CI, 1994, AM J HUM GENET, V54, P535; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 1993, Memory, V1, P65, DOI 10.1080/09658219308258225; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Barrett S, 1999, AM J MED GENET, V88, P609; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; BARTLETT CW, 2003, AM J HUM GENET S, V73, pA1884; BEITCHMAN JH, 1994, J AM ACAD CHILD PSY, V33, P1322, DOI 10.1097/00004583-199411000-00015; BISHOP DVM, 1987, J CHILD PSYCHOL PSYC, V28, P1, DOI 10.1111/j.1469-7610.1987.tb00646.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P189, DOI 10.1111/1469-7610.00710; BISHOP DVM, 1986, BRIT J DISORD COMMUN, V21, P321; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; CANTWELL DP, 1987, J COMMUN DISORD, V20, P151, DOI 10.1016/0021-9924(87)90006-2; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Doyle AE, 2001, AM J PSYCHIAT, V158, P1666, DOI 10.1176/appi.ajp.158.10.1666; Fagerheim T, 1999, J MED GENET, V36, P664; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Gallagher A, 2000, J CHILD PSYCHOL PSYC, V41, P203, DOI 10.1111/1469-7610.00601; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hsu L, 2002, AM J MED GENET, V114, P471, DOI 10.1002/ajmg.10523; Johnson CJ, 1999, J SPEECH LANG HEAR R, V42, P744, DOI 10.1044/jslhr.4203.744; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kovac I, 2001, J COMMUN DISORD, V34, P339, DOI 10.1016/S0021-9924(01)00054-5; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Law J, 1998, Health Technol Assess, V2, P1; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; NEILS J, 1986, PERCEPT MOTOR SKILL, V63, P655, DOI 10.2466/pms.1986.63.2.655; Newbury DF, 2002, AM J HUM GENET, V70, P384; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Rust J, 1993, WECHSLER OBJECTIVE R; Semel EM, 1992, CLIN EVALUATION LANG; Snowling M, 2000, J CHILD PSYCHOL PSYC, V41, P587, DOI 10.1111/1469-7610.00651; Snowling MJ, 2001, INT J LANG COMM DIS, V36, P173, DOI 10.1080/13682820010019892; Stein CM, 2004, AM J HUM GENET, V74, P283, DOI 10.1086/381562; Stromswold K, 1998, HUM BIOL, V70, P297; TALLAL P, 1989, J SPEECH HEAR DISORD, V54, P167, DOI 10.1044/jshd.5402.167; Tomblin JB, 2003, INT J LANG COMM DIS, V38, P235, DOI 10.1080/1368282031000086363; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Wijsman EM, 2000, AM J HUM GENET, V67, P631, DOI 10.1086/303044; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	56	130	131	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1225	1238		10.1086/421529	http://dx.doi.org/10.1086/421529			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	823ZB	15133743	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000221651900015
J	Muller, D; Kausalya, PJ; Claverie-Martin, F; Meij, IC; Eggert, P; Garcia-Nieto, V; Hunziker, W				Muller, D; Kausalya, PJ; Claverie-Martin, F; Meij, IC; Eggert, P; Garcia-Nieto, V; Hunziker, W			A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TIGHT JUNCTION; PDZ DOMAINS; IDIOPATHIC HYPERCALCIURIA; FAMILIAL HYPOMAGNESEMIA; PARACELLIN-1; PROTEINS; GENE; CHILDREN; ENURESIS; STRANDS	Mutations in the gene coding for the renal tight junction protein claudin 16 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis, an autosomal recessive disorder of renal Ca2+ and Mg2+ handling that progressively leads to chronic renal failure, with nephrolithiasis having been reported in heterozygous carriers. Screening a cohort of 11 families with idiopathic hypercalciuria identified a novel homozygous mutation in the claudin 16 gene in two families. In contrast to classical symptoms of familial hypomagnesemia with hypercalciuria and nephrocalcinosis, the patients displayed serious but self-limiting childhood hypercalciuria with preserved glomerular filtration rate. The mutation results in inactivation of a PDZ-domain binding motif, thereby disabling the association of the tight junction scaffolding protein ZO-1 with claudin 16. In contrast to wild-type claudin 16, the mutant no longer localizes to tight,junctions in kidney epithelial cells but instead accumulates in lysosomes. Thus, mutations at different intragenic sites in the claudin 16 gene may lead to particular clinical phenotypes with a distinct prognosis. Mutations in claudin 16 that affect. interaction with ZO-1 lead to lysosomal mistargeting, providing-for the first time, to our knowledge-insight into the molecular mechanism of a disease-associated mutation in the claudin 16 gene.	Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore 117609, Singapore; Charite Childrens Hosp, Dept Pediat Nephrol, D-13353 Berlin, Germany; Nuestra Senora Candelaria Univ Hosp, Res Unit, Tenerife, Spain; Nuestra Senora Candelaria Univ Hosp, Pediat Nephrol Unit, Tenerife, Spain; Nijmegen Ctr Mol Life Sci, Dept Pharmacol Toxicol, Nijmegen, Netherlands; Univ Childrens Hosp Kiel, Kiel, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; University of Kiel; Schleswig Holstein University Hospital	Muller, D (corresponding author), Inst Mol & Cell Biol, Epithelial Cell Biol Lab, 30 Med Dr, Singapore 117609, Singapore.	dominik.mueller@charite.de	Hunziker, Walter/GSM-8190-2022; Hunziker, Walter/B-3140-2010	Hunziker, Walter/0000-0002-5265-4933; Claverie-Martin, Felix/0000-0003-2468-3267				ALON U, 1990, J PEDIATR-US, V116, P103, DOI 10.1016/S0022-3476(05)81654-3; Alon US, 2000, PEDIATR NEPHROL, V14, P1011, DOI 10.1007/s004670050064; ASPLIN JR, 1996, KIDNEY, P1893; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Kausch AP, 2001, PLANT MOL BIOL, V45, P1, DOI 10.1023/A:1006487326533; KRUSE K, 1984, EUR J PEDIATR, V143, P25, DOI 10.1007/BF00442743; Meij IC, 2003, NEPHROL DIAL TRANSPL, V18, P512, DOI 10.1093/ndt/18.3.512; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller D, 2002, LANCET, V359, P495, DOI 10.1016/S0140-6736(02)07667-5; Muller D, 2002, NEPHROL DIAL TRANSPL, V17, P1614, DOI 10.1093/ndt/17.9.1614; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Ohba Y, 2000, GENOMICS, V68, P229, DOI 10.1006/geno.2000.6298; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; STAPLETON FB, 1984, NEW ENGL J MED, V310, P1345, DOI 10.1056/NEJM198405243102102; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valenti G, 2000, J AM SOC NEPHROL, V11, P1873, DOI 10.1681/ASN.V11101873; Weber S, 2001, J AM SOC NEPHROL, V12, P2664, DOI 10.1681/ASN.V12122664; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872; Weber S, 2000, EUR J HUM GENET, V8, P414, DOI 10.1038/sj.ejhg.5200475; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8	29	130	134	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1293	1301		10.1086/380418	http://dx.doi.org/10.1086/380418			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628289	Green Published, Bronze			2022-12-18	WOS:000187491100007
J	Bond, J; Scott, S; Hampshire, DJ; Springell, K; Corry, P; Abramowicz, MJ; Mochida, GH; Hennekam, RCM; Maher, ER; Fryns, JP; Alswaid, A; Jafri, H; Rashid, Y; Mubaidin, A; Walsh, CA; Roberts, E; Woods, CG				Bond, J; Scott, S; Hampshire, DJ; Springell, K; Corry, P; Abramowicz, MJ; Mochida, GH; Hennekam, RCM; Maher, ER; Fryns, JP; Alswaid, A; Jafri, H; Rashid, Y; Mubaidin, A; Walsh, CA; Roberts, E; Woods, CG			Protein-truncating mutations in ASPM cause variable reduction in brain size	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE MICROCEPHALY MAPS; ABNORMAL SPINDLE; MITOTIC SPINDLE; LOCUS; DROSOPHILA; GENE	Mutations in the ASPM gene at the MCPH5 locus are expected to be the most common cause of human autosomal recessive primary microcephaly (MCPH), a condition in which there is a failure of normal fetal brain development, resulting in congenital microcephaly and mental retardation. We have performed the first comprehensive mutation screen of the 10.4-kb ASPM gene, identifying all 19 mutations in a cohort of 23 consanguineous families. Mutations occurred throughout the ASPM gene and were all predicted to be protein truncating. Phenotypic variation in the 51 affected individuals occurred in the degree of microcephaly (5-11 SDs below normal) and of mental retardation (mild to severe) but appeared independent of mutation position.	Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St James Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; St Lukes Hosp, Dept Pediat, Bradford BD5 0NA, W Yorkshire, England; Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; Med Genet Lab, Brussels, Belgium; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Harvard Inst Med,Dept Neurol,Div Neurogenet, Boston, MA USA; Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med Mol Genet, Birmingham, W Midlands, England; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Riyadh Armed Forces Hosp, Riyadh, Saudi Arabia; King Hussein Med Ctr, Dept Neurol, Amman, Jordan	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; KU Leuven; University Hospital Leuven; Prince Sultan Military Medical City	Bond, J (corresponding author), Univ Leeds, St James Hosp, Mol Med Unit, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	j.bond@leeds.ac.uk	Hampshire, Daniel/Q-3540-2019; MAHER, EAMONN R/A-9507-2008; Abramowicz, Marc/AAX-6419-2020; woods, christopher g/A-1361-2010	MAHER, EAMONN R/0000-0002-6226-6918; Abramowicz, Marc/0000-0003-0623-8768; Mochida, Ganeshwaran/0000-0001-7912-4097				Aicardi J, 1998, DIS NERVOUS SYSTEM C, P90; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; BUNDEY S, 1997, EMERY RIMOINS PRINCI, P730; Craig R, 1998, J CELL SCI, V111, P3609; GONZALEZ C, 1990, J CELL SCI, V96, P605; GONZALEZ C, 1989, GENETICS, V123, P371; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; QAZI QH, 1975, CLIN GENET, V7, P85; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; VANDENBOSCH J, 1958, ANN HUM GENET, V23, P91	20	130	136	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1170	1177		10.1086/379085	http://dx.doi.org/10.1086/379085			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574646	Bronze, Green Published			2022-12-18	WOS:000186493400018
J	Stefansson, SE; Jonsson, H; Ingvarsson, T; Manolescu, I; Jonsson, HH; Olafsdottir, G; Palsdottir, E; Stefansdottir, G; Sveinbjornsdottir, G; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K				Stefansson, SE; Jonsson, H; Ingvarsson, T; Manolescu, I; Jonsson, HH; Olafsdottir, G; Palsdottir, E; Stefansdottir, G; Sveinbjornsdottir, G; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K			Genomewide scan for hand osteoarthritis: A novel mutation in matrilin-3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; CARTILAGE MATRIX PROTEIN; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; HIP OSTEOARTHRITIS; ASSOCIATION; GENE; CHROMOSOME-6; ICELAND; JOINTS	Osteoarthritis (OA) is the most common human joint disease, characterized by loss and/or remodeling of joint synovium, cartilage, and bone. Here, we describe a genomewide linkage analysis of patients with idiopathic hand OA who were carefully phenotyped for involvement of either or both the distal interphalangeal (DIP) joints and the first carpometacarpal (CMC1) joints. The best linkage peaks were on chromosomes 4q and 3p and on the short arm of chromosome 2. Genomewide significance was reached for a locus on chromosome 2 for patients with affected CMC1 joints (LOD = 4.97); this locus was also significant for patients with CIA in both CMC1 and DIP joints (LOD = 4.44). The peak LOD score at this locus coincides with a gene, MATN3, encoding the noncollagenous cartilage extracellular matrix protein, matrilin-3. Subsequent screening of the genomic sequence revealed a missense mutation, of a conserved amino acid codon, changing threonine to methionine in the epidermal growth factor-like domain in matrilin-3. The missense mutation cosegregates with hand OA in several families. The mutation frequency is slightly more than 2% in patients with hand OA in the Icelandic population and has a relative risk of 2.1.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitalinn Univ Hosp, Reykjavik, Iceland; Genet Res Serv Ctr, Reykjavik, Iceland; Cent Hosp, Akureyri, Iceland	Landspitali National University Hospital	Stefansson, SE (corresponding author), deCODE Genet, Sturligata 8, IS-101 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019	Jonsson, Helgi/0000-0003-0187-8985				Bijkerk C, 1999, ARTHRITIS RHEUM, V42, P1729, DOI 10.1002/1529-0131(199908)42:8<1729::AID-ANR23>3.0.CO;2-H; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen XN, 1999, GENOME RES, V9, P492; Cicuttini FM, 1997, J RHEUMATOL, V24, P1164; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Demissie S, 2002, ARTHRITIS RHEUM, V46, P946, DOI 10.1002/art.10149; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FJALLDAL JB, 2001, P INT JOINT C NEUR N, pA1; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Ingvarsson T, 2001, ARTHRITIS RHEUM-US, V44, P2548, DOI 10.1002/1529-0131(200111)44:11<2548::AID-ART435>3.0.CO;2-S; Ingvarsson T, 2000, ARTHRITIS RHEUM, V43, P2785, DOI 10.1002/1529-0131(200012)43:12<2785::AID-ANR19>3.0.CO;2-I; Jonsson H, 2003, ARTHRITIS RHEUM, V48, P391, DOI 10.1002/art.10785; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Loughlin J, 1999, AM J HUM GENET, V65, P1795, DOI 10.1086/302685; Loughlin J, 2000, ARTHRITIS RHEUM, V43, P1423, DOI 10.1002/1529-0131(200006)43:6<1423::AID-ANR31>3.0.CO;2-4; Loughlin J, 2002, EUR J HUM GENET, V10, P562, DOI 10.1038/sj.ejhg.5200848; Makihira S, 1999, J BIOL CHEM, V274, P11417, DOI 10.1074/jbc.274.16.11417; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Mortier GR, 2001, EUR J HUM GENET, V9, P606, DOI 10.1038/sj.ejhg.5200690; NICOLAE DL, 1999, THESIS U CHICAGO CHI; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Pullig O, 2002, OSTEOARTHR CARTILAGE, V10, P253, DOI 10.1053/joca.2001.0508; ROBERTS J, 1966, VITAL HLTH STAT, V11, P1; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Strusberg I, 2002, CLIN EXP RHEUMATOL, V20, P543; Wagener R, 2000, MAMM GENOME, V11, P85, DOI 10.1007/s003350010018; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wright GD, 1996, ANN RHEUM DIS, V55, P317, DOI 10.1136/ard.55.5.317; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	44	130	139	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1448	1459		10.1086/375556	http://dx.doi.org/10.1086/375556			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12736871	Bronze, Green Published			2022-12-18	WOS:000183275500008
J	Mitchell, AA; Cutler, DJ; Chakravarti, A				Mitchell, AA; Cutler, DJ; Chakravarti, A			Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MICROSATELLITE MARKERS; DISEQUILIBRIUM; MUTATIONS	The transmission/disequilibrium test (TDT), a family-based test of linkage and association, is a popular and intuitive statistical test for studies of complex inheritance, as it is nonparametric and robust to population stratification. We carried out a literature search and located 79 significant TDT-derived associations between a microsatellite marker allele and a disease. Among these, there were 31 (39%) in which the most common allele was found to exhibit distorted transmission to affected offspring, implying that the allele may be associated with either susceptibility to or protection from a disease. In 27 of these 31 studies (87%), the most common allele appeared to be overtransmitted to affected offspring (a risk factor), and, in the remaining 4 studies, the most common allele appeared to be undertransmitted (a protective factor). In a second literature search, we identified 92 case-control studies in which a microsatellite marker allele was found to have significantly different frequencies in case and control groups. Of these, there were 37 instances (40%) in which the most common allele was involved. In 12 of these 37 studies (32%), the most common allele was enriched in cases relative to controls (a risk factor), and, in the remaining 25 studies, the most common allele was enriched in controls (a protective factor). Thus, the most common allele appears to be a risk factor when identified through the TDT, and it appears to be protective when identified through case-control analysis. To understand this phenomenon, we incorporated an error model into the calculation of the TDT statistic. We show that undetected genotyping error can cause apparent transmission distortion at markers with alleles of unequal frequency. We demonstrate that this distortion is in the direction of overtransmission for common alleles. Therefore, we conclude that undetected genotyping errors may be contributing to an inflated false-positive rate among reported TDT-derived associations and that genotyping fidelity must be increased.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, 600 N Wolfe St,Jefferson St Bldg,2-109, Baltimore, MD 21287 USA.	aravinda@jhmi.edu	Mitchell, Adele/AAZ-1994-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL054466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NHLBI NIH HHS [5U10HL54466-08, U10 HL054466] Funding Source: Medline; NIGMS NIH HHS [5T32GM07814, T32 GM007814] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Gordon D, 2001, Pac Symp Biocomput, P18; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Hall JM, 1996, GENOME RES, V6, P781, DOI 10.1101/gr.6.9.781; Heath S.C., 1998, AM J HUM GENET S, V63, pA292; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MANSFIELD DC, 1994, GENOMICS, V24, P225, DOI 10.1006/geno.1994.1610; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; SMITH JR, 1995, GENOME RES, V5, P312, DOI 10.1101/gr.5.3.312; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Weeks DE, 2002, GENOME RES, V12, P430, DOI 10.1101/gr.211502	25	130	133	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					598	610		10.1086/368203	http://dx.doi.org/10.1086/368203			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12587097	Bronze, Green Published			2022-12-18	WOS:000181152600010
J	Petek, E; Windpassinger, C; Vincent, JB; Cheung, J; Boright, AP; Scherer, SW; Kroisel, PM; Wagner, K				Petek, E; Windpassinger, C; Vincent, JB; Cheung, J; Boright, AP; Scherer, SW; Kroisel, PM; Wagner, K			Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLOCATION BREAKPOINT; IDENTIFICATION; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; DISORDERS; PROTEASE; LINKAGE; CLONING; AUTISM	Gilles de la Tourette syndrome (GTS) is a complex neuropsychiatric disorder characterized by multiple motor and phonic tics. We identified a male patient with GTS and other anomalies. It was determined that he carried a de novo duplication of the long arm of chromosome 7 [46,XY,dup(7)(q22.1-q31.1)]. Further molecular analysis revealed that the duplication was inverted. The distal chromosomal breakpoint occurred between the two genetic markers D7S515 and D7S522, which define a region previously shown to be disrupted in a familiar case of GTS. Yeast and bacterial artificial chromosome clones spanning the breakpoints were identified by means of FISH analysis. To further characterize the distal breakpoint for a role in GTS, we performed Southern blot hybridization analysis and identified a 6.5-kb SacI junction fragment in the patient's genomic DNA. The DNA sequence of this fragment revealed two different breaks in 7q31 within a region of similar to 500 kb. IMMP2L, a novel gene coding for the apparent human homologue of the yeast mitochondrial inner membrane peptidase subunit 2, was found to be disrupted by both the breakpoint in the duplicated fragment and the insertion site in 7q31. The cDNA of the human IMMP2L gene was cloned, and analysis of the complete 1,522-bp transcript revealed that it encompassed six exons spanning 860 kb. The possible role of IMMP2L and several other candidate genes within the region of chromosomal rearrangement, including NRCAM, Leu-Rch Rep, and Reelin, is discussed. The 7q31 breakpoint interval has also been implicated in other neuropsychiatric diseases that demonstrate some clinical overlap with GTS, including autism and speech-language disorder.	Graz Univ, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada	University of Graz; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Petek, E (corresponding author), Graz Univ, Inst Med Biol & Human Genet, Harrachgasse 21-8, A-8010 Graz, Austria.		Scherer, Stephen W./B-3785-2013	Scherer, Stephen W./0000-0002-8326-1999; Cheung, Joseph/0000-0002-1222-7603				Baron-Cohen S, 1999, PSYCHOL MED, V29, P1151, DOI 10.1017/S003329179900896X; Barr CL, 1998, CAN J PSYCHIAT, V43, P351, DOI 10.1177/070674379804300402; BoghosianSell L, 1996, AM J HUM GENET, V59, P999; CARTER AS, 1994, J AM ACAD CHILD PSY, V33, P377, DOI 10.1097/00004583-199403000-00012; CURTIS D, 1992, BRIT J PSYCHIAT, V160, P845, DOI 10.1192/bjp.160.6.845; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; DONNAI D, 1987, LANCET, V1, P627; Freeman RD, 2000, DEV MED CHILD NEUROL, V42, P436, DOI 10.1017/S0012162200000839; Graeber MB, 1998, J NEUROL SCI, V153, P251, DOI 10.1016/S0022-510X(97)00295-5; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; KROISEL PM, IN PRESS AM J MED GE; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Megarbane A, 2000, AM J MED GENET, V95, P164, DOI 10.1002/1096-8628(20001113)95:2<164::AID-AJMG14>3.3.CO;2-7; Merette C, 2000, AM J HUM GENET, V67, P1008, DOI 10.1086/303093; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Petek E, 1997, BIOTECHNIQUES, V23, P72, DOI 10.2144/97231bm15; ROBERTSON MM, 1994, J CHILD PSYCHOL PSYC, V35, P597, DOI 10.1111/j.1469-7610.1994.tb01209.x; SHARK KB, 1995, GENE, V155, P213, DOI 10.1016/0378-1119(94)00830-L; Taniguchi H, 1996, MOL BRAIN RES, V36, P45, DOI 10.1016/0169-328X(95)00243-L; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409	25	130	139	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					848	858		10.1086/319523	http://dx.doi.org/10.1086/319523			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	414KQ	11254443	Bronze, Green Published			2022-12-18	WOS:000167666000006
J	Sinden, RR				Sinden, RR			Biological implications of the DNA structures associated with disease causing triplet repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEATS; ESCHERICHIA-COLI; REPLICATION; GENES; CCG; EXPANSION; SEQUENCE; DELETION; BLOCKS		Texas A&M Univ, Inst Biosci & Biotechnol, Ctr Genome Res, Houston, TX 77030 USA	Texas A&M University System	Sinden, RR (corresponding author), Texas A&M Univ, Inst Biosci & Biotechnol, Ctr Genome Res, 2121 W Holcombe Blvd, Houston, TX 77030 USA.		Sinden, Richard/AAE-3086-2019					Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; BARAN N, 1987, MOL CELL BIOL, V7, P2636, DOI 10.1128/MCB.7.7.2636; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Chastain PD, 1998, J MOL BIOL, V275, P405, DOI 10.1006/jmbi.1997.1502; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P585; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; RAO BS, 1988, NUCLEIC ACIDS RES, V16, P8077, DOI 10.1093/nar/16.16.8077; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Schumacher S, 1998, J MOL BIOL, V279, P1101, DOI 10.1006/jmbi.1998.1827; Sinden R, 1994, DNA STRUCTURE FUNCTI; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; SINDEN RR, 1991, GENETICS, V129, P991; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Usdin K, 1998, NUCLEIC ACIDS RES, V26, P4078, DOI 10.1093/nar/26.17.4078; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; Wells R.D., 1998, GENETIC INSTABILITIE; WONG LJC, 1995, AM J HUM GENET, V56, P114	33	130	135	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					346	353		10.1086/302271	http://dx.doi.org/10.1086/302271			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973271	Green Published, Bronze			2022-12-18	WOS:000078740600003
J	Bianchi, NO; Catanesi, CI; Bailliet, G; Martinez-Marignac, VL; Bravi, CM; Vidal-Rioja, LB; Herrera, RJ; Lopez-Camelo, JS				Bianchi, NO; Catanesi, CI; Bailliet, G; Martinez-Marignac, VL; Bravi, CM; Vidal-Rioja, LB; Herrera, RJ; Lopez-Camelo, JS			Characterization of ancestral and derived Y-chromosome haplotypes of new world native populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; MTDNA VARIATION; AMERICA; MICROSATELLITES; POLYMORPHISMS; ORIGIN; FREQUENCIES; AMERINDIANS; AFFINITIES; MIGRATION	We analyze the allelic polymorphisms in seven Y-specific microsatellite loci and a Y-specific alphoid system with 27 variants (alpha h I-XXVII), in a total of 89 Y chromosomes carrying the DYS199T allele and belonging to populations representing Amerindian and Na-Dene linguistic groups. Since there are no indications of recurrence for the DYS199C-->T transition, it is assumed that all DYS199T haplotypes derive from a single individual in whom the C-->T mutation occurred for the first time. We identified both the ancestral founder haplotype, OA, of the DYS199T lineage and seven derived haplogroups diverging from the ancestral one by one to seven mutational steps. The OA haplotype (5.7% of Native American chromosomes) had the following constitution: DYS199T, alpha h II, DYS19/13, DYS389a/10, DYS389b/27, DYS390/24, DYS391/10, DYS392/14, and DYS393/13 (microsatellite alleles are indicated as number of repeats). We analyzed the Y-specific microsatellite mutation rate in 1,743 father-son transmissions, and we pooled our data with data in the literature, to obtain an average mutation rate of .0012. We estimated that the OA haplotype has an average age-of 22,770 years (minimum 13,500 years, maximum 58,700 years). Since the DYS199T allele is found with high frequency in Native American chromosomes, we propose that 0A is one of the most prevalent founder paternal lineages of New World aborigines.	IMBICE, La Plata, Argentina; Florida Int Univ, Coll Arts & Sci, Dept Sci Biol, Miami, FL 33199 USA	State University System of Florida; Florida International University	Bianchi, NO (corresponding author), IMBICE, Calle 526 E-10 & 111900, La Plata, Argentina.	imbice@satlink.com		Catanesi, Cecilia Ines/0000-0002-5970-5027; Lopez-Camelo, Jorge S./0000-0002-3146-5447				ADOVASIO JM, 1990, AM ANTIQUITY, V55, P348, DOI 10.2307/281652; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bravi CM, 1997, HUM BIOL, V69, P641; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Dipierri JE, 1998, HUM BIOL, V70, P1001; Forster P, 1997, AM J HUM GENET, V61, P246; Forster P, 1996, AM J HUM GENET, V59, P935; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; NEI M, 1986, EVOLUTION, V40, P643, DOI 10.1111/j.1558-5646.1986.tb00516.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NEVES WA, 1991, J HUM EVOL, V21, P261, DOI 10.1016/0047-2484(91)90107-7; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; POWELL J, IN PRESS ANTROPOL FI; Rodriguez-Delfin L, 1997, ANN HUM GENET, V61, P439, DOI 10.1046/j.1469-1809.1997.6150439.x; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; RUHLEN M, 1997, GUIDE WORLDS LANGUAG, V1; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; Santos FR, 1996, HUM GENET, V97, P309, DOI 10.1007/BF02185760; SANTOS FR, 1993, HUM GENET, V90, P655; Santos FR, 1996, AM J HUM GENET, V58, P1369; Scozzari R, 1997, AM J HUM GENET, V60, P241; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; SZARHMARY EJ, 1993, EVOL ANTHROPOL, V1, P202; SZATHMARY E J E, 1984, Acta Anthropogenetica, V8, P79; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	46	130	142	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1862	1871		10.1086/302141	http://dx.doi.org/10.1086/302141			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	151EL	9837838	Green Published, Bronze			2022-12-18	WOS:000077707700031
J	Zinn, AR; Tonk, VS; Chen, Z; Flejter, WL; Gardner, HA; Guerra, R; Kushner, H; Schwartz, S; Sybert, VP; Van Dyke, DL; Ross, JL				Zinn, AR; Tonk, VS; Chen, Z; Flejter, WL; Gardner, HA; Guerra, R; Kushner, H; Schwartz, S; Sybert, VP; Van Dyke, DL; Ross, JL			Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; X-CHROMOSOME; SHORT STATURE; SHORT ARM; CYSTIC HYGROMA; GROWTH GENE(S); SEX-CHROMOSOME; DOWN-SYNDROME; DELETIONS; PHENOTYPE	Turner syndrome is the complex human phenotype associated with complete or partial monosomy X. Principle features of Turner syndrome include short stature, ovarian failure, and a variety of other anatomic and physiological abnormalities, such as webbed neck, lymphedema, cardiovascular and renal anomalies, hypertension, and autoimmune thyroid disease, We studied 28 apparently nonmosaic subjects with partial deletions of Xp, in order to map loci responsible for various components of the Turner syndrome phenotype. Subjects were carefully evaluated for the presence or absence of Turner syndrome features, and their deletions were mapped by FISH with a panel of Xp markers; Using a statistical method to examine genotype/phenotype correlations, we mapped one or more Turner syndrome traits to a critical region in Xp11.2-p22.1. These traits included short stature, ovarian failure, high-arched palate, and autoimmune thyroid disease. The results are useful for genetic counseling of individuals with partial monosomy X. Study of additional subjects should refine the localization of Turner syndrome loci and provide a rational basis for exploration of candidate genes.	Univ Texas, SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75235 USA; Univ Texas, SW Med Sch, Dept Internal Med, Dallas, TX 75235 USA; So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA; Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Lubbock, TX 79430 USA; Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; Genzyme Genet, Santa Fe, NM USA; Univ Utah, Dept Pediat, Salt Lake City, UT USA; Oshawa Gen Hosp, Oshawa, ON, Canada; Univ Toronto, Depb Lab Med & Pathobiol, Toronto, ON, Canada; Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Dermatol, Seattle, WA 98195 USA; Henry Ford Hosp, Dept Med Genet, Detroit, MI 48202 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Southern Methodist University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Sanofi-Aventis; Genzyme Corporation; Utah System of Higher Education; University of Utah; University of Toronto; Jefferson University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Henry Ford Health System; Henry Ford Hospital	Zinn, AR (corresponding author), Univ Texas, SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.			Ross, Judith/0000-0002-8613-2498; Zinn, Andrew/0000-0002-4935-3291	NINDS NIH HHS [R01 NS35554] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035554] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Belmont JW, 1996, AM J HUM GENET, V58, P1101; BROOK CGD, 1977, ANN HUM BIOL, V4, P17, DOI 10.1080/03014467700001911; BURGOYNE PS, 1985, J REPROD FERTIL, V75, P633, DOI 10.1530/jrf.0.0750633; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; EPSTEIN CJ, 1988, TURNER SYNDROME, P13; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FRACCARO M, 1977, HUM GENET, V39, P283, DOI 10.1007/BF00295421; FRYNS JP, 1981, HUM GENET, V57, P385, DOI 10.1007/BF00281690; GILBRET J, 1995, CURRENT PROTOCOLS HU, V2; GOLDMAN B, 1982, CLIN GENET, V21, P36; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; KALOUSEK D, 1979, J PEDIATR-US, V94, P891, DOI 10.1016/S0022-3476(79)80208-5; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KRAUSS CM, 1987, NEW ENGL J MED, V317, P125, DOI 10.1056/NEJM198707163170301; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LIPPE B, 1991, ENDOCRIN METAB CLIN, V20, P121, DOI 10.1016/S0889-8529(18)30284-6; Luoh SW, 1997, DEVELOPMENT, V124, P2275; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MASSA G, 1992, EUR J PEDIATR, V151, P893, DOI 10.1007/BF01954124; MATHUR A, 1991, AM J HUM GENET, V48, P682; Migeon BR, 1998, CYTOGENET CELL GENET, V80, P142, DOI 10.1159/000014971; Miyabara S, 1997, AM J MED GENET, V68, P135, DOI 10.1002/(SICI)1096-8628(19970120)68:2<135::AID-AJMG3>3.0.CO;2-O; MIYABARA S, 1989, AM J MED GENET, V34, P489, DOI 10.1002/ajmg.1320340408; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; OGATA T, 1992, J MED GENET, V29, P455; OGATA T, 1995, HUM GENET, V95, P607; OGATA T, 1992, J MED GENET, V29, P624, DOI 10.1136/jmg.29.9.624; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SIMPSON JL, 1988, TURNER SYNDROME, P65; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; SPEED RM, 1986, CHROMOSOMA, V94, P115, DOI 10.1007/BF00286989; SYBERT V, 1909, TURNER SYNDROME LIFE, P205; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; TEMTAMY SA, 1992, CLIN GENET, V41, P147; Wolff DJ, 1996, AM J HUM GENET, V58, P154; ZEHETNER G, 1994, NATURE, V367, P489, DOI 10.1038/367489a0; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	44	130	138	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1757	1766		10.1086/302152	http://dx.doi.org/10.1086/302152			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837829	Green Published, Bronze			2022-12-18	WOS:000077707700022
J	Jaeken, J; Matthijs, G; Saudubray, JM; Dionisi-Vici, C; Bertini, E; de Lonlay, P; Henri, H; Carchon, H; Schollen, E; Van Schaftingen, E				Jaeken, J; Matthijs, G; Saudubray, JM; Dionisi-Vici, C; Bertini, E; de Lonlay, P; Henri, H; Carchon, H; Schollen, E; Van Schaftingen, E			Phosphomannose isomerase deficiency: A carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TRANSFERRIN; TRANSPORTER; EXPRESSION; GLUCOSE; CLONING; SERUM; CELLS; LIVER		Katholieke Univ Leuven, Dept Pediat, Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Hop Necker Enfants Malad, Clin Genet Med, Paris, France; Bambino Gesu Hosp, Dept Metab, Rome, Italy; Bambino Gesu Hosp, Dept Neuropediat, Rome, Italy; Ctr Hosp Univ Vaudois, Lab Cent Chim Clin, Lausanne, Switzerland; Univ Louvain, Physiol Chem Lab, Int Inst Cellular & Mol Pathol, Brussels, Belgium	KU Leuven; KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite Catholique Louvain	Jaeken, J (corresponding author), Katholieke Univ Leuven, Dept Pediat, Louvain, Belgium.		Bertini, Enrico/A-2284-2014; Dionisi-Vici, Carlo/K-2045-2018; Van+Schaftingen, Emile/AAF-5532-2020; Bertini, Enrico/ABG-1278-2020	Bertini, Enrico/0000-0001-9276-4590; Dionisi-Vici, Carlo/0000-0002-0007-3379; Van Schaftingen, Emile/0000-0002-6199-7647; Matthijs, Gert/0000-0001-6710-1912				Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; DEVILLEMEUR TB, 1995, JOURN PAR PED 1995, P119; Etchison JR, 1997, CLIN CHEM, V43, P533; FREEZE H, 1997, GLYCOBIOLOGY, V7, P1020; Jaeken J, 1997, J INHERIT METAB DIS, V20, P447, DOI 10.1023/A:1005331523477; JAEKEN J, 1993, GLYCOBIOLOGY, V3, P423, DOI 10.1093/glycob/3.5.423; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JAEKEN J, 1997, EUR J PAEDIAT NEUROL, V2, P61; KEPES F, 1988, J BIOL CHEM, V263, P9155; KRASNEWICH DM, 1995, GLYCOBIOLOGY, V5, P503, DOI 10.1093/glycob/5.5.503; MARQUARDT T, 1997, AMINO ACIDS, V12, P389; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mayatepek E, 1997, ACTA PAEDIATR, V86, P1138, DOI 10.1111/j.1651-2227.1997.tb14825.x; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Panneerselvam K, 1996, J BIOL CHEM, V271, P9417, DOI 10.1074/jbc.271.16.9417; Panneerselvam K, 1997, J BIOL CHEM, V272, P23123, DOI 10.1074/jbc.272.37.23123; PELLETIER VA, 1986, J PEDIATR-US, V108, P61, DOI 10.1016/S0022-3476(86)80769-7; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; POWELL LD, 1994, J CLIN INVEST, V94, P1901, DOI 10.1172/JCI117540; PROUDFOOT AEI, 1994, EUR J BIOCHEM, V219, P415, DOI 10.1111/j.1432-1033.1994.tb19954.x; REYES A, 1984, BIOCHEM J, V221, P303, DOI 10.1042/bj2210303; Sambrook J, 1989, MOL CLONING LAB MANU; SOLS A, 1954, J BIOL CHEM, V210, P581; STIBLER H, 1990, ARCH DIS CHILD, V65, P107, DOI 10.1136/adc.65.1.107; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1	30	130	133	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1535	1539		10.1086/301873	http://dx.doi.org/10.1086/301873			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585601	Green Published, Bronze			2022-12-18	WOS:000074174700032
J	OZELIUS, LJ; KRAMER, PL; DELEON, D; RISCH, N; BRESSMAN, SB; SCHUBACK, DE; BRIN, MF; KWIATKOWSKI, DJ; BURKE, RE; GUSELLA, JF; FAHN, S; BREAKEFIELD, XO				OZELIUS, LJ; KRAMER, PL; DELEON, D; RISCH, N; BRESSMAN, SB; SCHUBACK, DE; BRIN, MF; KWIATKOWSKI, DJ; BURKE, RE; GUSELLA, JF; FAHN, S; BREAKEFIELD, XO			STRONG ALLELIC ASSOCIATION BETWEEN THE TORSION DYSTONIA GENE (DYTI) AND LOCI ON CHROMOSOME 9Q34 IN ASHKENAZI JEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; FAMILIAL DYSAUTONOMIA; SEGREGATION ANALYSIS; DNA POLYMORPHISMS; LINKAGE ANALYSIS; COMPLEX; MAP	The DYT1 gene responsible for early-onset, idiopathic torsion dystonia (ITD) in the Ashkenazi Jewish population, as well as in one large non-Jewish family, has been mapped to chromosome 9q32-34. Using (GT)n and RFLP markers in this region, we have identified obligate recombination events in some of these Jewish families, which further delineate the area containing the DYT1 gene to a 6-cM region bounded by loci AK1 and ASS. In 52 unrelated, affected Ashkenazi Jewish individuals, we have found highly significant linkage disequilibrium between a particular extended haplotype at the ABL-ASS loci and the DYT1 gene. The 4/A12 haplotype for ABL-ASS is present on 69% of the disease-bearing chromosomes among affected Jewish individuals and on only 1% of control Jewish chromosomes (chi-2 = 91.07, P << .001). The allelic association between this extended haplotype and DYT1 predicts that these three genes lie within 1-2 cM of each other; on the basis of obligate recombination events, the DYT1 gene is centromeric to ASS. Furthermore, this allelic association supports the idea that a single mutation event is responsible for most hereditary cases of dystonia in the Jewish population. Of the 53 definitely affecteds typed, 13 appear to be sporadic, with no family history of dystonia. However, the proportion of sporadic cases which potentially carry the A12 haplotype at ASS (8/13 [62%]) is similar to the proportion of familial cases with A12 (28/40 [70%]). This suggests that many sporadic cases are hereditary, that the disease gene frequency is greater than 1115,000, and that the penetrance is lower than 30%, as previously estimated in this population. Most affected individuals were heterozygous for the ABL-ASS haplotype, a finding supporting autosomal dominant inheritance of the DYT1 gene. The ABL-ASS extended-haplotype status will provide predictive value for carrier status in Jewish individuals. This information can be used for molecular diagnosis, evaluation of subclinical expression of the disease, and elucidation of environmental factors which may modify clinical symptoms.	MASSACHUSETTS GEN HOSP E,NEUROSCI CTR NEUROL,MOLEC NEUROGENET UNIT,13TH ST,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT MED,BOSTON,MA 02114; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; COLUMBIA PRESBYTERIAN MED CTR,DEPT NEUROL,DYSTONIA CLIN RES CTR,NEW YORK,NY 10032; YALE UNIV,SCH MED,DEPT EPIDEMIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Oregon Health & Science University; Columbia University; NewYork-Presbyterian Hospital; Yale University; Yale University; Yale University			Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553	NINDS NIH HHS [NS26656, NS28384, NS26836] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026836, R29NS026836, R01NS028384, R01NS026656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; BECHHANSEN NT, 1989, NUCLEIC ACIDS RES, V17, P4004, DOI 10.1093/nar/17.10.4004; BREAKEFIELD XO, 1986, J NEUROGENET, V3, P159, DOI 10.3109/01677068609106846; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; FAHN S, 1988, ANN NEUROL, V24, P179; FAHN S, 1987, MOVEMENT DISORD, V2, P332; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FLEISS JL, 1981, STATISTICAL METHODS, P56; FLETCHER NA, 1990, BRAIN, V113, P379, DOI 10.1093/brain/113.2.379; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HAINES JL, 1990, GENOMICS, V8, P1, DOI 10.1016/0888-7543(90)90218-J; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KUPKE KG, 1990, AM J MED GENET, V36, P237, DOI 10.1002/ajmg.1320360219; KWIATKOWSKI D, 1991, NUCLEIC ACIDS RES, V19, P4967; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V49, P366; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1988, GENOMICS, V3, P361; Lee L V, 1976, Adv Neurol, V14, P137; LITT M, 1989, AM J HUM GENET, V44, P397; MAAYAN C, 1987, CLIN GENET, V32, P106; MULLER U, 1990, HUM GENET, V84, P107; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10607, DOI 10.1093/nar/15.24.10607; NORTHRUP H, 1989, GENOMICS, V5, P442, DOI 10.1016/0888-7543(89)90007-4; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS L, IN PRESS CYTOGENET C; PAULS DL, 1990, NEUROLOGY, V40, P1107, DOI 10.1212/WNL.40.7.1107; RISCH NJ, 1990, AM J HUM GENET, V46, P533; SCHUBACK DE, 1991, NUCLEIC ACIDS RES, V19, P5798; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; WEBER JL, 1989, AM J HUM GENET, V44, P388; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77; ZILBER N, 1984, J MED GENET, V21, P13, DOI 10.1136/jmg.21.1.13	40	130	131	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					619	628						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347197				2022-12-18	WOS:A1992HH97400022
J	JORDE, LB; HASSTEDT, SJ; RITVO, ER; MASONBROTHERS, A; FREEMAN, BJ; PINGREE, C; MCMAHON, WM; PETERSEN, B; JENSON, WR; MOLL, A				JORDE, LB; HASSTEDT, SJ; RITVO, ER; MASONBROTHERS, A; FREEMAN, BJ; PINGREE, C; MCMAHON, WM; PETERSEN, B; JENSON, WR; MOLL, A			COMPLEX SEGREGATION ANALYSIS OF AUTISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UTAH EPIDEMIOLOGIC SURVEY; MULTIFACTORIAL QUALITATIVE TRAITS; FENFLURAMINE TREATMENT; 1ST-DEGREE RELATIVES; INFANTILE-AUTISM; RECURRENCE RISKS; GENETIC ANALYSIS; FRAGILE-X; ELECTRORETINOGRAMS; PEDIGREES	A complex segregation analysis of autism in 185 Utah families was carried out using the mixed model. The 209 affected individuals in these families represent nearly complete ascertainment of the autistic cases born in Utah between 1965 and 1984. The sibling recurrence risk for autism was 4.5% (95% confidence limits 2.8%-6.2%). Likelihoods were maximized for major-gene models, a polygenic model, a sibling-effect model, and a mixed model consisting of major-gene and shared-sibling effects. The analysis provided no evidence for major-locus inheritance of autism. Subdivision of the sample according to the probands' IQ levels showed that sibling recurrence risk did not vary consistently with IQ level. A segregation analysis of families in which the proband had an IQ < 50 also failed to provide evidence for a major locus. However, because of the etiologic heterogeneity of this disorder, genetic analysis of other meaningful subsets of families could prove informative.	UNIV UTAH,SCH MED,DEPT PSYCHIAT,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DEPT EDUC PSYCHOL,SALT LAKE CITY,UT 84112; AUTISM SOC UTAH,SALT LAKE CITY,UT; UNIV CALIF LOS ANGELES,SCH MED,INST NEUROPSYCHIAT,LOS ANGELES,CA 90024	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	JORDE, LB (corresponding author), UNIV UTAH,SCH MED,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,ROOM 2100,SALT LAKE CITY,UT 84112, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017463, R23HD017463] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000347] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABRAMSON RK, 1989, J AUTISM DEV DISORD, V19, P397, DOI 10.1007/BF02212938; AMAN MG, 1989, J AM ACAD CHILD PSY, V28, P549, DOI 10.1097/00004583-198907000-00014; BAIRD TD, 1985, J AUTISM DEV DISORD, V15, P315, DOI 10.1007/BF01531501; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; CAMPBELL M, 1988, J CHILD PSYCHOL PSYC, V29, P1, DOI 10.1111/j.1469-7610.1988.tb00684.x; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; COHEN IL, 1991, AM J HUM GENET, V48, P195; Coleman M, 1985, BIOL AUTISTIC SYNDRO; CREEL DJ, 1989, CLIN VISION SCI, V4, P85; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; GLADSTIEN K, 1978, AM J MED GENET, V2, P7, DOI 10.1002/ajmg.1320020103; JORDE LB, 1989, ANN HUM GENET, V53, P339, DOI 10.1111/j.1469-1809.1989.tb01803.x; JORDE LB, 1990, AM J MED GENET, V36, P85, DOI 10.1002/ajmg.1320360116; KHOURY MJ, 1987, AM J MED GENET, V28, P159, DOI 10.1002/ajmg.1320280123; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; MASONBROTHERS A, 1990, PEDIATRICS, V86, P514; MATTHYSSE S, 1979, P NATL ACAD SCI USA, V76, P2862, DOI 10.1073/pnas.76.6.2862; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MORTON NE, 1974, AM J HUM GENET, V26, P489; PAYTON JB, 1989, J AM ACAD CHILD PSY, V28, P417, DOI 10.1097/00004583-198905000-00019; REALMUTO G, 1989, CAN J PSYCHIAT, V34, P435, DOI 10.1177/070674378903400513; RICE J, 1979, BIOMETRICS, V35, P451, DOI 10.2307/2530347; RITVO ER, 1990, AM J PSYCHIAT, V147, P1614; RITVO ER, 1986, PSYCHOPHARMACOL BULL, V22, P133; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; RITVO ER, 1989, AM J PSYCHIAT, V146, P194; RITVO ER, 1988, AM J PSYCHIAT, V145, P229; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; SPENCE MA, 1985, BEHAV GENET, V15, P1; VOGLER GP, 1990, BEHAV GENET, V20, P461, DOI 10.1007/BF01067712; WAGENER DK, 1988, GENET EPIDEMIOL, V5, P95, DOI 10.1002/gepi.1370050205; WAHLSTROM J, 1989, AM J MED GENET, V32, P19, DOI 10.1002/ajmg.1320320105; WARREN RP, 1990, IMMUNOL INVEST, V19, P245, DOI 10.3109/08820139009041839; ZAHNER GEP, 1987, HDB AUTISM PERVASIVE, P199; [No title captured]; 1980, DIAGNOSTIC STATISTIC; [No title captured]; [No title captured]; [No title captured]; [No title captured]	46	130	134	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					932	938						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GM873	1928098				2022-12-18	WOS:A1991GM87300003
J	ZIMRAN, A; GELBART, T; WESTWOOD, B; GRABOWSKI, GA; BEUTLER, E				ZIMRAN, A; GELBART, T; WESTWOOD, B; GRABOWSKI, GA; BEUTLER, E			HIGH-FREQUENCY OF THE GAUCHER DISEASE MUTATION AT NUCLEOTIDE-1226 AMONG ASHKENAZI JEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JEWISH MUTATION; DIAGNOSIS; HETEROGENEITY	Reliable estimates of the frequency of Gaucher disease-producing mutations are not available. The high frequency of Gaucher disease in the Ashkenazi Jewish population is due to the occurrence of a mutation at nucleotide (nt) 1226. We have screened 593 DNA samples from normal Ashkenazi Jews, as well as 62 DNA samples from all of our Ashkenazi Jewish patients with Gaucher disease, for the presence of the 1226 mutation. In the 593 presumed normal Ashkenazi Jewish individuals the 1226 mutation was identified in the heterozygous state in 37 and in the homozygous state in two, giving a gene frequency of .035 for the mutation. This 1226 mutation represented 73% of the 124 Gaucher disease alleles in Jewish Gaucher disease patients. Accordingly we estimate that the gene frequency for Gaucher disease among the Ashkenazi Jewish population is .047, which is equivalent to a carrier frequency of 8.9% and a birth incidence of 1:450.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA; CUNY MT SINAI SCH MED, DIV MED & MOLEC GENET, NEW YORK, NY 10029 USA; SHAARE ZEDEK MED CTR, DEPT MED, IL-91000 JERUSALEM, ISRAEL	Scripps Research Institute; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Hebrew University of Jerusalem; Shaare Zedek Medical Center					NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK36639, DK36729] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036639, R01DK036729] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERREBI A, 1984, NOUV REV FR HEMATOL, V26, P201; BEUTLER E, 1970, J LAB CLIN MED, V76, P747; BEUTLER E, 1990, BLOOD, V76, P646; BEUTLER E, 1990, CLIN CHIM ACTA, V194, P161, DOI 10.1016/0009-8981(90)90130-K; BEUTLER E, 1977, JAMA-J AM MED ASSOC, V237, P2529, DOI 10.1001/jama.237.23.2529; BEUTLER E, 1988, BLOOD REV, V2, P59, DOI 10.1016/0268-960X(88)90009-4; BRINN L, 1962, N Y State J Med, V62, P2346; DESNICK RJ, 1982, GAUCHER DISEASE CENT, P1; FRIED K, 1973, ISRAEL J MED SCI, V9, P1396; FRIED K, 1958, 4TH B RES COUNC IS B, V7, P213; GRABOWSKI GA, 1982, GAUCHER DISEASE CENT, P573; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; Kolodny EH, 1982, GAUCHER DISEASE CENT, P33; KUMAR R, 1989, ONCOGENE RES, V4, P235; Maniatis T., 1982, MOL CLONING; MATOTH Y, 1987, AM J MED GENET, V27, P561; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P5708; ZIMRAN A, 1990, AM J CLIN PATHOL, V93, P788, DOI 10.1093/ajcp/93.6.788; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, AM J HUM GENET, V46, P902	23	130	133	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					855	859						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897529				2022-12-18	WOS:A1991GG66500017
J	WILKIE, AOM; BUCKLE, VJ; HARRIS, PC; LAMB, J; BARTON, NJ; REEDERS, ST; LINDENBAUM, RH; NICHOLLS, RD; BARROW, M; BETHLENFALVAY, NC; HUTZ, MH; TOLMIE, JL; WEATHERALL, DJ; HIGGS, DR				WILKIE, AOM; BUCKLE, VJ; HARRIS, PC; LAMB, J; BARTON, NJ; REEDERS, ST; LINDENBAUM, RH; NICHOLLS, RD; BARROW, M; BETHLENFALVAY, NC; HUTZ, MH; TOLMIE, JL; WEATHERALL, DJ; HIGGS, DR			CLINICAL-FEATURES AND MOLECULAR ANALYSIS OF THE ALPHA-THALASSEMIA MENTAL-RETARDATION SYNDROMES .1. CASES DUE TO DELETIONS INVOLVING CHROMOSOME BAND 16P13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; YALE UNIV,DEPT INTERNAL MED,NEPHROL SECT,NEW HAVEN,CT 06520; DUNCAN GUTHRIE INST MED GENET,GLASGOW,SCOTLAND; INST BIOCIENCIAS,DEPT GENET,PORTO ALEGRE,BRAZIL; UNIV FLORIDA,COLL MED,DEPT NEUROSCI,GAINESVILLE,FL 32611; CITY HOSP NOTTINGHAM,DEPT CLIN GENET,NOTTINGHAM NG5 1PB,ENGLAND; FITZSIMONS ARMY MED CTR,AURORA,CO 80045	University of Oxford; University of Oxford; Yale University; State University System of Florida; University of Florida; Nottingham University Hospital NHS Trust; Nottingham City Hospital			Hutz, Mara H/I-4070-2012; Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Lamb, Janette/0000-0002-8926-0516; Hutz, Mara/0000-0002-9146-1229	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANNEREN G, 1984, ACTA PAEDIATR SCAND, V73, P281, DOI 10.1111/j.1651-2227.1984.tb09947.x; BAUKNECHT T, 1976, HUM GENET, V34, P227, DOI 10.1007/BF00278894; BOROCHOVITZ D, 1970, CLIN PEDIATR, V9, P432, DOI 10.1177/000992287000900716; BOWCOCK AM, 1984, BRIT J HAEMATOL, V56, P69, DOI 10.1111/j.1365-2141.1984.tb01272.x; BREUNING MH, 1987, HUM GENET, V76, P287; BREUNING MH, 1987, LANCET, V2, P1359; BUCKLE VJ, 1988, J MED GENET, V25, P847, DOI 10.1136/jmg.25.12.847; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; CHODIRKER BN, 1988, AM J MED GENET, V31, P145, DOI 10.1002/ajmg.1320310117; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EMANUEL B, 1982, AM J HUM GENET, V34, pA124; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GALANELLO R, 1984, ACTA HAEMATOL-BASEL, V72, P34, DOI 10.1159/000206353; GERMINO GG, 1990, AM J HUM GENET, V46, P925; GOLDEN NL, 1981, CLIN GENET, V19, P41; HALL JG, 1988, AM J HUM GENET, V43, P355; HARRIS PC, 1989, CYTOGENET CELL GENET, V51, P1011; HARRIS PC, IN PRESS GENOMICS; HIGGS DR, 1989, BLOOD, V73, P1081; HJELLE B, 1982, AM J HEMATOL, V13, P319, DOI 10.1002/ajh.2830130407; HUTZ MH, 1986, 7TH INT C HUM GEN BE, P458; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LAMB J, 1989, LANCET, V2, P819; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MOSER HW, 1983, PRINCIPLES PRACTICE, P352; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3122, DOI 10.1093/nar/16.7.3122; NAZARENKO SA, 1987, TSITOL GENET+, V21, P434; NEIDENGARD L, 1981, HUM GENET, V59, P175, DOI 10.1007/BF00293072; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NIELSEN KB, 1983, DAN MED BULL, V30, P5; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; PAWLOWITZKI IH, 1979, CLIN GENET, V15, P167; PERGAMENT E, 1970, J PEDIATR-US, V76, P745, DOI 10.1016/S0022-3476(70)80295-5; QUINTANA A, 1983, CLIN GENET, V23, P243; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; Rudolph A., 1977, PEDIATRICS, P1109; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; VILLEGAS A, 1990, EUR J HAEMATOL, V44, P109; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WILKIE AOM, 1990, AM J HUM GENET, V46; WINTER RM, 1988, J MED GENET, V25, P118, DOI 10.1136/jmg.25.2.118; WOLFF E, 1988, NUCLEIC ACIDS RES, V16, P9885, DOI 10.1093/nar/16.20.9885; XIAO GH, 1987, CYTOGENET CELL GENET, V46, P721	54	130	134	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1112	1126						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339704				2022-12-18	WOS:A1990DF20200012
J	NGO, KY; VERGNAUD, G; JOHNSSON, C; LUCOTTE, G; WEISSENBACH, J				NGO, KY; VERGNAUD, G; JOHNSSON, C; LUCOTTE, G; WEISSENBACH, J			A DNA PROBE DETECTING MULTIPLE HAPLOTYPES OF THE HUMAN Y-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST PASTEUR, CNRS,LAB 271,INSERM,U163, UNITE RECOMBINAISON & EXPRESS GENET, F-75724 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	NGO, KY (corresponding author), CTR NATL TRANSFUS SANGUINE INST, GENET MOLEC LAB, 6 RUE ALEXANDRE CABANEL, F-75015 PARIS, FRANCE.		Vergnaud, Gilles/P-1304-2015	Vergnaud, Gilles/0000-0003-0913-194X				Avise J.C., 1983, P147; AVISE JC, 1979, P NATL ACAD SCI USA, V76, P6694, DOI 10.1073/pnas.76.12.6694; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown W.M., 1983, P62; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; GAUTREAU C, 1983, ANAL BIOCHEM, V134, P320, DOI 10.1016/0003-2697(83)90304-4; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; KAN YW, 1978, LANCET, V2, P910; LAMAR EE, 1984, CELL, V37, P171, DOI 10.1016/0092-8674(84)90312-X; LANSMAN RA, 1983, EVOLUTION, V37, P1, DOI 10.1111/j.1558-5646.1983.tb05509.x; LANSMAN RA, 1981, J MOL EVOL, V17, P214, DOI 10.1007/BF01732759; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; RAHUEL C, 1983, REV FR TRANSFUS IMMU, V26, P539, DOI 10.1016/S0338-4535(83)80123-8; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WOLFE J, 1984, EMBO J, V3, P1997, DOI 10.1002/j.1460-2075.1984.tb02081.x	32	130	133	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					407	418						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3010708				2022-12-18	WOS:A1986C489300001
J	Han, B; Diogo, D; Eyre, S; Kallberg, H; Zhernakova, A; Bowes, J; Padyukov, L; Okada, Y; Gonzalez-Gay, MA; Rantapaa-Dahlqvist, S; Martin, J; Huizinga, TWJ; Plenge, RM; Worthington, J; Gregersen, PK; Klareskog, L; de Bakker, PIW; Raychaudhuri, S				Han, Buhm; Diogo, Dorothee; Eyre, Steve; Kallberg, Henrik; Zhernakova, Alexandra; Bowes, John; Padyukov, Leonid; Okada, Yukinori; Gonzalez-Gay, Miguel A.; Rantapaa-Dahlqvist, Solbritt; Martin, Javier; Huizinga, Tom W. J.; Plenge, Robert M.; Worthington, Jane; Gregersen, Peter K.; Klareskog, Lars; de Bakker, Paul I. W.; Raychaudhuri, Soumya			Fine Mapping Seronegative and Seropositive Rheumatoid Arthritis to Shared and Distinct HLA Alleles by Adjusting for the Effects of Heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLIC CITRULLINATED PEPTIDE; GENOME-WIDE ASSOCIATION; ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY LOCI; DISEASE RISK; MHC; DETERMINANTS; PREDICTION; ANTIBODIES; PSORIASIS	Despite progress in defining human leukocyte antigen (HLA) alleles for anti-citrullinated-protein-autoantibody-positive (ACPA(+)) rheumatoid arthritis (RA), identifying HLA alleles for ACPA-negative (ACPA(-)) RA has been challenging because of clinical heterogeneity within clinical cohorts. We imputed 8,961 classical HLA alleles, amino acids, and SNPs from Immunochip data in a discovery set of 2,406 ACPA(-) RA case and 13,930 control individuals. We developed a statistical approach to identify and adjust for clinical heterogeneity within ACPA RA and observed independent associations for serine and leucine at position 11 in HLA-DR beta 1 (p = 1.4 x 10 (13), odds ratio [OR] = 1.30) and for aspartate at position 9 in HLA-B (p = 2.7 x 10(-12), OR = 1.39) within the peptide binding grooves. These amino acid positions induced associations at HLA-DRB1*03 (encoding serine at 11) and HLA-B*08 (encoding aspartate at 9). We validated these findings in an independent set of 427 ACPA(-) case subjects, carefully phenotyped with a highly sensitive ACPA assay, and 1,691 control subjects (HLA-DR beta 1 Ser11+Leu11: p = 5.8 x 10(-4), OR = 1.28; HLA-B Asp9: p = 2.6 x 10(-3), OR = 1.34). Although both amino acid sites drove risk of ACPA(+) and ACPA(-) disease, the effects of individual residues at HLA-DR beta 1 position 11 were distinct (p < 2.9 x 10(-107)). We also identified an association with ACPA(+) RA at HLA-A position 77 (p = 2.7 x 10(-8), OR = 0.85) in 7,279 ACPA(+) RA case and 15,870 control subjects. These results contribute to mounting evidence that ACPA(+) and ACPA(-) RA are genetically distinct and potentially have separate autoantigens contributing to pathogenesis. We expect that our approach might have broad applications in analyzing clinical conditions with heterogeneity at both major histocompatibility complex (MHC) and non-MHC regions.	[Han, Buhm; Diogo, Dorothee; Okada, Yukinori; de Bakker, Paul I. W.; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Han, Buhm; Diogo, Dorothee; Okada, Yukinori; de Bakker, Paul I. W.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Han, Buhm; Diogo, Dorothee; Okada, Yukinori; de Bakker, Paul I. W.; Raychaudhuri, Soumya] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Han, Buhm; Diogo, Dorothee; Okada, Yukinori; Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA 02115 USA; [Diogo, Dorothee; Okada, Yukinori; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Eyre, Steve; Bowes, John; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Musculoskeletal Res Grp, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Eyre, Steve; Bowes, John; Worthington, Jane] Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester M13 9PT, Lancs, England; [Kallberg, Henrik; Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Kallberg, Henrik; Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, S-17176 Stockholm, Sweden; [Zhernakova, Alexandra; Huizinga, Tom W. J.] Leiden Univ Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Gonzalez-Gay, Miguel A.] Hosp Univ Marques Valdecilla, Rheumatol Div, Inst Formac & Invest Marques Valdecilla, Santander 39008, Spain; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Rheumatol, S-90185 Umea, Sweden; [Martin, Javier] CSIC, Inst Parasitol Biomed Lopez Neyra, Granada 18100, Spain; [Plenge, Robert M.] Merck & Co Inc, Merck Res Labs, Boston, MA 02115 USA; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, NL-3584 CG Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; University of Manchester; University of Manchester; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; University of Groningen; Hospital Universitario Marques de Valdecilla (HUMV); Umea University; Umea University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Merck & Company; Northwell Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	soumya@broadinstitute.org	Martin, Javier/B-8141-2008; Worthington, Jane/M-9770-2014; González-Gay, Miguel A./B-2306-2008; de Bakker, Paul IW/B-8730-2009; Martín, María/HDL-9512-2022; eyre, stephen/K-3776-2017; Zhernakova, Alexandra/ABA-9372-2020; Han, Buhm/AAQ-9672-2020; Martín, Javier/AAV-5209-2021; Padyukov, Leonid/A-4890-2009	Martin, Javier/0000-0002-2202-0622; Worthington, Jane/0000-0003-0544-042X; González-Gay, Miguel A./0000-0002-7924-7406; de Bakker, Paul IW/0000-0001-7735-7858; eyre, stephen/0000-0002-1251-6974; Klareskog, Lars/0000-0001-9601-6186; DIOGO, DOROTHEE/0000-0003-2913-5913; Zhernakova, Alexandra/0000-0002-4574-0841; Raychaudhuri, Soumya/0000-0002-1901-8265; Padyukov, Leonid/0000-0003-2950-5670; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863	National Institutes of Health [K08AR055688, 1R01AR062886-01, 1R01AR063759-01A1, 5U01GM092691-04]; Arthritis Foundation; Doris Duke Foundation; Be the Cure For Rheumatoid Arthritis grant; Innovative Medicine Initiative program from the European Union; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; Dutch Reumafonds [11-1-101]; Rosalind Franklin Fellowship from the University of Groningen (the Netherlands); Rheumatoid Arthritis International Consortium; Netherlands Organization for Scientific Research [016.126.354]; Red de Investigacion en Inflamacion y Enfermedades Reumaticas of the Redes Tematicas de Investigacion Cooperativa en Salud from the Instituto de Salud Carlos III Health Ministry (Spain) [RD12/0009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, K08AR055688, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Be the Cure For Rheumatoid Arthritis grant; Innovative Medicine Initiative program from the European Union; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Dutch Reumafonds; Rosalind Franklin Fellowship from the University of Groningen (the Netherlands); Rheumatoid Arthritis International Consortium; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Red de Investigacion en Inflamacion y Enfermedades Reumaticas of the Redes Tematicas de Investigacion Cooperativa en Salud from the Instituto de Salud Carlos III Health Ministry (Spain); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (K08AR055688, 1R01AR062886-01, 1R01AR063759-01A1, and 5U01GM092691-04), the Arthritis Foundation, and the Doris Duke Foundation and in part through the Be the Cure For Rheumatoid Arthritis grant funded by the Innovative Medicine Initiative program from the European Union. This research used data provided by the Type 1 Diabetes Genetics Consortium (a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International). A.Z. was supported by a grant from the Dutch Reumafonds (11-1-101) and the Rosalind Franklin Fellowship from the University of Groningen (the Netherlands). These data also included data generously provided by the Rheumatoid Arthritis International Consortium. P.I.W.d.B. is the recipient of a Vidi award from the Netherlands Organization for Scientific Research (project 016.126.354). This work was partially supported by the Red de Investigacion en Inflamacion y Enfermedades Reumaticas (RD12/0009) of the Redes Tematicas de Investigacion Cooperativa en Salud from the Instituto de Salud Carlos III Health Ministry (Spain).	BOIRE G, 1993, J RHEUMATOL, V20, P1654; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Daha NA, 2011, NAT REV RHEUMATOL, V7, P203, DOI 10.1038/nrrheum.2011.28; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Ho PYPC, 2007, ANN RHEUM DIS, V66, P807, DOI 10.1136/ard.2006.064972; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; Lundberg K, 2013, ANN RHEUM DIS, V72, P652, DOI 10.1136/annrheumdis-2012-201484; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van der Linden MPM, 2009, ARTHRITIS RHEUM-US, V60, P2232, DOI 10.1002/art.24716; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wiik AS, 2010, AUTOIMMUN REV, V10, P90, DOI 10.1016/j.autrev.2010.08.009	34	129	130	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					522	532		10.1016/j.ajhg.2014.02.013	http://dx.doi.org/10.1016/j.ajhg.2014.02.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24656864	Green Published, Bronze			2022-12-18	WOS:000333765300004
J	Zhang, XY; Wen, JM; Yang, W; Wang, C; Gao, LN; Zheng, LH; Wang, T; Ran, KK; Li, YL; Li, XY; Xu, M; Luo, JY; Feng, SL; Ma, XX; Ma, HY; Chai, ZY; Zhou, ZA; Yao, J; Zhang, X; Liu, JY				Zhang, Xiang Yang; Wen, Jingmin; Yang, Wei; Wang, Cheng; Gao, Luna; Zheng, Liang Hong; Wang, Tao; Ran, Kaikai; Li, Yulei; Li, Xiangyang; Xu, Ming; Luo, Junyu; Feng, Shenglei; Ma, Xixiang; Ma, Hongying; Chai, Zuying; Zhou, Zhuan; Yao, Jing; Zhang, Xue; Liu, Jing Yu			Gain-of-Function Mutations in SCN11A Cause Familial Episodic Pain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-CHANNEL NA(V)1.7; RESISTANT NA+ CURRENT; SCN9A; EXCITABILITY; ACTIVATION; EXPRESSION; THRESHOLD; NAV1.9	Many ion channel genes have been associated with human genetic pain disorders. Here we report two large Chinese families with autosomal-dominant episodic pain. We performed a genome-wide linkage scan with microsatellite markers after excluding mutations in three known genes (SCN9A, SCN10A, and TRPA1) that cause similar pain syndrome to our findings, and we mapped the genetic locus to a 7.81 Mb region on chromosome 3p22.3-p21.32. By using whole-exome sequencing followed by conventional Sanger sequencing, we identified two missense mutations in the gene encoding voltage-gated sodium channel Na(v)1.9 (SCN11A): c.673C>T (p.Arg225Cys) and c.2423C>G (p.Ala808Gly) (one in each family). Each mutation showed a perfect cosegregation with the pain phenotype in the corresponding family, and neither of them was detected in 1,021 normal individuals. Both missense mutations were predicted to change a highly conserved amino acid residue of the human Na(v)1.9 channel. We expressed the two SCN11A mutants in mouse dorsal root ganglion (DRG) neurons and showed that both mutations enhanced the channel's electrical activities and induced hyperexcitablity of DRG neurons. Taken together, our results suggest that gain-of-function mutations in SCN11A can be causative of an autosomal-dominant episodic pain disorder.	[Zhang, Xiang Yang; Wen, Jingmin; Wang, Cheng; Gao, Luna; Li, Yulei; Li, Xiangyang; Xu, Ming; Feng, Shenglei; Ma, Xixiang; Ma, Hongying; Yao, Jing; Liu, Jing Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Zhang, Xiang Yang; Wen, Jingmin; Wang, Cheng; Gao, Luna; Li, Yulei; Li, Xiangyang; Xu, Ming; Feng, Shenglei; Ma, Xixiang; Ma, Hongying; Yao, Jing; Liu, Jing Yu] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China; [Yang, Wei; Zhang, Xue] Chinese Acad Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Yang, Wei; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Yang, Wei; Zhang, Xue] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zheng, Liang Hong; Chai, Zuying; Zhou, Zhuan] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Zheng, Liang Hong; Chai, Zuying; Zhou, Zhuan] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zheng, Liang Hong; Chai, Zuying; Zhou, Zhuan] Peking Univ, Inst Mol Med, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Wang, Tao] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Wuhan 430070, Hubei, Peoples R China; [Ran, Kaikai] Xinxiang Med Univ, Henan Univ, Key Open Lab Tissue Regenerat, Xinxiang 453003, Henan, Peoples R China; [Luo, Junyu] Wuhan Inst Technol, Sch Chem Engn & Pharm, Wuhan 430073, Hubei, Peoples R China; [Yao, Jing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Peking University; Peking University; Huazhong University of Science & Technology; Henan University; Xinxiang Medical University; Wuhan Institute of Technology; Wuhan University	Yao, J (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.	jyao@whu.edu.cn; liujy@mail.hust.edu.cn		Yao, Jing/0000-0003-1844-3988; Wang, Cheng/0000-0002-7822-259X	National Natural Science Foundation of China [31230045, 81271252, 31271209, 31100597]; Program for Changjiang Scholars and Innovative Research Team in University [LRT1006]; National Science & Technology Pillar Program [2012BAI09B04]; Specialized Research Fund for the Doctoral Program of Higher Education of Ministry of Education of China [20120142120062]; National Basic Research Program of China [2014CB910304/02, 2012CB518006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science & Technology Pillar Program; Specialized Research Fund for the Doctoral Program of Higher Education of Ministry of Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program of China(National Basic Research Program of China)	We thank the affected individuals and their families' members who participated in the study for their continuous support. This study was mainly supported by the National Natural Science Foundation of China grants 31230045 and 81271252 (J.Y.L.), 31271209 (J.Y.), and 31100597 (L.H.Z.), by the Program for Changjiang Scholars and Innovative Research Team in University (LRT1006 to X.Z.), by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAI09B04) (J.Y.L.), and by Specialized Research Fund for the Doctoral Program of Higher Education of Ministry of Education of China (No. 20120142120062 to J.Y.), and the National Basic Research Program of China 2014CB910304/02 (J.Y.) and 2012CB518006 (Z.Z.).	Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Blair NT, 2002, J NEUROSCI, V22, P10277; Bosmans F, 2011, J GEN PHYSIOL, V138, P59, DOI 10.1085/jgp.201110614; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dabby R, 2011, J NEUROL SCI, V301, P90, DOI 10.1016/j.jns.2010.10.006; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 2002, MOL NEUROBIOL, V26, P235, DOI 10.1385/MN:26:2-3:235; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Goldberg YP, 2012, CLIN GENET, V82, P367, DOI 10.1111/j.1399-0004.2012.01942.x; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Hoeijmakers JGJ, 2012, CLIN GENET, V82, P351, DOI 10.1111/j.1399-0004.2012.01937.x; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Keh SM, 2008, LARYNGOSCOPE, V118, P573, DOI 10.1097/MLG.0b013e3181625d5a; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Lolignier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023083; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Scroggs RS, 2012, NEUROSCIENCE, V222, P205, DOI 10.1016/j.neuroscience.2012.07.012; Scroggs RS, 2010, NEUROSCIENCE, V165, P1293, DOI 10.1016/j.neuroscience.2009.11.042; Shields SD, 2012, J NEUROSCI, V32, P10819, DOI 10.1523/JNEUROSCI.0304-12.2012; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	35	129	138	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					957	966		10.1016/j.ajhg.2013.09.016	http://dx.doi.org/10.1016/j.ajhg.2013.09.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207120	Bronze, Green Published			2022-12-18	WOS:000326996600016
J	Ravenscroft, G; Miyatake, S; Lehtokari, VL; Todd, EJ; Vomauen, P; Yau, KS; Hayashi, YK; Miyake, N; Tsurusaki, Y; Doi, H; Saitsu, H; Osaka, H; Yamashita, S; Ohya, T; Sakamoto, Y; Koshimizu, E; Imamura, S; Yamashita, M; Ogata, K; Shiina, M; Bryson-Richardson, RJ; Vaz, R; Ceyhan, O; Brownstein, CA; Swanson, LC; Monnot, S; Romero, NB; Amthor, H; Kresoje, N; Sivadorai, P; Kiraly-Borri, C; Haliloglu, G; Talim, B; Orhan, D; Kale, G; Charles, AK; Fabian, VA; Davis, MR; Lammens, M; Sewry, CA; Manzur, A; Muntoni, F; Clarke, NF; North, KN; Bertini, E; Nevo, Y; Willichowski, E; Silberg, IE; Topaloglu, H; Beggs, AH; Allcock, RJN; Nishino, I; Wallgren-Pettersson, C; Matsumoto, N; laing, NG				Ravenscroft, Gianina; Miyatake, Satoko; Lehtokari, Vilma-Lotta; Todd, Emily J.; Vomauen, Pauliina; Yau, Kyle S.; Hayashi, Yukiko K.; Miyake, Noriko; Tsurusaki, Yoshinori; Doi, Hiroshi; Saitsu, Hirotomo; Osaka, Hitoshi; Yamashita, Sumimasa; Ohya, Takashi; Sakamoto, Yuko; Koshimizu, Eriko; Imamura, Shintaro; Yamashita, Michiaki; Ogata, Kazuhiro; Shiina, Masaaki; Bryson-Richardson, Robert J.; Vaz, Raquel; Ceyhan, Ozge; Brownstein, Catherine A.; Swanson, Lindsay C.; Monnot, Sophie; Romero, Norma B.; Amthor, Helge; Kresoje, Nina; Sivadorai, Padma; Kiraly-Borri, Cathy; Haliloglu, Goknur; Talim, Beril; Orhan, Diclehan; Kale, Gulsev; Charles, Adrian K.; Fabian, Victoria A.; Davis, Mark R.; Lammens, Martin; Sewry, Caroline A.; Manzur, Adnan; Muntoni, Francesco; Clarke, Nigel F.; North, Kathryn N.; Bertini, Enrico; Nevo, Yoram; Willichowski, Eldthard; Silberg, Inger E.; Topaloglu, Haluk; Beggs, Alan H.; Allcock, Richard J. N.; Nishino, Ichizo; Wallgren-Pettersson, Carina; Matsumoto, Naomichi; laing, Nigel G.			Mutations in KLHL40 Are a Frequent Cause of Severe Autosomal-Recessive Nemaline Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; GENE; PROTEIN; REVEALS; KBTBD13; DISEASE; MODELS; FAMILY; ONSET	Nemaline myopathy (NEM) is a common congenital myopathy. At the very severe end of the NEM clinical spectrum are genetically unresolved cases of autosomal-recessive fetal akinesia sequence. We studied a multinational cohort of 143 severe-NEM-affected families lacking genetic diagnosis. We performed whole-exome sequencing of six families and targeted gene sequencing of additional families. We identified 19 mutations in KLHL40 (kelch-like family member 40) in 28 apparently unrelated NEM kindreds of various ethnicities. Accounting for up to 28% of the tested individuals in the Japanese cohort, KLHL40 mutations were found to be the most common cause of this severe form of NEM. Clinical features of affected individuals were severe and distinctive and included fetal akinesia or hypokinesia and contractures, fractures, respiratory failure, and swallowing difficulties at birth. Molecular modeling suggested that the missense substitutions would destabilize the protein. Protein studies showed that KLHL40 is a striated-muscle-specific protein that is absent in KLHL40-associated NEM skeletal muscle. In zebrafish, klhl40a and klhl40b expression is largely confined to the myotome and skeletal muscle, and knockdown of these isoforms results in disruption of muscle structure and loss of movement. We identified KLHL40 mutations as a frequent cause of severe autosomal-recessive NEM and showed that it plays a key role in muscle development and function. Screening of KLHL40 should be a priority in individuals who are affected by autosomal-recessive NEM and who present with prenatal symptoms and/or contractures and in all Japanese individuals with severe NEM.	[Ravenscroft, Gianina; Todd, Emily J.; Yau, Kyle S.; laing, Nigel G.] Univ Western Australia, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Todd, Emily J.; Yau, Kyle S.; laing, Nigel G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Miyatake, Satoko; Miyake, Noriko; Tsurusaki, Yoshinori; Doi, Hiroshi; Saitsu, Hirotomo; Koshimizu, Eriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Lehtokari, Vilma-Lotta; Vomauen, Pauliina; Wallgren-Pettersson, Carina] Univ Helsinki, Biomedicum Helsinki, Samfundet Folkhalsan, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Lehtokari, Vilma-Lotta; Vomauen, Pauliina; Wallgren-Pettersson, Carina] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki 00014, Finland; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; [Osaka, Hitoshi; Yamashita, Sumimasa] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Yokohama, Kanagawa 2328555, Japan; [Ohya, Takashi; Sakamoto, Yuko] Odawara Municipal Hosp, Dept Pediat, Odawara, Kanagawa 2328558, Japan; [Imamura, Shintaro; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Ogata, Kazuhiro; Shiina, Masaaki] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Bryson-Richardson, Robert J.; Vaz, Raquel] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Ceyhan, Ozge; Brownstein, Catherine A.; Swanson, Lindsay C.; Beggs, Alan H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res Genet & Genom, Boston, MA 02115 USA; [Ceyhan, Ozge; Brownstein, Catherine A.; Swanson, Lindsay C.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Monnot, Sophie; Amthor, Helge] Univ Paris 05, Hop Necker Enfants Malad, Serv Genet Med, F-75015 Paris, France; [Romero, Norma B.] INSERM, Inst Myol, Unite Morphol Neuromusculaire, F-75651 Paris, France; [Kresoje, Nina; Allcock, Richard J. N.] Univ Western Australia, Lotterywest State Biomed Facil Genom, Perth, WA 6000, Australia; [Kresoje, Nina; Allcock, Richard J. N.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6000, Australia; [Sivadorai, Padma; Fabian, Victoria A.; Davis, Mark R.] Royal Perth Hosp, Dept Anat Pathol, Perth, WA 6000, Australia; [Kiraly-Borri, Cathy] Princess Margaret Hosp Children, Genet Serv Western Australia, Subiaco, WA 6008, Australia; [Kiraly-Borri, Cathy] King Edward Mem Hosp Women, Subiaco, WA 6008, Australia; [Haliloglu, Goknur; Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Childrens Hosp, Dept Pediat Neurol, TR-06100 Ankara, Turkey; [Orhan, Diclehan; Kale, Gulsev] Hacettepe Univ, Childrens Hosp, Dept Pediat Pathol, TR-06100 Ankara, Turkey; [Charles, Adrian K.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA 6009, Australia; [Lammens, Martin] Univ Antwerp Hosp, Dept Pathol, B-2650 Antwerp, Belgium; [Sewry, Caroline A.; Manzur, Adnan; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Sewry, Caroline A.; Manzur, Adnan; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Clarke, Nigel F.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bertini, Enrico] Bambino Gesu Pediat Hosp, Unit Neuromuscular Disorders, I-00165 Rome, Lazio, Italy; [Nevo, Yoram] Hebrew Univ Jerusalem, Hadassah Med Ctr, Neuropediat Unit, IL-91240 Jerusalem, Israel; [Willichowski, Eldthard] Univ Med Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Silberg, Inger E.] Natl Hosp Norway, Oslo Univ Hosp, Women & Childrens Div, Neonatal Intens Care Unit,Dept Pediat Res, N-0424 Oslo, Norway	University of Western Australia; University of Western Australia; Yokohama City University; Samfundet Folkhalsan; University of Helsinki; University of Helsinki; National Center for Neurology & Psychiatry - Japan; Japan Fisheries Research & Education Agency (FRA); Yokohama City University; Monash University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; Hacettepe University; Hacettepe University; University of Western Australia; University of Antwerp; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; IRCCS Bambino Gesu; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Gottingen; University of Oslo; National Hospital Norway	laing, NG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Nedlands, WA 6009, Australia.	naomat@yokohama-cu.ac.jp; nigel.laing@uwa.edu.au	Lammens, Martin/AAI-9343-2021; Nishino, Ichizo/G-2676-2010; Saitsu, Hirotomo/AAM-7131-2021; Lammens, Martin/H-1503-2011; Bertini, Enrico/ABG-1278-2020; Bryson-Richardson, Robert/B-7556-2008; North, Kathryn N/K-6476-2012; TOPALOGLU, HALUK AYDIN/I-9318-2013; Bertini, Enrico/A-2284-2014; Vaz, Raquel/AAI-4231-2021; Ravenscroft, Gina/H-5695-2014; monnot, sophie/H-6152-2017	Nishino, Ichizo/0000-0001-9452-112X; Lammens, Martin/0000-0002-3881-6692; Bryson-Richardson, Robert/0000-0002-9501-8208; North, Kathryn N/0000-0003-0841-8009; Bertini, Enrico/0000-0001-9276-4590; Ravenscroft, Gina/0000-0003-3634-211X; monnot, sophie/0000-0002-1872-8089; Tsurusaki, Yoshinori/0000-0002-7240-6355; Lehtokari, Vilma-Lotta/0000-0002-8276-0972; Charles, Adrian/0000-0002-3193-1065; Vaz, Raquel/0000-0001-7518-1801; Beggs, Alan/0000-0001-8818-0568; Brownstein, Catherine/0000-0002-7371-0340; Laing, Nigel/0000-0001-5111-3732; Saitsu, Hirotomo/0000-0003-0723-0960; Kiraly-Borri, Catherine/0000-0003-1711-8390	National Health and Medical Research Council of Australia [APP1035955, APP1002147, APP1022707]; Association Francaise contre les Myopathies (AFM) [AFM15734]; university postgraduate awards; Ministry of Health, Labour, and Welfare; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; National Institutes of Health [R01-AR044345]; Muscular Dystrophy Association [MDA201302]; Telethon [GUP08005]; Ministry of Health on Congenital Myopathies; Great Ormond Street Children's Charity; National Specialist Commissioning Group; AFM; Sigrid Juselius Foundation; Academy of Finland; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Monash Graduate Research Scholarship; Faculty of Science Dean's International Postgraduate Research Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345] Funding Source: NIH RePORTER; Medical Research Council [MR/K000608/1] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/0924, RA4/924] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); university postgraduate awards; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Ministry of Health on Congenital Myopathies(Ministry of Health - Turkey); Great Ormond Street Children's Charity; National Specialist Commissioning Group; AFM(Association Francaise contre les Myopathies); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Monash Graduate Research Scholarship; Faculty of Science Dean's International Postgraduate Research Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the National Health and Medical Research Council of Australia (fellowships APP1035955 to G.R. and APP1002147 to N.G.L. and grant APP1022707) and Association Francaise contre les Myopathies (AFM; AFM15734). E.T. and K.S.Y. are supported by university postgraduate awards. This work received grants from the Ministry of Health, Labour, and Welfare (N. Miyake, H.S., and N. Matsumoto), Japan Science and Technology Agency (N. Matsumoto), Strategic Research Program for Brain Sciences (E.K. and N. Matsumoto), and Takeda Science Foundation (N. Miyake and N. Matsumoto) and Grants-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (N. Miyake and N. Matsumoto) and for Scientific Research from the Japan Society for the Promotion of Science (N. Miyake, H.S., and N. Matsumoto). The A.H.B. laboratory was supported by the National Institutes of Health (R01-AR044345) and the Muscular Dystrophy Association (MDA201302). O.C. is a Dubai Harvard Foundation for Medical Research Fellow and a grantee of the Schlumberger Foundation Faculty for the Future Program. E.B. is supported by grants from Telethon (GUP08005) and the Ministry of Health on Congenital Myopathies. RM. is supported by the Great Ormond Street Children's Charity and National Specialist Commissioning Group. P.V. and V.-L.L. were supported by grants to C.W.-P. by the AFM, Sigrid Juselius Foundation, Academy of Finland, Finska Lakaresallskapet, and Medicinska Understodsforeningen Liv och Halsa r.f. R.V. is supported by a Monash Graduate Research Scholarship and a Faculty of Science Dean's International Postgraduate Research Scholarship.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Embree E. J., 2007, THESIS U TEXAS SW ME; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; KIMURA M, 1973, GENETICS, V75, P199; Lacson AG, 2002, PEDIATR PATHOL MOL M, V21, P569, DOI 10.1080/15227950290112824; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lammens M, 1997, NEUROPEDIATRICS, V28, P116, DOI 10.1055/s-2007-973683; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370; Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nowak KJ, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2012.70; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; QUINN CM, 1991, HISTOPATHOLOGY, V19, P155, DOI 10.1111/j.1365-2559.1991.tb00006.x; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Ravenscroft G, 2013, NEUROMUSCULAR DISORD, V23, P165, DOI 10.1016/j.nmd.2012.11.005; Ravenscroft G, 2011, J MED GENET, V48, P793, DOI 10.1136/jmedgenet-2011-100211; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Ruparelia AA, 2012, HUM MOL GENET, V21, P4073, DOI 10.1093/hmg/dds231; Sambuughin N, 2012, BIOCHEM BIOPH RES CO, V421, P743, DOI 10.1016/j.bbrc.2012.04.074; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	37	129	138	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					6	18		10.1016/j.ajhg.2013.05.004	http://dx.doi.org/10.1016/j.ajhg.2013.05.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746549	Green Published, Bronze			2022-12-18	WOS:000321804500001
J	Benyamin, B; Mcrae, AE; Zhu, G; Gordon, S; Henders, AK; Palotie, A; Peltonen, L; Martin, NG; Montgomery, GW; Whitfield, JB; Visscher, PM				Benyamin, Beben; McRae, Allan E.; Zhu, Gu; Gordon, Scott; Henders, Anjali K.; Palotie, Aarno; Peltonen, Leena; Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.; Visscher, Peter M.			Variants in TF and HFE Explain similar to 40% of Genetic Variation in Serum-Transferrin Levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; IRON-DEFICIENCY ANEMIA; WIDE ASSOCIATION; G277S MUTATION; POLYMORPHISMS; POPULATION; FAMILIES; TMPRSS6; STORES; WOMEN	Only a small proportion of genetic variation in complex traits has been explained by SNPs from genome-wide association studies (GWASs), We report the results from two GWASs for serum markers of iron status (serum iron, serum transferrin, transferrin saturation with iron, and serum ferritin), which are important in iron overload (e.g., hemochromatosis) and deficiency (e.g., anemia) conditions. We performed two GWASs on samples of Australians of European descent. In the first GWAS, 411 adolescent twins and their siblings were genotyped with 100K SNPs. rs1830084, 10.8 kb 3' of TF, was significantly associated with serum transferrin (p total association test = 1.0 x 10(-9); p within-family test = 2.2 x 10(-5)). In the second GWAS on an independent sample of 459 female monozygotic (MZ) twin pairs genotyped with 300K SNPs, we found rs3811647 (within intron 11 of TF, HapMap CEU r(2) with rs1830084 = 0.86) was significantly associated with serum transferrin (p = 3.0 x 10(-1)5). In the second GWAS, we found two additional and independent SNPs on TF (rs1799852 and rs2280673) and confirmed the known C282Y mutation in HFE to be independently associated with serum transferrin. The three variants in TF (rs3811647, rs1799852 and rs2280673) plus the HFE C282Y mutation explained similar to 40% of genetic variation in serum transferrin (p = 7.8 x 10(-25)). These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease.	[Benyamin, Beben; McRae, Allan E.; Zhu, Gu; Gordon, Scott; Henders, Anjali K.; Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John B.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Palotie, Aarno] Univ Helsinki, Dept Clin Chem, Helsinki 00290, Finland; [Palotie, Aarno] Univ Helsinki, Inst Mol Med, Finnish Genome Ctr, Helsinki 00290, Finland; [Palotie, Aarno; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Univ Helsinki, Inst Mol Med, Helsinki 00290, Finland; [Peltonen, Leena] Natl Publ Hlth Inst, Helsinki 00290, Finland	QIMR Berghofer Medical Research Institute; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute; University of Helsinki; Finland National Institute for Health & Welfare	Benyamin, B (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	bebenb@qimr.edu.au	Visscher, Peter/ABB-6151-2020; Benyamin, Beben/D-9195-2012; McRae, Allan F/J-2644-2014; Montgomery, Grant W/B-7148-2008; Henders, Anjali/E-3126-2017	Visscher, Peter/0000-0002-2143-8760; Benyamin, Beben/0000-0001-5608-2293; McRae, Allan F/0000-0001-5286-5485; Montgomery, Grant W/0000-0002-4140-8139; Palotie, Aarno/0000-0002-2527-5874; Whitfield, John/0000-0002-1103-0876; Henders, Anjali/0000-0003-3672-1451; Martin, Nicholas/0000-0003-4069-8020	National Health and Medical Research Council of Australia (NHMRC); European Commission [QLG2-CT-2002-01254]; Center of Excellence in Complex Disease Genetics of the Academy of Finland	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Commission(European CommissionEuropean Commission Joint Research Centre); Center of Excellence in Complex Disease Genetics of the Academy of Finland(Academy of Finland)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC). The genotyping was performed at the Australian Genome Research Facility and the Finnish Genome Center. The GenomEUtwin project is supported by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (QLG2-CT-2002-01254). We acknowledge support from the Center of Excellence in Complex Disease Genetics of the Academy of Finland. We thank Stuart Macgregor, Rita Middelberg, Harry Beeby, and Dale Nyholt of the Queensland Institute of Medical Research (QIMR) for assistance in data preparation and analysis. We thank Leanne Wallace and Megan Campbell for assistance with sample preparation. We thank Dongliang Ge of Duke Institute for Genome Sciences & Policy for advice on using the WGAViewer software. We thank Nathan Subramaniam and Greg Anderson (QIMR) for helpful discussions. The authors declare that they have no competing financial interests.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Delanghe J, 2006, BRIT J HAEMATOL, V132, P249, DOI 10.1111/j.1365-2141.2005.05871.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lee PL, 2001, BRIT J HAEMATOL, V115, P329, DOI 10.1046/j.1365-2141.2001.03096.x; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P539, DOI 10.1006/bcmd.2001.0418; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/twin.6.5.354; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sarria B, 2007, EUR J NUTR, V46, P57, DOI 10.1007/s00394-006-0631-x; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; Whitfield JB, 2003, BRIT J HAEMATOL, V120, P860, DOI 10.1046/j.1365-2141.2003.04224.x; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186	23	129	136	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					60	65		10.1016/j.ajhg.2008.11.011	http://dx.doi.org/10.1016/j.ajhg.2008.11.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19084217	Green Published, Bronze			2022-12-18	WOS:000262679500007
J	Massa, V; Fernandez-Vizarra, E; Alshahwan, S; Bakhsh, E; Goffrini, P; Ferrero, I; Mereghetti, P; D'Adamo, P; Gasparini, P; Zeviani, M				Massa, Valeria; Fernandez-Vizarra, Erika; Alshahwan, Saad; Bakhsh, Eman; Goffrini, Paola; Ferrero, Ileana; Mereghetti, Paolo; D'Adamo, Pio; Gasparini, Paolo; Zeviani, Massimo			Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL; DEFICIENCY; GENES; DEFECTS; ENZYME; YEAST	Cytochrome c oxidase (COX) deficiency, one of the most common respiratory-chain defects in humans, has been associated with mutations in either mitochondrial DNA genes or nucleus-encoded proteins that are not part in but promote the biogenesis of COX. Mutations of nucleus-encoded structural subunits were sought for but never found in COX-defective patients, leading to the conjecture that they may be incompatible with extra-uterine survival. We report a disease-associated mutation in one such subunit, COX6B1. Nuclear-encoded COX genes should be reconsidered and included in the diagnostic mutational screening of human disorders related to COX deficiency.	[Massa, Valeria; Fernandez-Vizarra, Erika; Zeviani, Massimo] Neurol Inst C Besta, Dept Mol Neurogenet, Fdn IRCCS, I-20126 Milan, Italy; [Alshahwan, Saad] Riyadh Mil Hosp, Dept Pediat, Riyadh 11159, Saudi Arabia; [Bakhsh, Eman] Riyadh Mil Hosp, Dept Neuroradiol, Riyadh 11159, Saudi Arabia; [Goffrini, Paola; Ferrero, Ileana] Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy; [Mereghetti, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [D'Adamo, Pio; Gasparini, Paolo] Univ Trieste, IRCCS Burlo Garofolo, Dept Med Genet, I-34137 Trieste, Italy	IRCCS Istituto Neurologico Besta; Prince Sultan Military Medical City; Prince Sultan Military Medical City; University of Parma; University of Milano-Bicocca; IRCCS Burlo Garofolo; University of Trieste	Zeviani, M (corresponding author), Neurol Inst C Besta, Dept Mol Neurogenet, Fdn IRCCS, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Goffrini, Paola/C-3860-2015; Gasparini, Paolo/B-6173-2014; d'Adamo, Adamo Pio/G-4064-2011; Zeviani, Massimo/AAU-2632-2021; Fernandez-Vizarra, Erika/AAE-5600-2020; Zeviani, Massimo/K-2891-2014	Goffrini, Paola/0000-0002-8650-4765; d'Adamo, Adamo Pio/0000-0001-9367-4909; Zeviani, Massimo/0000-0002-9067-5508; Gasparini, Paolo/0000-0002-0859-0856; Mereghetti, Paolo/0000-0001-6012-592X; Fernandez-Vizarra, Erika/0000-0002-2469-142X	Telethon [GGP07019] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Coenen MJH, 2006, J CHILD NEUROL, V21, P508, DOI 10.1177/08830738060210062501; DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; FERRERO I, 1981, A VAN LEEUW J MICROB, V47, P11, DOI 10.1007/BF00399063; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895; LAMARCHE AEP, 1992, J BIOL CHEM, V267, P22473; Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pecina P, 2004, PHYSIOL RES, V53, pS213; Sambrook J, 2001, MOL CLONING LAB MANU; Sampson V, 2001, EUR J BIOCHEM, V268, P6534, DOI 10.1046/j.0014-2956.2001.02608.x; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wharton DC., 1967, METHOD ENZYMOL, P245; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Yoshikawa S, 1998, J BIOENERG BIOMEMBR, V30, P7, DOI 10.1023/A:1020595108560; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	34	129	133	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1281	1289		10.1016/j.ajhg.2008.05.002	http://dx.doi.org/10.1016/j.ajhg.2008.05.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18499082	Green Published, Bronze			2022-12-18	WOS:000256647000006
J	Wessel, J; Schork, NJ				Wessel, Jennifer; Schork, Nicholas J.			Generalized genomic distance-based regression methodology for multilocus association analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PHYLOGENETIC TREES; GENE; RELATEDNESS; EXPRESSION; MUTATIONS; SOFTWARE; STRATEGY; CLUSTER; PREDICT	Large-scale, multilocus genetic association studies require powerful and appropriate statistical-analysis tools that are designed to relate genotype and haplotype information to phenotypes of interest. Many analysis approaches consider relating allelic, haplotypic, or genotypic information to a trait through use of extensions of traditional analysis techniques, such as contingency-table analysis, regression methods, and analysis-of-variance techniques. In this work, we consider a complementary approach that involves the characterization and measurement of the similarity and dissimilarity of the allelic composition of a set of individuals' diploid genomes at multiple loci in the regions of interest. We describe a regression method that can be used to relate variation in the measure of genomic dissimilarity (or "distance") among a set of individuals to variation in their trait values. Weighting factors associated with functional or evolutionary conservation information of the loci can be used in the assessment of similarity. The proposed method is very flexible and is easily extended to complex multilocus-analysis settings involving covariates. In addition, the proposed method actually encompasses both single-locus and haplotype-phylogeny analysis methods, which are two of the most widely used approaches in genetic association analysis. We showcase the method with data described in the literature. Ultimately, our method is appropriate for high-dimensional genomic data and anticipates an era when cost-effective exhaustive DNA sequence data can be obtained for a large number of individuals, over and above genotype information focused on a few well-chosen loci.	Univ Calif San Diego, Dept Psychiat, Polymorphism Res Lab, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Epidemiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biostat, Dept Family & Prevent Med, Moores Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Human Genet & Genom, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; San Diego State Univ, Grad Program Publ Hlth, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University	Schork, NJ (corresponding author), Univ Calif San Diego, Dept Psychiat, Polymorphism Res Lab, 2062 Basic Sci Bldg,9500 Gilman Dr, La Jolla, CA 92093 USA.	nschork@ucsd.edu		Wessel, Jennifer/0000-0002-7031-0085; Schork, Nicholas/0000-0003-0920-5013	NHLBI NIH HHS [U01 HL064777, R01 HL070137-01, U01 HL064777-06, R01 HL070137, R01 HL074730, R01 HL074730-02] Funding Source: Medline; NIA NIH HHS [U19 AG023122, U19 AG023122-01] Funding Source: Medline; PHS HHS [5 R01 HLMH065571-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074730, U01HL064777, R01HL070137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Bardel C, 2006, EUR J HUM GENET, V14, P202, DOI 10.1038/sj.ejhg.5201501; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Brudno M, 2004, GENOME RES, V14, P685, DOI 10.1101/gr.2067704; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Edgington E. S., 1995, RANDOMIZATION TESTS; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; GNANADESIKAN R, 1995, J CLASSIF, V12, P113, DOI 10.1007/BF01202271; Good P., 2000, PERMUTATION TESTS; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hamon SC, 2004, ANN HUM GENET, V68, P521, DOI 10.1046/j.1529-8817.2003.00112.x; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hughes T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-48; Humphreys K, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S74; JOCKEL KH, 1986, ANN STAT, V14, P336, DOI 10.1214/aos/1176349860; Kibbey C, 2005, J CHEM INF MODEL, V45, P523, DOI 10.1021/ci0496954; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; Lee JH, 2003, HUM MOL GENET, V12, P2321, DOI 10.1093/hmg/ddg243; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Luo XG, 2006, AM J HUM GENET, V78, P973, DOI 10.1086/504113; Lynch M, 1999, GENETICS, V152, P1753; Manly B. F., 1997, RANDOMIZATION BOOTST; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; MULLER T, 2005, CLUSTER ANAL COMP DI; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Owen MJ, 2005, CLIN THER, V27, pS2, DOI 10.1016/j.clinthera.2005.07.014; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Seltman H, 2003, GENET EPIDEMIOL, V25, P48, DOI 10.1002/gepi.10246; Seltman H, 2001, AM J HUM GENET, V68, P1250, DOI 10.1086/320110; Shah N, 2004, BIOINFORMATICS, V20, P636, DOI 10.1093/bioinformatics/btg459; Shriver Mark D, 2004, Hum Genomics, V1, P274; SIELINSKI S, 2005, SIMILARITY MEASURES; Small KM, 2004, P NATL ACAD SCI USA, V101, P13020, DOI 10.1073/pnas.0405074101; Templeton AR, 2000, GENETICS, V156, P1259; TEMPLETON AR, 1987, GENETICS, V117, P343; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wang Z, 2003, PROTEINS, V53, P748, DOI 10.1002/prot.10522; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weinshenker Brian G., 2001, Mutation Research, V458, P7, DOI 10.1016/S1383-5726(00)00008-X; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu K, 2004, GENET EPIDEMIOL, V27, P182, DOI 10.1002/gepi.20022	54	129	132	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					792	806		10.1086/508346	http://dx.doi.org/10.1086/508346			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033957	Green Published, Bronze			2022-12-18	WOS:000241667400002
J	Behar, DM; Metspalu, E; Kivisild, T; Achilli, A; Hadid, Y; Tzur, S; Pereira, L; Amorim, A; Quintana-Murci, L; Majamaa, K; Herrnstadt, C; Howell, N; Balanovsky, O; Kutuev, I; Pshenichnov, A; Gurwitz, D; Bonne-Tamir, B; Torroni, A; Villems, R; Skorecki, K				Behar, DM; Metspalu, E; Kivisild, T; Achilli, A; Hadid, Y; Tzur, S; Pereira, L; Amorim, A; Quintana-Murci, L; Majamaa, K; Herrnstadt, C; Howell, N; Balanovsky, O; Kutuev, I; Pshenichnov, A; Gurwitz, D; Bonne-Tamir, B; Torroni, A; Villems, R; Skorecki, K			The matrilineal ancestry of Ashkenazi Jewry: Portrait of a recent founder event	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA HAPLOGROUP-H; MITOCHONDRIAL-DNA; NEAR-EASTERN; REGION SEQUENCES; GENE FLOW; ORIGIN; SINGLE; SETTLEMENT; SOUTHWEST; LINEAGES	Both the extent and location of the maternal ancestral deme from which the Ashkenazi Jewry arose remain obscure. Here, using complete sequences of the maternally inherited mitochondrial DNA ( mtDNA), we show that close to one-half of Ashkenazi Jews, estimated at 8,000,000 people, can be traced back to only 4 women carrying distinct mtDNAs that are virtually absent in other populations, with the important exception of low frequencies among non-Ashkenazi Jews. We conclude that four founding mtDNAs, likely of Near Eastern ancestry, underwent major expansion(s) in Europe within the past millennium.	Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; Techn & Rambam Med Ctr, Rappaport Fac Med, Haifa, Israel; Techn & Rambam Med Ctr, Res Inst, Haifa, Israel; Estonian Bioctr, Tartu, Estonia; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Porto, Inst Patol & Immunol Mol, P-4100 Oporto, Portugal; Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal; Inst Pasteur, CNRS, FRE 2849, Unit Mol Prevent & Therapy Human Dis, Paris, France; Univ Turku, Dept Neurol, Turku, Finland; MitoKor Inc, San Diego, CA USA; Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; Russian Acad Sci, Inst Biochem & Genet, Ufa Res Ctr, Ufa 450001, Russia; Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	University of Tartu; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Estonian Biocentre; University of Pavia; Universidade do Porto; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Turku; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Tel Aviv University; Sackler Faculty of Medicine	Villems, R (corresponding author), Univ Tartu, Dept Evolutionary Biol, Riia 23, EE-51010 Tartu, Estonia.	rvillems@ebc.ee	Torroni, Antonio/E-1557-2011; Quintana-Murci, Lluis/AAB-7468-2022; Achilli, Alessandro/I-9236-2012; Balanovsky, Oleg/G-1549-2014; Pereira, Luisa/H-3050-2011; Amorim, Antonio/A-7938-2008; Kivisild, Toomas/P-5889-2017; Majamaa, Kari/A-1344-2012; Gurwitz, David/E-7642-2013	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Pereira, Luisa/0000-0002-4271-1527; Amorim, Antonio/0000-0002-7518-6247; Kivisild, Toomas/0000-0002-6297-7808; Gurwitz, David/0000-0002-9363-1869; Majamaa, Kari/0000-0002-9070-3791; Quintana-Murci, Lluis/0000-0003-2429-6320				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Baasner A, 1998, FORENSIC SCI INT, V98, P169, DOI 10.1016/S0379-0738(98)00163-7; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; DellaPergola S., 2001, PAPERS JEWISH DEMOGR, V11, P11; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MAYR E, 1963, ANIMAL SPECIES EVOLU, P162; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2004, INT J LEGAL MED, V118, P132, DOI 10.1007/s00414-003-0424-1; Pfeiffer H, 2001, INT J LEGAL MED, V114, P169, DOI 10.1007/s004140000165; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 1996, GENETICS, V144, P1835	38	129	130	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					487	497		10.1086/500307	http://dx.doi.org/10.1086/500307			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16404693	Green Published, Bronze			2022-12-18	WOS:000236747500015
J	Tarpey, P; Parnau, J; Blow, M; Woffendin, H; Bignell, G; Cox, C; Cox, J; Davies, H; Edkins, S; Holden, S; Korny, A; Mallya, U; Moon, J; O'Meara, S; Parker, A; Stephens, P; Stevens, C; Teague, J; Donnelly, A; Mangelsdorf, M; Mulley, J; Partington, M; Turner, G; Stevenson, R; Schwartz, C; Young, I; Easton, D; Bobrow, M; Futreal, PA; Stratton, MR; Gecz, J; Wooster, R; Raymond, FL				Tarpey, P; Parnau, J; Blow, M; Woffendin, H; Bignell, G; Cox, C; Cox, J; Davies, H; Edkins, S; Holden, S; Korny, A; Mallya, U; Moon, J; O'Meara, S; Parker, A; Stephens, P; Stevens, C; Teague, J; Donnelly, A; Mangelsdorf, M; Mulley, J; Partington, M; Turner, G; Stevenson, R; Schwartz, C; Young, I; Easton, D; Bobrow, M; Futreal, PA; Stratton, MR; Gecz, J; Wooster, R; Raymond, FL			Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-TERM POTENTIATION; RECEPTOR TRAFFICKING; PROTEIN; IDENTIFICATION; HIPPOCAMPUS; INTERACTS; EPILEPSY; SYNAPSES; COMPLEX; SAP102	We have identified truncating mutations in the human DLG3 ( neuroendocrine dlg) gene in 4 of 329 families with moderate to severe X-linked mental retardation. DLG3 encodes synapse-associated protein 102 (SAP102), a member of the membrane-associated guanylate kinase protein family. Neuronal SAP102 is expressed during early brain development and is localized to the postsynaptic density of excitatory synapses. It is composed of three amino-terminal PDZ domains, an src homology domain, and a carboxyl-terminal guanylate kinase domain. The PDZ domains interact directly with the NR2 subunits of the NMDA glutamate receptor and with other proteins responsible for NMDA receptor localization, immobilization, and signaling. The mutations identified in this study all introduce premature stop codons within or before the third PDZ domain, and it is likely that this impairs the ability of SAP102 to interact with the NMDA receptor and/or other proteins involved in downstream NMDA receptor signaling pathways. NMDA receptors have been implicated in the induction of certain forms of synaptic plasticity, such as long-term potentiation and long-term depression, and these changes in synaptic efficacy have been proposed as neural mechanisms underlying memory and learning. The disruption of NMDA receptor targeting or signaling, as a result of the loss of SAP102, may lead to altered synaptic plasticity and may explain the intellectual impairment observed in individuals with DLG3 mutations.	Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Wellcome Trust Sanger Inst, Hinxton, England; Univ Cambridge, Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge, England; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia; Univ Newcastle, Waratah, Australia; Hunter Genet, Waratah, Australia; Greenwood Genet Ctr, Greenwood, SC USA; Leicester Royal Infirm, Dept Med Genet, Leicester, Leics, England	University of Cambridge; Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Womens & Childrens Hospital Australia; University of Adelaide; University of Newcastle; Greenwood Genetic Center; University of Leicester	Raymond, FL (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	flr24@cam.ac.uk	Gecz, Jozef/X-3469-2019; Mangelsdorf, Marie E/A-2318-2013; Cox, James/R-1910-2016; Blow, Matthew/G-6369-2012	Gecz, Jozef/0000-0002-7884-6861; Mangelsdorf, Marie E/0000-0002-7855-7701; Blow, Matthew/0000-0002-8844-9149; Edkins, Sarah/0000-0003-0717-1972	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD026202, HD 26202] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Guerrini R, 2000, ANN NEUROL, V47, P117; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Makino K, 1997, ONCOGENE, V14, P2425, DOI 10.1038/sj.onc.1201087; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; Meloni I, 2002, NAT GENET, V30, P436, DOI 10.1038/ng857; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Vervoort VS, 2002, SCIENCE, V296, P2401; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	29	129	136	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					318	324		10.1086/422703	http://dx.doi.org/10.1086/422703			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15185169	Green Published, Bronze			2022-12-18	WOS:000222702000016
J	Wen, B; Xie, XH; Gao, S; Li, H; Shi, H; Song, XF; Qian, TZ; Xiao, CJ; Jin, JZ; Su, B; Lu, D; Chakraborty, R; Jin, L				Wen, B; Xie, XH; Gao, S; Li, H; Shi, H; Song, XF; Qian, TZ; Xiao, CJ; Jin, JZ; Su, B; Lu, D; Chakraborty, R; Jin, L			Analyses of genetic structure of Tibeto-Burman populations reveals sex-biased admixture in southern Tibeto-Burmans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME DIVERSITY; MITOCHONDRIAL-DNA; LINKAGE DISEQUILIBRIUM; PARENTAL POPULATIONS; ETHNIC POPULATIONS; AFRICAN-AMERICAN; MOLECULAR-DATA; PROPORTIONS; MTDNA; ORIGINS	An unequal contribution of male and female lineages from parental populations to admixed ones is not uncommon in the American continents, as a consequence of directional gene flow from European men into African and Hispanic Americans in the past several centuries. However, little is known about sex-biased admixture in East Asia, where substantial migrations are recorded. Tibeto-Burman ( TB) populations were historically derived from ancient tribes of northwestern China and subsequently moved to the south, where they admixed with the southern natives during the past 2,600 years. They are currently extensively distributed in China and Southeast Asia. In this study, we analyze the variations of 965 Y chromosomes and 754 mtDNAs in >20 TB populations from China. By examining the haplotype group distributions of Y-chromosome and mtDNA markers and their principal components, we show that the genetic structure of the extant southern Tibeto-Burman (STB) populations were primarily formed by two parental groups: northern immigrants and native southerners. Furthermore, the admixture has a bias between male and female lineages, with a stronger influence of northern immigrants on the male lineages (similar to62%) and with the southern natives contributing more extensively to the female lineages (similar to56%) in the extant STBs. This is the first genetic evidence revealing sex-biased admixture in STB populations, which has genetic, historical, and anthropological implications.	Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; Yunnan Univ, Dept Biol, Kunming 650091, Peoples R China; Yunnan Univ, Ctr Human Genet, Kunming 650091, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China; Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH USA	Fudan University; Fudan University; Yunnan University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University System of Ohio; University of Cincinnati	Wen, B (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin@fudan.edu.cn; li.jin@uc.edu	Li, Hui/A-2014-2010; Jin, Li/M-5063-2019; Wen, Bo/P-5332-2019; Xie, xuanhua Peter/C-5267-2012; Jin, Li/C-1468-2009	Wen, Bo/0000-0003-0394-7366; Xie, xuanhua Peter/0000-0001-8032-4715; Jin, Li/0000-0002-4546-2415	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41399, R01 GM041399] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bortolini MC, 1999, AM J HUM BIOL, V11, P551, DOI 10.1002/(SICI)1520-6300(1999)11:4<551::AID-AJHB15>3.0.CO;2-Z; CANG M, 1997, STUDY MIGRATION CULT; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1998, 18 INT C GEN BEIJ AU, P102; Di Benedetto G, 2001, AM J PHYS ANTHROPOL, V115, P144, DOI 10.1002/ajpa.1064; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Qian YP, 2001, J HUM GENET, V46, P211, DOI 10.1007/s100380170091; ROBERTS DF, 1965, HUM BIOL, V37, P38; Roessli D, 2000, ARLEQUIN VERSION 2 0; Sans M, 2000, HUM BIOL, V72, P155; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Sans M, 1997, HUM BIOL, V69, P161; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Wang JL, 2003, GENETICS, V164, P747; WANG Z, 1994, HIST NATIONALITIES C; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, J HUM GENET, V47, P311, DOI 10.1007/s100380200042; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2000, GENES GENET SYST, V75, P173, DOI 10.1266/ggs.75.173	43	129	147	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					856	865		10.1086/386292	http://dx.doi.org/10.1086/386292			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15042512	Bronze, Green Published			2022-12-18	WOS:000220926100007
J	Shahbazian, MD; Zoghbi, HY				Shahbazian, MD; Zoghbi, HY			Rett syndrome and MeCP2: Linking epigenetics and neuronal function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CPG-BINDING PROTEIN-2; X-CHROMOSOME INACTIVATION; HISTONE DEACETYLASE COMPLEX; LINKED MENTAL-RETARDATION; TRANSCRIPTIONAL REPRESSOR MECP2; DNA METHYLTRANSFERASE GENE; METHYLATED DNA; PRESERVED SPEECH; SUBSTANCE-P; SYNDROME MUTATIONS		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T807,MS 225, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349				ADLER DA, 1995, MAMM GENOME, V6, P491, DOI 10.1007/BF00356163; Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir R, 2000, AM J MED GENET, V90, P69, DOI 10.1002/(SICI)1096-8628(20000103)90:1<69::AID-AJMG12>3.0.CO;2-W; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARCHIDIACONO N, 1991, HUM GENET, V86, P604; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; ARMSTRONG DD, 1992, BRAIN DEV-JPN, V14, pS89; Armstrong DD, 2001, BRAIN DEV-JPN, V23, pS72, DOI 10.1016/S0387-7604(01)00332-1; Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Armstrong J, 2001, ANN NEUROL, V50, P692, DOI 10.1002/ana.1272; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Barresi V, 1999, INT J DEV NEUROSCI, V17, P821, DOI 10.1016/S0736-5748(99)00059-3; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Ben Zeev B, 2002, J CHILD NEUROL, V17, P20, DOI 10.1177/088307380201700105; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Bourdon V, 2001, HUM GENET, V108, P43, DOI 10.1007/s004390000422; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Buyse IM, 2000, AM J HUM GENET, V67, P1428, DOI 10.1086/316913; Chae JH, 2002, J CHILD NEUROL, V17, P33; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; CIRIGNOTTA F, 1986, AM J MED GENET, V24, P167; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; COMINGS DE, 1986, AM J MED GENET, V24, P383; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; CURTIS ARJ, 1993, HUM GENET, V90, P551; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; De Bona C, 2000, EUR J HUM GENET, V8, P325, DOI 10.1038/sj.ejhg.5200473; Deguchi K, 2000, PEDIATR NEUROL, V22, P259, DOI 10.1016/S0887-8994(00)00120-X; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; El-Maarri O, 1998, AM J HUM GENET, V63, P1001, DOI 10.1086/302065; El-Osta A, 2001, BIOCHEM BIOPH RES CO, V289, P733, DOI 10.1006/bbrc.2001.6023; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; ELLISON KA, 1992, AM J HUM GENET, V50, P278; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Erlandson A, 2001, EUR CHILD ADOLES PSY, V10, P117, DOI 10.1007/s007870170034; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; FENICHEL GM, 1968, NEUROLOGY, V18, P817, DOI 10.1212/WNL.18.8.817; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fujita N, 1999, MOL CELL BIOL, V19, P6415; FUTAMURA M, 1995, ONCOGENE, V10, P1119; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Girard M, 2001, EUR J HUM GENET, V9, P231, DOI 10.1038/sj.ejhg.5200618; Giunti L, 2001, BRAIN DEV-JPN, V23, pS242, DOI 10.1016/S0387-7604(01)00342-4; GLAZE DG, 1987, ARCH NEUROL-CHICAGO, V44, P1053, DOI 10.1001/archneur.1987.00520220051016; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; GOUTIERES F, 1986, AM J MED GENET, V24, P183; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Guideri F, 1999, NEUROPEDIATRICS, V30, P146, DOI 10.1055/s-2007-973480; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1986, AM J MED GENET, V24, P47; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; HANEFELD F, 1985, BRAIN DEV-JPN, V7, P320, DOI 10.1016/S0387-7604(85)80037-1; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; HOLM VA, 1986, AM J MED GENET, V24, P119; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Inui K, 2001, BRAIN DEV-JPN, V23, P212, DOI 10.1016/S0387-7604(01)00197-8; JELLINGER K, 1986, AM J MED GENET, V24, P259; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; KAUFMANN WE, 1995, NEUROPEDIATRICS, V26, P109, DOI 10.1055/s-2007-979738; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, BRAIN DEV-JPN, V19, P25, DOI 10.1016/S0387-7604(96)00047-2; KERR AM, 1985, BRIT MED J, V291, P579, DOI 10.1136/bmj.291.6495.579; Kerr AM, 1997, EUR CHILD ADOLES PSY, V6, P71; KILLIAN W, 1986, AM J MED GENET, V24, P369; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; KOZINETZ CA, 1993, PEDIATRICS, V91, P445; Kudo S, 2001, BRAIN DEV-JPN, V23, pS165, DOI 10.1016/S0387-7604(01)00345-X; Kudo S, 2002, J MED GENET, V39, P132, DOI 10.1136/jmg.39.2.132; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lappalainen R, 1997, ACTA NEUROL SCAND, V95, P44, DOI 10.1111/j.1600-0404.1997.tb00067.x; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Lee SSJ, 2001, BRAIN DEV-JPN, V23, pS138; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Leonard H, 2001, J CHILD NEUROL, V16, P333, DOI 10.2310/7010.2001.17195; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; LUGARESI E, 1985, BRAIN DEV-JPN, V7, P329, DOI 10.1016/S0387-7604(85)80039-5; Matsuishi T, 1997, ANN NEUROL, V42, P978, DOI 10.1002/ana.410420621; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Monros E, 2001, BRAIN DEV-JPN, V23, pS251, DOI 10.1016/S0387-7604(01)00374-6; NAIDU S, 1986, AM J MED GENET, V24, P61; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nicolao P, 2001, HUM MUTAT, V18, P132, DOI 10.1002/humu.1162; NIEDERMEYER E, 1986, AM J MED GENET, V24, P195; NIELSEN JB, 1990, ARCH NEUROL-CHICAGO, V47, P982, DOI 10.1001/archneur.1990.00530090054013; Nielsen JB, 2001, EUR J HUM GENET, V9, P178, DOI 10.1038/sj.ejhg.5200600; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Persengiev SP, 1996, NEUROREPORT, V8, P227, DOI 10.1097/00001756-199612200-00046; Persengiev SP, 1997, NEUROREPORT, V8, P2091, DOI 10.1097/00001756-199707070-00001; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; Reichwald K, 2000, MAMM GENOME, V11, P182, DOI 10.1007/s003350010035; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; RETT A, 1986, AM J MED GENET, V24, P21; RICE MA, 1988, J CHILD NEUROL, V3, pS35, DOI 10.1177/0883073888003001S08; RUCH A, 1989, PEDIATR NEUROL, V5, P320, DOI 10.1016/0887-8994(89)90027-1; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Schanen NC, 1997, AM J HUM GENET, V61, P634, DOI 10.1086/515525; Schanen NC, 1999, J CHILD NEUROL, V14, P806, DOI 10.1177/088307389901401207; Schwartzman JS, 2001, NEUROPEDIATRICS, V32, P162, DOI 10.1055/s-2001-16620; SEKUL EA, 1994, J PEDIATR-US, V125, P80, DOI 10.1016/S0022-3476(94)70128-8; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; SOUTHALL DP, 1988, ARCH DIS CHILD, V63, P1039, DOI 10.1136/adc.63.9.1039; SPENCE AM, 1971, NEUROLOGY, V21, P386, DOI 10.1212/WNL.21.4.386; Subramaniam B, 1997, NEUROLOGY, V48, P399, DOI 10.1212/WNL.48.2.399; Suzuki H, 1996, BIOCHEM BIOPH RES CO, V229, P902, DOI 10.1006/bbrc.1996.1900; Thomas GH, 1996, AM J HUM GENET, V58, P1364; THOMAS L, 1992, ANN GEOPHYS, V10, P690; Topcu M, 2002, EUR J HUM GENET, V10, P77, DOI 10.1038/sj.ejhg.5200745; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; VERMA NP, 1986, ELECTROEN CLIN NEURO, V64, P394, DOI 10.1016/0013-4694(86)90072-6; Vilain A, 1996, CYTOGENET CELL GENET, V74, P293, DOI 10.1159/000134438; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Vorsanova SG, 1996, NEUROREPORT, V8, P187, DOI 10.1097/00001756-199612200-00038; Vorsanova SG, 2001, BRAIN DEV-JPN, V23, pS196, DOI 10.1016/S0387-7604(01)00347-3; Wan MH, 1998, AM J MED GENET, V78, P169, DOI 10.1002/(SICI)1096-8628(19980630)78:2<169::AID-AJMG14>3.3.CO;2-D; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Webb T, 1998, J MED GENET, V35, P997, DOI 10.1136/jmg.35.12.997; WHITTY CJ, 1993, NEUROSCI LETT, V164, P141, DOI 10.1016/0304-3940(93)90877-N; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Xiang FQ, 1998, J MED GENET, V35, P297, DOI 10.1136/jmg.35.4.297; Yamada Y, 2001, Hum Mutat, V18, P253, DOI 10.1002/humu.1186.abs; Yamashita Y, 2001, BRAIN DEV-JPN, V23, pS157, DOI 10.1016/S0387-7604(01)00378-3; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu F, 2000, NUCLEIC ACIDS RES, V28, P2201, DOI 10.1093/nar/28.10.2201; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; ZAPPELLA M, 1992, BRAIN DEV-JPN, V14, P98, DOI 10.1016/S0387-7604(12)80094-5; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; ZOGHBI H, 1988, J CHILD NEUROL, V3, pS76, DOI 10.1177/0883073888003001S15; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	173	129	138	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1259	1272		10.1086/345360	http://dx.doi.org/10.1086/345360			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12442230	Green Published, Bronze			2022-12-18	WOS:000179586800001
J	Pankratz, N; Nichols, WC; Uniacke, SK; Halter, C; Rudolph, A; Shults, C; Conneally, PM; Foroud, T				Pankratz, N; Nichols, WC; Uniacke, SK; Halter, C; Rudolph, A; Shults, C; Conneally, PM; Foroud, T		Parkinson Study Grp	Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-SYNUCLEIN GENE; POSITRON EMISSION TOMOGRAPHY; FAMILIAL AGGREGATION; EARLY-ONSET; JUVENILE PARKINSONISM; CLINICAL-DIAGNOSIS; LINKAGE ANALYSIS; WILSONS-DISEASE; PAIR ANALYSIS; F-18 DOPA	Parkinson disease (PD) is a common neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity, and postural instability, as well as by a clinically significant response to treatment with levodopa. Mutations in the a alpha-synuclein gene have been found to result in autosomal dominant PD, and mutations in the parkin gene produce autosomal recessive juvenile-onset PD. We have studied 203 sibling pairs with PD who were evaluated by a rigorous neurological assessment based on (a) inclusion criteria consisting of clinical features highly associated with autopsy-confirmed PD and (b) exclusion criteria highly associated with other, non-PD pathological diagnoses. Families with positive LOD scores for a marker in an intron of the parkin gene were prioritized for parkin-gene testing, and mutations in the parkin gene were identified in 22 families. To reduce genetic heterogeneity, these families were not included in subsequent genome-screen analysis. Thus, a total of 160 multiplex families without evidence of a parkin mutation were used in multipoint nonparametric linkage analysis to identify PD-susceptibility genes. Two models of PD affection status were considered: model I included only those individuals with a more stringent diagnosis of verified PD (96 sibling pairs from 90 families), whereas model II included all examined individuals as affected, regardless of their final diagnostic classification (170 sibling pairs from 160 families). Under model I, the highest LOD scores were observed on chromosome X (LOD score 2.1) and on chromosome 2 (LOD score 1.9). Analyses performed with all available sibling pairs (model II) found even greater evidence of linkage to chromosome X (LOD score 2.7) and to chromosome 2 (LOD score 2.5). Evidence of linkage was also found to chromosomes 4, 5, and 13 (LOD scores >1.5). Our findings are consistent with those of other linkage studies that have reported linkage to chromosomes 5 and X.	Indiana Univ, Med Ctr, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Childrens Hosp, Div Human Genet, Med Ctr, Cincinnati, OH 45229 USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; Vet Adm San Diego Healthcare Syst, San Diego, CA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center; University of Rochester; University of California System; University of California San Diego	Foroud, T (corresponding author), Indiana Univ, Med Ctr, Dept Med & Mol Genet, IB 130,975 W Walnut St, Indianapolis, IN 46202 USA.	tforoud@iupui.edu	; Tuite, Paul/P-3164-2014; Sanchez-Ramos, Juan/A-1188-2009	Marek, Kenneth/0000-0002-4197-5627; Martin, WR Wayne/0000-0002-3416-691X; Pankratz, Nathan/0000-0001-5958-693X; Tuite, Paul/0000-0003-1413-7924; Kang, Un/0000-0002-5970-6839; Sanchez-Ramos, Juan/0000-0002-3391-7857; Walker, Francis/0000-0002-7817-9421; Camicioli, Richard/0000-0003-2977-8660	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037167] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS37167, R01 NS037167] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Autere JM, 2000, J NEUROL NEUROSUR PS, V69, P107, DOI 10.1136/jnnp.69.1.107; Bandopadhyay R, 2001, NEUROSCI LETT, V307, P125, DOI 10.1016/S0304-3940(01)01935-8; Bostantjopoulou S, 2001, MOVEMENT DISORD, V16, P1007, DOI 10.1002/mds.1221; Brice A, 1998, SCIENCE, V279, P1116; BURN DJ, 1992, NEUROLOGY, V42, P1894, DOI 10.1212/WNL.42.10.1894; Chan P, 1998, NEUROLOGY, V50, P1136, DOI 10.1212/WNL.50.4.1136; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; COX DW, 1972, AM J HUM GENET, V24, P646; DeMichele G, 1995, J NEURAL TRANSM-SUPP, P21; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; DeStefano AL, 2001, NEUROLOGY, V57, P1124, DOI 10.1212/WNL.57.6.1124; Dickson D, 2001, NEUROLOGY, V56, P981, DOI 10.1212/WNL.56.7.981; Elbaz A, 1999, NEUROLOGY, V52, P1876, DOI 10.1212/WNL.52.9.1876; Farrer M, 2001, NEUROBIOL DIS, V8, P317, DOI 10.1006/nbdi.2000.0326; Farrer M, 1998, ANN NEUROL, V43, P394, DOI 10.1002/ana.410430320; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Hicks A, 2001, AM J HUM GENET, V69, P200; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kim YS, 2001, BRAIN RES, V908, P93, DOI 10.1016/S0006-8993(01)02575-6; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koller W.C., 1992, HDB PARKINSONS DISEA, P59; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuopio AM, 2001, PARKINSONISM RELAT D, V7, P297, DOI 10.1016/S1353-8020(00)00051-1; Lang A. E. T., 1989, QUANTIFICATION NEURO, P285; Lee LV, 2001, J CLIN PATHOL-MOL PA, V54, P362; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Nemeth AH, 1999, GENOMICS, V60, P320, DOI 10.1006/geno.1999.5929; NICHOLS WC, IN PRESS HUM GENET; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Paik SR, 2000, ARCH BIOCHEM BIOPHYS, V378, P269, DOI 10.1006/abbi.2000.1822; PALL HS, 1987, LANCET, V2, P238; Pastor P, 2001, MOVEMENT DISORD, V16, P1115, DOI 10.1002/mds.1198; PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417; Piccini P, 1997, ANN NEUROL, V41, P222, DOI 10.1002/ana.410410213; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Preux PM, 2000, NEUROEPIDEMIOLOGY, V19, P333, DOI 10.1159/000026273; Riordan SM, 2001, J HEPATOL, V34, P165, DOI 10.1016/S0168-8278(00)00028-3; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; SIEMERS ER, 1998, MOVEMENT DISORD, V13, P862; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; TANNER C M, 1992, Neurology, V42, P194; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Uitti RJ, 1997, CAN J NEUROL SCI, V24, P127, DOI 10.1017/S0317167100021454; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; Vaughan JR, 1998, HUM MOL GENET, V7, P751, DOI 10.1093/hmg/7.4.751; VIEREGGE P, 1994, NERVENARZT, V65, P390; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239	62	129	135	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					124	135		10.1086/341282	http://dx.doi.org/10.1086/341282			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12058349	Green Published, Bronze			2022-12-18	WOS:000176307700012
J	Cambien, F; Poirier, O; Nicaud, V; Herrmann, SM; Mallet, C; Ricard, S; Behague, I; Hallet, V; Blanc, H; Loukaci, V; Thillet, J; Evans, A; Ruidavets, JB; Arveiler, D; Luc, G; Tiret, L				Cambien, F; Poirier, O; Nicaud, V; Herrmann, SM; Mallet, C; Ricard, S; Behague, I; Hallet, V; Blanc, H; Loukaci, V; Thillet, J; Evans, A; Ruidavets, JB; Arveiler, D; Luc, G; Tiret, L			Sequence diversity in 36 candidate genes for cardiovascular disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; PLASMA ACE LEVELS; NUCLEOTIDE SUBSTITUTIONS; MYOCARDIAL-INFARCTION; LINKAGE ANALYSIS; HUMAN DNA; POLYMORPHISMS; LIPOPROTEIN; RISK; SEGREGATION	Two strategies involving whole-genome association studies have been proposed for the identification of genes involved in complex diseases. The first one seeks to characterize all common variants of human genes and to test their association with disease. The second one seeks to develop dense maps of single-nucleotide polymorphisms (SNPs) and to detect susceptibility genes through linkage disequilibrium. We performed a molecular screening of the coding and/or flanking regions of 36 candidate genes for cardiovascular diseases. All polymorphisms identified by this screening were further genotyped in 750 subjects of European descent. In the whole set of genes, the lengths explored spanned 53.8 kb in the 5' regions, 68.4 kb in exonic regions, and 13 kb in the 3' regions. The strength of linkage disequilibrium within candidate regions suggests that genomewide maps of SNPs might be efficient ways to identify new disease-susceptibility genes, provided that the maps are sufficiently dense. However, the relatively large number of polymorphisms within coding and regulatory regions of candidate genes raises the possibility that several of them might be functional and that the pattern of genotype-phenotype association might be more complex than initially envisaged, as actually has been observed in some well-characterized genes. These results argue in favor of both genomewide association studies and detailed studies of the overall sequence variation of candidate genes, as complementary approaches.	INSERM U525, F-75005 Paris, France; INSERM SC7, Paris, France; INSERM U321, Paris, France; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast MONICA Project, Belfast, Antrim, North Ireland; Projet MONICA Haute Garonne, Toulouse, France; Projet MONICA Bas Rhin, Strasbourg, France; INSERM U325, SERLIA, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tiret, L (corresponding author), INSERM U525, 17 Rue du Fer Moulin, F-75005 Paris, France.	tiret@idf.inserm.fr	Cambien, Francois/AAP-9751-2020					Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; Cambien F, 1997, MOL MED TODAY, V3, P197, DOI 10.1016/S1357-4310(97)01027-7; COLLINS DW, 1994, GENOMICS, V20, P386, DOI 10.1006/geno.1994.1192; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; FUMERON F, 1995, J CLIN INVEST, V96, P1664, DOI 10.1172/JCI118207; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LI WH, 1991, GENETICS, V129, P513; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; Poirier O, 1998, J HYPERTENS, V16, P1443, DOI 10.1097/00004872-199816100-00007; Poirier O, 1996, HUM MUTAT, V8, P282; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIRET L, 1991, AM J HUM GENET, V48, P926; TIRET L, 1992, AM J HUM GENET, V51, P197; Villard E, 1996, AM J HUM GENET, V58, P1268; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746	26	129	149	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					183	191		10.1086/302448	http://dx.doi.org/10.1086/302448			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364531	Bronze, Green Published			2022-12-18	WOS:000081224300023
J	Chinnery, PF; Samuels, DC				Chinnery, PF; Samuels, DC			Relaxed replication of mtDNA: A model with implications for the expression of disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATIONS; KEARNS-SAYRE SYNDROME; SKELETAL-MUSCLE; HUMAN-EVOLUTION; GENOMES; MELAS; MAINTENANCE; DELETIONS; FIBERS	Heteroplasmic mtDNA defects are an important cause of human disease with clinical features that primarily involve nondividing (postmitotic) tissues. Within single cells the percentage level of mutated mtDNA must exceed a critical threshold level before the genetic defect is expressed. Although the level of mutated mtDNA may alter over time, the mechanism behind the change is not understood. It currently is not possible to directly measure the level of mutant mtDNA within living cells. We therefore developed a mathematical model of human mtDNA replication, based on a solid foundation of experimentally derived parameters, and studied,the dynamics of intracellular heteroplasmy in postmitotic cells. Our simulations show that the level of intracellular heteroplasmy can vary greatly over a short period of time and that a high copy number of mtDNA molecules delays the time to fixation of an allele. We made the assumption that the optimal state for a cell is to contain 100% wild-type molecules. For cells that contain pathogenic mutations, the nonselective proliferation of mutant and wild-type mtDNA molecules further delays the fixation of both alleles, but this leads to a rapid increase in the mean percentage level of mutant mtDNA within a tissue. On its own, this mechanism will lead to the appearance of a critical threshold level of mutant mtDNA that must be exceeded before a cell expresses: a biochemical defect. The hypothesis that we present is in accordance with the available data and may explain the late presentation and insidious progression of mtDNA diseases.	Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Math, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Samuels, David C/A-5393-2008; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; BOULET L, 1992, AM J HUM GENET, V51, P1187; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559; Clayton DA, 1996, NAT GENET, V14, P123, DOI 10.1038/ng1096-123; FLORY PJ, 1973, J MOL BIOL, V74, P81, DOI 10.1016/0022-2836(73)90100-9; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Howell N, 1997, AM J HUM GENET, V61, P19, DOI 10.1086/513910; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Johnson N.L., 1995, CONTINUOUS UNIVARIAT, VVolumes 1 and 2; Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101; TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407; Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weber K, 1997, AM J HUM GENET, V60, P373; ZHANG H, 1994, MOL PHARMACOL, V46, P1063	32	129	133	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1158	1165		10.1086/302311	http://dx.doi.org/10.1086/302311			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090901	Green Published, Bronze			2022-12-18	WOS:000079632900027
J	GUAYWOODFORD, LM; MUECHER, G; HOPKINS, SD; AVNER, ED; GERMINO, GG; GUILLOT, AP; HERRIN, J; HOLLEMAN, R; IRONS, DA; PRIMACK, W; THOMSON, PD; WALDO, FB; LUNT, PW; ZERRES, K				GUAYWOODFORD, LM; MUECHER, G; HOPKINS, SD; AVNER, ED; GERMINO, GG; GUILLOT, AP; HERRIN, J; HOLLEMAN, R; IRONS, DA; PRIMACK, W; THOMSON, PD; WALDO, FB; LUNT, PW; ZERRES, K			THE SEVERE PERINATAL FORM OF AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE MAPS TO CHROMOSOME 6P21.1-P12 - IMPLICATIONS FOR GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDHOOD	Autosomal recessive polycystic kidney disease (ARPKD) is a one of the most common hereditary renal cystic diseases in children. Its clinical spectrum is widely variable with most cases presenting in infancy. Most affected neonates die within the first few hours of life. At present, prenatal diagnosis relies on fetal sonography, which is often imprecise in detecting even the severe form of the disease. Recently, in a cohort of families with mostly milder ARPKD phenotypes, an ARPKD locus was mapped to a 13-cM region of chromosome 6p21-cen. To determine whether severe perinatal ARPKD also maps to chromosome 6p, we have analyzed the segregation of seven microsatellite markers from the ARPKD interval in 22 families with the severe phenotype. In the majority of the affected infants, ARPKD was documented by histopathology. Our data confirm linkage and refine the ARPKD region to a 3.8-cM interval, delimited by the markers D6S465/D6S427/D6S436/D6S272 and D6S466. Taken together, these results suggest that, despite the wide variability in clinical phenotypes, there is a single ARPKD gene. These linkage data and the absence of genetic heterogeneity in all families tested to date have important implications for DNA-based prenatal diagnoses as well as for the isolation of the ARPKD gene.	UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294; UNIV BONN,INST HUMAN GENET,W-5300 BONN,GERMANY; WASHINGTON UNIV,CHILDRENS HOSP & MED CTR,DEPT PEDIAT,SEATTLE,WA; JOHNS HOPKINS UNIV,DEPT MED,BALTIMORE,MD; UNIV VERMONT,DEPT PEDIAT,BURLINGTON,VT; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,BOSTON,MA; QUINCY PEDIAT ASSOC,QUINCY,MA; UNIV MASSACHUSETTS,DEPT PEDIAT,WORCESTER,MA; UNIV WITWATERSRAND,DEPT PEDIAT,JOHANNESBURG,SOUTH AFRICA; BRISTOL ROYAL HOSP SICK CHILDREN,INST CHILD HLTH,CLIN GENET SERV,BRISTOL,AVON,ENGLAND	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Bonn; Seattle Children's Hospital; Johns Hopkins University; University of Vermont; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Witwatersrand; Bristol Royal Hospital For Children; University of Bristol			Lunt, Peter/AAF-8265-2020	primack, william/0000-0003-1240-8161; Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048006, R37DK048006] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48006] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernstein J, 1992, PEDIAT KIDNEY DIS, P1139; BLYTH H, 1971, J MED GENET, V8, P257, DOI 10.1136/jmg.8.3.257; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; GUAYWOODFORD LM, 1993, J AM SOC NEPHROL, V4, pA814; GUAYWOODFORD LM, IN PRESS OXFORD U PR; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KAARIAINEN H, 1988, PEDIATR NEPHROL, V2, P296; KAPLAN BS, 1989, PEDIATR NEPHROL, V3, P43, DOI 10.1007/BF00859625; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; MUECHER G, 1994, AM J HUM GENET, V55, P1281; OSATHANONDH V, 1964, ARCH PATHOL, V77, P466; PREMINGER GM, 1982, J UROLOGY, V127, P556, DOI 10.1016/S0022-5347(17)53911-7; PRIEST JH, 1991, ACT CYTOGENETICS LAB, P166; REUSS A, 1991, ULTRASOUND MED BIOL, V17, P687, DOI 10.1016/0301-5629(91)90100-B; SIMON EA, 1994, GENOMICS, V21, P415, DOI 10.1006/geno.1994.1285; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; ZERRES K, 1992, CLIN INVESTIGATOR, V70, P794; ZERRES K, 1988, PRENATAL DIAG, V8, P215, DOI 10.1002/pd.1970080308; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429; ZERRES K, 1984, HUM GENET, V68, P124	22	129	135	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1101	1107						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726165				2022-12-18	WOS:A1995QU58600012
J	KAPLAN, NL; HILL, WG; WEIR, BS				KAPLAN, NL; HILL, WG; WEIR, BS			LIKELIHOOD METHODS FOR LOCATING DISEASE GENES IN NONEQUILIBRIUM POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS LOCUS; LINKAGE DISEQUILIBRIUM; FRIEDREICH ATAXIA; HUNTINGTONS-DISEASE; NONUNIFORM RECOMBINATION; EXTENDED HAPLOTYPES; ITALIAN FAMILIES; REGION; POLYMORPHISMS; LOCALIZATION	Until recently, attempts to map disease genes on the basis of population associations with linked markers have been based on expected values of linkage disequilibrium. These methods suffer from the large variances imposed on disequilibrium measures by the evolutionary process, but a more serious problem for many diseases is that they assume an equilibrium population. For diseases that arose only a few hundred generations ago, it is more appropriate to concentrate on the initial growth phase of the disease. We invoke a Poisson branching process for this early growth, and estimate the likelihood for the recombination fraction between marker and disease loci, on the basis of simulated disease populations. The limits of the resulting support intervals for the recombination fraction vary inversely with the age of the disease in generations. We illustrate the procedure with data on cystic fibrosis and diastrophic dysplasia, for which the method appears appropriate, and for Friedreich ataxia and Huntington disease, for which it does not. A valuable aspect of the method is the ability in some cases to compare likelihoods of the three orders for a disease locus and two linked marker loci.	N CAROLINA STATE UNIV, DEPT STAT, PROGRAM STAT GENET, RALEIGH, NC 27695 USA; NIEHS, STAT & BIOMATH BRANCH, RES TRIANGLE PK, NC 27709 USA; UNIV EDINBURGH, INST CELL ANIM & POPULAT BIOL, EDINBURGH, MIDLOTHIAN, SCOTLAND	University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Edinburgh					NIGMS NIH HHS [GM45344] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM S, 1991, AM J HUM GENET, V48, P595; ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; ANDREW SE, 1994, AM J HUM GENET, V54, P852; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1989, AM J HUM GENET, V44, P319; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CHAMBERLAIN S, 1993, AM J HUM GENET, V52, P99; COX T K, 1989, American Journal of Human Genetics, V45, pA136; CUTTING GR, 1989, AM J HUM GENET, V44, P307; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Ewens W.J., 1979, MATH POPULATION GENE; FARRALL M, 1988, AM J HUM GENET, V43, P471; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; HANUAER A, 1990, AM J HUM GENET, V46, P133; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL WG, 1994, AM J HUM GENET, V54, P705; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HILL WG, 1994, THEOR POPUL BIOL, V54, P705; KAPLAN N, 1992, AM J HUM GENET, V51, P333; KAPLAN N, IN PRESS NATURE GENE; KAPLAN N, IN PRESS MATH POPULA; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; RODIUS F, 1994, AM J HUM GENET, V54, P1050; ROMEO G, 1983, AM J HUM GENET, V35, P523; SERRE JL, 1990, HUM GENET, V84, P449; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SKRAASTAD MI, 1992, AM J HUM GENET, V51, P730; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WEIR BS, 1989, PROG CLIN BIOL RES, V329, P81; WEIR BS, 1986, AM J HUM GENET, V38, P776; WEIR BS, 1980, GENETICS, V95, P477; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769	43	129	130	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					18	32						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825575				2022-12-18	WOS:A1995QC10100004
J	WANG, JCC; PASSAGE, MB; YEN, PH; SHAPIRO, LJ; MOHANDAS, TK				WANG, JCC; PASSAGE, MB; YEN, PH; SHAPIRO, LJ; MOHANDAS, TK			UNIPARENTAL HETERODISOMY FOR CHROMOSOME-14 IN A PHENOTYPICALLY ABNORMAL FAMILIAL BALANCED 13/14 ROBERTSONIAN TRANSLOCATION CARRIER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETERMINES METHYLATION; TRANSGENIC MICE; MOUSE; EXPRESSION; MECHANISM; GENOMES; ORIGIN; DISOMY	A 9-year-old mentally retarded girl with multiple congenital anomalies was found to carry a balanced 13/ 14 Robertsonian translocation [45,XX,t(13ql4q)] which was also present in her father. Her mother carried a balanced reciprocal translocation between chromosomes 1 and 14 [46,XX,t(1;14) (q32;q32)]. Both of her parents were phenotypically normal. Molecular studies were carried out to determine the parental origin of chromosomes 1, 13, and 14 in the patient. Using probes for D14Sl3 and D14S22, we could show that the patient inherited both chromosomes 14 from her father and none from her mother. Similar studies using probes for chromosomes 1 (D1S76) and 13 (D13S37) loci showed the presence of both maternal and paternal alleles in the patient. Our findings indicate that paternal uniparental heterodisomy for chromosome 14 most likely accounts for the phenotypic abnormalities observed in our patient. It is suggested that uniparental disomy may be the basis for abnormal development in at least some phenotypically abnormal familial balanced-translocation carriers.	UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,HOWARD HUGHES MED INST,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	WANG, JCC (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MED GENET,E-4,1124 W CARSON ST,TORRANCE,CA 90509, USA.							CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; HADCHOUEL M, 1987, NATURE, V329, P454, DOI 10.1038/329454a0; HALL JG, 1990, AM J HUM GENET, V46, P857; Laskey R A, 1980, Methods Enzymol, V65, P363; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P6255, DOI 10.1093/nar/16.13.6255; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9368, DOI 10.1093/nar/16.19.9368; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; Sambrook J., 1989, MOL CLONING LAB MANU; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; VOSS R, 1989, AM J HUM GENET, V45, P373	17	129	131	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1069	1074						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035528				2022-12-18	WOS:A1991FP09200007
J	ABEL, L; DEMENAIS, F				ABEL, L; DEMENAIS, F			DETECTION OF MAJOR GENES FOR SUSCEPTIBILITY TO LEPROSY AND ITS SUBTYPES IN A CARIBBEAN ISLAND - DESIRADE ISLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ABEL, L (corresponding author), INSERM,U155,UNITE RECH GENET EPIDEMIOL,CHATEAU LONGCHAMP,BOIS BOULOGNE,F-75016 PARIS,FRANCE.		Demenais, Florence/G-3298-2013; Abel, Laurent/H-8888-2017	Demenais, Florence/0000-0001-8361-0936; Abel, Laurent/0000-0001-7016-6493				BEIGUELMAN B, 1972, ACTA GENET MED GEMEL, V21, P21, DOI 10.1017/S1120962300011094; BROWN IN, 1982, IMMUNOLOGY, V47, P149; CURTIS J, 1984, INFECT IMMUN, V46, P635, DOI 10.1128/IAI.46.3.635-638.1984; DEMENAIS F, 1983, AM J HUM GENET, V35, P1156; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS F, 1986, GENET EPIDEMIOL S, V1, P49; DEMENAIS F, 1985, GENETIC CONTROL HOST, P319; ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245; GOLDIN L R, 1984, Genetic Epidemiology, V1, P285, DOI 10.1002/gepi.1370010307; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; JACQUARD A, 1977, CONCEPTS GENETIQUE P; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1980, POINTER COMPUTER PRO; LASSERRE G, 1961, GUADELOUPE, V2, P884; MILLAN J, 1979, ACTA LEPROL GENEVE, V77, P129; MORTON NE, 1974, AM J HUM GENET, V26, P489; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; SANSONETTI P, 1981, REV INFECT DIS, V3, P422; SERJEANTSON S, 1979, ANN HUM BIOL, V6, P375, DOI 10.1080/03014467900003761; SERJEANTSON SW, 1983, IMMUNOL REV, V70, P89, DOI 10.1111/j.1600-065X.1983.tb00711.x; SKAMENE E, 1984, IMMUNOGENETICS, V19, P117, DOI 10.1007/BF00387854; SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0; SMITH DG, 1979, HUM GENET, V50, P163, DOI 10.1007/BF00390238; VANEDEN W, 1985, J INFECT DIS, V151, P9, DOI 10.1093/infdis/151.1.9; VANEDEN W, 1984, LEPROSY REV, V55, P89; WILSON SR, 1979, ANN HUM GENET, V42, P513, DOI 10.1111/j.1469-1809.1979.tb00684.x	30	129	133	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					256	266						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341381				2022-12-18	WOS:A1988M313300006
J	LANGE, K; BOEHNKE, M				LANGE, K; BOEHNKE, M			HOW MANY POLYMORPHIC GENES WILL IT TAKE TO SPAN THE HUMAN GENOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LANGE, K (corresponding author), UNIV CALIF LOS ANGELES, DEPT BIOMATH, LOS ANGELES, CA 90024 USA.				NICHD NIH HHS [K04-HD00307] Funding Source: Medline; PHS HHS [07104] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COOKE PJ, 1974, J APPL PROBAB, V11, P281, DOI 10.2307/3212749; EDENS E, 1975, INDAG MATH, V37, P373; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; Feller W., 1971, INTRO PROBABILITY TH, VII; FLATTO L, 1977, ACTA MATH-DJURSHOLM, V138, P241, DOI 10.1007/BF02392317; FLATTO L, 1973, ISRAEL J MATH, V15, P167, DOI 10.1007/BF02764603; FLATTO L, 1962, SIAM REV, V4, P211, DOI 10.1137/1004058; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HOLST L, 1980, J APPL PROBAB, V17, P284, DOI 10.2307/3212948; HOUSMAN D, 1981, GENETIC RES STRATEGI, P17; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAPLAN N, 1977, ANN PROBAB, V5, P787, DOI 10.1214/aop/1176995720; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; Solomon Herbert, 1978, GEOMETRIC PROBABILIT; Stevens WL, 1939, ANN EUGENIC, V9, P315, DOI 10.1111/j.1469-1809.1939.tb02216.x; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WHITE R, 1980, BANBURY REPORT, V4, P409; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; 1971, BIRTH DEFECTS ORIG A, V7, P7	20	129	130	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					842	845						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	6960692				2022-12-18	WOS:A1982PU21100002
J	REUSER, AJJ; KOSTER, JF; KOSTER, JF; HOOGEVEEN, A; GALJAARD, H				REUSER, AJJ; KOSTER, JF; KOSTER, JF; HOOGEVEEN, A; GALJAARD, H			BIOCHEMICAL, IMMUNOLOGICAL, AND CELL GENETIC STUDIES IN GLYCOGENOSIS TYPE-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ERASMUS UNIV,DEPT CELL BIOL & GENET,ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT BIOCHEM,ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus University Rotterdam								ANGELINI C, 1973, ARCH BIOCHEM BIOPHYS, V156, P350, DOI 10.1016/0003-9861(73)90374-3; ANGELINI C, 1972, ARCH NEUROL-CHICAGO, V26, P344, DOI 10.1001/archneur.1972.00490100074007; BROWN BI, 1975, PHYSIOLOGICAL EFFECT, P232; Cori GT, 1957, MOD PROBLEMS PAEDIAT, V3, P344; de Barsy T, 1972, Eur J Biochem, V31, P156; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; ENGEL AG, 1970, BRAIN, V93, P599, DOI 10.1093/brain/93.3.599; GALJAARD H, 1973, CLIN CHIM ACTA, V49, P361, DOI 10.1016/0009-8981(73)90234-9; GALJAARD H, 1975, NATURE, V257, P60, DOI 10.1038/257060a0; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; HERS HG, 1973, LYSOSOMES STORAGE DI, P197; HERS HG, 1963, BIOCHEM J, V86, P1; HUDGSON P, 1975, J PATHOL, V116, P139, DOI 10.1002/path.1711160303; HUG G, 1973, NEW ENGL J MED, V288, P216; HUIJING F, 1970, CLIN CHIM ACTA, V30, P567, DOI 10.1016/0009-8981(70)90246-9; JEFFREY PL, 1970, BIOCHEMISTRY-US, V9, P1416, DOI 10.1021/bi00808a016; KOSTER JF, 1972, EUR J CLIN INVEST, V2, P467, DOI 10.1111/j.1365-2362.1972.tb00678.x; KOSTER JF, 1976, CLIN CHIM ACTA, V68, P49, DOI 10.1016/0009-8981(76)90287-4; KOSTER JF, 1977, BIOCH BIOPHYS ACTA, V482, P87; McKusick V. A, 1975, MENDELIAN INHERITANC; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; PALMER TN, 1971, BIOCHEM J, V124, P713, DOI 10.1042/bj1240713; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; REUSER AJJ, 1976, J HISTOCHEM CYTOCHEM, V24, P578, DOI 10.1177/24.4.1063791; ROSENFELD EL, 1975, PATHOL BIOL, V23, P71; SMITH HL, 1966, AM J DIS CHILD, V111, P475, DOI 10.1001/archpedi.1966.02090080053002; SMITH J, 1967, NEUROLOGY, V17, P537, DOI 10.1212/WNL.17.6.537; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0	28	129	139	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					132	143						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	350041				2022-12-18	WOS:A1978EV59500004
J	THERMAN, E; DEMARS, RI; PATAU, K; SMITH, DW				THERMAN, E; DEMARS, RI; PATAU, K; SMITH, DW			D TRISOMY SYNDROME AND XO GONADAL DYSGENESIS IN 2 SISTERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOEOEK JA, 1959, ACTA PAEDIATR, V48, P453; CHU EHY, 1959, AM J HUM GENET, V11, P63; EDWARDS JH, 1960, LANCET, V1, P787; FORD CE, 1959, LANCET, V1, P711; FORD CE, 1959, LANCET, V1, P709; HARDEN DG, 1960, ANN HUM GENET, V24, P165; HAYWARD MD, 1960, LANCET, V2, P844; LEVAN A, 1959, HEREDITAS, V45, P665; PATAU K, 1960, LANCET, V1, P790; PATAU K, 1960, AM J HUM GENET, V12, P250; PATAU K, 1961, CHROMOSOMA; POLANI PE, 1960, LANCET, V1, P721; SMITH DW, 1960, J PEDIATR-US, V57, P338, DOI 10.1016/S0022-3476(60)80241-7; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; TJIO JH, 1958, J EXP MED, V108, P259, DOI 10.1084/jem.108.2.259	15	129	130	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					193	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	13776246				2022-12-18	WOS:A19612960A00007
J	Smedley, D; Schubach, M; Jacobsen, JOB; Kohler, S; Zemojtel, T; Spielmann, M; Jager, M; Hochheiser, H; Washington, NL; McMurry, JA; Haendel, MA; Mungall, CJ; Lewis, SE; Groza, T; Valentini, G; Robinson, PN				Smedley, Damian; Schubach, Max; Jacobsen, Julius O. B.; Koehler, Sebastian; Zemojtel, Tomasz; Spielmann, Malte; Jaeger, Marten; Hochheiser, Harry; Washington, Nicole L.; McMurry, Julie A.; Haendel, Melissa A.; Mungall, Christopher J.; Lewis, Suzanna E.; Groza, Tudor; Valentini, Giorgio; Robinson, Peter N.			A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-VARIATION; MODEL ORGANISM; PHENOTYPE; REGIONS; MUTATIONS; DATABASE; PRIORITIZATION; POLYMORPHISMS; TRANSLATION; EXPRESSION	The interpretation of non-coding variants still constitutes a major challenge in the application of whole-genome sequencing in Mendelian disease, especially for single-nucleotide and other small non-coding variants. Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders. Overall, Genomiser is able to identify causal regulatory variants as the top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.	[Smedley, Damian] Queen Mary Univ London, London E1 4NS, England; [Smedley, Damian] Genom England Ltd, London EC1M 6BQ, England; [Schubach, Max; Koehler, Sebastian; Zemojtel, Tomasz; Spielmann, Malte; Jaeger, Marten; Robinson, Peter N.] Charite, Inst Med & Human Genet, Augustenburger Pl 1, D-13353 Berlin, Germany; [Jacobsen, Julius O. B.] Wellcome Trust Sanger Inst, Skarnes Fac Grp, Hinxton CB10 1SA, England; [Zemojtel, Tomasz] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Spielmann, Malte; Robinson, Peter N.] Max Planck Inst Mol Genet, Ihnestr 63-73, D-14195 Berlin, Germany; [Jaeger, Marten; Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Augustenburger Pl 1, D-13353 Berlin, Germany; [Hochheiser, Harry] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15206 USA; [Hochheiser, Harry] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA 15206 USA; [Washington, Nicole L.; Mungall, Christopher J.; Lewis, Suzanna E.] Lawrence Berkeley Natl Lab, Div Environm Genom & Syst Biol, Berkeley, CA 94720 USA; [McMurry, Julie A.; Haendel, Melissa A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Groza, Tudor] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW 2010, Australia; [Groza, Tudor] Univ New South Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW 2010, Australia; [Valentini, Giorgio] Univ Milan, Anadeto Lab, Dept Comp Sci, Via Comel, I-20135 Milan, Italy; [Robinson, Peter N.] Free Univ Berlin, Inst Bioinformat, Dept Math & Comp Sci, D-14195 Berlin, Germany; [Robinson, Peter N.] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA	University of London; Queen Mary University London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wellcome Trust Sanger Institute; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Oregon Health & Science University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Milan; Free University of Berlin; Jackson Laboratory	Robinson, PN (corresponding author), Charite, Inst Med & Human Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.; Robinson, PN (corresponding author), Max Planck Inst Mol Genet, Ihnestr 63-73, D-14195 Berlin, Germany.; Robinson, PN (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Augustenburger Pl 1, D-13353 Berlin, Germany.; Robinson, PN (corresponding author), Free Univ Berlin, Inst Bioinformat, Dept Math & Comp Sci, D-14195 Berlin, Germany.; Robinson, PN (corresponding author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA.	peter.robinson@jax.org	Schubach, Max/AAE-4017-2019; Spielmann, Malte/H-2230-2018; Mungall, Chris/I-6006-2019; Smedley, Damian/AAL-8172-2021	Schubach, Max/0000-0002-2032-6679; Spielmann, Malte/0000-0002-0583-4683; Mungall, Chris/0000-0002-6601-2165; Valentini, Giorgio/0000-0002-5694-3919; Jager, Marten/0000-0002-1774-7085; McMurry, Julie/0000-0002-9353-5498; Groza, Tudor/0000-0003-2267-8333; Jacobsen, Julius/0000-0002-3265-1591; Haendel, Melissa/0000-0001-9114-8737	European Union [602300]; NIH [1 U54 HG006370-01]; NIH Office of the Director [5R24OD011883]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Bundesministerium fur Bildung and Forschung (BMBF) [0313911, 01EC1402B]; Deutsche Forschungsgemeinschaft [DFG SP1532/2-1]; DAAD Funding programme Research Stays for University Academics and Scientists [57210259]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006370, U54HG006370] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011883] Funding Source: NIH RePORTER	European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD Funding programme Research Stays for University Academics and Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the European Union Seventh Framework Programme (FP7/2007-2013) ("SYBIL" grant No. 602300), NIH (1 U54 HG006370-01), the NIH Office of the Director (#5R24OD011883), the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (Contract No. DE-AC02-05CH11231), the Bundesministerium fur Bildung and Forschung (BMBF project numbers 0313911 and 01EC1402B), the Deutsche Forschungsgemeinschaft (DFG SP1532/2-1), and the DAAD Funding programme Research Stays for University Academics and Scientists (ID 57210259).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bone WP, 2016, GENET MED, V18, P608, DOI 10.1038/gim.2015.137; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cammaerts S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00186; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Chuzhanova Nadia, 2007, Genomic Med, V1, P29, DOI 10.1007/s11568-006-9000-3; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gordon CT, 2014, NAT GENET, V46, P3, DOI 10.1038/ng.2861; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Jager M, 2014, HUM MUTAT, V35, P548, DOI 10.1002/humu.22531; Jarinova O, 2012, HUM MUTAT, V33, P1021, DOI 10.1002/humu.22083; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Jones Bryony L, 2011, Hugo J, V5, P13, DOI 10.1007/s11568-011-9155-4; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kawahara Y, 2014, CONGENIT ANOM, V54, P12, DOI 10.1111/cga.12043; Khan Imtiaz A., 2006, In Silico Biology, V6, P23; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2014, J MED GENET, V51, P766, DOI 10.1136/jmedgenet-2014-102633; Kohler Sebastian, 2014, Nucleic Acids Res, V42, pD966, DOI 10.1093/nar/gkt1026; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Ma M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S3; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Mungall CJ, 2015, HUM MUTAT, V36, P979, DOI 10.1002/humu.22857; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Riggs ER, 2012, HUM MUTAT, V33, P787, DOI 10.1002/humu.22052; Ritchie GRS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0087-1; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Savinkova LK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P117, DOI 10.1134/S0006297909020011; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Smedley D, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0199-2; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Washington N.L., 2013, PHENODAY2014, P1; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/nmeth.3484, 10.1038/NMETH.3484]; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	75	128	131	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					595	606		10.1016/j.ajhg.2016.07.005	http://dx.doi.org/10.1016/j.ajhg.2016.07.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569544	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000383114800006
J	Clayton-Smith, J; O'Sullivan, J; Daly, S; Bhaskar, S; Day, R; Anderson, B; Voss, AK; Thomas, T; Biesecker, LG; Smith, P; Fryer, A; Chandler, KE; Kerr, B; Tassabehji, M; Lynch, SA; Krajewska-Walasek, M; McKee, S; Smith, J; Sweeney, E; Mansour, S; Mohammed, S; Donnai, D; Black, G				Clayton-Smith, Jill; O'Sullivan, James; Daly, Sarah; Bhaskar, Sanjeev; Day, Ruth; Anderson, Beverley; Voss, Anne K.; Thomas, Tim; Biesecker, Leslie G.; Smith, Philip; Fryer, Alan; Chandler, Kate E.; Kerr, Bronwyn; Tassabehji, May; Lynch, Sally-Ann; Krajewska-Walasek, Malgorzata; McKee, Shane; Smith, Janine; Sweeney, Elizabeth; Mansour, Sahar; Mohammed, Shehla; Donnai, Dian; Black, Graeme			Whole-Exome-Sequencing Identifies Mutations in Histone Acetyltransferase Gene KAT6B in Individuals with the Say-Barber-Biesecker Variant of Ohdo Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; BLEPHAROPHIMOSIS SYNDROME; HYPOPLASTIC TEETH; SIMPSON TYPE; MORF; QUERKOPF; FACIES; MICE	Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS or Ohdo syndrome) is a multiple anomaly syndrome characterized by severe intellectual disability, blepharophimosis, and a mask-like facial appearance. A number of individuals with SBBYSS also have thyroid abnormalities and cleft palate. The condition usually occurs sporadically and is therefore presumed to be due in most cases to new dominant mutations. In individuals with SBBYSS, a whole-exome sequencing approach was used to demonstrate de novo protein-truncating mutations in the highly conserved histone acetyltransferase gene KAT6B (MYST4/MORF)) in three out of four individuals sequenced. Sanger sequencing was used to confirm truncating mutations of KAT6B, clustering in the final exon of the gene in all four individuals and in a further nine persons with typical SBBYSS. Where parental samples were available, the mutations were shown to have occurred de novo. During mammalian development KAT6B is upregulated specifically in the developing central nervous system, facial structures, and limb buds. The phenotypic features seen in the Qkf mouse, a hypomorphic Kat6b mutant, include small eyes, ventrally placed ears and long first digits that mirror the human phenotype. This is a further example of how perturbation of a protein involved in chromatin modification might give rise to a multisystem developmental disorder.	[Clayton-Smith, Jill; O'Sullivan, James; Daly, Sarah; Bhaskar, Sanjeev; Day, Ruth; Anderson, Beverley; Smith, Philip; Chandler, Kate E.; Kerr, Bronwyn; Tassabehji, May; Donnai, Dian; Black, Graeme] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Sch Biomed, Manchester M13 9WL, Lancs, England; [Voss, Anne K.; Thomas, Tim] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Voss, Anne K.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Fryer, Alan; Sweeney, Elizabeth] Alder Hey Hosp, Cheshire & Merseyside Genet Serv, Liverpool L12 2AP, Merseyside, England; [Lynch, Sally-Ann] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; [Krajewska-Walasek, Malgorzata] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [McKee, Shane] Belfast City Hosp, Dept Med Genet, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Smith, Janine] Childrens Hosp Westmead, Dept Clin Genet, Westmead, NSW 2145, Australia; [Mansour, Sahar] St Georges Med Sch, Dept Med Genet, London SW17 0RE, England; [Mohammed, Shehla] Guys Hosp, Dept Clin Genet, London SE1 9RT, England	University of Manchester; Walter & Eliza Hall Institute; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Our Ladys Children Hospital Crumlin; Children's Memorial Health Institute; Belfast City Hospital; University of Sydney; St Georges University London; Guy's & St Thomas' NHS Foundation Trust	Clayton-Smith, J (corresponding author), Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Sch Biomed, Manchester M13 9WL, Lancs, England.	jill.clayton-smith@cmft.nhs.uk	Voss, Anne K/F-5110-2013; Biesecker, Leslie/AAG-2526-2021; Black, Graeme/K-7374-2015	Voss, Anne K/0000-0002-3853-9381; Black, Graeme/0000-0001-8727-6592; Lynch, Sally Ann/0000-0003-3540-1333; Thomas, Tim/0000-0002-7623-8344; Krajewska-Walasek, Malgorzata/0000-0001-8721-210X	Manchester Biomedical Research Centre; National Institute for Health Research; Healing Foundation; National Institute of Health; Australian NHMRC; Victorian government; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0509-10185] Funding Source: researchfish	Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Healing Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian government; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Health Research(National Institute for Health Research (NIHR))	Clinical and Laboratory work carried out within the Genetic Medicine Department at St Mary's Hospital was supported by the Manchester Biomedical Research Centre funded by the National Institute for Health Research. Research into clefting syndromes in Manchester is supported by the Healing Foundation. The Clinseq project was funded by the National Institute of Health. A.K.V. and T.T. were supported by project grants and research fellowships from the Australian NHMRC as well as through infrastructure funding from the Victorian government.	[Anonymous], ELEMENTS MORPHOLOGY; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; BIESECKER LG, 1991, J MED GENET, V28, P131, DOI 10.1136/jmg.28.2.131; Clayton-Smith J, 1994, Clin Dysmorphol, V3, P115; Day R, 2008, CLIN GENET, V74, P434, DOI 10.1111/j.1399-0004.2008.01087.x; *ENS, ENS GEN BROWS; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; McGraw S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-123; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; OHDO S, 1986, J MED GENET, V23, P242, DOI 10.1136/jmg.23.3.242; Panagopoulos I, 2001, HUM MOL GENET, V10, P395, DOI 10.1093/hmg/10.4.395; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; SAY B, 1987, J MED GENET, V24, P511, DOI 10.1136/jmg.24.8.511-a; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Szakszon K, 2011, AM J MED GENET A, V155A, P634, DOI 10.1002/ajmg.a.33837; Thomas T, 2000, DEVELOPMENT, V127, P2537; Tzschach A, 2010, EUR J HUM GENET, V18, P291, DOI 10.1038/ejhg.2009.163; Verloes A, 2006, AM J MED GENET A, V140A, P1285, DOI 10.1002/ajmg.a.31270; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 2000, DEVELOPMENT, V127, P1; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; YOUNG ID, 1987, J MED GENET, V24, P715, DOI 10.1136/jmg.24.11.715; DATABASE GENOMIC VAR	25	128	135	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					675	681		10.1016/j.ajhg.2011.10.008	http://dx.doi.org/10.1016/j.ajhg.2011.10.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22077973	Green Published, Bronze			2022-12-18	WOS:000297090100010
J	Koscinski, I; Ellnati, E; Fossard, C; Redin, C; Muller, J; de la Calle, JV; Schmitt, F; Ben Khelifa, M; Ray, P; Kilani, Z; Barratt, CLR; Viville, S				Koscinski, Isabelle; Ellnati, Elias; Fossard, Camille; Redin, Claire; Muller, Jean; de la Calle, Juan Velez; Schmitt, Francoise; Ben Khelifa, Mariem; Ray, Pierre; Kilani, Zaid; Barratt, Christopher L. R.; Viville, Stephane			DPY19L2 Deletion as a Major Cause of Globozoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; FAMILIAL GLOBOZOOSPERMIA; MALE-INFERTILITY; MUTATION; SPERM; PREGNANCY; INJECTION; GENOME; PICK1; GENE	Globozoospermia, characterized by round-headed spermatozoa, is a rare (< 0.1% in male infertile patients) and severe teratozoospermia consisting primarily of spermatozoa lacking an acrosome. Studying a Jordanian consanguineous family in which five brothers were diagnosed with complete globozoospermia, we showed that the four out of five analyzed infertile brothers carried a homozygous deletion of 200 kb on chromosome 12 encompassing only DPY19L2. Very similar deletions were found in three additional unrelated patients, suggesting that DPY19L2 deletion is a major cause of globozoospermia, given that 19% (4 of 21) of the analyzed patients had such deletion. The deletion is most probably due to a nonallelic homologous recombination (NAHR), because the gene is surrounded by two low copy repeats (LCRs). We found DPY19L2 deletion in patients from three different origins and two different breakpoints, strongly suggesting that the deletion results from recurrent events linked to the specific architectural feature of this locus rather than from a founder effect, without fully excluding a recent founder effect. DPY19L2 is associated with a complete form of globozoospermia, as is the case for the first two genes found to be associated with globozoospermia, SPATA16 or PICK1. However, in contrast to SPATA16, for which no pregnancy was reported, pregnancies were achieved, via intracytoplasmic sperm injection, for two patients with DPY19L2 deletion, who then fathered three children.	[Koscinski, Isabelle; Viville, Stephane] CHU Strasbourg, Serv Biol Reprod, F-67000 Strasbourg, France; [Koscinski, Isabelle; Ellnati, Elias; Fossard, Camille; Redin, Claire; Muller, Jean; Viville, Stephane] Univ Strasbourg, IGBMC, INSERM, CNRS,U964,UMR 1704, F-67404 Illkirch Graffenstaden, France; [Muller, Jean] CHU Strasbourg, Nouvel Hop Civil, Lab Diagnost Genet, F-67000 Strasbourg, France; [de la Calle, Juan Velez] Clin Pasteur, Unite FIV, F-29200 Brest, France; [Schmitt, Francoise] Ctr Hosp Mulhouse, Reprod Biol Lab, F-68100 Mulhouse, France; [Ben Khelifa, Mariem; Ray, Pierre] Univ Grenoble 1, Fac Med Pharm, Grenoble 9, France; [Ray, Pierre] Team AGIM, TIMC, IMAG, CNRS,UMR 5525, F-38710 La Tronche, France; [Ray, Pierre] CHU Grenoble, F-38700 Grenoble, France; [Kilani, Zaid] Farah Hosp, Amman 11183, Jordan; [Barratt, Christopher L. R.] Univ Dundee, Ninewells Hosp, Maternal & Child Hlth Sci Labs, Ctr Oncol & Mol Med, Dundee DD1 9SY, Scotland	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Dundee	Viville, S (corresponding author), CHU Strasbourg, Serv Biol Reprod, F-67000 Strasbourg, France.	viville@igbmc.fr	Muller, Jean/L-7412-2018; Ray, Pierre F/D-7315-2019	Muller, Jean/0000-0002-7682-559X; Ray, Pierre F/0000-0003-1544-7449; Viville, Stephane/0000-0002-5088-3003; Fossard, Camille/0000-0002-3427-6406; Barratt, christopher/0000-0003-0062-9979; ElInati, Elias/0000-0002-4364-9358	French Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicate (INSERM); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; University of Strasbourg; University Hospital of Strasbourg; Agence de la BioMedecine	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicate (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; University of Strasbourg; University Hospital of Strasbourg; Agence de la BioMedecine	We are very grateful to our colleagues Manuel Mark, for his help in interpreting the gametogenesis of our patients, and Michel Koenig and Regen Drouin, for their critical reading of this manuscript. We would also like to thanks all of the clinicians-C. Jimenez (Dijon), F. Carre-Pigeon (Reims), J.M. Grillot (Marseille), F. Brugnon (Clermont Ferrand), D. De Briel (Colmar), and S. Decleve-Paulhac (Limoges)-who have sent us samples from globozoospermic patients and for whom we still expect to find a mutation. We would like to recognize the intellectual input of Jean-Louis Mandel, Christelle Thibault-Carpentier, and Mirna Assoum and the technical help of Anne-Sophie Jaeger and Nathalie Drouot. We would like to thank Frederic Plewniak (plewniak@igbmc.fr) from the Bioinformatics Platform of Strasbourg for the development of the HomoSNP software. We are grateful to the Institute of Genetics and Molecular and Cellular Biology (IGBMC) services and the Department of Human Genetics for their invaluable assistance. This work was supported by the French Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicate (INSERM), the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, the University of Strasbourg, the University Hospital of Strasbourg, and the Agence de la BioMedecine.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banker Manish R, 2009, J Hum Reprod Sci, V2, P81, DOI 10.4103/0974-1208.57228; Bechoua S, 2009, ANDROLOGIA, V41, P55, DOI 10.1111/j.1439-0272.2008.00884.x; Carrell DT, 1999, FERTIL STERIL, V71, P511, DOI 10.1016/S0015-0282(98)00498-1; Carson AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-45; Coetzee K, 2001, J ASSIST REPROD GEN, V18, P311, DOI 10.1023/A:1016678604207; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Dirican EK, 2008, ASIAN J ANDROL, V10, P332, DOI 10.1111/j.1745-7262.2008.00248.x; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Honigberg L, 2000, DEVELOPMENT, V127, P4655; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; INHORN M, 2009, ANTHR PUBLIC HLTH BR, P165; Inhorn MC, 2009, FERTIL STERIL, V91, P1104, DOI 10.1016/j.fertnstert.2008.01.008; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kilani Z, 2004, FERTIL STERIL, V82, P1436, DOI 10.1016/j.fertnstert.2004.03.064; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Liu G, 2010, ASIAN J ANDROL, V12, P556, DOI 10.1038/aja.2010.47; Machev N, 2005, CYTOGENET GENOME RES, V111, P352, DOI 10.1159/000086910; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Viville S, 2000, HUM REPROD, V15, P2563, DOI 10.1093/humrep/15.12.2563; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230	28	128	142	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					344	350		10.1016/j.ajhg.2011.01.018	http://dx.doi.org/10.1016/j.ajhg.2011.01.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397063	Bronze, Green Published			2022-12-18	WOS:000288589000011
J	Tse, KP; Su, WH; Chang, KP; Tsang, NM; Yu, CJ; Tang, P; See, LC; Hsueh, C; Yang, ML; Hao, SP; Li, HY; Wang, MH; Liao, LP; Chen, LC; Lin, SR; Jorgensen, TJ; Chang, YS; Shugart, YY				Tse, Ka-Po; Su, Wen-Hui; Chang, Kai-Ping; Tsang, Ngan-Ming; Yu, Chia-Jung; Tang, Petrus; See, Lee-Chu; Hsueh, Chuen; Yang, Min-Lee; Hao, Sheng-Po; Li, Hong-Yi; Wang, Ming-Hsi; Liao, Li-Ping; Chen, Lih-Chyang; Lin, Sheue-Rong; Jorgensen, Timothy J.; Chang, Yu-Sun; Shugart, Yin Yao			Genome-wide Association Study Reveals Multiple Nasopharyngeal Carcinoma-Associated Loci within the HLA Region at Chromosome 6p21.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINOBUTYRIC-ACID GABA; CLASS-I; GENETIC POLYMORPHISMS; SUSCEPTIBILITY LOCUS; CANCER; EXPRESSION; DNA; LINKAGE; GROWTH; TUMORS	Nasopharyngeal carcinoma (NPC) is a multifactorial malignancy closely associated with genetic factors and Epstein-Barr virus infection. To identify the common genetic variants linked to NPC susceptibility, we conducted a genome-wide association study (GWAS) in 277 NPC patients and 285 healthy controls within the Taiwanese population, analyzing 480,365 single-nucleotide polymorphisms (SNPS). Twelve statistically significant SNPs were identified and mapped to chromosome 6p2l.3. Associations were replicated in two independent sets of case-control samples. Two of the most significant SNPs (rs2517713 and rs2975042; P-combined = 3.9 X 10(-20) and 1.6 x 10(-19), respectively) were located in the HLA-A gene. Moreover, we detected significant associations between NPC and two genes: specifically, gamma aminobutyric acid b receptor 1 (GABBR1) (rs29232; P-combined = 8.9 7 X 10(-17)) and HLA-F (rs3129055 and rs92S8122; P-combined = 7.36 x 10(-11) and 3.33 x 10(-10), respectively). Notably, the association of rs29232 remained significant (residual p < 5 X 10(-4)) after adjustment for age, gender, and HLA-related SNPs. Furthermore, higher GABA(B) receptor 1 expression levels can be found in the tumor cells in comparison to the adjacent epithelial cells (p < 0.001) in NPC biopsies, implying a biological role of GABBR1 in NPC carcinogenesis. To our knowledge, it is the first GWAS report of NPC showing that multiple loci (HLA-A, HLA-F, and GABBR1) within chromosome 6p21.3 are associated with NPC. Although some of these relationships may be attributed to linkage disequilibrium between the loci, the findings clearly provide a fresh direction for the study of NPC development.	[Tse, Ka-Po; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Chang, Kai-Ping; Hao, Sheng-Po] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol, Tao Yuan 333, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Tao Yuan 333, Taiwan; [Hsueh, Chuen] Chang Gung Mem Hosp Lin Kou, Dept Pathol, Tao Yuan 333, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Dept Biochem & Mol & Cellular Biol, Tao Yuan 333, Taiwan; [See, Lee-Chu; Li, Hong-Yi] Chang Gung Univ, Dept Publ Hlth, Tao Yuan 333, Taiwan; [Shugart, Yin Yao] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Wang, Ming-Hsi; Jorgensen, Timothy J.; Shugart, Yin Yao] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Lin, Sheue-Rong] Hlth Bur Taoyuan Cty, Directors Off, Tao Yuan 33053, Taiwan; [Jorgensen, Timothy J.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Radiat Med, Washington, DC 20057 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Chang, YS (corresponding author), Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan 333, Taiwan.	ysc@mail.cgu.edu.tw	Chang, Kai-Ping/B-5135-2011	See, Lai-Chu/0000-0002-1379-8969; Tang, Petrus/0000-0002-2779-0116; Su, Wen-Hui/0000-0003-1037-4615; Hsueh, Chuen/0000-0001-7860-5964; YAO, YIN/0000-0003-3053-8429; Chang, Yu-Sun/0000-0002-6457-3890; Yang, Min-Lee/0000-0003-2823-8320	SNPs [ss120095059, ss120095075, ss120095079, ss120095083]; NATIONAL CANCER INSTITUTE [R03CA123620] Funding Source: NIH RePORTER	SNPs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NCBI dbSNP accession numbers for the SNPs reported in this paper are ss120095059, ss120095075, ss120095079, and ss 120095083.	Aly TA, 2008, DIABETES, V57, P770, DOI 10.2337/db07-0900; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BUELL P, 1974, CANCER RES, V34, P1189; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAN SH, 1983, INT J CANCER, V32, P171, DOI 10.1002/ijc.2910320206; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cheng YJ, 2003, CANCER EPIDEM BIOMAR, V12, P179; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; FERLAY J, 1997, CANC INCIDENCE FIVE, V7, pR1; HEIMBERG W, 2004, NUCLEIC ACIDS RES, V32, pW173; HILDESHEIM A, 1995, CANCER EPIDEM BIOMAR, V4, P607; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Kleinrok Z, 1998, J PHYSIOL PHARMACOL, V49, P303; Lee N, 2003, J IMMUNOL, V171, P5264, DOI 10.4049/jimmunol.171.10.5264; Lu CC, 2003, INT J CANCER, V103, P745, DOI 10.1002/ijc.10861; Lu CC, 2005, INT J CANCER, V115, P742, DOI 10.1002/ijc.20946; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marks JE, 1998, CANCER, V83, P582, DOI 10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R; Matuszek M, 2001, Med Sci Monit, V7, P377; McAulay KA, 2007, J CLIN INVEST, V117, P3042, DOI 10.1172/JCI32377; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Niens M, 2006, CANCER EPIDEM BIOMAR, V15, P2280, DOI 10.1158/1055-9965.EPI-06-0476; Ooi EE, 1997, INT J CANCER, V74, P229; Opolski A, 2000, J EXP CLIN CANC RES, V19, P383; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI 10.1093/nar/GKG070; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shanmugaratnam K., 1978, IARC SCI PUBL, V20, P3; Simons M J, 1975, IARC Sci Publ, P249; Su CK, 2002, INT J RADIAT ONCOL, V54, P752, DOI 10.1016/S0360-3016(02)02969-3; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Tse KP, 2007, CLIN CANCER RES, V13, P6320, DOI 10.1158/1078-0432.CCR-07-1029; Watanabe M, 2006, HISTOL HISTOPATHOL, V21, P1135, DOI 10.14670/HH-21.1135; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	40	128	136	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					194	203		10.1016/j.ajhg.2009.07.007	http://dx.doi.org/10.1016/j.ajhg.2009.07.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19664746	Green Published, Bronze			2022-12-18	WOS:000269332900008
J	Krakow, D; Vriens, J; Camacho, N; Luong, P; Deixler, H; Funari, TL; Bacino, CA; Irons, MB; Holm, IA; Sadler, L; Okenfuss, EB; Janssens, A; Voets, T; Rimoin, DL; Lachman, RS; Nilius, B; Cohn, DH				Krakow, Deborah; Vriens, Joris; Camacho, Natalia; Luong, Phi; Deixler, Hannah; Funari, Tara L.; Bacino, Carlos A.; Irons, Mira B.; Holm, Ingrid A.; Sadler, Laurie; Okenfuss, Ericka B.; Janssens, Annelies; Voets, Thomas; Rimoin, David L.; Lachman, Ralph S.; Nilius, Bernd; Cohn, Daniel H.			Mutations in the Gene Encoding the Calcium-Permeable Ion Channel TRPV4 Produce Spondylometaphyseal Dysplasia, Kozlowski Type and Metatropic Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODULATION	The spondylometaphyseal dysplasias (SMDs) are a group of short-stature disorders distinguished by abnormalities in the ver-tebrae and the metaphyses of the tubular bones. SMD Kozlowski type (SMDK) is a well-defined autosomal-dominant SMD characterized by significant scoliosis and mild metaphyseal abnormalities in the pelvis. The vertebrae exhibit platyspondyly and overfaced pedicles similar to autosomal-dominant brachyolmia, which can result from heterozygosity for activating mutations in the gene encoding TRPV4, a calcium-permeable Ion channel. Mutation analysis in six out of six patients with SMDK demonstrated heterozygosity for missense mutations in TRPV4, and one mutation, predicting a R594H substitution, was recurrent in four patients. Similar to autosomal-dominant brachyolmia, the mutations altered basal calcium channel activity in vitro. Metatropic dysplasia is another SMD that has been proposed to have both clinical and genetic heterogeneity. Patients with the nonlethal form of metatropic dysplasia present with a progressive scoliosis, widespread metaphyseal involvement of the appendicular skeleton, and carpal ossification delay. Because of some similar radiographic features between SMDK and metatropic dysplasia, 'FRPV4 was tested as a disease gene for nonlethal metatropic dysplasia. In two sporadic cases, heterozygosity for de novo missense mutations in TRPV4 was found. The findings demonstrate that mutations in TRPV4 produce a phenotypic spectrum of skeletal dysplasias from the mild autosomal-dominant brachyolmia to SMDK to autosomal-dominant metatropic dysplasia, suggesting that these disorders should be grouped into a new bone dysplasia family.	[Krakow, Deborah; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; [Krakow, Deborah; Camacho, Natalia; Luong, Phi; Deixler, Hannah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90024 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Rimoin, David L.; Lachman, Ralph S.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Rimoin, David L.; Lachman, Ralph S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Lachman, Ralph S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Krakow, Deborah; Funari, Tara L.; Rimoin, David L.; Cohn, Daniel H.] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Bacino, Carlos A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Irons, Mira B.; Holm, Ingrid A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Sadler, Laurie] Womens & Childrens Hosp, Buffalo, NY 14222 USA; [Okenfuss, Ericka B.] Kaiser Permanente, Oakland, CA 94611 USA; [Vriens, Joris; Janssens, Annelies; Voets, Thomas; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Baylor College of Medicine; Harvard University; Boston Children's Hospital; Women & Children's Hospital of Buffalo; Kaiser Permanente; KU Leuven	Cohn, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA.	dan.cohn@cshs.org	Voets, Thomas/AAD-4389-2019; Vriens, Joris/G-9966-2018; Voets, Thomas/E-2466-2012; Krakow, Deborah/B-5778-2009	Voets, Thomas/0000-0001-5526-5821; Vriens, Joris/0000-0002-2502-0409; Voets, Thomas/0000-0001-5526-5821; Krakow, Deborah/0000-0001-9906-4968; Janssens, Annelies/0000-0002-6735-8248; Holm, Ingrid/0000-0003-4712-8821	National Institutes of Health [HD22657]; Belgian Federal Government; Flemish Government; Onderzoeksraad KU Leuven; Flemish Research Foundation (FWO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Federal Government; Flemish Government(European Commission); Onderzoeksraad KU Leuven(KU Leuven); Flemish Research Foundation (FWO)(FWO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank the patients and their families for their participation, and thank Maryann Priore for her efforts on behalf of this study. This project was supported by National Institutes of Health grant HD22657 to D.K., D.C., R.S.L., and D.L.R. and by the Belgian Federal Government, the Flemish Government, and the Onderzoeksraad KU Leuven (Interuniversity Poles of Attraction Program, Prime Minister's Office IUAP Nr.3P4/23 and Excellentiefinanciering EF/95/010) to B.N. J.V. is a postdoctoral fellow of the Flemish Research Foundation (FWO).	BECK M, 1983, EUR J PEDIATR, V140, P231, DOI 10.1007/BF00443368; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; GARDI C, 1994, THORAX, V49, P312, DOI 10.1136/thx.49.4.312; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Genevieve D, 2008, AM J MED GENET A, V146A, P992, DOI 10.1002/ajmg.a.32191; Kannu P, 2007, AM J MED GENET A, V143A, P2512, DOI 10.1002/ajmg.a.31941; Kozlowski K, 1982, Prog Clin Biol Res, V104, P89; KOZLOWSKI K, 1967, Presse Medicale, V75, P2769; KOZLOWSKI K, 1973, PROGR PEDIAT RADIOLO, V4, P229; LACHMAN RS, 2007, AYBI LACHMANS RADIOL, P1080; Leet AI, 2006, J PEDIATR ORTHOPED, V26, P347, DOI 10.1097/01.bpo.0000214923.95314.ad; MAROTEAUX P, 1991, PEDIATR RADIOL, V21, P293, DOI 10.1007/BF02018629; Maroteaux P, 1966, Arch Kinderheilkd, V173, P211; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Myers BR, 2008, J GEN PHYSIOL, V132, P481, DOI 10.1085/jgp.200810104; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nural Mehmet Selim, 2006, Diagn Interv Radiol, V12, P70; Pan Z, 2008, CELL CALCIUM, V44, P374, DOI 10.1016/j.ceca.2008.01.008; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; SHOHAT M, 1989, J PEDIATR-US, V114, P239, DOI 10.1016/S0022-3476(89)80789-9; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200	31	128	138	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					307	315		10.1016/j.ajhg.2009.01.021	http://dx.doi.org/10.1016/j.ajhg.2009.01.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19232556	Green Published, Bronze			2022-12-18	WOS:000264304200002
J	Saada, A; Edvardson, S; Rapoport, M; Shaag, A; Amry, K; Miller, C; Lorberboum-Galski, H; Elpeleg, O				Saada, Ann; Edvardson, Simon; Rapoport, Matan; Shaag, Avraham; Amry, Khaled; Miller, Chaya; Lorberboum-Galski, Haya; Elpeleg, Orly			C6ORF66 is an assembly factor of mitochondrial complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; PROTEIN; GENE; IDENTIFICATION; DISORDERS; CHAPERONE; HRPAP20; ECSIT	Homozygosity mapping was performed in five patients from a consanguineous family who presented with infantile mitochondrial encephalomyopathy attributed to isolated NADH:ubiquinone oxidoreductase (complex I) deficiency. This resulted in the identification of a missense mutation in a conserved residue of the C6ORF66 gene, which encodes a 20.2 kDa mitochondrial protein. The mutation was also detected in a patient who presented with antenatal cardiomyopathy. In muscle of two patients, the levels of the C6ORF66 protein and of the fully assembled complex I were markedly reduced. Transfection of the patients' fibroblasts with wild-type C6ORF66 cDNA restored complex I activity. These data suggest that C6ORF66 is an assembly factor of complex I. Interestingly, the C6ORF66 gene product was previously shown to promote breast cancer cell invasiveness.	[Saada, Ann; Shaag, Avraham; Miller, Chaya; Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Edvardson, Simon] Hadassah Hebrew Univ Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; [Amry, Khaled] Palestinian Med Relief Soc, Ramallah, Palestine; [Rapoport, Matan; Lorberboum-Galski, Haya] Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem & Human Genet, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Elpeleg, O (corresponding author), Hadassah Hebrew Univ Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	elpeleg@cc.huji.ac.il	Saada, Ann/J-6864-2017; Lorberboum-Galski, Haya/K-8839-2019	Saada, Ann/0000-0003-2951-0656; Edvardson, Simon/0000-0003-2878-1278				Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; EDVARDSON S, 2007, IN PRESS AM J HUM; FEARNLEY IM, 2006, METHOD MOL BIOL, V357, P103; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Karp CM, 2007, ONCOGENE, V26, P1780, DOI 10.1038/sj.onc.1209980; Karp CM, 2004, CANCER RES, V64, P1016, DOI 10.1158/0008-5472.CAN-03-0023; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006; Tsuneoka M, 2005, J BIOL CHEM, V280, P19977, DOI 10.1074/jbc.M501231200; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	24	128	133	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					32	38		10.1016/j.ajhg.2007.08.003	http://dx.doi.org/10.1016/j.ajhg.2007.08.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179882	Green Published, Bronze			2022-12-18	WOS:000253223800004
J	Pearson, JV; Huentelman, MJ; Halperin, RF; Tembe, WD; Melquist, S; Homer, N; Brun, M; Szelinger, S; Coon, KD; Zismann, VL; Webster, JA; Beach, T; Sando, SB; Aasly, JO; Heun, R; Jessen, F; Koelsch, H; Tsolaki, M; Daniilidou, M; Reiman, EM; Papassotiropoulos, A; Hutton, ML; Stephan, DA; Craig, DW				Pearson, John V.; Huentelman, Matthew J.; Halperin, Rebecca F.; Tembe, Waibhav D.; Melquist, Stacey; Homer, Nils; Brun, Marcel; Szelinger, Szabolcs; Coon, Keith D.; Zismann, Victoria L.; Webster, Jennifer A.; Beach, Thomas; Sando, Sigrid B.; Aasly, Jan O.; Heun, Reinhard; Jessen, Frank; Koelsch, Heike; Tsolaki, Magdalini; Daniilidou, Makrina; Reiman, Eric M.; Papassotiropoulos, Andreas; Hutton, Michael L.; Stephan, Dietrich A.; Craig, David W.			Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; NINDS NEUROPATHOLOGIC CRITERIA; ALLELE FREQUENCY ESTIMATION; LARGE-SCALE ASSOCIATION; MILD MENTAL IMPAIRMENT; POOLED DNA; ALZHEIMERS-DISEASE; VULNERABILITY LOCI; MASS-SPECTROMETRY; APOLIPOPROTEIN-E	We report the development and validation of experimental methods, study designs, and analysis software for pooling-based genomewide association (GWA) studies that use high-throughput single-nucleotide-polymorphism ( SNP) genotyping microarrays. We first describe a theoretical framework for establishing the effectiveness of pooling genomic DNA as a low-cost alternative to individually genotyping thousands of samples on high-density SNP microarrays. Next, we describe software called "GenePool," which directly analyzes SNP microarray probe intensity data and ranks SNPs by increased likelihood of being genetically associated with a trait or disorder. Finally, we apply these methods to experimental case-control data and demonstrate successful identification of published genetic susceptibility loci for a rare monogenic disease (sudden infant death with dysgenesis of the testes syndrome), a rare complex disease (progressive supranuclear palsy), and a common complex disease (Alzheimer disease) across multiple SNP genotyping platforms. On the basis of these theoretical calculations and their experimental validation, our results suggest that pooling-based GWA studies are a logical first step for determining whether major genetic associations exist in diseases with high heritability.	TGen, Neurogenom Div, Phoenix, AZ 85004 USA; Arizona Alzheimers Consortium, Phoenix, AZ USA; Mayo Coll Med, Dept Neurosci, Jacksonville, FL USA; Sun Hlth Res Inst, Sun City, AZ USA; St Olavs Hosp, Dept Neurol, Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Aristotle Univ Thessaloniki, Dept Neurol, GR-54006 Thessaloniki, Greece; Univ Arizona, Banner Alzheimers Inst, Tucson, AZ USA; Univ Arizona, Dept Psychiat, Tucson, AZ USA; Univ Zurich, Dept Psychiat Res, Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	Translational Genomics Research Institute; Mayo Clinic; Banner Research; Banner Health; Banner Sun Health Research Institute; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bonn; Aristotle University of Thessaloniki; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; University of Arizona; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Craig, DW (corresponding author), TGen, Neurogenom Div, 445 N 5th St, Phoenix, AZ 85004 USA.	dcraig@tgen.org	Jessen, Frank/E-7655-2012; Craig, David Wesley/K-6961-2019; Pearson, John V/F-2249-2011; Jessen, Frank/AAK-6170-2020; Pearson, John/AAT-4211-2020	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Papassotiropoulos, Andreas/0000-0002-2210-9651; Brun, Marcel/0000-0002-6452-5856; Tsolaki, Magda/0000-0002-2072-8010	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS043571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01-HL086528-01, U01 HL086528] Funding Source: Medline; NIA NIH HHS [P30 AG019610, P30 AG19610] Funding Source: Medline; NIMH NIH HHS [R01 MH057899] Funding Source: Medline; NINDS NIH HHS [U24 NS043571, 1U24NS043571] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AUDERMAN WJ, 2006, QUANTO 1 1 COMPUTER; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Brohede J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni142; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Butcher LM, 2005, MOL PSYCHIATR, V10, P384, DOI 10.1038/sj.mp.4001589; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Caselli RJ, 2002, J AM GERIATR SOC, V50, P49, DOI 10.1046/j.1532-5415.2002.50007.x; Caselli RJ, 2001, J NEUROL SCI, V189, P93, DOI 10.1016/S0022-510X(01)00577-9; Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138; Craig DW, 2005, EXPERT REV MOL DIAGN, V5, P159, DOI 10.1586/14737159.5.2.159; FRANCISCO A, 2002, PRACTICAL APPROACH M; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hinds David A., 2004, Human Genomics, V1, P421; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Huentelman MJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-149; Johnson C, 2006, AM J MED GENET B, V141B, P844, DOI 10.1002/ajmg.b.30346; Jurinke C, 2001, Methods Mol Biol, V170, P103; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Le Hellard S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf070; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Meaburn E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-52; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Moskvina V, 2005, GENET EPIDEMIOL, V28, P273, DOI 10.1002/gepi.20062; Nelson MR, 2004, GENOME RES, V14, P1664, DOI 10.1101/gr.2421604; Norton N, 2004, ANN MED, V36, P146, DOI 10.1080/07853890310021724; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Qiu C, 2004, J NEUROL NEUROSUR PS, V75, P828, DOI 10.1136/jnnp.2003.021493; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Simpson CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni028; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tang K, 2004, J PROTEOME RES, V3, P218, DOI 10.1021/pr034080s; Toft M, 2005, MECH AGEING DEV, V126, P1201, DOI 10.1016/j.mad.2005.06.010; Yang HC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl446; Yang HC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-233; Zou GH, 2004, GENET EPIDEMIOL, V26, P1, DOI 10.1002/gepi.10277; Zuo YJ, 2006, GENETICS, V173, P1747, DOI 10.1534/genetics.105.042648	49	128	135	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					126	139		10.1086/510686	http://dx.doi.org/10.1086/510686			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160900	Green Published, Bronze			2022-12-18	WOS:000243102500012
J	Britanova, O; Depew, MJ; Schwark, M; Thomas, BL; Miletich, I; Sharpe, P; Tarabykin, V				Britanova, Olga; Depew, Michael J.; Schwark, Manuela; Thomas, Bethan L.; Miletich, Isabelle; Sharpe, Paul; Tarabykin, Victor			Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEFT-PALATE; GENE; MSX1; EXPRESSION; MUTANT	The recent identification of SATB2 as a candidate gene responsible for the craniofacial dysmorphologies associated with deletions and translocations at 2q32-q33, one of only three regions of the genome for which haploinsufficiency has been significantly associated with isolated cleft palate, led us to investigate the in vivo functions of murine Satb2. We find that, similar to the way in which SATB2 is perceived to act in humans, craniofacial defects due to haploinsufficiency of Satb2, including cleft palate (in similar to 25% of cases), phenocopy those seen with 2q32-q33 deletions and translocations in humans. Full functional loss of Satb2 results in amplification of these defects and leads both to increased apoptosis in the craniofacial mesenchyme where Satb2 is usually expressed and to changes in the pattern of expression of three genes implicated in the regulation of craniofacial development in humans and mice: Pax9, Alx4, and Msx1. The Satb2-dosage sensitivity in craniofacial development is conspicuous-along with its control of cell survival, pattern of expression, and reversible functional modification by SUMOylation, it suggests that Satb2/SATB2 function in craniofacial development may prove to be more profound than has been anticipated previously. Because jaw development is Satb2-dosage sensitive, the regulators of Satb2 expression and posttranslational modification become of critical importance both ontogenetically and evolutionarily, especially since such regulators plausibly play undetected roles in jaw and palate development and in the etiology of craniofacial malformations.	Kings Coll Hosp London, Dept Craniofacial Dev, Guys Hosp, London SE1 9RT, England; Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; RAS, Lab Mol Technol, Shemiakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; DFG, Res Ctr Mol Physiol Brain, Gottingen, Germany	Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Max Planck Society; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; German Research Foundation (DFG)	Depew, MJ (corresponding author), Kings Coll Hosp London, Dept Craniofacial Dev, Guys Hosp, London Bridge,Floors 27-28, London SE1 9RT, England.	michael.depew@kcl.ac.uk; tarabykin@em.mpg.de	Tarabykin, Victor/F-9467-2014	Sharpe, Paul/0000-0003-2116-9561; Tarabykin, Viktor/0000-0001-8931-7263; Miletich, Isabelle/0000-0003-2817-7492	Medical Research Council [G0200709] Funding Source: Medline; MRC [G0200709] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beverdam A, 2001, DEVELOPMENT, V128, P3975; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Brewer CM, 1999, AM J HUM GENET, V65, P387, DOI 10.1086/302498; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Cohen MM, 1999, AM J MED GENET, V84, P311; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; Depew MJ, 2006, DEV DYNAM, V235, P1256, DOI 10.1002/dvdy.20796; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gorlin R.J., 2001, SYNDROMES HEAD NECK, V4th ed., DOI 10.17245/jdapm.2019.19.5.261; Jakobsen LP, 2006, CLEFT PALATE-CRAN J, V43, P155, DOI 10.1597/05-008.1; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Petersen J, 1998, INTERNET WORLD, V9, P12; Rice DPC, 2005, CURR MOL MED, V5, P699, DOI 10.2174/156652405774641043; Romer A, 1956, OSTEOLOGY REPTILES; ROMER AS, 1947, MAN VERTEBRATES; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schuffenhauer S, 1999, J MED GENET, V36, P233; THOROGOOD P, 1997, EMBRYOS GENES BIRTH; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Van Buggenhout G, 2005, EUR J MED GENET, V48, P276, DOI 10.1016/j.ejmg.2005.05.005; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	32	128	134	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					668	678		10.1086/508214	http://dx.doi.org/10.1086/508214			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960803	Green Published, Bronze			2022-12-18	WOS:000240855900008
J	Ai, MR; Heeger, S; Bartels, CF; Schelling, DK				Ai, MR; Heeger, S; Bartels, CF; Schelling, DK		Osteoporosis-Pseudoglioma Collaborat Grp	Clinical and molecular findings in osteoporosis-pseudoglioma syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR-RELATED PROTEIN-5; FAMILIAL EXUDATIVE VITREORETINOPATHY; HIGH-BONE-MASS; LDL-RECEPTOR-RELATED-PROTEIN-5 LRP5 GENE; OSTEOGENESIS IMPERFECTA; MISSENSE MUTATIONS; DENSITY; MICE; DISEASE; POLYMORPHISMS	Mutations in the low-density lipoprotein receptor-related protein 5 gene (LRP5) cause autosomal recessive osteoporosis-pseudoglioma syndrome (OPPG). We sequenced the coding exons of LRP5 in 37 probands suspected of having OPPG on the basis of the co-occurrence of severe congenital or childhood-onset visual impairment with bone fragility or osteoporosis recognized by young adulthood. We found two putative mutant alleles in 26 probands, only one mutant allele in 4 probands, and no mutant alleles in 7 probands. Looking for digenic inheritance, we sequenced the genes encoding the functionally related receptor LRP6, an LRP5 coreceptor FZD4, and an LRP5 ligand, NDP, in the four probands with one mutant allele, and, looking for locus heterogeneity, we sequenced FZD4 and NDP in the seven probands with no mutations, but we found no additional mutations. When we compared clinical features between probands with and without LRP5 mutations, we found no difference in the severity of skeletal disease, prevalence of cognitive impairment, or family history of consanguinity. However, four of the seven probands without detectable mutations had eye pathology that differed from pathology previously described for OPPG. Since many LRP5 mutations are missense changes, to differentiate between a disease-causing mutation and a benign variant, we measured the ability of wild-type and mutant LRP5 to transduce Wnt and Norrin signal ex vivo. Each of the seven OPPG mutations tested, had reduced signal transduction compared with wild-type mutations. These results indicate that early bilateral vitreoretinal eye pathology coupled with skeletal fragility is a strong predictor of LRP5 mutation and that mutations in LRP5 cause OPPG by impairing Wnt and Norrin signal transduction.	Case Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Ai, MR (corresponding author), Case Sch Med, Dept Genet, BRB 719,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mlw14@case.edu						Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; BEIGHTON P, 1985, CLIN GENET, V28, P69; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bollerslev J, 2005, BONE, V36, P599, DOI 10.1016/j.bone.2005.01.006; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; DEPAEPE A, 1993, AM J MED GENET, V45, P30, DOI 10.1002/ajmg.1320450110; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Hartikka H, 2005, J BONE MINER RES, V20, P783, DOI 10.1359/JBMR.050101; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lev D, 2003, ISRAEL MED ASSOC J, V5, P419; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; SIMS KB, 2004, GENEREVIEWS; SOMER H, 1988, J MED GENET, V25, P543, DOI 10.1136/jmg.25.8.543; SteichenGersdorf E, 1997, CLIN DYSMORPHOL, V6, P171; SUPERTIFURGA A, 1986, CLIN GENET, V29, P184; SWOBODA W, 1988, PEDIATR RADIOL, V18, P399, DOI 10.1007/BF02388045; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zacharin M, 2000, J PEDIATR-US, V137, P410, DOI 10.1067/mpd.2000.107838	41	128	134	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					741	753		10.1086/497706	http://dx.doi.org/10.1086/497706			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252235	Bronze, Green Published			2022-12-18	WOS:000232569600005
J	Giallourakis, C; Stoll, M; Miller, K; Hampe, J; Lander, ES; Daly, MJ; Schreiber, S; Rioux, JD				Giallourakis, C; Stoll, M; Miller, K; Hampe, J; Lander, ES; Daly, MJ; Schreiber, S; Rioux, JD			IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn disease and identification of a novel association with ulcerative colitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE STRUCTURE; GENETIC-VARIATION; NOD2 GENE; SUSCEPTIBILITY; GENOTYPE; CLASSIFICATION; POPULATION; MUTATIONS	Inflammatory bowel disease (IBD) refers to complex chronic relapsing autoimmune disorders of the gastrointestinal tract that have been traditionally classified into Crohn disease ( CD) and ulcerative colitis (UC). We have previously reported that genetic variation within a 250-kb haplotype (IBD5) in the 5q31 cytokine gene cluster confers susceptibility to CD in a Canadian population. In the current study, we first replicated this association by examining 368 German trios with CD and demonstrating, by transmission/ disequilibrium testing (TDT), that the same haplotype is associated with CD (chi(2) = 5.97; P = .007). Our original association study focused on the role of IBD5 in CD; we next explored the potential contribution of this locus to UC susceptibility in 187 German trios. Given the TDT results in the present cohort with UC, IBD5 may also act as a susceptibility locus for UC (chi(2) = 8.10; P = .002). We then examined locus-locus interactions between IBD5 and CARD15, a locus reported elsewhere to confer risk exclusively to CD. Our current results indicate that the two loci act independently to confer risk to CD but that these two loci may behave in an epistatic fashion to promote the development of UC. Moreover, IBD5 was not associated with particular clinical manifestations upon phenotypic stratification in the current cohort with CD. Taken together, our results suggest that IBD5 may act as a general risk factor for IBD, with loci such as CARD15 modifying the clinical characteristics of disease.	Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Univ Kiel, Dept Internal Med, Kiel, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; University of Kiel	Rioux, JD (corresponding author), Whitehead Inst, Ctr Genome Res, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.	rioux@genome.wi.mit.edu	Rioux, John D/A-9599-2015; Hampe, Jochen/A-2555-2010; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Hampe, Jochen/0000-0002-2421-6127; Daly, Mark J/0000-0002-0949-8752				Abreu MT, 2002, GASTROENTEROLOGY, V123, P679, DOI 10.1053/gast.2002.35393; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; FARMER RG, 1993, DIGEST DIS SCI, V38, P1137, DOI 10.1007/BF01295733; FELDMAN M, 1998, GASTROINTESTINAL LIV, V2, P1708; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Moum B, 1996, SCAND J GASTROENTERO, V31, P362, DOI 10.3109/00365529609006411; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124	21	128	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					205	211		10.1086/376417	http://dx.doi.org/10.1086/376417			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12776251	Green Published, Bronze			2022-12-18	WOS:000183904900018
J	Fogli, A; Rodriguez, D; Eymard-Pierre, E; Bouhour, F; Labauge, P; Meaney, BF; Zeesman, S; Kaneski, CR; Schiffmann, R; Boespflug-Tanguy, O				Fogli, A; Rodriguez, D; Eymard-Pierre, E; Bouhour, F; Labauge, P; Meaney, BF; Zeesman, S; Kaneski, CR; Schiffmann, R; Boespflug-Tanguy, O			Ovarian failure related to eukaryotic initiation factor 2B mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VANISHING WHITE-MATTER; NERVOUS-SYSTEM HYPOMYELINATION; CHILDHOOD ATAXIA; FACTOR EIF2B; LEUKOENCEPHALOPATHY; LEUKODYSTROPHY; DYSGENESIS; IDENTIFICATION; APOPTOSIS; PHENOTYPE	Ovarian failure (OF) at age <40 years occurs in &SIM;1% of all women. Other than karyotype abnormalities, very few genes are known to be associated with this ovarian dysfunction. We studied eight patients who presented with premature OF and white-matter abnormalities on magnetic resonance imaging. Neurological signs may be absent or present after OR In seven patients, we report for the first time mutations in three of the five EIF2B genes (EIF2B2, -4, and -5) that were recently shown to cause childhood ataxia with central nervous system hypomyelination/vanishing white-matter disease leukodystrophy. The correlation we observed between the age at onset of the neurological deterioration and the severity of OF suggests a common pathophysiological pathway.	Fac Med, INSERM, UMR 384, F-63001 Clermont Ferrand, France; Hop A Trousseau, Serv Neuropediat, INSERM, U546, Paris, France; Hop Pierre Wertheimer, Lyon, France; Ctr Hosp Univ, Dept Neurol, Nimes, France; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; Hamilton Hlth Sci, Hamilton Reg Lab Med Program, Hamilton, ON, Canada; NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Universite de Montpellier; CHU de Nimes; McMaster University; McMaster University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Boespflug-Tanguy, O (corresponding author), Fac Med, INSERM, UMR 384, 28 Pl Henri Dunant,BP 38, F-63001 Clermont Ferrand, France.		Meaney, Brandon/AAY-1138-2021; Fogli, Anne/AAL-6640-2020; EYMARD-PIERRE, ELEONORE/Y-4187-2019	Meaney, Brandon/0000-0003-0704-3583; Fogli, Anne/0000-0002-2651-7441; EYMARD-PIERRE, ELEONORE/0000-0003-0460-8112; Kaneski, Christine/0000-0003-1453-2502	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATTOMAKI K, 1995, CELL, V82, P959; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boltshauser E, 2002, NEUROPEDIATRICS, V33, P57, DOI 10.1055/s-2002-32363; Bruck W, 2001, ANN NEUROL, V50, P532, DOI 10.1002/ana.1227; Christin-Maitre S, 1998, MOL CELL ENDOCRINOL, V145, P75, DOI 10.1016/S0303-7207(98)00172-5; Conway GS, 1997, CURR OPIN OBSTET GYN, V9, P202; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Francalanci P, 2001, NEUROLOGY, V57, P265, DOI 10.1212/WNL.57.2.265; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Liu ZP, 2001, J COMP NEUROL, V441, P1, DOI 10.1002/cne.1393; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schiffmann R, 1997, ANN NEUROL, V41, P654, DOI 10.1002/ana.410410515; Schlessinger D, 2002, AM J MED GENET, V111, P328, DOI 10.1002/ajmg.10565; Shelling AN, 2000, AUST NZ J MED, V30, P5, DOI 10.1111/j.1445-5994.2000.tb01046.x; Shelling AN, 2000, HUM REPROD, V15, P2644, DOI 10.1093/humrep/15.12.2644; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Verghese J, 2002, EUR J NEUROL, V9, P663, DOI 10.1046/j.1468-1331.2002.00469.x; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234	28	128	144	1	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1544	1550		10.1086/375404	http://dx.doi.org/10.1086/375404			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12707859	Bronze, Green Published			2022-12-18	WOS:000183275500017
J	Zhang, HP; Leckman, JF; Pauls, DL; Tsai, CP; Kidd, KK; Campos, MR				Zhang, HP; Leckman, JF; Pauls, DL; Tsai, CP; Kidd, KK; Campos, MR		Tourette Syndrome Assoc Int Consor	Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSESSIVE-COMPULSIVE DISORDER; COMPLEX SEGREGATION ANALYSIS; QUANTITATIVE-TRAIT LOCI; SYMPTOM; FAMILY; EPIDEMIOLOGY; PERSONALITY; LINKAGE; HUMANS	A genome scan of the hoarding phenotype (a component of obsessive-compulsive disorder) was conducted on 77 sib pairs collected by the Tourette Syndrome Association International Consortium for Genetics (TSAICG). All sib pairs were concordant for a diagnosis of Gilles de la Tourette syndrome (GTS). However, the analyses reported here were conducted for hoarding as both a dichotomous trait and a quantitative trait. Not all sib pairs in the sample were concordant for hoarding. Standard linkage analyses were performed using GENEHUNTER and Haseman-Elston methods. In addition, novel analyses with a recursive-partitioning technique were employed. Significant allele sharing was observed for both the dichotomous and the quantitative hoarding phenotypes for markers at 4q34-35 (P = .0007), by use of GENEHUNTER, and at 5q35.2-35.3 (P = .000002) and 17q25 (P = .00002), by use of the revisited Haseman-Elston method. The 4q site is in proximity to D4S1625, which was identified by the TSAICG as a region linked to the GTS phenotype. The recursive-partitioning technique examined multiple markers simultaneously. Results suggest joint effects of specific loci on 5q and 4q, with an overall P value of .000003. Although P values were not adjusted for multiple comparison, nearly all were much smaller than the customary significance level of .0001 for genomewide scans.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, HP (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	heping.zhang@yale.edu	Leckman, James/O-2426-2015		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125, M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH000508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040024, T32NS007338, R01NS040024, R01NS016648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012468] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 MH000508] Funding Source: Medline; NCRR NIH HHS [M01 RR000044, M01 RR000125] Funding Source: Medline; NIDA NIH HHS [R01 DA012468] Funding Source: Medline; NINDS NIH HHS [R01 NS040024, T32 NS007338, U01 NS040024, R01 NS016648] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alsobrook JP, 1999, AM J MED GENET, V88, P669, DOI 10.1002/(SICI)1096-8628(19991215)88:6<669::AID-AJMG17>3.0.CO;2-N; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 1999, Am J Hum Genet, V65, P1428; APTER A, 1993, ARCH GEN PSYCHIAT, V50, P734; BAER L, 1994, J CLIN PSYCHIAT, V55, P18; Black DW, 1998, J CLIN PSYCHIAT, V59, P420, DOI 10.4088/JCP.v59n0804; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Cavallini MC, 1999, AM J MED GENET, V88, P38, DOI 10.1002/(SICI)1096-8628(19990205)88:1<38::AID-AJMG7>3.0.CO;2-#; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; FROST RO, 1995, BEHAV RES THER, V33, P897, DOI 10.1016/0005-7967(95)00043-W; Frost RO, 2000, BEHAV RES THER, V38, P1071, DOI 10.1016/S0005-7967(99)00137-0; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; King RA, 1998, TOURETTES SYNDROME T, P43; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Leckman JF, 2000, LEA SER PER CLIN PSY, P43; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Leckman JF, 2001, AM J MED GENET, V105, P28, DOI 10.1002/1096-8628(20010108)105:1<28::AID-AJMG1050>3.3.CO;2-#; LECKMAN JF, 1993, AM J PSYCHIAT, V150, P98; LECKMAN JF, 2000, DIMENSIONAL YALE BRO; Mataix-Cols D, 1999, AM J PSYCHIAT, V156, P1409; Nestadt G, 2000, AM J HUM GENET, V67, P1611, DOI 10.1086/316898; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; NICOLINI H, 1991, AM J HUM GENET, V49, P477; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Rao DC, 1998, GENET EPIDEMIOL, V15, P1; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Shannon WD, 2001, GENET EPIDEMIOL, V20, P293, DOI 10.1002/gepi.1; Simonic I, 2001, AM J MED GENET, V105, P163, DOI 10.1002/ajmg.1192; Summerfeldt LJ, 1999, BEHAV RES THER, V37, P297, DOI 10.1016/S0005-7967(98)00134-X; Veenstra-VanderWeele J, 2001, MOL PSYCHIATR, V6, P160, DOI 10.1038/sj.mp.4000806; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5; Zhang HP, 2001, P NATL ACAD SCI USA, V98, P6730, DOI 10.1073/pnas.111153698; Zhang HP, 1996, AM J HUM GENET, V59, P951; Zhang HP, 2001, GENET EPIDEMIOL, V21, pS317, DOI 10.1002/gepi.2001.21.s1.s317; Zhang HP, 1999, RECURSIVE PARTITIONI	44	128	135	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					896	904		10.1086/339520	http://dx.doi.org/10.1086/339520			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11840360	Green Published, Bronze			2022-12-18	WOS:000174252100007
J	Hall, MA; Rich, SS				Hall, MA; Rich, SS			Laws restricting health insurers' use of genetic information: Impact on genetic discrimination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSURANCE; LIFE	Since 1991, 28 states have enacted laws that prohibit insurers' use of genetic information in pricing, issuing, or structuring health insurance. This article evaluates whether these laws reduce the extent of genetic discrimination by health insurers. From the data collected at multiple sites, we find that there are almost no well-documented cases of health insurers either asking for or using presyptomatic genetic test results in their underwriting decisions, either (a) before or after these laws have been enacted or (b) in states with or without these laws. By using both in-person interviews with insurers and a direct market test, we found that a person with a serious genetic condition who is presymptomatic faces little or no difficulty in obtaining health insurance. Furthermore, there are few indications that the degree of difficulty varies according to whether a state regulates the use-of genetic information. Nevertheless, these laws have made it less likely that insurers will use genetic information in the future. Although insurers and agents are only vaguely aware of these laws, the laws have shaped industry norms and attitudes about the legitimacy of using this information.	Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA	Wake Forest University	Hall, MA (corresponding author), Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, 2D Floor MRI Ctr, Winston Salem, NC 27157 USA.	mhall@law.wfu.edu		Rich, Stephen/0000-0003-3872-7793	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001662] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG01662] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abraham K, 1986, DISTRIBUTING RISK IN; ABRAHAM KS, 1985, VA LAW REV, V71, P403, DOI 10.2307/1072963; Alper J S, 1994, J Public Health Policy, V15, P345, DOI 10.2307/3342910; Alper JS, 1998, SCI ENG ETHICS, V4, P141, DOI 10.1007/s11948-998-0044-8; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BONNIE RJ, 1986, NEBRASKA S MOTIVATIO, P131; BOWLESBIESECKER B, 1998, KENNEDY INST ETHIC J, V8, P145; Colby JA, 1998, AM J LAW MED, V24, P443; Davis Helen R, 1996, Jurimetrics, V37, P69; Ellickson RobertC., 1991, ORDER WITHOUT LAW; Field J. V., 1993, RISK HLTH SAFETY ENV, V4, P329; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; HALL MA, 1999, N AM ACTUARIAL J, V3, P34; Hall Mark A, 1996, Jurimetrics, V37, P13; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; IUCULANO CK, 1987, HARVARD LAW REV, V100, P1806; Kaas Nancy E., 1997, GENETIC SECRETS PROT, P299; KENEN R, 1984, FIELD SOC SCI MED, V18, P541; KOTVAL JS, 1998, ALBANY LAW J SCI TEC, V9, P1; Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621; MCEWEN JE, 1993, AM J HUM GENET, V53, P33; MULHOLLAND W, 1999, JURIMETRICS J, V39, P1; Nelson DE, 1998, AM J PUBLIC HEALTH, V88, P245, DOI 10.2105/AJPH.88.2.245; *OH DEP INS, 1995, OH TASK FORC GEN TES; PAULY MV, 1985, ADV HLTH EC HLTH SER, P281; Pokorski RJ, 1997, AM J HUM GENET, V60, P205; REILLY PR, 1997, GENETIC DISCRIMINATI; Rodriguez-Bigas MA, 1998, AM J HUM GENET, V62, P736, DOI 10.1086/301753; Rothenberg KH, 1995, J LAW MED ETHICS, V23, P312, DOI 10.1111/j.1748-720X.1995.tb01373.x; Rothstein MA, 1998, AM J LAW MED, V24, P399; SHAPIRO MH, 1994, U PITT LAW REV, V55, P681; STONE DA, 1997, HUMAN GENOME PROJECT, P133; STONE DA, 1996, COLUMBIA LAW REV, V96, P903; Sunstein CR, 1996, U PENN LAW REV, V144, P2021, DOI 10.2307/3312647; *US C OFF TECHN AS, 1992, GEN TESTS HLTH INS R; Volpe LC, 1998, GENET TEST, V2, P9, DOI 10.1089/gte.1998.2.9; Wertz D C, 1997, J Contemp Health Law Policy, V13, P299; Wingrove EJ, 1996, AM J MED GENET, V64, P378, DOI 10.1002/(SICI)1096-8628(19960809)64:2<378::AID-AJMG29>3.0.CO;2-B; Yesley Michael S, 1997, Microb Comp Genomics, V2, P19; Yesley Michael S, 1998, Berkeley Technol Law J, V13, P653	40	128	128	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					293	307		10.1086/302714	http://dx.doi.org/10.1086/302714			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	279FK	10631158	Green Published, Bronze			2022-12-18	WOS:000085033600029
J	Radhakrishna, U; Bornholdt, D; Scott, HS; Patel, UC; Rossier, C; Engel, H; Bottani, A; Chandal, D; Blouin, JL; Solanki, JV; Grzeschik, KH; Antonarakis, SE				Radhakrishna, U; Bornholdt, D; Scott, HS; Patel, UC; Rossier, C; Engel, H; Bottani, A; Chandal, D; Blouin, JL; Solanki, JV; Grzeschik, KH; Antonarakis, SE			The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; No phenotype prediction from the position of GLI3 mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALLISTER-HALL SYNDROME; KINESIN-RELATED PROTEIN; FINGER GENE GLI3; CUBITUS-INTERRUPTUS; LINKAGE ANALYSIS; GREIG-SYNDROME; DROSOPHILA; FAMILIES; COSTAL2; SIGNAL	Functional characterization of a gene often requires the discovery of the full spectrum of its associated phenotypes. Mutations in the human GLI3 gene have been identified in Greig cepalopolysyndactyly, Pallister-Hall syndrome (PHS), and postaxial polydactyly type-A (PAP-A). We studied the involvement of GLI3 in additional phenotypes of digital abnormalities in one family (UR003) with preaxial polydactyly type-IV (PPD-TV), three families (UR014, UR015, and UR016) with dominant PAP-A/B (with PPD-A and -B in the same family), and one family with PHS. Linkage analysis showed no recombination with GLI3-linked polymorphisms. Family UR003 had a l-nt frameshift insertion, resulting in a truncated protein of 1,245 amino acids. A frameshift mutation due to a l-nt deletion was found in family UR014, resulting in a truncated protein of 1,280 amino acids. Family UR015 had a nonsense mutation, R643X, and family UR016 had a missense mutation, G727R, in a highly conserved amino acid of domain 3. The patient with PHS had a nonsense mutation, E1147X. These results add two phenotypes to the phenotypic spectrum caused by GLI3 mutations: the combined PAP-A/B and PPD-TV. These mutations do not support the suggested association between the mutations in GLI3 and the resulting phenotypes. We propose that all phenotypes associated with GLI3 mutations be called "GLI3 morphopathies," since the phenotypic borders of the resulting syndromes are not well defined and there is no apparent genotype-phenotype correlation.	Ctr Med Univ Geneva, Div Med Genet, CH-1211 Geneva 4, Switzerland; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; Univ Marburg, Inst Human Genet, Marburg, Germany; Gujarat Agr Univ, Vet Coll, Dept Anim Breeding & Genet, Anand, Gujarat, India; Gujarat Univ, Dept Zool, Ahmadabad, Gujarat, India	University of Geneva; University of Geneva; University of Geneva; Philipps University Marburg; Anand Agricultural University; Gujarat University	Antonarakis, SE (corresponding author), Ctr Med Univ Geneva, Div Med Genet, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Stylianos.Antonarakis@medecine.unige.ch	Antonarakis, Stylianos E/N-8866-2014; Scott, Hamish/B-2122-2009	Antonarakis, Stylianos E/0000-0001-8907-5823; Scott, Hamish/0000-0002-5813-631X				Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BARAITSER M, 1983, CLIN GENET, V24, P257; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; BLOUIN JL, 1995, AM J HUM GENET, V57, P388; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; EPSTEIN CJ, 1995, P NATL ACAD SCI USA, V92, P8566, DOI 10.1073/pnas.92.19.8566; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; ISHIKIRIYAMA S, 1991, AM J MED GENET, V40, P41, DOI 10.1002/ajmg.1320400108; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; JOHNSON DR, 1969, GENET RES, V13, P275, DOI 10.1017/S0016672300002962; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kang S, 1997, HUM GENET, V101, P154, DOI 10.1007/s004390050605; KUCHERIA K, 1981, CLIN GENET, V20, P36; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Mehenni H, 1998, AM J HUM GENET, V63, P1641, DOI 10.1086/302159; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Radhakrishna U, 1997, AM J HUM GENET, V60, P597; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; REYNOLDS JF, 1984, CLIN GENET, V25, P267; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; SCHIMMANG T, 1994, MAMM GENOME, V5, P384, DOI 10.1007/BF00356560; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; TEMTAMY S, 1969, Birth Defects Original Article Series, V5, P125; Temtamy SA, 1978, GENETICS HAND MALFOR; Thien H, 1999, MAMM GENOME, V10, P205, DOI 10.1007/s003359900973; VANDERHOEVEN F, 1993, MAMM GENOME, V4, P276, DOI 10.1007/BF00417435; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979	36	128	134	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					645	655		10.1086/302557	http://dx.doi.org/10.1086/302557			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441570	Green Published, Bronze			2022-12-18	WOS:000082426400008
J	Rae, J; Newburger, PE; Dinauer, MC; Noack, D; Hopkins, PJ; Kuruto, R; Curnutte, JT				Rae, J; Newburger, PE; Dinauer, MC; Noack, D; Hopkins, PJ; Kuruto, R; Curnutte, JT			X-Linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUTROPHIL CYTOCHROME-B; HUMAN NADPH OXIDASE; INTERFERON-GAMMA; POINT MUTATIONS; CHROMOSOMAL LOCATION; JAPANESE PATIENTS; HEAVY-CHAIN; LIGHT CHAIN; DELETION; DNA	Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed "gp91-phox") of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.	Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Genet Microbiol, Worcester, MA 01605 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Indiana Univ, Med Ctr, Dept Pediat, Indianapolis, IN USA; Indiana Univ, Med Ctr, Dept Med & Mol Genet, Indianapolis, IN USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA; Sequana Therapeut, La Jolla, CA USA; Univ Shizuoka, Sch Food & Nutr Sci, Lab Microbiol & Host Def, Shizuoka, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Roche Holding; Genentech; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Scripps Research Institute; University of Shizuoka	Newburger, PE (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, 373 Plantat St, Worcester, MA 01605 USA.	peter.newburger@ummed.edu		Newburger, Peter/0000-0002-8615-673X	NIAID NIH HHS [AI33346, AI24838] Funding Source: Medline; NIDDK NIH HHS [DK41625] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838, R01AI033346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041625] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARIGA T, 1995, HUM GENET, V96, P6, DOI 10.1007/BF00214178; ARIGA T, 1994, HUM GENET, V94, P441; Ariga Tadashi, 1994, European Journal of Haematology, V52, P99; AZUMA H, 1995, BLOOD, V85, P3274, DOI 10.1182/blood.V85.11.3274.bloodjournal85113274; BAEHNER RL, 1986, P NATL ACAD SCI USA, V83, P3398, DOI 10.1073/pnas.83.10.3398; BERENDES H, 1957, Minn Med, V40, P309; BOLSCHER BGJM, 1991, BLOOD, V77, P2482; BRIDGES RA, 1959, AMA J DIS CHILD, V97, P387, DOI 10.1001/archpedi.1959.02070010389004; BUGHANIM HN, 1995, BLOOD, V86, P3575, DOI 10.1182/blood.V86.9.3575.bloodjournal8693575; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Condino-Neto A., 1997, Blood, V90, p136A; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; CURNUTTE JT, 1993, CLIN IMMUNOL IMMUNOP, V67, pS2, DOI 10.1006/clin.1993.1078; CURNUTTE JT, 1988, HEMATOL ONCOL CLIN N, V2, P241, DOI 10.1016/S0889-8588(18)30618-X; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; CURNUTTE JT, 1994, MOL BASIS BLOOD DIS, P493; DEBOER M, 1992, BLOOD, V80, P1553; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; DENSEN P, 1981, BLOOD, V58, P34; DESTBASILE G, 1988, HUM GENET, V80, P85, DOI 10.1007/BF00451463; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; EKLUND EA, 1995, J BIOL CHEM, V270, P8267, DOI 10.1074/jbc.270.14.8267; EZEKOWITZ RAB, 1987, J CLIN INVEST, V80, P1009, DOI 10.1172/JCI113153; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; FINN A, 1990, ARCH DIS CHILD, V65, P942, DOI 10.1136/adc.65.9.942; FORREST CB, 1988, HEMATOL ONCOL CLIN N, V2, P253, DOI 10.1016/S0889-8588(18)30619-1; FREY D, 1988, BLOOD, V71, P252; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOLMES B, 1966, LANCET, V1, P1225; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; IWATA M, 1994, BIOCHEM BIOPH RES CO, V199, P1372, DOI 10.1006/bbrc.1994.1382; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Kuribayashi F, 1996, HUM GENET, V97, P611; LANGE K, 1978, AM J HUM GENET, V30, P180; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LEUSEN JHW, 1994, J CLIN INVEST, V93, P2120, DOI 10.1172/JCI117207; Leusen JHW, 1996, J LAB CLIN MED, V128, P461, DOI 10.1016/S0022-2143(96)90043-8; MAQUAT LE, 1995, RNA, V1, P453; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; NEWBURGER PE, 1994, BLOOD, V84, P3861, DOI 10.1182/blood.V84.11.3861.bloodjournal84113861; NEWBURGER PE, 1994, J CLIN INVEST, V94, P1205, DOI 10.1172/JCI117437; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; RABBANI H, 1993, EUR J HAEMATOL, V51, P218; REDMAN CM, 1993, SEMIN HEMATOL, V30, P209; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Roos D, 1996, BLOOD, V87, P1663; Roos D, 1996, IMMUNOL TODAY, V17, P517; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Sambrook J., 1990, MOL CLONING LAB MANU; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; SEGAL AW, 1983, NEW ENGL J MED, V308, P245, DOI 10.1056/NEJM198302033080503; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; VOLPP BD, 1993, J CLIN INVEST, V91, P201, DOI 10.1172/JCI116171; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; WOODMAN RC, 1995, BLOOD, V85, P231, DOI 10.1182/blood.V85.1.231.bloodjournal851231; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288	67	128	134	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1320	1331		10.1086/301874	http://dx.doi.org/10.1086/301874			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585602	Green Published, Bronze			2022-12-18	WOS:000074174700008
J	Korkko, J; Ala-Kokko, L; De Paepe, A; Nuytinck, L; Earley, J; Prockop, DJ				Korkko, J; Ala-Kokko, L; De Paepe, A; Nuytinck, L; Earley, J; Prockop, DJ			Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of null-allele mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRO-ALPHA-2(I) COLLAGEN GENE; PROCOLLAGEN; CHAIN; DNA; REGION; RNA; CONSERVATION; REPEATS; CDNA; MICE	Although >90% of patients with osteogenesis imperfecta (OI) have been estimated to have mutations in the COL1A1 and COL1A2 genes for type I procollagen, mutations have been difficult to detect in all patients with the mildest forms of the disease (i.e., type I), In this study, we first searched for mutations in type I procollagen by analyses of protein and mRNA in fibroblasts from 10 patients with mild OI; no evidence of a mutation was found in 2 of the patients by the protein analyses, and no evidence of a mutation was found in 5 of the patients by the RNA analyses, We then searched for mutations in the original 10 patients and in 5 additional patients with mild OI, by analysis of genomic DNA, To assay the genomic DNA, we established a consensus sequence for the first 12 kb of the COL1A1 gene and for 30 kb of new sequences of the 38-kb COL1A2, gene, The sequences were then used to develop primers for PCR for the 103 exons and exon boundaries of the two genes, The PCR products were first scanned for heteroduplexes by conformation-sensitive gel electrophoresis, and then products containing heteroduplexes were sequenced, The results detected disease-causing mutations in 13 of the 15 patients and detected two additional probable disease-causing mutations in the remaining 2 patients, Analysis of the data developed in this study and elsewhere revealed common sequences for mutations causing null alleles.	Allegheny Univ Hlth Sci, MCP Hahnemann Sch Med, Ctr Gene Therapy, Philadelphia, PA 19102 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; Univ Oulu, Bioctr, Collagen Res Unit, Oulu, Finland; Univ Oulu, Dept Med Biochem, Oulu, Finland; Univ Ghent, Dept Med Genet, B-9000 Ghent, Belgium	Drexel University; Jefferson University; University of Oulu; University of Oulu; Ghent University	Prockop, DJ (corresponding author), Allegheny Univ Hlth Sci, MCP Hahnemann Sch Med, Ctr Gene Therapy, 245 N 15 St,10118 NCB,Mail Stop 421, Philadelphia, PA 19102 USA.	prockop@auhs.edu		Nuytinck, Lieve/0000-0002-5165-6937				AHMAD NN, 1995, ARCH OPHTHALMOL-CHIC, V113, P1454, DOI 10.1001/archopht.1995.01100110114034; ALAKOKKO L, 1995, BIOCHEM J, V308, P923, DOI 10.1042/bj3080923; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOEDTKER H, 1985, ANN NY ACAD SCI, V460, P85, DOI 10.1111/j.1749-6632.1985.tb51159.x; BROWN DM, 1995, HUM MOL GENET, V4, P141, DOI 10.1093/hmg/4.1.141; Byers Peter H., 1993, P317; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; CHU ML, 1985, J BIOL CHEM, V260, P2315; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DEWET W, 1987, J BIOL CHEM, V262, P16032; DICKSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P4524, DOI 10.1073/pnas.81.14.4524; DICKSON LA, 1985, NUCLEIC ACIDS RES, V13, P3427, DOI 10.1093/nar/13.10.3427; GANGULY A, 1995, ELECTROPHORESIS, V16, P1830, DOI 10.1002/elps.11501601301; GANGULY A, 1991, J BIOL CHEM, V266, P12035; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HANKE M, 1994, BIOTECHNIQUES, V17, P858; JEGO N, 1993, ONCOGENE, V8, P209; Korkko J, 1997, HUM MUTAT, V9, P148; KUIVANIEMI H, 1988, BIOCHEM J, V252, P633, DOI 10.1042/bj2520633; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LAEMMLI VK, 1975, NATURE, V227, P680; MAATTA A, 1991, FEBS LETT, V279, P9, DOI 10.1016/0014-5793(91)80237-W; MYERS JC, 1983, J BIOL CHEM, V258, P128; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NUYTINCK L, IN PRESS MATRIX BIOL; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; Saban J, 1996, BIOTECHNIQUES, V21, P190; SHERWOOD AL, 1990, GENE, V89, P239, DOI 10.1016/0378-1119(90)90011-F; SOKOLOV BP, 1991, HUM GENET, V88, P125; SYKES B, 1990, AM J HUM GENET, V46, P293; TROMP G, 1988, P NATL ACAD SCI USA, V85, P5254, DOI 10.1073/pnas.85.14.5254; VASAN NS, 1991, AM J HUM GENET, V48, P305; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; WESTERHAUSEN A, 1991, MATRIX, V11, P375, DOI 10.1016/S0934-8832(11)80191-5; WILLING MC, 1994, AM J HUM GENET, V55, P638; WILLING MC, 1992, AM J HUM GENET, V51, P508; Willing MC, 1996, AM J HUM GENET, V59, P799	42	128	137	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					98	110		10.1086/301689	http://dx.doi.org/10.1086/301689			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443882	Bronze, Green Published			2022-12-18	WOS:000072127900015
J	Hovnanian, A; Rochat, A; Bodemer, C; Petit, E; Rivers, CA; Prost, C; Fraitag, S; Christiano, AM; Uitto, J; Lathrop, M; Barrandon, Y; deProst, Y				Hovnanian, A; Rochat, A; Bodemer, C; Petit, E; Rivers, CA; Prost, C; Fraitag, S; Christiano, AM; Uitto, J; Lathrop, M; Barrandon, Y; deProst, Y			Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VII COLLAGEN GENE; EPIDERMAL BASEMENT-MEMBRANE; TRIPLE-HELICAL DOMAIN; PREMATURE TERMINATION CODONS; NONCOLLAGENOUS DOMAIN; MONOCLONAL-ANTIBODY; NONSENSE MUTATIONS; MISSENSE MUTATION; RNA-METABOLISM; DNA FRAGMENTS	We have characterized 21 mutations in the type VII collagen gene (COL7A1) encoding the anchoring fibrils, 18 of which were not previously reported, in patients from 15 unrelated families with recessive dystrophic epidermolysis bullosa (RDEB). COL7A1 mutations in both alleles were identified by screening the 118 exons of COL7A1 and flanking intron regions. Fourteen mutations created premature termination codons (PTCs) and consisted of nonsense mutations, small insertions, deletions, and splice-site mutations. A further seven mutations predicted glycine or arginine substitutions in the collagenous domain of the molecule. Two mutations were found in more than one family reported in this study, and six of the seven missense mutations showed clustering within exons 72-74 next to the hinge region of the protein. Patients who were homozygous or compound heterozygotes for mutations leading to PTCs displayed both absence or drastic reduction of COL7A1 transcripts and undetectable type VII collagen protein in skin. In contrast, missense mutations were associated with clearly detectable COL7A1 transcripts and with normal or reduced expression of type VII collagen protein at the dermo/epidermal junction. Our results provide evidence for at least two distinct molecular mechanisms underlying defective anchoring fibril formation in RDEB: one involving PTCs leading to mRNA instability and absence of protein synthesis, the other implicating mis-sense mutations resulting in the synthesis of type VII collagen polypeptide with decreased stability and/or altered function. Genotype-phenotype correlations suggested that the nature and location of these mutations are important determinants of the disease phenotype and showed evidence for interfamilial phenotypic variability.	ECOLE NORMALE SUPER, DEPT BIOL, F-75231 PARIS, FRANCE; HOP NECKER ENFANTS MALAD, DEPT DERMATOL, PARIS, FRANCE; HOP NECKER ENFANTS MALAD, DEPT HISTOL, PARIS, FRANCE; HOP ST LOUIS, DEPT HISTOL, PARIS, FRANCE; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT CUTANEOUS BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT MOL PHARMACOL, PHILADELPHIA, PA 19107 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Hovnanian, A (corresponding author), UNIV OXFORD, WELLCOME TRUST CTR HUMAN GENET, WINDMILL RD, OXFORD OX3 7BN, ENGLAND.		Hovnanian, Alain/I-4711-2017	Hovnanian, Alain/0000-0003-3412-7512	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Bonnemann CG, 1996, HUM MOL GENET, V5, P1953, DOI 10.1093/hmg/5.12.1953; Bruckner-Tuderman Leena, 1993, P507; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BRUCKNERTUDERMAN L, 1990, BRIT J DERMATOL, V122, P383, DOI 10.1111/j.1365-2133.1990.tb08287.x; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; Christiano AM, 1996, J INVEST DERMATOL, V106, P679, DOI 10.1111/1523-1747.ep12345508; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1995, HUM MOL GENET, V4, P1579; CHRISTIANO AM, 1994, P NATL ACAD SCI USA, V91, P3549, DOI 10.1073/pnas.91.9.3549; CHRISTIANO AM, 1995, J INVEST DERMATOL, V104, P438, DOI 10.1111/1523-1747.ep12666033; Christiano AM, 1996, AM J HUM GENET, V58, P671; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; Christiano AM, 1996, J INVEST DERMATOL, V106, P766, DOI 10.1111/1523-1747.ep12345814; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; CHRISTIANO AM, IN PRESS HUM MUTAT; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DUNNILL MGS, 1994, HUM MOL GENET, V3, P1693, DOI 10.1093/hmg/3.9.1693; Dunnill MGS, 1996, J INVEST DERMATOL, V107, P171, DOI 10.1111/1523-1747.ep12329570; DUNNILL MGS, 1994, J MED GENET, V31, P745, DOI 10.1136/jmg.31.10.745; Eady R. A. J., 1985, METHODS SKIN RES, P1; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GAMMON WR, 1992, J INVEST DERMATOL, V99, P691, DOI 10.1111/1523-1747.ep12614080; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gardella R, 1996, AM J HUM GENET, V59, P292; GREENSPAN DS, 1993, HUM MOL GENET, V2, P273, DOI 10.1093/hmg/2.3.273; HEAGERTY AHM, 1986, BRIT J DERMATOL, V115, P125, DOI 10.1111/j.1365-2133.1986.tb05707.x; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; HOVNANIAN A, 1993, ARCH DERMATOL, V129, P1566; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; Kivirikko S, 1996, J INVEST DERMATOL, V106, P1300, DOI 10.1111/1523-1747.ep12349019; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MAQUAT LE, 1995, RNA, V1, P453; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; Mikkola H, 1996, BLOOD, V87, P141; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAEYAERT JM, 1995, J INVEST DERMATOL, V104, P803, DOI 10.1111/1523-1747.ep12606999; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; PROSSER J, 1993, TRENDS BIOTECHNOL, V11, P238, DOI 10.1016/0167-7799(93)90135-V; PROST C, 1984, BRIT J DERMATOL, V110, P1, DOI 10.1111/j.1365-2133.1984.tb07305.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; RUSENKO KW, 1989, J INVEST DERMATOL, V92, P623, DOI 10.1111/1523-1747.ep12712167; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Shimizu H, 1996, J INVEST DERMATOL, V106, P119, DOI 10.1111/1523-1747.ep12329600; TANAKA T, 1994, BRIT J DERMATOL, V131, P472; TIDMAN MJ, 1984, J INVEST DERMATOL, V83, P448, DOI 10.1111/1523-1747.ep12273562; UITTO J, 1995, P ASSOC AM PHYSICIAN, V107, P245; UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713	61	128	130	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					599	610		10.1086/515495	http://dx.doi.org/10.1086/515495			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326325	Bronze, Green Published			2022-12-18	WOS:A1997XY52300017
J	ABELIOVICH, D; LAVON, IP; LERER, I; COHEN, T; SPRINGER, C; AVITAL, A; CUTTING, GR				ABELIOVICH, D; LAVON, IP; LERER, I; COHEN, T; SPRINGER, C; AVITAL, A; CUTTING, GR			SCREENING FOR 5 MUTATIONS DETECTS 97-PERCENT OF CYSTIC-FIBROSIS (CF) CHROMOSOMES AND PREDICTS A CARRIER FREQUENCY OF 1-29 IN THE JEWISH ASHKENAZI POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SITE-DIRECTED MUTAGENESIS; POLYMERASE CHAIN-REACTION; NUCLEOTIDE-BINDING FOLD; GENE; IDENTIFICATION; DNA	To determine the distribution and frequency of cystic fibrosis (CF) mutations in the Israeli population, we have screened 96 patients for 11 relatively common mutations. Five mutations-DELTAF508, G542X, W1282X, N1303K, and 3849 + 10kb C-->T-were found to account for 97% of the CF alleles in the Ashkenazi Jews. In contrast, of the 11 mutations tested, only DELTAF508 was detected in Jewish patients of Sephardic or Oriental origin, accounting for 43% of the CF alleles. Four mutations-DELTAF508, G542X, W1282X, and N1303K-accounted for 55% of the CF alleles in Arab patients. In a pilot screening study, a random sample of 424 Ashkenazi individuals was analyzed for three mutations-DELTAF508, W1282X, and G542X. Thirteen individuals were detected as heterozygotes (six for DELTAF508 and seven for W1282X), predicting a heterozygote frequency of 1:29. This is similar to the frequency of carriers in the Caucasian population of northern European ancestry. On the basis of these data, the Ashkenazi population is considered to be a candidate for CF heterozygote screening.	HADASSAH UNIV HOSP, INST PULM, IL-91120 JERUSALEM, ISRAEL; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA	Hebrew University of Jerusalem; Johns Hopkins University; Johns Hopkins University	ABELIOVICH, D (corresponding author), HADASSAH UNIV HOSP, DEPT HUMAN GENET, IL-91120 JERUSALEM, ISRAEL.							BEAUDET AL, 1990, AM J HUM GENET, V47, P603; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BONDUELLE M, 1990, HUM GENET, V85, P436; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; DAVIES K, 1990, NATURE, V348, P110, DOI 10.1038/348110a0; DEVOTO M, 1991, AM J HUM GENET, V48, P1127; FRIEDMAN K, 1990, CLIN CHEM, V36, P1702; FRIEDMAN KJ, 1990, CLIN CHEM, V36, P695; FRIEDMAN KJ, 1991, CLIN CHEM, V37, P753; KATZNELSON D, 1978, ISRAEL J MED SCI, V14, P204; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LERER I, 1992, J MED GENET, V29, P131, DOI 10.1136/jmg.29.2.131; LERER I, 1990, HUM GENET, V85, P416, DOI 10.1007/BF02428288; LEVIN S, 1963, GENETICS MIGRANT ISO, P294; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NG ISL, 1991, HUM GENET, V87, P613; NUNES V, 1991, HUM GENET, V87, P737; OSBORNE L, 1991, AM J HUM GENET, V48, P608; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMEO G, 1990, HUM GENET, V85, P391; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROZEN R, 1992, AM J MED GENET, V42, P360, DOI 10.1002/ajmg.1320420322; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; SIMONBOUY B, 1991, CLIN GENET, V40, P218; Tsui L C, 1991, Adv Hum Genet, V20, P153; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; 1990, NEW ENGL J MED, V323, P70	33	128	128	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					951	956						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1384328				2022-12-18	WOS:A1992JU84000003
J	KOCH, MC; GRIMM, T; HARLEY, HG; HARPER, PS				KOCH, MC; GRIMM, T; HARLEY, HG; HARPER, PS			GENETIC RISKS FOR CHILDREN OF WOMEN WITH MYOTONIC-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONSET; HETEROGENEITY; CHROMOSOME-19; MECHANISM; NEONATE; LINKAGE; DISEASE; BRITAIN; ORIGIN; DEATH	In genetic counseling, the recommended risk estimate that any heterozygous woman with myotonic dystrophy (DM) will have a congenitally affected child is 3%-9%. However, after already having had such an offspring, a DM mother's risk increases to 20%-37%. The risks of 10% and 41%, respectively, calculated in this study are similar to the estimates in the literature. However, our data on clinical status of the mothers demonstrate that only women with multisystem effects of the disorder at the time of pregnancy and delivery are likely to have congenitally affected offspring. No heterozygous woman with polychromatic lens changes but no other clinically detectable multisystem involvement had a congenitally affected child. In addition, our data suggest that the chance of having a more severely affected child increases with greater severity of maternal disease. The findings of this study are relevant for genetic counseling, as the risk of having a congenitally affected child for women with classical manifestations of the disease is shown to be higher than predicted by the overall risk estimate for any heterozygous woman. We consider it appropriate to give these classically affected women risk figures which approach the recurrence risk given to mothers with congenitally affected children. However, the risk of having a congenitally affected child for heterozygous women with no multisystem involvement appears to be minimal. Our findings support the earlier proposed hypothesis of maternal metabolites acting on a heterozygous offspring. Neither genomic imprinting nor mitochondrial inheritance is able to explain the correlation between the clinical status of heterozygous mothers and that of their children.	UNIV WURZBURG,INST HUMANGENET,W-8700 WURZBURG,GERMANY; UNIV COLL CARDIFF,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES	University of Wurzburg; Cardiff University	KOCH, MC (corresponding author), UNIV MARBURG,INST HUMANGENET,BAHNHOFSTR 7,W-3550 MARBURG,GERMANY.							BELL DB, 1972, J PEDIATR-US, V81, P83, DOI 10.1016/S0022-3476(72)80378-0; Betremieux P, 1985, J Genet Hum, V33, P21; BROEKHUIZEN FF, 1983, J REPROD MED, V28, P595; BUNDEY S, 1982, J MED GENET, V19, P341, DOI 10.1136/jmg.19.5.341; BUNDEY S, 1972, J MED GENET, V9, P311, DOI 10.1136/jmg.9.3.311; CALDERON R, 1966, J PEDIATR-US, V68, P423, DOI 10.1016/S0022-3476(66)80246-9; CURRY CJR, 1988, J PEDIATR-US, V113, P555, DOI 10.1016/S0022-3476(88)80651-6; DAVIS HA, 1958, J OBSTET GYNAECOL, V65, P479; DODGE PR, 1965, PEDIATRICS, V35, P3; DYKEN P, 1969, NEUROLOGY, V19, P292; DYKEN PR, 1973, NEUROLOGY, V23, P465, DOI 10.1212/WNL.23.5.465; EIBERG H, 1983, CLIN GENET, V24, P159; ERICKSON RP, 1985, AM J HUM GENET, V37, P827; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; Fleiseher B., 1918, ALBRECHT GRAEFES ARC, V96, P91, DOI DOI 10.1007/BF02018704; FRIED K, 1975, CLIN GENET, V7, P417; GLANZ A, 1984, J MED GENET, V21, P186, DOI 10.1136/jmg.21.3.186; GRIMM T, 1975, J GENET HUM, V23, P301; GRIMM T, 1983, CLIN GENET, V23, P212; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1972, LANCET, V2, P53; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HARPER PS, 1975, ARCH DIS CHILD, V50, P505, DOI 10.1136/adc.50.7.505; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; HOWELER CJ, 1990, J NEUROL SCI S, V98, P197; Howeler CJ, 1986, THESIS ERASMUS U ROT; Jaffe R, 1986, Obstet Gynecol Surv, V41, P272, DOI 10.1097/00006254-198605000-00003; KIMURA S, 1987, PEDIATR NEUROL, V3, P233, DOI 10.1016/0887-8994(87)90025-7; KLEIN D, 1958, J GENET HUM S, V7, P11; KORNELUK RG, 1989, GENOMICS, V5, P596, DOI 10.1016/0888-7543(89)90028-1; MERRIL CR, 1985, TRENDS GENET, V1, P140, DOI 10.1016/0168-9525(85)90056-3; OBRIEN T, 1983, J PEDIATR-US, V103, P762, DOI 10.1016/S0022-3476(83)80480-6; OBRIEN T, 1984, DEV MED CHILD NEUROL, V25, P62; PEARSE RG, 1979, ARCH DIS CHILD, V54, P331, DOI 10.1136/adc.54.5.331; POULTON J, 1988, ARCH DIS CHILD, V63, P883, DOI 10.1136/adc.63.8.883; PRUZANSKI W, 1966, BRAIN, V89, P563, DOI 10.1093/brain/89.3.563; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RUTHERFORD MA, 1989, ARCH DIS CHILD, V64, P191, DOI 10.1136/adc.64.2.191; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P459, DOI 10.1001/archneur.1976.00500070001001; SHAW DJ, 1985, HUM GENET, V70, P271; SILVER MM, 1985, MED HYPOTHESES, V16, P207, DOI 10.1016/0306-9877(85)90002-7; SIMPSON K, 1975, ARCH DIS CHILD, V50, P569, DOI 10.1136/adc.50.7.569; SUN SF, 1983, CLIN GENET, V23, P111; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TAKESHITA K, 1981, JPN J HUM GENET, V26, P295, DOI 10.1007/BF01876360; THOMASEN E, 1948, THESIS U AARHUS AARH; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; WATTERS GV, 1967, ARCH NEUROL-CHICAGO, V17, P137, DOI 10.1001/archneur.1967.00470260027003; WEBB D, 1978, AM J OBSTET GYNECOL, V132, P265, DOI 10.1016/0002-9378(78)90891-8	50	128	132	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1084	1091						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035529				2022-12-18	WOS:A1991FP09200009
J	THEOPHILUS, B; LATHAM, T; GRABOWSKI, GA; SMITH, FI				THEOPHILUS, B; LATHAM, T; GRABOWSKI, GA; SMITH, FI			GAUCHER DISEASE - MOLECULAR HETEROGENEITY AND PHENOTYPE-GENOTYPE CORRELATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DEPT MICROBIOL,DIV MED & MOLEC GENET,100TH ST & 5TH AVE,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED & MOLEC GENET,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [DK36729, DK38381] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038381, R29DK038381, R01DK036729] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P742; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; FABBRO D, 1987, AM J HUM GENET, V40, P15; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1988, LIPID STORAGE DISORD, P793; GRAVES PN, 1986, AM J HUM GENET, V39, P763; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Institute of Gaucher Disease, 2020, EP GAUCH DIS; Maniatis T., 1982, MOL CLONING; REINER O, 1988, DNA-J MOLEC CELL BIO, V7, P107, DOI 10.1089/dna.1988.7.107; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365	20	128	137	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					212	225						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2502917				2022-12-18	WOS:A1989AK38000004
J	GOLDGAR, DE; GREEN, P; PARRY, DM; MULVIHILL, JJ				GOLDGAR, DE; GREEN, P; PARRY, DM; MULVIHILL, JJ			MULTIPOINT LINKAGE ANALYSIS IN NEUROFIBROMATOSIS TYPE-I - AN INTERNATIONAL COLLABORATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112; COLLABORAT RES INC,BEDFORD,MA; NCI,CLIN EPIDEMIOL BRANCH,BETHESDA,MD 20205	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)					NCI NIH HHS [CA-36362, CA-28854] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R23CA036362, R01CA036362, R01CA028854] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; DIEHL SR, 1989, AM J HUM GENET, V44, P33; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FAIN PR, 1989, AM J HUM GENET, V44, P68; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; KITTUR SD, 1989, AM J HUM GENET, V44, P48; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; MATHEW CGP, 1989, AM J HUM GENET, V44, P38; MULVIHILL J J, 1987, Genomics, V1, P337, DOI 10.1016/0888-7543(87)90033-4; OCONNELL P, 1989, AM J HUM GENET, V44, P51; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SEIZINGER BR, 1989, AM J HUM GENET, V44, P30; Skolnick M H, 1987, Genomics, V1, P382, DOI 10.1016/0888-7543(87)90043-7; STEPHENS K, 1989, AM J HUM GENET, V44, P13; UPADHYAYA M, 1989, AM J HUM GENET, V44, P41; VANCE JM, 1989, AM J HUM GENET, V44, P25; WILLARD H F, 1987, Genomics, V1, P368, DOI 10.1016/0888-7543(87)90041-3; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	21	128	130	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					6	12						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2491784				2022-12-18	WOS:A1989R559600002
J	Austin-Tse, C; Halbritter, J; Zariwala, MA; Gilberti, RM; Gee, HY; Hellman, N; Pathak, N; Liu, Y; Panizzi, JR; Patel-King, RS; Tritschler, D; Bower, R; O'Toole, E; Porath, JD; Hurd, TW; Chaki, M; Diaz, KA; Kohl, S; Lovric, S; Hwang, DY; Braun, DA; Schueler, M; Airik, R; Otto, EA; Leigh, MW; Noone, PG; Carson, JL; Davis, SD; Pittman, JE; Ferkol, TW; Atkinson, JJ; Olivier, KN; Sagel, SD; Dell, SD; Rosenfeld, M; Milla, CE; Loges, NT; Omran, H; Porter, ME; King, SM; Knowles, MR; Drummond, IA; Hildebrandt, F				Austin-Tse, Christina; Halbritter, Jan; Zariwala, Maimoona A.; Gilberti, Renee M.; Gee, Heon Yung; Hellman, Nathan; Pathak, Narendra; Liu, Yan; Panizzi, Jennifer R.; Patel-King, Ramila S.; Tritschler, Douglas; Bower, Raqual; O'Toole, Eileen; Porath, Jonathan D.; Hurd, Toby W.; Chaki, Moumita; Diaz, Katrina A.; Kohl, Stefan; Lovric, Svjetlana; Hwang, Daw-Yang; Braun, Daniela A.; Schueler, Markus; Airik, Rannar; Otto, Edgar A.; Leigh, Margaret W.; Noone, Peadar G.; Carson, Johnny L.; Davis, Stephanie D.; Pittman, Jessica E.; Ferkol, Thomas W.; Atkinson, Jeffry J.; Olivier, Kenneth N.; Sagel, Scott D.; Dell, Sharon D.; Rosenfeld, Margaret; Milla, Carlos E.; Loges, Niki T.; Omran, Heymut; Porter, Mary E.; King, Stephen M.; Knowles, Michael R.; Drummond, Iain A.; Hildebrandt, Friedhelm			Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYNEIN REGULATORY COMPLEX; OUTER ARM DYNEIN; PROTEOMIC ANALYSIS; SCHMIDTEA-MEDITERRANEA; SEQUENCE-ANALYSIS; MOTILE CILIA; FLAGELLAR; GENES; CHAIN; PROTEIN	Primary ciliary dyskinesia (PCD) is caused when defects of motile cilia lead to chronic airway infections, male infertility, and situs abnormalities. Multiple causative PCD mutations account for only 65% of cases, suggesting that many genes essential for cilia function remain to be discovered. By using zebrafish morpholino knockdown of PCD candidate genes as an in vivo screening platform, we identified c21orf59, ccdc65, and c15orf26 as critical for cilia motility. c21orf59 and c15orf26 knockdown in zebrafish and planaria blocked outer dynein arm assembly, and ccdc65 knockdown altered cilia beat pattern. Biochemical analysis in Chlamydomonas revealed that the C21orf59 ortholog FBB18 is a flagellar matrix protein that accumulates specifically when cilia motility is impaired. The Chlamydomonas ida6 mutant identifies CCDC65/FAP250 as an essential component of the nexin-dynein regulatory complex. Analysis of 295 individuals with PCD identified recessive truncating mutations of C21orf59 in four families and CCDC65 in two families. Similar to findings in zebrafish and planaria, mutations in C21orf59 caused loss of both outer and inner dynein arm components. Our results characterize two genes associated with PCD-causing mutations and elucidate two distinct mechanisms critical for motile cilia function: dynein arm assembly for C21orf59 and assembly of the nexin-dynein regulatory complex for CCDC65.	[Austin-Tse, Christina; Hellman, Nathan; Pathak, Narendra; Liu, Yan; Panizzi, Jennifer R.; Drummond, Iain A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Austin-Tse, Christina; Drummond, Iain A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Nephrol,Dept Genet, Boston, MA 02115 USA; [Halbritter, Jan; Gee, Heon Yung; Porath, Jonathan D.; Kohl, Stefan; Lovric, Svjetlana; Hwang, Daw-Yang; Braun, Daniela A.; Schueler, Markus; Airik, Rannar; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Gilberti, Renee M.; Patel-King, Ramila S.; King, Stephen M.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Tritschler, Douglas; Bower, Raqual; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [O'Toole, Eileen] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA; [Hurd, Toby W.; Chaki, Moumita; Diaz, Katrina A.; Otto, Edgar A.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Leigh, Margaret W.; Noone, Peadar G.; Carson, Johnny L.; Davis, Stephanie D.; Pittman, Jessica E.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Atkinson, Jeffry J.] Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO 63110 USA; [Olivier, Kenneth N.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Sagel, Scott D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Dell, Sharon D.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Rosenfeld, Margaret] Childrens Hosp, Seattle, WA 98105 USA; [Rosenfeld, Margaret] Univ Washington, Seattle, WA 98105 USA; [Milla, Carlos E.] Stanford Univ, Dept Pediat, Stanford, CA 94304 USA; [Loges, Niki T.; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Knowles, Michael R.] Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Stanford University; University of Munster; Howard Hughes Medical Institute	Drummond, IA (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA.	idrummond@partners.org; friedhelm.hildebrandt@childrens.harvard.edu	Gilberti, Renee M./AAN-2226-2021; Braun, Daniela A/R-2259-2017; Austin-Tse, Christina/AFR-2048-2022; Schueler, Markus/AAF-6057-2021; Airik, Rannar/AAS-7810-2021; Gee, Heon Yung/K-7781-2019	Braun, Daniela A/0000-0003-3146-1566; Austin-Tse, Christina/0000-0001-6492-6716; Airik, Rannar/0000-0002-7055-6325; Gee, Heon Yung/0000-0002-8741-6177; Rosenfeld, Margaret/0000-0002-8105-614X; Omran, Heymut/0000-0003-0282-6765; Milla, Carlos/0000-0001-5515-3053; Atkinson, Jeffrey/0000-0001-9125-7968; Otto, Edgar/0000-0002-2387-9973; Dell, Sharon/0000-0003-2169-9407; Muraglia, Katrina/0000-0002-4162-4667	National Institutes of Health; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft; IZKF Muenster; European Community; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053093, R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293, R37GM055667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Muenster; European Community(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all PCD subjects and family members for their participation and thank the US PCD Foundation and to the investigators and the coordinators of the "Genetic Disorders of Mucociliary Clearance Consortium." We are also grateful to the funding agencies that supported this work; these include the National Institutes of Health, the Howard Hughes Medical Institute, the Deutsche Forschungsgemeinschaft, the IZKF Muenster, and the European Community's Seventh Framework Programme. Detailed acknowledgements can be found in the Supplemental Data.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Costa G L, 1996, Methods Mol Biol, V57, P239; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Geremek M, 2008, EUR J HUM GENET, V16, P688, DOI 10.1038/ejhg.2008.5; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hellman NE, 2010, P NATL ACAD SCI USA, V107, P18499, DOI 10.1073/pnas.1005998107; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; JOHNSON NT, 1991, AM REV RESPIR DIS, V144, P1091, DOI 10.1164/ajrccm/144.5.1091; KATO T, 1993, CELL STRUCT FUNCT, V18, P371, DOI 10.1247/csf.18.371; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; OTOOLE E, 1995, METHOD CELL BIOL, V47, P183, DOI 10.1016/S0091-679X(08)60808-0; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Porter ME, 1996, GENETICS, V144, P569; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rompolas P, 2012, MOL BIOL CELL, V23, P3554, DOI 10.1091/mbc.E12-04-0287; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Rompolas P, 2009, METHOD CELL BIOL, V93, P81, DOI 10.1016/S0091-679X(08)93004-1; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; WILLIAMS BD, 1989, J CELL BIOL, V109, P235, DOI 10.1083/jcb.109.1.235; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD; Zietkiewicz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033667	71	127	135	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					672	686		10.1016/j.ajhg.2013.08.015	http://dx.doi.org/10.1016/j.ajhg.2013.08.015			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094744	Bronze, Green Published			2022-12-18	WOS:000326305600009
J	Manzini, MC; Tambunan, DE; Hill, RS; Yu, TW; Maynard, TM; Heinzen, EL; Shianna, KV; Stevens, CR; Partlow, JN; Barry, BJ; Rodriguez, J; Gupta, VA; Al-Qudah, AK; Eyaid, WM; Friedman, JM; Salih, MA; Clark, R; Moroni, I; Mora, M; Beggs, AH; Gabriel, SB; Walsh, CA				Manzini, M. Chiara; Tambunan, Dimira E.; Hill, R. Sean; Yu, Tim W.; Maynard, Thomas M.; Heinzen, Erin L.; Shianna, Kevin V.; Stevens, Christine R.; Partlow, Jennifer N.; Barry, Brenda J.; Rodriguez, Jacqueline; Gupta, Vandana A.; Al-Qudah, Abdel-Karim; Eyaid, Wafaa M.; Friedman, Jan M.; Salih, Mustafa A.; Clark, Robin; Moroni, Isabella; Mora, Marina; Beggs, Alan H.; Gabriel, Stacey B.; Walsh, Christopher A.			Exome Sequencing and Functional Validation in Zebrafish Identify GTDC2 Mutations as a Cause of Walker-Warburg Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; DEFECTIVE GLYCOSYLATION; O-MANNOSYLATION; DYSTROGLYCAN; VARIANTS; DISEASE; GENES; MODEL; FKRP	Whole-exome sequencing (WES), which analyzes the coding sequence of most annotated genes in the human genome, is an ideal approach to studying fully penetrant autosomal-recessive diseases, and it has been very powerful in identifying disease-causing mutations even when enrollment of affected individuals is limited by reduced survival. In this study, we combined WES with homozygosity analysis of consanguineous pedigrees, which are informative even when a single affected individual is available, to identify genetic mutations responsible for Walker-Warburg syndrome (WWS), a genetically heterogeneous autosomal-recessive disorder that severely affects the development of the brain, eyes, and muscle. Mutations in seven genes are known to cause WWS and explain 50%-60% of cases, but multiple additional genes are expected to be mutated because unexplained cases show suggestive linkage to diverse loci. Using WES in consanguineous WWS-affected families, we found multiple deleterious mutations in GTDC2 (also known as AGO61). GTDC2's predicted role as an uncharacterized glycosyltransferase is consistent with the function of other genes that are known to be mutated in WWS and that are involved in the glycosylation of the transmembrane receptor dystroglycan. Therefore, to explore the role of GTDC2 loss of function during development, we used morpholino-mediated knockdown of its zebrafish ortholog, gtdc2. We found that gtdc2 knockdown in zebrafish replicates all WWS features (hydrocephalus, ocular defects, and muscular dystrophy), strongly suggesting that GTDC2 mutations cause WWS.	[Manzini, M. Chiara; Tambunan, Dimira E.; Hill, R. Sean; Yu, Tim W.; Partlow, Jennifer N.; Barry, Brenda J.; Rodriguez, Jacqueline; Gupta, Vandana A.; Beggs, Alan H.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Manzini, M. Chiara; Tambunan, Dimira E.; Hill, R. Sean; Yu, Tim W.; Partlow, Jennifer N.; Barry, Brenda J.; Rodriguez, Jacqueline; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Maynard, Thomas M.] George Washington Univ, Sch Med, Dept Pharmacol & Physiol, Washington, DC 20037 USA; [Heinzen, Erin L.; Shianna, Kevin V.] Duke Univ, Dept Med, Ctr Human Genome Variat, Sch Med, Durham, NC 27708 USA; [Stevens, Christine R.; Gabriel, Stacey B.; Walsh, Christopher A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Gupta, Vandana A.; Beggs, Alan H.] Boston Childrens Hosp, Genom Program, Boston, MA 02115 USA; [Al-Qudah, Abdel-Karim] Univ Jordan, Dept Pediat, Amman 11941, Jordan; [Eyaid, Wafaa M.] King Abdul Aziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Friedman, Jan M.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Salih, Mustafa A.] King Saud Univ, Coll Med, Div Pediat Neurol, Dept Pediat, Riyadh 11461, Saudi Arabia; [Clark, Robin] Loma Linda Univ, Med Ctr, Div Genet, Dept Pediat, Loma Linda, CA 92354 USA; [Moroni, Isabella] Fdn Ist Ric & Cura Carattere Sci Ist Neurol C Bes, Div Pediat Neurol, I-20126 Milan, Italy; [Mora, Marina] Fdn Ist Ric & Cura Carattere Sci Ist Neurol C Bes, Div Neuromuscular Dis & Neuroimmunol, I-20126 Milan, Italy	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; George Washington University; Duke University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Jordan; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of British Columbia; Child & Family Research Institute; King Saud University; Loma Linda University	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Maynard, Thomas/I-9039-2012; Moroni, Isabella/AAL-1336-2021; Yu, Timothy W./AAF-5738-2019; Salih, Mustafa/C-1222-2014; Mora, Marina/J-2883-2018; al-qudah, abdelkarim/B-2914-2018	Maynard, Thomas/0000-0001-6976-3936; Moroni, Isabella/0000-0002-3322-1681; Yu, Timothy W./0000-0003-2988-7701; Salih, Mustafa/0000-0002-4379-2111; Manzini, M. Chiara/0000-0001-7175-1096; Stevens, Christine/0000-0002-2621-2234; Mora, Marina/0000-0002-5765-2320; Gupta, Vandana/0000-0002-4057-8451; Walsh, Christopher/0000-0002-0156-2238; Beggs, Alan/0000-0001-8818-0568; al-qudah, abdelkarim/0000-0002-8056-2745; Friedman, Jan/0000-0002-7482-9570	Telethon Network Genetic Biobanks [GTB07001F]; Manton Center for Orphan Disease Research; National Institutes of Health (NIH) (National Institute of Child Health & Human Development [K99/R00, K99HD067379]; Clinical Investigator Training Program at Harvard-MIT Health Science and Technology; Nancy Lurie Marks Junior Faculty MeRIT Fellowship; NIH (National Institute of Neurological Disorders and Stroke) [R01NS035129]; NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01AR044345]; Muscular Dystrophy Association; William Randolph Hearst Fund; Intellectual and Developmental Disabilities Research Centers [P30HD19655]; NIH; American Recovery & Reinvestment Act (National Institute of Mental Health) [RC2MH089952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD067379] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062601, R01AR044345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R01NS035129] Funding Source: NIH RePORTER	Telethon Network Genetic Biobanks(Fondazione Telethon); Manton Center for Orphan Disease Research; National Institutes of Health (NIH) (National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical Investigator Training Program at Harvard-MIT Health Science and Technology; Nancy Lurie Marks Junior Faculty MeRIT Fellowship; NIH (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); William Randolph Hearst Fund; Intellectual and Developmental Disabilities Research Centers; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery & Reinvestment Act (National Institute of Mental Health); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families who enrolled in our studies and the physicians who have contributed individuals to our validation cohort. The EuroBioBank and Telethon Network Genetic Biobanks (GTB07001F) are also acknowledged for providing biological samples. We are also grateful to A.J. Barkovich for help with the review of the magnetic resonance imaging scans. M.C.M. was supported by a Junior Faculty Career Development Award from the Manton Center for Orphan Disease Research and a K99/R00 Transition to Independence award from the National Institutes of Health (NIH) (National Institute of Child Health & Human Development, K99HD067379). T.W.Y. was supported by a NIH T32 grant (T32NS007484-08), the Clinical Investigator Training Program at Harvard-MIT Health Science and Technology, and the Nancy Lurie Marks Junior Faculty MeRIT Fellowship. Research was supported by grants from the NIH (National Institute of Neurological Disorders and Stroke R01NS035129 to C.A.W. and National Institute of Arthritis and Musculoskeletal and Skin Diseases R01AR044345 to A.H.B), the Muscular Dystrophy Association to M.C.M. and A.H.B., the William Randolph Hearst Fund to M.C.M. and V.A.G., and the Manton Center for Orphan Disease Research to M.C.M., A.H.B., and C.A.W. Sequencing and Sequenom genotyping at Boston Children's Hospital were supported by the Intellectual and Developmental Disabilities Research Centers (P30HD19655). Sequencing at the Broad Institute was supported by a grant from the NIH and the American Recovery & Reinvestment Act (National Institute of Mental Health RC2MH089952). C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Avsar-Ban E, 2010, GLYCOBIOLOGY, V20, P1089, DOI 10.1093/glycob/cwq069; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bello L., 2012, EUR J HUM GENET; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Clement E, 2008, ANN NEUROL, V64, P573, DOI 10.1002/ana.21482; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; Detrich H. W., 2009, ESSENTIAL ZEBRAFISH; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Hu HY, 2011, J COMP NEUROL, V519, P1320, DOI 10.1002/cne.22572; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YY, 2011, HUM MOL GENET, V20, P1763, DOI 10.1093/hmg/ddr059; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore CJ, 2008, GENOMICS, V92, P159, DOI 10.1016/j.ygeno.2008.05.008; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Thornhill P, 2008, BRAIN, V131, P1551, DOI 10.1093/brain/awn078; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252	29	127	141	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					541	547		10.1016/j.ajhg.2012.07.009	http://dx.doi.org/10.1016/j.ajhg.2012.07.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958903	Green Published, Bronze			2022-12-18	WOS:000308683100015
J	Johnson, T; Gaunt, TR; Newhouse, SJ; Padmanabhan, S; Tomaszewski, M; Kumari, M; Morris, RW; Tzoulaki, I; O'Brien, ET; Poulter, NR; Sever, P; Shields, DC; Thom, S; Wannamethee, SG; Whincup, PH; Brown, MJ; Connell, JM; Dobson, RJ; Howard, PJ; Mein, CA; Onipinla, A; Shaw-Hawkins, S; Zhang, Y; Smith, GD; Day, INM; Lawlor, DA; Goodall, AH; Fowkes, FG; Abecasis, GR; Elliott, P; Gateva, V; Braund, PS; Burton, PR; Nelson, CP; Tobin, MD; van der Harst, P; Glorioso, N; Neuvrith, H; Salvi, E; Staessen, JA; Stucchi, A; Devos, N; Jeunemaitre, X; Plouin, PF; Tichet, J; Juhanson, P; Org, E; Putku, M; Sober, S; Veldre, G; Viigimaa, M; Levinsson, A; Rosengren, A; Thelle, DS; Hastie, CE; Hedner, T; Lee, WK; Melander, O; Wahlstrand, B; Hardy, R; Wong, A; Cooper, JA; Palmen, J; Chen, L; Stewart, AFR; Wells, GA; Westra, HJ; Wolfs, MGM; Clarke, R; Franzosi, MG; Goel, A; Hamsten, A; Lathrop, M; Peden, JF; Seedorf, U; Watkins, H; Ouwehand, WH; Sambrook, J; Stephens, J; Casas, JP; Drenos, F; Holmes, MV; Kivimaki, M; Shah, S; Shah, T; Talmud, PJ; Whittaker, J; Wallace, C; Delles, C; Laan, M; Kuh, D; Humphries, SE; Nyberg, F; Cusi, D; Roberts, R; Newton-Cheh, C; Franke, L; Stanton, AV; Dominiczak, AF; Farrall, M; Hingorani, AD; Samani, NJ; Caulfield, MJ; Munroe, PB				Johnson, Toby; Gaunt, Tom R.; Newhouse, Stephen J.; Padmanabhan, Sandosh; Tomaszewski, Maciej; Kumari, Meena; Morris, Richard W.; Tzoulaki, Ioanna; O'Brien, Eoin T.; Poulter, Neil R.; Sever, Peter; Shields, Denis C.; Thom, Simon; Wannamethee, Sasiwarang G.; Whincup, Peter H.; Brown, Morris J.; Connell, John M.; Dobson, Richard J.; Howard, Philip J.; Mein, Charles A.; Onipinla, Abiodun; Shaw-Hawkins, Sue; Zhang, Yun; Smith, George Davey; Day, Ian N. M.; Lawlor, Debbie A.; Goodall, Alison H.; Fowkes, F. Gerald; Abecasis, Goncalo R.; Elliott, Paul; Gateva, Vesela; Braund, Peter S.; Burton, Paul R.; Nelson, Christopher P.; Tobin, Martin D.; van der Harst, Pim; Glorioso, Nicola; Neuvrith, Hani; Salvi, Erika; Staessen, Jan A.; Stucchi, Andrea; Devos, Nabila; Jeunemaitre, Xavier; Plouin, Pierre-Francois; Tichet, Jean; Juhanson, Peeter; Org, Elin; Putku, Margus; Sober, Siim; Veldre, Gudrun; Viigimaa, Margus; Levinsson, Anna; Rosengren, Annika; Thelle, Dag S.; Hastie, Claire E.; Hedner, Thomas; Lee, Wai K.; Melander, Olle; Wahlstrand, Bjoern; Hardy, Rebecca; Wong, Andrew; Cooper, Jackie A.; Palmen, Jutta; Chen, Li; Stewart, Alexandre F. R.; Wells, George A.; Westra, Harm-Jan; Wolfs, Marcel G. M.; Clarke, Robert; Franzosi, Maria Grazia; Goel, Anuj; Hamsten, Anders; Lathrop, Mark; Peden, John F.; Seedorf, Udo; Watkins, Hugh; Ouwehand, Willem H.; Sambrook, Jennifer; Stephens, Jonathan; Casas, Juan-Pablo; Drenos, Fotios; Holmes, Michael V.; Kivimaki, Mika; Shah, Sonia; Shah, Tina; Talmud, Philippa J.; Whittaker, John; Wallace, Chris; Delles, Christian; Laan, Mans; Kuh, Diana; Humphries, Steve E.; Nyberg, Fredrik; Cusi, Daniele; Roberts, Robert; Newton-Cheh, Christopher; Franke, Lude; Stanton, Alice V.; Dominiczak, Anna F.; Farrall, Martin; Hingorani, Aroon D.; Samani, Nilesh J.; Caulfield, Mark J.; Munroe, Patricia B.		Cardiogenics Consortium; Global BPgen Consortium	Blood Pressure Loci Identified with a Gene-Centric Array	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE-TRAIT LOCI; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; COMMON VARIANTS; LINKAGE; ANGIOTENSINOGEN; METAANALYSIS; SINGLE; POLYMORPHISMS	Raised blood pressure (BP) is a major risk factor for cardiovascular disease. Previous studies have identified 47 distinct genetic variants robustly associated with BP, but collectively these explain only a few percent of the heritability for BP phenotypes. To find additional BP loci, we used a bespoke gene-centric array to genotype an independent discovery sample of 25,118 individuals that combined hypertensive case-control and general population samples. We followed up four SNPs associated with BP at our p < 8.56 x 10(-7) study-specific significance threshold and six suggestively associated SNPs in a further 59,349 individuals. We identified and replicated a SNP at LSP1/TNNT3, a SNP at MTHFR-NPPB independent (r(2) = 0.33) of previous reports, and replicated SNPs at AGT and ATP2B1 reported previously. An analysis of combined discovery, and follow-up data identified SNPs significantly associated with BP at p < 8.56 x 10(-7) at four further loci (NPR3, FIFE, NOS3, and SOX6). The high number of discoveries made with modest genotyping effort can be attributed to using a large-scale yet targeted genotyping array and to the development of a weighting scheme that maximized power when meta-analyzing results from samples ascertained with extreme phenotypes, in combination with results from nonascertained or population samples. Chromatin immunoprecipitation and transcript expression data highlight potential gene regulatory mechanisms at the MTHFR and NOS3 loci. These results provide candidates for further study to help dissect mechanisms affecting BP and highlight the utility of studying SNPs and samples that are independent of those studied previously even when the sample size is smaller than that in previous studies.	[Johnson, Toby; Newhouse, Stephen J.; Howard, Philip J.; Mein, Charles A.; Onipinla, Abiodun; Shaw-Hawkins, Sue; Zhang, Yun; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Barts & London Genome Ctr, London EC1M 6BQ, England; [Gaunt, Tom R.; Smith, George Davey; Day, Ian N. M.; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Med Res Council MRC Ctr Causal Anal Translat Epid, Bristol BS8 2BN, Avon, England; [Newhouse, Stephen J.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Padmanabhan, Sandosh; Hastie, Claire E.; Lee, Wai K.; Shah, Sonia; Delles, Christian; Dominiczak, Anna F.] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Tomaszewski, Maciej; Goodall, Alison H.; Braund, Peter S.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Tomaszewski, Maciej; Goodall, Alison H.; Braund, Peter S.; Burton, Paul R.; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Hosp, Leicester Natl Inst Hlth Res NIHR Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Kumari, Meena; Seedorf, Udo; Ouwehand, Willem H.; Sambrook, Jennifer; Casas, Juan-Pablo; Hingorani, Aroon D.] UCL, Div Populat Hlth, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Morris, Richard W.; Wannamethee, Sasiwarang G.] UCL Med Sch, Dept Primary Care & Populat Hlth, Div Populat Hlth, London NW3 2PF, England; [Tzoulaki, Ioanna] Univ Ioannina, Dept Hyg & Epidemiol, Ioannina 45110, Greece; [Tzoulaki, Ioanna; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [O'Brien, Eoin T.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Poulter, Neil R.; Sever, Peter; Thom, Simon] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1PG, England; [Shields, Denis C.] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 4, Ireland; [Whincup, Peter H.] St Georges Univ London, London SW17 0RE, England; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Dobson, Richard J.] Kings Coll London, S London & Maudsley Natl Hlth Serv Fdn Trust, NIHR Biomed Res Ctr Mental Hlth, London SE5 8AF, England; [Dobson, Richard J.] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Fowkes, F. Gerald] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Abecasis, Goncalo R.; Gateva, Vesela] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48103 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy Ctr Environm & Hlth, London W2 1PG, England; [Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [van der Harst, Pim] Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Glorioso, Nicola] Univ Sassari, Azienda Osped Univ, Hypertens & Related Dis Ctr, I-07100 Sassari, Italy; [Neuvrith, Hani] IBM Res, Machine Learning & Data Min Grp, IL-31905 Haifa, Israel; [Salvi, Erika; Stucchi, Andrea; Cusi, Daniele] Univ Milan, Dept Med Surg & Dent, I-20142 Milan, Italy; [Salvi, Erika; Stucchi, Andrea; Cusi, Daniele] Univ Milan, Grad Sch Nephrol, San Paolo Hosp, Div Nephrol, I-20142 Milan, Italy; [Salvi, Erika; Cusi, Daniele] Fdn Filarete, Genom & Bioinformat Unit, I-20139 Milan, Italy; [Staessen, Jan A.] Univ Louvain, Dept Cardiovasc Sci, Div Hypertens & Cardiovasc Rehabil, BE-3000 Louvain, Belgium; [Devos, Nabila; Jeunemaitre, Xavier; Plouin, Pierre-Francois] Paris Ctr Rech Cardiovasc, INSERM, UMRS 970, F-75015 Paris, France; [Jeunemaitre, Xavier; Plouin, Pierre-Francois] Univ Paris 05, Fac Med, F-75908 Paris 15, France; [Jeunemaitre, Xavier] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris 15, France; [Plouin, Pierre-Francois] Hop Europeen Georges Pompidou, Dept Genet, F-75908 Paris 15, France; [Tichet, Jean] Inst Interreg Sante, F-37520 Tours, La Riche, France; [Juhanson, Peeter; Org, Elin; Putku, Margus; Sober, Siim; Veldre, Gudrun; Shah, Tina; Laan, Mans] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Veldre, Gudrun] Univ Tartu, Dept Cardiol, EE-51014 Tartu, Estonia; [Viigimaa, Margus] Tallinn Univ Technol, Inst Biomed Engn, EE-19086 Tallinn, Estonia; [Viigimaa, Margus] N Estonia Med Ctr, Ctr Cardiol, EE-13419 Tallinn, Estonia; [Levinsson, Anna; Wallace, Chris; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, S-40530 Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, S-41685 Gothenburg, Sweden; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0317 Oslo, Norway; [Hedner, Thomas; Wahlstrand, Bjoern] Univ Gothenburg, Sahlgrenska Acad, Inst Internal Med, SE-40530 Gothenburg, Sweden; [Melander, Olle] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Melander, Olle] Skane Univ Hosp, Ctr Emergency Med, SE-20502 Malmo, Sweden; [Hardy, Rebecca; Wong, Andrew; Talmud, Philippa J.; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Cooper, Jackie A.; Palmen, Jutta; Watkins, Hugh; Drenos, Fotios; Whittaker, John; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Chen, Li; Stewart, Alexandre F. R.; Wells, George A.; Roberts, Robert] Univ Ottawa, Inst Heart, Ottawa Heart Genom Study, Ottawa, ON K1Y 4W7, Canada; [Westra, Harm-Jan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Wolfs, Marcel G. M.] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands; [Clarke, Robert] Clin Trial Serv Unit, Oxford OX3 7LF, England; [Franzosi, Maria Grazia] Ist Mario Negri, Dept Cardiovasc Res, I-20156 Milan, Italy; [Goel, Anuj; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Goel, Anuj; Farrall, Martin] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; Karolinska Univ, Hosp Solna, Ctr Mol Med, Karolinska Inst,Dept Med Solna,Atherosclerosis Re, S-17176 Stockholm, Sweden; Ctr Natl Genotypage, F-91057 Evry, France; Univ Munster, LIFA, Gesell Arterioskleroseforsch eV, D-48149 Munster, Germany; [Hamsten, Anders; Lathrop, Mark; Peden, John F.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Hamsten, Anders; Lathrop, Mark; Peden, John F.] Natl Hlth Serv Blood & Transplant, Cambridge CB2 0PT, England; [Hamsten, Anders] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Seedorf, Udo; Holmes, Michael V.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Stephens, Jonathan] UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London WC1E 6BT, England; [Casas, Juan-Pablo] UCL, Rayne Inst, Div Med, Ctr Clin Pharmacol, London WC1E 6JJ, England; [Holmes, Michael V.] GlaxoSmithKline, Med Res Ctr, Genet, Stevenage SG1 2NY, Herts, England; [Kivimaki, Mika] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn,Addenbrookes Hosp, Cambridge CB2 0XY, England; [Wallace, Chris; Nyberg, Fredrik] AstraZeneca R&D, S-43183 Molndal, Sweden; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Stanton, Alice V.] Royal Coll Surgeons Ireland, Dublin 2, Ireland	University of London; Queen Mary University London; University of Bristol; University of London; King's College London; University of Glasgow; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; University College London; University of London; University College London; University of Ioannina; Imperial College London; University College Dublin; Imperial College London; University College Dublin; St Georges University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Dundee; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Edinburgh; University of Michigan System; University of Michigan; Imperial College London; University of Leicester; University of Groningen; University of Sassari; International Business Machines (IBM); University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Tartu; University of Tartu; Tallinn University of Technology; University of Gothenburg; University of Gothenburg; University of Oslo; University of Gothenburg; Lund University; Lund University; Skane University Hospital; University of London; University College London; University of Ottawa; University of Ottawa Heart Institute; University of Groningen; University of Groningen; University of Oxford; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; Karolinska University Hospital; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Munster; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; King's College London; University College London; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; AstraZeneca; Harvard University; Massachusetts General Hospital; Royal College of Surgeons - Ireland	Johnson, T (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Barts & London Genome Ctr, Charterhouse Sq, London EC1M 6BQ, England.	t.johnson@qmul.ac.uk; p.b.munroe@qmul.ac.uk	Hardy, Rebecca/AFR-1989-2022; Padmanabhan, Sandosh/S-3963-2016; Thelle, Dag Steinar/ABD-1867-2020; Stewart, Alexandre F.R./A-5677-2011; Wong, Andrew/M-8899-2016; Beckmann, Jacques S/A-9772-2008; Kuh, Diana/L-6019-2014; Colaus, PsyColaus/K-6607-2013; Burton, Paul R/H-7527-2016; Franke, Lude/P-7036-2016; Laan, Maris/A-4100-2011; Uda, Manuela/AAC-2645-2019; Viigimaa, Margus/AAX-3864-2020; Org, Elin/AAJ-9631-2021; Bochud, Murielle/A-3981-2010; Grobbee, Diederick/C-7651-2014; Dominiczak, Anna F/P-9390-2017; Lucas, Gavin/D-4346-2012; Davey Smith, George/A-7407-2013; Wong, Andrew/AAE-6995-2019; Onland-Moret, N. Charlotte/G-9185-2011; JEUNEMAITRE, Xavier/AAQ-4853-2021; Gaunt, Tom R/O-3918-2014; Dobson, Richard j/C-9269-2011; Whittaker, John C/B-8609-2012; Matullo, Giuseppe/K-6383-2016; Salvi, Erika/C-1033-2015; Tzoulaki, Ioanna/ABE-6269-2020; Kivimaki, Mika/B-3607-2012; Pfeufer, Arne/B-6634-2013; Abecasis, Goncalo R/B-7840-2010; Newhouse, Stephen J/C-9330-2011; Meitinger, Thomas/O-1318-2015; Staessen, Jan A/A-1065-2011; Salvi, Erika/AAA-1415-2019; Stanton, Alice V/F-4697-2012; Shah, Sonia/N-7547-2013; Luben, Robert/H-5519-2015	Thelle, Dag Steinar/0000-0002-4417-5967; Wong, Andrew/0000-0003-2079-4779; Beckmann, Jacques S/0000-0002-9741-1900; Kuh, Diana/0000-0001-7386-2857; Franke, Lude/0000-0002-5159-8802; Laan, Maris/0000-0002-8519-243X; Uda, Manuela/0000-0002-4890-6456; Bochud, Murielle/0000-0002-5727-0218; Grobbee, Diederick/0000-0003-4472-4468; Dominiczak, Anna F/0000-0003-4913-3608; Davey Smith, George/0000-0002-1407-8314; Wong, Andrew/0000-0003-2079-4779; Onland-Moret, N. Charlotte/0000-0002-2360-913X; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Gaunt, Tom R/0000-0003-0924-3247; Dobson, Richard j/0000-0003-4224-9245; Whittaker, John C/0000-0002-3529-2379; Matullo, Giuseppe/0000-0003-0674-7757; Salvi, Erika/0000-0002-2724-2291; Tzoulaki, Ioanna/0000-0002-4275-9328; Kivimaki, Mika/0000-0002-4699-5627; Newhouse, Stephen J/0000-0002-1843-9842; Staessen, Jan A/0000-0002-3026-1637; Salvi, Erika/0000-0002-2724-2291; Shah, Sonia/0000-0001-5860-4526; Drenos, Fotios/0000-0003-2469-5516; Bergman, Richard/0000-0003-1539-4471; Wain, Louise/0000-0003-4951-1867; Goel, Anuj/0000-0003-2307-4021; Stewart, Alexandre/0000-0003-2673-9164; Morris, Richard/0000-0001-7240-4563; Lawlor, Debbie A/0000-0002-6793-2262; Watkins, Hugh/0000-0002-5287-9016; Talmud, Philippa/0000-0002-5560-1933; Nyberg, Fredrik/0000-0003-0892-5668; Sacerdote, Carlotta/0000-0002-8008-5096; Ouwehand, Willem/0000-0002-7744-1790; Forouhi, Nita/0000-0002-5041-248X; Humphries, Stephen E/0000-0002-8221-6547; Shah, Tina/0000-0001-7724-7210; Padmanabhan, Sandosh/0000-0003-3869-5808; Hingorani, Aroon/0000-0001-8365-0081; Meitinger, Thomas/0000-0002-8838-8403; Viigimaa, Margus/0000-0001-5575-5978; s, hema/0000-0002-3440-9475; Abecasis, Goncalo/0000-0003-1509-1825; Dorr, Marcus/0000-0001-7471-475X; Tomaszewski, Maciej/0000-0001-8215-6567; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Org, Elin/0000-0001-8688-9717; Johnson, Toby/0000-0002-5998-3270; Stanton, Alice/0000-0002-4961-165X; Marrugat, Jaume/0000-0003-3320-554X; Wallace, Chris/0000-0001-9755-1703; Melander, Olle/0000-0002-2581-484X; Wannamethee, Sasiwarang/0000-0001-9484-9977; Munroe, Patricia/0000-0002-4176-2947; Luben, Robert/0000-0002-5088-6343; Seedorf, Udo/0000-0003-4652-5358; Shields, Denis/0000-0003-4015-2474; Caulfield, Mark/0000-0001-9295-3594; Lakatta, Edward/0000-0002-4772-0035; Hardy, Rebecca/0000-0001-9949-0799; Nelson, Christopher/0000-0001-8025-2897; Kumari, Meena/0000-0001-9716-1035; Stephens, Jonathan/0000-0003-2020-9330; Elliott, Paul/0000-0002-7511-5684; Tobin, Martin/0000-0002-3596-7874; Org, Elin/0000-0003-1451-9375; Lee, Wai Kwong/0000-0001-8560-8063; Whincup, Peter/0000-0002-5589-4107; Zeggini, Eleftheria/0000-0003-4238-659X; Goodall, Alison/0000-0002-7883-9645	Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, ZIAAG000675, R01AG017644, R37AG013196, ZIAAG001050] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/013/25942, RG/08/008/25291, RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U137686857, G0902037, MC_U106179471, MC_U123092720, G0802432, MC_U123092723, G0401527, G9521010, G19/35, G8802774, G9817803B, G0501942, G1000143, G0801056, G0400874, G0100222, MC_UP_A100_1003, G0801056B, G0701863] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; MRC [G0501942, G0801056, MC_UP_A100_1003, G0902037, MC_U123092723, G0802432, G0400874, G0701863, MC_U137686857, G9521010, MC_U123092720] Funding Source: UKRI	Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Author and cohort acknowledgements and author contributions are cited in the Supplemental Data. The following authors declare the following potential conflicts of interest: F.N. is a full-time employee at AstraZeneca. J.W. is a full-time employee at GlaxoSmithKline. N.R.P. has received financial support and consultancy fees from several pharmaceutical companies that manufacture either blood-pressure-lowering or lipid-lowering agents or both. P.S. has received research awards from Pfizer.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Chalmers J, 1999, J HYPERTENS, V17, P151; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI 10.1080/10409230701829110 ; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JONGSTRABILEN J, 1992, J CELL BIOL, V118, P1443, DOI 10.1083/jcb.118.6.1443; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; Lalouel JM, 2001, J AM SOC NEPHROL, V12, P606, DOI 10.1681/ASN.V123606; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Munroe PB, 2009, CURR CARDIOVASC RISK, V3, P418, DOI 10.1007/s12170-009-0062-3; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; OHAGAN A, 2004, KEND ADV THEOR STA B, V2; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rose RA, 2008, J PHYSIOL-LONDON, V586, P353, DOI 10.1113/jphysiol.2007.144253; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stefancsik R, 2003, COMP FUNCT GENOM, V4, P609, DOI 10.1002/cfg.343; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Tang YQ, 2010, GENET EPIDEMIOL, V34, P522, DOI 10.1002/gepi.20498; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Valouev A, 2008, NAT METHODS, V5, P829, DOI [10.1038/nmeth.1246, 10.1038/NMETH.1246]; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wallace C, 2006, AM J HUM GENET, V78, P498, DOI 10.1086/500562; Watkins WS, 2010, J HYPERTENS, V28, P65, DOI 10.1097/HJH.0b013e328332031a; *WHO, CHRON DIS CAUS HLT 2, pCH1; World Health Organization, RAIS BLOOD PRESS SIT; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	65	127	127	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					688	700		10.1016/j.ajhg.2011.10.013	http://dx.doi.org/10.1016/j.ajhg.2011.10.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22100073	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000298208700001
J	Newbury, DF; Winchester, L; Addis, L; Paracchini, S; Buckingham, LL; Clark, A; Cohen, W; Cowie, H; Dworzynski, K; Everitt, A; Goodyer, IM; Hennessy, E; Kindley, AD; Miller, LL; Nasir, J; O'Hare, A; Shaw, D; Simkin, Z; Simonoff, E; Slonims, V; Watson, J; Ragoussis, J; Fisher, SE; Seckl, JR; Helms, PJ; Bolton, PF; Pickles, A; Conti-Ramsden, G; Baird, G; Bishop, DVM; Monaco, AP				Newbury, Dianne F.; Winchester, Laura; Addis, Laura; Paracchini, Silvia; Buckingham, Lyn-Louise; Clark, Ann; Cohen, Wendy; Cowie, Hilary; Dworzynski, Katharina; Everitt, Andrea; Goodyer, Ian M.; Hennessy, Elizabeth; Kindley, A. David; Miller, Laura L.; Nasir, Jamal; O'Hare, Anne; Shaw, Duncan; Simkin, Zoe; Simonoff, Emily; Slonims, Vicky; Watson, Jocelynne; Ragoussis, Jiannis; Fisher, Simon E.; Seckl, Jonathon R.; Helms, Peter J.; Bolton, Patrick F.; Pickles, Andrew; Conti-Ramsden, Gina; Baird, Gillian; Bishop, Dorothy V. M.; Monaco, Anthony P.			CMIP and ATP2C2 Modulate Phonological Short-Term Memory in Language Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WORKING-MEMORY; TC-MIP; CHILDREN; SPEECH; ASSOCIATION; CALCIUM; LITERACY; DISORDER; DEFICITS; PROTEIN	Specific language impairment (SLI) is a common developmental disorder characterized by difficulties in language acquisition despite otherwise normal development and in the absence of any obvious explanatory factors. We performed a high-density screen of SLI1, a region of chromosome 16q that shows highly significant and consistent linkage to nonword repetition, a measure of phonological short-term memory that is commonly impaired in SLI. Using two independent language-impaired samples, one family-based (211 families) and another selected from a population cohort on the basis of extreme language measures (490 cases), we detected association to two genes in the SLI 1 region: that encoding c-maf-inducing protein (CMIP, minP = 5.5 x 10(-7) at rs6564903) and that encoding calcium-transporting ATPase, type2C, member2 (ATP2C2, minP = 2.0 x 10(-5) at rs11860694). Regression modeling indicated that each of these loci exerts an independent effect upon nonword repetition ability. Despite the consistent findings in language-impaired samples, investigation in a large unselected cohort (n = 3612) did not detect association. We therefore propose that variants in CMIP and ATP2C2 act to modulate phonological short-term memory primarily in the context of language impairment. As such, this investigation supports the hypothesis that some causes of language impairment are distinct from factors that influence normal language variation. This work therefore implicates CMIP and ATP2C2 in the etiology of SLI and provides molecular evidence for the importance of phonological short-term memory in language acquisition.	[Newbury, Dianne F.; Winchester, Laura; Addis, Laura; Paracchini, Silvia; Buckingham, Lyn-Louise; Ragoussis, Jiannis; Fisher, Simon E.; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Clark, Ann] Queen Margaret Univ, Edinburgh EH21 6UU, Midlothian, Scotland; [Cohen, Wendy] Univ Strathclyde, Dept Educ & Profess Studies, Glasgow G13 1PP, Lanark, Scotland; [Cowie, Hilary] Royal Hosp Sick Children, Dept Speech & Language Therapy, Edinburgh EH9 1LF, Midlothian, Scotland; [Dworzynski, Katharina; Simonoff, Emily] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Everitt, Andrea; Hennessy, Elizabeth; Shaw, Duncan] Univ Aberdeen, Dept Child Hlth, Aberdeen AB25 2GZ, Scotland; [Goodyer, Ian M.] Univ Cambridge, Dev Psychiat Sect, Cambridge CB2 8AH, England; [Kindley, A. David] Raeden Ctr & Grampian Univ Hosp Trust, Aberdeen AB2 4PE, Scotland; [Miller, Laura L.] Univ Bristol, Dept Social Med, Bristol BS8 2BN, Avon, England; [Nasir, Jamal] St Georges Univ London, Div Clin Dev Sci, London SW17 0RE, England; [O'Hare, Anne] Univ Edinburgh, Dept Reprod & Dev Sci, Edinburgh EH9 1UW, Midlothian, Scotland; [Simkin, Zoe; Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Slonims, Vicky; Baird, Gillian] Guys Hosp, Newcomen Ctr, London SE1 9RT, England; [Seckl, Jonathon R.] Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Bolton, Patrick F.] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Bolton, Patrick F.] Kings Coll London, Inst Psychiat, MRC, Ctr Social Dev & Genet Psychiat, London SE5 8AF, England; [Pickles, Andrew] Univ Manchester, Sch Epidemiol & Hlth Sci, Biostat Grp, Manchester M13 9PL, Lancs, England; [Bishop, Dorothy V. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; Wellcome Centre for Human Genetics; Queen Margaret University; University of Strathclyde; University of London; King's College London; University of Aberdeen; University of Cambridge; University of Bristol; St Georges University London; University of Edinburgh; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; University of London; King's College London; University of London; King's College London; University of Manchester; University of Oxford	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	anthony@well.ox.ac.uk	Seckl, Jonathan R/C-3555-2013; Monaco, Anthony P/A-4495-2010; Paracchini, Silvia/AAU-6813-2021; Ragoussis, Ioannis/AAD-9790-2022; Addis, Laura/R-1385-2016; Fisher, Simon E./E-9130-2012; Pickles, Andrew/A-9625-2011; Simonoff, Emily A/B-7593-2011	Monaco, Anthony P/0000-0001-7480-3197; Paracchini, Silvia/0000-0001-9934-8602; Addis, Laura/0000-0001-8455-4278; Fisher, Simon E./0000-0002-3132-1996; Pickles, Andrew/0000-0003-1283-0346; Ragoussis, Ioannis/0000-0002-8515-0934; Nasir, Jamal/0000-0001-6378-5616; Bishop, Dorothy/0000-0002-2448-4033; Cohen, Wendy/0000-0002-1271-9229; Simonoff, Emily/0000-0002-5450-0823	Wellcome Trust; British Telecom; Isaac Newton Trust; National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award; NHS Eastern Region R&D Training Fellowship Award; Grampian Healthcare Trust; Grampian Primary Care NHS Trust; Wellcome Trust Principal Research Fellow; Royal Society Research Fellow; MRC [G0800523] Funding Source: UKRI; Medical Research Council [G0700704B, G0800523] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Telecom; Isaac Newton Trust; National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award; NHS Eastern Region R&D Training Fellowship Award; Grampian Healthcare Trust; Grampian Primary Care NHS Trust; Wellcome Trust Principal Research Fellow(Wellcome Trust); Royal Society Research Fellow(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the families and professionals who participated in the study, Caroline Durrant and Jean-Baptiste Cazier for statistical advice, members of the Monaco lab for support, and Leila Jannoun, Jane Addison, Clare Craven, Deborah Jones, Tilly Storr, Til Utting-Brown, Margaret Main, Jane Steele, and Alan MacLean for assistance with data collection and management. We are extremely grateful to all the families who took part in the ALSPAC study, to the midwives for their help in recruiting them, and to the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors, and D.F. Newbury and A.P. Monaco will serve as guarantors for this paper's contents. The Wellcome Trust specifically funded this research. All laboratory work and the collection of data from families ascertained by Guy's Hospital and the University of Manchester were funded by The Wellcome Trust. CLASP was funded by The Wellcome Trust, British Telecom, Isaac Newton Trust, National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award, and an NHS Eastern Region R&D Training Fellowship Award. The Edinburgh group was supported by the Chief Scientist's Office, Scotland. The Aberdeen group was supported by Grampian Healthcare Trust and Grampian Primary Care NHS Trust. D.V.M. Bishop is a Wellcome Trust Principal Research Fellow, and S.E. Fisher is a Royal Society Research Fellow.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Archibald LMD, 2007, PSYCHON B REV, V14, P919, DOI 10.3758/BF03194122; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Bishop DVM, 2006, CURR DIR PSYCHOL SCI, V15, P217, DOI 10.1111/j.1467-8721.2006.00439.x; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1017/S0021963098002832; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; Clark A, 2007, ARCH DIS CHILD, V92, P614, DOI 10.1136/adc.2006.101758; Cohen NJ, 2000, J CHILD PSYCHOL PSYC, V41, P353, DOI 10.1111/1469-7610.00619; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2007, J CHILD PSYCHOL PSYC, V48, P147, DOI 10.1111/j.1469-7610.2006.01703.x; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Falcaro M, 2008, GENES BRAIN BEHAV, V7, P393, DOI 10.1111/j.1601-183X.2007.00364.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gathercole SE, 2006, J CHILD PSYCHOL PSYC, V47, P4, DOI 10.1111/j.1469-7610.2005.01446.x; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gathercole SE, 2008, Q J EXP PSYCHOL, V61, P474, DOI 10.1080/17470210701273443; Goldschmidt R, 2001, FOCUS BIOTECHNOL, V1, P15; Grimbert P, 2004, MOL IMMUNOL, V40, P1257, DOI 10.1016/j.molimm.2003.11.035; Grimbert P, 2003, J EXP MED, V198, P797, DOI 10.1084/jem.20030566; Harel S, 1996, PEDIATR NEUROL, V15, P305, DOI 10.1016/S0887-8994(96)00222-6; Hayiou-Thomas ME, 2008, J COMMUN DISORD, V41, P397, DOI 10.1016/j.jcomdis.2008.03.002; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; Kamal M, 2009, MOL IMMUNOL, V46, P991, DOI 10.1016/j.molimm.2008.09.034; Kibby M, 2008, CHILD NEUROPSYCHOL, V14, P525, DOI 10.1080/09297040701821752; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P384; Normandin L, 2002, METAB BRAIN DIS, V17, P375, DOI 10.1023/A:1021970120965; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rust J., 1996, WOLD WECHSLER OBJECT; Semel EM, 1992, CLIN EVALUATION LANG; Wechsler D., 1992, WECHSLER INTELLIGENC; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	42	127	134	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					264	272		10.1016/j.ajhg.2009.07.004	http://dx.doi.org/10.1016/j.ajhg.2009.07.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	488EV	19646677	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-18	WOS:000269332900015
J	Zeitz, C; Kloeckener-Gruissem, B; Forster, U; Kohl, S; Magyar, I; Wissinger, B; Matyas, G; Borruat, FX; Schorderet, DF; Zrenner, E; Munier, FL; Berger, W				Zeitz, Christina; Kloeckener-Gruissem, Barbara; Forster, Ursula; Kohl, Susanne; Magyar, Istvan; Wissinger, Bernd; Matyas, Gabor; Borruat, Francois-Xavier; Schorderet, Daniel F.; Zrenner, Eberhart; Munier, Francis L.; Berger, Wolfgang			Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROZYGOUS MISSENSE MUTATION; CALCIUM-CHANNEL; CACNA1F MUTATIONS; INCOMPLETE TYPE; RHODOPSIN GENE; MOUSE RETINA; FAMILIES; ELECTRORETINOGRAM; SUBUNIT; FORM	Mutations in genes encoding either components of the phototransduction cascade or proteins presumably involved in signaling from photoreceptors to adjacent second-order neurons have been shown to cause congenital stationary night blindness (CSNB). Sequence alterations in CACNA1F lead to the incomplete type of CSNB (CSNB2), which can be distinguished by standard electroretinography ( ERG). CSNB2 is associated with a reduced rod b-wave, a substantially reduced cone a-wave, and a reduced 30-Hz flicker ERG response. CACNA1F encodes the alpha(1)-subunit of an L-type Ca2+ channel (Cav1.4 alpha), which is specific to photoreceptors and is present at high density in the synaptic terminals. Ten of our patients with CSNB2 showed no mutation in CACNA1F. To identify the disease-causing mutations, we used a candidate-gene approach. CABP4, a member of the calcium-binding protein (CABP) family, is located in photoreceptor synaptic terminals and is directly associated with the C-terminal domain of the Cav1.4a. Mice lacking either Cabp4 or Cav1.4a display a CSNB2-like phenotype. Here, we report for the first time that mutations in CABP4 lead to autosomal recessive CSNB. Our studies revealed homozygous and compound heterozygous mutations in two families. We also show that these mutations reduce the transcript levels to 30%-40% of those in controls. This suggests that the reduced amount of CABP4 is the reason for the signaling defect in these patients.	Univ Zurich, Inst Med Genet, Div Med Mol Genet & Gene Diagnost, CH-8603 Schwerzenbach, Switzerland; Univ Eye Hosp, Genet Mol Lab, Tubingen, Germany; Jules Gonin Eye Hosp, Unit Oculogenet, Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Lausanne, Switzerland; Inst Rech Ophthalmol, Sion, Switzerland	University of Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Zeitz, C (corresponding author), Schorenstr 16, CH-8603 Schwerzenbach, Switzerland.	zeitz@medgen.unizh.ch	Zeitz, Christina/F-2757-2017; Matyas, PD Dr. Gabor/AAJ-9868-2020	Zeitz, Christina/0000-0002-3510-1712; Matyas, PD Dr. Gabor/0000-0002-3212-9963; Kohl, Susanne/0000-0002-6438-6331				al-Jandal N, 1999, HUM MUTAT, V13, P75, DOI 10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO;2-4; Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Heon E, 1994, MOL GENETICS INHERIT, P277; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Jacobi FK, 2003, AM J OPHTHALMOL, V135, P733, DOI 10.1016/S0002-9394(02)02109-8; Kloeckener-Gruissem B, 2006, MOL VIS, V12, P350; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Marmor MF, 1999, DOC OPHTHALMOL, V97, P143; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P1610; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2005, MOL VIS, V11, P179; Zito I, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9106	38	127	133	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					657	667		10.1086/508067	http://dx.doi.org/10.1086/508067			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960802	Green Published, Bronze			2022-12-18	WOS:000240855900007
J	Fernandez, T; Morgan, T; Davis, N; Klin, A; Morris, A; Farhi, A; Lifton, RP; State, MW				Fernandez, T; Morgan, T; Davis, N; Klin, A; Morris, A; Farhi, A; Lifton, RP; State, MW			Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-ADHESION MOLECULE; MENTAL-RETARDATION; IMMUNOGLOBULIN SUPERFAMILY; GENE-EXPRESSION; SHORT ARM; PHENOTYPE; PATIENT; MICE; 3P25-PTER; SUBGROUP	3p deletion syndrome is a rare contiguous-gene disorder involving the loss of the telomeric portion of the short arm of chromosome 3 and characterized by developmental delay, growth retardation, and dysmorphic features. All reported cases have involved, at a minimum, the deletion of chromosome 3 telomeric to the band 3p25.3. Despite the presence of several genes in this region that are involved in neural development, a causative relationship between a particular transcript and the observed clinical manifestations has remained elusive. We have identified a child with characteristic physical features of 3p deletion syndrome and both verbal and nonverbal developmental delay who carries a de novo balanced translocation involving chromosomes 3 and 10. Fine mapping of this rearrangement demonstrates that the translocation breakpoint on chromosome 3 falls within the recently identified minimal candidate region for 3p deletion syndrome and disrupts the Contactin 4 (CNTN4) mRNA transcript at 3p26.2-3p26.3. This transcript (also known as BIG-2) is a member of the immunoglobulin super family of neuronal cell adhesion molecules involved in axon growth, guidance, and fasciculation in the central nervous system (CNS). Our results demonstrate the association of CNTN4 disruption with the 3p deletion syndrome phenotype and strongly suggest a causal relationship. These findings point to an important role for CNTN4 in normal and abnormal CNS development.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	State, MW (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.	Matthew.State@Yale.edu	Morgan, Tom/C-3478-2012; Fernandez, Thomas V/D-4295-2009; State, Matthew/W-2256-2019	Fernandez, Thomas V/0000-0003-0830-022X; State, Matthew/0000-0003-1624-8302	NCRR NIH HHS [RR-16118, K23 RR016118] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016118] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Benini D, 1999, EUR J PEDIATR, V158, P955, DOI 10.1007/s004310051256; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BRAND A, 1987, PEDIATR CARDIOL, V8, P55, DOI 10.1007/BF02308387; Cargile CB, 2002, AM J MED GENET, V109, P133, DOI 10.1002/ajmg.10323; Drumheller T, 1996, J MED GENET, V33, P842, DOI 10.1136/jmg.33.10.842; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Green EK, 2000, J MED GENET, V37, P581, DOI 10.1136/jmg.37.8.581; Hansford LM, 2003, CYTOGENET GENOME RES, V101, P17, DOI 10.1159/000073412; Higgins JJ, 2000, NEUROLOGY, V55, P335, DOI 10.1212/WNL.55.3.335; Kamei Y, 2000, GENOMICS, V69, P113, DOI 10.1006/geno.2000.6310; KNIGHT LA, 1995, J MED GENET, V32, P994, DOI 10.1136/jmg.32.12.994; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; McClure RJ, 1996, J MED GENET, V33, P625, DOI 10.1136/jmg.33.7.625; Montag-Sallaz M, 2003, J NEUROBIOL, V57, P67, DOI 10.1002/neu.10254; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; MOWREY PN, 1993, AM J MED GENET, V46, P623, DOI 10.1002/ajmg.1320460604; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; NARAHARA K, 1990, AM J MED GENET, V35, P269, DOI 10.1002/ajmg.1320350225; Ogawa J, 1996, NEUROSCI LETT, V218, P173, DOI 10.1016/S0304-3940(96)13156-6; PHIPPS ME, 1994, HUM MOL GENET, V3, P903, DOI 10.1093/hmg/3.6.903; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Saito H, 1998, DEV BRAIN RES, V110, P69, DOI 10.1016/S0165-3806(98)00096-0; SCHWYZER U, 1988, HELV PAEDIATR ACTA, V42, P309; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Sparrow SS, 1984, VINELAND ADAPTIVE BE; State MW, 2003, P NATL ACAD SCI USA, V100, P4684, DOI 10.1073/pnas.0730775100; TAZELAAR J, 1991, AM J MED GENET, V39, P130, DOI 10.1002/ajmg.1320390203; VERJAAL M, 1978, AM J DIS CHILD, V132, P43, DOI 10.1001/archpedi.1978.02120260045012; Wechsler D., 1992, WECHSLER INTELLIGENC; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; Zeng L, 2002, J HUM GENET, V47, P497, DOI 10.1007/s100380200073	33	127	146	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1286	1293		10.1086/421474	http://dx.doi.org/10.1086/421474			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15106122	Green Published, Bronze			2022-12-18	WOS:000221651900023
J	Zerjal, T; Wells, RS; Yuldasheva, N; Ruzibakiev, R; Tyler-Smith, C				Zerjal, T; Wells, RS; Yuldasheva, N; Ruzibakiev, R; Tyler-Smith, C			A genetic landscape reshaped by recent events: Y-chromosomal insights into Central Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; DIVERSITY; POPULATIONS; MICROSATELLITE; HAPLOTYPES; LINEAGES; PATTERNS; EUROPE; PHYLOGEOGRAPHY; PERSPECTIVE	Sixteen Y-chromosomal microsatellites and 16 binary markers have been used to analyze DNA variation in 408 male subjects from 15 populations in Central Asia. Large genetic differences were found between populations, but these did not display an obvious geographical or linguistic pattern like that usually seen for Y-chromosomal variation. Nevertheless, an underlying east-west clinal pattern could be detected by the Autocorrelation Index for DNA Analysis and admixture analysis, and this pattern was interpreted as being derived from the ancient peopling of the area, reinforced by subsequent migrations. Two particularly striking features were seen: an extremely high level of Y-chromosomal differentiation between geographically close populations, accompanied by low diversity within some populations. These were due to the presence of high-frequency population-specific lineages and suggested the occurrence of several recent bottlenecks or founder events. Such events could account for the lack of a clear overall pattern and emphasize the importance of multiple recent events in reshaping this genetic landscape.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Imperial Canc Res Fund, Canc & Immunogenet Lab, Headington, England; Acad Sci, Inst Immunol, Tashkent, Uzbekistan; Univ Oxford, Welcome Trust Ctr Human Genet, Headington, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Tyler-Smith, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.		zerjal, tatiana/AAO-9473-2020; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358				ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao WD, 2000, GENE, V244, P29, DOI 10.1016/S0378-1119(00)00021-4; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BERTORELLE G, 1995, GENETICS, V140, P811; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; de Knijff P, 2000, AM J HUM GENET, V67, P1055; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; DEROSA L, 1992, SIGNIFICANCE SILK RO, P193; Du R., 1993, ETHNIC GROUPS CHINA; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Forde CD, 1948, HABITAT EC SOC GEOGR; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Jones-Bley K., 1997, KURGAN CULTURE INDOE; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KATO K, 1992, SIGNIFICANCE SILK RO, P5; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LIN MC, 1992, SIGNIFICANCE SILK RO, P91; PANDYA A, 1998, IND J HUM GENET, V4, P52; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RANOV VA, 1995, CURR ANTHROPOL, V36, P337, DOI 10.1086/204366; RANOV VA, 1979, CURR ANTHROPOL, V20, P249, DOI 10.1086/202265; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 1998, GENETICS, V150, P499; Zerjal T, 1999, GENOMIC DIVERSITY, P91; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879	51	127	133	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					466	482		10.1086/342096	http://dx.doi.org/10.1086/342096			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145751	Green Published, Bronze			2022-12-18	WOS:000177489600002
J	Silverman, EK; Palmer, LJ; Mosley, JD; Barth, M; Senter, JM; Brown, A; Drazen, JM; Kwiatkowski, DJ; Chapman, HA; Campbell, EJ; Province, MA; Rao, DC; Reilly, JJ; Ginns, LC; Speizer, FE; Weiss, ST				Silverman, EK; Palmer, LJ; Mosley, JD; Barth, M; Senter, JM; Brown, A; Drazen, JM; Kwiatkowski, DJ; Chapman, HA; Campbell, EJ; Province, MA; Rao, DC; Reilly, JJ; Ginns, LC; Speizer, FE; Weiss, ST			Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK-FACTORS; WIDE SEARCH; EPIDEMIOLOGY; ASTHMA; FLOW; IDENTIFICATION; DEFICIENCY; FAMILIES; PROBANDS; SMOKING	Chronic obstructive pulmonary disease (COPD) is a common, complex disease associated with substantial morbidity and mortality. COPD is defined by irreversible airflow obstruction; airflow obstruction is typically determined by reductions in quantitative spirometric indices, including forced expiratory volume at 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC). To identify genetic determinants of quantitative spirometric phenotypes, an autosomal 10-cM genomewide scan of short tandem repeat (STR) polymorphic markers was performed in 72 pedigrees (585 individuals) ascertained through probands with severe early-onset COPD. Multipoint variance-component linkage analysis (using SOLAR) was performed for quantitative phenotypes, including FEV1, FVC, and FEV1/FVC. In the initial genomewide scan, significant evidence for linkage to FEV1/FVC was demonstrated on chromosome 2q (LOD score 4.12 at 222 cM). Suggestive evidence was found for linkage to FEV1/FVC on chromosomes 1 (LOD score 1.92 at 120 cM) and 17 (LOD score 2.03 at 67 cM) and to FVC on chromosome 1 (LOD score 2.05 at 13 cM). The highest LOD score for FEV1 in the initial genomewide scan was 1.53, on chromosome 12, at 36 cM. After inclusion of 12 additional STR markers on chromosome 12p, which had been previously genotyped in this population, suggestive evidence for linkage of FEV1 (LOD score 2.43 at 37 cM) to this region was demonstrated. These observations provide both significant evidence for an early-onset COPD-susceptibility locus on chromosome 2 and suggestive evidence for linkage of spirometry-related phenotypes to several other genomic regions. The significant linkage of FEV1/FVC to chromosome 2q could reflect one or more genes influencing the development of airflow obstruction or dysanapsis.	Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Washington University (WUSTL)	Silverman, EK (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu	Barth, Matthew/I-4117-2019; Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019; Drazen, Jeffrey M/E-5841-2012	Barth, Matthew/0000-0001-5263-9509; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Mosley, Jonathan/0000-0001-6421-2887	American Heart Association-American Stroke Association [16FTF30130005] Funding Source: Medline; NHLBI NIH HHS [U01 HL066795, P50 HL56383, HL 67204, U01 HL 66795, HL 61575, R37 HL067204, HL 46440] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061575, P50HL056383, R37HL067204, U01HL066795, R01HL046440] Funding Source: NIH RePORTER	American Heart Association-American Stroke Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BEATY TH, 1987, GENET EPIDEMIOL, V4, P211, DOI 10.1002/gepi.1370040306; Blumenthal MN, 1998, CLIN EXP ALLERGY, V28, P51; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BURROWS B, 1987, AM REV RESPIR DIS, V135, P788, DOI 10.1164/arrd.1987.135.4.788; Celedon JC, 1999, EUR RESPIR J, V14, P1009, DOI 10.1183/09031936.99.14510099; COHEN BH, 1977, AM J EPIDEMIOL, V105, P223, DOI 10.1093/oxfordjournals.aje.a112378; COHEN BH, 1980, AM J EPIDEMIOL, V112, P274, DOI 10.1093/oxfordjournals.aje.a112994; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DAVIS RM, 1989, AM REV RESPIR DIS, V140, pS82, DOI 10.1164/ajrccm/140.3_Pt_2.S82; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoyert D L, 1999, Natl Vital Stat Rep, V47, P1; HSU KHK, 1979, J PEDIATR-US, V95, P14, DOI 10.1016/S0022-3476(79)80075-X; JANUS ED, 1985, LANCET, V1, P152; Kelner MJ, 2000, J BIOL CHEM, V275, P13000, DOI 10.1074/jbc.275.17.13000; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KUEPPERS F, 1977, AM J MED, V63, P336, DOI 10.1016/0002-9343(77)90270-4; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; Lomas DA, 2001, RESP RES, V2, P20, DOI 10.1186/rr34; Marsh DG, 1997, NAT GENET, V15, P389; MEAD J, 1980, AM REV RESPIR DIS, V121, P339; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Silverman EK, 1996, MED CLIN N AM, V80, P501, DOI 10.1016/S0025-7125(05)70451-X; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; SILVERMAN EK, 2002, IN PRESS HUM MOL GEN; TOBIN MJ, 1983, BRIT J DIS CHEST, V77, P14, DOI 10.1016/S0007-0971(83)80054-0; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806	39	127	132	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1229	1239		10.1086/340316	http://dx.doi.org/10.1086/340316			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11914989	Green Published, Bronze			2022-12-18	WOS:000175012400012
J	Lell, JT; Sukernik, RI; Starikovskaya, YB; Su, B; Jin, L; Schurr, TG; Underhill, PA; Wallace, DC				Lell, JT; Sukernik, RI; Starikovskaya, YB; Su, B; Jin, L; Schurr, TG; Underhill, PA; Wallace, DC			The dual origin and Siberian affinities of native American Y chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMERINDIAN MITOCHONDRIAL DNAS; NEW-WORLD; MTDNA VARIATION; EVOLUTIONARY HISTORY; POPULATIONS; POLYMORPHISMS; HAPLOTYPES; MICROSATELLITES; MIGRATION; SEQUENCES	The Y chromosomes of 549 individuals from Siberia and the Americas were analyzed for 12 biallelic markers, which defined 15 haplogroups. The addition of four microsatellite markers increased the number of haplotypes to 111. The major Native American founding lineage, haplogroup M3, accounted for 66% of male Y chromosomes and was defined by the biallelic markers M89, M9, M45, and M3. The founder haplotype also harbored the microsatellite alleles DYS19 (10 repeats), DYS388 (11 repeats), DYS390 (11 repeats), and DYS391 (10 repeats). In Siberia, the M3 haplogroup was confined to the Chukotka peninsula, adjacent to Alaska. The second major group of Native American Y chromosomes, haplogroup M45, accounted for about one-quarter of male lineages. M45 was subdivided by the biallelic marker M173 and by the four microsatellite loci alleles into two major subdivisions: M45a, which is found throughout the Americas, and M45b, which incorporates the M173 variant and is concentrated in North and Central America. In Siberia, M45a haplotypes, including the direct ancestor of haplogroup M3, are concentrated in Middle Siberia, whereas M45b haplotypes are found in the Lower Amur River and Sea of Okhotsk regions of eastern Siberia. Among the remaining 5% of Native American Y chromosomes is haplogroup RPS4Y-T, found in North America. In Siberia, this haplogroup, along with haplogroup M45b, is concentrated in the Lower Amur River/Sea of Okhotsk region. These data suggest that Native American male lineages were derived from two major Siberian migrations. The first migration originated in southern Middle Siberia with the founding haplotype M45a (10-11-11-10). In Beringia, this gave rise to the predominant Native American lineage, M3 (10-11-11-10), which crossed into the New World. A later migration came from the Lower Amur/Sea of Okhkotsk region, bringing haplogroup RPS4Y-T and subhaplogroup M45b, with its associated M173 variant. This migration event contributed to the modern genetic pool of the Na-Dene and Amerinds of North and Central America.	Emory Univ, Ctr Mol Med, Sch Med, Atlanta, GA 30322 USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Univ Cincinnati, Ctr Genome Informat, Cincinnati, OH USA; Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA	Emory University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University System of Ohio; University of Cincinnati; University of Pennsylvania; Stanford University	Wallace, DC (corresponding author), Emory Univ, Ctr Mol Med, Sch Med, 1462 Clifton Rd,Room 420, Atlanta, GA 30322 USA.	dwallace@gen.emory.edu	Jin, Li/M-5063-2019; Sukernik, Rem I/N-6990-2015; Jin, Li/C-1468-2009; Starikovskaya, Elena/N-5636-2015	Jin, Li/0000-0002-4546-2415; 	NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG13154, R01 AG013154] Funding Source: Medline; NINDS NIH HHS [NS21328, R01 NS021328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; BLACK LT, 1988, CROSSROADS CONTINENT, P24; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Forster P, 1996, AM J HUM GENET, V59, P935; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Krauss ME, 1988, CROSSROADS CONTINENT, P145; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Levin MG, 1964, PEOPLES SIBERIA; Merriwether DA, 1996, AM J HUM GENET, V59, P204; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; ROEWER L, 1992, HUM GENET, V89, P389; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Scozzari R, 1997, AM J HUM GENET, V60, P241; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Sukernik RI, 1996, GENETIKA+, V32, P432; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; Zerjal T, 1997, AM J HUM GENET, V60, P1174	46	127	143	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					192	206		10.1086/338457	http://dx.doi.org/10.1086/338457			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	499LD	11731934	Green Published, Bronze			2022-12-18	WOS:000172571900017
J	Wakeley, J; Nielsen, R; Liu-Cordero, SN; Ardlie, K				Wakeley, J; Nielsen, R; Liu-Cordero, SN; Ardlie, K			The discovery of single-nucleotide polymorphisms - and inferences about human demographic history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EFFECTIVE POPULATION-SIZE; NEUTRAL ALLELE MODEL; MITOCHONDRIAL-DNA; HUMAN-EVOLUTION; SEGREGATING SITES; HUMAN GENOME; RECOMBINATION; PARAMETERS; DIVERSITY; SEQUENCES	A method of historical inference that accounts for ascertainment bias is developed and applied to single-nucleotide polymorphism (SNP) data in humans. The data consist of 84 short fragments of the genome that were selected, from three recent SNP surveys, to contain at least two polymorphisms in their respective ascertainment samples and that were then fully resequenced in 47 globally distributed individuals. Ascertainment bias is the deviation, from what would be observed in a random sample, caused either by discovery of polymorphisms in small samples or by locus selection based on levels or patterns of polymorphism. The three SNP surveys from which the present data were derived differ both in their protocols for ascertainment and in the size of the samples used for discovery. We implemented a Monte Carlo maximum-likelihood method to fit a subdivided-population model that includes a possible change in effective size at some time in the past. Incorrectly assuming that ascertainment bias does not exist causes errors in inference, affecting both estimates of migration rates and historical changes in size. Migration rates are overestimated when ascertainment bias is ignored. However, the direction of error in inferences about changes in effective population size (whether the population is inferred to be shrinking or growing) depends on whether either the numbers of SNPs per fragment or the SNP-allele frequencies are analyzed. We use the abbreviation "SDL," for "(S) under bar NP-(d) under bar iscovered locus," in recognition of the genomic-discovery context of SNPs. When ascertainment bias is modeled fully, both the number of SNPs per SDL and their allele frequencies support a scenario of growth in effective size in the context of a subdivided population. If subdivision is ignored, however, the hypothesis of constant effective population size cannot be rejected. An important conclusion of this work is that, in demographic or other studies, SNP data are useful only to the extent that their ascertainment can be modeled.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Wakeley, J (corresponding author), 2102 Biol Labs, 16 Divin Ave, Cambridge, MA 02138 USA.		Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Arratia R., 1992, ANN APPL PROBAB, V2, P519; Bowcock A M, 1987, Gene Geogr, V1, P47; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; FU XY, 1995, THEOR POPUL BIOL, V48, P172; FU XY, 1994, GENETICS, V138, P1375; FU XY, 1993, GENETICS, V133, P693; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kuhner MK, 2000, GENETICS, V156, P439; Matullo G, 1994, Gene Geogr, V8, P25; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; NEI M, 1993, J MOL EVOL, V37, P240, DOI 10.1007/BF00175500; Nielsen R, 2000, GENETICS, V154, P931; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sherry ST, 1997, GENETICS, V147, P1977; SLATKIN M, 1991, GENETICS, V129, P555; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; Wakeley J, 1999, GENETICS, V153, P1863; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wall JD, 2000, GENETICS, V155, P1865; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795	42	127	129	1	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1332	1347		10.1086/324521	http://dx.doi.org/10.1086/324521			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704929	Green Published, Bronze			2022-12-18	WOS:000172086900017
J	Schwabe, GC; Tinschert, S; Buschow, C; Meinecke, P; Wolff, G; Gillessen-Kaesbach, G; Oldridge, M; Wilkie, AOM; Komec, R; Mundlos, S				Schwabe, GC; Tinschert, S; Buschow, C; Meinecke, P; Wolff, G; Gillessen-Kaesbach, G; Oldridge, M; Wilkie, AOM; Komec, R; Mundlos, S			Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSENSE-MEDIATED DECAY; CYTOPLASMIC TRANSLATION; FAMILY; RNA	Brachydactyly type B (BDB) is an autosomal dominant skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. Recently, heterozygous mutations of the orphan receptor tyrosine kinase (TK) ROR2, located within a distinct segment directly after the TK domain, have been shown to be responsible for BDB. We report four novel mutations in ROR2 (two frameshifts, one splice mutation, and one nonsense mutation) in five families with BDB. The mutations predict truncation of the protein within two distinct regions immediately before and after the TK domain, resulting in a complete or partial loss of the intracellular portion of the protein. Patients affected with the distal mutations have a more severe phenotype than do those with the proximal mutation. Our analysis includes the first description of homozygous BDB in an individual with a 5-bp deletion proximal to the TK domain. His phenotype resembles an extreme form of brachydactyly, with extensive hypoplasia of the phalanges and metacarpals/metatarsals and absence of nails. In addition, he has vertebral anomalies, brachymelia of the arms, and a ventricular septal defect-features that are reminiscent of Robinow syndrome, which has also been shown to be caused by mutations in ROR2. The BDB phenotype, as well as the location and the nature of the BDB mutations, suggests a specific mutational effect that cannot be explained by simple haploinsufficiency and that is distinct from that in Robinow syndrome.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Inst Med Genet, Charite, Berlin, Germany; Altonaer Kinderkrankenhaus, Hamburg, Germany; Univ Freiburg, Inst Humangenet, Freiburg, Germany; Univ Essen Gesamthsch Klinikum, Inst Humangenet, D-4300 Essen, Germany; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Univ Klinikum Mannheim, Kinderklin, Mannheim, Germany; Johannes Gutenberg Univ Mainz, Kinderklin, D-6500 Mainz, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Duisburg Essen; University of Oxford; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	mundlos@molgen.mpg.de	Mundlos, Stefan/ABH-9585-2020; Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Mundlos, Stefan/0000-0002-9788-3166; Schwabe, Georg C./0000-0003-4299-3410				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Gong YQ, 1999, AM J HUM GENET, V64, P570, DOI 10.1086/302249; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Innis JW, 1998, CLIN GENET, V53, P337; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Manouvrier-Hanu S, 1999, TRENDS GENET, V15, P409, DOI 10.1016/S0168-9525(99)01823-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Oishi I, 1997, J BIOL CHEM, V272, P11916, DOI 10.1074/jbc.272.18.11916; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Oldridge M, 1999, AM J HUM GENET, V64, P578, DOI 10.1086/302255; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; WILSON C, 1993, P NATL ACAD SCI USA, V90, P7109, DOI 10.1073/pnas.90.15.7109; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272	18	127	138	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					822	831		10.1086/303084	http://dx.doi.org/10.1086/303084			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986040	Green Published, Bronze			2022-12-18	WOS:000089651100006
J	Grigorenko, EL; Wood, FB; Meyer, MS; Pauls, DL				Grigorenko, EL; Wood, FB; Meyer, MS; Pauls, DL			Chromosome 6p influences on different dyslexia-related cognitive processes: Further confirmation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; LINKAGE ANALYSIS; DEVELOPMENTAL DYSLEXIA; STATISTICS	In this study, which is a continuation and an extension of an earlier study, we enrolled two new families (N = 31) and recruited more individuals from the previously ascertained families (N = 56). The eight multiplex families (N = 171) presented in this study were ascertained from a sample of adult probands whose childhood reading history is well documented through archival information. Six: phenotypes were constructed to span a range of dyslexia-related cognitive processes. These phenotypes were (1) phonemic awareness (of spoken words); (2) phonological decoding (of printed nonwords); (3) rapid automatized naming (of colored squares or object drawings); (4) single-word reading (orally, of printed real words); (5) vocabulary; and (6) spelling (of dictated words). Ln addition, the diagnosis of lifelong dyslexia was established by clinical means. Genotyping was done with nine highly polymorphic markers from the 6p22.3-6p21.3 region. The results of two- and multipoint identity-by-descent and identity-by-state analyses supported the importance of a putative locus in the D6S464-D6S273 region for a number of dyslexia-related cognitive deficits.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Moscow State Univ, Dept Psychol, Moscow, Russia; Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Sect Neuropsychol, Winston Salem, NC 27103 USA	Yale University; Yale University; Lomonosov Moscow State University; Wake Forest University; Wake Forest Baptist Medical Center	Grigorenko, EL (corresponding author), Yale Univ, Dept Psychol, POB 208025, New Haven, CT 06520 USA.		Grigorenko, Elena/V-2418-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD021887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH000508] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 MH000508] Funding Source: Medline; NICHD NIH HHS [HD21887, P01 HD021887] Funding Source: Medline; NIMH NIH HHS [MH00508] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blachman B. A., 1997, FDN READING ACQUISIT; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Davis S, 1996, AM J HUM GENET, V58, P867; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; Dunn L. M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Elston RC, 1997, AM J HUM GENET, V60, P255; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FELTON RH, 1990, BRAIN LANG, V39, P485, DOI 10.1016/0093-934X(90)90157-C; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; GRIGORENKO EL, 1997, 4 WORLD C DYSL SEPT; Jastak J., 1984, WIDE RANGE ACHIEVEME; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINDAMOOD CH, 1971, LAINDAMOOD AUDITORY; LYON GR, 1995, ANN DYSLEXIA, V35, P3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; RICHARDSON E, 1985, DECODING SKILLS; Rosner J., 1979, TEST AUDITORY ANAL S; SIEGEL LS, 1998, DYSLEXIA, V4, P90, DOI DOI 10.1002/(SICI)1099-0909(199806)4:2<90::AID-DYS105>3.0.CO;2-3; Sobel E, 1996, AM J HUM GENET, V58, P1323; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Woodcock R.W., 1977, WOODCOCK JOHNSON PSY	29	127	130	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					715	723		10.1086/302755	http://dx.doi.org/10.1086/302755			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677331	Green Published, Bronze			2022-12-18	WOS:000088373100038
J	Johnson, D; Horsley, SW; Moloney, DM; Oldridge, M; Twigg, SRF; Walsh, S; Barrow, M; Njolstad, PR; Kunz, J; Ashworth, GJ; Wall, SA; Kearney, L; Wilkie, AOM				Johnson, D; Horsley, SW; Moloney, DM; Oldridge, M; Twigg, SRF; Walsh, S; Barrow, M; Njolstad, PR; Kunz, J; Ashworth, GJ; Wall, SA; Kearney, L; Wilkie, AOM			A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAETHRE-CHOTZEN-SYNDROME; APPARENTLY BALANCED TRANSLOCATIONS; CROUZON SYNDROME; GENE; DELETIONS; MAP; MECHANISMS; PROTEIN; PATTERN; LOCUS	Mutations in the coding region of the TWIST gene (encoding a basic helix-loop-helix transcription factor) have been identified in some cases of Saerhre-Chotzen syndrome. Haploinsufficiency appears to be the pathogenic mechanism involved. To investigate the possibility that complete deletions of the TWIST gene also contribute to this disorder, we have developed a comprehensive strategy to screen for coding-region mutations and for complete gene deletions. Heterozygous TWIST mutations were identified in 8 of 10 patients with Saethre-Chotzen syndrome and in 2 of 43 craniosynostosis patients with no clear diagnosis. In addition to six coding-region mutations, our strategy revealed four complete TWIST deletions, only one of which associated with a translocation was suspected on the basis of conventional cytogenetic analysis. This case and two interstitial deletions were detectable by analysis of polymorphic microsatellite loci, including a novel (CA)(n) locus 7.9 kb way from TWIST, combined with FISH; these deletions ranged in size from 3.5 Mb to >11.6 Mb. The remaining, much smaller deletion tvas detected by Southern blot analysis and removed 2,924 bp, with a 2-bp orphan sequence at the breakpoint. Significant learning difficulties were present in the three patients with megabase-sized deletions, which suggests that haploinsufficiency of genes neighboring TWIST contributes to developmental delay. Our results identify a new microdeletion disorder that maps to chromosome band 7p21.1 and that causes a significant proportion of Saethre-Chotzen syndrome.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Radcliffe Infirm NHS Trust, Dept Plast & Reconstruct Surg, Oxford, England; Radcliffe Infirm NHS Trust, Oxford Craniofacial Unit, Oxford, England; Leicester Royal Infirm, Leicester Clin Genet Serv, Leicester, Leics, England; Univ Bergen, Haukeland Hosp, Dept Pediat, Bergen, Norway; Univ Marburg, Med Zentrum Humangenet, Marburg, Germany	University of Oxford; Radcliffe Infirmary; Radcliffe Infirmary; University of Leicester; University of Bergen; Haukeland University Hospital; Philipps University Marburg	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Twigg, Stephen/AAU-1135-2021; Wilkie, Andrew/AAC-3820-2020	Twigg, Stephen/0000-0001-5024-049X; Wilkie, Andrew/0000-0002-2972-5481	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Bourgeois P, 1996, MAMM GENOME, V7, P915, DOI 10.1007/s003359900269; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; CHOTAI KA, 1994, AM J MED GENET, V51, P270, DOI 10.1002/ajmg.1320510320; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN M M JR, 1986, P413; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; El Ghouzzi V, 1997, AM J HUM GENET, V61, pA332; ElGhouzzi V, 1997, NAT GENET, V15, P42; HALL JG, 1989, HDB NORMAL PHYSICAL; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; KETTERLING RP, 1993, HUM MUTAT, V2, P53, DOI 10.1002/humu.1380020110; Krebs I, 1997, HUM MOL GENET, V6, P1079, DOI 10.1093/hmg/6.7.1079; LEWANDA AF, 1994, AM J HUM GENET, V55, P1195; Moloney DM, 1997, LANCET, V349, P1059, DOI 10.1016/S0140-6736(96)09082-4; MONNAT RJ, 1992, GENOMICS, V13, P777, DOI 10.1016/0888-7543(92)90153-J; Muenke M, 1997, AM J HUM GENET, V60, P555; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; Pantke O A, 1975, Birth Defects Orig Artic Ser, V11, P190; Paznekas WA, 1998, AM J HUM GENET, V62, P1370, DOI 10.1086/301855; Raynham H, 1996, QJM-MON J ASSOC PHYS, V89, P169; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, J MED GENET, V31, P393, DOI 10.1136/jmg.31.5.393; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; Rose CSP, 1997, HUM MOL GENET, V6, P1369, DOI 10.1093/hmg/6.8.1369; ROSE CSP, 1994, HUM MOL GENET, V3, P1405; Rose CSP, 1997, TRENDS GENET, V13, P384, DOI 10.1016/S0168-9525(97)01296-1; ROTH DB, 1989, MOL CELL BIOL, V9, P3049, DOI 10.1128/MCB.9.7.3049; SIMPSON P, 1983, GENETICS, V105, P615; Tosi S, 1996, LEUKEMIA, V10, P644; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WILKIE AOM, 1995, J MED GENET, V32, P174, DOI 10.1136/jmg.32.3.174; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	40	127	127	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1282	1293		10.1086/302122	http://dx.doi.org/10.1086/302122			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792856	Green Published, Bronze			2022-12-18	WOS:000076985200005
J	Neuhausen, SL; Godwin, AK; Gershoni-Baruch, R; Schubert, E; Garber, J; Stoppa-Lyonnet, D; Olah, E; Csokay, B; Serova, O; Lalloo, F; Osorio, A; Stratton, M; Offit, K; Boyd, J; Caligo, MA; Scott, RJ; Schofield, A; Teugels, E; Schwab, M; Cannon-Albright, L; Bishop, T; Easton, D; Benitez, J; King, MC; Ponder, BAJ; Weber, B; Devilee, P; Borg, A; Narod, SA; Goldgar, D				Neuhausen, SL; Godwin, AK; Gershoni-Baruch, R; Schubert, E; Garber, J; Stoppa-Lyonnet, D; Olah, E; Csokay, B; Serova, O; Lalloo, F; Osorio, A; Stratton, M; Offit, K; Boyd, J; Caligo, MA; Scott, RJ; Schofield, A; Teugels, E; Schwab, M; Cannon-Albright, L; Bishop, T; Easton, D; Benitez, J; King, MC; Ponder, BAJ; Weber, B; Devilee, P; Borg, A; Narod, SA; Goldgar, D			Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI-JEWISH INDIVIDUALS; BREAST-CANCER; CARRIER FREQUENCY; GENE; WOMEN; MAP	Several BRCA2 mutations are found to occur in geographically diverse breast and ovarian cancer families. To investigate both mutation origin and mutation-specific phenotypes due to BRCA2, we constructed a haplotype of 10 polymorphic short tandem-repeat (STR) markers flanking the BRCA2 locus, in a set of 111 breast or breast/ovarian cancer families selected for having one of nine recurrent BRCA2 mutations. Six of the individual mutations are estimated to have arisen 400-2,000 years ago. In particular, the 6174delT mutation, found in similar to 1% of individuals of Ashkenazi Jewish ancestry, was estimated to have arisen 29 generations ago (1-LOD support interval 22-38). This is substantially more recent than the estimated age of the BRCA1 185delAG mutation (46 generations), derived from our analogous study of BRCA1 mutations. In general, there was no evidence of multiple origins of identical BRCA2 mutations. Our study data were consistent with the previous report of a higher incidence of ovarian cancer in families with mutations in a 3.3-kb region of exon 11 (the ovarian cancer cluster region [OCCR]) (P = .10); but that higher incidence was not statistically significant. There was significant evidence that age at diagnosis of breast cancer varied by mutation (P < .001), although only 8% of the variance in age at diagnosis could be explained by the specific mutation, and there was no evidence of family-specific effects. When the age at diagnosis of the breast cancer cases was examined by OCCR, cases associated with mutations in the OCCR had a significantly older mean age at diagnosis than was seen in those outside this region (48 years vs. 42 years; P = .0005).	Univ Utah, Sch Med, Dept Med Informat, Div Genet Epidemiol,Genet Epidemiol Grp, Salt Lake City, UT 84108 USA; Univ Penn, Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Hematol Oncol, Philadelphia, PA 19104 USA; Rambam Med Ctr, Dept Human Genet, Haifa, Israel; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Genet, Seattle, WA USA; Inst Curie, Unite Genet Oncol, Paris, France; Dana Farber Canc Inst, Boston, MA 02115 USA; Natl Inst Oncol, Budapest, Hungary; Int Agcy Res Canc, F-69372 Lyon, France; Univ Manchester, Dept Med Genet, Manchester, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Fdn Jimenez Diaz, Dept Genet, E-28040 Madrid, Spain; Inst Canc Res, Sect Mol Carcinogenesis, Sutton, Surrey, England; Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Univ Pisa, Dept Oncol, Pisa, Italy; Kantonsspital Basel, Dept Human Genet, Basel, Switzerland; Univ Aberdeen, Sch Med, Dept Med Genet, Aberdeen AB9 2ZD, Scotland; Free Univ Brussels, Ctr Oncol, Brussels, Belgium; German Canc Res Ctr, D-6900 Heidelberg, Germany; Imperial Canc Res Fund, Genet Epidemiol Lab, Leeds, W Yorkshire, England; Inst Publ Hlth, Genet Epidemiol Unit, CRC, Cambridge, England; Univ Cambridge, Dept Oncol, Human Canc Genet Grp, CRC, Cambridge, England; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON, Canada	Utah System of Higher Education; University of Utah; Fox Chase Cancer Center; University of Pennsylvania; University of Pennsylvania; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Harvard University; Dana-Farber Cancer Institute; National Institute of Oncology Hungary; World Health Organization; International Agency for Research on Cancer (IARC); University of Manchester; University of Manchester; University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pisa; University of Aberdeen; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; University of Cambridge; Leiden University; Leiden University - Excl LUMC; Lund University; Skane University Hospital; University of Toronto	Neuhausen, SL (corresponding author), Univ Utah, Sch Med, Dept Med Informat, Div Genet Epidemiol,Genet Epidemiol Grp, 391 Chipeta Way,Suite D2, Salt Lake City, UT 84108 USA.		DEVILEE, PETER/ABR-2140-2022; Caligo, Adelaide Maria/K-4289-2018; Scott, Rodney J/B-2827-2013; Osorio, Ana/I-4324-2014; Narod, Steven A/AAA-6112-2022	Caligo, Adelaide Maria/0000-0003-0589-1829; Scott, Rodney J/0000-0001-7724-3404; Osorio, Ana/0000-0001-8124-3984; Bishop, Tim/0000-0002-8752-8785; King, Mary-Claire/0000-0001-9426-1743; albright, lisa/0000-0003-2602-3668	NCI NIH HHS [N01-CN-6700, R01 CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abeliovich D, 1997, AM J HUM GENET, V60, P505; Bar-Sade RB, 1997, EUR J HUM GENET, V5, P413, DOI 10.1159/000484800; Couch FJ, 1996, GENOMICS, V36, P86, DOI 10.1006/geno.1996.0428; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Hakansson S, 1997, AM J HUM GENET, V60, P1068; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Sher C, 1996, NEW ENGL J MED, V334, P1199; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	20	127	128	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1381	1388		10.1086/301885	http://dx.doi.org/10.1086/301885			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585613	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000074174700014
J	Reiter, LT; Hastings, PJ; Nelis, E; De Jonghe, P; Van Broeckhoven, C; Lupski, JR				Reiter, LT; Hastings, PJ; Nelis, E; De Jonghe, P; Van Broeckhoven, C; Lupski, JR			Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; DUPLICATED CHROMOSOMAL SEQUENCES; DENSITY-LIPOPROTEIN RECEPTOR; HEREDITARY NEUROPATHY; PRESSURE PALSIES; MAMMALIAN-CELLS; FAMILIAL HYPERCHOLESTEROLEMIA; SACCHAROMYCES-CEREVISIAE; SUBSTRATE LENGTH; REPEAT SEQUENCES	The HNPP (hereditary neuropathy with liability to pressure palsies) deletion and CMT1A (Charcot-Marie-Tooth disease type 1A) duplication are the reciprocal products of homologous recombination events between misaligned flanking CMT1A-REP repeats on chromosome 17p11.2-p12. A 1.7-kb hotspot for homologous recombination was previously identified wherein the relative risk of an exchange event is 50 times higher than in the surrounding 98.7% identical sequence shared by the CMT1A-REPs. To refine the region of exchange further, we designed a PCR strategy to amplify the recombinant CMT1A-REP from HNPP patients as well as the proximal and distal CMT1A-REPs from control individuals. By comparing the sequences across recombinant CMT1A-REPs to that of the proximal and distal CMT1A-REPs, the exchange was mapped to a 557-bp region within the previously identified 1.7-kb hotspot in 21 of 23 unrelated HNPP deletion patients. Two patients had recombined sequences suggesting an exchange event closer to the mariner-like element previously identified near the hotspot. Five individuals also had interspersed patches of proximal or distal repeat specific DNA sequence indicating potential gene conversion during the exchange of genetic material. Our studies provide a direct observation of human meiotic recombination products. These results are consistent with the hypothesis that minimum efficient processing segments, which have been characterized in Escherichia coli, yeast, and cultured mammalian cells, may be required for efficient homologous meiotic recombination in humans.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Program Mol & Cell Biol, Houston, TX 77030 USA; Univ Antwerp VIB, Neurogenet Lab, Born Bunge Fdn, Dept Biochem, B-2020 Antwerp, Belgium; Acad Hosp, Div Neurol, Antwerp, Belgium	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Flanders Institute for Biotechnology (VIB); University of Antwerp	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 609F, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Reiter, Lawrence/H-4161-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Reiter, Lawrence/0000-0002-4100-2630	NINDS NIH HHS [R01NS2742] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hartl DL, 1997, TRENDS GENET, V13, P197, DOI 10.1016/S0168-9525(97)01087-1; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; KEYEUX G, 1989, GENOMICS, V5, P431, DOI 10.1016/0888-7543(89)90006-2; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Lagerstedt K, 1997, HUM MOL GENET, V6, P627, DOI 10.1093/hmg/6.4.627; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; LISKAY RM, 1987, GENETICS, V115, P161; LISKAY RM, 1986, P NATL ACAD SCI USA, V83, P1802, DOI 10.1073/pnas.83.6.1802; Lopes J, 1996, AM J HUM GENET, V58, P1223; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lupski JR, 1997, HOSP PRACT, V32, P83, DOI 10.1080/21548331.1997.11443485; METZENBERG AB, 1991, GENETICS, V128, P143; Murakami T, 1996, MEDICINE, V75, P233, DOI 10.1097/00005792-199609000-00001; Nelis E, 1996, EUR J HUM GENET, V4, P25; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RAY A, 1988, J MOL BIOL, V201, P247, DOI 10.1016/0022-2836(88)90136-2; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; REITER LT, 1996, MENTAL RETARDAT DEV, V2, P139; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; Robertson HM, 1997, J HERED, V88, P195, DOI 10.1093/oxfordjournals.jhered.a023088; RUDIGER NS, 1991, EUR J BIOCHEM, V198, P107, DOI 10.1111/j.1432-1033.1991.tb15992.x; SHEN P, 1986, GENETICS, V112, P441; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; SOBELL HM, 1972, P NATL ACAD SCI USA, V69, P2483, DOI 10.1073/pnas.69.9.2483; STAHL F, 1995, J HERED, V86, P327, DOI 10.1093/oxfordjournals.jhered.a111599; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Timmerman V, 1997, J MED GENET, V34, P43, DOI 10.1136/jmg.34.1.43; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; WISE CA, 1993, AM J HUM GENET, V53, P853; Yamamoto M, 1997, HUM GENET, V99, P151, DOI 10.1007/s004390050330; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	43	127	130	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1023	1033		10.1086/301827	http://dx.doi.org/10.1086/301827			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545397	Green Published, Bronze			2022-12-18	WOS:000073487000005
J	Oh, J; Ho, LL; Ala-Mello, S; Amato, D; Armstrong, L; Bellucci, S; Carakushansky, G; Ellis, JP; Fong, CT; Green, JS; Heon, E; Legius, E; Levin, AV; Nieuwenhuis, HK; Pinckers, A; Tamura, N; Whiteford, ML; Yamasaki, H; Spritz, RA				Oh, J; Ho, LL; Ala-Mello, S; Amato, D; Armstrong, L; Bellucci, S; Carakushansky, G; Ellis, JP; Fong, CT; Green, JS; Heon, E; Legius, E; Levin, AV; Nieuwenhuis, HK; Pinckers, A; Tamura, N; Whiteford, ML; Yamasaki, H; Spritz, RA			Mutation analysis of patients with Hermansky-Pudlak syndrome: A frameshift hot spot in the HPS gene and apparent locus heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION	Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder in which oculocutaneous albinism, bleeding, and lysosomal ceroid storage result from defects of multiple cytoplasmic organelles-melanosomes, platelet-dense granules, and lysosomes. As reported elsewhere, we mapped the human HPS gene to chromosome segment 10q23, positionally cloned the gene, and identified three pathologic mutations of the gene, in patients from Puerto Rico, Japan, and Europe. Here, we describe mutation analysis of 44 unrelated Puerto Rican and 24 unrelated non-Puerto Rican HPS patients. A 16-bp frameshift duplication, the result of an apparent founder effect, is nearly ubiquitous among Puerto Rican patients. A frameshift at codon 322 may be the most frequent HPS mutation in Europeans. We also describe six novel HPS mutations: a 5' splice-junction mutation of IVS5, three frameshifts, a nonsense mutation, and a one-codon in-frame deletion. These mutations define an apparent frameshift hot spot at codons 321-322. Overall, however, we detected mutations in the HPS gene in only about half of non-Puerto Rican patients, and we present evidence that suggests locus heterogeneity for HPS.	Univ Wisconsin, Genet Lab, Dept Med Genet, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Dept Pediat, Madison, WI 53706 USA; Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; Mt Sinai Hosp, Dept Hematol, Toronto, ON, Canada; Univ Toronto, Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; NYU, Med Ctr, Dept Med, New York, NY 10016 USA; Hop Lariboisiere, Hematol Lab, F-75475 Paris, France; Fed Univ Rio De Janeiro, Sch Med, Dept Pediat, Rio De Janeiro, Brazil; Princess Margaret Hosp, Dept Dermatol, Swindon, Wilts, England; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Mem Univ Newfoundland, Newfoundland & Labrador Med Genet Program, St Johns, NF, Canada; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Utrecht Hosp, Dept Hematol, Utrecht, Netherlands; Univ Nijmegen, Dept Ophthalmol, Nijmegen, Netherlands; Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan; Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; Kumamoto Univ, Sch Med, Dept Internal Med 1, Kumamoto 860, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Rio de Janeiro; University of Rochester; Memorial University Newfoundland; KU Leuven; University Hospital Leuven; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Juntendo University; Kumamoto University	Spritz, RA (corresponding author), Univ Wisconsin, Genet Lab, Dept Med Genet, 445 Henry Mall, Madison, WI 53706 USA.		Legius, Eric/H-1735-2011		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bailin T, 1997, J INVEST DERMATOL, V108, P923, DOI 10.1111/1523-1747.ep12294634; BENNETT DC, 1993, INT REV CYTOL, V146, P191, DOI 10.1016/S0074-7696(08)60383-6; ELLIS JP, 1995, J ROY SOC MED, V88, pP293; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; FUKAI K, 1995, HUM MOL GENET, V4, P1665, DOI 10.1093/hmg/4.9.1665; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; GERRITSEN SM, 1977, SCAND J HAEMATOL, V18, P249; Hazelwood S, 1997, AM J HUM GENET, V61, P1088, DOI 10.1086/301611; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; LATTION F, 1983, HELV PAEDIATR ACTA, V38, P495; Lee ST, 1995, MOL CELLS, V5, P668; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; SCHALLREUTER KU, 1993, DERMATOLOGY, V187, P248, DOI 10.1159/000247258; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; ZIELENSKI J, 1995, CLIN GENET, V47, P125; [No title captured]; [No title captured]	21	127	130	1	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					593	598		10.1086/301757	http://dx.doi.org/10.1086/301757			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497254	Green Published, hybrid			2022-12-18	WOS:000072894400012
J	Shovlin, CL; Hughes, JMB; Scott, J; Seidman, CE; Seidman, JG				Shovlin, CL; Hughes, JMB; Scott, J; Seidman, CE; Seidman, JG			Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-BETA; HUMAN ENDOTHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; BINDING-PROTEIN; GENE; DNA; ULTRASTRUCTURE; EXPRESSION; TYPE-1; FORMS	To identify mutations that cause hereditary hemorrhagic telangiectasia (HHT, or Rendu-Osler-Weber syndrome), clinical evaluations and genetic studies were performed on 32 families. Linkage studies in four of eight families indicated an endoglin (ENG) gene mutation. ENG sequences of affected members of the four linked families and probands from the 24 small families were screened for mutations, by Southern blot analyses and by cycle sequencing of PCR-amplified DNA. Seven novel mutations were identified in eight families. Two mutations (a termination codon in exon 4 and a large genomic deletion extending 3' of intron 8) did not produce a stable ENG transcript in lymphocytes. Five other mutations (two donor splice-site mutations and three deletions) produce altered mRNAs that are predicted to encode markedly truncated ENG proteins. Mutations in other families are predicted to lie in ENG-regulatory regions or in one of the additional genes that may cause HHT. These data suggest that the molecular mechanism by which ENG mutations cause HHT is haploinsufficiency. Furthermore, because the clinical manifestation of disease in these eight families was similar, we hypothesize that phenotypic variation of HHT is not related to a particular ENG mutation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON,ENGLAND	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Imperial College London				Shovlin, Claire/0000-0001-9007-5775	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; BRAVERMAN IM, 1983, J INVEST DERMATOL, V81, P489, DOI 10.1111/1523-1747.ep12522736; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CHILVERS ER, 1990, AM REV RESPIR DIS, V142, P420, DOI 10.1164/ajrccm/142.2.420; CLARK ER, 1940, AM J ANAT, V66, P2; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hecker KH, 1996, BIOTECHNIQUES, V20, P478; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KOH GY, 1995, J CLIN INVEST, V95, P114, DOI 10.1172/JCI117627; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; MADRI JA, 1992, ENDOTHELIAL CELL DYS; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; Piantanida M, 1996, J MED GENET, V33, P441, DOI 10.1136/jmg.33.6.441; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; PUFFENBERGER EG, 1991, NUCLEIC ACIDS RES, V19, P1161, DOI 10.1093/nar/19.5.1161; RENDU H, 1896, GAZ HOP PARIS, V135, P132; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shovlin CL, 1996, ANNU REV PHYSIOL, V58, P483, DOI 10.1146/annurev.ph.58.030196.002411; Shovlin CL, 1995, QJM-INT J MED, V88, P879; SHOVLIN CL, 1994, J IMMUNOL, V153, P2331; SHOVLIN CL, 1994, NAT GENET, V6, P205, DOI 10.1038/ng0294-205; Shovlin CL, 1996, BIOTECHNIQUES, V21, P388; SHOVLIN CL, 1995, ANN HUM GENET, V59, P381; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Zhang HW, 1996, J IMMUNOL, V156, P565; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231	36	127	132	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					68	79		10.1086/513906	http://dx.doi.org/10.1086/513906			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245986	Bronze, Green Published			2022-12-18	WOS:A1997XM72800013
J	Goyette, P; Christensen, B; Rosenblatt, DS; Rozen, R				Goyette, P; Christensen, B; Rosenblatt, DS; Rozen, R			Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK FACTOR; VASCULAR-DISEASE; DEFICIENCY	Methyltnetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, a methyl donor in the conversion of homocysteine to methionine. Patients with severe MTHFR deficiency have hyperhomocysteinemia, hypomethioninemia, and a range of neurological and vascular findings with a variable age at onset. We have previously described nine mutations in patients with severe MTHFR deficiency. A mild form of MTHFR deficiency, associated with a thermolabile enzyme, has been proposed as a genetic risk factor for cardiovascular disease and for neural tube defects, We have shown that a common missense mutation (an alanine-to-valine substitution) encodes this thermolabile variant. We now report an additional five mutations causing severe MTHFR deficiency and an analysis of genotype (alanine/valine status) and enzyme thermolability in 22 patients with this inborn error of metabolism. Six of these patients have four mutations in the MTHFR gene-two rare mutations causing severe deficiency and two mutations for the common alanine-to-valine mutation that results in thermolability. Even in severe MTHFR deficiency, the thermolabile variant is frequently observed, and there is a strong relationship between the presence of this variant and increased enzyme thermolability.	MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL,PQ H3A 2T5,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA	McGill University; McGill University; McGill University; McGill University			Rozen, Rima/AAE-9294-2020					BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; CHRISTENSEN B, IN PRESS ARTERIOSCLE; ERBE RW, 1986, FOLATE PTERINE, V3, P413; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOYETTE P, 1995, AM J HUM GENET, V56, P1052; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1991, AM J HUM GENET, V48, P545; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; Motulsky AG, 1996, AM J HUM GENET, V58, P17; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1141, DOI 10.1203/00006450-197711000-00005; ROSENBLATT DS, 1992, BIOCHEM MED METAB B, V47, P221, DOI 10.1016/0885-4505(92)90029-X; Rosenblatt DS., 1995, METABOLIC MOL BASES, P3111; SUMNER J, 1986, J BIOL CHEM, V261, P7697; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763	18	127	140	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1268	1275						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940272				2022-12-18	WOS:A1996VV31500013
J	CORDELL, HJ; TODD, JA; BENNETT, ST; KAWAGUCHI, Y; FARRALL, M				CORDELL, HJ; TODD, JA; BENNETT, ST; KAWAGUCHI, Y; FARRALL, M			2-LOCUS MAXIMUM LOD SCORE ANALYSIS OF A MULTIFACTORIAL TRAIT - JOINT CONSIDERATION OF IDDM2 AND IDDM4 WITH IDDM1 IN TYPE-I DIABETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; LINKAGE STRATEGIES	To investigate the genetic component of multifactorial diseases such as type 1 (insulin-dependent) diabetes mellitus (IDDM), models involving the joint action of several disease loci are important. These models can give increased power to detect an effect and a greater understanding of etiological mechanisms. Here, we present an extension of the maximum lod score method of N. Risch, which allows the simultaneous detection and modeling of two unlinked disease loci. Genetic constraints on the identical-by-descent sharing probabilities, analogous to the ''triangle'' restrictions in the single-locus method, are derived, and the size and power of the test statistics are investigated. The method is applied to affected-sib-pair data, and the joint effects of IDDM1 (HLA) and IDDM2 (the INS VNTR) and of IDDM1 and IDDM4 (FGF3-linked) are assessed with relation to the development of IDDM. In the presence of genetic heterogeneity, there is seen to be a significant advantage in analyzing more than one locus simultaneously. Analysis of these families indicates that the effects at IDDM1 and IDDM2 are well described by a multiplicative genetic model, while those at IDDM1 and IDDM4 follow a heterogeneity model.	UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT MED,OXFORD OX3 7BN,ENGLAND	University of Oxford; Wellcome Centre for Human Genetics	CORDELL, HJ (corresponding author), UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT SURG,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Cordell, Heather/0000-0002-1879-5572	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COX DR, 1974, THEORETICAL STATISTI, P279; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DIZIER MH, 1994, AM J HUM GENET, V55, P1042; DIZIER MH, 1986, GENET EPIDEMIOL, V5, P343; Hammersley J.M., 1964, MONTE CARLO METHODS; HOLMANS P, 1993, AM J HUM GENET, V52, P362; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; KNAPP M, 1994, AM J HUM GENET, V55, P1030; KONG A, 1992, AM J HUM GENET, V51, P1413; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127	17	127	131	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					920	934						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573054				2022-12-18	WOS:A1995RV79300024
J	SPEER, MC; YAMAOKA, LH; GILCHRIST, JH; GASKELL, CP; STAJICH, JM; VANCE, JM; KAZANTSEV, A; LASTRA, AA; HAYNES, CS; BECKMANN, JS; COHEN, D; WEBER, JL; ROSES, AD; PERICAKVANCE, MA				SPEER, MC; YAMAOKA, LH; GILCHRIST, JH; GASKELL, CP; STAJICH, JM; VANCE, JM; KAZANTSEV, A; LASTRA, AA; HAYNES, CS; BECKMANN, JS; COHEN, D; WEBER, JL; ROSES, AD; PERICAKVANCE, MA			CONFIRMATION OF GENETIC-HETEROGENEITY IN LIMB-GIRDLE MUSCULAR-DYSTROPHY - LINKAGE OF AN AUTOSOMAL DOMINANT FORM TO CHROMOSOME-5Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Limb-girdle muscular dystrophy (LGMD) is a clinically and genetically heterogeneous group of disorders, with both recessive and dominant forms reported. Recently, a series of recessive LGMD families were linked to chromosome 15q. We report herein the results of our linkage studies in a previously reported large autosomal dominant family. The LGMD gene in this family was localized to chromosome 5q22.3-31.3 by using a series of CA(n) microsatellite repeat markers. Linkage to 15q was excluded. These findings confirm genetic heterogeneity in this clinically diverse syndrome.	DUKE UNIV, MED CTR, DIV NEUROL, BOX 2900, DURHAM, NC 27710 USA; DUKE UNIV, PROGRAM GENET, DURHAM, NC 27706 USA; DUKE UNIV, DEPT ZOOL, DURHAM, NC 27706 USA; RHODE ISL HOSP, DEPT NEUROL, PROVIDENCE, RI 02902 USA; BROWN UNIV, PROVIDENCE, RI 02912 USA; UNIV N CAROLINA, DEPT COMP SCI, CHAPEL HILL, NC 27514 USA; CTR ETUD POLYMORPHISME HUMAIN, PARIS, FRANCE; MARSHFIELD CLIN FDN MED RES & EDUC, MARSHFIELD, WI 54449 USA	Duke University; Duke University; Duke University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of North Carolina; University of North Carolina Chapel Hill; Marshfield Clinic			Beckmann, Jacques S/A-9772-2008	Beckmann, Jacques S/0000-0002-9741-1900; Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS019999] Funding Source: NIH RePORTER; NIA NIH HHS [AG05128] Funding Source: Medline; NINDS NIH HHS [NS26630, NS19999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BROOKE MH, 1986, CLIN VIEW NEUROMUSCU; CHUTKOW JG, 1986, ANN NEUROL, V20, P240, DOI 10.1002/ana.410200210; CHYATTE SAMUEL B., 1966, ARCH PHYS MED REHABIL, V47, P499; COERS C, 1979, NEUROLOGY, V29, P957; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DECOSTER W, 1974, EUR NEUROL, V12, P159, DOI 10.1159/000114615; DONLON TA, 1991, CYTOGENET CELL GENET, V58, P624, DOI 10.1159/000133175; FARBER RA, 1988, NUCLEIC ACIDS RES, V16, P2360, DOI 10.1093/nar/16.5.2360; GILCHRIST JM, 1988, NEUROLOGY, V38, P5, DOI 10.1212/WNL.38.1.5; JACKSON CE, 1968, PEDIATRICS, V41, P495; KAZAKOV VM, 1977, EUR NEUROL, V16, P90; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1959, AM J HUM GENET, V11, P360; NAKAMURA Y, 1987, NUCLEIC ACIDS RESS, V15, P1003; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P688; SHOKEIR MHK, 1976, CLIN GENET, V9, P197; SPEER MC, 1989, CYTOGENET CELL GENET, V51, P1083; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, UNPUB MAPPING HUMAN; YAMAOKA LH, 1990, NEUROLOGY, V40, P222, DOI 10.1212/WNL.40.2.222; YOUNG K, 1991, CYTOGENET CELL GENET, V58, P1996; [No title captured]	26	127	127	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1211	1217						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598902				2022-12-18	WOS:A1992HY65400008
J	LEITERSDORF, E; CHAKRAVARTI, A; HOBBS, HH				LEITERSDORF, E; CHAKRAVARTI, A; HOBBS, HH			POLYMORPHIC DNA HAPLOTYPES AT THE LDL RECEPTOR LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, SW MED CTR, DEPT MOLEC GENET, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA; UNIV PITTSBURGH, DIV HUMAN GENET, PITTSBURGH, PA 15260 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					FOGARTY INTERNATIONAL CENTER [F05TW003742] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER; FIC NIH HHS [IF-05-TW03742] Funding Source: Medline; NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BARKER D, 1984, AM J HUM GENET, V36, P1159; BLANTON S H, 1987, American Journal of Human Genetics, V41, pA250; BLOCK WD, 1965, TECHNICON S AUTOMATI, P345; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1985, AM J HUM GENET, V37, P984; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; FUNKE H, 1986, NUCLEIC ACIDS RES, V14, P7820, DOI 10.1093/nar/14.19.7820; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Goldstein JL, 1983, METABOLIC BASIS INHE, P672; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HIROKO P, 1987, HUM GENET, V75, P264; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1988, J CLIN INVEST, V81, P909, DOI 10.1172/JCI113402; HOBBS HH, 1987, NUCLEIC ACIDS RES, V15, P379, DOI 10.1093/nar/15.1.379; HOBBS HH, 1985, P NATL ACAD SCI USA, V82, P7651, DOI 10.1073/pnas.82.22.7651; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HORSTHEMKE B, 1987, EUR J BIOCHEM, V164, P77, DOI 10.1111/j.1432-1033.1987.tb10995.x; HUMPHRIES SE, 1985, LANCET, V1, P1003; KAN YW, 1987, NEW ENGL J MED, V316, P478, DOI 10.1056/NEJM198702193160810; KESSLER G, 1965, TECHNICON S AUTOMATI, P341; KOTZE MJ, 1987, NUCLEIC ACIDS RES, V15, P376, DOI 10.1093/nar/15.1.376; KOTZE MJ, 1986, S AFR MED J, V70, P77; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LEITERSDORF E, 1987, NUCLEIC ACIDS RES, V15, P2782, DOI 10.1093/nar/15.6.2782; LEWONTIN RC, 1964, GENETICS, V49, P49; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RUSSELL DW, IN PRESS ATHEROSCLER; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SWOFFORD D. L., 1985, PHYLOGENETIC ANAL US; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; Wainscoat J S, 1983, Mol Biol Med, V1, P191; WATLARSON GA, 1977, THEOR POPUL BIOL, V11, P141; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; 1982, NIH75628 DHEW PUBL	59	127	129	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					409	421						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2563635				2022-12-18	WOS:A1989T353500015
J	MACLEAN, CJ; MORTON, NE; LEW, R				MACLEAN, CJ; MORTON, NE; LEW, R			ANALYSIS OF FAMILY RESEMBLANCE .4. OPERATIONAL CHARACTERISTICS OF SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System					NICHD NIH HHS [HD 06003] Funding Source: Medline; NIGMS NIH HHS [GM 17173] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COTTERMAN CW, 1939, J AM STAT ASSOC, V34, P151; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher RA, 1937, ANN EUGENIC, V8, P74, DOI 10.1111/j.1469-1809.1937.tb02162.x; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1974, AM J HUM GENET, V26, P489; RAO DB, IN PRESS; RAO DC, 1974, AM J HUM GENET, V26, P331; SMITH C, 1971, Clinical Genetics, V2, P303; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256	10	127	127	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					365	384						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803017				2022-12-18	WOS:A1975AD23600011
J	DELACHAPELLE, A; SCHRODER, J; STENSTRAND, K; FELLMAN, J; HERVA, R; SAARNI, M; ANTTOLAINEN, I; TALLILA, I; TERVILA, L; HUSA, L; TALLQVIST, G; ROBSON, EB; COOK, PJL; SANGER, R				DELACHAPELLE, A; SCHRODER, J; STENSTRAND, K; FELLMAN, J; HERVA, R; SAARNI, M; ANTTOLAINEN, I; TALLILA, I; TERVILA, L; HUSA, L; TALLQVIST, G; ROBSON, EB; COOK, PJL; SANGER, R			PERICENTRIC INVERSIONS OF HUMAN CHROMOSOMES 9 AND 10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LISTER INST, MRC, BLOOD GRP UNIT, LONDON, ENGLAND; FOLKHALSAN INST GENET, HELSINKI, FINLAND; UNIV OULU, DEPT PEDIAT, OULU, FINLAND; UNIV OULU, DEPT PATHOL, OULU, FINLAND; HATANPAA HOSP, DEPT INTERN MED, TAMPERE, FINLAND; KESKI POHJANMAA CENT HOSP, DEPT PEDIAT, KOKKOLA, FINLAND; KESKI POHJANMAA CENT HOSP, DEPT GYNECOL, KOKKOLA, FINLAND; LAHTI CENT HOSP, DEPT GYNECOL, LAHTI, FINLAND; LAPLAND CENT HOSP, DEPT GYNECOL, ROVANIEMI, FINLAND; MARIA HOSP, DEPT PATHOL, HELSINKI, FINLAND; UCL, MRC, HUMAN BIOCHEM GENET UNIT, GALTON LAB, LONDON, ENGLAND	University of Oulu; University of Oulu; University of London; University College London								ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; BUCKTON K E, 1973, P196; CASPERSSON T, 1972, EXP CELL RES, V75, P541, DOI 10.1016/0014-4827(72)90469-7; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DELACHAPELLE A, 1972, CLIN GENET, V3, P470; DELACHAPELLE A, 1973, INT J FERTIL, V18, P215; DELACHAPELLE A, 1962, LANCET, V2, P460; Dobzhansky T., 1952, COPEIA, V1952, P287; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; DUTRILLAUX B, 1973, CYTOGENET CELL GENET, V12, P245, DOI 10.1159/000130460; DUTRILLAUX B, 1973, P205; DUTRILLAUX B, 1972, JOURNEES PARISIENNES, P13; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; EVANS HJ, 1971, CHROMOSOMA, V35, P310, DOI 10.1007/BF00326281; FERGUSON-SMITH M. A., 1962, CYTO GENETICS [BASEL], V1, P325, DOI 10.1159/000129743; FERGUSONSMITH MA, 1967, 3RD P INT C HUM GEN, P69; FRIEDRICH U, 1973, CLIN GENET, V4, P333; HAMERTON JL, 1972, CAN MED ASSOC J, V106, P776; Hamerton JL, 1971, HUMAN CYTOGENETICS, V1; HOLMBERG M, 1973, HEREDITAS, V74, P57; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; HOWARD PN, 1973, HUMANGENETIK, V18, P271, DOI 10.1007/BF00290607; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; JACOBS PA, 1967, ANN HUM GENET, V31, P219; JONES KW, 1973, CHROMOSOMA, V42, P445, DOI 10.1007/BF00399411; JONES KW, 1973, J MED GENET, V10, P273, DOI 10.1136/jmg.10.3.273; Lejeune J, 1965, Ann Genet, V8, P21; LUBS H A, 1973, P241; LUBS HA, 1971, NATURE, V233, P134, DOI 10.1038/233134a0; MAYNARDSMITH S, 1961, MATHEMATICAL TABLES; MOSCETTI G, 1971, HUMANGENETIK, V12, P56, DOI 10.1007/BF00291033; PAGE BM, 1973, CYTOGENET CELL GENET, V12, P254, DOI 10.1159/000130461; PEARSON PL, 1973, MODERN ASPECTS CYTOG, P201; RENWICK JH, 1971, ANN HUM GENET, V35, P79, DOI 10.1111/j.1469-1809.1956.tb01381.x; SCHRODER J, 1971, HUMANGENETIK, V13, P15, DOI 10.1007/BF00446409; SEABRIGH.M, 1971, LANCET, V2, P971; SEABRIGHT M, 1973, CHROMOSOMA, V40, P333, DOI 10.1007/BF00399426; UNNERUS V, 1967, CYTOGENETICS, V6, P213, DOI 10.1159/000129943; WAHRMAN J, 1972, CYTOGENETICS, V11, P132, DOI 10.1159/000130182; WALZER S, 1969, J PEDIATR-US, V74, P438, DOI 10.1016/S0022-3476(69)80202-7; WILSON M G, 1970, American Journal of Human Genetics, V22, P679; 1972, BIRTH DEFECTS OAS	44	127	129	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					746	766						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4140690				2022-12-18	WOS:A1974V091100010
J	Cornec-Le Gall, E; Olson, RJ; Besse, W; Heyer, CM; Gainullin, VG; Smith, JM; Audrezet, MP; Hopp, K; Porath, B; Shi, B; Baheti, S; Senum, SR; Arroyo, J; Madsen, CD; Ferec, C; Joly, D; Jouret, F; Fikri-Benbrahim, O; Charasse, C; Coulibaly, JM; Yu, AS; Khalili, K; Pei, Y; Somlo, S; Le Meur, Y; Torres, VE; Harris, PC				Cornec-Le Gall, Emilie; Olson, Rory J.; Besse, Whitney; Heyer, Christina M.; Gainullin, Vladimir G.; Smith, Jessica M.; Audrezet, Marie-Pierre; Hopp, Katharina; Porath, Binu; Shi, Beili; Baheti, Saurabh; Senum, Sarah R.; Arroyo, Jennifer; Madsen, Charles D.; Ferec, Claude; Joly, Dominique; Jouret, Francois; Fikri-Benbrahim, Oussamah; Charasse, Christophe; Coulibaly, Jean-Marie; Yu, Alan S.; Khalili, Korosh; Pei, York; Somlo, Stefan; Le Meur, Yannick; Torres, Vicente E.; Harris, Peter C.		Genkyst Study Grp; HALT Progression Polycystic Kidne; Consortium Radiologic Imaging Stud	Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOPLASMIC-RETICULUM; DNAJ HOMOLOG; DIAGNOSIS; MANAGEMENT; STRESS; VOLUME; GANAB; ERDJ3; RARE	Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by the progressive development of kidney cysts, often resulting in end-stage renal disease (ESRD). This disorder is genetically heterogeneous with similar to 7% of families genetically unresolved. We performed whole-exome sequencing (WES) in two multiplex ADPKD-like pedigrees, and we analyzed a further 591 genetically unresolved, phenotypically similar families by targeted next-generation sequencing of 65 candidate genes. WES identified a DNAJB11 missense variant (p.Pro54Arg) in two family members presenting with non-enlarged polycystic kidneys and a frameshifting change (c.166_167insTT) in a second family with small renal and liver cysts. DNAJB11 is a co-factor of BiP, a key chaperone in the endoplasmic reticulum controlling folding, trafficking, and degradation of secreted and membrane proteins. Five additional multigenerational families carrying DNAJB11 mutations were identified by the targeted analysis. The clinical phenotype was consistent in the 23 affected members, with non-enlarged cystic kidneys that often evolved to kidney atrophy; 7 subjects reached ESRD from 59 to 89 years. The lack of kidney enlargement, histologically evident interstitial fibrosis in non-cystic parenchyma, and recurring episodes of gout (one family) suggested partial phenotypic overlap with autosomal-dominant tubulointerstitial diseases (ADTKD). Characterization of DNAJB11-null cells and kidney samples from affected individuals revealed a pathogenesis associated with maturation and trafficking defects involving the ADPKD protein, PC1, and ADTKD proteins, such as UMOD. DNAJB11-associated disease is a phenotypic hybrid of ADPKD and ADTKD, characterized by normal-sized cystic kidneys and progressive interstitial fibrosis resulting in late-onset ESRD.	[Cornec-Le Gall, Emilie; Heyer, Christina M.; Gainullin, Vladimir G.; Smith, Jessica M.; Porath, Binu; Senum, Sarah R.; Arroyo, Jennifer; Madsen, Charles D.; Torres, Vicente E.; Harris, Peter C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Olson, Rory J.; Harris, Peter C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Baheti, Saurabh] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Cornec-Le Gall, Emilie; Le Meur, Yannick] European Univ Brittany, Univ Hosp, Dept Nephrol, F-29200 Brest, Brittany, France; [Cornec-Le Gall, Emilie; Audrezet, Marie-Pierre; Ferec, Claude] INSERM, Natl Inst Hlth & Med Sci, U1078, Dept Mol Genet, F-29200 Brest, France; [Besse, Whitney; Somlo, Stefan] Yale Sch Med, Nephrol Sect, New Haven, CT 06520 USA; [Hopp, Katharina] Univ Colorado, Denver Anschutz Med Campus, Div Renal Dis & Hypertens, Aurora, CO 80202 USA; [Shi, Beili; Pei, York] Univ Hlth Network, Div Nephrol, Toronto, ON M5G 2C4, Canada; [Khalili, Korosh] Univ Hlth Network, Dept Med Imaging, Toronto, ON M5G 2C4, Canada; [Joly, Dominique] Hop Necker Enfants Malad, Serv Nephrol, F-75231 Paris, France; [Jouret, Francois] Univ Liege, Div Nephrol, B-4000 Liege, Belgium; [Fikri-Benbrahim, Oussamah] Serv Nephrol & Hemodialysis, F-17108 Saintes, France; [Charasse, Christophe; Coulibaly, Jean-Marie] Yves Le Foll Hosp, Serv Nephrol, F-22000 St Brieuc, France; [Yu, Alan S.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; CHU Brest; Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Kansas; University of Kansas Medical Center	Harris, PC (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Harris, PC (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	harris.peter@mayo.edu	Gall, Emilie Cornec-Le/AAJ-8467-2020; Yu, Alan/AID-7467-2022; Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; Torres, Vicente/0000-0003-2008-1576; Khalili, Korosh/0000-0002-3496-8744; Le Meur, Yannick/0000-0001-8913-415X; Besse, Whitney/0000-0002-8283-1507; Senum, Sarah/0000-0002-5489-9117; CORNEC-LE GALL, Emilie/0000-0003-1958-4459; , Jennifer/0000-0001-8271-7184	NIDDK [DK058816, DK056943, DK056956, DK056957, DK056961, DK062410, DK062408, DK062402, DK082230, DK062411, DK062401]; Mayo Translational PKD Center [DK090728]; American Society of Nephrology (ASN) Foundation Kidney Research Fellowship; Fulbright Association; Foundation Monaham; PKD Foundation fellowship; American Heart Association postdoctoral fellowship; ASN Ben J. Lipps Fellowship; NIDDK Predoctoral Studentships; Mayo Graduate School; Zell Family Foundation; Belgian Fonds National de la Recherche Scientifique; National Center for Research Resources General Clinical Research Centers; National Center for Advancing Translational Sciences Clinical and Translational Science Awards; National Plans for Clinical Research; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest); French Society of Nephrology; National Human Genome Research Institute [UM1 HG006504]; National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program; Yale O'Brien Kidney Center [P30 DK079310]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058816, U01DK062408, R01DK044863, P30DK079310, U01DK062401, U01DK056956, U01DK062402, U01DK056961, U01DK056957, U01DK062410, U01DK062411, P30DK106912, U01DK082230, T32DK007276, P30DK090728, U01DK056943] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Translational PKD Center; American Society of Nephrology (ASN) Foundation Kidney Research Fellowship; Fulbright Association; Foundation Monaham; PKD Foundation fellowship; American Heart Association postdoctoral fellowship(American Heart Association); ASN Ben J. Lipps Fellowship; NIDDK Predoctoral Studentships; Mayo Graduate School; Zell Family Foundation; Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); National Center for Research Resources General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences Clinical and Translational Science Awards; National Plans for Clinical Research; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest); French Society of Nephrology; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program; Yale O'Brien Kidney Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families and coordinators for involvement in the study, and Dr. Cornet (Verviers Hospital, Belgium) and Andrew Metzger and Marie Edwards (Mayo Clinic) for their assistance. The study was supported by NIDDK grant DK058816 (P.C.H.), the Mayo Translational PKD Center (DK090728; V.E.T.), an American Society of Nephrology (ASN) Foundation Kidney Research Fellowship (E.C.-L.G.), the Fulbright Association and the Foundation Monaham (E.C.-L.G.), a PKD Foundation fellowship (W.B.), an American Heart Association postdoctoral fellowship (B.P.), an ASN Ben J. Lipps Fellowship (K.H.), NIDDK Predoctoral Studentships (F31; R.J.O. and J.A.), Mayo Graduate School (R.J.O. and J.A.), the Zell Family Foundation, Robert M. and Billie Kelley Pirnie, and the Belgian Fonds National de la Recherche Scientifique (F.J.). The CRISP and HALT-PKD studies were supported by NIDDK cooperative agreements (DK056943, DK056956, DK056957, DK056961, DK062410, DK062408, DK062402, DK082230, DK062411, and DK062401), National Center for Research Resources General Clinical Research Centers, and National Center for Advancing Translational Sciences Clinical and Translational Science Awards. The Genkyst cohort was supported by National Plans for Clinical Research, Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest), and the French Society of Nephrology. The Yale Center for Mendelian Genomics (UM1 HG006504) is funded by the National Human Genome Research Institute. Funds were also provided by the National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program and by the Yale O'Brien Kidney Center (P30 DK079310). Acknowledgment to other HALT PKD, CRISP, and Genkyst investigators is given in the Supplemental Data.	Besse W, 2018, HUM MUTAT, V39, P378, DOI 10.1002/humu.23383; Besse W, 2017, J CLIN INVEST, V127, P1772, DOI 10.1172/JCI90129; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Cornec-Le Gall E, 2018, J AM SOC NEPHROL, V29, P13, DOI 10.1681/ASN.2017050483; Cornec-Le Gall E, 2016, J AM SOC NEPHROL, V27, P942, DOI 10.1681/ASN.2015010016; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Devuyst O, 2017, NAT REV NEPHROL, V13, P525, DOI 10.1038/nrneph.2017.101; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Gainullin VG, 2015, J CLIN INVEST, V125, P607, DOI 10.1172/JCI76972; Genereux JC, 2015, EMBO J, V34, P4, DOI 10.15252/embj.201488896; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Heyer CM, 2016, J AM SOC NEPHROL, V27, P2872, DOI 10.1681/ASN.2015050583; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Hwang YH, 2016, J AM SOC NEPHROL, V27, P1861, DOI 10.1681/ASN.2015060648; Iliuta IA, 2017, J AM SOC NEPHROL, V28, P2768, DOI 10.1681/ASN.2016090938; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Porath B, 2016, AM J HUM GENET, V98, P1193, DOI 10.1016/j.ajhg.2016.05.004; Quaglia M, 2014, CLIN TRANSPLANT, V28, P995, DOI 10.1111/ctr.12408; Rahbari-Oskoui F, 2017, SEMIN DIALYSIS, V30, P373, DOI 10.1111/sdi.12605; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Cabezas OR, 2017, J AM SOC NEPHROL, V28, P2529, DOI 10.1681/ASN.2016121312; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; WARD CJ, 1994, CELL, V77, P881; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063	38	126	127	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					832	844		10.1016/j.ajhg.2018.03.013	http://dx.doi.org/10.1016/j.ajhg.2018.03.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706351	Bronze, Green Published			2022-12-18	WOS:000432440100009
J	Lu, DS; Lou, HY; Yuan, K; Wang, XJ; Wang, YC; Zhang, C; Lu, Y; Yang, X; Deng, LA; Zhou, Y; Feng, QD; Hu, Y; Ding, QL; Yang, YJ; Li, SL; Jin, L; Guan, YQ; Su, B; Kang, LL; Xu, SH				Lu, Dongsheng; Lou, Haiyi; Yuan, Kai; Wang, Xiaoji; Wang, Yuchen; Zhang, Chao; Lu, Yan; Yang, Xiong; Deng, Lian; Zhou, Ying; Feng, Qidi; Hu, Ya; Ding, Qiliang; Yang, Yajun; Li, Shilin; Jin, Li; Guan, Yaqun; Su, Bing; Kang, Longli; Xu, Shuhua			Ancestral Origins and Genetic History of Tibetan Highlanders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SEQUENCE; HIGH-ALTITUDE; MUTATION-RATE; NEANDERTHAL; HAPLOTYPES; INTROGRESSION; ADAPTATION; SETTLEMENT; FRAMEWORK; ADMIXTURE	The origin of Tibetans remains one of the most contentious puzzles in history, anthropology, and genetics. Analyses of deeply sequenced (30x-60x) genomes of 38 Tibetan highlanders and 39 Han Chinese lowlanders, together with available data on archaic and modem humans, allow us to comprehensively characterize the ancestral makeup of Tibetans and uncover their origins. Non-modem human sequences compose-6% of the Tibetan gene pool and form unique haplotypes in some genomic regions, where Denisovan-like, Neanderthal -like, ancient-Siberian-like, and unknown ancestries are entangled and elevated. The shared ancestry of Tibetan-enriched sequences dates back to similar to 62,000-38,000 years ago, predating the Last Glacial Maximum (LGM) and representing early colonization of the plateau. Nonetheless, most of the Tibetan gene pool is of modern human origin and diverged from that of Han Chinese similar to 15,000 to similar to 9,000 years ago, which can be largely attributed to post-LGM arrivals. Analysis of similar to 200 contemporary populations showed that Tibetans share ancestry with populations from East Asia (-82%), Central Asia and Siberia (similar to 11%), South Asia (similar to 6%), and western Eurasia and Oceania (similar to 1%). Our results support that Tibetans arose from a mixture of multiple ancestral gene pools but that their origins are much more complicated and ancient than previously suspected. We provide compelling evidence of the co-existence of Paleolithic and Neolithic ancestries in the Tibetan gene pool, indicating a genetic continuity between pre-historical highland-foragers and presentday Tibetans. In particular, highly differentiated sequences harbored in highlanders' genomes were most likely inherited from pre-LGM settlers of multiple ancestral origins (SUNDer) and maintained in high frequency by natural selection.	[Lu, Dongsheng; Lou, Haiyi; Yuan, Kai; Wang, Xiaoji; Wang, Yuchen; Zhang, Chao; Lu, Yan; Yang, Xiong; Deng, Lian; Zhou, Ying; Feng, Qidi; Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Max Planck Independent Res, Shanghai 200031, Peoples R China; [Lu, Dongsheng; Yuan, Kai; Wang, Xiaoji; Wang, Yuchen; Zhang, Chao; Yang, Xiong; Deng, Lian; Zhou, Ying; Feng, Qidi; Xu, Shuhua] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Xiaoji; Xu, Shuhua] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Hu, Ya; Ding, Qiliang; Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Hu, Ya; Ding, Qiliang; Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, Minist Educ, Sch Life Sci, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Guan, Yaqun] Xinjiang Med Univ, Dept Biochem & Mol Biol, Preclin Med Coll, Urumqi 830011, Peoples R China; [Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Kang, Longli] Xizang Minzu Univ, Sch Med, Key Lab Mol Genet Mech & Intervent Res High Altit, Xianyang 712082, Shaanxi, Peoples R China; [Xu, Shuhua] Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Fudan University; Xinjiang Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Xizang Minzu University	Xu, SH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Max Planck Independent Res, Shanghai 200031, Peoples R China.; Xu, SH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Xu, SH (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China.; Xu, SH (corresponding author), Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China.	xushua@picb.ac.cn	Jin, Li/C-1468-2009; Zhou, Ying/AAT-2949-2020; XU, SHUHUA/D-5345-2009; Jin, Li/M-5063-2019; Zhang, Chao/HHN-2713-2022; Xu, Shuhua/AAH-7620-2020	Jin, Li/0000-0002-4546-2415; Zhou, Ying/0000-0002-8107-3927; XU, SHUHUA/0000-0002-1975-1002; Zhang, Chao/0000-0002-0687-9058; Xu, Shuhua/0000-0002-1975-1002; Yuan, Kai/0000-0002-8460-6581	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB13040100]; National Natural Science Foundation of China [91331204, 31501011, 31601046, 31260252, 31460286, 31260263]; National Science Fund for Distinguished Young Scholars [31525014]; Program of Shanghai Academic Research Leader [16XD1404700]; Science and Technology Commission of Shanghai Municipality [14YF1406800, 16YF1413900]; National High-Tech Research and Development Program [2012AA021802]; National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA021802, R00AA021802] Funding Source: NIH RePORTER	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program of Shanghai Academic Research Leader; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work acknowledges financial support from the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) (XDB13040100 to S.X.), the National Natural Science Foundation of China (91331204 to S.X., 31501011 to Y.L., 31601046 to H.L., 31260252 and 31460286 to L.K., and 31260263 to Y.G.), the National Science Fund for Distinguished Young Scholars (31525014 to S.X.), the Program of Shanghai Academic Research Leader (16XD1404700 to S.X.), the Science and Technology Commission of Shanghai Municipality (14YF1406800 to Y.L. and 16YF1413900 to H.L.), and the National High-Tech Research and Development Program (2012AA021802 to Y.Y.). S.X. is a Max Planck Independent Research Group Leader and a member of the CAS Youth Innovation Promotion Association. S.X. also gratefully acknowledges support from the National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project. We thank Dr. Mark Stoneking for his helpful discussion and Dr. Yundi Chen and his colleagues from WuxiNextCODE for their technical assistance during whole-genome sequencing. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bhandari S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16249; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding QL, 2014, MOL BIOL EVOL, V31, P1994, DOI 10.1093/molbev/msu180; Ding QL, 2014, MOL BIOL EVOL, V31, P683, DOI 10.1093/molbev/mst260; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hu Y, 2015, MOL BIOL EVOL, V32, P3108, DOI 10.1093/molbev/msv176; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Kang LL, 2013, MOL BIOL EVOL, V30, P2579, DOI 10.1093/molbev/mst147; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lou HY, 2015, AM J HUM GENET, V97, P54, DOI 10.1016/j.ajhg.2015.05.005; Martin AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004549; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nachman MW, 2000, GENETICS, V156, P297; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vemot B, 2014, SCIENCE, V343, P1017; Wang W. S.-Y., 1998, ORIGINS MODERN HUMAN, P247; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	57	126	132	11	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					580	594		10.1016/j.ajhg.2016.07.002	http://dx.doi.org/10.1016/j.ajhg.2016.07.002			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569548	Green Published, Bronze			2022-12-18	WOS:000383114800005
J	Adam, R; Spier, I; Zhao, B; Kloth, M; Marquez, J; Hinrichsen, I; Kirfel, J; Tafazzoli, A; Horpaopan, S; Uhlhaas, S; Stienen, D; Friedrichs, N; Altmuller, J; Laner, A; Holzapfel, S; Peters, S; Kayser, K; Thiele, H; Holinski-Feder, E; Marra, G; Kristiansen, G; Nothen, MM; Buttner, R; Moslein, G; Betz, RC; Brieger, A; Lifton, RP; Aretz, S				Adam, Ronja; Spier, Isabel; Zhao, Bixiao; Kloth, Michael; Marquez, Jonathan; Hinrichsen, Inga; Kirfel, Jutta; Tafazzoli, Aylar; Horpaopan, Sukanya; Uhlhaas, Siegfried; Stienen, Dietlinde; Friedrichs, Nicolaus; Altmueller, Janine; Laner, Andreas; Holzapfel, Stefanie; Peters, Sophia; Kayser, Katrin; Thiele, Holger; Holinski-Feder, Elke; Marra, Giancarlo; Kristiansen, Glen; Noethen, Markus M.; Buettner, Reinhard; Moeslein, Gabriela; Betz, Regina C.; Brieger, Angela; Lifton, Richard P.; Aretz, Stefan			Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISMATCH REPAIR FUNCTION; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; TETRANUCLEOTIDE REPEATS; CANCER PREDISPOSITION; GENETIC INSTABILITY; PROTEIN EXPRESSION; CANDIDATE GENES; RARE VARIANTS; COLON-CANCER	In similar to 30% of families affected by colorectal adenomatous polyposis, no germline mutations have been identified in the previously implicated genes APC, MUTYH, POLE, POLD1, and NTHL1, although a hereditary etiology is likely. To uncover further genes with high-penetrance causative mutations, we performed exome sequencing of leukocyte DNA from 102 unrelated individuals with unexplained adenomatous polyposis. We identified two unrelated individuals with differing compound- heterozygous loss-of-function (LoF) germline mutations in the mismatch-repair gene MSH3. The impact of the MSH3 mutations (c.1148delA, c.2319 -1G> A, c.2760delC, and c.3001-2A>C) was indicated at the RNA and protein levels. Analysis of the diseased individuals' tumor tissue demonstrated high microsatellite instability of di-and tetranucleotides (EMAST), and immunohistochemical staining illustrated a complete loss of nuclear MSH3 in normal and tumor tissue, confirming the LoF effect and causal relevance of the mutations. The pedigrees, genotypes, and frequency of MSH3 mutations in the general population are consistent with an autosomal-recessive mode of inheritance. Both index persons have an affected sibling carrying the same mutations. The tumor spectrum in these four persons comprised colorectal and duodenal adenomas, colorectal cancer, gastric cancer, and an early-onset astrocytoma. Additionally, we detected one unrelated individual with biallelic PMS2 germline mutations, representing constitutional mismatch-repair deficiency. Potentially causative variants in 14 more candidate genes identified in 26 other individuals require further workup. In the present study, we identified biallelic germline MSH3 mutations in individuals with a suspected hereditary tumor syndrome. Our data suggest that MSH3 mutations represent an additional recessive subtype of colorectal adenomatous polyposis.	[Adam, Ronja; Spier, Isabel; Tafazzoli, Aylar; Horpaopan, Sukanya; Uhlhaas, Siegfried; Stienen, Dietlinde; Holzapfel, Stefanie; Peters, Sophia; Kayser, Katrin; Noethen, Markus M.; Betz, Regina C.; Aretz, Stefan] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Adam, Ronja; Spier, Isabel; Holzapfel, Stefanie; Aretz, Stefan] Univ Bonn, Ctr Hereditary Tumor Syndromes, D-53127 Bonn, Germany; [Zhao, Bixiao; Marquez, Jonathan; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; [Kloth, Michael; Friedrichs, Nicolaus; Buettner, Reinhard] Univ Cologne, Inst Pathol, D-50937 Cologne, Germany; [Hinrichsen, Inga; Brieger, Angela] Goethe Univ Frankfurt, Biomed Res Lab, Med Clin 1, D-60590 Frankfurt, Germany; [Kirfel, Jutta; Kristiansen, Glen] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany; [Tafazzoli, Aylar; Noethen, Markus M.; Betz, Regina C.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Horpaopan, Sukanya] Naresuan Univ, Fac Med Sci, Dept Anat, Chiang Mai 50200, Thailand; [Altmueller, Janine; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50937 Cologne, Germany; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50937 Cologne, Germany; [Laner, Andreas; Holinski-Feder, Elke] Univ Munich, Med Klin & Poliklin 4, D-80336 Munich, Germany; [Laner, Andreas; Holinski-Feder, Elke] Ctr Med Genet, D-80335 Munich, Germany; [Marra, Giancarlo] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Moeslein, Gabriela] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, D-42283 Wuppertal, Germany	University of Bonn; University of Bonn; Howard Hughes Medical Institute; Yale University; University of Cologne; Goethe University Frankfurt; University of Bonn; University of Bonn; Naresuan University; University of Cologne; University of Cologne; University of Munich; University of Zurich; Helios Kliniken; Witten Herdecke University	Aretz, S (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.; Aretz, S (corresponding author), Univ Bonn, Ctr Hereditary Tumor Syndromes, D-53127 Bonn, Germany.	stefan.aretz@uni-bonn.de	Betz, Regina C/E-8591-2011; Aretz, Stefan/C-1241-2008; Thiele, Holger/ABE-6792-2020; Wang, Guilin/G-8794-2018	Betz, Regina C/0000-0001-5024-3623; Aretz, Stefan/0000-0002-5228-1890; Thiele, Holger/0000-0002-0169-998X; Zhao, Bixiao/0000-0002-1775-1690; Nothen, Markus/0000-0002-8770-2464; Altmuller, Janine/0000-0003-4372-1521; Marquez, Jonathan/0000-0003-3377-7599	German Cancer Aid (Deutsche Krebshilfe, Bonn) [108421]; Gerok-Stipendium of the University Hospital Bonn [O-149.0098]; NIH Centers for Mendelian Genomics [5U54HG006504]; German Research Foundation (Deutsche Forschungsgemeinschaft); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	German Cancer Aid (Deutsche Krebshilfe, Bonn); Gerok-Stipendium of the University Hospital Bonn; NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the individuals and their families for participating in the study and Prof. Grazia Graziani (University of Rome Tor Vergata, Italy) for generously providing the pcDNA3.1<SUP>-</SUP>/MSH3-WT vector. This work was supported by the German Cancer Aid (grant no. 108421, Deutsche Krebshilfe, Bonn), the Gerok-Stipendium of the University Hospital Bonn (grant no. O-149.0098), and NIH Centers for Mendelian Genomics (5U54HG006504). R.C.B. and M.M.N. are members of the Excellence Cluster ImmunoSensation, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft). The funding sources had no involvement in the study design; the collection, analysis, or interpretation of data; the writing of the report; or the decision to submit the paper for publication. The corresponding author (S.A.) had full access to all data in the study and had final responsibility for the decision to submit the manuscript for publication.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Arai H, 2013, INT J CLIN EXP PATHO, V6, P395; Aretz S, 2005, J MED GENET, V42, P185, DOI 10.1136/jmg.2004.022822; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bellizzi AM, 2009, ADV ANAT PATHOL, V16, P405, DOI 10.1097/PAP.0b013e3181bb6bdc; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; Boland CR, 1998, CANCER RES, V58, P5248; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Burger M, 2006, EUR UROL, V50, P770, DOI 10.1016/j.eururo.2006.04.010; Campregher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050541; Carethers JM, 2015, GENES-BASEL, V6, P185, DOI 10.3390/genes6020185; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Dallosso AR, 2008, GUT, V57, P1252, DOI 10.1136/gut.2007.145748; Danaee H, 2002, ONCOGENE, V21, P4894, DOI 10.1038/sj.onc.1205619; de Voer RM, 2013, GASTROENTEROLOGY, V145, P544, DOI 10.1053/j.gastro.2013.06.001; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duraturo F, 2011, INT J CANCER, V129, P1643, DOI 10.1002/ijc.25824; Durno CA, 2015, EUR J CANCER, V51, P977, DOI 10.1016/j.ejca.2015.02.008; Edelmann L, 2004, AM J MED GENET C, V129C, P91, DOI 10.1002/ajmg.c.30021; Edelmann W, 2000, CANCER RES, V60, P803; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; FUJII H, 1989, J BIOL CHEM, V264, P10057; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Grover S, 2012, JAMA-J AM MED ASSOC, V308, P485, DOI 10.1001/jama.2012.8780; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hegan DC, 2006, CARCINOGENESIS, V27, P2402, DOI 10.1093/carcin/bgl079; Herkert JC, 2011, EUR J CANCER, V47, P965, DOI 10.1016/j.ejca.2011.01.013; Hes FJ, 2014, J MED GENET, V51, P55, DOI 10.1136/jmedgenet-2013-102000; Hile SE, 2013, MUTAT RES-FUND MOL M, V743, P67, DOI 10.1016/j.mrfmmm.2012.11.003; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Horpaopan S, 2015, INT J CANCER, V136, pE578, DOI 10.1002/ijc.29215; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Jafary F, 2012, ASIAN PAC J CANCER P, V13, P6055, DOI 10.7314/APJCP.2012.13.12.6055; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kloth M, 2016, GUT, V65, P1296, DOI 10.1136/gutjnl-2014-309026; Knudsen Anne Lyster, 2003, Fam Cancer, V2, P43, DOI 10.1023/A:1023286520725; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Lavoine N, 2015, J MED GENET, V52, P770, DOI 10.1136/jmedgenet-2015-103299; Lefevre JH, 2012, J HUM GENET, V57, P709, DOI 10.1038/jhg.2012.99; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Mazzei F, 2013, MUTAT RES-FUND MOL M, V743, P33, DOI 10.1016/j.mrfmmm.2013.03.003; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Mongin C, 2012, CLIN GENET, V81, P38, DOI 10.1111/j.1399-0004.2011.01676.x; Niessen RC, 2009, GENE CHROMOSOME CANC, V48, P737, DOI 10.1002/gcc.20678; Ohmiya N, 2001, GENE, V272, P301, DOI 10.1016/S0378-1119(01)00517-0; Orimo H, 2000, J HUM GENET, V45, P228, DOI 10.1007/s100380070031; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Plaschke J, 2012, INT J COLORECTAL DIS, V27, P911, DOI 10.1007/s00384-011-1408-0; Renkonen ET, 2005, J CLIN ONCOL, V23, P5651, DOI 10.1200/JCO.2005.14.712; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Rivera B, 2015, NEW ENGL J MED, V373, P1985, DOI 10.1056/NEJMc1506878; Segui N, 2015, GASTROENTEROLOGY, V149, P563, DOI 10.1053/j.gastro.2015.05.056; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Spier I, 2016, FAM CANCER, V15, P281, DOI 10.1007/s10689-016-9870-z; Spier I, 2016, J MED GENET, V53, P172, DOI 10.1136/jmedgenet-2015-103468; Spier I, 2015, INT J CANCER, V137, P320, DOI 10.1002/ijc.29396; Spier I, 2012, HUM MUTAT, V33, P1045, DOI 10.1002/humu.22082; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Tentori L, 2013, CANCER CHEMOTH PHARM, V72, P117, DOI 10.1007/s00280-013-2175-0; Thirlwell C, 2007, BRIT J CANCER, V96, P1729, DOI 10.1038/sj.bjc.6603789; Tieu AH, 2016, J CLIN GASTROENTEROL, V50, P584, DOI 10.1097/MCG.0000000000000416; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616; Valle L, 2014, HUM MOL GENET, V23, P3506, DOI 10.1093/hmg/ddu058; Vaughn CP, 2010, HUM MUTAT, V31, P588, DOI 10.1002/humu.21230; Venesio T, 2003, LAB INVEST, V83, P1859, DOI 10.1097/01.LAB.0000106722.37873.8D; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Will O, 2007, GASTROENTEROLOGY, V132, P527, DOI 10.1053/j.gastro.2006.11.043; Yang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125571; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109	82	126	127	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					337	351		10.1016/j.ajhg.2016.06.015	http://dx.doi.org/10.1016/j.ajhg.2016.06.015			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27476653	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000381617200006
J	McMillin, MJ; Beck, AE; Chong, JX; Shively, KM; Buckingham, KJ; Gildersleeve, HIS; Aracena, MI; Aylsworth, AS; Bitoun, P; Carey, JC; Clericuzio, CL; Crow, YJ; Curry, CJ; Devriendt, K; Everman, DB; Fryer, A; Gibson, K; Uzielli, MLG; Graham, JM; Hall, JG; Hecht, JT; Heidenreich, RA; Hurst, JA; Irani, S; Krapels, IPC; Leroy, JG; Mowat, D; Plant, GT; Robertson, SP; Schorry, EK; Scott, RH; Seaver, LH; Sherr, E; Splitt, M; Stewart, H; Stumpel, C; Temel, SG; Weaver, DD; Whiteford, M; Williams, MS; Tabor, HK; Smith, JD; Shendure, J; Nickerson, DA; Washington, U; Bamshad, MJ				McMillin, Margaret J.; Beck, Anita E.; Chong, Jessica X.; Shively, Kathryn M.; Buckingham, Kati J.; Gildersleeve, Heidi I. S.; Aracena, Mariana I.; Aylsworth, Arthur S.; Bitoun, Pierre; Carey, John C.; Clericuzio, Carol L.; Crow, Yanick J.; Curry, Cynthia J.; Devriendt, Koenraad; Everman, David B.; Fryer, Alan; Gibson, Kate; Uzielli, Maria Luisa Giovannucci; Graham, John M., Jr.; Hall, Judith G.; Hecht, Jacqueline T.; Heidenreich, Randall A.; Hurst, Jane A.; Irani, Sarosh; Krapels, Ingrid P. C.; Leroy, Jules G.; Mowat, David; Plant, Gordon T.; Robertson, Stephen P.; Schorry, Elizabeth K.; Scott, Richard H.; Seaver, Laurie H.; Sherr, Elliott; Splitt, Miranda; Stewart, Helen; Stumpel, Constance; Temel, Sehime G.; Weaver, David D.; Whiteford, Margo; Williams, Marc S.; Tabor, Holly K.; Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Washington, Univ; Bamshad, Michael J.			Mutations in PIEZO2 Cause Gordon Syndrome, Marden-Walker Syndrome, and Distal Arthrogryposis Type 5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AASE-SMITH-SYNDROME; CLEFT-PALATE; MULTIPLEX CONGENITA; CLUB FEET; SPECTRUM; IIB; DELINEATION; FAMILY	Gordon syndrome (GS), or distal arthrogyposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet. Exome sequencing of five GS-affected families identified mutations in piezo-type mechano-sensitive ion channel component 2 (PIEZO2) in each family. Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation. The phenotype of GS overlaps with distal arthrogryposis type 5 (DA5) and Marden-Walker syndrome (MWS). Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families. The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001). Collectively, although GS, DA5, and MWS have traditionally been considered separate disorders, our findings indicate that they are etiologically related and perhaps represent variable expressivity of the same condition.	[McMillin, Margaret J.; Beck, Anita E.; Chong, Jessica X.; Shively, Kathryn M.; Buckingham, Kati J.; Gildersleeve, Heidi I. S.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Beck, Anita E.; Tabor, Holly K.; Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Aracena, Mariana I.] Hosp Dr Luis Calvo Mackenna, Genet Unit, Santiago 7500539, Chile; [Aracena, Mariana I.] Pontificia Univ Catolica Chile, Div Pediat, Santiago 8330074, Chile; [Aylsworth, Arthur S.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Aylsworth, Arthur S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Bitoun, Pierre] Hop Jean Verdier, AP HP, Serv Pediat, F-93143 Bondy, France; [Carey, John C.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Clericuzio, Carol L.; Heidenreich, Randall A.] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Crow, Yanick J.] Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Crow, Yanick J.] Univ Manchester, Manchester M13 9NT, Lancs, England; [Curry, Cynthia J.] Univ Calif San Francisco, Fresno, CA 93701 USA; [Devriendt, Koenraad] Univ Hosp KU Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Fryer, Alan] Alder Hey Childrens Hosp, Dept Clin Genet, Liverpool L12 2AP, Merseyside, England; [Gibson, Kate] Christchurch Hosp, Genet Hlth Serv New Zealand, Christchurch 8140, New Zealand; [Uzielli, Maria Luisa Giovannucci] Univ Florence, Dipartimento Sci Salute, I-50132 Florence, Italy; [Graham, John M., Jr.] Cedars Sinai Med Ctr, Div Clin Genet & Dysmorphol, Los Angeles, CA 90048 USA; [Hall, Judith G.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Hall, Judith G.] Univ British Columbia, Dept Pediat, Vancouver, BC V6H 3N1, Canada; [Hall, Judith G.] BC Childrens Hosp, Vancouver, BC V6H 3N1, Canada; [Hecht, Jacqueline T.] Univ Texas Med Sch, Dept Pediat, Houston, TX 77030 USA; [Hurst, Jane A.; Scott, Richard H.] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3BH, England; [Irani, Sarosh] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Krapels, Ingrid P. C.; Stumpel, Constance] Maastricht UMC, Dept Clin Genet, Sch Oncol & Dev Biol, NL-6229 GR Maastricht, Netherlands; [Leroy, Jules G.] Ghent Univ Hosp, Princess Elisabeth Childrens Hosp, B-9000 Ghent, Belgium; [Mowat, David] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW 2031, Australia; [Mowat, David] Univ New S Wales, UNSW Med, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Plant, Gordon T.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Robertson, Stephen P.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin 9054, New Zealand; [Schorry, Elizabeth K.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Seaver, Laurie H.] Univ Hawaii, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96826 USA; [Sherr, Elliott] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Splitt, Miranda] Inst Med Genet, Northern Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Stewart, Helen] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Clin Genet, Oxford 0X3 7LJ, England; [Temel, Sehime G.] Uludag Univ, Fac Med, Dept Med Genet, TR-16059 Bursa, Turkey; [Temel, Sehime G.] Uludag Univ, Fac Med, Dept Histol & Embryol, TR-16059 Bursa, Turkey; [Temel, Sehime G.] Near East Univ, Fac Med, Dept Histol & Embryol, TR-10 Trnc Mersin, Turkey; [Weaver, David D.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Whiteford, Margo] So Gen Hosp, Dept Clin Genet, Glasgow G51 4TF, Lanark, Scotland; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Tabor, Holly K.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Pontificia Universidad Catolica de Chile; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Utah System of Higher Education; University of Utah; University of New Mexico; University of Manchester; University of Manchester; University of California System; University of California San Francisco; University of California San Francisco at Fresno; KU Leuven; University Hospital Leuven; Greenwood Genetic Center; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Christchurch Hospital New Zealand; University of Florence; Cedars Sinai Medical Center; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Texas System; University of Texas Health Science Center Houston; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; Maastricht University; Maastricht University Medical Centre (MUMC); Ghent University; Ghent University Hospital; University of Sydney; University of New South Wales Sydney; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Otago; Cincinnati Children's Hospital Medical Center; University of Hawaii System; University of California System; University of California San Francisco; Newcastle University - UK; Oxford University Hospitals NHS Foundation Trust; Uludag University; Uludag University; Near East University; Indiana University System; Indiana University Bloomington; University of Glasgow; Geisinger Health System; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@uw.edu	Temel, Sehime/AAG-8385-2021; Graham, John M./J-1429-2019; Beck, Anita E./AAS-8775-2021; Chong, Jessica/GZH-1625-2022; Shendure, Jay/AAU-3684-2021; Irani, Sarosh/AAO-6911-2020; Crow, Yanick J/N-6120-2014	Beck, Anita E./0000-0002-7965-0326; Irani, Sarosh/0000-0002-7667-9748; Crow, Yanick J/0000-0001-7211-7564; Chong, Jessica/0000-0002-1616-2448; Shendure, Jay/0000-0002-1516-1865; Hall, Judith G./0000-0001-5062-491X; Bitoun, Pierre/0000-0001-6557-6826; Robertson, Stephen/0000-0002-5181-7809; Temel, Sehime G/0000-0002-9802-0880	NIH National Human Genome Research Institute [1U54HG006493, 1RC2HG005608, 5R000HG004316]; NIH National Institute of Child Health and Human Development [1R01HD048895, 5K23HD057331]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057331, R01HD048895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, R00HG004316, U54HG006493, UM1HG006493] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Life Sciences Discovery Fund; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and support, Paul Frisby and Rosanna Pallotta for referral of affected individuals, and Christa Poel for technical assistance. Our work was supported in part by grants from the NIH National Human Genome Research Institute (1U54HG006493 to M.J.B., D.A.N., and J.S.; 1RC2HG005608 to M.J.B., D.A.N., and J.S.; 5R000HG004316 to H.K.T.), the NIH National Institute of Child Health and Human Development (1R01HD048895 to M.J.B.; 5K23HD057331 to A.E.B.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation.	AlGhamdi MA, 1997, AM J MED GENET, V71, P401, DOI 10.1002/(SICI)1096-8628(19970905)71:4<401::AID-AJMG6>3.0.CO;2-W; Altman HS, 1939, J PEDIATR-US, V15, P551, DOI 10.1016/S0022-3476(39)80012-9; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; Becker K, 2001, CLIN DYSMORPHOL, V10, P41, DOI 10.1097/00019605-200101000-00009; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2011, M S-MED SCI, V27, P17, DOI 10.1051/medsci/201127117; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; FRIEDMAN BD, 1995, AM J MED GENET, V58, P125, DOI 10.1002/ajmg.1320580207; Fryns JP, 1998, CLIN GENET, V54, P86; GORDON H, 1969, Journal of Medical Genetics, V6, P266, DOI 10.1136/jmg.6.3.266; Gripp KW, 1996, AM J MED GENET, V65, P286, DOI 10.1002/(SICI)1096-8628(19961111)65:4<286::AID-AJMG8>3.3.CO;2-R; HALAL F, 1979, J MED GENET, V16, P149, DOI 10.1136/jmg.16.2.149; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; HIGGINS JV, 1972, AM J HUM GENET, V24, pA58; IOAN DM, 1993, CLIN GENET, V43, P300; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; LAI MMR, 1991, J MED GENET, V28, P701, DOI 10.1136/jmg.28.10.701; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pallotta R, 2000, AM J MED GENET, V95, P477, DOI 10.1002/1096-8628(20001218)95:5<477::AID-AJMG13>3.0.CO;2-M; PATTON MA, 1985, CLIN GENET, V28, P521; ROBINOW M, 1981, AM J MED GENET, V9, P139, DOI 10.1002/ajmg.1320090208; Sahni J, 2004, AM J MED GENET A, V127A, P35, DOI 10.1002/ajmg.a.20634; SAY B, 1980, J MED GENET, V17, P405, DOI 10.1136/jmg.17.5.405; SCHRANDERSTUMPEL CTRM, 1993, J MED GENET, V30, P78, DOI 10.1136/jmg.30.1.78; Williams M S, 1993, Clin Dysmorphol, V2, P211; Williams MS, 2007, AM J MED GENET A, V143A, P752, DOI 10.1002/ajmg.a.31648	32	126	137	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					734	744		10.1016/j.ajhg.2014.03.015	http://dx.doi.org/10.1016/j.ajhg.2014.03.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24726473	Green Published, Bronze			2022-12-18	WOS:000335485700007
J	Ghezzi, D; Baruffini, E; Haack, TB; Invernizzi, F; Melchionda, L; Dallabona, C; Strom, TM; Parini, R; Burlina, AB; Meitinger, T; Prokisch, H; Ferrero, I; Zeviani, M				Ghezzi, Daniele; Baruffini, Enrico; Haack, Tobias B.; Invernizzi, Federica; Melchionda, Laura; Dallabona, Cristina; Strom, Tim M.; Parini, Rossella; Burlina, Alberto B.; Meitinger, Thomas; Prokisch, Holger; Ferrero, Ileana; Zeviani, Massimo			Mutations of the Mitochondrial-tRNA Modifier MTO1 Cause Hypertrophic Cardiomyopathy and Lactic Acidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENCY; GENE; PATHOGENESIS; EXPRESSION; DEAFNESS; ACAD9	Dysfunction of mitochondrial respiration is an increasingly recognized cause of isolated hypertrophic cardiomyopathy. To gain insight into the genetic origin of this condition, we used next-generation exome sequencing to identify mutations in MTO1, which encodes mitochondrial translation optimization 1. Two affected siblings carried a maternal c.1858dup (p.Arg620Lysfs(star)8) frameshift and a paternal c.1282G>A (p.Ala428Thr) missense mutation. A third unrelated individual was homozygous for the latter change. In both humans and yeast, MTO1 increases the accuracy and efficiency of mtDNA translation by catalyzing the 5-carboxymethylaminomethylation of the wobble uridine base in three mitochondrial tRNAs (mt-tRNAs). Accordingly, mutant muscle and fibroblasts showed variably combined reduction in mt DNA-dependent respiratory chain activities. Reduced respiration in mutant cells was corrected by expressing a wild-type MTO1 cDNA. Conversely, defective respiration of a yeast mto1 Delta strain failed to be corrected by an Mto1(Pro622 star) variant, equivalent to human MTO1(Arg620Lysfs star 8) whereas incomplete correction was achieved by an Mto1(Ala431Thr) variant, corresponding to human MTO1(Ala28Thr). The respiratory yeast phenotype was dramatically worsened in stress conditions and in the presence of a paromomycin-resistant (P-R) mitochondrial rRNA mutation. Lastly, in vivo mtDNA translation was impaired in the mutant yeast strains.	[Ghezzi, Daniele; Invernizzi, Federica; Melchionda, Laura; Zeviani, Massimo] Fdn IRCCS, Unit Mol Neurogenet, Ist Neurol Carlo Besta, I-20126 Milan, Italy; [Baruffini, Enrico; Dallabona, Cristina; Ferrero, Ileana] Univ Parma, Dept Genet Biol Microorganisms Anthropol & Evolut, I-43124 Parma, Italy; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80333 Munich, Germany; [Parini, Rossella] Univ Milano Bicocca, San Gerardo Hosp, Pediat Clin, Rare Metab Dis Unit, I-20090 Monza, Italy; [Burlina, Alberto B.] Univ Padua, Sch Med, Dept Pediat, Metab Dis Unit, I-35128 Padua, Italy	IRCCS Istituto Neurologico Besta; University of Parma; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; San Gerardo Hospital; University of Milano-Bicocca; University of Padua	Zeviani, M (corresponding author), Fdn IRCCS, Unit Mol Neurogenet, Ist Neurol Carlo Besta, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Baruffini, Enrico/AAL-2608-2020; Meitinger, Thomas/O-1318-2015; Ghezzi, Daniele/J-7873-2016; Baruffini, Enrico/C-1057-2015; Zeviani, Massimo/AAU-2632-2021; Invernizzi, Federica/J-9849-2016; Zeviani, Massimo/K-2891-2014; Parini, Rossella/J-9202-2018; Prokisch, Holger/N-8964-2013; burlina, alberto/AHE-6095-2022	Baruffini, Enrico/0000-0002-8280-7849; Ghezzi, Daniele/0000-0002-6564-3766; Baruffini, Enrico/0000-0002-8280-7849; Zeviani, Massimo/0000-0002-9067-5508; Invernizzi, Federica/0000-0001-8072-0152; Parini, Rossella/0000-0003-4505-1306; Prokisch, Holger/0000-0003-2379-6286; Meitinger, Thomas/0000-0002-8838-8403; DALLABONA, Cristina/0000-0003-4397-9143	Pierfranco and Luisa Mariani Foundation of Italy; Fondazione Telethon [GGP11011, GPP10005]; CARIPLO [2011/0526]; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]; German Federal Ministry of Education and Research (BMBF) [SysMBo 0315494A]; German Network for Mitochondrial Disorders [mitoNET 01GM0867, 01GM0862]; E-Rare grant [GenoMit JTC2011]	Pierfranco and Luisa Mariani Foundation of Italy; Fondazione Telethon(Fondazione TelethonEuropean Commission); CARIPLO(Fondazione Cariplo); Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Helmholtz Alliance for Mental Health in an Ageing Society; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders; E-Rare grant	We thank Alexander Tzagoloff for the generous gift of the P<SUP>R</SUP> yeast strain. We are grateful to Erika Fernandez-Vizarra for help with the in vivo translation assay, to Alessia Nasca for the screening of the Italian DNA control samples, and to Ilaria D'Amato for technical support with microscale oxygraphy. This work was supported by the Pierfranco and Luisa Mariani Foundation of Italy; Fondazione Telethon grants GGP11011 and GPP10005; CARIPLO grant 2011/0526; the Italian Association of Mitochondrial Disease Patients and Families (Mitocon); the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215) and the German Federal Ministry of Education and Research (BMBF)-funded Systems Biology of Metabotypes grant (SysMBo 0315494A); the German Network for Mitochondrial Disorders (mitoNET 01GM0867 and 01GM0862); and E-Rare grant GenoMit JTC2011.	Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; BURLINA AB, 1993, EUR J PEDIATR, V152, P537, DOI 10.1007/BF01955069; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; Fernandez-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2; Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	24	126	129	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1079	1087		10.1016/j.ajhg.2012.04.011	http://dx.doi.org/10.1016/j.ajhg.2012.04.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608499	Green Published, hybrid			2022-12-18	WOS:000305262600012
J	Hussain, MS; Baig, SM; Neumann, S; Nurnberg, G; Farooq, M; Ahmad, I; Alef, T; Hennies, HC; Technau, M; Altmuller, J; Frommolt, P; Thiele, H; Noegel, AA; Nurnberg, P				Hussain, Muhammad Sajid; Baig, Shahid Mahmood; Neumann, Sascha; Nuernberg, Gudrun; Farooq, Muhammad; Ahmad, Ilyas; Alef, Thomas; Hennies, Hans Christian; Technau, Martin; Altmueller, Janine; Frommolt, Peter; Thiele, Holger; Noegel, Angelika Anna; Nuernberg, Peter			A Truncating Mutation of CEP135 Causes Primary Microcephaly and Disturbed Centrosomal Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME SEGREGATION; PROTEIN; CENTRIOLE; CDK5RAP2; SIZE; PRIORITIZATION; LOCALIZATION; CARTWHEEL; BLD10P; BRAIN	Autosomal-recessive primary microcephaly (MCPH) is a rare congenital disorder characterized by intellectual disability, reduced brain and head size, but usually without defects in cerebral cortical architecture, and other syndromic abnormalities. MCPH is heterogeneous. The underlying genes of the seven known loci code for centrosomal proteins. We studied a family from northern Pakistan with two microcephalic children using homozygosity mapping and found suggestive linkage for regions on chromosomes 2, 4, and 9. We sequenced two positional candidate genes and identified a homozygous frameshift mutation in the gene encoding the 135 kDa centrosomal protein (CEP135), located in the linkage interval on chromosome 4, in both affected children. Post hoc whole-exome sequencing corroborated this mutation's identification as the causal variant. Fibroblasts obtained from one of the patients showed multiple and fragmented centrosomes, disorganized microtubules, and reduced growth rate. Similar effects were reported after knockdown of CEP135 through RNA interference; we could provoke them also by ectopic overexpression of the mutant protein. Our findings suggest an additional locus for MCPH at HSA 4q12 (MCPH8), further strengthen the role of centrosomes in the development of MCPH, and place CEP135 among the essential components of this important organelle in particular for a normal neurogenesis.	[Hussain, Muhammad Sajid; Nuernberg, Gudrun; Ahmad, Ilyas; Alef, Thomas; Hennies, Hans Christian; Altmueller, Janine; Frommolt, Peter; Thiele, Holger; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Hussain, Muhammad Sajid; Neumann, Sascha; Technau, Martin; Noegel, Angelika Anna] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Hussain, Muhammad Sajid; Nuernberg, Gudrun; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Hussain, Muhammad Sajid; Baig, Shahid Mahmood; Farooq, Muhammad; Ahmad, Ilyas] NIBGE, Hlth Biotechnol Div, Faisalabad 38000, Pakistan	University of Cologne; University of Cologne; University of Cologne; Pakistan Institute of Engineering & Applied Science	Noegel, AA (corresponding author), Univ Cologne, CCG, D-50931 Cologne, Germany.	noegel@uni-koeln.de; nuernberg@uni-koeln.de	Hennies, Hans C/G-9424-2014; Frommolt, Peter/L-9656-2016; Ahmad, Ilyas/AAT-6577-2021; Thiele, Holger/ABE-6792-2020; BAig, Shahid Mahmood/AAS-8365-2020; Baig, Shahid Mahmood/I-7309-2015	Hennies, Hans C/0000-0001-7210-2389; Frommolt, Peter/0000-0002-1966-8014; Ahmad, Ilyas/0000-0003-4845-9227; Thiele, Holger/0000-0002-0169-998X; Alef, Thomas/0000-0002-9084-5722; Altmuller, Janine/0000-0003-4372-1521; Hussain, Muhammad Sajid/0000-0002-1353-8809	Higher Education Commission (HEC) of Pakistan; German Academic Exchange Service (DAAD); Center for Molecular Medicine Cologne (CMMC)	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Center for Molecular Medicine Cologne (CMMC)	We are grateful to all family members for their participation in this study. We wish to thank Ursula Euteneuer and Ludwig Eichinger for helpful discussion and Ingelore Bassmann, Martina Munck, and Alexandra Herzog for technical assistance. P.N. is a founder, CEO, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a service provider for genomic analyses. This work was supported by grants from the Higher Education Commission (HEC) of Pakistan, the German Academic Exchange Service (DAAD), and the Center for Molecular Medicine Cologne (CMMC).	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Marchal JA, 2011, CELL CYCLE, V10, P2967, DOI 10.4161/cc.10.17.16871; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kim K, 2008, EXP CELL RES, V314, P3692, DOI 10.1016/j.yexcr.2008.09.016; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Uetake Y, 2004, CELL MOTIL CYTOSKEL, V58, P53, DOI 10.1002/cm.10175; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	29	126	132	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					871	878		10.1016/j.ajhg.2012.03.016	http://dx.doi.org/10.1016/j.ajhg.2012.03.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22521416	Green Published, Bronze			2022-12-18	WOS:000303907500011
J	Park, DJ; Lesueur, F; Nguyen-Dumont, T; Pertesi, M; Odefrey, F; Hammet, F; Neuhausen, SL; John, EM; Andrulis, IL; Terry, MB; Daly, M; Buys, S; Le Calvez-Kelm, F; Lonie, A; Pope, BJ; Tsimiklis, H; Voegele, C; Hilbers, FM; Hoogerbrugge, N; Barroso, A; Osorio, A; Giles, GG; Devilee, P; Benitez, J; Hopper, JL; Tavtigian, SV; Goldgar, DE; Southey, MC				Park, D. J.; Lesueur, F.; Nguyen-Dumont, T.; Pertesi, M.; Odefrey, F.; Hammet, F.; Neuhausen, S. L.; John, E. M.; Andrulis, I. L.; Terry, M. B.; Daly, M.; Buys, S.; Le Calvez-Kelm, F.; Lonie, A.; Pope, B. J.; Tsimiklis, H.; Voegele, C.; Hilbers, F. M.; Hoogerbrugge, N.; Barroso, A.; Osorio, A.; Giles, G. G.; Devilee, P.; Benitez, J.; Hopper, J. L.; Tavtigian, S. V.; Goldgar, D. E.; Southey, M. C.		Breast Canc Family Registry; Kathleen Cuningham Fdn Consortium	Rare Mutations in XRCC2 Increase the Risk of Breast Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; FAMILY REGISTRY; OVARIAN-CANCER; DNA-REPAIR; PROTEIN; ENCODES; RAD51C; BRCA2; CELLS	An exome-sequencing study of families with multiple breast-cancer-affected individuals identified two families with XRCC2 mutations, one with a protein-truncating mutation and one with a probably deleterious missense mutation. We performed a population-based case-control mutation-screening study that identified six probably pathogenic coding variants in 1,308 cases with early-onset breast cancer and no variants in 1,120 controls (the severity grading was p < 0.02). We also performed additional mutation screening in 689 multiple-case families. We identified ten breast-cancer-affected families with protein-truncating or probably deleterious rare missense variants in XRCC2. Our identification of XRCC2 as a breast cancer susceptibility gene thus increases the proportion of breast cancers that are associated with homologous recombination-DNA-repair dysfunction and Fanconi anemia and could therefore benefit from specific targeted treatments such as PARP (poly ADP ribose polymerase) inhibitors. This study demonstrates the power of massively parallel sequencing for discovering susceptibility genes for common, complex diseases.	[Park, D. J.; Nguyen-Dumont, T.; Odefrey, F.; Hammet, F.; Tsimiklis, H.; Southey, M. C.] Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Lesueur, F.; Pertesi, M.; Le Calvez-Kelm, F.; Voegele, C.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Neuhausen, S. L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [John, E. M.] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [John, E. M.] Stanford Canc Ctr Inst, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Andrulis, I. L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Terry, M. B.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Daly, M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Buys, S.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Lonie, A.; Pope, B. J.] Victorian Life Sci Computat Initiat, Carlton, Vic 3010, Australia; [Hilbers, F. M.; Devilee, P.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Hoogerbrugge, N.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Barroso, A.; Osorio, A.; Benitez, J.] Spanish Natl Canc Ctr, Human Canc Genet Program, Human Genet Grp, Madrid 28029, Spain; [Giles, G. G.] Canc Council Victoria, Ctr Canc Epidemiol, Carlton, Vic 3052, Australia; [Osorio, A.; Benitez, J.] Spanish Network Rare Dis, Valencia 46010, Spain; [Devilee, P.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Hopper, J. L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Tavtigian, S. V.] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Goldgar, D. E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA	University of Melbourne; World Health Organization; International Agency for Research on Cancer (IARC); City of Hope; Beckman Research Institute of City of Hope; Cancer Prevention Institute of California; Stanford Cancer Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Columbia University; Fox Chase Cancer Center; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Centro Nacional de Investigaciones Oncologicas (CNIO); Cancer Council Victoria; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Southey, MC (corresponding author), Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia.	msouthey@unimelb.edu.au	Hoogerbrugge, Nicoline/O-1016-2013; Osorio, Ana/I-4324-2014; Lonie, Andrew/F-3258-2017; Hilbers, Florentine/AAB-8162-2019; Andrulis, Irene L./E-7267-2013; DEVILEE, PETER/ABR-2140-2022; Lesueur, Fabienne/R-2178-2017; Devilee, Peter/GXV-8005-2022	Hoogerbrugge, Nicoline/0000-0003-2393-8141; Osorio, Ana/0000-0001-8124-3984; Lonie, Andrew/0000-0002-2006-3856; Hilbers, Florentine/0000-0002-6764-3102; Lesueur, Fabienne/0000-0001-7404-4549; Pope, Bernard/0000-0002-4840-1095; Terry, Mary Beth/0000-0002-4106-5033; Nguyen-Dumont, Tu/0000-0002-6217-0182; Park, Daniel/0000-0002-6354-0931; Southey, Melissa/0000-0002-6313-9005; Giles, Graham/0000-0003-4946-9099; Thorne, Heather/0000-0003-3610-2511; Le Calvez-Kelm, Florence/0000-0003-0063-5068	Cancer Council Victoria [628774]; National Institutes of Health [R01CA155767, R01CA121245]; Australian National Health and Medical Research Council [466668]; University of Melbourne; Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne [VR00353]; initiative of the Victorian Government; Dutch Cancer Society [UL 2009-4388]; Morris and Horowitz Families Endowment; Spanish Association Against Cancer and Health Ministry [FIS08/1120]; NATIONAL CANCER INSTITUTE [U01CA069631, R01CA121245, U01CA069638, U01CA069467, U01CA069446, U01CA069417, U01CA069398, R01CA155767] Funding Source: NIH RePORTER	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne; initiative of the Victorian Government; Dutch Cancer Society(KWF Kankerbestrijding); Morris and Horowitz Families Endowment; Spanish Association Against Cancer and Health Ministry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Council Victoria (grant 628774), the National Institutes of Health (R01CA155767 and R01CA121245), the Australian National Health and Medical Research Council (grant 466668), The University of Melbourne (infrastructure award to J.L.H.), a Victorian Life Sciences Computation Initiative grant (VR00353) on its Peak Computing Facility at the University of Melbourne, and an initiative of the Victorian Government and Dutch Cancer Society (grant UL 2009-4388). The research resources, including the Melbourne Collaborative Cohort Study, the Australian Breast Cancer Family Study, the Breast Cancer Family Registry, and the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, are further acknowledged in the supplementary information. We wish to thank Nivonirina Robinot and Geoffroy Durand for their technical help during the case-control mutation screening at the International Agency for Research on Cancer, Georgia Chenevix-Trench for her support of and contribution to the establishment of the case-control mutation-screening study, and Greg Wilhoite for sequencing the male breast cancer cases at the Beckman Research Institute of City of Hope. This work and partial support for S.L.N. was provided by the Morris and Horowitz Families Endowment. Work at the Spanish National Cancer Center was partially funded by the Spanish Association Against Cancer and Health Ministry (FIS08/1120). M.C.S. is a National Health and Medical Research Council (NHMRC) Senior Research Fellow and a Victorian Breast Cancer Research Consortium (VBCRC) Group Leader. J.L.H. is a NHMRC Australia Fellow and a VBCRC Group Leader. T.N.-D. is a Susan G. Komen for the Cure Postdoctoral Fellow.	Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Deans B, 2003, CANCER RES, V63, P8181; Ding YC, 2011, BREAST CANCER RES TR, V126, P227, DOI 10.1007/s10549-010-1271-7; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Giles G.G., 2002, IARC SCI PUBL, V156, P2; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Rafii S, 2002, HUM MOL GENET, V11, P1433, DOI 10.1093/hmg/11.12.1433; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shamseldin HE, 2012, J MED GENET, V49, P184, DOI 10.1136/jmedgenet-2011-100585; Tambini CE, 2010, DNA REPAIR, V9, P517, DOI 10.1016/j.dnarep.2010.01.016; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turnbull C, 2012, HUM MOL GENET, V21, P958, DOI 10.1093/hmg/ddr525	25	126	129	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					734	739		10.1016/j.ajhg.2012.02.027	http://dx.doi.org/10.1016/j.ajhg.2012.02.027			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22464251	Green Published, Bronze			2022-12-18	WOS:000302833400018
J	Rotthier, A; Auer-Grumbach, M; Janssens, K; Baets, J; Penno, A; Almeida-Souza, L; Van Hoof, K; Jacobs, A; De Vriendt, E; Schlotter-Weigel, B; Loscher, W; Vondracek, P; Seeman, P; De Jonghe, P; Van Dijck, P; Jordanova, A; Hornemann, T; Timmerman, V				Rotthier, Annelies; Auer-Grumbach, Michaela; Janssens, Katrien; Baets, Jonathan; Penno, Anke; Almeida-Souza, Leonardo; Van Hoof, Kim; Jacobs, An; De Vriendt, Els; Schlotter-Weigel, Beate; Loscher, Wolfgang; Vondracek, Petr; Seeman, Pavel; De Jonghe, Peter; Van Dijck, Patrick; Jordanova, Albena; Hornemann, Thorsten; Timmerman, Vincent			Mutations in the SPTLC2 Subunit of Serine Palmitoyltransferase Cause Hereditary Sensory and Autonomic Neuropathy Type I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPHINGOLIPID METABOLISM; BIOSYNTHESIS; ACCUMULATION; HOMEOSTASIS; INHIBITION; PHENOTYPE; FUMONISIN; DISEASES; PROTEIN; GENES	Hereditary sensory and autonomic neuropathy type I (HSAN-I) is an axonal peripheral neuropathy associated with progressive distal sensory loss and severe ulcerations Mutations in the first subunit of the enzyme serine palmitoyltransferase (SPT) have been associated with HSAN-I The SPT enzyme catalyzes the first and rate-limiting step in the de novo sphingolipid synthesis pathway However, different studies suggest the implication of other genes in the pathology of HSAN-I Therefore, we screened the two other known subunits of SPT, SPTLC2 and SPTLC3, in a cohort of 78 HSAN patients No mutations were found in SPTLC3, but we identified three heterozygous missense mutations in the SPTLC2 subunit of with four families presenting with a typical HSAN-I phenotype We demonstrate that these mutations result in a partial to complete loss of SPT activity in vitro and in vivo Moreover, they cause the accumulation of the atypical and neurotoxic sphingoid metabolite I-deoxy-sphinganine Our findings extend the genetic heterogeneity in HSAN-I and enlarge the group of HSAN neuropathies associated with SPT defects. We further show that HSAN-I is consistently associated with an Increased formation of the neurotoxic 1-deoxysphinganine, suggesting a common pathomechanism for HSAN-I.	[Rotthier, Annelies; Janssens, Katrien; Almeida-Souza, Leonardo; Van Hoof, Kim; Jacobs, An; Timmerman, Vincent] Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, B-2610 Antwerp, Belgium; [Baets, Jonathan; De Vriendt, Els; De Jonghe, Peter; Jordanova, Albena] Univ Antwerp, Neurogenet Grp, VIB Dept Mol Genet, B-2610 Antwerp, Belgium; [Rotthier, Annelies; Janssens, Katrien; Baets, Jonathan; Almeida-Souza, Leonardo; Van Hoof, Kim; Jacobs, An; De Vriendt, Els; De Jonghe, Peter; Jordanova, Albena; Timmerman, Vincent] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2610 Antwerp, Belgium; [Auer-Grumbach, Michaela] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, A-8036 Graz, Austria; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, B-2650 Antwerp, Belgium; [Penno, Anke; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Penno, Anke] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Schlotter-Weigel, Beate] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Loscher, Wolfgang] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Vondracek, Petr] Univ Hosp & Masaryk Univ, Dept Paediat Neurol, CZ-61300 Brno, Czech Republic; [Seeman, Pavel] Charles Univ Prague, Sch Med Prague 2, Dept Child Neurol, CZ-15006 Prague, Czech Republic; [Van Dijck, Patrick] Katholieke Univ Leuven, VIB Dept Mol Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium; [Hornemann, Thorsten] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Hornemann, Thorsten] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Medical University of Graz; University of Antwerp; University of Zurich; University Zurich Hospital; University of Munich; Medical University of Innsbruck; Masaryk University Brno; Charles University Prague; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Timmerman, V (corresponding author), Univ Antwerp, Peripheral Neuropathy Grp, VIB Dept Mol Genet, B-2610 Antwerp, Belgium.		Almeida-Souza, Leonardo/C-3437-2011; Jordanova, Albena/H-8323-2015; Timmerman, Vincent/O-7283-2019	Almeida-Souza, Leonardo/0000-0002-7169-1238; Jordanova, Albena/0000-0002-3833-3754; Timmerman, Vincent/0000-0002-2162-0933; Loscher, Wolfgang/0000-0002-7593-3222	University of Antwerp; FWO-Flanders; Medical Foundation Queen Elisabeth; Association Beige centre les Maladies Neuromusculaires; Belgian Federal Science Policy Office (BELSPO); Austrian Science Fond (FWF) [P19455-05]; Institute for Science and Technology (IWT); EMBO; BELSPO; IGA MH CR grant [10552-3]; German Society for Clinical Chemistry and Laboratory Medicine; Gebert Ruf Foundation; European Commission [LSHM-CT-2006-037631]	University of Antwerp; FWO-Flanders(FWO); Medical Foundation Queen Elisabeth; Association Beige centre les Maladies Neuromusculaires; Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EMBO(European Molecular Biology Organization (EMBO)); BELSPO(Belgian Federal Science Policy Office); IGA MH CR grant; German Society for Clinical Chemistry and Laboratory Medicine; Gebert Ruf Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	We are grateful to the patients and their families for their cooperation in our research project We thank the Genetic Service Facility (VIB) for DNA sequencing and Ilse Palmans and Deborah Seys for technical assistance with the yeast assays. This project was funded in part by a Methusalem grant of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), the Association Beige centre les Maladies Neuromusculaires (ABMM), the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO), and the Austrian Science Fond (FWF, P19455-05) A R and J B are supported by Ph D. fellowships of the Institute for Science and Technology (IWT) and FWO-Flanders, respectively A R received an EMBO Short Term Fellowship K J holds a postdoctoral fellowship from BELSPO PS is supported by an IGA MH CR grant (no 10552-3) Support for HT. was provided by the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), the Gebert Ruf Foundation, and the European Commission (LSHM-CT-2006-037631)	Auer-Grumbach M, 2004, DRUG TODAY, V40, P385, DOI 10.1358/dot.2004.40.5.850487; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Dawkins JL, 2002, NEUROMUSCULAR DISORD, V12, P656, DOI 10.1016/S0960-8966(02)00015-9; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dedov VN, 2004, BBA-MOL BASIS DIS, V1688, P168, DOI 10.1016/j.bbadis.2003.12.005; Dunn TM, 2000, METHOD ENZYMOL, V312, P317; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verpoorten N, 2006, NEUROBIOL DIS, V21, P247, DOI 10.1016/j.nbd.2005.08.004; WANG E, 1991, J BIOL CHEM, V266, P14486; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Weckx S, 2004, NUCLEIC ACIDS RES, V32, pW170, DOI 10.1093/nar/gkh369; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	35	126	131	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					513	522		10.1016/j.ajhg.2010.09.010	http://dx.doi.org/10.1016/j.ajhg.2010.09.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20920666	Green Published, Bronze			2022-12-18	WOS:000283037600007
J	Kanazawa, A; Tsukada, S; Sekine, A; Tsunoda, T; Takahashi, A; Kashiwagi, A; Tanaka, Y; Babazono, T; Matsuda, M; Kaku, K; Iwamoto, Y; Kawamori, R; Kikkawa, R; Nakamura, Y; Maeda, S				Kanazawa, A; Tsukada, S; Sekine, A; Tsunoda, T; Takahashi, A; Kashiwagi, A; Tanaka, Y; Babazono, T; Matsuda, M; Kaku, K; Iwamoto, Y; Kawamori, R; Kikkawa, R; Nakamura, Y; Maeda, S			Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; APOPTOSIS; RISK	Recent reports have suggested that WNT signaling is an important regulator for adipogenesis or insulin secretion and might be involved in the pathogenesis of type 2 diabetes. To investigate possible roles of the WNT genes in conferring susceptibility to type 2 diabetes, we examined the association of the genes that encode members of the WNT family with type 2 diabetes in the Japanese population. First, 40 single-nucleotide polymorphism ( SNP) loci within 11 WNT genes were analyzed in 188 subjects with type 2 diabetes (case-1) and 564 controls (control-1). Among them, six SNP loci exhibited a significant difference (P < .05) in the allele and/or genotype distributions between case and control subjects. These SNP loci were further analyzed in another set of case (case-2;) n = 733 and control (control-2; n = 375) subjects to confirm their statistical significance. As a result, one SNP locus in the WNT5B gene was strongly associated with type 2 diabetes (chi(2) = 15.6; P = .00008; odds; ratio = 1.74; 95% confidence interval 1.32-2.29). Expression of the WNT5B gene was detectable in several tissues, including adipose, pancreas, and liver. Subsequent in vitro experiments identified the fact that expression of the Wnt5b gene was increased at an early phase of adipocyte differentiation in mouse 3T3-L1 cells. Furthermore, overexpression of the Wnt5b gene in preadipocytes resulted in the promotion of adipogenesis and the enhancement of adipocytokine-gene expression. These results indicate that the WNT5B gene may contribute to conferring susceptibility to type 2 diabetes and may be involved in the pathogenesis of this disease through the regulation of adipocyte function.	Inst Phys & Chem Res, SNP Res Ctr, Lab Diabet Nephropathy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Inst Phys & Chem Res, Lab Genotyping, Yokohama, Kanagawa 2300045, Japan; Inst Phys & Chem Res, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; Inst Phys & Chem Res, SNP Res Ctr, Res Grp Personalized Med, Yokohama, Kanagawa 2300045, Japan; Shiga Univ Med Sci, Dept Med, Shiga, Japan; Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo, Japan; Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Kawasaki Med Sch, Dept Internal Med, Div Endocrinol & Metab, Okayama, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Shiga University of Medical Science; Juntendo University; Tokyo Women's Medical University; University of Tokyo; Kawasaki Medical School	Maeda, S (corresponding author), Inst Phys & Chem Res, SNP Res Ctr, Lab Diabet Nephropathy, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	smaeda@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kashiwagi, Atsunori/H-8712-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Matsuda, Masafumi/0000-0001-8543-1616				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jamali M, 2001, J BIOL CHEM, V276, P42252, DOI 10.1074/jbc.M107814200; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kishida K, 2001, J BIOL CHEM, V276, P36251, DOI 10.1074/jbc.M106040200; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saito S, 2001, J HUM GENET, V46, P529, DOI 10.1007/s100380170035; Saitoh T, 2001, INT J ONCOL, V19, P347; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Weir B., 1996, GENETIC DATA ANAL; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324	23	126	175	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					832	843		10.1086/425340	http://dx.doi.org/10.1086/425340			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15386214	Green Published, Bronze			2022-12-18	WOS:000224303500008
J	Schwarze, U; Schievink, WI; Petty, E; Jaff, MR; Babovic-Vuksanovic, D; Cherry, KJ; Pepin, M; Byers, PH				Schwarze, U; Schievink, WI; Petty, E; Jaff, MR; Babovic-Vuksanovic, D; Cherry, KJ; Pepin, M; Byers, PH			Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMPERFECTA TYPE-I; COL1A1 NULL ALLELES; OSTEOGENESIS IMPERFECTA; MESSENGER-RNA; UNRELATED PATIENTS; GENE COL3A1; COLLAGEN-I; MUTATIONS; CHAIN; POLYMORPHISM	Mutations in the COL3A1 gene that encodes the chains of type III procollagen result in the vascular form of Ehlers-Danlos syndrome (EDS), EDS type IV, if they alter the sequence in the triple-helical domain. Although other fibrillar collagen-gene mutations that lead to allele instability or failure to incorporate pro alpha -chains into trimers-and that thus reduce the amount of mature molecules produced-result in clinically apparent phenotypes, no such mutations have been identified in COL3A1. Furthermore, mice heterozygous for Col3a1 "null" alleles have no identified phenotype. We have now found three frameshift mutations (1832delAA, 413delC, and 555delT) that lead to premature termination codons (PTCs) in exons 27, 6, and 9, respectively, and to allele-product instability. The mRNA from each mutant allele was transcribed efficiently but rapidly degraded, presumably by the mechanisms of nonsense-mediated decay. In a fourth patient, we identified a point mutation, in the final exon, that resulted in a PTC (4294C -->T [Arg1432Ter]). In this last instance, the mRNA was stable but led to synthesis of a truncated protein that was not incorporated into mature type III procollagen molecules. In all probands, the presenting feature was vascular aneurysm or rupture. Thus, in contrast to mutations in genes that encode the dominant protein of a tissue (e.g., COL1A1 and COL2A1), in which "null" mutations result in phenotypes milder than those caused by mutations that alter protein sequence, the phenotypes produced by these mutations in COL3A1 overlap with those of the vascular form of EDS. This suggests that the major effect of many of these dominant mutations in the "minor" collagen genes may be expressed through protein deficiency rather than through incorporation of structurally altered molecules into fibrils.	Cedars Sinai Med Ctr, Inst Neurosurg, Los Angeles, CA 90048 USA; Univ Calif Irvine, Dept Neurosurg, Irvine, CA 92717 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Inst Heart & Vasc, Morristown, NJ 07962 USA; Mayo Clin, Dept Med Genet, Rochester, MN USA; Mayo Clin, Dept Surg, Rochester, MN USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Cedars Sinai Medical Center; University of California System; University of California Irvine; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.	pbyers@u.washington.edu		Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR21557, P01 AR021557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BYERS PH, IN PRESS EMERY RIMOI; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu Mon-Li, 1993, P149; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Freddi S, 2000, AM J MED GENET, V90, P398, DOI 10.1002/(SICI)1096-8628(20000228)90:5<398::AID-AJMG10>3.0.CO;2-7; Kadler KE, 1996, BIOCHEM J, V316, P1; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; KUIVANIEMI H, 1993, NEUROLOGY, V43, P2652, DOI 10.1212/WNL.43.12.2652; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; POPE FM, 1977, J MED GENET, V14, P200, DOI 10.1136/jmg.14.3.200; POPE FM, 1988, ARCH DIS CHILD, V63, P1016, DOI 10.1136/adc.63.9.1016; Pope FM, 1996, BRIT J DERMATOL, V135, P163, DOI 10.1046/j.1365-2133.1996.d01-971.x; POPE FM, 1980, J ROY SOC MED, V73, P180, DOI 10.1177/014107688007300305; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; ROMANIC AM, 1991, J BIOL CHEM, V266, P12703; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwartz BB, 1999, MEMORY, V7, P1, DOI 10.1080/741943714; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SEYER JM, 1996, VASCULAR MED TXB VAS, P39; STOVER ML, 1993, J CLIN INVEST, V92, P1994, DOI 10.1172/JCI116794; TROMP G, 1993, J CLIN INVEST, V91, P2539, DOI 10.1172/JCI116490; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P681, DOI 10.1093/nar/19.3.681; Ward L M, 2001, Hum Mutat, V17, P434, DOI 10.1002/humu.1124; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1994, AM J HUM GENET, V55, P638; Willing MC, 1996, AM J HUM GENET, V59, P799; ZAFARULLAH K, 1990, NUCLEIC ACIDS RES, V18, P6180, DOI 10.1093/nar/18.20.6180	41	126	135	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					989	1001		10.1086/324123	http://dx.doi.org/10.1086/324123			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11577371	Green Published, Bronze			2022-12-18	WOS:000171413400007
J	Pajukanta, P; Cargill, M; Viitanen, L; Nuotio, I; Kareinen, A; Perola, M; Terwilliger, JD; Kempas, E; Day, M; Lilja, H; Rioux, JD; Brettin, T; Viikari, JSA; Ronnemaa, T; Laakso, M; Lander, ES; Peltonen, L				Pajukanta, P; Cargill, M; Viitanen, L; Nuotio, I; Kareinen, A; Perola, M; Terwilliger, JD; Kempas, E; Day, M; Lilja, H; Rioux, JD; Brettin, T; Viikari, JSA; Ronnemaa, T; Laakso, M; Lander, ES; Peltonen, L			Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEALTH-CARE PROFESSIONALS; LINKAGE DISEQUILIBRIUM; RISK-FACTOR; PARENTAL HISTORY; GENE; SCHIZOPHRENIA; ASSOCIATION; FRAMINGHAM; STATEMENT; PROGRAM	Coronary heart disease (CHD) is a complex disorder constituting a major health problem in Western societies. To assess the genetic background of CHD, we performed a genomewide linkage scan in two study samples from the genetically isolated population of Finland. An initial study sample consisted of family material from the northeastern part of Finland, settled by a small number of founders similar to 300 years ago. A second study sample originated from the southwestern region of Finland, settled similar to2,000 years ago. Families were ascertained through probands exhibiting premature CHD, defined as >50% stenosis bf at least two coronary arteries at a young age, as verified by coronary angiography. Both study samples and the pooled data set provided evidence for linkage in two chromosomal regions. A region on chromosome 2q21.1-22 yielded two-point LOD scores of 3.2, 1.9, and 3.7, in the affected sib-pair (ASP) analyses of the northeastern, southwestern, and pooled study samples. The corresponding multipoint maximum-likelihood scores (MLSs) for these three study samples were 2.4, 1.3, and 3.0. In addition, a region on chromosome Xq23-26 resulted in two-point LOD scores of 1.9, 3.5, and 2.9 and in multipoint MLSs of 3.4, 3.1, and 2.5, respectively. In conclusion, this study identifies two loci likely to contribute to premature CHD: one on chromosome 2q21.1-22 and another on chromosome Xq23-26.	Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Los Angeles, CA 90095 USA; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; MIT, Dept Biol, Cambridge, MA USA; Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; Univ Turku, Dept Med, Turku, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA	University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Eastern Finland; University of Turku; Columbia University; Columbia University	Peltonen, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, 695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu	Rioux, John D/A-9599-2015	Rioux, John D/0000-0001-7560-8326				BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; GENEST J, 1995, AM J CARDIOL, V76, pA8; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; GRUNDY SM, 1990, EUR HEART J, V11, P462, DOI 10.1093/oxfordjournals.eurheartj.a059730; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; Jousilahti P, 1998, ANN MED, V30, P481, DOI 10.3109/07853899809002490; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kraft HG, 1996, ARTERIOSCL THROM VAS, V16, P713, DOI 10.1161/01.ATV.16.6.713; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lonjou C, 1999, P NATL ACAD SCI USA, V96, P1621, DOI 10.1073/pnas.96.4.1621; Mosca L, 1997, CIRCULATION, V96, P2468; NEI M, 1984, MOL EVOLUTIONARY GEN; Noll G, 1998, ATHEROSCLEROSIS, V140, pS3, DOI 10.1016/S0021-9150(98)00113-0; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; *POOL PROJ RES GRO, 1978, MON AM HEART ASS, V60; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROSE G, 1964, BRIT J PREV SOC MED, V18, P75; Rose G, 1982, CARDIOVASCULAR SURVE; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SALOMAA V, 1992, AM J EPIDEMIOL, V136, P1303, DOI 10.1093/oxfordjournals.aje.a116442; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHOLTZ RI, 1975, AM J EPIDEMIOL, V102, P350, DOI 10.1093/oxfordjournals.aje.a112171; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Weiss KM., 1995, GENETIC VARIATION HU; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	55	126	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1481	1493		10.1086/316902	http://dx.doi.org/10.1086/316902			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078477	Bronze, Green Published			2022-12-18	WOS:000165607600013
J	Conley, YP; Erturk, D; Keverline, A; Mah, TS; Keravala, A; Barnes, LR; Bruchis, A; Hess, JF; FitzGerald, PG; Weeks, DE; Ferrell, RE; Gorin, MB				Conley, YP; Erturk, D; Keverline, A; Mah, TS; Keravala, A; Barnes, LR; Bruchis, A; Hess, JF; FitzGerald, PG; Weeks, DE; Ferrell, RE; Gorin, MB			A juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; LENS; GENE	Juvenile-onset cataracts are distinguished from congenital cataracts by the initial clarity of the lens at birth and the gradual development of lens opacity in the second and third decades of life. Genomewide linkage analysis in a multigenerational pedigree, segregating for autosomal dominant juvenile-onset cataracts, identified a locus in chromosome region 3q21.2-q22.3. Because of the proximity of the gene coding for lens beaded filament structural protein-2 (BFSP2) to this locus, we screened for mutations in the coding sequence of BFSP2. We observed a unique C-->T transition, one that was not observed in 200 normal chromosomes. We predicted that this led to a nonconservative R287W substitution in exon 4 that cosegregated with cataracts. This mutation alters an evolutionarily conserved arginine residue in the central rod domain of the intermediate filament. On consideration of the proposed function of BFSP2 in the lens cytoskeleton, it is likely that this alteration is the cause of cataracts in the members of the family we studied. This is the first example of a mutation in a noncrystallin structural gene that leads to a juvenile-onset, progressive cataract.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15261 USA; Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Gorin, MB (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, 130 DeSoto St, Pittsburgh, PA 15261 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Mah-Fraser, Tammy/0000-0003-1795-8031	NEI NIH HHS [R01 EY008747, EY08747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008747] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Hess JF, 1996, J BIOL CHEM, V271, P6729, DOI 10.1074/jbc.271.12.6729; HESS JF, 1995, CURR EYE RES, V14, P11, DOI 10.3109/02713689508999909; Jakobs PM, 2000, AM J HUM GENET, V66, P1432, DOI 10.1086/302872; Kramer PL, 2000, INVEST OPHTH VIS SCI, V41, P36; MacDonald IM, 1998, OPHTHALMIC GENET, V19, P1, DOI 10.1076/opge.19.1.1.2181; MAISEL H, 1972, EXP EYE RES, V14, P7, DOI 10.1016/0014-4835(72)90136-4; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOBEL E, 1995, IMA VOLUMES MATH ITS, V81, P89; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; WEEKS DE, 1995, AM J HUM GENET, V56, P1506	13	126	133	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1426	1431		10.1086/302871	http://dx.doi.org/10.1086/302871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10729115	Bronze, Green Published			2022-12-18	WOS:000088373400026
J	Nance, MA; Seltzer, W; Ashizawa, T; Bennett, R; McIntosh, N; Myers, RH; Potter, T; Shea, DK				Nance, MA; Seltzer, W; Ashizawa, T; Bennett, R; McIntosh, N; Myers, RH; Potter, T; Shea, DK		Amer Coll Med Genetics Amer Soc Human Genetics	Laboratory guidelines for Huntington disease genetic testing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; TRINUCLEOTIDE CAG REPEAT; INTERMEDIATE ALLELES; (CAG)(N) REPEAT; EXPANSION; INSTABILITY; ATROPHY; LENGTH; SPERM; SENSITIVITY		Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Athena Diagnost, Worcester, MA USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Washington, Seattle, WA 98195 USA; DIANON Syst, Stratford, CT USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Tennessee, Knoxville, TN USA; Fdn Care & Cure Huntington Dis, Islamorada, FL USA	Hennepin County Medical Center; Baylor College of Medicine; University of Washington; University of Washington Seattle; Boston University; University of Tennessee System; University of Tennessee Knoxville	Nance, MA (corresponding author), Pk Nicollet Clin, 6490 Excelsior Blvd,Suite E500, St Louis Pk, MN 55426 USA.			Myers, Richard/0000-0002-8365-2674				*AM COLL MED GEN, 1993, STAND GUID CLIN GEN; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BENITEZ J, 1995, HUM GENET, V96, P229, DOI 10.1007/BF00207386; BENJAMIN CM, 1994, AM J HUM GENET, V55, P606; Beresford HR, 1996, NEUROLOGY, V47, P1343; BROHOLM J, 1994, NEUROLOGY, V44, P1533; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; Guida M, 1996, CLIN CHEM, V42, P1711; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Legius Eric, 1994, European Journal of Human Genetics, V2, P44; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; MCGLENNAN RC, 1995, AM J HUM GENET S, V57, pA246; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nance MA, 1996, AM J HUM GENET, V59, P1; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Persichetti F, 1994, Neurobiol Dis, V1, P159, DOI 10.1006/nbdi.1994.0019; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	38	126	127	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1243	1247		10.1086/301846	http://dx.doi.org/10.1086/301846			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545416	Bronze			2022-12-18	WOS:000073487000028
J	Matthijs, G; Schollen, E; Van Schaftingen, E; Cassiman, JJ; Jaeken, J				Matthijs, G; Schollen, E; Van Schaftingen, E; Cassiman, JJ; Jaeken, J			Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient Glycoprotein syndrome type 1A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; TRANSFERRIN; SERUM; CDG1	Carbohydrate-deficient-glycoprotein syndrome type 1 (CDG1; also known as "Jaeken syndrome") is an autosomal recessive disorder characterized by defective glycosylation. Most patients show a deficiency of phosphomannomutase (PMM), the enzyme that converts mannose 6-phosphate to mannose 1-phosphate in the synthesis of GDP-mannose. The disease is linked to chromosome 16p13, and mutations have recently seen identified in the PMM2 gene in CDG1 patients with a PMM deficiency (CDG1A). The availability of the genomic sequences of PMM2 allowed us to screen for mutations in 56 CDG1 patients from different geographic origins, By SSCP analysis and by sequencing, we identified 23 different missense mutations and 1 single-base-pair deletion. In total, mutations were found on 99% of the disease chromosomes in CDG1A patients, The R141H substitution is present on 43 of the 112 disease alleles. However, this mutation was never observed in the homozygous state, suggesting that-homozygous for these alterations is incompatible with life. On the other hand, patients were found homozygous for the D65Y and F119L mutations, which must therefore be mild mutations. One particular genotype, R141H/D188G, which is prevalent in Belgium and the Netherlands, is associated with a severe phenotype and a high mortality, Apart from this, there is only a limited relation between the genotype and the clinical phenotype.	Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Hosp Leuven, Ctr Metab Dis, Louvain, Belgium; Int Inst Cellular & Mol Pathol, Physiol Chem Lab, Brussels, Belgium; Univ Louvain, Brussels, Belgium	Universite Catholique Louvain; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	Matthijs, G (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Herestr 49,Campus Gasthuisberg O&N6, B-3000 Louvain, Belgium.	gert.matthijs@med.kuleuven.ac.be	Van+Schaftingen, Emile/AAF-5532-2020	Matthijs, Gert/0000-0001-6710-1912; Van Schaftingen, Emile/0000-0002-6199-7647				Bjursell C, 1997, GENOMICS, V39, P247, DOI 10.1006/geno.1996.4488; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Jaeken J, 1997, J INHERIT METAB DIS, V20, P447, DOI 10.1023/A:1005331523477; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; JAEKEN J, 1980, PEDIATR RES, V14, P179, DOI 10.1203/00006450-198002000-00117; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JAEKEN J, 1997, EUR J PAEDIAT NEUROL, V2, P61; MARTINSSON T, 1994, HUM MOL GENET, V3, P2037; Matthijs G, 1997, NAT GENET, V16, P316, DOI 10.1038/ng0797-316; Matthijs G, 1996, GENOMICS, V35, P597, DOI 10.1006/geno.1996.0404; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; MATTHIJS G, 1998, IN PRESS EUR J HUM G; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; Pineda M, 1996, ARCH DIS CHILD, V74, P242, DOI 10.1136/adc.74.3.242; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; Schollen E, 1998, HUM MOL GENET, V7, P157, DOI 10.1093/hmg/7.2.157; STIBLER H, 1993, NEUROPEDIATRICS, V24, P51, DOI 10.1055/s-2008-1071513; STIBLER H, 1995, NEUROPEDIATRICS, V26, P235, DOI 10.1055/s-2007-979762; Tan J, 1996, AM J HUM GENET, V59, P810; VanderKnaap MS, 1996, J INHERIT METAB DIS, V19, P787, DOI 10.1007/BF01799174; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6	24	126	128	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					542	550		10.1086/301763	http://dx.doi.org/10.1086/301763			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497260	Green Published, Bronze			2022-12-18	WOS:000072894400007
J	Carrington, M; Kissner, T; Gerrard, B; Ivanov, S; O'Brien, SJ; Dean, M				Carrington, M; Kissner, T; Gerrard, B; Ivanov, S; O'Brien, SJ; Dean, M			Novel alleles of the chemokine-receptor gene CCR5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIV-1 INFECTION; FUNCTIONAL EXPRESSION; DISEASE PROGRESSION; MIP-1-ALPHA; INDIVIDUALS; MIP-1-BETA; RESISTANCE; PHENOTYPE; COFACTOR; CLONING	The CCR5 gene encodes a cell-surface chemokine-receptor molecule that serves as a coreceptor for macrophage-tropic strains of HIV-1. Mutations in this gene may alter expression or function of the protein product, thereby altering chemokine binding/signaling or HIV-1 infection of cells that normally express CCR5 protein. Indeed, homozygotes for a 32-bp deletion allele of CCR5 (CCR5-Delta 32), which causes a frameshift at amino acid 185, are relatively resistant to HIV-1 infection. Here we report the identification of 16 additional mutations in the coding region of the CCR5 gene, all but 3 of which are codon altering or "nonsynonymous." Most mutations were rare (found only once or twice in the sample); five were detected exclusively among African Americans, whereas eight were observed only in Caucasians. The mutations included 11 codon-altering nonsynonymous variants, one trinucleotide deletion, one chain-termination mutant, and three synonymous mutations. The high predominance of codon-altering alleles among CCR5 mutants (14/17 [81%], including CCR5-Delta 32) is consistent with an adaptive accumulation of function-altering alleles for this gene, perhaps as a consequence of historic selective pressures.	Sci Applicat Int Corp, Intramural Res Support Program, Frederick, MD USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA	Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carrington, M (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA.		Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; OBRIEN, STEPHEN/ABD-1346-2020	Dean, Michael C/0000-0003-2234-0631; Ivanov, Sergey/0000-0001-9770-7237; OBRIEN, STEPHEN/0000-0001-7857-0757				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ANSRILARI MA, 1997, NAT GENET, V16, P221; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; CONNOR RI, 1994, J VIROL, V68, P4400, DOI 10.1128/JVI.68.7.4400-4408.1994; Cullen M, 1997, AM J HUM GENET, V60, P397; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Li W.H., 1997, MOL EVOLUTION; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; ROOS MTL, 1992, J INFECT DIS, V165, P427, DOI 10.1093/infdis/165.3.427; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Theodorou I, 1997, LANCET, V349, P1219; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	28	126	135	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1261	1267		10.1086/301645	http://dx.doi.org/10.1086/301645			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399903	Bronze, Green Published			2022-12-18	WOS:000071555900008
J	WEEKS, DE; SOBEL, E; OCONNELL, JR; LANGE, K				WEEKS, DE; SOBEL, E; OCONNELL, JR; LANGE, K			COMPUTER-PROGRAMS FOR MULTILOCUS HAPLOTYPING OF GENERAL PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE		UNIV OXFORD, WELLCOME TRUST CTR HUMAN GENET, OXFORD, ENGLAND; UNIV CALIF LOS ANGELES, DEPT BIOMATH, LOS ANGELES, CA USA; UNIV MICHIGAN, DEPT BIOSTAT, ANN ARBOR, MI 48109 USA	University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan	WEEKS, DE (corresponding author), UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA 15260 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Sobel, Eric/0000-0002-1718-0031	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000932] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16042] Funding Source: Medline; NHGRI NIH HHS [HG00932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; HAINES JL, 1992, GENOMICS, V14, P517, DOI 10.1016/S0888-7543(05)80257-5; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, AM J HUM GENET, V45, P959; LITT M, 1994, AM J HUM GENET, V55, P702; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OEHLMANN R, 1993, AM J HUM GENET, V53, P1250; Press WH., 1980, NUMERICAL RECIPES FO; SOBEL E, IMA VOLUMES MATH ITS; Van Laarhoven P.J., 1987, SIMULATED ANNEALING, P7; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356	15	126	129	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1506	1507						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762577				2022-12-18	WOS:A1995RA79400034
J	RASKIND, WH; CONRAD, EU; CHANSKY, H; MATSUSHITA, M				RASKIND, WH; CONRAD, EU; CHANSKY, H; MATSUSHITA, M			LOSS OF HETEROZYGOSITY IN CHONDROSARCOMAS FOR MARKERS LINKED TO HEREDITARY MULTIPLE EXOSTOSES LOCI ON CHROMOSOME-8 AND CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR SUPPRESSOR GENES; PROGNOSTIC FACTORS; ALLELE LOSS; CANCER; DNA; RETINOBLASTOMA; MUTATIONS; HOMOLOG; BONE	Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant condition characterized by growth of multiple benign cartilage-capped tumors. EXT greatly increases the relative risk to develop chondrosarcoma, although most chondrosarcomas are sporadic. This observation suggests that, like the genes responsible for retinoblastoma and other dominantly inherited cancer susceptibility disorders, the genes that cause EXT may have tumor-suppressor function and may play a role in the pathogenesis of the related sporadic tumors. To investigate this hypothesis, we evaluated chondrosarcomas for loss of constitutional heterozygosity (LOH) at polymorphic loci linked to three recently identified genomic regions containing genes involved in EXT. LOH for markers linked to EXT1 on chromosome 8 was detected in a chondrosarcoma that arose in a man with EXT. Four of 17 sporadic tumors showed LOH for markers linked to EXT1, and 7 showed LOH for markers linked to EXT2 on chromosome 11. In all, LOH was observed for markers linked to EXT1 or EXT2 in 44% of the 18 tumors, whereas heterozygosity was retained for markers on 19p linked to EXT3. These findings support the hypothesis that genes on 8q and the pericentromeric region of 11 have tumor-suppressor function and play a role in the development of chondrosarcomas.	UNIV WASHINGTON, DEPT ORTHOPAED, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	RASKIND, WH (corresponding author), UNIV WASHINGTON, DEPT MED, RG-25, SEATTLE, WA 98195 USA.				NATIONAL CANCER INSTITUTE [R37CA016448] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA16448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENEDICT WF, 1990, J CLIN INVEST, V85, P988, DOI 10.1172/JCI114575; BONNER CE, 1994, NATURE, V368, P258; CAVENEE WK, 1983, NATURE, V309, P172; CAWKWELL L, 1993, BRIT J CANCER, V67, P1262, DOI 10.1038/bjc.1993.236; COOK A, 1993, AM J HUM GENET, V53, P71; DAHLIN DC, 1986, BONE TUMORS GENERAL, P227; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FUJIWARA Y, 1993, CANCER RES, V53, P1172; GARRISON RC, 1982, CANCER, V49, P1890, DOI 10.1002/1097-0142(19820501)49:9<1890::AID-CNCR2820490923>3.0.CO;2-U; GITELIS S, 1981, J BONE JOINT SURG AM, V63, P1248, DOI 10.2106/00004623-198163080-00006; GORDON SL, 1981, J MED GENET, V18, P428, DOI 10.1136/jmg.18.6.428; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAMPTON GM, 1994, P NATL ACAD SCI USA, V91, P6953, DOI 10.1073/pnas.91.15.6953; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUVOS AG, 1991, BONE TUMORS DIAGNOSI, P264; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; JONES MH, 1994, GENE CHROMOSOME CANC, V9, P119, DOI 10.1002/gcc.2870090207; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KREICBERGS A, 1982, CANCER, V50, P577, DOI 10.1002/1097-0142(19820801)50:3<577::AID-CNCR2820500332>3.0.CO;2-G; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MATSUNO T, 1988, J BONE JOINT SURG AM, V70A, P137, DOI 10.2106/00004623-198870010-00025; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PETERSON HA, 1989, CLIN ORTHOP RELAT R, V239, P222; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SOLOMON L, 1974, S AFR MED J, V48, P671; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; TSUCHIYA H, 1990, JPN J CLIN ONCOL, V20, P296; VOUTSINAS S, 1983, J MED GENET, V20, P345, DOI 10.1136/jmg.20.5.345; WADAYAMA B, 1993, BRIT J CANCER, V68, P1134, DOI 10.1038/bjc.1993.493; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167	42	126	130	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1132	1139						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726169				2022-12-18	WOS:A1995QU58600016
J	JANICIC, N; PAUSOVA, Z; COLE, DEC; HENDY, GN				JANICIC, N; PAUSOVA, Z; COLE, DEC; HENDY, GN			INSERTION OF AN ALU SEQUENCE IN THE CA2+-SENSING RECEPTOR GENE IN FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; BENIGN HYPERCALCEMIA; HOPEWELL; ELEMENTS; KINDREDS; CLONING; CDNA; DNA	Missense mutations in the calcium-sensing receptor (CaR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). We studied family members of a Nova Scotian deme expressing both FHH and NSHPT and found, by PCR amplification of CaR gene exons, that FHH individuals were heterozygous and NSHPT individuals were homozygous for an abnormally large exon 7. This is due to an insertion at codon 877 of an Alu-repetitive element of the predicted-variant/human-specific-1 subfamily. It is in the opposite orientation to the CaR gene and contains an exceptionally long poly(A) tract. Stop signals are introduced in all reading frames within the Alu sequence, leading to a predicted shortened mutant CaR protein. The loss of the majority of the CaR carboxyl-terminal intracellular domain would dramatically impair its signal transduction capability. Identification of the specific mutation responsible for the FHH/NSHPT phenotype in this community will allow rapid testing of at-risk individuals.	ROYAL VICTORIA HOSP,CALCIUM RES LAB,MONTREAL,PQ H3A 1A1,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PHYSIOL,MONTREAL,PQ,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT MED,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT GENET,TORONTO,ON,CANADA; BANTING & BEST INST,TORONTO,ON,CANADA	McGill University; Royal Victoria Hospital; McGill University; McGill University; University of Toronto; University of Toronto; University of Toronto; University of Toronto								AUSABEL FM, 1987, CURRENT PROTOCOLS MO; BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BICHET DG, 1992, AM J HUM GENET, V51, P1089; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWNELL E, 1989, ONCOGENE, V4, P935; CAPUANO JV, 1994, J BONE MINER RES  S1, V9, pA98; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; COLE DEC, 1990, J CRAN GENET DEV BIO, V10, P205; Deininger PL, 1989, MOBILE DNA, P619; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FINEGOLD DN, 1994, PEDIATR RES, V36, P414, DOI 10.1203/00006450-199409000-00024; FOLEY TP, 1972, J PEDIATR-US, V81, P1060, DOI 10.1016/S0022-3476(72)80232-4; GOLDBERG YP, 1993, NATURE, V362, P370, DOI 10.1038/362370a0; GOLDBLOOM RB, 1972, PEDIATRICS, V49, P514; HEATH H, 1993, AM J HUM GENET, V53, P193; HEATH H, 1994, J BONE MINER RES  S1, V9, pAC426; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; LUNDWALL AB, 1985, J BIOL CHEM, V260, P2108; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MARX SJ, 1986, J CLIN ENDOCR METAB, V62, P445, DOI 10.1210/jcem-62-2-445; MATERA AG, 1991, MOL CELL BIOL, V10, P5424; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; NAYLOR SL, 1994, CYTOGENET CELL GENET, V65, P1; PEARCE SHS, 1994, J BONE MINER RES  S1, V9, pA99; PERRY YM, 1994, AM J HUM GENET S, V55, P79; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; PRATT EL, 1947, J PEDIATR, V30, P388, DOI 10.1016/S0022-3476(47)80079-4; SHEN MR, 1991, J MOL EVOL, V33, P311; TRUMP D, 1993, J BONE MINER RES  S1, V8, pA202; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	41	126	132	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					880	886						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717399				2022-12-18	WOS:A1995QP66300009
J	JORDE, LB; WATKINS, WS; CARLSON, M; GRODEN, J; ALBERTSEN, H; THLIVERIS, A; LEPPERT, M				JORDE, LB; WATKINS, WS; CARLSON, M; GRODEN, J; ALBERTSEN, H; THLIVERIS, A; LEPPERT, M			LINKAGE DISEQUILIBRIUM PREDICTS PHYSICAL DISTANCE IN THE ADENOMATOUS POLYPOSIS-COLI REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; GLOBIN GENE-CLUSTER; HYDROXYLASE PAH LOCUS; HUMAN INSULIN GENE; NONUNIFORM RECOMBINATION; GAMETIC DISEQUILIBRIUM; SAMPLING DISTRIBUTION; PHENYLKETONURIA PKU; RECEPTOR LOCUS; LINKED MARKERS	To test the reliability of linkage-disequilibrium analysis for gene mapping, we compared physical distance and linkage disequilibrium among seven polymorphisms in the adenomatous polyposis coli (ADC) region on chromosome 5. Three of them lie within the APC gene, and two lie within the nearby MCC (mutated in colon cancer) gene. One polymorphism lies between the two genes, and one is likely to be 5' of MCC. Five of these polymorphisms are newly reported. All polymorphisms were typed in the CEPH kindreds, yielding 179-205 unrelated two-locus haplotypes. Linkage disequilibrium between each pair of polymorphisms is highly correlated with physical distance in this 550-kb region (correlation coefficient -.80, P <.006). This result is replicated in both the Utah and non-Utah CEPH kindreds. There is a tendency for greater disequilibrium among pairs of polymorphisms located within the same gene than among other pairs of polymorphisms. Trigenic, quadrigenic, three-locus, and four-locus disequilibrium measures were also estimated, but these measures revealed much less disequilibrium than did the two-locus disequilibrium measures. A review of 19 published disequilibrium studies, including this one, shows that linkage disequilibrium nearly always correlates significantly with physical distance in genomic regions >50-60 kb but that it does not do so in smaller genomic regions. We show that this agrees with theoretical predictions. This finding helps to resolve controversies regarding the use of disequilibrium for inferring gene order. Disequilibrium mapping is unlikely to predict gene order correctly in regions (50-60 kb in size but can often be applied successfully in regions of 50-500 kb or so in size. It is convenient that this is the range in which other mapping techniques, including chromosome walking and linkage mapping, become difficult.			JORDE, LB (corresponding author), UNIV UTAH, HLTH SCI CTR, DEPT HUMAN GENET, ECCLES INST HUMAN GENET 2100, SALT LAKE CITY, UT 84112 USA.				NHGRI NIH HHS [HG-00347, HG-00199] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000199, P30HG000199, R01HG000347] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AJIOKA RS, UNPUB LINKAGE DISEQU; ASCHBACHER A, 1985, American Journal of Human Genetics, V37, pA186; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENLIAN P, 1991, AM J HUM GENET, V48, P903; BORRESEN AL, 1988, HUM GENET, V78, P216, DOI 10.1007/BF00291664; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ELBEIN SC, 1992, AM J HUM GENET, V51, P1103; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GERHARD DS, 1984, P NATL ACAD SCI-BIOL, V81, P7875, DOI 10.1073/pnas.81.24.7875; GOLDING GB, 1984, GENETICS, V108, P257; GRIMM T, 1989, AM J HUM GENET, V45, P368; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HEDRICK PW, 1987, GENETICS, V117, P331; HEGELE RA, 1990, GENET EPIDEMIOL, V7, P69, DOI 10.1002/gepi.1370070114; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HUDSON RR, 1985, GENETICS, V109, P611; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KUPKE KG, 1992, AM J HUM GENET, V50, P808; LALOUEL JM, 1988, ANN NY ACAD SCI, V526, P34, DOI 10.1111/j.1749-6632.1988.tb55490.x; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; LITT M, 1986, AM J HUM GENET, V39, P166; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MANTEL N, 1967, CANCER RES, V27, P209; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MISEREZ AR, 1993, AM J HUM GENET, V52, P808; MORTON NE, 1983, HUM GENET, V64, P103, DOI 10.1007/BF00327102; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1984, EVOL BIOL, V17, P73; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; SKRAASTAD MI, 1992, AM J HUM GENET, V51, P730; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; STEINMETZ M, 1987, TRENDS GENET, V3, P7, DOI 10.1016/0168-9525(87)90154-5; SVED J A, 1971, Theoretical Population Biology, V2, P125; TANZI RE, 1992, AM J HUM GENET, V50, P551; TEMPLETON AR, 1987, GENETICS, V117, P343; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TRECO D, 1985, MOL CELL BIOL, V5, P2029, DOI 10.1128/MCB.5.8.2029; TZALL S, 1989, AM J HUM GENET, V44, P864; WALTER MA, 1991, AM J HUM GENET, V49, P917; WARKINS WS, 1994, UNPUB LINKAGE DISEQU; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1986, AM J HUM GENET, V38, P776; Weir BS, 1990, GENETIC DATA ANAL; WEIR BS, 1989, GENETIC ANAL WORKSHO, V6, P81; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1993, CURR OPIN GENET DEV, V3, P414, DOI 10.1016/0959-437X(93)90114-5; WILLS C, 1990, NATURE, V348, P398, DOI 10.1038/348398a0; ZERBA KE, 1991, GENETICS, V129, P525; [No title captured]	81	126	127	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					884	898						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178829				2022-12-18	WOS:A1994NH39400019
J	SHIBUYA, A; YOSHIDA, A				SHIBUYA, A; YOSHIDA, A			GENOTYPES OF ALCOHOL-METABOLIZING ENZYMES IN JAPANESE WITH ALCOHOL LIVER-DISEASES - A STRONG ASSOCIATION OF THE USUAL CAUCASIAN-TYPE ALDEHYDE DEHYDROGENASE GENE (ALDH-2(1)) WITH THE DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR, BECKMAN RES INT, DEPT BIOCHEM GENET, DUARTE, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope					NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005763] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA05763] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BENNION LJ, 1976, NEW ENGL J MED, V294, P9, DOI 10.1056/NEJM197601012940103; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; GOEDDE HW, 1979, HUM GENET, V51, P331; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1980, AM J HUM GENET, V32, P8; HOSKINS PJ, 1987, CLIN SCI, V73, P77, DOI 10.1042/cs0730077; HSU LC, 1987, AM J HUM GENET, V41, P996; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; IKAWA M, 1983, J BIOL CHEM, V258, P6282; IKUTA T, 1985, P NATL ACAD SCI USA, V82, P2703, DOI 10.1073/pnas.82.9.2703; IKUTA T, 1988, BIOCHEM GENET, V26, P519, DOI 10.1007/BF02399419; KANAYAMA R, 1983, ALCOHOL METABOLISM L, V2, P223; KOGAME M, 1985, Japanese Journal of Alcohol Studies and Drug Dependence, V20, P122; MANIATIS T, 1982, MOL CLONING LABORATO; REX DK, 1984, 2D C INT SOC BIOM RE, P115; SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; TAKEUCHI J, 1987, Japanese Journal of Gastroenterology, V84, P1623; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; WOLFF PH, 1973, AM J HUM GENET, V25, P193; YIN SJ, 1984, BIOCHEM GENET, V22, P169, DOI 10.1007/BF00499296; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YOSHIHARA H, 1983, PHARMACOL BIOCHEM BE, V18, P425, DOI 10.1016/0091-3057(83)90211-3; ZEINER AR, 1984, 2ND C INT SOC BIOM R, P129	26	126	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					744	748						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189338				2022-12-18	WOS:A1988Q933600022
J	HASSOLD, T; BENHAM, F; LEPPERT, M				HASSOLD, T; BENHAM, F; LEPPERT, M			CYTOGENETIC AND MOLECULAR ANALYSIS OF SEX-CHROMOSOME MONOSOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CORNELL UNIV,MED CTR,COLL MED,DEPT PEDIAT,DIV HUMAN GENET,NEW YORK,NY 10021; GUYS HOSP,SCH MED,PEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	Cornell University; Guy's & St Thomas' NHS Foundation Trust; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NCRR NIH HHS [BRSGS07 RR05396] Funding Source: Medline; NICHD NIH HHS [HD21341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON M, 1986, SCIENCE, V233, P856; CATTANACH B, 1985, NATURE, V311, P374; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1985, AM J HUM GENET, V37, P965; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; HOOK EB, 1977, AM J HUM GENET, V29, P94; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS PA, IN PRESS J MED GENET; MULLER U, 1987, HUM GENET, V75, P109, DOI 10.1007/BF00591069; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANGER R, 1977, J MED GENET, V14, P210, DOI 10.1136/jmg.14.3.210; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STALVEY JRD, 1987, HUM GENET, V76, P240; TIPPETT P, 1985, HUM GENET, V70, P92, DOI 10.1007/BF00389469; WARBURTON D, 1980, LANCET, V1, P167; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P420	18	126	131	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					534	541						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6316	2894760				2022-12-18	WOS:A1988M631600002
J	UCHIDA, IA; MCRAE, KN; WANG, HC; RAY, M				UCHIDA, IA; MCRAE, KN; WANG, HC; RAY, M			FAMILIAL SHORT ARM DEFICIENCY OF CHROMOSOME 18 CONCOMITANT WITH ARHINENCEPHALY AND ALOPECIA CONGENITA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUHLER EM, 1964, LANCET, V1, P170; Danforth CH, 1925, ARCH DERMATOL SYPH, V12, P195, DOI 10.1001/archderm.1925.02370080039004; de Grouchy J., 1963, CR HEBD ACAD SCI, V258, P1028; DEMYER W, 1963, NEUROLOGY, V13, P913, DOI 10.1212/WNL.13.11.913; DEMYER W, 1964, ANN PAEDIATR-BASEL, V203, P169; DILL FJ, 1963, PERSONAL COMMUNICATI; FAINT S, 1964, PERSONAL COMMUNICATI; HAWORTH JC, 1961, J PEDIATR-US, V59, P726, DOI 10.1016/S0022-3476(61)80010-3; HICKOX DB, 1964, PERSONAL COMMUNICATI; KLOPSTOCK A, 1921, MONATSCHR GEBURTSH G, V56, P59; LANDAU JW, 1963, J PEDIATR-US, V62, P895, DOI 10.1016/S0022-3476(63)80104-3; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; LEWIS FJW, 1963, PERSONAL COMMUNICATI; SUMMITT RL, 1964, CYTOGENETICS, V3, P201, DOI 10.1159/000129811; VANDYKE HE, 1964, AM J HUM GENET, V16, P364	15	126	126	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					410	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334740				2022-12-18	WOS:A19656785100005
J	Ranciaro, A; Campbell, MC; Hirbo, JB; Ko, WY; Froment, A; Anagnostou, P; Kotze, MJ; Ibrahim, M; Nyambo, T; Omar, SA; Tishkoff, SA				Ranciaro, Alessia; Campbell, Michael C.; Hirbo, Jibril B.; Ko, Wen-Ya; Froment, Alain; Anagnostou, Paolo; Kotze, Maritha J.; Ibrahim, Muntaser; Nyambo, Thomas; Omar, Sabah A.; Tishkoff, Sarah A.			Genetic Origins of Lactase Persistence and the Spread of Pastoralism in Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME VARIATION; INTESTINAL LACTASE; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; STATISTICAL-METHOD; HUMAN ADAPTATION; SOFT SWEEPS; LACTOSE; POLYMORPHISM; DIVERSITY	In humans, the ability to digest lactose, the sugar in milk, declines after weaning because of decreasing levels of the enzyme lactasephlorizin hydrolase, encoded by LCT. However, some individuals maintain high enzyme amounts and are able to digest lactose into adulthood (i. e., they have the lactase-persistence [LP] trait). It is thought that selection has played a major role in maintaining this genetically determined phenotypic trait in different human populations that practice pastoralism. To identify variants associated with the LP trait and to study its evolutionary history in Africa, we sequenced MCM6 introns 9 and 13 and similar to 2 kb of the LCT promoter region in 819 individuals from 63 African populations and in 154 non-Africans from nine populations. We also genotyped four microsatellites in an similar to 198 kb region in a subset of 252 individuals to reconstruct the origin and spread of LP-associated variants in Africa. Additionally, we examined the association between LP and genetic variability at candidate regulatory regions in 513 individuals from eastern Africa. Our analyses confirmed the association between the LP trait and three common variants in intron 13 (C-14010, G-13907, and G-13915). Furthermore, we identified two additional LP-associated SNPs in intron 13 and the promoter region (G-12962 and T-956, respectively). Using neutrality tests based on the allele frequency spectrum and long-range linkage disequilibrium, we detected strong signatures of recent positive selection in eastern African populations and the Fulani from central Africa. In addition, haplotype analysis supported an eastern African origin of the C-14010 LP-associated mutation in southern Africa.	[Ranciaro, Alessia; Campbell, Michael C.; Hirbo, Jibril B.; Ko, Wen-Ya; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Froment, Alain] Museum Natl Hist Nat, Musee Homme, UMR 208, F-75116 Paris, France; [Froment, Alain] Inst Rech Dev, F-75116 Paris, France; [Anagnostou, Paolo] Univ Roma La Sapienza, Dipartimento Biol Ambientale, I-00185 Rome, Italy; [Anagnostou, Paolo] Ist Italiano Antropol, I-00100 Rome, Italy; [Kotze, Maritha J.] Univ Stellenbosch, Fac Hlth Sci, Dept Pathol, Div Anat Patol, ZA-7505 Tygerberg, South Africa; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum 1513, Sudan; [Nyambo, Thomas] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Omar, Sabah A.] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi 5484000200, Kenya; [Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); Sapienza University Rome; Stellenbosch University; University of Khartoum; Muhimbili University of Health & Allied Sciences; Kenya Medical Research Institute; University of Pennsylvania	Ranciaro, A (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	aissela19@yahoo.it; tishkoff@mail.med.upenn.edu	Kotze, Maritha J/GMX-0989-2022	Hirbo, Jibril/0000-0002-8932-7311; Kotze, Martha/0000-0002-6050-2876; Anagnostou, Paolo/0000-0003-0768-4612	National Science Foundation [BCS-0196183, BCS-0827436]; National Institutes of Health [5-R01-GM076637-05, 8DP1ES022577-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jacques Loiselet and Charles Wambebe for providing Lebanese and Nigerian samples, respectively. We thank Lilian A. Nyndodo, Eva Aluvalla, Daniel Kariuki, Godfrey Lema, Kweli Powell, Holly Mortensen, Maha Osman, Floyd A. Reed, Alex Tibwitta, George Ogutu, and Hussein Musa for assisting in sample collection. We thank Floyd A. Reed, Guido Barbujani, Dongbo Hu, Laura B. Scheinfeldt, and Karuna Panchapakesan for technical assistance and for valuable discussions. Most of all, we thank all of the African participants who generously donated DNA and phenotype information so that we might learn more about the genetic basis of lactase persistence and the spread of pastoralism in Africa. This research was funded by National Science Foundation grants BCS-0196183 and BCS-0827436 and National Institutes of Health grants 5-R01-GM076637-05 and 8DP1ES022577-04 to S.A.T.	Alexander J, 2001, WORLD ARCHAEOL, V33, P44, DOI 10.1080/00438240120047627; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; AROLA H, 1994, SCAND J GASTROENTERO, V29, P26, DOI 10.3109/00365529409091742; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Campbell Anthony K., 2005, Science Progress, V88, P157, DOI 10.3184/003685005783238408; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cerny V, 2006, HUM BIOL, V78, P9, DOI 10.1353/hub.2006.0024; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Cook G. C., 1984, Critical Reviews in Tropical Medicine, V2, P117; COOK GC, 1978, MAN, V13, P418, DOI 10.2307/2801938; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; CRUZDEVA.E, 1974, J DEV AREAS, V8, P199; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s; DENBOW J, 1986, J AFR HIST, V27, P3, DOI 10.1017/S0021853700029170; Durham WH., 1992, COEVOLUTION GENES CU, P226; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; EHRET C, 1967, J AFR HIST, V8, P1, DOI 10.1017/S0021853700006782; Ehret C., 1998, AFRICAN CLASSICAL AG; Ehret C., 2002, CIVILIZATIONS AFRICA; Ehret Christopher, 1971, SO NILOTIC HIST LING; Ehret Christopher, 2006, ARCHAEOLOGY EARLY NE, P1019; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; FLEMING HC, 1969, ETHNOLOGY, V8, P1, DOI 10.2307/3772935; FREUND JN, 1991, ENZYME, V45, P71, DOI 10.1159/000468868; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hollox EJ, 1999, EUR J HUM GENET, V7, P791, DOI 10.1038/sj.ejhg.5200369; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HOLZEL A, 1959, LANCET, V1, P1126; Hoogendijk CF, 2003, MOL CELL PROBE, V17, P175, DOI 10.1016/S0890-8508(03)00050-1; HUDSON RR, 1992, GENETICS, V132, P583; Imtiaz F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.051631; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Ingram CJE, 2009, J MOL EVOL, V69, P579, DOI 10.1007/s00239-009-9301-y; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jacobi A., 1901, T AM PEDIATR SOC, V13, P150; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Jensen TGK, 2011, HUM GENET, V130, P483, DOI 10.1007/s00439-011-0966-0; Jones BL, 2013, AM J HUM GENET, V93, P538, DOI 10.1016/j.ajhg.2013.07.008; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; Kumari Archana, 2011, Acta Biomed, V82, P177; Levy TE, 2002, J ANTHROPOL ARCHAEOL, V21, P83, DOI 10.1006/jaar.2001.0390; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Newman J., 1995, PEOPLING AGRICA; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Olds LC, 2011, HUM GENET, V129, P111, DOI 10.1007/s00439-010-0898-0; OLIVER R, 1982, J AFR HIST, V23, P433, DOI 10.1017/S0021853700021289; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Pennings PS, 2006, MOL BIOL EVOL, V23, P1076, DOI 10.1093/molbev/msj117; Phillipson D.W., 1977, LATER PREHISTORY E S; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Ranciaro A., 2012, CAUSES CONSEQUENCES, P135; Robbins LH, 2005, CURR ANTHROPOL, V46, P671, DOI 10.1086/432748; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; SAHI T, 1994, SCAND J GASTROENTERO, V29, P1, DOI 10.3109/00365529409091739; Saulnier DM, 2009, CURR PHARM DESIGN, V15, P1403, DOI 10.2174/138161209788168128; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; Schlebusch CM, 2013, EUR J HUM GENET, V21, P550, DOI 10.1038/ejhg.2012.199; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; SMITH AB, 1992, ANNU REV ANTHROPOL, V21, P125; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun HM, 2007, ASIA PAC J CLIN NUTR, V16, P598; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Swallow DM, 2001, DRUG METAB DISPOS, V29, P513; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torniainen S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-31; Troelsen JT, 2005, BBA-GEN SUBJECTS, V1723, P19, DOI 10.1016/j.bbagen.2005.02.003; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Vanhove M., 2006, P 7 INT STUD C; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WACKER H, 1992, J BIOL CHEM, V267, P18744; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751	95	125	131	6	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					496	510		10.1016/j.ajhg.2014.02.009	http://dx.doi.org/10.1016/j.ajhg.2014.02.009			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24630847	Green Published, Bronze			2022-12-18	WOS:000333765300002
J	Pagani, L; Kivisild, T; Tarekegn, A; Ekong, R; Plaster, C; Romero, IG; Ayub, Q; Mehdi, SQ; Thomas, MG; Luiselli, D; Bekele, E; Bradman, N; Balding, DJ; Tyler-Smith, C				Pagani, Luca; Kivisild, Toomas; Tarekegn, Ayele; Ekong, Rosemary; Plaster, Chris; Romero, Irene Gallego; Ayub, Qasim; Mehdi, S. Qasim; Thomas, Mark G.; Luiselli, Donata; Bekele, Endashaw; Bradman, Neil; Balding, David J.; Tyler-Smith, Chris			Ethiopian Genetic Diversity Reveals Linguistic Stratification and Complex Influences on the Ethiopian Gene Pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; Y-CHROMOSOME; UNRELATED INDIVIDUALS; POSITIVE SELECTION; MODERN HUMANS; HOMO-SAPIENS; MIDDLE AWASH; AFRICA; ASSOCIATION; HOMINIDS	Humans and their ancestors have traversed the Ethiopian landscape for millions of years, and present-day Ethiopians show great cultural, linguistic, and historical diversity, which makes them essential for understanding African variability and human origins. We genotyped 235 individuals from ten Ethiopian and two neighboring (South Sudanese and Somali) populations on an Illumina Omni 1M chip. Genotypes were compared with published data from several African and non-African populations. Principal-component and STRUCTURE-like analyses confirmed substantial genetic diversity both within and between populations, and revealed a match between genetic data and linguistic affiliation. Using comparisons with African and non-African reference samples in 40-SNP genomic windows, we identified "African" and "non-African" haplotypic components for each Ethiopian individual. The non-African component, which includes the SLC24A5 allele associated with light skin pigmentation in Europeans, may represent gene flow into Africa, which we estimate to have occurred similar to 3 thousand years ago (kya). The non-African component was found to be more similar to populations inhabiting the Levant rather than the Arabian Peninsula, but the principal route for the expansion out of Africa similar to 60 kya remains unresolved. Linkage-disequilibrium decay with genomic distance was less rapid in both the whole genome and the African component than in southern African samples, suggesting a less ancient history for Ethiopian populations.	[Pagani, Luca; Kivisild, Toomas] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England; [Pagani, Luca; Romero, Irene Gallego; Ayub, Qasim; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Tarekegn, Ayele; Bekele, Endashaw] Univ Addis Ababa, Addis Ababa, Ethiopia; [Tarekegn, Ayele; Bekele, Endashaw] Ctr Human Genet Divers, Addis Ababa, Ethiopia; [Ekong, Rosemary; Plaster, Chris; Bradman, Neil] UCL, Ctr Genet Anthropol, London WC1E 6BT, England; [Mehdi, S. Qasim] Sindh Inst Urol & Transplantat, Ctr Human Genet, Karachi 74200, Pakistan; [Thomas, Mark G.] UCL, Mol & Cultural Evolut Lab, London WC1E 6BT, England; [Luiselli, Donata] Univ Bologna, Dept Expt Evolutionary Biol, Anthropol Unit, I-40126 Bologna, Italy; [Balding, David J.] UCL, UCL Genet Inst, London WC1E 6BT, England	University of Cambridge; Wellcome Trust Sanger Institute; Addis Ababa University; University of London; University College London; Dow University of Health Sciences; University of London; University College London; University of Bologna; University of London; University College London	Pagani, L (corresponding author), Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England.	lp8@sanger.ac.uk	Mehdi, Syed Qasim/L-2385-2015; Pagani, Luca/G-8511-2017; Kivisild, Toomas/P-5889-2017; Balding, David/G-9898-2011; Thomas, Mark G/A-2219-2012	Pagani, Luca/0000-0002-6639-524X; Kivisild, Toomas/0000-0002-6297-7808; Balding, David/0000-0002-1480-6115; Thomas, Mark G/0000-0002-2452-981X; Ayub, Qasim/0000-0003-3291-0917; Gallego Romero, Irene/0000-0003-1613-8998; Ekong, Rosemary/0000-0002-5984-7893	Wellcome Trust [098051]; Domestic Research Scholarship; Cambridge European Trust; Emmanuel College, Cambridge, UK; Melford Charitable Trust; Cordell Homes Ltd.	Wellcome Trust(Wellcome TrustEuropean Commission); Domestic Research Scholarship; Cambridge European Trust; Emmanuel College, Cambridge, UK; Melford Charitable Trust; Cordell Homes Ltd.	The authors would like to acknowledge all the Ethiopian donors and collaborators, as well as Sarah Edkins, Emma Gray, Sarah Hunt, Avazeh Tashakkori Ghanbarian, and the staff at the Sanger Institute who performed the genotyping. Great help has also been provided by Priya Moorjani, David Reich, and Nick Patterson for a better understanding of the mathematics underlying the ROLLOFF approach. This work was supported by grant number 098051 from the Wellcome Trust. L.P. would like to thank the providers of a Domestic Research Scholarship, the Cambridge European Trust, and Emmanuel College, Cambridge, UK for sponsoring his research. N.B. is the settlor and senior trustee of Melford Charitable Trust and owner of Cordell Homes Ltd., which have in part funded this research. Neither N.B., the charitable trust, nor the company have any intellectual property or other rights with respect to the results of the study.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Cann HM, 2002, SCIENCE, V296, P261; COCKERHAM CC, 1986, ANN HUM GENET, V50, P271, DOI 10.1111/j.1469-1809.1986.tb01048.x; Ehret Christopher, 1995, RECONSTRUCTING PROTO; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Freeman Dena, 2003, PERIPHERAL PEOPLE EX; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hansberry W.L, 1974, PILLARS ETHIOPIAN HI; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Horsfall LJ, 2011, ANN HUM GENET, V75, P236, DOI 10.1111/j.1469-1809.2010.00638.x; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; Kaplan I, 1971, AREA HDB ETHIOPIA; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Levine D.N, 1974, GREATER ETHIOPIA; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lovell A, 2005, ANN HUM GENET, V69, P275, DOI 10.1046/j.1529-8817.2005.00152.x; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pankhurst R., 1998, ETHIOPIANS; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Phillipson D. W., 1993, ARCHAEOLOGY AFRICA F, P344; PHILLIPSON D. W., 1998, ANCIENT ETHIOPIA AKS; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plaster CA, 2011, THESIS U COLL LONDON; Poloni ES, 2009, ANN HUM GENET, V73, P582, DOI 10.1111/j.1469-1809.2009.00541.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802	55	125	125	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					83	96		10.1016/j.ajhg.2012.05.015	http://dx.doi.org/10.1016/j.ajhg.2012.05.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22726845	Green Published, Bronze			2022-12-18	WOS:000306445000007
J	Molho-Pessach, V; Lerer, I; Abeliovich, D; Agha, Z; Abu Libdeh, A; Broshtilova, V; Elpeleg, O; Zlotogorski, A				Molho-Pessach, Vered; Lerer, Israela; Abeliovich, Dvorah; Agha, Ziad; Abu Libdeh, Abdulasalam; Broshtilova, Valentina; Elpeleg, Orly; Zlotogorski, Abraham			The H Syndrome Is Caused by Mutations in the Nucleoside Transporter hENT3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL; DISORDERS; SKIN; TOXICITY; DISEASE; FAMILY	The H syndrome is a recently reported autosomal-recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, short stature, hallux valgus, and fixed flexion contractures of the toe joints and the proximal interphalangeal joints. Homozygosity mapping in five consanguineous families resulted in the identification of mutations in the SLC29A3 gene, which encodes the equilibrative nucleoside transporter hENT3. Three mutations were found in I I families of Arab and Bulgarian origin. The finding of several different mutations in a small geographic region implies that the H syndrome might be rather common. The identification of mutations in the SLC29A3 gene in patients with a mild clinical phenotype Suggests that this is a largely underdiagnosed condition and strongly Suggests that even oligosymptomatic individuals might have the disorder.	[Molho-Pessach, Vered; Agha, Ziad; Zlotogorski, Abraham] Hebrew Univ Jerusalem, Med Ctr, Dept Dermatol, IL-91120 Jerusalem, Israel; [Lerer, Israela; Abeliovich, Dvorah] Hebrew Univ Jerusalem, Med Ctr, Dept Human Genet, IL-91120 Jerusalem, Israel; [Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Dept Metab Dis, IL-91120 Jerusalem, Israel; [Molho-Pessach, Vered; Zlotogorski, Abraham] Hebrew Univ Jerusalem, Med Ctr, Ctr Genet Dis Skin & Hair, IL-91120 Jerusalem, Israel; [Abu Libdeh, Abdulasalam] Makassed Islam Charitable Hosp, Dept Pediat, IL-19482 Jerusalem, Israel; [Broshtilova, Valentina] Med Univ Sofia, Fac Med, Dept Dermatol & Venerol, Sofia 1431, Bulgaria	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Medical University Sofia	Zlotogorski, A (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Dept Dermatol, IL-91120 Jerusalem, Israel.	zloto@cc.huji.ac.il	Broshtilova, Valentina/AAD-8407-2019	Broshtilova, Valentina/0000-0003-2317-0398	Authority for Research and Development; Hebrew University of Jerusalem; Hadassah Medical Center; North American Hair Research Society	Authority for Research and Development; Hebrew University of Jerusalem; Hadassah Medical Center; North American Hair Research Society	We thank the family members for their participation in this study and Sofia Babay and Ruth Bargal for expert technical assistance. This study was supported in part by the Authority for Research and Development, Hebrew University of Jerusalem (A.Z.), the Hadassah Medical Center physician scientist program, the Hadassah-Hebrew University joint research fund (V.M.P.), and the North American Hair Research Society (Z.A.).	Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Birch-Machin MA, 2000, CLIN EXP DERMATOL, V25, P141, DOI 10.1046/j.1365-2230.2000.00605.x; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; Govindarajan R, 2008, FASEB J, V22; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hamadah Issam R, 2006, J Am Acad Dermatol, V54, pS189, DOI 10.1016/j.jaad.2005.06.032; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; Leung GPH, 2007, EXPERT OPIN DRUG MET, V3, P705, DOI 10.1517/17425225.3.5.705; Marina S, 2006, PEDIATR DERMATOL, V23, P145, DOI 10.1111/j.1525-1470.2006.00201.x; Molho-Pessach V, 2008, J AM ACAD DERMATOL, V59, P79, DOI 10.1016/j.jaad.2008.03.021; MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603; Prendiville J, 2007, PEDIATR DERMATOL, V24, P101, DOI 10.1111/j.1525-1470.2007.00352.x; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x	15	125	129	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					529	534		10.1016/j.ajhg.2008.09.013	http://dx.doi.org/10.1016/j.ajhg.2008.09.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940313	Green Published, Bronze			2022-12-18	WOS:000260239200011
J	Tanaka, M; Olsen, RW; Medina, MT; Schwartz, E; Alonso, ME; Duron, RM; Castro-Ortega, R; Martinez-Juarez, IE; Pascual-Castroviejo, I; Machado-Salas, J; Silva, R; Bailey, JN; Bai, DS; Ochoa, A; Jara-Prado, A; Pineda, G; Macdonald, RL; Delgado-Escueta, AV				Tanaka, Miyabi; Olsen, Richard W.; Medina, Marco T.; Schwartz, Emily; Alonso, Maria Elisa; Duron, Reyna M.; Castro-Ortega, Ramon; Martinez-Juarez, Iris E.; Pascual-Castroviejo, Ignacio; Machado-Salas, Jesus; Silva, Rene; Bailey, Julia N.; Bai, Dongsheng; Ochoa, Adriana; Jara-Prado, Aurelio; Pineda, Gregorio; Macdonald, Robert L.; Delgado-Escueta, Antonio V.			Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBUNIT MESSENGER-RNAS; A RECEPTOR; RAT-BRAIN; BETA-3; GENE; SEIZURES; NEURONS; AUTISM; MICE; ELECTROENCEPHALOGRAM	Childhood absence epilepsy (CAE) accounts for 10% to 12% of epilepsy in children under 16 years of age. We screened for mutations in the GABA(A) receptor (GABAR) beta 3 subunit gene (GABRB3) in 48 probands and families with remitting CAE. We found that four out of 48 families (8%) had mutations in GABRB3. One heterozygous missense mutation (P11S) in exon 1a segregated with four CAE-affected persons in one multiplex, two-generation Mexican family. P11S was also found in a singleton from Mexico. Another heterozygous missense mutation (S15F) was present in a singleton from Honduras. An exon 2 heterozygous missense mutation (G32R) was present in two CAE-affected persons and two persons affected with EEG-recorded spike and/or sharp wave in a two-generation Honduran family. All mutations were absent in 630 controls. We studied functions and possible pathogenicity by expressing mutations in HeLa cells with the use of Western blots and an in vitro translation and translocation system. Expression levels did not differ from those of controls, but all mutations showed hyperglycosylation in the in vitro translation and translocation system with canine microsomes. Functional analysis of human GABA(A) receptors (alpha 1 beta 3-v2 gamma 2S, alpha 1 beta 3-v2[P11S]gamma 2S, alpha 1 beta 3-v2[S15F]gamma 2S, and alpha 1 beta 3-v2[G32R]gamma 2S) transiently expressed in HEK293T cells with the use of rapid agonist application showed that each amino acid transversion in the beta 3-v2 subunit (P11S, S15F, and G32R) reduced GABA-evoked current density from whole cells. Mutated beta 3 subunit protein could thus cause absence seizures through a gain in glycosylation of mutated exon 1a and exon 2, affecting maturation and trafficking of GABAR from endoplasmic reticulum to cell surface and resulting in reduced GABA-evoked currents.	[Tanaka, Miyabi; Duron, Reyna M.; Martinez-Juarez, Iris E.; Machado-Salas, Jesus; Bailey, Julia N.; Bai, Dongsheng; Pineda, Gregorio; Delgado-Escueta, Antonio V.] US Dept Vet Affairs Greater Los Angeles Healthcar, Epilepsy Genet & Genom Lab, Epilepsy Ctr, Neurol & Res Serv, Los Angeles, CA 90073 USA; [Tanaka, Miyabi; Olsen, Richard W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Bai, Dongsheng; Delgado-Escueta, Antonio V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90073 USA; [Medina, Marco T.; Duron, Reyna M.] Natl Autonomous Univ Honduras, Neurol Training Program, Tegucigalpa, Honduras; [Schwartz, Emily] Vanderbilt Univ, Grad Program Neurosci, Sch Med, Nashville, TN 37232 USA; [Alonso, Maria Elisa; Martinez-Juarez, Iris E.; Ochoa, Adriana; Jara-Prado, Aurelio] Natl Inst Neurol & Neurosurg, Mexico City 14269, DF, Mexico; [Castro-Ortega, Ramon] Univ Sonora, Hermosillo 83190, Sonora, Mexico; [Pascual-Castroviejo, Ignacio] Univ Hosp La Paz, Madrid 28027, Spain; [Silva, Rene] Nuestra Senora de La Paz Hosp, San Miguel, El Salvador; [Bailey, Julia N.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Macdonald, Robert L.] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Nacional Autonoma de Honduras; Vanderbilt University; Universidad de Sonora; Hospital Universitario La Paz; University of California System; University of California Los Angeles; Vanderbilt University; Vanderbilt University; Vanderbilt University	Delgado-Escueta, AV (corresponding author), US Dept Vet Affairs Greater Los Angeles Healthcar, Epilepsy Genet & Genom Lab, Epilepsy Ctr, Neurol & Res Serv, Los Angeles, CA 90073 USA.	escueta@ucla.edu	Jara-Prado, Aurelio/AAU-3017-2020; Iris E. Martínez-Juárez, MSc/AAZ-9428-2020; Ochoa, Adriana/AAU-2918-2020; Martinez-Juarez, Iris E/S-5351-2017; Durón, Reyna M./AAX-4407-2020	Iris E. Martínez-Juárez, MSc/0000-0001-6512-5312; Ochoa, Adriana/0000-0003-1084-2984; Duron, Reyna M./0000-0002-9425-2289; Jara-Prado, Aurelio/0000-0001-8985-3744; Medina, Marco Tulio/0000-0003-0469-054X; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055057, P01NS035985] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35985, R01 NS055057, P01 NS035985] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Audenaert D, 2006, HUM MUTAT, V27, P391, DOI 10.1002/humu.20279; Berg AT, 2000, EPILEPSIA, V41, P1269, DOI 10.1111/j.1528-1157.2000.tb04604.x; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Callenbach PMC, 1998, EPILEPSIA, V39, P331, DOI 10.1111/j.1528-1157.1998.tb01382.x; Childs J A, 1997, J Neurosci Nurs, V29, P244; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; CURRIER RD, 1963, NEUROLOGY, V13, P959, DOI 10.1212/WNL.13.11.959; DELOREY TM, 1992, J BIOL CHEM, V267, P16747; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Feucht M, 1999, BIOL PSYCHIAT, V46, P997, DOI 10.1016/S0006-3223(99)00039-6; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; Gabis L, 2005, EPILEPSY BEHAV, V7, P652, DOI 10.1016/j.yebeh.2005.08.008; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; GIBBERD FB, 1966, BRAIN, V89, P531, DOI 10.1093/brain/89.3.531; Gibbs FA, 1935, ARCH NEURO PSYCHIATR, V34, P1133, DOI 10.1001/archneurpsyc.1935.02250240002001; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; Glatt K, 1997, GENOMICS, V41, P63, DOI 10.1006/geno.1997.4639; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; Handforth A, 2005, EPILEPSIA, V46, P1860, DOI 10.1111/j.1528-1167.2005.00287.x; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; HERTOFT P, 1963, EPILEPSIA, V4, P298, DOI 10.1111/j.1528-1157.1963.tb05227.x; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; KIRKNESS EF, 1993, J BIOL CHEM, V268, P4420; Korpi ER, 2002, PROG NEUROBIOL, V67, P113, DOI 10.1016/S0301-0082(02)00013-8; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lennox WG, 1960, EPILEPSY RELATED DIS, V1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liljelund P, 2005, DEV BRAIN RES, V157, P150, DOI 10.1016/j.devbrainres.2005.03.014; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; LOISEAU P, 1995, EPILEPSIA, V36, P1182, DOI 10.1111/j.1528-1157.1995.tb01060.x; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; METRAKOS JD, 1966, CLIN PEDIATR, V5, P536, DOI 10.1177/000992286600500908; METRAKOS K, 1961, ELECTROEN CLIN NEURO, V13, P289, DOI 10.1016/0013-4694(61)90146-8; METRAKOS K, 1961, NEUROLOGY, V11, P474, DOI 10.1212/WNL.11.6.474; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Minassian BA, 1998, ANN NEUROL, V43, P485, DOI 10.1002/ana.410430412; MINSHEW NJ, 1991, PEDIATRICS, V87, P774; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Morita R, 1999, EPILEPSY RES, V37, P151, DOI 10.1016/S0920-1211(99)00061-3; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; RAPIN I, 1991, PEDIATRICS, V87, P751; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Taylor PM, 1999, J NEUROSCI, V19, P6360; Urak L, 2006, HUM MOL GENET, V15, P2533, DOI 10.1093/hmg/ddl174; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; ZHANG JH, 1991, DEV BRAIN RES, V58, P289, DOI 10.1016/0165-3806(91)90017-D; ZHANG JH, 1991, J COMP NEUROL, V308, P586, DOI 10.1002/cne.903080407	60	125	138	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1249	1261		10.1016/j.ajhg.2008.04.020	http://dx.doi.org/10.1016/j.ajhg.2008.04.020			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18514161	Bronze, Green Published			2022-12-18	WOS:000256647000003
J	Baptista, J; Mercer, C; Prigmore, E; Gribble, SM; Carter, NP; Maloneys, V; Thomas, NS; Jacobs, PA; Crolla, JA				Baptista, Julia; Mercer, Catherine; Prigmore, Elena; Gribble, Susan M.; Carter, Nigel P.; Maloneys, Viv; Thomas, N. Simon; Jacobs, Patricia A.; Crolla, John A.			Breakpoint mapping and array CGH in translocations: Comparison of a phenotypically normal and an abnormal cohort	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BALANCED CHROMOSOME REARRANGEMENTS; COMPARATIVE GENOMIC HYBRIDIZATION; SEVERE MENTAL-RETARDATION; RECIPROCAL TRANSLOCATIONS; DNA MICROARRAYS; GENE; DISRUPTION; DELETIONS; PATIENT; IDENTIFICATION	We report the analyses of breakpoints in 31 phenotypically normal and 14 abnormal carriers of balanced translocations. Our study assesses the differences between balanced translocations in normal carriers and those in abnormal carriers, focusing on the presence of genomic imbalances at the breakpoints or elsewhere in the genome, presence of cryptic chromosome rearrangements, and gene disruption. Our hypothesis is that all four features will be associated with phenotypic abnormalities and absent or much less frequent in a normal population. In the normal cohort, we identified neither genomic imbalances at the breakpoints or elsewhere in the genome nor cryptic chromosome rearrangements.. In contrast, we identified candidate disease-causing imbalances in 4/14 abnormal patients. These were three breakpoint associated deletions and three deletions unrelated to the breakpoints. All six de novo deletions originated on the paternally inherited chromosome. Additional complexity was also present in one of these cases. Gene disruption by the breakpoints was present in 16/31 phenotypically normal individuals and in 5/14 phenotypically abnormal patients. Our results show that translocations in phenotypically abnormal patients are molecularly distinct from those in normal individuals: the former are more likely to be associated with genomic imbalances at the breakpoints or elsewhere and with chromosomal complexity, whereas the frequency of gene disruption is similar in both normal and abnormal translocation carriers.	[Baptista, Julia; Thomas, N. Simon; Jacobs, Patricia A.; Crolla, John A.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Baptista, Julia; Thomas, N. Simon; Jacobs, Patricia A.; Crolla, John A.] Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England; [Mercer, Catherine] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Prigmore, Elena; Gribble, Susan M.; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge, England; [Maloneys, Viv] Salisbury Hosp NHS Trust, Natl Genet Ref Lab Wessex, Salisbury, Wilts, England	Salisbury District Hospital; University of Southampton; Wellcome Trust Sanger Institute; Salisbury District Hospital	Crolla, JA (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England.	john.crolla@salisbury.nhs.uk	Baptista, Julia/AGR-5239-2022	Baptista, Julia/0000-0003-0915-5028	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Astbury C, 2004, GENET MED, V6, P81, DOI 10.1097/01.GIM.0000117850.04443.C9; Baptista J, 2005, EUR J HUM GENET, V13, P1205, DOI 10.1038/sj.ejhg.5201488; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Borg I, 2005, EUR J HUM GENET, V13, P921, DOI 10.1038/sj.ejhg.5201429; Borg I, 2002, J MED GENET, V39, P391, DOI 10.1136/jmg.39.6.391; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Ciccone R, 2005, HUM GENET, V117, P571, DOI 10.1007/s00439-005-1324-x; Cox JJ, 2003, J MED GENET, V40, P169, DOI 10.1136/jmg.40.3.169; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Feng Y, 2005, MOL PSYCHIATR, V10, P998, DOI 10.1038/sj.mp.4001722; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fiegler H, 2003, J MED GENET, V40, P664, DOI 10.1136/jmg.40.9.664; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; Hayashi S, 2007, AM J MED GENET A, V143A, P1191, DOI 10.1002/ajmg.a.31737; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Johnson D, 2006, J MED GENET, V43, P280, DOI 10.1136/jmg.2005.032946; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kumar A, 1998, HUM GENET, V103, P173; Madan K, 1997, HUM GENET, V99, P806, DOI 10.1007/s004390050453; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Patsalis PC, 2004, EUR J HUM GENET, V12, P647, DOI 10.1038/sj.ejhg.5201211; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3; TOMMERUP N, 1993, J MED GENET, V30, P713, DOI 10.1136/jmg.30.9.713; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Wirth J, 1999, J MED GENET, V36, P271; Yue Y, 2005, HUM GENET, V117, P1, DOI 10.1007/s00439-005-1273-4; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	35	125	129	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					927	936		10.1016/j.ajhg.2008.02.012	http://dx.doi.org/10.1016/j.ajhg.2008.02.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18371933	Green Published, Bronze			2022-12-18	WOS:000255103900011
J	Bauchet, M; McEvoy, B; Pearson, LN; Quillen, EE; Sarkisian, T; Hovhannesyan, K; Deka, R; Bradley, DG; Shriver, MD				Bauchet, Marc; McEvoy, Brian; Pearson, Laurel N.; Quillen, Ellen E.; Sarkisian, Tamara; Hovhannesyan, Kristine; Deka, Ranjan; Bradley, Daniel G.; Shriver, Mark D.			Measuring European population stratification with microarray genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRINCIPAL-COMPONENTS; ORIGINS; INFERENCE; PATTERNS; GENOME	A proper understanding of population genetic stratification - differences in individual ancestry within a population - is crucial in attempts to find genes for complex traits through association mapping. We report on genomewide typing of similar to 10,000 single-nucleotide polymorphisms in 297 individuals, to explore population structure in Europeans of known and unknown ancestry. The results reveal the presence of several significant axes of stratification, most prominently in a northern-southeastern trend, but also along an east-west axis. We also demonstrate the selection and application of EuroAIMs ( European ancestry informative markers) for ancestry estimation and correction. The Coriell Caucasian and CEPH ( Centre d'E tude du Polymorphisme Humain) Utah sample panels, often used as proxies for European populations, are found to reflect different subsets of the continent's ancestry.	Penn State Univ, Dept Anthropol, University Pk, PA 16801 USA; Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; Ctr Med Genet & Primary Hlth Care, Yerevan, Armenia; Univ Montreal, Hop St Justine, Ctr Rech, Montreal, PQ H3C 3J7, Canada; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45221 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Trinity College Dublin; Universite de Montreal; University System of Ohio; University of Cincinnati	Bauchet, M (corresponding author), Penn State Univ, Dept Anthropol, Carpenter Bldg 409, University Pk, PA 16801 USA.	marcb@psu.edu	Bradley, Daniel G/A-3240-2012	Bradley, Daniel G/0000-0001-7335-7092; Sarkisian, Tamara/0000-0002-4767-7567; Shriver, Mark/0000-0003-0006-0479; Quillen, Ellen/0000-0003-2033-8693	NHGRI NIH HHS [HG002154, R01 HG002154] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bauduer F, 2005, HUM BIOL, V77, P619, DOI 10.1353/hub.2006.0001; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chae SS, 2006, COMPUT STAT DATA AN, V50, P1407, DOI 10.1016/j.csda.2005.01.013; CHAKRABORTY R, 1993, EXS, V67, P153; Chessel D, 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; MANTEL N, 1967, CANCER RES, V27, P209; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shriver Mark D., 2005, Human Genomics, V2, P81; Shriver Mark D, 2004, Hum Genomics, V1, P274; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	29	125	127	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					948	956		10.1086/513477	http://dx.doi.org/10.1086/513477			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436249	Green Published, Bronze			2022-12-18	WOS:000245973200013
J	Chatterjee, N; Kalaylioglu, Z; Moslehi, R; Peters, U; Wacholder, S				Chatterjee, Nilanjan; Kalaylioglu, Zeynep; Moslehi, Roxana; Peters, Ulrike; Wacholder, Sholom			Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-ACETYLTRANSFERASE; LINKAGE ANALYSIS; COMPLEX TRAITS; GENOTYPE DATA; DISEASE; STRATEGIES; DETERMINANTS; IDENTITY; SAMPLE; LOCI	In modern genetic epidemiology studies, the association between the disease and a genomic region, such as a candidate gene, is often investigated using multiple SNPs. We propose a multilocus test of genetic association that can account for genetic effects that might be modified by variants in other genes or by environmental factors. We consider use of the venerable and parsimonious Tukey's 1-degree-of-freedom model of interaction, which is natural when individual SNPs within a gene are associated with disease through a common biological mechanism; in contrast, many standard regression models are designed as if each SNP has unique functional significance. On the basis of Tukey's model, we propose a novel but computationally simple generalized test of association that can simultaneously capture both the main effects of the variants within a genomic region and their interactions with the variants in another region or with an environmental exposure. We compared performance of our method with that of two standard tests of association, one ignoring gene-gene/gene-environment interactions and the other based on a saturated model of interactions. We demonstrate major power advantages of our method both in analysis of data from a case-control study of the association between colorectal adenoma and DNA variants in the NAT2 genomic region, which are well known to be related to a common biological phenotype, and under different models of gene-gene interactions with use of simulated data.	NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Informat Management Syst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center	Chatterjee, N (corresponding author), 6120 Execut Blvd,EPS 8038, Rockville, MD 20852 USA.	chattern@mail.nih.gov	Kalaylioglu, Zeynep/AAZ-7260-2020		NATIONAL CANCER INSTITUTE [Z01CP010181] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; DUPUIS J, 1995, GENETICS, V140, P843; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2001, HUM HERED, V52, P34, DOI 10.1159/000053352; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; HEIN DW, 1994, HUM MOL GENET, V3, P729; HEIN DW, 1995, P W PHARMACOL SOC, V38, P59; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HODGE SE, 1981, AM J HUM GENET, V33, P381; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; Lin DY, 2004, GENET EPIDEMIOL, V27, P202, DOI 10.1002/gepi.20017; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Peng J, 2005, GENET EPIDEMIOL, V29, P173, DOI 10.1002/gepi.20100; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SCHEFFE H, 1959, ANAL VARIANCE, P129; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	39	125	127	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1002	1016		10.1086/509704	http://dx.doi.org/10.1086/509704			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186459	Green Published, Bronze			2022-12-18	WOS:000242131600002
J	Grupe, A; Li, YH; Rowland, C; Nowotny, P; Hinrichs, AL; Smemo, S; Kauwe, JSK; Maxwell, TJ; Cherny, S; Doil, L; Tacey, K; van Luchene, R; Myers, A; Vrieze, FW; Kaleem, M; Hollingworth, P; Jehu, L; Foy, C; Archer, N; Hamilton, G; Holmans, P; Morris, CM; Catanese, J; Sninsky, J; White, TJ; Powell, J; Hardy, J; O'Donovan, M; Lovestone, S; Jones, L; Morris, JC; Thal, L; Owen, M; Williams, J; Goate, A				Grupe, A; Li, YH; Rowland, C; Nowotny, P; Hinrichs, AL; Smemo, S; Kauwe, JSK; Maxwell, TJ; Cherny, S; Doil, L; Tacey, K; van Luchene, R; Myers, A; Vrieze, FW; Kaleem, M; Hollingworth, P; Jehu, L; Foy, C; Archer, N; Hamilton, G; Holmans, P; Morris, CM; Catanese, J; Sninsky, J; White, TJ; Powell, J; Hardy, J; O'Donovan, M; Lovestone, S; Jones, L; Morris, JC; Thal, L; Owen, M; Williams, J; Goate, A			A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIBOSOMAL-PROTEIN S3A; HAPLOTYPE RECONSTRUCTION; SUSCEPTIBILITY LOCUS; GENOME SCREEN; HUMAN BRAIN; GENE; POPULATION; LINKAGE; GENOTYPE; FAMILIES	Strong evidence of linkage to late-onset Alzheimer disease ( LOAD) has been observed on chromosome 10, which implicates a wide region and at least one disease-susceptibility locus. Although significant associations with several biological candidate genes on chromosome 10 have been reported, these findings have not been consistently replicated, and they remain controversial. We performed a chromosome 10-specific association study with 1,412 genebased single-nucleotide polymorphisms ( SNPs), to identify susceptibility genes for developing LOAD. The scan included SNPs in 677 of 1,270 known or predicted genes; each gene contained one or more markers, about half (48%) of which represented putative functional mutations. In general, the initial testing was performed in a white case-control sample from the St. Louis area, with 419 LOAD cases and 377 age-matched controls. Markers that showed significant association in the exploratory analysis were followed up in several other white case-control sample sets to confirm the initial association. Of the 1,397 markers tested in the exploratory sample, 69 reached significance (P < .05). Five of these markers replicated at P < .05 in the validation sample sets. One marker, rs498055, located in a gene homologous to RPS3A ( LOC439999), was significantly associated with Alzheimer disease in four of six case-control series, with an allelic P value of .0001 for a meta-analysis of all six samples. One of the case-control samples with significant association to rs498055 was derived from the linkage sample (P = .0165). These results indicate that variants in the RPS3A homologue are associated with LOAD and implicate this gene, adjacent genes, or other functional variants ( e. g., noncoding RNAs) in the pathogenesis of this disorder.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Biol, St Louis, MO 63110 USA; Washington Univ, Dept Genet, St Louis, MO 63110 USA; Celera Diagnost, Alameda, CA USA; NIA, Bethesda, MD 20892 USA; Cardiff Univ, Dept Psychol Med, Wales Coll Med, Cardiff, Wales; Cardiff Univ, Biostat & Bioinformat Unit, Wales Coll Med, Cardiff, Wales; Kings Coll London, Dept Neurosci, Inst Psychiat, London WC2R 2LS, England; Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cardiff University; Cardiff University; University of London; King's College London; Newcastle General Hospital; Newcastle University - UK; University of California System; University of California San Diego	Goate, A (corresponding author), Washington Univ, Sch Med, Dept Psychiat, B8134,660 S Euclid Ave, St Louis, MO 63110 USA.	goate@icarus.wustl.edu	Lovestone, Simon/E-8725-2010; Cherny, Stacey S/B-3315-2008; O'Donovan, Michael C/P-7005-2018; Powell, John F/G-4412-2011; Kauwe, John/AAC-6646-2021; Kauwe, John/B-2034-2009; Morris, John C/A-1686-2012; Myers, Amanda J/B-1796-2010; Hunter, Gillian/A-1952-2015; Hardy, John/C-2451-2009; Holmans, Peter/F-4518-2015	Cherny, Stacey S/0000-0002-0269-3352; O'Donovan, Michael C/0000-0001-7073-2379; Powell, John F/0000-0001-6124-439X; Kauwe, John/0000-0001-8641-2468; Kauwe, John/0000-0001-8641-2468; Myers, Amanda J/0000-0002-3100-9396; Hardy, John/0000-0002-3122-0423; Holmans, Peter/0000-0003-0870-9412; Lovestone, Simon/0000-0003-0473-4565; Li, Yonghong/0000-0001-7326-0717; Morris, Christopher/0000-0002-3749-0993; Williams, Julie/0000-0002-4069-0259; Goate, Alison/0000-0002-0576-2472	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046373, U01MH046281, U01MH046290, P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, P50AG008671, U24AG021886, P50AG005131, P50AG005681, P50AG005128, P50AG005146, Z01AG000950, P01AG003991, R01AG016208] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0300429, G0701075, G9810900] Funding Source: Medline; NHGRI NIH HHS [T32 HG000045] Funding Source: Medline; NIA NIH HHS [P50 AG008671, P01 AG03991, P50-AG08671, AG05128, AG 05146, P50 AG005146, R01 AG16208, P50 AG016570, P50 AG005128, P50 AG16570, P50 AG05681, P50 AG005681, U24 AG021886, P50 AG005131, R01 AG016208, P50 AG05131, P01 AG003991] Funding Source: Medline; NIGMS NIH HHS [P50 GM065509, GM065509] Funding Source: Medline; NIMH NIH HHS [U01 MH046281, MH60451, U01 MH046373, U01 MH046290, P50 MH060451] Funding Source: Medline; NINDS NIH HHS [NS39764, P50 NS039764] Funding Source: Medline; MRC [G0300429, G9810900] Funding Source: UKRI	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Balciuniene J, 2002, HUM GENET, V110, P1; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Hu ZB, 2000, BLOOD, V95, P1047, DOI 10.1182/blood.V95.3.1047.003k43_1047_1055; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Knoblauch H, 2002, HUM MOL GENET, V11, P1477, DOI 10.1093/hmg/11.12.1477; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YH, 2005, HUM MUTAT, V25, P270, DOI 10.1002/humu.20138; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Myers AJ, 2004, AM J MED GENET B, V124B, P29, DOI 10.1002/ajmg.b.20036; Nowotny P, 2005, AM J MED GENET B, V136B, P62, DOI 10.1002/ajmg.b.30186; Pastor Pau, 2004, Curr Psychiatry Rep, V6, P125, DOI 10.1007/s11920-004-0052-6; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Song DM, 2002, BIOCHEMISTRY-US, V41, P929, DOI 10.1021/bi015669c; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; Templeton AR, 2000, GENETICS, V156, P1259; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Westfall P.H., 1993, RESAMPLING BASED MUL	38	125	132	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					78	88		10.1086/498851	http://dx.doi.org/10.1086/498851			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385451	Green Published, Bronze			2022-12-18	WOS:000233930400008
J	Zeng, WQ; Al-Yamani, E; Acierno, JS; Slaugenhaupt, S; Gillis, T; MacDonald, ME; Ozand, PT; Gusella, JF				Zeng, WQ; Al-Yamani, E; Acierno, JS; Slaugenhaupt, S; Gillis, T; MacDonald, ME; Ozand, PT; Gusella, JF			Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL STRIATAL NECROSIS; ANEMIA GENE SLC19A2; MEGALOBLASTIC-ANEMIA; HOLOCARBOXYLASE SYNTHETASE; FUNCTIONAL EXPRESSION; LINKAGE ANALYSIS; TRANSPORTER; DEFICIENCY; ENCODES; PATIENT	Biotin- responsive basal ganglia disease ( BBGD) is a recessive disorder with childhood onset that presents as a subacute encephalopathy, with confusion, dysarthria, and dysphagia, and that progresses to severe cogwheel rigidity, dystonia, quadriparesis, and eventual death, if left untreated. BBGD symptoms disappear within a few days with the administration of high doses of biotin ( 5 - 10 mg/ kg/ d). On brain magnetic resonance imaging examination, patients display central bilateral necrosis in the head of the caudate, with complete or partial involvement of the putamen. All patients diagnosed to date are of Saudi, Syrian, or Yemeni ancestry, and all have consanguineous parents. Using linkage analysis in four families, we mapped the genetic defect near marker D2S2158 in 2q36.3 (;) to a minimum candidate region (similar to 2 Mb) between D2S2354 and D2S1256, on the basis of LOD p 5.9 v p 0.0 complete homozygosity. In this segment, each family displayed one of two different missense mutations that altered the coding sequence of SLC19A3, the gene for a transporter related to the reduced- folate ( encoded by SLC19A1) and thiamin ( encoded by SLC19A2) transporters.	Massachusetts Gen Hosp E, Ctr Human Genet Res, Mol Neurogenet Unit, Charlestown, MA 02129 USA; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Gusella, JF (corresponding author), Massachusetts Gen Hosp E, Ctr Human Genet Res, Mol Neurogenet Unit, Room 6214,149 13th St, Charlestown, MA 02129 USA.	gusella@helix.mgh.harvard.edu		Acierno, James/0000-0002-5301-4970	NINDS NIH HHS [P50 NS016367, NS16367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, P50NS016367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki Y, 1995, BBA-MOL BASIS DIS, V1272, P168, DOI 10.1016/0925-4439(95)00082-8; Balamurugan K, 2002, AM J PHYSIOL-GASTR L, V283, pG37, DOI 10.1152/ajpgi.00547.2001; Baron D, 2002, MOL MED, V8, P462, DOI 10.1007/BF03402026; Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69; BUCK SH, 1981, BRAIN RES, V209, P464, DOI 10.1016/0006-8993(81)90171-2; COMBS GF, 1992, VITAMINS FUNDAMENTAL, P329; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Dupuis L, 1996, HUM MOL GENET, V5, P1011, DOI 10.1093/hmg/5.7.1011; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; FINCH CE, 1980, ANN NEUROL, V7, P406, DOI 10.1002/ana.410070503; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; FOIS A, 1986, J INHERIT METAB DIS, V9, P284, DOI 10.1007/BF01799663; FUJITA K, 1994, PEDIATR NEUROL, V10, P157, DOI 10.1016/0887-8994(94)90050-7; GASCON GG, 1994, BRAIN DEV-JPN, V16, P94, DOI 10.1016/0387-7604(94)90102-3; Gritli S, 2001, BRIT J HAEMATOL, V113, P508, DOI 10.1046/j.1365-2141.2001.02774.x; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Lagarde WH, 2004, AM J MED GENET A, V125A, P299, DOI 10.1002/ajmg.a.20506; Larsen PD, 1996, PEDIATR INFECT DIS J, V15, P1124, DOI 10.1097/00006454-199612000-00015; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LEUZZI V, 1992, J NEUROL NEUROSUR PS, V55, P16, DOI 10.1136/jnnp.55.1.16; MARTIN JJ, 1988, J NEUROL SCI, V84, P189, DOI 10.1016/0022-510X(88)90124-4; McMahon RJ, 2002, ANNU REV NUTR, V22, P221, DOI 10.1146/annurev.nutr.22.121101.112819; MEDINA L, 1990, AM J NEURORADIOL, V11, P379; MOSS J, 1971, ADV ENZYMOL RAMB, V35, P321; Narisawa K, 1996, Nihon Rinsho, V54, P259; Okiyama R, 1994, No To Shinkei, V46, P579; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; POMPONIO RJ, 1995, NAT GENET, V11, P96, DOI 10.1038/ng0995-96; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Rajgopal A, 2001, BBA-MOL BASIS DIS, V1537, P175, DOI 10.1016/S0925-4439(01)00073-4; Raz T, 2000, HUM MUTAT, V16, P37, DOI 10.1002/1098-1004(200007)16:1<37::AID-HUMU7>3.0.CO;2-9; Rodriguez-Melendez R, 2003, J NUTR BIOCHEM, V14, P680, DOI 10.1016/j.jnutbio.2003.07.001; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Scharfe C, 2000, J MED GENET, V37, P669, DOI 10.1136/jmg.37.9.669; SENER RN, 1993, PEDIATR RADIOL, V23, P157, DOI 10.1007/BF02012417; SOLAMARTINEZ MT, 1994, NEURORADIOLOGY, V36, P245, DOI 10.1007/BF00588144; SPECTOR R, 1987, J NEUROCHEM, V48, P400, DOI 10.1111/j.1471-4159.1987.tb04107.x; Straussberg R, 2002, NEUROLOGY, V59, P983, DOI 10.1212/WNL.59.7.983; SUCHY SF, 1985, NEUROLOGY, V35, P1510, DOI 10.1212/WNL.35.10.1510; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vlasova TI, 2005, J NUTR, V135, P42, DOI 10.1093/jn/135.1.42; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; WOLF B, 1982, AM J HUM GENET, V34, P699; Zambrino CA, 2000, MOVEMENT DISORD, V15, P1023, DOI 10.1002/1531-8257(200009)15:5<1023::AID-MDS1045>3.0.CO;2-A	53	125	137	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					16	26		10.1086/431216	http://dx.doi.org/10.1086/431216			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15871139	Bronze, Green Published			2022-12-18	WOS:000229794500002
J	Tsutsumi, S; Kamata, N; Vokes, TJ; Maruoka, Y; Nakakuki, K; Enomoto, S; Omura, K; Amagasa, T; Nagayama, M; Saito-Ohara, F; Inazawa, J; Moritani, M; Yamaoka, T; Inoue, H; Itakura, M				Tsutsumi, S; Kamata, N; Vokes, TJ; Maruoka, Y; Nakakuki, K; Enomoto, S; Omura, K; Amagasa, T; Nagayama, M; Saito-Ohara, F; Inazawa, J; Moritani, M; Yamaoka, T; Inoue, H; Itakura, M			The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIODONTAL-LIGAMENT ORIGIN; FIBROOSSEOUS LESIONS; OSTEOSARCOMA CELLS; CALCIUM; CA2+	Gnathodiaphyseal dysplasia (GDD) is a rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. By linkage analysis of a large Japanese family with GDD, we previously mapped the GDD locus to chromosome 11p14.3-15.1. In the critical region determined by recombination mapping, we identified a novel gene (GDD1) that encodes a 913-amino-acid protein containing eight putative transmembrane-spanning domains. Two missense mutations (C356R and C356G) of GDD1 were identified in the two families with GDD (the original Japanese family and a new African American family), and both missense mutations occur at the cysteine residue at amino acid 356, which is evolutionarily conserved among human, mouse, zebrafish, fruit fly, and mosquito. Cellular localization to the endoplasmic reticulum suggests a role for GDD1 in the regulation of intracellular calcium homeostasis.	Univ Tokushima, Dept Oral & Maxillofacial Surg 1, Sch Dent, Tokushima 770, Japan; Univ Tokushima, Div Genet Informat, Inst Genome Res, Tokushima 770, Japan; Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; Tokyo Med & Dent Univ, Sect Oral Surg, Dept Oral Restitut, Div Oral Hlth Sci, Tokyo, Japan; Tokyo Med & Dent Univ, Sect Maxillofacial Surg, Grad Sch, Tokyo, Japan; Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Tokyo, Japan	Tokushima University; Tokushima University; University of Chicago; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kamata, N (corresponding author), Hiroshima Univ, Dept Oral & Maxillofacial Surg, Div Cervicognathostomatol, Grad Sch Biomed Sci,Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	nokam@hiroshima-u.ac.jp			NCRR NIH HHS [M01RR00055, M01 RR000055] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akasaka Y, 1969, Nihon Seikeigeka Gakkai Zasshi, V43, P381; COLAVITA N, 1984, Australasian Radiology, V28, P226, DOI 10.1111/j.1440-1673.1984.tb02511.x; HAHN TJ, 1988, J BONE MINER RES, V3, P359; KUMAGAI H, 1991, J BONE MINER RES, V6, P697; LEVIN LS, 1985, AM J MED GENET, V21, P257, DOI 10.1002/ajmg.1320210207; LJUNGGREN O, 1991, J BONE MINER RES, V6, P443; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; MESZAROS JG, 1995, J BONE MINER RES, V10, P704; NEVILLE BW, 1986, ORAL SURG ORAL MED O, V62, P340, DOI 10.1016/0030-4220(86)90018-6; Nishimura G, 1996, SKELETAL RADIOL, V25, P717, DOI 10.1007/s002560050167; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Riminucci M, 2001, J BONE MINER RES, V16, P1710, DOI 10.1359/jbmr.2001.16.9.1710; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tsutsumi S, 2003, J BONE MINER RES, V18, P413, DOI 10.1359/jbmr.2003.18.3.413; WALDRON CA, 1973, ORAL SURG ORAL MED O, V35, P340, DOI 10.1016/0030-4220(73)90072-8	16	125	137	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1255	1261		10.1086/421527	http://dx.doi.org/10.1086/421527			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15124103	Green Published, Bronze			2022-12-18	WOS:000221651900018
J	Dagoneau, N; Scheffer, D; Huber, C; Al-Gazali, LI; Di Rocco, M; Godard, A; Martinovic, J; Raas-Rothschild, A; Sigaudy, S; Unger, S; Nicole, S; Fontaine, B; Taupin, JL; Moreau, JF; Superti-Furga, A; Le Merrer, M; Bonaventure, J; Munnich, A; Legeai-Mallet, L; Cormier-Daire, V				Dagoneau, N; Scheffer, D; Huber, C; Al-Gazali, LI; Di Rocco, M; Godard, A; Martinovic, J; Raas-Rothschild, A; Sigaudy, S; Unger, S; Nicole, S; Fontaine, B; Taupin, JL; Moreau, JF; Superti-Furga, A; Le Merrer, M; Bonaventure, J; Munnich, A; Legeai-Mallet, L; Cormier-Daire, V			Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; AFFINITY; SURVIVAL; PATHWAYS; SKELETAL; DEFECTS; KINASE; GP130; CHAIN	Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality. Clinical overlap with Schwartz-Jampel type 2 syndrome (SJS2) has suggested that SWS and SJS2 could be allelic disorders. Through studying a series of 19 families with SWS/SJS2, we have mapped the disease gene to chromosome 5p13.1 at locus D5S418 (Z(max)=10.66 at theta=0) and have identified null mutations in the leukemia inhibitory factor receptor (LIFR or gp190 chain) gene. A total of 14 distinct mutations were identified in the 19 families. An identical frameshift insertion (653_654insT) was identified in families from the United Arab Emirates, suggesting a founder effect in that region. It is interesting that 12/14 mutations predicted premature termination of translation. Functional studies indicated that these mutations alter the stability of LIFR messenger RNA transcripts, resulting in the absence of the LIFR protein and in the impairment of the JAK/STAT3 signaling pathway in patient cells. We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.	Hop Necker Enfants Malad, Dept Med Genet, F-75015 Paris, France; Univ Paris 06, INSERM, U546, Paris, France; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Ist Giannina Gaslini, Unit Pediat 2, I-16148 Genoa, Italy; Inst Biol, INSERM, U463, Nantes, France; Hadassah Univ, Med Ctr, Dept Genet, Jerusalem, Israel; Hop Enfants La Timone, Marseille, France; Univ Toronto, Div Clin & Genet Metab, Toronto, ON, Canada; Univ Bordeaux 2, CNRS, UMR 5540, F-33076 Bordeaux, France; Univ Lausanne, Dept Pediat, Lausanne, Switzerland; Hop Necker Enfants Malad, INSERM, U393, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; United Arab Emirates University; University of Genoa; IRCCS Istituto Giannina Gaslini; Institut National de la Sante et de la Recherche Medicale (Inserm); Hebrew University of Jerusalem; Hadassah University Medical Center; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Hop Necker Enfants Malad, Dept Med Genet, 149 Rue Sevres, F-75015 Paris, France.	cormier@necker.fr	superti-furga, andrea/E-9162-2015; Legeai-Mallet, Laurence/E-6112-2016; unger, sheila/E-9177-2015; cormier-daire, valerie/H-6520-2017; NICOLE, Sophie/N-4348-2018	superti-furga, andrea/0000-0002-3543-7531; Legeai-Mallet, Laurence/0000-0003-4989-5856; Scheffer, Deborah/0000-0002-6066-5907; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655; NICOLE, Sophie/0000-0001-8793-7928; Unger, Sheila/0000-0002-9539-8941				Al-Gazali LI, 2003, CLIN DYSMORPHOL, V12, P1, DOI 10.1097/00019605-200301000-00001; AlGazali LI, 1996, J MED GENET, V33, P203, DOI 10.1136/jmg.33.3.203; ALLAN EH, 1990, J CELL PHYSIOL, V145, P110, DOI 10.1002/jcp.1041450116; Bitard J, 2003, J BIOL CHEM, V278, P16253, DOI 10.1074/jbc.M207193200; Chabrol B, 1997, AM J MED GENET, V72, P222, DOI 10.1002/(SICI)1096-8628(19971017)72:2<222::AID-AJMG18>3.0.CO;2-P; Chen E, 2001, AM J MED GENET, V101, P240, DOI 10.1002/ajmg.1382; Cormier-Daire V, 1998, AM J MED GENET, V78, P146, DOI 10.1002/(SICI)1096-8628(19980630)78:2<146::AID-AJMG9>3.0.CO;2-M; Di Rocco M, 2003, AM J MED GENET A, V118A, P362, DOI 10.1002/ajmg.a.10242; Dziennis S, 2003, J BIOL CHEM, V278, P15897, DOI 10.1074/jbc.M212480200; GEARING DP, 1993, GENOMICS, V18, P148, DOI 10.1006/geno.1993.1441; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GODARD A, 1992, J BIOL CHEM, V267, P3214; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Kozlowski K, 1996, AM J MED GENET, V63, P17; Lesser SS, 2000, NAT NEUROSCI, V3, P851, DOI 10.1038/78738; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Liu F, 2002, BONE, V31, P212, DOI 10.1016/S8756-3282(02)00806-2; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Starr R, 1997, J BIOL CHEM, V272, P19982, DOI 10.1074/jbc.272.32.19982; STUVE A, 1971, LANCET, V2, P495, DOI 10.1016/S0140-6736(71)92666-3; Superti-Furga A, 1998, AM J MED GENET, V78, P150, DOI 10.1002/(SICI)1096-8628(19980630)78:2<150::AID-AJMG10>3.0.CO;2-M; Tomida M, 1996, J BIOCHEM-TOKYO, V120, P201; WARE CB, 1995, DEVELOPMENT, V121, P1283	26	125	127	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					298	305		10.1086/381715	http://dx.doi.org/10.1086/381715			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740318	Green Published, Bronze			2022-12-18	WOS:000188860000010
J	McCandless, SE; Brunger, JW; Cassidy, SB				McCandless, SE; Brunger, JW; Cassidy, SB			The burden of genetic disease on inpatient care in a children's hospital	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOLYTIC-UREMIC SYNDROME; CONGENITAL-ANOMALIES; BIRTH-DEFECTS; FREQUENCY; UNIT; MORTALITY; POPULATION	The important role of genetics in pediatric illness has been increasingly recognized, but the true impact has not been well delineated. An important study of pediatric inpatient admissions to a children's hospital in 1978 found a genetic basis for disease in just less than half of admitted patients. We sought to update this study in light of current hospitalization practices and new knowledge about genetics. We systematically reviewed the records of 5,747 consecutive admissions ( 4,224 individuals), representing 98% of patients admitted in 1996 to Rainbow Babies and Children's Hospital ( Cleveland, OH). Each patient was assigned to one of five groups on the basis of the presence or absence of an underlying chronic medical condition and whether that condition had a genetic basis or susceptibility. An underlying disorder with a significant genetic component was found in 71% of admitted children. The vast majority (96%) of underlying chronic disorders in children in this study were either clearly genetic or had a genetic susceptibility. Total charges for 1996 were >$62 million, of which $50 million (81%) was accounted for by disorders with a genetic determinant. The 34% of admissions with clearly genetic underlying disorders accounted for 50% (>$31 million) of the total hospital charges. The mean length of stay was 40% longer for individuals with an underlying disease with a genetic basis than for those with no underlying disease. Charges and length of stay were similar for children with underlying chronic disorders, regardless of the cause. This study begins to quantify the enormous impact of genetic disease on inpatient pediatrics and the health care system. Additional study and frank public discourse are needed to understand the implications on the future health care workforce and on the utilization of health care resources.	Case Western Reserve Univ, Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Pediat, Cleveland, OH 44106 USA; Roswell Pk Canc Inst, Dept Canc Genet, Clin Genet Serv, Buffalo, NY 14263 USA; Univ Calif Irvine, Sch Med, Div Human Genet, Dept Pediat, Irvine, CA 92717 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Roswell Park Cancer Institute; University of California System; University of California Irvine	McCandless, SE (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Ctr Human Genet, 11100 Euclid Ave,1500 Lakeside, Cleveland, OH 44106 USA.							CARNEVALE A, 1985, AM J MED GENET, V20, P665, DOI 10.1002/ajmg.1320200412; CHUNG CS, 1987, AM J MED GENET, V27, P505, DOI 10.1002/ajmg.1320270304; CUNNIFF C, 1995, PEDIATRICS, V95, P678; DAY N, 1973, AM J HUM GENET, V25, P237; FITZPATRICK DR, 1991, ARCH DIS CHILD, V66, P639, DOI 10.1136/adc.66.5.639; Hall JG, 1997, ARCH PEDIAT ADOL MED, V151, P1082, DOI 10.1001/archpedi.1997.02170480012002; HALL JG, 1978, AM J MED GENET, V1, P417, DOI 10.1002/ajmg.1320010405; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; LING EW, 1991, AM J PERINAT, V8, P164, DOI 10.1055/s-2007-999369; LING EWY, 1992, SEMIN PERINATOL, V16, P352; McKusick V.A., 1998, MENDELIAN INHERITANC; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; SCRIVER CR, 1973, CAN MED ASSOC J, V108, P1111; Yoon PW, 1997, ARCH PEDIAT ADOL MED, V151, P1096, DOI 10.1001/archpedi.1997.02170480026004	15	125	135	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					121	127		10.1086/381053	http://dx.doi.org/10.1086/381053			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681831	Bronze, Green Published			2022-12-18	WOS:000187723500011
J	Wu, XD; Cooper, RS; Borecki, I; Hanis, C; Bray, M; Lewis, CE; Zhu, XF; Kan, DH; Luke, A; Curb, D				Wu, XD; Cooper, RS; Borecki, I; Hanis, C; Bray, M; Lewis, CE; Zhu, XF; Kan, DH; Luke, A; Curb, D			A combined analysis of genomewide linkage scans for body mass index, from the National Heart, Lung, and Blood Institute Family Blood Pressure Program	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; AUTOSOMAL GENOMIC SCAN; DEPENDENT DIABETES-MELLITUS; OB GENE REGION; EXTREME OBESITY; PIMA-INDIANS; FAT MASS; SUSCEPTIBILITY LOCUS; VARIANCE-COMPONENTS; SIBPAIR LINKAGE	A combined analysis of genome scans for obesity was undertaken using the interim results from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. In this research project, four multicenter networks of investigators conducted eight individual studies. Data were available on 6, 849 individuals from four ethnic groups (white, black, Mexican American, and Asian). The sample represents the largest single collection of genomewide scan data that has been analyzed for obesity and provides a test of the reproducibility of linkage analysis for a complex phenotype. Body mass index (BMI) was used as the measure of adiposity. Genomewide linkage analyses were first performed separately in each of the eight ethnic groups in the four networks, through use of the variance-component method. Only one region in the analyses of the individual studies showed significant linkage with BMI: 3q22.1 (LOD 3.45, for the GENOA network black sample). Six additional regions were found with an associated LOD 1 2, including 3p24.1, 7p15.2, 7q22.3, 14q24.3, 16q12.2, and 17p11.2. Among these findings, the linkage at 7p15.2, 7q22.3, and 17p11.2 has been reported elsewhere. A modified Fisher's omnibus procedure was then used to combine the P values from each of the eight genome scans. A complimentary approach to the meta-analysis was undertaken, combining the average allele-sharing identity by descent ((&pi;) over cap) for whites, blacks, and Mexican Americans. Using this approach, we found strong linkage evidence for a quantitative-trait locus at 3q27 (marker D3S2427; LOD 3.40, P=.03). The same location has been shown to be linked with obesity-related traits and diabetes in at least two other studies. These results (1) confirm the previously reported obesity-susceptibility locus on chromosomes 3, 7, and 17 and (2) demonstrate that combining samples from different studies can increase the power to detect common genes with a small-to-moderate effect, so long as the same gene has an effect in all samples considered.	Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Alabama, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; Pacific Hlth Res Inst, Honolulu, HI USA	Loyola University Chicago; Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; Pacific Health Research & Education Institute	Wu, XD (corresponding author), Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.		Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	NHLBI NIH HHS [UO1 HL54485, HL65702, U01 HL054466, HL54495, U01 HL054495, HL54472, U01 HL054473, HL47910, HL54509, U10 HL054495, U10 HL054464, HL54471, U01 HL054509, R37 HL045508, HL54515, U01 HL054464, HL54466, HL51021, U10 HL054481, HL54496, R37 HL051021, U10 HL054466, U01 HL054471, U01 HL054496, U01 HL054481, U10 HL054473, HL54473, HL54481, U01 HL054485, HL45508, U01 HL054472, U10 HL054472, U10 HL054496, HL54464, U10 HL054471, U10 HL054509] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054471, U10HL054496, U01HL054509, U01HL054466, U10HL054481, R37HL051021, U01HL054464, U01HL054473, R01HL051021, U10HL054495, U10HL054472, U10HL054464, U10HL054466, R37HL045508, R01HL045508, U01HL054472, U01HL054495, U01HL054485, U01HL054481, R03HL065702, U10HL054509, U10HL054473, R01HL047910, U10HL054471, U01HL054496, U10HL054515] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1998, GENETICS, V148, P859; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; [Anonymous], 1932, STAT METHODS RES WOR; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BECK B, 1992, INT J OBESITY, V16, P295; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BORECKI IB, 1991, INT J OBESITY, V15, P763; Borecki IB, 1998, AM J HUM GENET, V63, P831, DOI 10.1086/302006; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Bouchard C., 1998, HDB OBESITY, P157; Bray MS, 1999, GENET EPIDEMIOL, V16, P397; Chagnon YC, 2000, OBES RES, V8, P89, DOI 10.1038/oby.2000.12; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 2001, J MOL MED, V79, P57, DOI 10.1007/s001090100202; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; de Andrade M, 2000, GENET EPIDEMIOL, V19, P333, DOI 10.1002/1098-2272(200012)19:4<333::AID-GEPI5>3.3.CO;2-R; Duggirala R, 1996, AM J HUM GENET, V59, P694; Gu C, 1998, GENET EPIDEMIOL, V15, P609, DOI 10.1002/(SICI)1098-2272(1998)15:6<609::AID-GEPI5>3.0.CO;2-N; Guerra R, 1999, GENET EPIDEMIOL, V17, pS605; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hasstedt SJ, 1997, AM J HUM GENET, V61, P668, DOI 10.1086/515509; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lapsys NM, 1997, OBES RES, V5, P430; Lecomte E, 1997, GENET EPIDEMIOL, V14, P51, DOI 10.1002/(SICI)1098-2272(1997)14:1<51::AID-GEPI4>3.0.CO;2-8; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Li ZH, 1996, GENET EPIDEMIOL, V13, P377, DOI 10.1002/(SICI)1098-2272(1996)13:4<377::AID-GEPI6>3.3.CO;2-5; Lonjou C, 1999, CLIN EXP ALLERGY, V29, P57; Luke A, 2001, INT J OBESITY, V25, P1034, DOI 10.1038/sj.ijo.0801650; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mitchell BD, 1999, DIABETES, V48, P1863, DOI 10.2337/diabetes.48.9.1863; MORLEY JE, 1987, ENDOCR REV, V8, P256, DOI 10.1210/edrv-8-3-256; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Palmer LJ, 2001, HUM MOL GENET, V10, P891, DOI 10.1093/hmg/10.8.891; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; PRICE RA, 1990, HUM BIOL, V62, P747; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; Roth H, 1997, EXP CLIN ENDOCR DIAB, V105, P341, DOI 10.1055/s-0029-1211776; van der Kallen CJH, 2000, INT J OBESITY, V24, P1381, DOI 10.1038/sj.ijo.0801412; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Walder K, 2000, INT J OBESITY, V24, P559, DOI 10.1038/sj.ijo.0801197; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Zhu XF, 2002, DIABETES, V51, P541, DOI 10.2337/diabetes.51.2.541	56	125	129	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1247	1256		10.1086/340362	http://dx.doi.org/10.1086/340362			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11923912	Bronze, Green Published			2022-12-18	WOS:000175012400014
J	van der Velden, PA; Sandkuijl, LA; Bergman, W; Pavel, S; van Mourik, L; Frants, RR; Gruis, NA				van der Velden, PA; Sandkuijl, LA; Bergman, W; Pavel, S; van Mourik, L; Frants, RR; Gruis, NA			Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RED HAIR; PIGMENTATION PHENOTYPE; MSH RECEPTOR; SKIN-CANCER; MUTATIONS; GENE; POLYMORPHISMS; EXPOSURE; ALLELES; MOUSE	Germline mutations of the cell-cycle regulator p16 (also called "CDKN2A") in kindreds with melanoma implicate this gene in susceptibility to malignant melanoma. Most families with familial atypical multiple-mole melanoma (FAMMM) who are registered at the Leiden dermatology clinic share the same p16-inactivating deletion (p16-Leiden). Incomplete penetrance and variable clinical expression suggest risk modification by other genetic and/or environmental factors. Variants of the melanocortin-1 receptor (MC1R) gene have been shown to be associated with red hair, fair skin, and melanoma in humans. Carriers of the p16-Leiden deletion in Dutch families with FAMMM show an increased risk of melanoma when they also carry MC1R variant alleles. The R151C variant is overrepresented in patients with melanoma who are from families with the p16-Leiden mutation. Although some of the effect of the R151C variant on melanoma risk may be attributable to its effect on skin type, our analyses indicate that the R151C variant contributes an increased melanoma risk even after statistical correction for its effect on skin type. These findings suggest that the R151C variant may be involved in melanoma tumorigenesis in a dual manner, both as a determinant of fair skin and as a component in an independent additional pathway.	Leiden Univ, Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gruis, NA (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.			Gruis, Nelleke/0000-0002-5210-9150; van der Velden, Pieter/0000-0002-5710-9256				Armstrong BK, 1996, CANCER SURV, V26, P133; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; BERGMAN W, 1992, CYTOGENET CELL GENET, V59, P161, DOI 10.1159/000133232; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; COUGHLIN SR, 1994, CURR OPIN CELL BIOL, V6, P191, DOI 10.1016/0955-0674(94)90135-X; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; GRUIS NA, 1995, MELANOMA RES, V5, P169, DOI 10.1097/00008390-199506000-00005; Hayward Nicholas K., 1996, Current Opinion in Oncology, V8, P136, DOI 10.1097/00001622-199603000-00011; Healy E, 2000, LANCET, V355, P1072, DOI 10.1016/S0140-6736(00)02042-0; Healy E, 1999, J INVEST DERMATOL, V112, P512, DOI 10.1046/j.1523-1747.1999.00554.x; HENDERSON BE, 1991, SCIENCE, V254, P1131, DOI 10.1126/science.1957166; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; JACKSON IJ, 1994, PIGM CELL RES, V7, P73, DOI 10.1111/j.1600-0749.1994.tb00024.x; Kamb A, 1994, Nat Genet, V8, P23; KAMB A, 1994, SCIENCE, V264, P440; KENNEDY C, IN PRESS J INVEST DE; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Piepkorn M, 2000, J AM ACAD DERMATOL, V42, P705, DOI 10.1067/mjd.2000.104687; Rees JL, 1999, ANN NY ACAD SCI, V885, P134; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	39	125	128	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					774	779		10.1086/323411	http://dx.doi.org/10.1086/323411			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11500806	Green Published, Bronze			2022-12-18	WOS:000171008200010
J	Duggirala, R; Blangero, J; Almasy, L; Arya, R; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP				Duggirala, R; Blangero, J; Almasy, L; Arya, R; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP			A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DEPENDENT DIABETES-MELLITUS; MEMBRANE GLYCOPROTEIN PC-1; QUANTITATIVE TRAIT LOCUS; AUTOSOMAL GENOMIC SCAN; HOMEOSTASIS MODEL ASSESSMENT; MULTIPOINT LINKAGE ANALYSIS; CARDIOVASCULAR RISK-FACTORS; SUSCEPTIBILITY LOCUS; LEPTIN CONCENTRATIONS; GLUCOSE-TOLERANCE	Insulin resistance and hyperinsulinemia are strong correlates of obesity and type 2 diabetes, but little is known about their genetic determinants. Using data on nondiabetics from Mexican American families and a multipoint linkage approach, we scanned the genome and identified a major locus near marker D6S403 for fasting "true" insulin levels (LOD score 4.1, empirical P < .0001), which do not crossreact with insulin precursors. Insulin resis tance, as assessed by the homeostasis model using fasting glucose and specific insulin (FSI) values, was also strongly linked (LOD score 3.5, empirical (P < .0001) with this region. Two other regions across the genome were found to be suggestively linked to FSI: a location on chromosome 2q, near marker D2S141, and another location on chromosome 6q, near marker D6S264. Since several insulin-resistance syndrome (IRS)-related phenotypes were mapped independently to the regions on chromosome 6q, we conducted bivariate multipoint linkage analyses to map the correlated IRS phenotypes. These analyses implicated the same chromosomal region near marker D6S403 (6q22-q23) as harboring a major gene with strong pleiotropic effects on obesity and on lipid measures, including leptin concentrations (e.g., LODeq for traits-specific insulin and leptin was 4.7). A positional candidate gene for insulin resistance in this chromosomal region is the plasma cell-membrane glycoprotein PC-1 (6q22-q23). The genetic location on chromosome 6q, near marker D6S264 (6q25.2-q26), was also identified by the bivariate analysis as exerting significant pleiotropic influences on IRS-related phenotypes (e.g., LODeq for traits-specific insulin and leptin was 4.1). This chromosomal region harbors positional candidate genes, such as the insulin-like growth factor 2 receptor (IGF2R, 6q26) and acetyl-CoA acetyltransferase 2 (ACAT2, 6q25.3-q26). In sum, we found substantial evidence for susceptibility loci on chromosome 6q that influence insulin concentrations and other IRS-related phenotypes in Mexican Americans.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Baylor College of Medicine	Duggirala, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, Mail Code 7873,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	duggirala@uthscsa.edu	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021	Leach, Robin/0000-0002-3201-5579	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047482, R01DK053889, R01DK042273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; BOEHNKE M, 1986, AM J MED GENET, V23, P775, DOI 10.1002/ajmg.1320230306; Borecki I B, 1994, Obes Res, V2, P213; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCKLEY MF, 1990, J BIOL CHEM, V265, P17506; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Cave H, 2000, DIABETES, V49, P108, DOI 10.2337/diabetes.49.1.108; Chagnon YC, 2000, METABOLISM, V49, P203, DOI 10.1016/S0026-0495(00)91299-X; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; DeFronzo RA, 1995, NEW HORIZONS DIABETE, P11; Donahue RP, 1999, DIABETES CARE, V22, P1092, DOI 10.2337/diacare.22.7.1092; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duggirala R, 1996, AM J HUM GENET, V59, P694; DUGGIRALA R, 1999, 2 RES S GEN DIAB SAN; DYKE B, 1996, 2 PGL SW FDN BIOM RE; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Falconer D. S., 1996, Introduction to quantitative genetics.; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; Ferrer J, 1996, DIABETES, V45, P262, DOI 10.2337/diabetes.45.2.262; FLIER JS, 1992, DIABETES, V41, P1207, DOI 10.2337/diabetes.41.9.1207; Gardner RJ, 1999, J MED GENET, V36, P192; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Goldfine ID, 1998, MOL CELL BIOCHEM, V182, P177, DOI 10.1023/A:1006878001180; GREEN P, 1989, DOCUMENTATION CRI MA; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Haffner SM, 1999, AM J CARDIOL, V84, p11J; Haffner SM, 1996, DIABETES, V45, P822, DOI 10.2337/diabetes.45.6.822; HAFFNER SM, 1987, DIABETES, V36, P43, DOI 10.2337/diabetes.36.1.43; Haffner SM, 1998, INT J OBESITY, V22, P899, DOI 10.1038/sj.ijo.0800679; Haffner SM, 1997, DIABETOLOGIA, V40, P830, DOI 10.1007/s001250050756; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; HALES CN, 1995, NEW HORIZONS DIABETE, P146; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hanson RL, 1998, DIABETES, V47, pA170; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Hermans MP, 1999, DIABETOLOGIA, V42, P678, DOI 10.1007/s001250051215; Iwasaki N., 1999, 2 RES S GEN DIAB SAN; Kahn CR, 1996, ANNU REV MED, V47, P509; KEIFFER TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Klupa T, 2000, DIABETES, V49, P2212, DOI 10.2337/diabetes.49.12.2212; Kolaczynski JW, 1996, DIABETES, V45, P699, DOI 10.2337/diabetes.45.5.699; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lonnqvist F, 1999, J INTERN MED, V245, P643, DOI 10.1046/j.1365-2796.1999.00493.x; LUO DF, 1995, AM J HUM GENET, V57, P911; Ma ZM, 1996, CLIN CHEM, V42, P942; MacDonald MJ, 1997, DIABETES, V46, P1660, DOI 10.2337/diacare.46.10.1660; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitchell BD, 1996, ARTERIOSCL THROM VAS, V16, P281, DOI 10.1161/01.ATV.16.2.281; Mitchell BD, 2000, DIABETES, V49, P513, DOI 10.2337/diabetes.49.3.513; Mitchell BD, 1999, DIABETES, V48, P1863, DOI 10.2337/diabetes.48.9.1863; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ruige JB, 1999, DIABETES CARE, V22, P1097, DOI 10.2337/diacare.22.7.1097; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Smith A, 1999, AM J MED GENET, V84, P125, DOI 10.1002/(SICI)1096-8628(19990521)84:2<125::AID-AJMG8>3.0.CO;2-W; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Stern Michael P., 1999, V12, P3; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359; Temple IK, 1996, HUM MOL GENET, V5, P1117, DOI 10.1093/hmg/5.8.1117; Van Gaal LF, 1999, INT J OBESITY, V23, P29, DOI 10.1038/sj.ijo.0800792; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Vionnet N, 1997, DIABETES, V46, P1062, DOI 10.2337/diabetes.46.6.1062; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Zimmet P, 1996, BRIT MED J, V313, P965, DOI 10.1136/bmj.313.7063.965; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	102	125	131	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1149	1164		10.1086/320100	http://dx.doi.org/10.1086/320100			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283790	Bronze, Green Published			2022-12-18	WOS:000168171200009
J	Watanabe, RM; Ghosh, S; Langefeld, CD; Valle, TT; Hauser, ER; Magnuson, VL; Mohlke, KL; Silander, K; Ally, DS; Chines, P; Blaschak-Harvan, J; Douglas, JA; Duren, WL; Epstein, MP; Fingerlin, TE; Kaleta, HS; Lange, EM; Li, C; McEachin, RC; Stringham, HM; Trager, E; White, PP; Balow, J; Birznieks, G; Chang, J; Eldridge, W; Erdos, MR; Karanjawala, ZE; Knapp, JI; Kudelko, K; Martin, C; Morales-Mena, A; Musick, A; Musick, T; Pfahl, C; Porter, R; Rayman, JB; Rha, D; Segal, L; Shapiro, S; Sharaf, R; Shurtleff, B; So, A; Tannenbaum, J; Te, C; Tovar, J; Unni, A; Welch, C; Whiten, R; Witt, A; Kohtamaki, K; Ehnholm, C; Eriksson, J; Toivanen, L; Vidgren, G; Nylund, SJ; Tuomilehto-Wolf, E; Ross, EH; Demirchyan, E; Hagopian, WA; Buchanan, TA; Tuomilehto, J; Bergman, RN; Collins, FS; Boehnke, M				Watanabe, RM; Ghosh, S; Langefeld, CD; Valle, TT; Hauser, ER; Magnuson, VL; Mohlke, KL; Silander, K; Ally, DS; Chines, P; Blaschak-Harvan, J; Douglas, JA; Duren, WL; Epstein, MP; Fingerlin, TE; Kaleta, HS; Lange, EM; Li, C; McEachin, RC; Stringham, HM; Trager, E; White, PP; Balow, J; Birznieks, G; Chang, J; Eldridge, W; Erdos, MR; Karanjawala, ZE; Knapp, JI; Kudelko, K; Martin, C; Morales-Mena, A; Musick, A; Musick, T; Pfahl, C; Porter, R; Rayman, JB; Rha, D; Segal, L; Shapiro, S; Sharaf, R; Shurtleff, B; So, A; Tannenbaum, J; Te, C; Tovar, J; Unni, A; Welch, C; Whiten, R; Witt, A; Kohtamaki, K; Ehnholm, C; Eriksson, J; Toivanen, L; Vidgren, G; Nylund, SJ; Tuomilehto-Wolf, E; Ross, EH; Demirchyan, E; Hagopian, WA; Buchanan, TA; Tuomilehto, J; Bergman, RN; Collins, FS; Boehnke, M			The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; PIMA-INDIANS; GLUCOSE-TOLERANCE; LINKAGE ANALYSIS; SUSCEPTIBILITY GENES; MEXICAN-AMERICANS; FINNISH FAMILIES; MINIMAL-MODEL; MAPPING GENES; WIDE SEARCH	Type 2 diabetes mellitus is a complex disorder encompassing multiple metabolic defects. We report results from an autosomal genome scan for type 2 diabetes-related quantitative traits in 580 Finnish families ascertained for an affected sibling pair and analyzed by the variance components-based quantitative-trait locus (QTL) linkage approach. We analyzed diabetic and nondiabetic subjects separately, because of the possible impact of disease on the traits of interest. In diabetic individuals, our strongest results were observed on chromosomes 3 (fasting C-peptide/glucose: maximum LOD score [MLS] = 3.13 at 53.0 cM) and 13 (body-mass index: MLS = 3.28 at 5.0 cM). In nondiabetic individuals, the strongest results were observed on chromosomes 10 (acute insulin response: MLS = 3.11 at 21.0 cM), 13 (2-h insulin: MLS = 2.86 at 65.5 cM), and 17 (fasting insulin/glucose ratio: MLS = 3.20 at 9.0 cM). In several cases, there was evidence for overlapping signals between diabetic and nondiabetic individuals; therefore we performed joint analyses. In these joint analyses, we observed strong signals for chromosomes 3 (body-mass index: MLS = 3.43 at 59.5 cM), 17 (empirical insulin-resistance index: MLS = 3.61 at 0.0 cM), and 19 (empirical insulin-resistance index: MLS = 2.80 at 74.5 cM). Integrating genome-scan results from the companion article by Ghosh et al., we identify several regions that may harbor susceptibility genes for type 2 diabetes in the Finnish population.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; Univ Washington, Dept Med, Seattle, WA USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Finland National Institute for Health & Welfare; University of Southern California; University of Southern California; University of Washington; University of Washington Seattle	Boehnke, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.		Addington, Anjene/C-3460-2008; Li, Chun/B-8388-2012	Hauser, Elizabeth/0000-0003-0367-9189; Li, Chun/0000-0002-8819-2443; Rayman, Joseph/0000-0003-0149-0024	Intramural NIH HHS [Z01 HG000040] Funding Source: Medline; NHGRI NIH HHS [HG00376, R56 HG000376, R01 HG000376, T32 HG000040] Funding Source: Medline; NIDDK NIH HHS [R37 DK027619, R01 DK027619, F32 DK009525, R01 DK029867] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, R01HG000376, R29HG000376, Z01HG000040, R56HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027619, F32DK009525, R01DK027619, R01DK029867] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMOS CI, 1994, AM J HUM GENET, V54, P535; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; BACH LA, 1992, DIABETES METAB REV, V8, P229, DOI 10.1002/dmr.5610080304; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duggirala R, 1996, AM J HUM GENET, V59, P694; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; GROOP LC, 1993, NEW ENGL J MED, V328, P10, DOI 10.1056/NEJM199301073280102; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HARRIS M, 1979, DIABETES, V28, P1039; HARRIS MI, 1990, DIABETES METAB REV, V6, P71, DOI 10.1002/dmr.5610060202; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Jacquard A., 1974, GENETIC STRUCTURE PO; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lehtovirta M, 2000, DIABETOLOGIA, V43, P285, DOI 10.1007/s001250050046; LILLIOJA S, 1988, DIABETES METAB REV, V4, P517, DOI 10.1002/dmr.5610040508; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Majer M, 1996, DIABETOLOGIA, V39, P314; OHLSON LO, 1988, DIABETOLOGIA, V31, P798; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SLUITER WJ, 1976, DIABETES, V25, P245, DOI 10.2337/diabetes.25.4.245; St Jean PL, 1999, DIABETES, V48, pA46; STEIL GM, 1993, DIABETES, V42, P250, DOI 10.2337/diabetes.42.2.250; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; THOMPSON DB, 1995, DIABETES, V44, P478, DOI 10.2337/diabetes.44.4.478; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Watanabe RM, 1999, HUM HERED, V49, P159, DOI 10.1159/000022865; *WHO, 1985, 727 WHO	54	125	127	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1186	1200						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032784				2022-12-18	WOS:000165091600016
J	Bruno, C; Martinuzzi, A; Tang, YY; Andreu, AL; Pallotti, F; Bonilla, E; Shanske, S; Fu, J; Sue, CM; Angelini, C; DiMauro, S; Manfredi, G				Bruno, C; Martinuzzi, A; Tang, YY; Andreu, AL; Pallotti, F; Bonilla, E; Shanske, S; Fu, J; Sue, CM; Angelini, C; DiMauro, S; Manfredi, G			A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL GENOME; SIDEROBLASTIC ANEMIA; PROTEIN-SYNTHESIS; LEIGH-SYNDROME; SUBUNIT-I; DNA; DEFICIENCY; PATIENT; MYOPATHY; MICRODELETION	We have identified a novel stop-codon mutation in the mtDNA of a young woman with a multisystem mitochondrial disorder. Histochemical analysis of a muscle-biopsy sample showed virtually absent cytochrome c oxidase (COX) stain, and biochemical studies confirmed an isolated reduction of COX activity. Sequence analysis of the mitochondrial-encoded COX-subunit genes identified a heteroplasmic G-->A transition at nucleotide position 6930 in the gene for subunit I (COX I). The mutation changes a glycine codon to a stop codon, resulting in a predicted loss of the last 170 amino acids (33%) of the polypeptide. The mutation was present in the patient's muscle, myoblasts, and blood and was not detected in normal or disease controls. It was not detected in mtDNA from leukocytes of the patient's mother, sister, and four maternal aunts. We studied the genetic, biochemical, and morphological characteristics of transmitochondrial cybrid cell lines, obtained by fusing of platelets from the patient with human cells lacking endogenous mtDNA (po cells). There was a direct relationship between the proportion of mutant mtDNA and the biochemical defect. We also observed that the threshold for the phenotypic expression of this mutation was lower than that reported in mutations involving tRNA genes. We suggest that the G6930A mutation causes a disruption in the assembly of the respiratory-chain complex IV.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, H Houston Merritt Clin Res Ctr Muscular Dystrophy, New York, NY 10032 USA; Univ Genoa, Ist Giannina Gaslini, Dept Pediat, Genoa, Italy; Congeliano Res Ctr, Sci Inst E Medea, Conegliano, Italy; Hosp Gen Valle Hebron, Ctr Invet Bioquim & Biol Mol, Barcelona, Spain; Univ Padua, Dept Neurol, Padua, Italy	Columbia University; Columbia University; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Eugenio Medea; Hospital Universitari Vall d'Hebron; University of Padua	Manfredi, G (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,P&S Bldg,Room 4-431, New York, NY 10032 USA.	gm73@columbia.edu	Martinuzzi, Andrea/K-3887-2016; Angelini, Corrado I/J-3655-2019; Bruno, Claudio/A-3148-2015; Martinuzzi, Andrea/AAC-3127-2022	Martinuzzi, Andrea/0000-0002-0319-3579; Angelini, Corrado I/0000-0002-9554-8794; Bruno, Claudio/0000-0002-3426-2901; ANDREU, antonio luis/0000-0002-3936-3234; Pallotti, Francesco/0000-0001-9946-8516	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766, R01NS032527, R01NS028828] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28828, NS11766, NS32527] Funding Source: Medline; Telethon [C.54] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444; Broker S, 1998, EUR J BIOCHEM, V258, P132, DOI 10.1046/j.1432-1327.1998.2580132.x; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; MARZUKI S, 1991, HUM GENET, V88, P139; MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SERVIDEI S, 1999, NEUROMUSCULAR DISORD, V9, pR15; Shoubridge E A, 1996, Methods Enzymol, V264, P465, DOI 10.1016/S0076-6879(96)64042-7; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	33	125	126	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					611	620		10.1086/302546	http://dx.doi.org/10.1086/302546			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441567	Green Published, Bronze			2022-12-18	WOS:000082426400005
J	Mardy, S; Miura, Y; Endo, F; Matsuda, I; Sztriha, L; Frossard, P; Moosa, A; Ismail, EAR; Macaya, A; Andria, G; Toscano, E; Gibson, W; Graham, GE; Indo, Y				Mardy, S; Miura, Y; Endo, F; Matsuda, I; Sztriha, L; Frossard, P; Moosa, A; Ismail, EAR; Macaya, A; Andria, G; Toscano, E; Gibson, W; Graham, GE; Indo, Y			Congenital insensitivity to pain with anhidrosis: Novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINE KINASE; NEUROTROPHIN RECEPTORS; BINDING-SITES; PROTOONCOGENE; SHC; DISEASE; SYSTEM; ORGANIZATION; LOCALIZATION; ONCOGENE	Congenital insensitivity to pain with anhidrosis (CIPA) is characterized by recurrent episodes of unexplained fever, anhidrosis (inability to sweat),absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. Human TRKA encodes a. high-affinity tyrosine kinase receptor for nerve growth factor (NGF), a member of the neurotrophin family that induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons. We have recently demonstrated that TRKA is responsible for CIPA by identifying three mutations in a region encoding the intracellular tyrosine, kinase domain of TRKA in one Ecuadorian and three Japanese families. We have developed a comprehensive strategy to screen for TRKA mutations, on the basis of the gene's structure and organization. Here we report 11 novel mutations, in seven affected families. These are six missense mutations, two frameshift mutations, one nonsense mutation, and two splice-site mutations. Mendelian inheritance of the mutations is confirmed in six families for which parent samples are available. Two mutations are linked, on the same chromosome, to Arg85Ser and to His598Tyr;Gly607Val, hence, they probably represent double and triple mutations. The mutations are distributed in an extracellular domain, involved in NGF binding, as well as the intracellular signal-transduction domain. These data suggest that TRKA,defects cause CIPA in various ethnic groups.	Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 8608556, Japan; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Kuwait Univ, Fac Med, Dept Pediat, Safat, Kuwait; Farwaniya Hosp, Dept Pediat, Salmiya, Kuwait; Hosp Maternoinfantil Vall Hebron, Child Neurol Sect, Barcelona, Spain; Univ Naples Federico II, Dept Pediat, Naples, Italy; Univ Calgary, Dept Med Genet, Calgary, AB, Canada; Alberta Childrens Hosp, Calgary, AB, Canada	Kumamoto University; United Arab Emirates University; Kuwait University; Hospital Universitari Vall d'Hebron; University of Naples Federico II; University of Calgary; Alberta Childrens Hospital; University of Calgary	Indo, Y (corresponding author), Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 8608556, Japan.		andria, generoso/V-7172-2019; Melis, Daniela/AAD-3623-2019	Melis, Daniela/0000-0002-9458-3926; Macaya Ruiz, Alfons/0000-0001-7998-4185				AINSWORTH PJ, 1992, AM J HUM GENET, V51, P802; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; BARKER PA, 1993, J BIOL CHEM, V268, P15150; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P1557; Greco A, 1996, ONCOGENE, V13, P2463; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Indo Y, 1997, JPN J HUM GENET, V42, P343, DOI 10.1007/BF02766957; Ismail EAR, 1998, J CHILD NEUROL, V13, P243, DOI 10.1177/088307389801300511; Jensen HK, 1997, HUM MUTAT, V9, P437, DOI 10.1002/(SICI)1098-1004(1997)9:5<437::AID-HUMU10>3.0.CO;2-3; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LANGER J, 1981, ACTA NEUROPATHOL, V54, P199, DOI 10.1007/BF00687742; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P2073; MIOZZO M, 1990, ONCOGENE, V5, P1411; MORRIS CM, 1991, ONCOGENE, V6, P1093; NAKAGAWARA A, 1995, GENOMICS, V25, P538, DOI 10.1016/0888-7543(95)80055-Q; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; RAFEL E, 1980, MUSCLE NERVE, V3, P216, DOI 10.1002/mus.880030305; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SWANSON AG, 1965, ARCH NEUROL-CHICAGO, V12, P12, DOI 10.1001/archneur.1965.00460250016002; SWANSON AG, 1963, ARCH NEUROL-CHICAGO, V8, P299, DOI 10.1001/archneur.1963.00460030083008; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; Tsuruta M, 1998, J HUM GENET, V43, P91, DOI 10.1007/s100380050047	39	125	136	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1570	1579		10.1086/302422	http://dx.doi.org/10.1086/302422			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330344	Green Published, Bronze			2022-12-18	WOS:000080696200009
J	Oliver, FJ; Menissier-de Murcia, J; de Murcia, G				Oliver, FJ; Menissier-de Murcia, J; de Murcia, G			Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; CLEAVAGE; DEATH; P53; NECROSIS; DEGRADATION; ACTIVATION; SYNTHETASE; INDUCTION; RADIATION		Ecole Super Biotechnol Strasbourg, CEA, Lab Convent, CNRS,UPR 9003, F-67400 Strasbourg, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Oliver, FJ (corresponding author), Ecole Super Biotechnol Strasbourg, CEA, Lab Convent, CNRS,UPR 9003, Blvd Sebastien Brant, F-67400 Strasbourg, France.		Oliver, Javier/S-1725-2018	Oliver, Javier/0000-0001-8468-1998				Agarwal ML, 1997, ONCOGENE, V15, P1035, DOI 10.1038/sj.onc.1201274; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; DANTZER FSV, 1991, BIOCHIMIE, V81, P69; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Guillouf C, 1999, EXP CELL RES, V246, P384, DOI 10.1006/excr.1998.4316; Hirsch T, 1997, ONCOGENE, V15, P1573, DOI 10.1038/sj.onc.1201324; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Leadon SA, 1999, AM J HUM GENET, V64, P1259, DOI 10.1086/302390; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; LEE JS, 1994, LUPUS, V3, P113, DOI 10.1177/096120339400300210; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Maizels N, 1999, AM J HUM GENET, V64, P1270, DOI 10.1086/302393; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; MENISSIERDEMURC.M, 1997, P NATL ACAD SCI USA, V94, P7303; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; Oei S L, 1997, Rev Physiol Biochem Pharmacol, V131, P127; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Plaza S, 1999, ONCOGENE, V18, P1041, DOI 10.1038/sj.onc.1202406; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; Simbulan-Rosenthal CM, 1998, BIOCHEM BIOPH RES CO, V253, P864, DOI 10.1006/bbrc.1998.9792; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smulson ME, 1998, CANCER RES, V58, P3495; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Wang XJ, 1998, ONCOGENE, V17, P2819, DOI 10.1038/sj.onc.1202216; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WHITACRE CM, 1995, CANCER RES, V55, P3697; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	49	125	130	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1282	1288		10.1086/302389	http://dx.doi.org/10.1086/302389			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205258	Green Published, Bronze			2022-12-18	WOS:000080093000005
J	Wang, JT; Lin, CJ; Burridge, SM; Fu, GK; Labuda, M; Portale, AA; Miller, WL				Wang, JT; Lin, CJ; Burridge, SM; Fu, GK; Labuda, M; Portale, AA; Miller, WL			Genetics of vitamin D 1 alpha-hydroxylase deficiency in 17 families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D-DEPENDENT RICKETS; HUMAN ADRENODOXIN; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; MESSENGER-RNA; GENOMIC DNA; CDNA; 24-HYDROXYLASE; BIOSYNTHESIS; CHOLESTEROL	Vitamin D-dependent rickets type I (VDDR-I), also known as pseudo-vitamin D-deficiency rickets, appears to result from deficiency of renal vitamin D 1 alpha-hydroxylase activity. Prior work has shown that the affected gene lies on 12q13.3. We recently cloned the cDNA and gene for this enzyme, mitochondrial P450c1 alpha, and we and others have found mutations in its gene in a few patients. To determine whether all patients with VDDR-I have mutations in P450c1 alpha, we have analyzed the P450c1 alpha gene in 19 individuals from 17 families representing various ethnic groups. The whole gene was PCR amplified and subjected to direct sequencing; candidate mutations were confirmed by repeat PCR of the relevant exon from genomic DNA from the patients and their parents. Microsatellite haplotyping with the markers D12S90, D12S305, and D12S104 was also done in all families. All patients had P450c1 alpha mutations on both alleles. In the French Canadian population, among whom VDDR-I is common, 9 of 10 alleles bore the haplotype 4-7-1 and carried the mutation 958 Delta G. This haplotype and mutation were also seen in two other families and are easily identified because the mutation ablates a TaiI/MaeII site. Six families of widely divergent ethnic backgrounds carried a 7-bp duplication in association with four different microsatellite haplotypes, indicating a mutational hot spot, We found 14 different mutations, including 7 amino acid replacement mutations. When these missense mutations were analyzed by expressing the mutant enzyme in mouse Leydig MA-10 cells and assaying 1 alpha-hydroxylase activity, none retained detectable 1 alpha-hydroxylase activity. These studies show that most if not all patients with VDDR-I have severe mutations in P450c1 alpha, and hence the disease should be referred to as "1 alpha-hydroxylase deficiency."	Univ Calif San Francisco, Dept Pediat, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Ctr Rech Louis Charles Simard, Montreal, PQ, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite de Montreal	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Metab Res Unit, Bldg MR-IV,Room 209, San Francisco, CA 94143 USA.		Miller, Walter L/J-3696-2012; Lin, Chin J/B-7895-2013	Lin, Chin J/0000-0001-7489-560X	NIDDK NIH HHS [DK37922, DK07161, DK42154] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922, T32DK007161, R01DK042154] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braman J, 1996, Methods Mol Biol, V57, P31; BRENTANO ST, 1992, P NATL ACAD SCI USA, V89, P4099, DOI 10.1073/pnas.89.9.4099; BRUNETTE MG, 1978, NATURE, V276, P287, DOI 10.1038/276287a0; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CHANG CY, 1988, DNA-J MOLEC CELL BIO, V7, P609, DOI 10.1089/dna.1988.7.609; CHEN KS, 1993, P NATL ACAD SCI USA, V90, P4543, DOI 10.1073/pnas.90.10.4543; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; CONTE FA, 1994, J CLIN ENDOCR METAB, V78, P1287, DOI 10.1210/jc.78.6.1287; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DELVIN EE, 1981, J PEDIATR-US, V99, P26, DOI 10.1016/S0022-3476(81)80952-3; Fardella CE, 1996, J CLIN ENDOCR METAB, V81, P321, DOI 10.1210/jc.81.1.321; FARDELLA CE, 1994, J CLIN ENDOCR METAB, V79, P160, DOI 10.1210/jc.79.1.160; Feldman David, 1996, P205; FORSAYETH JR, 1994, BIOTECHNIQUES, V17, P354; FRASER D, 1973, NEW ENGL J MED, V289, P817, DOI 10.1056/NEJM197310182891601; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; Fu GK, 1997, DNA CELL BIOL, V16, P1499, DOI 10.1089/dna.1997.16.1499; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; KAWASHIMA H, 1981, P NATL ACAD SCI-BIOL, V78, P1199, DOI 10.1073/pnas.78.2.1199; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Labuda M, 1996, AM J HUM GENET, V59, P633; LaBuda MC, 1990, PERSPECTIVES DYSLEXI, P47; LIN D, 1990, P NATL ACAD SCI USA, V87, P8516, DOI 10.1073/pnas.87.21.8516; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Monkawa T, 1997, BIOCHEM BIOPH RES CO, V239, P527, DOI 10.1006/bbrc.1997.7508; MORNET E, 1989, J BIOL CHEM, V264, P20961; MOROHASHI K, 1987, J BIOCHEM-TOKYO, V101, P879, DOI 10.1093/oxfordjournals.jbchem.a121955; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; PICADOLEONARD J, 1988, J BIOL CHEM, V263, P3240; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Pronicka E, 1992, Endokrynol Pol, V43, P145; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; REINHARDT TA, 1984, J CLIN ENDOCR METAB, V58, P91, DOI 10.1210/jcem-58-1-91; SCRIVER CR, 1978, NEW ENGL J MED, V299, P976, DOI 10.1056/NEJM197811022991803; SOLISH SB, 1988, P NATL ACAD SCI USA, V85, P7104, DOI 10.1073/pnas.85.19.7104; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; Strewler GJ, 1995, ENDOCRINOLOGY METABO, P1407; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; USUI E, 1990, FEBS LETT, V262, P135, DOI 10.1016/0014-5793(90)80172-F	46	125	131	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1694	1702		10.1086/302156	http://dx.doi.org/10.1086/302156			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837822	Green Published, Bronze			2022-12-18	WOS:000077707700015
J	WIJNEN, J; VASEN, H; KHAN, PM; MENKO, FH; VANDERKLIFT, H; VANLEEUWEN, C; VANDENBROEK, M; VANLEEUWENCORNELISSE, I; NAGENGAST, F; MEIJERSHEIJBOER, A; LINDHOUT, D; GRIFFIOEN, G; CATS, A; KLEIBEUKER, J; VARESCO, L; BERTARIO, L; BISGAARD, ML; MOHR, J; FODDE, R				WIJNEN, J; VASEN, H; KHAN, PM; MENKO, FH; VANDERKLIFT, H; VANLEEUWEN, C; VANDENBROEK, M; VANLEEUWENCORNELISSE, I; NAGENGAST, F; MEIJERSHEIJBOER, A; LINDHOUT, D; GRIFFIOEN, G; CATS, A; KLEIBEUKER, J; VARESCO, L; BERTARIO, L; BISGAARD, ML; MOHR, J; FODDE, R			7 NEW MUTATIONS IN HMSH2, AN HNPCC GENE, IDENTIFIED BY DENATURING GRADIENT-GEL ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; POLYMERASE CHAIN-REACTION; SINGLE-BASE CHANGES; COLON-CANCER; HEREDITARY; INSTABILITY; POLYPOSIS; HOMOLOG	Hereditary nonpolyposis colorectal cancer (HNPCC) is a relatively common autosomal dominant cancer-susceptibility condition. The recent isolation of the DNA mismatch repair genes (hMSH2, hMLH1, hPMS1, and hPMS2) responsible for HNPCC has allowed the search for germ-line mutations in affected individuals. In this study we used denaturing gradient-gel electrophoresis to screen for mutations in the hMSH2 gene. Analysis of all the 16 exons of hMSH2, in 34 unrelated HNPCC kindreds, has revealed seven novel pathogenic germ-line mutations resulting in stop codons either directly or through frameshifts. Additionally, nucleotide substitutions giving rise to one missense, two silent, and one useful polymorphism have been identified. The proportion of families in which hMSH2 mutations were found is 21%. Although the spectrum of mutations spread at the hMSH2 gene among HNPCC patients appears extremely heterogeneous, we were not able to establish any correlation between the site of the individual mutations and the corresponding tumor spectrum. Our results indicate that, given the genomic size and organization of the hMSH2 gene and the heterogeneity of its mutation spectrum, a rapid and efficient mutation detection procedure is necessary for routine molecular diagnosis and presymptomatic detection of the disease in a clinical setup.	LEIDEN UNIV,SYLVIUS LAB,CTR MED GENET,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,FDN DETECT HEREDITARY TUMORS,LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,DEPT GASTROENTEROL,LEIDEN,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN GENET,AMSTERDAM,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT GASTROENTEROL,NIJMEGEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,ROTTERDAM,NETHERLANDS; UNIV GRONINGEN HOSP,DEPT GASTROENTEROL,GRONINGEN,NETHERLANDS; IST NAZL RIC CANC,IMMUNOGENET LAB,GENOA,ITALY; UNIV MILAN,REGISTRO ITALIANO POLIPOSI FAMILIARI,MILAN,ITALY; UNIV COPENHAGEN,PANUM INST,INST MED BIOCHEM & GENET,COPENHAGEN,DENMARK	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Erasmus University Rotterdam; University of Groningen; University of Genoa; IRCCS AOU San Martino IST; University of Milan; University of Copenhagen			van Leeuwen, Cornelis J/S-5815-2016; Varesco, Liliana/AAF-6521-2019; Lindhout, Dick/AAH-5765-2019; Fodde, Riccardo/AAW-9394-2021	van Leeuwen, Cornelis J/0000-0003-1605-4268; Varesco, Liliana/0000-0003-4871-6668; Fodde, Riccardo/0000-0001-9839-4324; Vasen, Hans/0000-0003-2682-2603; Bertario, Lucio/0000-0001-5653-1431; Lindhout, Dick/0000-0001-9580-624X				AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BURKS RT, ONCOGENE, V9, P1163; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; HAN HJ, 1993, CANCER RES, V53, P5087; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KOLODNER RD, 1995, GENOMICS, V24, P516; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MARY JL, 1994, HUM MOL GENET, V3, P2067; Myers R, 1989, PCR TECHNOLOGY PRINC, P71; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RISINGER JI, 1993, CANCER RES, V53, P5100; SANDKUIJL LA, 1993, 4TH P EUROFAP WORKSH, P26; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIJNEN J, 1994, HUM MOL GENET, V3, P2268, DOI 10.1093/hmg/3.12.2268-a; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152	34	125	128	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1060	1066						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726159				2022-12-18	WOS:A1995QU58600006
J	WILSON, LC; LEVERTON, K; LUTTIKHUIS, MEMO; OLEY, CA; FLINT, J; WOLSTENHOLME, J; DUCKETT, DP; BARROW, MA; LEONARD, JV; READ, AP; TREMBATH, RC				WILSON, LC; LEVERTON, K; LUTTIKHUIS, MEMO; OLEY, CA; FLINT, J; WOLSTENHOLME, J; DUCKETT, DP; BARROW, MA; LEONARD, JV; READ, AP; TREMBATH, RC			BRACHYDACTYLY AND MENTAL-RETARDATION - AN ALBRIGHT HEREDITARY OSTEODYSTROPHY-LIKE SYNDROME LOCALIZED TO 2Q37	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERMINAL DELETION; LONG ARM; CHROMOSOME-2; ACRODYSOSTOSIS; INDIVIDUALS; PHENOTYPE; REPEATS; INFANT	We report five patients with a combination of brachymetaphalangia and mental retardation, similar to that observed in Albright hereditary osteodystrophy (AHO). Four patients had cytogenetically visible de novo deletions of chromosome 2q37. The fifth patient was cytogenetically normal and had normal bioactivity of the alpha subunit of Gs (Gs alpha), the protein that is defective in AHO. In this patient, we have used a combination of highly polymorphic molecular markers and FISH to demonstrate a microdeletion at 2q37. The common region of deletion overlap involves the most telomeric 2q marker, D2S125, and extends proximally for a maximum distance of 17.6 cM. We suggest this represents a consistent phenotype associated with some deletions at 2q37 and that genes important for skeletal and neurodevelopment lie within this region. Screening for deletions at this locus should be considered in individuals with brachymetaphalangia and mental retardation. Furthermore, 2q37 represents a candidate region for type E brachydactyly.	UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,LEICS,ENGLAND; UNIV LEICESTER,DEPT MED,LEICESTER,LEICS,ENGLAND; LEICESTER ROYAL INFIRM,LEICESTER GENET CTR,LEICESTER,LEICS,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD,ENGLAND; INST CHILD HLTH,MED UNIT,LONDON,ENGLAND; INST CHILD HLTH,MOTHERCARE UNIT CLIN GENET & FETAL MED,LONDON,ENGLAND	University of Leicester; University of Leicester; University of Leicester; University of Manchester; Newcastle University - UK; University of Oxford; University of London; University College London; University of London; University College London								ABLOW RC, 1977, AM J ROENTGENOL, V128, P95, DOI 10.2214/ajr.128.1.95; ALBRIGHT F, 1952, T ASSOC AM PHYSICIAN, V65, P337; Albright F, 1942, ENDOCRINOLOGY, V30, P922; BOURNE HR, 1983, AM J MED GENET, V15, P469, DOI 10.1002/ajmg.1320150312; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; Buckle VJ, 1993, HUMAN GENETIC DISEAS, P59; COLDWELL JG, 1992, AM J HUM GENET S, V51, P301; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FITCH N, 1982, AM J MED GENET, V11, P11, DOI 10.1002/ajmg.1320110104; GORSKI JL, 1989, AM J MED GENET, V32, P350, DOI 10.1002/ajmg.1320320315; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LIBERT F, 1991, GENOMICS, V11, P225, DOI 10.1016/0888-7543(91)90125-X; LIN SP, 1992, AM J MED GENET, V44, P500, DOI 10.1002/ajmg.1320440424; LUTTIKHUIS MEMO, 1994, GENOMICS, V21, P455, DOI 10.1006/geno.1994.1297; MATSUI T, 1993, FEBS LETT, V336, P107, DOI 10.1016/0014-5793(93)81620-F; OLEY CA, 1992, AM J HUM GENET S, V51, P104; PHELAN MC, 1993, AM J HUM GENET, V53, P484; POZNANSKI AK, 1977, RADIOLOGY, V123, P707, DOI 10.1148/123.3.707; RAMER JC, 1989, AM J MED GENET, V32, P359, DOI 10.1002/ajmg.1320320318; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SANCHEZ JM, 1984, J MED GENET, V21, P147, DOI 10.1136/jmg.21.2.147; SCHWINDINGER WF, 1994, ENDOCRINOLOGIST, V4, P17, DOI 10.1097/00019616-199401000-00005; STEIN CK, 1992, AM J HUM GENET S, V51, P310; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WANG TH, 1994, AM J MED GENET, V49, P399, DOI 10.1002/ajmg.1320490410; WATERS BL, 1993, AM J MED GENET, V47, P1099, DOI 10.1002/ajmg.1320470734; YOUNG RS, 1983, J MED GENET, V20, P199, DOI 10.1136/jmg.20.3.199	28	125	129	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					400	407						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847374				2022-12-18	WOS:A1995QF42300007
J	Azaiez, H; Booth, KT; Ephraim, SS; Crone, B; Black-Ziegelbein, EA; Marini, RJ; Shearer, AE; Sloan-Heggen, CM; Kolbe, D; Casavant, T; Schnieders, MJ; Nishimura, C; Braun, T; Smith, RJH				Azaiez, Hela; Booth, Kevin T.; Ephraim, Sean S.; Crone, Bradley; Black-Ziegelbein, Elizabeth A.; Marini, Robert J.; Shearer, A. Eliot; Sloan-Heggen, Christina M.; Kolbe, Diana; Casavant, Thomas; Schnieders, Michael J.; Nishimura, Carla; Braun, Terry; Smith, Richard J. H.			Genomic Landscape and Mutational Signatures of Deafness-Associated Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORINEURAL HEARING-LOSS; SEQUENCE VARIANTS; CLINICAL INTERPRETATION; FUNCTIONAL PREDICTIONS; ALLELE FREQUENCY; WOLFRAM-SYNDROME; HUMAN-DISEASE; WFS1 GENE; GUIDELINES; DATABASE	The classification of genetic variants represents a major challenge in the post-genome era by virtue of their extraordinary number and the complexities associated with ascribing a clinical impact, especially for disorders exhibiting exceptional phenotypic, genetic, and allelic heterogeneity. To address this challenge for hearing loss, we have developed the Deafness Variation Database (DVD), a comprehensive, open-access resource that integrates all available genetic, genomic, and clinical data together with expert curation to generate a single classification for each variant in 152 genes implicated in syndromic and non-syndromic deafness. We evaluate 876,139 variants and classify them as pathogenic or likely pathogenic (more than 8,100 variants), benign or likely benign (more than 172,000 variants), or of uncertain significance (more than 695,000 variants); 1,270 variants are re-categorized based on expert curation and in 300 instances, the change is of medical significance and impacts clinical care. We show that more than 96% of coding variants are rare and novel and that pathogenicity is driven by minor allele frequency thresholds, variant effect, and protein domain. The mutational landscape we define shows complex gene-specific variability, making an understanding of these nuances foundational for improved accuracy in variant interpretation in order to enhance clinical decision making and improve our understanding of deafness biology.	[Azaiez, Hela; Booth, Kevin T.; Ephraim, Sean S.; Crone, Bradley; Black-Ziegelbein, Elizabeth A.; Kolbe, Diana; Nishimura, Carla; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA; [Booth, Kevin T.; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Mol Med, Iowa City, IA 52242 USA; [Marini, Robert J.; Casavant, Thomas; Braun, Terry] Univ Iowa, Coll Engn, Ctr Bioinformat & Computat Biol, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Marini, Robert J.; Casavant, Thomas; Braun, Terry] Univ Iowa, Coll Engn, Ctr Bioinformat & Computat Biol, Dept Biomed Engn, Iowa City, IA 52242 USA; [Shearer, A. Eliot; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Sloan-Heggen, Christina M.; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Med Scientist Training Program, Iowa City, IA 52242 USA; [Schnieders, Michael J.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Smith, Richard J. H.] Univ Iowa, Iowa Inst Human Genet, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Mol Med, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Med Scientist Training Program, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Iowa Inst Human Genet, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu	Booth, Kevin T/P-9435-2019; Azaiez, Hela/AAQ-7011-2020; Schnieders, Michael J/C-4706-2019	Booth, Kevin T/0000-0003-3061-3652; Azaiez, Hela/0000-0002-2863-6970; Schnieders, Michael J/0000-0003-1260-4592; Smith, Richard/0000-0003-1201-6731	NIDCD [RO1 DC003544, RO1 DC002842, RO1 DC012049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003544, R01DC002842, R01DC012049] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Julie S. Wertz and Andrea Hallier for help with bioinformatic troubleshooting. The authors are also grateful to all DVD users who have submitted data and provided feedback. This work was supported by NIDCD RO1s DC003544, DC002842, and DC012049 to R.J.H.S.	Acke FRE, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-84; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; [Anonymous], 2016, NAT METHODS, V13, P103, DOI 10.1038/nmeth.3762; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Bean LJH, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0508-z; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Eisenberger T, 2018, GENET MED, V20, P614, DOI 10.1038/gim.2017.155; Garber KB, 2016, AM J HUM GENET, V99, P1140, DOI 10.1016/j.ajhg.2016.09.015; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Harrison SM, 2017, GENET MED, V19, P1096, DOI 10.1038/gim.2017.14; Hoskinson DC, 2017, CURR OPIN GENET DEV, V42, P33, DOI 10.1016/j.gde.2017.01.001; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Moteki H, 2016, CLIN GENET, V89, P466, DOI 10.1111/cge.12677; Neuhaus C, 2017, CLIN GENET, V91, P892, DOI 10.1111/cge.12915; Patel RY, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0391-z; Peterson TA, 2012, J AM MED INFORM ASSN, V19, P275, DOI 10.1136/amiajnl-2011-000655; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Rose PS, 2005, AM J MED GENET A, V138A, P199, DOI 10.1002/ajmg.a.30955; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shearer AE, 2014, GENOME MED, V6, DOI 10.1186/gm554; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Sivley RM, 2018, AM J HUM GENET, V102, P415, DOI 10.1016/j.ajhg.2018.01.017; Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8; Sloan-Heggen CM, 2015, J MED GENET, V52, P823, DOI 10.1136/jmedgenet-2015-103389; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tompson SW, 2010, AM J HUM GENET, V87, P708, DOI 10.1016/j.ajhg.2010.10.009; Ueyama T, 2016, EMBO MOL MED, V8, P1310, DOI 10.15252/emmm.201606609	54	124	125	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					484	497		10.1016/j.ajhg.2018.08.006	http://dx.doi.org/10.1016/j.ajhg.2018.08.006			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30245029	Green Published, hybrid			2022-12-18	WOS:000446312200003
J	van den Boogaard, ML; Lemmers, RJLF; Balog, J; Wohlgemuth, M; Auranen, M; Mitsuhashi, S; van der Vliet, PJ; Straasheijm, KR; van den Akker, RFP; Kriek, M; Laurense-Bik, MEY; Raz, V; van Ostaijen-ten Dam, MM; Hansson, KBM; van der Kooi, EL; Kiuru-Enari, S; Udd, B; van Tol, MJD; Nishino, I; Tawil, R; Tapscott, SJ; van Engelen, BGM; van der Maarel, SM				van den Boogaard, Marlinde L.; Lemmers, Richard J. L. F.; Balog, Judit; Wohlgemuth, Marielle; Auranen, Mari; Mitsuhashi, Satomi; van der Vliet, Patrick J.; Straasheijm, Kirsten R.; van den Akker, Rob F. P.; Kriek, Marjolein; Laurense-Bik, Marlies E. Y.; Raz, Vered; van Ostaijen-ten Dam, Monique M.; Hansson, Kerstin B. M.; van der Kooi, Elly L.; Kiuru-Enari, Sari; Udd, Bjarne; van Tol, Maarten J. D.; Nishino, Ichizo; Tawil, Rabi; Tapscott, Stephen J.; van Engelen, Baziel G. M.; van der Maarel, Silvere M.			Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; MUSCULAR-DYSTROPHY; ICF SYNDROME; IMMUNODEFICIENCY SYNDROME; CHROMOSOME INSTABILITY; DISEASE SEVERITY; SKELETAL-MUSCLE; SATELLITE DNA; ADD DOMAIN; METHYLATION	Facioscapulohumeral dystrophy (FSHD) is associated with somatic chromatin relaxation of the D4Z4 repeat array and derepression of the D4Z4-encoded DUX4 retrogene coding for a germline transcription factor. Somatic DUX4 derepression is caused either by a 1-10 unit repeat-array contraction (FSHD1) or by mutations in SMCHD1, which encodes a chromatin repressor that binds to D4Z4 (FSHD2). Here, we show that heterozygous mutations in DNA methyltransferase 3B (DNMT3B) are a likely cause of D4Z4 derepression associated with low levels of DUX4 expression from the D4Z4 repeat and increased penetrance of FSHD. Recessive mutations in DNMT3B were previously shown to cause immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome. This study suggests that transcription of DUX4 in somatic cells is modified by variations in its epigenetic state and provides a basis for understanding the reduced penetrance of FSHD within families.	[van den Boogaard, Marlinde L.; Lemmers, Richard J. L. F.; Balog, Judit; van der Vliet, Patrick J.; Straasheijm, Kirsten R.; van den Akker, Rob F. P.; Kriek, Marjolein; Raz, Vered; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Wohlgemuth, Marielle; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Auranen, Mari; Kiuru-Enari, Sari] Univ Helsinki, Neurol, Clin Neurosci, Helsinki 00029, Finland; [Auranen, Mari; Kiuru-Enari, Sari] Helsinki Univ Hosp, Helsinki 00029, Finland; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan; [Kriek, Marjolein; Laurense-Bik, Marlies E. Y.; Hansson, Kerstin B. M.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [van Ostaijen-ten Dam, Monique M.; van Tol, Maarten J. D.] Leiden Univ, Med Ctr, Dept Pediat, NL-2333 ZA Leiden, Netherlands; [van der Kooi, Elly L.] Med Ctr Leeuwarden, NL-8934 AD Leeuwarden, Netherlands; [Udd, Bjarne] Tampere Univ Hosp, Neuromuscular Res Ctr, Dept Neurol, Tampere 33520, Finland; [Udd, Bjarne] Univ Tampere, Tampere 33520, Finland; [Tawil, Rabi] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; National Center for Neurology & Psychiatry - Japan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical Center Leeuwarden; Tampere University; Tampere University Hospital; University of Rochester; Fred Hutchinson Cancer Center	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands.	s.m.van_der_maarel@lumc.nl	Nishino, Ichizo/G-2676-2010; van der Maarel, Silvere/X-3631-2018; van Engelen, Baziel/H-8027-2014	Nishino, Ichizo/0000-0001-9452-112X; van der Maarel, Silvere/0000-0001-8103-711X; van Engelen, Baziel/0000-0001-9867-9047; Tapscott, Stephen/0000-0002-0319-0968	NIH National Institute of Neurological Disorders and Stroke [P01NS069539]; Prinses Beatrix Spierfonds [W.OR12-20, W.OP14-01]; European Union [2012-305121]; FSH Society; Spieren voor Spieren; FSHD Global Research Foundation; FSHD Stichting; Friends of FSH Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Prinses Beatrix Spierfonds; European Union(European Commission); FSH Society; Spieren voor Spieren; FSHD Global Research Foundation; FSHD Stichting; Friends of FSH Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all families for participating in our studies. We thank Marcellus Ubbink (Leiden Institute of Chemistry, Leiden University) for assistance with modeling the mutations and Nisha Verwey (Human Genetics, Leiden University Medical Center) for assistance with the Cellomics platform. Our studies are supported by grants from the NIH National Institute of Neurological Disorders and Stroke (P01NS069539), the Prinses Beatrix Spierfonds (W.OR12-20 and W.OP14-01), the European Union Framework Programme 7 (agreement 2012-305121, NEUROMICS), the FSH Society, Spieren voor Spieren, the FSHD Global Research Foundation, FSHD Stichting, and Friends of FSH Research.	Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Balog J, 2012, EPIGENETICS-US, V7, P579, DOI 10.4161/epi.20001; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; CARPENTER NJ, 1988, J PEDIATR-US, V112, P757, DOI 10.1016/S0022-3476(88)80698-X; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hagleitner MM, 2008, J MED GENET, V45, P93, DOI 10.1136/jmg.2007.053397; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hartweck LM, 2013, NEUROLOGY, V80, P392, DOI 10.1212/WNL.0b013e31827f075c; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Huichalaf C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115278; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jones TI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0072-6; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Larsen Jan, 2011, BMC Res Notes, V4, P490, DOI 10.1186/1756-0500-4-490; Larsen M, 2015, EUR J HUM GENET, V23, P808, DOI 10.1038/ejhg.2014.191; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Noh KM, 2016, ACS CHEM BIOL, V11, P554, DOI 10.1021/acschembio.5b00830; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Racca AW, 2015, HUM MOL GENET, V24, P3348, DOI 10.1093/hmg/ddv084; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Ricci G, 2013, BRAIN, V136, P3408, DOI 10.1093/brain/awt226; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Youngson NA, 2013, MAMM GENOME, V24, P206, DOI 10.1007/s00335-013-9451-5; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	45	124	126	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					1020	1029		10.1016/j.ajhg.2016.03.013	http://dx.doi.org/10.1016/j.ajhg.2016.03.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153398	Green Published, Bronze			2022-12-18	WOS:000375869300019
J	Browning, SR; Browning, BL				Browning, Sharon R.; Browning, Brian L.			Accurate Non-parametric Estimation of Recent Effective Population Size from Segments of Identity by Descent	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTING IDENTITY; GENOME SEQUENCES; HISTORY; EVOLUTION; VARIANTS; LESSONS; FINLAND; GROWTH; EXCESS	Existing methods for estimating historical effective population size from genetic data have been unable to accurately estimate effective population size during the most recent past. We present a non-parametric method for accurately estimating recent effective population size by using inferred long segments of identity by descent (IBD). We found that inferred segments of IBD contain information about effective population size from around 4 generations to around 50 generations ago for SNP array data and to over 200 generations ago for sequence data. In human populations that we examined, the estimates of effective size were approximately one-third of the census size. We estimate the effective population size of European-ancestry individuals in the UK four generations ago to be eight million and the effective population size of Finland four generations ago to be 0.7 million. Our method is implemented in the open-source IBDNe software package.	[Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, SR (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	sguy@uw.edu	Browning, Sharon/B-1530-2008; Browning, Brian/ABC-4543-2021; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	NIH [HG004960, HG005701, GM099568, GM075091]; Wellcome Trust [076113, 085475, WT091310]; National Heart, Lung, and Blood Institute (NHLBI); Broad Institute; University of California, Los Angeles (UCLA); University of Oulu; National Institute for Health and Welfare in Finland; Medical Research Council [MC_PC_15018] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM075091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Broad Institute; University of California, Los Angeles (UCLA)(University of California System); University of Oulu; National Institute for Health and Welfare in Finland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH research grants HG004960, HG005701, GM099568, and GM075091. This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC). A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. Funding for the WTCCC project was provided by the Wellcome Trust under awards 076113 and 085475. This study made use of data generated by the UK10K Consortium and derived from samples from cohorts UK10K-COHORTS_TWINSUK and UK10K_COHORT_ALSPAC. A full list of the investigators who contributed to the generation of the data is available from the UK10K website. Funding for UK10K was provided by the Wellcome Trust under award WT091310. The 1966 Northern Finland Birth Cohort (NFBC1966) study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the Broad Institute; University of California, Los Angeles (UCLA), University of Oulu, and National Institute for Health and Welfare in Finland. This manuscript does not necessarily reflect the opinions or views of the NFBC1966 study investigators, Broad Institute, UCLA, University of Oulu, National Institute for Health and Welfare in Finland, or NHLBI. The study set "Genome-wide association study of amyotrophic lateral sclerosis in Finland" was obtained via dbGaP (National Institute of Neurological Disorders and Stroke). We thank the original study authors and participating subjects.	Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FELSENSTEIN J, 1971, GENETICS, V68, P581; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gattepaille LM, 2013, HEREDITY, V110, P409, DOI 10.1038/hdy.2012.120; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Han E, 2014, MOL BIOL EVOL, V31, P723, DOI 10.1093/molbev/mst229; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Heyde CC, 1996, J ROY STAT SOC B MET, V58, P317; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Waples RS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1339; Wright S, 1931, GENETICS, V16, P0097	27	124	124	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					404	418		10.1016/j.ajhg.2015.07.012	http://dx.doi.org/10.1016/j.ajhg.2015.07.012			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26299365	Green Published, Bronze			2022-12-18	WOS:000361084700004
J	Bohm, J; Chevessier, F; De Paula, AM; Koch, C; Attarian, S; Feger, C; Hantai, D; Laforet, P; Ghorab, K; Vallat, JM; Fardeau, M; Figarella-Branger, D; Pouget, J; Romero, NB; Koch, M; Ebel, C; Levy, N; Krahn, M; Eymard, B; Bartoli, M; Laporte, J				Boehm, Johann; Chevessier, Frederic; De Paula, Andre Maues; Koch, Catherine; Attarian, Shahram; Feger, Claire; Hantai, Daniel; Laforet, Pascal; Ghorab, Karima; Vallat, Jean-Michel; Fardeau, Michel; Figarella-Branger, Dominique; Pouget, Jean; Romero, Norma B.; Koch, Marc; Ebel, Claudine; Levy, Nicolas; Krahn, Martin; Eymard, Bruno; Bartoli, Marc; Laporte, Jocelyn			Constitutive Activation of the Calcium Sensor STIM1 Causes Tubular-Aggregate Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; SKELETAL-MUSCLE; CRAC CHANNELS; STORE; ORAI1; MUTATION; IMMUNODEFICIENCY; DEFICIENCY; INITIATION	Tubular aggregates are regular arrays of membrane tubules accumulating in muscle with age. They are found as secondary features in several muscle disorders, including alcohol- and drug-induced myopathies, exercise-induced cramps, and inherited myasthenia, but also exist as a pure genetic form characterized by slowly progressive muscle weakness. We identified dominant STIM1 mutations as a genetic cause of tubular-aggregate myopathy (TAM). Stromal interaction molecule 1 (STIM1) is the main Ca2+ sensor in the endoplasmic reticulum, and all mutations were found in the highly conserved intraluminal Ca2+-binding EF hands. Ca2+ stores are refilled through a process called store-operated Ca2+ entry (SOCE). Upon Ca2+-store depletion, wild-type STIM1 oligomerizes and thereby triggers extracellular Ca2+ entry. In contrast, the missense mutations found in our four TAM-affected families induced constitutive STIM1 clustering, indicating that Ca2+ sensing was impaired. By monitoring the calcium response of TAM myoblasts to SOCE, we found a significantly higher basal Ca2+ level in TAM cells and a dysregulation of intracellular Ca2+ homeostasis. Because recessive STIM1 loss-of-function mutations were associated with immunodeficiency, we conclude that the tissue-specific impact of STIM1 loss or constitutive activation is different and that a tight regulation of STIM1-dependent SOCE is fundamental for normal skeletal-muscle structure and function.	[Boehm, Johann; Koch, Catherine; Feger, Claire; Laporte, Jocelyn] Inst Genet & Biol Mol & Cellulaire, Dept Med Translat & Neurogenet, F-67404 Illkirch Graffenstaden, France; [Boehm, Johann; Koch, Catherine; Feger, Claire; Koch, Marc; Ebel, Claudine; Laporte, Jocelyn] INSERM, U964, F-67404 Illkirch Graffenstaden, France; [Boehm, Johann; Koch, Catherine; Feger, Claire; Koch, Marc; Ebel, Claudine; Laporte, Jocelyn] CNRS, Unite Mixte Rech 7104, F-67404 Illkirch Graffenstaden, France; [Boehm, Johann; Koch, Catherine; Feger, Claire; Koch, Marc; Ebel, Claudine; Laporte, Jocelyn] Univ Strasbourg, F-67404 Illkirch Graffenstaden, France; [Boehm, Johann; Koch, Catherine; Feger, Claire; Laporte, Jocelyn] Coll France, Chaire Genet Humaine, F-67404 Illkirch Graffenstaden, France; [Chevessier, Frederic; Hantai, Daniel; Laforet, Pascal; Romero, Norma B.; Eymard, Bruno] Grp Hosp Pitie Salpetriere, Ctr Reference Pathol Neuromusculaire Paris Est, F-75013 Paris, France; [De Paula, Andre Maues; Levy, Nicolas; Krahn, Martin; Bartoli, Marc] Aix Marseille Univ, Fac Med Marseille, Unite Mixte Rech S910, F-13385 Marseille, France; [De Paula, Andre Maues; Levy, Nicolas; Krahn, Martin; Bartoli, Marc] INSERM, Unite Mixte Rech S910, F-13385 Marseille, France; [De Paula, Andre Maues; Figarella-Branger, Dominique] Hop Enfants La Timone, Assistance Publ Hop Marseille, Serv Anat Pathol & Neuropathol, F-13385 Marseille, France; [Attarian, Shahram; Pouget, Jean] Hop Enfants La Timone, Ctr Reference Malad Neuromusculaires & Sclerose L, F-13385 Marseille, France; [Hantai, Daniel] Hop La Pitie Salpetriere, INSERM, Unite Mixte Rech S975, Ctr Rech,Inst Cerveau & Moelle, F-75013 Paris, France; [Ghorab, Karima; Vallat, Jean-Michel] Ctr Hosp Univ Limoges, Dept Neurol, F-87042 Limoges, France; [Ghorab, Karima; Vallat, Jean-Michel] Ctr Hosp Univ Limoges, Ctr Natl Reference Neuropathies Peripher Rares, F-87042 Limoges, France; [Fardeau, Michel; Romero, Norma B.] Grp Hosp Univ La Pitie Salpetriere, Inst Myol, Unite Morphol Neuromusculaire, F-75013 Paris, France; [Romero, Norma B.] Univ Paris 06, INSERM, Unite R76, Unite Mixte Rech 974, F-75013 Paris, France; [Romero, Norma B.] Grp Hosp Univ La Pitie Salpetriere, Inst Myol, CNRS, Unite Mixte Rech 7215, F-75013 Paris, France; [Koch, Marc] Inst Genet & Biol Mol & Cellulaire, Ctr Imagerie, F-67404 Illkirch Graffenstaden, France; [Ebel, Claudine] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Levy, Nicolas; Krahn, Martin; Bartoli, Marc] Hop Enfants La Timone, AP HP, Dept Med Genet, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Limoges; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Laporte, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Med Translat & Neurogenet, F-67404 Illkirch Graffenstaden, France.	jocelyn@igbmc.fr	LEVY, Nicolas/J-1632-2014; laporte, jocelyn/J-7008-2012; Bartoli, Marc/Q-5979-2017; Böhm, Johann/O-1652-2016; Bartoli, Marc/O-8893-2016; laporte, jocelyn/O-4888-2019; Laporte, Jocelyn/H-6801-2016; Attarian, Shahram/AAE-6214-2021	LEVY, Nicolas/0000-0001-5171-6365; Bartoli, Marc/0000-0003-3339-9858; Böhm, Johann/0000-0001-8019-9504; Bartoli, Marc/0000-0003-3339-9858; Bohm, Johann/0000-0001-7370-3469; Koch, Catherine/0000-0003-0790-1429; Koch, Marc/0000-0002-2678-235X	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite de Strasbourg; Aix-Marseille Universite; College de France; Agence Nationale de la Recherche [ANR-11-BSV1-026]; Fondation Maladies Rares; Groupement d'Interet Scientifique-Maladies Rares; Association Francaise contre les Myopathies; Muscular Dystrophy Association; Myotubular Trust	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Aix-Marseille Universite; College de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Maladies Rares; Groupement d'Interet Scientifique-Maladies Rares; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Myotubular Trust	We thank the members of the families for their cooperation and interest in this study. We also thank Sophie Nicole, Danielle Chateau, Jean-Paul Leroy, Rana El Dahr, Nicolas Demaurex, Bernard Jost, Stephanie Le Gras, Jean-Francois Pelissier, Sebastien Courrier, Valerie Biancalana, and Beate Heizmann for material supply, discussions, and technical assistance. This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite de Strasbourg, Aix-Marseille Universite, College de France, Agence Nationale de la Recherche (ANR-11-BSV1-026), Fondation Maladies Rares, Groupement d'Interet Scientifique-Maladies Rares, Association Francaise contre les Myopathies, Muscular Dystrophy Association, and Myotubular Trust.	Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Boncompagni S, 2012, AGE, V34, P27, DOI 10.1007/s11357-011-9211-y; Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; ENGEL AG, 1982, ANN NEUROL, V11, P553, DOI 10.1002/ana.410110603; ENGEL WK, 1970, J ULTRA MOL STRUCT R, V31, P507, DOI 10.1016/S0022-5320(70)90166-8; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Kiviluoto S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-16; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Muller HD, 2001, ACTA NEUROPATHOL, V102, P27; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schiaffino S, 2012, NEUROMUSCULAR DISORD, V22, P199, DOI 10.1016/j.nmd.2011.10.005; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	31	124	128	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					271	278		10.1016/j.ajhg.2012.12.007	http://dx.doi.org/10.1016/j.ajhg.2012.12.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332920	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000315179600012
J	Jeanne, M; Labelle-Dumais, C; Jorgensen, J; Kauffman, WB; Mancini, GM; Favor, J; Valant, V; Greenberg, SM; Rosand, J; Gould, DB				Jeanne, Marion; Labelle-Dumais, Cassandre; Jorgensen, Jeff; Kauffman, W. Berkeley; Mancini, Grazia M.; Favor, Jack; Valant, Valerie; Greenberg, Steven M.; Rosand, Jonathan; Gould, Douglas B.			COL4A2 Mutations Impair COL4A1 and COL4A2 Secretion and Cause Hemorrhagic Stroke	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; CAENORHABDITIS-ELEGANS; IDENTIFICATION; ANGIOPATHY; DISEASE; BRAIN; ONSET	Collagen, type IV, alpha 1 (COL4A1) and alpha 2 (COL4A2) form heterotrimers and are abundant components of basement membranes, including those of the cerebral vasculature. COL4A1 mutations are an increasingly recognized cause of multisystem disorders, including highly penetrant cerebrovascular disease and intracerebral hemorrhage (ICH). Because COL4A1 and COL4A2 are structurally and functionally associated, we hypothesized that variants in COL4A2 would also cause ICH. We sequence COL4A2 in 96 patients with ICH and identify three rare, nonsynonymous coding variants in four patients that are not present in a cohort of 144 ICH-free individuals. All three variants change evolutionarily conserved amino acids. Using a cellular assay, we show that these putative mutations cause intracellular accumulation of COL4A1 and COL4A2 at the expense of their secretion, which supports their pathogenecity. Furthermore, we show that Col4a2 mutant mice also have completely penetrant ICH and that mutations in mouse and human lead to retention of COL4A1 and COL4A2 within the endoplasmic reticulum (ER). Importantly, two of the three putative mutations found in patients trigger ER stress and activate the unfolded protein response. The identification of putative COL4A2 mutations that might contribute to ICH in human patients provides insight into the pathogenic mechanisms of this disease. Our data suggest that COL4A2 mutations impair COL4A1 and COL4A2 secretion and can also result in cytotoxicity. Finally, our findings suggest that, collectively, mutations in COL4A1 and COL4A2 contribute to sporadic cases of ICH.	[Jeanne, Marion; Labelle-Dumais, Cassandre; Jorgensen, Jeff; Kauffman, W. Berkeley; Gould, Douglas B.] Univ Calif San Francisco, Dept Ophthalmol, Inst Human Genet, San Francisco, CA 94143 USA; [Jeanne, Marion; Labelle-Dumais, Cassandre; Jorgensen, Jeff; Kauffman, W. Berkeley; Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, Inst Human Genet, San Francisco, CA 94143 USA; [Mancini, Grazia M.] Erasmus MC, Dept Clin Genet, NL-3015 GJ Rotterdam, Netherlands; [Favor, Jack] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Valant, Valerie; Greenberg, Steven M.; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Hemorrhag Stroke Res Grp, Boston, MA 02114 USA; [Valant, Valerie; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Valant, Valerie; Rosand, Jonathan] Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Boston, MA 02114 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Gould, DB (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, Inst Human Genet, San Francisco, CA 94143 USA.	gouldd@vision.ucsf.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Kauffman, William/0000-0003-0571-5403; Dichgans, Martin/0000-0002-0654-387X; Jeanne, Marion/0000-0001-7334-3061	American Heart Association; National Institutes of Health (NIH)- National Institute of Neurological Disorders and Stroke [R01NS059727]; Research To Prevent Blindness; NIH- National Eye Institute (NEI) [R01EY019887]; NEI [EY02162]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY019887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059727] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)- National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research To Prevent Blindness(Research to Prevent Blindness (RPB)); NIH- National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a research grant from the American Heart Association (D.B.G.) and by National Institutes of Health (NIH)- National Institute of Neurological Disorders and Stroke grant R01NS059727 (S.M.G. and J.R.). Salary support was also provided by Research To Prevent Blindness (C.L.D.), and NIH- National Eye Institute (NEI) grant R01EY019887 (B.K.). Additional support was provided by a core grant from the NEI (EY02162) and a Research To Prevent Blindness Unrestricted Grant (UCSF Department of Ophthalmology).	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; Biffi A, 2010, NEUROLOGY, V75, P693, DOI 10.1212/WNL.0b013e3181eee40f; Bilguvar K, 2009, J PEDIATR-US, V155, P743, DOI 10.1016/j.jpeds.2009.04.014; Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; de Vries LS, 2009, ANN NEUROL, V65, P12, DOI 10.1002/ana.21525; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FATEMI SH, 1987, CONNECT TISSUE RES, V16, P1, DOI 10.3109/03008208709001990; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; GUO XD, 1991, NATURE, V349, P707, DOI 10.1038/349707a0; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; MAYNE R, 1984, J CELL BIOL, V98, P1637, DOI 10.1083/jcb.98.5.1637; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Plaisier E, 2005, KIDNEY INT, V67, P2354, DOI 10.1111/j.1523-1755.2005.00341.x; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; Plaisier E, 2010, AM J MED GENET A, V152A, P2550, DOI 10.1002/ajmg.a.33659; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Rouaud T, 2010, NEUROLOGY, V75, P747, DOI 10.1212/WNL.0b013e3181eee440; Shah S, 2010, EUR J PAEDIATR NEURO, V14, P182, DOI 10.1016/j.ejpn.2009.04.010; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; TRUEB B, 1982, J BIOL CHEM, V257, P5239; Vahedi K, 2007, STROKE, V38, P1461, DOI 10.1161/STROKEAHA.106.475194; Vermeulen RJ, 2011, NEUROPEDIATRICS, V42, P1, DOI 10.1055/s-0031-1275343; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214	37	124	128	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					91	101		10.1016/j.ajhg.2011.11.022	http://dx.doi.org/10.1016/j.ajhg.2011.11.022			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22209247	Green Published, Bronze			2022-12-18	WOS:000299409100009
J	Yang, YZ; Yang, YQ; Liang, B; Liu, JQ; Li, J; Grunnet, M; Olesen, SP; Rasmussen, HB; Ellinor, PT; Gao, LJ; Lin, XP; Li, L; Wang, L; Xiao, JJ; Liu, Y; Liu, Y; Zhang, SL; Liang, DD; Peng, LY; Jespersen, T; Chen, YH				Yang, Yanzong; Yang, Yiqing; Liang, Bo; Liu, Jinqiu; Li, Jun; Grunnet, Morten; Olesen, Soren-Peter; Rasmussen, Hanne B.; Ellinor, Patrick T.; Gao, Lianjun; Lin, Xiaoping; Li, Li; Wang, Lei; Xiao, Junjie; Liu, Yi; Liu, Ying; Zhang, Shulong; Liang, Dandan; Peng, Luying; Jespersen, Thomas; Chen, Yi-Han			Identification of a Kir3.4 Mutation in Congenital Long QT Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							K+ CHANNEL SUBUNIT; G-PROTEIN; CARDIAC-ARRHYTHMIA; VENTRICULAR MYOCYTES; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; I-KACH; EXPRESSION; ACTIVATION; ACETYLCHOLINE	Congenital long QT syndrome (LQTS) is a hereditary disorder that leads to sudden cardiac death secondary to fatal cardiac arrhythmias. Although many genes for LQTS have been described, the etiology remains unknown in 30%-40% of cases. In the present study, a large Chinese family (four generations, 49 individuals) with autosomal-dominant LQTS was clinically evaluated. Genome-wide linkage analysis was performed by using polymorphic microsatellite markers to map the genetic locus, and positional candidate genes were screened by sequencing for mutations. The expression pattern and functional characteristics of the mutated protein were investigated by western blotting and patch-clamp electrophysiology. The genetic locus of the LQTS-associated gene was mapped to chromosome 11q23.3-24.3. A heterozygous mutation (Kir3.4-Gly387Arg) was identified in the G protein-coupled, inwardly rectifying potassium channel subunit Kir3.4, encoded by the KCNJ5 gene. The Kir3.4-Gly387Arg mutation was present in all nine affected family members and absent in 528 ethnically matched controls. Western blotting of human cardiac tissue demonstrated significant Kir3.4 expression levels in the cardiac ventricles. Heterologous expression studies with Kir3.4-Gly387Arg revealed a loss-of-function electrophysiological phenotype resulting from reduced plasma membrane expression. Our findings suggest a role for Kir3.4 in the etiology of LQTS.	[Yang, Yanzong; Yang, Yiqing; Li, Jun; Lin, Xiaoping; Li, Li; Wang, Lei; Xiao, Junjie; Liu, Yi; Liu, Ying; Liang, Dandan; Peng, Luying; Chen, Yi-Han] Tongji Univ, Sch Med, Minist Educ, East Hosp,Key Lab Arrhythmias, Shanghai 200120, Peoples R China; [Yang, Yanzong; Liu, Jinqiu; Gao, Lianjun; Zhang, Shulong] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian 116011, Peoples R China; [Yang, Yanzong; Liu, Jinqiu; Gao, Lianjun; Zhang, Shulong] Minist Hlth, Training Ctr Intervent Therapy Arrhythmias, Dalian 116011, Peoples R China; [Yang, Yiqing; Lin, Xiaoping; Wang, Lei; Chen, Yi-Han] Tongji Univ, Sch Med, Dept Cardiol, East Hosp, Shanghai 200120, Peoples R China; [Yang, Yiqing; Li, Jun; Lin, Xiaoping; Li, Li; Wang, Lei; Xiao, Junjie; Liang, Dandan; Peng, Luying; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai 200120, Peoples R China; [Liang, Bo; Grunnet, Morten; Olesen, Soren-Peter; Rasmussen, Hanne B.; Jespersen, Thomas] Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-2200 Copenhagen, Denmark; [Liang, Bo; Grunnet, Morten; Olesen, Soren-Peter; Rasmussen, Hanne B.; Jespersen, Thomas] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Grunnet, Morten; Olesen, Soren-Peter] NeuroSearch AS, DK-2750 Ballerup, Denmark; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA	Tongji University; Dalian Medical University; Tongji University; Tongji University; Danmarks Grundforskningsfond; University of Copenhagen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Chen, YH (corresponding author), Tongji Univ, Sch Med, Minist Educ, East Hosp,Key Lab Arrhythmias, Shanghai 200120, Peoples R China.	yihanchen@hotmail.com	Jespersen, Thomas/G-4860-2011; Rasmussen, Hanne B/N-9652-2016; Olesen, Søren P/H-4206-2011; Olesen, Søren-Peter/B-9621-2012; Liang, Bo/C-7210-2012	Jespersen, Thomas/0000-0001-6575-360X; Rasmussen, Hanne B/0000-0002-2218-5646; Olesen, Søren P/0000-0002-4381-5192; Ellinor, Patrick/0000-0002-2067-0533	"973" Program Fund of China [2007CB512100]; "863" Program Fund of China [2007AA02Z438]; Program Fund for Shanghai Subject Chief Scientists; Ministry of Education of China; National Science Fund of China [30425016, 30330290]; Shanghai Pujiang Program Fund [07114058]; Danish National Research Foundation; Danish National Research Council; Lundbeck Foundation; National Institutes of Health [HL092577, DA027021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104156, K24HL105780, R01HL092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027021] Funding Source: NIH RePORTER	"973" Program Fund of China(National Basic Research Program of China); "863" Program Fund of China(National High Technology Research and Development Program of China); Program Fund for Shanghai Subject Chief Scientists; Ministry of Education of China(Ministry of Education, China); National Science Fund of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program Fund(Shanghai Pujiang Program); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish National Research Council(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Yunfu Sun, Emelia J. Benjamin, and Kui Hong for their helpful comments. This work was supported by the "973" Program Fund of China (2007CB512100), the "863" Program Fund of China (2007AA02Z438), the Program Fund for Shanghai Subject Chief Scientists, the Program Fund for Innovative Research Teams by the Ministry of Education of China, the National Science Fund of China (30425016 and 30330290 to Y.-H.C.), the Shanghai Pujiang Program Fund (07114058 to L.P.), the Danish National Research Foundation (to S.-P.O.), the Danish National Research Council (to B.L. and M.G.), the Lundbeck Foundation (to T.J.), and the National Institutes of Health (HL092577 and DA027021 to P.T.E.).	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Arora R, 2003, CIRCULATION, V107, P1816, DOI 10.1161/01.CIR.0000058461.86339.7E; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Beckmann C, 2008, CELL PHYSIOL BIOCHEM, V21, P259, DOI 10.1159/000129381; Bender K, 2001, J BIOL CHEM, V276, P28873, DOI 10.1074/jbc.M102328200; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Dobrzynski H, 2002, AM J PHYSIOL-HEART C, V283, pH615, DOI 10.1152/ajpheart.00130.2002; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Fatkin D, 2007, CIRCULATION, V116, P782, DOI 10.1161/CIRCULATIONAHA.106.688889; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; ITO H, 1995, N-S ARCH PHARMACOL, V351, P610; Jespersen T, 2004, J CELL SCI, V117, P4517, DOI 10.1242/jcs.01318; Johnson JN, 2008, HEART RHYTHM, V5, P704, DOI 10.1016/j.hrthm.2008.02.007; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Koumi S, 1997, J MEMBRANE BIOL, V157, P71, DOI 10.1007/s002329900217; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; Landeen LK, 2008, AM J PHYSIOL-HEART C, V294, pH736, DOI 10.1152/ajpheart.00316.2007; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WANG S, 1996, P 5 CHIN C GLAC GEOC, V1, P17; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yang ZK, 1996, J PHYSIOL-LONDON, V492, P789, DOI 10.1113/jphysiol.1996.sp021346; Zareba W, 2008, PROG CARDIOVASC DIS, V51, P264, DOI 10.1016/j.pcad.2008.10.006	42	124	129	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					872	880		10.1016/j.ajhg.2010.04.017	http://dx.doi.org/10.1016/j.ajhg.2010.04.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT		Green Published, Bronze			2022-12-18	WOS:000278948900005
J	Zhernakova, A; Elbers, CC; Ferwerda, B; Romanos, J; Trynka, G; Dubois, PC; de Kovel, CGF; Franke, L; Oosting, M; Barisani, D; Bardella, MT; Joosten, LAB; Saavalainen, P; van Heel, DA; Catassi, C; Netea, MG; Wijmenga, C				Zhernakova, Alexandra; Elbers, Clara C.; Ferwerda, Bart; Romanos, Jihane; Trynka, Gosia; Dubois, Patrick C.; de Kovel, Carolien G. F.; Franke, Lude; Oosting, Marije; Barisani, Donatella; Bardella, Maria Teresa; Joosten, Leo A. B.; Saavalainen, Paivi; van Heel, David A.; Catassi, Carlo; Netea, Mihai G.; Wijmenga, Cisca		Finnish Celiac Dis Study Grp	Evolutionary and Functional Analysis of Celiac Risk Loci Reveals SH2B3 as a Protective Factor against Bacterial Infection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POSITIVE SELECTION; BLOOD-PRESSURE; DISEASE; POPULATION; MORTALITY; VARIANTS; GENETICS; COHORT; SUSCEPTIBILITY	Celiac disease (CD) is an intolerance to dietary proteins of wheat, barley, and rye. CD may have substantial morbidity, yet it is quite common with a prevalence of 1%-2% in Western populations. It is not clear why the CD phenotype is so prevalent despite its negative effects on human health, especially because appropriate treatment in the form of a gluten-free diet has only been available since the 1950s, when dietary gluten was discovered to be the triggering factor. The high prevalence of CD might suggest that genes underlying this disease may have been favored by the process of natural selection. We assessed signatures of selection for ten confirmed CD-associated loci in several genome-wide data sets, comprising 8154 controls from four European populations and 195 individuals from a North African population, by studying haplotype lengths via the integrated haplotype score (iHS) method. Consistent signs of positive selection for CD-associated derived alleles were observed in three loci: IL12A, IL18RAP, and SH2B3. For the SH2B3 risk allele, we also show a difference in allele frequency distribution (F-st) between HapMap phase II populations. Functional investigation of the effect of the SH2B3 genotype in response to lipopolysaccharide and muramyl dipeptide revealed that carriers of the SH2B3 rs3184504*A risk allele showed stronger activation of the NOD2 recognition pathway. This suggests that SH2B3 plays a role in protection against bacteria infection, and it provides a possible explanation for the selective sweep on SH2B3, which occurred sometime between 1200 and 1700 years ago.	[Romanos, Jihane; Trynka, Gosia; Franke, Lude; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Romanos, Jihane; Trynka, Gosia; Franke, Lude; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Zhernakova, Alexandra; Elbers, Clara C.; de Kovel, Carolien G. F.] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; [Zhernakova, Alexandra] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Elbers, Clara C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Ferwerda, Bart; Oosting, Marije; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Ferwerda, Bart; Oosting, Marije; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands; [Dubois, Patrick C.; Franke, Lude; van Heel, David A.] Queen Mary Univ London, Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London E1 2AT, England; [Barisani, Donatella] Univ Milano Bicocca, Fac Med, Dept Expt Med, I-20052 Monza, Italy; [Bardella, Maria Teresa] Fdn IRCCS Osped Maggiore Policlin, I-20122 Milan, Italy; [Bardella, Maria Teresa] Univ Milan, Dept Med Sci, I-20122 Milan, Italy; Univ Tampere, Tampere 33014, Finland; [Finnish Celiac Dis Study Grp] Univ Tampere, Sch Med, Tampere Univ Hosp, Tampere 33014, Finland; [Saavalainen, Paivi] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [Saavalainen, Paivi] Univ Helsinki, Res Program Mol Med, Helsinki 00014, Finland; [Catassi, Carlo] Univ Politecn Marche, Dept Pediat, I-60123 Ancona, Italy; [Catassi, Carlo] Univ Maryland, Sch Med, Ctr Celiac Res, Baltimore, MD 21201 USA	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; University of London; Queen Mary University London; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Marche Polytechnic University; University System of Maryland; University of Maryland Baltimore	Wijmenga, C (corresponding author), Univ Med Ctr Groningen, Dept Genet, POB 30-001, NL-9700 RB Groningen, Netherlands.	cisca.wijmenga@med.umcg.nl	Franke, Lude/P-7036-2016; Wijmenga, Cisca/AAE-7719-2019; Joosten, Leo AB/H-3138-2015; de Kovel, Carolien/AAI-3531-2021; Oosting, Marije/H-7437-2015; Romanos, Jihane/F-7372-2012; Saavalainen, Päivi M/E-8621-2011; Wijmenga, Cisca/D-2173-2009; Zhernakova, Alexandra/ABA-9372-2020; Netea, Mihai/N-5155-2014	Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Joosten, Leo AB/0000-0001-6166-9830; de Kovel, Carolien/0000-0002-7818-1396; van Heel, David/0000-0002-0637-2265; Ferwerda, Bart/0000-0002-7050-5931; Trynka, Gosia/0000-0002-6955-9529; Zhernakova, Alexandra/0000-0002-4574-0841; Kurppa, Kalle/0000-0003-4757-2164	Celiac Disease Consortium; Dutch Government; Netherlands Organization for Scientific Research; EU; SenterNovem (IOP genomics); Wellcome Trust; UK Medical Research Council; Royal Netherlands Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF) [U01 DK062418]; MRC [G0700545, G0000934] Funding Source: UKRI; Medical Research Council [G0700545, G0000934] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Celiac Disease Consortium; Dutch Government; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); SenterNovem (IOP genomics); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Netherlands Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the Celiac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government, the Netherlands Organization for Scientific Research, EU STREP KP6, SenterNovem (IOP genomics), and the Wellcome Trust. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council and the Wellcome Trust. G.T. was awarded a Ter Meulen Fund travel grant by the Royal Netherlands Academy of Arts and Sciences (KNAW). M.G.N. was supported by a VIDI grant from the Netherlands Organization for Scientific Research (NWO). P.C.D. is an MRC Clinical Training Fellow. We thank all the clinicians and Coeliac UK for their help in recruiting individuals for this study. The Finnish Celiac Disease Study Group is represented by Katri Kaukinen, Kalle Kurppa, and Markku Maki. This study used data generated by the Wellcome Trust Case-Control Consortium 2 and resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. We thank all the individuals who participated in the study. A full list of personal acknowledgements is given in the Supplemental Data.	Abu-Zekry M, 2008, J PEDIATR GASTR NUTR, V47, P136, DOI 10.1097/MPG.0b013e31815ce5d1; Amundsen SS, 2010, GENES IMMUN, V11, P79, DOI 10.1038/gene.2009.67; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Catassi C, 2008, CURR OPIN GASTROEN, V24, P687, DOI 10.1097/MOG.0b013e32830edc1e; Cheng F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-221; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Dema B, 2009, J MED GENET, V46, P617, DOI 10.1136/jmg.2009.067041; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferwerda B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006870; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LEWONTIN RC, 1973, GENETICS, V74, P175; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Romanos J, 2009, J MED GENET, V46, P60, DOI 10.1136/jmg.2008.061457; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Viljamaa M, 2006, DIGEST LIVER DIS, V38, P374, DOI 10.1016/j.dld.2006.03.002; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	37	124	126	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					970	977		10.1016/j.ajhg.2010.05.004	http://dx.doi.org/10.1016/j.ajhg.2010.05.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20560212	Green Published, Bronze			2022-12-18	WOS:000278948900015
J	Kennerson, ML; Nicholson, GA; Kaler, SG; Kowalski, B; Mercer, JFB; Tang, JR; Llanos, RM; Chu, SN; Takata, RI; Speck-Martins, CE; Baets, J; Almeida-Souza, L; Fischer, D; Timmerman, V; Taylor, PE; Scherer, SS; Ferguson, TA; Bird, TD; De Jonghe, P; Feely, SME; Shy, ME; Garbern, JY				Kennerson, Marina L.; Nicholson, Garth A.; Kaler, Stephen G.; Kowalski, Bartosz; Mercer, Julian F. B.; Tang, Jingrong; Llanos, Roxana M.; Chu, Shannon; Takata, Reinaldo I.; Speck-Martins, Carlos E.; Baets, Jonathan; Almeida-Souza, Leonardo; Fischer, Dirk; Timmerman, Vincent; Taylor, Philip E.; Scherer, Steven S.; Ferguson, Toby A.; Bird, Thomas D.; De Jonghe, Peter; Feely, Shawna M. E.; Shy, Michael E.; Garbern, James Y.			Missense Mutations in the Copper Transporter Gene ATP7A Cause X-Linked Distal Hereditary Motor Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; MARIE-TOOTH-DISEASE; MENKES-DISEASE; NEURON DISEASE; CANDIDATE GENE; WILSON; TRAFFICKING; EXPRESSION; ATPASES; ENCODES	Distal hereditary motor neuropathies comprise a clinically and genetically heterogeneous group of disorders. We recently mapped an X-linked form of this condition to chromosome Xq13.1-q21 in two large unrelated families. The region of genetic linkage included ATP7A, which encodes a copper-transporting P-type ATPase mutated in patients with Menkes disease, a severe infantile-onset neurodegenerative condition. We identified two unique ATP7A missense mutations (p.P1386S and p.T9941) in males with distal motor neuropathy in two families. These molecular alterations impact highly conserved amino acids in the carboxyl half of ATP7A and do not directly involve the copper transporter's known critical functional domains. Studies of p.P1386S revealed normal ATP7A mRNA and protein levels, a defect in ATP7A trafficking, and partial rescue of a S. cerevisiae copper transport knockout. Although ATP7A mutations are typically associated with severe Menkes disease or its milder allelic variant, occipital horn syndrome, we demonstrate here that certain missense mutations at this locus can cause a syndrome restricted to progressive distal motor neuropathy without overt signs of systemic copper deficiency. This previously unrecognized genotype-phenotype correlation suggests an important role of the ATP7A copper transporter in motor-neuron maintenance and function.	[Kennerson, Marina L.; Nicholson, Garth A.; Kowalski, Bartosz; Chu, Shannon] Univ Sydney, ANZAC Res Inst, Northcott Neurosci Lab, Concord, Australia; [Kennerson, Marina L.; Nicholson, Garth A.] Concord Hosp, Mol Med Lab, Concord, Australia; [Kaler, Stephen G.; Tang, Jingrong] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Human Copper Metab, Program Mol Med, NIH, Bethesda, MD USA; [Mercer, Julian F. B.; Llanos, Roxana M.; Taylor, Philip E.] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Australia; [Takata, Reinaldo I.; Speck-Martins, Carlos E.] Sarah Network Rehabil Hosp, Brasilia, DF, Brazil; [Baets, Jonathan; Almeida-Souza, Leonardo; Timmerman, Vincent; De Jonghe, Peter] Flanders Inst Biotechnol, Dept Mol Genet, Antwerp, Belgium; [Baets, Jonathan; Almeida-Souza, Leonardo; Timmerman, Vincent; De Jonghe, Peter] Univ Antwerp, B-2020 Antwerp, Belgium; [Fischer, Dirk] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fischer, Dirk] Univ Childrens Hosp Basel, Dept Neuropediat, Basel, Switzerland; [Scherer, Steven S.; Ferguson, Toby A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Med Genet, Seattle, WA USA; [Bird, Thomas D.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Feely, Shawna M. E.; Shy, Michael E.; Garbern, James Y.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Feely, Shawna M. E.; Shy, Michael E.; Garbern, James Y.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Deakin University; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Basel; University of Basel; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Wayne State University; Wayne State University	Kennerson, ML (corresponding author), Univ Sydney, ANZAC Res Inst, Northcott Neurosci Lab, Concord, Australia.	marinak@anzac.edu.au	Mercer, Julian/R-8583-2019; Research Institute, ANZAC/CAE-9030-2022; Almeida-Souza, Leonardo/C-3437-2011; Timmerman, Vincent/O-7283-2019; Kaler, Stephen/GPT-3845-2022; Kennerson, Marina L/B-5058-2014; Scherer, Steven S/F-7979-2011	Almeida-Souza, Leonardo/0000-0002-7169-1238; Timmerman, Vincent/0000-0002-2162-0933; Shy, Michael/0000-0001-8460-6971; Kennerson, Marina/0000-0003-3332-5074; Nicholson, Garth/0000-0001-9694-066X	Motor Neuron Disease Research Institute of Australia; National Health and Medical Research Council of Australia; Intramural Research program of the National Institute of Child Health and Human Development; Methusalem project of the University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program [P6/43]; Belgian Federal Science Policy Office (BELSPO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008892, ZIAHD008768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS065157] Funding Source: NIH RePORTER	Motor Neuron Disease Research Institute of Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Intramural Research program of the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Methusalem project of the University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and family members for their participation in this study. We thank Rabia Chaudhry and Alison Blake for their assistance with Cell Cultures and Jose Centeno for fibroblast copper measurements. This work was supported by grants from the Motor Neuron Disease Research Institute of Australia, the National Health and Medical Research Council of Australia, the Intramural Research program of the National Institute of Child Health and Human Development, the Methusalem project of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), and the Interuniversity Attraction Poles program (P6/43) of the Belgian Federal Science Policy Office (BELSPO). J.B. and L.S. are Supported by PhD fellowships of the FWO-Flanders and the University of Antwerp, respectively. We thank Professor David Handelsman for his useful constructive comments on the manuscript.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Daube J.R, 2014, CLIN NEUROPHYSIOL; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Donsante A, 2007, J MED GENET, V44, P492, DOI 10.1136/jmg.2007.050013; El Meskini R, 2007, MOL CELL NEUROSCI, V34, P409, DOI 10.1016/j.mcn.2006.11.018; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Goodman BP, 2009, J NEUROL NEUROSUR PS, V80, P524, DOI 10.1136/jnnp.2008.144683; Harding AE, 1993, PERIPHERAL NEUROPATH, P1051; Hsi G, 2004, HUM GENET, V114, P165, DOI 10.1007/s00439-003-1045-y; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Irobi-Devolder J, 2008, Verh K Acad Geneeskd Belg, V70, P25; Kaler S G, 1994, Adv Pediatr, V41, P263; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2008, NEW ENGL J MED, V358, P605, DOI 10.1056/NEJMoa070613; Kaler SG, 2009, ANN NEUROL, V65, P108, DOI 10.1002/ana.21576; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; Kelkar Praful, 2008, J Clin Neuromuscul Dis, V10, P1, DOI 10.1097/CND.0b013e3181828cf7; Kennerson M, 2009, NEUROLOGY, V72, P246, DOI 10.1212/01.wnl.0000339483.86094.a5; Kim BE, 2002, J BIOL CHEM, V277, P44079, DOI 10.1074/jbc.M208737200; Kumar N, 2006, NEURORADIOLOGY, V48, P78, DOI 10.1007/s00234-005-0016-5; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lem KE, 2007, MOL GENET METAB, V91, P30, DOI 10.1016/j.ymgme.2007.01.010; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Maystadt I, 2007, AM J HUM GENET, V81, P67, DOI 10.1086/518900; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Spain RI, 2009, NAT CLIN PRACT NEURO, V5, P106, DOI 10.1038/ncpneuro1008; Takata RI, 2004, J MED GENET, V41, P224, DOI 10.1136/jmg.2003.013201; Tang JR, 2008, MOL GENET METAB, V95, P174, DOI 10.1016/j.ymgme.2008.06.015; Tang JR, 2006, GENET MED, V8, P711, DOI 10.1097/01.gim.0000245578.94312.1e; Veldhuis N, 2009, BIOMETALS, V22, P177, DOI 10.1007/s10534-008-9183-2; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Weihl CC, 2006, MUSCLE NERVE, V34, P789, DOI 10.1002/mus.20631; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zara G, 2009, J NEUROL SCI, V277, P184, DOI 10.1016/j.jns.2008.10.017	47	124	127	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					343	352		10.1016/j.ajhg.2010.01.027	http://dx.doi.org/10.1016/j.ajhg.2010.01.027			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170900	Green Published, Bronze			2022-12-18	WOS:000275678800006
J	Poulter, JA; Ali, M; Gilmour, DF; Rice, A; Kondo, H; Hayashi, K; Mackey, DA; Kearns, LS; Ruddle, JB; Craig, JE; Pierce, EA; Downey, LM; Mohamed, MD; Markham, AF; Inglehearn, CF; Toomes, C				Poulter, James A.; Ali, Manir; Gilmour, David F.; Rice, Aine; Kondo, Hiroyuki; Hayashi, Kenshi; Mackey, David A.; Kearns, Lisa S.; Ruddle, Jonathan B.; Craig, Jamie E.; Pierce, Eric A.; Downey, Louise M.; Mohamed, Moin D.; Markham, Alexander F.; Inglehearn, Chris F.; Toomes, Carmel			Mutations in TSPAN12 Cause Autosomal-Dominant Familial Exudative Vitreoretinopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORRIE-DISEASE GENE; FZD4 MUTATIONS; TETRASPANIN PROTEINS; FRIZZLED-4 GENE; LRP5; VASCULARIZATION; ANGIOGENESIS; VASCULATURE; DOMAINS; LOCUS	Familial exudative vitreoretinopathy (FEVR) is an inherited blinding disorder of the retinal vascular system. Although mutations in three genes (LRP5, FZD4, and NDP) are known to cause FEVR, these account for only a fraction of FEVR cases. The proteins encoded by these FEVR genes form part of a signaling complex that activates the Norrin-beta-catenin signaling pathway. Recently, through a large-scale reverse genetic screen in mice, Junge and colleagues identified an additional member of this signaling complex, Tspan12. Here, we report that mutations in TSPAN12 also cause autosomal-dominant FEVR. We describe seven mutations identified in a cohort of 70 FEVR patients in whom we had already excluded the known FEVR genes. This study provides further evidence for the importance of the Norrin-beta-catenin signaling pathway in the development of the retinal vasculature and also indicates that more FEVR genes remain to be identified.	[Poulter, James A.; Ali, Manir; Gilmour, David F.; Rice, Aine; Downey, Louise M.; Markham, Alexander F.; Inglehearn, Chris F.; Toomes, Carmel] St James Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Kondo, Hiroyuki] Fukuoka Univ, Sch Med, Dept Ophthalmol, Fukuoka 8140180, Japan; [Hayashi, Kenshi] Kyushu Univ, Med Inst Bioregulat, Div Genome Anal, Fukuoka 8128582, Japan; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Mackey, David A.; Kearns, Lisa S.; Ruddle, Jonathan B.] Univ Melbourne, Dept Ophthalmol, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Craig, Jamie E.] Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA 5042, Australia; [Pierce, Eric A.] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Downey, Louise M.] Hull Royal Infirm, Dept Ophthalmol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Mohamed, Moin D.] St Thomas Hosp, Dept Ophthalmol, London SE1 7EH, England	Saint James's University Hospital; University of Leeds; Fukuoka University; Kyushu University; Lions Eye Institute; University of Western Australia; Centre for Eye Research Australia; University of Melbourne; Flinders Medical Centre; University of Pennsylvania; Pennsylvania Medicine; University of Hull; Guy's & St Thomas' NHS Foundation Trust	Toomes, C (corresponding author), St James Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	c.toomes@leeds.ac.uk	Mackey, David A/H-5340-2014; Poulter, James A/A-8190-2013; Ali, Manir/ABE-5251-2020; Inglehearn, Chris/GYD-9783-2022	Mackey, David A/0000-0001-7914-4709; Poulter, James A/0000-0003-2048-5693; Ali, Manir/0000-0003-3204-3788; Pierce, Eric/0000-0002-2354-4102; Toomes, Carmel/0000-0001-8373-9545; Parry, David/0000-0003-0376-7736; Craig, Jamie/0000-0001-9955-9696; Kearns, Lisa/0000-0001-9432-4054	The Royal Society; Wellcome Trust [080313/Z/06]; University of Leeds	The Royal Society(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds	We thank the FEVR families for their help in this study. The financial support of The Royal Society (C.T. is a Royal Society University Research Fellow) and the Wellcome Trust (080313/Z/06) is gratefully acknowledged. J.A.P. is supported by an Emma and Leslie Reid Scholarship from the University of Leeds.	Benson W E, 1995, Trans Am Ophthalmol Soc, V93, P473; Berger W, 1996, HUM MOL GENET, V5, P51, DOI 10.1093/hmg/5.1.51; Boonstra FN, 2009, INVEST OPHTH VIS SCI, V50, P4379, DOI 10.1167/iovs.08-3320; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clevers H, 2009, CELL, V139, P227, DOI 10.1016/j.cell.2009.09.027; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; Downey LM, 2006, BRIT J OPHTHALMOL, V90, P1163, DOI 10.1136/bjo.2006.092114; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kondo H, 2003, BRIT J OPHTHALMOL, V87, P1291, DOI 10.1136/bjo.87.10.1291; Kondo H, 2007, INVEST OPHTH VIS SCI, V48, P1276, DOI 10.1167/iovs.06-1042; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Nallathambi J, 2006, MOL VIS, V12, P1086; OBER RR, 1980, BRIT J OPHTHALMOL, V64, P112, DOI 10.1136/bjo.64.2.112; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Toomes C, 2004, INVEST OPHTH VIS SCI, V45, P2083, DOI 10.1167/iovs.03-1044; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	33	124	139	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					248	253		10.1016/j.ajhg.2010.01.012	http://dx.doi.org/10.1016/j.ajhg.2010.01.012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159112	Green Published, hybrid			2022-12-18	WOS:000274637200014
J	Peretz, I; Cummings, S; Dube, MP				Peretz, Isabelle; Cummings, Stephanie; Dube, Marie-Pierre			The genetics of congenital amusia (tone deafness): A family-aggregation study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABSOLUTE PITCH; MUSIC; GENES; BRAIN; PERCEPTION; DISORDERS; DYSLEXIA; TUNE	Congenital amusia (commonly known as "tone deafness") is a lifelong impairment of music perception that affects 4% of the population. To estimate whether congenital amusia can be genetically transmitted, its prevalence was quantified by direct auditory testing of 71 members of 9 large families of amusic probands, as well as of 75 members of 10 control families. The results confirm that congenital amusia is expressed by a deficit in processing musical pitch but not musical time and also show that the pitch disorder has a hereditary component. In amusic families, 39% of first-degree relatives have the same cognitive disorder, whereas only 3% have it in the control families. The identification of multiplex families with a high relative risk of experiencing a musical pitch deficit (lambda(s) = 10.8; 95% confidence interval 8-13.5) enables the mapping of genetic loci for hereditary amusia.	Univ Montreal, Int Lab brain Music & Sound Res BRAMS, Montreal, PQ, Canada; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Res Ctr, Montreal Heart Inst, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Peretz, I (corresponding author), Univ Montreal, Int Lab brain Music & Sound Res BRAMS, BRAMS Pavillon 1420 Mt Royal, Montreal, PQ, Canada.	isabelle.peretz@umontreal.ca	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393				Allen G, 1878, MIND, V3, P157, DOI [DOI 10.1093/MIND/OS-3.10.157, 10.1093/mind/os-3.10.157]; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; FRY DB, 1948, EXPT STUDY TONE DEAF, P1; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; HYDE K, 2006, NEUROIMAGE, V31, P1; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde ML, 2005, PLASTICITY AND SIGNAL REPRESENTATION IN THE AUDITORY SYSTEM, P291; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Mithen S., 2005, SINGING NEANDERTHALS; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Stromswold K, 1998, HUM BIOL, V70, P297; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	26	124	130	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					582	588		10.1086/521337	http://dx.doi.org/10.1086/521337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701903	Green Published, Bronze			2022-12-18	WOS:000249128200014
J	DeMeo, DL; Mariani, TJ; Lange, C; Srisuma, S; Litonjua, AA; Celedon, JC; Lake, SL; Reilly, JJ; Chapman, HA; Mecham, BH; Haley, KJ; Sylvia, JS; Sparrow, D; Spira, AE; Beane, J; Pinto-Plata, V; Speizer, FE; Shapiro, SD; Weiss, ST; Silverman, EK				DeMeo, DL; Mariani, TJ; Lange, C; Srisuma, S; Litonjua, AA; Celedon, JC; Lake, SL; Reilly, JJ; Chapman, HA; Mecham, BH; Haley, KJ; Sylvia, JS; Sparrow, D; Spira, AE; Beane, J; Pinto-Plata, V; Speizer, FE; Shapiro, SD; Weiss, ST; Silverman, EK			The SERPINE2 gene is associated with chronic obstructive pulmonary disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE LINKAGE; AIR-FLOW OBSTRUCTION; PROTEASE-NEXIN; SPIROMETRIC PHENOTYPES; PLASMINOGEN-ACTIVATOR; EXPIRATORY FLOW; EXPRESSION; TESTS; LUNG; EPIDEMIOLOGY	Chronic obstructive pulmonary disease ( COPD) is a complex human disease likely influenced by multiple genes, cigarette smoking, and gene-by-smoking interactions, but only severe alpha 1-antitrypsin deficiency is a proven genetic risk factor for COPD. Prior linkage analyses in the Boston Early-Onset COPD Study have demonstrated significant linkage to a key intermediate phenotype of COPD on chromosome 2q. We integrated results from murine lung development and human COPD gene-expression microarray studies with human COPD linkage results on chromosome 2q to prioritize candidate-gene selection, thus identifying SERPINE2 as a positional candidate susceptibility gene for COPD. Immunohistochemistry demonstrated expression of serpine2 protein in mouse and human adult lung tissue. In family-based association testing of 127 severe, early-onset COPD pedigrees from the Boston Early-Onset COPD Study, we observed significant association with COPD phenotypes and 18 single-nucleotide polymorphisms ( SNPs) in the SERPINE2 gene. Association of five of these SNPs with COPD was replicated in a case-control analysis, with cases from the National Emphysema Treatment Trial and controls from the Normative Aging Study. Family-based and case-control haplotype analyses supported similar regions of association within the SERPINE2 gene. When significantly associated SNPs in these haplotypic regions were included as covariates in linkage models, LOD score attenuation was observed most markedly in a smokers-only linkage model ( LOD 4.41, attenuated to 1.74). After the integration of murine and human microarray data to inform candidate-gene selection, we observed significant family-based association and independent replication of association in a case-control study, suggesting that SERPINE2 is a COPD-susceptibility gene and is likely influenced by gene-by-smoking interaction.	Channing Labs, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Vet Affairs Med Ctr, Boston, MA USA; Boston Univ, Med Ctr, Coll Engn, Ctr Pulm, Boston, MA USA; Boston Univ, Med Ctr, Coll Engn, Bioinformat Program, Boston, MA USA; Caritas St Elizabeths Med Ctr, Dept Med, Div Pulm & Crit Care, Boston, MA USA; Mahidol Univ, Fac Med, Siriraj Hosp, Dept Physiol, Bangkok 10700, Thailand; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Boston University; St. Elizabeth's Medical Center; Mahidol University; University of California System; University of California San Francisco	DeMeo, DL (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	dawn.demeo@channing.harvard.edu		Spira, Avrum/0000-0003-1467-0489; Litonjua, Augusto/0000-0003-0422-5875; Beane-Ebel, Jennifer/0000-0002-6699-2132	DIVISION OF LUNG DISEASES [N01HR076119, N01HR076118, N01HR076101] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071885, R37HL067204, R01HL075478, R01HL071393, K08HL072918, R01HL071771, R01HL061575, R01HL054853] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01HR76118, HL71393, K08 HL072918, HL54853, N01HR76119, HL072918, R01 HL071885, HL61575, HL075478, R01 HL054853, R01 HL075478, R01 HL071393, N01HR76101-N01HR7611, HL71771, R01 HL071771, HL67204, HL071885, N01HR76101, R37 HL067204] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALESSANDRI C, 1994, THROMB HAEMOSTASIS, V72, P343; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Ashitani J, 2002, INTERNAL MED, V41, P181, DOI 10.2169/internalmedicine.41.181; BAKER JB, 1982, J CELL PHYSIOL, V112, P291, DOI 10.1002/jcp.1041120220; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; BELL B, 1966, GERONTOLOGIST, V6, P179, DOI 10.1093/geront/6.4.179; BERGMAN BL, 1986, P NATL ACAD SCI USA, V83, P996, DOI 10.1073/pnas.83.4.996; BRANTIGAN OC, 1966, DIS CHEST, V49, P491; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Chambers RC, 2003, EUR RESPIR J, V22, p33S, DOI 10.1183/09031936.03.00001003; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; DeMeo DL, 2004, AM J RESP CRIT CARE, V170, P1294, DOI 10.1164/rccm.200404-524OC; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hersh CP, 2005, AM J RESP CELL MOL, V33, P71, DOI 10.1165/rcmb.2005-0073OC; HOUENOU LJ, 1995, P NATL ACAD SCI USA, V92, P895, DOI 10.1073/pnas.92.3.895; HSU KHK, 1979, J PEDIATR-US, V95, P14, DOI 10.1016/S0022-3476(79)80075-X; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Malhotra A, 2003, AM J RESP CRIT CARE, V168, P556, DOI 10.1164/rccm.200303-410OC; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Mecham BH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh071; Palmer LJ, 2003, HUM MOL GENET, V12, P1199, DOI 10.1093/hmg/ddg125; Rodarte J, 1999, J THORAC CARDIOV SUR, V118, P518; Rossignol P, 2004, J BIOL CHEM, V279, P10346, DOI 10.1074/jbc.M310964200; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Silverman EK, 2002, HUM MOL GENET, V11, P623, DOI 10.1093/hmg/11.6.623; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569	43	124	132	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					253	264		10.1086/499828	http://dx.doi.org/10.1086/499828			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16358219	Green Published, Bronze			2022-12-18	WOS:000236744900007
J	Dowling, O; Difeo, A; Ramirez, MC; Tukel, T; Narla, G; Bonafe, L; Kayserili, H; Yuksel-Apak, M; Paller, AS; Norton, K; Teebi, AS; Grum-Tokars, V; Martin, GS; Davis, GE; Glucksman, MJ; Martignetti, JA				Dowling, O; Difeo, A; Ramirez, MC; Tukel, T; Narla, G; Bonafe, L; Kayserili, H; Yuksel-Apak, M; Paller, AS; Norton, K; Teebi, AS; Grum-Tokars, V; Martin, GS; Davis, GE; Glucksman, MJ; Martignetti, JA			Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; PYLORIC ATRESIA; PROTEIN; DOMAIN; EXPRESSION; REGULATOR; LAMININS; SIBLINGS; COLLAGEN; DENSITY	Juvenile hyaline fibromatosis (JHF) and infantile systemic hyalinosis (ISH) are autosomal recessive syndromes of unknown etiology characterized by multiple, recurring subcutaneous tumors, gingival hypertrophy, joint contractures, osteolysis, and osteoporosis. Both are believed to be allelic disorders; ISH is distinguished from JHF by its more severe phenotype, which includes hyaline deposits in multiple organs, recurrent infections, and death within the first 2 years of life. Using the previously reported chromosome 4q21 JHF disease locus as a guide for candidate-gene identification, we identified and characterized JHF and ISH disease-causing mutations in the capillary morphogenesis factor-2 gene (CMG2). Although CMG2 encodes a protein upregulated in endothelial cells during capillary formation and was recently shown to function as an anthrax-toxin receptor, its physiologic role is unclear. Two ISH family-specific truncating mutations, E220X and the 1-bp insertion P357insC that results in translation of an out-of-frame stop codon, were generated by site-directed mutagenesis and were shown to delete the CMG2 transmembrane and/or cytosolic domains, respectively. An ISH compound mutation, I189T, is predicted to create a novel and destabilizing internal cavity within the protein. The JHF family-specific homoallelic missense mutation G105D destabilizes a vonWillebrand factor A extracellular domain alpha-helix, whereas the other mutation, L329R, occurs within the transmembrane domain of the protein. Finally, and possibly providing insight into the pathophysiology of these diseases, analysis of fibroblasts derived from patients with JHF or ISH suggests that CMG2 mutations abrogate normal cell interactions with the extracellular matrix.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; Istanbul Univ, Istanbul Fac Med, Dept Pediat, Istanbul, Turkey; Istanbul Univ, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; Istanbul Univ, Inst Expt Med, Dept Genet, Istanbul, Turkey; CHU Vaudois, Div Mol Paediat, Lausanne, Switzerland; Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Dept Pediat, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Dept Dermatol, Chicago, IL 60611 USA; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Finch Univ Hlth Sci Chicago Med Sch, Midw Proteome Ctr, N Chicago, IL 60064 USA; Finch Univ Hlth Sci Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Dept Pathol, College Stn, TX USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Istanbul University; Istanbul University; Istanbul University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Chicago Medical School; Chicago Medical School; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Martignetti, JA (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Room 14-70B,1425 Madison Ave, New York, NY 10029 USA.		Kayserili, Hülya/AAA-5593-2021; Narla, Goutham/AAZ-5710-2020	Kayserili, Hülya/0000-0003-0376-499X; Narla, Goutham/0000-0003-4098-4203; DiFeo, Analisa/0000-0001-8319-6763; Paller, Amy/0000-0001-6187-6549	NCRR NIH HHS [S10 RR 015935, S10 RR015935] Funding Source: Medline; NHLBI NIH HHS [R01 HL059373, HL59373] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015935] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059373] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bell SE, 2001, J CELL SCI, V114, P2755; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; FAYAD M N, 1987, American Journal of Medical Genetics, V26, P123, DOI 10.1002/ajmg.1320260119; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Jones JCR, 2000, MICROSC RES TECHNIQ, V51, P211, DOI 10.1002/1097-0029(20001101)51:3<211::AID-JEMT1>3.0.CO;2-P; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keser G, 1999, CLIN RHEUMATOL, V18, P248, DOI 10.1007/s100670050094; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDING B H, 1986, Pediatric Pathology, V6, P55; Lonai P, 2003, J ANAT, V202, P43, DOI 10.1046/j.1469-7580.2003.00143.x; Mancini GMS, 1999, DERMATOLOGY, V198, P18, DOI 10.1159/000018058; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Rahman N, 2002, AM J HUM GENET, V71, P975, DOI 10.1086/342776; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Scott JP, 1998, THROMB HAEMOSTASIS, V80, P546; Stucki U, 2001, AM J MED GENET, V100, P122, DOI 10.1002/1096-8628(20010422)100:2<122::AID-AJMG1236>3.0.CO;2-0; Takano K, 2003, PROTEIN ENG, V16, P5, DOI 10.1093/proeng/gzg001; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	28	124	133	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					957	966		10.1086/378781	http://dx.doi.org/10.1086/378781			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12973667	Green Published, Bronze			2022-12-18	WOS:000185676100021
J	Walsh, EC; Mather, KA; Schaffner, SF; Farwell, L; Daly, MJ; Patterson, N; Cullen, M; Carrington, M; Bugawan, TL; Erlich, H; Campbell, J; Barrett, J; Miller, K; Thomson, G; Lander, ES; Rioux, JD				Walsh, EC; Mather, KA; Schaffner, SF; Farwell, L; Daly, MJ; Patterson, N; Cullen, M; Carrington, M; Bugawan, TL; Erlich, H; Campbell, J; Barrett, J; Miller, K; Thomson, G; Lander, ES; Rioux, JD			An integrated haplotype map of the human major histocompatibility complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; LINKAGE DISEQUILIBRIUM; MULTIPLE-SCLEROSIS; CEPH FAMILIES; HUMAN GENOME; MEIOTIC RECOMBINATION; GENETIC-BASIS; HLA; MHC; ASSOCIATION	Numerous studies have clearly indicated a role for the major histocompatibility complex (MHC) in susceptibility to autoimmune diseases. Such studies have focused on the genetic variation of a small number of classical human-leukocyte-antigen (HLA) genes in the region. Although these genes represent good candidates, given their immunological roles, linkage disequilibrium (LD) surrounding these genes has made it difficult to rule out neighboring genes, many with immune function, as influencing disease susceptibility. It is likely that a comprehensive analysis of the patterns of LD and variation, by using a high-density map of single-nucleotide polymorphisms ( SNPs), would enable a greater understanding of the nature of the observed associations, as well as lead to the identification of causal variation. We present herein an initial analysis of this region, using 201 SNPs, nine classical HLA loci, two TAP genes, and 18 microsatellites. This analysis suggests that LD and variation in the MHC, aside from the classical HLA loci, are essentially no different from those in the rest of the genome. Furthermore, these data show that multi-SNP haplotypes will likely be a valuable means for refining association signals in this region.	Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; NCI, Basic Res Program, Sci Applicat Int Corp, Lab Genom Divers, Frederick, MD 21701 USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Roche Holding	Rioux, JD (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017; Schaffner, Stephen F/D-1189-2011; Rioux, John D/A-9599-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Schaffner, Stephen/0000-0001-6699-3568	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline; NIGMS NIH HHS [R01 GM035326, GM35326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; ALPER CA, 1992, EXP CLIN IMMUNOGENET, V9, P58; Barcellos LF, 2002, BRAIN, V125, P150; Beck S, 2000, ANNU REV GENOM HUM G, V1, P117, DOI 10.1146/annurev.genom.1.1.117; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266; CARRINGTON M, 1994, HUM IMMUNOL, V41, P234, DOI 10.1016/0198-8859(94)90041-8; Chataway J, 1998, BRAIN, V121, P1869, DOI 10.1093/brain/121.10.1869; Cullen M, 2003, IMMUNOGENETICS, V54, P900, DOI 10.1007/s00251-002-0535-8; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Drouet M, 1998, EUR J DERMATOL, V8, P330; Fearnhead P, 2001, GENETICS, V159, P1299; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEWONTIN RC, 1964, GENETICS, V49, P49; Martin MP, 1998, IMMUNOGENETICS, V47, P131; Moonsamy PV, 1997, HUM IMMUNOL, V58, P112, DOI 10.1016/S0198-8859(97)00208-5; Okazaki A, 2000, J Dermatol, V27, P149; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4	31	124	137	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					580	590		10.1086/378101	http://dx.doi.org/10.1086/378101			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12920676	Green Published, Bronze			2022-12-18	WOS:000185134000010
J	Ishii, S; Nakao, S; Minamikawa-Tachino, R; Desnick, RJ; Fan, JQ				Ishii, S; Nakao, S; Minamikawa-Tachino, R; Desnick, RJ; Fan, JQ			Alternative splicing in the alpha-galactosidase A gene: Increased exon inclusion results in the Fabry cardiac phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; A-GENE; ATYPICAL VARIANT; POINT MUTATIONS; DISEASE; SEQUENCE; EXPRESSION; ENHANCER; ELEMENTS; IDENTIFICATION	Fabry disease is an inborn error of glycosphingolipid catabolism, resulting from deficient activity of lysosomal a galactosidase A (alpha-Gal A). A rare alternative splicing that introduces a 57-nucleotide (nt) intronic sequence to the alpha-Gal A transcript from intron 4 of the gene has been identified. In addition, a novel midintronic base substitution that results in substantially increased alternative splicing has been identified in a patient with Fabry disease who has the cardiac variant phenotype. The sequence of the patient's intron 4 contains a single G-->A transversion at genomic nt 9331 (IVS4+919G-->A), located at the 5 4 position of the 3 end of the intronic insertion (nts 9278-9334 in the genomic sequence). Minigene constructs containing the entire intron 4 sequence with G, A, C, or T at nt 9331 within an alpha-Gal A complementary DNA expression vector were prepared and expressed in COS-1 cells. Whereas transfection of the G or T minigenes transcribed predominantly normal-sized transcripts, the transfection of the A or C minigenes produced a large amount of the alternatively spliced transcript. These results suggest that the G A mutation, within an A/C-rich domain, results in increased recognition of the alternative splicing by an A/C-rich enhancer-type exonic splicing enhancer. The intronic mutation was not observed in 100 unrelated unaffected men but was present in 6 unrelated patients with cardiac Fabry disease. Reverse-transcriptase polymerase chain reaction of total RNA of various normal human tissues revealed that the alternatively spliced transcript was present in all of the samples, and especially at a higher ratio in the lung and muscle. The normal transcript was present in the patients' lymphoblasts and resulted in similar to10% residual enzyme activity, leading to a cardiac phenotype of Fabry disease.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Usuki Bio Res Ctr, Oita, Japan; Kagoshima Prefectural Kanoya Hosp, Kagoshima, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Icahn School of Medicine at Mount Sinai; Tokyo Metropolitan Institute of Medical Science	Fan, JQ (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.		Tachino, Reiko/Q-9946-2019					AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; [Anonymous], 2014, METABOLIC MOL BASES; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Germain D, 1996, HUM GENET, V98, P719, DOI 10.1007/s004390050292; Germain DP, 1999, BIOCHEM BIOPH RES CO, V257, P708, DOI 10.1006/bbrc.1999.0310; ISHII S, 1992, HUM GENET, V89, P29, DOI 10.1007/BF00207037; ISHII S, 1993, BIOCHEM BIOPH RES CO, V197, P1585, DOI 10.1006/bbrc.1993.2659; ISHII S, 1994, BBA-PROTEIN STRUCT M, V1204, P265, DOI 10.1016/0167-4838(94)90017-5; KOIDE T, 1990, FEBS LETT, V259, P353, DOI 10.1016/0014-5793(90)80046-L; KORNREICH R, 1989, NUCLEIC ACIDS RES, V17, P3301, DOI 10.1093/nar/17.8.3301; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Matsumura T, 1998, Hum Mutat, V11, P483; MINAMIKAWATACHINO R, 1993, INT J BIOMED COMPUT, V33, P277, DOI 10.1016/0020-7101(93)90041-4; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGAWA K, 1990, HUM PATHOL, V21, P1067, DOI 10.1016/0046-8177(90)90258-7; Okumiya T, 1996, JPN J HUM GENET, V41, P313, DOI 10.1007/BF01913174; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; SAKURABA H, 1990, AM J HUM GENET, V47, P784; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Topaloglu AK, 1999, MOL MED, V5, P806, DOI 10.1007/BF03401993; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VANOERS CCM, 1994, MOL CELL BIOL, V14, P951, DOI 10.1128/MCB.14.2.951; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; WANG Z, 1995, RNA, V1, P21; YOKOI T, 1991, JPN J HUM GENET, V36, P245, DOI 10.1007/BF01910542	39	124	127	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					994	1002		10.1086/339431	http://dx.doi.org/10.1086/339431			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11828341	Bronze, Green Published			2022-12-18	WOS:000174252100016
J	Gordon, D; Heath, SC; Liu, X; Ott, J				Gordon, D; Heath, SC; Liu, X; Ott, J			A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RELATIVE RISK; LINKAGE ANALYSIS; RECOMBINATION FRACTIONS; IDENTIFICATION; INCOMPATIBILITIES; DISEQUILIBRIUM; INTERFERENCE; ASSOCIATIONS; MARKERS; GENOME	The present study assesses the effects of genotyping errors on the type I error rate of a particular transmission/disequilibrium test (TDTstd), which assumes that data are errorless, and introduces a new transmission/disequilibrium test (TDTae) that allows for random genotyping errors. We evaluate the type I error rate and power of the TDTae under a variety of simulations and perform a power comparison between the TDTstd and the TDTae, for errorless data. Both the TDTstd and the TDTae statistics are computed as two times a log-likelihood difference, and both are asymptotically distributed as chi (2) with 1 df. Genotype data for trios are simulated under a null hypothesis and under an alternative (power) hypothesis. For each simulation, errors are introduced randomly via a computer algorithm with different probabilities (called "allelic error rates"). The TDTstd statistic is computed on all trios that show Mendelian consistency, whereas the TDTae statistic is computed on all trios. The results indicate that TDTstd shows a significant increase in type I error when applied to data in which inconsistent trios are removed. This type I error increases both with an increase in sample size and with an increase in the allelic error rates. TDTae always maintains correct type I error rates for the simulations considered. Factors affecting the power of the TDTae are discussed. Finally, the power of TDTstd is at least that of TDTae for simulations with errorless data. Because data are rarely error free, we recommend that researchers use methods, such as the TDTae, that allow for errors in genotype data.	Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Lab Math Genet, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Gordon, D (corresponding author), Rockefeller Univ, Lab Stat Genet, Box 192,1230 York Ave, New York, NY 10021 USA.	gordon@linkage.rockefeller.edu	Heath, Simon C/J-4138-2012; Gordon, Derek/AAU-2281-2020	Heath, Simon C/0000-0002-9550-0897; Gordon, Derek/0000-0003-2945-1748	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059492] Funding Source: NIH RePORTER; NHGRI NIH HHS [K01 HG000055, K01-HG00055-01] Funding Source: Medline; NIMH NIH HHS [MH59492] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; [Anonymous], 2005, STAT EXPT DESIGN INN; Broman KW, 1999, GENET EPIDEMIOL, V17, pS79; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Ehm MG, 1996, AM J HUM GENET, V58, P225; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Fisher R.A., 1966, DESIGN EXPT; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Giordano M, 2001, J BIOCHEM BIOPH METH, V47, P101, DOI 10.1016/S0165-022X(00)00156-1; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Gordon D, 2001, Pac Symp Biocomput, P18; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gordon D, 1999, GENET EPIDEMIOL, V17, pS587; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Heath S.C., 1998, AM J HUM GENET S, V63, pA292; KENDALL MG, 1991, KENDALLS ADV THEOR A, V2; Lee MH, 2001, EUR J HUM GENET, V9, P375, DOI 10.1038/sj.ejhg.5200628; LEWONTIN RC, 1964, GENETICS, V49, P49; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LUNETTA KL, 1995, GENOME RES, V5, P151, DOI 10.1101/gr.5.2.151; Matise TC, 1995, GENET EPIDEMIOL, V12, P641, DOI 10.1002/gepi.1370120620; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Connell JR, 1999, AM J HUM GENET, V65, P1733, DOI 10.1086/302663; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Sham P., 1998, STAT HUMAN GENETICS; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Stringham HM, 1996, AM J HUM GENET, V59, P946; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Xiong M, 2000, Pac Symp Biocomput, P675; Xiong MM, 1998, HUM HERED, V48, P295, DOI 10.1159/000022821	49	124	125	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					371	380		10.1086/321981	http://dx.doi.org/10.1086/321981			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443542	Green Published, Bronze			2022-12-18	WOS:000170108200012
J	Sippel, KC; Fraioli, RE; Smith, GD; Schalkoff, ME; Sutherland, J; Gallie, BL; Dryja, TP				Sippel, KC; Fraioli, RE; Smith, GD; Schalkoff, ME; Sutherland, J; Gallie, BL; Dryja, TP			Frequency of somatic and germ-line mosaicism in retinoblastoma: Implications for genetic counseling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TUMOR-SUPPRESSOR GENE; ONCOGENIC POINT MUTATIONS; HEREDITARY RETINOBLASTOMA; RB1 GENE; BILATERAL RETINOBLASTOMA; NEUROFIBROMATOSIS TYPE-1; INCOMPLETE PENETRANCE; SUSCEPTIBILITY GENE; RECURRENCE RISK	Although mosaicism can have important implications for genetic counseling of families with hereditary disorders, information regarding the incidence of mosaicism is available for only a few generic diseases. Here we describe an evaluation of 156 families with retinoblastoma; the initial oncogenic mutation in the retinoblastoma gene had been identified in these families, In 15 (similar to 10%) families, Ne were able to document mosaicism for the initial mutation in the retinoblastoma gene, either in the proband or in one of the proband's parents. The true incidence of mosaicism in this group of 156 families is probably higher than our findings indicate; in some additional families beyond the 15 we identified, mosaicism was likely but could not be proven, because somatic or germ-line DNA from key family members was unavailable. Germ-line DNA from Two mosaic fathers was analyzed: in one of these, the mutation was detected in both sperm and leukocyte DNA; in the other, the mutation was detected only in sperm DNA. Our data suggest that mosaicism is more common than is generally appreciated, especially In disorders such as retinoblastoma, in which a high proportion of cases represent nem mutations. The possibility of mosaicism should always be considered during the genetic counseling of newly identified families with retinoblastoma, As demonstrated here, generic tests of germ-line DNA can provide valuable information that is not available through analysis of somatic (leukocyte) DNA.	Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ocular Mol Genet Inst, Boston, MA USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Boston Fertil Labs, Brookline, MA USA; Univ Toronto, Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; University of Chicago; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Dryja, TP (corresponding author), Massachusetts Eye & Ear Infirm, 243 Charles St, Boston, MA 02114 USA.	dryja@helix.mgh.harvard.edu		Gallie, Brenda/0000-0002-9697-9211	NEI NIH HHS [EY05321, EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005321, R01EY008683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BADER JL, 1982, CANCER GENET CYTOGEN, V5, P203, DOI 10.1016/0165-4608(82)90026-7; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BOURN D, 1994, AM J HUM GENET, V55, P69; Bremner R, 1997, AM J HUM GENET, V61, P556, DOI 10.1086/515499; BRIARDGUILLEMOT ML, 1974, HUMANGENETIK, V24, P271, DOI 10.1007/BF00297591; CARLSON EA, 1979, AM J MED GENET, V4, P365, DOI 10.1002/ajmg.1320040408; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Colman SD, 1996, AM J HUM GENET, V58, P484; Cowell JK, 1996, ONCOGENE, V12, P431; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; Dryja TP, 1997, HUM GENET, V100, P446, DOI 10.1007/s004390050531; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0; GREGER V, 1994, HUM GENET, V94, P491; GREGER V, 1990, AM J HUM GENET, V46, P1187; HALL JG, 1988, AM J HUM GENET, V43, P355; HOGG A, 1992, ONCOGENE, V7, P1445; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; KRATZKE RA, 1994, ONCOGENE, V9, P1321; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; LOHMANN DR, 1994, HUM GENET, V94, P349; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; MCCLURE RD, 1989, FERTIL STERIL, V51, P874; MCGEE TL, 1990, NUCLEIC ACIDS RES, V18, P207, DOI 10.1093/nar/18.1.207-a; McLean IW, 1996, OPHTHALMIC PATHOLOGY, P1332; MOTEGI T, 1984, HUM GENET, V66, P186, DOI 10.1007/BF00286598; MUNIER F, 1989, OPHTHALMIC PAED GEN, V10, P129, DOI 10.3109/13816818909088353; Noorani HZ, 1996, AM J HUM GENET, V59, P301; OhtaniFujita N, 1997, CANCER GENET CYTOGEN, V98, P43, DOI 10.1016/S0165-4608(96)00395-0; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; ORD T, 1990, HUM REPROD, V5, P987, DOI 10.1093/oxfordjournals.humrep.a137233; ORYE E, 1982, CLIN GENET, V22, P37; PALLER AS, 1994, NEW ENGL J MED, V331, P1408, DOI 10.1056/NEJM199411243312103; PASSOSBUENO MR, 1990, J MED GENET, V27, P727, DOI 10.1136/jmg.27.11.727; RIBEIRO MCM, 1988, CANCER GENET CYTOGEN, V32, P169, DOI 10.1016/0165-4608(88)90279-8; Rothberg PG, 1997, MOL CARCINOGEN, V19, P69, DOI 10.1002/(SICI)1098-2744(199707)19:2<69::AID-MC1>3.0.CO;2-G; SAKAI T, 1991, AM J HUM GENET, V48, P880; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SCHAPPER.J, 1966, OPHTHALMOLOGICA, V151, P197, DOI 10.1159/000304891; SCHEFFER H, 1989, AM J HUM GENET, V45, P252; Schubert EL, 1997, HUM GENET, V100, P557, DOI 10.1007/s004390050551; SHIMIZU T, 1994, AM J HUM GENET, V54, P793; SQUIRE J, 1986, P NATL ACAD SCI USA, V83, P6573, DOI 10.1073/pnas.83.17.6573; Sterner JM, 1996, CELL GROWTH DIFFER, V7, P53; TOGUCHIDA J, 1993, GENOMICS, V17, P535, DOI 10.1006/geno.1993.1368; VAUGHN GL, 1990, NUCLEIC ACIDS RES, V18, P4965, DOI 10.1093/nar/18.16.4965; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1979, HUM GENET, V52, P1; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WIGGS JL, 1988, AM J OPHTHALMOL, V106, P346, DOI 10.1016/0002-9394(88)90373-X; WIJSMAN EM, 1991, AM J HUM GENET, V48, P654; YANDELL DW, 1989, AM J HUM GENET, V45, P547; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	60	124	130	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					610	619		10.1086/301766	http://dx.doi.org/10.1086/301766			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497263	Bronze, Green Published			2022-12-18	WOS:000072894400014
J	Terwilliger, JD; Shannon, WD; Lathrop, GM; Nolan, JP; Goldin, LR; Chase, GA; Weeks, DE				Terwilliger, JD; Shannon, WD; Lathrop, GM; Nolan, JP; Goldin, LR; Chase, GA; Weeks, DE			True and false positive peaks in genomewide scans: Applications of length-biased sampling to linkage mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; COMPLEX TRAITS; RESOLUTION; PARAMETERS; DISSECTION; IDENTITY; DESCENT	Disease-susceptibility Loci are now being mapped via genomewide scans in which a linkage statistic is computed at each of a large number of markers, Such disease-susceptibility loci may be identified via a peak in the test statistic when the latter is plotted against the genetic map, In this paper we establish, by appealing to renewal theory, that true positive peaks are expected to be longer than false positive peaks, These results are verified by a realistic simulation of a genomewide linkage study based on the affected-sib-pair design, Since longer peaks are more likely to contain a gene of interest than are shorter peaks, these differences may aid in linkage mapping, justifying assignment of lower priority to shorter peaks, However, since these differences are generally small, statistics based on both peak length and height may not be much more powerful than those based on height alone, The results presented here also provide a theoretical framework for methods that use the length of shared haplotypes in populations to map disease genes.	UNIV OXFORD, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7BN, ENGLAND; COLUMBIA UNIV, DEPT PSYCHIAT, NEW YORK, NY USA; COLUMBIA UNIV, COLUMBIA GENOME CTR, NEW YORK, NY USA; UNIV WASHINGTON, SCH MED, ST LOUIS, MO USA; AMERICAN UNIV, DEPT MATH & STAT, WASHINGTON, DC 20016 USA; NATL CTR HLTH STAT, NATL INST HLTH, HYATTSVILLE, MD USA; GEORGETOWN UNIV, MED CTR, WASHINGTON, DC 20007 USA; NIMH, CLIN NEUROGENET BRANCH, BETHESDA, MD 20892 USA; UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA USA	University of Oxford; Wellcome Centre for Human Genetics; Columbia University; Columbia University; Washington University (WUSTL); American University; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Weeks, Daniel E/B-2995-2012; Nolan, John/Q-6571-2019	Weeks, Daniel E/0000-0001-9410-7228; Nolan, John/0000-0002-9669-382X	NHGRI NIH HHS [HG00008, HG00719] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000719] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bailey NTJ., 1961, INTRO MATH THEORY GE; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; BROWN DL, 1994, AM J HUM GENET, V54, P544; Cox D., 1980, POINT PROCESSES; Cox DR., 1962, RENEWAL THEORY; COX DR, 1966, STATISTICAL ANAL SER; EWENS WJ, 1984, BIOMETRICS, V40, P367, DOI 10.2307/2531390; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; Feller W., 1971, INTRO PROBABILITY TH, VII; Goldin LR, 1995, GENET EPIDEMIOL, V12, P765, DOI 10.1002/gepi.1370120639; GOLDIN LR, IN PRESS GENET EPIDE; Grigelionis B., 1963, THEORY PROBABILITY I, V8, P177, DOI [10.1137/1108017, DOI 10.1137/1108017]; Guo SW, 1996, AM J HUM GENET, V58, P408; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; Hemenway R158 D., 1982, MATH MAG, V55, P162, DOI [10.2307/2690083, DOI 10.2307/2690083]; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; KHINCHIN AI, 1960, GRIFFINS STAT MONOGR, V7; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1985, AM J HUM GENET, V37, P853; MCFADDEN JA, 1962, J R STAT SOC B, V24, P364; MECKE J, 1969, WISS Z F SCHILLER U, V18, P387; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Nelson R., 1995, PROBABILITY STOCHAST; OWEN ARG, 1948, P ROY SOC LOND B BIO, V136, P67; Palm C., 1943, ERICSSON TECHNICS, V44, P1; PATIL GP, 1978, BIOMETRICS, V34, P179, DOI 10.2307/2530008; RESNICK SI, 1994, ADVENTURES STOCHASTI; SAMUELS SM, 1974, J APPL PROBAB, V11, P72, DOI 10.2307/3212584; SCHEAFFER RL, 1972, TECHNOMETRICS, V14, P635, DOI 10.2307/1267291; SCHOTZ WE, 1971, J THEOR BIOL, V32, P383, DOI 10.1016/0022-5193(71)90175-5; SEN PK, 1987, STAT PROBABIL LETT, V5, P95, DOI 10.1016/0167-7152(87)90062-9; Shannon W. D., 1995, American Journal of Human Genetics, V57, pA35; SIMON R, 1980, AM J EPIDEMIOL, V111, P444, DOI 10.1093/oxfordjournals.aje.a112920; SMITH WL, 1958, J ROY STAT SOC B, V20, P243; STURT E, 1976, ANN HUM GENET, V40, P147, DOI 10.1111/j.1469-1809.1976.tb00175.x; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402	40	124	124	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					430	438		10.1086/514855	http://dx.doi.org/10.1086/514855			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311749	Green Published, hybrid			2022-12-18	WOS:A1997XX70100022
J	Becker, J; Schwaab, R; MollerTaube, A; Schwaab, U; Schmidt, W; Brackmann, HH; Grimm, T; Olek, K; Oldenburg, J				Becker, J; Schwaab, R; MollerTaube, A; Schwaab, U; Schmidt, W; Brackmann, HH; Grimm, T; Olek, K; Oldenburg, J			Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type-dependent sex ratio of mutation frequencies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; HUMAN GENETIC-DISEASE; POINT MUTATIONS; A PATIENTS; MOLECULAR CHARACTERIZATION; DNA; REARRANGEMENTS; SUBSTITUTIONS; DINUCLEOTIDE; POLYMORPHISM	The clinical manifestation of hemophilia A is caused by a wide range of different mutations. In this study the factor VIII genes of 147 severe hemophilia A patients-all exclusively from sporadic families-were screened for mutations by use of the complete panel of modem DNA techniques. The pathogenous defect could be characterized in 126 patients (85.7%). Fifty-five patients (37.4%) showed a F8A-gene inversion, 47 (32.0%) a point mutation, 14 (9.5%) a small deletion, 8 (5.4%) a large deletion, and 2 (1.4%) a small insertion. Further, four (2.7%) mutations were localized but could not be sequenced yet. No mutation could be identified in 17 patients (11.6%). Sixteen (10.9%) of the identified mutations occurred in the B domain. Four of these were located in an adenosine nucleotide stretch at codon 1192, indicating a mutation hotspot. Somatic mosaicisms were detected in 3 (3.9%) of 76 patients' mothers, comprising 3 of 16 de novo mutations in the patients' mothers. Investigation of family relatives allowed detection of a de novo mutation in 16 of 76 two-generation and 28 of 34 three-generation families. On the basis of these data, the male:female ratio of mutation frequencies (k) was estimated as k = 3.6. By use of the quotients of mutation origin in maternal grandfather to patient's mother or to maternal grandmother, k was directly estimated as k = 15 and k = 7.5, respectively. Considering each mutation type separately, we revealed a mutation type-specific sex ratio of mutation frequencies. Point mutations showed a 5-to-10-fold-higher and inversions a >10-fold-higher mutation rate in male germ cells, whereas deletions showed a >5-fold-higher mutation rate in female germ cells. Consequently, and in accordance with the data of other diseases like Duchenne muscular dystrophy, our results indicate that at least for X-chromosomal disorders the male:female mutation rate of a disease is determined by its proportion of the different mutation types.	UNIV WURZBURG,BIOCTR,INST HUMAN GENET,D-97074 WURZBURG,GERMANY; UNIV BONN,INST MOLEK BIOL DIAGNOST,W-5300 BONN,GERMANY; UNIV BONN,INST EXPTL HAMATOL & TRANSFUS MED,W-5300 BONN,GERMANY	University of Wurzburg; University of Bonn; University of Bonn			Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100				ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; BARRAI I, 1985, AM J HUM GENET, V37, P680; BIGGS R, 1976, LANCET, V2, P431; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; BROCKERVRIENDS AHJT, 1991, J MED GENET, V28, P672, DOI 10.1136/jmg.28.10.672; CASULA L, 1990, BLOOD, V75, P662; COLLINS PW, 1994, LANCET, V343, P791, DOI 10.1016/S0140-6736(94)91866-X; COOPER DN, 1990, HUM GENET, V85, P55; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DEMCZUK S, 1995, HUM GENET, V96, P9, DOI 10.1007/BF00214179; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FIGUEIREDO MS, 1995, J BIOL CHEM, V270, P11828, DOI 10.1074/jbc.270.20.11828; GITSCHIER J, 1985, NATURE, V314, P730; GOODEVE AC, 1994, LANCET, V343, P329, DOI 10.1016/S0140-6736(94)91165-7; GRAHAM JB, 1990, BRIT J HAEMATOL, V76, P75, DOI 10.1111/j.1365-2141.1990.tb07839.x; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HERRMANN J, 1966, HUMANGENETIK, V3, P1, DOI 10.1007/BF00273014; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; HIGUCHI M, 1989, BLOOD, V74, P1045; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KOCHHAN L, 1994, BLOOD COAGUL FIBRIN, V5, P497; KOGAN S, 1990, P NATL ACAD SCI USA, V87, P2092, DOI 10.1073/pnas.87.6.2092; KOSOWER N, 1962, AM J HUM GENET, V14, P159; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804; LEVINSON B, 1990, AM J HUM GENET, V46, P53; LIN SW, 1993, GENOMICS, V18, P496, DOI 10.1016/S0888-7543(11)80005-4; LJUNG R, 1995, EUR J HAEMATOL, V54, P310; MICHAELIDES K, 1995, PCR 2 PRACTICAL APPR, P255; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MULLER B, 1992, HUM GENET, V89, P204; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; NAYLOR JA, 1991, LANCET, V337, P635, DOI 10.1016/0140-6736(91)92450-G; OBERLE I, 1985, NEW ENGL J MED, V312, P682, DOI 10.1056/NEJM198503143121103; OLDENBURG J, 1993, AM J HUM GENET, V53, P1229; PATTINSON JK, 1990, BLOOD, V76, P2242; PEAKE I, 1992, THROMB HAEMOSTASIS, V67, P277; PIENEMAN WC, 1995, BRIT J HAEMATOL, V90, P442; RICHARDS B, 1991, NUCLEIC ACIDS RES, V19, P1944, DOI 10.1093/nar/19.8.1944; ROSENDAAL FR, 1990, HUM GENET, V86, P139, DOI 10.1007/BF00197695; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGENTINI NJ, 1985, MUTAT RES, V154, P1, DOI 10.1016/0165-1110(85)90007-7; SCHWAAB R, 1995, BRIT J HAEMATOL, V91, P458, DOI 10.1111/j.1365-2141.1995.tb05322.x; SHIMMIN LC, 1993, NATURE, V362, P747; STRAUSS HS, 1967, PEDIATRICS, V39, P186; TIZANO EF, 1995, THROMB HAEMOSTASIS, V73, P6; TIZZANO EF, 1994, BLOOD, V83, P3826; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; TUDDENHAM EGD, 1994, NUCLEIC ACIDS RES, V22, P3511, DOI 10.1093/nar/22.17.3511; VOGEL F, 1965, HUMANGENETIK, V1, P253, DOI 10.1007/BF00395656; VOGEL F, 1977, AM J HUM GENET, V29, P312; VOGEL F, 1986, HUM GENET, P301; WILLIAMS SM, 1985, J THEOR BIOL, V116, P625, DOI 10.1016/S0022-5193(85)80092-8; WINTER RM, 1983, HUM GENET, V32, P156; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	68	124	130	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					657	670						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644728				2022-12-18	WOS:A1996UA38000002
J	NARCISI, TME; SHOULDERS, CC; CHESTER, SA; READ, J; BRETT, DJ; HARRISON, GB; GRANTHAM, TT; FOX, MF; POVEY, S; DEBRUIN, TWA; ERKELENS, DW; MULLER, DPR; LLOYD, JK; SCOTT, J				NARCISI, TME; SHOULDERS, CC; CHESTER, SA; READ, J; BRETT, DJ; HARRISON, GB; GRANTHAM, TT; FOX, MF; POVEY, S; DEBRUIN, TWA; ERKELENS, DW; MULLER, DPR; LLOYD, JK; SCOTT, J			MUTATIONS OF THE MICROSOMAL TRIGLYCERIDE-TRANSFER-PROTEIN GENE IN ABETALIPOPROTEINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-B GENE; RNA SPLICE JUNCTIONS; ENDOPLASMIC-RETICULUM; HEP-G2 CELLS; VITAMIN-E; SECRETION; DNA; DEGRADATION; EXPRESSION; COMPLEX	Elevated plasma levels of apolipoprotein B (apoB)-containing lipoproteins constitute a major risk factor for the development of coronary heart disease. In the rare recessively inherited disorder abetalipoproteinemia (ABL) the production of apoB-containing lipoproteins is abolished, despite no abnormality of the apoB gene. In the current study we have characterized the gene encoding a microsomal triglyceride-transfer protein (MTP), localized to chromosome 4q22-24, and have identified a mutation of the MTP gene in both alleles of all individuals in a cohort of eight patients with classical ABL. Each mutant allele is predicted to encode a truncated form of MTP with a variable number of aberrant amino acids at its C-terminal end. Expression of genetically engineered forms of MTP in Cos-1 cells indicates that the C-terminal portion of MTP is necessary for triglyceride-transfer activity. Deletion of 20 amino acids from the carboxyl terminus of the 894-amino-acid protein and a missense mutation of cysteine 878 to serine both abolished activity. These results establish that defects of the MTP gene are the predominant, if not sole, cause of hereditary ABL and that an intact carboxyl terminus is necessary for activity.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, MRC, MOLEC MED GRP, LONDON W12 0NN, ENGLAND; UCL, MRC, HUMAN BIOCHEM GENET UNIT, LONDON, ENGLAND; UNIV LONDON, INST CHILD HLTH, MEMBRANE BIOCHEM & MICRONUTRIENTS UNIT, LONDON WC1N 1EH, ENGLAND; UNIV UTRECHT HOSP, DEPT INTERNAL MED, UTRECHT, NETHERLANDS	Imperial College London; University of London; University College London; University of London; University College London; Utrecht University; Utrecht University Medical Center			Muller, David/C-1928-2008					ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021; BERG LP, 1992, GENOMICS, V13, P1359, DOI 10.1016/0888-7543(92)90070-9; BOREN J, 1990, J BIOL CHEM, V265, P10556; BRETT DJ, 1995, BIOCHEM J, V310, P11, DOI 10.1042/bj3100011; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1991, J BIOL CHEM, V266, P5080; DULLAART RPF, 1986, J CLIN INVEST, V78, P1397, DOI 10.1172/JCI112727; GHARIB B, 1993, ANN HUM GENET, V57, P9, DOI 10.1111/j.1469-1809.1993.tb00882.x; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; HAGIWAR Y, 1994, AM J HUM GENET, V54, P53; HARLOW E, 1988, LABORATORY MANUAL, P283; Herbert P. N., 1982, METABOLIC BASIS INHE, P589; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4837; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Kane J.B., 1989, METABOLIC BASIS INHE, P1139; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEIPER JM, 1994, J BIOL CHEM, V269, P21951; MULLER DPR, 1983, LANCET, V1, P225; MULLER DPR, 1977, ARCH DIS CHILD, V52, P209, DOI 10.1136/adc.52.3.209; OSHIMA T, 1993, HUM MOL GENET, V2, P1497; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; RICCI B, 1995, J BIOL CHEM, V270, P14281, DOI 10.1074/jbc.270.24.14281; SAKATA N, 1993, J BIOL CHEM, V268, P22967; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHARP D, 1994, BIOCHEMISTRY-US, V33, P9057, DOI 10.1021/bi00197a005; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; SHOULDERS CC, 1994, NAT STRUCT BIOL, V1, P285, DOI 10.1038/nsb0594-285; TALL AR, 1993, J LIPID RES, V34, P1255; TALMUD PJ, 1988, J CLIN INVEST, V82, P1803, DOI 10.1172/JCI113795; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; TIMMINS PA, 1992, SCIENCE, V257, P652, DOI 10.1126/science.1496377; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; WAHLI W, 1988, TRENDS GENET, V4, P227, DOI 10.1016/0168-9525(88)90155-2; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WHITE AL, 1992, J BIOL CHEM, V267, P15657; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; 1980, POPULATION STUDIES D; 1992, INT J CARDIOL S1, V37, pS1	48	124	128	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1298	1310						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533758				2022-12-18	WOS:A1995TE65500006
J	BICHET, DG; BIRNBAUMER, M; LONERGAN, M; ARTHUS, MF; ROSENTHAL, W; GOODYER, P; NIVET, H; BENOIT, S; GIAMPIETRO, P; SIMONETTI, S; FISH, A; WHITLEY, CB; JAEGER, P; GERTNER, J; NEW, M; DIBONA, FJ; KAPLAN, BS; ROBERTSON, GL; HENDY, GN; FUJIWARA, TM; MORGAN, K				BICHET, DG; BIRNBAUMER, M; LONERGAN, M; ARTHUS, MF; ROSENTHAL, W; GOODYER, P; NIVET, H; BENOIT, S; GIAMPIETRO, P; SIMONETTI, S; FISH, A; WHITLEY, CB; JAEGER, P; GERTNER, J; NEW, M; DIBONA, FJ; KAPLAN, BS; ROBERTSON, GL; HENDY, GN; FUJIWARA, TM; MORGAN, K			NATURE AND RECURRENCE OF AVPR2 MUTATIONS IN X-LINKED NEPHROGENIC DIABETES-INSIPIDUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENETIC-DISEASE; HUMAN ANTIDIURETIC-HORMONE; VASOPRESSIN RECEPTOR GENE; HOPEWELL	X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine-vasopressin V-2 receptor responses due to mutations in the AVPR2 gene in Xq28. We analyzed 31 independent NDI families to determine the nature and recurrence of AVPR2 mutations. Twenty-one new putative disease-causing mutations were identified: 113delCT, 253del35, 255del9, 274insG, V88M, R106C, 402delCT, C112R, Y124X, S126F, W164S, S167L, 684delTA, 804insG, W284X, A285P, W293X, R337X, and three large deletions or gene rearrangements. Five other mutations-R113W, Y128S, R137H, R181C, and R202C-that previously had been reported in other families were detected. There was evidence for recurrent mutation for four mutations (R113W, R137H, S167L, and R337X). Eight de novo mutation events were detected (274insG, R106C, Y128S, 167L [twice], R202C, 684delTA, and R337X). The origins were maternal (one), grandmaternal (one), and grandpaternal (six). In the 31 NDI families and 6 families previously reported by us, there is evidence both for mutation hot spots for nucleotide substitutions and for small deletions and insertions. More than half (58%) of the nucleotide substitutions in 26 families could be a consequence of 5-methyl-cytosine deamination at a CpG dinucleotide. Most of the small deletions and insertions could be attributed to slipped mispairing during DNA replication.	UNIV MONTREAL,HOP SACRE COEUR,DEPT MED,SERV NEPHROL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PHYSIOL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL,PQ,CANADA; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; CHU TOURS,UNITE NEPHROL PEDIAT,TOURS,FRANCE; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PEDIAT,NEW YORK,NY 10021; OSPED GIOVANNI 23,DIV MALLAT METAB & GENET,BARI,ITALY; UNIV MINNESOTA HOSP,DEPT PEDIAT,MINNEAPOLIS,MN; UNIV MINNESOTA HOSP,DEPT PEDIAT NEPHROL,MINNEAPOLIS,MN; UNIV MINNESOTA HOSP,INST HUMAN GENET,MINNEAPOLIS,MN; UNIV BERN,HOP ILE,MED POLICLIN,BERN,SWITZERLAND; AIKEN RENAL PHYSICIANS,AIKEN,SC; CHILDRENS HOSP PHILADELPHIA,DIV NEPHROL,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104; CLIN RES CTR,CHICAGO,IL; NORTHWESTERN UNIV,SCH MED,CHICAGO,IL	Universite de Montreal; McGill University; McGill University; McGill University; McGill University; McGill University; Baylor College of Medicine; CHU Tours; Cornell University; NewYork-Presbyterian Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Bern; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Northwestern University	BICHET, DG (corresponding author), UNIV MONTREAL,HOP SACRE COEUR,CTR RECH,UNITE RECH CLIN,5400 BLVD GOUIN OUEST,MONTREAL H4J 1C5,PQ,CANADA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041244] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-41244] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BICHET DG, 1992, AM J HUM GENET, V51, P1089; BICHET DG, 1988, NEW ENGL J MED, V318, P881, DOI 10.1056/NEJM198804073181403; BICHET DG, 1992, OXFORD TXB CLIN NEPH, P789; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; CHAKRAVARTI A, 1992, NAT GENET, V1, P237, DOI 10.1038/ng0792-237; COOPER DN, 1990, HUM GENET, V85, P55; ENG CM, 1993, AM J HUM GENET, V53, P1186; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; HOLTZMAN EJ, 1993, NEW ENGL J MED, V328, P1534, DOI 10.1056/NEJM199305273282105; HOLTZMAN EJ, 1993, HUM MOL GENET, V2, P1201, DOI 10.1093/hmg/2.8.1201; JEANPIERRE M, 1992, AM J HUM GENET, V50, P960; KRAWCZAK M, 1991, HUM GENET, V86, P425; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1585; MERENDINO JJ, 1993, CLIN RES, V41, pA131; MORENDINO JJ, 1993, NEW ENGL J MED, V328, P1538; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; REEVES WB, 1989, METABOLIC BASIS INHE, P1985; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; SCHLESSINGER D, 1993, CYTOGENET CELL GENET, V64, P147, DOI 10.1159/000133572; SEIBOLD A, 1992, AM J HUM GENET, V51, P1078; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; TSUKAGUCHI H, 1993, BIOCHEM BIOPH RES CO, V197, P1000, DOI 10.1006/bbrc.1993.2578; VANDENOUWELAND AMW, 1992, NAT GENET, V2, P99, DOI 10.1038/ng1092-99	25	124	125	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					278	286						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037205				2022-12-18	WOS:A1994NZ33600007
J	SARFARAZI, M; WIJMENGA, C; UPADHYAYA, M; WEIFFENBACH, B; HYSER, C; MATHEWS, K; MURRAY, J; GILBERT, J; PERICAKVANCE, M; LUNT, P; FRANTS, RR; JACOBSEN, S; HARPER, PS; PADBERG, GW				SARFARAZI, M; WIJMENGA, C; UPADHYAYA, M; WEIFFENBACH, B; HYSER, C; MATHEWS, K; MURRAY, J; GILBERT, J; PERICAKVANCE, M; LUNT, P; FRANTS, RR; JACOBSEN, S; HARPER, PS; PADBERG, GW			REGIONAL MAPPING OF FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY GENE ON 4Q35 - COMBINED ANALYSIS OF AN INTERNATIONAL CONSORTIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; LANDOUZY-DEJERINE DISEASE; FACTOR-XI GENE; LONG ARM; DISTAL END; DNA MARKER; MAP; CHROMOSOME-4; LOCUS; RFLP	Members of an international consortium for linkage analysis of the facioscapulohumeral muscular dystrophy (FSHD) gene have pooled data for joint analyses, in an attempt to determine the precise location of the FSHD gene and the order of four DNA markers on 4q35 region. Six laboratories determined a total of 3,078 genotypes in 65 families, consisting of a total of 504 affected subjects and 559 unaffected subjects. For each marker, a mean of 648 meioses were informative. D4S139 and D4S163 were identified as the closest linked markers to the FSHD locus, with 99% upper confidence intervals of recombination fractions of .08 and .10, respectively. We have used the CRI-MAP program to construct the most likely order of cen-D4S171-F11-D4S163-D4S139-FSHD-tel, with favorable odds of 10(8)-10(114) over all other orders except that in which F11 and D4S171 are reversed, for which the odds ratio was 191:1. With this order, the genetic map of this region extends 25.5 cM in males and 13.8 cM in females (averaging 19.5 cM for sexes combined); the sex difference was statistically significant (P = .0013). Comparison between families for the two-point and multipoint lod scores involving FSHD showed no evidence for heterogeneity of this disorder. However, after the completion of this analysis, one large family which might show heterogeneity was identified. In view of this and the fact that all of the linked markers reside on the same side of the FSHD locus, the clinical application of these markers is not recommended at this time.	LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT NEUROL,2300 RA LEIDEN,NETHERLANDS; UNIV WALES COLL MED,DEPT MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; COLLABORAT RES INC,DEPT HUMAN GENET,WALTHAM,MA; UNIV ROCHESTER,MED CTR,DEPT NEUROL,ROCHESTER,NY 14642; UNIV IOWA,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; DUKE UNIV,MED CTR,DIV NEUROL,DURHAM,NC 27710; CHILDRENS HOSP,CLIN GENET UNIT,BRISTOL,ENGLAND; UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Cardiff University; University of Rochester; University of Iowa; Duke University; Bristol Royal Hospital For Children; University of California System; University of California San Diego	SARFARAZI, M (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,263 FARMINGTON AVE,FARMINGTON,CT 06030, USA.		Lunt, Peter/AAF-8265-2020; Padberg, G.W.A.M./H-8079-2014; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; mathews, katherine/0000-0003-4160-0435				ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BOWDEN DW, 1989, GENOMICS, V5, P718, DOI 10.1016/0888-7543(89)90113-4; BUETOW KH, 1990, GENOMICS, V8, P13, DOI 10.1016/0888-7543(90)90220-O; BUTLER MG, 1990, NUCLEIC ACIDS RES, V18, P5327, DOI 10.1093/nar/18.17.5327-a; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GILBERT JR, 1992, AM J HUM GENET, V51, P424; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; JACOBSEN SJ, 1990, AM J HUM GENET, V47, P376; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LUNT PW, 1989, J MED GENET, V26, P535, DOI 10.1136/jmg.26.8.535; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; MATHEWS KD, 1992, AM J HUM GENET, V51, P428; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; NEUWEILER J, 1990, NUCLEIC ACIDS RES, V18, P691, DOI 10.1093/nar/18.3.691; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Padberg G., 1982, THESIS U LEIDEN LEID; SARFARAZI M, 1989, J MED GENET, V26, P481, DOI 10.1136/jmg.26.8.481; UPADHYAYA M, 1992, AM J HUM GENET, V51, P404; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; UPADHYAYA M, 1991, J MED GENET, V28, P665, DOI 10.1136/jmg.28.10.665; WEIFFENBACH B, 1992, AM J HUM GENET, V51, P416; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; WIJMENGA C, 1992, AM J HUM GENET, V51, P411; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; WOLAK G, 1987, J MED GENET, V24, P246; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; [No title captured]; [No title captured]; [No title captured]	38	124	127	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					396	403						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642237				2022-12-18	WOS:A1992JF77600020
J	WETMUR, JG; KAYA, AH; PLEWINSKA, M; DESNICK, RJ				WETMUR, JG; KAYA, AH; PLEWINSKA, M; DESNICK, RJ			MOLECULAR CHARACTERIZATION OF THE HUMAN DELTA-AMINOLEVULINATE DEHYDRATASE-2 (ALAD2) ALLELE - IMPLICATIONS FOR MOLECULAR SCREENING OF INDIVIDUALS FOR GENETIC SUSCEPTIBILITY TO LEAD-POISONING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID DEHYDRATASE; PORPHOBILINOGEN SYNTHASE; 5-AMINOLEVULINATE DEHYDRATASE; NUCLEOTIDE-SEQUENCE; HUMAN-ERYTHROCYTES; BOVINE LIVER; POLYMORPHISM; EXPOSURE; ZINC; PHYSIOLOGY	The second enzyme in the heme biosynthetic pathway, delta-aminolevulinate dehydratase (ALAD), is a homooctameric protein encoded by a gene localized to human chromosome 9q34. Expression of the two common alleles, ALAD1 (p = .9) and ALAD2 (q = .1), results in a polymorphic enzyme system with three distinct charge isozymes, designated 1-1, 1-2, and 2-2. Individuals heterozygous (2pq = .18) or homozygous (q2 = .01) for the ALAD2 allele have significantly higher blood lead levels than do ALAD1 homozygotes, when exposed to low or high levels of lead in the environment. To investigate the molecular nature of this common polymorphism, total RNA from an ALAD2 homozygote was oligo-dT primed and reverse transcribed, and then the ALAD2 cDNA was amplified, subcloned, and sequenced. Compared with the ALAD1 sequence, the only difference in the ALAD2 cDNA was a G-to-C transversion of nucleotide 177 in the coding region, which created an MspI restriction site. This base substitution predicted the replacement of a positively charged lysine by a neutral asparagine (K59N), an amino acid change consistent with the more electronegative charge of the ALAD-2 subunit. The ALAD1 and ALAD2 alleles were easily detected by amplification of a 916-bp region of genomic DNA and MspI digestion which results in 582- and 511-bp products, respectively. Molecular analysis of 85 ALAD1/ALAD2 heterozygotes and of eight ALAD2 homozygotes revealed no discrepancy between the predicted genotype and the erythrocyte isozyme phenotype, indicating that all the ALAD2 alleles analyzed had the G-to-C transversion. In addition, the previously identified RsaI polymorphism of ALAD coding nucleotide 168 also was detected in the same amplification product, permitting rapid assignment of the MspI (ALAD genotype)/RsaI haplotype. The rapid and accurate determination of the ALAD genotype permits molecular-based screening of populations to identify individuals who are genetically more susceptible to lead poisoning.	CUNY MT SINAI SCH MED, DIV MED & MOLEC GENET, 5TH AVE & 100TH ST, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT MICROBIOL, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005046] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK26824] Funding Source: Medline; NIEHS NIH HHS [ES05046] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; ASTRIN KH, 1987, ANN NY ACAD SCI, V514, P23, DOI 10.1111/j.1749-6632.1987.tb48757.x; ASTRIN KH, IN PRESS NUCLEIC ACI; AUDESIRK G, 1985, PROG NEUROBIOL, V24, P199, DOI 10.1016/0301-0082(85)90006-1; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P223, DOI 10.1111/j.1469-1809.1981.tb00333.x; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; BENKMANN HG, 1983, HUM HERED, V33, P62, DOI 10.1159/000153351; BEVAN DR, 1980, J BIOL CHEM, V255, P2030; BISHOP TR, 1986, NUCLEIC ACIDS RES, V14, P10115, DOI 10.1093/nar/14.24.10115; BISHOP TR, 1989, NUCLEIC ACIDS RES, V17, P1775, DOI 10.1093/nar/17.4.1775; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOTTOMLEY SS, 1988, SEMIN HEMATOL, V25, P282; BRENNAN MJ, 1981, NATURE, V38, P49; BRENNAN MJW, 1979, NATURE, V280, P514, DOI 10.1038/280514a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CUTLER MG, 1985, NEUROPHARMACOLOGY, V24, P1005, DOI 10.1016/0028-3908(85)90129-7; DENT AJ, 1990, BIOCHEMISTRY-US, V29, P7822, DOI 10.1021/bi00486a007; DOSS M, 1979, KLIN WOCHENSCHR, V57, P1123, DOI 10.1007/BF01481493; DOSS M, 1984, INT ARCH OCC ENV HEA, V54, P55, DOI 10.1007/BF00378728; DOSS M, 1982, KLIN WOCHENSCHR, V60, P599, DOI 10.1007/BF01711435; ECHELARD Y, 1988, MOL GEN GENET, V214, P503, DOI 10.1007/BF00330487; GEISSE S, 1983, CLIN CHIM ACTA, V135, P239, DOI 10.1016/0009-8981(83)90141-9; GIBBS P, 1981, Biochemical Society Transactions, V9, P232; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; JAFFE EK, 1984, J BIOL CHEM, V259, P5032; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; MINNEMA DJ, 1986, TOXICOL APPL PHARM, V86, P437, DOI 10.1016/0041-008X(86)90371-6; MULLER WE, 1977, ANN NEUROL, V2, P340, DOI 10.1002/ana.410020415; NEEDLEMAN HL, 1990, NEW ENGL J MED, V322, P83, DOI 10.1056/NEJM199001113220203; PETRUCCI R, 1982, HUM GENET, V60, P289, DOI 10.1007/BF00303023; POTLURI VR, 1987, HUM GENET, V76, P236; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SCHLOSSER M, 1987, BIOL CHEM H-S, V368, P1469, DOI 10.1515/bchm3.1987.368.2.1469; TSUKAMOTO I, 1979, BIOCHIM BIOPHYS ACTA, V570, P167, DOI 10.1016/0005-2744(79)90211-0; WETMUR JG, 1986, P NATL ACAD SCI USA, V83, P7703, DOI 10.1073/pnas.83.20.7703; WU WH, 1974, P NATL ACAD SCI USA, V71, P1767, DOI 10.1073/pnas.71.5.1767; ZIEMSEN B, 1986, INT ARCH OCC ENV HEA, V58, P245, DOI 10.1007/BF00432107	38	124	140	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					757	763						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1716854				2022-12-18	WOS:A1991GG66500007
J	WARBURTON, D; KLINE, J; STEIN, Z; HUTZLER, M; CHIN, A; HASSOLD, T				WARBURTON, D; KLINE, J; STEIN, Z; HUTZLER, M; CHIN, A; HASSOLD, T			DOES THE KARYOTYPE OF A SPONTANEOUS-ABORTION PREDICT THE KARYOTYPE OF A SUBSEQUENT ABORTION - EVIDENCE FROM 273 WOMEN WITH 2 KARYOTYPED SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10032; COLUMBIA UNIV,SERGIEVSKY CTR & SCH PUBL HLTH,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032; CORNELL UNIV,DEPT PEDIAT,NEW YORK,NY 10021	Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University	WARBURTON, D (corresponding author), COLUMBIA UNIV,DEPT GENET & DEV,630 W 168TH ST,NEW YORK,NY 10032, USA.				NICHD NIH HHS [1R01 HD 12207, 1R01 HD 08838] Funding Source: Medline; NIDA NIH HHS [1R01 DA 02090] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AAGESEN L, 1984, ANN HUM GENET, V48, P297, DOI 10.1111/j.1469-1809.1984.tb00843.x; ALBERMAN E, 1975, BRIT J OBSTET GYNAEC, V82, P366, DOI 10.1111/j.1471-0528.1975.tb00651.x; ALBERMAN E, 1981, TRISOMY 2U DOWNS SYN, P69; AYME S, 1979, CLIN GENET, V15, P112; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; BOUE J, 1973, HUMANGENETIK, V19, P275, DOI 10.1007/BF00278402; BRESLOW NE, 1980, IARC SCI PUBL, V32, P162; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; FORSSMAN H., 1967, CIBA FOUND STUDY GROUP, V25, P23; HARRIS DJ, 1982, AM J HUM GENET, V34, P125; HASSOLD T, 1984, AM J HUM GENET, V36, P1349; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1982, HUM GENET, V61, P31, DOI 10.1007/BF00291327; HASSOLD T, 1985, ANEUPLOIDY ETIOLOGY, P103; HASSOLD TJ, 1980, AM J HUM GENET, V32, P723; HECHT F, 1964, NEW ENGL J MED, V271, P1081, DOI 10.1056/NEJM196411192712102; HOOK EB, 1981, OBSTET GYNECOL, V58, P282; HOOK EB, 1983, AM J HUM GENET, V35, P1307; HOOK EB, 1983, AM J HUM GENET, V35, P558; Hook EB, 1981, TRISOMY 21 DOWN SYND, P3; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; KLINE J, 1986, PERINATAL GENETICS, P3; Lauritsen J G, 1976, Acta Obstet Gynecol Scand Suppl, V52, P1; Mikkelsen M, 1979, PRENATAL DIAGNOSIS, P22; Penrose L.S., 1966, DOWNS ANOMALY; PENROSE LS, 1964, GENET TODAY, V3, P980; RISCH N, 1986, AM J HUM GENET, V39, P68; STEIN Z, 1986, LANCET, V1, P944; STENE J, 1984, PRENATAL DIAG, V4, P81, DOI 10.1002/pd.1970040707; STENE J, 1970, HUM HERED, V20, P112, DOI 10.1159/000152301; STENE J, 1981, AM J HUM GENET, V33, P484; STROBINO B, 1986, AM J PUBLIC HEALTH, V76, P986, DOI 10.2105/AJPH.76.8.986; UCHIDA IA, 1985, HUM GENET, V70, P246; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; WARBURTON D, 1986, PERINATAL GENETICS D, P23; WARBURTON D, 1985, ANEUPLOIDY ETIOLOGY, P133	36	124	129	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					465	483						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631080				2022-12-18	WOS:A1987K019100011
J	OROURKE, DH; GOTTESMAN, II; SUAREZ, BK; RICE, J; REICH, T				OROURKE, DH; GOTTESMAN, II; SUAREZ, BK; RICE, J; REICH, T			REFUTATION OF THE GENERAL SINGLE-LOCUS MODEL FOR THE ETIOLOGY OF SCHIZOPHRENIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT ANTHROPOL,SALT LAKE CITY,UT 84112; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT BIOSTAT,ST LOUIS,MO 63110	Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL)	OROURKE, DH (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110, USA.		G, I/D-8042-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH025430, P30MH031302, U01MH025430, P50MH031302, T32MH014677] Funding Source: NIH RePORTER; NIMH NIH HHS [MH14677, MH25430, MH31302] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bleuler M, 1930, Z GESAMTE NEUROL PSY, V127, P321, DOI 10.1007/BF02864212; Bleuler M., 1978, SCHIZOPHRENIC DISORD; BLEULER M, 1941, KRANKHEITSVERLAUF PE; BOOK J A, 1953, Acta Genet Stat Med, V4, P1; BOOK JA, 1978, CLIN GENET, V14, P373; CRITTENDEN L, 1961, ANN NY ACAD SCI, V91, P769, DOI 10.1111/j.1749-6632.1961.tb31106.x; DEBRAY Q, 1978, NEUROPSYCHOBIOLOGY, V4, P257, DOI 10.1159/000117639; DEBRAY Q, 1979, HUM HERED, V29, P27, DOI 10.1159/000153012; ELSTON RC, 1978, NEUROPSYCHOBIOLOGY, V4, P193, DOI 10.1159/000117633; ELSTON RC, 1970, BEHAV GENET, V1, P3, DOI 10.1007/BF01067366; ESSEN-MOLLER E, 1955, Acta Genet Stat Med, V5, P334; ESSENMOLLER E, 1979, HUM HERED, V29, P161, DOI 10.1159/000153034; FALCONER DS, 1967, ANN HUM GENET, V31, P1; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FISCHER M, 1973, ACTA PSYCHIATR SCA S, V383; FISHMAN PM, 1978, AM J HUM GENET, V30, P283; FULKER DW, 1973, SOC BIOL, V20, P266, DOI 10.1080/19485565.1973.9988053; Galatschjan A, 1937, SCHWEIZ ARCH NEUROL, V39, P291; GARRONE G, 1962, J GENET HUM, V11, P89; GOLDEN RR, 1978, ANN HUM GENET, V41, P507, DOI 10.1111/j.1469-1809.1978.tb00924.x; Gottesman I. I., 1972, SCHIZOPHRENIA GENETI; GOTTESMAN II, 1976, SCHIZOPHRENIA BULL, V2, P360, DOI 10.1093/schbul/2.3.360; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; GURLAND B, 1978, NATURE SCHIZOPHRENIA, P686; HAGNELL O, 1966, PROSPECTIVE INCIDENC; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819; HESTON LL, 1970, SCIENCE, V167, P249; JACKSON DD, 1960, ETIOLOGY SCHIZOPHREN, P57; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KALLMANN FJ, 1946, AM J PSYCHIAT, V103, P309, DOI 10.1176/ajp.103.3.309; Kallmann Franz Josef, 1938, GENETICS SCHIZOPHREN; KAPLAN EB, 1972, U N CAROLINA I STATI, V823; KARLSSON JL, 1974, ACTA PSYCHIATR SCA S, V247; KARLSSON JL, 1968, TRANSMISSION SCHIZOP, P85; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; Kety S., 1968, TRANSMISSION SCHIZOP, P345, DOI DOI 10.1016/0022-3956(68)90026-5; Kety S S, 1975, Proc Annu Meet Am Psychopathol Assoc, P147; KIDD KK, 1973, SOC BIOL, V20, P254, DOI 10.1080/19485565.1973.9988051; KIDD KK, 1975, GENETIC RES PSYCHIAT, P135; Kringlen E., 1967, HEREDITY ENV FUNCTIO; KRINGLEN E, 1978, NATURE SCHIZOPHRENIA, P9; LIDZ T, 1976, SCHIZOPHRENIA BULL, V2, P402, DOI 10.1093/schbul/2.3.402; LINDELIUS R, 1970, ACTA PSYCHIATR SCA S, V216; LUXENBURGER H, 1936, Z NEUR, V154, P351; MATTHYSSE S, 1978, ANN HUM GENET, V41, P477, DOI 10.1111/j.1469-1809.1978.tb00919.x; MATTHYSSE S, 1978, GENETIC EPIDEMIOLOGY, P311; MATTHYSSE SW, 1976, AM J PSYCHIAT, V133, P185; Meehl P.E., 1972, SCHIZOPHRENIA GENETI, P367; MODRZEWSKA K, 1980, CLIN GENET, V17, P191; MORTON LA, 1979, BEHAV GENET, V9, P389, DOI 10.1007/BF01066977; MORTON NE, 1974, AM J HUM GENET, V26, P489; ODEGAARD O, 1952, COMPTE RENDUS, V6, P84; POLLIN W, 1969, AM J PSYCHIAT, V126, P597, DOI 10.1176/ajp.126.5.597; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; Reed SC, 1973, PSYCHOSES FAMILY STU; REICH T, 1975, BRIT J PSYCHIAT, V127, P1, DOI 10.1192/bjp.127.1.1; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; RICE J, 1982, HUM HERED; Rosanoff AJ, 1911, AM J INSANITY, V68, P221, DOI 10.1176/ajp.68.2.221; Rosenthal D., 1970, GENETIC THEORY ABNOR; Rosenthal D., 2002, J PSYCHIATR RES, V6, P377, DOI [10.1016/0022-3956(68)90028-9, DOI 10.1016/0022-3956(68)90028-9]; RUDIN E, 1916, ZUR VERERBUNG NEUENT; SCHULZ BRUNO, 1932, ZEITSCHR GES NEUROL U PSYCHIATR, V143, P175; SHIELDS J, 1967, ACTA PSYCHIAT SCAND, V43, P385, DOI 10.1111/j.1600-0447.1967.tb05776.x; SHIELDS J, 1975, GENETIC RES PSYCHIAT, P167; SLATER E, 1958, Acta Genet Stat Med, V8, P50; SLATER E, 1953, MED RES COUNCIL SPEC, V278; Slater E, 1971, GENETICS MENTAL DISO; Smith JC, 1936, Z GESAMTE NEUROL PSY, V156, P361, DOI 10.1007/BF02870805; SPENCE MA, 1976, NEUROPSYCHOBIOLOGY, V2, P328; STEWART J, 1980, AM J HUM GENET, V32, P55; STEWART J, 1980, AM J HUM GENET, V32, P47; Stromgren E, 1935, Z GESAMTE NEUROL PSY, V153, P784, DOI 10.1007/BF02865780; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x; SUAREZ BK, 1977, HUM HERED, V27, P336, DOI 10.1159/000152888; TIENARI P, 1971, PSYCHIATRIA FENNICA, P97; TSUANG MT, 1974, COMPR PSYCHIAT, V15, P295, DOI 10.1016/0010-440X(74)90050-9; WENDER PH, 1974, ARCH GEN PSYCHIAT, V30, P121; WENDER PH, 1973, ARCH GEN PSYCHIAT, V28, P318; ZERBINRUBIN E, 1967, HUMANGENETIK EIN KUR, V2, P446	81	124	124	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					630	649						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	NY863	7102677				2022-12-18	WOS:A1982NY86300010
J	RICCIUTI, FC; GELEHRTER, TD; ROSENBERG, LE				RICCIUTI, FC; GELEHRTER, TD; ROSENBERG, LE			X-CHROMOSOME INACTIVATION IN HUMAN LIVER - CONFIRMATION OF X-LINKAGE OF ORNITHINE TRANSCARBAMYLASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	Yale University; University of Michigan System; University of Michigan								CAMPBELL AG, 1973, NEW ENGL J MED, V288, P1, DOI 10.1056/NEJM197301042880101; CATHELINEAU L, 1973, LANCET, V1, P261; CATHELINEAU L, 1974, ENZYME, V18, P103, DOI 10.1159/000459417; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DEOL MS, 1972, NATURE-NEW BIOL, V238, P159, DOI 10.1038/newbio238159a0; DEYS BF, 1972, SCIENCE, V175, P1002, DOI 10.1126/science.175.4025.1002; DREWS U, 1974, J EMBRYOL EXP MORPH, V32, P217; GOLDSTEIN AS, 1974, PEDIATR RES, V8, P5, DOI 10.1203/00006450-197401000-00002; GOLDSTEIN JL, 1971, P NATL ACAD SCI USA, V68, P1425, DOI 10.1073/pnas.68.7.1425; Humason G., 1967, ANIMAL TISSUE TECHNI; LEVIN B, 1969, ARCH DIS CHILD, V44, P152, DOI 10.1136/adc.44.234.152; LEVIN B, 1969, ARCH DIS CHILD, V44, P162, DOI 10.1136/adc.44.234.162; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCURDY PR, 1971, NEW ENGL J MED, V285, P218, DOI 10.1056/NEJM197107222850409; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; MIZUTANI A, 1968, J HISTOCHEM CYTOCHEM, V16, P172, DOI 10.1177/16.3.172; NUZUM CT, 1971, SCIENCE, V172, P1042, DOI 10.1126/science.172.3987.1042; PASSARGE E, 1973, NATURE-NEW BIOL, V245, P58, DOI 10.1038/newbio245058a0; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; ROSENBERG LE, 1974, DUNCANS DISEASES MET, P465; RUSSELL A, 1962, LANCET, V2, P699; SCOTT CR, 1972, LANCET, V2, P1148; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8	25	124	124	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					332	338						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	941900				2022-12-18	WOS:A1976BX34500002
J	KARP, GW; SUTTON, HE				KARP, GW; SUTTON, HE			SOME NEW PHENOTYPES OF HUMAN RED CELL ACID PHOSPHATASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GEORGATSOS JG, 1965, ARCH BIOCHEM BIOPHYS, V100, P354; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; KRISTJAN.FK, 1965, GENETICS, V52, P627; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585	6	124	124	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					54	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	6019303				2022-12-18	WOS:A19678855200005
J	van der Meij, KRM; Sistermans, EA; Macville, MVE; Stevens, SJC; Bax, CJ; Bekker, MN; Bilardo, CM; Boon, EMJ; Boter, M; Diderich, KEM; de Die-Smulders, CEM; Duin, LK; Faas, BHW; Feenstra, I; Haak, MC; Hoffer, MJV; den Hollander, NS; Hollink, IHIM; Jehee, FS; Knapen, MFCM; Kooper, AJA; van Langen, IM; Lichtenbelt, KD; Linskens, IH; van Maarle, MC; Oepkes, D; Pieters, MJ; Schuring-Blom, GH; Sikkel, E; Sikkema-Raddatz, B; Smeets, DFCM; Srebniak, MI; Suijkerbuijk, RF; Tan-Sindhunata, GM; van der Ven, AJEM; van Zelderen-Bhola, SL; Henneman, L; Galjaard, RJH; Van Opstal, D; Weiss, MM				van der Meij, Karuna R. M.; Sistermans, Erik A.; Macville, Merryn V. E.; Stevens, Servi J. C.; Bax, Caroline J.; Bekker, Mireille N.; Bilardo, Caterina M.; Boon, Elles M. J.; Boter, Marjan; Diderich, Karin E. M.; de Die-Smulders, Christine E. M.; Duin, Leonie K.; Faas, Brigitte H. W.; Feenstra, Ilse; Haak, Monique C.; Hoffer, Mariette J. V.; den Hollander, Nicolette S.; Hollink, Iris H. I. M.; Jehee, Fernanda S.; Knapen, Maarten F. C. M.; Kooper, Angelique J. A.; van Langen, Irene M.; Lichtenbelt, Klaske D.; Linskens, Ingeborg H.; van Maarle, Merel C.; Oepkes, Dick; Pieters, Mijntje J.; Schuring-Blom, G. Heleen; Sikkel, Esther; Sikkema-Raddatz, Birgit; Smeets, Dominique F. C. M.; Srebniak, Malgorzata I.; Suijkerbuijk, Ron F.; Tan-Sindhunata, Gita M.; van der Ven, A. Jeanine E. M.; van Zelderen-Bhola, Shama L.; Henneman, Lidewij; Galjaard, Robert-Jan H.; Van Opstal, Diane; Weiss, Marjan M.		Dutch NIPT Consortium	TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-FREE DNA; PREGNANT-WOMEN; DOWN-SYNDROME; HEALTH; ORGANIZATION; EXPERIENCE; IMPACT	The Netherlands launched a nationwide implementation study on non-invasive prenatal testing (NIPT) as a first-tier test offered to all pregnant women. This started on April 1, 2017 as the TRIDENT-2 study, licensed by the Dutch Ministry of Health. In the first year, NIPT was performed in 73,239 pregnancies (42% of all pregnancies), 7,239 (4%) chose first-trimester combined testing, and 54% did not participate. The number of trisomies 21 (239, 0.33%), 18 (49, 0.07%), and 13 (55, 0.08%) found in this study is comparable to earlier studies, but the Positive Predictive Values (PPV)-96% for trisomy 21, 98% for trisomy 18, and 53% for trisomy 13-were higher than expected. Findings other than trisomy 21, 18, or 13 were reported on request of the pregnant women; 78% of women chose to have these reported. The number of additional findings was 207 (0.36%); these included other trisomies (101, 0.18%, PPV 6%, many of the remaining 94% of cases are likely confined placental mosaics and possibly clinically significant), structural chromosomal aberrations (95, 0.16%, PPV 32%,) and complex abnormal profiles indicative of maternal malignancies (11, 0.02%, PPV 64%). The implementation of genome-wide NIPT is under debate because the benefits of detecting other fetal chromosomal aberrations must be balanced against the risks of discordant positives, parental anxiety, and a potential increase in (invasive) diagnostic procedures. Our first-year data, including clinical data and laboratory follow-up data, will fuel this debate. Furthermore, we describe how NIPT can successfully be embedded into a national screening program with a single chain for prenatal care including counseling, testing, and follow-up.	[van der Meij, Karuna R. M.; Sistermans, Erik A.; Boon, Elles M. J.; Tan-Sindhunata, Gita M.; van Zelderen-Bhola, Shama L.; Henneman, Lidewij; Weiss, Marjan M.] Vrije Univ Amsterdam, Amsterdam UMC, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Macville, Merryn V. E.; Stevens, Servi J. C.; de Die-Smulders, Christine E. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands; [Bax, Caroline J.] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Bekker, Mireille N.] Univ Utrecht, Med Ctr, Dept Obstet & Gynaecol, NL-3584 CX Utrecht, Netherlands; [Bilardo, Caterina M.; Linskens, Ingeborg H.] Vrije Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynaecol, NL-1081 HV Amsterdam, Netherlands; [Boter, Marjan; Diderich, Karin E. M.; Hollink, Iris H. I. M.; Jehee, Fernanda S.; Srebniak, Malgorzata I.; Galjaard, Robert-Jan H.; Van Opstal, Diane] Erasmus MC, Dept Clin Genet, NL-3015 GD Rotterdam, Netherlands; [Duin, Leonie K.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstetry & Gynaecol, NL-9713 GZ Groningen, Netherlands; [Faas, Brigitte H. W.; Feenstra, Ilse; Smeets, Dominique F. C. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Genet, NL-6525 GA Nijmegen, Netherlands; [Haak, Monique C.; Oepkes, Dick] Leiden Univ, Med Ctr, Dept Obstet, NL-2333 ZA Leiden, Netherlands; [Hoffer, Mariette J. V.; den Hollander, Nicolette S.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Knapen, Maarten F. C. M.] Erasmus MC, Dept Obstet & Fetal Med, NL-3015 GD Rotterdam, Netherlands; [Kooper, Angelique J. A.; van Maarle, Merel C.; Sikkema-Raddatz, Birgit; Suijkerbuijk, Ron F.] Univ Amsterdam, Amsterdam UMC, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [van Langen, Irene M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands; [Lichtenbelt, Klaske D.; Schuring-Blom, G. Heleen] Univ Utrecht, Med Ctr, Dept Genet, NL-3584 CX Utrecht, Netherlands; [Pieters, Mijntje J.] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, NL-6229 HX Maastricht, Netherlands; [Sikkel, Esther] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 GA Nijmegen, Netherlands; [van der Ven, A. Jeanine E. M.] Verloskundigenpraktijk Velp, NL-6883 AX Velp, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; University of Amsterdam; Utrecht University; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; University of Groningen; Utrecht University; Maastricht University; Radboud University Nijmegen	Sistermans, EA (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands.	e.sistermans@amsterdamumc.nl	Weiss, Janneke/AAO-8489-2020; Weiss, Marjan M/AAN-4979-2020; Stevens, Servi/P-8450-2015; Sistermans, Erik/B-1109-2009	Weiss, Marjan M/0000-0002-0936-1406; Stevens, Servi/0000-0001-8769-3150; Sistermans, Erik/0000-0001-7187-4563; Macville, Merryn/0000-0003-1675-2234; van Langen, Irene/0000-0002-0960-7154; Haak, Monique/0000-0002-0443-1997; Henneman, Lidewij/0000-0003-3531-0597; van der Meij, Karuna/0000-0002-1801-588X; Diderich, Karin/0000-0003-2637-9998	Netherlands Organization for Health Research and Development (ZonMw) [543002001]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The authors would like to thank all participating women for their contribution to the TRIDENT-2 study. Moreover, we thank all who have contributed to the set-up and execution of the study, including health professionals, laboratory staff, and other supporting staff. Staff members of RIVM/CvB, the Regional Centers for Prenatal Screening, and Peridos are acknowledged for their collaboration. Sandra van 't Padje is acknowledged for all her work as functional manager of the Consortium. This work was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bakker M, 2012, PRENATAL DIAG, V32, P1305, DOI 10.1002/pd.4001; Bayindir B, 2015, EUR J HUM GENET, V23, P1286, DOI 10.1038/ejhg.2014.282; Benn P, 2018, ULTRASOUND OBST GYN, V51, P429, DOI 10.1002/uog.19014; Bianchi DW, 2018, NEW ENGL J MED, V379, P464, DOI 10.1056/NEJMra1705345; Blondel B, 2017, J GYNECOL OBSTET HUM, V46, P701, DOI 10.1016/j.jogoh.2017.09.002; Chan RWY, 2014, P NATL ACAD SCI USA, V111, pE5302, DOI 10.1073/pnas.1421126111; Chandrasekharan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008704; Chitty LS, 2018, PRENATAL DIAG, V38, P160, DOI 10.1002/pd.5216; Crombag NMTH, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-437; Deans ZC, 2017, PRENATAL DIAG, V37, P699, DOI 10.1002/pd.5068; Eckmann-Scholz C, 2012, J PERINAT MED, V40, P215, DOI [10.1515/jpm.2011.130, 10.1515/JPM.2011.130]; Ehrich M, 2017, GENET MED, V19, P1332, DOI 10.1038/gim.2017.56; Ekelund CK, 2015, ACTA OBSTET GYN SCAN, V94, P577, DOI 10.1111/aogs.12581; Fiorentino F, 2017, PRENATAL DIAG, V37, P593, DOI 10.1002/pd.5053; Gammon BL, 2020, J MATERN-FETAL NEO M, V33, P1412, DOI 10.1080/14767058.2018.1519541; Gezondheidsraad, 2016, 201610 GEZ; Gil MM, 2017, ULTRASOUND OBST GYN, V50, P302, DOI 10.1002/uog.17484; Goodfellow LR, 2011, PLACENTA, V32, P699, DOI 10.1016/j.placenta.2011.06.008; Green ED, 2017, NATURE, V550, P179, DOI 10.1038/550179a; Gregg AR, 2016, GENET MED, V18, P1056, DOI 10.1038/gim.2016.97; Hill M, 2016, EUR J HUM GENET, V24, P968, DOI 10.1038/ejhg.2015.249; Horn R, 2018, PRENATAL DIAG, V38, P20, DOI 10.1002/pd.5114; Hui L, 2017, GENET MED, V19, P1338, DOI 10.1038/gim.2017.55; Huijsdens-van Amsterdam K, 2018, GENET MED, V20, P1472, DOI 10.1038/gim.2018.32; Lenaerts L, 2019, ANN ONCOL, V30, P85, DOI 10.1093/annonc/mdy476; Lewis C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153147; Liefers J., 2018, MONITOR 2017 PRENATA; Liefers J, 2017, MONITOR 2016 PRENATA; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; National Cancer Institute S. Epidemiology and End Results Program (SEER), EP END RES PROGR SEE; Nederend J, 2012, ANN ONCOL, V23, P3098, DOI 10.1093/annonc/mds146; Oepkes D, 2016, PRENATAL DIAG, V36, P1083, DOI 10.1002/pd.4945; Pertile MD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1240; Pescia G, 2017, GENET MED, V19, P169, DOI 10.1038/gim.2016.72; Schuring-Blom H, 2016, PRENATAL DIAG, V36, P790, DOI 10.1002/pd.4863; Srebniak MI, 2017, HUM MUTAT, V38, P880, DOI 10.1002/humu.23232; Straver R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt992; Taylor-Phillips S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010002; Toutain J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195905; van Beek DM, 2017, PRENATAL DIAG, V37, P769, DOI 10.1002/pd.5079; van der Steen SL, 2015, CLIN GENET, V88, P25, DOI 10.1111/cge.12479; van El CG, 2012, J COMMUN GENET, V3, P79, DOI 10.1007/s12687-011-0063-z; Van Opstal D, 2018, GENET MED, V20, P480, DOI 10.1038/gim.2017.132; Van Opstal D, 2016, EXPERT REV MOL DIAGN, V16, P513, DOI 10.1586/14737159.2016.1152890; van Schendel RV, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2618-0; van Schendel RV, 2015, PRENATAL DIAG, V35, P598, DOI 10.1002/pd.4579	47	123	126	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1091	1101		10.1016/j.ajhg.2019.10.005	http://dx.doi.org/10.1016/j.ajhg.2019.10.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31708118	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000500935400003
J	Zariwala, MA; Gee, HY; Kurkowiak, M; Al-Mutairi, DA; Leigh, MW; Hurd, TW; Hjeij, R; Dell, SD; Chaki, M; Dougherty, GW; Adan, M; Spear, PC; Esteve-Rudd, J; Loges, NT; Rosenfeld, M; Diaz, KA; Olbrich, H; Wolf, WE; Sheridan, E; Batten, TFC; Halbritter, J; Porath, JD; Kohl, S; Lovric, S; Hwang, DY; Pittman, JE; Burns, KA; Ferkol, TW; Sagel, SD; Olivier, KN; Morgan, LC; Werner, C; Raidt, J; Pennekamp, P; Sun, ZX; Zhou, WB; Airik, R; Natarajan, S; Allen, SJ; Amirav, I; Wieczorek, D; Landwehr, K; Nielsen, K; Schwerk, N; Sertic, J; Kohler, G; Washburn, J; Levy, S; Fan, SL; Koerner-Rettberg, C; Amselem, S; Williams, DS; Mitchell, BJ; Drummond, LA; Otto, EA; Omran, H; Knowles, MR; Hildebrandt, F				Zariwala, Maimoona A.; Gee, Heon Yung; Kurkowiak, Malgorzata; Al-Mutairi, Dalal A.; Leigh, Margaret W.; Hurd, Toby W.; Hjeij, Rim; Dell, Sharon D.; Chaki, Moumita; Dougherty, Gerard W.; Adan, Mohamed; Spear, Philip C.; Esteve-Rudd, Julian; Loges, Niki T.; Rosenfeld, Margaret; Diaz, Katrina A.; Olbrich, Heike; Wolf, Whitney E.; Sheridan, Eamonn; Batten, Trevor F. C.; Halbritter, Jan; Porath, Jonathan D.; Kohl, Stefan; Lovric, Svjetlana; Hwang, Daw-Yang; Pittman, Jessica E.; Burns, Kimberlie A.; Ferkol, Thomas W.; Sagel, Scott D.; Olivier, Kenneth N.; Morgan, Lucy C.; Werner, Claudius; Raidt, Johanna; Pennekamp, Petra; Sun, Zhaoxia; Zhou, Weibin; Airik, Rannar; Natarajan, Sivakumar; Allen, Susan J.; Amirav, Israel; Wieczorek, Dagmar; Landwehr, Kerstin; Nielsen, Kim; Schwerk, Nicolaus; Sertic, Jadranka; Koehler, Gabriele; Washburn, Joseph; Levy, Shawn; Fan, Shuling; Koerner-Rettberg, Cordula; Amselem, Serge; Williams, David S.; Mitchell, Brian J.; Drummond, Lain A.; Otto, Edgar A.; Omran, Heymut; Knowles, Michael R.; Hildebrandt, Friedhelm			ZMYND10 Is Mutated in Primary Ciliary Dyskinesia and Interacts with LRRC6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYNEIN REGULATORY COMPLEX; CELL-CYCLE; MUTATIONS; CILIOGENESIS; DEFECTS; CILIOPATHY; MOTILITY; DISEASE; HUMANS; GENES	Defects of motile cilia cause primary ciliary dyskinesia (PCD), characterized by recurrent respiratory infections and male infertility Using whole-exome resequencing and high-throughput mutation analysis, we identified recessive biallelic mutations in ZMYND10 in 14 families and mutations in the recently identified LRRC6 in 13 families. We show that ZMYND10 and LRRC6 interact and that certain ZMYND10 and LRRC6 mutations abrogate the interaction between the LRRC6 CS domain and the ZMYND10 C-terminal domain. Additionally ZMYND10 and LRRC6 colocalize with the centriole markers SAS6 and PCM1. Mutations in ZMYND10 result in the absence of the axonemal protein components DNAH5 and DNALI1 from respiratory cilia. Animal models support the association between ZMYND10 and human PCD, given that zmynd10 knockdown in zebrafish caused ciliary paralysis leading to cystic kidneys and otolith defects and that knockdown in Xenopus interfered with ciliogenesis. Our findings suggest that a cytoplasmic protein complex containing ZMYND10 and LRRC6 is necessary for motile ciliary function.	[Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Gee, Heon Yung; Halbritter, Jan; Porath, Jonathan D.; Kohl, Stefan; Lovric, Svjetlana; Hwang, Daw-Yang; Airik, Rannar; Hildebrandt, Friedhelm] Harvard Univ, Boston Childrens Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA 02115 USA; [Kurkowiak, Malgorzata; Hjeij, Rim; Dougherty, Gerard W.; Loges, Niki T.; Olbrich, Heike; Werner, Claudius; Raidt, Johanna; Pennekamp, Petra; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Kurkowiak, Malgorzata] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Kurkowiak, Malgorzata] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Al-Mutairi, Dalal A.] Kuwait Univ, Fac Med, Hlth Sci Ctr, Dept Pathol, Safat 13110, Kuwait; [Batten, Trevor F. C.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Leigh, Margaret W.; Pittman, Jessica E.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Hurd, Toby W.] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Dell, Sharon D.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Chaki, Moumita; Diaz, Katrina A.; Zhou, Weibin; Natarajan, Sivakumar; Allen, Susan J.; Otto, Edgar A.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Adan, Mohamed; Drummond, Lain A.] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Spear, Philip C.; Mitchell, Brian J.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Esteve-Rudd, Julian; Williams, David S.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol & Neurobiol, Los Angeles, CA 90095 USA; [Rosenfeld, Margaret] Univ Washington, Sch Med, Seattle Childrens Hosp, Seattle, WA 98105 USA; [Wolf, Whitney E.; Burns, Kimberlie A.; Knowles, Michael R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Sagel, Scott D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Olivier, Kenneth N.] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Morgan, Lucy C.] Concord Hosp, Dept Resp Med, Concord 2139, NSW, Australia; [Sun, Zhaoxia] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Amirav, Israel] Bar Ilan Univ, Fac Med, Ziv Med Ctr, Dept Pediat, IL-13100 Safed, Israel; [Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Human Genet, D-45122 Essen, Germany; [Landwehr, Kerstin] Evangel Krankenhaus Bielefeld, Klin Kinder & Jugendmed, D-33617 Bielefeld, Nordrhein Westf, Germany; [Nielsen, Kim] Copenhagen Univ Hosp, Rigshosp, Dept Paediat & Adolescent Med, Paediat Pulm Serv, DK-2100 Copenhagen, Denmark; [Schwerk, Nicolaus] Hannover Med Sch, Univ Childrens Hosp, Dept Pneumol Allergy & Neonatol, D-30625 Hannover, Germany; [Sertic, Jadranka] Univ Zagreb, Sch Med, Zagreb Clin Hosp, Clin Inst Lab Diag, Zagreb 10000, Croatia; [Koehler, Gabriele] Univ Hosp Muenster, Dept Pathol, D-48149 Munster, Germany; [Washburn, Joseph] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Fan, Shuling] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Koerner-Rettberg, Cordula] Ruhr Univ Bochum, St Josef Hosp, Klin Kinder & Jugendmed, D-44791 Bochum, Germany; [Amselem, Serge] Univ Paris 06, INSERM, Unite Mixte Rech S933, F-75012 Paris, France; [Drummond, Lain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Munster; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Kuwait University; University of Leeds; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Northwestern University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Saint James's University Hospital; University of Leeds; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Concord Repatriation General Hospital; Yale University; Bar Ilan University; Ziv Medical Center; University of Duisburg Essen; Evangelical Hospital Bethel (EvKB) - House Gilead I; Rigshospitalet; University of Copenhagen; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zagreb; University of Munster; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; University of Michigan System; University of Michigan; Ruhr University Bochum; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Harvard Univ, Boston Childrens Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA 02115 USA.	knowles@med.unc.edu; friedhelm.hildebrandt@childrens.harvard.edu	Spear, Philip/L-5446-2014; Koerner-Rettberg, Cordula/AGI-3532-2022; schwerk, nicolaus/AAU-5676-2020; Nielsen, KG/AAE-6575-2020; Airik, Rannar/AAS-7810-2021; Gee, Heon Yung/K-7781-2019; Wieczorek, Dagmar/AAU-6008-2021; Amirav, Israel/I-9286-2019	Spear, Philip/0000-0002-7657-3433; Koerner-Rettberg, Cordula/0000-0003-0946-1009; Nielsen, KG/0000-0001-5906-9449; Airik, Rannar/0000-0002-7055-6325; Gee, Heon Yung/0000-0002-8741-6177; Wieczorek, Dagmar/0000-0003-2812-6492; Amirav, Israel/0000-0002-6917-5285; Omran, Heymut/0000-0003-0282-6765; Batten, Trevor/0000-0003-3988-5603; Otto, Edgar/0000-0002-2387-9973; Levy, Shawn/0000-0002-1369-5740; Raidt, Johanna/0000-0002-1571-2647; Morgan, Lucy/0000-0001-6389-1953; Dell, Sharon/0000-0003-2169-9407; Hjeij, Rim/0000-0003-1464-7289; Rosenfeld, Margaret/0000-0002-8105-614X; Mitchell, Brian/0000-0001-6281-1536; Muraglia, Katrina/0000-0002-4162-4667	National Institutes of Health (NIH) [DK068306, DK090917, DK091405, DK053093, DK070263, EY013408, DK092808-01A1, 5 U54 HL096458-06]; NIH from the National Center for Advancing Translational Sciences [UL1 TR000083, UL1 TR000154]; project "Studies of nucleic acids and proteins from basic to applied research"; Foundation for Polish Science; European Union Regional Development Fund; Department of Pathology, Faculty of Medicine, Kuwait University; Office of the Director; Office of Rare Diseases Research; National Heart, Lung, and Blood Institute (NHLBI); NIH NHLBI [5 R01HL071798]; Deutsche Forschungsgemeinschaft [DFG Om 6/4, Om 6/5, GRK1104, SFB592]; IZKF Munster; Cell Dynamics and Disease graduate school; project SYSCILIA from the European Community; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019480] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013408, P30EY000331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071798, U54HL096458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053093, RC4DK090917, R00DK091405, R01DK092808, R01DK070263, R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089970] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the National Center for Advancing Translational Sciences; project "Studies of nucleic acids and proteins from basic to applied research"; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Regional Development Fund(European Commission); Department of Pathology, Faculty of Medicine, Kuwait University; Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Rare Diseases Research; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Munster; Cell Dynamics and Disease graduate school; project SYSCILIA from the European Community; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all individuals with primary ciliary dyskinesia (PCD) and family members for their participation, as well as Michele Manion, who founded the United States PCD Foundation. We thank the German support group "Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V." This research was supported by grants from the National Institutes of Health (NIH) to F.H. (DK068306 and DK090917), to W.Z. (DK091405), to I.A.D. (DK053093 and DK070263), to D.S.W (EY013408), and to Z.S. (DK092808-01A1). This work was supported in part by NIH grants UL1 TR000083 and UL1 TR000154 from the National Center for Advancing Translational Sciences. M.K. is supported by the project "Studies of nucleic acids and proteins from basic to applied research," sponsored by the International PhD Projects Programme of Foundation for Polish Science. The project is cofinanced by the European Union Regional Development Fund. D.A.M. was supported by the Department of Pathology, Faculty of Medicine, Kuwait University. M.A.Z., M.W.L., S.D.D., M.R., T.W.F., S.D.S., J.E.P., K.N.O., and M.R.K. are supported by NIH research grant 5 U54 HL096458-06, funded by the Office of the Director, and supported by the Office of Rare Diseases Research and the National Heart, Lung, and Blood Institute (NHLBI). M.A.Z. and M.R.K. are supported by NIH NHLBI grant 5 R01HL071798. H.O. is supported by the Deutsche Forschungsgemeinschaft (DFG Om 6/4 and Om 6/5, GRK1104, and SFB592), IZKF Munster, the Cell Dynamics and Disease graduate school, and project SYSCILIA from the European Community. Additional acknowledgements are provided in the Supplemental Data.	Albee AJ, 2013, G3-GENES GENOM GENET, V3, P979, DOI 10.1534/g3.113.006338; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; SOROKIN SP, 1968, J CELL SCI, V3, P207; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Zariwala M.A., 1993, PRIMARY CILIARY DYSK; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang XN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-267; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	33	123	130	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					336	345		10.1016/j.ajhg.2013.06.007	http://dx.doi.org/10.1016/j.ajhg.2013.06.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23891469	Green Published, Bronze			2022-12-18	WOS:000323186200014
J	Stevens, E; Carss, KJ; Cirak, S; Foley, R; Torelli, S; Willer, T; Tambunan, DE; Yau, S; Brodd, L; Sewry, CA; Feng, L; Haliloglu, G; Orhan, D; Dobyns, WB; Enns, GM; Manning, M; Krause, A; Salih, MA; Walsh, CA; Hurles, M; Campbell, KP; Manzini, MC; Stemple, D; Lin, YY; Muntoni, F				Stevens, Elizabeth; Carss, Keren J.; Cirak, Sebahattin; Foley, Reghan; Torelli, Silvia; Willer, Tobias; Tambunan, Dimira E.; Yau, Shu; Brodd, Lina; Sewry, Caroline A.; Feng, Lucy; Haliloglu, Goknur; Orhan, Diclehan; Dobyns, William B.; Enns, Gregory M.; Manning, Melanie; Krause, Amanda; Salih, Mustafa A.; Walsh, Christopher A.; Hurles, Matthew; Campbell, Kevin P.; Manzini, M. Chiara; Stemple, Derek; Lin, Yung-Yao; Muntoni, Francesco		UK10K Consortium	Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of alpha-Dystroglycan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WALKER-WARBURG-SYNDROME; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; ISPD; DEFICIENCY; FORM	Mutations in several known or putative glycosyltransferases cause glycosylation defects in alpha-dystroglycan (alpha-DG), an integral component of the dystrophin glycoprotein complex. The hypoglycosylation reduces the ability of alpha-DG to bind laminin and other extracellular matrix ligands and is responsible for the pathogenesis of an inherited subset of muscular dystrophies known as the dystroglycanopathies. By exome and Sanger sequencing we identified two individuals affected by a dystroglycanopathy with mutations in beta-1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2). B3GALNT2 transfers N-acetyl galactosamine (GalNAc) in a beta-1,3 linkage to N-acetyl glucosamine (GlcNAc). A subsequent study of a separate cohort of individuals identified recessive mutations in four additional cases that were all affected by dystroglycanopathy with structural brain involvement. We show that functional dystroglycan glycosylation was reduced in the fibroblasts and muscle (when available) of these individuals via flow cytometry, immunoblotting, and immunocytochemistry. B3GALNT2 localized to the endoplasmic reticulum, and this localization was perturbed by some of the missense mutations identified. Moreover, knockdown of b3galnt2 in zebrafish recapitulated the human congenital muscular dystrophy phenotype with reduced motility, brain abnormalities, and disordered muscle fibers with evidence of damage to both the myosepta and the sarcolemma. Functional dystroglycan glycosylation was also reduced in the b3galnt2 knockdown zebralish embryos. Together these results demonstrate a role for B3GALNT2 in the glycosylation of alpha-DG and show that B3GALNT2 mutations can cause dystroglycanopathy with muscle and brain involvement.	[Stevens, Elizabeth; Cirak, Sebahattin; Foley, Reghan; Torelli, Silvia; Sewry, Caroline A.; Feng, Lucy; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Carss, Keren J.; Hurles, Matthew; Stemple, Derek; Lin, Yung-Yao] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Dept Neurol,Dept Internal Med, Iowa City, IA 52242 USA; [Tambunan, Dimira E.; Walsh, Christopher A.; Manzini, M. Chiara] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Tambunan, Dimira E.; Walsh, Christopher A.; Campbell, Kevin P.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yau, Shu; Brodd, Lina] GSTS Pathol, DNA Lab, London SE1 9RT, England; [Sewry, Caroline A.] Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Haliloglu, Goknur; Orhan, Diclehan] Hacettepe Univ, Dept Paediat Neurol, Fac Med, TR-06100 Ankara, Turkey; [Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Enns, Gregory M.; Manning, Melanie] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94304 USA; [Krause, Amanda] Univ Witwatersrand, Div Human Genet, Natl Hlth Lab Serv, ZA-2000 Johannesburg, South Africa; [Krause, Amanda] Univ Witwatersrand, Sch Pathol, ZA-2000 Johannesburg, South Africa; [Salih, Mustafa A.] King Saud Univ, Dept Pediat, Div Pediat Neurol, Coll Med, Riyadh 11461, Saudi Arabia; [Lin, Yung-Yao] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England	University of London; University College London; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; University of Iowa; University of Iowa; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Hacettepe University; Seattle Children's Hospital; Stanford University; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; King Saud University; University of London; Queen Mary University London	Muntoni, F (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.	f.muntoni@ucl.ac.uk	Cirak, Sebahattin/AAZ-6829-2020; Cirak, Sebahattin/AAX-9593-2020; Dobyns, William Brian/ABC-6525-2021; Krause, Amanda/AAQ-7038-2020; Salih, Mustafa/C-1222-2014; Dobyns, William/AAI-2768-2020	Krause, Amanda/0000-0002-7157-0807; Salih, Mustafa/0000-0002-4379-2111; Dobyns, William/0000-0002-7681-2844; Carss, Keren/0000-0003-4939-156X; Campbell, Kevin/0000-0003-2066-5889; Lin, Yung-Yao/0000-0002-0435-7694; Manzini, M. Chiara/0000-0001-7175-1096	UK National Specialised Commissioned Team funding for the Congenital Muscular Dystrophies and Congenital Myopathy service; Great Ormond Street Children's Charity; GOSH Biomedical Research Centre; Paul D. Wellstone Muscular Dystrophy Cooperative Research Centre [1U54NS053672]; Medical Research Council (MRC) Neuromuscular Centre; MRC; Child Health Research Appeal Trust (CHRAT); Wellcome Trust; Muscular Dystrophy Campaign; Muscular Dystrophy Association; William Randolph Hearst Fund; Manton Centre for Orphan Disease Research [K99/R00]; NIH (NICHD) [K99HD067379]; Intellectual and Developmental Disabilities Research Centres (CHB DDRC) [P30HD19655]; NIH; American Recovery St Reinvestment Act [NIMH RC2MH089952]; MRC [MR/K000608/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD067379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; Medical Research Council [MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/0924, RA4/924] Funding Source: researchfish	UK National Specialised Commissioned Team funding for the Congenital Muscular Dystrophies and Congenital Myopathy service; Great Ormond Street Children's Charity; GOSH Biomedical Research Centre; Paul D. Wellstone Muscular Dystrophy Cooperative Research Centre; Medical Research Council (MRC) Neuromuscular Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Child Health Research Appeal Trust (CHRAT); Wellcome Trust(Wellcome TrustEuropean Commission); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); William Randolph Hearst Fund; Manton Centre for Orphan Disease Research; NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intellectual and Developmental Disabilities Research Centres (CHB DDRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery St Reinvestment Act; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK	We are grateful to the UK10K consortium for making this study possible. We wish to thank the following funding bodies: the UK National Specialised Commissioned Team funding for the Congenital Muscular Dystrophies and Congenital Myopathy service, the Great Ormond Street Children's Charity and the GOSH Biomedical Research Centre (F.M.), the Paul D. Wellstone Muscular Dystrophy Cooperative Research Centre Grant (1U54NS053672; K.P.C., T.W., and EM.), and the Medical Research Council (MRC) Neuromuscular Centre (F.M.). E.S. is a PhD student supported by the MRC, Great Ormond Street Children's Charity, and the Child Health Research Appeal Trust (CHRAT) (F.M.). K.J.C. is a PhD student supported by the Wellcome Trust. A.R.F. is a Clinical Research Fellow supported by the Muscular Dystrophy Campaign (F.M.). M.C.M. was supported by a Development Grant from the Muscular Dystrophy Association and by the William Randolph Hearst Fund and is currently the recipient of a Junior Faculty Career Development Award from the Manton Centre for Orphan Disease Research and a K99/R00 Transition to Independence award from the NIH (NICHD, K99HD067379). Sequencing at Boston Children's Hospital was supported by the Intellectual and Developmental Disabilities Research Centres (CHB DDRC, P30HD19655). Sequencing at the Broad Institute was supported by a grant from NIH and the American Recovery St Reinvestment Act (NIMH RC2MH089952). K.P.C. and C.A.W. are Investigators of the Howard Hughes Medical Institute. We are very grateful to A. Eddaoudi and his team for their excellent support of the flow cytometry core facility at Great Ormond Street Hospital.	Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brockington M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014434; Cirak S, 2013, BRAIN, V136, P269, DOI 10.1093/brain/aws312; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Dubowitz V., 2012, MUSCLE BIOPSY PRACTI; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Herzog C, 2004, J INVEST DERMATOL, V122, P1372, DOI 10.1111/j.0022-202X.2004.22605.x; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lin YY, 2011, HUM MOL GENET, V20, P1763, DOI 10.1093/hmg/ddr059; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rojek JM, 2007, MOL BIOL CELL, V18, P4493, DOI 10.1091/mbc.E07-04-0374; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, CLIN GENET, V67, P281, DOI 10.1111/j.1399-0004.2004.00368.x; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T., 2010, AIDS RES HUM RETRO S, V327, P88, DOI DOI 10.1126/SCIENCE.1180512	47	123	127	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					354	365		10.1016/j.ajhg.2013.01.016	http://dx.doi.org/10.1016/j.ajhg.2013.01.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23453667	Green Published, Bronze			2022-12-18	WOS:000316161700008
J	Wong, LP; Ong, RTH; Poh, WT; Liu, X; Chen, P; Li, R; Lam, KKY; Pillai, NE; Sim, KS; Xu, H; Sim, NL; Teo, SM; Foo, JN; Tan, LWL; Lim, Y; Koo, SH; Gan, LSH; Cheng, CY; Wee, S; Yap, EPH; Ng, PC; Lim, WY; Soong, R; Wenk, MR; Aung, T; Wong, TY; Khor, CC; Little, P; Chia, KS; Teo, YY				Wong, Lai-Ping; Ong, Rick Twee-Hee; Poh, Wan-Ting; Liu, Xuanyao; Chen, Peng; Li, Ruoying; Lam, Kevin Koi-Yau; Pillai, Nisha Esakimuthu; Sim, Kar-Seng; Xu, Haiyan; Sim, Ngak-Leng; Teo, Shu-Mei; Foo, Jia-Nee; Tan, Linda Wei-Lin; Lim, Yenly; Koo, Seok-Hwee; Gan, Linda Seo-Hwee; Cheng, Ching-Yu; Wee, Sharon; Yap, Eric Peng-Huat; Ng, Pauline Crystal; Lim, Wei-Yen; Soong, Richie; Wenk, Markus Rene; Aung, Tin; Wong, Tien-Yin; Khor, Chiea-Chuen; Little, Peter; Chia, Kee-Seng; Teo, Yik-Ying			Deep Whole-Genome Sequencing of 100 Southeast Asian Malays	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HUMAN-POPULATIONS; HIGH-RISK; VARIANTS; COMMON; DATABASE; METAANALYSIS; MUTATIONS; AFRICA	Whole-genome sequencing across multiple samples in a population provides an unprecedented opportunity for comprehensively characterizing the polymorphic variants in the population. Although the 1000 Genomes Project (1KGP) has offered brief insights into the value of population-level sequencing, the low coverage has compromised the ability to confidently detect rare and low-frequency variants. In addition, the composition of populations in the 1KGP is not complete, despite the fact that the study design has been extended to more than 2,500 samples from more than 20 population groups. The Malays are one of the Austronesian groups predominantly present in Southeast Asia and Oceania, and the Singapore Sequencing Malay Project (SSMP) aims to perform deep whole-genome sequencing of 100 healthy Malays. By sequencing at a minimum of 30x coverage, we have illustrated the higher sensitivity at detecting low-frequency and rare variants and the ability to investigate the presence of hotspots of functional mutations. Compared to the low-pass sequencing in the 1KGP, the deeper coverage allows more functional variants to be identified for each person. A comparison of the fidelity of genotype imputation of Malays indicated that a population-specific reference panel, such as the SSMP, outperforms a cosmopolitan panel with larger number of individuals for common SNPs. For lower-frequency (<5%) markers, a larger number of individuals might have to be whole-genome sequenced so that the accuracy currently afforded by the 1KGP can be achieved. The SSMP data are expected to be the benchmark for evaluating the value of deep population-level sequencing versus low-pass sequencing, especially in populations that are poorly represented in population-genetics studies.	[Wong, Lai-Ping; Ong, Rick Twee-Hee; Poh, Wan-Ting; Liu, Xuanyao; Chen, Peng; Li, Ruoying; Lam, Kevin Koi-Yau; Xu, Haiyan; Teo, Shu-Mei; Tan, Linda Wei-Lin; Lim, Yenly; Cheng, Ching-Yu; Wee, Sharon; Lim, Wei-Yen; Khor, Chiea-Chuen; Chia, Kee-Seng; Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Liu, Xuanyao; Teo, Shu-Mei; Teo, Yik-Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Pillai, Nisha Esakimuthu; Little, Peter; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Sim, Kar-Seng; Sim, Ngak-Leng; Foo, Jia-Nee; Ng, Pauline Crystal; Khor, Chiea-Chuen; Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Koo, Seok-Hwee] Natl Univ Singapore, Pharmacogenet Lab, Singapore 117597, Singapore; [Gan, Linda Seo-Hwee; Yap, Eric Peng-Huat] Def Med & Environm Res Inst, DSO Natl Labs, Singapore 117510, Singapore; [Soong, Richie] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Wenk, Markus Rene] Natl Univ Singapore, Dept Biochem, Singapore 117596, Singapore; [Wenk, Markus Rene] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Cheng, Ching-Yu; Aung, Tin; Wong, Tien-Yin; Khor, Chiea-Chuen] Natl Univ Singapore, Dept Ophthalmol, Singapore 119074, Singapore; [Cheng, Ching-Yu; Aung, Tin; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168571, Singapore; [Khor, Chiea-Chuen] Natl Univ Singapore, Dept Paediat, Singapore 119228, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore.	statyy@nus.edu.sg	Yap, Eric/F-9501-2015; Cheng, Ching-Yu/Y-2229-2019; Foo, Jia Nee/D-6069-2014; Liu, Xuanyao/J-8387-2014; Cheng, Ching-Yu/K-7017-2013; Chen, Peng/E-5546-2015; Wenk, Markus Rene/D-1441-2014; Wong, Tien Yin/AAC-9724-2020	Cheng, Ching-Yu/0000-0003-0655-885X; Foo, Jia Nee/0000-0001-9899-2308; Cheng, Ching-Yu/0000-0003-0655-885X; Chen, Peng/0000-0002-1422-4641; Wong, Tien Yin/0000-0002-8448-1264; Soong, Richie/0000-0002-0152-1225; Sim, Kar Seng/0000-0002-3822-7759; Teo, Shu Mei/0000-0002-4563-7836; Khor, Chiea Chuen/0000-0002-1128-4729	Yong Loo Lin School of Medicine; National University Health System; Life Sciences Institute; Office of the Deputy President (Research and Technology) from the National University of Singapore; National Research Foundation [NRF-RF-2010-05]; Singapore Biomedical Research Council [05/1/21/19/425, 11/1/21/18/678]	Yong Loo Lin School of Medicine(National University of Singapore); National University Health System; Life Sciences Institute; Office of the Deputy President (Research and Technology) from the National University of Singapore(National University of Singapore); National Research Foundation; Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	We thank all the subjects in this study for their participation. This project acknowledges the support of the Yong Loo Lin School of Medicine, the National University Health System, the Life Sciences Institute, and the Office of the Deputy President (Research and Technology) from the National University of Singapore. We also acknowledge the support from the National Research Foundation (NRF-RF-2010-05) and the Singapore Biomedical Research Council (05/1/21/19/425 and 11/1/21/18/678).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Han SY, 2011, HUM MOL GENET, V20, P3693, DOI 10.1093/hmg/ddr269; Hatin WI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018312; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Ju YS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-132; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xu HY, 2011, HUM MUTAT, V32, P1341, DOI 10.1002/humu.21601	45	123	125	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					52	66		10.1016/j.ajhg.2012.12.005	http://dx.doi.org/10.1016/j.ajhg.2012.12.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23290073	Green Published, Bronze			2022-12-18	WOS:000313759000005
J	Foulquier, F; Amyere, M; Jaeken, J; Zeevaert, R; Schollen, E; Race, V; Bammens, R; Morelle, W; Rosnoblet, C; Legrand, D; Demaegd, D; Buist, N; Cheillan, D; Guffon, N; Morsomme, P; Annaert, W; Freeze, HH; Van Schaftingen, E; Vikkula, M; Matthijs, G				Foulquier, Francois; Amyere, Mustapha; Jaeken, Jaak; Zeevaert, Renate; Schollen, Els; Race, Valerie; Bammens, Riet; Morelle, Willy; Rosnoblet, Claire; Legrand, Dominique; Demaegd, Didier; Buist, Neil; Cheillan, David; Guffon, Nathalie; Morsomme, Pierre; Annaert, Willem; Freeze, Hudson H.; Van Schaftingen, Emile; Vikkula, Miikka; Matthijs, Gert			TMEM165 Deficiency Causes a Congenital Disorder of Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROARRAYS; REVEALS	Protein glycosylation is a complex process that depends not only on the activities of several enzymes and transporters but also on a subtle balance between vesicular Golgi trafficking, compartmental pH, and ion homeostasis. Through a combination of autozygosity mapping and expression analysis in two siblings with an abnormal serum-transferrin isoelectric focusing test (type 2) and a peculiar skeletal phenotype with epiphyseal, metaphyseal, and diaphyseal dysplasia, we identified TMEM165 (also named TPARL) as a gene involved in congenital disorders of glycosylation (CDG). The affected individuals are homozygous for a deep. intronic splice mutation in TMEM165. In our cohort of unsolved CDG-II cases, we found another individual with the same mutation and two unrelated individuals with missense mutations in TMEM165. TMEM165 encodes a putative transmembrane 324 amino acid protein whose cellular functions are unknown. Using a siRNA strategy, we showed that TMEM165 deficiency causes Golgi glycosylation defects in HEK cells.	[Schollen, Els; Race, Valerie; Bammens, Riet; Matthijs, Gert] Univ Louvain, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Foulquier, Francois; Morelle, Willy; Rosnoblet, Claire; Legrand, Dominique] Univ Lille 1, Inst Federatif Rech 147, Struct & Funct Glycobiol Unit, CNRS,UMR 8576, F-59655 Villeneuve Dascq, France; [Amyere, Mustapha; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium; [Jaeken, Jaak; Zeevaert, Renate] Univ Hosp Gasthuisberg, Dept Pediat, Ctr Metab Dis, B-3000 Louvain, Belgium; [Demaegd, Didier; Morsomme, Pierre] Catholic Univ Louvain, Inst Sci Vie, Mol Physiol Grp, B-1348 Louvain, Belgium; [Buist, Neil] Oregon Heath & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Buist, Neil] Oregon Heath & Sci Univ, Dept Med Genet, Portland, OR 97239 USA; [Cheillan, David; Guffon, Nathalie] Ctr Reference Malad Hereditaires Metab, F-69677 Bron, France; [Annaert, Willem] Univ Louvain, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Annaert, Willem] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Freeze, Hudson H.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite Catholique Louvain; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Sanford Burnham Prebys Medical Discovery Institute; Universite Catholique Louvain	Matthijs, G (corresponding author), Univ Louvain, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium.	gert.matthijs@uzleuven.be	FOULQUIER, FRANCOIS/AAI-1182-2021; foulquier, francois/ABE-5886-2020; Legrand, Dominique/AAT-5715-2021; Morsomme, Pierre/AAD-9600-2019; Rosnoblet, Claire/AAD-3462-2020; Vikkula, Miikka/Q-1038-2018; Van+Schaftingen, Emile/AAF-5532-2020	foulquier, francois/0000-0002-6551-3240; Rosnoblet, Claire/0000-0002-1906-0922; Vikkula, Miikka/0000-0002-6236-338X; Foulquier, Francois/0000-0001-5084-4015; Matthijs, Gert/0000-0001-6710-1912; Morsomme, Pierre/0000-0001-7780-7230; cheillan, david/0000-0001-9535-2567; LEGRAND, Dominique/0000-0002-0814-221X; Van Schaftingen, Emile/0000-0002-6199-7647; Freeze, Hudson/0000-0001-6316-0501	FWO (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen, Belgium) [G.0553.08]; AFM (Association Francaise contre les Myopathies, France) [12540]; PEPS-CNRS (Projets Exploratoires/Premier Soutien du Centre National de la Recherche Scientifique, France); Marie Curie Reintegration Grant (VTG-CDG); Agence Nationale Recherche Jeune Chercheur; F.R.S.-FNRS (Fonds de la Recherche Scientifique, Wallonie); la Communaute Francaise de Wallonie-Bruxelles; la Loterie Nationale (Belgium); Interuniversity Attraction Poles Program of the Belgian Science Policy (Belgium) [6/05]; Rocket Fund; European Commission [LSHM-CT.2005-512131]; Korber Stiftung;  [R01DK55615]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	FWO (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen, Belgium)(FWO); AFM (Association Francaise contre les Myopathies, France)(Association Francaise contre les Myopathies); PEPS-CNRS (Projets Exploratoires/Premier Soutien du Centre National de la Recherche Scientifique, France); Marie Curie Reintegration Grant (VTG-CDG); Agence Nationale Recherche Jeune Chercheur(French National Research Agency (ANR)); F.R.S.-FNRS (Fonds de la Recherche Scientifique, Wallonie)(Fonds de la Recherche Scientifique - FNRS); la Communaute Francaise de Wallonie-Bruxelles; la Loterie Nationale (Belgium); Interuniversity Attraction Poles Program of the Belgian Science Policy (Belgium); Rocket Fund; European Commission(European CommissionEuropean Commission Joint Research Centre); Korber Stiftung; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to Ragna Sannerud for providing advice and tools for the imaging experiments and to Professor Eric Berger, Professor Thierry Hennet, Ellen Reynders, Professor Jack Rohrer, and many others for helpful discussions. The work was supported by grant G.0553.08 from the FWO (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen, Belgium) and grant 12540 from the AFM (Association Francaise contre les Myopathies, France) to G.M.; a PEPS-CNRS (Projets Exploratoires/Premier Soutien du Centre National de la Recherche Scientifique, France), a Marie Curie Reintegration Grant (VTG-CDG), and an Agence Nationale Recherche Jeune Chercheur to RE; grants from the F.R.S.-FNRS (Fonds de la Recherche Scientifique, Wallonie), la Communaute Francaise de Wallonie-Bruxelles, and la Loterie Nationale (Belgium) to M.V.; the Interuniversity Attraction Poles Program (network 6/05) of the Belgian Science Policy (Belgium) to E.V.S., G.M., and M.V.; grant R01DK55615 and The Rocket Fund to H.F.; the European Commission (Sixth Framework Program, contract LSHM-CT.2005-512131 to EUROGLYCANET) to G.M. and E.V.S.; and the Korber Stiftung to J.J., E.V.S., and G.M. M.A. is a "Scientific Logistics Manager" of the F.R.S.-FNRS. The authors thank the Genomics/Transcriptomics platform of Universite catholique de Louvain for performing the Affymetrix chip experiments and the Bioimaging Core Facility of Lille (Institut de Recherche Interdisciplinaire, CNRS).	CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Foulquier F, 2009, BBA-MOL BASIS DIS, V1792, P896, DOI 10.1016/j.bbadis.2008.10.020; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Miura Y, 2008, MOL CELL PROTEOMICS, V7, P370, DOI 10.1074/mcp.M700377-MCP200; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; Reynders E, 2009, HUM MOL GENET, V18, P3244, DOI 10.1093/hmg/ddp262; Schachter H, 2009, BBA-MOL BASIS DIS, V1792, P925, DOI 10.1016/j.bbadis.2008.11.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	19	123	126	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					15	26		10.1016/j.ajhg.2012.05.002	http://dx.doi.org/10.1016/j.ajhg.2012.05.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22683087	Bronze, Green Published			2022-12-18	WOS:000306445000002
J	Kimura, R; Yamaguchi, T; Takeda, M; Kondo, O; Toma, T; Haneji, K; Hanihara, T; Matsukusa, H; Kawamura, S; Maki, K; Osawa, M; Ishida, H; Oota, H				Kimura, Ryosuke; Yamaguchi, Tetsutaro; Takeda, Mayako; Kondo, Osamu; Toma, Takashi; Haneji, Kuniaki; Hanihara, Tsunehiko; Matsukusa, Hirotaka; Kawamura, Shoji; Maki, Koutaro; Osawa, Motoki; Ishida, Hajime; Oota, Hiroki			A Common Variation in EDAR Is a Genetic Determinant of Shovel-Shaped Incisors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXILLARY CENTRAL INCISOR; MAJOR HUMAN-POPULATIONS; POSITIVE SELECTION; ASIAN POPULATIONS; RYUKYU ISLANDERS; DENTAL DIVERSITY; HAIR THICKNESS; RECEPTOR EDAR; ACTIVATION; GENOME	Shovel shape of upper incisors is a common characteristic in Asian and Native American populations but is rare or absent in African and European populations. Like other common dental traits, genetic polymorphisms involved in the tooth shoveling have not yet been clarified. In ectodysplasin A receptor (EDAR), where dysfunctional mutations cause hypohidrotic ectodermal dysplasia, there is a nonsynonymous-derived variant, 1540C (rs3827760), that has a geographic distribution similar to that of the tooth shoveling. This allele has been recently reported to be associated with Asian-specific hair thickness. We aimed to clarify whether EDAR 1540C is also associated with dental morphology. For this purpose, we measured crown diameters and tooth-shoveling grades and analyzed the correlations between the dental traits and EDAR genotypes in two Japanese populations, inhabitants around Tokyo and in Sakishima Islands. The number of EDAR 1540C alleles in an individual was strongly correlated with the tooth-shoveling grade (p = 7.7 x 10(-10)). The effect of the allele was additive and explained 18.9% of the total variance in the shoveling grade, which corresponds to about one-fourth of the heritability of the trait reported previously. For data reduction of individual-level metric data, we applied a principal-component analysis, which yielded PCI-4, corresponding to four patterns of tooth size; this result implies that multiple factors are involved in dental morphology. The 1540C allele also significantly affected PC1 (p = 4.9 x 10(-3)), which denotes overall tooth size, and PC2 (p = 2.6 x 10(-3)), which denotes the ratio of mesiodistal diameter to buccolingual diameter.	[Kimura, Ryosuke] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Okinawa 9030215, Japan; [Kimura, Ryosuke; Osawa, Motoki] Tokai Univ, Sch Med, Dept Forens Med, Kanagawa 2591193, Japan; [Yamaguchi, Tetsutaro; Maki, Koutaro] Showa Univ, Sch Dent, Dept Orthodont, Tokyo 1458515, Japan; [Takeda, Mayako; Kondo, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Toma, Takashi] Adventist Med Ctr, Dept Oral & Maxillofacial Surg, Okinawa 9030201, Japan; [Haneji, Kuniaki; Ishida, Hajime] Univ Ryukyus, Fac Med, Dept Anat, Okinawa 9030215, Japan; [Hanihara, Tsunehiko] Kitasato Univ, Sch Med, Dept Anat, Kanagawa 2288555, Japan; [Matsukusa, Hirotaka; Kawamura, Shoji; Oota, Hiroki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of the Ryukyus; Tokai University; Showa University; University of Tokyo; University of the Ryukyus; Kitasato University; University of Tokyo	Kimura, R (corresponding author), Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Okinawa 9030215, Japan.	rkimura@lab.u-ryukyu.ac.jp	Kimura, Ryosuke/B-3354-2015	Yamaguchi, Tetsutaro/0000-0001-9806-7163	Rising Star Program for Subtropical Island Sciences of the University of the Ryukyus; Japan Society for the Promotion of Science USPS)	Rising Star Program for Subtropical Island Sciences of the University of the Ryukyus; Japan Society for the Promotion of Science USPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are deeply grateful to the people participating in this study. We also thank Y. Tomoyasu for her assistance in collecting samples at the Showa University Dental Hospital. This study is partly supported by the Rising Star Program for Subtropical Island Sciences of the University of the Ryukyus and by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science USPS).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; BLANCO R, 1976, AM J PHYS ANTHROPOL, V44, P233, DOI 10.1002/ajpa.1330440204; BRACE CL, 1982, AM J PHYS ANTHROPOL, V59, P399, DOI 10.1002/ajpa.1330590410; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Fraser GJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-32; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; GARN SM, 1977, J DENT RES, V56, P697, DOI 10.1177/00220345770560062601; HANIHARA K, 1975, J ANTHROPOL SOC NIP, V83, P107; HANIHARA K, 1967, J DENT RES, V46, P923, DOI 10.1177/00220345670460055101; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; HARRIS EF, 1988, AM J PHYS ANTHROPOL, V75, P87, DOI 10.1002/ajpa.1330750110; HARRIS EF, 1980, AM J PHYS ANTHROPOL, V52, P541, DOI 10.1002/ajpa.1330520411; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Higa T, 2003, AM J HUM BIOL, V15, P127, DOI 10.1002/ajhb.10138; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; MATSUKUSA H, 2010, AM J PHYS A IN PRESS; MIZOGUCHI Y, 1985, B U MUSEUM, V26; Mizoguchi Y., 1977, B NATL SCI MUS TOKYO, V3, P37; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; ROTHHAMMER F, 1968, Zeitschrift fuer Morphologie und Anthropologie, V60, P162; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Toma T, 2007, ANTHROPOL SCI, V115, P119, DOI 10.1537/ase.061219; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; TURNER CG, 1979, AM J PHYS ANTHROPOL, V51, P619, DOI 10.1002/ajpa.1330510413; Weidenreich F., 1937, Palaeontologia Sinica, Vno. 101, P1; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	39	123	126	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					528	535		10.1016/j.ajhg.2009.09.006	http://dx.doi.org/10.1016/j.ajhg.2009.09.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19804850	Bronze, Green Published			2022-12-18	WOS:000270836000010
J	Boland, E; Clayton-Smith, J; Woo, VG; McKee, S; Manson, FDC; Medne, L; Zackai, E; Swanson, EA; Fitzpatrick, D; Millen, KJ; Sherr, EH; Dobyns, WB; Black, GCM				Boland, Elena; Clayton-Smith, Jill; Woo, Victoria G.; McKee, Shane; Manson, Forbes D. C.; Medne, Livija; Zackai, Elaine; Swanson, Eric A.; Fitzpatrick, David; Millen, Kathleen J.; Sherr, Elliott H.; Dobyns, William B.; Black, Graeme C. M.			Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN PAX6 GENE; B-GAMMA; GLUCOSE-HOMEOSTASIS; SONIC HEDGEHOG; HUMAN GENOME; PROTEIN; MUTATIONS; BRAIN; CHROMOSOME-1; MICROARRAY	Deletions of chromosome I q42-q44 have been reported in a variety of developmental abnormalities of the brain, including microcephaly (MIC) and agenesis of the corpus callosum (ACC). Here, we describe detailed mapping studies of patients with unbalanced structural rearrangements of distal 1q4. These define a 3.5-Mb critical region extending from RP1180B9 to RP11-241M7 that we hypothesize contains one or more genes that lead to MIC and ACC when present in only one functional copy. Next, mapping of a balanced reciprocal t(l;13)(q44;q32) translocation in a patient with postnatal MIC and ACC demonstrated a breakpoint within this region that is situated 20 kb upstream of AKT3, a serine-threonine kinase. The murine orthologue Akt3 is required for the developmental regulation of normal brain size and callosal development. Whereas sequencing of AKT3 in a panel of 45 patients with ACC did not demonstrate any pathogenic variations, whole-mount in situ hybridization confirmed expression of Akt3 in the developing central nervous system during mouse embryogenesis. AKT3 represents an excellent candidate for developmental human MIC and ACC, and we suggest that haploinsufficiency causes both postnatal MIC and ACC.	Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 9PL, Lancs, England; Univ Manchester, St Marys Hosp, Reg Genet Serv, Manchester M13 9PL, Lancs, England; Univ Manchester, Ctr Mol Med, Manchester M13 9PL, Lancs, England; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Belfast City Hosp, No Ireland Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Western Gen Hosp, MRC, Med Genet Sect, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Manchester; University of Manchester; University of Manchester; University of California System; University of California San Francisco; Belfast City Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Chicago; University of Edinburgh	Black, GCM (corresponding author), Cent Manchester Univ Hosp, Dept Clin Genet, St Marys Hosp, Natl Hlth Serv Trust, Hathersage Rd, Manchester M13 0JH, Lancs, England.	gblack@manchester.ac.uk	FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; Manson, Forbes/G-2222-2015; Black, Graeme/K-7374-2015	Dobyns, William/0000-0002-7681-2844; Manson, Forbes/0000-0002-8342-660X; Millen, Kathleen/0000-0001-9978-675X; FitzPatrick, David R./0000-0003-4861-969X; Black, Graeme/0000-0001-8727-6592	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050375] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093] Funding Source: Medline; NCRR NIH HHS [UL RR024131-01, UL1 RR024131] Funding Source: Medline; NINDS NIH HHS [R01 NS050375, R01-NS050375] Funding Source: Medline; MRC [MC_U127561093] Funding Source: UKRI	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Becker KG, 1997, INT J DEV NEUROSCI, V15, P891, DOI 10.1016/S0736-5748(97)00034-8; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Daniel A, 2003, AM J MED GENET A, V117A, P57, DOI 10.1002/ajmg.a.10048; De Rosa G, 2005, EUR J PEDIATR, V164, P255, DOI 10.1007/s00431-005-1620-4; De Vries BBA, 2001, J MED GENET, V38, P175, DOI 10.1136/jmg.38.3.175; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Gentile M, 2003, AM J MED GENET A, V117A, P251, DOI 10.1002/ajmg.a.10018; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hamilton G, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl160; Hathout EH, 1998, AM J MED GENET, V80, P396, DOI 10.1002/(SICI)1096-8628(19981204)80:4<396::AID-AJMG17>3.3.CO;2-R; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kang JS, 2001, ACTA BIOCH BIOPH SIN, V33, P563; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; MEINECKE P, 1987, AM J MED GENET, V28, P371, DOI 10.1002/ajmg.1320280215; Meng GY, 2000, GENE, V242, P59, DOI 10.1016/S0378-1119(99)00477-1; Puthuran MJ, 2005, AM J MED GENET A, V138A, P68, DOI 10.1002/ajmg.a.30888; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; van Bever Y, 2005, AM J MED GENET A, V135A, P91, DOI 10.1002/ajmg.a.30695; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zollino M, 2003, AM J MED GENET A, V117A, P65, DOI 10.1002/ajmg.a.10068	40	123	135	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					292	303		10.1086/519999	http://dx.doi.org/10.1086/519999			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668379	Bronze, Green Published			2022-12-18	WOS:000248540400009
J	Hoskins, BE; Cramer, CH; Silvius, D; Zou, D; Raymond, RM; Orten, DJ; Kimberling, WJ; Smith, RJH; Weil, D; Petit, C; Otto, EA; Xu, PX; Hildebrandt, F				Hoskins, Bethan E.; Cramer, Carl H., II; Silvius, Derek; Zou, Dan; Raymond, Richard M., Jr.; Orten, Dana J.; Kimberling, William J.; Smith, Richard J. H.; Weil, Dominique; Petit, Christine; Otto, Edgar A.; Xu, Pin-Xian; Hildebrandt, Friedhelm			Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOR SYNDROME; EYES ABSENT; HEARING-LOSS; GENE LOCUS; EYA1; DROSOPHILA; DEFECTS; TRANSLOCATION; FAMILY; REGION	Branchio-oto-renal syndrome (BOR) is an autosomal dominant developmental disorder characterized by the association of branchial arch defects, hearing loss, and renal anomalies. Mutations in EYA1 are known to cause BOR. More recently, mutations in SIX1, which interacts with EYA1, were identified as an additional cause of BOR. A second member of the SIX family of proteins, unc-39 (SIX5), has also been reported to directly interact with eya-1 in Caenorhabditis elegans. We hypothesized that this interaction would be conserved in humans and that interactors of EYA1 represent good candidate genes for BOR. We therefore screened a cohort of 95 patients with BOR for mutations in SIX5. Four different heterozygous missense mutations were identified in five individuals. Functional analyses of these mutations demonstrated that two mutations affect EYA1-SIX5 binding and the ability of SIX5 or the EYA1-SIX5 complex to activate gene transcription. We thereby identified heterozygous mutations in SIX5 as a novel cause of BOR.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; McLaughlin Res Inst Biomed Sci, Great Falls, MT USA; Boys Town Natl Res Hosp, Usher Syndrome Ctr, Omaha, NE 68131 USA; Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Inst Pasteur, INSERM, UMRS587, Unite Genet Deficits Sensoriels, F-75015 Paris, France; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; McLaughlin Research Institute for Biomedical Sciences, Inc.; Boys Town National Research Hospital; University of Iowa; University of Iowa; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Hildebrandt, F (corresponding author), Univ Michigan, Hlth Syst, 8220C MRSB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fhilde@umich.edu		Petit, Christine/0000-0002-9069-002X; Smith, Richard/0000-0003-1201-6731; Otto, Edgar/0000-0002-2387-9973	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005824] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005824] Funding Source: Medline; NIDDK NIH HHS [R01 DK064640, R01-DK045345-01, T32DK0655517-01, DK064640] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Clarke JC, 2006, CLIN GENET, V70, P63, DOI 10.1111/j.1399-0004.2006.00642.x; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Harris SE, 2000, NUCLEIC ACIDS RES, V28, P1871, DOI 10.1093/nar/28.9.1871; HEIMLER A, 1986, AM J MED GENET, V25, P15, DOI 10.1002/ajmg.1320250104; Izzedine H, 2004, KIDNEY INT, V65, P369, DOI 10.1111/j.1523-1755.2004.00390.x; Kalatzis V, 1996, GENOMICS, V34, P422, DOI 10.1006/geno.1996.0307; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kumar S, 2000, AM J HUM GENET, V66, P1715, DOI 10.1086/302890; Kumar S, 1998, AM J MED GENET, V76, P395, DOI 10.1002/(SICI)1096-8628(19980413)76:5<395::AID-AJMG6>3.3.CO;2-5; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pham YCN, 2005, J CELL BIOCHEM, V95, P990, DOI 10.1002/jcb.20454; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Ruf RG, 2003, J MED GENET, V40, P515, DOI 10.1136/jmg.40.7.515; Stratakis CA, 1998, AM J MED GENET, V79, P209, DOI 10.1002/(SICI)1096-8628(19980923)79:3<209::AID-AJMG12>3.3.CO;2-D; Vervoort VS, 2002, EUR J HUM GENET, V10, P757, DOI 10.1038/sj.ejhg.5200877; Vincent C, 1997, EUR J HUM GENET, V5, P242, DOI 10.1159/000484770; Weber KM, 1999, CLIN GENET, V56, P306, DOI 10.1034/j.1399-0004.1999.560408.x	24	123	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					800	804		10.1086/513322	http://dx.doi.org/10.1086/513322			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357085	Green Published, Bronze			2022-12-18	WOS:000245465200020
J	Reiner, AP; Ziv, E; Lind, DL; Nievergelt, CM; Schork, NJ; Cummings, SR; Phong, A; Burchard, EG; Harris, TB; Psaty, BM; Kwok, PY				Reiner, AP; Ziv, E; Lind, DL; Nievergelt, CM; Schork, NJ; Cummings, SR; Phong, A; Burchard, EG; Harris, TB; Psaty, BM; Kwok, PY			Population structure, admixture, and aging-related phenotypes in African American adults: The cardiovascular health study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE RISK; ADMIXED POPULATIONS; RACIAL-DIFFERENCES; GENETIC ADMIXTURE; ASSOCIATION; ANCESTRY; PROPORTIONS; INFERENCE; LINKAGE; LIFE	U.S. populations are genetically admixed, but surprisingly little empirical data exists documenting the impact of such heterogeneity on type I and type II error in genetic-association studies of unrelated individuals. By applying several complementary analytical techniques, we characterize genetic background heterogeneity among 810 self-identified African American subjects sampled as part of a multisite cohort study of cardiovascular disease in older adults. On the basis of the typing of 24 ancestry-informative biallelic single-nucleotide-polymorphism markers, there was evidence of substantial population substructure and admixture. We used an allele-sharing-based clustering algorithm to infer evidence for four genetically distinct subpopulations. Using multivariable regression models, we demonstrate the complex interplay of genetic and socioeconomic factors on quantitative phenotypes related to cardiovascular disease and aging. Blood glucose level correlated with individual African ancestry, whereas body mass index was associated more strongly with genetic similarity. Blood pressure, HDL cholesterol level, C-reactive protein level, and carotid wall thickness were not associated with genetic background. Blood pressure and HDL cholesterol level varied by geographic site, whereas C-reactive protein level differed by occupation. Both ancestry and genetic similarity predicted the number and quality of years lived during follow-up, but socioeconomic factors largely accounted for these associations. When the 24 genetic markers were tested individually, there were an excess number of marker-trait associations, most of which were attenuated by adjustment for genetic ancestry. We conclude that the genetic demography underlying older individuals who self identify as African American is complex, and that controlling for both genetic admixture and socioeconomic characteristics will be required in assessing genetic associations with chronic-disease-related traits in African Americans. Complementary methods that identify discrete subgroups on the basis of genetic similarity may help to further characterize the complex biodemographic structure of human populations.	Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA 98101 USA; Univ Washington, Dept Lab Med, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; NIA, Geriatr Epidemiol Sect, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Psychiat, Polymorphism Res Lab, La Jolla, CA 92093 USA; Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; California Pacific Medical Center; California Pacific Medical Center Research Institute; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reiner, AP (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	apreiner@u.washington.edu	Kwok, Pui-Yan/F-7725-2014; Ziv, Elad/L-5396-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Nievergelt, Caroline/0000-0001-5766-8923; Schork, Nicholas/0000-0003-0920-5013	NCI NIH HHS [K22 CA109351] Funding Source: Medline; NHLBI NIH HHS [N01-HC-85083, N01 HC015103, N01-HC-85085, N01HC85086, N01-HC-85080, N01-HC-85086, N01-HC-85084, N01 HC035129, N01-HC-85079, N01-HC-85081, N01HC85079, N01-HC-85082] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085080, N01HC085079, N01HC085085, N01HC085086, N01HC085084, N01HC085082, N01HC085083, N01HC085081, N01HC035129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; Chen XN, 1999, GENOME RES, V9, P492; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Curtis D, 2002, ANN HUM GENET, V66, P235, DOI 10.1017/S0003480002001094; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Diehr P, 1998, J CLIN EPIDEMIOL, V51, P343, DOI 10.1016/S0895-4356(97)00298-9; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Falush D, 2003, GENETICS, V164, P1567; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gower BA, 2003, DIABETES, V52, P1047, DOI 10.2337/diabetes.52.4.1047; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hutchinson RG, 1997, ANGIOLOGY, V48, P279, DOI 10.1177/000331979704800401; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kuller L, 1998, ARTERIOSCL THROM VAS, V18, P283, DOI 10.1161/01.ATV.18.2.283; Lehmann E. L., 1998, NONPARAMETRICS STAT; Lin CC, 2003, ETHNIC DIS, V13, P240; Lynch M, 1999, GENETICS, V152, P1753; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Schork NJ, 2001, ADV GENET, V42, P299, DOI 10.1016/S0065-2660(01)42030-X; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Sharma S, 2004, ETHNIC DIS, V14, P43; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sundquist J, 2001, J AM GERIATR SOC, V49, P109, DOI 10.1046/j.1532-5415.2001.49030.x; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yashin AI, 1999, AM J HUM GENET, V65, P1178, DOI 10.1086/302572	50	123	125	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					463	477		10.1086/428654	http://dx.doi.org/10.1086/428654			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15660291	Bronze, Green Published			2022-12-18	WOS:000226851900009
J	Zhou, XP; Marsh, DJ; Morrison, CD; Chaudhury, AR; Maxwell, M; Reifenberger, G; Eng, C				Zhou, XP; Marsh, DJ; Morrison, CD; Chaudhury, AR; Maxwell, M; Reifenberger, G; Eng, C			Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Human-Genetics	NOV 04-08, 2003	LOS ANGELES, CALIFORNIA	Amer Soc Human Genet			CELL-CYCLE ARREST; GENOTYPE-PHENOTYPE CORRELATIONS; BANNAYAN-ZONANA-SYNDROME; TUMOR-SUPPRESSOR PTEN; BREAST-CANCER MODEL; COWDEN-DISEASE; PHOSPHATASE-ACTIVITY; MUTATION SPECTRUM; PTEN/MMAC1 GENE; SOMA SIZE	Lhermitte-Duclos disease (LDD), or dysplastic gangliocytoma of the cerebellum, is an unusual hamartomatous overgrowth disorder. LDD can be familial or, more commonly, sporadic. It has been only recently recognized that LDD may be associated with Cowden syndrome (CS). Over 80% of patients with CS carry germline mutations in PTEN. It remains unclear whether all cases of LDD, even without features of CS, are caused by germline PTEN mutation and whether somatic PTEN mutation occurs in sporadic LDD. We obtained paraffin-embedded LDD lesions from 18 unselected, unrelated patients and performed mutational analysis of PTEN. Overall, 15 (83%) of 18 samples were found to carry a PTEN mutation. All individuals with mutations were adult-onset patients, but the three without mutations were diagnosed at the ages of 1, 3, and 11 years. Germline DNA was available from six adult-onset cases, and all had germline PTEN mutations. Of these six, two had CS features, one did not have CS features, and three were of unknown CS status. Immunohistochemistry revealed that 75% of the LDD samples had complete or partial loss of PTEN expression accompanied by elevated phosphorylated Akt, specifically in the dysplastic gangliocytoma cells. These data suggest that the loss of PTEN function is sufficient to cause LDD. The high frequency and spectrum of germline PTEN mutations in patients ascertaining by LDD alone confirm that LDD is an important defining feature of CS. Individuals with LDD, even without apparent CS features, should be counseled as in CS.	Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc,Div Human Canc Genet, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc,Div Human Canc Genet, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Dana Farber Canc Inst, Charles A Dana Human Canc Genet Unit, Dept Adult Oncol, Translat Res Lab, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurosurg Serv, Boston, MA USA; Royal N Shore Hosp, Kolling Inst Med Res, Canc Genet Lab, Sydney, NSW, Australia; Univ Sydney, Dept Mol Med, Sydney, NSW 2006, Australia; Univ Dusseldorf, Inst Neuropathol, D-4000 Dusseldorf, Germany; Univ Cambridge, Human Canc Genet Res Grp, Canc Res UK, Cambridge CB2 1TN, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Heinrich Heine University Dusseldorf; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc,Div Human Canc Genet, Dept Mol Virol Immunol & Med Genet, 420 W 12th Ave,Suite 690 TMRF, Columbus, OH 43210 USA.		Reifenberger, Guido/AAE-3599-2019; Marsh, Deborah J/I-1491-2014	Marsh, Deborah J/0000-0001-5899-4931; Eng, Charis/0000-0002-3693-5145	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16058, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO;2-E; AMBLER M, 1969, J NEUROPATH EXP NEUR, V28, P622, DOI 10.1097/00005072-196910000-00005; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; ENG C, 2003, IN PRESS HUM MUTAT; Furnari FB, 1998, CANCER RES, V58, P5002; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Iida S, 1998, INT J MOL MED, V1, P925; Koch R, 1999, J NEUROSURG, V90, P776, DOI 10.3171/jns.1999.90.4.0776; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Li DM, 1997, CANCER RES, V57, P2124; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Mori AC, 2003, NEUROPEDIATRICS, V34, P30, DOI 10.1055/s-2003-38623; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nelen MR, 1999, EUR J HUM GENET, V7, P267, DOI 10.1038/sj.ejhg.5200289; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Nowak DA, 2002, ACTA NEUROL SCAND, V105, P137, DOI 10.1034/j.1600-0404.2002.1r127.x; PADBERG GW, 1991, ANN NEUROL, V29, P517, DOI 10.1002/ana.410290511; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Reardon W, 2001, J MED GENET, V38, P820, DOI 10.1136/jmg.38.12.820; Robinson S, 2000, NEUROSURGERY, V46, P371, DOI 10.1097/00006123-200002000-00021; RUSSELLJONES R, 1981, BRIT J DERMATOL, V105, P57; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sutphen R, 1999, AM J MED GENET, V82, P290, DOI 10.1002/(SICI)1096-8628(19990212)82:4<290::AID-AJMG3>3.0.CO;2-0; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Weng LP, 1999, CANCER RES, V59, P5808; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; Weng LP, 2001, HUM MOL GENET, V10, P251, DOI 10.1093/hmg/10.3.251; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	47	123	132	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1191	1198		10.1086/379382	http://dx.doi.org/10.1086/379382			8	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14566704	Bronze, Green Published			2022-12-18	WOS:000186493400020
J	Bourgain, C; Hoffjan, S; Nicolae, R; Newman, D; Steiner, L; Walker, K; Reynolds, R; Ober, C; McPeek, MS				Bourgain, C; Hoffjan, S; Nicolae, R; Newman, D; Steiner, L; Walker, K; Reynolds, R; Ober, C; McPeek, MS			Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; GENES; POWER	To avoid problems related to unknown population substructure, association studies may be conducted in founder populations. In such populations, however, the relatedness among individuals may be considerable. Neglecting such correlations among individuals can lead to seriously spurious associations. Here, we propose a method for case-control association studies of binary traits that is suitable for any set of related individuals, provided that their genealogy is known. Although we focus here on large inbred pedigrees, this method may also be used in outbred populations for case-control studies in which some individuals are relatives. We base inference on a quasi-likelihood score (QLS) function and construct a QLS test for allelic association. This approach can be used even when the pedigree structure is far too complex to use an exact-likelihood calculation. We also present an alternative approach to this test, in which we use the known genealogy to derive a correction factor for the case-control association chi(2) test. We perform analytical power calculations for each of the two tests by deriving their respective noncentrality parameters. The QLS test is more powerful than the corrected chi(2) test in every situation considered. Indeed, under certain regularity conditions, the QLS test is asymptotically the locally most powerful test in a general class of linear tests that includes the corrected chi(2) test. The two methods are used to test for associations between three 2 asthma-associated phenotypes and 48 SNPs in 35 candidate genes in the Hutterites. We report a highly significant novel association (P = 2.10(-6)) between atopy and an amino acid polymorphism in the P-selectin gene, detected with the QLS test and also, but less significantly (P = .0014), with the transmission/ disequilibrium test.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Roche Mol Syst, Alameda, CA USA	University of Chicago; University of Chicago; Roche Holding	Bourgain, C (corresponding author), Hop Paul Brousse, INSERM, U535, Batiment Leriche,BP 100, F-94817 Villejuif, France.	bourgain@vjf.inserm.fr	Bourgain, Catherine/L-1505-2017		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG001645, R29 HG001645, R01 HG001645] Funding Source: Medline; NHLBI NIH HHS [P50 HL056399, HL56399, HL63533] Funding Source: Medline; NIDDK NIH HHS [DK55889, R01 DK055889] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bourgain C, 2002, AM J HUM GENET, V71, P177; BOYCE AJ, 1983, J HERED, V74, P400, DOI 10.1093/oxfordjournals.jhered.a109825; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cox DR., 1974, THEORETICAL STAT; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Heyde C. C., 1997, QUASILIKELIHOOD ITS; Hinds DA, 1996, ASPEX PACKAGE AFFECT; Lukacs NW, 2002, J IMMUNOL, V169, P2120, DOI 10.4049/jimmunol.169.4.2120; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; McGinnis R, 2000, AM J HUM GENET, V67, P1340; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Newman DL, 2001, AM J HUM GENET, V69, P1146, DOI 10.1086/323659; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schott J. R, 1996, MATRIX ANAL STAT; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Tsunemi Y, 2002, J DERMATOL SCI, V29, P222, DOI 10.1016/S0923-1811(02)00038-5; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wu X, 2000, AM J HUM GENET, V67, P326	24	123	125	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					612	626		10.1086/378208	http://dx.doi.org/10.1086/378208			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12929084	Green Published, Bronze			2022-12-18	WOS:000185134000013
J	Gilad, Y; Bustamante, CD; Lancet, D; Paabo, S				Gilad, Y; Bustamante, CD; Lancet, D; Paabo, S			Natural selection on the olfactory receptor gene family in humans and chimpanzees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-GENETICS; STATISTICAL TESTS; DNA-SEQUENCES; POLYMORPHISM; EVOLUTION; HITCHHIKING; CONVERSION; DIVERSITY; PROGRAM; CLUSTER	The olfactory receptor ( OR) genes constitute the largest gene family in mammalian genomes. Humans have 11,000 OR genes, of which only similar to 40% have an intact coding region and are therefore putatively functional. In contrast, the fraction of intact OR genes in the genomes of the great apes is significantly greater (68% - 72%), suggesting that selective pressures on the OR repertoire vary among these species. We have examined the evolutionary forces that shaped the OR gene family in humans and chimpanzees by resequencing 20 OR genes in 16 humans, 16 chimpanzees, and one orangutan. We compared the variation at the OR genes with that at intergenic regions. In both humans and chimpanzees, OR pseudogenes seem to evolve neutrally. In chimpanzees, patterns of variability are consistent with purifying selection acting on intact OR genes, whereas, in humans, there is suggestive evidence for positive selection acting on intact OR genes. These observations are likely due to differences in lifestyle, between humans and great apes, that have led to distinct sensory needs.	Max Planck Inst Evolutinary Anthropol, D-04103 Leipzig, Germany; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Max Planck Society; Weizmann Institute of Science; Cornell University	Gilad, Y (corresponding author), Max Planck Inst Evolutinary Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.	gilad@eva.mpg.de		Bustamante, Carlos D./0000-0002-4187-7920				BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; EWENS WJ, 1978, AM J HUM GENET, V30, P328; Fay JC, 2000, GENETICS, V155, P1405; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Hacia JG, 2001, TRENDS GENET, V17, P637, DOI 10.1016/S0168-9525(01)02494-5; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Przeworski M, 2002, GENETICS, V160, P1179; Rouquier S, 1998, HUM MOL GENET, V7, P1337, DOI 10.1093/hmg/7.9.1337; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAWYER SA, 1992, GENETICS, V132, P1161; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wall JD, 2001, MOL BIOL EVOL, V18, P1134, DOI 10.1093/oxfordjournals.molbev.a003884; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	41	123	129	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					489	501		10.1086/378132	http://dx.doi.org/10.1086/378132			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12908129	Bronze, Green Published			2022-12-18	WOS:000185134000003
J	Wilson, SG; Reed, PW; Bansal, A; Chiano, M; Lindersson, M; Langdown, M; Prince, RL; Thompson, D; Thompson, E; Bailey, M; Kleyn, PW; Sambrook, P; Shi, MM; Spector, TD				Wilson, SG; Reed, PW; Bansal, A; Chiano, M; Lindersson, M; Langdown, M; Prince, RL; Thompson, D; Thompson, E; Bailey, M; Kleyn, PW; Sambrook, P; Shi, MM; Spector, TD			Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GROWTH-FACTOR; SIB PAIRS; APOLIPOPROTEIN-E; FEMALE TWINS; GENE; OSTEOPOROSIS; RECEPTOR; STANDARDIZATION; DISEQUILIBRIUM	Low bone mineral density (BMD) is a major risk factor for osteoporotic fracture. Studies of BMD in families and twins have shown that this trait is under strong genetic control. To identify regions of the genome that contain quantitative trait loci (QTL) for BMD, we performed independent genomewide screens, using two complementary study designs. We analyzed unselected nonidentical twin pairs (1,094 pedigrees) and highly selected, extremely discordant or concordant (EDAC) sib pairs (254 pedigrees). Nonparametric multipoint linkage (NPL) analyses were undertaken for lumbar spine and total-hip BMD in both cohorts and for whole-body BMD in the unselected twin pairs. The maximum evidence of linkage in the unselected twins (spine BMD, LOD 2.7) and the EDAC pedigrees (spine BMD, LOD 2.1) was observed at chromosome 3p21 (76 cM and 69 cM, respectively). These combined data indicate the presence, in this region, of a gene that regulates BMD. Furthermore, evidence of linkage in the twin cohort (whole-body BMD; LOD 2.4) at chromosome 1p36 (17 cM) supports previous findings of suggestive linkage to BMD in the region. Weaker evidence of linkage (LOD 1.0-2.3) in either cohort, but not both, indicates the locality of additional QTLs. These studies validate the use, in linkage analysis, of large cohorts of unselected twins phenotyped for multiple traits, and they highlight the importance of conducting genome scans in replicate populations as a prelude to positional cloning and gene discovery.	St Thomas Hosp, Twin & Genet Epidemiol Res Unit, London SE1 7EH, England; Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; Sequenom, San Diego, CA USA; LifeSci Advisory Grp LLC, Wellesley, MA USA; Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia	Guy's & St Thomas' NHS Foundation Trust; University of Western Australia; Sequenom; University of Sydney	Spector, TD (corresponding author), St Thomas Hosp, Twin & Genet Epidemiol Res Unit, Lambeth Palace Rd, London SE1 7EH, England.		Spector, Tim D/F-6533-2012	Wilson, Scott/0000-0002-0357-1373				Albagha OME, 2002, HUM MOL GENET, V11, P2289, DOI 10.1093/hmg/11.19.2289; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; CAREY G, 1991, AM J HUM GENET, V49, P786; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Devoto M, 2001, HUM MOL GENET, V10, P2447, DOI 10.1093/hmg/10.21.2447; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dolan CV, 1999, AM J HUM GENET, V64, P268, DOI 10.1086/302189; Dolan CV, 1998, BEHAV GENET, V28, P197, DOI 10.1023/A:1021423214032; Duncan EL, 1999, J BONE MINER RES, V14, P1993, DOI 10.1359/jbmr.1999.14.12.1993; FAVUS MJ, 1999, PRIMER METABOLIC BON, P483; FULKER DW, 1994, AM J HUM GENET, V54, P1092; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hanson J, 1997, J BONE MINER RES, V12, P1316, DOI 10.1359/jbmr.1997.12.8.1316; Hocking LJ, 2001, AM J HUM GENET, V69, P1055, DOI 10.1086/323798; Hunter DJ, 2001, OSTEOPOROSIS INT, V12, P406, DOI 10.1007/s001980170110; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; Keen RW, 2001, RHEUMATOLOGY, V40, P48, DOI 10.1093/rheumatology/40.1.48; Keen RW, 1999, OSTEOPOROSIS INT, V10, P161, DOI 10.1007/s001980050211; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; Koller DL, 2001, J BONE MINER RES, V16, P985, DOI 10.1359/jbmr.2001.16.6.985; Kovacs CS, 2001, ENDOCRINOLOGY, V142, P4983, DOI 10.1210/en.142.11.4983; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kurihara N, 1998, EXP HEMATOL, V26, P1080; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; LOOKER AC, 1995, J BONE MINER RES, V10, P796; MacGregor AJ, 2000, TRENDS GENET, V16, P131, DOI 10.1016/S0168-9525(99)01946-0; MACGREGOR AJ, 1997, J BONE MINER RES, V12, pS492; Niu TH, 1999, HUM GENET, V104, P226, DOI 10.1007/s004390050940; PRITCHARD LE, 1995, HUM MOL GENET, V4, P197, DOI 10.1093/hmg/4.2.197; Recker RR, 2002, ENDOCRINE, V17, P55, DOI 10.1385/ENDO:17:1:55; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch NJ, 1996, AM J HUM GENET, V58, P836; Rodan Gideon A., 1996, P979; Salamone LM, 2000, J BONE MINER RES, V15, P308, DOI 10.1359/jbmr.2000.15.2.308; Shiraki M, 1997, J BONE MINER RES, V12, P1438, DOI 10.1359/jbmr.1997.12.9.1438; Spotila LD, 2001, J BONE MINER RES, V16, pS167; STEIGER P, 1995, J BONE MINER RES, V10, P1602; THOMPSON D, 2000, HUM MUTAT, V17, P327; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; WILSON SG, 2000, CALCIFIED TISSUE INT, V67, pA484; Zhang P, 1998, J CLIN ENDOCR METAB, V83, P3365, DOI 10.1210/jc.83.9.3373	43	123	130	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					144	155		10.1086/345819	http://dx.doi.org/10.1086/345819			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12478480	Green Published, Bronze			2022-12-18	WOS:000180186800014
J	Yesim, F; Demirci, K; Rigatti, BW; Wen, GP; Radak, AL; Mah, TS; Baic, CL; Traboulsi, EI; Alitalo, T; Ramser, J; Gorin, MB				Yesim, F; Demirci, K; Rigatti, BW; Wen, GP; Radak, AL; Mah, TS; Baic, CL; Traboulsi, EI; Alitalo, T; Ramser, J; Gorin, MB			X-linked cone-rod dystrophy (locus COD1): Identification of mutations in RPGR exon ORF15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RETINITIS-PIGMENTOSA; POSITIONAL CLONING; FEMALE CARRIERS; AFFECTED MALES; GENE; LOCALIZATION; RP2; DEGENERATION; SPECTRUM	X-linked cone-rod dystrophy (COD1) is a retinal disease that primarily affects the cone photoreceptors; the disease was originally mapped to a limited region of Xp11.4. We evaluated the three families from our original study with new markers and clinically reassessed all key recombinants; we determined that the critical intervals in families 2 and 3 overlapped the RP3 locus and that a status change (from affected to probably unaffected) of a key recombinant individual in family 1 also reassigned the disease locus to include RP3 as well. Mutation analysis of the entire RPGR coding region identified two different 2-nucleotide (nt) deletions in ORF15, in family 2 (delAG) and in families 1 and 3 (delGG), both of which result in a frameshift leading to altered amino acid structure and early termination. In addition, an independent individual with X-linked cone-rod dystrophy demonstrated a 1-nt insertion (insA) in ORF15. The presence of three distinct mutations associated with the same disease phenotype provides strong evidence that mutations in RPGR exon ORF15 are responsible for COD1. Genetic heterogeneity was observed in three other families, including the identification of an in-frame 12-nt deletion polymorphism in ORF15 that did not segregate with the disease in one of these families.	Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA; Inst Mol Biotechnol, Dept Genome Anal, Jena, Germany; Cleveland Clin Fdn, Cole Eye Inst, Ctr Genet Eye Dis, Cleveland, OH 44195 USA; Univ Helsinki Hosp, Dept Obstet Gynecol, Helsinki, Finland; Univ Munich, Dept Med Genet, Munich, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; University of Helsinki; Helsinki University Central Hospital; University of Munich	Gorin, MB (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Eye & Ear Inst Bldg,203 Lothrop St,Rm 1027, Pittsburgh, PA 15213 USA.		Traboulsi, Elias/AAY-7443-2020	Mah-Fraser, Tammy/0000-0003-1795-8031; Demirci, F. Yesim/0000-0001-6907-9843	NATIONAL EYE INSTITUTE [R01EY013130, P30EY008098] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY008098, R01 EY013130, EY 08098] Funding Source: Medline; PHS HHS [WY 13130] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARTLEY J, 1989, CYTOGENET CELL GENET, V51, P959; BERGEN AAB, 1993, GENOMICS, V18, P463, DOI 10.1006/geno.1993.1504; BERGEN AAB, 1994, CLIN GENET, V45, P236; Bergen AAB, 1997, AM J HUM GENET, V60, P1468, DOI 10.1086/515458; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Brown J, 2000, OPHTHALMOLOGY, V107, P1104, DOI 10.1016/S0161-6420(00)00086-5; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; HONG HK, 1994, AM J HUM GENET, V55, P1173; JACOBSON DM, 1989, OPHTHALMOLOGY, V96, P885; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Mears AJ, 2000, AM J HUM GENET, V67, P1000, DOI 10.1086/303091; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEIRE FM, 1994, BRIT J OPHTHALMOL, V78, P103, DOI 10.1136/bjo.78.2.103; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; PINCKERS A, 1987, INT OPHTHALMOL, V10, P241, DOI 10.1007/BF00155631; PINCKERS A, 1981, OPHTHALMIC PAED GEN, V1, P17, DOI 10.3109/13816818109036022; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Seymour AB, 1998, AM J HUM GENET, V62, P122, DOI 10.1086/301667; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Yokoyama A, 2001, AM J MED GENET, V104, P232, DOI 10.1002/ajmg.10035.abs; Zito I, 2000, HUM MUTAT, V15, P386, DOI 10.1002/(SICI)1098-1004(200004)15:4<386::AID-HUMU23>3.0.CO;2-4	25	123	127	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1049	1053		10.1086/339620	http://dx.doi.org/10.1086/339620			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11857109	Green Published, Bronze			2022-12-18	WOS:000174252100025
J	Lehmann, OJ; Ebenezer, ND; Jordan, T; Fox, M; Ocaka, L; Payne, A; Leroy, BP; Clark, BJ; Hitchings, RA; Povey, S; Khaw, PT; Bhattacharya, SS				Lehmann, OJ; Ebenezer, ND; Jordan, T; Fox, M; Ocaka, L; Payne, A; Leroy, BP; Clark, BJ; Hitchings, RA; Povey, S; Khaw, PT; Bhattacharya, SS			Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FKHL7; 6P25	The forkhead transcription factor gene FOXC1 (formerly FKHL7) is responsible for a number of glaucoma phenotypes in families in which the disease maps to 6p25, although mutations have not been found in all families in which the disease maps to this region. In a large pedigree with iris hypoplasia and glaucoma mapping to 6p25 (peak LOD score 6.20 [recombination fraction 0] at DGS967), no FOXC1 mutations were detected by direct sequencing. However, genotyping with microsatellite repeat markers suggested the presence of a chromosomal duplication that segregated with the disease phenotype. The duplication was confirmed in affected individuals by FISH with markers encompassing FOXC1. These results provide evidence of gene duplication causing developmental disease in humans, with increased gene dosage of either FOXC1 or other, as yet unknown genes within the duplicated segment being the probable mechanism responsible for the phenotype.	Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; UCL, Galton Lab, Human Biochem Genet Unit, MRC, London, England; Moorfields Eye Hosp, London, England; Inst Ophthalmol, Dept Pathol, London, England; Southampton Gen Hosp, Eye Unit, Southampton SO9 4XY, Hants, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Southampton	Lehmann, OJ (corresponding author), Inst Ophthalmol, Dept Mol Genet, Bath St, London EC1V 9EL, England.	OJLehmann@yahoo.com	Bhattacharya, Shom/N-2926-2016; Khaw, Peng T/C-1881-2008; Payne, Annette/F-8877-2013	Bhattacharya, Shom/0000-0002-1601-6344; Khaw, Sir Peng Tee/0000-0002-8087-2268; Payne, Annette/0000-0002-2009-0141				Alward WLM, 2000, INVEST OPHTH VIS SCI, V41, pS526; Craig J E, 1999, Curr Opin Ophthalmol, V10, P126, DOI 10.1097/00055735-199904000-00009; Davies AF, 1999, J MED GENET, V36, P708; FOX M, 2000, PRACT APPROACH SER, V217, P154; Jones C, 2000, HUM MOL GENET, V9, P1201, DOI 10.1093/hmg/9.8.1201; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; Kawase K, 2000, INVEST OPHTH VIS SCI, V41, pS824; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mackey DA, 2000, INVEST OPHTH VIS SCI, V41, pS527; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Morissette J, 1997, AM J HUM GENET, V61, pA286; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Sheffield VC, 1999, INVEST OPHTH VIS SCI, V40, pS596; Walter MA, 2000, INVEST OPHTH VIS SCI, V41, pS527; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	20	123	127	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1129	1135						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11007653				2022-12-18	WOS:000165091600010
J	Mesa, NR; Mondragon, MC; Soto, ID; Parra, MV; Duque, C; Ortiz-Barrientos, D; Garcia, LF; Velez, ID; Bravo, ML; Munera, JG; Bedoya, G; Bortolini, MC; Ruiz-Linares, A				Mesa, NR; Mondragon, MC; Soto, ID; Parra, MV; Duque, C; Ortiz-Barrientos, D; Garcia, LF; Velez, ID; Bravo, ML; Munera, JG; Bedoya, G; Bortolini, MC; Ruiz-Linares, A			Autosomal, mtDNA, and Y-chromosome diversity in Amerinds: Pre- and post-Columbian patterns of gene flow in South America	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II ALLELES; CLUSTER HAPLOTYPES; HUMAN-EVOLUTION; NEW-WORLD; POPULATION-GENETICS; MOLECULAR ANALYSIS; HIGH-RESOLUTION; TANDEM REPEATS; MITOCHONDRIAL; TRIBES	To evaluate sex-specific differences in gene flow between Native American populations from South America and between those populations and recent immigrants to the New World, we examined the genetic diversity at uni- and biparental genetic markers of five Native American populations from Colombia and in published surveys from native South Americans. The Colombian populations were typed for five polymorphisms in mtDNA, five restriction sites in the beta -globin gene cluster, the DQA1 gene, and nine autosomal microsatellites. Elsewhere, we published results for seven Y-chromosome microsatellites in the same populations. Autosomal polymorphisms showed a mean G(ST) of 6.8%, in agreement with extensive classical marker studies of South American populations. MtDNA and Y-chromosome markers resulted in G(ST) values of 0.18 and 0.165, respectively. When only Y chromosomes of confirmed Amerind origin were used in the calculations las defined by the presence of allele T at locus DYS199), G(ST) increased to 0.22. G(ST) values calculated from published data for other South American natives were 0.3 and 0.29 for mtDNA and Amerind Y chromosomes, respectively. The concordance of these estimates does not support an important difference in migration rates between the sexes throughout the history of South Amerinds. Admixture analysis of the Colombian populations suggests an asymmetric pattern of mating involving mostly immigrant men and native women.	Univ Antioquia, Fac Med, Dept Bioquim & Fisiol, Genet Mol Lab, Medellin, Colombia; Univ Antioquia, Fac Med, Lab Cent Invest, Medellin, Colombia; Univ Antioquia, Fac Med, PECET, Medellin, Colombia; Univ Antioquia, Dept Biol, Medellin, Colombia; Univ Antioquia, Dept Antropol, Medellin, Colombia; Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Dept Med & Community Genet, Harrow HA1 3UJ, Middx, England	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidade Federal do Rio Grande do Sul; Imperial College London	Ruiz-Linares, A (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	andres.ruiz@ic.ac.uk	Soto-Calderón, Iván/P-2639-2019; Ruiz-Linares, Andres/AAR-1104-2021; Ortiz-Barrientos, Daniel/B-2274-2010; Ortiz-Barrientos, Daniel/N-3294-2019	Soto-Calderón, Iván/0000-0002-6311-8378; Ruiz-Linares, Andres/0000-0001-8372-1011; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome Trust)		[Anonymous], 1996, ETHNOLOGUE LANGUAGE; Arango R, 1998, PUEBLOS INDIGENAS CO; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; BEVILAQUA LRM, 1995, AM J PHYS ANTHROPOL, V98, P395, DOI 10.1002/ajpa.1330980402; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bortolini MC, 1996, BRAZ J GENET, V19, P527; Bortolini MC, 1999, AM J HUM BIOL, V11, P551, DOI 10.1002/(SICI)1520-6300(1999)11:4<551::AID-AJHB15>3.0.CO;2-Z; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Burton ML, 1996, CURR ANTHROPOL, V37, P87, DOI 10.1086/204474; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; CERNA M, 1993, HUM IMMUNOL, V37, P213, DOI 10.1016/0198-8859(93)90504-T; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; FLINT J, 1993, HUM GENET, V91, P91; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; GUEDEZ YB, 1994, TISSUE ANTIGENS, V44, P125, DOI 10.1111/j.1399-0039.1994.tb02368.x; GUERREIRO JF, 1994, HUM HERED, V44, P142, DOI 10.1159/000154206; HAMMER NF, 1997, EVOL ANTHROPOL, V4, P116; Hewitt R, 1996, AM J HUM GENET, V58, P1303; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaufman L, 1998, GENET MOL BIOL, V21, P435, DOI 10.1590/S1415-47571998000400003; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; *LAB GEM POP, 2000, GENETIX LOG WIND TM; Lewis P.O., 2000, GENETIC DATA ANAL CO; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1990, AM J PHYS ANTHROPOL, V81, P113, DOI 10.1002/ajpa.1330810112; Loukotka Cestmir, 1968, CLASSIFICATION S AM, V7; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; Migot-Nabias F, 1999, TISSUE ANTIGENS, V53, P580, DOI 10.1034/j.1399-0039.1999.530610.x; Mourant AE, 1976, DISTRIBUTION HUMAN B; Murdock G. P., 1981, ATLAS WORLD CULTURES; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; Nei M., 1987, MOL EVOLUTIONARY GEN; OTA T, 1993, DISPAN GENETIC PHYLO; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; Rodriguez-Delfin L, 1997, ANN HUM GENET, V61, P439, DOI 10.1046/j.1469-1809.1997.6150439.x; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; RUHLAN M, 1991, GUIDE WORLDS LANGUAG; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; RUIZLINARES A, 1999, MICROSATELLITES EVOL; SALZANO FM, 1988, S AM INDIANS CASE ST, V6; SANCHEZALBORNOZ N, 1977, POBLACION AM LATINA; Schneider S., 2000, ARLEQUIN VERSION 200; Schnittger L, 1997, TISSUE ANTIGENS, V50, P546, DOI 10.1111/j.1399-0039.1997.tb02911.x; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SLATKIN M, 1995, GENETICS, V139, P457; Stoneking M, 1998, NAT GENET, V20, P219, DOI 10.1038/3012; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; SUTTON M, 1989, AM J HEMATOL, V32, P66, DOI 10.1002/ajh.2830320113; TORRONI A, 1993, AM J HUM GENET, V53, P563; Trachtenberg EA, 1996, TISSUE ANTIGENS, V48, P174, DOI 10.1111/j.1399-0039.1996.tb02625.x; Voegelin CharlesFrederick., 1977, CLASSIFICATION INDEX; WegRemers S, 1997, HUM GENET, V100, P548, DOI 10.1007/s004390050550; Weir BS, 1996, SINAUER ASS SUNDERL; YUNIS JJ, 1994, HUM IMMUNOL, V41, P248, DOI 10.1016/0198-8859(94)90043-4; Zago MA, 1996, HUM HERED, V46, P274, DOI 10.1159/000154364	63	123	140	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1277	1286		10.1016/S0002-9297(07)62955-3	http://dx.doi.org/10.1016/S0002-9297(07)62955-3			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032789	Green Published, Bronze			2022-12-18	WOS:000165091600022
J	Witte, JS; Goddard, KAB; Conti, DV; Elston, RC; Lin, J; Suarez, BK; Broman, KW; Burmester, JK; Weber, JL; Catalona, WJ				Witte, JS; Goddard, KAB; Conti, DV; Elston, RC; Lin, J; Suarez, BK; Broman, KW; Burmester, JK; Weber, JL; Catalona, WJ			Genomewide scan for prostate cancer-aggressiveness loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-CATENIN EXPRESSION; E-CADHERIN FUNCTION; SUSCEPTIBILITY LOCUS; CLINICAL PRESENTATION; GENETIC DISSECTION; ANDROGEN RECEPTOR; MOLECULAR-BIOLOGY; COMPLEX TRAITS; ALLELIC LOSS; HETEROZYGOSITY	The aggressiveness of prostate cancer (PCa) varies widely: some tumors progress to invasive, potentially life-threatening disease, whereas others stay latent for the remainder of an individual's lifetime. The mechanisms resulting in this variability are not yet understood, but they are likely to involve both genetic and environmental influences. To investigate genetic factors, we conducted a genomewide linkage analysis of 513 brothers with PCa, using the Gleason score, which reflects tumor histology, as a quantitative measure of PCa aggressiveness. To our knowledge, this is the first time that a measure of PCa aggressiveness has been directly investigated as a quantitative trait in a genomewide scan. We employed a generalized multipoint Haseman-Elston linkage-analysis approach that regresses the mean-corrected cross product between the brothers' Gleason scores on the estimated proportion of alleles shared by brothers identical by descent at each marker location. Our results suggest that candidate regions on chromosomes 5q, 7q, and 19q give evidence for linkage to PCa-aggressiveness genes. In particular, the strongest signals detected in these regions were at the following markers (with corresponding P values): for chromosome 5q31-33, between markers D5S1480 and D5S820 (P =.0002); for chromosome 7q32, between markers D7S3061 and D7S1804 (P =.0007); and, for chromosome 19q12, at D19S433 (P =.0004). This indicates that one or more of these candidate regions may contain genes that influence the progression of PCa from latent to invasive disease. Identification of such genes would be extremely valuable for elucidation of the mechanism underlying PCa progression and for determination of treatment in men in whom this disease has been diagnosed.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Div Urol Surg, St Louis, MO 63110 USA; Marshfield Clin Fdn Med Res & Educ, Ctr Med Genet, Marshfield, WI 54449 USA	Case Western Reserve University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Marshfield Clinic	Witte, JS (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	witte@darwin.cwru.edu		Broman, Karl/0000-0002-4914-6671	NATIONAL CANCER INSTITUTE [R29CA073270] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA073270, CA73270] Funding Source: Medline; NCRR NIH HHS [P41 RR003655] Funding Source: Medline; NHLBI NIH HHS [N01HV48141] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R37 GM028356, GM28356] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CARTER HB, 1990, J UROLOGY, V143, P742, DOI 10.1016/S0022-5347(17)40078-4; Cunningham JM, 1996, CANCER RES, V56, P4475; DHOM G, 1983, J CANCER RES CLIN, V106, P210, DOI 10.1007/BF00402610; Elo JP, 1999, BRIT J CANCER, V79, P156, DOI 10.1038/sj.bjc.6690025; Elo JP, 1997, CANCER RES, V57, P3356; ELSTON RC, 2000, IN PRESS GENET EPIDE; EWING CM, 1995, CANCER RES, V55, P4813; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hayward SW, 1998, INT J ONCOL, V13, P35; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; ISAACS WB, 1995, CANCER SURV, V23, P19; Komiya A, 1996, GENE CHROMOSOME CANC, V17, P245; KOSARY CL, 1995, NIH PUB; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Latil A, 1995, CLIN CANCER RES, V1, P1385; Latil A, 1997, CANCER RES, V57, P1058; McMenamin ME, 1999, CANCER RES, V59, P4291; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; Nupponen N, 1999, EUR UROL, V35, P351, DOI 10.1159/000019907; OTT J, 1999, ANAL HUMAN GENETIC L, P243; PALMER LJ, 2000, IN PRESS GENET EPIDE; Paris PL, 1999, CANCER EPIDEM BIOMAR, V8, P901; PARIS PL, IN PRESS CANC RES; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Richmond PJM, 1997, CANCER RES, V57, P3189; *SAGE, 2000, STAT AN GEN EP REL 4; Sakr WA, 1997, EUR UROL, V32, P15; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1999, NIH PUB, V99-4543; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; TAKAHASHI S, 1995, CANCER RES, V55, P4114; TAKAHASHI S, 1994, CANCER RES, V54, P3574; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Umbas R, 1997, INT J CANCER, V74, P374, DOI 10.1002/(SICI)1097-0215(19970822)74:4<374::AID-IJC2>3.0.CO;2-S; WARE JL, 1994, AM J PATHOL, V145, P983; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Yuan B, 1997, AM J HUM GENET, V60, P459; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370	47	123	128	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					92	99		10.1086/302960	http://dx.doi.org/10.1086/302960			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10825281	Green Published, Bronze			2022-12-18	WOS:000088926900012
J	Disse, S; Abergel, E; Berrebi, A; Houot, AM; Le Heuzey, JY; Diebold, B; Guize, L; Carpentier, A; Corvol, P; Jeunemaitre, X				Disse, S; Abergel, E; Berrebi, A; Houot, AM; Le Heuzey, JY; Diebold, B; Guize, L; Carpentier, A; Corvol, P; Jeunemaitre, X			Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONNECTIVE-TISSUE; LINKAGE ANALYSIS; SYSTOLIC-CLICK; COLLAGEN GENES; ASSOCIATION; ABNORMALITIES; INHERITANCE; EXPRESSION; DIAGNOSIS	Myxomatous mitral-valve prolapse (MMVP), also called Barlow disease, is a common cardiac abnormality and affects up to 5% of the population. It is characterized by an excess of tissue that leads to billowing of the mitral leaflets, sometimes complicated by prolapse. Typical histological findings include myxomatous degeneration and degradation of collagen and elastin. Previous reports have proposed an autosomal dominant inheritance of the trait, with age- and sex-dependent expression. By systematic echocardiographic screening of the first-degree relatives of 17 patients who underwent mitral-valve repair, we have identified four pedigrees showing such an inheritance. Genomewide linkage analysis of the most informative pedigree (24 individuals, three generations) showed a significant linkage for markers mapping to chromosome 16p, with a two-point maximum LOD score for D16S3068 (Z(max) = 3.30 at theta = 0). Linkage to D16S3068 was confirmed in a second family (Z(max) = 2.02 at theta = 0) but was excluded for the two remaining families, thus demonstrating the genetic heterogeneity of the disease. Multipoint linkage analysis performed, with nine additional markers, on the two families with linkage gave maximum multipoint LOD scores of 5.45 and 5.68 for D16S3133, according to a conservative and a stringent model, respectively. Haplotype analysis defined a 5-cM minimal MMVP-1 locus between D16S3068 (16p11.2) and D16S420 (16p12.1) and a 34-cM maximal interval between D16S404 and D16S3068 when recombination events were taken into account only in affected individuals. The identification of this locus represents a first step toward a new molecular classification of mitral-valve prolapse.	Coll France, INSERM, U36, F-75005 Paris, France; Hop Broussais, Serv Chirurg Cardiovasc, F-75674 Paris, France; Hop Broussais, Mol Biol Lab, Assistance Publ Hop Paris, F-75674 Paris, France; Hop Broussais, Ctr Invest Clin, Assistance Publ Hop Paris, F-75674 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Jeunemaitre, X (corresponding author), Coll France, INSERM, U36, 3 Rue Ulm, F-75005 Paris, France.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X				ALPERT JS, 1998, TXB CARDIOVASCULAR M, P519; BAREISS P, 1976, ARCH MAL COEUR VAISS, V69, P71; BARLOW JB, 1963, AM HEART J, V66, P443, DOI 10.1016/0002-8703(63)90375-2; BARLOW JB, 1979, AM HEART J, V97, P277, DOI 10.1016/0002-8703(79)90425-3; BOUDARIAS JP, 1991, ARCH MAL COEUR VAISS, V854, P981; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; CARPENTIER A, 1980, J THORAC CARDIOV SUR, V79, P338; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COOPER MJ, 1981, AM J DIS CHILD, V135, P647, DOI 10.1001/archpedi.1981.02130310051017; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; DEVEREUX RB, 1976, CIRCULATION, V54, P3, DOI 10.1161/01.CIR.54.1.3; FRABLE WJ, 1969, J THORAC CARDIOV SUR, V58, P62, DOI 10.1016/S0022-5223(19)42629-9; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; HENNEY AM, 1989, BRIT HEART J, V61, P292; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; HUTCHINS GM, 1986, NEW ENGL J MED, V314, P535, DOI 10.1056/NEJM198602273140902; KERN WH, 1972, AM HEART J, V84, P294, DOI 10.1016/0002-8703(72)90361-4; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyndt F, 1998, AM J HUM GENET, V62, P627, DOI 10.1086/301747; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; LEVY D, 1987, AM HEART J, V113, P1981; NISHIMURA RA, 1985, NEW ENGL J MED, V313, P1305, DOI 10.1056/NEJM198511213132101; OLSEN EGJ, 1980, BRIT HEART J, V44, P674; Ott J., 1991, ANAL HUMAN GENETIC L; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; PERLOFF JK, 1986, AM J CARDIOL, V57, P1124, DOI 10.1016/0002-9149(86)90686-7; PROCACCI PM, 1976, NEW ENGL J MED, V294, P1086, DOI 10.1056/NEJM197605132942004; SHAPPELL SD, 1973, CIRCULATION, V48, P1128, DOI 10.1161/01.CIR.48.5.1128; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VIRMANI R, 1987, HUM PATHOL, V18, P596, DOI 10.1016/S0046-8177(87)80359-3; WEISS AN, 1975, CIRCULATION, V52, P1091, DOI 10.1161/01.CIR.52.6.1091; WHITTAKER P, 1987, BRIT HEART J, V57, P264; WORDSWORTH P, 1989, BRIT HEART J, V61, P300; Zuppiroli A, 1998, AM J CARDIOL, V82, P823, DOI 10.1016/S0002-9149(98)00454-8	37	123	140	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1242	1251		10.1086/302624	http://dx.doi.org/10.1086/302624			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521289	Bronze, Green Published			2022-12-18	WOS:000083531000005
J	Sleat, DE; Gin, RM; Sohar, I; Wisniewski, K; Sklower-Brooks, S; Pullarkat, RK; Palmer, DN; Lerner, TJ; Boustany, RM; Uldall, P; Siakotos, AN; Donnelly, RJ; Lobel, P				Sleat, DE; Gin, RM; Sohar, I; Wisniewski, K; Sklower-Brooks, S; Pullarkat, RK; Palmer, DN; Lerner, TJ; Boustany, RM; Uldall, P; Siakotos, AN; Donnelly, RJ; Lobel, P			Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BATTEN-DISEASE; THIOESTERASE DEFICIENCY; GENE; VARIANT; GLYCOPROTEINS; FORMS; CLN3	The late-infantile form of neuronal ceroid lipofuscinosis (LINCL) is a progressive and ultimately fatal neurodegenerative disease of childhood. The defective gene in this hereditary disorder, CLN2, encodes a recently identified lysosomal pepstatin-insensitive acid protease. To better understand the molecular pathology of LINCL, we conducted a genetic survey of CLN2 in 74 LINCL families. In 14 patients, CLN2 protease activities were normal and no mutations were identified, suggesting other forms of NCL. Both pathogenic alleles were identified in 57 of the other 60 LINCL families studied. In total, 24 mutations were associated with LINCL, comprising six splice-junction mutations, 11 missense mutations, 3 nonsense mutations, 3 small deletions, and 1 single-nucleotide insertion. Two mutations were particularly common: an intronic G-->C transversion in the invariant AG of a 3' splice junction, found in 38 of 115 alleles, and a C-->T transition in 32 of 115 alleles, which prematurely terminates translation at amino acid 208 of 563. An Arg-->His substitution was identified, which was associated with a late age at onset and protracted clinical phenotype, in a number of other patients originally diagnosed with juvenile NCL.	Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Lab Med & Pathol, Newark, NJ 07103 USA; New York State Inst Basic Res Dev Disabil, Dept Pathol Neurobiol, Staten Isl, NY 10314 USA; New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; Lincoln Univ, Anim & Food Sci Div, Canterbury, New Zealand; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Duke Univ, Med Ctr, Dept Pediat & Neurobiol, Durham, NC USA; Juliane Marie Ctr, Neuropediat Clin, Copenhagen, Denmark; Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Lincoln University - New Zealand; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis	Lobel, P (corresponding author), Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	Sleal@waksman.rutgers.edu; Lobel@waksman.rutgers.edu	Mengali, Giovanni/Q-7124-2019; Palmer, David/B-7344-2008	Mengali, Giovanni/0000-0002-4277-1765; 	NIDDK NIH HHS [DK45992] Funding Source: Medline; NINDS NIH HHS [NS37918] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boustany R., 1996, HDB CLIN NEUROLOGY, V66, P671; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Das AK, 1998, J CLIN INVEST, V102, P361, DOI 10.1172/JCI3112; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; GABEL CA, 1993, MECH INTRACELLULAR T, P103; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Haines JL, 1998, NEUROGENETICS, V1, P217, DOI 10.1007/s100480050032; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; Mitchison HM, 1998, HUM MOL GENET, V7, P291, DOI 10.1093/hmg/7.2.291; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Pearce DA, 1998, P NATL ACAD SCI USA, V95, P6915, DOI 10.1073/pnas.95.12.6915; Ranta S, 1996, GENOME RES, V6, P351, DOI 10.1101/gr.6.5.351; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Sharp JD, 1997, HUM MOL GENET, V6, P591, DOI 10.1093/hmg/6.4.591; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; SOHAR I, 1999, IN PRESS J NEUROCHEM, V78; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Wisniewski KE, 1998, PEDIATR NEUROL, V18, P119, DOI 10.1016/S0887-8994(97)00173-2; Wisniewski KE, 1998, PEDIATR NEUROL, V18, P36, DOI 10.1016/S0887-8994(97)00188-4; Zhong N, 1998, CLIN GENET, V54, P234	29	123	128	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1511	1523		10.1086/302427	http://dx.doi.org/10.1086/302427			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330339	Bronze, Green Published			2022-12-18	WOS:000080696200004
J	Lau, YFC				Lau, YFC			Gonadoblastoma, testicular and prostate cancers, and the TSPY gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; IN-SITU HYBRIDIZATION; PROTEIN PHOSPHATASE 2A; SUSCEPTIBILITY LOCUS; MYELOID LEUKEMOGENESIS; PUTATIVE ONCOGENE; X-CHROMOSOME; LEUKEMIA; FAMILY; SET		Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, Div Cell & Dev Genet, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lau, YFC (corresponding author), Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, Div Cell & Dev Genet, 111C5,4150 Clement St, San Francisco, CA 94121 USA.	clau@itsa.ucsf.edu	Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050				ABELIOVICH D, 1994, CANCER GENET CYTOGEN, V76, P70, DOI 10.1016/0165-4608(94)90075-2; ADACHI Y, 1994, J BIOL CHEM, V269, P2258; ARNEMANN J, 1987, NUCLEIC ACIDS RES, V15, P8713, DOI 10.1093/nar/15.21.8713; ARNEMANN J, 1991, GENOMICS, V11, P108, DOI 10.1016/0888-7543(91)90107-P; Brothman AR, 1997, CANCER GENET CYTOGEN, V95, P116, DOI 10.1016/S0165-4608(96)00302-0; Conrad C, 1996, CHROMOSOME RES, V4, P201, DOI 10.1007/BF02254960; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Dave BJ, 1996, CANCER GENET CYTOGEN, V87, P24, DOI 10.1016/0165-4608(95)00245-6; Dunsmuir WD, 1998, BRIT J CANCER, V78, P1430, DOI 10.1038/bjc.1998.703; Elliott DJ, 1998, J CELL SCI, V111, P1255; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Esposito T, 1999, HUM MOL GENET, V8, P61, DOI 10.1093/hmg/8.1.61; Gburek BM, 1997, J UROLOGY, V157, P223, DOI 10.1016/S0022-5347(01)65331-X; Gianfrancesco F, 1998, HUM MOL GENET, V7, P407, DOI 10.1093/hmg/7.3.407; Glaser B, 1998, MAMM GENOME, V9, P226, DOI 10.1007/s003359900730; Hunter T, 1998, NAT GENET, V18, P303; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Iezzoni JC, 1997, AM J CLIN PATHOL, V108, P197; JacksonCook C, 1996, CANCER GENET CYTOGEN, V87, P14, DOI 10.1016/0165-4608(95)00232-4; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Kim HS, 1996, AM J PHYS ANTHROPOL, V100, P301; KIRK JA, 1994, GENE CHROMOSOME CANC, V11, P141, DOI 10.1002/gcc.2870110302; KLINK A, 1995, HUM MOL GENET, V4, P869, DOI 10.1093/hmg/4.5.869; Knudson AG, 1997, ANN NY ACAD SCI, V833, P58, DOI 10.1111/j.1749-6632.1997.tb48593.x; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; KONIG JJ, 1994, PROSTATE, V25, P281, DOI 10.1002/pros.2990250602; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; Mazeyrat S, 1998, HUM MOL GENET, V7, P557, DOI 10.1093/hmg/7.3.557; McElreavey K, 1999, AM J HUM GENET, V64, P928, DOI 10.1086/302351; McLachlan RI, 1996, J ENDOCRINOL, V148, P1, DOI 10.1677/joe.0.1480001; Mertens F, 1997, CANCER RES, V57, P2765; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Myers MP, 1997, AM J HUM GENET, V61, P1234, DOI 10.1086/301659; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; PAGE DC, 1987, DEVELOPMENT, V101, P151; Ried K, 1998, HUM MOL GENET, V7, P1771, DOI 10.1093/hmg/7.11.1771; RISKE CB, 1994, CANCER GENET CYTOGEN, V72, P44, DOI 10.1016/0165-4608(94)90108-2; SALIDO EC, 1992, AM J HUM GENET, V50, P303; SALO P, 1995, GENE CHROMOSOME CANC, V14, P210, DOI 10.1002/gcc.2870140309; Schiebel K, 1997, CYTOGENET CELL GENET, V76, P49, DOI 10.1159/000134514; SCHIEBEL K, 1970, CANCER, V25, P1340; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; SCULLY RE, 1953, CANCER-AM CANCER SOC, V6, P455, DOI 10.1002/1097-0142(195305)6:3<455::AID-CNCR2820060303>3.0.CO;2-U; SULTANA R, 1995, GENE CHROMOSOME CANC, V13, P257, DOI 10.1002/gcc.2870130405; TSUCHIYA K, 1995, AM J HUM GENET, V57, P1400; VERP MS, 1987, CANCER GENET CYTOGEN, V25, P191, DOI 10.1016/0165-4608(87)90180-4; Vogel T, 1998, CHROMOSOME RES, V6, P35, DOI 10.1023/A:1009214307764; Vogel T, 1997, MAMM GENOME, V8, P491, DOI 10.1007/s003359900482; Vogel T, 1998, CYTOGENET CELL GENET, V81, P265, DOI 10.1159/000015042; Vogt PH, 1997, CYTOGENET CELL GENET, V79, P2; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Watanabe A, 1996, CANCER GENET CYTOGEN, V89, P85, DOI 10.1016/0165-4608(95)00351-7; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Yong EL, 1998, REV REPROD, V3, P141, DOI 10.1530/ror.0.0030141; Zhang Julie S., 1992, Human Molecular Genetics, V1, P717, DOI 10.1093/hmg/1.9.717	61	123	134	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					921	927		10.1086/302353	http://dx.doi.org/10.1086/302353			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090875	Green Published, Bronze			2022-12-18	WOS:000079632900001
J	Knapp, M				Knapp, M			The transmission/disequilibrium test and parental-genotype reconstruction: The reconstruction-combined transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION	Spielman and Ewens recently proposed a method for testing a marker for linkage with a disease, which combines data from families with and without information on parental genotypes. For some families without parental-genotype information, it may be possible to reconstruct missing parental genotypes from the genotypes of their offspring. The treatment of such a reconstructed family as if parental genotypes have been typed, however, can introduce bias. In the present study, a new method is presented that employs parental-genotype reconstruction and corrects for the biases resulting from reconstruction. The results of an application of this method to a real data set and of a simulation study suggest that this approach may increase the power to detect linkage.	Univ Bonn, Inst Med Stat, D-53105 Bonn, Germany	University of Bonn	Knapp, M (corresponding author), Univ Bonn, Inst Med Stat, Sigmund Freud Str 25, D-53105 Bonn, Germany.	knapp@imsdd.meb.uni-bonn.de						Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Hodge SE, 1995, GENET EPIDEMIOL, V12, P545, DOI 10.1002/gepi.1370120604; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Spielman RS, 1999, AM J HUM GENET, V64, P668, DOI 10.1086/302265	7	123	126	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					861	870		10.1086/302285	http://dx.doi.org/10.1086/302285			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053021	Green Published, Bronze			2022-12-18	WOS:000079204700024
J	Donger, C; Krejci, E; Serradell, AP; Eymard, B; Bon, S; Nicole, S; Chateau, D; Gary, F; Fardeau, M; Massoulie, J; Guicheney, P				Donger, C; Krejci, E; Serradell, AP; Eymard, B; Bon, S; Nicole, S; Chateau, D; Gary, F; Fardeau, M; Massoulie, J; Guicheney, P			Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (type Ic)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDPLATE ACETYLCHOLINESTERASE; TAILED ACETYLCHOLINESTERASE; EXPRESSION; SUBUNITS; MUSCLE; FORMS; MAP	Congenital myasthenic syndrome (CMS) with end-plate acetylcholinesterase (AChE) deficiency is a rare autosomal recessive disease, recently classified as CMS type Ic (CMS-Ic). It is characterized by onset in childhood, generalized weakness increased by exertion, refractoriness to anticholinesterase drugs, and morphological abnormalities of the neuromuscular junctions (NMJs), The collagen-tailed form of AChE, which is normally concentrated at NMJs, is composed of catalytic tetramers associated with a specific collagen, COLQ. In CMS-Ic patients, these collagen-tailed forms are often absent. We studied a large family comprising 11 siblings, 6 of whom are affected by a mild form of CMS-Ic. The muscles of the patients contained collagen-tailed AChE. We first excluded the ACHE gene (7q22) as potential culprit, by linkage analysis; then we mapped COLQ to chromosome 3p24.2. By analyzing 3p24.2 markers located close to the gene, we found that the six affected patients were homozygous for an interval of 14 cM between D3S1597 and D3S2338. We determined the COLQ coding sequence and found that the patients present a homozygous missense mutation, Y431S, in the conserved C-terminal domain of COLQ. This mutation is thought to disturb the attachment of collagen-tailed AChE to the NMJ, thus constituting the first genetic defect causing CMS-Ic.	Grp Hosp Pitie Salpetriere, INSERM U153, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Inst Myol, F-75651 Paris, France; Grp Hosp Pitie Salpetriere, INSERM CJF9608, F-75651 Paris 13, France; Ecole Normale Super, CNRS URA 1857, Neurobiol Cellulaire & Mol Lab, F-75231 Paris, France; Hosp Mar, Serv Neurol, Barcelona, Spain; Genethon, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Guicheney, P (corresponding author), Grp Hosp Pitie Salpetriere, INSERM U153, Batiment Babinski,47 Blvd Hop, F-75651 Paris 13, France.		Guicheney, Pascale/D-1034-2017; NICOLE, Sophie/N-4348-2018	Guicheney, Pascale/0000-0002-7663-2050; NICOLE, Sophie/0000-0001-8793-7928				Andres C, 1997, P NATL ACAD SCI USA, V94, P8173, DOI 10.1073/pnas.94.15.8173; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; BRANDAN E, 1985, J CELL BIOL, V101, P985, DOI 10.1083/jcb.101.3.985; BUNDEY S, 1972, J NEUROL NEUROSUR PS, V35, P41, DOI 10.1136/jnnp.35.1.41; CAMP S, 1995, J CLIN INVEST, V95, P333, DOI 10.1172/JCI117661; CARSON S, 1979, FEBS LETT, V97, P348, DOI 10.1016/0014-5793(79)80119-2; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COUSSEN F, 1995, EUR J CELL BIOL, V67, P254; DEPREZ PN, 1995, J BIOL CHEM, V270, P11043, DOI 10.1074/jbc.270.19.11043; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EHRLICH G, 1992, GENOMICS, V13, P1192, DOI 10.1016/0888-7543(92)90037-S; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENGEL AG, 1977, ANN NEUROL, V1, P315, DOI 10.1002/ana.410010403; FENICHEL GM, 1978, ARCH NEUROL-CHICAGO, V35, P97, DOI 10.1001/archneur.1978.00500260035009; GETMAN DK, 1992, AM J HUM GENET, V51, P170; GROS V, 1918, NEUES MIKROSKOPISCHE, P1; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HUTCHINSON DO, 1993, BRAIN, V116, P633, DOI 10.1093/brain/116.3.633; JENNEKENS FGI, 1992, MUSCLE NERVE, V15, P63, DOI 10.1002/mus.880150112; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Middleton LT, 1996, NEUROMUSCULAR DISORD, V6, P133, DOI 10.1016/0960-8966(95)00037-2; Rotundo RL, 1997, J CELL BIOL, V136, P367, DOI 10.1083/jcb.136.2.367; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Sternfeld M, 1998, J NEUROSCI, V18, P1240; [No title captured]	30	123	125	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					967	975		10.1086/302059	http://dx.doi.org/10.1086/302059			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758617	Bronze, Green Published			2022-12-18	WOS:000076577800008
J	Wirth, B; Schmidt, T; Hahnen, E; RudnikSchoneborn, S; Krawczak, M; MullerMyhsok, B; Schonling, J; Zerres, K				Wirth, B; Schmidt, T; Hahnen, E; RudnikSchoneborn, S; Krawczak, M; MullerMyhsok, B; Schonling, J; Zerres, K			De novo rearrangements found in 2% of index patients with spinal muscular atrophy: Mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; DE-NOVO; CYSTIC-FIBROSIS; SMN GENE; MATERNAL ORIGIN; DENOVO MUTATION; 5Q13 REGION; DELETIONS; DISEASE; INDIVIDUALS	Spinal muscular atrophy (SMA) is a relatively common autosomal recessive neuromuscular disorder. We have identified de novo rearrangements in 7 (similar to 2%) index patients from 340 informative SMA families. In each, the rearrangements resulted in the absence of the telomeric copy of the survival motor neuron (SMN) gene (telSMN), in two cases accompanied by the loss of the neuronal apoptosis-inhibitory protein gene. Haplotype analysis revealed unequal recombination in four cases, with loss of markers Ag1-CA and C212, which are near the 5' ends of the SMN genes. In one case, an interchromosomal rearrangement involving both the SMN genes and a regrouping of Ag1-CA and C212 alleles must have occurred, suggesting either interchromosomal gene conversion or double recombination. In two cases, no such rearrangement was observed, but loss of telSMN plus Ag1-CA and C212 alleles in one case suggested intrachromosomal deletion or gene conversion. In six of the seven cases, the de novo rearrangement had occurred during paternal meiosis. Direct detection of de novo SMA mutations by molecular genetic means has allowed us to estimate for the first time the mutation rate for a recessive disorder in humans. The sex-averaged rate of 1.1 x 10(-4), arrived at in a proband-based approach, compares well with the rate of 0.9 x 10(-4) expected under a mutation-selection equilibrium for SMA. These findings have important implications for genetic counseling and prenatal diagnosis in that they emphasize the relevance of indirect genotype analysis in combination with direct SMN-gene deletion testing in SMA families.	UNIV WALES COLL CARDIFF,COLL MED,INST MED GENET,CARDIFF CF1 3NS,S GLAM,WALES; BERNHARD NOCHT INST TROP MED,HAMBURG,GERMANY	Cardiff University; Bernhard Nocht Institut fur Tropenmedizin	Wirth, B (corresponding author), INST HUMAN GENET,WILHELMSTR 31,D-53111 BONN,GERMANY.		Rudnik-Schöneborn, Sabine/F-8473-2015; Wirth, Brunhilde/H-3192-2019; Krawczak, Michael/A-8964-2010	Krawczak, Michael/0000-0003-2603-1502; Wirth, Brunhilde/0000-0003-4051-5191				Blair IP, 1996, AM J HUM GENET, V58, P472; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burglen L, 1997, AM J HUM GENET, V60, P72; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Capon F, 1996, HUM MUTAT, V7, P198; CAPON F, 1995, PRENATAL DIAG, V15, P93, DOI 10.1002/pd.1970150121; CHANDLEY AC, 1989, J MED GENET, V26, P546, DOI 10.1136/jmg.26.9.546; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cremonesi L, 1996, HUM GENET, V98, P119, DOI 10.1007/s004390050171; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GRAHE C, 1996, HUM MOL GENET, V5, P1971; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; Hahnen ET, 1996, HUM GENET, V98, P122, DOI 10.1007/s004390050172; *INT SMA CONS, 1992, NEUROMUSCULAR DISORD, V2, P423; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LeGuern E, 1996, HUM MOL GENET, V5, P103, DOI 10.1093/hmg/5.1.103; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; Raclin V, 1997, J MED GENET, V34, P86, DOI 10.1136/jmg.34.1.86; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; RudnikSchoneborn S, 1996, AM J HUM GENET, V59, P1163; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VOGEL F, 1996, HUMAN GENETICS PROBL, P398; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WHITE MB, 1991, GENOMICS, V11, P778, DOI 10.1016/0888-7543(91)90092-S; WIRTH B, 1995, PRENATAL DIAG, V15, P407, DOI 10.1002/pd.1970150503; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	47	123	127	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1102	1111		10.1086/301608	http://dx.doi.org/10.1086/301608			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345102	Green Published, Bronze			2022-12-18	WOS:A1997YH01700015
J	Spriggs, EL; Rademaker, AW; Martin, RH				Spriggs, EL; Rademaker, AW; Martin, RH			Aneuploidy in human sperm: The use of multicolor FISH to test various theories of nondisjunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-SATELLITE DNA; PARENTAL ORIGIN; REDUCED RECOMBINATION; EXTRA CHROMOSOME; ASSOCIATION; TRISOMY-21; HAPLOTYPES; FREQUENCY; NUCLEOLUS; OOCYTES	While it is known that all chromosomes are susceptible to meiotic nondisjunction, it is not clear whether all chromosomes display the same frequency of nondisjunction. By use of multicolor FISH and chromosome-specific probes, the frequency of disomy in human sperm was determined for chromosomes 1, 2, 4, 3, 12, 15, 16, 18, 20, and 21, and the sex chromosomes. A minimum of 10,000 sperm nuclei were scored from each of five healthy, chromosomally normal donors for every chromosome studied, giving a total of 418,931. sperm nuclei. The mean frequencies of disomy obtained were 0.09% for chromosome 1; 0.08% for chromosome 2; 0.11% for chromosome 4; 0.14% for chromosome 9; 0.16% for chromosome 12; 0.11% for chromosomes 15, 16, and 18; 0.12% for chromosome 20; 0.29% for chromosome 21; and 0.43% for the sex chromosomes. Data for chromosomes 1, 12, 15, and 18, and the sex chromosomes have been published elsewhere. When the mean frequencies of disomy were compared, the sex chromosomes and chromosome 21 had significantly higher frequencies of disomy than that of any other autosome studied. These results corroborate the pooled data obtained from human sperm karyotypes and suggest that the sex chromosome bivalent and the chromosome 21. bivalent are more susceptible to nondisjunction during spermatogenesis. From these findings, theories proposed to explain the variable incidence of nondisjunction can be supported or discarded as improbable.	ALBERTA CHILDRENS PROV GEN HOSP,DEPT GENET,CALGARY,AB T2T 5C7,CANADA; UNIV CALGARY,DEPT MED GENET,CALGARY,AB,CANADA; NORTHWESTERN UNIV,SCH MED,CTR CANC,BIOMETRY SECT,CHICAGO,IL 60611	Alberta Childrens Hospital; University of Calgary; University of Calgary; Northwestern University								ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1985, P NATL ACAD SCI USA, V82, P3360, DOI 10.1073/pnas.82.10.3360; BALDINI A, 1990, AM J HUM GENET, V46, P784; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; FISHER JM, 1993, AM J HUM GENET, V52, P1139; FORD JH, 1982, CYTOGENET CELL GENET, V33, P327, DOI 10.1159/000131779; GARCIA M, 1989, HUM GENET, V82, P147, DOI 10.1007/BF00284048; GREIG GM, 1989, AM J HUM GENET, V45, P862; HASSOLD T, 1992, HUM GENET, V89, P647; HASSOLD T, 1993, CHROMOSOMES TODAY, V11, P313; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; JABS EW, 1989, P NATL ACAD SCI USA, V86, P202, DOI 10.1073/pnas.86.1.202; Jacobs P A, 1992, Oxf Rev Reprod Biol, V14, P47; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MARTIN RH, 1991, AM J MED GENET, V39, P321, DOI 10.1002/ajmg.1320390315; MIRRE C, 1980, P NATL ACAD SCI-BIOL, V77, P6017, DOI 10.1073/pnas.77.10.6017; NOTHEN MM, 1993, HUM GENET, V92, P347, DOI 10.1007/BF01247332; PELLESTOR F, 1991, HUM GENET, V86, P283; POLANI PE, 1960, LANCET, V1, P721; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SACCHI N, 1988, P NATL ACAD SCI USA, V85, P4794, DOI 10.1073/pnas.85.13.4794; SCHMICKEL RD, 1985, ANN NY ACAD SCI, V450, P121, DOI 10.1111/j.1749-6632.1985.tb21488.x; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; TAGARRO I, 1994, HUM GENET, V93, P383; WATT JL, 1987, J MED GENET, V24, P60, DOI 10.1136/jmg.24.1.60; ZARAGOZA RV, 1994, HUM GENET, V94, P411	33	123	126	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					356	362						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571962				2022-12-18	WOS:A1996TR79100012
J	DAVIES, DR; ARMSTRONG, JG; THAKKER, N; HORNER, K; GUY, SP; CLANCY, T; SLOAN, P; BLAIR, V; DODD, C; WARNES, TW; HARRIS, R; EVANS, DGR				DAVIES, DR; ARMSTRONG, JG; THAKKER, N; HORNER, K; GUY, SP; CLANCY, T; SLOAN, P; BLAIR, V; DODD, C; WARNES, TW; HARRIS, R; EVANS, DGR			SEVERE GARDNER-SYNDROME IN FAMILIES WITH MUTATIONS RESTRICTED TO A SPECIFIC REGION OF THE APC GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENOMATOUS POLYPOSIS-COLI; OCULAR FUNDUS LESIONS; IDENTIFICATION; LOCUS; CHROMOSOME-5Q21; MARKERS; CANCER; FAP	Familial adenomatous polyposis (FAP) is associated with a number of extraintestinal manifestations, which include osteomas, epidermoid cysts, and desmoid tumors, often referred to as ''Gardner syndrome.'' Recent studies have suggested that some of the phenotypic features of FAP are dependent on the position of the mutation within the APC gene. In particular, the correlation between congenital hypertrophy of the retinal pigment epithelium (CHRPE) and APC genotype indicates that affected families may be divided into distinct groups. We have investigated the association between the dento-osseous features of GS on dental panoramic radiographs (DPRs) and APC genotype in a regional cohort of FAP families. DPRs were performed on 84 affected individuals from 36 families, and the dento-osseous features of FAP were quantified by a weighted scoring system. Significant DPR abnormalities were present in 69% of affected individuals. The APC gene mutation was identified in 27 of these families, and for statistical analysis these were subdivided into three groups. Group 1 comprised 18 affected individuals from seven families with mutations 5' of exon 3; these families (except one) did not express CHRPE. Groups 2 comprised 38 individuals from 16 families with mutations between exon 9 and codon 1444, all of whom expressed CHRPE. Group 3 comprised 11 individuals from four families with mutations 3' of codon 1444, none of whom expressed CHRPE. Families with mutations 3' of codon 1444 had significantly more lesions on DPRs (P < .001) and appeared to have a higher incidence of desmoid tumors. These results suggest that the severity of some of the features of Gardner syndrome may correlate with genotype in FAP.	ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; UNIV MANCHESTER,DENT HOSP,MANCHESTER,LANCS,ENGLAND; CHRISTIE HOSP,DEPT CANC EPIDEMIOL,MANCHESTER,LANCS,ENGLAND; MANCHESTER ROYAL EYE HOSP,MANCHESTER,LANCS,ENGLAND; MANCHESTER ROYAL INFIRM,DEPT GASTROENTEROL,MANCHESTER,LANCS,ENGLAND	University of Manchester; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; Manchester Royal Eye Hospital; University of Manchester			Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				BURN J, 1991, J MED GENET, V28, P289, DOI 10.1136/jmg.28.5.289; CASPARI R, 1994, LANCET, V343, P629, DOI 10.1016/S0140-6736(94)92634-4; CASPARI R, 1995, HUM MOL GENET, V4, P337, DOI 10.1093/hmg/4.3.337; Cochran WG, 1957, EXPT DESIGNS; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GARDNER EJ, 1962, AM J HUM GENET, V14, P376; GARDNER EJ, 1952, AM J HUM GENET, V4, P31; GIARDIELLO FM, 1991, GUT, V32, P1170, DOI 10.1136/gut.32.10.1170; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GURBUZ AK, 1994, GUT, V35, P377, DOI 10.1136/gut.35.3.377; HODGSON SV, 1994, J MED GENET, V31, P55, DOI 10.1136/jmg.31.1.55; JAGELMAN DG, 1988, LANCET, V1, P1149; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MIYAKI M, 1993, CANCER RES, V53, P5079; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NUGENT KP, 1994, GUT, V35, P1622, DOI 10.1136/gut.35.11.1622; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; PAUL P, 1993, HUM MOL GENET, V2, P925, DOI 10.1093/hmg/2.7.925; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; SCOTT RJ, 1995, GUT, V36, P731, DOI 10.1136/gut.36.5.731; SENGUPTA S, 1993, LANCET, V342, P552, DOI 10.1016/0140-6736(93)91677-E; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; THAKKER N, 1995, J MED GENET, V32, P458, DOI 10.1136/jmg.32.6.458; TRABOULSI EI, 1987, NEW ENGL J MED, V316, P661, DOI 10.1056/NEJM198703123161104; UTSUNOMIYA J, 1975, BRIT J SURG, V62, P45, DOI 10.1002/bjs.1800620111; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; WOLF J, 1986, BRIT J ORAL MAX SURG, V24, P410, DOI 10.1016/0266-4356(86)90054-9	32	123	125	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1151	1158						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485167				2022-12-18	WOS:A1995TA44900023
J	FINK, JK; WU, CTB; JONES, SM; SHARP, GB; LANGE, BM; LESICKI, A; REINGLASS, T; VARVIL, T; OTTERUD, B; LEPPERT, M				FINK, JK; WU, CTB; JONES, SM; SHARP, GB; LANGE, BM; LESICKI, A; REINGLASS, T; VARVIL, T; OTTERUD, B; LEPPERT, M			AUTOSOMAL-DOMINANT FAMILIAL SPASTIC PARAPLEGIA - TIGHT LINKAGE TO CHROMOSOME 15Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; LOCUS; GENE; RECOMBINATION; MAPS	Autosomal dominant, uncomplicated familial spastic paraplegia (FSP) is a genetically heterogeneous disorder characterized by insidiously progressive lower-extremity spasticity. Recently, a locus on chromosome 14q was shown to be tightly linked with the disorder in one of three families. We performed linkage analysis in a kindred with autosomal dominant uncomplicated FSP. After excluding the chromosome 14q locus, we observed tight linkage of the disorder to a group of markers on chromosome 15q (maximum two-point lod score 9.70; theta = .05). Our results clearly establish the existence of a locus for autosomal dominant FSP in the centromeric region of chromosome 15q. Comparing clinical and genetic features in FSP families linked to chromosome 14q with those linked to chromosome 15q may provide insight into the pathophysiology of this disorder.	ARKANSAS CHILDRENS HOSP,DEPT NEUROL,LITTLE ROCK,AR 72202; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT; UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT	Arkansas Children's Hospital; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	FINK, JK (corresponding author), UNIV MICHIGAN,DEPT NEUROL,MED SCI RES BLDG 3,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.				NCRR NIH HHS [M01-RR00042] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BARAITSER M, 1990, GENETICS NEUROLOGICA, P275; BEHAN W, 1993, J NEUROL NEUROSUR PS, V37, P8; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOUSTANY RMN, 1987, NEUROLOGY, V37, P910, DOI 10.1212/WNL.37.6.910; CARTLIDGE NE, 1973, NEUROLOGY, V23, P1160, DOI 10.1212/WNL.23.11.1160; CHAMBERLAIN S, 1993, AM J HUM GENET, V52, P99; DURR A, 1994, NEUROLOGY, V44, P1274, DOI 10.1212/WNL.44.7.1274; Fink J. K., 1994, American Journal of Human Genetics, V55, pA185; FINK JK, IN PRESS NEUROLOGY; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HENTATI A, 1993, HUM GENET, V53, P1013; HOLMES GL, 1977, J NEUROL NEUROSUR PS, V40, P1003, DOI 10.1136/jnnp.40.10.1003; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MCKUSICK VA, 1988, MENDELIAN INHERITANC, P677; OPJORDSMOEN S, 1980, ACTA NEUROL SCAND, V61, P35; PHILIPP E, 1949, N Z Med J, V48, P22; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RHEIN J, 1914, J NERV MENT DIS, V44, P115; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROE PF, 1963, J NEUROL NEUROSUR PS, V26, P516, DOI 10.1136/jnnp.26.6.516; SCHELTENS P, 1990, ACTA NEUROL SCAND, V82, P169, DOI 10.1111/j.1600-0404.1990.tb04484.x; SCHWARZ GA, 1956, ARCH NEURO PSYCHIATR, V75, P144, DOI 10.1001/archneurpsyc.1956.02330200038005; SKRE H, 1993, CLIN GENET, V6, P165; SUTHERLAND JM, 1975, HDB CLIN NEUROLOGY, V22, P420; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	33	123	127	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					188	192						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825577				2022-12-18	WOS:A1995QC10100024
J	GOLDSTEIN, AM; DRACOPOLI, NC; HO, EC; FRASER, MC; KEARNS, KS; BALE, SJ; MCBRIDE, OW; CLARK, WH; TUCKER, MA				GOLDSTEIN, AM; DRACOPOLI, NC; HO, EC; FRASER, MC; KEARNS, KS; BALE, SJ; MCBRIDE, OW; CLARK, WH; TUCKER, MA			FURTHER EVIDENCE FOR A LOCUS FOR CUTANEOUS MALIGNANT-MELANOMA DYSPLASTIC NEVUS (CMM/DN) ON CHROMOSOME IP, AND EVIDENCE FOR GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRECURSOR LESIONS; PRONE FAMILIES; LINKAGE; RISK	Assignment of a susceptibility locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) to chromosome 1p remains controversial. We examined the relationship between CMM/DN and markers D1S47, PND, and D1S160 on seven new families (set B) plus updated versions of six previously reported families (set A). Three linkage analyses were performed: (1) CMM alone-all individuals without confirmed melanoma or borderline lesions were considered unaffected (model I); (2) CMM/DN with variable age at onset and sporadics (model II); and (3) CMM/DN using the model of Bale et al. (model III). For CMM alone and D1S47, Z(max) = 3.12 at theta = .10. For D1S160 and CMM alone, Z(max) = 1.76 at theta = .10. PND showed no evidence for linkage to CMM alone. Models II and III showed strong evidence for linkage to D1S47, D1S160, and PND in the set A pedigrees but not in the set B families. We tested for homogeneity of CMM/DN (model II) by splitting families into two groups on the basis of (1) the proportion of CMM/DN cases and (2) the occurrence of immune-related tumors. In group 1 there was significant evidence of heterogeneity with both D1S47 and D1S160, and in group 2 there was significant evidence of heterogeneity with D1S160. Thus, diagnostic, clinical, and genetic heterogeneity are the likely reasons that previous studies have failed to confirm linkage of CMM/DN to chromosome 1p. The results showed significant evidence for a CMM locus linked to D1S47, as well as significant evidence for heterogeneity with only a subset of the families appearing linked to chromosome 1p.	NCI,BIOCHEM LAB,BETHESDA,MD 20892; NIAMSD,SKIN BIOL LAB,GENET STUDIES SECT,BETHESDA,MD; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,PIGMENTED LES STUDY GRP,PHILADELPHIA,PA 19104	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of Pennsylvania	GOLDSTEIN, AM (corresponding author), NCI,GENET EPIDEMIOL BRANCH,FAMILY STUDIES SECT,EXECUT PLAZA N,ROOM 439,BETHESDA,MD 20892, USA.		Tucker, Margaret A/B-4297-2015	Dracopoli, Nicholas/0000-0003-3962-4059				BALE SJ, 1986, AM J HUM GENET, V38, P188; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BERGMAN W, 1992, CYTOGENET CELL GENET, V59, P161, DOI 10.1159/000133232; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CLARK WH, 1990, PATHOLOGY SKIN, P684; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; ENGELSTEIN M, UNPUB PCR BASED LINK, V1; GOLDSTEIN AM, 1992, CYTOGENET CELL GENET, V59, P203, DOI 10.1159/000133246; Green A, 1982, Australas J Dermatol, V23, P105, DOI 10.1111/j.1440-0960.1982.tb00739.x; GREENE MH, 1985, ANN INTERN MED, V102, P458, DOI 10.7326/0003-4819-102-4-458; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; Hodge S E, 1991, N Engl J Med, V324, P925; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KRAEMER KH, 1983, LANCET, V2, P1076; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MEYER LJ, 1988, PIGMENT CELL RES S1, V1, P144; MORTON NE, 1956, AM J HUM GENET, V8, P80; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; OSTERLIND A, 1988, BRIT J CANCER, V58, P385, DOI 10.1038/bjc.1988.225; OTT J, 1988, MTEST TURBO PASCAL V; Ott J., 1991, ANAL HUMAN GENETIC L; PIEPKORN M, 1989, J AM ACAD DERMATOL, V20, P407, DOI 10.1016/S0190-9622(89)70050-5; REIMER RR, 1978, JAMA-J AM MED ASSOC, V239, P744, DOI 10.1001/jama.239.8.744; RIES LAG, 1991, NIH912789 NCI; SALMON JA, 1992, CYTOGENET CELL GENET, V59, P170, DOI 10.1159/000133235; TRAVIS LB, 1991, CANCER-AM CANCER SOC, V67, P2002, DOI 10.1002/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E; TRAVIS LB, 1992, JNCI-J NATL CANCER I, V84, P1422, DOI 10.1093/jnci/84.18.1422; Tucker M A, 1985, Natl Cancer Inst Monogr, V68, P161; TUCKER MA, 1985, ANN INTERN MED, V102, P37, DOI 10.7326/0003-4819-102-1-37; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; TUCKER MA, 1988, PIGMENT CELL, V9, P95; TUCKER MA, IN PRESS J INVEST DE; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; 1988, NCI882789 PUBL	38	123	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					537	550						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447320				2022-12-18	WOS:A1993KR72000011
J	MITCHELL, LE; RISCH, N				MITCHELL, LE; RISCH, N			MODE OF INHERITANCE OF NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE - A REANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; GROWTH FACTOR-ALPHA; SEGREGATION ANALYSIS; LINKAGE STRATEGIES; DANISH; ENGLAND; DISEASE; FAMILY; LOCUS	Nonsyndromic cleft lip with or without cleft palate (CL +/- P) is traditionally recognized as a multifactorial threshold trait (MFT). Recently, however, evidence for the involvement of a major gene in the etiology of CL +/- P has been reported. To assess the potential for major-gene involvement in the etiology of this trait, familial recurrence patterns from several family studies of CL +/- P were reanalyzed. The recurrence patterns in first-degree relatives of CL +/- P probands were found to be compatible with the expectations for either an MFT or a generalized single-major-locus (gSML) trait. The use of multiple thresholds based on proband sex, defect bilaterality, or palatal involvement did not help to discriminate between these models. However, the pattern of recurrence among MZ twins and more remote relatives of CL +/- P probands is not consistent with gSML inheritance but is compatible with either an MFT model or a model specifying multiple interacting loci. For such a model, no single locus can account for more than a sixfold increase in risk to first-degree relatives. These findings have important implications with regard to the feasibility of detecting linkage to loci conferring susceptibility to CL +/- P.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, NEW HAVEN, CT 06510 USA	Yale University; Yale University	MITCHELL, LE (corresponding author), WASHINGTON UNIV, SCH MED, DIV BIOSTAT, 660 S EUCLID AVE, BOX 8067, ST LOUIS, MO 63110 USA.				NHGRI NIH HHS [HG00348] Funding Source: Medline; NIEHS NIH HHS [5T32 ES07086-08, 5T32 ES07086-09] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007086] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEAR JC, 1976, CLIN GENET, V9, P277; BIXLER D, 1971, Clinical Genetics, V2, P155; BONAITI C, 1982, J MED GENET, V19, P8, DOI 10.1136/jmg.19.1.8; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHUNG CS, 1989, GENET EPIDEMIOL, V6, P625, DOI 10.1002/gepi.1370060507; CHUNG CS, 1986, AM J HUM GENET, V39, P603; CZEIZEL AE, 1984, AETIOLOGICAL STUDIES; DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; EIBERG H, 1987, CLIN GENET, V32, P129; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FARRALL M, 1992, AM J HUM GENET, V50, P270; FUJINO HIROSHI, 1967, JAP J HUM GENET, V12, P62; HAY S, 1970, American Journal of Human Genetics, V22, P662; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; KOGUCHI H, 1975, JPN J HUM GENET, V20, P207; KRUGER J, 1973, HUMANGENETIK, V17, P181, DOI 10.1007/BF00273637; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MARAZITA ML, 1986, GENET EPIDEMIOL, V3, P335, DOI 10.1002/gepi.1370030506; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; METRAKOS J D, 1958, Plast Reconstr Surg Transplant Bull, V22, P109, DOI 10.1097/00006534-195808000-00003; MITCHELL LE, 1991, THESIS YALE U NEW HA; OTTMAN R, 1987, J CHRON DIS, V40, P165, DOI 10.1016/0021-9681(87)90068-3; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; SHIELDS ED, 1979, CLEFT PALATE J, V16, P1; SMITH C, 1971, Clinical Genetics, V2, P303; WELCH J, 1980, J MED GENET, V17, P127, DOI 10.1136/jmg.17.2.127; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; WOOLF CM, 1963, AM J HUM GENET, V15, P209	39	123	124	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					323	332						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642234				2022-12-18	WOS:A1992JF77600012
J	NAKAMURA, Y; LARSSON, C; JULIER, C; BYSTROM, C; SKOGSEID, B; WELLS, S; OBERG, K; CARLSON, M; TAGGART, T; OCONNELL, P; LEPPERT, M; LALOUEL, JM; NORDENSKJOLD, M; WHITE, R				NAKAMURA, Y; LARSSON, C; JULIER, C; BYSTROM, C; SKOGSEID, B; WELLS, S; OBERG, K; CARLSON, M; TAGGART, T; OCONNELL, P; LEPPERT, M; LALOUEL, JM; NORDENSKJOLD, M; WHITE, R			LOCALIZATION OF THE GENETIC-DEFECT IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 WITHIN A SMALL REGION OF CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN; UNIV UPPSALA HOSP,DEPT INTERNAL MED,S-75014 UPPSALA,SWEDEN; UNIV UPPSALA HOSP,LUDWIG INST CANC RES,S-75014 UPPSALA,SWEDEN; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; WAYNE STATE UNIV,DETROIT,MI 48202	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital; Ludwig Institute for Cancer Research; Uppsala University; Uppsala University Hospital; Washington University (WUSTL); Wayne State University	NAKAMURA, Y (corresponding author), UNIV UTAH,SCH MED,HLTH SCI CTR,HOWARD HUGHES MED INST,DEPT HUMAN GENET,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132, USA.		Oberg, Kjell/AAG-7118-2019; JULIER, Cécile/M-9824-2017	JULIER, Cécile/0000-0002-1538-0240; Nordenskjold, Magnus/0000-0002-4974-425X				CARLSON M, 1988, NUCLEIC ACIDS RES, V16, P10403, DOI 10.1093/nar/16.21.10403; FRANTS RR, 1985, CYTOGENET CELL GENET, V40, P632; HALL J, 1987, CYTOGENET CELL GENET, V46, P625; HOLM T, 1988, NUCLEIC ACIDS RES, V16, P4746, DOI 10.1093/nar/16.10.4746; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, GENOMICS, V2, P157; LEACH R, 1984, CYTOGENET CELL GENET, V37, P521; MASLEN C, 1987, CYTOGENET CELL GENET, V46, P656; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P376, DOI 10.1093/nar/16.1.376; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SKOGSEID B, 1987, J CLIN ENDOCR METAB, V64, P1233, DOI 10.1210/jcem-64-6-1233; TAGGART RT, 1987, CYTOGENET CELL GENET, V46, P701	16	123	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					751	755						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565085				2022-12-18	WOS:A1989U333800017
J	MARTIN, RH; RADEMAKER, AW				MARTIN, RH; RADEMAKER, AW			THE EFFECT OF AGE ON THE FREQUENCY OF SPERM CHROMOSOMAL-ABNORMALITIES IN NORMAL MEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALGARY,FAC MED,DEPT PEDIAT,DIV MED GENET,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV CALGARY,FAC MED,DEPT COMMUNITY HLTH SCI,CALGARY T2N 1N4,ALBERTA,CANADA	University of Calgary; University of Calgary	MARTIN, RH (corresponding author), ALBERTA CHILDRENS PROV GEN HOSP,MED GENET CLIN,1820 RICHMOND RD,CALGARY T2T 5C7,ALBERTA,CANADA.							BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; ERICKSON JD, 1979, AM J HUM GENET, V31, P489; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HOOK EB, 1982, HUM GENET, V62, P167; HOOK EB, 1987, AM J HUM GENET, V40, P83; HOOK EB, 1984, AM J HUM GENET, V36, P413; HOOK EB, IN PRESS ANN HUM GEN; KAMIGUCHI Y, 1986, AM J HUM GENET, V38, P724; MARLHENS F, 1986, HUM GENET, V73, P290, DOI 10.1007/BF00279088; MARTIN RH, 1983, CYTOGENET CELL GENET, V35, P252, DOI 10.1159/000131876; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, IN PRESS HUM GENET; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; PENDIC B, 1980, RADIAT RES, V81, P478, DOI 10.2307/3575205; REGAL RR, 1980, AM J EPIDEMIOL, V112, P650, DOI 10.1093/oxfordjournals.aje.a113037; ROBERTS DF, 1980, J MED GENET, V17, P363, DOI 10.1136/jmg.17.5.363; ROECKER GO, 1983, AM J HUM GENET, V35, P1297; ROTH MP, 1983, PRENATAL DIAG, V3, P327, DOI 10.1002/pd.1970030409; ROTH MP, 1983, HUM GENET, V63, P149, DOI 10.1007/BF00291534; STEENLAND K, 1986, MUTAT RES, V170, P151, DOI 10.1016/0165-1218(86)90029-7; STENE J, 1981, HUM GENET, V59, P119, DOI 10.1007/BF00293059; STENE J, 1977, ANN HUM GENET, V40, P259; TOMAR D, 1984, AM J HUM GENET, V34, pS115; VOGEL F, 1979, HUMAN GENETICS; WORKING PK, 1984, ENVIRON MUTAGEN, V6, P273, DOI 10.1002/em.2860060304	27	123	125	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					484	492						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631081				2022-12-18	WOS:A1987K019100012
J	FEASTER, WW; KWOK, LW; EPSTEIN, CJ				FEASTER, WW; KWOK, LW; EPSTEIN, CJ			DOSAGE EFFECTS FOR SUPEROXIDE DISMUTASE-1 IN NUCLEATED CELLS ANEUPLOID FOR CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco								Beutler E, 1975, MANUAL BIOCHEMICAL M, V2; BOYSE EA, 1968, J EXP MED, V128, P85, DOI 10.1084/jem.128.1.85; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CROSTI N, 1976, HUM GENET, V31, P197, DOI 10.1007/BF00296146; DUMBLE L, 1975, TISSUE ANTIGENS, V5, P103; EPSTEIN CJ, 1977, NATURE, V267, P615, DOI 10.1038/267615a0; EPSTEIN CJ, 1972, SCIENCE, V175, P1467, DOI 10.1126/science.175.4029.1467; EPSTEIN LB, 1976, J INFECT DIS, V133, pA56, DOI 10.1093/infdis/133.Supplement_2.A56; FARBER RA, 1973, GENETICS, V74, P521; Frants R R, 1975, Lancet, V2, P42; FRIED R, 1975, BIOCHIMIE, V57, P657, DOI 10.1016/S0300-9084(75)80147-7; GILLES L, 1976, FEBS LETT, V69, P55, DOI 10.1016/0014-5793(76)80652-7; Hsia D., 1968, ANN NY ACAD SCI, V171, P526; HSIA DYY, 1969, MED CLIN N AM, V53, P857, DOI 10.1016/S0025-7125(16)32737-7; KOZAK LP, 1974, BIOCHEM GENET, V11, P41, DOI 10.1007/BF00486618; LAYZER RB, 1972, AM J HUM GENET, V24, P533; MAGENIS RE, 1975, P NATL ACAD SCI USA, V72, P4526, DOI 10.1073/pnas.72.11.4526; MARIMO B, 1975, NATURE, V256, P204, DOI 10.1038/256204a0; MASOUREDIS SP, 1967, J CLIN INVEST, V46, P681, DOI 10.1172/JCI105569; NADLER HL, 1967, BLOOD-J HEMATOL, V30, P669, DOI 10.1182/blood.V30.5.669.669; REVEL M, 1976, NATURE, V260, P139, DOI 10.1038/260139a0; SALIN ML, 1974, J CLIN INVEST, V54, P1005, DOI 10.1172/JCI107816; SANDLER L, 1973, AM J HUM GENET, V25, P332; SICHITIU S, 1974, HUMANGENETIK, V23, P65, DOI 10.1007/BF00295684; SINET P M, 1975, Biochemical and Biophysical Research Communications, V67, P910, DOI 10.1016/0006-291X(75)90763-9; SINET PM, 1976, EXP CELL RES, V97, P47, DOI 10.1016/0014-4827(76)90653-4; SINET PM, 1974, CR ACAD SCI D NAT, V278, P3267; SINET PM, 1975, BIOCHEM BIOPH RES CO, V67, P904, DOI 10.1016/0006-291X(75)90762-7; TAN YH, 1974, SCIENCE, V186, P61, DOI 10.1126/science.186.4158.61; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; WACHTEL SS, 1975, NEW ENGL J MED, V293, P1070, DOI 10.1056/NEJM197511202932105; WESTERVELD A, 1972, BIOCHEM GENET, V7, P33, DOI 10.1007/BF00487007	32	123	124	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					563	570						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	145179				2022-12-18	WOS:A1977EC27000002
J	NEEL, JV; SALZANO, FM				NEEL, JV; SALZANO, FM			FURTHER STUDIES ON XAVANTE INDIANS .X. SOME HYPOTHESES-GENERALIZATIONS RESULTING FROM THESE STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					AIRD JS, 1957, THESIS U MICHIGAN; ALLEN G, 1965, EUGEN QUART, V12, P181, DOI 10.1080/19485565.1965.9987629; ANDRADE AHP, 1967, FURTHER STUDIES XAVA; ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; AZEVEDO E, 1964, AM J HUM GENET, V16, P451; BLUMBERG BS, 1964, HUM BIOL, V36, P263; BROTHWELL D, 1963, SCIENCE ARCHEOLOG ED, P353; BROTHWELL D, 1963, SCIENCE ARCHEOLOGY, P325; BROWN KS, 1958, AM J HUM GENET, V10, P175; Cavalli-Sforza LL, 1965, GENETICS TODAY, V3, P923; CAVALLIS.LL, 1964, COLD SPRING HARB SYM, V29, P9, DOI 10.1101/SQB.1964.029.01.006; CHUNG CS, 1965, AM J HUM GENET, V17, P352; CROW J. F., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V3, P495; CROW JF, 1964, AM NAT, V98, P21, DOI 10.1086/282298; CURTAIN CC, 1965, AM J PHYS ANTHROPOL, V23, P363, DOI 10.1002/ajpa.1330230410; DEEVEY ES, 1960, SCI AM, V203, P195; Dobzhansky T, 1962, MANKIND EVOLVING; Dubos RJ., 1965, MAN ADAPTING; DUNN FL, IN PRESS; DUNNING RW, 1962, HUM ORGAN, V21, P17, DOI 10.17730/humo.21.1.873715365h4w21k8; DUNNING RW, 1959, SOCIAL ECONOMIC CHAN; EATON JOSEPH W., 1953, HUMAN BIOL, V25, P206; ELLIS FR, 1963, HUM BIOL, V35, P26; FORD DK, 1964, CAN MED ASSOC J, V90, P1295; FORTES M, 1954, CULTURE HUMAN FERTIL; FRASER AJF, IN PRESS; GEERTS SJ, 1965, GENETICS TODAY    ED, V3, P495; GEERTS SJ, 1965, GENETICS TODAY    ED, V3, P923; GENOVES S, 1963, SCIENCE ARCHEOLOGY, P353; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; GILES E, 1966, ANN NY ACAD SCI, V134, P655, DOI 10.1111/j.1749-6632.1966.tb43053.x; GUERRA R, 1965, ANN INTERN MED, V63, P619, DOI 10.7326/0003-4819-63-4-619; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HALDANE JBS, 1957, ACTA GENET STAT MED, V6, P321; Hallowell AI, 1938, AM ANTHROPOL, V40, P235, DOI 10.1525/aa.1938.40.2.02a00050; HALLOWELL AI, 1963, CURR ANTHROPOL, V4, P519, DOI 10.1086/200422; HAMILTON HB, 1961, J CLIN INVEST, V40, P2199, DOI 10.1172/JCI104446; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HARRISON GA, 1966, HUM BIOL, V38, P104; HEIZER RF, 28 VIK FUND PUBL  ED; HEIZER RF, 1960, APPLICATION QUANT ED, P181; HOOKER D, 1954, GENETICS INHERITA ED, P57; HUBBY JL, 1966, GENETICS, V54, P577; HUNT EE, 1950, COLD SPRING HARBOR S, V15, P314; JARCHO S, 1966, HUMAN PALAEOPATHO ED; JENNESS D, 1922, 12 CAN ARCT EXP REP; KEITER F, 1963, HOMO, V14, P193; KENNY JF, 1967, PEDIATRICS, V39, P202; KIMURA M, 1964, GENETICS, V49, P725; KING JL, 1967, GENETICS, V55, P483; KRAUS BS, 1956, AM ANTHROPOL, V58, P1017, DOI 10.1525/aa.1956.58.6.02a00040; KRZYWICKI L, 1934, PRIMITIVE SOCIETY IT; LAUGHLIN WS, 1950, COLD SPRING HARB SYM, V15, P165, DOI 10.1101/SQB.1950.015.01.019; LAYRISSE M, 1962, AM J PHYS ANTHROPOL, V20, P411, DOI 10.1002/ajpa.1330200402; LAYRISSE M, 1960, ANTIGENO SISTEMA SAN; Levi-Strauss C., 1963, STRUCTURAL ANTHR; LEVISTRAUSS C, 1944, T NEW YORK ACADEMY S, V7, P16, DOI DOI 10.1111/J.2164-0947.1944.TB00171.X; LEWONTIN RC, 1966, GENETICS, V54, P595; LIVINGSTONE FRANK B., 1960, HUMAN BIOL, V32, P17; LUNING KG, 1966, MUTAT RES, V3, P340, DOI 10.1016/0027-5107(66)90040-6; MACCLUER JW, 1963, AM J HUM GENET, V15, P191; MATSON GA, 1963, AM J PHYS ANTHROPOL, V21, P1, DOI 10.1002/ajpa.1330210102; MAYBURYLEWIS DL, 1967, AKWESHAVANTE SOCIETY; MILKMAN RD, 1967, GENETICS, V55, P493; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Mourant AE., 1958, ABO BLOOD GROUPS; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; NEEL JV, 1967, FURTHER STUDIES XAVA; NICHOLLS EM, 1965, AM J HUM GENET, V17, P293; NIJENHUIS LE, 1966, AM J HUM GENET, V18, P39; NISWANDER JD, 1967, AM J HUM GENET, V19, P543; NISWANDER JD, 1967, AM J HUM GENET, V19, P490; OBRIEN WM, 1966, ANN RHEUM DIS, V25, P117, DOI 10.1136/ard.25.2.117; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; OTTEN CM, 1967, CURR ANTHROPOL, V8, P209, DOI 10.1086/200794; PLATT JR, 1966, STEP MAN; Polunin I, 1953, J R ANTHROPOL INST G, V83, P215, DOI 10.2307/2844033; POST RH, 1962, EUGEN QUART, V9, P189, DOI 10.1080/19485565.1962.9987526; POST RH, 1966, EUGEN QUART, V13, P101, DOI 10.1080/19485565.1966.9987653; RIDE LT, 1934, CADUCEUS, V13, P126; SABIN AB, 1954, GENETICS INHERITANCE, P57; SALZANO FM, 1964, ACTA GENET MED GEMEL, V13, P278, DOI 10.1017/S1120962300015596; SALZANO FM, 1961, HUM BIOL, V33, P110; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SALZANO FM, 1961, AM J PHYS ANTHROPOL, V19, P391, DOI 10.1002/ajpa.1330190412; SCHULL W, 1963, GENETIC SELECTION ED; Schull WJ, 1965, EFFECTS INBREEDING J; SHREFFLER DC, 1967, AM J HUM GENET, V19, P514; SIMMONS RT, 1965, OCEANIA, V35, P218, DOI 10.1002/j.1834-4461.1965.tb00855.x; SIMMONS RT, 1962, AM J PHYS ANTHROPOL, V20, P303, DOI 10.1002/ajpa.1330200314; SIMMONS RT, 1964, AM J PHYS ANTHROPOL, V22, P5, DOI 10.1002/ajpa.1330220112; SVED JA, 1967, GENETICS, V55, P469; TASHIAN RE, 1967, AM J HUM GENET, V19, P524; TURNBULL C. M., 1965, WAYWARD SERVANTS; Vallois HV, 1937, ANTHROPOLOGIE, V47, P499; VALLOIS HV, 1960, APPLICATION QUANTITA, P181; VALLOIS HV, 28 VIK FUND PUBL ANT; VOGEL F., 1960, ACTA GENET ET STATIST MED, V10, P267; WAHLUND S, 1928, HEREDITAS, V2, P65; WALLACE BRUCE, 1965, AMER NATUR, V99, P335, DOI 10.1086/282375; WEBSTER LT, 1932, HARVEY LECT, P154; WRIGHT S, 1966, P NATL ACAD SCI USA, V55, P1074, DOI 10.1073/pnas.55.5.1074; Wright S, 1931, GENETICS, V16, P0097; Wynne-Edwards V. C., 1962, pUnpaginated; YASUDA M, 1966, THESIS U HAWAII	108	123	128	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					554	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	98570	6036274				2022-12-18	WOS:A19679857000008
J	Singleton, MV; Guthery, SL; Voelkerding, KV; Chen, K; Kennedy, B; Margraf, RL; Durtschi, J; Eilbeck, K; Reese, MG; Jorde, LB; Huff, CD; Yandell, M				Singleton, Marc V.; Guthery, Stephen L.; Voelkerding, Karl V.; Chen, Karin; Kennedy, Brett; Margraf, Rebecca L.; Durtschi, Jacob; Eilbeck, Karen; Reese, Martin G.; Jorde, Lynn B.; Huff, Chad D.; Yandell, Mark			Phevor Combines Multiple Biomedical Ontologies for Accurate Identification of Disease-Causing Alleles in Single Individuals and Small Nuclear Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNE DYSREGULATION; PHENOTYPE ONTOLOGY; STAT1 MUTATIONS; POLYENDOCRINOPATHY; ENTEROPATHY; VARIANTS; VAAST; TOOL	Phevor integrates phenotype, gene function, and disease information with personal genomic data for improved power to identify disease-causing alleles. Phevor works by combining knowledge resident in multiple biomedical ontologies with the outputs of variant-prioritization tools. It does so by using an algorithm that propagates information across and between ontologies. This process enables Phevor to accurately reprioritize potentially damaging alleles identified by variant-prioritization tools in light of gene function, disease, and phenotype knowledge. Phevor is especially useful for single-exome and family-trio-based diagnostic analyses, the most commonly occurring clinical scenarios and ones for which existing personal genome diagnostic tools are most inaccurate and underpowered. Here, we present a series of benchmark analyses illustrating Phevor's performance characteristics. Also presented are three recent Utah Genome Project case studies in which Phevor was used to identify disease-causing alleles. Collectively, these results show that Phevor improves diagnostic accuracy not only for individuals presenting with established disease phenotypes but also for those with previously undescribed and atypical disease presentations. Importantly, Phevor is not limited to known diseases or known disease-causing alleles. As we demonstrate, Phevor can also use latent information in ontologies to discover genes and disease-causing alleles not previously associated with disease.	[Singleton, Marc V.; Kennedy, Brett; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Sch Med, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA; [Eilbeck, Karen; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Salt Lake City, UT 84112 USA; [Eilbeck, Karen; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Res Ctr Genet Discovery, Salt Lake City, UT 84112 USA; [Voelkerding, Karl V.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Voelkerding, Karl V.; Margraf, Rebecca L.; Durtschi, Jacob] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA; [Guthery, Stephen L.] Univ Utah, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Salt Lake City, UT 84112 USA; [Chen, Karin] Univ Utah, Dept Pediat, Div Allergy Immunol & Rheumatol, Salt Lake City, UT 84112 USA; [Eilbeck, Karen] Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA; [Reese, Martin G.] Omicia Inc, Oakland, CA 94612 USA; [Huff, Chad D.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77230 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center	Yandell, M (corresponding author), Univ Utah, Sch Med, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA.	myandell@genetics.utah.edu		Kennedy, Brett/0000-0001-5018-5654; Eilbeck, Karen/0000-0002-0831-6427	National Institute of General Medical Sciences (NIGMS) [R01GM104390]; NIGMS [R01GM104390]; National Human Genome Research Institute (NHGRI) [R44HG006579]; NHGRI [R01HG004341]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK084198]; NIDDK [DK091374]; NIH National Center for Advancing Translational Sciences [1ULTR001067]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001066, UL1TR001067, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004341, R44HG006579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104390] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Phevor development was support by National Institute of General Medical Sciences (NIGMS) grant R01GM104390 to C.D.H., L.B.J., and M.Y. M.V.S. was supported by NIGMS grant R01GM104390 and by National Human Genome Research Institute (NHGRI) grant R44HG006579 to M.Y. and M.G.R. K.E. was supported by NHGRI grant R01HG004341. S.L.G. and C.D.H. were supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK084198. Additional support for S.L.G. was provided by NIDDK grant DK091374. Clinical sequencing and analyses were supported in part by the Utah Genome Project, the University of Utah's Program in Personalized Health Care, and the Utah Science, Technology, and Research Center for Genetic Discovery. Research reported in this publication was also supported by grant 1ULTR001067 from the NIH National Center for Advancing Translational Sciences. We thank Linda Book, John Bohnsack, W. Daniel Jackson, and Michael Pulsipher for their assistance in enrolling subjects.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baghdasaryan A., 2013, MOL ASPECTS MED; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Fauci A. S., 2008, HARRISONS PRINCIPLES, P237; Hu H, 2013, GENET EPIDEMIOL, V37, P622, DOI 10.1002/gepi.21743; Kohler S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-418; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; McElroy JJ, 2013, HUM GENET, V132, P935, DOI 10.1007/s00439-013-1304-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Robinson P.N., 2011, INTRO BIOONTOLOGIES; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith CL, 2012, MAMM GENOME, V23, P653, DOI 10.1007/s00335-012-9421-3; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yandell M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000218; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	38	122	125	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					599	610		10.1016/j.ajhg.2014.03.010	http://dx.doi.org/10.1016/j.ajhg.2014.03.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24702956	hybrid, Green Published			2022-12-18	WOS:000333765300010
J	Tragante, V; Barnes, MR; Ganesh, SK; Lanktree, MB; Guo, W; Franceschini, N; Smith, EN; Johnson, T; Holmes, MV; Padmanabhan, S; Karczewski, KJ; Almoguera, B; Barnard, J; Baumert, J; Chang, YPC; Elbers, CC; Farrall, M; Fischer, ME; Gaunt, TR; Gho, JMIH; Gieger, C; Goel, A; Gong, Y; Isaacs, A; Kleber, ME; Leach, IM; McDonough, CW; Meijs, MFL; Melander, O; Nelson, CP; Nolte, IM; Pankratz, N; Price, TS; Shaffer, J; Shah, S; Tomaszewski, M; van der Most, PJ; Van Iperen, EPA; Vonk, JM; Witkowska, K; Wong, COL; Zhang, L; Beitelshees, AL; Berenson, GS; Bhatt, DL; Brown, M; Burt, A; Cooper-DeHoff, RM; Connell, JM; Cruickshanks, KJ; Curtis, SP; Davey-Smith, G; Delles, C; Gansevoort, RT; Guo, XQ; Haiqing, S; Hastie, CE; Hofker, MH; Hovingh, GK; Kim, DS; Kirkland, SA; Klein, BE; Klein, R; Li, YR; Maiwald, S; Newton-Cheh, C; O'Brien, ET; Onland-Moret, NC; Palmas, W; Parsa, A; Penninx, BW; Pettinger, M; Vasan, RS; Ranchalis, JE; Ridker, PM; Rose, LM; Sever, P; Shimbo, D; Steele, L; Stolk, RP; Thorand, B; Trip, MD; van Duijn, CM; Verschuren, WM; Wijmenga, C; Wyatt, S; Young, JH; Zwinderman, AH; Bezzina, CR; Boerwinkle, E; Casas, JP; Caulfield, MJ; Chakravarti, A; Chasman, DI; Davidson, KW; Doevendans, PA; Dominiczak, AF; FitzGerald, GA; Gums, JG; Fornage, M; Hakonarson, H; Halder, I; Hillege, HL; Illig, T; Jarvik, GP; Johnson, JA; Kastelein, JJP; Koenig, W; Kumari, M; Marz, W; Murray, SS; O'Connell, JR; Oldehinkel, AJ; Pankow, JS; Rader, DJ; Redline, S; Reilly, MP; Schadt, EE; Kottke-Marchant, K; Snieder, H; Snyder, M; Stanton, AV; Tobin, MD; Uitterlinden, AG; van der Harst, P; van der Schouw, YT; Samani, NJ; Watkins, H; Johnson, AD; Reiner, AP; Zhu, XF; de Bakker, PIW; Levy, D; Asselbergs, FW; Munroe, PB; Keating, BJ				Tragante, Vinicius; Barnes, Michael R.; Ganesh, Santhi K.; Lanktree, Matthew B.; Guo, Wei; Franceschini, Nora; Smith, Erin N.; Johnson, Toby; Holmes, Michael V.; Padmanabhan, Sandosh; Karczewski, Konrad J.; Almoguera, Berta; Barnard, John; Baumert, Jens; Chang, Yen-Pei Christy; Elbers, Clara C.; Farrall, Martin; Fischer, Mary E.; Gaunt, Tom R.; Gho, Johannes M. I. H.; Gieger, Christian; Goel, Anuj; Gong, Yan; Isaacs, Aaron; Kleber, Marcus E.; Leach, Irene Mateo; McDonough, Caitrin W.; Meijs, Matthijs F. L.; Melander, Olle; Nelson, Christopher P.; Nolte, Ilja M.; Pankratz, Nathan; Price, Tom S.; Shaffer, Jonathan; Shah, Sonia; Tomaszewski, Maciej; van der Most, Peter J.; Van Iperen, Erik P. A.; Vonk, Judith M.; Witkowska, Kate; Wong, Caroline O. L.; Zhang, Li; Beitelshees, Amber L.; Berenson, Gerald S.; Bhatt, Deepak L.; Brown, Morris; Burt, Amber; Cooper-DeHoff, Rhonda M.; Connell, John M.; Cruickshanks, Karen J.; Curtis, Sean P.; Davey-Smith, George; Delles, Christian; Gansevoort, Ron T.; Guo, Xiuqing; Haiqing, Shen; Hastie, Claire E.; Hofker, Marten H.; Hovingh, G. Kees; Kim, Daniel S.; Kirkland, Susan A.; Klein, Barbara E.; Klein, Ronald; Li, Yun R.; Maiwald, Steffi; Newton-Cheh, Christopher; O'Brien, Eoin T.; Onland-Moret, N. Charlotte; Palmas, Walter; Parsa, Afshin; Penninx, Brenda W.; Pettinger, Mary; Vasan, Ramachandran S.; Ranchalis, Jane E.; Ridker, Paul M.; Rose, Lynda M.; Sever, Peter; Shimbo, Daichi; Steele, Laura; Stolk, Ronald P.; Thorand, Barbara; Trip, Mieke D.; van Duijn, Cornelia M.; Verschuren, W. Monique; Wijmenga, Cisca; Wyatt, Sharon; Young, J. Hunter; Zwinderman, Aeilko H.; Bezzina, Connie R.; Boerwinkle, Eric; Casas, Juan P.; Caulfield, Mark J.; Chakravarti, Aravinda; Chasman, Daniel I.; Davidson, Karina W.; Doevendans, Pieter A.; Dominiczak, Anna F.; FitzGerald, Garret A.; Gums, John G.; Fornage, Myriam; Hakonarson, Hakon; Halder, Indrani; Hillege, Hans L.; Illig, Thomas; Jarvik, Gail P.; Johnson, Julie A.; Kastelein, John J. P.; Koenig, Wolfgang; Kumari, Meena; Maerz, Winfried; Murray, Sarah S.; O'Connell, Jeffery R.; Oldehinkel, Albertine J.; Pankow, James S.; Rader, Daniel J.; Redline, Susan; Reilly, Muredach P.; Schadt, Eric E.; Kottke-Marchant, Kandice; Snieder, Harold; Snyder, Michael; Stanton, Alice V.; Tobin, Martin D.; Uitterlinden, Andre G.; van der Harst, Pim; van der Schouw, Yvonne T.; Samani, Nilesh J.; Watkins, Hugh; Johnson, Andrew D.; Reiner, Alex P.; Zhu, Xiaofeng; de Bakker, Paul I. W.; Levy, Daniel; Asselbergs, Folkert W.; Munroe, Patricia B.; Keating, Brendan J.			Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-KAPPA-B; SUSCEPTIBILITY LOCUS; COMMON VARIANTS; DRUG DISCOVERY; PULSE PRESSURE; RISK-FACTORS; EXPRESSION; HYPERTENSION; DISEASE	Blood pressure (BP) is a heritable risk factor for cardiovascular disease. To investigate genetic associations with systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), and pulse pressure (PP), we genotyped similar to 50,000 SNPs in up to 87,736 individuals of European ancestry and combined these in a meta-analysis. We replicated findings in an independent set of 68,368 individuals of European ancestry. Our analyses identified 11 previously undescribed associations in independent loci containing 31 genes including PDE1A, HLA-DQB1, CDK6, PRKAG2, VCL, H19, NUCB2, RELA, HOXC@ complex, FBN1, and NFAT5 at the Bonferroni-corrected array-wide significance threshold (p < 6 x 10(-7)) and confirmed 27 previously reported associations. Bioinformatic analysis of the 11 loci provided support for a putative role in hypertension of several genes, such as CDK6 and NUCB2. Analysis of potential pharmacological targets in databases of small molecules showed that ten of the genes are predicted to be a target for small molecules. In summary, we identified previously unknown loci associated with BP. Our findings extend our understanding of genes involved in BP regulation, which may provide new targets for therapeutic intervention or drug response stratification.	[Tragante, Vinicius; Gho, Johannes M. I. H.; Meijs, Matthijs F. L.; Doevendans, Pieter A.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands; [Tragante, Vinicius; Elbers, Clara C.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Barnes, Michael R.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Inst Hlth Biomed Res Unit, London EC1M 6BQ, England; [Ganesh, Santhi K.] Univ Michigan Hlth Syst, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Ganesh, Santhi K.] Univ Michigan Hlth Syst, Dept Human Genet, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Lanktree, Matthew B.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Guo, Wei; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Smith, Erin N.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Smith, Erin N.] Univ Calif San Diego, Radys Childrens Hosp, La Jolla, CA 92093 USA; [Johnson, Toby; Witkowska, Kate; Wong, Caroline O. L.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, London EC1M 6BQ, England; [Johnson, Toby; Witkowska, Kate; Wong, Caroline O. L.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; [Holmes, Michael V.; Steele, Laura; Keating, Brendan J.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Padmanabhan, Sandosh; Dominiczak, Anna F.] Univ Glasgow, BHF, Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Karczewski, Konrad J.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Almoguera, Berta; Li, Yun R.; Keating, Brendan J.] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Barnard, John; Zhang, Li] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Baumert, Jens; Thorand, Barbara] Helmholtz Zentrum Mu nchen, German Res Ctr Environm Hlth, Inst Epidemiol2, D-85764 Neuherberg, Germany; [Chang, Yen-Pei Christy] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Chang, Yen-Pei Christy] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Elbers, Clara C.; Hofker, Marten H.; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Farrall, Martin; Goel, Anuj; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Farrall, Martin; Goel, Anuj; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Fischer, Mary E.; Cruickshanks, Karen J.; Klein, Barbara E.; Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA; [Gaunt, Tom R.; Davey-Smith, George] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Gong, Yan; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Gong, Yan; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Ctr Pharmacogenom, Gainesville, FL 32610 USA; [Isaacs, Aaron; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 GE Rotterdam, Netherlands; [Kleber, Marcus E.; Jarvik, Gail P.; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, D-68167 Mannheim, Germany; [Leach, Irene Mateo; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Melander, Olle] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Melander, Olle] Skane Univ Hosp, Ctr Emergency Med, S-20502 Malmo, Sweden; [Nelson, Christopher P.; Tomaszewski, Maciej; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Hosp, NIHR, Lecister Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Nolte, Ilja M.; van der Most, Peter J.; Vonk, Judith M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Inst Human Genet, Minneapolis, MN 55455 USA; [Price, Tom S.] Inst Psychiat, MRC, SGDP Ctr, London SE5 8AF, England; [Shaffer, Jonathan; Shimbo, Daichi] Columbia Univ, Dept Med, New York, NY 10032 USA; [Shah, Sonia] UCL, Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Van Iperen, Erik P. A.; van der Harst, Pim; Asselbergs, Folkert W.] ICIN, Durrer Ctr Cardiogenet Res, Netherlands Heart Inst, NL-3511 GC Utrecht, Netherlands; [Van Iperen, Erik P. A.; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Beitelshees, Amber L.; Haiqing, Shen; Parsa, Afshin] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Burt, Amber; Ranchalis, Jane E.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Cruickshanks, Karen J.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53726 USA; [Curtis, Sean P.] Merck Res Labs, Rahway, NJ 07065 USA; [Delles, Christian; Hastie, Claire E.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Med, Div Nephrol, NL-9700 RB Groningen, Netherlands; [Guo, Xiuqing] Cedars Sinai Med Ctr, PEDS, Los Angeles, CA 90048 USA; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Div, NL-9700 RB Groningen, Netherlands; [Hovingh, G. Kees; Maiwald, Steffi; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kim, Daniel S.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Kim, Daniel S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kirkland, Susan A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS B3H 1V7, Canada; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [O'Brien, Eoin T.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Pettinger, Mary] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ridker, Paul M.; Rose, Lynda M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1LA, England; [Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Verschuren, W. Monique] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Wyatt, Sharon] Univ Mississippi, Med Ctr, Sch Nursing, Jackson, MS 39216 USA; [Wyatt, Sharon] Univ Mississippi, Med Ctr, Sch Med, Jackson, MS 39216 USA; [Young, J. Hunter] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Mol & Expt Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX 77030 USA; [Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Davidson, Karina W.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Davidson, Karina W.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Gums, John G.] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Gums, John G.] Univ Florida, Dept Community Hlth, Gainesville, FL 32610 USA; [Gums, John G.] Univ Florida, Dept Family Med, Gainesville, FL 32610 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Halder, Indrani] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; [Illig, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, Div Populat Hlth, London WC1E 7HB, England; [Jarvik, Gail P.] Synlab Serv GmbH, Synlab Acad, D-69214 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Inst Clin Med, A-8036 Graz, Austria; [Maerz, Winfried] Med Univ Graz, Chem Lab Diagnost, A-8036 Graz, Austria; [Murray, Sarah S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92037 USA; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, NL-9700 RB Groningen, Netherlands; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Redline, Susan] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kottke-Marchant, Kandice] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Stanton, Alice V.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Johnson, Andrew D.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Framingham, MA 01702 USA; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London WC1E 6BT, England; [Keating, Brendan J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of London; Queen Mary University London; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; McMaster University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Pennsylvania; Pennsylvania Medicine; University of Glasgow; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cleveland Clinic Foundation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Utrecht University; Utrecht University Medical Center; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Wisconsin System; University of Wisconsin Madison; University of Bristol; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; University of Groningen; Lund University; Lund University; Skane University Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities; University of London; King's College London; Columbia University; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University System of Maryland; University of Maryland Baltimore; Tulane University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Washington; University of Washington Seattle; University of Dundee; University of Wisconsin System; University of Wisconsin Madison; Merck & Company; University of Glasgow; University of Groningen; Cedars Sinai Medical Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Dalhousie University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; University College Dublin; Vrije Universiteit Amsterdam; Fred Hutchinson Cancer Center; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Groningen; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Johns Hopkins University; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Ulm University; University of London; University College London; SYNLAB Group; Medical University of Graz; Medical University of Graz; University of California System; University of California San Diego; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; Royal College of Surgeons - Ireland; University of Leicester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London; University College London; University of Pennsylvania; Pennsylvania Medicine	Munroe, PB (corresponding author), Queen Mary Univ London, London EC1M 6BQ, England.	p.b.munroe@qmul.ac.uk; bkeating@mail.med.upenn.edu	Price, Thomas S./B-7372-2008; Levy, Daniel/ABF-6873-2021; Shah, Sonia/N-7547-2013; Wijmenga, Cisca/D-2173-2009; Penninx, Brenda WJH/S-7627-2017; Wijmenga, Cisca/AAE-7719-2019; Lanktree, Matthew Bruce/I-9790-2019; Kastelein, John/AAF-7950-2020; Thorand, Barbara/B-5349-2014; Davey Smith, George/A-7407-2013; Dominiczak, Anna F/P-9390-2017; Jarvik, Gail P/N-6476-2014; Onland-Moret, N. Charlotte/G-9185-2011; Ramachandran, Vasan/Y-2527-2019; Padmanabhan, Sandosh/S-3963-2016; Davidson, Karina/AAG-2388-2019; Gaunt, Tom R/O-3918-2014; Davidson, Karina/GWC-0996-2022; de Bakker, Paul IW/B-8730-2009; Levy, Daniel/ABB-2752-2021; Vonk, Judith/K-8477-2019; Johnson, Andrew D/G-6520-2013; Stanton, Alice V/F-4697-2012; van der Schouw, Yvonne T./F-8327-2014; Asselbergs, Folkert W./ABD-6752-2021; Zhu, Xiaofeng/O-6874-2019; Vonk, Judith M/ABA-3009-2020; Hemingway, Harry/C-1219-2009; Karczewski, Jakub/L-7326-2018	Price, Thomas S./0000-0001-7356-2109; Levy, Daniel/0000-0003-1843-8724; Shah, Sonia/0000-0001-5860-4526; Penninx, Brenda WJH/0000-0001-7779-9672; Wijmenga, Cisca/0000-0002-5635-1614; Lanktree, Matthew Bruce/0000-0002-5750-6286; Thorand, Barbara/0000-0002-8416-6440; Davey Smith, George/0000-0002-1407-8314; Dominiczak, Anna F/0000-0003-4913-3608; Jarvik, Gail P/0000-0002-6710-8708; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Ramachandran, Vasan/0000-0001-7357-5970; Davidson, Karina/0000-0002-9162-477X; Gaunt, Tom R/0000-0003-0924-3247; Davidson, Karina/0000-0002-9162-477X; de Bakker, Paul IW/0000-0001-7735-7858; Vonk, Judith/0000-0001-7531-4547; Johnson, Andrew D/0000-0001-6369-5178; van der Schouw, Yvonne T./0000-0002-4605-435X; Asselbergs, Folkert W./0000-0002-1692-8669; Vonk, Judith M/0000-0001-7531-4547; Padmanabhan, Sandosh/0000-0003-3869-5808; Bezzina, Connie/0000-0002-0633-3514; Caulfield, Mark/0000-0001-9295-3594; Pankow, James/0000-0001-7076-483X; Kirkland, Susan/0000-0002-8182-2369; Reilly, Muredach/0000-0002-3035-9386; Kleber, Marcus/0000-0003-0663-7275; Tomaszewski, Maciej/0000-0001-8215-6567; Goel, Anuj/0000-0003-2307-4021; Watkins, Hugh/0000-0002-5287-9016; Johnson, Toby/0000-0002-5998-3270; Karczewski, Konrad/0000-0003-2878-4671; Stanton, Alice/0000-0002-4961-165X; Zhu, Xiaofeng/0000-0003-0037-411X; Van Duijn, Cornelia/0000-0002-2374-9204; Hemingway, Harry/0000-0003-2279-0624; Li, Yun Rose/0000-0002-8077-4975; Stolk, Ronald/0000-0002-0518-1205; Karczewski, Jakub/0000-0001-9322-7842; Pankratz, Nathan/0000-0001-5958-693X; Kim, Daniel Seung/0000-0003-2971-1909; Tobin, Martin/0000-0002-3596-7874; Gieger, Christian/0000-0001-6986-9554; Barnes, Michael/0000-0001-9097-7381; Snyder, Michael/0000-0003-0784-7987; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Munroe, Patricia/0000-0002-4176-2947; McDonough, Caitrin/0000-0001-6393-7288; Nelson, Christopher/0000-0001-8025-2897; s, hema/0000-0002-3440-9475; Koenig, Wolfgang/0000-0002-2064-9603; Melander, Olle/0000-0002-2581-484X	MRC [G0802432, G0902313, MC_UU_12013/1, MC_UU_12013/8, MR/K013351/1, G9521010] Funding Source: UKRI; National Institute for Health Research [NF-SI-0512-10052, NF-SI-0508-10116, NF-SI-0513-10059, NF-SI-0512-10113] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, R01HL074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592, R37AG011099, R01AG021917] Funding Source: NIH RePORTER; British Heart Foundation [FS/12/33/29561, PG/07/085/23349, SP/08/002/24118, FS/12/8/29377, FS/14/12/30540, PG/09/022/26739, FS/11/35/28871] Funding Source: Medline; Medical Research Council [G0802432, MC_UU_12013/8, MR/K013351/1, MR/K006584/1, MC_UU_12013/1, G0902313, G9521010] Funding Source: Medline; NCATS NIH HHS [UL1 TR000064, UL1 TR000124] Funding Source: Medline; NHLBI NIH HHS [R01 HL074730, R01 HL088120] Funding Source: Medline; NIA NIH HHS [R01 AG021917, R01 AG016592, R37 AG011099] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, P30 DK072488] Funding Source: Medline; NIGMS NIH HHS [U01 GM074492] Funding Source: Medline; NLM NIH HHS [T15 LM007033] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust)		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Angelone T, 2013, CELL MOL LIFE SCI, V70, P495, DOI 10.1007/s00018-012-1138-7; [Anonymous], 2011, PLOS GENET, V7; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Cvek B, 2007, CURR PHARM DESIGN, V13, P3155, DOI 10.2174/138161207782110390; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Diercks GFH, 2000, EUR HEART J, V21, P1922, DOI 10.1053/euhj.2000.2248; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ekins S, 2007, BRIT J PHARMACOL, V152, P21, DOI 10.1038/sj.bjp.0707306; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giachini FR, 2011, HYPERTENSION, V57, P655, DOI 10.1161/HYPERTENSIONAHA.110.164327; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Halterman JA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00313; Halterman JA, 2011, ARTERIOSCL THROM VAS, V31, P2287, DOI 10.1161/ATVBAHA.111.232165; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kim YH, 2011, CARDIOVASC RES, V91, P519, DOI 10.1093/cvr/cvr110; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kokubo Y, 2006, HYPERTENS RES, V29, P611, DOI 10.1291/hypres.29.611; Kompass KS, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-6; Kupper N, 2005, HYPERTENSION, V45, P80, DOI 10.1161/01.HYP.0000149952.84391.54; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Liu YI, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S14; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Medley TL, 2002, CIRCULATION, V105, P810, DOI 10.1161/hc0702.104129; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Powell JT, 1997, HEART, V78, P396, DOI 10.1136/hrt.78.4.396; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S; Xu WM, 1998, DEVELOPMENT, V125, P327; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhan WH, 2010, AM J EPIDEMIOL, V171, P260, DOI 10.1093/aje/kwp370; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhu F, 2011, CLIN CARDIOL, V34, P302, DOI 10.1002/clc.20852; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	114	122	125	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					349	360		10.1016/j.ajhg.2013.12.016	http://dx.doi.org/10.1016/j.ajhg.2013.12.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24560520	Green Published, Bronze			2022-12-18	WOS:000332611400009
J	Simons, C; Wolf, NI; McNeil, N; Caldovic, L; Devaney, JM; Takanohashi, A; Crawford, J; Ru, KL; Grimmond, SM; Miller, D; Tonduti, D; Schmidt, JL; Chudnow, RS; van Coster, R; Lagae, L; Kisler, J; Sperner, J; van der Knaap, MS; Schiffmann, R; Taft, RJ; Vanderver, A				Simons, Cas; Wolf, Nicole I.; McNeil, Nathan; Caldovic, Ljubica; Devaney, Joseph M.; Takanohashi, Asako; Crawford, Joanna; Ru, Kelin; Grimmond, Sean M.; Miller, David; Tonduti, Davide; Schmidt, Johanna L.; Chudnow, Robert S.; van Coster, Rudy; Lagae, Lieven; Kisler, Jill; Sperner, Juergen; van der Knaap, Marjo S.; Schiffmann, Raphael; Taft, Ryan J.; Vanderver, Adeline			A De Novo Mutation in the beta-Tubulin Gene TUBB4A Results in the Leukoencephalopathy Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; H-ABC; FRAMEWORK; VARIANTS	Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) is a rare hereditary leukoencephalopathy that was originally identified by MRI pattern analysis, and it has thus far defied all attempts at identifying the causal mutation. Only 22 cases are published in the literature to date. We performed exome sequencing on five family trios, two family quartets, and three single probands, which revealed that all eleven H-ABC-diagnosed individuals carry the same de novo single-nucleotide TUBB4A mutation resulting in nonsynonymous change p.Asp249Asn. Detailed investigation of one of the family quartets with the singular finding of an H-ABC-affected sibling pair revealed maternal mosaicism for the mutation, suggesting that rare de novo mutations that are initially phenotypically neutral in a mosaic individual can be disease causing in the subsequent generation. Modeling of TUBB4A shows that the mutation creates a nonsynonymous change at a highly conserved asparagine that sits at the intradimer interface of alpha-tubulin and beta-tubulin, and this change might affect tubulin dimerization, microtubule polymerization, or microtubule stability. Consistent with H-ABC's clinical presentation, TUBB4A is highly expressed in neurons, and a recent report has shown that an N-terminal alteration is associated with a heritable dystonia. Together, these data demonstrate that a single de novo mutation in TUBB4A results in H-ABC.	[Simons, Cas; Crawford, Joanna; Ru, Kelin; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Wolf, Nicole I.; van der Knaap, Marjo S.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [McNeil, Nathan; Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [Caldovic, Ljubica; Devaney, Joseph M.; Takanohashi, Asako; Schmidt, Johanna L.; Vanderver, Adeline] Childrens Natl Med Ctr, Ctr Genet Med Res, Washington, DC 20010 USA; [Grimmond, Sean M.; Miller, David] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Tonduti, Davide] Univ Pavia, Dept Publ Hlth Neurosci Expt & Forens Med, I-27100 Pavia, Italy; [Chudnow, Robert S.] Texas Child Neurol, Plano, TX 75075 USA; [van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Lagae, Lieven] Univ Hosp Leuven, Dept Pediat Neurol, B-3000 Louvain, Belgium; [Kisler, Jill] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Dept Paediat Neurol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Kisler, Jill] Child Neurol Serv, D-23501 Lubeck, Germany	University of Queensland; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Baylor Scott & White Health; Baylor University Medical Center; Children's National Health System; University of Queensland; University of Pavia; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Taft, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.taft@uq.edu.au; avanderv@childrensnational.org	Grimmond, Sean/K-3246-2019; Vanderver, Adeline/CAG-5072-2022; Grimmond, Sean M/J-5304-2016; Crawford, Joanna/F-9135-2013; Wolf, Nicole I/H-3943-2014; Simons, Cas/A-7905-2011; tonduti, davide/K-1673-2016	Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Crawford, Joanna/0000-0003-0786-6889; Wolf, Nicole I/0000-0003-1721-0728; Simons, Cas/0000-0003-3147-8042; tonduti, davide/0000-0001-9371-7454; Takanohashi, Asako/0000-0003-3292-1595; Vanderver, Adeline/0000-0002-6290-6751; Cadwgan, Jill/0000-0002-1198-8400	National Institutes of Health Intramural Program; Myelin Disorders Bioregistry Project, ZonMw TOP grant [91211005]; Institute for Molecular Bioscience Core Sequencing facility; NeCTAR Genomics Virtual Lab; University of Queensland Foundation; Australian Research Council;  [K08NS060695]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myelin Disorders Bioregistry Project, ZonMw TOP grant; Institute for Molecular Bioscience Core Sequencing facility; NeCTAR Genomics Virtual Lab; University of Queensland Foundation(University of Queensland); Australian Research Council(Australian Research Council); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health Intramural Program, the Myelin Disorders Bioregistry Project, ZonMw TOP grant 91211005, the Institute for Molecular Bioscience Core Sequencing facility, the NeCTAR Genomics Virtual Lab (G.V.L.), and a University of Queensland Foundation Research Excellence Award. A.V. is supported by K08NS060695. R.J.T. is supported by an Australian Research Council Discovery Early Career Research Award and is a consultant to Isis Pharmaceuticals.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; Davis B, 2008, J VET INTERN MED, V22, P540, DOI 10.1111/j.1939-1676.2008.0085.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LEE MGS, 1984, NUCLEIC ACIDS RES, V12, P5823, DOI 10.1093/nar/12.14.5823; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mercimek-Mahmutoglu S, 2005, NEUROPEDIATRICS, V36, P223, DOI 10.1055/s-2005-865715; Mercimek-Mahmutoglu S, 2007, TOHOKU J EXP MED, V211, P95, DOI 10.1620/tjem.211.95; Narumi Y, 2011, CLIN DYSMORPHOL, V20, P166, DOI 10.1097/MCD.0b013e32834659a8; SAVAGE C, 1994, J CELL SCI, V107, P2165; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; van der Knaap MS, 2007, NEUROLOGY, V69, P166, DOI 10.1212/01.wnl.0000265592.74483.a6; van der Knaap MS, 2002, AM J NEURORADIOL, V23, P1466; Wakusawa K, 2007, TOHOKU J EXP MED, V213, P373, DOI 10.1620/tjem.213.373; Wakusawa K, 2006, TOHOKU J EXP MED, V209, P163, DOI 10.1620/tjem.209.163; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilcox RA, 2011, MOVEMENT DISORD, V26, P2404, DOI 10.1002/mds.23866	24	122	127	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					767	773		10.1016/j.ajhg.2013.03.018	http://dx.doi.org/10.1016/j.ajhg.2013.03.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23582646	Green Published, Bronze			2022-12-18	WOS:000318582800011
J	Taft, RJ; Vanderver, A; Leventer, RJ; Damiani, SA; Simons, C; Grimmond, SM; Miller, D; Schmidt, J; Lockhart, PJ; Pope, K; Ru, KL; Crawford, J; Rosser, T; de Coo, IFM; Juneja, M; Verma, IC; Prabhakar, P; Blaser, S; Raiman, J; Pouwels, PJW; Bevova, MR; Abbink, TEM; van der Knaap, MS; Wolf, NI				Taft, Ryan J.; Vanderver, Adeline; Leventer, Richard J.; Damiani, Stephen A.; Simons, Cas; Grimmond, Sean M.; Miller, David; Schmidt, Johanna; Lockhart, Paul J.; Pope, Kate; Ru, Kelin; Crawford, Joanna; Rosser, Tena; de Coo, Irenaeus F. M.; Juneja, Monica; Verma, Ishwar C.; Prabhakar, Prab; Blaser, Susan; Raiman, Julian; Pouwels, Petra J. W.; Bevova, Marianna R.; Abbink, Truus E. M.; van der Knaap, Marjo S.; Wolf, Nicole I.			Mutations in DARS Cause Hypomyelination with Brain Stem and Spinal Cord Involvement and Leg Spasticity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA-SYNTHETASE; MARIE-TOOTH-DISEASE; DNA-SEQUENCING DATA; LACTATE ELEVATION; PERRAULT SYNDROME; HEARING-LOSS; LEUKOENCEPHALOPATHY; AMINOACYLATION; FRAMEWORK; GENE	Inherited white-matter disorders are a broad class of diseases for which treatment and classification are both challenging. Indeed, nearly half of the children presenting with a leukoencephalopathy remain without a specific diagnosis. Here, we report on the application of high-throughput genome and exome sequencing to a cohort of ten individuals with a leukoencephalopathy of unknown etiology and clinically characterized by hypomyelination with brain stem and spinal cord involvement and leg spasticity (HBSL), as well as the identification of compound-heterozygous and homozygous mutations in cytoplasmic aspartyl-tRNA synthetase (DARS). These mutations cause nonsynonymous changes to seven highly conserved amino acids, five of which are unchanged between yeast and man, in the DARS C-terminal lobe adjacent to, or within, the active-site pocket. Intriguingly, HBSL bears a striking resemblance to leukoencephalopathy with brain stem and spinal cord involvement and elevated lactate (LBSL), which is caused by mutations in the mitochondria-specific DARS2, suggesting that these two diseases might share a common underlying molecular pathology. These findings add to the growing body of evidence that mutations in tRNA synthetases can cause a broad range of neurologic disorders.	[Taft, Ryan J.; Simons, Cas; Ru, Kelin; Crawford, Joanna] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Vanderver, Adeline; Schmidt, Johanna] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Leventer, Richard J.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic 3052, Australia; [Leventer, Richard J.; Lockhart, Paul J.; Pope, Kate] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Damiani, Stephen A.] Mission Massimo Fdn, Melbourne, Vic 3000, Australia; [Grimmond, Sean M.; Miller, David] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Rosser, Tena] Childrens Hosp Los Angeles, Dept Neurol, Los Angeles, CA 90027 USA; [de Coo, Irenaeus F. M.] Erasmus MC, Dept Neurol, NL-3000 Rotterdam, Netherlands; [Juneja, Monica] Maulana Azad Med Coll & Associated Lok Nayak Hosp, Child Dev Ctr, Dept Pediat, New Delhi 110002, India; [Verma, Ishwar C.] Sir Ganga Ram Hosp, Ctr Med Genet, New Delhi 110060, India; [Prabhakar, Prab] Great Ormond St Hosp Sick Children, Dept Paediat Neurol, London W1W 5AH, England; [Blaser, Susan] Univ Toronto, Hosp Sick Children, Div Pediat Neuroradiol, Toronto, ON M5G 1X8, Canada; [Raiman, Julian] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Pouwels, Petra J. W.] Vrije Univ Amsterdam Med Ctr, Dept Phys & Med Technol, NL-1081 HZ Amsterdam, Netherlands; [Bevova, Marianna R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 HZ Amsterdam, Netherlands; [Abbink, Truus E. M.; van der Knaap, Marjo S.; Wolf, Nicole I.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1081 HZ Amsterdam, Netherlands	University of Queensland; Children's National Health System; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Queensland; Children's Hospital Los Angeles; Erasmus University Rotterdam; Erasmus MC; Maulana Azad Medical College; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Taft, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.taft@imb.uq.edu.au; n.wolf@vumc.nl	Abbink, Truus/N-4990-2018; Grimmond, Sean/K-3246-2019; Lockhart, Paul J/E-7753-2011; Vanderver, Adeline/CAG-5072-2022; Simons, Cas/A-7905-2011; Wolf, Nicole I/H-3943-2014; Grimmond, Sean M/J-5304-2016; Crawford, Joanna/F-9135-2013	Grimmond, Sean/0000-0002-8102-7998; Lockhart, Paul J/0000-0003-2531-8413; Simons, Cas/0000-0003-3147-8042; Wolf, Nicole I/0000-0003-1721-0728; Grimmond, Sean M/0000-0002-8102-7998; Crawford, Joanna/0000-0003-0786-6889; de Coo, Irenaeus/0000-0003-0533-7422; Vanderver, Adeline/0000-0002-6290-6751; van der Knaap, Marjo/0000-0001-8912-0954; Juneja, Monica/0000-0003-1894-7801; Prabhakar, Prab/0000-0002-1641-8714	Australian Research Council; National Institute of Neurologic Disorders and Stroke, National Institutes of Health [1K08NS060695]; Myelin Disorders Bioregistry Project; Mission Massimo Foundation; Victorian State Government Operational Infrastructure Support Program; Institute for Molecular Bioscience funds; NeCTAR Genomics Virtual Lab; University of Queensland Foundation Research Excellence Award; ZonMw TOP [91211005]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Institute of Neurologic Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Myelin Disorders Bioregistry Project; Mission Massimo Foundation; Victorian State Government Operational Infrastructure Support Program; Institute for Molecular Bioscience funds; NeCTAR Genomics Virtual Lab; University of Queensland Foundation Research Excellence Award(University of Queensland); ZonMw TOP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for the support and cooperation of the subjects with hypomyelination with brain stem and spinal cord involvement and leg spasticity, as well as their families. We wish to thank Illumina for their reagent contributions and continuous support of this project. We also thank Dennis Gascoigne and Michael Pheasant for their early support of this work and data-analysis advice, as well as David Amor of the Victorian Clinical Genetics Services. We are indebted to Emiel Polder and Nienke Postma for their help with DARS sequencing and to Marianna Bugiani for discussions on DABS expression. R.J.T. is supported by an Australian Research Council Discovery Early Career Research Award and is a consultant to Isis Pharmaceuticals. A.V. is supported by a grant from the National Institute of Neurologic Disorders and Stroke, National Institutes of Health (1K08NS060695) and by the Myelin Disorders Bioregistry Project. This work was supported by the Mission Massimo Foundation, the Victorian State Government Operational Infrastructure Support Program, the Institute for Molecular Bioscience funds, the NeCTAR Genomics Virtual Lab, a University of Queensland Foundation Research Excellence Award, and ZonMw TOP grant 91211005.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Hurto RL, 2011, ADV EXP MED BIOL, V722, P137, DOI 10.1007/978-1-4614-0332-6_9; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Klipcan L, 2004, J THEOR BIOL, V228, P389, DOI 10.1016/j.jtbi.2004.01.014; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; PREVOST G, 1989, EUR J BIOCHEM, V180, P351, DOI 10.1111/j.1432-1033.1989.tb14655.x; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564; van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	30	122	130	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					774	780		10.1016/j.ajhg.2013.04.006	http://dx.doi.org/10.1016/j.ajhg.2013.04.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643384	Bronze, Green Published			2022-12-18	WOS:000318582800012
J	Aldahmesh, MA; Mohamed, JY; Alkuraya, HS; Verma, IC; Puri, RD; Alaiya, AA; Rizzo, WB; Alkuraya, FS				Aldahmesh, Mohammed A.; Mohamed, Jawahir Y.; Alkuraya, Hisham S.; Verma, Ishwar C.; Puri, Ratna D.; Alaiya, Ayodele A.; Rizzo, William B.; Alkuraya, Fowzan S.			Recessive Mutations in ELOVL4 Cause Ichthyosis, Intellectual Disability, and Spastic Quadriplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SJOGREN-LARSSON-SYNDROME; LONG-CHAIN; MACULAR DYSTROPHY; FATTY-ACIDS; GENE; IDENTIFICATION; ELONGATION; PATHOGENESIS; EXPRESSION; MECHANISM	Very-long-chain fatty acids (VLCFAs) play important roles in membrane structure and cellular signaling, and their contribution to human health is increasingly recognized. Fatty acid elongases catalyze the first and rate-limiting step in VLCFA synthesis. Heterozygous mutations in ELOVL4, the gene encoding one of the elongases, are known to cause macular degeneration in humans and retinal abnormalities in mice. However, biallelic ELOVL4 mutations have not been observed in humans, and murine models with homozygous mutations die within hours of birth as a result of a defective epidermal water barrier. Here, we report on two human individuals with recessive ELOVL4 mutations revealed by a combination of autozygome analysis and exome sequencing. These individuals exhibit clinical features of ichthyosis, seizures, mental retardation, and spasticity-a constellation that resembles Sjogren-Larsson syndrome (SLS) but presents a more severe neurologic phenotype. Our findings identify recessive mutations in ELOVL4 as the cause of a neuro-ichthyotic disease and emphasize the importance of VLCFA synthesis in brain and cutaneous development.	[Aldahmesh, Mohammed A.; Mohamed, Jawahir Y.; Alkuraya, Hisham S.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Hisham S.] King Abdul Aziz Med City, King Fahad Natl Guard Hosp, Dept Surg, Div Ophthalmol, Riyadh 11426, Saudi Arabia; [Verma, Ishwar C.; Puri, Ratna D.] Sir Ganga Ram Hosp, Ctr Med Genet, New Delhi 110060, India; [Alaiya, Ayodele A.] King Faisal Specialist Hosp & Res Ctr, Stem Cell Therapy Program, Prote Unit, Riyadh 11211, Saudi Arabia; [Rizzo, William B.] Univ Nebraska Med Ctr, Munroe Meyer Inst Genet & Rehabil, Dept Pediat, Omaha, NE 68198 USA; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; University of Nebraska System; University of Nebraska Medical Center; King Saud University; King Khalid University Hospital; King Saud University; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009; Puri, Ratna Dua/AAY-5849-2021	Alkuraya, Fowzan S./0000-0003-4158-341X; Aldahmesh, Mohammed Abdullah/0000-0003-0130-9029	King Abdulaziz City for Science and Technology [08-MED497-20]; Dubai Harvard Foundation for Medical Research; National Institutes of Health [R01 AR 044552]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044552] Funding Source: NIH RePORTER	King Abdulaziz City for Science and Technology; Dubai Harvard Foundation for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the two families for their participation, the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their help, and Kristen Jackson and Dana S'Aulis for their technical assistance. This work was funded in part by the King Abdulaziz City for Science and Technology grant 08-MED497-20 (F.S.A.), Dubai Harvard Foundation for Medical Research Collaborative grant (F.S.A.), and National Institutes of Health grant R01 AR 044552 (W.B.R.).	Aldahmesh MA, 2011, J MED GENET, V48, P597, DOI 10.1136/jmedgenet-2011-100306; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; Brush RS, 2010, INVEST OPHTH VIS SCI, V51, P4422, DOI 10.1167/iovs.09-5134; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Edwards AO, 2001, INVEST OPHTH VIS SCI, V42, P2652; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Karan G, 2005, MOL VIS, V11, P657; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Maugeri A, 2004, INVEST OPHTH VIS SCI, V45, P4263, DOI 10.1167/iovs.04-0078; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; McMahon A, 2007, MOL VIS, V13, P258; McMahon A, 2011, J LIPID RES, V52, P1128, DOI 10.1194/jlr.M014415; Molday RS, 2010, PROG LIPID RES, V49, P476, DOI 10.1016/j.plipres.2010.07.002; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; POULOS A, 1992, ADV EXP MED BIOL, V318, P331; Raz-Prag D, 2006, INVEST OPHTH VIS SCI, V47, P3603, DOI 10.1167/iovs.05-1527; Rizzo WB, 1999, AM J HUM GENET, V65, P1547, DOI 10.1086/302681; Rizzo WB, 2007, MOL GENET METAB, V90, P1, DOI 10.1016/j.ymgme.2006.08.006; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; Vasireddy V, 2005, MOL VIS, V11, P665; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; UNIGENE; TISSUE SPECIFIC GENE	34	122	128	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					745	750		10.1016/j.ajhg.2011.10.011	http://dx.doi.org/10.1016/j.ajhg.2011.10.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22100072	Green Published, Bronze			2022-12-18	WOS:000298208700005
J	Huze, C; Bauche, S; Richard, P; Chevessier, F; Goillot, E; Gaudon, K; Ben Ammar, A; Chaboud, A; Grosjean, I; Lecuyer, HA; Bernard, V; Rouche, A; Alexandri, N; Kuntzer, T; Fardeau, M; Fournier, E; Brancaccio, A; Ruegg, MA; Koenig, J; Eymard, B; Schaeffer, L; Hantai, D				Huze, Caroline; Bauche, Stephanie; Richard, Pascale; Chevessier, Frederic; Goillot, Evelyne; Gaudon, Karen; Ben Ammar, Asma; Chaboud, Annie; Grosjean, Isabelle; Lecuyer, Heba-Aude; Bernard, Veronique; Rouche, Andree; Alexandri, Nektaria; Kuntzer, Thierry; Fardeau, Michel; Fournier, Emmanuel; Brancaccio, Andrea; Rueegg, Markus A.; Koenig, Jeanine; Eymard, Bruno; Schaeffer, Laurent; Hantai, Daniel			Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACETYLCHOLINE-RECEPTOR; MUSCLE AGRIN; DYSTROGLYCAN; BINDING; DIFFERENTIATION; DEFICIENT; PROTEIN; ALPHA; GLYCOPROTEIN; MAINTENANCE	We report the case of a congenital myasthenic syndrome due to a mutation in AGRN, the gene encoding agrin, ail extracellular matrix molecule released by the nerve and critical for formation of the neuromuscular junction. Gene analysis identified a homozygous missense mutation, c.5125G>C, leading to the p.Gly1709Arg variant. The muscle-biopsy specimen showed a major disorganization of the neuromuscular junction, including changes in the nerve-terminal cytoskeleton and fragmentation of the synaptic gutters. Experiments performed in nonmuscle cells or in cultured C2C12 myotubes and using recombinant mini-agrin for the mutated and the wildtype forms showed that the mutated form did not impair the activation of MuSK or change the total number of induced acetylcholine receptor aggregates. A solid-phase assay using the dystrophin glycoprotein complex showed that the mutation did not affect the binding of agrin to a-dystroglycan. Injection of wild-type or mutated agrin into rat soleus muscle induced the formation of nonsynaptic acetylcholine receptor clusters, but the mutant protein specifically destabilized the endogenous neuromuscular junctions. Importantly, the changes observed in rat muscle injected with mutant agrin recapitulated the pre- and post-synaptic modifications observed in the patient. These results indicate that the mutation does not interfere with the ability of agrin to induce postsynaptic structures but that it dramatically perturbs the maintenance of the neuromuscular junction.	[Bauche, Stephanie; Chevessier, Frederic; Ben Ammar, Asma; Rouche, Andree; Alexandri, Nektaria; Koenig, Jeanine; Eymard, Bruno; Hantai, Daniel] Hop La Pitie Salpetriere, Inst Cerveau & Moelle, Ctr Rech, INSERM,UMR S975, Paris, France; [Huze, Caroline; Goillot, Evelyne; Lecuyer, Heba-Aude; Schaeffer, Laurent] Univ Lyon, CNRS, Ecole Normale Super Lyon, UMR 5239,Equipe Differenciat Neuromusculaire, Lyon, France; [Bauche, Stephanie; Ben Ammar, Asma; Koenig, Jeanine; Eymard, Bruno; Hantai, Daniel] Univ Paris 06, Paris, France; [Bauche, Stephanie] Ecole Prat Hautes Etud, Paris, France; [Richard, Pascale; Gaudon, Karen] Hop La Pitie Salpetriere, AP HP, Unit fonct Cardiogenet & Myogenet, Paris, France; [Chevessier, Frederic] Max Planck Inst Med Res, D-69120 Heidelberg 1, Germany; [Ben Ammar, Asma] Univ Tunis El Manar, Inst Natl Neurol, Tunis, Tunisia; [Chaboud, Annie; Grosjean, Isabelle] Inst Federatif Rech, Lyon, France; [Bernard, Veronique] Univ Paris 05, INSERM, U686, Paris, France; [Kuntzer, Thierry] CHU Vaudois, Neurol Serv, Nerve Muscle Unit, CH-1011 Lausanne, Switzerland; [Kuntzer, Thierry] Univ Lausanne, Lausanne, Switzerland; [Fardeau, Michel; Eymard, Bruno; Hantai, Daniel] Hop La Pitie Salpetriere, AP HP, Ctr Natl Reference Maladies Neuromusculaires Pari, Inst Myol, Paris, France; [Fournier, Emmanuel] Hop La Pitie Salpetriere, AP HP, Serv Electrophysiol, Paris, France; [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol, Rome, Italy; [Rueegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland; [Koenig, Jeanine] Univ Bordeaux 2, F-33076 Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Universite de Tunis-El-Manar; Institut National de Neurologie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Basel; UDICE-French Research Universities; Universite de Bordeaux	Hantai, D (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle, Ctr Rech, INSERM,UMR S975, Paris, France.	d.hantai@institut-myologie.org	Brancaccio, Andrea/C-5876-2009; Ruegg, Markus/X-7256-2019; Kuntzer, Thierry/O-8589-2016; Bernard, Veronique/A-9691-2012	Brancaccio, Andrea/0000-0003-4690-8826; Ruegg, Markus/0000-0002-4974-9384; Kuntzer, Thierry/0000-0002-7788-1673; Bernard, Veronique/0000-0003-4748-5167; Bauche, Stephanie/0000-0002-6926-339X; Goillot, Evelyne/0000-0003-0026-4690; schaeffer, laurent/0000-0001-6600-503X; Richard, Pascale/0000-0002-2390-3005	Assistance Publique-Hopitaux de Paris [1036]; Reseaux Inserm; ANR-Maladies Rares [ANR-07-MRAR-001]; Association Francaise contre les Myopathies; Comite Mixte Franco-Tunisien Pour la Cooperation Universitaire [05G0809]; Contrat d'Interface AP-HP Inserm	Assistance Publique-Hopitaux de Paris; Reseaux Inserm; ANR-Maladies Rares(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Comite Mixte Franco-Tunisien Pour la Cooperation Universitaire; Contrat d'Interface AP-HP Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Assistance Publique-Hopitaux de Paris (PHRC AOM 1036), Reseaux Inserm, ANR-Maladies Rares (#ANR-07-MRAR-001), Association Francaise contre les Myopathies, Comite Mixte Franco-Tunisien Pour la Cooperation Universitaire (CMCU Project #05G0809), and a Contrat d'Interface AP-HP Inserm (to D.H.).	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Bezakova G, 2001, J CELL BIOL, V153, P1453, DOI 10.1083/jcb.153.7.1453; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bezakova G, 2001, P NATL ACAD SCI USA, V98, P9924, DOI 10.1073/pnas.171539698; Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654; BROOKE MH, 1969, J HISTOCHEM CYTOCHEM, V17, P431, DOI 10.1177/17.6.431; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Denzer AJ, 1997, CELL TISSUE RES, V290, P357, DOI 10.1007/s004410050941; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004; Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Ishigaki K, 2003, NEUROMUSCULAR DISORD, V13, P236, DOI 10.1016/S0960-8966(02)00243-2; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Pun S, 1997, J NEUROCHEM, V69, P2555; RUPP F, 1992, J NEUROSCI, V12, P3535; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; SOBEL A, 1978, P NATL ACAD SCI USA, V75, P510, DOI 10.1073/pnas.75.1.510; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	41	122	127	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					155	167		10.1016/j.ajhg.2009.06.015	http://dx.doi.org/10.1016/j.ajhg.2009.06.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19631309	Green Published, Bronze			2022-12-18	WOS:000269332900005
J	Li, DX; Parks, SB; Kushner, JD; Nauman, D; Burgess, D; Ludwigsen, S; Partain, J; Nixon, RR; Allen, CN; Irwin, RP; Jakobs, PM; Litt, M; Hershberger, RE				Li, Duanxiang; Parks, Sharie B.; Kushner, Jessica D.; Nauman, Deirdre; Burgess, Donna; Ludwigsen, Susan; Partain, Julie; Nixon, Randal R.; Allen, Charles N.; Irwin, Robert P.; Jakobs, Petra M.; Litt, Michael; Hershberger, Ray E.			Mutations of presenilin genes in dilated cardiomyopathy and heart failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; BETA-CATENIN; MESENCHYMAL TRANSFORMATION; CA2+; DEFECTS; ASSOCIATION; FIBROBLASTS; EXPRESSION; MEDICINE	Two common disorders of the elderly are heart failure and Alzheimer disease (AD). Heart failure usually results from dilated cardiomyopathy (DCM). DCM of unknown cause in families has recently been shown to result from genetic disease, highlighting newly discovered disease mechanisms. AD is the most frequent neurodegenerative disease of older Americans. Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations, a discovery that has greatly advanced the field. The presenilins are also expressed in the heart and are critical to cardiac development. We hypothesized that mutations in presenilins may also be associated with DCM and that their discovery could provide new insight into the pathogenesis of DCM and heart failure. A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2. Families positive for mutations underwent additional clinical, genetic, and functional studies. A novel PSEN1 missense mutation (Asp333Gly) was identified in one family, and a single PSEN2 missense mutation (Ser130Leu) was found in two other families. Both mutations segregated with DCM and heart failure. The PSEN1 mutation was associated with complete penetrance and progressive disease that resulted in the necessity of cardiac transplantation or in death. The PSEN2 mutation showed partial penetrance, milder disease, and a more favorable prognosis. Calcium signaling was altered in cultured skin fibroblasts from PSEN1 and PSEN2 mutation carriers. These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial disease.	Oregon Hlth Sci Univ, Div Cardiovasc Med, Familial Dilated Cardiomyopathy Res Program, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Med, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Layton Ctr Aging & Alzheimers Dis Res, Dept Pathol, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Oregon Brain Bank, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Hershberger, RE (corresponding author), Oregon Hlth Sci Univ, Div Cardiovasc Med, Familial Dilated Cardiomyopathy Res Program, UHN-62,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hershber@ohsu.edu		Hershberger, Ray/0000-0001-5683-6526	NCRR NIH HHS [M01 RR000334, 5 M01 RR000334] Funding Source: Medline; NHLBI NIH HHS [R01-HL58626, R01 HL058626] Funding Source: Medline; NIA NIH HHS [P30 AG08017, P30 AG008017] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Crispell KA, 1999, J AM COLL CARDIOL, V34, P837, DOI 10.1016/S0735-1097(99)00276-4; Czech C, 2000, PROG NEUROBIOL, V60, P363, DOI 10.1016/S0301-0082(99)00033-7; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Finckh U, 2000, NEUROLOGY, V54, P2006, DOI 10.1212/WNL.54.10.2006; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2001, NEUROSCI LETT, V306, P203, DOI 10.1016/S0304-3940(01)01910-3; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; IRWIN RP, 1992, NEUROSCI LETT, V141, P30, DOI 10.1016/0304-3940(92)90327-4; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOHNSON CL, 1990, AM J PHYSIOL, V258, pC533, DOI 10.1152/ajpcell.1990.258.3.C533; Kushner JD, 2006, J CARD FAIL, V12, P422, DOI 10.1016/j.cardfail.2006.03.009; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liang W, 2003, J MOL CELL CARDIOL, V35, P379, DOI 10.1016/S0022-2828(03)00010-5; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; Nakajima M, 2004, DEV DYNAM, V230, P795, DOI 10.1002/dvdy.20098; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tedde A, 2003, ARCH NEUROL-CHICAGO, V60, P1541, DOI 10.1001/archneur.60.11.1541; Thinakaran G, 2004, PHARMACOL RES, V50, P411, DOI 10.1016/j.phrs.2003.12.026	43	122	128	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1030	1039		10.1086/509900	http://dx.doi.org/10.1086/509900			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186461	Green Published, Bronze			2022-12-18	WOS:000242131600004
J	Dudbridge, F; Koeleman, BPC				Dudbridge, F; Koeleman, BPC			Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALSE DISCOVERY RATE; LINKAGE-DISEQUILIBRIUM; STATISTICAL SIGNIFICANCE; DISEASE ASSOCIATIONS; TRUNCATED PRODUCT; GENE; TESTS; SNPS; SUSCEPTIBILITY; POLYMORPHISMS	Large exploratory studies, including candidate-gene-association testing, genomewide linkage-disequilibrium scans, and array-expression experiments, are becoming increasingly common. A serious problem for such studies is that statistical power is compromised by the need to control the false-positive rate for a large family of tests. Because multiple true associations are anticipated, methods have been proposed that combine evidence from the most significant tests, as a more powerful alternative to individually adjusted tests. The practical application of these methods is currently limited by a reliance on permutation testing to account for the correlated nature of single-nucleotide polymorphism (SNP)-association data. On a genomewide scale, this is both very time-consuming and impractical for repeated explorations with standard marker panels. Here, we alleviate these problems by fitting analytic distributions to the empirical distribution of combined evidence. We fit extreme-value distributions for fixed lengths of combined evidence and a beta distribution for the most significant length. An initial phase of permutation sampling is required to fit these distributions, but it can be completed more quickly than a simple permutation test and need be done only once for each panel of tests, after which the fitted parameters give a reusable calibration of the panel. Our approach is also a more efficient alternative to a standard permutation test. We demonstrate the accuracy of our approach and compare its efficiency with that of permutation tests on genomewide SNP data released by the International HapMap Consortium. The estimation of analytic distributions for combined evidence will allow these powerful methods to be applied more widely in large exploratory studies.	MRC, Biostat Unit, Cambridge CB2 2SR, England; MRC, Rosalind Franklin Ctr Gen Res, Cambridge CB2 2SR, England; Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	MRC Biostatistics Unit; Utrecht University; Utrecht University Medical Center	Dudbridge, F (corresponding author), MRC, Biostat Unit, Robinson Way, Cambridge CB2 2SR, England.	frank.dudbridge@mrc-bsu.cam.ac.uk						[Anonymous], 1932, STAT METHODS RES WOR; Austin Melissa A, 2003, Community Genet, V6, P37, DOI 10.1159/000069544; BAILEY TL, 1999, 3 INT C COMP MOL BIO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Coles S, 2001, INTRO STAT MODELLING; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Gumbel E., 1958, STAT EXTREMES; Hao K, 2004, GENET EPIDEMIOL, V26, P22, DOI 10.1002/gepi.10293; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Johnson GCL, 2002, AM J MED GENET, V113, P158, DOI 10.1002/ajmg.10737; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; LI W, 2003, 7 INT C COMP MOL BIO; *NT HAPMAP CONS, 2003, NATURE, V426, P789; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pesarin F., 2001, MULTIVARIATE PERMUTA; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; R Development Core Team, 2003, R LANG ENV STAT COMP; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sabatti C, 2003, GENETICS, V164, P829; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Sawcer S, 2002, BRAIN, V125, P1337, DOI 10.1093/brain/awf143; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; Schulze A, 2001, NAT CELL BIOL, V3, pE190, DOI 10.1038/35087138; Service SK, 2003, AM J HUM GENET, V72, P1213, DOI 10.1086/375165; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Stephenson AG, 2002, R NEWS, V2, P31; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wille A, 2003, GENET EPIDEMIOL, V25, P350, DOI 10.1002/gepi.10263; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; ZAYKIN DV, 1999, THESIS N CAROLINA ST	45	122	125	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					424	435		10.1086/423738	http://dx.doi.org/10.1086/423738			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15266393	Bronze, Green Published			2022-12-18	WOS:000223272200007
J	Simpson, MA; Cross, H; Proukakis, C; Pryde, A; Hershberger, R; Chatonnet, A; Patton, MA; Crosby, AH				Simpson, MA; Cross, H; Proukakis, C; Pryde, A; Hershberger, R; Chatonnet, A; Patton, MA; Crosby, AH			Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORY NEUROPATHY; PARAPARESIS; MOTOR; PROTEINS; DISEASE; FAMILY; LOM	Mast syndrome is an autosomal recessive, complicated form of hereditary spastic paraplegia with dementia that is present at high frequency among the Old Order Amish. Subtle childhood abnormalities may be present, but the main features develop in early adulthood. The disease is slowly progressive, and cerebellar and extrapyramidal signs are also found in patients with advanced disease. Patients have a thin corpus callosum and white-matter abnormalities, as seen on magnetic resonance imaging. Using an extensive Amish pedigree, we have mapped the Mast syndrome locus (SPG21) to a small interval of chromosome 15q22.31 that encompasses just three genes. Sequence analysis of the three transcripts revealed that all 14 affected cases were homozygous for a single base-pair insertion (601insA) in the acid-cluster protein of 33 kDa (ACP33) gene. This frameshift results in the premature termination (fs201-212X213) of the encoded product, which is designated "maspardin" ((M) under bar ast syndrome, (s) under bar pastic (p) under bar araplegia, (a) under bar utosomal (r) under bar ecessive with (d) under bar ementia), and has been shown elsewhere to localize to intracellular endosomal/trans-Golgi transportation vesicles and may function in protein transport and sorting.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London, England; Univ Arizona, Sch Med, Dept Ophthalmol, Tucson, AZ USA; Windows Hope Genet Studies, Baltic, OH USA; Inst Natl Rech Agron, Dept Anim Physiol, Montpellier, France	St Georges University London; University of London; University College London; UCL Medical School; University of Arizona; INRAE	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Cross, J. Helen/ACK-3032-2022; Chatonnet, Arnaud/E-2190-2017; Proukakis, Christos/G-4548-2013; Chatonnet, Arnaud/AAM-5569-2021; proukakis, christos/ABE-3447-2020; Crosby, Andrew H/E-2218-2015; Simpson, Michael/F-4737-2011	Cross, J. Helen/0000-0001-7345-4829; Chatonnet, Arnaud/0000-0002-4057-3896; proukakis, christos/0000-0001-6423-6539; Crosby, Andrew H/0000-0003-3667-9054; Simpson, Michael/0000-0002-8539-8753				Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Byrne PC, 2000, NEUROLOGY, V54, P1510, DOI 10.1212/WNL.54.7.1510; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; Crosby AH, 2003, LANCET NEUROL, V2, P311, DOI 10.1016/S1474-4422(03)00383-1; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P1; Dobyns WB, 1996, AM J HUM GENET, V58, P7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.3.CO;2-6; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KITAMOTO T, 1993, ANN NEUROL, V34, P808, DOI 10.1002/ana.410340609; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Murillo FM, 1999, NEUROLOGY, V53, P50, DOI 10.1212/WNL.53.1.50; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	23	122	131	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1147	1156		10.1086/379522	http://dx.doi.org/10.1086/379522			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14564668	Green Published, Bronze			2022-12-18	WOS:000186493400015
J	Yang, QH; Khoury, MJ; Botto, L; Friedman, JM; Flanders, WD				Yang, QH; Khoury, MJ; Botto, L; Friedman, JM; Flanders, WD			Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-VEIN THROMBOSIS; LIKELIHOOD RATIOS; VENOUS THROMBOSIS; CLINICAL-PRACTICE; DNA CHIPS; THROMBOEMBOLISM; POPULATION; MEDICINE; GENETICS	Studies have argued that genetic testing will provide limited information for predicting the probability of common diseases, because of the incomplete penetrance of genotypes and the low magnitude of associated risks for the general population. Such studies, however, have usually examined the effect of one gene at time. We argue that disease prediction for common multifactorial diseases is greatly improved by considering multiple predisposing genetic and environmental factors concurrently, provided that the model correctly reflects the underlying disease etiology. We show how likelihood ratios can be used to combine information from several genetic tests to compute the probability of developing a multifactorial disease. To show how concurrent use of multiple genetic tests improves the prediction of a multifactorial disease, we compute likelihood ratios by logistic regression with simulated case-control data for a hypothetical disease influenced by multiple genetic and environmental risk factors. As a practical example, we also apply this approach to venous thrombosis, a multifactorial disease influenced by multiple genetic and nongenetic risk factors. Under reasonable conditions, the concurrent use of multiple genetic tests markedly improves prediction of disease. For example, the concurrent use of a panel of three genetic tests (factor V Leiden, prothrombin variant G20210A, and protein C deficiency) increases the positive predictive value of testing for venous thrombosis at least eightfold. Multiplex genetic testing has the potential to improve the clinical validity of predictive testing for common multifactorial diseases.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA 30341 USA; Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; University of British Columbia	Yang, QH (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,Mailstop F-45, Atlanta, GA 30341 USA.	qyang@cdc.gov		Friedman, Jan/0000-0002-7482-9570				ALBERT A, 1982, CLIN CHEM, V28, P1113; Barber JCK, 1998, J MED GENET, V35, P443, DOI 10.1136/jmg.35.6.443; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Breslow NE, 1980, STAT METHODS CANC RE; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; COUGHLIN SS, 1992, J CLIN EPIDEMIOL, V45, P1, DOI 10.1016/0895-4356(92)90180-U; Evans JP, 2001, BMJ-BRIT MED J, V322, P1052, DOI 10.1136/bmj.322.7293.1052; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Holtzman NA, 1997, SCIENCE, V278, P602, DOI 10.1126/science.278.5338.602; Holtzman NA., 1998, PROMOTING SAFE EFFEC; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Kleinbaum D, 1998, APPL REGRESSION ANAL; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Pennisi E, 1999, SCIENCE, V283, P17, DOI 10.1126/science.283.5398.17; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; SIMEL DL, 1993, J CLIN EPIDEMIOL, V46, P85, DOI 10.1016/0895-4356(93)90012-P; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2; WALD N, 2000, ANTENATAL NEONATAL S; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006	31	122	127	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					636	649		10.1086/367923	http://dx.doi.org/10.1086/367923			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12592605	Green Published, Bronze			2022-12-18	WOS:000181152600013
J	Lindholm, E; Ekholm, B; Shaw, S; Jalonen, P; Johansson, G; Pettersson, U; Sherrington, R; Adolfsson, R; Jazin, E				Lindholm, E; Ekholm, B; Shaw, S; Jalonen, P; Johansson, G; Pettersson, U; Sherrington, R; Adolfsson, R; Jazin, E			A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER ALLELE FREQUENCIES; GENOME-WIDE SCAN; LINKAGE ANALYSIS; VULNERABILITY LOCUS; CHROMOSOME; SUPPORT; REGION; GENES; FAMILIES; 13Q32	We have completed a genome scan of a 12-generation, 3,400-member pedigree with schizophrenia. Samples from 210 individuals were collected from the pedigree. We performed an "affecteds-only" genome-scan analysis using 43 members of the pedigree. The affected individuals included 29 patients with schizophrenia, 10 with schizoaffective disorders, and 4 with psychosis not otherwise specified. Two sets of white-European allele frequencies were used-one from a Swedish control population (46 unrelated individuals) and one from the pedigree (210 individuals). All analyses pointed to the same region: D6S264, located at 6q25.2, showed a maximum LOD score of 3.45 when allele frequencies in the Swedish control population were used, compared with a maximum LOD score of 2.59 when the pedigree's allele frequencies were used. We analyzed additional markers in the 6q25 region and found a maximum LOD score of 6.6 with marker D6S253, as well as a 6-cM haplotype (markers D6S253-D6S264) that segregated, after 12 generations, with the majority of the affected individuals. Multipoint analysis was performed with the markers in the 6q25 region, and a maximum LOD score of 7.7 was obtained. To evaluate the significance of the genome scan, we simulated the complete analysis under the assumption of no linkage. The results showed that a LOD score > 2.2 should be considered as suggestive of linkage, whereas a LOD score > 3.7 should be considered as significant. These results suggest that a common ancestral region was inherited by the affected individuals in this large pedigree.	Univ Uppsala, Dept Genet & Pathol, S-75123 Uppsala, Sweden; Umea Univ, Dept Clin Sci, Umea, Sweden; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Pfizer Global Res & Dev, Alameda Lab, Alameda, CA USA	Uppsala University; Umea University; University of California System; University of California San Diego; University of California System; University of California San Diego; Pfizer	Jazin, E (corresponding author), Univ Uppsala, Dept Genet & Pathol, Box 589, S-75123 Uppsala, Sweden.			Adolfsson, Rolf/0000-0001-9785-8473; Jazin, Elena/0000-0002-0363-3466				Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Crowe Raymond R., 1998, Psychiatric Genetics, V8, P73; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Hall JM, 1996, GENOME RES, V6, P781, DOI 10.1101/gr.6.9.781; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Levinson DF, 1996, GENET EPIDEMIOL, V13, P11, DOI 10.1002/(SICI)1098-2272(1996)13:1<11::AID-GEPI2>3.0.CO;2-9; Lindholm E, 1999, AM J MED GENET, V88, P369, DOI 10.1002/(SICI)1096-8628(19990820)88:4<369::AID-AJMG14>3.0.CO;2-9; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; NECHIPORUK A, 1993, AM J MED GENET, V48, P63, DOI 10.1002/ajmg.1320480113; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nurnberger JI, 1999, AM J MED GENET, V88, P233, DOI 10.1002/(SICI)1096-8628(19990618)88:3<233::AID-AJMG5>3.0.CO;2-B; OTT J, 1992, AM J HUM GENET, V51, P283; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; SJOGREN T, 1935, ANN GENET, V4, P253; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Sukumar S, 1999, AM J MED GENET, V87, P17, DOI 10.1002/(SICI)1096-8628(19991105)87:1<17::AID-AJMG4>3.0.CO;2-G; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	35	122	126	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					96	105		10.1086/321288	http://dx.doi.org/10.1086/321288			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389481	Bronze, Green Published			2022-12-18	WOS:000170108100010
J	Calloway, CD; Reynolds, RL; Herrin, GL; Anderson, WW				Calloway, CD; Reynolds, RL; Herrin, GL; Anderson, WW			The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increases with age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; MATERNAL INHERITANCE; POINT MUTATIONS; SKELETAL-MUSCLE; HUMAN BRAIN; D-LOOP; SEQUENCE; IDENTIFICATION; REMAINS; AMPLIFICATION	An immobilized sequence-specific oligonucleotide (SSO) probe system consisting of 16 SSO probes that detect sequence polymorphisms within five regions of the mtDNA control region was used to investigate the frequency of heteroplasmy in human mtDNA. Five regions of hypervariable region II (HVII) of the control region were studied in blood-, muscle-, heart-, and brain-tissue samples collected from 43 individuals during autopsy. An initial search for heteroplasmy was conducted by use of the SSO probe system. Samples in which multiple probe signals were detected within a region were sequenced for the HVII region, to verify the typing-strip results. The frequency of heteroplasmy was 5 of 43 individuals, or 1.1.6%. The frequency of heteroplasmy differed across tissue types, being higher in muscle tissue. The difference in the frequency of heteroplasmy across different age groups was statistically significant, which suggests that heteroplasmy increases with age. As a test for contamination and to confirm heteroplasmy, the samples were sequenced for the HVI region and were typed by use of a panel of five polymorphic nuclear markers. Portions of the tissues that appeared to be heteroplasmic were extracted at least one additional time; all gave identical results. The results from these tests indicate that the multiple sequences present in individual samples result from heteroplasmy and not from contamination.	Roche Mol Syst, Dept Human Genet, Alameda, CA 94501 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Georgia Bur Invest, Div Forens Sci, Decatur, GA USA	Roche Holding; University System of Georgia; University of Georgia	Calloway, CD (corresponding author), Roche Mol Syst, Dept Human Genet, 1145 Atlantic Ave, Alameda, CA 94501 USA.	Sandy.Calloway@Roche.com						Allen M, 1998, J FORENSIC SCI, V43, P453; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUADRO CF, 1983, GENETICS, V103, P287; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bendall KE, 1996, AM J HUM GENET, V59, P1276; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; BODOWLE B, 1995, J FORENSIC SCI, V40, P45; Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1; CALLOWAY C, 1998, THESIS U GEORGIA ATH; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; FILDES N, 1995, J FORENSIC SCI, V40, P279; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; KONDO R, 1990, GENETICS, V126, P657; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; Manly B. F., 1997, RANDOMIZATION BOOTST; Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473; Marchington DR, 1997, AM J HUM GENET, V60, P408; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; Pallotti F, 1996, AM J HUM GENET, V59, P591; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; REYNODLS R, IN PRESS J FORENSIC; SHOFFNER JM, 1995, METABOLIC MOL BASES, P1535; Sokal R. R., 1995, BIOMETRY; SULLIVAN KM, 1992, INT J LEGAL MED, V105, P83, DOI 10.1007/BF02340829; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WALSH PS, 1992, NUCLEIC ACIDS RES, V20, P5061, DOI 10.1093/nar/20.19.5061; WILSON MR, 1995, BIOTECHNIQUES, V18, P662; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907; ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158; Zischler H, 1998, MOL BIOL EVOL, V15, P463, DOI 10.1093/oxfordjournals.molbev.a025943; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0; ZOUROS E, 1992, NATURE, V359, P412, DOI 10.1038/359412a0	53	122	135	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1384	1397		10.1086/302844	http://dx.doi.org/10.1086/302844			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739761	Green Published, Bronze			2022-12-18	WOS:000088373400019
J	Suarez, BK; Lin, J; Burmester, JK; Broman, KW; Weber, JL; Banerjee, TK; Goddard, KAB; Witte, JS; Elston, RC; Catalona, WJ				Suarez, BK; Lin, J; Burmester, JK; Broman, KW; Weber, JL; Banerjee, TK; Goddard, KAB; Witte, JS; Elston, RC; Catalona, WJ			A genome screen of multiplex sibships with prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROGEN RECEPTOR GENE; FAMILIAL BREAST-CANCER; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CHROMOSOME 1Q42.2-43; UNITED-STATES; DOMINANT INHERITANCE; SCOTTISH MALES; COMPLEX TRAITS; CAG REPEAT	Analysis of a genome screen of 504 brothers with prostate cancer (CaP) who were from 230 multiplex sibships identified five regions with nominally positive linkage signals, on chromosomes 2q, 12p, 15q, 16p, and 16q. The strongest signal in these data is found on chromosome 16q, between markers D16S515 and D16S3040, a region suspected to contain a tumor-suppressor gene. On the basis of findings from previous genome screens of families with Cap, three preplanned subanalyses were carried out, in the hope of increasing the subgroup homogeneity. Subgroups were formed by dividing the sibships into a group with a positive family history (FH+) that met criteria for "hereditary" Cap (n = 111) versus those which did not meet the criteria (n = 119) and by dividing the families into those with a mean onset age below the median (n = 115) versus those with a mean onset age above the median (n = 115). A separate subanalysis was carried out for families with a history of breast cancer (CaB+ [n = 53]). Analyses of these subgroups revealed a number of potentially important differences in regions that were nonsignificant when all the families were analyzed together. In particular, the subgroup without a positive family history (FH -) had a signal in a region that is proximal to the putative site of the HPC1 locus on chromosome 1, whereas the late-age-at-onset group had a signal on 4q. The CaB+ subgroup revealed a strong linkage signal at 1p35.1.	Washington Univ, Sch Med, Dept Surg, Div Urol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Marshfield Clin Fdn Med Res & Educ, Dept Oncol, Marshfield, WI 54449 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Marshfield Clinic; Case Western Reserve University	Catalona, WJ (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Urol Surg, 4960 Childrens Pl, St Louis, MO 63110 USA.	catalonaw@msnotes.wustl.edu		Broman, Karl/0000-0002-4914-6671	NCRR NIH HHS [P41 RR003655] Funding Source: Medline; NHGRI NIH HHS [F32 HG000198, HG00198] Funding Source: Medline; NHLBI NIH HHS [N01HV48141] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM28356, R37 GM028356] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R37HG000198, R01HG000198, F32HG000198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbaszadegan M. R., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P365; Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; BERGERHEIM USR, 1991, GENE CHROMOSOME CANC, V3, P215, DOI 10.1002/gcc.2870030308; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bieche I, 1999, GENE CHROMOSOME CANC, V24, P255, DOI 10.1002/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO;2-2; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; CHER ML, 1995, J UROLOGY, V153, P249, DOI 10.1097/00005392-199501000-00086; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Correa-Cerro L, 1999, EUR J HUM GENET, V7, P357, DOI 10.1038/sj.ejhg.5200298; Curtis D, 1996, NAT GENET, V12, P356, DOI 10.1038/ng0496-356; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; DUNN JE, 1975, CANCER RES, V35, P3240; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Elo JP, 1997, CANCER RES, V57, P3356; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GHADIRIAN P, 1991, PROSTATE, V19, P43, DOI 10.1002/pros.2990190105; Giardiello FM, 1997, JAMA-J AM MED ASSOC, V278, P1278, DOI 10.1001/jama.278.15.1278; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Goring H. H. H., 1995, American Journal of Human Genetics, V57, pA192; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gronberg H, 1997, CANCER RES, V57, P4707; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; HOLLOWAY SM, 1992, DIS MARKERS, V10, P109; HOLLOWAY SM, 1992, J EPIDEMIOL COMMUN H, V46, P368, DOI 10.1136/jech.46.4.368; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Ingles SA, 1998, CANCER RES, V58, P1620; KEETCH DW, 1995, J UROLOGY, V154, P2100, DOI 10.1016/S0022-5347(01)66705-3; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KRAIN LS, 1974, PREV MED, V3, P154, DOI 10.1016/0091-7435(74)90070-X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Latil A, 1997, CANCER RES, V57, P1058; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MEIKLE AW, 1985, PROSTATE, V6, P121; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millikan RC, 1999, GENE CHROMOSOME CANC, V25, P354, DOI 10.1002/(SICI)1098-2264(199908)25:4<354::AID-GCC7>3.3.CO;2-F; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; MORGANTI G, 1956, Acta Genet Stat Med, V6, P304; Osman I, 1997, INT J CANCER, V71, P580, DOI 10.1002/(SICI)1097-0215(19970516)71:4<580::AID-IJC12>3.0.CO;2-G; OTT J, 1985, Genetic Epidemiology, V2, P79, DOI 10.1002/gepi.1370020108; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Perri P, 1999, CYTOGENET CELL GENET, V84, P111, DOI 10.1159/000015233; REICHARDT JKV, 1995, CANCER RES, V55, P3973; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STASZEWSKI J, 1965, JNCI-J NATL CANCER I, V35, P291; STEELE R, 1971, J CHRON DIS, V24, P29, DOI 10.1016/0021-9681(71)90056-7; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Suzuki H, 1996, GENE CHROMOSOME CANC, V17, P225, DOI 10.1002/(SICI)1098-2264(199612)17:4<225::AID-GCC4>3.0.CO;2-5; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Taylor JA, 1996, CANCER RES, V56, P4108; White RA, 1997, GENOMICS, V39, P406, DOI 10.1006/geno.1996.4499; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; WHITTEMORE AS, 1994, CANCER SURV, V20, P309; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Yuan B, 1997, AM J HUM GENET, V60, P459	81	122	124	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					933	944		10.1086/302818	http://dx.doi.org/10.1086/302818			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712208	Bronze, Green Published			2022-12-18	WOS:000088373200016
J	Verhoef, S; Bakker, L; Tempelaars, AMP; Hesseling-Janssen, ALW; Mazurczak, T; Jozwiak, S; Fois, A; Bartalini, G; Zonnenberg, BA; van Essen, AJ; Lindhout, D; Halley, DJJ; van den Ouweland, AMW				Verhoef, S; Bakker, L; Tempelaars, AMP; Hesseling-Janssen, ALW; Mazurczak, T; Jozwiak, S; Fois, A; Bartalini, G; Zonnenberg, BA; van Essen, AJ; Lindhout, D; Halley, DJJ; van den Ouweland, AMW			High rate of mosaicism in tuberous sclerosis complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC MOSAICISM; NON-PENETRANCE; TSC2 GENE; PARENTS	Six families with mosaicism are identified in a series of 62 unrelated families with a mutation in one of the two tuberous sclerosis complex (TSC) genes, TSC1 or TSC2. In five families, somatic mosaicism was present in a mildly affected parent of an index patient. In one family with clinically unaffected parents, gonadal mosaicism was detected after TSC was found in three children. The detection. of mosaicism has consequences for genetic counseling of the families involved, as changed risks apply to individuals with mosaicism, both siblings and parents. Clinical investigation of parents of patients with seemingly sporadic mutations is essential to determine their residual chance of gonadal and/or somatic mosaicism, unless a mosaic pattern is detected in the index patient, proving a de novo event. In our data set, the exclusion of signs of TSC in the parents of a patient with TSC reduced the chance of one of the parents to be a (mosaic) mutation carrier from 10% to 2%. In the five families with somatic mosaicism, the parent was given the diagnosis after the diagnosis was made in the child.	Erasmus Univ, MGC Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Acad Hosp Rotterdam, NL-3000 DR Rotterdam, Netherlands; Acad Hosp Utrecht, Dept Internal Med, Utrecht, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands; Inst Mother & Child Hlth, Dept Genet, Warsaw, Poland; Univ Siena, Ist Clin Pediat, I-53100 Siena, Italy; Szpital Pomnik, Centrum Zdrowia Dziecka, Dept Neurol, Warsaw, Poland	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Siena; Children's Memorial Health Institute	Verhoef, S (corresponding author), Erasmus Univ, MGC Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	Verhoef@kgen.fgg.eur.nl	Lindhout, Dick/AAH-5765-2019	Jozwiak, Sergiusz/0000-0003-3350-6326; Lindhout, Dick/0000-0001-9580-624X				Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; BARAITSER M, 1985, J MED GENET, V22, P29, DOI 10.1136/jmg.22.1.29; Berberich M S, 1979, Birth Defects Orig Artic Ser, V15, P297; CONNOR JM, 1986, LANCET, V2, P1275; HALL JG, 1988, AM J HUM GENET, V43, P355; HALL JG, 1987, LANCET, V1, P751; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; Kumar A, 1997, HUM MUTAT, V9, P64; NELLIST M, 1993, CELL, V75, P1305; ROACH ES, 1992, J CHILD NEUROL, V7, P221, DOI 10.1177/088307389200700219; ROTT HD, 1991, CLIN GENET, V39, P306; Ruggieri M, 1997, J MED GENET, V34, P256, DOI 10.1136/jmg.34.3.256; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; van Slegtenhorst M, 1999, J MED GENET, V36, P285; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verhoef S, 1998, HUM MUTAT, pS85; VERHOEF S, 1995, LANCET, V345, P202, DOI 10.1016/S0140-6736(95)90213-9; WEBB DW, 1991, J MED GENET, V28, P417, DOI 10.1136/jmg.28.6.417; Yates JRW, 1997, HUM MOL GENET, V6, P2265, DOI 10.1093/hmg/6.13.2265; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	21	122	126	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1632	1637		10.1086/302412	http://dx.doi.org/10.1086/302412			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330349	Green Published, Bronze			2022-12-18	WOS:000080696200014
J	Monros, E; Molto, MD; Martinez, F; Canizares, J; Blanca, J; Vilchez, JJ; Prieto, F; deFrutos, R; Palau, F				Monros, E; Molto, MD; Martinez, F; Canizares, J; Blanca, J; Vilchez, JJ; Prieto, F; deFrutos, R; Palau, F			Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X SYNDROME; MYOTONIC-DYSTROPHY; LINKAGE DISEQUILIBRIUM; CTG REPEAT; CARDIAC INVOLVEMENT; GENETIC HOMOGENEITY; FOUNDER CHROMOSOMES; CLINICAL-FEATURES; CGG REPEAT; EXPANSION	The Friedreich ataxia (FA) mutation has recently been identified as an unstable trinucleotide GAA repeat present 7-22 times in the normal population but amplified as many as >1,000 times in FA. Since it is an autosomal recessive disease, FA does not show typical features observed in other dynamic mutation disorders, such as genetic anticipation. We have analyzed the GAA repeat in 104 FA patients and 163 carrier relatives previously defined by linkage analysis. The GAA expansion was detected in all patients, most (94%) of them being homozygous for the mutation. We have demonstrated that clinical variability in FA is related to the size of the expanded alleles: milder forms of the disease-late-onset FA and FA with retained reflexes-are associated with shorter expansions, especially with the smaller of the two expanded alleles. Absence of cardiomyopathy is also associated with shorter alleles. Dynamics of the GAA repeat has been investigated in 212 parent-offspring pairs. Meiotic instability showed a sex bias: paternally transmitted alleles tend to decrease in a linear way that depends on the paternal expansion size, whereas maternal alleles can either increase or decrease. A different pattern of intergenerational variation was also observed, depending on the genetic status of the sib: patients had shorter expansions than were seen in heterozygous carriers. This finding has been interpreted as a postzygotic event. Finally, we have observed that the size of the expansion remains constant in the population through carriers.	HOSP UNIV LA FE,UNITAT GENET,VALENCIA 46009,SPAIN; HOSP UNIV LA FE,DEPT NEUROL,VALENCIA 46009,SPAIN; UNIV VALENCIA,FAC CIENCIES,DEPT GENET,VALENCIA,SPAIN	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; University of Valencia			Canizares, Joaquin/M-3255-2014; Martinez, Francisco/A-2543-2009; Blanca, Jose M/H-6695-2015; Canizares, Joaquin/X-9702-2019; Palau, Francesc/A-9391-2014	Canizares, Joaquin/0000-0001-9002-5516; Martinez, Francisco/0000-0002-0589-2584; Blanca, Jose M/0000-0002-5884-8624; Canizares, Joaquin/0000-0001-9002-5516; Palau, Francesc/0000-0002-8635-5421; Vilchez, Juan J/0000-0002-0532-2872; Molto, Maria Dolores/0000-0001-5219-2022				ALBOLIRAS ET, 1986, AM J CARDIOL, V58, P518, DOI 10.1016/0002-9149(86)90026-3; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CHILD JS, 1986, J AM COLL CARDIOL, V7, P1370, DOI 10.1016/S0735-1097(86)80159-0; DEMICHELE G, 1994, J NEUROL NEUROSUR PS, V57, P977, DOI 10.1136/jnnp.57.8.977; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Filla A, 1996, AM J HUM GENET, V59, P554; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1983, Q J MED, V52, P489; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HEWER RL, 1969, BRIT HEART J, V31, P514; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LAVEDAN C, 1994, J MED GENET, V31, P33, DOI 10.1136/jmg.31.1.33; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; LOPEZARLANDIS JM, 1995, NEUROEPIDEMIOLOGY, V14, P14, DOI 10.1159/000109774; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; Monros E, 1996, EUR J HUM GENET, V4, P191; Monros Eugenia, 1994, European Journal of Human Genetics, V2, P291; MULLEY JC, 1992, J MED GENET, V29, P368, DOI 10.1136/jmg.29.6.368; OUDET C, 1993, AM J HUM GENET, V52, P297; PALAU F, 1995, ANN NEUROL, V37, P359, DOI 10.1002/ana.410370312; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, NAT GENET, V1, P5; ROMEO G, 1983, AM J HUM GENET, V35, P523; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; WINTER RM, 1981, CLIN GENET, V20, P419	39	122	123	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					101	110		10.1086/513887	http://dx.doi.org/10.1086/513887			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245990	Green Published, Bronze			2022-12-18	WOS:A1997XM72800017
J	Puy, H; Deybach, JC; Lamoril, J; Robreau, AM; DaSilva, V; Gouya, L; Grandchamp, B; Nordmann, Y				Puy, H; Deybach, JC; Lamoril, J; Robreau, AM; DaSilva, V; Gouya, L; Grandchamp, B; Nordmann, Y			Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; HYDROXYMETHYLBILANE SYNTHASE GENE; SINGLE-BASE CHANGES; PORPHOBILINOGEN DEAMINASE; POINT MUTATION; HETEROGENEITY; IDENTIFICATION; POLYMORPHISMS; EXPRESSION; INITIATION	Acute intermittent porphyria (AIP) is the major autosomal dominant form of acute hepatic porphyrias. The disease is due to mutations in the gene encoding for porphobilinogen (PEG) deaminase and is characterized by life-threatening neurovisceral attacks, often precipitated by drugs, fasting, cyclical hormonal changes, or infectious diseases. This report describes a prospective study on the molecular epidemiology of PEG deaminase gene defects in AIP. It uses a sensitive, reliable, and easy-to-handle method for routine AIP molecular diagnosis and family study based on an exon-by-exon denaturing gradient gel electrophoresis (DGGE) strategy followed by direct sequencing. Fifteen genomic DNA fragments, including all the coding sequence and covering 3.35 kb of the PEG deaminase gene, were investigated in 405 subjects from 121 unrelated French Caucasian AIP families who had not been screened previously at the DNA level. PEG deaminase gene mutations were identified in 109 families, but only 78 were of different type, and each of them had a prevalence rate <5%. Among these mutations, 33 had not been published previously. Sixty percent of these 78 mutations were located in only three exons (exons 10, 12, and 14), 44% were missense, 18% were splice defect, 13% were frameshift, and 16% were nonsense. In addition, two de novo mutational events were characterized. The evaluation of the efficiency of the standard PEG deaminase enzymatic screening method for gene-carrier detection indicated 95% of con-cordancy with the molecular-based diagnosis.	HOP LOUIS MOURIER,CTR FRANCAIS PORPHYRIES,INSERM U409,F-92701 COLOMBES,FRANCE; FAC XAVIER BICHAT,INSERM U409,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			PUY, HERVE/O-1785-2017	PUY, HERVE/0000-0003-3362-2634; Gouya, Laurent/0000-0002-1326-7025				ASTRIN KH, 1994, HUM MUTAT, V4, P243, DOI 10.1002/humu.1380040403; BONAITIPELLIE C, 1984, AM J MED GENET, V19, P755, DOI 10.1002/ajmg.1320190415; Bonkovsky HL, 1982, HEPATOLOGY TXB LIVER, P351; BROWNLIE PD, 1994, PROTEIN SCI, V3, P1644, DOI 10.1002/pro.5560031004; CHEN CH, 1994, J CLIN INVEST, V94, P1927, DOI 10.1172/JCI117543; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DELFAU MH, 1990, J CLIN INVEST, V86, P1511, DOI 10.1172/JCI114869; DELFAU MH, 1991, AM J HUM GENET, V49, P421; DEYBACH JC, 1995, J BIOENERG BIOMEMBR, V27, P197, DOI 10.1007/BF02110034; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GRANDCHAMP B, 1989, EUR J CLIN INVEST, V19, P415, DOI 10.1111/j.1365-2362.1989.tb00252.x; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; GU XF, 1994, HUM GENET, V93, P47, DOI 10.1007/BF00218912; GU XF, 1993, HUM GENET, V91, P128, DOI 10.1007/BF00222712; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HIGUCHI G, 1990, PCR PROTOCOLS, P31; JORDAN PM, 1991, BIOCHEM J, V280, P445, DOI 10.1042/bj2800445; Kappas A, 1995, METABOLIC MOL BASES, P2103; KAUPPINEN R, 1992, MEDICINE, V71, P1; KAUPPINEN R, 1995, HUM MOL GENET, V4, P215, DOI 10.1093/hmg/4.2.215; LAMON JM, 1977, ARCH NEUROL-CHICAGO, V34, P709, DOI 10.1001/archneur.1977.00500230079014; LEE JS, 1991, P NATL ACAD SCI USA, V88, P10912, DOI 10.1073/pnas.88.23.10912; LEE JS, 1991, HUM GENET, V87, P484; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LLEWELLYN DH, 1993, HUM MOL GENET, V2, P1315, DOI 10.1093/hmg/2.8.1315; LUNDIN G, 1995, J MED GENET, V32, P979, DOI 10.1136/jmg.32.12.979; MEYER UA, 1972, NEW ENGL J MED, V286, P1277, DOI 10.1056/NEJM197206152862401; MGONE CS, 1992, HUM GENET, V90, P12; MGONE CS, 1994, HUM MOL GENET, V3, P809; MGONE CS, 1993, HUM GENET, V92, P619, DOI 10.1007/BF00420949; MORITA Y, 1995, JPN J HUM GENET, V40, P207, DOI 10.1007/BF01883579; MUSTAJOKI P, 1985, BRIT MED J, V291, P505, DOI 10.1136/bmj.291.6494.505; MUSTAJOKI P, 1981, ANN INTERN MED, V95, P162, DOI 10.7326/0003-4819-95-2-162; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAMBA H, 1991, CYTOGENET CELL GENET, V57, P105, DOI 10.1159/000133123; Ong PML, 1996, MOL CELL PROBE, V10, P57, DOI 10.1006/mcpr.1996.0008; PETERSEN NE, 1995, CLIN CHEM, V6, P156; Puy H, 1996, HUM HERED, V46, P177, DOI 10.1159/000154349; SASSA S, 1974, P NATL ACAD SCI USA, V7, P732; SCHREIBER WE, 1995, HUM GENET, V96, P161, DOI 10.1007/BF00207373; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; STEIN JA, 1970, MEDICINE, V49, P1, DOI 10.1097/00005792-197001000-00001; WHATLEY SD, 1995, LANCET, V346, P1007, DOI 10.1016/S0140-6736(95)91692-X; WILSON JHP, 1986, NETH J MED, V29, P393; WOOD S, 1995, MOL MED TODAY, V5, P232; YOO HW, 1993, GENOMICS, V15, P21, DOI 10.1006/geno.1993.1005	47	122	127	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1373	1383		10.1086/515455	http://dx.doi.org/10.1086/515455			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199558	Green Published, Bronze			2022-12-18	WOS:A1997XE29400015
J	Xiong, MM; Guo, SW				Xiong, MM; Guo, SW			Fine-scale genetic mapping based on linkage disequilibrium: Theory and applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEPWISE MUTATION MODEL; MARKER LOCI D9S5; HUNTINGTONS-DISEASE; POSITIONAL CLONING; FRIEDREICH ATAXIA; POPULATIONS; REGION; POLYMORPHISMS; LOCALIZATION; ASSOCIATION	Linkage-disequilibrium mapping (LDM) recently has been hailed as a powerful statistical method for fine-scale mapping of disease genes. After reviewing its historical background and methodological development, we present a general, mathematical, and conceptually coherent framework for LDM that incorporates multilocus and multiallelic markers and mutational processes at the marker and disease loci. With this framework, we address several issues relevant to fine-scale mapping and propose some efficient computational methods for LDM. We implement various LDM methods that incorporate population growth, recurrent mutation, and marker mutations, on the basis of a general framework. We demonstrate these methods by applying them to published data on cystic fibrosis, Huntington disease, Friedreich ataxia, and progressive myoclonus epilepsy. Since the genes responsible for these diseases all have been cloned, we can evaluate the performance of our methods and can compare ours with that of other methods. Using the proposed methods, we successfully and accurately predicted the locations of genes responsible for these diseases, on the basis of published data only.	UNIV MINNESOTA, SCH PUBL HLTH, INST HUMAN GENET, DIV EPIDEMIOL, MINNEAPOLIS, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052205, R01GM056515] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29-GM52205, R01-GM56515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COX T K, 1989, American Journal of Human Genetics, V45, pA136; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ethier S. N., 1986, WILEY SERIES PROBABI, DOI DOI 10.1002/9780470316658; FISHER R A, 1947, Am Sci, V35, P95; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haldane JBS, 1919, J GENET, V8, P299; Hammersley J.M., 1964, MONTE CARLO METHODS; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEDRICK PW, 1980, GENETICS, V94, P791; Hill W.G., 1976, P339; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1994, AM J HUM GENET, V54, P705; Jennings HS, 1917, GENETICS, V2, P97; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KAPLAN NL, 1995, AM J HUM GENET, V57, P1486; Karlin S., 1969, EQUILIBRIUM BEHAV PO; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI 10.1111/j.1558-5646.1967.tb03408.x; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANGE K, 1985, AM J HUM GENET, V37, P853; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; NEI M, 1973, GENETICS, V75, P213; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Ott J., 1991, ANAL HUMAN GENETIC L; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Revuz D, 1994, CONTINUOUS MARTINGAL; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Robbins RB, 1918, GENETICS, V3, P375; SHRIVER MD, 1993, GENETICS, V134, P983; SINNOCK P, 1972, AM J HUM GENET, V24, P393; SLATKIN M, 1994, GENETICS, V137, P331; SMOUSE PE, 1977, GENETICS, V85, P733; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; Stone NE, 1996, GENOME RES, V6, P218, DOI 10.1101/gr.6.3.218; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMSON G, 1977, GENETICS, V85, P753; TURNER JRG, 1972, EVOLUTION, V26, P334, DOI 10.1111/j.1558-5646.1972.tb01939.x; VALDES AM, 1993, GENETICS, V133, P737; Virtaneva K, 1996, AM J HUM GENET, V58, P1247; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEINBERG W, 1909, Z ABST V VERERB, V1, P277; WEIR BS, 1972, GENETICS, V72, P505; WEIR BS, 1989, MULTIPOINT MAPPING L, V6, P81; [No title captured]	61	122	128	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1513	1531		10.1086/515475	http://dx.doi.org/10.1086/515475			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199574	Green Published, Bronze			2022-12-18	WOS:A1997XE29400031
J	Bidichandani, SI; Ashizawa, T; Patel, PI				Bidichandani, SI; Ashizawa, T; Patel, PI			Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CLINICAL-FEATURES; LOCUS		BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN & MOL GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; VET AFFAIRS MED CTR,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072; Bidichandani, Sanjay/0000-0001-6191-6475				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P526, DOI 10.1017/S0317167100034995; BIDICHANDANI SI, 1995, HUM GENET, V95, P531; BIDICHANDANI SI, 1996, CURRENT NEUROLOGY, P1; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; Cossee M, 1997, NAT GENET, V15, P337, DOI 10.1038/ng0497-337; DEMICHELE G, 1994, J NEUROL NEUROSUR PS, V57, P977, DOI 10.1136/jnnp.57.8.977; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Filla A, 1996, AM J HUM GENET, V59, P554; FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Mckusick V.A., 1994, MENDELIAN INHERITANC; PALAU F, 1995, ANN NEUROL, V37, P359, DOI 10.1002/ana.410370312	14	122	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1251	1256						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150176				2022-12-18	WOS:A1997WX76000029
J	Weeda, G; Eveno, E; Donker, I; Vermeulen, W; ChevallierLagente, O; Taieb, A; Stary, A; Hoeijmakers, JHJ; Mezzina, M; Sarasin, A				Weeda, G; Eveno, E; Donker, I; Vermeulen, W; ChevallierLagente, O; Taieb, A; Stary, A; Hoeijmakers, JHJ; Mezzina, M; Sarasin, A			A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; COMPLEMENTATION GROUP-D; PIGMENTOSUM GROUP-D; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; BTF2 TFIIH; DEFECT; CELLS; PHOTOSENSITIVITY; PHOTOPRODUCTS	Trichothiodystrophy (TTD) is a rare, autosomal recessive disorder characterized by sulfur-deficient brittle hair and nails, mental retardation, impaired sexual development, and ichthyosis. Photosensitivity has been reported in similar to 50% of the cases, but no skin cancer is associated with TTD. Virtually all photosensitive TTD patients have a deficiency in the nucleotide excision repair (NER) of UV-induced DNA damage that is indistinguishable from that of xeroderma pigmentosum (XP) complementation group D (XP-D) patients. DNA repair defects in XP-D are associated with two additional, quite different diseases; XP, a sun-sensitive and cancer-prone repair disorder, and Cockayne syndrome (CS), a photosensitive condition characterized by physical and mental retardation and wizened facial appearance. One photosensitive TTD case constitutes a new repair-deficient complementation group, TTD-A. Remarkably, both TTD-A and XP-D defects are associated with subunits of TFIIH, a basal transcription factor with a second function in DNA repair. Thus, mutations in TFIIH components may, on top of a repair defect, also cause transcriptional insufficiency, which may explain part of the non-XP clinical features of TTD. Besides XPD and TTDA, the XPB gene product is also part of TFIIH. To date, three patients with the remarkable conjunction of XP and CS but not TTD have been assigned to XP complementation group B (XP-B). Here we present the characterization of the NER defect in mio mild ?TD patients (TTD6VI and TTD4VI) and confirm the assignment to X-PB. The causative mutation was found to be a single base substitution resulting in a missense mutation (T119P) in a region of the XPB protein completely conserved in yeast, Drosophila, mouse, and man. These findings define a third TTD complementation group, extend the clinical heterogeneity associated with XP-B, stress the exclusive relationship between TTD and mutations in subunits of repair/transcription factor TFIIH, and strongly support the concept of ''transcription syndromes.''.	INST RECH CANC,GENET MOL LAB,UPR 42,INST FEDERATIF CNRS,IFC1,VILLEJUIF,FRANCE; HOP ENFANTS,UNITE DERMATOL PEDIAT,CTR HOSP UNIV,GRP PELLEGRIN,BORDEAUX,FRANCE	CHU Bordeaux	Weeda, G (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT CELL BIOL & GENET,MGC,POB 1738,NL-3000 DR ROTTERDAM,NETHERLANDS.		stary, anne/GRY-3781-2022; Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; Eveno, Eric/0000-0002-7282-280X				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BOHR VA, 1991, CARCINOGENESIS, V12, P1983, DOI 10.1093/carcin/12.11.1983; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; CARREAU M, 1995, CARCINOGENESIS, V16, P1003, DOI 10.1093/carcin/16.5.1003; CLEAVER JE, 1994, METABOLIC BASIS INHE, P4393; CRUICKSHANK CND, 1960, J INVEST DERMATOL, V34, P339, DOI 10.1038/jid.1960.57; DAYAGROSJEAN L, 1987, MUTAT RES, V183, P185, DOI 10.1016/0167-8817(87)90061-7; EVENO E, 1995, CANCER RES, V55, P4325; GALLOWAY AM, 1994, J BIOL CHEM, V269, P974; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANAWALT PC, 1994, CURR BIOL, V4, P518, DOI 10.1016/S0960-9822(00)00112-3; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; HOEIJMAKERS JHJ, 1994, EUR J CANCER, V30A, P1912, DOI 10.1016/0959-8049(94)00381-E; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; LEHMANN A R, 1987, Cancer Reviews, V7, P82; MEZZINA M, 1994, CARCINOGENESIS, V15, P1493, DOI 10.1093/carcin/15.8.1493; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MOUNKES LC, 1992, CELL, V71, P925, DOI 10.1016/0092-8674(92)90389-T; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; NUZZO F, 1989, DNA DAMAGE REPAIR, P61; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASIN A, 1992, BRIT J DERMATOL, V127, P485, DOI 10.1111/j.1365-2133.1992.tb14845.x; SARASIN A, 1991, CANCER J - FRANCE, V4, P233; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SCOTT RJ, 1993, J AM ACAD DERMATOL, V29, P883, DOI 10.1016/0190-9622(93)70263-S; Stary A, 1996, CANCER SURV, V26, P155; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1987, MUTAT RES, V191, P117, DOI 10.1016/0165-7992(87)90139-4; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; TAIEB A, 1987, CLIN EXP DERMATOL, V12, pA231; Takayama K, 1996, AM J HUM GENET, V58, P263; TAKAYAMA K, 1995, CANCER RES, V55, P5656; VANNESTE D, 1989, TRENDS IN HUMAN HAIR GROWTH AND ALOPECIA RESEARCH, P195; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1986, MUTAT RES, V165, P199, DOI 10.1016/0167-8817(86)90055-6; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	46	122	124	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					320	329						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012405				2022-12-18	WOS:A1997WE93100011
J	McKeigue, PM				McKeigue, PM			Mapping genes underlying ethnic differences in disease risk by linkage disequilibrium in recently admired populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; CARDIOVASCULAR RISK; BLOOD-PRESSURE; SOUTH ASIANS; EPIDEMIOLOGY; ADMIXTURE; PREVALENCE; GUIDELINES; OBESITY	Where recent admixture has occurred between two populations that have different disease rates for genetic reasons, family-based association studies can be used to map the genes underlying these differences, if the ancestry of the alleles at each locus examined can be assigned to one of the two founding populations, This article explores the statistical power and design requirements of this approach, Markers suitable for assigning the ancestry of genomic regions could be defined by grouping alleles at closely spaced microsatellite loci into haplotypes, or generated by representational difference analysis. For a given relative risk between populations, the sample size required to detect a disease locus that accounts for this relative risk by linkage-disequilibrium mapping in an admixed population is not critically dependent on assumptions about genotype penetrances or allele frequencies. Using the transmission-disequilibrium test to search the genome for a locus that accounts for a relative risk of between 2 and 3 in a high-risk population, compared with a low-risk population, generally requires between 150 and 800 case-parent pairs of mixed descent, The optimal strategy is to conduct an initial study using markers spaced at less than or equal to 10 cM with cases from the second and third generations of mixed descent, and then to map the disease loci more accurately in a subsequent study of a population with a longer history of admixture, This approach has greater statistical power than allele-sharing designs and has obvious applications to the genetics of hypertension, non-insulin-dependent diabetes, and obesity.			McKeigue, PM (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,EPIDEMIOL UNIT,KEPPEL ST,LONDON WC1E 7HT,ENGLAND.							Breslow N, 1980, STAT METHODS CANC RE, P248; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHATURVEDI N, 1993, HYPERTENSION, V22, P90, DOI 10.1161/01.HYP.22.1.90; DUNN JE, 1975, CANCER RES, V35, P3240; EWENS WJ, 1995, AM J HUM GENET, V57, P455; GORDON T, 1982, PUBLIC HLTH REP, V97, P983; HODGE AM, 1994, BAILLIERE CLIN ENDOC, V8, P577, DOI 10.1016/S0950-351X(05)80287-3; KEMPTHORNE O, 1969, INTRO GENETIC STAT, P311; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MANATUNGA AK, 1993, HYPERTENSION, V22, P84, DOI 10.1161/01.HYP.22.1.84; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MILLER GJ, 1989, INT J EPIDEMIOL, V18, P808, DOI 10.1093/ije/18.4.808; NEEL JV, 1962, AM J HUM GENET, V14, P353; PERUSSE L, 1989, AM J HUM GENET, V45, P240; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; PRINEAS RJ, 1985, HYPERTENSION BLACKS, P17; REID DD, 1971, ISRAEL J MED SCI, V12, P1592; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1992, AM J HUM GENET S, V51, P13; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; THOMSON G, 1995, AM J HUM GENET, V57, P487; TINKER H, 1989, S ASIA SHORT HIST, P4; Younger C., 1987, ANGLO INDIANS NEGLEC; ZIMMET PZ, 1992, DIABETES CARE, V15, P232, DOI 10.2337/diacare.15.2.232	27	122	126	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					188	196						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981962				2022-12-18	WOS:A1997WA81800025
J	Norman, RA; Thompson, DB; Foroud, T; Garvey, WT; Bennett, PH; Bogardus, C; Ravussin, E				Norman, RA; Thompson, DB; Foroud, T; Garvey, WT; Bennett, PH; Bogardus, C; Ravussin, E			Genomewide search for genes influencing percent body fat in Pima Indians: Suggestive linkage at chromosome 11q21-q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-RAY ABSORPTIOMETRY; MASS INDEX; MAJOR GENE; SEGREGATION ANALYSIS; QUANTITATIVE TRAIT; COMPLEX TRAITS; MALE TWINS; OBESITY; PREVALENCE; LOCI	On the basis of accumulating evidence that obesity has a substantial genetic component, a genomewide search fur linkages of DNA markers to percent body fat is ongoing in Pima Indians, a population with a very high prevalence of obesity, An initial screen oi: the genome (>600 markers in 874 individuals) has been completed using highly polymorphic markers (mean heterozygosity = .67), Reported here are the sib-pair linkage results for percent body fat (277 siblings), the best available indicator of overall obesity, Single-marker linkages to percent body fat were evaluated by sib-pair analysis for quantitative traits, From these analyses, the best evidence of genes influencing body fat came from markers at chromosome 11q21-q22 and 3p24.2-p22 (P = .001; LOD = 2.0), Regions flanking these markers were further investigated by multipoint linkage. The evidence for linkage at 11q21-q22 increased to P = .0002 (LOD = 2.8), peaking between markers D11S2000 and D11S2366, Evidence for linkage at 3p24.2-p22 did nor change, No association was detected for any marker in the region, Although several genes are known in the 11q21-q22 region, none have been implicated as candidate genes for obesity.	INDIANA UNIV, DEPT MOL & MED GENET, INDIANAPOLIS, IN 46204 USA; MED UNIV S CAROLINA, DIV ENDOCRINOL DIABET & MED GENET, CHARLESTON, SC 29425 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Medical University of South Carolina	Norman, RA (corresponding author), NIDDKD, CLIN DIABET & NUTR SECT, NIH, ROOM 541, 4212 N 16TH ST, PHOENIX, AZ 85016 USA.		Ravussin, Eric/N-1985-2017; Steib, Lori/B-6628-2014; Bennett, Peter/AAH-9605-2021	Ravussin, Eric/0000-0003-2129-547X; Steib, Lori/0000-0001-8274-318X; 	NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BENNETT PH, 1971, LANCET, V2, P488; BORECKI IB, 1993, AM J HUM GENET, V53, P676; BORECKI IB, 1995, OBES RES, V3, P1; BOUCHARD C, 1988, INT J OBESITY, V12, P205; BOUCHARD C, 1991, AM J CLIN NUTR, V53, pS1561, DOI 10.1093/ajcn/53.6.1561S; BUNYAN J, 1976, BRIT J NUTR, V35, P25, DOI 10.1079/BJN19760005; CARMELLI D, 1994, AM J HUM GENET, V55, P566; COMINGS DE, 1993, BIOCHEM MED METAB B, V50, P176, DOI 10.1006/bmmb.1993.1059; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; FABSITZ RR, 1994, AM J EPIDEMIOL, V140, P711, DOI 10.1093/oxfordjournals.aje.a117319; FULKER DW, 1994, AM J HUM GENET, V54, P1092; GARN SM, 1986, AM J CLIN NUTR, V44, P996, DOI 10.1093/ajcn/44.6.996; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Herskind A, 1996, INT J OBESITY, V20, P106; JOHANSSON AG, 1993, AM J CLIN NUTR, V57, P323, DOI 10.1093/ajcn/57.3.323; KNOWLER WC, 1991, AM J CLIN NUTR, V53, pS1543, DOI 10.1093/ajcn/53.6.1543S; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; KUSKOWSKAWOLK A, 1993, J EPIDEMIOL COMMUN H, V47, P195, DOI 10.1136/jech.47.3.195; KUSKOWSKAWOLK A, 1993, J EPIDEMIOL COMMUN H, V47, P103, DOI 10.1136/jech.47.2.103; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; NEEL JV, 1962, AM J HUM GENET, V14, P353; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; OLSON JM, 1995, GENET EPIDEMIOL, V12, P177, DOI 10.1002/gepi.1370120206; RICE T, 1993, AM J HUM GENET, V52, P967; *SAGE, 1994, STAT AN GEN EP 2 62; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHWENGEL DA, 1994, GENOMICS, V22, P46, DOI 10.1006/geno.1994.1344; SEIDELL JC, 1995, INT J OBESITY, V19, P924; Siri W.E., 1961, TECHNIQUES MEASURING, V61, P223; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; SVENDSEN OL, 1993, AM J CLIN NUTR, V57, P605, DOI 10.1093/ajcn/57.5.605; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; VANHEYNINGEN V, 1995, CYTOGENET CELL GENET, V69, P128, DOI 10.1159/000133953; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644	43	122	126	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					166	173						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981960				2022-12-18	WOS:A1997WA81800023
J	DAS, S; LEVINSON, B; WHITNEY, S; VULPE, C; PACKMAN, S; GITSCHIER, J				DAS, S; LEVINSON, B; WHITNEY, S; VULPE, C; PACKMAN, S; GITSCHIER, J			DIVERSE MUTATIONS IN PATIENTS WITH MENKES DISEASE OFTEN LEAD TO EXON SKIPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATIONS; CANDIDATE GENE; MESSENGER-RNA; ENTEROCOCCUS-HIRAE; OSMIUM-TETROXIDE; HYDROXYLAMINE; ENCODES; ATPASE	Fibroblast cultures from 12 unrelated patients with classical Menkes disease were analyzed for mutations in the MNK gene, by reverse transcription-PCR (RT-PCR) and chemical cleavage mismatch detection. Mutations were observed in 10 patients, and in each case a different mutation was present. All of the mutations would be predicted to have adverse effects on protein expression. Mutations that resulted in splicing abnormalities, detected by RT-PCR alone, were observed in six patients and included two splice-site changes, a nonsense mutation, a missense mutation, a small duplication, and a small deletion, Chemical cleavage analysis of the remaining six patients revealed the presence of one nonsense mutation, two adjacent 5-bp deletions, and one missense mutation. A valine/leucine polymorphism was also observed. These findings, combined with the prior observation of deletions in 15%-20% of Menkes patients, suggest that Southern blot hybridization and RT-PCR will identify mutations in the majority	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DIV GENET,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco			Vulpe, Chris/AAF-9170-2020	Vulpe, Chris/0000-0001-5134-8929	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR01271] Funding Source: Medline; NIGMS NIH HHS [GM07618] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CONDIE A, 1993, HUM MUTAT, V2, P58, DOI 10.1002/humu.1380020111; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FUKUDA I, 1992, CELL STRUCT FUNCT, V17, P427, DOI 10.1247/csf.17.427; GERDES AM, 1988, EUR J PEDIATR, V148, P132, DOI 10.1007/BF00445920; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HAAS RH, 1981, NEUROLOGY, V31, P852, DOI 10.1212/WNL.31.7.852; KALER SG, 1994, PEDIATR RES, V35, pA152; LEVINSON B, 1993, NAT GENET, V3, P6, DOI 10.1038/ng0193-6; LIGTENBERG MJL, 1990, NUCLEIC ACIDS RES, V19, P297; MATSUO M, 1991, J CLIN INVEST, V87, P2127, DOI 10.1172/JCI115244; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; NAYLOR JA, 1992, HUM MOL GENET, V2, P11; ODERMATT A, 1992, ANN NY ACAD SCI, V671, P484, DOI 10.1111/j.1749-6632.1992.tb43836.x; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; PACKMAN S, 1987, J CLIN INVEST, V79, P1338, DOI 10.1172/JCI112959; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; TONNESEN T, 1992, AM J HUM GENET, V50, P1012; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	26	122	124	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					883	889						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977350				2022-12-18	WOS:A1994QB68200006
J	WILLING, MC; DESCHENES, SP; SCOTT, DA; BYERS, PH; SLAYTON, RL; PITTS, SH; ARIKAT, H; ROBERTS, EJ				WILLING, MC; DESCHENES, SP; SCOTT, DA; BYERS, PH; SLAYTON, RL; PITTS, SH; ARIKAT, H; ROBERTS, EJ			OSTEOGENESIS IMPERFECTA TYPE-I - MOLECULAR HETEROGENEITY FOR COL1A1 NULL ALLELES OF TYPE-I COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA STABILITY; BETA-GLOBIN GENE; PRO-ALPHA-1(I) CHAIN; NONSENSE MUTATIONS; SPLICING MUTATION; COL1A1 GENE; SUBSTITUTION; PROCOLLAGEN; CYSTEINE; GLYCINE	Osteogenesis imperfecta (OI) type I is the mildest form of inherited brittle-bone disease. Dermal fibroblasts from most affected individuals produce about half the usual amount of type I procollagen, as a result of a COL1A1 ''null'' allele. Using PCR amplification of genomic DNA from affected individuals, followed by denaturing gradient gel electrophoresis (DGGE) and SSCP, we identified seven different COL1A1 gene mutations in eight unrelated families with OI type I. Three families have single nucleotide substitutions that alter 5' donor splice sites; two of these unrelated families have the same mutation. One family has a point mutation, in an exon, that creates a premature termination codon, and four have small deletions or insertions, within exons, that create translational frameshifts and new termination codons downstream of the mutation sites. Each mutation leads to both marked reduction in steady-state levels of mRNA from the mutant allele and a quantitative decrease in type I procollagen production. Our data demonstrate that different molecular mechanisms that have the same effect on type I collagen production result in the same clinical phenotype.	UNIV IOWA,SCH MED,IOWA CITY,IA 52242; UNIV IOWA,SCH DENT,IOWA CITY,IA; UNIV WASHINGTON,DEPT MED,SEATTLE,WA; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Iowa; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	WILLING, MC (corresponding author), UNIV IOWA,DEPT PEDIAT,2JCP,IOWA CITY,IA 52242, USA.			Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR 41223, AR 40334] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041223, R29AR040334] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BAIRD M, 1981, P NATL ACAD SCI-BIOL, V78, P4218, DOI 10.1073/pnas.78.7.4218; BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; BOTTO M, 1990, J CLIN INVEST, V86, P1158, DOI 10.1172/JCI114821; Byers Peter H., 1993, P317; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN DH, 1988, J BIOL CHEM, V263, P14605; CONSTANTINOU CD, 1990, NUCLEIC ACIDS RES, V18, P5577, DOI 10.1093/nar/18.18.5577; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; DEAK SB, 1991, J BIOL CHEM, V266, P21827; DRISCOLL DM, 1989, CELL, V58, P519, DOI 10.1016/0092-8674(89)90432-7; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; GAREY JR, 1990, J CLIN INVEST, V86, P1416, DOI 10.1172/JCI114856; GENOVESE C, 1987, METHOD ENZYMOL, V145, P223; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; HUMPHRIES RK, 1984, BLOOD, V64, P23; JACK HM, 1989, EUR J IMMUNOL, V19, P843, DOI 10.1002/eji.1830190510; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LIEBHABER SA, 1987, J CLIN INVEST, V80, P154, DOI 10.1172/JCI113041; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MOTTES M, 1992, HUM GENET, V89, P480; Myers R, 1989, PCR TECHNOLOGY PRINC, P71; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; NICHOLLS AC, 1984, BRIT MED J, V288, P112, DOI 10.1136/bmj.288.6411.112; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORKIN SH, 1981, P NATL ACAD SCI-BIOL, V78, P5041, DOI 10.1073/pnas.78.8.5041; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; PRUCHNO CJ, 1991, HUM GENET, V87, P33, DOI 10.1007/BF01213088; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOKATA I, 1990, P NATL ACAD SCI USA, V87, P9908, DOI 10.1073/pnas.87.24.9908; SHAPIRO JR, 1992, J CLIN INVEST, V89, P567, DOI 10.1172/JCI115622; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; Steinmann Beat, 1993, P351; STOVER ML, 1993, J CLIN INVEST, V92, P1994, DOI 10.1172/JCI116794; SYKES B, 1977, NEW ENGL J MED, V296, P1200, DOI 10.1056/NEJM197705262962104; SYKES B, 1986, LANCET, V2, P69; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WESTERHAUSEN A, 1991, MATRIX, V11, P375, DOI 10.1016/S0934-8832(11)80191-5; WESTERHAUSEN AI, 1990, NUCLEIC ACIDS RES, V18, P4968, DOI 10.1093/nar/18.16.4968; WILLING MC, 1993, AM J MED GENET, V45, P223, DOI 10.1002/ajmg.1320450214; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1992, AM J HUM GENET, V51, P508; WINSLOW RM, 1976, J CLIN INVEST, V57, P772, DOI 10.1172/JCI108336; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139	58	122	126	1	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					638	647						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942841				2022-12-18	WOS:A1994PJ02700005
J	RYYNANEN, M; KNOWLTON, RG; PARENTE, MG; CHUNG, LC; CHU, ML; UITTO, J				RYYNANEN, M; KNOWLTON, RG; PARENTE, MG; CHUNG, LC; CHU, ML; UITTO, J			HUMAN TYPE-VII COLLAGEN - GENETIC-LINKAGE OF THE GENE (COL7AI) ON CHROMOSOME-3 TO DOMINANT DYSTROPHIC EPIDERMOLYSIS-BULLOSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANCHORING FIBRILS; PROCOLLAGEN; SIMPLEX; ANTIGEN; FAMILY; FORM	Epidermolysis bullosa (EB) is a heterogeneous group of heritable blistering disorders affecting the skin and the mucous membranes. Previous ultrastructural studies on the dystrophic (scarring) forms of EB have demonstrated abnormalities in the anchoring fibrils, morphologically distinct structures below the basal lamina at the dermal/epidermal basement membrane zone. Type VII collagen is the major collagenous component of the anchoring fibrils, and it is therefore a candidate gene for mutations in some families with dystrophic forms of EB. In this study, we performed genetic linkage analyses in a large kindred with dominant dystrophic EB. A 1.9-kb type VII collagen cDNA clone was used to identify a PvuII RFLP to follow the inheritance of the gene. This RFLP cosegregated with the EB phenotype in this family, strongly supporting genetic linkage (Z = 5.37; theta = .0). In addition, we assigned the type VII collagen gene (COL7A1) to chromosome 3 by hybridization to a panel of human x rodent somatic cell hybrids. These data demonstrate very close genetic linkage between the clinical phenotype in this family and the polymorphism in the type VII collagen gene mapped to chromosome 3. The absence of recombination between EB and the type VII collagen gene locus, as well as the observed abnormalities in the anchoring fibrils, strongly suggest that this collagen gene is the mutant locus in this kindred.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL,DEPT DERMATOL,233 S 10TH ST, BLSB 450, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON INST MOLEC MED, MOLEC DERMATOL SECT, PHILADELPHIA, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [T32-AR7869, P01-AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BRIGGAMAN RA, 1985, J INVEST DERMATOL, V84, P371, DOI 10.1111/1523-1747.ep12265450; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FINE JD, 1990, J AM ACAD DERMATOL, V22, P188, DOI 10.1016/0190-9622(90)70021-9; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1988, ARCH DERMATOL, V124, P713, DOI 10.1001/archderm.124.5.713; Gedde-Dahl T Jr, 1981, Acta Derm Venereol Suppl (Stockh), V95, P74; GHADIALLY FN, 1988, ULTRASTRUCT PATHOL, V2, P1228; HUMPHRIES M, 1990, J INVEST DERMATOL, V95, P568, DOI 10.1111/1523-1747.ep12505546; HUMPHRIES MM, 1990, GENOMICS, V7, P377, DOI 10.1016/0888-7543(90)90171-P; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KERO M, 1984, ACTA DERM-VENEREOL, P1; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; LUNSTRUM GP, 1987, J BIOL CHEM, V262, P13706; MORRIS NP, 1986, J BIOL CHEM, V261, P5638; MULLEY JC, 1984, AM J MED GENET, V19, P573, DOI 10.1002/ajmg.1320190320; OLAISEN B, 1973, HUM HERED, V23, P189, DOI 10.1159/000152573; OTT J, 1974, AM J HUM GENET, V26, P588; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWAMURA D, 1990, GENOMICS, V8, P722, DOI 10.1016/0888-7543(90)90261-R; SMITH LT, 1990, J INVEST DERMATOL, V94, P261, DOI 10.1111/1523-1747.ep12874614; TIDMAN MJ, 1985, J INVEST DERMATOL, V84, P374, DOI 10.1111/1523-1747.ep12265460; UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373	27	122	128	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					797	803						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1680286				2022-12-18	WOS:A1991GG66500011
J	ZEVIANI, M; AMATI, P; BRESOLIN, N; ANTOZZI, C; PICCOLO, G; TOSCANO, A; DIDONATO, S				ZEVIANI, M; AMATI, P; BRESOLIN, N; ANTOZZI, C; PICCOLO, G; TOSCANO, A; DIDONATO, S			RAPID DETECTION OF THE A-]G(8344) MUTATION OF MTDNA IN ITALIAN FAMILIES WITH MYOCLONUS EPILEPSY AND RAGGED-RED FIBERS (MERRF)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; TRANSFER-RNA; SEQUENCE; DISEASE	We devised a rapid PCR-based method to screen for an A --> G transition at nucleotide 8344 of the human mitochondrial tRNA(Lys) gene, which was recently reported, by Shoffner and co-workers, to be associated with myoclonus epilepsy and ragged-red fibers (MERRF), a maternally transmitted mitochondrial encephalomyopathy (Shoffner et al. 1990). We confirmed this association in five of seven Italian MERRF pedigrees. The mutation was specific for the MERRF trait, because it was never found in mtDNA of non-MERRF individuals, including 14 normal and 110 diseased controls. Our study corroborates the idea that the A --> G(8344) mutation is the most frequent and widespread genetic cause of MERRF.	UNIV STATALE MILANO,IST CLIN NEUROL,MILAN,ITALY; UNIV STATALE MESSINA,NEUROL CLIN,MESSINA,ITALY; UNIV STATALE PAVIA,NEUROL CLIN,PAVIA,ITALY	University of Milan	ZEVIANI, M (corresponding author), IST NEUROCHIRURG C BESTA,DEPT BIOCHEM & GENET,VIA CELORIA 11,I-20133 MILAN,ITALY.		Di Donato, Stefano/B-9717-2012; amati-bonneau, patrizia/K-6198-2015; Zeviani, Massimo/K-2891-2014; Antozzi, Carlo/AAB-8787-2019; Zeviani, Massimo/AAU-2632-2021	Antozzi, Carlo/0000-0001-9270-5224; Zeviani, Massimo/0000-0002-9067-5508; Bresolin, Nereo/0000-0001-6694-3595				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Battey, 1986, BASIC METHODS MOL BI; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; RICH A, 1978, SCI AM, V238, P56; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHIMMEL P, 1982, TRENDS BIOCHEM SCI, V7, P209, DOI 10.1016/0968-0004(82)90092-5; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; WALLACE DC, 1986, AM J HUM GENET, V38, P461; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	19	122	123	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					203	211						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1899320				2022-12-18	WOS:A1991EV74400004
J	RICHARDS, CS; WATKINS, SC; HOFFMAN, EP; SCHNEIDER, NR; MILSARK, IW; KATZ, KS; COOK, JD; KUNKEL, LM; CORTADA, JM				RICHARDS, CS; WATKINS, SC; HOFFMAN, EP; SCHNEIDER, NR; MILSARK, IW; KATZ, KS; COOK, JD; KUNKEL, LM; CORTADA, JM			SKEWED X INACTIVATION IN A FEMALE MZ TWIN RESULTS IN DUCHENNE MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEXAS SCOTTISH RITE HOSP CRIPPLED CHILDREN,DALLAS,TX; DANA FARBER CANC INST,BOSTON,MA; HOWARD HUGHES MED INST,BOSTON,MA; UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT PEDIAT,DALLAS,TX 75235; UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT PATHOL,DALLAS,TX 75235; CHILDRENS HOSP MED CTR,BOSTON,MA 02115	Texas Scottish Rite Hospital for Children; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital			Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Hoffman, Eric/0000-0001-6470-5139				ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1989, NEW ENGL J MED, V320, P138, DOI 10.1056/NEJM198901193200302; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BONILLA E, 1988, AM J PATHOL, V133, P440; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BOYD Y, 1987, CLIN GENET, V31, P265; BURN J, 1986, J MED GENET, V23, P494, DOI 10.1136/jmg.23.6.494; CHEN JD, 1988, AM J HUM GENET, V42, P777; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CHUTKOW JG, 1987, NEUROLOGY, V37, P1147, DOI 10.1212/WNL.37.7.1147; CULLEN CR, 1986, EMBO J, V5, P2223, DOI 10.1002/j.1460-2075.1986.tb04488.x; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GOMEZ MR, 1977, NEUROLOGY, V27, P537, DOI 10.1212/WNL.27.6.537; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HALL JG, 1988, AM J HUM GENET, V43, P355; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; INGERSLEV J, 1989, CLIN GENET, V35, P41; JAMES WH, 1988, J MED GENET, V25, P213; JONGBLOET PH, 1988, J MED GENET, V25, P214, DOI 10.1136/jmg.25.3.214; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KNUDSON CM, 1988, J BIOL CHEM, V263, P8480; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LASCARI AD, 1969, AM J DIS CHILD, V117, P585, DOI 10.1001/archpedi.1969.02100030587016; LINDLOF M, 1989, AM J HUM GENET, V44, P496; LYON MF, 1962, AM J HUM GENET, V14, P135; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NISEN P, 1986, NEW ENGL J MED, V315, P1139, DOI 10.1056/NEJM198610303151806; PENA SDJ, 1987, J NEUROL SCI, V79, P337, DOI 10.1016/0022-510X(87)90240-1; PHELAN MC, 1980, AM J HUM GENET, V32, pA123; PHILIP J, 1969, ANN HUM GENET, V33, P185, DOI 10.1111/j.1469-1809.1969.tb01644.x; Smith D W, 1976, Birth Defects Orig Artic Ser, V12, P53; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SUGITA H, 1988, P JPN ACAD B-PHYS, V64, P37, DOI 10.2183/pjab.64.37; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WATKINS SC, 1909, MUSCLE NERVE, V12, P861; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; WTKINS SC, 1988, NATURE, V33, P863; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759; ZATZ M, 1988, AM J MED GENET, V32, P7	46	122	123	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					672	681						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2180286				2022-12-18	WOS:A1990CW54900006
J	Dusi, S; Valetta, L; Haack, TB; Tsuchiya, Y; Venco, P; Pasqualato, S; Goffrini, P; Tigano, M; Demchenko, N; Wieland, T; Schwarzmayr, T; Strom, TM; Invernizzi, F; Garavaglia, B; Gregory, A; Sanford, L; Hamada, J; Bettencourt, C; Houlden, H; Chiapparini, L; Zorzi, G; Kurian, MA; Nardocci, N; Prokisch, H; Hayflick, S; Gout, I; Tiranti, V				Dusi, Sabrina; Valetta, Lorella; Haack, Tobias B.; Tsuchiya, Yugo; Venco, Paola; Pasqualato, Sebastiano; Goffrini, Paola; Tigano, Marco; Demchenko, Nikita; Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Invernizzi, Federica; Garavaglia, Barbara; Gregory, Allison; Sanford, Lynn; Hamada, Jeffrey; Bettencourt, Conceicao; Houlden, Henry; Chiapparini, Luisa; Zorzi, Giovanna; Kurian, Manju A.; Nardocci, Nardo; Prokisch, Holger; Hayflick, Susan; Gout, Ivan; Tiranti, Valeria			Exome Sequence Reveals Mutations in CoA Synthase as a Cause of Neurodegeneration with Brain Iron Accumulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; HALLERVORDEN-SPATZ-SYNDROME; COENZYME-A; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIA; GENE; BIOSYNTHESIS; YEAST; NBIA; IDENTIFICATION	Neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of disorders with progressive extrapyramidal signs and neurological deterioration, characterized by iron accumulation in the basal ganglia. Exome sequencing revealed the presence of recessive missense mutations in COASY, encoding coenzyme A (CoA) synthase in one NBIA-affected subject. A second unrelated individual carrying mutations in COASY was identified by Sanger sequence analysis. CoA synthase is a bifunctional enzyme catalyzing the final steps of CoA biosynthesis by coupling phosphopantetheine with ATP to form dephospho-CoA and its subsequent phosphorylation to generate CoA. We demonstrate alterations in RNA and protein expression levels of CoA synthase, as well as CoA amount, in fibroblasts derived from the two clinical cases and in yeast. This is the second inborn error of coenzyme A biosynthesis to be implicated in NBIA.	[Dusi, Sabrina; Valetta, Lorella; Venco, Paola; Invernizzi, Federica; Garavaglia, Barbara; Tiranti, Valeria] IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy; [Haack, Tobias B.; Strom, Tim M.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Munich, Germany; [Tsuchiya, Yugo; Demchenko, Nikita; Gout, Ivan] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Pasqualato, Sebastiano] European Inst Oncol, Dept Expt Oncol, Crystallog Unit, I-20139 Milan, Italy; [Goffrini, Paola; Tigano, Marco] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Gregory, Allison; Sanford, Lynn; Hamada, Jeffrey; Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97329 USA; [Bettencourt, Conceicao; Houlden, Henry] UCL Inst Neurol, London WC1N 3BG, England; [Bettencourt, Conceicao; Houlden, Henry] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Chiapparini, Luisa] IRCCS Fdn Neurol Inst C Besta, Unit Neuroradiol, I-20133 Milan, Italy; [Zorzi, Giovanna; Nardocci, Nardo] IRCCS Fdn Neurol Inst C Besta, Unit Child Neurol, I-20133 Milan, Italy; [Kurian, Manju A.] Great Ormond St Hosp Sick Children, UCL Inst Child Hlth, Neurosci Unit, London WC1N 3JH, England; [Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 3JH, England	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; Birkbeck University London; University College London; IRCCS European Institute of Oncology (IEO); University of Parma; Oregon Health & Science University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tiranti, V (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, I-20126 Milan, Italy.	tiranti@istituto-besta.it	Nardocci, Nardo/AAB-9903-2019; Invernizzi, Federica/J-9849-2016; Dusi, Sabrina/H-6561-2016; Tiranti, Valeria/AFN-5783-2022; Chiapparini, Luisa/K-4019-2016; Garavaglia, Barbara/J-5257-2018; Goffrini, Paola/C-3860-2015; Houlden, Henry J/C-1532-2008; Zorzi, Giovanna/AAM-4138-2021; Tiranti, Valeria/J-8233-2016	Nardocci, Nardo/0000-0001-5863-5592; Invernizzi, Federica/0000-0001-8072-0152; Dusi, Sabrina/0000-0002-4935-5174; Tiranti, Valeria/0000-0002-3584-7338; Chiapparini, Luisa/0000-0001-8115-9897; Garavaglia, Barbara/0000-0003-4323-9145; Goffrini, Paola/0000-0002-8650-4765; Houlden, Henry J/0000-0002-2866-7777; Zorzi, Giovanna/0000-0001-7041-5365; Tiranti, Valeria/0000-0002-3584-7338; Pasqualato, Sebastiano/0000-0002-9038-7768; Tigano, Marco/0000-0002-4353-9220; Prokisch, Holger/0000-0003-2379-6286; Bettencourt, Conceicao/0000-0001-9090-7690	Telethon [GGP11088]; TIRCON project of the European Commission's Seventh Framework Programme (FP7, HEALTH-F2) [277984]; Cell line and DNA bank of paediatric movement disorders of the Telethon Genetic Biobank Network [GTB07001]; Mariani Foundation of Milan; NBIA Disorders Association; MRC UK [G0802870]; Backman-Strauss Foundation; Biotechnology and Biological Sciences Research Council [BB/L010410/1] Funding Source: researchfish; Medical Research Council [G108/638, MR/J004758/1, G0802760, G1001253] Funding Source: researchfish; BBSRC [BB/L010410/1] Funding Source: UKRI; MRC [G1001253, G0802760, MR/J004758/1, G108/638] Funding Source: UKRI	Telethon(Fondazione Telethon); TIRCON project of the European Commission's Seventh Framework Programme (FP7, HEALTH-F2); Cell line and DNA bank of paediatric movement disorders of the Telethon Genetic Biobank Network(Fondazione Telethon); Mariani Foundation of Milan; NBIA Disorders Association; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Backman-Strauss Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Mario Savoiardo and Federica Zibordi for helpful neuroradiological and clinical support and Fabrizio Villa for experimental advice. The financial support of Telethon GGP11088 to V.T. is gratefully acknowledged. This work was supported by TIRCON project of the European Commission's Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, grant agreement no. 277984). We thank the Cell line and DNA bank of paediatric movement disorders of the Telethon Genetic Biobank Network (project no. GTB07001) and the Bank for the Diagnosis and Research of Movement Disorders (MDB) of the EuroBiobank. The financial support of Mariani Foundation of Milan is gratefully acknowledged. T.B.H. and S.H. were supported by the NBIA Disorders Association. M.A.K. is a Wellcome Trust Intermediate Clinical Fellow. H.H. and C.B. are grateful to the MRC UK (grant number G0802870) and Backman-Strauss Foundation.	Aghajanian S, 2002, BIOCHEM J, V365, P13, DOI 10.1042/BJ20020569; Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Bosveld Floris, 2008, BMC Res Notes, V1, P75, DOI 10.1186/1756-0500-1-75; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Kruer MC, 2010, ANN NEUROL, V68, P611, DOI 10.1002/ana.22122; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; MAGNI GE, 1962, GENETICS, V47, P1097; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nemazanyy I, 2006, BIOCHEM BIOPH RES CO, V341, P995, DOI 10.1016/j.bbrc.2006.01.051; Nemazanyy I, 2004, FEBS LETT, V578, P357, DOI 10.1016/j.febslet.2004.10.091; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; Panteghini C, 2012, SEMIN PEDIATR NEUROL, V19, P75, DOI 10.1016/j.spen.2012.03.006; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Sambrook J, 2001, MOL CLONING LAB MANU; Simon-Kayser B, 2005, GENE CHROMOSOME CANC, V43, P83, DOI 10.1002/gcc.20170; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; TAHILIANI AG, 1991, VITAM HORM, V46, P165; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Walia G., 2011, PLOS ONE, V6; Walia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021390; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	41	121	124	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					11	22		10.1016/j.ajhg.2013.11.008	http://dx.doi.org/10.1016/j.ajhg.2013.11.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360804	hybrid, Green Published			2022-12-18	WOS:000329888400002
J	Oates, EC; Rossor, AM; Hafezparast, M; Gonzalez, M; Speziani, F; MacArthur, DG; Lek, M; Cottenie, E; Scoto, M; Foley, AR; Hurles, M; Houlden, H; Greensmith, L; Auer-Grumbach, M; Pieber, TR; Strom, TM; Schule, R; Herrmann, DN; Sowden, JE; Acsadi, G; Menezes, MP; Clarke, NF; Zuchner, S; Muntoni, F; North, KN; Reilly, MM				Oates, Emily C.; Rossor, Alexander M.; Hafezparast, Majid; Gonzalez, Michael; Speziani, Fiorella; MacArthur, Daniel G.; Lek, Monkol; Cottenie, Ellen; Scoto, Mariacristina; Foley, A. Reghan; Hurles, Matthew; Houlden, Henry; Greensmith, Linda; Auer-Grumbach, Michaela; Pieber, Thomas R.; Strom, Tim M.; Schule, Rebecca; Herrmann, David N.; Sowden, Janet E.; Acsadi, Gyula; Menezes, Manoj P.; Clarke, Nigel F.; Zuechner, Stephan; Muntoni, Francesco; North, Kathryn N.; Reilly, Mary M.		UK10K	Mutations in BICD2 Cause Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BICAUDAL-D; TRANSPORT; OOGENESIS; NEURONS; GENOME; FORM	Dominant congenital spinal muscular atrophy (DCSMA) is a disorder of developing anterior horn cells and shows lower-limb predominance and clinical overlap with hereditary spastic paraplegia (HSP), a lower-limb-predominant disorder of corticospinal motor neurons. We have identified four mutations in bicaudal D homolog 2 (Drosophila) (BICD2) in six kindreds affected by DCSMA, DCSMA with upper motor neuron features, or HSP. BICD2 encodes BICD2, a key adaptor protein that interacts with the dynein-dynactin motor complex, which facilitates trafficking of cellular cargos that are critical to motor neuron development and maintenance. We demonstrate that mutations resulting in amino acid substitutions in two binding regions of BICD2 increase its binding affinity for the cytoplasmic dynein-dynactin complex, which might result in the perturbation of BICD2-dynein-dynactin-mediated trafficking, and impair neurite outgrowth. These findings provide insight into the mechanism underlying both the static and the slowly progressive clinical features and the motor neuron pathology that characterize BICD2-associated diseases, and underscore the importance of the dynein-dynactin transport pathway in the development and survival of both lower and upper motor neurons.	[Oates, Emily C.; Menezes, Manoj P.; Clarke, Nigel F.; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [Oates, Emily C.; Menezes, Manoj P.; Clarke, Nigel F.] Univ Sydney, Fac Med, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Rossor, Alexander M.; Cottenie, Ellen; Houlden, Henry; Greensmith, Linda; Reilly, Mary M.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Gonzalez, Michael; Speziani, Fiorella; Zuechner, Stephan] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael; Speziani, Fiorella; Zuechner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [MacArthur, Daniel G.; Lek, Monkol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, Daniel G.; Lek, Monkol] Broad Inst Harvard & MIT, Boston, MA 02142 USA; [Scoto, Mariacristina; Foley, A. Reghan; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Hurles, Matthew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Houlden, Henry] UCL Inst Neurol, Neurogenet Lab, London WC1N 3BG, England; [Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Auer-Grumbach, Michaela] Med Univ Vienna, Div Orthopaed, A-1090 Vienna, Austria; [Pieber, Thomas R.] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, A-8036 Graz, Austria; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-85748 Garching, Germany; [Schule, Rebecca] Univ Tubingen, Hertie Inst Clin Brain Res, D-72074 Tubingen, Germany; [Schule, Rebecca] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, D-72074 Tubingen, Germany; [Herrmann, David N.; Sowden, Janet E.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Herrmann, David N.] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Acsadi, Gyula] Connecticut Childrens Med Ctr, Dept Neurol, Hartford, CT 06106 USA; [North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [North, Kathryn N.] Univ Melbourne, Dept Paediat, Parkville, Vic 3010, Australia	University of Sydney; University of Sydney; University of London; University College London; University of Sussex; University of Miami; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; University College London; Wellcome Trust Sanger Institute; University of London; University College London; University of London; University College London; University of London; University College London; Medical University of Vienna; Medical University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rochester; University of Rochester; Connecticut Children's Medical Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	North, KN (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia.	kathryn.north@mcri.edu.au	Houlden, Henry J/C-1532-2008; Hafezparast, Majid/N-8292-2019; Schüle, Rebecca/B-5763-2019; Hafezparast, Majid/H-6728-2018; Rossor, Alexander/AAH-6870-2019; North, Kathryn N/K-6476-2012	Houlden, Henry J/0000-0002-2866-7777; Hafezparast, Majid/0000-0002-5262-7150; Schüle, Rebecca/0000-0002-7781-2766; Rossor, Alexander/0000-0003-4648-2896; North, Kathryn N/0000-0003-0841-8009; MacArthur, Daniel/0000-0002-5771-2290; Pieber, Thomas/0000-0003-3554-0405; Menezes, Manoj/0000-0003-3160-6112; Reilly, Mary/0000-0003-0686-905X	National Human Genome Research Institute, National Institutes of Health [U54 HG003067]; Inherited Neuropathies Consortium (Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke) [1U54NS0657]; Wellcome Trust [WT091310]; MRC [G0802760, MR/J004758/1, MR/K000608/1, G1001253, G108/638] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248, K07NS000657, U54NS065712] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23223] Funding Source: researchfish; Medical Research Council [MR/J004758/1, G1001253, G108/638, MR/K000608/1, G0802760] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Inherited Neuropathies Consortium (Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK	We would like to thank Leigh Waddell for coordination of AUS1 exome samples, Katy Eichinger for research evaluation of USA1, and Garth Nicholson, Marina Kennerson, Giovanni Stevanin, and Matthew Harms for further investigating additional BICD2 variants that ultimately did not segregate with the disease phenotype in their kindreds. AUS1 exome sequencing was supported by a grant from the National Human Genome Research Institute, National Institutes of Health (Medical Sequencing Program grant U54 HG003067 to E.S. Lander, the principal investigator at the Broad Institute of Harvard and MIT). Genetic testing of AUSTRAI1, UK1, USA1, and GERMANY1 was supported by the Inherited Neuropathies Consortium (Rare Disease Clinical Research Network, National Institute of Neurological Disorders and Stroke 1U54NS0657). The study makes use of data (from sample set NM5061932 [UK2]) generated by the UK10K Consortium with funding from the Wellcome Trust (award WT091310). Investigators who contributed to the generation of these data are listed at www.UK10K.org. Funding sources for individual authors are summarized in the Supplemental Acknowledgments.	Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; FLEURY P, 1985, J NEUROL NEUROSUR PS, V48, P1037, DOI 10.1136/jnnp.48.10.1037; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P125, DOI 10.1016/j.nmd.2003.09.005; Oates EC, 2012, BRAIN, V135, P1714, DOI 10.1093/brain/aws108; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Reddel S, 2008, NEUROMUSCULAR DISORD, V18, P530, DOI 10.1016/j.nmd.2008.04.016; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Swan A, 1996, DEVELOPMENT, V122, P3577; Swift S, 2010, J BIOL CHEM, V285, P11402, DOI 10.1074/jbc.M110.105403; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	21	121	124	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					965	973		10.1016/j.ajhg.2013.04.018	http://dx.doi.org/10.1016/j.ajhg.2013.04.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23664120	Green Published, Bronze			2022-12-18	WOS:000320415300013
J	Kott, E; Duquesnoy, P; Copin, B; Legendre, M; Dastot-Le Moal, F; Montantin, G; Jeanson, L; Tamalet, A; Papon, JF; Siffroi, JP; Rives, N; Mitchell, V; de Blic, J; Coste, A; Clement, A; Escalier, D; Toure, A; Escudier, E; Amselem, S				Kott, Esther; Duquesnoy, Philippe; Copin, Bruno; Legendre, Marie; Dastot-Le Moal, Florence; Montantin, Guy; Jeanson, Ludovic; Tamalet, Aline; Papon, Jean-Francois; Siffroi, Jean-Pierre; Rives, Nathalie; Mitchell, Valerie; de Blic, Jacques; Coste, Andre; Clement, Annick; Escalier, Denise; Toure, Aminata; Escudier, Estelle; Amselem, Serge			Loss-of-Function Mutations in LRRC6, a Gene Essential for Proper Axonemal Assembly of Inner and Outer Dynein Arms, Cause Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMOTILE-CILIA; CYSTIC KIDNEY; PROTEIN; FLAGELLAR; MOTILITY; COMPLEX; HUMANS; DOMAIN; DEFECT	Primary ciliary dyskinesia (PCD) is a group of autosomal-recessive disorders resulting from cilia and sperm-flagella defects, which lead to respiratory infections and male infertility. Most implicated genes encode structural proteins that participate in the composition of axonemal components, such as dynein arms (DAs), that are essential for ciliary and flagellar movements; they explain the pathology in fewer than half of the affected individuals. We undertook this study to further understand the pathogenesis of PCD due to the absence of both DAs. We identified, via homozygosity mapping, an early frameshift in LRRC6, a gene that encodes a leucine-rich-repeat (LRR)-containing protein. Subsequent analyses of this gene mainly expressed in testis and respiratory cells identified biallelic mutations in several independent individuals. The situs inversus observed in two of them supports a key role for LRRC6 in embryonic nodal cilia. Study of native LRRC6 in airway epithelial cells revealed that it localizes to the cytoplasm and within cilia, whereas it is absent from cells with loss-of-function mutations, in which DA protein markers are also missing. These results are consistent with the transmission-electron-microscopy data showing the absence of both DAs in cilia or flagella from individuals with LRRC6 mutations. In spite of structural and functional similarities between LRRC6 and DNAAF1, another LRR-containing protein involved in the same PCD phenotype, the two proteins are not redundant. The evolutionarily conserved LRRC6, therefore, emerges as an additional player in DA assembly, a process that is essential for proper axoneme building and that appears to be much more complex than was previously thought.	[Kott, Esther; Duquesnoy, Philippe; Copin, Bruno; Legendre, Marie; Dastot-Le Moal, Florence; Montantin, Guy; Jeanson, Ludovic; Siffroi, Jean-Pierre; Escalier, Denise; Escudier, Estelle; Amselem, Serge] Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France; [Tamalet, Aline; Clement, Annick] Hop Armand Trousseau, AP HP, Ctr Natl Reference Malad Resp Rares, Unite Pneumol Pediat, F-75012 Paris, France; [Papon, Jean-Francois; Coste, Andre] Hop Intercommunal Creteil, UMR S955, F-94000 Creteil, France; [Papon, Jean-Francois; Coste, Andre] Hop Intercommunal Creteil, Serv ORL & Chirurg Cervicofaciale, F-94000 Creteil, France; [Papon, Jean-Francois; Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, AP HP, F-94000 Creteil, France; [Rives, Nathalie] Ctr Hosp Reg Univ, Lab Biol Reprod, F-76000 Rouen, France; [Mitchell, Valerie] Inst Reprod Biol, Equipe Accueil 4308, F-59000 Lille, France; [de Blic, Jacques] Grp Hosp Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, F-75015 Paris, France; [Toure, Aminata] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Amselem, S (corresponding author), Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France.	serge.amselem@inserm.fr	TOURE, Aminata/B-3236-2018; Legendre, Marie/AAD-7018-2021	TOURE, Aminata/0000-0001-5629-849X; Legendre, Marie/0000-0003-2178-0846; COSTE, Andre/0000-0002-8386-3455; Papon, Jean Francois/0000-0002-2323-9239	Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation; Assistance Publique-Hopitaux de Paris [PHRC AOM06053, P060245]; Fondation pour la Recherche Medicale [DEQ20120323689]	Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation; Assistance Publique-Hopitaux de Paris; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We are grateful to the affected persons and their families, whose cooperation made this study possible, and we thank all referring physicians. This work was supported by grants from the Legs Poix from the Chancellerie des Universites, the Milena Carvajal ProKartagener Foundation, the Assistance Publique-Hopitaux de Paris (PHRC AOM06053 and P060245), and the Fondation pour la Recherche Medicale (DEQ20120323689).	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Blouin JL, 2000, EUR J HUM GENET, V8, P109, DOI 10.1038/sj.ejhg.5200429; Ceulemans H, 1999, FEBS LETT, V456, P349, DOI 10.1016/S0014-5793(99)00965-5; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Escudier E, 2009, PAEDIATR RESPIR REV, V10, P51, DOI 10.1016/j.prrv.2009.02.001; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; Kartagener M., 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tamalet A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e86; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Xue JC, 2000, BIOL REPROD, V62, P1278, DOI 10.1095/biolreprod62.5.1278	27	121	124	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					958	964		10.1016/j.ajhg.2012.10.003	http://dx.doi.org/10.1016/j.ajhg.2012.10.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23122589	Bronze, Green Published			2022-12-18	WOS:000311011400020
J	Thornton, T; Tang, H; Hoffmann, TJ; Ochs-Balcom, HM; Caan, BJ; Risch, N				Thornton, Timothy; Tang, Hua; Hoffmann, Thomas J.; Ochs-Balcom, Heather M.; Caan, Bette J.; Risch, Neil			Estimating Kinship in Admixed Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ANCESTRY; INFERENCE; HERITABILITY; INDIVIDUALS; IDENTITY; ACCOUNT; DESIGN; COMMON; LOCUS	Genome-wide association studies (GWASs) are commonly used for the mapping of genetic loci that influence complex traits. A problem that is often encountered in both population-based and family-based GWASs is that of identifying cryptic relatedness and population stratification because it is well known that failure to appropriately account for both pedigree and population structure can lead to spurious association. A number of methods have been proposed for identifying relatives in samples from homogeneous populations. A strong assumption of population homogeneity, however, is often untenable, and many GWASs include samples from structured populations. Here, we consider the problem of estimating relatedness in structured populations with admixed ancestry. We propose a method, REAP (relatedness estimation in admixed populations), for robust estimation of identity by descent (IBD)-sharing probabilities and kinship coefficients in admixed populations. REAP appropriately accounts for population structure and ancestry-related assortative mating by using individual-specific allele frequencies at SNPs that are calculated on the basis of ancestry derived from whole-genome analysis. In simulation studies with related individuals and admixture from highly divergent populations, we demonstrate that REAP gives accurate IBD-sharing probabilities and kinship coefficients. We apply REAP to the Mexican Americans in Los Angeles, California (MXL) population sample of release 3 of phase III of the International Haplotype Map Project; in this sample, we identify third- and fourth-degree relatives who have not previously been reported. We also apply REAP to the African American and Hispanic samples from the Women's Health Initiative SNP Health Association Resource (WHI-SHARe) study, in which hundreds of pairs of cryptically related individuals have been identified.	[Thornton, Timothy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tang, Hua] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Ochs-Balcom, Heather M.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14214 USA; [Caan, Bette J.; Risch, Neil] Kaiser Permanente, Div Res, Oakland, CA 94612 USA	University of Washington; University of Washington Seattle; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Kaiser Permanente	Thornton, T (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	tathornt@u.washington.edu; rischn@humgen.ucsf.edu	Ochs-Balcom, Heather M/F-3500-2012	Caan, Bette/0000-0002-5803-310X	National Institutes of Health [K01 CA148958, GM073059, 5K07CA136969, R25 CA112355]; National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health; United States Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NHLBI [N02-HL-64278]; NATIONAL CANCER INSTITUTE [K01CA148958, R25CA112355, K07CA136969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032108, N01WH042107, N01WH032115, N01WH032100, N01WH032118, N01WH022110, N01WH032122, N01WH032105, N01WH042129, N01WH032111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Health and Human Services; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by the National Institutes of Health grants K01 CA148958 (to T.T.), GM073059 (to H.T.), 5K07CA136969 (H.O.-B.), and R25 CA112355 (to T.H.). The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, and the United States Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Funding for WHI SNP Health Association Resource (WHI-SHARe) genotyping was provided by NHLBI contract N02-HL-64278. The datasets used for the WHI-SHARe analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/ sites/entrez?db=gap through dbGaP accession number phs000200.v1.p1. This manuscript was prepared in collaboration with investigators of the WHI and has been reviewed and/or approved by the WHI. WHI investigators are listed at http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf. We thank Fouad Zakharia for his assistance with the frappe software program and two anonymous reviewers for their helpful comments.	Abney M, 2009, BIOINFORMATICS, V25, P1561, DOI 10.1093/bioinformatics/btp185; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; Day-Williams AG, 2011, GENET EPIDEMIOL, V35, P360, DOI 10.1002/gepi.20584; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; LAWRANCE AJ, 1976, AM STAT, V30, P146, DOI 10.2307/2683864; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; S.A.G.E, 2009, STAT ANAL GENETIC EP; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Sebro R, 2010, GENET EPIDEMIOL, V34, P674, DOI 10.1002/gepi.20528; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng Q, 2009, KININBCOEF CALCULATI	32	121	124	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					122	138		10.1016/j.ajhg.2012.05.024	http://dx.doi.org/10.1016/j.ajhg.2012.05.024			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22748210	Bronze, Green Published			2022-12-18	WOS:000306445000010
J	Bernier, FP; Caluseriu, O; Ng, S; Schwartzentruber, J; Buckinghams, KJ; Innes, AM; Jabs, EW; Innis, JW; Schuette, JL; Gorski, JL; Byers, PH; Andelfinger, G; Siu, V; Lauzon, J; Fernandez, BA; McMillin, M; Scott, RH; Racher, H; Majewski, J; Nickerson, DA; Shendure, J; Bamshad, MJ; Parboosingh, JS				Bernier, Francois P.; Caluseriu, Oana; Ng, Sarah; Schwartzentruber, Jeremy; Buckinghams, Kati J.; Innes, A. Micheil; Jabs, Ethylin Wang; Innis, Jeffrey W.; Schuette, Jane L.; Gorski, Jerome L.; Byers, Peter H.; Andelfinger, Gregor; Siu, Victoria; Lauzon, Julie; Fernandez, Bridget A.; McMillin, Margaret; Scott, Richard H.; Racher, Hilary; Majewski, Jacek; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.; Parboosingh, Jillian S.		FORGE Canada Consortium	Haploinsufficiency of SF3B4, a Component of the Pre-mRNA Spliceosomal Complex, Causes Nager Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACROFACIAL DYSOSTOSIS SYNDROME; DOMINANT RETINITIS-PIGMENTOSA; SPLICING FACTOR; SEQUENCING DATA; BMPR-IA; GENE; INHERITANCE; MUTATIONS	Nager syndrome, first described more than 60 years ago, is the archetype of a class of disorders called the acrofacial dysostoses, which are characterized by craniofacial and limb malformations. Despite intensive efforts, no gene for Nager syndrome has yet been identified. In an international collaboration, FORGE Canada and the National Institutes of Health Centers for Mendelian Genomics used exome sequencing as a discovery tool and found that mutations in SF3B4, a component of the U2 pre-mRNA spliceosomal complex, cause Nager syndrome. After Sanger sequencing of SF3B4 in a validation cohort, 20 of 35 (57%) families affected by Nager syndrome had 1 of 18 different mutations, nearly all of which were frameshifts. These results suggest that most cases of Nager syndrome are caused by haploinsufficiency of SF3B4. Our findings acid Nager syndrome to a growing list of disorders caused by mutations in genes that encode major components of the spliceosome and also highlight the synergistic potential of international collaboration when exome sequencing is applied in the search for genes responsible for rare Mendelian phenotypes.	[Bernier, Francois P.; Caluseriu, Oana; Innes, A. Micheil; Lauzon, Julie; Racher, Hilary; Parboosingh, Jillian S.] Univ Calgary, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Ng, Sarah; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bernier, Francois P.; Innes, A. Micheil; Lauzon, Julie; Parboosingh, Jillian S.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB T3B 6A8, Canada; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Buckinghams, Kati J.; McMillin, Margaret; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Innis, Jeffrey W.; Schuette, Jane L.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.; Schuette, Jane L.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Gorski, Jerome L.] Univ Missouri, Columbia Sch Med, Dept Child Hlth, Columbia, MO 65212 USA; [Gorski, Jerome L.] Univ Missouri, Columbia Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Andelfinger, Gregor] McGill Univ, Dept Pediat, Montreal, PQ H3A 1B1, Canada; [Siu, Victoria] Univ Western Ontario, Dept Pediat, London, ON N6A 5W9, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Scott, Richard H.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Scott, Richard H.] Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada	University of Calgary; University of Washington; University of Washington Seattle; Alberta Childrens Hospital; University of Calgary; McGill University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle; McGill University; Western University (University of Western Ontario); Memorial University Newfoundland; Memorial University Newfoundland; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; McGill University	Bernier, FP (corresponding author), Univ Calgary, Dept Med Genet, Calgary, AB T3B 6A8, Canada.	francois.bernier@albertahealthservices.ca; mbamshad@u.washington.edu	Bernier, Francois/AAP-2174-2020; Bernier, Francois/V-7150-2018; Scherer, Stephen W./B-3785-2013; Caluseriu, Oana/AAK-9563-2020; innes, allan micheil/A-9955-2017; Shendure, Jay/AAU-3684-2021	Scherer, Stephen W./0000-0002-8326-1999; Innes, Micheil/0000-0001-9881-5467; Byers, Peter H./0000-0001-7786-7030; Jabs, Ethylin/0000-0001-8983-5466; Bernier, Francois/0000-0001-7063-4269; Schwartzentruber, Jeremy/0000-0002-6183-2092; Shendure, Jay/0000-0002-1516-1865	Foundation for Nager and Miller Syndromes; National Institutes of Health (NIH) National Human Genome Research Institute [1U54HG006493, 1RC2HG005608, 5RO1HG004316]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; NIH National Institute of Child Health and Human Development [1R01HD048895]; Agency for Science Technology and Research, Singapore; Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; Fondation Nussia et Andre Aisenstadt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004316, K99HG004316, UM1HG006493, U54HG006493, RC2HG005608] Funding Source: NIH RePORTER	Foundation for Nager and Miller Syndromes; National Institutes of Health (NIH) National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Life Sciences Discovery Fund; Washington Research Foundation; NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; Fondation Nussia et Andre Aisenstadt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and the Foundation for Nager and Miller Syndromes for their support. Our work was supported in part by grants from the National Institutes of Health (NIH) National Human Genome Research Institute (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., ON., and J.S.; and 5RO1HG004316 to H.T.), the Life Sciences Discovery Fund (2065508 and 0905001), the Washington Research Foundation, and the NIH National Institute of Child Health and Human Development (1R01HD048895 to M.B.). S.B.N. is supported by the Agency for Science Technology and Research, Singapore. The FORGE (Finding of Rare Disease Genes) Steering Committee includes Kym Boycott (leader; University of Ottawa), Jan Friedman (coleader; University of British Columbia), Jacques Michaud (coleader; Universite de Montreal), Francois Bernier (University of Calgary), Michael Brudno (University of Toronto), Bridget Fernandez (Memorial University), Bartha Knoppers (McGill University), Mark Samuels (Universite de Montreal), and Steve Scherer (University of Toronto). FORGE CANADA was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. O.C. and H.R. are supported by the CIHR Training Program in Genetics, Child Development, and Health. G.A. is a Clinician Scientist of the CIHR and is supported by the Fondation Nussia et Andre Aisenstadt.	AYLSWORTH AS, 1991, AM J MED GENET, V41, P83, DOI 10.1002/ajmg.1320410121; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; CHEMKE J, 1988, J MED GENET, V25, P230, DOI 10.1136/jmg.25.4.230; HALAL F, 1983, AM J MED GENET, V14, P209, DOI 10.1002/ajmg.1320140203; HALL BD, 1989, AM J MED GENET, V33, P394, DOI 10.1002/ajmg.1320330321; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Johnson T.L., 2012, BIOCH BIOPHYS ACTA; Kennedy SJ, 2004, AM J MED GENET A, V129A, P73, DOI 10.1002/ajmg.a.30113; LEMERRER M, 1989, AM J MED GENET, V33, P318, DOI 10.1002/ajmg.1320330307; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; MCDONALD MT, 1993, J MED GENET, V30, P779, DOI 10.1136/jmg.30.9.779; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; MILLER M, 1979, J PEDIATR-US, V95, P970, DOI 10.1016/S0022-3476(79)80285-1; NAGER F. R., 1948, PRACT OTO RHINO LARYNGOL, V10, P1; Nagy R, 2012, CLIN GENET, V82, P140, DOI 10.1111/j.1399-0004.2011.01756.x; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishanian TG, 2004, BIOCHEM BIOPH RES CO, V323, P91, DOI 10.1016/j.bbrc.2004.08.060; OPITZ JM, 1987, AM J MED GENET, V27, P959, DOI 10.1002/ajmg.1320270425; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; RuizLozano P, 1997, DEV DYNAM, V208, P482, DOI 10.1002/(SICI)1097-0177(199704)208:4<482::AID-AJA4>3.0.CO;2-E; Schlieve T, 2012, J ORAL MAXIL SURG, V70, P616, DOI 10.1016/j.joms.2011.02.053; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Waggoner DJ, 1999, AM J MED GENET, V82, P301, DOI 10.1002/(SICI)1096-8628(19990212)82:4<301::AID-AJMG5>3.0.CO;2-J; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe H, 2007, J BIOL CHEM, V282, P20728, DOI 10.1074/jbc.M703292200; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	33	121	129	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					925	933		10.1016/j.ajhg.2012.04.004	http://dx.doi.org/10.1016/j.ajhg.2012.04.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541558	Bronze, Green Published			2022-12-18	WOS:000303907500018
J	Pala, M; Olivieri, A; Achilli, A; Accetturo, M; Metspalu, E; Reidla, M; Tamm, E; Karmin, M; Reisberg, T; Kashani, BH; Perego, UA; Carossa, V; Gandini, F; Pereira, JB; Soares, P; Angerhofer, N; Rychkov, S; Al-Zahery, N; Carelli, V; Sanati, MH; Houshmand, M; Hatina, J; Macaulay, V; Pereira, L; Woodward, SR; Davies, W; Gamble, C; Baird, D; Semino, O; Villems, R; Torroni, A; Richards, MB				Pala, Maria; Olivieri, Anna; Achilli, Alessandro; Accetturo, Matteo; Metspalu, Ene; Reidla, Maere; Tamm, Erika; Karmin, Monika; Reisberg, Tuuli; Kashani, Baharak Hooshiar; Perego, Ugo A.; Carossa, Valeria; Gandini, Francesca; Pereira, Joana B.; Soares, Pedro; Angerhofer, Norman; Rychkov, Sergei; Al-Zahery, Nadia; Carelli, Valerio; Sanati, Mohammad Hossein; Houshmand, Massoud; Hatina, Jiri; Macaulay, Vincent; Pereira, Luisa; Woodward, Scott R.; Davies, William; Gamble, Clive; Baird, Douglas; Semino, Ornella; Villems, Richard; Torroni, Antonio; Richards, Martin B.			Mitochondrial DNA Signals of Late Glacial Recolonization of Europe from Near Eastern Refugia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; ANCIENT DNA; MTDNA VARIATION; GENETIC LEGACY; WESTERN; POPULATION; DIFFUSION; LINEAGES; REVEALS; SAAMI	Human populations, along with those of many other species, are thought to have contracted into a number of refuge areas at the height of the last Ice Age. European populations are believed to be, to a large extent, the descendants of the inhabitants of these refugia, and some extant mtDNA lineages can be traced to refugia in Franco-Cantabria (haplogroups Ell, H3, V, and U5b1), the Italian Peninsula (U5b3), and the East European Plain (U4 and U5a). Parts of the Near East, such as the Levant, were also continuously inhabited throughout the Last Glacial Maximum, but unlike western and eastern Europe, no archaeological or genetic evidence for Late Glacial expansions into Europe from the Near East has hitherto been discovered. Here we report, on the basis of an enlarged whole-genome mitochondrial database, that a substantial, perhaps predominant, signal from mitochondrial haplogroups J and T, previously thought to have spread primarily from the Near East into Europe with the Neolithic population, may in fact reflect dispersals during the Late Glacial period, similar to 19-12 thousand years (ka) ago.	[Pala, Maria; Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Pala, Maria; Pereira, Joana B.; Richards, Martin B.] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; [Pala, Maria; Olivieri, Anna; Achilli, Alessandro; Accetturo, Matteo; Kashani, Baharak Hooshiar; Perego, Ugo A.; Carossa, Valeria; Gandini, Francesca; Al-Zahery, Nadia; Semino, Ornella; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06123 Perugia, Italy; [Metspalu, Ene; Reidla, Maere; Tamm, Erika; Karmin, Monika; Reisberg, Tuuli; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Metspalu, Ene; Reidla, Maere; Tamm, Erika; Karmin, Monika; Reisberg, Tuuli; Villems, Richard] Estonian Bioctr, EE-51010 Tartu, Estonia; [Perego, Ugo A.; Angerhofer, Norman; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT 84115 USA; [Pereira, Joana B.; Soares, Pedro; Pereira, Luisa] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal; [Rychkov, Sergei] Vavilov Inst Gen Genet, Moscow 119991, Russia; [Al-Zahery, Nadia] Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad 10001, Iraq; [Carelli, Valerio] Univ Bologna, Dipartimento Sci Neurol, I-40123 Bologna, Italy; [Sanati, Mohammad Hossein; Houshmand, Massoud] NIGER, Dept Med Genet, Tehran 479811087, Iran; [Hatina, Jiri] Charles Univ Prague, Med Fac Pilsen, Inst Biol, Plzen, Czech Republic; [Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow G12 8QW, Lanark, Scotland; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Davies, William; Gamble, Clive] Univ Southampton, Southampton SO17 1BF, Hants, England; [Baird, Douglas] Univ Liverpool, Sch Archaeol Class & Egyptol, Liverpool L69 3BX, Merseyside, England; [Semino, Ornella] Univ Pavia, Ctr Interdipartimentale Studi Genere, I-27100 Pavia, Italy	University of Huddersfield; University of Leeds; University of Pavia; University of Perugia; University of Tartu; Estonian Biocentre; Universidade do Porto; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Baghdad; University of Bologna; Charles University Prague; University of Glasgow; Universidade do Porto; University of Southampton; University of Liverpool; University of Pavia	Richards, MB (corresponding author), Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England.	m.b.richards@hud.ac.uk	Pereira, Joana B./J-6026-2013; Gandini, Francesca/H-8936-2015; Pereira, Luisa/H-3050-2011; OLIVIERI, ANNA/I-9235-2012; Al-Zahery, Nadia/AAV-5878-2020; Perego, Ugo/AAG-9327-2019; Torroni, Antonio/E-1557-2011; Soares, Pedro A/G-9422-2011; Tamm, Erika/G-2818-2017; Achilli, Alessandro/I-9236-2012; Houshmand, Massoud/AEG-9909-2022	Pereira, Joana B./0000-0002-4409-514X; Gandini, Francesca/0000-0001-8930-8295; Pereira, Luisa/0000-0002-4271-1527; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Soares, Pedro A/0000-0002-2807-690X; Tamm, Erika/0000-0003-0694-3598; Achilli, Alessandro/0000-0001-6871-3451; Karmin, Monika/0000-0001-9827-5579; RICHARDS, MARTIN/0000-0003-3118-0967; Reisberg, Tuuli/0000-0002-1193-5616; Houshmand, Massoud/0000-0002-2198-223X; CARELLI, VALERIO/0000-0003-4923-6404; Macaulay, Vincent/0000-0001-9084-2700; sanati, Mohammad Hossein/0000-0002-0292-7673; SEMINO, Ornella/0000-0002-9675-9403; , Masoud/0000-0001-7687-7464; Pala, Maria/0000-0001-9202-8331	Marie Curie Early Stage Training "Advanced Genetic Analysis in the Post-genomic Era" (European Union) [MEST-CT-2004-504318]; Newton International Fellowship; Italian Ministry of Education, University, and Research; Fondazione Alma Mater Ticinensis; European Commission, Directorate-General for Research [205419]; European Union through the Centre of Excellence in Genomics; Estonian Ministry of Education and Research [SF 0270177As08, SF 0270177Bs08]; Estonian Science Foundation [7858]; FCT (Portuguese Foundation for Science and Technology) [PTDC/CS-ANT/113832/2009, SFRH/BD/45657/2008, SFRH/BPD/64233/2009]; DeLaszlo Foundation; Institute of International Education; FCT; Fundação para a Ciência e a Tecnologia [PTDC/CS-ANT/113832/2009] Funding Source: FCT	Marie Curie Early Stage Training "Advanced Genetic Analysis in the Post-genomic Era" (European Union); Newton International Fellowship; Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Alma Mater Ticinensis; European Commission, Directorate-General for Research(European CommissionEuropean Commission Joint Research Centre); European Union through the Centre of Excellence in Genomics; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); DeLaszlo Foundation; Institute of International Education; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	We thank Dimitar Dimitrov, Mukaddes Golge, Oksana Naumova, Ariella Oppenheim, Mark Thomas, and the donors themselves, for generously providing DNA samples. M.P. was supported by Marie Curie Early Stage Training "Advanced Genetic Analysis in the Post-genomic Era" (European Union MEST-CT-2004-504318) and by a Newton International Fellowship. This research was also supported by the Italian Ministry of Education, University, and Research: Progetti FIRB-Futuro in Ricerca 2008 (to A.A. and A.O.), and Progetti Ricerca Interesse Nazionale 2009 (to A.A., O.S. and A.T.); Fondazione Alma Mater Ticinensis (to A.T. and O.S.); the European Commission, Directorate-General for Research (FP7 Ecogene grant number 205419, to R.V.); the European Union Regional Development Fund (through the Centre of Excellence in Genomics, to R.V.); the Estonian Ministry of Education and Research (Basic Research grant numbers SF 0270177As08, to R.V., and SF 0270177Bs08, to E.M.); the Estonian Science Foundation (grant number 7858, to EM.); and the FCT (Portuguese Foundation for Science and Technology), through research project PTDC/CS-ANT/113832/2009 and personal grants to J.B.P. (SFRH/BD/45657/2008) and P.S. (SFRH/BPD/64233/2009). P.S. also received support from the DeLaszlo Foundation. N.A.-Z. was supported by the Institute of International Education fellowship. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology, and Higher Education (FCT) and is partially supported by FCT.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Baird D., 2011, NEOLITHIC TURKEY NEW, P285; Bar-Yosef O., 1990, WORLD 18000 BP, V1, P58; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Busby G.B., 2012, P BIOL SCI, V279, P844; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Dolukhanov P., 1993, CULTURAL TRANSFORMAT, P122; Dolukhanov P. M, 1996, EARLY SLAVS; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Gamble C, 1993, CTR ARCHAEOLOGY CENT, P37; Gamble C, 2009, EVOL ANTHROPOL, V18, P144, DOI 10.1002/evan.20209; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Kuhrt A., 1995, ANCIENT NEAR E, VI; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 1999, ANN HUM GENET, V63, P489, DOI 10.1017/S0003480099007794; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Otte M, 1995, ANTIQUITY, V69, P931, DOI 10.1017/S0003598X00082478; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SVOBODA J, 1996, HUNTERS E W; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898	57	121	123	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					915	924		10.1016/j.ajhg.2012.04.003	http://dx.doi.org/10.1016/j.ajhg.2012.04.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22560092	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000303907500017
J	Perrault, I; Saunier, S; Hanein, S; Filhol, E; Bizet, AA; Collins, F; Salih, MAM; Gerber, S; Delphin, N; Bigot, K; Orssaud, C; Silva, E; Baudouin, V; Oud, MM; Shannon, N; Le Merrer, M; Roche, O; Pietrement, C; Goumid, J; Baumann, C; Bole-Feysot, C; Nitschke, P; Zahrate, M; Beales, P; Arts, HH; Munnich, A; Kaplan, J; Antignac, C; Cormier-Daire, V; Rozet, JM				Perrault, Isabelle; Saunier, Sophie; Hanein, Sylvain; Filhol, Emilie; Bizet, Albane A.; Collins, Felicity; Salih, Mustafa A. M.; Gerber, Sylvie; Delphin, Nathalie; Bigot, Karine; Orssaud, Christophe; Silva, Eduardo; Baudouin, Veronique; Oud, Machteld M.; Shannon, Nora; Le Merrer, Martine; Roche, Olivier; Pietrement, Christine; Goumid, Jamal; Baumann, Clarisse; Bole-Feysot, Christine; Nitschke, Patrick; Zahrate, Mohammed; Beales, Philip; Arts, Heleen H.; Munnich, Arnold; Kaplan, Josseline; Antignac, Corinne; Cormier-Daire, Valerie; Rozet, Jean-Michel			Mainzer-Saldino Syndrome Is a Ciliopathy Caused by IFT140 Mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; SENIOR-LOKEN SYNDROME; INTRAFLAGELLAR TRANSPORT; FUNCTIONAL-ANALYSIS; PROTEIN; GENE; CILIOGENESIS; DYSPLASIA; DISEASE; IFT46	Mainzer-Saldino syndrome (MSS) is a rare disorder characterized by phalangeal cone-shaped epiphyses, chronic renal failure, and early-onset, severe retinal dystrophy. Through a combination of ciliome resequencing and Sanger sequencing, we identified IFT140 mutations in six MSS families and in a family with the clinically overlapping Jeune syndrome. IFT140 is one of the six currently known components of the intraflagellar transport complex A (IFT-A) that regulates retrograde protein transport in ciliated cells. Ciliary abundance and localization of anterograde IFTs were altered in fibroblasts of affected individuals, a result that supports the pivotal role of IFT140 in proper development and function of ciliated cells.	[Perrault, Isabelle; Hanein, Sylvain; Gerber, Sylvie; Delphin, Nathalie; Le Merrer, Martine; Munnich, Arnold; Kaplan, Josseline; Cormier-Daire, Valerie; Rozet, Jean-Michel] Paris Descartes Univ, INSERM, U781, F-75015 Paris, France; [Perrault, Isabelle; Hanein, Sylvain; Gerber, Sylvie; Delphin, Nathalie; Le Merrer, Martine; Munnich, Arnold; Kaplan, Josseline; Cormier-Daire, Valerie; Rozet, Jean-Michel] Paris Descartes Univ, Dept Genet, F-75015 Paris, France; [Saunier, Sophie; Filhol, Emilie; Bizet, Albane A.; Antignac, Corinne] Paris Descartes Univ, INSERM, U983, F-75015 Paris, France; [Collins, Felicity] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2145, Australia; [Salih, Mustafa A. M.] King Saud Univ, Div Pediat Neurol, Coll Med, Riyadh 11461, Saudi Arabia; [Bigot, Karine] CERTO, F-75015 Paris, France; [Orssaud, Christophe; Roche, Olivier] Paris Descartes Univ, Dept Ophthalmol, F-75015 Paris, France; [Silva, Eduardo] Coimbra Univ Hosp, Dept Ophthalmol, P-3000548 Coimbra, Portugal; [Baudouin, Veronique] Ctr Hosp Univ CHU Robert Debre, Dept Nephrol, F-75019 Paris, France; [Oud, Machteld M.; Arts, Heleen H.] Radboud Univ Nijmegen, Dept Genet, NL-6525 GA Nijmegen, Netherlands; [Shannon, Nora] City Hosp Nottingham, Clin Genet Serv, Nottingham NG5 1PB, England; [Pietrement, Christine] CHU Reims, Amer Mem Hosp, Dept Pediat, F-51092 Reims, France; [Goumid, Jamal; Baumann, Clarisse] CHU Robert Debre, Dept Genet, F-75019 Paris, France; [Bole-Feysot, Christine; Zahrate, Mohammed] Imagine Fdn, F-75015 Paris, France; [Beales, Philip] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sydney; King Saud University; UDICE-French Research Universities; Universite Paris Cite; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Radboud University Nijmegen; Nottingham University Hospital NHS Trust; Nottingham City Hospital; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Kaplan, J (corresponding author), Paris Descartes Univ, INSERM, U781, F-75015 Paris, France.	josseline.kaplan@inserm.fr; jean-michel.rozet@inserm.fr	hanein, sylvain/AAG-4933-2019; ROZET, Jean-Michel/E-5737-2016; Saunier, Sophie/G-6044-2015; Oud, Machteld/S-9062-2019; arts, heleen/ACL-6040-2022; Oud, Machteld/P-6939-2015; Beales, Philip L/C-7367-2009; ANTIGNAC, Corinne/H-8945-2017; Ghoumid, Jamal/N-7818-2019; Orssaud, Christophe/ACM-6549-2022; Bizet, Albane/L-2622-2017; cormier-daire, valerie/H-6520-2017; perrault, isabelle/H-3047-2017; Salih, Mustafa/C-1222-2014; KAPLAN, Josseline/I-2622-2017	hanein, sylvain/0000-0001-5817-6330; ROZET, Jean-Michel/0000-0001-7951-7886; Saunier, Sophie/0000-0002-1069-0047; Oud, Machteld/0000-0003-4864-9346; ANTIGNAC, Corinne/0000-0002-9934-4940; Ghoumid, Jamal/0000-0002-7111-0050; Silva, Eduardo/0000-0002-2739-9854; Bizet, Albane/0000-0003-4187-9659; GERBER, Sylvie/0000-0002-6827-1769; cormier-daire, valerie/0000-0002-2839-9856; perrault, isabelle/0000-0002-8560-1379; Salih, Mustafa/0000-0002-4379-2111; KAPLAN, Josseline/0000-0002-1849-8658; Arts, Heleen/0000-0002-9860-3744	Retina France; Fondation pour la Recherche Medicale (FRM) [DEQ20071210558]; Agence Nationale de la Recherche [R09087KS, RPV11012KK]; Dutch Kidney Foundation [KJPB09.009, 1P11.58]	Retina France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Dutch Kidney Foundation	We are grateful to all affected individuals and their families for their participation in the study. We thank R. Devaux for confocal microscopy and C. Masson and S. Pruvost for technical assistance. This work was supported by grants from Retina France, the Fondation pour la Recherche Medicale (FRM DEQ20071210558 to S.S.), the Agence Nationale de la Recherche (grants R09087KS and RPV11012KK to S.S.), and the Dutch Kidney Foundation (KJPB09.009 and 1P11.58 to H.H.A.).	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Beals RK, 2007, AM J MED GENET A, V143A, P2444, DOI 10.1002/ajmg.a.31948; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7	24	121	126	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					864	870		10.1016/j.ajhg.2012.03.006	http://dx.doi.org/10.1016/j.ajhg.2012.03.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22503633	Green Published, Bronze			2022-12-18	WOS:000303907500010
J	Bem, D; Yoshimura, SI; Nunes-Bastos, R; Bond, FF; Kurian, MA; Rahman, F; Handley, MTW; Hadzhiev, Y; Masood, I; Straatman-Iwanowska, AA; Cullinane, AR; McNeill, A; Pasha, SS; Kirby, GA; Foster, K; Ahmed, Z; Morton, JE; Williams, D; Graham, JM; Dobyns, WB; Burglen, L; Ainsworth, JR; Gissen, P; Muller, F; Maher, ER; Barr, FA; Aligianis, IA				Bem, Danai; Yoshimura, Shin-Ichiro; Nunes-Bastos, Ricardo; Bond, Frances F.; Kurian, Manju A.; Rahman, Fatima; Handley, Mark T. W.; Hadzhiev, Yavor; Masood, Imran; Straatman-Iwanowska, Ania A.; Cullinane, Andrew R.; McNeill, Alisdair; Pasha, Shanaz S.; Kirby, Gail A.; Foster, Katharine; Ahmed, Zubair; Morton, Jenny E.; Williams, Denise; Graham, John M.; Dobyns, William B.; Burglen, Lydie; Ainsworth, John R.; Gissen, Paul; Mueller, Ferenc; Maher, Eamonn R.; Barr, Francis A.; Aligianis, Irene A.			Loss-of-Function Mutations in RAB18 Cause Warburg Micro Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASE-ACTIVATING PROTEINS; LIPID DROPLETS; NONCATALYTIC SUBUNIT; OVEREXPRESSION; LOCALIZATION; SUBFAMILY; CLONING; RAB3A; RAB43	Warburg Micro syndrome and Martsolf syndrome are heterogenous autosomal-recessive developmental disorders characterized by brain, eye, and endocrine abnormalities. Previously, identification of mutations in RAB3GAP1 and RAB3GAP2 in both these syndromes implicated dysregulation of the RAB3 cycle (which controls calcium-mediated exocytcsis of neurotransmitters and hormones) in disease pathogenesis. RAB3GAP1 and RAB3GAP2 encode the catalytic and noncatalytic subunits of the hetrodimeric enzyme RAB3GAP (RAB3GTPase-activating protein), a key regulator of the RAB3 cycle. We performed autozygosity mapping in five consanguineous families without RAB3GAP1/2 mutations and identified loss-of-function mutations in RAB18. A c.71T > A (p.Leu24Gln) founder mutation was identified in four Pakistani families, and a homozygous exon 2 deletion (predicted to result in a frameshift) was found in the fifth family. A single family whose members were compound heterozygotes for an anti-termination mutation of the stop codon c.619T > C (p.X207QextX20) and an inframe arginine deletion c.277_279 del (p.Arg93 del) were identified after direct gene sequencing and multiplex ligation-dependent probe amplification (MLPA) of a further 58 families. Nucleotide binding assays for RAB18(Leu24Gln) and RAB18(Arg93del) showed that these mutant proteins were functionally null in that they were unable to bind guanine. The clinical features of Warburg Micro syndrome patients with RAB3GAP1 or RAB3GAP2 mutations and RAB18 mutations are indistinguishable, although the role of RAB18 in trafficking is still emerging, and it has not been linked previously to the RAB3 pathway. Knockdown of rob 18 in zebrafish suggests that it might have a conserved developmental role. Our findings imply that RAB18 has a critical role in human. brain and eye development and neurodegeneration.	[Bem, Danai; Kurian, Manju A.; Rahman, Fatima; Hadzhiev, Yavor; Straatman-Iwanowska, Ania A.; Cullinane, Andrew R.; McNeill, Alisdair; Pasha, Shanaz S.; Kirby, Gail A.; Gissen, Paul; Mueller, Ferenc; Maher, Eamonn R.; Aligianis, Irene A.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Bem, Danai; Kurian, Manju A.; Rahman, Fatima; Hadzhiev, Yavor; Straatman-Iwanowska, Ania A.; Cullinane, Andrew R.; McNeill, Alisdair; Pasha, Shanaz S.; Kirby, Gail A.; Gissen, Paul; Mueller, Ferenc; Maher, Eamonn R.; Aligianis, Irene A.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Yoshimura, Shin-Ichiro; Nunes-Bastos, Ricardo; Barr, Francis A.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Bond, Frances F.; McNeill, Alisdair; Morton, Jenny E.; Williams, Denise; Maher, Eamonn R.; Aligianis, Irene A.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Handley, Mark T. W.; Aligianis, Irene A.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Masood, Imran] UCL, Inst Neurol, London WC1E 6BT, England; [Masood, Imran] Queen Elizabeth Hosp Natl Hlth Serv Fdn Trust, Dept Cellular Pathol, Birmingham B15 2WB, W Midlands, England; [Foster, Katharine] Birmingham Childrens Hosp, Dept Radiol, Birmingham B4 6NH, W Midlands, England; [Ahmed, Zubair] Univ Birmingham, Sch Clin & Expt Med, Mol Neurosci Grp, Birmingham B15 2TT, W Midlands, England; [Ainsworth, John R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Dobyns, William B.] Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; [Burglen, Lydie] Hop Enfants Armand Trousseau, Serv Genet Med, F-75571 Paris, France; [Ainsworth, John R.] Birmingham Childrens Hosp, Dept Paediat Ophthalmol, Birmingham B4 6NH, W Midlands, England	University of Birmingham; University of Birmingham; University of Liverpool; Birmingham Women's Hospital; University of Edinburgh; University of London; University College London; University of Birmingham; University of Birmingham; Cedars Sinai Medical Center; University of Chicago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Birmingham	Aligianis, IA (corresponding author), MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	irene.aligianis@hgu.mrc.ac.uk	Graham, John M./J-1429-2019; mcneill, alisdair/B-1267-2012; Muller, Ferenc/C-6426-2009; Gissen, Paul/A-4352-2010; MAHER, EAMONN R/A-9507-2008; Ahmed, Zubair/AAN-1869-2021; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Gissen, Paul/0000-0002-9712-6122; MAHER, EAMONN R/0000-0002-6226-6918; Dobyns, William/0000-0002-7681-2844; Nunes Bastos, Ricardo/0000-0002-7328-0977; mueller, ferenc/0000-0002-0996-774X; Hadzhiev, Yavor/0000-0002-1134-4904; Handley, Mark/0000-0001-7200-747X; Barr, Francis/0000-0001-7518-253X	UK New life Charity and Well Child; Wellcome Trust [082467/Z/07/Z]; Medical Research Council; Medical Research Council [MC_PC_U127597123, MC_U127597123] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [ICH1031] Funding Source: researchfish; MRC [MC_U127597123, MC_PC_U127597123] Funding Source: UKRI	UK New life Charity and Well Child; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families who helped with this research; many colleagues for referring affected families; and the West Midlands Regional Genetics laboratory, with whom we worked closely. We thank the UK New life Charity and Well Child for financial support. Work in the group of F.A.B. was supported by a Wellcome Trust programme award (082467/Z/07/Z). I.A.A. is funded through a Programme Leader Development Track Fellowship from the Medical Research Council.	Ainsworth JR, 2001, OPHTHALMOLOGY, V108, P491, DOI 10.1016/S0161-6420(00)00540-6; Aligianis IA, 2006, AM J HUM GENET, V78, P702, DOI 10.1086/502681; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Borck G, 2011, HUM GENET, V129, P45, DOI 10.1007/s00439-010-0896-2; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hofsli E, 2005, BRIT J CANCER, V92, P1506, DOI 10.1038/sj.bjc.6602535; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Liu PS, 2008, METHOD ENZYMOL, V439, P327, DOI 10.1016/S0076-6879(07)00424-7; LUTCKE A, 1994, J CELL SCI, V107, P3437; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Morris-Rosendahl DJ, 2010, EUR J HUM GENET, V18, P1100, DOI 10.1038/ejhg.2010.79; Nagano F, 1998, J BIOL CHEM, V273, P24781, DOI 10.1074/jbc.273.38.24781; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Sisodiya SM, 2007, J MED GENET, V44, P373, DOI 10.1136/jmg.2006.047407; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893; Vazquez-Martinez R, 2007, TRAFFIC, V8, P867, DOI 10.1111/j.1600-0854.2007.00570.x; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yoshimura SI, 2008, METHOD ENZYMOL, V439, P353, DOI 10.1016/S0076-6879(07)00426-0; Yuksel A, 2007, CLIN DYSMORPHOL, V16, P89, DOI 10.1097/MCD.0b013e328054c404; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	36	121	126	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					499	507		10.1016/j.ajhg.2011.03.012	http://dx.doi.org/10.1016/j.ajhg.2011.03.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21473985	Bronze, Green Published			2022-12-18	WOS:000289664300011
J	Talkowski, ME; Ernst, C; Heilbut, A; Chiang, C; Hanscom, C; Lindgren, A; Kirby, A; Liu, ST; Muddukrishna, B; Ohsumi, TK; Shen, YP; Borowsky, M; Daly, MJ; Morton, CC; Gusella, JF				Talkowski, Michael E.; Ernst, Carl; Heilbut, Adrian; Chiang, Colby; Hanscom, Carrie; Lindgren, Amelia; Kirby, Andrew; Liu, Shangtao; Muddukrishna, Bhavana; Ohsumi, Toshiro K.; Shen, Yiping; Borowsky, Mark; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.			Next-Generation Sequencing Strategies Enable Routine Detection of Balanced Chromosome Rearrangements for Clinical Diagnostics and Genetic Research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC ENRICHMENT	The contribution of balanced chromosomal rearrangements to complex disorders remains unclear because they are not detected routinely by genome-wide microarrays and clinical localization is imprecise. Failure to consider these events bypasses a potentially powerful complement to single nucleotide polymorphism and copy-number association approaches to complex disorders, where much of the heritability remains unexplained. To capitalize on this genetic resource, we have applied optimized sequencing and analysis strategies to test whether these potentially high-impact variants can be mapped at reasonable cost and throughput. By using a whole-genome multiplexing strategy, rearrangement breakpoints could be delineated at a fraction of the cost of standard sequencing. For rearrangements already mapped regionally by karyotyping and fluorescence in situ hybridization, a targeted approach enabled capture and sequencing of multiple breakpoints simultaneously. Importantly, this strategy permitted capture and unique alignment of up to 97% of repeat-masked sequences in the targeted regions. Genome-wide analyses estimate that only 3.7% of bases should be routinely omitted from genomic DNA capture experiments. Illustrating the power of these approaches, the rearrangement breakpoints were rapidly defined to base pair resolution and revealed unexpected sequence complexity, such as co-occurrence of inversion and translocation as an underlying feature of karyotypically balanced alterations. These findings have implications ranging from genome annotation to de novo assemblies and could enable sequencing screens for structural variations at a cost comparable to that of microarrays in standard clinical practice.	[Talkowski, Michael E.; Ernst, Carl; Heilbut, Adrian; Chiang, Colby; Hanscom, Carrie; Kirby, Andrew; Liu, Shangtao; Shen, Yiping; Daly, Mark J.; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Talkowski, Michael E.; Ernst, Carl; Ohsumi, Toshiro K.; Borowsky, Mark; Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Talkowski, Michael E.; Ernst, Carl; Ohsumi, Toshiro K.; Borowsky, Mark; Gusella, James F.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Muddukrishna, Bhavana; Ohsumi, Toshiro K.; Borowsky, Mark] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lindgren, Amelia; Morton, Cynthia C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Lindgren, Amelia; Morton, Cynthia C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Talkowski, Michael E.; Kirby, Andrew; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gusella, JF (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	gusella@helix.mgh.harvard.edu	Heilbut, Adrian M/J-9427-2012; Daly, Mark J/B-2453-2017	Heilbut, Adrian M/0000-0002-8169-7967; Daly, Mark J/0000-0002-0949-8752; Talkowski, Michael/0000-0003-2889-0992; Chiang, Colby/0000-0002-4113-6065	National Institutes of Health [GM061354, HD065286]; Simons Foundation Autism Research Initiative and Autism Speaks; National Institute of Mental Health [F32MH087123]; MGH Executive Committee; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative and Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MGH Executive Committee; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Tammy Gillis, Mary Anne Anderson, and Diane Lucente at the Center for Human Genetic Research of Massachusetts General Hospital (MGH) and the Genome Sequencing Platform at the Broad Institute for technical assistance. We also thank Oleg Iartchouk, Madelyn Light, Peter Rossetti, and colleagues at the Partners Center for Personalized Genomic Medicine for contributing the HiSeq 2000 data and Dennis Gurgul of Partners Research Computing at Massachusetts General Hospital for assistance with computational resources. This work was funded by grants GM061354 and HD065286 from the National Institutes of Health and by the Simons Foundation Autism Research Initiative and Autism Speaks. M.E.T. was supported by an National Institute of Mental Health National Research Service Award (F32MH087123) and an MGH Executive Committee on Research Fund for Medical Discovery. C.E. was supported by a Canadian Institutes of Health Research Bisby Fellowship.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chen W, 2010, EUR J HUM GENET, V18, P539, DOI 10.1038/ejhg.2009.211; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; ROWLEY JD, 1979, BLOOD TRANSFUS, V23, P43; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Slade I, 2010, J MED GENET, V47, P342, DOI 10.1136/jmg.2009.072983; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110	22	121	129	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					469	481		10.1016/j.ajhg.2011.03.013	http://dx.doi.org/10.1016/j.ajhg.2011.03.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21473983	Green Published, Bronze			2022-12-18	WOS:000289664300007
J	Jee, SH; Sull, JW; Lee, JE; Shin, C; Park, J; Kimm, H; Cho, EY; Shin, ES; Yun, JE; Park, JW; Kim, SY; Lee, SJ; Jee, EJ; Baik, I; Kao, L; Yoon, SK; Jang, Y; Beaty, TH				Jee, Sun Ha; Sull, Jae Woong; Lee, Jong-Eun; Shin, Chol; Park, Jongkeun; Kimm, Heejin; Cho, Eun-Young; Shin, Eun-Soon; Yun, Ji Eun; Park, Ji Wan; Kim, Sang Yeun; Lee, Sun Ju; Jee, Eun Jung; Baik, Inkyung; Kao, Linda; Yoon, Sungjoo Kim; Jang, Yangsoo; Beaty, Terri H.			Adiponectin Concentrations: A Genome-wide Association Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HORMONE ADIPONECTIN; INSULIN-RESISTANCE; T-CADHERIN; DISEASE; OBESITY; TRAITS; FAT	Adiponectin is associated with obesity and insulin resistance. To date, there has been no genome-wide association study (GWAS) of adiponectin levels in Asians Here we present a GWAS of a cohort of Korean volunteers. A total of 4,001 subjects were genotyped by using a genome-wide marker panel in a two-stage design (979 subjects initially and 3,022 in a second stage) Another 2,304 subjects were used for follow-up replication studies with selected markers In the discovery phase, the top SNP associated with mean log adiponectin was rs3865188 in CDH13 on chromosome 16 (p = 1 69 x 10(-15) in the initial sample, p = 6.58 x 10(-39) in the second genome-wide sample, and p = 2.12 x 10(-32) in the replication sample). The meta-analysis p value for rs3865188 in all 6,305 individuals was 2 82 x 10(-83) The association of rs3865188 with high-molecular-weight adiponectm (p = 7.36 x 10(-58)) was even stronger in the third sample. A reporter assay that evaluated the effects of a CDH13 promoter SNP in complete linkage disequilibrium with rs3865188 revealed that the major allele increased expression 2.2-fold This study clearly shows that genetic variants in CDH13 Influence adiponectm levels in Korean adults.	[Jee, Sun Ha; Kimm, Heejin; Yun, Ji Eun; Kim, Sang Yeun; Lee, Sun Ju; Jee, Eun Jung] Yonsei Univ, Dept Epidemiol & Hlth Promot, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 102752, South Korea; [Jee, Sun Ha; Kao, Linda; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Sull, Jae Woong] Eulji Univ, Dept Biomed Lab Sci, Coll Hlth Sci, Songnam 461713, South Korea; [Lee, Jong-Eun; Cho, Eun-Young; Shin, Eun-Soon] DNA Link Inc, Seoul 121850, South Korea; [Shin, Chol] Korea Univ, Ansan Hosp, Dept Internal Med, Ansan 425707, South Korea; [Park, Jongkeun; Yoon, Sungjoo Kim] Catholic Univ Korea, Res Inst Mol Genet, Seoul 137701, South Korea; [Park, Jongkeun; Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137701, South Korea; [Park, Ji Wan] Hallym Univ, Dept Med Genet, Coll Med, Chunchon 200702, South Korea; [Baik, Inkyung] Kookmin Univ, Dept Food & Nutr, Coll Nat Sci, Seoul 136702, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Div Cardiol, Seoul 102752, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul 102752, South Korea	Yonsei University; Yonsei University Health System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Eulji University; DNA Link, Inc.; Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Catholic University of Korea; Hallym University; Kookmin University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jee, SH (corresponding author), Yonsei Univ, Dept Epidemiol & Hlth Promot, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 102752, South Korea.		Jang, Yang Soo/D-4803-2012	Jee, Sun Ha/0000-0001-9519-3068; Park, Ji Wan/0000-0003-0840-1696; Kimm, Heejin/0000-0003-4526-0570; Baik, Inkyung/0000-0002-9524-4344; Jang, Yangsoo/0000-0002-2169-3112; lee, sunju/0000-0002-6582-8795	Seoul RBD Program [10526]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A000385]	Seoul RBD Program(Seoul RBD program); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was funded by the Seoul R&BD Program (10526) and was partially supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A000385).	Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; HUI L, 2008, CURR PROTOC HUM GENE, V56; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; JEE SH, 2007, KOREAN J EPIDEMIOL, V29, P165; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Sull JW, 2009, EUR J ENDOCRINOL, V160, P39, DOI 10.1530/EJE-08-0603; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; World Health Organization (WHO), 2000, WHO TECHN REP SER, V894; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon SJ, 2008, METABOLISM, V57, P853, DOI 10.1016/j.metabol.2008.01.031	23	121	131	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					545	552		10.1016/j.ajhg.2010.09.004	http://dx.doi.org/10.1016/j.ajhg.2010.09.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20887962	Bronze, Green Published			2022-12-18	WOS:000283037600011
J	Barel, O; Shalev, SA; Ofir, R; Cohen, A; Zlotogora, J; Shorer, Z; Mazor, G; Finer, G; Khateeb, S; Zilberberg, N; Birk, OS				Barel, Ortal; Shalev, Stavit A.; Ofir, Rivka; Cohen, Asi; Zlotogora, Joel; Shorer, Zamir; Mazor, Galia; Finer, Gal; Khateeb, Shareef; Zilberberg, Noam; Birk, Ohad S.			Maternally inherited Birk barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR GRANULE NEURONS; TASK CHANNELS; GENES; CONDUCTANCE; FAMILY; IDENTIFICATION; CHROMOSOME-8; EXPRESSION; ISODISOMY; SUBUNITS	We describe a maternally transmitted genomic-imprinting syndrome of mental retardation, hypotonia, and unique dysmorphism with elongated face. We mapped the disease-associated locus to similar to 7.27 Mb on chromosome 8q24 and demonstrated that the disease is caused by a missense mutation in the maternal copy of KCNK9 within this locus. KCNK9 is maternally transmitted (imprinted with paternal silencing) and encodes K(2P)9.1, a member of the two pore-domain potassium channel (K-2P) subfamily. The mutation fully abolishes the channel's currents-both when functioning as a homodimer or as a heterodimer with K(2P)3.1.	[Barel, Ortal; Ofir, Rivka; Finer, Gal; Khateeb, Shareef; Birk, Ohad S.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel; [Shalev, Stavit A.; Mazor, Galia] Emek Med Ctr, Genet Inst, Afula, Israel; [Shalev, Stavit A.; Mazor, Galia] Emek Med Ctr, Child Dev Ctr, Afula, Israel; [Shalev, Stavit A.; Mazor, Galia] Technion Israel Inst Technol, Rappaport Fac Med, IL-18101 Haifa, Israel; [Cohen, Asi; Zilberberg, Noam] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Cohen, Asi; Zilberberg, Noam] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Zlotogora, Joel] Minist Hlth, Publ Hlth Serv, Dept Community Genet, IL-52662 Ramat Gan, Israel; [Shorer, Zamir; Birk, Ohad S.] Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Emek Medical Center; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il	Zilberberg, Noam/F-2005-2012; Finer, Gal/C-7858-2015	Zilberberg, Noam/0000-0002-7848-2391; Birk, Ohad/0000-0003-1430-1296				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Benlian P, 1996, AM J HUM GENET, V59, P431; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Davies W, 2004, GENE EXPR PATTERNS, V4, P741, DOI 10.1016/j.modgep.2004.03.008; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Harel T, 2004, EUR J HUM GENET, V12, P38, DOI 10.1038/sj.ejhg.5201087; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Karanjawala ZE, 2000, AM J MED GENET, V93, P207, DOI 10.1002/1096-8628(20000731)93:3<207::AID-AJMG9>3.0.CO;2-A; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Linden AM, 2007, J PHARMACOL EXP THER, V323, P924, DOI 10.1124/jpet.107.129544; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; Meuth SG, 2003, J NEUROSCI, V23, P6460; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Ruf N, 2007, HUM MOL GENET, V16, P2591, DOI 10.1093/hmg/ddm216; Rusznak Z, 2004, CELL MOL LIFE SCI, V61, P1532, DOI 10.1007/s00018-004-4082-3; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Temple IK, 2007, ENDOCRIN DEV, V12, P113, DOI 10.1159/000109638; Zanzouri M, 2006, J BIOL CHEM, V281, P28910, DOI 10.1074/jbc.M606092200; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	27	121	124	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					193	199		10.1016/j.ajhg.2008.07.010	http://dx.doi.org/10.1016/j.ajhg.2008.07.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18678320	Green Published, Bronze			2022-12-18	WOS:000258418200004
J	Skipper, L; Wilkes, K; Toft, M; Baker, M; Lincoln, S; Hulihan, M; Ross, OA; Hutton, M; Aasly, J; Farrer, M				Skipper, L; Wilkes, K; Toft, M; Baker, M; Lincoln, S; Hulihan, M; Ross, OA; Hutton, M; Aasly, J; Farrer, M			Linkage disequilibrium and association of MAPT H1 in Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; TAU GENE; 2 PARTS; HAPLOTYPE; IDENTIFICATION; ONSET; 1ST	The MAPT H1 haplotype has been associated with four-repeat (4R) tauopathies, including progressive supranuclear palsy, corticobasal degeneration, and argyrophilic grain disease. More controversial is that the same haplotype has been associated with Parkinson disease (PD). Using H1-specific single-nucleotide polymorphisms, we demonstrate that MAPT H1 is a misnomer and consists of a family of recombining H1 alleles. Population genetics, linkage disequilibrium, and association analyses have shown that specific MAPT H1 subhaplotypes are preferentially associated with Parkinson disease. Using a sliding scale of MAPT H1-specific haplotypes - in age/sex-matched PD cases and controls from central Norway - we have refined the disease association to within an similar to90-kb interval of the 5' end of the MAPT locus.	St Olavs Hosp, Dept Neurol, Trondheim, Norway; Queens Univ Belfast, Sch Biol & Biochem, Belfast, Antrim, North Ireland	Norwegian University of Science & Technology (NTNU); Queens University Belfast	Farrer, M (corresponding author), Mayo Clin Jacksonville, Dept Neurosci, Labs Neurogenet, Birdsall Bldg,Room 206, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu	Toft, Mathias/AAY-5212-2021; Ross, Owen/D-7573-2013	Ross, Owen/0000-0003-4813-756X; Toft, Mathias/0000-0002-6723-6865; Farrer, Matthew/0000-0003-1159-5321; Skipper, Lisa/0000-0002-1524-9787				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738; de Silva R, 2002, TRENDS NEUROSCI, V25, P327, DOI 10.1016/S0166-2236(02)02170-7; FAHN S, 1993, RECENT DEV PARKINSON; Fahn S, 1987, RECENT DEV PARKINSON; Farrer M, 2002, NEUROSCI LETT, V322, P83, DOI 10.1016/S0304-3940(02)00106-4; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Golbe LI, 2001, MOVEMENT DISORD, V16, P442, DOI 10.1002/mds.1087; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Hutton M, 2001, NEUROLOGY, V56, pS21, DOI 10.1212/WNL.56.suppl_4.S21; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Kehrer-Sawatzki H, 2002, AM J HUM GENET, V71, P375, DOI 10.1086/341963; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Maraganore DM, 2001, ANN NEUROL, V50, P658, DOI 10.1002/ana.1228; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Pastor P, 2002, MOVEMENT DISORD, V17, P550, DOI 10.1002/mds.10076; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; SCHNEIDER S, 1997, ARLEQUIN V 1 1 SOFTW; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547, DOI 10.1093/jnen/61.6.547; Webster EL, 1998, ANN NY ACAD SCI, V840, P21, DOI 10.1111/j.1749-6632.1998.tb09545.x; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1	35	121	124	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					669	677		10.1086/424492	http://dx.doi.org/10.1086/424492			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15297935	Bronze, Green Published			2022-12-18	WOS:000223634100013
J	Reidla, M; Kivisild, T; Metspalu, E; Kaldma, K; Tambets, K; Tolk, HV; Parik, J; Loogvali, EL; Derenko, M; Malyarchuk, B; Bermisheva, M; Zhadanov, S; Pennarun, E; Gubina, M; Golubenko, M; Damba, L; Fedorova, S; Gusar, V; Grechanina, E; Mikerezi, I; Moisan, JP; Chaventre, A; Khusnutdinova, E; Osipova, L; Stepanov, V; Voevoda, M; Achilli, A; Rengo, C; Rickards, O; De Stefano, GF; Papiha, S; Beckman, L; Janicijevic, B; Rudan, P; Anagnou, N; Michalodimitrakis, E; Koziel, S; Usanga, E; Geberhiwot, T; Herrnstadt, C; Howell, N; Torroni, A; Villems, R				Reidla, M; Kivisild, T; Metspalu, E; Kaldma, K; Tambets, K; Tolk, HV; Parik, J; Loogvali, EL; Derenko, M; Malyarchuk, B; Bermisheva, M; Zhadanov, S; Pennarun, E; Gubina, M; Golubenko, M; Damba, L; Fedorova, S; Gusar, V; Grechanina, E; Mikerezi, I; Moisan, JP; Chaventre, A; Khusnutdinova, E; Osipova, L; Stepanov, V; Voevoda, M; Achilli, A; Rengo, C; Rickards, O; De Stefano, GF; Papiha, S; Beckman, L; Janicijevic, B; Rudan, P; Anagnou, N; Michalodimitrakis, E; Koziel, S; Usanga, E; Geberhiwot, T; Herrnstadt, C; Howell, N; Torroni, A; Villems, R			Origin and diffusion of mtDNA haplogroup X	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; CONTROL-REGION; D-LOOP; AFRICAN POPULATIONS; SEQUENCE DIVERSITY; GENETIC DIVERSITY; NEAR-EASTERN; LINEAGES; ANCIENT; INDIVIDUALS	A maximum parsimony tree of 21 complete mitochondrial DNA ( mtDNA) sequences belonging to haplogroup X and the survey of the haplogroup-associated polymorphisms in 13,589 mtDNAs from Eurasia and Africa revealed that haplogroup X is subdivided into two major branches, here defined as "X1" and "X2." The first is restricted to the populations of North and East Africa and the Near East, whereas X2 encompasses all X mtDNAs from Europe, western and Central Asia, Siberia, and the great majority of the Near East, as well as some North African samples. Subhaplogroup X1 diversity indicates an early coalescence time, whereas X2 has apparently undergone a more recent population expansion in Eurasia, most likely around or after the last glacial maximum. It is notable that X2 includes the two complete Native American X sequences that constitute the distinctive X2a clade, a clade that lacks close relatives in the entire Old World, including Siberia. The position of X2a in the phylogenetic tree suggests an early split from the other X2 clades, likely at the very beginning of their expansion and spread from the Near East.	Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, EE-51010 Tartu, Estonia; Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; Inst Biol Problems N, Genet Lab, Magadan, Russia; Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; Fac Med, Lab Etud Polymorphisme ADN, Nantes, France; Russian Acad Med Sci, Inst Med Genet, Siberian Branch, Tomsk, Russia; Russian Acad Med Sci, Yakut Sci Ctr, Yakutsk, Russia; Govt Republ Sakha Yakutia, Yakutsk, Russia; Ctr Clin Genet & Prenatal Diagnost, Kharkov, Ukraine; Tirana Univ, Fac Nat Sci, Dept Biol, Tirana, Albania; Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Newcastle Univ, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Gotland Univ, Visby, Sweden; Inst Anthropol Res, Zagreb, Croatia; Univ Crete, Sch Med, Inst Mol Biol & Biotechnol, Iraklion, Greece; Univ Crete, Sch Med, Dept Basic Sci, Iraklion, Greece; Univ Crete, Sch Med, Dept Forens Sci & Toxicol, Iraklion, Greece; Inst Anthropol, Wroclaw, Poland; Univ Calabar, Dept Haematol, Calabar, Nigeria; Birmingham & Solihull Teaching Hosp, Birmingham, W Midlands, England; MitoKor, San Diego, CA USA	Estonian Biocentre; University of Tartu; University of Tartu; Institute of Biological Problems of the North; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Russian Academy of Medical Sciences; Yakut Science Centre of Complex Medical Problems; University of Tirana (UT); University of Rome Tor Vergata; University of Pavia; Newcastle University - UK; Institute for Anthropological Research Zagreb; University of Crete; University of Crete; University of Crete; University of Calabar	Reidla, M (corresponding author), Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, Riia 23, EE-51010 Tartu, Estonia.	mreidla@ebc.ee	Gusar, Vladyslava/ABB-9155-2021; Stepanov, Vadim/G-4320-2013; Voevoda, Mikhail/N-6713-2015; Golubenko, Maria V/A-8107-2014; Achilli, Alessandro/I-9236-2012; Torroni, Antonio/E-1557-2011; Kozieł, Sławomir/AAE-1003-2022; Rickards, Olga/L-7878-2015; Kivisild, Toomas/P-5889-2017; Osipova, Ludmila P/O-6480-2014; Fedorova, Sardana/K-5445-2017; Anagnou, Nicholas/GLR-3609-2022; Pennarun, Erwan/AAW-7041-2020; Gubina, Marina/AAD-9163-2019; Stepanov, Vadim A./N-7657-2014; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Khusnutdinova, Elza Kamilevna/A-4810-2013; Tambets, Kristiina/M-2568-2019; Grecanina, Elena/H-6931-2018	Stepanov, Vadim/0000-0002-5166-331X; Voevoda, Mikhail/0000-0001-9425-413X; Golubenko, Maria V/0000-0002-7692-9954; Achilli, Alessandro/0000-0001-6871-3451; Torroni, Antonio/0000-0002-4163-4478; Kozieł, Sławomir/0000-0002-0584-4427; Rickards, Olga/0000-0003-2880-7466; Kivisild, Toomas/0000-0002-6297-7808; Osipova, Ludmila P/0000-0001-7602-1156; Pennarun, Erwan/0000-0002-8267-883X; Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Tambets, Kristiina/0000-0002-8173-6380; Grecanina, Elena/0000-0002-8196-1617; Gusar, Vladyslava/0000-0003-3990-6224; Fedorova, Sardana/0000-0002-6952-3868	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BALLINGER SW, 1992, GENETICS, V130, P139; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANDELT HJ, IN PRESS ANN HUM GEN; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHEN YS, 1995, AM J HUM GENET, V57, P133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; Dimo-Simonin N, 2000, INT J LEGAL MED, V113, P89, DOI 10.1007/PL00007715; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malhi RS, 2002, AM J PHYS ANTHROPOL, V119, P84, DOI 10.1002/ajpa.10106; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mogentale-Profizi N, 2001, ANN HUM GENET, V65, P153, DOI 10.1017/S0003480001008545; NEI M, 1987, MOL EVOLUTIONARY GEN, P145; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Renfrew C, 2000, ARCHAEOGENETICS DNA, P3; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Scozzari R, 1997, AM J HUM GENET, V60, P241; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1999, PHILOS T R SOC B, V354, P153, DOI 10.1098/rstb.1999.0368; Tagliabracci A, 2001, INT J LEGAL MED, V114, P224, DOI 10.1007/s004140000168; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	62	121	128	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1178	1190		10.1086/379380	http://dx.doi.org/10.1086/379380			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574647	Green Published, Bronze			2022-12-18	WOS:000186493400019
J	Atwood, LD; Heard-Costa, NL; Cupples, LA; Jaquish, CE; Wilson, PWF; D'Agostino, RB				Atwood, LD; Heard-Costa, NL; Cupples, LA; Jaquish, CE; Wilson, PWF; D'Agostino, RB			Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS; PEDIGREES; LOCUS	We performed a genomewide linkage analysis of six separate measurements of body mass index (BMI) taken over a span of 28 years, from 1971 to 1998, in the Framingham Heart Study. Variance-components linkage analysis was performed on 330 families, using 401 polymorphic markers. The number of individuals with data at each exam ranged from 1,930, in 1971, to 1,401, in 1998. Sex, age, and age squared were included as covariates in the model. There was substantial evidence for linkage on chromosome 6q23-25, in the area of D6S1009, GATA184A08, D6S2436, and D6S305. The six measurements had maximum LOD scores of 4.64, 2.29, 2.41, 1.40, 0.99, and 3.08, respectively, all in the chromosome 6q23-25 region. There was also evidence for linkage of multiple measures on chromosome 11q14 in the area of D11S1998, D11S4464, and D11S912. The six measurements had maximum LOD scores of 0.61, 3.27, 1.30, 0.68, 1.30, and 2.29, respectively, all in the chromosome 11q14 region. Both of these regions have been reported in previous studies. Evidence in the same regions from multiple measurements does not constitute replication; however, it does indicate that linkage studies of BMI are robust with respect to measurement error. It is unclear whether the variation in LOD scores in these regions is due to age effects, varying sample size, or other confounding factors.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Dept Math & Stat, Boston, MA 02118 USA; NHLBI, Bethesda, MD 20892 USA	Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Atwood, LD (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,B-609, Boston, MA 02118 USA.		Wilson, Peter W.F./J-2455-2016	Cupples, L. Adrienne/0000-0003-0273-7965; Heard-Costa, Nancy/0000-0001-9730-0306	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01HC25195, HC-25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Cupples L, 1988, FRAMINGHAM HEART STU; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Dyke B, 1996, PEDSYS PEDIGREE DATA; Feitosa MF, 2002, AM J HUM GENET, V70, P72, DOI 10.1086/338144; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hunt SC, 2001, HUM GENET, V109, P279, DOI 10.1007/s004390100581; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362; Zhu XF, 2002, DIABETES, V51, P541, DOI 10.2337/diabetes.51.2.541	19	121	125	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1044	1050		10.1086/343822	http://dx.doi.org/10.1086/343822			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12355400	Bronze, Green Published			2022-12-18	WOS:000178884300004
J	Inoue, K; Osaka, H; Thurston, VC; Clarke, JTR; Yoneyama, A; Rosenbarker, L; Bird, TD; Hodes, ME; Shaffer, LG; Lupski, JR				Inoue, K; Osaka, H; Thurston, VC; Clarke, JTR; Yoneyama, A; Rosenbarker, L; Bird, TD; Hodes, ME; Shaffer, LG; Lupski, JR			Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOLIPID PROTEIN GENE; PELIZAEUS-MERZBACHER-DISEASE; BETA-GLOBIN GENE; SEGMENTAL DUPLICATIONS; MECHANISMS; MYELIN; DUCHENNE; FEATURES; REPEAT	In the majority of patients with Pelizaeus-Merzbacher disease, duplication of the proteolipid protein gene PLP1 is responsible, whereas deletion of PLP1 is infrequent. Genomic mechanisms for these submicroscopic chromosomal rearrangements remain unknown. We identified three families with PLP1 deletions (including one family described elsewhere) that arose by three distinct processes. In one family, PLP1 deletion resulted from a maternal balanced submicroscopic insertional translocation of the entire PLP1 gene to the telomere of chromosome 19. PLP1 on the 19qtel is probably inactive by virtue of a position effect, because a healthy male sibling carries the same der(19) chromosome along with a normal X chromosome. Genomic mapping of the deleted segments revealed that the deletions are smaller than most of the PLP1 duplications and involve only two other genes. We hypothesize that the deletion is infrequent, because only the smaller deletions can avoid causing either infertility or lethality. Analyses of the DNA sequence flanking the deletion breakpoints revealed Alu-Alu recombination in the family with translocation. In the other two families, no homologous sequence flanking the breakpoints was found, but the distal breakpoints were embedded in novel low-copy repeats, suggesting the potential involvement of genome architecture in stimulating these rearrangements. In one family, junction sequences revealed a complex recombination event. Our data suggest that PLP1 deletions are likely caused by nonhomologous end joining.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Japan Sci & Technol Corp, Dept Degenerat Neurol Dis, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo, Japan; NCNP, Natl Inst Neurosci, Tokyo, Japan; Natl Rehabil Ctr Disabled Children, Dept Pediat, Tokyo, Japan; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Center for Neurology & Psychiatry - Japan; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Rm 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD24064, P01 HD38420, R01 HD038420, P30 HD024064] Funding Source: Medline; NINDS NIH HHS [R01 NS027042, R01 NS27042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Garbern J, 1999, ARCH NEUROL-CHICAGO, V56, P1210, DOI 10.1001/archneur.56.10.1210; Garbern JY, 1997, NEURON, V19, P205, DOI 10.1016/S0896-6273(00)80360-8; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hodes ME, 2000, AM J HUM GENET, V67, P14, DOI 10.1086/302965; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; HUDSON LD, 2001, METABOLIC MOL BASIS, P5789; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; IKENAKA K, 1995, DEV NEUROSCI-BASEL, V17, P127, DOI 10.1159/000111281; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2001, ANN NEUROL, V50, P747, DOI 10.1002/ana.10036; Inoue K, 1996, AM J HUM GENET, V59, P32; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; MIMAULT C, 1995, HUM GENET, V96, P236, DOI 10.1007/BF00207388; Osaka H, 1999, ANN NEUROL, V45, P59, DOI 10.1002/1531-8249(199901)45:1<59::AID-ART11>3.0.CO;2-3; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sekino M, 2001, MAR BIOTECHNOL, V3, P45, DOI 10.1007/s101260000046; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Sistermans EA, 1996, HUM GENET, V97, P337, DOI 10.1007/s004390050046; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Spiteri E, 2001, AM J HUM GENET, V69, P329; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; WILLARD HF, 2001, METABOLIC MOL BASES, P1191; Woodward K, 1998, AM J HUM GENET, V63, P207, DOI 10.1086/301933; Wu CY, 1996, NUCLEIC ACIDS RES, V24, P2614, DOI 10.1093/nar/24.13.2614	44	121	123	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					838	853		10.1086/342728	http://dx.doi.org/10.1086/342728			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12297985	Bronze, Green Published			2022-12-18	WOS:000178613800012
J	Arikawa-Hirasawa, E; Le, AH; Nishino, I; Nonaka, I; Ho, NC; Francomano, CA; Govindraj, P; Hassell, JR; Devaney, JM; Spranger, J; Stevenson, RE; Iannaccone, S; Dalakas, MC; Yamada, Y				Arikawa-Hirasawa, E; Le, AH; Nishino, I; Nonaka, I; Ho, NC; Francomano, CA; Govindraj, P; Hassell, JR; Devaney, JM; Spranger, J; Stevenson, RE; Iannaccone, S; Dalakas, MC; Yamada, Y			Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; ACETYLCHOLINESTERASE DEFICIENCY; CHONDRODYSTROPHIC MYOTONIA; BASEMENT-MEMBRANES; MYASTHENIC SYNDROME; CELL-ADHESION; DOMAIN-V; CARTILAGE; FIBULIN-2; RECEPTOR	Perlecan, a large heparan sulfate proteoglycan, is a component of the basement membrane and other extracellular matrices and has been implicated in multiple biological functions. Mutations in the perlecan gene (HSPG2) cause two classes of skeletal disorders: the relatively mild Schwartz-Jampel syndrome (SJS) and severe neonatal lethal dyssegmental dysplasia, Silverman-Handmaker type (DDSH). SJS is an autosomal recessive skeletal dysplasia characterized by varying degrees of myotonia and chondrodysplasia, and patients with SJS survive. The molecular mechanism underlying the chondrodystrophic myotonia phenotype of SJS is unknown. In the present report, we identify five different mutations that resulted in various forms of perlecan in three unrelated patients with SJS. Heterozygous mutations in two patients with SJS either produced truncated perlecan that lacked domain V or significantly reduced levels of wild-type perlecan. The third patient had a homozygous 7-kb deletion that resulted in reduced amounts of nearly full-length perlecan. Unlike DDSH, the SJS mutations result in different forms of perlecan in reduced levels that are secreted to the extracellular matrix and are likely partially functional. These findings suggest that perlecan has an important role in neuromuscular function and cartilage formation, and they define the molecular basis involved in the difference in the phenotypic severity between DDSH and SJS.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, Bethesda, MD USA; NINCDS, Bethesda, MD 20892 USA; Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; NIA, Genet Lab, Baltimore, MD 21224 USA; Johns Hopkins Bayview Med Ctr, Baltimore, MD USA; Shriners Hosp Children, Tampa, FL USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Center for Neurology & Psychiatry - Japan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine; Children's National Health System; Greenwood Genetic Center; Texas Scottish Rite Hospital for Children	Yamada, Y (corresponding author), NIDCR, NIH, Bldg 30,Room 405,30 Convent Dr, Bethesda, MD 20892 USA.		Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000665] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABERFELD DC, 1965, BRAIN, V88, P313, DOI 10.1093/brain/88.2.313; ABERFELD DC, 1970, ARCH NEUROL-CHICAGO, V22, P455, DOI 10.1001/archneur.1970.00480230073009; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Dolan M, 1997, J BIOL CHEM, V272, P4316, DOI 10.1074/jbc.272.7.4316; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; ENGEL AG, 1977, ANN NEUROL, V1, P315, DOI 10.1002/ana.410010403; FOWLER WM, 1974, J NEUROL SCI, V22, P127; French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103; Friedrich MVK, 1999, J MOL BIOL, V294, P259, DOI 10.1006/jmbi.1999.3259; Giedion A, 1997, EUR J PEDIATR, V156, P214, DOI 10.1007/s004310050587; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; JABLECKI C, 1982, MUSCLE NERVE       S, V5, P64; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; PASCUZZI RM, 1991, SEMIN NEUROL, V11, P267, DOI 10.1055/s-2008-1041231; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; SPAANS F, 1990, MUSCLE NERVE, V13, P516, DOI 10.1002/mus.880130608; Spranger J, 2000, AM J MED GENET, V94, P287, DOI 10.1002/1096-8628(20001002)94:4<287::AID-AJMG5>3.0.CO;2-G; STEVENSON R, 1982, P GREENWOOD GENET CT, V1, P52; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; TAYLOR RG, 1972, ELECTROEN CLIN NEURO, V33, P497, DOI 10.1016/0013-4694(72)90213-1	32	121	129	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1368	1375		10.1086/340390	http://dx.doi.org/10.1086/340390			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11941538	Bronze, Green Published			2022-12-18	WOS:000175012400028
J	Macari, F; Landau, M; Cousin, P; Mevorah, B; Brenner, S; Panizzon, R; Schorderet, DF; Hohl, D; Huber, M				Macari, F; Landau, M; Cousin, P; Mevorah, B; Brenner, S; Panizzon, R; Schorderet, DF; Hohl, D; Huber, M			Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHANNELS; LINKAGE	Erythrokeratodermia variabilis (EKV) is an autosomal dominant keratinization disorder characterized by migratory erythematous lesions and fixed keratotic plaques. All families with EKV show mapping to chromosome 1p34-p35, and mutations in the gene for connexin 31 (Cx31) have been reported in some but not all families. We studied eight affected and three healthy subjects in an Israeli family, of Kurdish origin, with EKV. After having mapped the disorder to chromosome 1p34-p35, we found no mutations in the genes for Cx31, Cx31.1, and Cx37. Further investigation revealed a heterozygous T-->C transition leading to the missense mutation (F137L) in the human gene for Cx30.3 that colocalizes on chromosome 1p34-p35. This nucleotide change cosegregated with the disease and was not found in 200 alleles from normal individuals. This mutation concerns a highly conserved phenylalanine, in the third transmembrane region of the Cx30.3 molecule, known to be implicated in the wall formation of the gap-junction pore. Our results show that mutations in the gene for Cx30.3 can be causally involved in EKV and point to genetic heterogeneity of this disorder. Furthermore, we suggest that our family presents a new type of EKV because of the hitherto unreported association with erythema gyratum repens.	Univ Lausanne Hosp, Dept Dermatol, Lausanne, Switzerland; Univ Lausanne Hosp, Div Med Genet, Lausanne, Switzerland; Ichilov Hosp, Dept Dermatol, IL-64239 Tel Aviv, Israel	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Tel Aviv University	Hohl, D (corresponding author), CHU Vaudois, Dept Dermatol, Dermatogenet Unit, BT-437, CH-1011 Lausanne, Switzerland.		macari, francoise/E-9941-2014; Huber, Marcel/M-8822-2016; Hohl, Daniel M/N-7554-2016	macari, francoise/0000-0001-8942-1845; Huber, Marcel/0000-0003-3821-2378; 				BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Braun-Falco O., 1991, DERMATOLOGY, P403, DOI [10.1007/978-3-662-00181-3_14, DOI 10.1007/978-3-662-00181-3_14]; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; HACHAMZADEH S, 1978, CLIN GENET, V13, P404; HENNEMANN H, 1992, J BIOL CHEM, V267, P17225; HOH JH, 1991, J BIOL CHEM, V266, P6524; Itahana K, 1996, ENDOCRINOLOGY, V137, P5036, DOI 10.1210/en.137.11.5036; Krutovskikh V, 2000, MUTAT RES-REV MUTAT, V462, P197, DOI 10.1016/S1383-5742(00)00037-5; Krutovskikh V, 1996, CARCINOGENESIS, V17, P1761, DOI 10.1093/carcin/17.8.1761; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu XZ, 2000, HUM MOL GENET, V9, P63, DOI 10.1093/hmg/9.1.63; RAPPAPORT IP, 1986, ARCH DERMATOL, V122, P441, DOI 10.1001/archderm.122.4.441; Richard G, 2000, HUM GENET, V106, P321, DOI 10.1007/s004390051045; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rouger H, 1997, HUM MUTAT, V10, P443, DOI 10.1002/(SICI)1098-1004(1997)10:6<443::AID-HUMU5>3.3.CO;2-K; SCHWARZ HJ, 1992, SOMAT CELL MOLEC GEN, V18, P351, DOI 10.1007/BF01235758; TUCKER MA, 1994, EXP CELL RES, V213, P224, DOI 10.1006/excr.1994.1194; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilgoss A, 1999, J INVEST DERMATOL, V113, P1119, DOI 10.1046/j.1523-1747.1999.00792.x; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X	24	121	129	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1296	1301						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11017804				2022-12-18	WOS:000165091600024
J	Sina, M; Hinney, A; Ziegler, A; Neupert, T; Mayer, H; Siegfried, W; Blum, WF; Remschmidt, H; Hebebrand, J				Sina, M; Hinney, A; Ziegler, A; Neupert, T; Mayer, H; Siegfried, W; Blum, WF; Remschmidt, H; Hebebrand, J			Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; FRAMESHIFT MUTATION; WEIGHT; MC4R	Recently, haploinsufficiency mutations in the melanocortin-4 receptor gene (MC4-R) were detected which were assumed to lead to the phenotype of extreme obesity. Previously, we detected three obese carriers among 306 index patients. Here we describe the detection of one haploinsufficiency carrier in an additional study group of 186 obese individuals, We subsequently genotyped and phenotyped 43 family members of these four index patients, two of whom were second-degree cousins. A total of 19 carriers were identified. Extreme obesity was the predominating phenotype. However, moderate obesity occurred in three of the carriers. No other specific phenotypic abnormalities were detected. Female haploinsufficiency carriers were heavier than male carriers in the respective families, a finding similar to findings in MC4-R-knockout mice. In conclusion, our data fully support the etiologic role of MC4-R haploinsufficiency mutations in obesity.	Univ Marburg, Dept Child & Adolescent Psychiat, Clin Res Grp, D-35033 Marburg, Germany; Univ Marburg, Inst Med Biometry & Epidemiol, D-35033 Marburg, Germany; Childrens Hosp Hochried, Murnau, Germany; Obes Rehabil Ctr Insula, Berchtesgaden, Germany; Univ Giessen, Childrens Hosp, Giessen, Germany; Lilly Deutschland GmbH, Bad Homburg, Germany	Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; Eli Lilly; Lilly Deutschland GmbH	Hinney, A (corresponding author), Univ Marburg, Dept Child & Adolescent Psychiat, Clin Res Grp, Hans Sachs Str 6, D-35033 Marburg, Germany.		Hinney, Anke/D-6953-2011; Ziegler, Andreas/G-4246-2012	Hinney, Anke/0000-0001-5659-0706; Ziegler, Andreas/0000-0002-8386-5397				BLUM WF, 1997, LEPTIN VOICE ADIPOSE, P318; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRONK CE, 1982, AM J CLIN NUTR, V35, P347, DOI 10.1093/ajcn/35.2.347; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; GANTZ I, 1993, J BIOL CHEM, V268, P15174; *GAUSS, 1994, GAUSS, V2; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Hebebrand J, 1996, INT J EAT DISORDER, V19, P359, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;359::AID-EAT4&gt;3.0.CO;2-K; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Organization WH, 1998, WELLB MEAS PRIM HLTH; *STATXACT, 1996, STATXACT 3 WIND US M; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WITTCHEN HU, 1995, J PSYCHIAT RES, V29, P95, DOI 10.1016/0022-3956(94)00044-R; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	17	121	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1501	1507		10.1086/302660	http://dx.doi.org/10.1086/302660			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577903	Bronze, Green Published			2022-12-18	WOS:000084282500004
J	Shotelersuk, V; Larson, D; Anikster, Y; McDowell, G; Lemons, R; Bernardini, I; Guo, JR; Thoene, J; Gahl, WA				Shotelersuk, V; Larson, D; Anikster, Y; McDowell, G; Lemons, R; Bernardini, I; Guo, JR; Thoene, J; Gahl, WA			CTNS mutations in an American-based population of cystinosis patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUKOCYTE GRANULAR FRACTIONS; NEPHROPATHIC CYSTINOSIS; CYSTEAMINE THERAPY; COUNTER-TRANSPORT; RENAL-FUNCTION; FIBROBLASTS; LYSOSOMES; GROWTH; 17P13; GENE	Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS; has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb "European" deletion involving marker D17S829 and II. small mutations, Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G-->A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found, Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland, Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations. in America and provide a basis for possible molecular diagnosis in this population.	NICHHD, Heritable Disorders Branch, Sect Human Biochem Genet, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Med Genet Branch, Bethesda, MD USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan	Gahl, WA (corresponding author), NICHHD, Heritable Disorders Branch, Sect Human Biochem Genet, NIH, 10 Ctr Dr,MSC 1830,Bldg 10,Room 9S-241, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Thoene, Jess/AAF-5305-2020	Shotelersuk, Vorasuk/0000-0002-1856-0589	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025548] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25548] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHARNAS LR, 1994, ANN NEUROL, V35, P181, DOI 10.1002/ana.410350209; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; EHRICH JHH, 1979, NEUROPADIATRIE, V10, P128, DOI 10.1055/s-0028-1085319; FINK JK, 1989, ARCH NEUROL-CHICAGO, V46, P543, DOI 10.1001/archneur.1989.00520410077027; FIVUSH B, 1987, AM J DIS CHILD, V141, P1087, DOI 10.1001/archpedi.1987.04460100065027; Gahl W A, 1986, Adv Pediatr, V33, P95; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1985, BIOCHEM J, V228, P545, DOI 10.1042/bj2280545; GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GAHL WA, 1984, AM J HUM GENET, V36, P277; GAHL WA, 1992, BIOCHEM MED METAB B, V48, P275, DOI 10.1016/0885-4505(92)90074-9; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; Jean G, 1996, AM J HUM GENET, V58, P535; JONAS AJ, 1982, J BIOL CHEM, V257, P13185; KAISERKUPFER MI, 1986, ARCH OPHTHALMOL-CHIC, V104, P706, DOI 10.1001/archopht.1986.01050170096030; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; McDowell G, 1996, BIOCHEM MOL MED, V58, P135, DOI 10.1006/bmme.1996.0041; MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246; OBERFIELD SE, 1981, DEV PHARMACOL THERAP, V2, P80; OSHIMA RG, 1977, J CELL PHYSIOL, V93, P129, DOI 10.1002/jcp.1040930116; Peters U, 1997, EUR J HUM GENET, V5, P9, DOI 10.1159/000484725; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; SONIES BC, 1990, NEW ENGL J MED, V323, P565, DOI 10.1056/NEJM199008303230903; STEINHERZ R, 1982, J BIOL CHEM, V257, P6041; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; TIETZE F, 1989, J BIOL CHEM, V264, P15316; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872	36	121	131	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1352	1362		10.1086/302118	http://dx.doi.org/10.1086/302118			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792862	Green Published, Bronze			2022-12-18	WOS:000076985200011
J	Brewer, C; Holloway, S; Zawalnyski, P; Schinzel, A; FitzPatrick, D				Brewer, C; Holloway, S; Zawalnyski, P; Schinzel, A; FitzPatrick, D			A chromosomal deletion map of human malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL-MALFORMATIONS; PAX6 GENE; ABNORMALITIES; ANEUPLOIDY; FREQUENCY; DISEASE; GENOME	Malformations are common causes of pediatric morbidity and mortality, and genetic factors are a significant component of their etiology. Autosomal deletions, in almost all cases, cause a nonspecific embryopathy that presents after birth as growth failure, mental retardation, and multiple malformations. We have constructed a chromosome map of autosomal deletions associated with 47 different congenital malformations, using detailed clinical and cytogenetic information on 1,753 patients with nonmosaic single contiguous autosomal deletions. The 1,753 deletions involved 258 (89%) of 289 possible autosomal bands (by the use of ISCN 400-band nomenclature), giving a total of 4,190 deleted autosomal bands for analysis. We compared the band distributions of deletions associated with common major malformations with the distribution of all 1,753 deletions. We noted 283 positive associations between deleted bands and specific malformations, of which 199 were significant (P < .05, P > .001) and 84 were highly significant (P < .001). These "malformation-associated bands" (MABs) were distributed among 137 malformation-associated chromosome regions (MACRs). An average of 6 MABs in 2.9 MACRs were detected per malformation studied; 18 (6%) of 283 MABs contain a locus known to be associated with the particular malformation. A further 18 (6%) of 283 are in seven recognized specific malformation-associated aneuploid regions. Therefore, 36 (26%) of 137 of the MACRs contain an MAB coinciding with a previously recognized locus or malformation-associated aneuploid region. This map should facilitate identification of genes important in human development.	Western Gen Hosp, MMC, Dept Human & Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Zurich, Inst Med Genet, Zurich, Switzerland	University of Edinburgh; University of Zurich	FitzPatrick, D (corresponding author), Western Gen Hosp, MMC, Dept Human & Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland.		FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008	FitzPatrick, David R./0000-0003-4861-969X				Ballabio A, 1991, CURR OPIN GENET DEV, V1, P25, DOI 10.1016/0959-437X(91)80036-L; CHUNG CS, 1968, AM J HUM GENET, V20, P44; Epstein C J, 1993, Prog Clin Biol Res, V384, P1; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P24, DOI 10.1159/000131684; FITZPATRICK DR, 1991, ARCH DIS CHILD, V66, P639, DOI 10.1136/adc.66.5.639; HALL JG, 1978, AM J MED GENET, V1, P417, DOI 10.1002/ajmg.1320010405; Hecht F, 1987, ANEUPLOIDY A, P9; Hogue C J, 1989, MMWR CDC Surveill Summ, V38, P1; HRUBEC Z, 1984, NEW ENGL J MED, V310, P435, DOI 10.1056/NEJM198402163100706; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P369; LINDSLEY DL, 1972, GENETICS, V71, P157; LURIE IW, 1993, AM J MED GENET, V47, P410, DOI 10.1002/ajmg.1320470323; LYNCH SA, 1995, NAT GENET, V11, P93, DOI 10.1038/ng0995-93; MITTELMAN F, 1995, ISCN INT SYSTEM HUMA; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCHINZEL A, 1994, HUMAN CYTOGENETICS D; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; TOMMERUP N, 1992, AM J MED GENET, V44, P237, DOI 10.1002/ajmg.1320440223; VASARHELYI K, 1989, ANN HUM GENET, V53, P375, DOI 10.1111/j.1469-1809.1989.tb01805.x; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; YUN Y, 1997, NAT GENET, V15, P285	29	121	128	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1153	1159		10.1086/302041	http://dx.doi.org/10.1086/302041			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758599	Green Published, Bronze			2022-12-18	WOS:000076577800029
J	Nordborg, M				Nordborg, M			On the probability of Neanderthal ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; POPULATION; AFRICAN		Univ Lund, Dept Genet, S-22362 Lund, Sweden	Lund University	Nordborg, M (corresponding author), Univ Lund, Dept Genet, Solvegatan 29, S-22362 Lund, Sweden.			Nordborg, Magnus/0000-0001-7178-9748				DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Harding RM, 1997, AM J HUM GENET, V60, P772; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; Kahn P, 1997, SCIENCE, V277, P176, DOI 10.1126/science.277.5323.176; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lindahl T, 1997, CELL, V90, P1, DOI 10.1016/S0092-8674(00)80306-2; MARJORAM P, 1997, PROGR POPULATION GEN, P107; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAUNDERS IW, 1984, ADV APPL PROBAB, V16, P471, DOI 10.2307/1427285; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WADE A, 1997, NY TIMES A      0711; Ward R, 1997, NATURE, V388, P225, DOI 10.1038/40746; WATTERSON GA, 1982, ADV APPL PROBAB, V14, P206, DOI 10.2307/1426517; 1997, ECONOMIST       0712, V344, P71	18	121	124	0	16	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1237	1240		10.1086/302052	http://dx.doi.org/10.1086/302052			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758610	Green Published, Bronze			2022-12-18	WOS:000076577800041
J	Korvatska, E; Munier, FL; Djemai, A; Wang, MX; Frueh, B; Chiou, AGY; Uffer, S; Ballestrazzi, E; Braunstein, RE; Forster, RK; Culbertson, WW; Boman, H; Zografos, L; Schorderet, DF				Korvatska, E; Munier, FL; Djemai, A; Wang, MX; Frueh, B; Chiou, AGY; Uffer, S; Ballestrazzi, E; Braunstein, RE; Forster, RK; Culbertson, WW; Boman, H; Zografos, L; Schorderet, DF			Mutation hot spots in 5q31-linked corneal dystrophies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REIS-BUCKLERS	Mutations in the BIGH3 gene on chromosome 5q31 cause four distinct autosomal dominant diseases of the human cornea: granular (Groenouw type I), Reis-Bucklers, lattice type I, and Avellino corneal dystrophies. All four diseases are characterized by both progressive accumulation of corneal deposits and eventual loss of vision, We have identified a specific recurrent missense mutation for each type of dystrophy, in 10 independently ascertained families, Genotype analysis with microsatellite markers surrounding the BIGH3 locus was performed in these 10 families and in 5 families reported previously. The affected haplotype could be determined in 10 of the 15 families and was different in each family. These data indicate that R555W, R124C, and R124H mutations occurred independently in several ethnic groups and that these mutations do not reflect a putative founder effect, Furthermore, this study confirms the specific importance of the R124 and R555 amino acids in the pathogenesis of autosomal dominant corneal dystrophies limited to 5q.	CHU Vaudois, Mol Genet Unit, CH-1011 Lausanne, Switzerland; CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; Hop Jules Gonin, Dept Ophthalmol, Lausanne, Switzerland; Vanderbilt Univ, Sch Med, Dept Ophthalmol, Nashville, TN 37212 USA; Univ Bern, Inselspital, Augenklin, CH-3010 Bern, Switzerland; Clin Oculist, Laquila, Italy; Columbia Presbyterian Med Ctr, Edward S Harkness Eye Inst, New York, NY 10032 USA; Bascom Palmer Eye Inst, Miami, FL 33136 USA; Univ Bergen, Haukeland Hosp, Dept Med Genet, N-5021 Bergen, Norway	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Vanderbilt University; University of Bern; University Hospital of Bern; Columbia University; NewYork-Presbyterian Hospital; Bascom Palmer Eye Institute; University of Bergen; Haukeland University Hospital	Schorderet, DF (corresponding author), CHU Vaudois, Mol Genet Unit, CH-1011 Lausanne, Switzerland.							FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; Hirano K, 1996, CURR EYE RES, V15, P965, DOI 10.3109/02713689609017642; KLINTWOR.GK, 1967, AM J PATHOL, V50, P371; Korvatska E, 1996, EUR J HUM GENET, V4, P214; KUCHLE M, 1995, CORNEA, V14, P333; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; RIDGWAY AEA, 1992, OPHTHALMOLOGY, V99, P1753; ROGERS C, 1993, AUST NZ J OPHTHALMOL, V21, P247, DOI 10.1111/j.1442-9071.1993.tb00963.x	8	121	128	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					320	324		10.1086/301720	http://dx.doi.org/10.1086/301720			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463327	hybrid, Green Published			2022-12-18	WOS:000072416000015
J	Jacoby, LB; Jones, D; Davis, K; Kronn, D; Short, MP; Gusella, J; MacCollin, M				Jacoby, LB; Jones, D; Davis, K; Kronn, D; Short, MP; Gusella, J; MacCollin, M			Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-2; DINUCLEOTIDE REPEAT; NEURILEMMOMATOSIS; MUTATIONS; ABNORMALITIES; POLYMORPHISM; SEVERITY; DISEASE; LOCUS	Patients with multiple schwannomas without vestibular schwannomas have been postulated to compose a distinct subclass of neurofibromatosis (NF), termed "schwannomatosis." To compare the molecular-genetic basis of schwannomatosis with NF2, we examined the NF2 locus in 20 unrelated schwannomatosis patients and their affected relatives. Tumors from these patients frequently harbored typical truncating mutations of the NF2 gene and loss of heterozygosity of the surrounding region of chromosome 22, Surprisingly, unlike patients with NF2, no heterozygous NF2-gene changes were seen in normal tissues. Examination of multiple tumors from the same patient revealed that some schwannomatosis patients are somatic mosaics for NF2-gene changes. By contrast, other individuals, particularly those with a positive family history, appear to have an inherited predisposition to formation of tumors that carry somatic alterations of the NF2 gene. Further work is needed to define the pathogenetics of this unusual disease mechanism.	Massachusetts Gen Hosp, Neurol Serv, Charlestown, MA USA; Massachusetts Gen Hosp, Neurosurg Serv, Charlestown, MA USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA; New York Med Coll, Div Med Genet, Valhalla, NY 10595 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; New York Medical College; University of Chicago; University of Chicago	MacCollin, M (corresponding author), Massachusetts Gen Hosp E, Bldg 149,13th St, Charlestown, MA 02129 USA.	maccollin@helix.mgh.harvard.edu			NCI NIH HHS [CA51410] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051410] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; BIJLSMA EK, 1994, GENE CHROMOSOME CANC, V11, P7, DOI 10.1002/gcc.2870110103; BOURN D, 1995, HUM GENET, V95, P712; BOUZAS EA, 1993, NEUROLOGY, V43, P622, DOI 10.1212/WNL.43.3_Part_1.622; BRUCE DR, 1987, J AM ACAD DERMATOL, V16, P1087, DOI 10.1016/S0190-9622(87)70140-6; BUENGER KM, 1993, CUTIS, V51, P36; Evans DGR, 1997, J NEUROL NEUROSUR PS, V62, P361, DOI 10.1136/jnnp.62.4.361; EVANS DGR, 1992, Q J MED, V84, P603; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Harkin JC, 1969, ATLAS TUMOR PATHOL, P29; HONDA M, 1995, J INVEST DERMATOL, V104, P74, DOI 10.1111/1523-1747.ep12613537; Jacoby LB, 1996, GENE CHROMOSOME CANC, V17, P45, DOI 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; LEWIS RC, 1981, J HAND SURG-AM, V6, P406, DOI 10.1016/S0363-5023(81)80054-8; MACCOLLIN M, 1994, AM J HUM GENET, V55, P314; MacCollin M, 1996, NEUROLOGY, V46, P1072, DOI 10.1212/WNL.46.4.1072; MacCollin M, 1997, ANN NEUROL, V42, pP50; Maccollin Mia, 1997, Neurology, V48, pA429; MARINEAU C, 1993, HUM MOL GENET, V2, P336, DOI 10.1093/hmg/2.3.336-a; MAUTNER VF, 1993, NEUROSURGERY, V33, P92; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Parry DM, 1996, AM J HUM GENET, V59, P529; Pulst SM, 1997, NEUROLOGY, V48, P787, DOI 10.1212/WNL.48.3.787; PURCELL SM, 1989, ARCH DERMATOL, V125, P390, DOI 10.1001/archderm.125.3.390; RAGGE NK, 1995, AM J OPHTHALMOL, V120, P634, DOI 10.1016/S0002-9394(14)72210-X; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; SAINZ J, 1993, HUM MOL GENET, V2, P2203, DOI 10.1093/hmg/2.12.2203; SASAKI T, 1992, J AM ACAD DERMATOL, V26, P786, DOI 10.1016/S0190-9622(08)80565-8; SHISHIBA T, 1984, J AM ACAD DERMATOL, V10, P744, DOI 10.1016/S0190-9622(84)70089-2; Stangl AP, 1997, J NEUROSURG, V86, P853, DOI 10.3171/jns.1997.86.5.0853; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827	37	121	134	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1293	1302		10.1086/301633	http://dx.doi.org/10.1086/301633			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399891	Bronze, Green Published			2022-12-18	WOS:000071555900012
J	Knebelmann, B; Breillat, C; Forestier, L; Arrondel, C; Jacassier, D; Giatras, I; Drouot, L; Deschenes, G; Grunfeld, JP; Broyer, M; Gubler, MC; Antignac, C				Knebelmann, B; Breillat, C; Forestier, L; Arrondel, C; Jacassier, D; Giatras, I; Drouot, L; Deschenes, G; Grunfeld, JP; Broyer, M; Gubler, MC; Antignac, C			Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; MESSENGER-RNA; SYNDROME PATIENT; IDENTIFICATION; ALPHA-5(IV); CHAIN; EXPRESSION; DELETIONS; DOMAIN	Alport syndrome is a mainly X-linked hereditary disease of basement membranes that is characterized by progressive renal failure, deafness, and ocular lesions. It is associated with mutations of the COL4A5 gene located at Xq22 and encoding the alpha 5 chain of type IV collagen. We have screened 48 of the 51 exons of the COL4A5 gene by SSCP analysis and have identified 64 mutations and 10 sequence variants among 131 unrelated Alport syndrome patients. This represents a mutation-detection rate of 50%. There were no hot-spot mutations and no recurrent mutations in our population. The identified mutations were 6 nonsense mutations, 12 frameshift mutations, 17 splice-site mutations, and 29 missense mutations, 27 of the latter being glycine substitutions in the collagenous domain. Two of these occurred on the same allele in one patient and segregated with the disease in the family. We showed that some of the glycine substitutions could be associated with the lack of immunological expression of the alpha 3(IV)-alpha 5(IV) collagen chains in the glomerular basement membrane.	UNIV PARIS 05,HOP NECKER ENFANTS MALAD,INSERM,U423,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,DEPT NEPHROL,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT NEPHROL,PARIS,FRANCE; HOP TROUSSEAU,DEPT PEDIAT NEPHROL,F-75571 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite			ANTIGNAC, Corinne/H-8945-2017; ARRONDEL, Christelle/H-8908-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; ARRONDEL, Christelle/0000-0001-9522-4186; Gubler, Marie-Claire/0000-0002-3526-5661; deschenes, georges/0000-0002-5158-2915				ANTIGNAC C, 1994, J CLIN INVEST, V93, P1195, DOI 10.1172/JCI117073; Barker DF, 1996, AM J HUM GENET, V58, P1157; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BOYE E, 1995, HUM MUTAT, V5, P197, DOI 10.1002/humu.1380050303; BOYE E, 1993, HUM MOL GENET, V2, P595, DOI 10.1093/hmg/2.5.595; Byers Peter H., 1993, P317; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cooper DN, 1995, METABOLIC MOL BASES, P259; DING J, 1994, KIDNEY INT, V46, P1504; Gubler M C, 1993, Adv Nephrol Necker Hosp, V22, P15; GUBLER MC, 1995, KIDNEY INT, V47, P1142, DOI 10.1038/ki.1995.163; GUO CY, 1995, J CLIN INVEST, V95, P1832, DOI 10.1172/JCI117862; GUO CY, 1993, KIDNEY INT, V44, P1316, DOI 10.1038/ki.1993.384; Heiskari N, 1996, J AM SOC NEPHROL, V7, P702; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; Kawai S, 1996, KIDNEY INT, V49, P814, DOI 10.1038/ki.1996.113; KLEPPEL MM, 1992, J BIOL CHEM, V267, P4137; KLEPPEL MM, 1989, LAB INVEST, V61, P278; KNEBELMANN B, 1992, AM J HUM GENET, V51, P135; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEMMINK HH, 1994, HUM MOL GENET, V3, P317, DOI 10.1093/hmg/3.2.317; LEMMINK HH, 1993, GENOMICS, V17, P485, DOI 10.1006/geno.1993.1351; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Nakanishi K, 1996, J AM SOC NEPHROL, V7, P938; NAKAZATO H, 1995, AM J KIDNEY DIS, V26, P732, DOI 10.1016/0272-6386(95)90436-0; NAKAZATO H, 1993, KIDNEY INT, V44, P1091, DOI 10.1038/ki.1993.353; NAKAZATO H, 1994, KIDNEY INT, V46, P1037; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; NETZER KO, 1993, KIDNEY INT, V43, P486, DOI 10.1038/ki.1993.71; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NOMURA S, 1993, KIDNEY INT, V43, P1116, DOI 10.1038/ki.1993.157; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PEISSEL B, 1994, HUM MUTAT, V3, P386, DOI 10.1002/humu.1380030410; RENIERI A, 1993, HUM GENET, V92, P417, DOI 10.1007/BF01247348; RENIERI A, 1994, NEPHRON, V67, P444, DOI 10.1159/000188020; Renieri A, 1996, AM J HUM GENET, V58, P1192; RENIERI A, 1994, HUM MOL GENET, V3, P201, DOI 10.1093/hmg/3.1.201; SMEETS HJM, 1992, KIDNEY INT, V42, P83, DOI 10.1038/ki.1992.264; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1994, J BIOL CHEM, V269, P6608; ZHOU J, 1993, KIDNEY INT, V43, P722, DOI 10.1038/ki.1993.103; ZHOU J, 1992, J BIOL CHEM, V267, P12475; [No title captured]	47	121	131	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1221	1232						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940267				2022-12-18	WOS:A1996VV31500008
J	LAING, NG; LAING, BA; MEREDITH, C; WILTON, SD; ROBBINS, P; HONEYMAN, K; DOROSZ, S; KOZMAN, H; MASTAGLIA, FL; KAKULAS, BA				LAING, NG; LAING, BA; MEREDITH, C; WILTON, SD; ROBBINS, P; HONEYMAN, K; DOROSZ, S; KOZMAN, H; MASTAGLIA, FL; KAKULAS, BA			AUTOSOMAL-DOMINANT DISTAL MYOPATHY - LINKAGE TO CHROMOSOME-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DNA; DISEASE; CHAIN; MAP	We have studied a family segregating a form of autosomal dominant distal myopathy (MIM 160500) and containing nine living affected individuals. The myopathy in this family is closest in clinical phenotype to that first described by Gowers in 1902. A search for linkage was conducted using microsatellite, VNTR, and RFLP markers. In total, 92 markers on all 22 autosomes were run. Positive linkage was obtained with 14 of 15 markers tested on chromosome 14, with little indication of linkage elsewhere in the genome. Maximum two-point LOD scores of 2.60 at recombination fraction .00 were obtained for the markers MYH7 and D14S64-the family structure precludes a two-point LOD score greater than or equal to 3. Recombinations with D14S72 and D14S493 indicate that this distal myopathy locus, MPD1, should lie between these markers. A multipoint analysis assuming 100% penetrance and using the markers D14S72, D14S50, MYH7, D14S64, D14S54, and D14S49 gave a LOD score of exactly 3 at MYH7. Analysis at a penetrance of 80% gave a LOD score of 2.8 at this marker. This probable localization of a gene for distal myopathy, MPD1, on chromosome 14 should allow other investigators studying distal myopathy families to test this region for linkage in other types of the disease, to confirm linkage or to demonstrate the likely genetic heterogeneity.	QUEEN ELIZABETH II MED CTR,DEPT PATHOL,PERTH,WA,AUSTRALIA; EDITH COWAN UNIV,PERTH,WA,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA	University of Western Australia; Edith Cowan University	LAING, NG (corresponding author), UNIV WESTERN AUSTRALIA,QUEEN ELIZABETH II MED CTR,AUSTRALIAN NEUROMUSCULAR RES INST,NEDLANDS,WA 6009,AUSTRALIA.			Laing, Nigel/0000-0001-5111-3732; Wilton, Steve/0000-0002-9400-893X				EDSTROM L, 1980, J NEUROL SCI, V47, P171, DOI 10.1016/0022-510X(80)90002-7; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; Gowers W R, 1902, Br Med J, V2, P89; JANDRESKI MA, 1987, HUM GENET, V77, P127, DOI 10.1007/BF00272378; MARKESBERY WR, 1974, NEUROLOGY, V24, P127, DOI 10.1212/WNL.24.2.127; MASTAGLIA FL, 1991, CLIN NEUROLOGY, P1300; MATSUOKA R, 1989, AM J MED GENET, V29, P369; McKusick V.A., 1992, MENDELIAN INHERITANC; MEREDITH C, 1994, MUSCLE NERVE       S, V1, pS89; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULLEY JC, 1993, AM J HUM GENET, V52, P398; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; OTT J, 1974, AM J HUM GENET, V26, P588; Sambrook J., 1989, MOL CLONING LAB MANU; SARFARAZI M, 1989, J MED GENET, V26, P481, DOI 10.1136/jmg.26.8.481; Walton JN, 1981, JN W DISORDER VOLUNT, P481; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIFFENBACH B, 1993, NAT GENET, V4, P165, DOI 10.1038/ng0693-165; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Welander L, 1951, ACTA MED SCAND, V141, P1; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; 1992, SCIENCE, V258, P62	24	121	123	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					422	427						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847377				2022-12-18	WOS:A1995QF42300010
J	MERANTE, F; TEIN, I; BENSON, L; ROBINSON, BH				MERANTE, F; TEIN, I; BENSON, L; ROBINSON, BH			MATERNALLY INHERITED HYPERTROPHIC CARDIOMYOPATHY DUE TO A NOVEL T-TO-C TRANSITION AT NUCLEOTIDE-9997 IN THE MITOCHONDRIAL TRNA(GLYCINE) GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAGGED-RED FIBERS; TRANSFER-RNA GENES; HEAVY-CHAIN GENE; LACTIC-ACIDOSIS; TRANSFER RNALEU(UUR); MYOCLONIC EPILEPSY; EPISODES MELAS; NEUROMUSCULAR DISEASES; CYTOCHROME-OXIDASE; SKELETAL-MUSCLE	We report a unique heteroplasmic T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene in a multiplex family who manifested nonobstructive cardiomyopathy. The degree of mtDNA heteroplasmy generally correlated with the severity of the symptoms. This T-to-C transition disrupts hydrogen bonding in the region adjacent to the acceptor stem of the tRNA molecule. The thymine residue at position 9997 is highly conserved in mammals, as well as in various vertebrates and invertebrates. A PCR diagnostic test for the presence of the 9997 T-to-C transition revealed that the base change was always present in high proportion in affected family members, not present in unaffected family members, and never present in control subjects from various ethnic groups (25 groups sampled, 42 individuals), thus ruling out the possibility that this change represents a polymorphic variant in the general population. The degree of heteroplasmy in lymphoblast cultures also correlated with the level of enzyme activity present for cytochrome c oxidase (complex IV) and succinate cytochrome c oxidoreductase (complexes II and III). The absence of previously reported mtDNA mutations associated with hypertrophic cardiomyopathy was verified by both PCR diagnostic procedures and sequence analysis. All mitochondrial tRNA genes, as well as genes encoding ATPase subunits 6 and 8, were sequenced and found not to possess base changes consistent with the clinical profile. More detailed biochemical and molecular biological investigations are discussed.	HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; BOULET L, 1992, AM J HUM GENET, V51, P1187; BOURGERON T, 1992, BIOCHEM BIOPH RES CO, V186, P16, DOI 10.1016/S0006-291X(05)80769-7; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DAUSSE E, 1993, J CLIN INVEST, V92, P2807, DOI 10.1172/JCI116900; GAWEHN K, 1974, METHOD ENZYMAT AN, V4, P2239; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GLERUM M, 1987, AM J HUM GENET, V41, P584; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOWELL N, 1992, AM J HUM GENET, V50, P1333; JOHANSEN S, 1990, NUCLEIC ACIDS RES, V18, P411, DOI 10.1093/nar/18.3.411; KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107; LANDER ES, 1990, CELL, V61, P925, DOI 10.1016/0092-8674(90)90055-J; LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393; LOWSKY R, 1993, GUT, V34, P279, DOI 10.1136/gut.34.2.279; Maniatis T, 1989, DECONTAMINATION DILU; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MARZUKI S, 1991, HUM GENET, V88, P139; MERANTE F, 1993, AM J HUM GENET, V53, P481; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORAES CT, 1992, AM J HUM GENET, V50, P934; MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484; NOER AS, 1991, AM J HUM GENET, V49, P715; OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W; OLSEN EGJ, 1980, BRIT HEART J, V44, P672; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B; PENISSONBESNIER I, 1992, J NEUROL SCI, V110, P144, DOI 10.1016/0022-510X(92)90021-C; ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/S0005-2728(05)80021-0; SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; Singer-Sam J, 1989, AMPLIFICATIONS, V3, P11; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; SPRINZL M, 1987, NUCLEIC ACIDS RES, V15, pR53, DOI 10.1093/nar/15.suppl.r53; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308; WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023; WALLACE DC, 1993, TRENDS GENET, V9, P128, DOI 10.1016/0168-9525(93)90207-X; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Wynne J, 1988, HEART DIS, P1410; YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D	51	121	125	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					437	446						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079988				2022-12-18	WOS:A1994PF50900004
J	HEATH, H; JACKSON, CE; OTTERUD, B; LEPPERT, MF				HEATH, H; JACKSON, CE; OTTERUD, B; LEPPERT, MF			GENETIC-LINKAGE ANALYSIS IN FAMILIAL BENIGN (HYPOCALCIURIC) HYPERCALCEMIA - EVIDENCE FOR LOCUS HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE PRIMARY HYPERPARATHYROIDISM; ASSOCIATION; KINDREDS; PARENTS	Familial benign hypercalcemia (FBH, or hypocalciuric hypercalcemia) is characterized by inheritance, in an autosomal dominant pattern, of lifelong hypercalcemia without hypercalciuria, which is often mistaken for classical primary hyperparathyroidism. Recently, the FBH trait was linked, in four families, to chromosome 3q. We report genetic linkage analysis in 140 persons from five additional families having FBH (65 affected, 67 unaffected, and 8 unclassifiable). In four families, FBH mapped to chromosome 3q, between D3S1215 and D3S20, maximum multipoint lod score 12.9. By contrast, in the fifth kindred FBH mapped to chromosome 19p13.3, tightly linked to the marker loci D19S20 and D19S266 (two-point lod score at recombination fraction = .001 is 3.44 and 3.70, respectively). Thus, the FBH phenotype results from mutations at two separate loci on chromosomes 3q and 19p.	UNIV UTAH,SCH MED,ECCLES INST HUMAN GENET,HOWARD HUGHES MED RES INST,SALT LAKE CITY,UT 84132; UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; HENRY FORD HOSP,DEPT MED,DIV CLIN & MOLEC GENET,DETROIT,MI 48202	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Henry Ford Health System; Henry Ford Hospital	HEATH, H (corresponding author), UNIV UTAH,SCH MED,DEPT INTERNAL MED,DIV ENDOCRINOL METAB & DIABET,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NHGRI NIH HHS [8-RO1-HG-00367] Funding Source: Medline; NIDDK NIH HHS [DK-38855, DK-44292] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK044292, R01DK038855] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMAHROOS GM, 1987, J ENDOCRINOL, V115, P183, DOI 10.1677/joe.0.1150183; BURRITT MF, 1990, MAYO CLIN PROC, V65, P329, DOI 10.1016/S0025-6196(12)62533-6; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; COOPER L, 1986, PEDIATRICS, V78, P263; FOLEY TP, 1972, J PEDIATR-US, V81, P1060, DOI 10.1016/S0022-3476(72)80232-4; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HEATH DA, 1989, TRENDS ENDOCRIN MET, V1, P6, DOI 10.1016/1043-2760(89)90022-2; HEATH H, 1992, J CLIN ENDOCR METAB, V75, P846, DOI 10.1210/jc.75.3.846; HEATH H, 1989, ENDOCRIN METAB CLIN, V18, P723, DOI 10.1016/S0889-8529(18)30362-1; KAO PC, 1992, MAYO CLIN PROC, V67, P637, DOI 10.1016/S0025-6196(12)60717-4; KEATING FR, 1969, J LAB CLIN MED, V73, P825; KOWALSKA G, 1987, TISSUE ANTIGENS, V30, P91; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; MARX SJ, 1977, AM J MED, V62, P698, DOI 10.1016/0002-9343(77)90873-7; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MARX SJ, 1981, J CLIN ENDOCR METAB, V52, P736, DOI 10.1210/jcem-52-4-736; MENKO FH, 1984, HUM GENET, V67, P452, DOI 10.1007/BF00291409; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; PATERSON CR, 1985, CLIN ENDOCRINOL, V23, P111, DOI 10.1111/j.1365-2265.1985.tb00204.x; RAJALA MM, 1987, J CLIN ENDOCR METAB, V65, P1039, DOI 10.1210/jcem-65-5-1039; SOPWITH AM, 1984, CLIN ENDOCRINOL, V21, P57, DOI 10.1111/j.1365-2265.1984.tb00136.x; STEINMANN B, 1984, HELV PAEDIATR ACTA, V39, P171; WEBER JL, 1989, AM J HUM GENET, V44, P388; 1992, SCIENCE, V258, P148	26	121	124	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					193	200						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317484				2022-12-18	WOS:A1993LJ38500023
J	FOY, C; NEWTON, V; WELLESLEY, D; HARRIS, R; READ, AP				FOY, C; NEWTON, V; WELLESLEY, D; HARRIS, R; READ, AP			ASSIGNMENT OF THE LOCUS FOR WAARDENBURG SYNDROME TYPE-I TO HUMAN-CHROMOSOME 2Q37 AND POSSIBLE HOMOLOGY TO THE SPLOTCH MOUSE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MANCHESTER,DEPT MED GENET,MANCHESTER M13 9PL,LANCS,ENGLAND; UNIV MANCHESTER,CTR AUDIOL,MANCHESTER M13 9PL,LANCS,ENGLAND; PRINCESS MARGARET HOSP,PERTH,AUSTRALIA	University of Manchester; University of Manchester								AMER M, 1974, BRIT J DERMATOL, V90, P255, DOI 10.1111/j.1365-2133.1974.tb06399.x; ARIAS S, 1975, HUMANGENETIK, V27, P145; ARIAS S, 1978, CYTOGENET CELL GENET, V22, P291, DOI 10.1159/000130956; ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ATTWOOD J, 1988, ANN HUM GENET, V52, P529; BARTON DE, 1989, GENOMICS, V5, P91, DOI 10.1016/0888-7543(89)90091-8; BEESON D, 1989, CYTOGENET CELL GENET, V51, P960; COHENHAGUENAUER O, 1987, CYTOGENET CELL GENET, V46, P595; COHENHAGUENAUER O, 1988, HUM GENET, V78, P65, DOI 10.1007/BF00291237; COMINGS DE, 1966, JAMA-J AM MED ASSOC, V195, P510; DARIAVACH P, 1989, CYTOGENET CELL GENET, V51, P983; DAVID TJ, 1972, P ROY SOC MED, V65, P601, DOI 10.1177/003591577206500713; DEOL MS, 1966, NATURE, V209, P219, DOI 10.1038/209219a0; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCH L, 1959, J Laryngol Otol, V73, P355, DOI 10.1017/S0022215100055420; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; GOODMAN RM, 1982, AM J MED GENET, V11, P425, DOI 10.1002/ajmg.1320110407; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234; HULTEN MA, 1987, J MED GENET, V24, P568, DOI 10.1136/jmg.24.9.568; ISHIKIRIYAMA S, 1989, AM J HUM GENET, V33, P506; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOGAN C, 1989, GENOMICS, V4, P206, DOI 10.1016/0888-7543(89)90301-7; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; Maniatis T., 1982, MOL CLONING; MARTIN D, 1987, NUCLEIC ACIDS RES, V15, P9104, DOI 10.1093/nar/15.21.9104; MARTIN D, 1987, ANN HUM GENET, V51, P145, DOI 10.1111/j.1469-1809.1987.tb01056.x; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MOCK B, 1989, GENOMICS, V5, P291, DOI 10.1016/0888-7543(89)90060-8; NEMANSKY J, 1975, AM J ROENTGENOL, V124, P250, DOI 10.2214/ajr.124.2.250; OCONNELL P, 1989, GENOMICS, V5, P738, DOI 10.1016/0888-7543(89)90115-8; ORMEROD F C, 1960, J Laryngol Otol, V74, P919, DOI 10.1017/S0022215100057376; REED WB, 1967, ARCH DERMATOL, V95, P176, DOI 10.1001/archderm.95.2.176; ROUSSEAUMERCK MF, 1988, HUM GENET, V78, P130, DOI 10.1007/BF00278181; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SIMPSON JL, 1974, HUMANGENETIK, V23, P45, DOI 10.1007/BF00295681; SKOW L C, 1987, Genomics, V1, P283, DOI 10.1016/0888-7543(87)90057-7; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1989, DEVELOPMENT, V107, P453	42	121	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1017	1023						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339698				2022-12-18	WOS:A1990DF20200002
J	WERKMEISTER, JW; NEW, MI; DUPONT, B; WHITE, PC				WERKMEISTER, JW; NEW, MI; DUPONT, B; WHITE, PC			FREQUENT DELETION AND DUPLICATION OF THE STEROID 21-HYDROXYLASE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CORNELL UNIV,MED CTR,COLL MED,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,525 E 68TH ST,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,HUMAN IMMUNOGENET LAB,NEW YORK,NY 10021	Cornell University; Memorial Sloan Kettering Cancer Center					NCI NIH HHS [CA22507, CA09149, CA08478] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA022507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1978, HISTOCOMPATIBILITY T; CARROLL MC, 1984, PHILOS T ROY SOC B, V306, P379, DOI 10.1098/rstb.1984.0098; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DONOHOUE PA, 1986, BIOCHEM BIOPH RES CO, V136, P722, DOI 10.1016/0006-291X(86)90499-7; DUPONT B, 1977, LANCET, V2, P1309; DUPONT B, 1984, HISTOCOMPATIBILITY T, P660; FINKELSTEIN M, 1979, PHYSIOL REV, V59, P353, DOI 10.1152/physrev.1979.59.2.353; FLEISCHNICK E, 1983, LANCET, V1, P152; GARLEPP MJ, 1986, IMMUNOGENETICS, V23, P100, DOI 10.1007/BF00377968; NEW MI, 1981, HUM GENET, V58, P123; NEW MI, 1982, METABOLIC BASIS INHE, P973; ONEILL GJ, 1982, CLIN IMMUNOL IMMUNOP, V23, P312, DOI 10.1016/0090-1229(82)90117-9; RAUM D, 1984, AM J HUM GENET, V36, P72; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RUMSBY G, 1986, J MED GENET, V23, P204, DOI 10.1136/jmg.23.3.204; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEISER PW, 1985, AM J HUM GENET, V37, P650; STONER E, 1986, CLIN ENDOCRINOL, V24, P9, DOI 10.1111/j.1365-2265.1986.tb03249.x; VOGELSTEIN B, 1979, P NATL ACAD SCI US, V75, P3727; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	23	121	123	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					461	469						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	3490178				2022-12-18	WOS:A1986E706300004
J	MORTON, NE				MORTON, NE			ANALYSIS OF FAMILY RESEMBLANCE .1. INTRODUCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								ADAMS MS, 1967, PEDIATRICS, V40, P55; BALAKRISHNAN V, 1973, GENETIC STRUCTURE PO; BOOK JA, 1957, ANN HUM GENET, V21, P191; BRESLER JB, 1970, SOC BIOL, V17, P17, DOI 10.1080/19485565.1970.9987838; Broman Birger, 1942, ACTA PACDIATRICA [UPPSALA], V30, P1, DOI 10.1111/j.1651-2227.1942.tb16006.x; CATTELL RB, 1960, PSYCHOL REV, V67, P353, DOI 10.1037/h0043487; DAHLBERG G, 1948, MATHEMATICAL METHODS; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; EAVES LJ, 1972, BEHAV GENET, V2, P241, DOI 10.1007/BF01065692; ECKLAND BK, 1972, GENETICS ENVIRONMENT; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FRIEDLAENDER JS, 1971, AM J PHYS ANTHROPOL, V35, P13, DOI 10.1002/ajpa.1330350104; FURUSHO TOSHIYUKI, 1965, JAP J HUM GENET, V10, P22; Hulse Frederick, 1957, ARCH SUISS ANTHROPOL, V22, P103; HULTKRANZ JV, 1927, NOVA ACTA REG SOC SC; JENSEN A, 1973, EDUCABILITY GROUP DI; JENSEN AR, 1969, HARVARD EDUC REV, V39, P1; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; KRIEGER H, 1966, THESIS U HAWAII; Lewontin RC., 1970, B SCI, V26, P2; Lewontin Richard C., 1970, B ATOM SCI, V26, P23, DOI DOI 10.1080/00963402.1970.11457808; MACLEAN CJ, 1972, ANN HUM GENET, V36, P341; Malecot G, 1948, MATH HEREDITE; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; MORTON NE, 1968, AM J HUM GENET, V20, P411; MORTON NE, TO BE PUBLISHED; MORTON NE, 1970, CONGENITAL MALFORMAT, P264; MORTON NE, 1972, GENETICS ENVIRONMENT; MORTON NE, IN PRESS; MORTON NE, 1967, GENETICS INTERRACIAL; MORTON NE, 1965, GENETICS TODAY, P936; RAO DC, 1974, AM J HUM GENET, V26, P331; SALDANHA PH, 1964, CONGENITAL MALFORMAT, P323; SCARRSALAPATEK S, 1971, SCIENCE, V174, P1285, DOI 10.1126/science.174.4016.1285; SCARRSALAPATEK S, 1971, SCIENCE, V174, P1223; Schull WJ, 1965, EFFECTS INBREEDING J; SLATIS HM, 1961, AM J HUM GENET, V13, P28; TREVOR JC, 1953, EUGEN LAB MEM U LOND, V36, P45; WOLANSKI N, 1970, SOC BIOL, V17, P1; Wright S, 1931, J AM STAT ASSOC, V26, P155	40	121	121	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					318	330						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T0991	4827365				2022-12-18	WOS:A1974T099100003
J	Abdollahi, MR; Morrison, E; Sirey, T; Molnar, Z; Hayward, BE; Carr, IM; Springell, K; Woods, CG; Ahmed, M; Hattingh, L; Corry, P; Pilz, DT; Stoodley, N; Crow, Y; Taylor, GR; Bonthron, DT; Sheridan, E				Abdollahi, Mohammad R.; Morrison, Ewan; Sirey, Tamara; Molnar, Zoltan; Hayward, Bruce E.; Carr, Ian M.; Springell, Kelly; Woods, C. Geoff; Ahmed, Mushtaq; Hattingh, Louise; Corry, Peter; Pilz, Daniela T.; Stoodley, Neil; Crow, Yanick; Taylor, Graham R.; Bonthron, David T.; Sheridan, Eamonn			Mutation of the Variant alpha-Tubulin TUBA8 Results in Polymicrogyria with Optic Nerve Hypoplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBRAL-CORTEX; CELL; MIGRATION; DISEASE; 22Q11.2; MALFORMATIONS; ORGANIZATION; EXPRESSION; SPECTRUM; MOUSE	The critical importance of cytoskeletal function for correct neuronal migration during development of the cerebral cortex has been underscored by the identities of germline mutations underlying a number of human neurodevelopmental disorders. The proteins affected include TUBA1A, a major alpha-tubulin isoform, and microtubule-associated components such as doublecortin, and LIS1. Mutations in these genes are associated with the anatomical abnormality lissencephaly, which is believed to reflect failure of neuronal migration. An important recent observation has been the dependence of cortical neuronal migration upon acetylation of alpha-tubulin at lysine 40 by the histone acetyltransferase Elongator complex. Here, we describe a recognizable autosomal recessive syndrome, characterized by generalized polymicrogyria in association with optic nerve hypoplasia (PMGOH). By autozygosity mapping, we show that the molecular basis for this condition is mutation of the TUBA8 gene, encoding a variant alpha-tubulin of unknown function that is not susceptible to the lysine 40 acetylation that regulates microtubule function during cortical neuron migration. Together with the unique expression pattern of TUBA8 within the developing cerebral cortex, these observations suggest a role for this atypical microtubule component in regulating mammalian brain development.	[Abdollahi, Mohammad R.; Hayward, Bruce E.; Carr, Ian M.; Taylor, Graham R.; Bonthron, David T.; Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Mol Med, Genet Sect, Leeds LS9 7TF, W Yorkshire, England; [Morrison, Ewan; Springell, Kelly] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Sirey, Tamara; Molnar, Zoltan] Dept Anat Physiol & Genet, Oxford OX1 3QX, England; [Woods, C. Geoff] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Ahmed, Mushtaq] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Hattingh, Louise] Bradford Royal Infirm, Dept Radiol, Bradford BD9 6RJ, W Yorkshire, England; [Corry, Peter] St Lukes Hosp, Child Dev Ctr, Bradford BD5 0NA, W Yorkshire, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Stoodley, Neil] Frenchay Hosp, Dept Neuroradiol, Bristol BS16 1LE, Avon, England; [Crow, Yanick] Univ Manchester, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; University of Cambridge; Chapel Allerton Hospital; Bradford Royal Infirmary; Cardiff University; University of Manchester	Sheridan, E (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Genet Sect, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	e.sheridan@leeds.ac.uk	Crow, Yanick J/N-6120-2014; Ahmed, Mushtaq/GSN-9818-2022; woods, christopher g/A-1361-2010; Molnar, Zoltan/J-7281-2012	Crow, Yanick J/0000-0001-7211-7564; Molnar, Zoltan/0000-0002-6852-6004; Bonthron, David/0000-0001-8132-8179	UK Department of Health [H033]	UK Department of Health	This work was supported by funding from the UK Department of Health under the "New and Emerging Applications of Technology" (NEAT) scheme (H033; "New Technologies in Recessive Diseases").	Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Bahi-Buisson N, 2008, J MED GENET, V45, P647, DOI 10.1136/jmg.2008.058073; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Carr IM, 2009, HUM MUTAT, V30, P960, DOI 10.1002/humu.20974; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; GLASER T, 1994, GENOMICS, V19, P145, DOI 10.1006/geno.1994.1024; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jalali GR, 2008, HUM MUTAT, V29, P433, DOI 10.1002/humu.20640; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Langford KJ, 2006, CELL MOTIL CYTOSKEL, V63, P483, DOI 10.1002/cm.20139; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Morris-Rosendahl DJ, 2008, CLIN GENET, V74, P425, DOI 10.1111/j.1399-0004.2008.01093.x; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Robin NH, 2006, AM J MED GENET A, V140A, P2416, DOI 10.1002/ajmg.a.31443; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Wang WZ, 2005, BRAIN RES BULL, V66, P454, DOI 10.1016/j.brainresbull.2005.05.010	32	120	126	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					737	744		10.1016/j.ajhg.2009.10.007	http://dx.doi.org/10.1016/j.ajhg.2009.10.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19896110	Bronze, Green Published			2022-12-18	WOS:000271916500021
J	Moller, RS; Kubart, S; Hoeltzenbein, M; Heye, B; Vogel, I; Hansen, CP; Menzel, C; Ullmann, R; Tommerup, N; Ropers, HH; Tumer, Z; Kalscheuer, VM				Moller, Rikke S.; Kuebart, Sabine; Hoeltzenbein, Maria; Heye, Babett; Vogel, Ida; Hansen, Christian P.; Menzel, Corinna; Ullmann, Reinhard; Tommerup, Niels; Ropers, Hans-Hilger; Tumer, Zeynep; Kalscheuer, Vera M.			Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME CRITICAL REGION; MICE; MINIBRAIN; OVEREXPRESSION; BRAIN; HAPLOINSUFFICIENCY; ABNORMALITIES; RETARDATION; DEFECTS; KINASE	We have identified and characterized two unrelated patients with prenatal onset of microcephaly, intrauterine growth retardation, feeding problems, developmental delay, and febrile seizures/epilepsy who both carry a de novo balanced translocation that truncates the DYRK1A gene at chromosome 21q22.2. DYRK1A belongs to the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family, which is highly conserved throughout evolution. Given its localization in both the Down syndrome critical region and in the minimal region for partial monosomy 21, the gene has been studied intensively in animals and in humans, and DYRK1A has been proposed to be involved in the neurodevelopmental alterations associated with these syndromes. In the present study, we show that truncating mutations of DYRK1A result in a clinical phenotype including microcephaly.	[Moller, Rikke S.; Tommerup, Niels; Tumer, Zeynep] Univ Copenhagen, Inst Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark; [Moller, Rikke S.; Hansen, Christian P.] Danish Epillepsy Ctr, DK-4293 Dianalund, Denmark; [Kuebart, Sabine; Hoeltzenbein, Maria; Menzel, Corinna; Ullmann, Reinhard; Ropers, Hans-Hilger; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Heye, Babett] Univ Munich, Inst Soziale Padiat & Jugendmed, Genet Abt, Kinderzentrum Munchen, D-81377 Munich, Germany; [Vogel, Ida] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus C, Denmark	University of Copenhagen; Max Planck Society; University of Munich; Aarhus University	Tumer, Z (corresponding author), Univ Copenhagen, Inst Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	zeynep@imbg.ku.dk	Tommerup, Niels/T-8776-2017; Hoeltzenbein, Maria/B-1134-2016; Tumer, Zeynep/AAF-8501-2019; Hoeltzenbein, Maria/AAP-4145-2020; Tümer, Zeynep/C-4235-2014; Vogel, Ida/AAD-1087-2019	Tommerup, Niels/0000-0003-2304-0112; Hoeltzenbein, Maria/0000-0002-2451-4247; Tumer, Zeynep/0000-0002-4777-5802; Hoeltzenbein, Maria/0000-0002-2451-4247; Vogel, Ida/0000-0002-1125-0393; Moller, Rikke S./0000-0002-9664-1448; Kalscheuer, Vera/0000-0001-6898-3259				Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; de Lagran MM, 2007, GENES BRAIN BEHAV, V6, P569, DOI 10.1111/j.1601-183X.2006.00285.x; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Erdogan F, 2006, CYTOGENET GENOME RES, V115, P247, DOI 10.1159/000095921; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Matsumoto N, 1997, AM J HUM GENET, V60, P997; Nikolaienko E, 2005, GENE, V364, P90, DOI 10.1016/j.gene.2005.07.019; Osoegawa K, 1996, GENOMICS, V32, P375, DOI 10.1006/geno.1996.0132; Ronan A, 2007, J MED GENET, V44, P448, DOI 10.1136/jmg.2006.047373; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; WISNIEWSKI KE, 1990, AM J MED GENET, P274; YAMAMOTO Y, 1979, HUM GENET, V48, P321, DOI 10.1007/BF00272832	24	120	121	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1165	1170		10.1016/j.ajhg.2008.03.001	http://dx.doi.org/10.1016/j.ajhg.2008.03.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18405873	Green Published, Bronze			2022-12-18	WOS:000255923600016
J	Struys, EA; Salomons, GS; Achouri, Y; Van Schaftingen, E; Grosso, S; Craigen, WJ; Verhoeven, NM; Jakobs, C				Struys, EA; Salomons, GS; Achouri, Y; Van Schaftingen, E; Grosso, S; Craigen, WJ; Verhoeven, NM; Jakobs, C			Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							L-2-HYDROXYGLUTARIC ACIDURIA	D-2-hydroxyglutaric aciduria is a neurometabolic disorder with both a mild and a severe phenotype and with unknown etiology. Recently, a novel enzyme, D-2-hydroxyglutarate dehydrogenase, which converts D-2-hydroxyglutarate into 2-ketoglutarate, and its gene were identified. In the genes of two unrelated patients affected with D-2- hydroxyglutaric aciduria, we identified disease-causing mutations. One patient was homozygous for a missense mutation (c.1331T-->C; p.Val444Ala). The other patient was compound heterozygous for a missense mutation (c.440T-->G; p.Ile147Ser) and a splice-site mutation (IVS1-23A-->G) that resulted in a null allele. Overexpression studies in HEK-293 cells of proteins containing the missense mutations showed a marked reduction of D-2-hydroxyglutarate dehydrogenase activity, proving that mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria.	VU Univ Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands; Univ Catholique Louvain, Physiol Chem Lab, B-1200 Brussels, Belgium; Christian de Duve Inst Cellular Pathol, Brussels, Belgium; Univ Siena, Dept Pediat, Pediat Neurol Sect, I-53100 Siena, Italy; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Universite Catholique Louvain; University of Siena; Baylor College of Medicine; Baylor College of Medicine	Jakobs, C (corresponding author), VU Univ Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands.	c.jakobs@vumc.nl	Van+Schaftingen, Emile/AAF-5532-2020	ACHOURI, Younes/0000-0001-7409-1441; Van Schaftingen, Emile/0000-0002-6199-7647				Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; GIBSON KM, 1993, J INHERIT METAB DIS, V16, P497, DOI 10.1007/BF00711664; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Struys EA, 2003, CLIN CHEM, V49, P1133, DOI 10.1373/49.7.1133; van der Knaap MS, 1999, ANN NEUROL, V45, P111, DOI 10.1002/1531-8249(199901)45:1<111::AID-ART17>3.0.CO;2-N	6	120	153	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					358	360		10.1086/427890	http://dx.doi.org/10.1086/427890			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15609246	Green Published, Bronze			2022-12-18	WOS:000226215100021
J	Levinson, DF; Levinson, MD; Segurado, R; Lewis, CM				Levinson, DF; Levinson, MD; Segurado, R; Lewis, CM			Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; LINKAGE; MULTICENTER; SUPPORT; LOCUS	This is the first of three articles on a meta-analysis of genome scans of schizophrenia (SCZ) and bipolar disorder (BPD) that uses the rank-based genome scan meta-analysis ( GSMA) method. Here we used simulation to determine the power of GSMA to detect linkage and to identify thresholds of significance. We simulated replicates resembling the SCZ data set ( 20 scans; 1,208 pedigrees) and two BPD data sets using very narrow ( 9 scans; 347 pedigrees) and narrow ( 14 scans; 512 pedigrees) diagnoses. Samples were approximated by sets of affected sibling pairs with incomplete parental data. Genotypes were simulated and nonparametric linkage (NPL) scores computed for 20 180-cM chromosomes, each containing six 30-cM bins, with three markers/ bin ( or two, for some scans). Genomes contained 0, 1, 5, or 10 linked loci, and we assumed relative risk to siblings (lambda(sibs)) values of 1.15, 1.2, 1.3, or 1.4. For each replicate, bins were ranked within-study by maximum NPL scores, and the ranks were averaged (R-avg) across scans. Analyses were repeated with weighted ranks ( for each scan). Two P values were rootN[ genotyped cases] determined for each R-avg : P-AvgRnk ( the pointwise probability) and P-ord (the probability, given the bin's place in the order of average ranks). GSMA detected linkage with power comparable to or greater than the underlying NPL scores. Weighting for sample size increased power. When no genomewide significant P values were observed, the presence of linkage could be inferred from the number of bins with nominally significant P-AvgRnk, P-ord, or (most powerfully) both. The results suggest that GSMA can detect linkage across multiple genome scans.	Univ Penn, Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; Trinity Coll Dublin, Dept Genet, Dublin, Ireland; Guys Kings & St Thomas Sch Med, Div Genet & Dev, London, England	University of Pennsylvania; Pennsylvania Medicine; Trinity College Dublin; University of London; King's College London	Levinson, DF (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, 3535 Market St,Room 4006, Philadelphia, PA 19104 USA.	DFL@mail.med.upenn.edu	Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Segurado, Ricardo/K-6116-2014	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Segurado, Ricardo/0000-0002-3547-6733	NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH064197] Funding Source: NIH RePORTER; NIMH NIH HHS [K24 MH064197, K24 MH 64197, MH 61602] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Dorr DA, 1997, GENET EPIDEMIOL, V14, P617, DOI 10.1002/(SICI)1098-2272(1997)14:6<617::AID-GEPI11>3.0.CO;2-T; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson D.F., 2000, GENETIC INFLUENCES N, P47; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; 2002, MOL PSYCHIAT, V7, P405	21	120	125	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					17	33		10.1086/376548	http://dx.doi.org/10.1086/376548			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12802787	Green Published, Bronze			2022-12-18	WOS:000183904900003
J	Tease, C; Hartshorne, GM; Hulten, MA				Tease, C; Hartshorne, GM; Hulten, MA			Patterns of meiotic recombination in human fetal oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL MEIOSIS-I; CROSSING-OVER; SYNAPTONEMAL COMPLEXES; CHROMOSOME SYNAPSIS; HUMAN GENOME; NONDISJUNCTION; PACHYTENE; ORIGIN; MLH1; MICE	Abnormal patterns of meiotic recombination (i.e., crossing-over) are believed to increase the risk of chromosome nondisjunction in human oocytes. To date, information on recombination has been obtained using indirect, genetic methods. Here we use an immunocytological approach, based on detection of foci of a DNA mismatch-repair protein, MLH1, on synaptonemal complexes at prophase I of meiosis, to provide the first direct estimate of the frequency of meiotic recombination in human oocytes. At pachytene, the stage of maximum homologous chromosome pairing, we found a mean of 70.3 foci (i.e., crossovers) per oocyte, with considerable intercell variability (range 48-102 foci). This mean equates to a genetic-map length of 3,515 cM. The numbers and positions of foci were determined for chromosomes 21, 18, 13, and X. These chromosomes yielded means of 1.23 foci (61.5 cM), 2.36 foci (118 cM), 2.5 foci (125 cM), and 3.22 foci (161 cM), respectively. The foci were almost invariably located interstitially and were only occasionally located close to chromosome ends. These data confirm the large difference, in recombination frequency, between human oocytes and spermatocytes and demonstrate a clear intersex variation in distribution of crossovers. In a few cells, chromosomes 21 and 18 did not have any foci (i.e., were presumptively noncrossover); however, configurations that lacked foci were not observed for chromosomes 13 and X. For the latter two chromosome pairs, the only instances of absence of foci were observed in abnormal cells that showed chromosome-pairing errors affecting these chromosomes. We speculate that these abnormal fetal oocytes may be the source of the nonrecombinant chromosomes 13 and X suggested, by genetic studies, to be associated with maternally derived chromosome nondisjunction.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Tease, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	ctease@bio.warwick.ac.uk						Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BOJKO M, 1983, CARLSBERG RES COMMUN, V48, P457, DOI 10.1007/BF02911920; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Browne J, 2000, PHYSIOL MEAS, V21, P515, DOI 10.1088/0967-3334/21/4/308; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; FISHER JM, 1995, AM J HUM GENET, V56, P669; Hartshorne GM, 1999, HUM REPROD, V14, P172, DOI 10.1093/humrep/14.1.172; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HULTEN M, 1974, HEREDITAS, V76, P55; HULTEN MA, 2001, HUMAN CYTOGENETICS C, P211; Jeffreys A, 1999, ELECTROPHORESIS, V20, P1665, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1665::AID-ELPS1665>3.0.CO;2-L; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lamb NE, 1997, GENETICS, V146, P1011; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; Libby BJ, 2002, DEV BIOL, V242, P174, DOI 10.1006/dbio.2001.0535; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; POLKINGHORNE J, 1989, CM762; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SPEED RM, 1985, HUM GENET, V69, P69, DOI 10.1007/BF00295532; SPEED RM, 1988, HUM GENET, V78, P260, DOI 10.1007/BF00291673; Thomas NS, 2001, HUM MOL GENET, V10, P243, DOI 10.1093/hmg/10.3.243; WALLACE BMN, 1985, ANN HUM GENET, V49, P215, DOI 10.1111/j.1469-1809.1985.tb01695.x; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	40	120	130	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1469	1479		10.1086/340734	http://dx.doi.org/10.1086/340734			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992253	Green Published, Bronze			2022-12-18	WOS:000175445700008
J	Hollox, EJ; Poulter, M; Zvarik, M; Ferak, V; Krause, A; Jenkins, T; Saha, N; Kozlov, AI; Swallow, DM				Hollox, EJ; Poulter, M; Zvarik, M; Ferak, V; Krause, A; Jenkins, T; Saha, N; Kozlov, AI; Swallow, DM			Lactase haplotype diversity in the Old World	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERSISTENCE/NON-PERSISTENCE POLYMORPHISM; MODERN HUMAN ORIGINS; LINKAGE DISEQUILIBRIUM; HUMAN-POPULATIONS; DNA POLYMORPHISMS; HUMAN-EVOLUTION; MODERN HUMANS; LOCUS; GENE; DEFICIENCY	Lactase persistence, the genetic trait in which intestinal lactase activity persists at childhood levels into adulthood, varies in frequency in different human populations, being most frequent in northern Europeans and certain African and Arabian nomadic tribes, who have a history of drinking fresh milk. Selection is likely to have played an important role in establishing these different frequencies since the development of agricultural pastoralism similar to9,000 years ago. We have previously shown that the element responsible for the lactase persistence/nonpersistence polymorphism in humans is cis-acting to the lactase gene and that lactase persistence is associated, in Europeans, with the most common 70-kb lactase haplotype, A. We report here a study of the 11-site haplotype in 1,338 chromosomes from 11 populations that differ in lactase persistence frequency. Our data show that haplotype diversity was generated both by point mutations and recombinations. The four globally common haplotypes (A, B, C, and U) are not closely related and have different distributions; the A haplotype is at high frequencies only in northern Europeans, where lactase persistence is common; and the U haplotype is virtually absent from Indo-European populations. Much more diversity is seen in sub-Saharan Africans than in non-Africans, consistent with an "Out of Africa" model for peopling of the Old World. Analysis of recent recombinant haplotypes by allele-specific PCR, along with deduction of the root haplotype from chimpanzee sequence, allowed construction of a haplotype network that assisted in evaluation of the relative roles of drift and selection in establishing the haplotype frequencies in the different populations. We suggest that genetic drift was important in shaping the general pattern of non-African haplotype diversity with recent directional selection in northern Europeans for the haplotype associated with lactase persistence.	UCL, Dept Biol, Galton Lab, MRC Human Biochem Genet Unit, London NW1 2HE, England; Comenius Univ, Dept Mol Biol, Bratislava, Slovakia; Univ Witwatersrand, Johannesburg, South Africa; S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa; Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; ArctAnC Innovat Res Lab, Moscow, Russia	University of London; University College London; Comenius University Bratislava; University of Witwatersrand; National University of Singapore	Swallow, DM (corresponding author), UCL, Dept Biol, Galton Lab, MRC Human Biochem Genet Unit, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	dswallow@hgmp.mrc.ac.uk	Kozlov, Andrew/Z-2925-2019; Krause, Amanda/AAQ-7038-2020	Krause, Amanda/0000-0002-7157-0807; Hollox, Edward/0000-0002-0115-2298				ANDERSON B, 1994, GUT, V35, P1487, DOI 10.1136/gut.35.10.1487; AOKI K, 1986, P NATL ACAD SCI USA, V83, P2929, DOI 10.1073/pnas.83.9.2929; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; BANDELT HJ, 1995, GENETICS, V141, P743; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; Bodmer W. F., 1976, GENETICS EVOLUTION M; BOLL W, 1991, AM J HUM GENET, V48, P889; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Durham WH, 1991, COEVOLUTION GENES CU, P226; Durham WilliamH., 1991, COEVOLUTION GENES CU; Feldman M. W., 1989, MATH EVOLUTIONARY TH, P145; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; HILL AVS, 1992, P NATL ACAD SCI USA, V89, P2277, DOI 10.1073/pnas.89.6.2277; Holden C, 1997, HUM BIOL, V69, P605; Hollox EJ, 1999, EUR J HUM GENET, V7, P791, DOI 10.1038/sj.ejhg.5200369; Jaruzelska J, 1999, MOL BIOL EVOL, V16, P1633, DOI 10.1093/oxfordjournals.molbev.a026076; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KOLARS JC, 1984, NEW ENGL J MED, V310, P1, DOI 10.1056/NEJM198401053100101; LLOYD M, 1992, J CLIN INVEST, V89, P524, DOI 10.1172/JCI115616; Meloni T, 1998, ITAL J GASTROENTEROL, V30, P490; Nei M., 1987, MOL EVOLUTIONARY GEN; Ott J., 1991, ANAL HUMAN GENETIC L; ROGERS AR, 1995, HUM BIOL, V67, P1; Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09; SIMOONS FJ, 1971, GEOGR REV, V61, P431, DOI 10.2307/213437; SWALLOW DM, 2000, METABOLIC MOL BASES; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; Weiss K. M., 1993, GENETIC VARIATION HU; XIONG WJ, 1991, AM J HUM GENET, V48, P383; Yip SP, 1999, HUM MOL GENET, V8, P1699, DOI 10.1093/hmg/8.9.1699; [No title captured]	47	120	121	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					160	172		10.1086/316924	http://dx.doi.org/10.1086/316924			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11095994	Green Published, Bronze			2022-12-18	WOS:000166399900015
J	Kidd, JR; Pakstis, AJ; Zhao, HY; Lu, RB; Okonofua, FE; Odunsi, A; Grigorenko, E; Bonne-Tamir, B; Friedlaender, J; Schulz, LO; Parnas, J; Kidd, KK				Kidd, JR; Pakstis, AJ; Zhao, HY; Lu, RB; Okonofua, FE; Odunsi, A; Grigorenko, E; Bonne-Tamir, B; Friedlaender, J; Schulz, LO; Parnas, J; Kidd, KK			Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; PRENATAL-DIAGNOSIS; PHENYLKETONURIA FAMILIES; MAXIMUM-LIKELIHOOD; MOLECULAR ANALYSIS; RFLP HAPLOTYPES; PCR DETECTION; DRD2 LOCUS; GENE; MUTATIONS	Because defects in the phenylalanine hydroxylase gene (PAH) cause phenylketonuria (PKU), PAH was studied for normal polymorphisms and linkage disequilibrium soon after the gene was cloned. Studies in the 1980s concentrated on European populations in which PKU was common and showed that haplotype-frequency variation exists between some regions of the world. In European populations, linkage disequilibrium generally was found not to exist between RFLPs at opposite ends of the gene but was found to exist among the RFLPs clustered at each end. We have now undertaken the first global survey of normal variation and disequilibrium across the PAH gene. Four well-mapped single-nucleotide polymorphisms (SNPs) spanning similar to 75 kb, two near each end of the gene, were selected to allow linkage disequilibrium across most of the gene to be examined. These SNPs were studied as PCR-RFLP markers in samples of, on average, 50 individuals for each of 29 populations, including, for the first time, multiple populations from Africa and from the Americas. All four sites are polymorphic in all 29 populations. Although all but 5 of the 16 possible haplotypes reach frequencies >5% somewhere in the world, no haplotype was seen in all populations. Overall linkage disequilibrium is highly significant in all populations, but disequilibrium between the opposite ends is significant only in Native American populations and in one African population. This study demonstrates that the physical extent of linkage disequilibrium can differ substantially among populations from different regions of the world, because of both ancient genetic drift in the ancestor common to a large regional group of modern populations and recent genetic drift affecting individual populations.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan; Univ Benin, Fac Med, Benin City, Nigeria; Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; Tel Aviv Univ, Sackler Sch Med, Dept Genet, IL-69978 Tel Aviv, Israel; Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA; Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA; Kommune Hosp, Inst Prevent Med, Copenhagen, Denmark	Yale University; Yale University; Yale University; Yale University; National Defense Medical Center; Tri-Service General Hospital; University of Benin; Roswell Park Cancer Institute; Tel Aviv University; Sackler Faculty of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Wisconsin System; University of Wisconsin Milwaukee	Kidd, JR (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHM 1353, New Haven, CT 06520 USA.		Okonofua, Friday/AAB-9703-2021; Grigorenko, Elena/V-2418-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; APOLD J, 1990, AM J HUM GENET, V47, P1002; BARIC I, 1992, HUM GENET, V90, P155, DOI 10.1007/BF00210763; BICKEL H, 1981, EUR J PEDIATR, V137, P133; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; CHAKRABORTY R, 1987, HUM GENET, V76, P40; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cheung K H, 2000, Pac Symp Biocomput, P639; Cheung KH, 1996, COMPUT BIOMED RES, V29, P327, DOI 10.1006/cbmr.1996.0024; Cheung KH, 2000, NUCLEIC ACIDS RES, V28, P361, DOI 10.1093/nar/28.1.361; CROW JF, 1995, EXP CLIN IMMUNOGENET, V12, P121; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; Degioanni Anna, 1994, European Journal of Human Genetics, V2, P166; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIANZANI I, 1990, HUM GENET, V86, P69; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P1958; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Feingold J., 1993, Developmental Brain Dysfunction, V6, P26; FRIEDMAN PA, 1973, P NATL ACAD SCI USA, V70, P552, DOI 10.1073/pnas.70.2.552; GOLTSOV AA, 1993, HUM MOL GENET, V2, P577, DOI 10.1093/hmg/2.5.577; GOLTSOV AA, 1992, NUCLEIC ACIDS RES, V20, P927, DOI 10.1093/nar/20.4.927-a; Good PI, 1995, PERMUTATION TESTS; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HERTZBERG M, 1989, AM J HUM GENET, V44, P382; HOFMAN KJ, 1991, AM J HUM GENET, V48, P791; Iyengar S, 1998, DNA SEQUENCE, V8, P317, DOI 10.3109/10425179809034076; JARUZELSKA J, 1991, HUM GENET, V86, P247; JORDE LB, 1994, AM J HUM GENET, V54, P884; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KIDD JR, 1991, HUM BIOL, V63, P775; KIDD JR, 1993, P 4 INT S HUM ID MAD, P21; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KIDD KK, 1987, NATURE, V327, P282, DOI 10.1038/327282a0; KIDD KK, 1996, MOL BIOL HUMAN DIVER, P242; KONECKI DS, 1991, HUM GENET, V87, P377; KOZAK L, 1995, HUM GENET, V96, P472, DOI 10.1007/BF00191809; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEWONTIN RC, 1964, GENETICS, V49, P49; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; LIDSKY AS, 1985, P NATL ACAD SCI USA, V82, P6221, DOI 10.1073/pnas.82.18.6221; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LONG JC, 1995, AM J HUM GENET, V56, P799; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Nowacki P, 1997, NUCLEIC ACIDS RES, V25, P139, DOI 10.1093/nar/25.1.139; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Piazza A., 1975, Histocompatibility testing 1975., P923; RUANO G, 1991, NUCLEIC ACIDS RES, V19, P6877, DOI 10.1093/nar/19.24.6877; Sambrook J, 1989, MOL CLONING LAB MANU; Scriver CR, 1996, CIBA F SYMP, V197, P73; STUHRMANN M, 1989, CLIN GENET, V36, P117; SVENSSON E, 1991, HUM GENET, V87, P11, DOI 10.1007/BF01213084; Tishkoff SA, 1996, HUM GENET, V97, P759; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WEDEMEYER N, 1991, NUCLEIC ACIDS RES, V19, P1959, DOI 10.1093/nar/19.8.1959; Weir B., 1996, GENETIC DATA ANAL; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; WORKMAN PL, 1970, AM J HUM GENET, V22, P24; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x; Zhao HY, 1997, AM J HUM GENET, V61, pA17; ZYGULSKA M, 1991, HUM GENET, V86, P292	69	120	121	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1882	1899		10.1086/302952	http://dx.doi.org/10.1086/302952			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10788337	Green Published, Bronze			2022-12-18	WOS:000088373800016
J	Tomita, H; Nagamitsu, S; Wakui, K; Fukushima, Y; Yamada, K; Sadamatsu, M; Masui, A; Konishi, T; Matsuishi, T; Aihara, M; Shimizu, K; Hashimoto, K; Mineta, M; Matsushima, M; Tsujita, T; Saito, M; Tanaka, H; Tsuji, S; Takagi, T; Nakamura, Y; Nanko, S; Kato, N; Nakane, Y; Niikawa, N				Tomita, H; Nagamitsu, S; Wakui, K; Fukushima, Y; Yamada, K; Sadamatsu, M; Masui, A; Konishi, T; Matsuishi, T; Aihara, M; Shimizu, K; Hashimoto, K; Mineta, M; Matsushima, M; Tsujita, T; Saito, M; Tanaka, H; Tsuji, S; Takagi, T; Nakamura, Y; Nanko, S; Kato, N; Nakane, Y; Niikawa, N			Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; POTASSIUM CHANNEL GENE; FRONTAL-LOBE EPILEPSY; DYSTONIC CHOREOATHETOSIS; INFANTILE CONVULSIONS; ATAXIA; DYSKINESIAS; MYOKYMIA; 2Q	Paroxysmal kinesigenic choreoathetosis (PKC), the most frequently described type of paroxysmal dyskinesia, is characterized by recurrent, brief attacks of involuntary movements induced by sudden voluntary movements. Some patients with PKC have a history of infantile afebrile convulsions with a favorable outcome. To localize the PKC locus, we performed genomewide linkage analysis on eight Japanese families with autosomal dominant PKC. Two-point linkage analysis provided a maximum LOD score of 10.27 (recombination fraction [theta] =.00; penetrance [p] =.7) at marker D16S3081, and a maximum multipoint LOD score for a subset of markers was calculated to be 11.51 (p = 0.8) at D16S3080. Haplotype analysis defined the disease locus within a region of similar to 12.4 cM between D16S3093 and D16S416. P1-derived artificial chromosome clones containing loci D16S3093 and D16S416 were mapped, by use of FISH, to 16p11.2 and 16q12.1, respectively. Thus, in the eight families studied, the chromosomal localization of the PKC critical region (PKCR) is 16p11.2-q12.1. The PKCR overlaps with a region responsible for "infantile convulsions and paroxysmal choreoathetosis" (MIM 602066), a recently recognized clinical entity with benign infantile convulsions and nonkinesigenic paroxysmal dyskinesias.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 8528523, Japan; Nagasaki Univ, Sch Med, Dept Neuropsychiat, Nagasaki 8528523, Japan; Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 390, Japan; Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga 52021, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Pediat, Sugitani, Toyama 93001, Japan; Yamanashi Med Coll, Dept Pediat, Yamanashi, Japan; Hamamatsu Med Coll, Dept Pediat, Hamamatsu, Shizuoka, Japan; Nippon Med Sch, Second Hosp, Dept Pediat, Tokyo, Japan; Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan; Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Neuropsychiat, Tokyo 113, Japan; Saga Med Sch, Dept Psychiat, Saga, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan	Nagasaki University; Nagasaki University; Kurume University; Shinshu University; Shiga University of Medical Science; University of Toyama; University of Yamanashi; Hamamatsu University School of Medicine; Nippon Medical School; Teikyo University; University of Tokyo; University of Tokyo; Saga University; Niigata University	Tomita, H (corresponding author), Nagasaki Univ, Sch Med, Dept Human Genet, Sakamoto 1-12-4, Nagasaki 8528523, Japan.			Tomita, Hiroaki/0000-0003-2628-880X				Auburger G, 1996, GENOMICS, V31, P90, DOI 10.1006/geno.1996.0013; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; FAHN S, 1994, MOVEMENT DISORD, V3, P310; Fink JK, 1996, AM J HUM GENET, V59, P140; Fouad GT, 1996, AM J HUM GENET, V59, P135; Fukuyama Y, 1968, Proc Aust Assoc Neurol, V5, P583; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827, DOI 10.1001/archneur.1978.00500360051010; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Hamada Yasushi, 1998, No To Hattatsu, V30, P483; HUDGINS RL, 1966, BRAIN, V89, P199, DOI 10.1093/brain/89.2.199; JUNG SS, 1973, NEUROLOGY, V23, P749, DOI 10.1212/WNL.23.7.749; KERTESZ AZ, 1967, NEUROLOGY, V17, P680, DOI 10.1212/WNL.17.7.680; LANCE JW, 1977, ANN NEUROL, V2, P285, DOI 10.1002/ana.410020405; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee WL, 1998, HUM GENET, V103, P608, DOI 10.1007/s004390050876; LISHMAN WA, 1962, BRAIN, V85, P93, DOI 10.1093/brain/85.1.93; LITT M, 1994, AM J HUM GENET, V55, P702; MANSFIELD DC, 1994, GENOMICS, V24, P225, DOI 10.1006/geno.1994.1610; Marsden CD, 1996, ADV NEUROL, V70, P467; Matsumoto N, 1997, GENOMICS, V45, P11, DOI 10.1006/geno.1997.4897; Nagamitsu S, 1999, MOVEMENT DISORD, V14, P658, DOI 10.1002/1531-8257(199907)14:4<658::AID-MDS1016>3.0.CO;2-7; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; ROZSA SK, 1997, GEN PHARMACOL, V29, P73; Sadamatsu M, 1999, EPILEPSIA, V40, P942, DOI 10.1111/j.1528-1157.1999.tb00801.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; Tan LCS, 1998, CLIN NEUROL NEUROSUR, V100, P187, DOI 10.1016/S0303-8467(98)00038-9; Wakui K, 1999, J HUM GENET, V44, P85, DOI 10.1007/s100380050115	36	120	149	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1688	1697		10.1086/302682	http://dx.doi.org/10.1086/302682			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577923	Bronze, Green Published			2022-12-18	WOS:000084282500024
J	Smeitink, J; van den Heuvel, L				Smeitink, J; van den Heuvel, L			Human mitochondrial complex I in health and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ELECTRON-TRANSPORT CHAIN; LEIGH-SYNDROME; IMPORT PORE; SUBUNIT; DEFICIENCY; MYOPATHY; GENES; DNA; INVOLVEMENT		Univ Nijmegen Hosp, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Smeitink, J (corresponding author), Univ Nijmegen Hosp, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; Smeitink, Jan/C-1351-2013	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; 				BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Clayton David A., 1998, Biofactors, V7, P203; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Duhig T, 1998, GENOMICS, V52, P72, DOI 10.1006/geno.1998.5372; Emahazion T, 1998, CYTOGENET CELL GENET, V82, P115, DOI 10.1159/000015082; EMAHAZION T, 1998, CYTOGENET CELL GENET, V82, P112; GALANTE YM, 1979, ARCH BIOCHEM BIOPHYS, V192, P559, DOI 10.1016/0003-9861(79)90126-7; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Lin X, 1999, HUM HERED, V49, P75, DOI 10.1159/000022848; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; Moyes CD, 1998, J EXP BIOL, V201, P299; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Schuelke M, 1998, BIOCHEM BIOPH RES CO, V245, P599, DOI 10.1006/bbrc.1998.8486; SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Skehel JM, 1998, FEBS LETT, V438, P301, DOI 10.1016/S0014-5793(98)01317-9; Smeitink J, 1998, HUM GENET, V103, P245, DOI 10.1007/s004390050813; Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573; SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; TRIEPELS RH, IN PRESS ANN NEUROL; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	38	120	125	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1505	1510		10.1086/302432	http://dx.doi.org/10.1086/302432			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330338	Green Published, Bronze			2022-12-18	WOS:000080696200003
J	Pajukanta, P; Terwilliger, JD; Perola, M; Hiekkalinna, T; Nuotio, I; Ellonen, P; Parkkonen, M; Hartiala, J; Ylitalo, K; Pihlajamaki, J; Porkka, K; Laakso, M; Viikari, J; Ehnholm, C; Taskinen, MR; Peltonen, L				Pajukanta, P; Terwilliger, JD; Perola, M; Hiekkalinna, T; Nuotio, I; Ellonen, P; Parkkonen, M; Hartiala, J; Ylitalo, K; Pihlajamaki, J; Porkka, K; Laakso, M; Viikari, J; Ehnholm, C; Taskinen, MR; Peltonen, L			Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; LINKAGE ANALYSIS; WIDE SEARCH; LPL GENE; IDENTIFICATION; POPULATIONS; DISORDER; COMPLEX; FINLAND; ACID	Familial combined hyperlipidemia (FCHL) is a common dyslipidemia predisposing to premature coronary heart disease (CHD). The disease is characterized by increased levels of serum total cholesterol (TC), triglycerides (TGs), or both. We recently localized the first locus for FCHL, on chromosome 1q21-q23. In the present study, a genomewide screen for additional FCHL loci was performed. In stage 1, we genotyped 368 polymorphic markers in 35 carefully characterized Finnish FCHL families. We identified six chromosomal regions with markers showing LOD score (Z) values >1.0, by using a dominant mode of inheritance for the FCHL trait. In addition, two more regions emerged showing Z > 2.0 with a TG trait. In stage 2, we genotyped 26 more markers and seven additional FCHL families for these interesting regions. Two chromosomal regions revealed Z > 2.0 in the linkage analysis: 10p11.2, Z = 3.20 (theta = .00), with the TG trait; and 21q21, Z = 2.24 (theta = .10), with the apoB trait. Furthermore, two more chromosomal regions produced Z > 2.0 in the affected-sib-pair analysis: 10q11.2-10qter produced Z = 2.59 with the TC trait and Z = 2.29 with FCHL, and 2q31 produced Z = 2.25 with the TG trait. Our results suggest additional putative loci influencing FCHL in Finnish families, some potentially affecting TG levels and some potentially affecting TC or apoB levels.	Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Dept Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Genome Ctr, New York, NY USA; Univ Turku, Dept Med, Turku, Finland; Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Columbia University; Columbia University; University of Turku; University of Eastern Finland	Peltonen, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, 695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu	Taskinen, Marja-Riitta/AAN-5432-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588; Pihlajamaki, Jussi/0000-0002-6241-6859; Hiekkalinna, Tero/0000-0002-3345-2981				Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; Arner P, 1997, CURR OPIN LIPIDOL, V8, P89, DOI 10.1097/00041433-199704000-00006; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; CUTHBERT JA, 1986, NEW ENGL J MED, V314, P879, DOI 10.1056/NEJM198604033141404; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; de Graaf J, 1998, CURR OPIN LIPIDOL, V9, P189, DOI 10.1097/00041433-199806000-00002; DEGRUIJTER M, 1991, METABOLISM, V40, P1119, DOI 10.1016/0026-0495(91)90203-9; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GAGNE E, 1994, ARTERIOSCLER THROMB, V14, P1250, DOI 10.1161/01.ATV.14.8.1250; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; Juo SHH, 1998, AM J HUM GENET, V63, P586, DOI 10.1086/301962; KAUFMANN NA, 1986, AM J CLIN NUTR, V43, P604, DOI 10.1093/ajcn/43.4.604; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Marcil M, 1996, J LIPID RES, V37, P309; NIKKILA EA, 1973, LANCET, V1, P954; Ott J., 1991, ANAL HUMAN GENETIC L; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Porkka KVK, 1997, ATHEROSCLEROSIS, V133, P245, DOI 10.1016/S0021-9150(97)00134-2; PORKKA KVK, 1994, ACTA PAEDIATR, V83, P838, DOI 10.1111/j.1651-2227.1994.tb13155.x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REYMER PWA, 1995, HUM MOL GENET, V4, P1543, DOI 10.1093/hmg/4.9.1543; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Rose G, 1982, CARDIOVASCULAR SURVE; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Vakkilainen J, 1998, EUR J CLIN INVEST, V28, P24; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Wijsman EM, 1998, ARTERIOSCL THROM VAS, V18, P215, DOI 10.1161/01.ATV.18.2.215; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; YANG WS, 1995, P NATL ACAD SCI USA, V92, P4462, DOI 10.1073/pnas.92.10.4462	52	120	121	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1453	1463		10.1086/302365	http://dx.doi.org/10.1086/302365			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205279	Green Published, Bronze			2022-12-18	WOS:000080093000026
J	Vargas-Poussou, R; Feldmann, D; Vollmer, M; Konrad, M; Kelly, L; van den Heuvel, LPWJ; Tebourbi, L; Brandis, M; Karolyi, L; Hebert, SC; Lemmink, HH; Deschenes, G; Hildebrandt, F; Seyberth, HW; Guay-Woodford, LM; Knoers, NVAM; Antignac, C				Vargas-Poussou, R; Feldmann, D; Vollmer, M; Konrad, M; Kelly, L; van den Heuvel, LPWJ; Tebourbi, L; Brandis, M; Karolyi, L; Hebert, SC; Lemmink, HH; Deschenes, G; Hildebrandt, F; Seyberth, HW; Guay-Woodford, LM; Knoers, NVAM; Antignac, C			Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERPROSTAGLANDIN-E SYNDROME; THICK ASCENDING LIMB; LINKED ALPORT SYNDROME; K-CL COTRANSPORTER; POINT MUTATIONS; ANGIOTENSIN-II; HYPERCALCIURIA; TRANSPORT; FRAGMENTS; POTASSIUM	Aratenatal Bartter syndrome is a variant of inherited renal-tubular disorders associated with hypokalemic alkalosis. This disorder typically presents as a life-threatening condition beginning in utero, with marked fetal polyuria that leads to polyhydramnios and premature delivery. Another hallmark of this variant is a marked hypercalciuria and, as a secondary consequence, the development of nephrocalcinosis and osteopenia, We have analyzed 15 probands belonging to 13 families and leave performed SSCP analysis of the coding sequence and the exon-intron boundaries of the NKCC2 gene; and we report 14 novel mutations in patients with antenatal Bartter syndrome, as well as the identification of three isoforms of human NKCC2 that arise from alternative splicing.	Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, F-75743 Paris, France; Armand Trousseau Hosp, Dept Biochem, Paris, France; Armand Trousseau Hosp, Dept Pediat Nephrol, Paris, France; Univ Freiburg, Dept Pediat, D-7800 Freiburg, Germany; Univ Marburg, Dept Pediat, Marburg, Germany; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Freiburg; Philipps University Marburg; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Antignac, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, Tour Lavoisier,6e Etage,149 Rue Sevres, F-75743 Paris, France.	antignac@necker.fr	van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; ANTIGNAC, Corinne/H-8945-2017; Vargas-Poussou, Rosa/AAD-7280-2020	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; ANTIGNAC, Corinne/0000-0002-9934-4940; Vargas-Poussou, Rosa/0000-0002-4169-0680; deschenes, georges/0000-0002-5158-2915				BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; DESCHENES G, 1993, ANN PEDIATR-PARIS, V40, P95; FANCONI A, 1971, HELV PAEDIATR ACTA, V26, P144; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; GOOD DW, 1984, AM J PHYSIOL, V247, pF35, DOI 10.1152/ajprenal.1984.247.1.F35; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; HIORT O, 1994, HUM MOL GENET, V3, P1163, DOI 10.1093/hmg/3.7.1163; HOGEWIND BL, 1981, ACTA MED SCAND, V209, P463; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Karolyi L, 1997, HUM MOL GENET, V6, P17; KNEBELMANN B, 1992, AM J HUM GENET, V51, P135; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; Kockerling A, 1996, J PEDIATR-US, V129, P519, DOI 10.1016/S0022-3476(96)70116-6; LEONHARDT A, 1992, J PEDIATR-US, V120, P546, DOI 10.1016/S0022-3476(05)82480-1; MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; PROESMANS W, 1985, INT J PED NEPHROL, V6, P63; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rozet JM, 1996, GENOMICS, V36, P554, DOI 10.1006/geno.1996.0508; Schwartz ID, 1996, J NEPHROL, V9, P81; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; SEYBERTH HW, 1987, PEDIATR NEPHROL, V1, P491, DOI 10.1007/BF00849259; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SHOEMAKER L, 1993, PEDIATR RES, V33, P92, DOI 10.1203/00006450-199301000-00019; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; WINTERS CJ, 1991, SEMIN NEPHROL, V11, P236; WIPPERMANN CF, 1993, J MATERN-FETAL INVES, V3, P91; Yang TX, 1996, AM J PHYSIOL-RENAL, V271, pF931, DOI 10.1152/ajprenal.1996.271.4.F931; ZUSMAN RM, 1980, KIDNEY INT, V17, P277, DOI 10.1038/ki.1980.33; ZUSMAN RM, 1977, J CLIN INVEST, V60, P215, DOI 10.1172/JCI108758	35	120	121	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1332	1340		10.1086/301872	http://dx.doi.org/10.1086/301872			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585600	Green Published, Bronze			2022-12-18	WOS:000074174700009
J	Cullen, M; Noble, J; Erlich, H; Thorpe, K; Beck, S; Klitz, W; Trowsdale, J; Carrington, M				Cullen, M; Noble, J; Erlich, H; Thorpe, K; Beck, S; Klitz, W; Trowsdale, J; Carrington, M			Characterization of recombination in the HLA class II region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; E-BETA GENE; MEIOTIC RECOMBINATION; MOLECULAR CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; HOT-SPOT; HOMOLOGOUS RECOMBINATION; OLIGONUCLEOTIDE PROBES; MOUSE H-2-COMPLEX; CEPH FAMILIES	Studies of linkage disequilibrium across the HLA class II region have been useful in predicting where recombination is most likely to occur. The strong associations between genes within the 85-kb region from DQB1 to DRB1 are consistent with low frequency of recombination in this segment of DNA. Conversely, a lack of association between alleles of TAP1 and TAP2 (similar to 15 kb) has been observed, suggesting that recombination occurs here with relatively high frequency. Much of the HLA class II region has now been sequenced, providing the tools to undertake detailed analysis of recombination. Twenty-seven families containing one or two recombinant chromosomes within the 500-kb interval between the DPB1 and DRB1 genes were used to determine patterns of recombination across this region. SSCP analysis and microsatellite typing yielded identification of 127 novel polymorphic markers distributed throughout the class II region, allowing refinement of the site of crossover in 30 class II recombinant chromosomes. The three regions where recombination was observed most frequently are as follows: the 45-kb interval between HLA-DNA and RING3 (11 cases), the 50-kb interval between DQB3 and DQB1 (6 cases), and an 8.8-kb segment of the TAP2 gene (3 cases). Six of the 10 remaining recombinants await further characterization, pending identification of additional informative markers, while four recombinants were localized to other intervals (outliers). Analysis of association between markers flanking HLA-DNA to RING3 (45 kb), as well as TAP1 to TAP2 (15 kb), by use of independent CEPH haplotypes indicated little or no linkage disequilibrium, supporting the familial recombination data. A notable sequence motif located within a region associated with increased rates of recombination consisted of a (TGGA)(12) tandem repeat within the TAP2 gene.	NCI, FREDERICK CANC RES & DEV CTR, SAIC FREDERICK, INTRAMURAL RES SUPPORT PROGRAM, FREDERICK, MD 21702 USA; ROCHE MOL SYST, DEPT HUMAN GENET, ALAMEDA, CA USA; SANGER CTR, HINXTON, ENGLAND; UNIV CALIF BERKELEY, DEPT INTEGRAT BIOL, BERKELEY, CA USA; IMPERIAL CANC RES FUND, HUMAN IMMUNOGENET LAB, LONDON WC2A 3PX, ENGLAND	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Roche Holding; Wellcome Trust Sanger Institute; University of California System; University of California Berkeley; Cancer Research UK					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN DM, 1991, IMMUNOL TODAY, V12, P267, DOI 10.1016/0167-5699(91)90124-C; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; Beck S, 1996, J MOL BIOL, V255, P1, DOI 10.1006/jmbi.1996.0001; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BENGER JC, 1991, GENOMICS, V9, P614, DOI 10.1016/0888-7543(91)90354-H; Bouissou C, 1995, GENOMICS, V30, P486, DOI 10.1006/geno.1995.1269; BOWCOCK AM, 1988, P NATL ACAD SCI USA, V85, P2701, DOI 10.1073/pnas.85.8.2701; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; CARRINGTON M, 1994, HUM MOL GENET, V3, P218, DOI 10.1093/hmg/3.1.218; CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266; CARRINGTON M, 1994, HUM IMMUNOL, V41, P234, DOI 10.1016/0198-8859(94)90041-8; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHARMLEY P, 1990, P NATL ACAD SCI USA, V87, P4823, DOI 10.1073/pnas.87.12.4823; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CROUAUROY B, 1993, HUM IMMUNOL, V38, P132, DOI 10.1016/0198-8859(93)90530-E; CULLEN M, 1995, AM J HUM GENET, V56, P1350; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2; EIERMANN TH, 1993, HUM IMMUNOL, V38, P217, DOI 10.1016/0198-8859(93)90544-B; FISCHERLINDAHL K, 1991, TRENDS GENET, V7, P273; GILLIES SD, 1984, NATURE, V310, P594, DOI 10.1038/310594a0; GREGERSEN PK, 1988, J IMMUNOL, V141, P1365; GRIMM T, 1989, AM J HUM GENET, V45, P368; HAAS JP, 1994, HUM IMMUNOL, V39, P31, DOI 10.1016/0198-8859(94)90098-1; HEINLEIN UAO, 1986, NUCLEIC ACIDS RES, V14, P6403, DOI 10.1093/nar/14.16.6403; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KLITZ W, 1995, AM J HUM GENET, V57, P1436; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; KOBORI JA, 1984, J MOL CELL IMMUNOL, V1, P125; KWOK WW, 1993, J IMMUNOL, V150, P2263; LAFUSE WP, 1992, IMMUNOGENETICS, V36, P110, DOI 10.1007/BF00215287; LAFUSE WP, 1986, IMMUNOGENETICS, V24, P352, DOI 10.1007/BF00377952; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; LEE MGS, 1984, NUCLEIC ACIDS RES, V12, P5823, DOI 10.1093/nar/12.14.5823; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; PACE T, 1990, MOL CELL BIOL, V10, P6759, DOI 10.1128/MCB.10.12.6759; PADGETT KA, 1991, J IMMUNOL, V147, P2764; PASSMORE HC, 1987, BIOCHEM GENET, V25, P513, DOI 10.1007/BF00554353; POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802; ROONEY SM, 1995, P NATL ACAD SCI USA, V92, P2141, DOI 10.1073/pnas.92.6.2141; SAHA BK, 1986, J IMMUNOL, V137, P4004; SAHA BK, 1986, J IMMUNOL, V136, P1112; SANTANGELO DB, 1992, GENOMICS, V13, P1334, DOI 10.1016/0888-7543(92)90061-V; SATYANARAYANA K, 1992, IMMUNOGENETICS, V35, P235, DOI 10.1007/BF00166828; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHIROISHI T, 1987, IMMUNOGENETICS, V25, P258, DOI 10.1007/BF00404696; SHIROISHI T, 1982, NATURE, V300, P370, DOI 10.1038/300370a0; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SHIROISHI T, 1993, GENETICA, V88, P187, DOI 10.1007/BF02424475; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; THOMAS BJ, 1991, CELL, V64, P1, DOI 10.1016/0092-8674(91)90199-9; THOMSEN M, 1989, TISSUE ANTIGENS, V33, P38, DOI 10.1111/j.1399-0039.1989.tb01675.x; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; UEMATSU Y, 1986, EMBO J, V5, P2123, DOI 10.1002/j.1460-2075.1986.tb04475.x; VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; *WI PACK, 1984, SEQ AN PACK PROGR BE; Yang S.Y., 1989, IMMUNOBIOLOGY HLA, P11, DOI [10.1007/978-1-4612-3552-1_2, DOI 10.1007/978-1-4612-3552-1_2]; YOSHINO M, 1995, GENOMICS, V27, P298, DOI 10.1006/geno.1995.1046; YOSHINO M, 1994, IMMUNOGENETICS, V40, P280, DOI 10.1007/BF00189973; YOSHINO M, 1994, IMMUNOGENETICS, V39, P381, DOI 10.1007/BF00176154; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; ZIMMERER EJ, 1991, IMMUNOGENETICS, V33, P132, DOI 10.1007/BF00210827	74	120	125	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					397	407						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012413				2022-12-18	WOS:A1997WE93100019
J	Duggirala, R; Stern, MP; Mitchell, BD; Reinhart, LJ; Shipman, PA; Uresandi, OC; Chung, WK; Leibel, RL; Hales, CN; OConnell, P; Blangero, J				Duggirala, R; Stern, MP; Mitchell, BD; Reinhart, LJ; Shipman, PA; Uresandi, OC; Chung, WK; Leibel, RL; Hales, CN; OConnell, P; Blangero, J			Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; JAPANESE-AMERICAN MEN; CARBOXYPEPTIDASE-E; MEXICAN-AMERICANS; PEDIGREE ANALYSIS; ADIPOSE-TISSUE; PIMA-INDIANS; SIB PAIRS; BODY-FAT; NIDDM	Despite the evidence that human obesity has strong genetic determinants, efforts at identifying specific genes that influence human obesity have largely been unsuccessful. Using the sibship data obtained from 32 low-income Mexican American pedigrees ascertained on a type II diabetic proband and a multipoint variance-components method, we tested for linkage between various obesity-related traits plus associated metabolic traits and 15 markers on human chromosome 7. We found evidence for linkage between markers in the OB gene region and various traits, as follows: D7S514 and extremity skinfolds (LOD = 3.1), human carboxypeptidase Al (HCPA1) and 32,33-split proinsulin level (LOD = 4.2), and HCPA1 and proinsulin level (LOD = 3.2). A putative susceptibility locus linked to the marker D7S514 explained 56% of the total phenotypic variation in extremity skinfolds. Variation at the HCPA1 locus explained 64% of phenotypic variation in proinsulin level and similar to 73% of phenotypic variation in split proinsulin concentration, respectively. Weaker evidence for linkage to several other obesity-related traits (e.g., waist circumference, body-mass index, fat mass by bioimpedance, etc.) was observed for a genetic location, which is similar to 15 chi telomeric to OB. In conclusion, our study reveals that the OB region plays a significant role in determining the phenotypic variation of both insulin precursors and obesity-related traits, at least in Mexican Americans.	UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284; SW FDN BIOMED RES,DEPT GENET,SAN ANTONIO,TX; ROCKEFELLER UNIV,NEW YORK,NY 10021; UNIV CAMBRIDGE,DEPT CLIN BIOCHEM,CAMBRIDGE CB2 1TN,ENGLAND	University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Rockefeller University; University of Cambridge	Duggirala, R (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV CLIN EPIDEMIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.		Mitchell, Braxton/CAF-0876-2022; Blangero, John/ABA-7175-2021	Mitchell, Braxton/0000-0003-4920-4744	NIDDK NIH HHS [DK42273, DK47482, DK44297, P30 DK026687] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047482, R01DK042273, P30DK026687, R29DK044297] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMOS CI, 1994, AM J HUM GENET, V54, P535; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BERNE C, 1994, DIABETOLOGIA, V37, pA57; Blangero J, 1995, GENET EPIDEMIOL, V12, P689, DOI 10.1002/gepi.1370120628; Borecki I B, 1994, Obes Res, V2, P213; BOUCHARD C, 1995, INT J OBESITY, V19, pS10; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BURNS TL, 1993, CRIT REV FOOD SCI, V33, P339, DOI 10.1080/10408399309527630; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; DYKE B, 1995, 2 PGL DEP GEN SW FDN; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FERRELL RE, 1993, HUM BIOL, V65, P967; FULKER DW, 1995, AM J HUM GENET, V56, P1224; FULKER DW, 1994, AM J HUM GENET, V54, P1092; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GREEN ED, 1995, GENOME RES, V5, P5, DOI 10.1101/gr.5.1.5; Green P, 1990, DOCUMENTATION CRI MA; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAFFNER SM, 1987, DIABETES, V36, P43, DOI 10.2337/diabetes.36.1.43; HAFFNER SM, 1994, DIABETES, V43, P1490, DOI 10.2337/diabetes.43.12.1490; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HALES CN, 1995, CURRENT SCI, P146; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; KAHN SE, 1995, J CLIN ENDOCR METAB, V80, P1399, DOI 10.1210/jc.80.4.1399; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LEIBEL RL, 1993, CRIT REV FOOD SCI, V33, P351, DOI 10.1080/10408399309527632; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; LUDVIK B, 1995, DIABETES, V44, P1121, DOI 10.2337/diabetes.44.9.1121; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; MYKKANEN L, 1994, DIABETOLOGIA, V37, pA74; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; OOHASHI H, 1993, DIABETES CARE, V16, P1340, DOI 10.2337/diacare.16.10.1340; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PERRIELLO G, 1995, J CLIN ENDOCR METAB, V80, P2464, DOI 10.1210/jc.80.8.2464; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; PROCHAZKA M, 1995, CYTOGENET CELL GENET, V71, P30; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; REED DR, 1995, INT J OBESITY, V19, P599; RHODES CJ, 1994, DIABETES, V43, P511, DOI 10.2337/diabetes.43.4.511; RICE T, 1993, AM J HUM GENET, V52, P967; SAAD MF, 1990, J CLIN ENDOCR METAB, V70, P1247, DOI 10.1210/jcem-70-5-1247; *SAGE, 1994, STAT AN GEN EP REL 2; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P175; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; SOOHEE L, 1983, BLOOD, V81, P2804; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; STERN MP, 1995, CURRENT SCI LONDON, P1; STIRLING B, 1995, DIABETES, V44, P999, DOI 10.2337/diabetes.44.8.999; TEMPLE RC, 1990, CLIN ENDOCRINOL, V32, P689, DOI 10.1111/j.1365-2265.1990.tb00915.x; Tsui L C, 1995, Cytogenet Cell Genet, V71, P2; WALKER M, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90314-3; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; *WHO, 1985, TECH REP SER WHO, V727; YOSHIDA H, 1995, DIABETES, V44, P389, DOI 10.2337/diabetes.44.4.389; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	66	120	122	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					694	703						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751871				2022-12-18	WOS:A1996VN62500024
J	LUO, DF; BUI, MM; MUIR, A; MACLAREN, NK; THOMSON, G; SHE, JX				LUO, DF; BUI, MM; MUIR, A; MACLAREN, NK; THOMSON, G; SHE, JX			AFFECTED-SIB-PAIR MAPPING OF A NOVEL SUSCEPTIBILITY GENE TO INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM8) ON CHROMOSOME 6Q25-Q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; REGION; MICE	Affected-sib-pair analyses were performed using 104 Caucasian families to map genes that predispose to insulin-dependent diabetes mellitus (IDDM). We have obtained linkage evidence for D6S446 (maximum lod score [MLS] = 2.8) and for D6S264 (MLS = 2.0) on 6q25-q27. Together with a previously reported data set, linkage can be firmly established (MLS = 3.4 for D6S264), and the disease locus has been designated IDDM8. With analysis of independent families, we confirmed linkage evidence for the previously identified IDDM3 (15q) and DDM7 (2q). We also typed additional markers in the regions containing IDDM3, IDDM4, IDDM5, and IDDM8. Preliminary linkage evidence for a novel region on chromosome 4q (D4S1566) has been found in 47 Florida families (P < .03). We also found evidence of linkage for two regions previously identified as potential linkages in the Florida subset: D3S1303 on 3q (P < .04) and D7S486 on 7q (P < .03). We could not confirm linkage with eight other regions (D1S191, D1S412, D4S1604, D8S264, D8S556, D10S193, D13S158, and D18S64) previously identified as potential linkages.	UNIV FLORIDA,COLL MED,DEPT PATHOL & LAB MED,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Berkeley					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731, R01HD019469] Funding Source: NIH RePORTER; NICHD NIH HHS [HD19469, HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; CAILLATZUCMAN S, 1993, EUR J IMMUNOL, V23, P1784, DOI 10.1002/eji.1830230808; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; DAVIES JL, 1994, AM J HUM GENET, V371, P130; DUNSWORTH TS, 1982, DIABETES, V31, P991, DOI 10.2337/diabetes.31.11.991; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HODGE SE, 1981, LANCET, V2, P893; HODGE SE, 1983, AM J HUM GENET, V35, P1139; JAMES RS, 1995, NAT GENET, V9, P110; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LANDER ES, 1994, SCIENCE, V265, P2307; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; OWERBACH D, 1994, AM J HUM GENET, V54, P909; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; SHE JX, 1994, AUTOIMMUNITY, V18, P195, DOI 10.3109/08916939409007996; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THORSBY E, 1992, ANN MED, V24, P523, DOI 10.3109/07853899209167006; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0	25	120	127	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					911	919						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573053				2022-12-18	WOS:A1995RV79300023
J	OUDET, C; MORNET, E; SERRE, JL; THOMAS, F; LENTESZENGERLING, S; KRETZ, C; DELUCHAT, C; TEJADA, I; BOUE, J; BOUE, A; MANDEL, JL				OUDET, C; MORNET, E; SERRE, JL; THOMAS, F; LENTESZENGERLING, S; KRETZ, C; DELUCHAT, C; TEJADA, I; BOUE, J; BOUE, A; MANDEL, JL			LINKAGE DISEQUILIBRIUM BETWEEN THE FRAGILE-X MUTATION AND 2 CLOSELY LINKED CA REPEATS SUGGESTS THAT FRAGILE-X CHROMOSOMES ARE DERIVED FROM A SMALL NUMBER OF FOUNDER CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSTABILITY	In order to investigate the origin of mutations responsible for the fragile X syndrome, two polymorphic CA repeats, one at 10 kb (FRAXAC2) and the other at 150 kb (DXS548) from the mutation target, were analyzed in normal and fragile X chromosomes. Contrary to observations made in myotonic dystrophy, fragile X mutations were not strongly associated with a single allele at the marker loci. However, significant differences in allelic and haplotypic distributions were observed between normal and fragile X chromosomes, indicating that a limited number of primary events may have been at the origin of most present-day fragile X chromosomes in Caucasian populations. We propose a putative scheme with six founder chromosomes from which most of the observed fragile X-linked haplotypes can be derived directly or by a single event at one of the marker loci, either a change of one repeat unit or a recombination between DXS548 and the mutation target. Such founder chromosomes may have carried a number of CGG repeats in an upper-normal range, from which recurrent multistep expansion mutations have arisen.	CTR ETUD BIOL PRENATALE,CHATEAU LONGCHAMP,BOIS BOULOGNE,FRANCE; INSERM,GENET EPIDEMIOL LAB,U155,F-75005 PARIS,FRANCE; SANTO HOSP CIVIL BILBAO,UNIDAD GENET HUMANA,BILBAO,SPAIN	Institut National de la Sante et de la Recherche Medicale (Inserm)	OUDET, C (corresponding author), FAC MED STRASBOURG,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.		M Isabel, Tejada/E-2394-2012					Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CHAKRAVARTI A, 1992, NAT GENET, V1, P237, DOI 10.1038/ng0792-237; DRUGGE U, 1992, AM J MED GENET, V43, P353, DOI 10.1002/ajmg.1320430154; FORNAGE M, 1992, GENOMICS, V12, P63, DOI 10.1016/0888-7543(92)90407-J; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HUANG THM, 1992, GENOMICS, V13, P375, DOI 10.1016/0888-7543(92)90256-R; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1991, AM J HUM GENET, V49, P311; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RIGGINS GJ, 1992, AM J MED GENET, V43, P237, DOI 10.1002/ajmg.1320430138; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SMITS A, 1992, AM J MED GENET, V43, P345, DOI 10.1002/ajmg.1320430153; TEJADA I, 1992, AM J MED GENET, V43, P282, DOI 10.1002/ajmg.1320430144; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1992, AM J HUM GENET, V50, P968	23	120	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					297	304						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8094266				2022-12-18	WOS:A1993KN27500007
J	KNOLL, JHM; NICHOLLS, RD; MAGENIS, RE; GLATT, K; GRAHAM, JM; KAPLAN, L; LALANDE, M				KNOLL, JHM; NICHOLLS, RD; MAGENIS, RE; GLATT, K; GRAHAM, JM; KAPLAN, L; LALANDE, M			ANGELMAN SYNDROME - 3 MOLECULAR CLASSES IDENTIFIED WITH CHROMOSOME-15Q11Q13-SPECIFIC DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,CTR BIRTH DEFECTS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDRENS,PORTLAND,OR 97201; CEDARS SINAI MED CTR,AHMANSON PEDIAT CTR,CTR MED GENET BIRTH DEFECTS,LOS ANGELES,CA 90048	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University; Oregon Health & Science University; Cedars Sinai Medical Center			Graham, John M./J-1429-2019	Knoll, Joan/0000-0001-6691-1710	NICHD NIH HHS [HD18658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; COOKE A, 1989, AM J MED GENET, V32, P545, DOI 10.1002/ajmg.1320320424; DONLON TA, 1988, HUM GENET, V80, P322, DOI 10.1007/BF00273644; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRELL RE, 1987, CYTOGENET CELL GENET, V46, P614; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HAINES JL, 1989, CYTOGENET CELL GENET, V51, P1010; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1989, HUM GENET, V83, P205, DOI 10.1007/BF00286723; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MATTEI JF, 1983, HUM GENET, V64, P356, DOI 10.1007/BF00292367; MCKUSICK VA, 1989, MENDELIAN INHERITANC; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIIKAWA N, 1985, HUM GENET, V69, P22, DOI 10.1007/BF00295524; PASHAYAN HM, 1982, AM J MED GENET, V13, P295, DOI 10.1002/ajmg.1320130311; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; RICH DC, 1988, NUCLEIC ACIDS RES, V16, P8740, DOI 10.1093/nar/16.17.8740; SAMPSON JR, 1989, CYTOGENET CELL GENET, V51, P1073; SEABRIGH.M, 1971, LANCET, V2, P971; SMITH M, 1989, CYTOGENET CELL GENET, V51, P1082; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	33	120	122	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					149	155						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971993				2022-12-18	WOS:A1990DK48200020
J	HAYDEN, MR; KIRK, H; CLARK, C; FROHLICH, J; RABKIN, S; MCLEOD, R; HEWITT, J				HAYDEN, MR; KIRK, H; CLARK, C; FROHLICH, J; RABKIN, S; MCLEOD, R; HEWITT, J			DNA POLYMORPHISMS IN AND AROUND THE APO-A1-CIII GENES AND GENETIC HYPERLIPIDEMIAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT INTERNAL MED,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia; University of British Columbia; University of British Columbia	HAYDEN, MR (corresponding author), UNIV BRITISH COLUMBIA,HLTH SCI CTR HOSP,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA.		Hayden, Michael R/D-8581-2011; McLeod, Roger/F-8014-2015	Hayden, Michael R/0000-0001-5159-1419; McLeod, Roger/0000-0002-6740-5569				ALBERS JJ, 1978, CLIN CHEM, V24, P853; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ASSMANN G, 1982, LIPID METABOLISM ATH; BRUNZELL JD, 1979, METABOLISM, V28, P901, DOI 10.1016/0026-0495(79)90089-1; BRUNZELL JD, 1983, J LIPID RES, V24, P147; BRUNZELL JD, 1976, METABOLISM, V25, P313, DOI 10.1016/0026-0495(76)90089-5; BRUNZELL JD, 1980, METABOLISM, V29, P624, DOI 10.1016/0026-0495(80)90106-7; Buccolo G., 1973, CLIN CHEM, V19, P476; COX DW, 1978, NEW ENGL J MED, V299, P1421, DOI 10.1056/NEJM197812282992601; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GLUECK CJ, 1973, METABOLISM, V22, P1287, DOI 10.1016/0026-0495(73)90274-6; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; HELGELAND A, 1978, AM J MED, V64, P34, DOI 10.1016/0002-9343(78)90177-8; HELGELAND A, 1978, POSSIBLE METABOLIC S; KESSLING AM, 1985, CLIN GENET, V28, P296; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; REES A, 1986, HUM GENET, V72, P168; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; REES A, 1983, LANCET, V1, P444; SCHAEFER EJ, 1984, ARTERIOSCLEROSIS, V4, P303, DOI 10.1161/01.ATV.4.4.303; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; UTERMANN G, 1980, AM J HUM GENET, V32, P339; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; VELLA M, 1985, HUM GENET, V69, P275, DOI 10.1007/BF00293040; WARNICK GR, 1979, CLIN CHEM, V25, P279; WINDLER E, 1980, J BIOL CHEM, V255, P8303	29	120	121	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					421	430						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	2883893				2022-12-18	WOS:A1987H575900004
J	COMINGS, DE; COMINGS, BG; DEVOR, EJ; CLONINGER, CR				COMINGS, DE; COMINGS, BG; DEVOR, EJ; CLONINGER, CR			DETECTION OF MAJOR GENE FOR GILLES-DE-LA-TOURETTE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63178; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT GENET,ST LOUIS,MO 63178	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,DUARTE,CA 91010, USA.		Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807	NIMH NIH HHS [MH-00048, MH-14677] Funding Source: Medline; NINDS NIH HHS [NS-14861] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014677] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABE K, 1980, DEV MED CHILD NEUROL, V22, P649; ABRAHAM K, 1921, SELECTED PAPERS K AB; ASCHER E, 1948, AM J PSYCHIAT, V105, P267, DOI 10.1176/ajp.105.4.267; BARON M, 1981, AM J HUM GENET, V33, P767; BRUUN RD, 1976, AM J PSYCHIAT, V133, P944; CHAPEL JL, 1964, AM J PSYCHIAT, V121, P608, DOI 10.1176/ajp.121.6.608; CHASE TN, 1982, GILLES TOURETTE SYND, V35; Cochran W.G, 1957, STAT METHODS, V6th ed; COMINGS D, 1984, J AM ACAD CHILD PSYC; COMINGS DE, 1982, AM J PSYCHIAT, V139, P913; DUNLAP JR, 1960, J NERV MENT DIS, V130, P340, DOI 10.1097/00005053-196004000-00008; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; Ferenczi S, 1921, INT Z PSYCHOANAL, V7, P33; FROST N, 1976, DIS NERV SYST, V37, P537; Gilles de la Tourette G, 1885, ARCH NEUROL-CHICAGO, V9, P158; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1977, J MED GENET, V14, P408, DOI 10.1136/jmg.14.6.408; LUCAS AR, 1973, CHILD PSYCHIATRY HUM, V3, P231; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1974, AM J HUM GENET, V26, P318; MORTON NE, 1983, HUMAN POPULATION GEN; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; POLLACK MA, 1977, ARCH NEUROL-CHICAGO, V34, P630, DOI 10.1001/archneur.1977.00500220064011; SANDERS DG, 1973, ARCH GEN PSYCHIAT, V28, P326; Shapiro AK, 1978, GILLES TOURETTES SYN; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x; SWEET RD, 1973, J NEUROL NEUROSUR PS, V36, P1, DOI 10.1136/jnnp.36.1.1; WAYNE HL, 1972, CLIN ELECTROENCEPHAL, V3, P160; WILLIAMS WR, 1982, HUM HERED, V32, P24, DOI 10.1159/000153254; WILSON RS, 1978, BEHAV GENET, V8, P503, DOI 10.1007/BF01067479; 1980, DIAGNOSTIC STATISTIC	36	120	121	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					586	600						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6587774				2022-12-18	WOS:A1984SY11900008
J	HODGE, SE; ANDERSON, CE; NEISWANGER, K; SPARKES, RS; RIMOIN, DL				HODGE, SE; ANDERSON, CE; NEISWANGER, K; SPARKES, RS; RIMOIN, DL			THE SEARCH FOR HETEROGENEITY IN INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) - LINKAGE STUDIES, 2-LOCUS MODELS, AND GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717; UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-25834] Funding Source: Medline; NICHD NIH HHS [HD-04612] Funding Source: Medline; NIMH NIH HHS [MH-33617] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON CE, 1983, METABOLISM, V32, P471, DOI 10.1016/0026-0495(83)90009-4; BARBOSA J, 1982, J CLIN ENDOCR METAB, V55, P193, DOI 10.1210/jcem-55-1-193; CAHILL GF, 1981, NEW ENGL J MED, V304, P1454, DOI 10.1056/NEJM198106113042403; CAHILL GF, 1979, GENETIC ANAL COMMON, P113; Christy M, 1979, Diabetes Care, V2, P209, DOI 10.2337/diacare.2.2.209; CLERGETDARPOUX F, 1981, ANN HUM GENET, V45, P199, DOI 10.1111/j.1469-1809.1981.tb00321.x; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; COOK PJL, 1982, CYTOGENET CELL GENET, V32, P111, DOI 10.1159/000131691; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; DUNSWORTH TS, 1982, DIABETES, V31, P990; GREEN A, 1982, TISSUE ANTIGENS, V19, P213, DOI 10.1111/j.1399-0039.1982.tb01442.x; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; GREENBERG DA, 1983, AM J MED GENET, V14, P487, DOI 10.1002/ajmg.1320140313; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1981, LANCET, V2, P893; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; HODGE SE, 1983, DIABETOLOGIA; Hodge SE, 1979, AM J HUM GENET, V31, P761; IRVINE WJ, 1978, J CLIN LAB IMMUNOL, V1, P111; KEATS BJB, 1979, SOURCE BOOK LINKAGE, P35; KENDALL M, 1973, ADV THEORY STAT, V2, P234; KIRK RL, 1979, DIABETES, V28, P949, DOI 10.2337/diabetes.28.10.949; LEWIS M, 1982, ANN HUM GENET, V46, P349, DOI 10.1111/j.1469-1809.1982.tb01585.x; LUCARELLI P, 1978, HUM HERED, V28, P89, DOI 10.1159/000152948; MCDEVITT HO, 1974, LANCET, V1, P1269; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; NAKAO Y, 1981, NEW ENGL J MED, V304, P407, DOI 10.1056/NEJM198102123040706; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1974, AM J HUM GENET, V26, P588; RAO DC, 1978, AM J HUM GENET, V30, P516; RAUM D, 1979, LANCET, V1, P1208; RAUM D, 1981, IMMUNOGENETICS, V12, P59, DOI 10.1007/BF01561651; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; ROTTER JI, 1981, AM J HUM GENET, V33, P835; ROTTER JI, 1978, DIABETES, V27, P599, DOI 10.2337/diabetes.27.5.599; RUBINSTEIN P, 1981, AM J HUM GENET, V33, P865; SCHERNTHANER G, 1982, GENETICS DIABETES ME, P99; SHOWS TB, 1982, CYTOGENET CELL GENET, V32, P221, DOI 10.1159/000131702; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; VAGUE P, 1978, DIABETOLOGIA, V15, P33, DOI 10.1007/BF01219325; WALSH LJ, 1982, AM J MED GENET, V11, P337, DOI 10.1002/ajmg.1320110310; 1980, HISTOCOMPATIBILITY T, P18	47	120	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1139	1155						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6580815				2022-12-18	WOS:A1983RU70500009
J	WOLF, B; FELDMAN, GL				WOLF, B; FELDMAN, GL			THE BIOTIN-DEPENDENT CARBOXYLASE DEFICIENCIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											WOLF, B (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT HUMAN GENET, RICHMOND, VA 23298 USA.				NIADDK NIH HHS [AM-26127, AM-00677, AM-25675] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM025675] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHUTAMURTHY PN, 1974, CAN J BIOCHEM CELL B, V52, P800, DOI 10.1139/o74-113; ATKIN BM, 1979, PEDIATR RES, V13, P1101, DOI 10.1203/00006450-197910000-00003; ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009; BARDEN RE, 1975, P NATL ACAD SCI USA, V72, P4308, DOI 10.1073/pnas.72.11.4308; BARNES ND, 1970, LANCET, V2, P244; BARTLETT K, 1980, CLIN CHIM ACTA, V100, P183, DOI 10.1016/0009-8981(80)90081-9; BARTLETT K, 1981, J INHERIT METAB DIS, V4, P183, DOI 10.1007/BF02263649; BARTLETT K, 1976, LANCET, V2, P804; BLOM W, 1981, NEW ENGL J MED, V305, P465; BRANDT IK, 1974, PEDIATRICS, V53, P391; BRUNETTE MG, 1972, PEDIATRICS, V50, P702; BUCHANAN PD, 1980, CLIN GENET, V18, P177; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHARLES BM, 1979, LANCET, V2, P118; COWAN MJ, 1979, LANCET, V2, P115; DEVIVO DC, 1977, J CLIN ENDOCR METAB, V45, P1281, DOI 10.1210/jcem-45-6-1281; du Vigneaud V, 1942, J AM CHEM SOC, V64, P188, DOI 10.1021/ja01253a513; DURAN M, 1978, CLIN CHIM ACTA, V82, P93, DOI 10.1016/0009-8981(78)90030-X; FELDMAN GL, 1981, AM J HUM GENET, V33, P692; FELDMAN GL, 1980, BIOCHEM GENET, V18, P617, DOI 10.1007/BF00484405; FELDMAN GL, 1980, PEDIATR RES, V14, P153, DOI 10.1203/00006450-198002000-00017; FELDMAN GL, 1981, CLIN CHIM ACTA, V111, P147, DOI 10.1016/0009-8981(81)90181-9; FINNIE MDA, 1976, CLIN CHIM ACTA, V73, P513, DOI 10.1016/0009-8981(76)90155-8; GIORGIO AJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P487, DOI 10.1016/0005-2744(67)90052-6; GOMPERTZ D, 1973, ARCH DIS CHILD, V48, P975, DOI 10.1136/adc.48.12.975; GOMPERTZ D, 1971, LANCET, V2, P22; GOMPERTZ D, 1975, CLIN GENET, V8, P244; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GROBE H, 1975, ACTA PAEDIATR SCAND, V64, P755, DOI 10.1111/j.1651-2227.1975.tb03916.x; GROVER WD, 1972, J PEDIATR-US, V81, P39, DOI 10.1016/S0022-3476(72)80371-8; HANSEN TL, 1979, J INHERIT METAB DIS, V2, P23; Harris SA, 1943, SCIENCE, V97, P447, DOI 10.1126/science.97.2524.447; Harris SA, 1944, J AM CHEM SOC, V66, P1757, DOI 10.1021/ja01238a042; HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589; HILLMAN RE, 1978, J PEDIATR-US, V92, P439, DOI 10.1016/S0022-3476(78)80441-7; HOMMES FA, 1968, ARCH DIS CHILD, V43, P423, DOI 10.1136/adc.43.230.423; HOMMES FA, 1980, INHERITED DISORDERS, P269; HSIA YE, 1971, J CLIN INVEST, V50, P127, DOI 10.1172/JCI106466; HSIA YE, 1979, PEDIATR RES, V13, P746, DOI 10.1203/00006450-197906000-00005; INOUE H, 1972, J BIOL CHEM, V247, P4825; KALOUSEK F, 1980, J BIOL CHEM, V255, P60; KEETON BR, 1976, ARCH DIS CHILD, V51, P636, DOI 10.1136/adc.51.8.636; KIDD JR, 1980, AM J HUM GENET, V32, P236; KIEN CL, 1981, J PEDIATR-US, V99, P546, DOI 10.1016/S0022-3476(81)80251-X; Kogl F, 1936, H-S Z PHYSIOL CHEM, V242, P43; LANE MD, 1964, J BIOL CHEM, V239, P2865; LANE MD, 1964, J BIOL CHEM, V239, P2858; LAU EP, 1979, P NATL ACAD SCI USA, V76, P214, DOI 10.1073/pnas.76.1.214; LEHNERT W, 1979, EUR J PEDIATR, V132, P107, DOI 10.1007/BF00447377; LEONARD JV, 1981, ARCH DIS CHILD, V56, P53, DOI 10.1136/adc.56.1.53; LEVY HL, 1973, NEW ENGL J MED, V288, P1299; MACKALL JC, 1977, BIOCHEM J, V162, P635, DOI 10.1042/bj1620635; MAESAKA H, 1976, EUR J PEDIATR, V122, P159, DOI 10.1007/BF00466274; MARSAC C, 1982, CLIN CHIM ACTA, V119, P121, DOI 10.1016/0009-8981(82)90412-0; MCKEON C, 1982, BIOCHEM GENET, V20, P77, DOI 10.1007/BF00484937; MCKEON C, 1980, CLIN CHIM ACTA, V101, P217, DOI 10.1016/0009-8981(80)90246-6; Melville DB, 1942, J BIOL CHEM, V146, P0487; Mistry S.P., 1972, BIOCH REV, V43, P1; MOCK DM, 1981, NEW ENGL J MED, V304, P820, DOI 10.1056/NEJM198104023041405; MOOSA A, 1974, ARCH DIS CHILD, V49, P246, DOI 10.1136/adc.49.3.246; MOSS J, 1971, ADV ENZYMOL RAMB, V35, P321; MULLER S, 1980, LANCET, V1, P551; MUNNICH A, 1980, LANCET, V1, P1080; MUNNICH A, 1981, LANCET, V2, P263; MUNNICH A, 1981, J INHERIT METAB DIS, V4, P113, DOI 10.1007/BF02263616; MUNNICH A, 1981, EUR J PEDIATR, V137, P203; MURPHY JV, 1981, PEDIATRICS, V68, P401; MURTHY PNA, 1977, PROG FOOD NUTR SCI, V2, P405; MURTHY PNA, 1974, P SOC EXP BIOL MED, V147, P114; PACKMAN S, 1981, J PEDIATR-US, V99, P418, DOI 10.1016/S0022-3476(81)80333-2; PACKMAN S, 1981, J PEDIATR-US, V99, P421, DOI 10.1016/S0022-3476(81)80334-4; PACKMAN S, 1981, AM J HUM GENET, V33, pA51; PACKMAN S, UNPUB PRENATAL TREAT; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROTH K, 1976, J PEDIATR-US, V88, P229, DOI 10.1016/S0022-3476(76)80987-0; ROTH K, 1981, METABOLISM CLIN IMPL, P411; ROTH KS, 1980, J PEDIATR-US, V96, P845, DOI 10.1016/S0022-3476(80)80554-3; SANDER JE, 1980, ANN NEUROL, V8, P544, DOI 10.1002/ana.410080514; SAUDUBRAY JM, 1976, ACTA PAEDIATR SCAND, V65, P717, DOI 10.1111/j.1651-2227.1976.tb04960.x; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; SHAFAI T, 1978, J PEDIATR-US, V92, P84, DOI 10.1016/S0022-3476(78)80081-X; STOKKE O, 1972, PEDIATRICS, V49, P726; SWEETMAN L, 1977, PEDIATR RES, V11, P1144, DOI 10.1203/00006450-197711000-00006; SWEETMAN L, 1979, JAMA-J AM MED ASSOC, V242, P1048, DOI 10.1001/jama.242.10.1048; SWEETMAN L, 1981, J INHERIT METAB DIS, V4, P53, DOI 10.1007/BF02263587; SWEETMAN L, 1981, PEDIATRICS, V68, P553; SWEETMAN L, 1978, BIOMED MASS SPECTROM, V5, P198, DOI 10.1002/bms.1200050307; TADA K, 1978, EUR J PEDIATR, V127, P141, DOI 10.1007/BF00445770; TADA K, 1973, TOHOKU J EXP MED, V109, P13, DOI 10.1620/tjem.109.13; TANABE T, 1975, EUR J BIOCHEM, V57, P15, DOI 10.1111/j.1432-1033.1975.tb02272.x; TANG TT, 1972, J PEDIATR-US, V81, P189, DOI 10.1016/S0022-3476(72)80428-1; THOENE J, 1981, NEW ENGL J MED, V304, P817, DOI 10.1056/NEJM198104023041404; TRUSCOTT RJW, 1979, BIOMED MASS SPECTROM, V6, P294, DOI 10.1002/bms.1200060706; Utter M F, 1980, Birth Defects Orig Artic Ser, V16, P289; VAGELOS PR, 1963, J BIOL CHEM, V238, P533; VANBIERVLIET JPGM, 1977, DEV MED CHILD NEUROL, V19, P392; VANLEEUWEN GH, 1981, AM J HUM GENET, V33, pA58; VIDAILHET M, 1981, J INHERIT METAB DIS, V4, P131, DOI 10.1007/BF02263625; WEYLER W, 1977, CLIN CHIM ACTA, V76, P321, DOI 10.1016/0009-8981(77)90158-9; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; WOLF B, 1978, J PEDIATR-US, V93, P471, DOI 10.1016/S0022-3476(78)81167-6; WOLF B, 1980, EXP CELL RES, V125, P502, DOI 10.1016/0014-4827(80)90147-0; WOLF B, 1981, PEDIATRICS, V68, P113; WOLF B, 1980, AM J HUM GENET, V32, P16; WOLF B, 1978, J CLIN INVEST, V62, P931, DOI 10.1172/JCI109221; WOLF B, 1979, BIOCHEM GENET, V17, P703, DOI 10.1007/BF00502128; WOLF B, 1978, AM J HUM GENET, V30, P455; WOLF B, 1979, J PEDIATR-US, V95, P563, DOI 10.1016/S0022-3476(79)80768-4; WOOD HG, 1977, ANNU REV BIOCHEM, V46, P385, DOI 10.1146/annurev.bi.46.070177.002125; YOSHIDA T, 1969, TOHOKU J EXP MED, V99, P121, DOI 10.1620/tjem.99.121; YOSHIDA T, 1970, TOHOKU J EXP MED, V101, P375, DOI 10.1620/tjem.101.375	112	120	122	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					699	716						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	6127031				2022-12-18	WOS:A1982PH24200003
J	GOODPASTURE, C; BLOOM, SE; HSU, TC; ARRIGHI, FE				GOODPASTURE, C; BLOOM, SE; HSU, TC; ARRIGHI, FE			HUMAN NUCLEOLUS ORGANIZERS - SATELLITES OR STALKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CANC CTR,DEPT BIOL,HOUSTON,TX 77030; CORNELL UNIV,DEPT POULTRY SCI,ITHACA,NY 14853	University of Texas System; UTMD Anderson Cancer Center; Cornell University								BLOOM SR, IN PRESS; DENTON TE, 1976, CHROMOSOMA, V55, P81, DOI 10.1007/BF00288330; DEV VG, 1971, CYTOGENETICS, V10, P436, DOI 10.1159/000130164; ELSEVIER SM, 1975, CHROMOSOMA, V52, P219, DOI 10.1007/BF00332112; EVANS HJ, 1974, CHROMOSOMA, V48, P405, DOI 10.1007/BF00290996; FERGUSONSMITH MA, 1961, LANCET, V2, P126; FUNAKI K, 1975, CHROMOSOMA, V49, P357, DOI 10.1007/BF00285128; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HENDERSON AS, 1974, CHROMOSOMA, V49, P155, DOI 10.1007/BF00348887; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; HOWELL WM, 1975, EXPERIENTIA, V31, P260, DOI 10.1007/BF01990741; HSU TC, 1975, CHROMOSOMA, V53, P25, DOI 10.1007/BF00329388; LAU YF, 1976, CYTOGENET CELL GENET, V17, P51, DOI 10.1159/000130687; MATSUI SI, 1973, NATURE, V246, P148, DOI 10.1038/246148a0; OHNO S, 1961, LANCET, V2, P123; PARDUE ML, 1975, J CELL BIOL, V64, P251, DOI 10.1083/jcb.64.1.251; 1966, BIRTH DEFECTS OAS	17	120	121	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	6					559	566						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ152	64114				2022-12-18	WOS:A1976CQ15200003
J	TASHIAN, RE				TASHIAN, RE			GENETIC VARIATION AND EVOLUTION OF CARBOXYLIC ESTERASES AND CARBONIC ANHYDRASES OF PRIMATE ERYTHROCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALDRIDGE WN, 1953, BIOCHEM J, V53, P110, DOI 10.1042/bj0530110; ARFORS KE, 1963, ACTA GENET STAT MED, V13, P226; AUGUSTINSSON K, 1961, ANN NY ACAD SCI, V94, P844, DOI 10.1111/j.1749-6632.1961.tb35578.x; BARNICOT NA, 1964, NATURE, V202, P199; BERGMANN F, 1957, BIOCHEM J, V67, P481, DOI 10.1042/bj0670481; BOYER PD, 1960, ENZYMES           ED, V4, P485; BOYER PD, 1960, ENZYMES           ED, V4, P475; Buettner-Janusch J., 1962, Annals of the New York Academy of Sciences, V102, P181; BUETTNERJANUSCH J, 1964, EVOLUTIONARY GENETIC, V2; BURSTONE MS, 1961, ENZYME HISTOCHEMISTR, P539; CAHN RD, 1962, SCIENCE, V136, P962, DOI 10.1126/science.136.3520.962; CHU EHY, 1962, ANN NY ACAD SCI, V102, P253, DOI 10.1111/j.1749-6632.1962.tb13644.x; FINE JM, 1963, NATURE, V200, P371, DOI 10.1038/200371a0; Goodman M., 1963, CLASSIFICATION HUMAN, P204, DOI DOI 10.1002/evan.10110; HILL RL, 1963, P NATL ACAD SCI USA, V50, P885, DOI 10.1073/pnas.50.5.885; HOFSTEE BHJ, 1960, ENZYMES, V4, P485; HUNTER RL, 1957, SCIENCE, V125, P1294, DOI 10.1126/science.125.3261.1294-a; INGRAM VM, 1961, NATURE, V189, P704, DOI 10.1038/189704a0; KASHA M, 1962, HORIZONS BIOCHEMI ED, P189; KLINGER HP, 1963, CLASSIFICATION HUMAN, P235; LAURENT G, 1963, BIOCHIM BIOPHYS ACTA, V77, P518, DOI 10.1016/0006-3002(63)90534-1; MICHELI A, 1964, BIOCHIM BIOPHYS ACTA, V89, P324, DOI 10.1016/0926-6569(64)90221-4; MYERS DK, 1960, ENZYMES, V4, P475; NYMAN PO, 1964, BIOCHIM BIOPHYS ACTA, V85, P141, DOI 10.1016/0926-6569(64)90174-9; PEARSE AGE, 1961, HISTOCHEMISTRY THEOR, P456; RICKLI EE, 1964, J BIOL CHEM, V239, P1065; RIEDER RF, 1964, NATURE, V203, P1364, DOI 10.1038/2031364a0; SHAW CR, 1963, P NATL ACAD SCI USA, V50, P211, DOI 10.1073/pnas.50.2.211; SHAW CR, 1962, SCIENCE, V138, P31, DOI 10.1126/science.138.3536.31; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; Sokal R, 1963, PRINCIPLES NUMERICAL; TASHIAN RE, 1963, SCIENCE, V140, P53, DOI 10.1126/science.140.3562.53; TASHIAN RE, 1961, P SOC EXP BIOL MED, V108, P364; TASHIAN RE, 1962, AM J HUM GENET, V14, P295; TASHIAN RE, 1964, BIOCHEM BIOPH RES CO, V14, P256, DOI 10.1016/0006-291X(64)90445-0; TASHIAN RE, 1963, 11 P INT C GEN, V1, P271; Washburn S.L., 1963, CLASSIFICATION HUMAN; WASHBURN SL, 1963, CLASSIFICATION HU ED, P235; WASHBURN SL, 1963, CLASSIFICATION HU ED, P204; WROBLEWSKI F, 1961, ANN NY ACAD SCI, V94, P665; ZUCKERKA.E, 1961, NATURE, V192, P984, DOI 10.1038/192984a0; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349; Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477	43	120	122	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					257	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295494				2022-12-18	WOS:A19656521900006
J	Boycott, KM; Beaulieu, CL; Kernohan, KD; Gebril, OH; Mhanni, A; Chudley, AE; Redl, D; Qin, W; Hampson, S; Kury, S; Tetreault, M; Puffenberger, EG; Scott, JN; Bezieau, S; Reis, A; Uebe, S; Schumacher, J; Hegele, RA; McLeod, DR; Galvez-Peralta, M; Majewski, J; Ramaekers, VT; Nebert, DW; Innes, AM; Parboosingh, JS; Abou Jamra, R				Boycott, Kym M.; Beaulieu, Chandree L.; Kernohan, Kristin D.; Gebril, Ola H.; Mhanni, Aziz; Chudley, Albert E.; Redl, David; Qin, Wen; Hampson, Sarah; Kuery, Sebastien; Tetreault, Martine; Puffenberger, Erik G.; Scott, James N.; Bezieau, Stephane; Reis, Andre; Uebe, Steffen; Schumacher, Johannes; Hegele, Robert A.; McLeod, D. Ross; Galvez-Peralta, Marina; Majewski, Jacek; Ramaekers, Vincent T.; Nebert, Daniel W.; Innes, A. Micheil; Parboosingh, Jillian S.; Abou Jamra, Rami		Care4Rare Canada Consortium	Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUTTERITE POPULATION; IDENTIFICATION; DEFICIENCY; ELEMENTS; FAMILY; ZIP8	Manganese (Mn) and zinc (Zn) are essential divalent cations used by cells as protein cofactors; various human studies and animal models have demonstrated the importance of Mn and Zn for development. Here we describe an autosomal-recessive disorder in six individuals from the Hutterite community and in an unrelated Egyptian sibpair; the disorder is characterized by intellectual disability, developmental delay, hypotonia, strabismus, cerebellar atrophy, and variable short stature. Exome sequencing in one affected Hutterite individual and the Egyptian family identified the same homozygous variant, c.112G>C (p.Gly38Arg), affecting a conserved residue of SLC39A8. The affected Hutterite and Egyptian individuals did not share an extended common haplotype, suggesting that the mutation arose independently. SLC39A8 is a member of the solute carrier gene family known to import Mn, Zn, and other divalent cations across the plasma membrane. Evaluation of these two metal ions in the affected individuals revealed variably low levels of Mn and Zn in blood and elevated levels in urine, indicating renal wasting. Our findings identify a human Mn and Zn transporter deficiency syndrome linked to SLC39A8, providing insight into the roles of Mn and Zn homeostasis in human health and development.	[Boycott, Kym M.; Beaulieu, Chandree L.; Kernohan, Kristin D.; Qin, Wen; Hampson, Sarah] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Gebril, Ola H.] Natl Res Ctr, El Bohoth St, Giza 12622, Egypt; [Mhanni, Aziz; Chudley, Albert E.] Univ Manitoba, Childrens Hosp, Sect Genet & Metab, Winnipeg, MB R3A 1S1, Canada; [Mhanni, Aziz; Chudley, Albert E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada; [Redl, David; McLeod, D. Ross; Innes, A. Micheil; Parboosingh, Jillian S.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Kuery, Sebastien; Bezieau, Stephane] CHU Nantes, Dept Med Genet, F-44093 Nantes, France; [Tetreault, Martine; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Puffenberger, Erik G.] Clin Special Children, Strasburg, PA 17579 USA; [Scott, James N.] Foothills Prov Gen Hosp, Dept Radiol, Calgary, AB T2N 2T9, Canada; [Reis, Andre; Uebe, Steffen; Abou Jamra, Rami] FAU Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Schumacher, Johannes] Univ Bonn, Inst Human Genet, D-53012 Bonn, Germany; [Hegele, Robert A.] Robarts Res Inst, London, ON N6A 5B7, Canada; [Hegele, Robert A.] Univ Western Ontario, London, ON N6A 5B7, Canada; [Galvez-Peralta, Marina; Nebert, Daniel W.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Ramaekers, Vincent T.] Ctr Hosp Univ, Dept Paediat Neurol, B-4032 Liege, Belgium; [Nebert, Daniel W.] Cincinnati Childrens Hosp, Dept Pediat & Mol Dev Biol, Div Human Genet, Cincinnati, OH 45229 USA	University of Ottawa; Children's Hospital of Eastern Ontario; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Calgary; Nantes Universite; CHU de Nantes; McGill University; University of Calgary; University of Erlangen Nuremberg; University of Bonn; Western University (University of Western Ontario); Western University (University of Western Ontario); University System of Ohio; University of Cincinnati; University of Liege; Cincinnati Children's Hospital Medical Center	Boycott, KM (corresponding author), Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada.	kboycott@cheo.on.ca; rami.aboujamra@medizin.uni-leipzig.de	Schumacher, Johannes/F-4970-2015; Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011; Abou Jamra, Rami/AAC-8192-2019; Jamra, Rami Abou/I-4805-2015; innes, allan micheil/A-9955-2017; Reis, André/D-2309-2009; KÜRY, Sébastien/G-5971-2015	Schumacher, Johannes/0000-0001-9217-6457; Hegele, Robert/0000-0003-2861-5325; Abou Jamra, Rami/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Reis, André/0000-0002-6301-6363; KÜRY, Sébastien/0000-0001-5497-0465; Puffenberger, Erik/0000-0002-6388-9148; Innes, Micheil/0000-0001-9881-5467; Gebril, Ola/0000-0001-7194-1711	Care4Rare Canada Consortium (Enhanced Care for Rare Genetic Diseases in Canada) - Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; DFG [AB393/2-2, AB393/4-1]; Alberta Children's Hospital Foundation; CIHR Training Program in Genetics, Child Development, and Health at the University of Calgary; NIH [R01 ES010416, T32 ES016646, P30 ES006096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES010416, T32ES016646] Funding Source: NIH RePORTER	Care4Rare Canada Consortium (Enhanced Care for Rare Genetic Diseases in Canada) - Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; DFG(German Research Foundation (DFG)); Alberta Children's Hospital Foundation; CIHR Training Program in Genetics, Child Development, and Health at the University of Calgary(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the families for their enthusiastic participation in this study. We gratefully acknowledge Jackie Morris and Linda MacLaren for clinical support and Dr. Brian Lowry for the initial clinical investigation of individual 2. The authors wish to acknowledge the contribution of the high throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre and of FAU Erlangen-Nurnberg. This work was supported by the Care4Rare Canada Consortium (Enhanced Care for Rare Genetic Diseases in Canada) funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, Children's Hospital of Eastern Ontario Foundation, Alberta Children's Hospital Research Institute, and Alberta Innovates Health Solutions. This project was also supported in part through funding of DFG (AB393/2-2 and AB393/4-1) to R.A.J. and A.R. and from the Alberta Children's Hospital Foundation to J.S.P. D.R.M. was supported by the CIHR Training Program in Genetics, Child Development, and Health at the University of Calgary. Work from Cincinnati was supported by NIH grants R01 ES010416 (D.W.N.), T32 ES016646 (M.G.-P.), and P30 ES006096 (D.W.N.). The project was selected for analysis by the Care4Rare Consortium Gene Discovery Steering Committee, consisting of K.M.B. (lead; University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa), J.M. (McGill University), Michael Brudno (University of Toronto), Dennis Bulman (University of Ottawa), and David Dyment (University of Ottawa).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Boycott KM, 2008, AM J MED GENET A, V146A, P1088, DOI 10.1002/ajmg.a.32245; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; ERWAY L, 1970, J NUTR, V100, P643, DOI 10.1093/jn/100.6.643; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Filipov NM, 2012, J APPL TOXICOL, V32, P310, DOI 10.1002/jat.1762; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Haberle J, 2006, J INHERIT METAB DIS, V29, P352, DOI 10.1007/s10545-006-0256-5; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; He Lei, 2009, Human Genomics, V3, P195; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; McDonald-McGinn DM, 2013, J MED GENET, V50, P80, DOI 10.1136/jmedgenet-2012-101320; Morris SM, 2012, CURR OPIN CLIN NUTR, V15, P64, DOI 10.1097/MCO.0b013e32834d1a08; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Ng E, 2015, HUM MOL GENET, V24, P4739, DOI 10.1093/hmg/ddv190; Nimgaonkar VL, 2000, AM J PSYCHIAT, V157, P1065, DOI 10.1176/appi.ajp.157.7.1065; Pennington JAT, 1996, INT J VITAM NUTR RES, V66, P350; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284	37	119	122	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					886	893		10.1016/j.ajhg.2015.11.002	http://dx.doi.org/10.1016/j.ajhg.2015.11.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637978	Green Published, Bronze			2022-12-18	WOS:000368437900011
J	Dyment, DA; Smith, AC; Alcantara, D; Schwartzentruber, JA; Basel-Vanagaite, L; Curry, CJ; Temple, IK; Reardon, W; Mansour, S; Haq, MR; Gilbert, R; Lehmann, OJ; Vanstone, MR; Beaulieu, CL; Majewski, J; Bulman, DE; O'Driscoll, M; Boycott, KM; Innes, AM				Dyment, David A.; Smith, Amanda C.; Alcantara, Diana; Schwartzentruber, Jeremy A.; Basel-Vanagaite, Lina; Curry, Cynthia J.; Temple, I. Karen; Reardon, William; Mansour, Sahar; Haq, Mushfequr R.; Gilbert, Rodney; Lehmann, Ordan J.; Vanstone, Megan R.; Beaulieu, Chandree L.; Majewski, Jacek; Bulman, Dennis E.; O'Driscoll, Mark; Boycott, Kym M.; Innes, A. Micheil		FORGE Canada Consortium	Mutations in PIK3R1 Cause SHORT Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOINOSITIDE 3-KINASE; INSULIN-RESISTANCE; P85-ALPHA SUBUNIT; SEQUENCING DATA; MICE LACKING; HYPOGLYCEMIA; VARIANTS; PITX2	SHORT syndrome is a rare, multisystem disease characterized by short stature, anterior-chamber eye anomalies, characteristic facial features, lipodystrophy, hernias, hyperextensibility, and delayed dentition. As part of the FORGE (Finding of Rare Disease Genes) Canada Consortium, we studied individuals with clinical features of SHORT syndrome to identify the genetic etiology of this rare disease. Whole-exome sequencing in a family trio of an affected child and unaffected parents identified a de novo frameshift insertion, c.1906_1907insC (p.Asn636Thrfs*18), in exon 14 of PIK3R1. Heterozygous mutations in exon 14 of PIK3R1 were subsequently identified by Sanger sequencing in three additional affected individuals and two affected family members. One of these mutations, c.1945C>T (p.Arg649Trp), was confirmed to be a de novo mutation in one affected individual and was also identified and shown to segregate with the phenotype in an unrelated family. The other mutation, a de novo truncating mutation (c.1971T>G [p.Tyr657*]), was identified in another affected individual. PIK3R1 is involved in the phosphatidylinositol 3 kinase (PI3K) signaling cascade and, as such, plays an important role in cell growth, proliferation, and survival. Functional studies on lymphoblastoid cells with the PIK3R1 c.1906_1907insC mutation showed decreased phosphorylation of the downstream S6 target of the PI3K-AKT-mTOR pathway. Our findings show that PIK3R1 mutations are the major cause of SHORT syndrome and suggest that the molecular mechanism of disease might involve down-regulation of the PI3K-AKT-mTOR pathway.	[Dyment, David A.; Boycott, Kym M.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Smith, Amanda C.; Vanstone, Megan R.; Beaulieu, Chandree L.; Bulman, Dennis E.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Alcantara, Diana; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Schwartzentruber, Jeremy A.; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy A.; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, Dept Pediat Genet, IL-49100 Petah Tiqwa, Israel; [Curry, Cynthia J.] Genet Med Cent Calif, Fresno, CA 93701 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 93701 USA; [Temple, I. Karen] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [Temple, I. Karen] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Reardon, William] Our Ladys Hosp Sick Children, Dublin 12, Ireland; [Mansour, Sahar] St George Hosp, Sch Med, South West Thames Reg Genet Serv, London SW17 0RE, England; [Haq, Mushfequr R.; Gilbert, Rodney] Univ Hosp Southampton NHS Fdn Mist, Southampton Childrens Hosp, Dept Paediat Nephrol, Southampton SO16 6YD, Hants, England; [Lehmann, Ordan J.] Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada; [Innes, A. Micheil] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Innes, A. Micheil] Univ Calgary, Res Inst Child & Maternal Hlth, Alberta Childrens Hosp, Calgary, AB T2N 4N1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Sussex; McGill University; University of California System; University of California San Francisco; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Our Ladys Children Hospital Crumlin; St Georges University London; University of Alberta; University of Calgary; Alberta Childrens Hospital; University of Calgary	Dyment, DA (corresponding author), Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada.	ddyment@cheo.on.ca; micheil.innes@alberthealthservices.ca	Scherer, Stephen W./B-3785-2013; temple, isabel K/K-2391-2015; innes, allan micheil/A-9955-2017	Scherer, Stephen W./0000-0002-8326-1999; O'Driscoll, Mark/0000-0003-2765-316X; Reardon, Willie/0000-0001-7329-9179; Alcantara, Diana/0000-0003-3185-1548; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Innes, Micheil/0000-0001-9881-5467; Gilbert, Rodney/0000-0001-7426-0188; Temple, Isabel Karen/0000-0002-6045-1781; Schwartzentruber, Jeremy/0000-0002-6183-2092	Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; CR-UK; Medical Research Council (UK); Leukaemia Lymphoma Research (UK); CIHR; CIHR from the Institute of Genetics; Cancer Research UK [15394] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; CR-UK(Cancer Research UK); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research (UK); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR from the Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would firstly like to thank the study participants and their families without their participation, this work would not have been possible. This work was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. M.O.D. is a Senior Cancer Research UK (CR-UK) Fellow whose lab is supported by CR-UK, the Medical Research Council (UK), and Leukaemia Lymphoma Research (UK). A.C.S. is supported by a CIHR postdoctoral fellowship. D.A.D and K.M.B are the recipients of a CIHR Clinical Investigator award from the Institute of Genetics. This work was selected for study by the FORGE Canada Steering Committee, consisting of K.M.B., J. Friedman, J. Michaud, E Bernier, M. Brudno, B. Fernandez, B. Knoppers, M. Samuels, and S. Scherer.	AARSKOG D, 1983, AM J MED GENET, V15, P29, DOI 10.1002/ajmg.1320150104; BANKIER A, 1995, CLIN DYSMORPHOL, V4, P304, DOI 10.1097/00019605-199510000-00005; Baynes KCR, 2000, DIABETOLOGIA, V43, P321, DOI 10.1007/s001250050050; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Brodsky MC, 1996, ARCH OPHTHALMOL-CHIC, V114, P1146, DOI 10.1001/archopht.1996.01100140348022; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Gorlin R J, 1975, Birth Defects Orig Artic Ser, V11, P39; Haan E, 1998, CLIN DYSMORPHOL, V7, P103, DOI 10.1097/00019605-199804000-00004; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Karadeniz NN, 2004, AM J MED GENET A, V130A, P406, DOI 10.1002/ajmg.a.30206; Koenig R, 2003, CLIN DYSMORPHOL, V12, P45, DOI 10.1097/00019605-200301000-00008; Lappalainen K, 2008, PROTEINS, V72, P779, DOI 10.1002/prot.21970; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lines MA, 2004, INVEST OPHTH VIS SCI, V45, P828, DOI 10.1167/iovs.03-0309; LIPSON AH, 1989, J MED GENET, V26, P473, DOI 10.1136/jmg.26.7.473; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Reardon W, 2008, AM J MED GENET A, V146A, P1296, DOI 10.1002/ajmg.a.32250; Reis L, 2011, HUM GENET, V130, P495, DOI 10.1007/s00439-011-0968-y; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; SCHWINGSHANDL J, 1993, AM J MED GENET, V47, P907, DOI 10.1002/ajmg.1320470619; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Sorge G, 1996, AM J MED GENET, V61, P178, DOI 10.1002/(SICI)1096-8628(19960111)61:2<178::AID-AJMG16>3.0.CO;2-R; Srour M, 2012, J MED GENET, V49, P636, DOI 10.1136/jmedgenet-2012-101132; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	31	119	126	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					158	166		10.1016/j.ajhg.2013.06.005	http://dx.doi.org/10.1016/j.ajhg.2013.06.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23810382	Green Published, hybrid			2022-12-18	WOS:000321804500016
J	Saitsu, H; Tohyama, J; Kumada, T; Egawa, K; Hamada, K; Okada, I; Mizuguchi, T; Osaka, H; Miyata, R; Furukawa, T; Haginoya, K; Hoshino, H; Goto, T; Hachiya, Y; Yamagata, T; Saitoh, S; Nagai, T; Nishiyama, K; Nishimura, A; Miyake, N; Komada, M; Hayashi, K; Hirai, S; Ogata, K; Kato, M; Fukuda, A; Matsumoto, N				Saitsu, Hirotomo; Tohyama, Jun; Kumada, Tatsuro; Egawa, Kiyoshi; Hamada, Keisuke; Okada, Ippei; Mizuguchi, Takeshi; Osaka, Hitoshi; Miyata, Rie; Furukawa, Tomonori; Haginoya, Kazuhiro; Hoshino, Hideki; Goto, Tomohide; Hachiya, Yasuo; Yamagata, Takanori; Saitoh, Shinji; Nagai, Toshiro; Nishiyama, Kiyomi; Nishimura, Akira; Miyake, Noriko; Komada, Masayuki; Hayashi, Kenji; Hirai, Syu-ichi; Ogata, Kazuhiro; Kato, Mitsuhiro; Fukuda, Atsuo; Matsumoto, Naomichi			Dominant-Negative Mutations in alpha-II Spectrin Cause West Syndrome with Severe Cerebral Hypomyelination, Spastic Quadriplegia, and Developmental Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OHTAHARA-SYNDROME; ANKYRIN-G; MEMBRANE; NODES	A de novo 9q33.3-q34.11 microdeletion involving STX8P1 has been found in one of four individuals (group A) with early-onset West syndrome, severe hypomyelination, poor visual attention, and developmental delay. Although haploinsufficiency of STXBP1 was involved in early infantile epileptic encephalopathy in a previous different cohort study (group B), no mutations of SIXBP1 were found in two of the remaining three subjects of group A (one was unavailable), We assumed that another gene within the deletion might contribute to the phenotype of group A. SPTAN1 encoding alpha-II spectrin, which is essential for proper myelination in zebratish, turned out to be deleted. In two subjects, an in-frame 3 bp deletion and a 6 bp duplication in SHAN1 were found at the initial nucleation site of the alpha/beta spectrin heterodimer. SPTAN1 was further screened in six unrelated individuals with WS and hypomyelination, but no mutations were found. Recombinant mutant (mut) and wild-type (WT) alpha-II spectrin could assemble heterodimers with beta-II spectrin, but alpha-II (mut)/beta-II spectrin heterodimers were thermolabile compared with the alpha-II (WT)/beta-II heterodimers. Transient expression in mouse cortical neurons revealed aggregation of alpha-II (mut)/beta-II and alpha-II (mut)/beta-III spectrin heterodimers, which was also observed in lymphoblastoid cells from two subjects with in-frame mutations. Clustering of ankyrinG and voltage-gated sodium channels at axon initial segment (AIS) was disturbed in relation to the aggregates, together with an elevated action potential threshold. These findings suggest that pathological aggregation of alpha/beta spectrin heterodimers and abnormal AIS integrity resulting from SPTAN1 mutations were involved in pathogenesis of infantile epilepsy.	[Saitsu, Hirotomo; Okada, Ippei; Mizuguchi, Takeshi; Nishiyama, Kiyomi; Nishimura, Akira; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Pediat, Epilepsy Ctr, Nishi Ku, Niigata 9502085, Japan; [Kumada, Tatsuro; Egawa, Kiyoshi; Furukawa, Tomonori; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan; [Hamada, Keisuke; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Clin Res Inst, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Miyata, Rie] Tokyo Kita Shakai Hoken Hosp, Dept Pediat, Kita Ku, Tokyo 1150053, Japan; [Haginoya, Kazuhiro] Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Hoshino, Hideki] Natl Ctr Child Hlth & Dev, Div Neurol, Setagaya Ku, Tokyo 1578535, Japan; [Goto, Tomohide] Tokyo Metropolitan Childrens Med Ctr, Dept Neurol, Fuchu, Tokyo 1838561, Japan; [Hachiya, Yasuo] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Fuchu, Tokyo 1830042, Japan; [Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan; [Saitoh, Shinji] Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hayashi, Kenji; Hirai, Syu-ichi] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kato, Mitsuhiro] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 9909585, Japan	Yokohama City University; Hamamatsu University School of Medicine; Yokohama City University; Tohoku University; National Center for Child Health & Development - Japan; Tokyo Metropolitan Children's Medical Center; Tokyo Metropolitan Institute for Neuroscience; Jichi Medical University; Hokkaido University; Dokkyo Medical University; Tokyo Institute of Technology; Yokohama City University; Yamagata University	Saitsu, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021; Furukawa, Tomonori/G-7014-2014; Fukuda, Atsuo/ABA-6843-2020; Kumada, Tatsuro/AAY-9117-2020	Fukuda, Atsuo/0000-0001-7112-4834; Kato, Mitsuhiro/0000-0003-1485-8553; Saitsu, Hirotomo/0000-0003-0723-0960; Saitoh, Shinji/0000-0001-6911-3351; Goto, Tomohide/0000-0002-5791-4837	Ministry of Health, Labour, and Welfare; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Yokohama Foundation for Advancement of Medical Science; Uehara Memorial Foundation; Japan Epilepsy Research Foundation; Yokohama City University; Naito Foundation	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama Foundation for Advancement of Medical Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Epilepsy Research Foundation; Yokohama City University; Naito Foundation(Naito Memorial Foundation)	The authors declare no conflict of interest. We would like to thank all the patients and their families for their participation in this study. We also thank Dr. Jun-ichi Miyazaki for permitting use of CAG promoter and Dr. Sean Megason for the pCIG vector. This work was supported by research grants from the Ministry of Health, Labour, and Welfare (N.M., J.T., and M. Kato), the Japan Science and Technology Agency (N.M.), a Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain disorder) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (N.M.), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (N.M. and M. Kato), a Grant-in-Aid for Young Scientist from Japan Society for the Promotion of Science (H.S.), the Research Promotion Fund from Yokohama Foundation for Advancement of Medical Science (H.S.), the Research Promotion Fund from the Uehara Memorial Foundation (H.S.), research grants from the Japan Epilepsy Research Foundation (H.S.), a grant from the 2009 Strategic Research Project of Yokohama City University (H.S.), and a research grant from the Naito Foundation (N.M.). This work has been done at Advanced Medical Research Center, Yokohama City University	Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Djukic A, 2006, EPILEPSY RES, V70, pS68, DOI 10.1016/j.eplepsyres.2005.11.022; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2006, EPILEPSY RES, V70, pS87, DOI 10.1016/j.eplepsyres.2006.02.008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Meary F, 2007, J BIOL CHEM, V282, P14226, DOI 10.1074/jbc.M700028200; Megason SG, 2002, DEVELOPMENT, V129, P2087; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Tohyama J, 2008, BRAIN DEV-JPN, V30, P349, DOI 10.1016/j.braindev.2007.10.006; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Xu JL, 2001, BRAIN RES, V898, P171, DOI 10.1016/S0006-8993(01)02156-4	29	119	125	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					881	891		10.1016/j.ajhg.2010.04.013	http://dx.doi.org/10.1016/j.ajhg.2010.04.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20493457	Green Published, Bronze			2022-12-18	WOS:000278948900006
J	Biason-Lauber, A; Konrad, D; Meyer, M; DeBeaufort, C; Schoenle, EJ				Biason-Lauber, Anna; Konrad, Daniel; Meyer, Monika; DeBeaufort, Carine; Schoenle, Eugen J.			Ovaries and Female Phenotype in a Girl with 46,XY Karyotype and Mutations in the CBX2 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCOMB-GROUP GENE; SEX DETERMINATION; RESPONSE ELEMENTS; DROSOPHILA; EXPRESSION; DIFFERENTIATION; ACTIVATION; REVERSAL; MOUSE; SOX9	A girl with a prenatal 46,XY karyotype was born with a completely normal female phenotype, including uterus and histologically normal ovaries. In mice with a similar phenotype, the ablation of M33, an ortholog of Drosophila Polycomb, causes male-to-female sex reversal. The analysis of the human homolog of M33, Chromobox homolog 2 (CBX2), in this girl revealed loss-of-function mutations that allowed us, by placing CBX2 upstream of SRY, to add an additional component to the still incomplete cascade of human sex development.	[Biason-Lauber, Anna; Konrad, Daniel; Meyer, Monika; Schoenle, Eugen J.] Univ Childrens Hosp, Div Endocrinol Diabetol, Toronto, ON, Canada; [Biason-Lauber, Anna; Konrad, Daniel; Schoenle, Eugen J.] Zurich Ctr Integrat Human Physiol, CH-8032 Zurich, Switzerland; [DeBeaufort, Carine] Clin Pediat Luxembourg, Div Pediat Endocrinol, L-1210 Luxembourg, Luxembourg	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Biason-Lauber, A (corresponding author), Univ Childrens Hosp, Div Endocrinol Diabetol, Toronto, ON, Canada.	anna.lauber@kispi.uzh.ch	de Beaufort, Carine/AAJ-8063-2021	de Beaufort, Carine/0000-0003-4310-6799; Konrad, Daniel/0000-0001-9067-4356	University of Zurich [54181801]; Swiss National Science Foundation [32-116636]	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Research Grant of the University of Zurich (54181801) and Grant 32-116636 of the Swiss National Science Foundation. We thank Christiane Donner, Rene Scheiden, Annemarie Tanous, and Paul Philippe for their contribution in the clinical characterization of the patient and Serdar E. Bulun for the generous gift of the SF1 promoter constructs. The authors deny any conflict of interest.	Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; CUI KH, 1994, LANCET, V343, P79, DOI 10.1016/S0140-6736(94)90815-X; FAUVARQUE MO, 1995, MECH DEVELOP, V52, P343, DOI 10.1016/0925-4773(95)00412-T; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Katoh-Fukui Y, 2005, BLOOD, V106, P1612, DOI 10.1182/blood-2004-08-3367; Kent J, 1996, DEVELOPMENT, V122, P2813; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; WEDEEN C, 1986, CELL, V44, P739, DOI 10.1016/0092-8674(86)90840-8; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494	24	119	129	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					658	663		10.1016/j.ajhg.2009.03.016	http://dx.doi.org/10.1016/j.ajhg.2009.03.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19361780	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000266338800010
J	Hammond, P; Hutton, TJ; Allanson, JE; Buxton, B; Campbell, LE; Smith, JC; Donnai, D; Smith, AK; Metcalfe, K; Murphy, KC; Patton, M; Pober, B; Prescott, K; Scambler, P; Shaw, A; Smith, ACM; Stevens, AF; Temple, IK; Hennekam, R; Tassabehji, M				Hammond, P; Hutton, TJ; Allanson, JE; Buxton, B; Campbell, LE; Smith, JC; Donnai, D; Smith, AK; Metcalfe, K; Murphy, KC; Patton, M; Pober, B; Prescott, K; Scambler, P; Shaw, A; Smith, ACM; Stevens, AF; Temple, IK; Hennekam, R; Tassabehji, M			Discriminating power of localized three-dimensional facial morphology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; BARDET-BIEDL-SYNDROME; NOONAN-SYNDROME; PHENOTYPE; FACE; GENE; MUTATIONS; GROWTH; TBX1	Many genetic syndromes involve a facial gestalt that suggests a preliminary diagnosis to an experienced clinical geneticist even before a clinical examination and genotyping are undertaken. Previously, using visualization and pattern recognition, we showed that dense surface models (DSMs) of full face shape characterize facial dysmorphology in Noonan and in 22q11 deletion syndromes. In this much larger study of 696 individuals, we extend the use of DSMs of the full face to establish accurate discrimination between controls and individuals with Williams, Smith-Magenis, 22q11 deletion, or Noonan syndromes and between individuals with different syndromes in these groups. However, the full power of the DSM approach is demonstrated by the comparable discriminating abilities of localized facial features, such as periorbital, perinasal, and perioral patches, and the correlation of DSM-based predictions and molecular findings. This study demonstrates the potential of face shape models to assist clinical training through visualization, to support clinical diagnosis of affected individuals through pattern recognition, and to enable the objective comparison of individuals sharing other phenotypic or genotypic properties.	UCL, Eastman Dent Inst, Biomed Informat Inst, London WC1X 8LD, England; UCL, Dept Comp Sci, London WC1X 8LD, England; UCL, Inst Child Hlth, London WC1X 8LD, England; Kings Coll London, Inst Psychiat, London WC2R 2LS, England; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Royal Coll Surgeons Ireland, Dublin 2, Ireland; Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Univ Manchester, St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Eastern Reg Genet Program, Ottawa, ON, Canada; Childrens Hosp, Boston, MA 02115 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Univ Southampton, Wessex Clin Genet Serv, Southampton, Hants, England; Univ Southampton, Div Human Genet, Southampton, Hants, England; Hosp Trust, Southampton, Hants, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; King's College London; St Georges University London; Royal College of Surgeons - Ireland; University of Manchester; University of Manchester; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; University of Southampton; University of Southampton	Hammond, P (corresponding author), UCL, Eastman Dent Inst, Biomed Informat Inst, 256 Grays Inn Rd, London WC1X 8LD, England.	p.hammond@eastman.ucl.ac.uk	Karmiloff-Smith, Annette/N-4535-2014; Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008; temple, isabel K/K-2391-2015; campbell, linda/C-6231-2013; Murphy, Kieran C/D-3577-2012	Karmiloff-Smith, Annette/0000-0002-2470-5609; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; campbell, linda/0000-0002-8872-9626; Temple, Isabel Karen/0000-0002-6045-1781; Murphy, Kieran/0000-0003-2930-4465	FIC NIH HHS [R21TW06761-01, R21 TW006761] Funding Source: Medline; NHGRI NIH HHS [01-HG-0109] Funding Source: Medline; Wellcome Trust Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R21TW006761] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000109] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allanson JE, 1999, J MED GENET, V36, P394; Allanson JE, 1996, AM J MED GENET, V65, P13, DOI 10.1002/(SICI)1096-8628(19961002)65:1<13::AID-AJMG2>3.0.CO;2-Z; ALLANSON JE, 1993, AM J MED GENET, V47, P748, DOI 10.1002/ajmg.1320470530; ALLANSON JE, 1985, AM J MED GENET, V21, P507, DOI 10.1002/ajmg.1320210313; Allanson JE, 1997, AM J MED GENET, V71, P414, DOI 10.1002/(SICI)1096-8628(19970905)71:4<414::AID-AJMG8>3.0.CO;2-T; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; Gorlin R.J., 2001, SYNDROMES HEAD NECK, V4th ed., DOI 10.17245/jdapm.2019.19.5.261; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; Hammond P, 2003, AM J HUM GENET, V73, P284; HAMMOND P, 2003, EUR J HUM GENET, V11, P102; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Loos HS, 2003, EUR J HUM GENET, V11, P555, DOI 10.1038/sj.ejhg.5200997; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SHARLAND M, 1993, AM J MED GENET, V45, P430, DOI 10.1002/ajmg.1320450406; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Vapnik V, 2013, NATURE STAT LEARNING; Ward RE, 2000, AM J MED GENET, V91, P8, DOI 10.1002/(SICI)1096-8628(20000306)91:1<8::AID-AJMG2>3.0.CO;2-#; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	25	119	126	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					999	1010		10.1086/498396	http://dx.doi.org/10.1086/498396			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380911	Green Published, Bronze			2022-12-18	WOS:000233241200009
J	Holm, P; Julier, C; Kockum, I; Senee, V; Blanc, H; Papp, J; Akesson, K; Bartsocas, C; de Leiva, A; Dahlquist, G; Ronningen, KS; Lathrop, M; Luthman, H; Pociot, F; Nerup, J				Holm, P; Julier, C; Kockum, I; Senee, V; Blanc, H; Papp, J; Akesson, K; Bartsocas, C; de Leiva, A; Dahlquist, G; Ronningen, KS; Lathrop, M; Luthman, H; Pociot, F; Nerup, J		European Consortium IDDM Genome S	A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: Identification of new loci with evidence of interactions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; INSULIN GENE REGION; CHILDREN 0-14 YEARS; LINKAGE DISEQUILIBRIUM; ASSOCIATION ANALYSIS; PAIR FAMILIES; TIME TRENDS; AGE-GROUP; PCR-SSP; CONCORDANCE	Type 1 diabetes mellitus (TIDM) has a multifactorial etiology, with major genetic-susceptibility determinants located in the HLA and insulin-gene (INS) regions. Linkage data implicating other disease-susceptibility loci are conflicting. This is likely due to (1) the limited power for detection of contributions of additional susceptibility loci, given the limited number of informative families available for study, (2) factors such as genetic heterogeneity between populations, and (3) potential gene-gene and gene-environment interactions. To circumvent some of these problems, we have conducted a genomewide linkage analysis for T1DM-susceptibility loci in 408 multiplex families from Scandinavia, a population expected to be homogeneous for genetic and environmental factors. In addition to verifying the HLA and INS susceptibility loci, the study provides confirmation of IDDM15 on chromosome 6q21. Suggestive evidence of additional susceptibility loci was found on chromosomes 2p, 5q, and 16p. For some loci, the support for linkage increased substantially when families were stratified on the basis of HLA or INS genotypes, with statistically significant heterogeneity between the stratified subgroups. Our data support both the existence of non-HLA genes of significance for T1DM and interaction between HLA and non-HLA loci in the determination of the T1DM phenotype.	Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Karolinska Inst, Dept Mol Med, Stockholm, Sweden; Inst Pasteur, Paris, France; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; Univ Athens, Fac Nursing, Childrens Hosp, GR-10679 Athens, Greece; Univ Autonoma Barcelona, Hosp La Santa Creu & Sat Pau, E-08193 Barcelona, Spain; Umea Univ, Dept Paediat, Umea, Sweden; Natl Publ Hlth Inst, Lab Mol Epidemiol, Oslo, Norway	Steno Diabetes Center; University of Oxford; Wellcome Centre for Human Genetics; Karolinska Institutet; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National & Kapodistrian University of Athens; Autonomous University of Barcelona; Umea University	Nerup, J (corresponding author), Steno Diabet Ctr, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.	jne@pres.dk	JULIER, Cécile/M-9824-2017; Senée, Valérie/M-9854-2017; Kockum, Ingrid/O-8781-2018	JULIER, Cécile/0000-0002-1538-0240; Senée, Valérie/0000-0001-7012-3944; Kockum, Ingrid/0000-0002-0867-4726; Pociot, Flemming/0000-0003-3274-5448	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BLOHME G, 1992, DIABETOLOGIA, V35, P56, DOI 10.1007/BF00400852; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cucca F, 1998, DIABETES, V47, P1525, DOI 10.2337/diabetes.47.9.1525; DAHLQUIST G, 1994, INT J EPIDEMIOL, V23, P1234, DOI 10.1093/ije/23.6.1234; DAHLQUIST G, 1982, ACTA PAEDIATR SCAND, V71, P7, DOI 10.1111/j.1651-2227.1982.tb09364.x; Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; DAHLQUIST G, 1985, DIABETOLOGIA, V28, P802, DOI 10.1007/BF00291068; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davies JL, 1996, HUM MOL GENET, V5, P1071, DOI 10.1093/hmg/5.7.1071; Davis JA, 1996, BRIT MED J, V312, P313; DEGNBOL B, 1978, ANN HUM GENET, V42, P25, DOI 10.1111/j.1469-1809.1978.tb00929.x; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Delepine M, 1997, AM J HUM GENET, V60, P174; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; JULIER C, 1994, AM J HUM GENET, V55, P1247; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KUMAR D, 1993, DIABETES, V42, P1351, DOI 10.2337/diabetes.42.9.1351; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; KYVIK KO, 1995, BRIT MED J, V311, P913; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Larsen ZM, 1999, AUTOIMMUNITY, V31, P35, DOI 10.3109/08916939908993857; Lorenzen T, 1998, DIABETOLOGIA, V41, P666, DOI 10.1007/s001250050966; LORENZEN T, 1994, DIABETOLOGIA, V37, P321, DOI 10.1007/BF00398061; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; LUO DF, 1995, AUTOIMMUNITY, V21, P143, DOI 10.3109/08916939508993363; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLBAK AG, 1994, DIABETIC MED, V11, P650, DOI 10.1111/j.1464-5491.1994.tb00327.x; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; NERUP J, 1974, LANCET, V2, P864; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; NYSTROM L, 1990, INT J EPIDEMIOL, V19, P141, DOI 10.1093/ije/19.1.141; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OLERUP O, 1993, TISSUE ANTIGENS, V41, P55; OLMOS P, 1988, DIABETOLOGIA, V31, P747, DOI 10.1007/BF00274777; OSTMAN J, 1986, ACTA MED SCAND, V220, P437; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; Paterson I, 1999, ORG LETT, V1, P19, DOI 10.1021/ol990004c; POCIOT F, 1993, DIABETOLOGIA, V36, P870, DOI 10.1007/BF00400364; Pociot F, 1996, DAN MED BULL, V43, P216; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; RISCH N, 1987, AM J HUM GENET, V40, P1; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STONE RA, 1990, DIABETES, V39, P858; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TILLIL H, 1987, DIABETES, V36, P93, DOI 10.2337/diabetes.36.1.93; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; Verge CF, 1998, J CLIN INVEST, V102, P1569, DOI 10.1172/JCI3379; WAGNER A, 1995, LANCET, V346, P380, DOI 10.1016/S0140-6736(95)92262-8	66	119	124	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1301	1313						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11598829				2022-12-18	WOS:000172086900015
J	Kelsell, DP; Di, WL; Houseman, MJ				Kelsell, DP; Di, WL; Houseman, MJ			Connexin mutations in skin disease and hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GAP-JUNCTION PROTEIN; 26 GENE GJB2; HIDROTIC ECTODERMAL DYSPLASIA; AUTOSOMAL-RECESSIVE DEAFNESS; PALMOPLANTAR KERATODERMA; CHILDHOOD DEAFNESS; SENSORINEURAL DEAFNESS; NEUROSENSORY DEAFNESS; MISSENSE MUTATION; CLOUSTON-SYNDROME		Univ London, Ctr Cutaneous Res, St Bartholomews & Royal London Sch Med & Dent, London E1 2AT, England; St James Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England	University of London; Queen Mary University London; Saint James's University Hospital; University of Leeds	Kelsell, DP (corresponding author), Univ London, Ctr Cutaneous Res, St Bartholomews & Royal London Sch Med & Dent, 2 Newark St, London E1 2AT, England.	kelsell@icrf.icnet.uk	Kelsell, David P/F-8767-2011	Kelsell, David/0000-0002-9910-7144				Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; [Anonymous], 1998, Neuromuscul Disord, V8, P591, DOI 10.1016/S0960-8966(98)00067-4; Bale S, 1999, J INVEST DERMATOL, V112, P550; Cao FL, 1998, J CELL SCI, V111, P31; Choudhry R, 1997, DEV DYNAM, V210, P417, DOI 10.1002/(SICI)1097-0177(199712)210:4<417::AID-AJA6>3.3.CO;2-0; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Fitzgerald DA, 1996, BRIT J DERMATOL, V134, P939; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Fuse Y, 1999, NEUROREPORT, V10, P1853, DOI 10.1097/00001756-199906230-00010; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Gasparini P, 1997, EUR J HUM GENET, V5, P83; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Griffith AJ, 2000, AM J HUM GENET, V67, P745, DOI 10.1086/303045; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; Heathcote K, 2000, J MED GENET, V37, P50, DOI 10.1136/jmg.37.1.50; Houseman MJ, 2001, J MED GENET, V38, P20, DOI 10.1136/jmg.38.1.20; IshidaYamamoto A, 1997, AM J HUM GENET, V61, P581, DOI 10.1086/515518; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 2000, EUR J HUM GENET, V8, P141, DOI 10.1038/sj.ejhg.5200407; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kelsell DP, 1999, MOL MED TODAY, V5, P107, DOI 10.1016/S1357-4310(98)01428-2; Kibar Z, 1996, HUM MOL GENET, V5, P543, DOI 10.1093/hmg/5.4.543; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kojima T, 1999, BIOCHEM BIOPH RES CO, V266, P222, DOI 10.1006/bbrc.1999.1778; Korge BP, 1997, J INVEST DERMATOL, V109, P604, DOI 10.1111/1523-1747.ep12337534; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Lerer I, 2000, AM J MED GENET, V95, P53, DOI 10.1002/1096-8628(20001106)95:1<53::AID-AJMG11>3.0.CO;2-2; Liu XZ, 2000, HUM MOL GENET, V9, P63, DOI 10.1093/hmg/9.1.63; LOFFELD A, 2000, BRIT J DERMATOL, V143, P38; Lopez-Bigas N, 2000, AM J HUM GENET, V67, P413; Macari F, 2000, AM J HUM GENET, V67, P1296; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Martin PEM, 1999, HUM MOL GENET, V8, P2369, DOI 10.1093/hmg/8.13.2369; MAW MA, 1995, AM J HUM GENET, V57, P629; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morle L, 2000, J MED GENET, V37, P368, DOI 10.1136/jmg.37.5.368; Murgia A, 1999, J MED GENET, V36, P829; Niessen H, 2000, J CELL SCI, V113, P1365; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Pitts JD, 1998, BIOESSAYS, V20, P1047, DOI 10.1002/(SICI)1521-1878(199812)20:12<1047::AID-BIES11>3.0.CO;2-0; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Radhakrishna U, 1997, AM J MED GENET, V71, P80, DOI 10.1002/(SICI)1096-8628(19970711)71:1<80::AID-AJMG15>3.0.CO;2-R; Richard G, 2000, HUM GENET, V106, P321, DOI 10.1007/s004390051045; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rook A, 1998, TXB DERMATOLOGY; Scherer SS, 1999, NOVART FDN SYMP, V219, P175; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.3.CO;2-1; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Sobe T, 2000, HUM GENET, V106, P50, DOI 10.1007/s004390051009; Stevens HP, 1999, BRIT J DERMATOL, V140, P963, DOI 10.1046/j.1365-2133.1999.02837.x; Taylor TD, 1998, J INVEST DERMATOL, V111, P83, DOI 10.1046/j.1523-1747.1998.00245.x; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; VANDERSCHROEFF JG, 1984, HUM GENET, V68, P165, DOI 10.1007/BF00279308; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wilgoss A, 1999, J INVEST DERMATOL, V113, P1119, DOI 10.1046/j.1523-1747.1999.00792.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	75	119	123	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					559	568		10.1086/318803	http://dx.doi.org/10.1086/318803			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179004	Bronze, Green Published			2022-12-18	WOS:000166994200001
J	Peoples, R; Franke, Y; Wang, YK; Perez-Jurado, L; Paperna, T; Cisco, M; Francke, U				Peoples, R; Franke, Y; Wang, YK; Perez-Jurado, L; Paperna, T; Cisco, M; Francke, U			A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome-deletion region at 7q11.23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; REPLICATION FACTOR-C; HUMAN GENOME; HUMAN GENE; POINT MUTATIONS; COMMON DELETION; PROTEIN; ELASTIN; LOCALIZATION; LOCUS	Williams-Beuren syndrome (WBS) is a developmental disorder caused by haploinsufficiency for genes in a 2-cM region of chromosome band 7q11.23. With the exception of vascular stenoses due to deletion of the elastin gene, the various features of WBS have not yet been attributed to specific genes. Although greater than or equal to 16 genes have been identified within the WBS deletion, completion of a physical map of the region has been difficult because of the large duplicated regions flanking the deletion. We present a physical map of the WBS deletion and flanking regions, based on assembly of a bacterial artificial chromosome/P1-derived artificial chromosome contig, analysis of high-throughput genome-sequence data, and long-range restriction mapping of genomic and cloned DNA by pulsed-field gel electrophoresis. Our map encompasses 3 Mb, including 1.6 Mb within the deletion. Two large duplicons, flanking the deletion, of greater than or equal to 320 kb contain unique sequence elements from the internal border regions of the deletion, such as sequences from GTF2I (telomeric) and FKBP6 (centromeric). A third copy of this duplicon exists in inverted orientation distal to the telomeric flanking one. These duplicons show stronger sequence conservation with regard to each other than to the presumptive ancestral loci within the common deletion region. Sequence elements originating from beyond 7q11.23 are also present in these duplicons. Although the duplicons are not present in mice, the order of the single-copy genes in the conserved syntenic region of mouse chromosome 5 is inverted relative to the human map. A model is presented for a mechanism of WBS-deletion formation, based on the orientation of duplicons' components relative to each other and to the ancestral elements within the deletion region.	Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Hosp Univ La Paz, Serv Genet, Madrid, Spain; Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain	Howard Hughes Medical Institute; Stanford University; Stanford University; Hospital Universitario La Paz; Autonomous University of Madrid	Francke, U (corresponding author), Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA.	francke@cmgm.stanford.edu	Pérez Jurado, Luis Alberto/M-7706-2015		NICHD NIH HHS [HD33505, HD00298] Funding Source: Medline; NIGMS NIH HHS [GM08404] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Dausset J, 1992, Behring Inst Mitt, P13; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; DeSilva U, 1999, GENOME RES, V9, P428; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DILTS CV, 1990, AM J MED GENET, P126; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Franke Y, 1999, CYTOGENET CELL GENET, V86, P296, DOI 10.1159/000015322; GILBERTDUSSARDIER B, 1995, AM J HUM GENET, V56, P542; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Hockenhull EL, 1999, GENOMICS, V58, P138, DOI 10.1006/geno.1999.5815; Hoogenraad CC, 1998, GENOMICS, V53, P348, DOI 10.1006/geno.1998.5529; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jadayel DM, 1998, GENE, V224, P35, DOI 10.1016/S0378-1119(98)00514-9; Jurado LAP, 1999, CYTOGENET CELL GENET, V86, P277, DOI 10.1159/000015319; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KAPLAN P, IN PRESS J CHILD NEU; KarmiloffSmith A, 1997, CHILD DEV, V68, P246, DOI 10.1111/j.1467-8624.1997.tb01938.x; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; KIPERSZTOK S, 1995, GENOMICS, V25, P354, DOI 10.1016/0888-7543(95)80033-I; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Lu XJ, 1998, GENOMICS, V54, P241, DOI 10.1006/geno.1998.5578; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; Meng X, 1998, HUM GENET, V103, P590, DOI 10.1007/s004390050874; OKUMURA K, 1995, GENOMICS, V25, P274, DOI 10.1016/0888-7543(95)80135-9; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; Osborne LR, 1997, AM J HUM GENET, V61, P449, DOI 10.1086/514850; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Ouellette BFF, 1997, GENOME RES, V7, P952, DOI 10.1101/gr.7.10.952; Paperna T, 1998, GENOMICS, V54, P453, DOI 10.1006/geno.1998.5619; Peoples R, 1996, AM J HUM GENET, V58, P1370; Peoples RJ, 1998, CYTOGENET CELL GENET, V82, P238, DOI 10.1159/000015110; Pober BR, 1996, CHILD ADOL PSYCH CL, V5, P929, DOI 10.1016/S1056-4993(18)30341-9; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Robinson WP, 1996, GENOMICS, V34, P17, DOI 10.1006/geno.1996.0237; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Touchman JW, 1997, GENOME RES, V7, P281, DOI 10.1101/gr.7.3.281; WANG MS, 1998, AM J HUM GENET S, V63, pA690; WANG PP, 1993, AM J DIS CHILD, V147, P1246, DOI 10.1001/archpedi.1993.02160350120019; WANG PP, 1995, BRAIN COGNITION, V29, P54, DOI 10.1006/brcg.1995.1267; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465; Wang YK, 1999, GENOMICS, V57, P235, DOI 10.1006/geno.1999.5773; Wedemeyer N, 1997, GENOMICS, V46, P313, DOI 10.1006/geno.1997.5027; Wu YQ, 1998, AM J MED GENET, V78, P82, DOI 10.1002/(SICI)1096-8628(19980616)78:1<82::AID-AJMG17>3.0.CO;2-K	70	119	122	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					47	68		10.1086/302722	http://dx.doi.org/10.1086/302722			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631136	Green Published, Bronze			2022-12-18	WOS:000085033600007
J	Rihet, P; Traore, Y; Abel, L; Aucan, C; Traore-Leroux, T; Fumoux, F				Rihet, P; Traore, Y; Abel, L; Aucan, C; Traore-Leroux, T; Fumoux, F			Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; COMPLEX TRAITS; MAJOR GENE; MAP; LOCUS; SUSCEPTIBILITY; INTERLEUKIN-4; MACROPHAGES; RESISTANCE; ANTIBODIES	Plasmodium falciparum malaria remains a major cause of morbidity and mortality in many tropical countries, especially those in sub-Saharan Africa. Human genetic control of malaria infection is poorly understood; in par ticular, genes controlling P. falciparum blood infection levels remain to be identified. We recently evidenced the existence of complex genetic factors controlling blood infection levels in an urban population living in Burkina Faso. We performed, on 153 sibs from 34 families, sib-pair linkage analyses between blood infection levels and chromosome 5q31-q33, which contains numerous candidate genes encoding immunological molecules. Our results, obtained by means of the two-point Haseman-Elston (HE) method and a nonparametric (NP) approach, show linkage of parasitemia to D5S393 (P = .002) and D5S658 (P = .0004). Multipoint analyses confirmed linkage, with a peak close to D5S658 (P = .0013 and P = .0007 with the HE and NP methods, respectively). The heritability of the locus was .48, according to the two-point results, and .43, according to the multipoint results; this indicates that its variation accounted for similar to 45 % of the variance of blood infection levels and that the locus plays a central role in the control of parasitemia. The identification of the gene is, therefore, of major interest in understanding the mechanisms controlling P. falciparum parasitemia.	INSERM, U399, F-13258 Marseille, France; Org Coordinat & Cooperat Contre Grandes Endemies, Ctr Muraz, Bobo Dioulasso, Burkina Faso; Grp Hosp Pitie Salpetriere, INSERM, U436, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Muraz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Rihet, P (corresponding author), Univ Mediterranee, Fac Sci Luminy, 163 Ave Luminy,13E Case 901, F-13288 Marseille 9, France.		Rihet, Pascal/GQP-1381-2022; Rihet, Pascal/AAD-2018-2022; Abel, Laurent/H-8888-2017; Rihet, Pascal/L-2173-2016	Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Abel, Laurent/0000-0001-7016-6493; Rihet, Pascal/0000-0002-9459-3905; Huynh, Chien/0000-0001-9801-845X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABEL L, 1992, AM J HUM GENET, V50, P1308; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Butler D, 1997, NATURE, V386, P535, DOI 10.1038/42306; CHANDRASEKHARAPPA SC, 1990, GENOMICS, V6, P94, DOI 10.1016/0888-7543(90)90452-Z; deVries JE, 1996, CHEM IMMUNOL, V63, P204; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FERRANTE A, 1990, IMMUNOL LETT, V25, P179, DOI 10.1016/0165-2478(90)90112-4; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; FREZAL J, 1996, GENOME INTERACTIVE D, V3; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; GARCIA A, INPRESS AM J TROP ME; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hill AVS, 1996, PARASITOLOGY, V112, pS75, DOI 10.1017/S003118200007668X; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; Jepson A, 1997, BRIT MED J, V315, P96, DOI 10.1136/bmj.315.7100.96; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MENDIS KN, 1995, PARASITOL TODAY, V11, pPT11; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Miller LH, 1996, NATURE, V383, P480, DOI 10.1038/383480a0; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MullerMyhsok B, 1997, AM J HUM GENET, V61, P452, DOI 10.1016/S0002-9297(07)64073-7; NAOTUNNE TD, 1991, J EXP MED, V173, P523, DOI 10.1084/jem.173.3.523; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Ramer-Quinn DS, 1997, J IMMUNOL, V159, P4857; RIHET P, 1998, INPRESS GENET EPIDEM; ROBERT V, 1986, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V24, P121; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; *SAGE, 1994, STAT ANAL GEN EP REL; SALTMAN DL, 1993, GENOMICS, V16, P726, DOI 10.1006/geno.1993.1254; SJOBERG K, 1992, P NATL ACAD SCI USA, V89, P2101, DOI 10.1073/pnas.89.6.2101; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; TROYEBLOMBERG M, 1990, P NATL ACAD SCI USA, V87, P5484, DOI 10.1073/pnas.87.14.5484; TROYEBLOMBERG M, 1994, CRIT REV IMMUNOL, V14, P131, DOI 10.1615/CritRevImmunol.v14.i2.20; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M	47	119	121	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					498	505		10.1086/301967	http://dx.doi.org/10.1086/301967			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683598	Bronze, Green Published			2022-12-18	WOS:000075360800025
J	Holm, IA; Huang, X; Kunkel, LM				Holm, IA; Huang, X; Kunkel, LM			Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUTRAL ENDOPEPTIDASE 24.11; REGION; LOCUS; MOUSE; MAP	X-linked hypophosphatemic rickets (HYP) is a dominant disorder characterized by renal phosphate wasting and abnormal vitamin D metabolism. PEX, the gene that is defective in HYP and is located on Xp22.1, is homologous to members of the neutral endopeptidase family. However, the complete coding sequence of the PEX cDNA, the structure of the PEX gene, and the role that PEX plays in phosphate transport remain unknown. We determined the genomic structure of the published PEX gene, which was found to be composed of 18 short exons, and demonstrated that the genomic organization of PEX shares homology to members of the family of neutral endopeptidases. Primer sets were designed from the intron sequence, to amplify each PEX exon from genomic DNA of HYP patients. Mutations in PEX were identified in 9/22 unrelated HYP patients, confirming that defects in PEX are responsible for HYP. The mutations detected included three nonsense mutations, a 1-bp deletion leading to a frameshift, a donor splice-site mutation, and missense mutations in four patients. Although the entire PEX gene has not been identified and some mutations may have been missed, the lack of detection of mutations in the remaining 13 patients, especially in 1 patient who has an apparently balanced, de novo 9;13 translocation, implies that there may be other loci involved in the generation of the HYP phenotype.	CHILDRENS HOSP,DEPT MED,HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Holm, IA (corresponding author), CHILDRENS HOSP,DIV GENET,300 LONGWOOD AVE,ENDERS 540,BOSTON,MA 02115, USA.			Holm, Ingrid/0000-0003-4712-8821	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000961] Funding Source: NIH RePORTER; NICHD NIH HHS [K11 HD00961] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchine J W, 1971, Birth Defects Orig Artic Ser, V7, P287; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; ECONS MJ, 1994, J CLIN ENDOCR METAB, V79, P1351, DOI 10.1210/jc.79.5.1351; ECONS MJ, 1995, J BONE MINER RES, V10, pS500; ECONS MJ, 1992, J CLIN ENDOCR METAB, V75, P201, DOI 10.1210/jc.75.1.201; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; FRANCIS F, 1994, GENOMICS, V21, P229, DOI 10.1006/geno.1994.1247; *HYP CONS, 1995, NAT GENET, V11, P130; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; LITTLE S, 1995, CURRENT PROTOCOLS HU, V1; MEYER RA, 1980, ENDOCRINOLOGY, V107, P1577, DOI 10.1210/endo-107-5-1577; RASMUSSEN H, 1989, METABOLIC BASIS INHE, V2, P2581; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; ROWE PSN, 1994, HUM GENET, V93, P291, DOI 10.1007/BF00212025; Sambrook J, 1989, MOL CLONING LAB MANU; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	19	119	128	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					790	797						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106524				2022-12-18	WOS:A1997WT61400007
J	Tan, J; Dunn, J; Jaeken, J; Schachter, H				Tan, J; Dunn, J; Jaeken, J; Schachter, H			Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM TRANSFERRIN; OLIGOSACCHARIDE; LOCALIZATION; EXPRESSION; DISORDERS; EMBRYOS; VARIANT; PROTEIN; CELLS; GOLGI	Carbohydrate-deficient glycoprotein syndrome (CDGS) type II is a multisystemic congenital disease with severe involvement of the nervous system. Two unrelated CDGS type II patients are shown to have point mutations (one patient having Ser-->Phe and the other having His-->Arg) in the catalytic domain of the gene MGAT2, encoding UDP-GlcNAc:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II (GnT II), an enzyme essential for biosynthesis of complex Asn-linked glycans. Both mutations caused both decreased expression of enzyme protein in a baculovirus/insect cell system and inactivation of enzyme activity, Restriction-endonuclease analysis of DNA from 23 blood relatives of one of these patients showed that 13 donors were heterozygotes; the other relatives and 21 unrelated donors were normal homozygotes. All heterozygotes showed a significant reduction (33%-68%) in mononuclear-cell GnT II activity. The data indicate that CDGS type II is an autosomal recessive disease and that complex Asn-linked glycans are essential for normal neurological development.	HOSP SICK CHILDREN,DEPT BIOCHEM RES,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,VISIBLE GENET INC,TORONTO,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA; UNIV HOSP GASTHUISBERG,DEPT BIOCHEM RES,LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,DEPT PEDIAT,B-3000 LOUVAIN,BELGIUM	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; KU Leuven; University Hospital Leuven; KU Leuven								BLENNOW G, 1991, ACTA PAEDIATR SCAND, V80, P14; CHARUK JHM, 1995, EUR J BIOCHEM, V230, P797; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Feizi Ten, 1993, Current Opinion in Structural Biology, V3, P701, DOI 10.1016/0959-440X(93)90053-N; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; FENDERSON BA, 1990, BIOESSAYS, V12, P173, DOI 10.1002/bies.950120406; Fukuda M., 1994, MOL GLYCOBIOLOGY, P1; HAGBERG BA, 1993, PEDIATR NEUROL, V9, P255, DOI 10.1016/0887-8994(93)90060-P; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; JAEKEN J, 1993, GLYCOBIOLOGY, V3, P423, DOI 10.1093/glycob/3.5.423; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P1041, DOI 10.1007/BF00711522; JAEKEN J, 1980, PEDIATR RES, V14, P179, DOI 10.1203/00006450-198002000-00117; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; JAEKEN J, 1991, ACTA PAEDIATR SCAND, V80, P6; KNAUER R, 1994, J INHERIT METAB DIS, V17, P541, DOI 10.1007/BF00711588; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MURAMATSU T, 1992, CELL SURFACE CARBOHY, P239; PANEERSELVAM K, 1995, BIOCH BIPHYS RES CO, V208, P517; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; POWELL LD, 1994, J CLIN INVEST, V94, P1901, DOI 10.1172/JCI117540; RAMAEKERS VT, 1991, J INHERIT METAB DIS, V14, P385, DOI 10.1007/BF01811710; Sambrook J, 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SCHACHTER H, 1995, GLYCOPROTEINS A, V29, P153; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; STIBLER H, 1993, NEUROPEDIATRICS, V24, P51, DOI 10.1055/s-2008-1071513; STIBLER H, 1995, NEUROPEDIATRICS, V26, P235, DOI 10.1055/s-2007-979762; STIBLER H, 1991, ACTA PAEDIATR SC   S, V375, P21; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; YAMASHITA K, 1993, J BIOL CHEM, V268, P5783; YAMASHITA K, 1993, J BIOCHEM-TOKYO, V114, P766, DOI 10.1093/oxfordjournals.jbchem.a124253; YASUGI E, 1994, BIOCHEM BIOPH RES CO, V200, P816, DOI 10.1006/bbrc.1994.1524	38	119	123	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					810	817						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808595				2022-12-18	WOS:A1996VL28300009
J	Koda, Y; Soejima, M; Liu, YH; Kimura, H				Koda, Y; Soejima, M; Liu, YH; Kimura, H			Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: A fusion gene generated by unequal crossover responsible for the enzyme deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D-GALACTOSIDE 2-ALPHA-L-FUCOSYL-TRANSFERASE; GROUP ALPHA(1,2)FUCOSYLTRANSFERASE GENE; LEWIS-NEGATIVE INDIVIDUALS; HUMAN GASTRIC-MUCOSA; BLOOD GROUP SYSTEM; GDP-L-FUCOSE; HUMAN SALIVA; HUMAN-SERUM; H-GENE; ANTIGENS	About 20%-25% of Caucasian individuals are nonsecretors who fail to express soluble A, B, H, and Lewis b histo-blood group antigens in secretory organs and secretory fluids because of the absence of the Secretor gene (FUT2)-encoded alpha(1,2)-fucosyltransferase (Se enzyme) activity. Recently, the FUT2 and a pseudogene have been isolated, and an Se enzyme-deficient allele (se) caused by a nonsense mutation (G428A, se1) in Caucasians has also been reported. Although we were unable to find the se1 allele, we have found a missense mutation (A385T, se2) and two nonsense mutations (C571T, se3 and C628T, se4) in the Japanese Se enzyme-deficient alleles. In addition, we have found a fusion gene, which consisted of the 5'-region of the pseudogene and the 3'-region of the functional FUT2, as a Se enzyme-deficient allele (se5). The DNA sequence analysis of the fusion gene indicated that the crossover region corresponded to regions between bases 253 and 313 of the pseudogene and between bases 211 and 271 of the FUT2. This finding suggested that the fusion gene was generated by homologous but unequal crossover. A population study on 141 randomly selected Japanese has indicated that the se2 is a common Se enzyme-deficient allele in the Japanese population. The results suggest that Se enzyme-deficient alleles are race specific.	KURUME UNIV,SCH MED,DEPT LEGAL MED,KURUME,FUKUOKA 830,JAPAN	Kurume University			Koda, Yoshiro/AAY-6902-2020	Koda, Yoshiro/0000-0003-1368-0116				CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; ELMGREN A, 1993, BIOCHEM BIOPH RES CO, V196, P515, DOI 10.1006/bbrc.1993.2280; Elmgren A, 1996, VOX SANG, V70, P97, DOI 10.1111/j.1423-0410.1996.tb01300.x; FRANCO RF, 1994, VOX SANG, V67, P299, DOI 10.1111/j.1423-0410.1994.tb01255.x; GONZALEZ AL, 1995, TRENDS GENET, V11, P216, DOI 10.1016/S0168-9525(00)89051-4; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; Henry S, 1996, VOX SANG, V70, P21, DOI 10.1111/j.1423-0410.1996.tb00991.x; HITOSHI S, 1995, J BIOL CHEM, V270, P8844, DOI 10.1074/jbc.270.15.8844; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; KODA Y, 1993, BLOOD, V82, P2915; KUMAZAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P4193, DOI 10.1073/pnas.81.13.4193; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LEPENDU J, 1985, AM J HUM GENET, V37, P749; MASUTANI H, 1995, J BIOCHEM-TOKYO, V118, P541, DOI 10.1093/oxfordjournals.jbchem.a124942; METZENBERG AB, 1991, GENETICS, V128, P143; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; NAKAJIMA T, 1993, J IMMUNOL METHODS, V159, P261, DOI 10.1016/0022-1759(93)90165-4; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NISHIHARA S, 1994, J BIOL CHEM, V269, P29271; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; ROUQUIER S, 1995, J BIOL CHEM, V270, P4632, DOI 10.1074/jbc.270.9.4632; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SARNESTO A, 1990, J BIOL CHEM, V265, P15067; SARNESTO A, 1992, J BIOL CHEM, V267, P2737; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; WANG BJ, 1994, VOX SANG, V66, P280, DOI 10.1111/j.1423-0410.1994.tb00330.x; WANG BJ, 1994, FORENSIC SCI INT, V67, P1, DOI 10.1016/0379-0738(94)90405-7; Watkins W.M., 1995, GLYCOPROTEINS, P313; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YU LC, 1995, BIOCHEM J, V312, P329, DOI 10.1042/bj3120329; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	34	119	133	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					343	350						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755920				2022-12-18	WOS:A1996VM28800009
J	Rittig, S; Robertson, GL; Siggaard, C; Kovacs, L; Gregersen, N; Nyborg, J; Pedersen, EB				Rittig, S; Robertson, GL; Siggaard, C; Kovacs, L; Gregersen, N; Nyborg, J; Pedersen, EB			Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EUKARYOTIC SIGNAL PEPTIDASE; ARGININE-VASOPRESSIN; ENDOPLASMIC-RETICULUM; CLEAVAGE SITE; HEREDITARY; SEQUENCE; OXYTOCIN; PROTEIN; PLASMA; PROKARYOTES	Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disorder characterized by progressive postnatal deficiency of arginine vasopressin as a result of mutation in the gene that encodes the hormone. To determine the extent of mutations in the coding region that produce the phenotype, we studied members of 17 unrelated kindreds with the disorder. We sequenced all 3 exons of the gene by using a rapid, direct dye-terminator method and found the causative mutation in each kindred. In four kindreds, the mutations were each identical to mutations described in other affected families. In the other 13 kindreds each mutation was unique. There were two missense mutations that altered the cleavage region of the signal peptide, seven missense mutations in exon 2, which codes for the conserved portion of the protein, one nonsense mutation in exon 2, and three nonsense mutations in exon 3. These findings, together with the clinical features of FNDI, suggest that each of the mutations exerts an effect by directing the production of a pre-prohormone that cannot be folded, processed, or degraded properly and eventually destroys vasopressinergic neurons.	AARHUS UNIV HOSP,SKEJBY HOSP,CTR MED MOLEC BIOL,DK-8000 AARHUS,DENMARK; AARHUS UNIV HOSP,SKEJBY HOSP,NEPHROL & HYPERTENS RES LAB,DK-8000 AARHUS,DENMARK; AARHUS UNIV,FAC HLTH SCI,AARHUS,DENMARK; AARHUS UNIV,INST CHEM,DK-8000 AARHUS,DENMARK; NORTHWESTERN UNIV,SCH MED,DEPT MED,CHICAGO,IL 60611; COMENIUS UNIV BRATISLAVA,SCH MED,DEPT PEDIAT,BRATISLAVA,SLOVAKIA; UNIV AARHUS,SKEJBY HOSP,RES LAB NEPHROL & HYPERTENS,AARHUS,DENMARK	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Northwestern University; Comenius University Bratislava; Aarhus University								ANDERSSON KE, 1974, ACTA MED SCAND, V195, P17; BAHNSEN U, 1992, EMBO J, V11, P19, DOI 10.1002/j.1460-2075.1992.tb05022.x; BAYLIS PH, 1981, POSTGRAD MED J, V57, P36, DOI 10.1136/pgmj.57.663.36; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; BLACKETT PR, 1983, AM J MED SCI, V286, P42, DOI 10.1097/00000441-198311000-00007; BLOCK LH, 1981, KLIN WOCHENSCHR, V59, P831, DOI 10.1007/BF01721052; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; BRAVERMAN LE, 1965, ANN INTERN MED, V63, P503, DOI 10.7326/0003-4819-63-3-503; BRESLOW EMG, 1993, VASOPRESSIN, P143; CHEN LQ, 1991, P NATL ACAD SCI USA, V88, P4240, DOI 10.1073/pnas.88.10.4240; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; DRIEDGER AA, 1973, CAN MED ASSOC J, V109, P594; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; FORSSMAN H, 1945, ACTA MED SCANDINAV S, V159, P1; FRASER FC, 1955, J GENET HUM, V4, P193; Gaupp R, 1941, Z GESAMTE NEUROL PSY, V171, P514, DOI 10.1007/BF02880551; Gaut JR, 1993, CURR OPIN CELL BIOL, V5, P589, DOI 10.1016/0955-0674(93)90127-C; GREEN JR, 1967, BRAIN, V90, P707, DOI 10.1093/brain/90.3.707; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; HALBAN PA, 1994, BIOCHEM J, V299, P1; HANHART E, 1940, HDB ERBBIOLOGIE ME 2, V4, P798; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HORTIN G, 1981, CELL, V24, P453, DOI 10.1016/0092-8674(81)90336-6; ITO M, 1991, J CLIN INVEST, V87, P725, DOI 10.1172/JCI115052; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; JENSEN HK, 1994, HUM MUTAT, V4, P102, DOI 10.1002/humu.1380040203; KAPLOWITZ PB, 1982, J PEDIATR-US, V100, P76, DOI 10.1016/S0022-3476(82)80238-2; KOVACS L, 1991, CLIN RES, V39, pA835; LAFORET GA, 1991, J BIOL CHEM, V266, P1326; LAND H, 1982, NATURE, V295, P299, DOI 10.1038/295299a0; LEVINGER EL, 1955, J CLIN ENDOCR METAB, V15, P547, DOI 10.1210/jcem-15-5-547; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MARTIN FIR, 1959, Q J MED, V28, P573; MCLEOD JF, 1993, J CLIN ENDOCR METAB, V77, pA599, DOI 10.1210/jcem.77.3.8370682; MEINDERS A E, 1970, Folia Medica Neerlandica, V13, P68; MOHR E, 1985, FEBS LETT, V193, P12, DOI 10.1016/0014-5793(85)80069-7; MULLER M, 1992, EXPERIENTIA, V48, P118; NAGAHORA H, 1988, FEBS LETT, V238, P329, DOI 10.1016/0014-5793(88)80506-4; NAGASAKI H, 1995, J CLIN ENDOCR METAB, V80, P1352, DOI 10.1210/jc.80.4.1352; NOTWEHR SF, 1990, J BIOL CHEM, V265, P17202; OS I, 1985, ACTA MED SCAND, V217, P429; PEDERSEN EB, 1984, EUR J CLIN PHARMACOL, V26, P543, DOI 10.1007/BF00543482; PEDERSEN EB, 1985, Q J MED, V57, P883; PENDER C, 1955, PEDIATRICS, V11, P246; PRABHAKARAN M, 1990, BIOCHEM J, V269, P691, DOI 10.1042/bj2690691; REPASKE DR, 1994, J CLIN ENDOCR METAB, V79, P421, DOI 10.1210/jc.79.2.421; RIDDELL DC, 1985, SOMAT CELL MOLEC GEN, V11, P189, DOI 10.1007/BF01534707; RITTIG S, 1993, VASOPRESSIN, P600; ROBERTSON GL, 1993, VASOPRESSIN, P493; ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; ROBERTSON GL, 1994, SEMIN NEPHROL, V14, P368; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; RUTISHAUSER J, 1994, 16TH ANN M END SOC A, P512; SAUSVILLE E, 1985, J BIOL CHEM, V260, P236; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; TOTH EL, 1984, CAN MED ASSOC J, V131, P1237; URADE R, 1992, FEBS LETT, V312, P83, DOI 10.1016/0014-5793(92)81415-I; Van Leeuwen F. W., 1994, Society for Neuroscience Abstracts, V20, P1152; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; YUASA H, 1993, J CLIN ENDOCR METAB, V77, P600, DOI 10.1210/jc.77.3.600	63	119	121	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					107	117						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554046				2022-12-18	WOS:A1996TL69700014
J	DEPREZ, RHL; BIANCHI, AB; GROEN, NA; SEIZINGER, BR; HAGEMEIJER, A; VANDRUNEN, E; BOOTSMA, D; KOPER, JW; AVEZAAT, CJJ; KLEY, N; ZWARTHOFF, EC				DEPREZ, RHL; BIANCHI, AB; GROEN, NA; SEIZINGER, BR; HAGEMEIJER, A; VANDRUNEN, E; BOOTSMA, D; KOPER, JW; AVEZAAT, CJJ; KLEY, N; ZWARTHOFF, EC			FREQUENT NF2 GENE TRANSCRIPT MUTATIONS IN SPORADIC MENINGIOMAS AND VESTIBULAR SCHWANNOMAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-2; ACOUSTIC NEUROMA; TUMOR-SUPPRESSOR; CHROMOSOME-22	The gene for the hereditary disorder neurofibromatosis type 2 (NF2), which predisposes for benign CNS tumors such as vestibular schwannomas and meningiomas, has been assigned to chromosome 22 and recently has been isolated. Mutations in the NF2 gene were found in both sporadic meningiomas and vestibular schwannomas. However, so far only 6 of the 16 exons of the gene have been analyzed. In order to extend the analysis of an involvement of the NF2 gene in the sporadic counterparts of these NF2-related tumors, we have used reverse transcriptase-PCR amplification followed by SSCP and DNA sequence analysis to screen for mutations in the coding region of the NF2 gene. Analysis of the NF2 gene transcript in 53 unrelated patients with meningiomas and vestibular schwannomas revealed mutations in 32% of the sporadic meningiomas (n = 44), in 50% of the sporadic vestibular schwannomas (n = 4), in 100% of the tumors found in NF2 patients (n = 2), and in one of three tumors from multiple-meningioma patients. Of the 18 tumors in which a mutation in the NF2 gene transcript was observed and the copy number of chromosome 22 could be established, 14 also showed loss of (parts of) chromosome 22. This suggests that in sporadic meningiomas and NF2-associated tumors the NF2 gene functions as a recessive tumor-suppressor gene. The mutations detected resulted mostly in frameshifts, predicting truncations starting within the N-terminal half of the putative protein.	ERASMUS UNIV ROTTERDAM,DEPT GENET,ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT NEUROSURG,ROTTERDAM,NETHERLANDS; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC GENET & CELL BIOL,ONCOL DRUG DISCOVERY,PRINCETON,NJ	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Bristol-Myers Squibb	DEPREZ, RHL (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT PATHOL,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.							BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; BIJLSMA EK, 1992, GENE CHROMOSOME CANC, V5, P201, DOI 10.1002/gcc.2870050305; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELLEMAN JW, 1978, NEUROLOGY, V28, P567, DOI 10.1212/WNL.28.6.567; DEPREZ RHL, 1991, AM J HUM GENET, V48, P783; DEPREZ RHL, 1994, GENE CHROMOSOME CANC, V9, P124, DOI 10.1002/gcc.2870090208; DUMANSKI JP, 1990, CANCER RES, V50, P5863; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Russell D., 1989, PATHOLOGY TUMORS NER; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WOOD MW, 1957, J NEUROPATH EXP NEUR, V16, P337, DOI 10.1097/00005072-195707000-00005; ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2; Zulch KJ., 1979, HISTOLOGICAL TYPING, V21; 1987, NEUROFIBROMATOSIS RE, V3, P3	23	119	121	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1022	1029						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	7911002				2022-12-18	WOS:A1994NP05300010
J	VERMEULEN, W; SCOTT, RJ; RODGERS, S; MULLER, HJ; COLE, J; ARLETT, CF; KLEIJER, WJ; BOOTSMA, D; HOEIJMAKERS, JHJ; WEEDA, G				VERMEULEN, W; SCOTT, RJ; RODGERS, S; MULLER, HJ; COLE, J; ARLETT, CF; KLEIJER, WJ; BOOTSMA, D; HOEIJMAKERS, JHJ; WEEDA, G			CLINICAL HETEROGENEITY WITHIN XERODERMA-PIGMENTOSUM ASSOCIATED WITH MUTATIONS IN THE DNA-REPAIR AND TRANSCRIPTION GENE ERCC3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CIRCULATING LYMPHOCYTES-T; COMPLEMENTATION GROUP-D; EXCISION REPAIR; COCKAYNE SYNDROME; MOLECULAR-CLONING; MUTANT FREQUENCY; YEAST HOMOLOG; ACTIVE DNA; GROUP-C; GROUP-A	The human DNA excision repair gene ERCC3 specifically corrects the nucleotide excision repair (NER) defect of xeroderma pigmentosum (XP) complementation group B. In addition to its function in NER, the ERCC3 DNA helicase was recently identified as one of the components of the human BTF2/TFIIH transcription factor complex, which is required for initiation of transcription of class II genes. To date, a single patient (XP11BE) has been assigned to this XP group B (XP-B), with the remarkable conjunction of two autosomal recessive DNA repair deficiency disorders: XP and Cockayne syndrome (CS). The intriguing involvement of the ERCC3 protein in the vital process of transcription may provide an explanation for the rarity, severity, and wide spectrum of clinical features in this complementation group. Here we report the identification of two new XP-B patients: XPCS1BA and XPCS2BA (siblings), by microneedle injection of the cloned ERCC3 repair gene as well as by cell hybridization. Molecular analysis of the ERCC3 gene in both patients revealed a single base substitution causing a missense mutation in a region that is completely conserved in yeast, Drosophila, mouse, and human ERCC3. As in patient XP11BE, the expression of only one allele (paternal) is detected. The mutation causes a virtually complete inactivation of the NER function of the protein. Despite this severe NER defect, both patients display a late onset of neurologic impairment, mild cutaneous symptoms, and a striking absence of skin tumors even at an age of >40 years. Analysis of the frequency of hprt- mutant T-lymphocytes in blood samples suggests a relatively low in vivo mutation frequency in these patients. Factors in addition to NER deficiency may be required for the development of cutaneous tumors.	ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV HOSP BASEL,DEPT RES,HUMAN GENET GRP,CH-4031 BASEL,SWITZERLAND; UNIV SUSSEX,MRC,CELL MUTAT UNIT,BRIGHTON,E SUSSEX,ENGLAND	Erasmus University Rotterdam; University of Basel; University of Sussex	VERMEULEN, W (corresponding author), ERASMUS UNIV ROTTERDAM,MGC,DEPT CELL BIOL & GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		Hoeijmakers, Jan/AAX-6972-2021; Vermeulen, Wim/W-8708-2019; Scott, Rodney J/B-2827-2013	Vermeulen, Wim/0000-0003-3616-734X; Scott, Rodney J/0000-0001-7724-3404				ARLETT CF, 1992, MUTAT RES, V273, P127, DOI 10.1016/0921-8777(92)90074-D; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BOHR VA, 1991, CARCINOGENESIS, V12, P1983, DOI 10.1093/carcin/12.11.1983; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BRIDGES BA, 1992, MUTAT RES, V270, P135, DOI 10.1016/0027-5107(92)90124-K; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; COLE J, 1992, MUTAT RES, V273, P171, DOI 10.1016/0921-8777(92)90078-H; COLE J, 1988, MUTAT RES, V204, P493, DOI 10.1016/0165-1218(88)90044-4; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HANAWALT PC, 1991, MUTAT RES, V247, P203, DOI 10.1016/0027-5107(91)90016-H; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; LEHMANN AR, 1990, BR J DERMATOL S, V35, P115; MARIANI E, 1992, CLIN EXP IMMUNOL, V88, P376; MORISON WL, 1985, CANCER RES, V45, P3929; MOUNKES LC, 1992, CELL, V71, P925, DOI 10.1016/0092-8674(92)90389-T; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; ODONOVAN A, 1993, NATURE, V363, P185, DOI 10.1038/363185a0; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; SCOTT RJ, IN PRESS J AM ACAD D; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5512, DOI 10.1073/pnas.86.14.5512; THOMPSON LH, 1985, MUTAT RES, V150, P423, DOI 10.1016/0027-5107(85)90139-3; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1986, MUTAT RES, V165, P199, DOI 10.1016/0167-8817(86)90055-6; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0	43	119	120	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					191	200						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304337				2022-12-18	WOS:A1994MU31500004
J	PUCKETT, C; CONCANNON, P; CASEY, C; HOOD, L				PUCKETT, C; CONCANNON, P; CASEY, C; HOOD, L			GENOMIC STRUCTURE OF THE HUMAN PRION PROTEIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREUTZFELDT-JAKOB DISEASE; GERSTMANN-STRAUSSLER SYNDROME; PRP GENE; SCRAPIE; DNA; LOCALIZATION; SEQUENCES; INSERTION	Creutzfeldt-Jacob disease and Gerstmann-Straussler syndrome are rare degenerative disorders of the nervous system which have been genetically linked to the prion protein (PrP) gene. The PrP gene encodes a host glycoprotein of unknown function and is located on the short arm of chromosome 20, a region with few known genes or anonymous markers. The complete structure of the PrP gene in man has not been determined despite considerable interest in its relationship to these unusual disorders. We have determined that the human PrP gene has the same simple genomic structure seen in the hamster gene and consists of two exons and a single intron. In contrast to the hamster PrP gene the human gene appears to have a single major transcriptional start site. The region immediately 5' of the transcriptional start site of the human PrP gene demonstrates the GC-rich features commonly seen in housekeeping genes. Curiously, the genomic clone we have isolated contains a 24-bp deletion that removes one of five octameric peptide repeats predicted to form a B-pleated sheet in this region of the PrP. We have also identified 5' of the PrP gene an RFLP which has a high degree of heterozygosity and which should serve as a useful marker for the pter-12 region of human chromosome 20.	CALTECH,DIV BIOL,147-75,PASADENA,CA 91125; UNIV WASHINGTON,VIRGINIA MASON RES CTR,DEPT IMMUNOL,SEATTLE,WA 98195	California Institute of Technology; University of Washington; University of Washington Seattle; Virginia Mason Medical Center				Concannon, Patrick/0000-0002-5801-1859	NINDS NIH HHS [NS 22786, NS 01163-04] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS022786, K08NS001163] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1301; BROWN P, 1979, ANN NEUROL, V6, P438, DOI 10.1002/ana.410060511; CALZONE FJ, 1988, METHOD ENZYMOL, V142, P611; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DIRINGER H, 1983, EUR J BIOCHEM, V134, P555, DOI 10.1111/j.1432-1033.1983.tb07602.x; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; DYNAN WS, 1986, NATURE, V319, P240; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GATTI R A, 1984, Biotechniques, V2, P148; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GOLDFARB L G, 1989, American Journal of Human Genetics, V45, pA189; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; HANSEN U, 1983, EMBO J, V2, P2293, DOI 10.1002/j.1460-2075.1983.tb01737.x; HARRIS MS, 1990, NUCLEIC ACIDS RES, V18, P385, DOI 10.1093/nar/18.2.385-a; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Kretzschmar H.A., 1986, DNA CELL BIOL, V5, P314; LAI E, 1988, NATURE, V331, P543, DOI 10.1038/331543a0; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LAPLANCHE JL, 1990, NUCLEIC ACIDS RES, V18, P6745, DOI 10.1093/nar/18.22.6745; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; LUND T, 1982, P NATL ACAD SCI-BIOL, V79, P520, DOI 10.1073/pnas.79.2.520; MASTERS CL, 1981, BRAIN, V104, P535, DOI 10.1093/brain/104.3.535; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OWEN F, 1990, MOL BRAIN RES, V7, P273, DOI 10.1016/0169-328X(90)90038-F; OWEN F, 1989, LANCET, V1, P51; OWEN F, 1990, AM J HUM GENET, V46, P1215; PATEL PI, 1986, MOL CELL BIOL, V6, P393, DOI 10.1128/MCB.6.2.393; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROBAKIS NK, 1986, BIOCHEM BIOPH RES CO, V140, P758, DOI 10.1016/0006-291X(86)90796-5; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WU Y, 1987, NUCLEIC ACIDS RES, V15, P3191, DOI 10.1093/nar/15.7.3191	42	119	124	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					320	329						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678248				2022-12-18	WOS:A1991GA86600008
J	NAKAMURA, Y; CARLSON, M; KRAPCHO, K; KANAMORI, M; WHITE, R				NAKAMURA, Y; CARLSON, M; KRAPCHO, K; KANAMORI, M; WHITE, R			NEW APPROACH FOR ISOLATION OF VNTR MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											NAKAMURA, Y (corresponding author), UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132, USA.							BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P9215, DOI 10.1093/nar/14.22.9215; KONDOLEON S, 1987, NUCLEIC ACIDS RES, V15, P10605, DOI 10.1093/nar/15.24.10605; LATHROP M, 1988, GENOMICS, V2, P157; LAU YF, 1983, P NATL ACAD SCI-BIOL, V80, P5225, DOI 10.1073/pnas.80.17.5225; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OCONNELL P, IN PRESS GENOMICS; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROYLE NJ, 1908, CYTOGENET CELL GENET, V46, P685; SPANDIDOS DA, 1987, FEBS LETT, V218, P41, DOI 10.1016/0014-5793(87)81014-1; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	21	119	124	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					854	859						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	2904220				2022-12-18	WOS:A1988R344900007
J	GOEDDE, HW; AGARWAL, DP; HARADA, S; MEIERTACKMANN, D; RUOFU, D; BIENZLE, U; KROEGER, A; HUSSEIN, L				GOEDDE, HW; AGARWAL, DP; HARADA, S; MEIERTACKMANN, D; RUOFU, D; BIENZLE, U; KROEGER, A; HUSSEIN, L			POPULATION GENETIC-STUDIES ON ALDEHYDE DEHYDROGENASE ISOZYME DEFICIENCY AND ALCOHOL SENSITIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									ACAD SINICA, INST GENET, BEIJING, PEOPLES R CHINA; LANDESIMPFANSTALT, Berlin, GERMANY; UNIV HEIDELBERG, INST TROP HYG OFFENTL GESUNDHEITSWESEN SUDASIEN IN, D-6900 HEIDELBERG 1, GERMANY; NATL RES CTR, CAIRO, EGYPT	Chinese Academy of Sciences; Ruprecht Karls University Heidelberg; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	GOEDDE, HW (corresponding author), UNIV HAMBURG, INST HUMAN GENET, D-2000 HAMBURG 13, GERMANY.			Hussein, Laila/0000-0003-0319-3197; Kroeger, Axel/0000-0001-8438-2904				AGARWAL DP, 1981, ALCOHOL CLIN EXP RES, V5, P12; GOEDDE HW, 1980, ENZYME, V25, P281, DOI 10.1159/000459265; GOEDDE HW, 1979, HUM GENET, V51, P331; GOEDDE HW, 1979, CLIN GENET, V16, P29; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1980, AM J HUM GENET, V32, P8; HARADA S, 1980, LIFE SCI, V26, P1773, DOI 10.1016/0024-3205(80)90577-9; HARADA S, 1981, LANCET, V2, P982; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141	9	119	126	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					769	772						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6881146				2022-12-18	WOS:A1983RG73100018
J	Shearer, AE; Eppsteiner, RW; Booth, KT; Ephraim, SS; Gurrola, J; Simpson, A; Black-Ziegelbein, EA; Joshi, S; Ravi, H; Giuffre, AC; Happe, S; Hildebrand, MS; Azaiez, H; Bayazit, YA; Erdal, ME; Lopez-Escamez, JA; Gazquez, I; Tamayo, ML; Gelvez, NY; Leal, GL; Jalas, C; Ekstein, J; Yang, T; Usami, S; Kahrizi, K; Bazazzadegan, N; Najmabadi, H; Scheetz, TE; Braun, TA; Casavant, TL; LeProust, EM; Smith, RJH				Shearer, A. Eliot; Eppsteiner, Robert W.; Booth, Kevin T.; Ephraim, Sean S.; Gurrola, Jose, II; Simpson, Allen; Black-Ziegelbein, E. Ann; Joshi, Swati; Ravi, Harini; Giuffre, Angelica C.; Happe, Scott; Hildebrand, Michael S.; Azaiez, Hela; Bayazit, Yildirim A.; Erdal, Mehmet Emin; Lopez-Escamez, Jose A.; Gazquez, Irene; Tamayo, Marta L.; Gelvez, Nancy Y.; Leal, Greizy Lopez; Jalas, Chaim; Ekstein, Josef; Yang, Tao; Usami, Shin-ichi; Kahrizi, Kimia; Bazazzadegan, Niloofar; Najmabadi, Hossein; Scheetz, Todd E.; Braun, Terry A.; Casavant, Thomas L.; LeProust, Emily M.; Smith, Richard J. H.			Utilizing Ethnic-Specific Differences in Minor Allele Frequency to Recategorize Reported Pathogenic Deafness Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROMIC HEARING-LOSS; GENETIC-VARIANTS; SEQUENCING DATA; MUTATIONS; PROTEIN; COMMON	Ethnic-specific differences in minor allele frequency impact variant categorization for genetic screening of nonsyndromic hearing loss (NSHL) and other genetic disorders. We sought to evaluate all previously reported pathogenic NSHL variants in the context of a large number of controls from ethnically distinct populations sequenced with orthogonal massively parallel sequencing methods. We used HGMD, ClinVar, and dbSNP to generate a comprehensive list of reported pathogenic NSHL variants and re-evaluated these variants in the context of 8,595 individuals from 12 populations and 6 ethnically distinct major human evolutionary phylogenetic groups from three sources (Exome Variant Server, 1000 Genomes project, and a control set of individuals created for this study, the OtoDB). Of the 2,197 reported pathogenic deafness variants, 325 (14.8%) were present in at least one of the 8,595 controls, indicating a minor allele frequency (MAF) >0.00006. MAFs ranged as high as 0.72, a level incompatible with pathogenicity for a fully penetrant disease like NSHL. Based on these data, we established MAF thresholds of 0.005 for autosomal-recessive variants (excluding specific variants in GJB2) and 0.0005 for autosomal-dominant variants. Using these thresholds, we recategorized 93 (4.2%) of reported pathogenic variants as benign. Our data show that evaluation of reported pathogenic deafness variants using variant MAFs from multiple distinct ethnicities and sequenced by orthogonal methods provides a powerful filter for determining pathogenicity. The proposed MAF thresholds will facilitate clinical interpretation of variants identified in genetic testing for NSHL. All data are publicly available to facilitate interpretation of genetic variants causing deafness.	[Shearer, A. Eliot; Eppsteiner, Robert W.; Booth, Kevin T.; Gurrola, Jose, II; Simpson, Allen; Black-Ziegelbein, E. Ann; Azaiez, Hela; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Ephraim, Sean S.; Scheetz, Todd E.; Braun, Terry A.; Casavant, Thomas L.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Joshi, Swati; Ravi, Harini; Giuffre, Angelica C.; Happe, Scott; LeProust, Emily M.] Agilent Technol, Cedar Creek, TX 78612 USA; [Hildebrand, Michael S.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Bayazit, Yildirim A.] Medipol Univ, Dept Otolaryngol, Fac Med, TR-34083 Istanbul, Turkey; [Erdal, Mehmet Emin] Mersin Univ, Dept Med Biol & Genet, TR-33160 Mersin, Turkey; [Lopez-Escamez, Jose A.; Gazquez, Irene] Ctr Genom & Oncol Res GENyO, Otol & Neurotol Grp CTS495, Granada 18012, Spain; [Tamayo, Marta L.; Gelvez, Nancy Y.; Leal, Greizy Lopez] Pontificia Univ Javeriana, Inst Genet Humana, Bogota 11001000, Colombia; [Jalas, Chaim] Bonei Olam, Ctr Rare Jewish Genet Disorders, Brooklyn, NY 11204 USA; [Ekstein, Josef] Dor Yeshorim, Comm Prevent Jewish Genet Dis, Brooklyn, NY 11211 USA; [Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 20025, Peoples R China; [Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai 20025, Peoples R China; [Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan; [Kahrizi, Kimia; Bazazzadegan, Niloofar; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 1985713834, Iran; [Scheetz, Todd E.; Braun, Terry A.; Casavant, Thomas L.] Univ Iowa, Ctr Bioinformat & Computat Biol, Iowa City, IA 52242 USA; [Scheetz, Todd E.; Braun, Terry A.; Casavant, Thomas L.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Smith, Richard J. H.] Univ Iowa, Interdept PhD Program Genet, Iowa City, IA 52242 USA; [Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Agilent Technologies; University of Melbourne; Istanbul Medipol University; Mersin University; Pontificia Universidad Javeriana; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shinshu University; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu	Erdal, Mehmet Emin/F-9241-2015; Kahrizi, Kimia/D-7989-2017; Booth, Kevin T/P-9435-2019; Najmabadi, Hossein/P-8182-2017; Bazazzadegan, Niloofar/GOV-6396-2022; Azaiez, Hela/AAQ-7011-2020; Lopez-Escamez, Jose Antonio/D-6642-2018; bayazit, yildirim ahmet/GLR-7132-2022	Erdal, Mehmet Emin/0000-0002-6191-2930; Booth, Kevin T/0000-0003-3061-3652; Azaiez, Hela/0000-0002-2863-6970; Lopez-Escamez, Jose Antonio/0000-0002-8583-1430; Hildebrand, Michael/0000-0003-2739-0515; Yang, Tao/0000-0001-6011-987X; Shearer, Aiden/0000-0002-5324-4805; Smith, Richard/0000-0003-1201-6731; Lopez Leal, Greizy/0000-0001-9380-0792; Gelvez, Nancy/0000-0002-3925-1451; Tamayo, Martha Lucia/0000-0001-8297-3970; Gurrola II, Jose/0000-0001-6801-5768; Bazazzadegan, Niloofar/0000-0002-5455-272X; Scheetz, Todd/0000-0002-1965-5811; Najmabadi, Hossein/0000-0002-6084-7778	NIDCD [1F30DC011674, RO1s DC003544, DC002842, DC012049]; Pontificia Universidad Javeriana (Bogota, Colombia) [ID4775]; NIDCD [1F30DC011674, RO1s DC003544, DC002842, DC012049]; Pontificia Universidad Javeriana (Bogota, Colombia) [ID4775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012049, R01DC002842, F30DC011674, R01DC003544] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Pontificia Universidad Javeriana (Bogota, Colombia); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Pontificia Universidad Javeriana (Bogota, Colombia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD 1F30DC011674 to A.E.S. and NIDCD RO1s DC003544, DC002842, and DC012049 to R.J.H.S. Colombian individuals and samples were obtained as part of the project "Frecuencias de variantes codificantes especificas de genes entre diferentes poblaciones," supported by Pontificia Universidad Javeriana, Grant ID4775 (Bogota, Colombia).	Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Eisenberger T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/humu.22532; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003959; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Shearer AE, 2014, GENOME MED, V6, DOI 10.1186/gm554; Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845	22	118	121	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					445	453		10.1016/j.ajhg.2014.09.001	http://dx.doi.org/10.1016/j.ajhg.2014.09.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25262649	Bronze, Green Published			2022-12-18	WOS:000342654300009
J	Martin, E; Schule, R; Smets, K; Rastetter, A; Boukhris, A; Loureiro, JL; Gonzalez, MA; Mundwiller, E; Deconinck, T; Wessner, M; Jornea, L; Oteyza, AC; Durr, A; Martin, JJ; Schols, L; Mhiri, C; Lamari, F; Zuchner, S; De Jonghe, P; Kabashi, E; Brice, A; Stevanin, G				Martin, Elodie; Schuele, Rebecca; Smets, Katrien; Rastetter, Agnes; Boukhris, Amir; Loureiro, Jose L.; Gonzalez, Michael A.; Mundwiller, Emeline; Deconinck, Tine; Wessner, Marc; Jornea, Ludmila; Oteyza, Andres Caballero; Durr, Alexandra; Martin, Jean-Jacques; Schoels, Ludger; Mhiri, Chokri; Lamari, Foudil; Zuechner, Stephan; De Jonghe, Peter; Kabashi, Edor; Brice, Alexis; Stevanin, Giovanni			Loss of Function of Glucocerebrosidase GBA2 Is Responsible for Motor Neuron Defects in Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID BETA-GLUCOSIDASE; AUTOSOMAL-DOMINANT; AXON OUTGROWTH; GENERATION; MUTATION; BETA-GLUCOSIDASE-2; GLUCOSYLCERAMIDE; ACCUMULATION; INHIBITION; FRAMEWORK	Spastic paraplegia 46 refers to a locus mapped to chromosome 9 that accounts for a complicated autosomal-recessive form of hereditary spastic paraplegia (HSP). With next-generation sequencing in three independent families, we identified four different mutations in GBA2 (three truncating variants and one missense variant), which were found to cosegregate with the disease and were absent in controls. GBA2 encodes a microsomal nonlysosomal glucosylceramidase that catalyzes the conversion of glucosylceramide to free glucose and ceramide and the hydrolysis of bile acid 3-O-glucosides. The missense variant was also found at the homozygous state in a simplex subject in whom no residual glucocerebrosidase activity of GBA2 could be evidenced in blood cells, opening the way to a possible measurement of this enzyme activity in clinical practice. The overall phenotype was a complex HSP with mental impairment, cataract, and hypogonadism in males associated with various degrees of corpus callosum and cerebellar atrophy on brain imaging. Antisense morpholino oligonucleotides targeting the zebrafish GBA2 orthologous gene led to abnormal motor behavior and axonal shortening/branching of motoneurons that were rescued by the human wild-type mRNA but not by applying the same mRNA containing the missense mutation. This study highlights the role of ceramide metabolism in HSP pathology.	[Martin, Elodie; Rastetter, Agnes; Mundwiller, Emeline; Jornea, Ludmila; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, Hop La Pitie Salpetriere, Ctr Rech Inst Cerveau & Moelle Epiniere, Unite Mixte Rech S975, F-75013 Paris, France; [Martin, Elodie; Rastetter, Agnes; Mundwiller, Emeline; Jornea, Ludmila; Durr, Alexandra; Kabashi, Edor; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, INSERM, U975, F-75013 Paris, France; [Martin, Elodie; Rastetter, Agnes; Mundwiller, Emeline; Jornea, Ludmila; Durr, Alexandra; Kabashi, Edor; Brice, Alexis; Stevanin, Giovanni] CNRS, Unite Mixte Rech 7225, F-75013 Paris, France; [Martin, Elodie; Rastetter, Agnes; Stevanin, Giovanni] Hop La Pitie Salpetriere, Ecole Prat Hautes Etud, Neurogenet Lab, F-75013 Paris, France; [Schuele, Rebecca; Oteyza, Andres Caballero; Schoels, Ludger] Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schuele, Rebecca; Oteyza, Andres Caballero; Schoels, Ludger] Ctr Neurol, D-72076 Tubingen, Germany; [Smets, Katrien; Deconinck, Tine] Univ Antwerp, VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Smets, Katrien; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, B-2610 Antwerp, Belgium; [Smets, Katrien; Deconinck, Tine; Martin, Jean-Jacques; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Boukhris, Amir; Mhiri, Chokri] Hop Univ Habib Bourguiba, Serv Neurol, Sfax 3029, Tunisia; [Boukhris, Amir] Univ Sfax, Fac Med, Sfax 3029, Tunisia; [Loureiro, Jose L.] UnIGENe, P-4050 Oporto, Portugal; [Loureiro, Jose L.] Ctr Genet Predit & Prevent, Inst Mol & Cellular Biol, P-4050 Oporto, Portugal; [Loureiro, Jose L.] Ctr Hosp Entre Douro & Vougat, Serv Neurol, P-4520211 Santa Maria Feira, Portugal; [Gonzalez, Michael A.; Zuechner, Stephan] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael A.; Zuechner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Mundwiller, Emeline; Stevanin, Giovanni] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Wessner, Marc] Genoscope, F-91057 Evry, France; [Brice, Alexis; Stevanin, Giovanni] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Schoels, Ludger] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Lamari, Foudil] Hop La Pitie Salpetriere, AP HP, Serv Biochim, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp; Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Sfax; Universidade do Porto; University of Miami; University of Miami; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Brice, A (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, Ctr Rech Inst Cerveau & Moelle Epiniere, Unite Mixte Rech S975, F-75013 Paris, France.	alexis.brice@upmc.fr; giovanni.stevanin@upmc.fr	Schüle, Rebecca/B-5763-2019; Stevanin, Giovanni/E-5038-2016; MARTIN, Elodie/ABF-3563-2020; Brice, Alexis/A-2170-2009; Loureiro, José Leal/K-6379-2013; Schöls, Ludger/ABB-2482-2021; Kabashi, Edor/C-5408-2014; brice, alexis/AAE-8275-2019; MHIRI, Chokri/O-8801-2014	Schüle, Rebecca/0000-0002-7781-2766; Stevanin, Giovanni/0000-0001-9368-8657; MARTIN, Elodie/0000-0002-4494-9168; Loureiro, José Leal/0000-0002-6195-5412; Schöls, Ludger/0000-0001-7774-5025; Kabashi, Edor/0000-0003-4118-251X; brice, alexis/0000-0002-0941-3990; MHIRI, Chokri/0000-0001-7591-6994; Caballero Garcia de Oteyza, Andres/0000-0002-8892-1255	Association Strumpell-Lorrain; Agence Nationale de la Recherche (ANR) ("SPAX"); Association Francaise contre les Myopathies ("LIGENAX"); European Union; ANR; Deutsches Zentrum fur Neurodegenerative Erkrankungen; Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen [1970-0-0]; Verum foundation; program "Investissements d'avenir" [ANR-10-IAIHU-06]; Agence Nationale de la Recherche (ANR) ("LIGENAX"); Agence Nationale de la Recherche (ANR) ("SPG11"); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	Association Strumpell-Lorrain; Agence Nationale de la Recherche (ANR) ("SPAX")(French National Research Agency (ANR)); Association Francaise contre les Myopathies ("LIGENAX")(Association Francaise contre les Myopathies); European Union(European Commission); ANR(French National Research Agency (ANR)); Deutsches Zentrum fur Neurodegenerative Erkrankungen; Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen; Verum foundation; program "Investissements d'avenir"(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) ("LIGENAX")(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) ("SPG11")(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the family members for their participation. We would like to thank S. Ciura, M. Nawara, J. Gomez, P. Coutinho, I. Alonso, N. Jezequel, P. Touraine, G. Gyapay, V. Meyer, S. Rivaud-Pechoux, S. Forlani, and the DNA and Cell Bank of the Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere for their contribution to this study. We also thank F. Mochel, F. Darios, K.H. El-Hachimi, and R. Schiffmann for their advice and the clinicians and collaborators of the Spastic paraplegia and ataxia (SPATAX) network who referred to us some of the affected subjects. This work was supported by the Association Strumpell-Lorrain (to SPATAX), the Agence Nationale de la Recherche (ANR) ("SPAX" to A.D. and "LIGENAX" and "SPG11" to G.S.), the Association Francaise contre les Myopathies ("LIGENAX" to G.S.), the European Union and ANR through the Eranet E-Rare program ("EUROSPA" to A.B. and L.S.), the Deutsches Zentrum fur Neurodegenerative Erkrankungen (to L.S.), the Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen (grant 1970-0-0 to R.S.), and the Verum foundation (to A.B.). This study also benefited from funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute, Paris).	Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Boukhris A, 2010, NEUROGENETICS, V11, P441, DOI 10.1007/s10048-010-0249-2; Cox TM, 2001, J INHERIT METAB DIS, V24, P106; Dekker N, 2011, BLOOD CELL MOL DIS, V46, P19, DOI 10.1016/j.bcmd.2010.07.009; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; HARDING AE, 1983, LANCET, V1, P1151; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Martin E, 2012, NEUROBIOL DIS, V48, P299, DOI 10.1016/j.nbd.2012.07.003; MATERN H, 1992, FEBS LETT, V314, P183, DOI 10.1016/0014-5793(92)80970-R; Matern H, 1997, J BIOL CHEM, V272, P11261; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mencarelli C., 2012, CELL MOL LIFE SCI; Nietupski JB, 2012, MOL GENET METAB, V105, P621, DOI 10.1016/j.ymgme.2012.01.020; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Soderblom C, 2010, NEUROGENETICS, V11, P369, DOI 10.1007/s10048-010-0252-7; Song Y., 2012, DIS MODEL MECH; Southgate L, 2010, NEUROGENETICS, V11, P379, DOI 10.1007/s10048-010-0243-8; Stevanin G, 2008, CURR NEUROL NEUROSCI, V8, P198, DOI 10.1007/s11910-008-0032-z; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	38	118	121	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					238	244		10.1016/j.ajhg.2012.11.021	http://dx.doi.org/10.1016/j.ajhg.2012.11.021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332916	Bronze, Green Published			2022-12-18	WOS:000315179600007
J	Lorget, F; Kaci, N; Peng, J; Benoist-Lasselin, C; Mugniery, E; Oppeneer, T; Wendt, DJ; Bell, SM; Bullens, S; Bunting, S; Tsuruda, LS; O'Neill, CA; Di Rocco, F; Munnich, A; Legeai-Mallet, L				Lorget, Florence; Kaci, Nabil; Peng, Jeff; Benoist-Lasselin, Catherine; Mugniery, Emilie; Oppeneer, Todd; Wendt, Dan J.; Bell, Sean M.; Bullens, Sherry; Bunting, Stuart; Tsuruda, Laurie S.; O'Neill, Charles A.; Di Rocco, Federico; Munnich, Arnold; Legeai-Mallet, Laurence			Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; PROMOTES BONE-GROWTH; NATRIURETIC PEPTIDE; FACTOR RECEPTOR-3; CHONDROCYTE DIFFERENTIATION; THANATOPHORIC DYSPLASIA; DWARFISM; MUTATIONS; OVEREXPRESSION; OVERGROWTH	Achondroplasia (ACH), the most common form of dwarfism, is an inherited autosomal-dominant chondrodysplasia caused by a gain-of-function mutation in fibroblast-growth-factor-receptor 3 (FGFR3). C-type natriuretic peptide (CNP) antagonizes FGFR3 downstream signaling by inhibiting the pathway of mitogen-activated protein kinase (MAPK). Here, we report the pharmacological activity of a 39 amino acid CNP analog (BMN 111) with an extended plasma half-life due to its resistance to neutral-endopeptidase (NEP) digestion. In ACH human growth-plate chondrocytes, we demonstrated a decrease in the phosphorylation of extracellular-signal-regulated kinases 1 and 2, confirming that this CNP analog inhibits fibroblast-growth-factor-mediated MAPK activation. Concomitantly, we analyzed the phenotype of Fgfr3(Y367C/+) mice and showed the presence of ACH-related clinical features in this mouse model. We found that in Fgfr3(Y367C/+) mice, treatment with this CNP analog led to a significant recovery of bone growth. We observed an increase in the axial and appendicular skeleton lengths, and improvements in dwarfism-related clinical features included flattening of the skull, reduced crossbite, straightening of the tibias and femurs, and correction of the growth-plate defect. Thus, our results provide the proof of concept that BMN 111, a NEP-resistant CNP analog, might benefit individuals with ACH and hypochondroplasia.	[Kaci, Nabil; Benoist-Lasselin, Catherine; Mugniery, Emilie; Di Rocco, Federico; Munnich, Arnold; Legeai-Mallet, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Unite 781,Inst Imagine, F-75015 Paris, France; [Lorget, Florence; Peng, Jeff; Oppeneer, Todd; Wendt, Dan J.; Bell, Sean M.; Bullens, Sherry; Bunting, Stuart; Tsuruda, Laurie S.; O'Neill, Charles A.] BioMarin Pharmaceut, Novato, CA 94949 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; BioMarin Pharmaceutical Inc.	Legeai-Mallet, L (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, Unite 781,Inst Imagine, F-75015 Paris, France.	laurence.legeai-mallet@inserm.fr	Legeai-Mallet, Laurence/E-6112-2016; DI ROCCO, Federico/C-6343-2015; Dambroise, Emilie/H-7531-2017	Legeai-Mallet, Laurence/0000-0003-4989-5856; Di Rocco, Federico/0000-0003-2145-5533; Dambroise, Emilie/0000-0003-2794-7344; KACI, Nabil/0000-0002-6952-6815; BENOIST, Catherine/0000-0003-1779-0312	Association des Personnes de Petites Tailles; Fondation des gueules cassees; BioMarin Pharmaceutical	Association des Personnes de Petites Tailles; Fondation des gueules cassees; BioMarin Pharmaceutical(Johnson & Johnson)	We thank Mika Aoyagi-Scharber, Tim Taylor, Shinong Long, and Chris Price from BioMarin Pharmaceutical for providing BMN 111 (patent US2010-0297021). We thank Rachid Zoubairi for his work at the animal facility of the Institut Federatif de Recherche Necker-Enfants Malades (Paris, France) and Eric Le Gall for the artwork. We are grateful to the Association des Personnes de Petites Tailles and the Fondation des gueules cassees for supporting the work of the Institut National de la Sante et de la Recherche Medicale team. This article is respectfully dedicated to the memory of David Rimoin in recognition of his pioneering contributions in skeletal dysplasias and his involvement in the early stage of the BMN 111 program. F.L., J.P., T.O., D.J.W., S.M.B., S. Bullens, S. Bunting, L.S.T., and C.A.O. are employees of BioMarin Pharmaceutical. This work was supported in part by a grant from BioMarin Pharmaceutical.	Agoston H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-18; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Benoist-Lasselin C, 2007, FEBS LETT, V581, P2593, DOI 10.1016/j.febslet.2007.04.079; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Jonquoy A, 2012, HUM MOL GENET, V21, P841, DOI 10.1093/hmg/ddr514; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Mericq V, 2000, PEDIATR RES, V47, P189, DOI 10.1203/00006450-200002000-00007; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Ozasa A, 2005, BONE, V36, P1056, DOI 10.1016/j.bone.2005.03.006; Pannier S, 2009, BBA-MOL BASIS DIS, V1792, P140, DOI 10.1016/j.bbadis.2008.11.010; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Sebastian A, 2011, J ORTHOP RES, V29, P375, DOI 10.1002/jor.21262; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Wright MJ, 2012, ARCH DIS CHILD, V97, P129, DOI 10.1136/adc.2010.189092; Yamashita Y, 2000, J BIOCHEM-TOKYO, V127, P177, DOI 10.1093/oxfordjournals.jbchem.a022591; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	31	118	137	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1108	1114		10.1016/j.ajhg.2012.10.014	http://dx.doi.org/10.1016/j.ajhg.2012.10.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23200862	Green Published, Bronze			2022-12-18	WOS:000312417400015
J	Schuurs-Hoeijmakers, JHM; Geraghty, MT; Kamsteeg, EJ; Ben-Salem, S; de Bot, ST; Nijhof, B; van de Vondervoort, IIGM; van der Graaf, M; Nobau, AC; Otte-Holler, I; Vermeer, S; Smith, AC; Humphreys, P; Schwartzentruber, J; Ali, BR; Al-Yahyaee, SA; Tariq, S; Pramathan, T; Bayoumi, R; Kremer, HPH; van de Warrenburg, BP; van den Akker, WMR; Gilissen, C; Veltman, JA; Janssen, IM; Vulto-van Silfhout, AT; van der Velde-Visser, S; Lefeber, DJ; Diekstra, A; Eramus, CE; Willemsen, MA; Vissers, LELM; Lammens, M; van Bokhoven, H; Brunner, HG; Wevers, RA; Schenck, A; Al-Gazali, L; de Vries, BBA; de Brouwer, APM				Schuurs-Hoeijmakers, Janneke H. M.; Geraghty, Michael T.; Kamsteeg, Erik-Jan; Ben-Salem, Salma; de Bot, Susanne T.; Nijhof, Bonnie; van de Vondervoort, Ilse I. G. M.; van der Graaf, Marinette; Nobau, Anna Castells; Otte-Holler, Irene; Vermeer, Sascha; Smith, Amanda C.; Humphreys, Peter; Schwartzentruber, Jeremy; Ali, Bassam R.; Al-Yahyaee, Saeed A.; Tariq, Said; Pramathan, Thachillath; Bayoumi, Riyad; Kremer, Hubertus P. H.; van de Warrenburg, Bart P.; van den Akker, Willem M. R.; Gilissen, Christian; Veltman, Joris A.; Janssen, Irene M.; Vulto-van Silfhout, Anneke T.; van der Velde-Visser, Saskia; Lefeber, Dirk J.; Diekstra, Adinda; Eramus, Corrie E.; Willemsen, Michel A.; Vissers, Lisenka E. L. M.; Lammens, Martin; van Bokhoven, Hans; Brunner, Han G.; Wevers, Ron A.; Schenck, Annette; Al-Gazali, Lihadh; de Vries, Bert B. A.; de Brouwer, Arjan P. M.		FORGE Canada Consortium	Mutations in DDHD2, Encoding an Intracellular Phospholipase A(1), Cause a Recessive Form of Complex Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; THIN CORPUS-CALLOSUM; INTELLECTUAL DISABILITY; NEUROMUSCULAR-JUNCTION; SEQUENCING DATA; DROSOPHILA; TRAFFICKING; PLASTICITY; KIAA0725P; PATHWAY	We report on four families affected by a clinical presentation of complex hereditary spastic paraplegia (HSP) due to recessive mutations in DDHD2, encoding one of the three mammalian intracellular phospholipases A(1) (iPLA(1)). The core phenotype of this HSP syndrome consists of very early-onset (<2 years) spastic paraplegia, intellectual disability, and a specific pattern of brain abnormalities on cerebral imaging. An essential role for DDHD2 in the human CNS, and perhaps more specifically in synaptic functioning, is supported by a reduced number of active zones at synaptic terminals in Ddhd-knockdown Drosophila models. All identified mutations affect the protein's DDHD domain, which is vital for its phospholipase activity. In line with the function of DDHD2 in lipid metabolism and its role in the CNS, an abnormal lipid peak indicating accumulation of lipids was detected with cerebral magnetic resonance spectroscopy, which provides an applicable diagnostic biomarker that can distinguish the DDHD2 phenotype from other complex HSP phenotypes. We show that mutations in DDHD2 cause a specific complex HSP subtype (SPG54), thereby linking a member of the PLA(1) family to human neurologic disease.	[Schuurs-Hoeijmakers, Janneke H. M.; Kamsteeg, Erik-Jan; Nijhof, Bonnie; van de Vondervoort, Ilse I. G. M.; Nobau, Anna Castells; Vermeer, Sascha; van den Akker, Willem M. R.; Gilissen, Christian; Veltman, Joris A.; Janssen, Irene M.; Vulto-van Silfhout, Anneke T.; van der Velde-Visser, Saskia; Diekstra, Adinda; Vissers, Lisenka E. L. M.; van Bokhoven, Hans; Brunner, Han G.; Schenck, Annette; de Vries, Bert B. A.; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 855, NL-6500 HB Nijmegen, Netherlands; [Schuurs-Hoeijmakers, Janneke H. M.; Gilissen, Christian; Veltman, Joris A.; Lefeber, Dirk J.; Vissers, Lisenka E. L. M.; Brunner, Han G.; Wevers, Ron A.; de Vries, Bert B. A.; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Schuurs-Hoeijmakers, Janneke H. M.; Nijhof, Bonnie; Nobau, Anna Castells; Gilissen, Christian; Veltman, Joris A.; Vissers, Lisenka E. L. M.; van Bokhoven, Hans; Brunner, Han G.; Schenck, Annette; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Geraghty, Michael T.; Humphreys, Peter] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Ben-Salem, Salma; Ali, Bassam R.; Pramathan, Thachillath; Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Ben-Salem, Salma; Ali, Bassam R.; Pramathan, Thachillath; Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; [de Bot, Susanne T.; van de Warrenburg, Bart P.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [de Bot, Susanne T.; Nijhof, Bonnie; Nobau, Anna Castells; van de Warrenburg, Bart P.; Vulto-van Silfhout, Anneke T.; Willemsen, Michel A.; van Bokhoven, Hans; Schenck, Annette; de Vries, Bert B. A.; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands; [van der Graaf, Marinette] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [van der Graaf, Marinette] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands; [Otte-Holler, Irene; Lammens, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Smith, Amanda C.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L1, Canada; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Al-Yahyaee, Saeed A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Genet, Muscat 123, Oman; [Tariq, Said] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Anat, Al Ain, U Arab Emirates; [Bayoumi, Riyad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, Muscat 123, Oman; [Kremer, Hubertus P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Eramus, Corrie E.; Willemsen, Michel A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, NL-6500 HB Nijmegen, Netherlands; [Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Ottawa; Children's Hospital of Eastern Ontario; United Arab Emirates University; United Arab Emirates University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Ottawa; Ottawa Hospital Research Institute; McGill University; Sultan Qaboos University; United Arab Emirates University; Sultan Qaboos University; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 855, POB 9101, NL-6500 HB Nijmegen, Netherlands.	b.devries@gen.umcn.nl	Wevers, Ron A./H-8116-2014; Schenck, Annette/E-4514-2012; Gilissen, Christian/E-5246-2012; de Brouwer, Arjan PM/P-5949-2015; Lefeber, Dirk DJ/A-2146-2014; AT, Vulto-van Silfhout/H-4199-2015; Brunner, Han/C-9928-2013; van der Graaf, Marinette/D-4086-2009; Diekstra, Adinda/P-8132-2015; Lammens, Martin/AAI-9343-2021; Janssen, Irene M/V-3667-2018; Lammens, Martin/H-1503-2011; de Bot, Susanne/ABE-4012-2021; Bayoumi, Riad/ABH-2732-2020; van de Warrenburg, Bart PC/D-1935-2010; Willemsen, Michel A.A.P./H-8119-2014; van Bokhoven, Hans/D-8764-2012; Castells-Nobau, Anna/AAA-3846-2020; Erasmus, C.E./L-4295-2015; Veltman, Joris A/F-5128-2010; Ben-Salem, Salma/E-1702-2016; Vissers, Lisenka ELM/A-2598-2015; Kamsteeg, Erik-Jan/L-4421-2015; Castells-Nobau, Anna/AAL-1905-2021; Bokhoven, J.H.L.M. van van/H-8015-2014; Otte-Holler, Irene/N-5708-2015	Wevers, Ron A./0000-0003-2278-9746; Schenck, Annette/0000-0002-6918-3314; Gilissen, Christian/0000-0003-1693-9699; Lammens, Martin/0000-0002-3881-6692; de Bot, Susanne/0000-0002-3512-2468; van de Warrenburg, Bart PC/0000-0003-4412-1616; Erasmus, C.E./0000-0002-6657-941X; Veltman, Joris A/0000-0002-3218-8250; Ben-Salem, Salma/0000-0001-5023-6781; Vissers, Lisenka ELM/0000-0001-6470-5497; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Bayoumi, Riad/0000-0001-8177-8129; Vermeer, Sascha/0000-0001-7625-1912; van den Akker, Willem M.R./0000-0001-9492-4359; Ali, Bassam R/0000-0003-1306-6618; Schwartzentruber, Jeremy/0000-0002-6183-2092; Castells-Nobau, Anna/0000-0002-6024-8353	Government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Netherlands Organization for Health Research and Development (VIDI) [917-86-319, 917-96-346]; GENCODYS project (EU) [241995]; Dutch Brain Foundation [2010(1)-30, 2009(1)-22]; Dubai Harvard Foundation for Medical Research; United Arab Emirates University	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Netherlands Organization for Health Research and Development (VIDI); GENCODYS project (EU); Dutch Brain Foundation; Dubai Harvard Foundation for Medical Research; United Arab Emirates University	We are grateful to the studied individuals and their families for their support and cooperation. We thank Prof. N. Knoers for her contribution to the collection of the follow-up cohort and A. Heister for homozygosity analysis in family 4. This work was completed with collaboration from the FORGE Canada Consortium-supported by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research, and the Ontario Genomics Institute (OGI-049)-as well as from the Netherlands Organization for Health Research and Development (VIDI grants 917-86-319 to B.B.A.d.V. and 917-96-346 to A.S.), the GENCODYS project (EU-7th-2010-241995 to H.v.B., A.S., A.T.V.v.S., and B.B.A.d.V.), and the Dutch Brain Foundation (2010(1)-30 to A.P.M.d.B. and 2009(1)-22 to B.B.A.d.V.). The laboratories of L.A. and B.R.A. are funded by the Dubai Harvard Foundation for Medical Research and the United Arab Emirates University.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Al-Yahyaee S, 2006, NEUROLOGY, V66, P1230, DOI 10.1212/01.wnl.0000208501.52849.dd; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Bauer P, 2012, NEUROGENETICS, V13, P73, DOI 10.1007/s10048-012-0314-0; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dreha-Kulaczewski S, 2006, NEURORADIOLOGY, V48, P893, DOI 10.1007/s00234-006-0148-2; Hobson GM, 2012, SEMIN NEUROL, V32, P62, DOI 10.1055/s-0032-1306388; Inoue H, 2012, BBA-MOL CELL RES, V1823, P930, DOI 10.1016/j.bbamcr.2012.02.002; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZH, 2011, J NEUROSCI, V31, P2052, DOI 10.1523/JNEUROSCI.3278-10.2011; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morikawa RK, 2009, J BIOL CHEM, V284, P26620, DOI 10.1074/jbc.M109.038869; Murmu RP, 2011, MOL CELL NEUROSCI, V47, P191, DOI 10.1016/j.mcn.2011.04.004; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Sato S, 2010, FEBS LETT, V584, P4389, DOI 10.1016/j.febslet.2010.09.047; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Stromillo ML, 2011, J NEUROL, V258, P2240, DOI 10.1007/s00415-011-6106-x; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wichmann C, 2010, J NEUROGENET, V24, P133, DOI 10.3109/01677063.2010.489626; Willemsen MAAP, 2001, BRAIN, V124, P1426, DOI 10.1093/brain/124.7.1426; Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	36	118	120	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1073	1081		10.1016/j.ajhg.2012.10.017	http://dx.doi.org/10.1016/j.ajhg.2012.10.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176823	Bronze, Green Published			2022-12-18	WOS:000312417400010
J	Johnston, JJ; Gropman, AL; Sapp, JC; Teer, JK; Martin, JM; Liu, CF; Yuan, X; Ye, ZH; Cheng, LZ; Brodsky, RA; Biesecker, LG				Johnston, Jennifer J.; Gropman, Andrea L.; Sapp, Julie C.; Teer, Jamie K.; Martin, Jodie M.; Liu, Cyndi F.; Yuan, Xuan; Ye, Zhaohui; Cheng, Linzhao; Brodsky, Robert A.; Biesecker, Leslie G.			The Phenotype of a Germline Mutation in PIGA: The Gene Somatically Mutated in Paroxysmal Nocturnal Hemoglobinuria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; STEM-CELLS; A GENE; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEINS; INACTIVATION; DEFICIENCY; ANEMIA; EXONS; PNH	Phosphatidylinositol glycan class A (PIGA) is involved in the first step of glycosylphosphatidylinositol (GPI) biosynthesis. Many proteins, including CD55 and CD59, are anchored to the cell by GPI. Loss of CD55 and CD59 on erythrocytes causes complement-mediated lysis in paroxysmal nocturnal hemoglobinuria (PNH), a disease that manifests after clonal expansion of hematopoietic cells with somatic PICA mutations. Although somatic PIGA mutations have been identified in many PNH patients, it has been proposed that germline mutations are lethal. We report a family with an X-linked lethal disorder involving cleft palate, neonatal seizures, contractures, central nervous system (CNS) structural malformations, and other anomalies. An X chromosome exome next-generation sequencing screen identified a single nonsense PICA mutation, c.1234C>T, which predicts p.Arg412*. This variant segregated with disease and carrier status in the family, is similar to mutations known to cause PNH as a result of PIGA dysfunction, and was absent in 409 controls. PIGA-null mutations are thought to be embryonic lethal, suggesting that p.Arg412* PICA has residual function. Transfection of a mutant p.Arg412* PIGA construct into PIGA-null cells showed partial restoration of GPI-anchored proteins. The genetic data show that the c.1234C>T (p.Arg412*) mutation is present in an affected child, is linked to the affected chromosome in this family, is rare in the population, and results in reduced, but not absent, biosynthesis of GPI anchors. We conclude that c.1234C>T in PIGA results in the lethal X-linked phenotype recognized in the reported family.	[Johnston, Jennifer J.; Sapp, Julie C.; Teer, Jamie K.; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Gropman, Andrea L.; Martin, Jodie M.] Childrens Natl Med Ctr, Div Neurol, Washington, DC 20010 USA; [Liu, Cyndi F.; Yuan, Xuan; Ye, Zhaohui; Cheng, Linzhao; Brodsky, Robert A.] Johns Hopkins Univ, Dept Internal Med, Div Hematol, Baltimore, MD USA; [Biesecker, Leslie G.] NHGRI, NIH, Intramural Sequencing Ctr, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Biesecker, Leslie/AAG-2526-2021	Sapp, Julie/0000-0002-4003-258X; Vento, Jodie/0000-0002-1413-4785; Ye, Zhaohui/0000-0001-5272-9168	National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank M. Abubakar, G. Bowles-Johnson, S. Covington, C. Gomez, A. Hutchins, F. Porter, M. Raygada, O. Rennert, and other clinicians at Georgetown University Hospital, Children's National Medical Center, and Johns Hopkins University for clinical investigations of this family. J. Hanover assisted with attempts to revive the frozen fibroblasts of patient IV-4. Julia Fekecs assisted with graphics. Most importantly, we gratefully acknowledge the family and dedicate this work to the memory of Walker P. Carter, Jr and Michael H. Carter III. This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health.	Almeida A, 2009, BBA-MOL BASIS DIS, V1792, P874, DOI 10.1016/j.bbadis.2008.12.010; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Brodsky RA, 2008, ANN INTERN MED, V148, P587, DOI 10.7326/0003-4819-148-8-200804150-00003; Brodsky RA, 2009, BLOOD, V113, P6522, DOI 10.1182/blood-2009-03-195966; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Karagogeos D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1304, DOI 10.2741/1214; Kawagoe K, 1996, BLOOD, V87, P3600, DOI 10.1182/blood.V87.9.3600.bloodjournal8793600; Keller P, 1999, P NATL ACAD SCI USA, V96, P7479, DOI 10.1073/pnas.96.13.7479; Keller P, 2001, J EXP MED, V194, P581, DOI 10.1084/jem.194.5.581; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Nafa K, 1998, BLOOD CELL MOL DIS, V24, P370, DOI 10.1006/bcmd.1998.0203; NAGARAJAN S, 1995, BLOOD, V86, P4656, DOI 10.1182/blood.V86.12.4656.bloodjournal86124656; Savage WJ, 2009, EXP HEMATOL, V37, P42, DOI 10.1016/j.exphem.2008.09.002; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; WARE RE, 1994, BLOOD, V83, P2418	24	118	122	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					295	300		10.1016/j.ajhg.2011.11.031	http://dx.doi.org/10.1016/j.ajhg.2011.11.031			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305531	Green Published, Bronze			2022-12-18	WOS:000300742200010
J	Lopez-Hernandez, T; Ridder, MC; Montolio, M; Capdevila-Nortes, X; Polder, E; Sirisi, S; Duarri, A; Schulte, U; Fakler, B; Nunes, V; Scheper, GC; Martinez, A; Estevez, R; van der Knaap, MS				Lopez-Hernandez, Tania; Ridder, Margreet C.; Montolio, Marisol; Capdevila-Nortes, Xavier; Polder, Emiel; Sirisi, Sonia; Duarri, Anna; Schulte, Uwe; Fakler, Bernd; Nunes, Virginia; Scheper, Gert C.; Martinez, Albert; Estevez, Raul; van der Knaap, Marjo S.			Mutant GlialCAM Causes Megalencephalic Leukoencephalopathy with Subcortical Cysts, Benign Familial Macrocephaly, and Macrocephaly with Retardation and Autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-ADHESION MOLECULE; MILD CLINICAL-COURSE; MARIE-TOOTH DISEASE; GENETIC-HETEROGENEITY; MLC1 PROTEIN; MUTATIONS; DOMINANT; BRAIN	Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a leukodystrophy characterized by early-onset macrocephaly and delayed-onset neurological deterioration. Recessive MLC1 mutations are observed in 75% of patients with MLC. Genetic-linkage studies failed to identify another gene. We recently showed that some patients without MLC1 mutations display the classical phenotype; others improve or become normal but retain macrocephaly. To find another MLC-related gene, we used quantitative proteomic analysis of affinity-purified MLC1 as an alternative approach and found that GlialCAM, an IgG-like cell adhesion molecule that is also called HepaCAM and is encoded by HEPA CAM, is a direct MLC1-binding partner. Analysis of 40 MLC patients without MLC1 mutations revealed multiple different HEPA CAM mutations. Ten patients with the classical, deteriorating phenotype had two mutations, and 18 patients with the improving phenotype had one mutation. Most parents with a single mutation had macrocephaly, indicating dominant inheritance. In some families with dominant HEPACAM mutations, the clinical picture and magnetic resonance imaging normalized, indicating that HEPA CAM mutations can cause benign familial macrocephaly. In other families with dominant HEPA CAM mutations, patients had macrocephaly and mental retardation with or without autism. Further experiments demonstrated that GlialCAM and MLC1 both localize in axons and colocalize in junctions between astrocytes. GlialCAM is additionally located in myelin. Mutant GlialCAM disrupts the localization of MLC1-GlialCAM complexes in astrocytic junctions in a manner reflecting the mode of inheritance. In conclusion, GlialCAM is required for proper localization of MLC1. HEPA CAM is the second gene found to be mutated in MLC. Dominant HEPA CAM mutations can cause either macrocephaly and mental retardation with or without autism or benign familial macrocephaly.	[Lopez-Hernandez, Tania; Montolio, Marisol; Capdevila-Nortes, Xavier; Sirisi, Sonia; Duarri, Anna; Estevez, Raul] Univ Barcelona, Secc Fisiol, Dept Ciencias Fisiol 2, Barcelona 08907, Spain; [Nunes, Virginia] Univ Barcelona, Secc Genet, Dept Ciencias Fisiol 2, Barcelona 08907, Spain; [Ridder, Margreet C.; Polder, Emiel; Scheper, Gert C.; van der Knaap, Marjo S.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Montolio, Marisol; Duarri, Anna; Estevez, Raul] ISCIII, Ctr Invest Red Enfermedades Raras CIBERER, U750, Barcelona 08907, Spain; [Nunes, Virginia] ISCIII, Ctr Invest Red Enfermedades Raras CIBERER, U730, Barcelona 08907, Spain; [Sirisi, Sonia; Nunes, Virginia] Lab Genet Mol IDIBELL, Barcelona 08907, Spain; [Schulte, Uwe; Fakler, Bernd] Logopharm GmbH, D-79108 Freiburg, Germany; [Martinez, Albert] Univ Barcelona, Fac Biol, Dept Cell Biol, Barcelona 08907, Spain; [Martinez, Albert] Univ Barcelona, Inst Res Biomed, Barcelona 08907, Spain	University of Barcelona; University of Barcelona; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Estevez, R (corresponding author), Univ Barcelona, Secc Fisiol, Dept Ciencias Fisiol 2, Barcelona 08907, Spain.	restevez@ub.edu; ms.vanderknaap@vumc.nl	Duarri, Anna/K-2811-2017; Scheper, Gert C/D-7001-2014; Estevez, Raul/D-8610-2015; Hernandez, Tania Lopez/AAH-8754-2019; Dolcet, Sonia Sirisi/AAG-9250-2019; Nunes, Virginia/AAD-1014-2019	Duarri, Anna/0000-0003-4075-5478; Estevez, Raul/0000-0003-1579-650X; Dolcet, Sonia Sirisi/0000-0002-5366-7832; Nunes, Virginia/0000-0002-5747-9310; Martinez, Albert/0000-0003-0831-9916; Lopez-Hernandez, Tania/0000-0002-0814-2850; Ridder, Margreet/0000-0001-7215-8534; Montolio, Marisol/0000-0001-5494-5737	Ministerio de Ciencia y Tecnologia (SAF) [2009-07014, 2009-12606-C02-02]; Fundacion Ramon Areces; European Leukodystrophy Association Foundation [2007-017C4]; ERARE [11-330-1024, PS09/02672-ERARE]; Grups de Recerca de Catalunya [719]; CIBERER [INTRA08/750, SGR01490]; Dutch Organization for Scientific Research ZonMw [9120.6002]; Hersenstichting [13F05.04, 15F07.30, 2009[2]-14]; Optimix Foundation for Scientific Research; ICREA Academia prize	Ministerio de Ciencia y Tecnologia (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; European Leukodystrophy Association Foundation; ERARE; Grups de Recerca de Catalunya; CIBERER; Dutch Organization for Scientific Research ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Hersenstichting; Optimix Foundation for Scientific Research; ICREA Academia prize(ICREA)	Research in our laboratories was supported by Ministerio de Ciencia y Tecnologia (SAF) 2009-07014 (RE.), Fundacion Ramon Areces project (R.E.), European Leukodystrophy Association Foundation 2007-017C4 project (R.E. and M.S.v.d.K.), PS09/02672-ERARE (RE.), ERARE grant 11-330-1024 (G.C.S. and M.S.v.d.K.), 2009 Grups de Recerca de Catalunya 719 (R.E.), SAF 2009-12606-C02-02 (V.N.), CIBERER INTRA08/750 (RE. and V.N.), and 2009 SGR01490 (V.N.). M.S.v.d.K., G.C.S., and M.C.R. are supported by the Dutch Organization for Scientific Research ZonMw (TOP Grant 9120.6002), the Hersenstichting (Grants 13F05.04, 15F07.30 and 2009[2]-14), and the Optimix Foundation for Scientific Research. R.E. is a recipient of an ICREA Academia prize. We thank all colleagues who contributed MRI, clinical information, and blood samples. We thank Alejandro Barrallo, Michael Pusch, and Jim M. Powers for critical review of the manuscript.	Blattner R, 2003, NEUROPEDIATRICS, V34, P215; Boor PKI, 2006, HUM MUTAT, V27, P505, DOI 10.1002/humu.20332; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Brignone MS, 2011, HUM MOL GENET, V20, P90, DOI 10.1093/hmg/ddq435; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Duarri A, 2008, HUM MOL GENET, V17, P3728, DOI 10.1093/hmg/ddn269; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Favre-Kontula L, 2008, GLIA, V56, P633, DOI 10.1002/glia.20640; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Kaganovich M, 2004, AM J MED GENET B, V125B, P31, DOI 10.1002/ajmg.b.20115; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Moh MC, 2005, J HEPATOL, V42, P833, DOI 10.1016/j.jhep.2005.01.025; Nicolaou P, 2010, NEUROEPIDEMIOLOGY, V35, P171, DOI 10.1159/000314351; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; PANDEY A, 2000, SCI STKE, pPL1; Patrono C, 2003, NEUROLOGY, V61, P534, DOI 10.1212/01.WNL.0000076184.21183.CA; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Schmitt A, 2003, GLIA, V44, P283, DOI 10.1002/glia.10304; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Spiegel I, 2006, NEURON GLIA BIOL, V2, P27, DOI 10.1017/S1740925X0600007X; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; van der Knaap MS, 2010, ANN NEUROL, V67, P834, DOI 10.1002/ana.21980; vanderKnaap MS, 1996, ACTA NEUROPATHOL, V92, P206, DOI 10.1007/s004010050510; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; White S, 2009, NEUROPSYCHOLOGIA, V47, P1274, DOI 10.1016/j.neuropsychologia.2009.01.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	29	118	127	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					422	432		10.1016/j.ajhg.2011.02.009	http://dx.doi.org/10.1016/j.ajhg.2011.02.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21419380	Bronze, Green Published			2022-12-18	WOS:000289664300002
J	Bolze, A; Byun, M; McDonald, D; Morgan, NV; Abhyankar, A; Premkumar, L; Puel, A; Bacon, CM; Rieux-Laucat, F; Pang, K; Britland, A; Abel, L; Cant, A; Maher, ER; Riedl, SJ; Hambleton, S; Casanova, JL				Bolze, Alexandre; Byun, Minji; McDonald, David; Morgan, Neil V.; Abhyankar, Avinash; Premkumar, Lakshmanane; Puel, Anne; Bacon, Chris M.; Rieux-Laucat, Frederic; Pang, Ki; Britland, Alison; Abel, Laurent; Cant, Andrew; Maher, Eamonn R.; Riedl, Stefan J.; Hambleton, Sophie; Casanova, Jean-Laurent			Whole-Exome-Sequencing-Based Discovery of Human FADD Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMAIN-CONTAINING PROTEIN; LYMPHOPROLIFERATIVE SYNDROME; DEATH DOMAIN; FAS; APOPTOSIS; MUTATIONS	Germline mutations in FAR. and FAS impair Fas-dependent apoptosis and cause recessively or dominantly inherited autoimmune lymphoproliferative syndrome (ALPS). Patients with ALPS typically present with no other clinical phenotype. We investigated a large, consanguineous, multiplex kindred in which biological features of ALPS were found in the context of severe bacterial and viral disease, recurrent hepatopathy and encephalopathy, and cardiac malformations. By a combination of genome-wide linkage and whole-exome sequencing, we identified a homozygous missense mutation in FADD, encoding the Fas-associated death domain protein (FADD), in the patients. This FADD mutation decreases steady-state protein levels and impairs Fas-dependent apoptosis in vitro, accounting for biological ALPS phenotypes in vivo. It also impairs Fas-independent signaling pathways. The observed bacterial infections result partly from functional hyposplenism, and viral infections result from impaired interferon immunity. We describe here a complex clinical disorder, its genetic basis, and some of the key mechanisms underlying its pathogenesis. Our findings highlight the key role of FADD in Fas-dependent and Fas-independent signaling pathways in humans.	[Bolze, Alexandre; Byun, Minji; Abhyankar, Avinash; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [McDonald, David; Cant, Andrew; Hambleton, Sophie] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Morgan, Neil V.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Wellchild Paediat Res Ctr, Birmingham B15 2TT, W Midlands, England; [Morgan, Neil V.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Premkumar, Lakshmanane; Riedl, Stefan J.] Sanford Burnham Med Res Inst, Apoptosis & Cell Death Res Program, La Jolla, CA 92037 USA; [Puel, Anne; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch, F-75015 Paris, France; [Bacon, Chris M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bacon, Chris M.] Newcastle Upon Tyne Hosp, Dept Cellular Pathol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Rieux-Laucat, Frederic] Univ Paris 05, Necker Hosp, APHP,INSERM,U768,Unit Pediat Immunol & Hematol, Normal & Pathol Dev Immune Syst Res Lab, F-75015 Paris, France; [Pang, Ki] Great N Childrens Hosp, Paediat Neurol Dept, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Britland, Alison] Airedale Dist Gen Hosp, Childrens Unit, Eastburn BD20 6TD, W Yorkshire, England; [Cant, Andrew; Hambleton, Sophie] Great N Childrens Hosp, Paediat Immunol Dept, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Immunol Hematol Unit, F-75015 Paris, France	Rockefeller University; Newcastle University - UK; University of Birmingham; University of Birmingham; Sanford Burnham Prebys Medical Discovery Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; Newcastle University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA.	jean-laurent.casanova@rockefeller.edu	Puel, Anne/H-7305-2017; Morgan, Neil V/A-5475-2009; Casanova, Jean-Laurent/I-3418-2017; Rieux-Laucat, Frédéric/A-7916-2017; MAHER, EAMONN R/A-9507-2008; Abel, Laurent/H-8888-2017; Bolze, Alexandre/A-1672-2012	Puel, Anne/0000-0003-2603-0323; Morgan, Neil V/0000-0001-6433-5692; Rieux-Laucat, Frédéric/0000-0001-7858-7866; MAHER, EAMONN R/0000-0002-6226-6918; Abel, Laurent/0000-0001-7016-6493; Byun, Minji/0000-0002-2830-4079; Casanova, Jean-Laurent/0000-0002-7782-4169; Bolze, Alexandre/0000-0001-7399-2766	INSERM; University Paris Descartes; Rockefeller University Center for Clinical Translational Science [5UL1RR024143-03]; Rockefeller University; St. Giles Foundation; MRC [G0701897]; ANR [ANR-08-GENO-015-01]; WellChild foundation; Cancer Research Institute;  [R01AA017238]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017238] Funding Source: NIH RePORTER; Medical Research Council [G0701897] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Rockefeller University Center for Clinical Translational Science; Rockefeller University; St. Giles Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ANR(French National Research Agency (ANR)); WellChild foundation; Cancer Research Institute; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients' family for their trust and all members of our laboratories for helpful discussions. We thank Capucine Picard for her expert analysis of the lymphocyte subsets of the patients. We thank Louise Tee for technical assistance and SNP genotyping and Shanaz Pasha for patient ascertainment. We thank Magorzata Dobaczewska for the production of proteins in bacteria and Andrey Bobkov (protein facility at SBMRI) for DSC measurement. The Laboratory of Human Genetics of Infectious Diseases is supported by grants from INSERM, University Paris Descartes, The Rockefeller University Center for Clinical Translational Science (grant number 5UL1RR024143-03), The Rockefeller University, and St. Giles Foundation. The laboratory of S.H. is supported by an MRC grant (G0701897). This work was also supported by a R01AA017238 grant to S.J.R., by an ANR grant (ANR-08-GENO-015-01) to F.R.L., and by the WellChild foundation. M.B. is supported by a fellowship from the Cancer Research Institute.	*1000 GEN, 1000 GEN PROJ; [Anonymous], ONLINE MENDELIAN INH; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bleesing JJH, 2001, BLOOD, V98, P2466, DOI 10.1182/blood.V98.8.2466; Brigden ML, 2001, AM FAM PHYSICIAN, V63, P499; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Del-Rey M, 2006, BLOOD, V108, P1306, DOI 10.1182/blood-2006-04-015776; DOLL DC, 1987, SOUTHERN MED J, V80, P999, DOI 10.1097/00007611-198708000-00016; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; KATCHER AL, 1980, PEDIATRICS, V65, P633; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magerus-Chatinet A, 2009, BLOOD, V113, P3027, DOI 10.1182/blood-2008-09-179630; Mahlaoui N, 2010, J PEDIAT; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; *PIC, PIC TOOLS; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Su HC, 2008, IMMUNOL ALLERGY CLIN, V28, P329, DOI 10.1016/j.iac.2008.01.002; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Walsh CM, 2010, CURR OPIN IMMUNOL, V22, P321, DOI 10.1016/j.coi.2010.03.005; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; SEATTLESEQ SNP ANNOT	37	118	124	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					873	881		10.1016/j.ajhg.2010.10.028	http://dx.doi.org/10.1016/j.ajhg.2010.10.028			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109225	Green Published, Bronze			2022-12-18	WOS:000285564600015
J	Senderek, J; Garvey, SM; Krieger, M; Guergueltcheva, V; Urtizberea, A; Roos, A; Elbracht, M; Stendel, C; Tournev, I; Mihailova, V; Feit, H; Tramonte, J; Hedera, P; Crooks, K; Bergmann, C; Rudnik-Schoneborn, S; Zerres, K; Lochmuller, H; Seboun, E; Weis, J; Beckmann, JS; Hauser, MA; Jackson, CE				Senderek, Jan; Garvey, Sean M.; Krieger, Michael; Guergueltcheva, Velina; Urtizberea, Andoni; Roos, Andreas; Elbracht, Miriam; Stendel, Claudia; Tournev, Ivailo; Mihailova, Violeta; Feit, Howard; Tramonte, Jeff; Hedera, Peter; Crooks, Kristy; Bergmann, Carsten; Rudnik-Schoeneborn, Sabine; Zerres, Klaus; Lochmueller, Hanns; Seboun, Eric; Weis, Joachim; Beckmann, Jacques S.; Hauser, Michael A.; Jackson, Charles E.			Autosomal-Dominant Distal Myopathy Associated with a Recurrent Missense Mutation in the Gene Encoding the Nuclear Matrix Protein, Matrin 3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; BODY MYOPATHY; PHARYNGEAL WEAKNESS; ATTACHMENT REGIONS; SCAFFOLD PROTEIN; GENOMIC FUNCTION; VOCAL CORD; MYOTILIN; IDENTIFICATION; LOCALIZATION	Distal myopathies represent a heterogeneous group of inherited skeletal muscle disorders. One type of adult-onset, progressive autosomal-dominant distal myopathy, frequently associated with dysphagia and dysphonia (vocal cord and pharyngeal weakness with distal myopathy [VCPDM]), has been mapped to chromosome 5q31 in a North American pedigree. Here, we report the identification of a second large VCPDM family of Bulgarian descent and fine mapping of the critical interval. Sequencing of positional candidate genes revealed precisely the same nonconservative S85C missense mutation affecting an interspecies conserved residue in the MATR3 gene in both families. MATR3 is expressed in skeletal muscle and encodes matrin 3, a component of the nuclear matrix, which is a proteinaceous network that extends throughout the nucleus. Different disease related haplotype signatures in the two families provided evidence that two independent mutational events at the same position in MATR3 cause VCPDM. Our data establish proof of principle that the nuclear matrix is crucial for normal skeletal muscle structure and function and put VCPDM on the growing list of monogenic disorders associated with the nuclear proteome.	[Senderek, Jan; Stendel, Claudia] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Senderek, Jan; Krieger, Michael; Elbracht, Miriam; Stendel, Claudia; Bergmann, Carsten; Rudnik-Schoeneborn, Sabine; Zerres, Klaus] Rhein Westfal TH Aachen, Inst Human Genet, D-52074 Aachen, Germany; [Garvey, Sean M.] Univ Virginia, Div Cardiovasc Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Garvey, Sean M.; Crooks, Kristy; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Guergueltcheva, Velina; Tournev, Ivailo; Mihailova, Violeta] Med Univ Sofia, Alexandrovska Univ Hosp, Neurol Clin, Sofia 1431, Bulgaria; [Urtizberea, Andoni] Hop Marin Hendaye, F-64701 Hendaye, France; [Feit, Howard] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Tramonte, Jeff] Scott & White Mem Hosp & Clin, Dept Neurol, Temple, TX 76508 USA; [Hedera, Peter] Vanderbilt Univ, Dept Neurol, Nashville, TN 37240 USA; [Lochmueller, Hanns] Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Seboun, Eric] Univ Paris 06, Div Genet & Microbiol, F-75005 Paris, France; [Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, D-52074 Aachen, Germany; [Beckmann, Jacques S.] Univ Lausanne, Dept & Serv Med Genet, CH-1005 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, CH-1005 Lausanne, Switzerland; [Jackson, Charles E.] Scott & White Mem Hosp & Clin, Dept Med, Temple, TX 76508 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; RWTH Aachen University; University of Virginia; Duke University; Medical University Sofia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Marin de Hendaye - APHP; Henry Ford Health System; Henry Ford Hospital; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Vanderbilt University; Newcastle University - UK; UDICE-French Research Universities; Sorbonne Universite; RWTH Aachen University; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Senderek, J (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	jan.senderek@cell.biol.ethz.ch	Elbracht, Miriam/ABN-8561-2022; Rudnik-Schöneborn, Sabine/F-8473-2015; Beckmann, Jacques S/A-9772-2008; Senderek, Jan/F-8405-2015; Weis, Joachim/G-1984-2014	Beckmann, Jacques S/0000-0002-9741-1900; Senderek, Jan/0000-0002-8263-1783; Weis, Joachim/0000-0003-3280-6773; Garvey, Sean/0000-0003-1013-7871; Hedera, Peter/0000-0003-2699-4085; Lochmuller, Hanns/0000-0003-2324-8001	Deutsche Forschungsgemeinschaft; Aachen University of Technology; START program of the Faculty Of Medicine of Aachen University of Technology; Doktor Robert Pfleger-Stiftung; Maximilian May-Stiftung; Swiss National Science Foundation; Bulgarian Ministry of Education and Science; Interdisciplinary Centre for Clinical Research BIOMAT; Faculty of Medicine of Aachen University of Technology; Medical Research Council [G0601943B] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Aachen University of Technology; START program of the Faculty Of Medicine of Aachen University of Technology; Doktor Robert Pfleger-Stiftung; Maximilian May-Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bulgarian Ministry of Education and Science; Interdisciplinary Centre for Clinical Research BIOMAT; Faculty of Medicine of Aachen University of Technology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to the members of the families with distal myopathies for their participation in this study. J. Senderek is a Heisenberg fellow and C. Stendel is a postdoctoral fellow of the Deutsche Forschungsgemeinschaft. A. Roos received a PhD scholarship from Aachen University of Technology. This work was supported by grants from the START program of the Faculty Of Medicine of Aachen University of Technology (to M. Elbracht), the Doktor Robert Pfleger-Stiftung and the Maximilian May-Stiftung (to J. Senderek), the Swiss National Science Foundation (to J.S.B.), the Bulgarian Ministry of Education and Science (to V.G., V.M., and I.T.), and the Interdisciplinary Centre for Clinical Research BIOMAT within the Faculty of Medicine of Aachen University of Technology (to J.S. and J.W.).	Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Berezney R, 1998, J CELL BIOCHEM, P238; Berezney R, 1995, INT REV CYTOL, V162A, P1; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boulikas T, 1995, INT REV CYTOL, V162A, P279; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dye BT, 2001, EXP CELL RES, V263, P131, DOI 10.1006/excr.2000.5097; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Foroud T, 2005, NEUROLOGY, V65, P1936, DOI 10.1212/01.wnl.0000188872.28149.9a; Garvey SM, 2006, ANN HUM GENET, V70, P414, DOI 10.1111/j.1469-1809.2005.00252.x; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 2006, BBA-GENE STRUCT EXPR, V1759, P195, DOI 10.1016/j.bbaexp.2006.04.010; HUTCHISON CJ, 1994, J CELL SCI, V107, P3259; Lattanzi G, 2003, BIOCHEM BIOPH RES CO, V303, P764, DOI 10.1016/S0006-291X(03)00415-7; Leonard D, 2003, BIOCHEM BIOPH RES CO, V308, P793, DOI 10.1016/S0006-291X(03)01486-4; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; Ng EKO, 2002, J CELL BIOCHEM, V84, P556, DOI 10.1002/jcb.10041.abs; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; Parnaik VK, 2006, J BIOSCIENCES, V31, P405, DOI 10.1007/BF02704113; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Tateyama M, 2002, NEUROLOGY, V58, P323, DOI 10.1212/WNL.58.2.323; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Udd B, 2001, CURR OPIN NEUROL, V14, P561, DOI 10.1097/00019052-200110000-00003; Udd B, 2007, BBA-MOL BASIS DIS, V1772, P145, DOI 10.1016/j.bbadis.2006.08.005; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Xu TR, 2004, FEBS LETT, V570, P20, DOI 10.1016/j.febslet.2004.05.080; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	52	118	121	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					511	518		10.1016/j.ajhg.2009.03.006	http://dx.doi.org/10.1016/j.ajhg.2009.03.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19344878	Green Published, Bronze			2022-12-18	WOS:000265232800011
J	Collin, RWJ; Littink, KW; Klevering, BJ; van den Born, LI; Koenekoop, RK; Zonneveld, MN; Blokland, EAW; Strom, TM; Hoyng, CB; den Hollander, AI; Cremers, FPM				Collin, Rob W. J.; Littink, Karin W.; Klevering, B. Jeroen; van den Born, L. Ingeborgh; Koenekoop, Robert K.; Zonneveld, Marijke N.; Blokland, Ellen A. W.; Strom, Tim M.; Hoyng, Carel B.; den Hollander, Anneke I.; Cremers, Frans P. M.			Identification of a 2 Mb Human Ortholog of Drosophila eyes shut/spacemaker that Is Mutated in Patients with Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; CANDIDATE GENES; DMD GENE; MUTATIONS; FAMILIES; CLONING; RP25; CRB1; LOCUS; CDNA	In patients with autosomal-recessive retinitis pigmentosa (arRP), homozygosity mapping was performed for detection of regions harboring genes that might be causative for RP In one affected sib pair, a shared homozygous region of 5.0 Mb was identified oil chromosome 6, within the RP25 locus. One of the genes residing in this interval was the retina-expressed gene EGFL 11. Several genes resembling EGFL I I were predicted just centromeric of EGFL 11. Extensive long-range RT-PCR, combined with 5'- and 3'- RACE analysis, resulted it the identification of a 10-kb transcript, starting with the annotated exons of EGFL I I and spanning 44 exons and 2 Mb of genomic DNA. The transcript is predicted to encode a 31 65-aa extracellular protein containing 28 EGF-like and five laminin A G-like domains. Interestingly, the second part of the protein was found to be the human ortholog of Drosophila eyes shut (cys), also known as spacemaker, a protein essential for photoreceptor morphology. Mutation analysis in the sib pair homozygous at RP25 revealed a nonsense mutation (p.Tyr3156X) segregating with RP The same mutation was identified homozygously in three arRP siblings of an unrelated family. A frame-shift Mutation (pPro2238ProfsX16) was found in an isolated RP patient. fir conclusion, we identified a gene, coined eyes shut homolog (EYS), consisting of EGFL11 and the human ortholog of Drosophila eys, which is mutated in patients with arRP. With a size of 2 Mb, it is one of the largest human genes, and it is by far the largest retinal dystrophy gene. The discovery of EYS might shed light on a critical component of photoreceptor morphogenesis.	[Collin, Rob W. J.; Littink, Karin W.; Zonneveld, Marijke N.; Blokland, Ellen A. W.; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Collin, Rob W. J.; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Littink, Karin W.; van den Born, L. Ingeborgh; Zonneveld, Marijke N.] Rotterdam Eye Hosp, NL-3000 LM Rotterdam, Netherlands; [Klevering, B. Jeroen; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 GA Nijmegen, Netherlands; [Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ H3H 1P3, Canada; [Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Rotterdam Eye Hospital; Radboud University Nijmegen; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.	r.collin@antrg.umcn.nl	Collin, Rob/N-3575-2014; Klevering, B.J./L-4434-2015; Hoyng, C.B./H-8050-2014; Koenekoop, Robert/AAT-6676-2021; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014	Cremers, Frans/0000-0002-4954-5592; 	Dutch Organisation for Scientific Research [916.56.160]; Foundation Fighting Blindness USA [BR-GE-0606-0349-RAD]; Stichting Wetenschappelijk Onderzoek Oogziekenhuis Rotterdam [2005-13]; Foods de la recherche en sante Quebec; Foundation Fighting Blindness-Canada; Toronto Dominion financial group; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Blindenhulp; Stichting Ondersteuning Oogheelkunde 's-Gravenhage	Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness USA; Stichting Wetenschappelijk Onderzoek Oogziekenhuis Rotterdam; Foods de la recherche en sante Quebec; Foundation Fighting Blindness-Canada; Toronto Dominion financial group; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Blindenhulp; Stichting Ondersteuning Oogheelkunde 's-Gravenhage	The authors thank C. Beumer, S. van Beersurn, D. Cremers, I. Lopez, S. van der Velde-Visser, and E. van Wijk for excellent technical assistance and J. Hehir-Kwa for data analysis. We also thank all of the participating RP patients and their families. This study was financially supported by: (1) the Dutch Organisation for Scientific Research (grant 916.56.160 to A.I.d.H.), (2) the Foundation Fighting Blindness USA (grant BR-GE-0606-0349-RAD to A.I.d.H.), (3) Stichting Wetenschappelijk Onderzoek Oogziekenhuis Rotterdam (grant 2005-13 to L.I.v.d.B., A.I.d.H., and F.P.M.C.), (4) Foods de la recherche en sante Quebec (to R.K.K), (5) the Foundation Fighting Blindness-Canada (to R.K.K and F.P.M.C), (6) Toronto Dominion financial group (to R.K.K), (7) Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (to F . F.P.M.C.), (8) Landelijke Stichting voor Blinden en Slechtzienden (to F.P.M.C.), (9) Rotterdamse Vereniging Blindenbelangen (to F.P.M.C.), (10) Stichting Blindenhulp (to F.P.M.C.), and (11) Stichting Ondersteuning Oogheelkunde 's-Gravenhage (to F.P.M.C.).	Abd El-Aziz M, 2005, CURR EYE RES, V30, P1081, DOI 10.1080/02713680500351039; Abd El-Aziz MM, 2006, OPHTHALMIC RES, V38, P19, DOI 10.1159/000088493; Barragan I, 2008, ANN HUM GENET, V72, P454, DOI 10.1111/j.1469-1809.2008.00448.x; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Barragan I, 2005, INT J MOL MED, V16, P1163; Barragan I, 2005, OPHTHALMIC RES, V37, P89, DOI 10.1159/000084250; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Daiger SP, 2006, ADV EXP MED BIOL, V572, P3; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; El-Aziz MMA, 2008, ANN HUM GENET, V72, P463, DOI 10.1111/j.1469-1809.2008.00455.x; El-Aziz MMA, 2007, ANN HUM GENET, V71, P281, DOI 10.1111/j.1469-1809.2006.00333.x; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li Y, 2001, J MED GENET, V38, P478, DOI 10.1136/jmg.38.7.478; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Marcos I, 2003, INT J MOL MED, V12, P983; Marcos I, 2002, J HUM GENET, V47, P677, DOI 10.1007/s100380200103; Marcos I, 2000, J Med Genet, V37, pE5, DOI 10.1136/jmg.37.6.e5; MARMOR MF, 1993, DOC OPHTHALMOL, V85, P115, DOI 10.1007/BF01371127; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2	39	118	122	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					594	603		10.1016/j.ajhg.2008.10.014	http://dx.doi.org/10.1016/j.ajhg.2008.10.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18976725	Green Published, Bronze			2022-12-18	WOS:000261006900005
J	Skinner, MA; Safford, SD; Reeves, JG; Jackson, ME; Freemerman, AJ				Skinner, Michael A.; Safford, Shawn D.; Reeves, Justin G.; Jackson, Margaret E.; Freemerman, Alex J.			Renal aplasia in humans is associated with RET mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDULLARY-THYROID CARCINOMA; NEOPLASIA TYPE 2B; ENTERIC NERVOUS-SYSTEM; TYROSINE KINASE DOMAIN; HIRSCHSPRUNGS-DISEASE; GERMLINE MUTATIONS; EXTRACELLULAR DOMAIN; KIDNEY DEVELOPMENT; HIGH PREVALENCE; MICE LACKING	In animal models, kidney formation is known to be controlled by the proteins RET, GDNF, and GFRA1; however, no human studies to date have shown an association between abnormal kidney development and mutation of these genes. We hypothesized that stillborn fetuses with congenital renal agenesis or severe dysplasia would possess mutations in RET, GDNF, or GFRA1. We assayed for mutations in these genes in 33 stillborn fetuses that had bilateral or unilateral renal agenesis (29 subjects) or severe congenital renal dysplasia (4 subjects). Mutations in RET were found in 7 of 19 fetuses with bilateral renal agenesis (37%) and 2 of 10 fetuses (20%) with unilateral agenesis. In two fetuses, there were two different RET mutations found, and a total of ten different sequence variations were identified. We also investigated whether these mutations affected RET activation; in each case, RET phosphorylation was either absent or constitutively activated. A GNDF mutation was identified in only one fetus with unilateral agenesis; this subject also had two RET mutations. No GFRA1 mutations were seen in any fetuses. These data suggest that in humans, mutations in RET and GDNF may contribute significantly to abnormal kidney development.	[Skinner, Michael A.] Childrens Med Ctr, Div Pediat Surg, Dallas, TX 75235 USA; [Skinner, Michael A.] Univ Texas SW, Sch Med, Dallas, TX 75235 USA; [Safford, Shawn D.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Reeves, Justin G.] Duke Univ, Med Ctr, Dept Surg, Dept Med, Durham, NC 27710 USA; [Jackson, Margaret E.; Freemerman, Alex J.] Duke Univ, Med Ctr, Dept Surg, Div Pediat Surg, Durham, NC 27710 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; Duke University	Skinner, MA (corresponding author), Childrens Med Ctr, Div Pediat Surg, Dallas, TX 75235 USA.	michael.skinner@childrens.com	Safford, Shawn/GPS-9686-2022					Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Arighi E, 2004, MOL ENDOCRINOL, V18, P1004, DOI 10.1210/me.2003-0173; Attie-Bitach T, 1998, AM J MED GENET, V80, P481, DOI 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO;2-6; Bates CM, 2000, MOL GENET METAB, V71, P391, DOI 10.1006/mgme.2000.3072; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Bounacer A, 1997, ONCOGENE, V15, P1263, DOI 10.1038/sj.onc.1200206; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; Carniti C, 2006, AM J PATHOL, V168, P1262, DOI 10.2353/ajpath.2006.050607; Cosma MP, 1998, MOL CELL BIOL, V18, P3321, DOI 10.1128/MCB.18.6.3321; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; EDERY P, 1994, J MED GENET, V31, P602, DOI 10.1136/jmg.31.8.602; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Ishiguro Y, 1999, ENDOCRINOLOGY, V140, P3992, DOI 10.1210/en.140.9.3992; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; IWAMOTO T, 1993, ONCOGENE, V8, P1087; Iwashita T, 2001, GASTROENTEROLOGY, V121, P24, DOI 10.1053/gast.2001.25515; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Kjaer S, 2003, HUM MOL GENET, V12, P2133, DOI 10.1093/hmg/ddg227; Klugbauer S, 1995, ONCOGENE, V11, P2459; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Larsen L A, 2001, Pharmacogenomics, V2, P387, DOI 10.1517/14622416.2.4.387; Lore F, 2000, NEW ENGL J MED, V342, P1218, DOI 10.1056/NEJM200004203421615; Lore F, 2001, J INTERN MED, V250, P37, DOI 10.1046/j.1365-2796.2001.00846.x; Miyauchi A, 2002, WORLD J SURG, V26, P1023, DOI 10.1007/s00268-002-6665-1; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Pelet A, 1998, J CLIN INVEST, V101, P1415, DOI 10.1172/JCI375; PELET A, 1994, LANCET, V344, P1769, DOI 10.1016/S0140-6736(94)92908-4; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; SANTORO M, 1990, ONCOGENE, V5, P1595; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SANTOS H, 1988, J MED GENET, V25, P204, DOI 10.1136/jmg.25.3.204; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SINNASSAMY P, 1986, INT J PED NEPHROL, V7, P1; Skinner MA, 2005, AM J PATHOL, V166, P265, DOI 10.1016/S0002-9440(10)62250-X; Takahashi M, 1999, HUM MUTAT, V13, P331, DOI 10.1002/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.3.CO;2-R; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; WILSON RD, 1985, AM J MED GENET, V21, P153, DOI 10.1002/ajmg.1320210123; Wong A, 2005, MOL CELL BIOL, V25, P9661, DOI 10.1128/MCB.25.21.9661-9673.2005; Yin L, 2007, INT J CANCER, V121, P292, DOI 10.1002/ijc.22378; Yu J, 2004, CURR OPIN GENET DEV, V14, P550, DOI 10.1016/j.gde.2004.07.009	54	118	127	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					344	351		10.1016/j.ajhg.2007.10.008	http://dx.doi.org/10.1016/j.ajhg.2007.10.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252215	Green Published, Bronze			2022-12-18	WOS:000253223900007
J	Epstein, MP; Allen, AS; Satten, GA				Epstein, Michael P.; Allen, Andrew S.; Satten, Glen A.			A simple and improved correction for population stratification in case-control studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPENSITY SCORE; STRUCTURED POPULATIONS; GENETIC ASSOCIATIONS; SEMIPARAMETRIC TEST; GENOMIC CONTROL; MODEL; SUBCLASSIFICATION; REGRESSION; TRAITS	Population stratification remains an important issue in case-control studies of disease-marker association, even within populations considered to be genetically homogeneous. Campbell et al. ( Nature Genetics 2005; 37: 868 - 872) illustrated this by showing that stratification induced a spurious association between the lactase gene (LCT) and tall/short status in a European American sample. Furthermore, existing approaches for controlling stratification by use of substructure-informative loci ( e. g., genomic control, structured association, and principal components) could not resolve this confounding. To address this problem, we propose a simple two-step procedure. In the first step, we model the odds of disease, given data on substructure-informative loci ( excluding the test locus). For each participant, we use this model to calculate a stratification score, which is that participant's estimated odds of disease calculated using his or her substructure- informative - loci data in the disease-odds model. In the second step, we assign subjects to strata defined by stratification score and then test for association between the disease and the test locus within these strata. The resulting association test is valid even in the presence of population stratification. Our approach is computationally simple and less model dependent than are existing approaches for controlling stratification. To illustrate these properties, we apply our approach to the data from Campbell et al. and find no association between the LCT locus and tall/short status. Using simulated data, we show that our approach yields a more appropriate correction for stratification than does principal components or genomic control.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA; Duke Univ, Duke Clin Res Inst, Durham, NC 27706 USA	Emory University; Centers for Disease Control & Prevention - USA; Duke University; Duke University	Epstein, MP (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.	mepstein@genetics.emory.edu		Allen, Andrew/0000-0002-7232-2143; Satten, Glen/0000-0001-7275-5371	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL077663] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003618] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003618, HG003618] Funding Source: Medline; NHLBI NIH HHS [HL077663, K25 HL077663] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGODINI R, 2001, EXPT OPTION LOOK DRO; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Benjamin DJ, 2003, J PUBLIC ECON, V87, P1259, DOI 10.1016/S0047-2727(01)00167-0; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Marx BD, 1996, TECHNOMETRICS, V38, P374, DOI 10.2307/1271308; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; *NAT RES COUNC, 1996, EV FOR DNA EV; Pike M C, 1979, J Epidemiol Community Health, V33, P104, DOI 10.1136/jech.33.1.104; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SASEINI P, 1997, BIOMETRICS, V53, P1253; SATTEN GA, 1993, J AM STAT ASSOC, V88, P200, DOI 10.2307/2290714; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhivotovsky LA, 2001, FORENSIC SCI INT, V119, P269, DOI 10.1016/S0379-0738(00)00442-4; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	29	118	125	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					921	930		10.1086/516842	http://dx.doi.org/10.1086/516842			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436246	Green Published, Bronze			2022-12-18	WOS:000245973200010
J	Raymond, FL; Tarpey, PS; Edkins, S; Tofts, C; O'Meara, S; Teague, J; Butler, A; Stevens, C; Barthorpe, S; Buck, G; Cole, J; Dicks, E; Gray, K; Halliday, K; Hills, K; Hinton, J; Jones, D; Menzies, A; Perry, J; Raine, K; Shepherd, R; Small, A; Varian, J; Widaa, S; Mallya, U; Moon, J; Luo, Y; Shaw, M; Boyle, J; Kerr, B; Turner, G; Quarrell, O; Cole, T; Easton, DF; Wooster, R; Bobrow, M; Schwartz, CE; Gecz, J; Stratton, MR; Futreal, PA				Raymond, F. Lucy; Tarpey, Patrick S.; Edkins, Sarah; Tofts, Calli; O'Meara, Sarah; Teague, Jon; Butler, Adam; Stevens, Claire; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Dicks, Ed; Gray, Kristian; Halliday, Kelly; Hills, Katy; Hinton, Jonathon; Jones, David; Menzies, Andrew; Perry, Janet; Raine, Keiran; Shepherd, Rebecca; Small, Alexandra; Varian, Jennifer; Widaa, Sara; Mallya, Uma; Moon, Jenny; Luo, Ying; Shaw, Marie; Boyle, Jackie; Kerr, Bronwyn; Turner, Gillian; Quarrell, Oliver; Cole, Trevor; Easton, Douglas F.; Wooster, Richard; Bobrow, Martin; Schwartz, Charles E.; Gecz, Jozef; Stratton, Michael R.; Futreal, P. Andrew			Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a marfanoid habitus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; GERMLINE MUTATIONS; BRAIN SIZE; PROTEIN; RAS; GENES; KRAS	We have identified one frameshift mutation, one splice-site mutation, and two missense mutations in highly conserved residues in ZDHHC9 at Xq26.1 in 4 of 250 families with X-linked mental retardation ( XLMR). In three of the families, the mental retardation phenotype is associated with a Marfanoid habitus, although none of the affected individuals meets the Ghent criteria for Marfan syndrome. ZDHHC9 is a palmitoyltransferase that catalyzes the posttranslational modification of NRAS and HRAS. The degree of palmitoylation determines the temporal and spatial location of these proteins in the plasma membrane and Golgi complex. The finding of mutations in ZDHHC9 suggests that alterations in the concentrations and cellular distribution of target proteins are sufficient to cause disease. This is the first XLMR gene to be reported that encodes a posttranslational modification enzyme, palmitoyltransferase. Furthermore, now that the first palmitoyltransferase that causes mental retardation has been identified, defects in other palmitoylation transferases become good candidates for causing other mental retardation syndromes.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Canc Res UK, Genet Epidemiol Unit, Cambridge, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Newcastle, Genet Learning Disabil GOLD Serv, Newcastle, NSW 2308, Australia; Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; Birmingham Womens Hosp, Birmingham, W Midlands, England; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Univ Adelaide, Womens & Childrens Hosp, Dept Genet Med, Adelaide, SA 5005, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA 5005, Australia; Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Manchester; University of Newcastle; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Birmingham Women's Hospital; Greenwood Genetic Center; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide	Raymond, FL (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	flr24@cam.ac.uk	Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Gray, Kristian/0000-0002-7035-7107; Buck, Gemma/0000-0001-5289-1050; Raine, Keiran/0000-0002-5634-1539	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD026202, HD26202] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; des Portes V, 1998, CELL, V92, P51; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703	20	118	124	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					982	987		10.1086/513609	http://dx.doi.org/10.1086/513609			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436253	Green Published, Bronze			2022-12-18	WOS:000245973200017
J	Shi, M; Christensen, K; Weinberg, CR; Romitti, P; Bathum, L; Lozada, A; Morris, RW; Lovett, M; Murray, JC				Shi, Min; Christensen, Kaare; Weinberg, Clarice R.; Romitti, Paul; Bathum, Lise; Lozada, Anthony; Morris, Richard W.; Lovett, Michael; Murray, Jeffrey C.			Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASE-PARENT TRIADS; SINGLE NUCLEOTIDE POLYMORPHISMS; LOG-LINEAR APPROACH; ORAL CLEFTS; ENVIRONMENT INTERACTION; CIGARETTE-SMOKING; CANDIDATE GENES; HUMAN GENOME; PALATE; LIP	Maternal smoking is a recognized risk factor for orofacial clefts. Maternal or fetal pharmacogenetic variants are plausible modulators of this risk. In this work, we studied 5,427 DNA samples, including 1,244 from subjects in Denmark and Iowa with facial clefting and 4,183 from parents, siblings, or unrelated population controls. We examined 25 single-nucleotide polymorphisms in 16 genes in pathways for detoxification of components of cigarette smoke, to look for evidence of gene-environment interactions. For genes identified as related to oral clefting, we studied gene-expression profiles in fetal development in the relevant tissues and time intervals. Maternal smoking was a significant risk factor for clefting and showed dosage effects, in both the Danish and Iowan data. Suggestive effects of variants in the fetal NAT2 and CYP1A1 genes were observed in both the Iowan and the Danish participants. In an expanded case set, NAT2 continued to show significant overtransmission of an allele to the fetus, with a final P value of .00003. There was an interaction between maternal smoking and fetal inheritance of a GSTT1-null deletion, seen in both the Danish ( P p) and Iowan (P = .002) studies, with a Fisher's combined P value of <.001, which remained significant after correction .03 for multiple comparisons. Gene-expression analysis demonstrated expression of GSTT1 in human embryonic craniofacial tissues during the relevant developmental interval. This study benefited from two large samples, involving independent populations, that provided substantial power and a framework for future studies that could identify a susceptible population for preventive health care.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malformat, Odense, Denmark; Duke Univ, Natl Inst Environm Hlth Sci, Biostat Branch, Durham, NC USA; Duke Univ, Dept Anesthesiol, Durham, NC USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO USA	University of Iowa; University of Iowa; University of Iowa; University of Southern Denmark; Duke University; Duke University; Washington University (WUSTL)	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, S Grand Ave,2182 ML, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Christensen, Kaare/C-2360-2009; Shi, Min/GXM-3977-2022	Christensen, Kaare/0000-0002-5429-5292; Morris, Richard/0000-0001-7240-4563; Weinberg, Clarice/0000-0002-7713-8556	Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [R01 DE011948, R01 DE008559, R37 DE008559, P50 DE016215, DE08559, R01 DE11948] Funding Source: Medline; PHS HHS [U50/CCU 71328] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011948, P50DE016215, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES045005] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P915; Centers for Disease Control and Prevention. Smoking during pregnancy-United States, 1990, MMWR-MORBID MORTAL W, V53, P911; Christensen K, 1999, AM J EPIDEMIOL, V149, P248; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Fisher R.A., 1958, STAT METHODS RES WOR; Fretland AJ, 2001, PHARMACOGENETICS, V11, P207, DOI 10.1097/00008571-200104000-00004; Gonzalez FJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P153, DOI 10.1016/S0003-9861(02)00364-8; Gonzalez FJ, 2001, TOXICOL LETT, V120, P199, DOI 10.1016/S0378-4274(01)00296-X; Hartsfield JK, 2001, AM J MED GENET, V102, P21, DOI 10.1002/1096-8628(20010722)102:1<21::AID-AJMG1409>3.0.CO;2-T; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Hayes C, 1996, AM J EPIDEMIOL, V143, P1229, DOI 10.1093/oxfordjournals.aje.a008710; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kistner EO, 2004, GENET EPIDEMIOL, V27, P33, DOI 10.1002/gepi.20001; Lammer EJ, 2005, EPIDEMIOLOGY, V16, P698, DOI 10.1097/01.ede.0000172136.26733.4b; Lammer EJ, 2004, EPIDEMIOLOGY, V15, P150, DOI 10.1097/01.ede.0000112214.33432.cc; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Lieff S, 1999, AM J EPIDEMIOL, V150, P683, DOI 10.1093/oxfordjournals.aje.a010071; Lin DY, 2006, AM J HUM GENET, V78, P505, DOI 10.1086/500812; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Mitchell LE, 2001, AM J EPIDEMIOL, V153, P1007, DOI 10.1093/aje/153.10.1007; Mitchell MK, 1999, DRUG METAB DISPOS, V27, P261; Mossey P., 2002, CLEFT LIP PALATE, P127; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Romitti PA, 1999, TERATOLOGY, V59, P39, DOI 10.1002/(SICI)1096-9926(199901)59:1<39::AID-TERA9>3.0.CO;2-7; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Shaw GM, 2003, AM J EPIDEMIOL, V157, P475, DOI 10.1093/aje/kwg013; Shi M, 2004, BIRTH DEFECTS RES A, V70, P65, DOI 10.1002/bdra.10153; Starr JR, 2005, AM J EPIDEMIOL, V161, P196, DOI 10.1093/aje/kwi021; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; van Rooij IALM, 2001, EPIDEMIOLOGY, V12, P502, DOI 10.1097/00001648-200109000-00007; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Yang QH, 2003, EPIDEMIOLOGY, V14, P161, DOI 10.1097/00001648-200303000-00009; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	45	118	125	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					76	90		10.1086/510518	http://dx.doi.org/10.1086/510518			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160896	Green Published, Bronze			2022-12-18	WOS:000243102500008
J	Scapoli, L; Palmieri, A; Martinelli, M; Pezzetti, F; Carinci, P; Tognon, M; Carinci, F				Scapoli, L; Palmieri, A; Martinelli, M; Pezzetti, F; Carinci, P; Tognon, M; Carinci, F			Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS	Cleft lip with or without cleft palate (CL/P) is one of the most common birth defects, but its etiology is largely unknown. It is very likely that both genetic and environmental factors contribute to this malformation. Mutations in the gene for interferon regulatory factor 6 (IRF6) have been shown to be the cause of Van der Woude syndrome, a dominant disorder that has CL/P as a common feature. Recently, it has been reported that genetic polymorphisms at the IRF6 locus are associated with nonsyndromic CL/P, with stronger association in Asian and South American populations. We investigated four markers spanning the IRF6 locus, using the transmission/disequilibrium test. A sample of 219 Italian triads of patients and their parents were enrolled in the study. Strong evidence of linkage disequilibrium was found between markers and disease in both single-allele (P = .002 at marker rs2235375) and haplotype (P = .0005) analyses. These findings confirm the contribution of IRF6 in the etiology of nonsyndromic CL/P and strongly support its involvement in populations of European ancestry.	Univ Ferrara, Dept Morphol & Embryol, Sect Histol & Embryol, I-44100 Ferrara, Italy; Univ Ferrara, Dept Maxillofacial Surg, I-44100 Ferrara, Italy; Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy; Univ Bologna, Ctr Mol Genet, Cassa Risparmio Bologna CARISBO Fdn, Bologna, Italy	University of Ferrara; University of Ferrara; University of Bologna; University of Bologna	Tognon, M (corresponding author), Univ Ferrara, Dept Morphol & Embryol, Sect Histol & Embryol, Via Fossato Mortara 64-B, I-44100 Ferrara, Italy.	tgm@unife.it	Scapoli, Luca/I-7609-2019; Scapoli, Luca/C-6152-2008	Scapoli, Luca/0000-0003-4006-9910; Scapoli, Luca/0000-0003-4006-9910	Telethon [E.1147] Funding Source: Medline	Telethon(Fondazione Telethon)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Carinci F, 2003, J CRANIOFAC SURG, V14, P130, DOI 10.1097/00001665-200303000-00002; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Pezzetti F, 2004, Hum Mutat, V24, P104, DOI 10.1002/humu.9257; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	10	118	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					180	183		10.1086/427344	http://dx.doi.org/10.1086/427344			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15558496	Green Published, Bronze			2022-12-18	WOS:000225643600018
J	Rahman, P; Bartlett, S; Siannis, F; Pellett, FJ; Farewell, VT; Peddle, L; Schentag, CT; Alderdice, CA; Hamilton, S; Khraishi, M; Tobin, Y; Hefferton, D; Gladman, DD				Rahman, P; Bartlett, S; Siannis, F; Pellett, FJ; Farewell, VT; Peddle, L; Schentag, CT; Alderdice, CA; Hamilton, S; Khraishi, M; Tobin, Y; Hefferton, D; Gladman, DD			CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; FRAMESHIFT MUTATION; ASSOCIATION; POPULATION; PSA; HLA; 16Q	A recent genomewide scan in psoriatic arthritis (PsA) revealed a susceptibility locus at 16q. This region overlaps CARD15, a susceptibility gene in Crohn disease. The possibility of a common susceptibility gene between PsA and Crohn disease is further supported by epidemiological studies that note an increased incidence of psoriasis in subjects with Crohn. We screened 187 patients with PsA and 136 healthy controls, all from Newfoundland, for the three common, independent sequence variants of CARD15 (R702W, leu1007fsinsC, and G908R), which were detected by polymerase chain reaction by use of allele-specific primers and visualized through gel electrophoresis. In total, 53/187 (28.3%) probands with PsA had at least one variant of the CARD15 gene, compared with 16/136 (11.8%) controls ( odds ratio 2.97; 95% confidence interval 1.61-5.47; P = .0005). Allele frequencies of R702W, leu1007fsinsC, and G908R were 10.43%, 3.21%, and 1.61%, respectively, in patients with PsA, compared with 3.31%, 2.57%, and 0.37%, respectively, in the control patients. CARD15 conferred susceptibility to PsA independent of HLA-Cw*0602. Thus, CARD15 represents a pleiotropic autoimmune gene and is the first non-MHC gene to be associated with PsA.	Mem Univ Newfoundland, St Clares Mercy Hosp, St Johns, NF A1C 5B8, Canada; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Univ Toronto, Univ Hlth Network, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada	Memorial University Newfoundland; MRC Biostatistics Unit; University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Rahman, P (corresponding author), Mem Univ Newfoundland, St Clares Mercy Hosp, 1 S,154 LeMarchant Rd, St Johns, NF A1C 5B8, Canada.		Khraishi, Majed/HDN-4826-2022	Khraishi, Majed/0000-0003-0293-5128; Farewell, Vernon/0000-0001-6704-5295				BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; Borgiani P, 2002, EUR J DERMATOL, V12, P540; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; COX DR, 1972, J R STAT SOC B, V34, P187; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; Gladman DD, 1999, HUM IMMUNOL, V60, P259, DOI 10.1016/S0198-8859(98)00123-2; GLADMAN DD, 1987, Q J MED, V62, P127; Gladman DD, 2002, CURR OPIN RHEUMATOL, V14, P361, DOI 10.1097/00002281-200207000-00005; GOODFIELD M, 1994, BAILLIERE CLIN RHEUM, V8, P295, DOI 10.1016/S0950-3579(94)80020-0; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 2002, CURR OPIN GASTROEN, V18, P410, DOI 10.1097/00001574-200207000-00003; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; LEE FI, 1990, AM J GASTROENTEROL, V85, P962; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; MOLL JMH, 1973, ANN RHEUM DIS, V32, P181, DOI 10.1136/ard.32.3.181; Nair RP, 2001, J INVEST DERMATOL, V117, P1671, DOI 10.1046/j.0022-202x.2001.01620.x; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Vasey FB, 1985, PSORIATIC ARTHRITIS, P45; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Wright V., 1976, SERONEGATIVE POLYART, P169	22	118	121	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					677	681		10.1086/378076	http://dx.doi.org/10.1086/378076			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12879366	Green Published, Bronze			2022-12-18	WOS:000185134000022
J	Doolin, MT; Barbaux, S; McDonnell, M; Hoess, K; Whitehead, AS; Mitchell, LE				Doolin, MT; Barbaux, S; McDonnell, M; Hoess, K; Whitehead, AS; Mitchell, LE			Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL-TUBE DEFECTS; CASE-PARENT TRIADS; TRANSMISSION DISEQUILIBRIUM TEST; METHIONINE SYNTHASE; LINKAGE DISEQUILIBRIUM; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE; METABOLISM; POLYMORPHISMS; PREGNANCY	There is currently considerable interest in the relationship between variation in genes that are involved in the folate-homocysteine metabolic axis and the risk of spina bifida. The evaluation of this relationship is, however, complicated by the potential involvement of both the maternal and the embryonic genotype in determination of disease risk. The present study was designed to address questions regarding both maternal and embryonic genetic risk factors for spina bifida by use of the two-step transmission/disequilibrium test. Analysis of data on variants of two genes involved in homocysteine remethylation/methionine biosynthesis-methionine synthase (MTR) A2756G and methionine synthase reductase (MTRR) A66G-provided evidence that both variants influence the risk of spina bifida via the maternal rather than the embryonic genotype. For both variants, the risk of having a child with spina bifida appears to increase with the number of high-risk alleles in the maternal genotype: MTR (R-1 = 2.16, 95% CI 0.92-5.06; R-2 = 6.58, 95% CI 0.87- 49.67) and MTRR (R-1 = 2.05, 95% CI 1.05-3.99; R-2 = 3.15, 95% CI 0.92-10.85). These findings highlight the importance of considering both the maternal and embryonic genotype when evaluating putative spina bifida susceptibility loci.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Pharmacogenet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Mitchell, LE (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.		Barbaux, Sandrine C/B-2878-2019	Barbaux, Sandrine C/0000-0002-8204-1855	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039195, R01HD039081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000240, M01-RR00240] Funding Source: Medline; NICHD NIH HHS [HD39081, R01 HD039195, HD39195, R01 HD039081] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barbaux S, 2000, CLIN CHEM, V46, P907; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; CURTIS D, 1995, AM J HUM GENET, V56, P811; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; Gilliam DM, 1997, ALCOHOL CLIN EXP RES, V21, P28; Harris MJ, 2001, TERATOLOGY, V63, P165, DOI 10.1002/tera.1030; Johanning GL, 2000, J MED GENET, V37, P949, DOI 10.1136/jmg.37.12.949; Lucock M, 2000, MOL GENET METAB, V70, P27, DOI 10.1006/mgme.2000.2994; Lucock MD, 1998, MOL GENET METAB, V65, P18, DOI 10.1006/mgme.1998.2738; MABRY CC, 1963, NEW ENGL J MED, V269, P1404, DOI 10.1056/NEJM196312262692604; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Mitchell LE, 1997, AM J HUM GENET, V60, P1006; Morrison K, 1997, J MED GENET, V34, P958, DOI 10.1136/jmg.34.11.958; Posey DL, 1996, LANCET, V347, P686, DOI 10.1016/S0140-6736(96)91236-2; Shaw GM, 1999, J MED GENET, V36, P86; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TRASLER DG, 1984, TERATOLOGY, V30, P423, DOI 10.1002/tera.1420300315; van den Oord EJCG, 2000, AM J HUM GENET, V66, P335, DOI 10.1086/302708; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; Walker AH, 1999, ENVIRON HEALTH PERSP, V107, P517, DOI 10.2307/3434392; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879	28	118	122	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1222	1226		10.1086/344209	http://dx.doi.org/10.1086/344209			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12375236	Green Published, Bronze			2022-12-18	WOS:000178884300022
J	Thomas, MG; Weale, ME; Jones, AL; Richards, M; Smith, A; Redhead, N; Torroni, A; Scozzari, R; Gratrix, F; Tarekegn, A; Wilson, JF; Capelli, C; Bradman, N; Goldstein, DB				Thomas, MG; Weale, ME; Jones, AL; Richards, M; Smith, A; Redhead, N; Torroni, A; Scozzari, R; Gratrix, F; Tarekegn, A; Wilson, JF; Capelli, C; Bradman, N; Goldstein, DB			Founding mothers of Jewish communities: Geographically separated Jewish groups were independently founded by very few female ancestors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; Y-CHROMOSOME; LINKAGE DISEQUILIBRIUM; AFRICAN POPULATIONS; GENETIC-EVIDENCE; MTDNA VARIATION; NEAR-EASTERN; LINEAGES; HAPLOGROUPS; HAPLOTYPES	We have analyzed the maternally inherited mitochondrial DNA from each of nine geographically separated Jewish groups, eight non-Jewish host populations, and an Israeli Arab/Palestinian population, and we have compared the differences found in Jews and non-Jews with those found using Y-chromosome data that were obtained, in most cases, from the same population samples. The results suggest that most Jewish communities were founded by relatively few women, that the founding process was independent in different geographic areas, and that subsequent genetic input from surrounding populations was limited on the female side. In sharp contrast to this, the paternally inherited Y chromosome shows diversity similar to that of neighboring populations and shows no evidence of founder effects. These sex-specific differences demonstrate an important role for culture in shaping patterns of genetic variation and are likely to have significant epidemiological implications for studies involving these populations. We illustrate this by presenting data from a panel of X-chromosome microsatellites, which indicates that, in the case of the Georgian Jews, the female-specific founder event appears to have resulted in elevated levels of linkage disequilibrium.	UCL, Dept Biol, London WC1E 6BT, England; Ctr Genet Anthropol, Dept Biol, London, England; Ctr Genet Anthropol, Dept Anthropol, London, England; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Inst Res, IL-31096 Haifa, Israel; Rambam Med Ctr, Haifa, Israel; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy	University of London; University College London; University of London; University College London; University of London; University College London; University of Huddersfield; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Pavia; Sapienza University Rome	Goldstein, DB (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.		Weale, Michael E/F-2587-2010; Wilson, James F/A-5704-2009; Goldstein, David/AAY-8125-2020; Torroni, Antonio/E-1557-2011; Thomas, Mark G/A-2219-2012	Weale, Michael E/0000-0003-4593-1186; Wilson, James F/0000-0001-5751-9178; Torroni, Antonio/0000-0002-4163-4478; Thomas, Mark G/0000-0002-2452-981X; RICHARDS, MARTIN/0000-0003-3118-0967; Capelli, Cristian/0000-0001-9348-9084	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1972, ENCY JUDAICA; BEINERT H, 1992, ATLAS MEDIEVAL JEWIS; Ben-Sasson H. H., 1976, HIST JEWISH PEOPLE, P570; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BONNETAMIR B, 1992, GENETIC DIVERSITY AMONG JEWS, P80; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; Chen Y.-S., 1995, American Journal of Human Genetics, V57, pA161; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; De Lange N, 1984, ATLAS JEWISH WORLD; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Ellis N, 2002, GENOME RES, V12, P339; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kolman CJ, 1996, GENETICS, V142, P1321; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LIVSHITS G, 1991, AM J HUM GENET, V49, P131; Lucotte G, 1999, HUM BIOL, V71, P989; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Mourant AE, 1978, BLOOD GROUPS DIS; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Nei M., 1987, MOL EVOLUTIONARY GEN; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reif S.C., 1993, JUDAISM HEBREW PRAYE; Rejwan Nissim, 1985, JEWS IRAQ; REYNOLDS J, 1983, GENETICS, V105, P767; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; RITTE U, 1993, HUM BIOL, V65, P359; RITTE U, 1993, J MOL EVOL, V37, P435; RITTE U, 1992, GENETIC DIVERSITY AMONG JEWS, P51; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Sokal R. R., 1995, BIOMETRY; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	54	118	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1411	1420		10.1086/340609	http://dx.doi.org/10.1086/340609			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992249	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000175445700003
J	Millat, G; Chikh, K; Naureckiene, S; Sleat, DE; Fensom, AH; Higaki, K; Elleder, M; Lobel, P; Vanier, MT				Millat, G; Chikh, K; Naureckiene, S; Sleat, DE; Fensom, AH; Higaki, K; Elleder, M; Lobel, P; Vanier, MT			Niemann-Pick disease type C: Spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR SECRETORY PROTEIN; STEROL-SENSING DOMAIN; CHOLESTEROL TRAFFICKING; MOLECULAR-BASIS; COMPLEMENTATION; 2ND; GENE; FORM; NIEMANN-PICK-C1-DISEASE; VARIABILITY	In Niemann-Pick disease type C (NPC), a genetic heterogeneity with two complementation groups-NPC1, comprising greater than or equal to 95% of the families, and NPC2-has been demonstrated. Mutations in the NPC1 gene have now been well characterized. HE1 was recently identified as the gene underlying the very rare NPC2. Here we report the first comprehensive study of eight unrelated families with NPC2, originating from France, Algeria, Italy, Germany, the Czech Republic, and Turkey. These cases represent essentially all patients with NPC2 who have been reported in the literature, as well as those known to us. All 16 mutant alleles were identified, but only five different mutations, all with a severe impact on the protein, were found; these five mutations were as follows: two nonsense mutations (E20X and E118X), a 1-bp deletion (27delG), a splice mutation (IVS2+5G -->A), and a missense mutation (S67P) resulting in reduced amounts of abnormal HE1 protein. E20X, with an overall allele frequency of 56%, was established as the common mutant allele. Prenatal diagnosis was achieved by mutation analysis of an uncultured chorionic-villus sample. All mutations except 27delG were observed in a homozygous state, allowing genotype/phenotype correlations. In seven families (with E20X, E118X, S67P, and E20X/27delG mutations), patients suffered a severe and rapid disease course, with age at death being 6 mo-4 years. A remarkable feature was the pronounced lung involvement, leading, in six patients, to early death caused by respiratory failure. Two patients also developed a severe neurological disease with onset during infancy. Conversely, the splice mutation corresponded to a very different clinical presentation, with juvenile onset of neurological symptoms and prolonged survival. This mutation generated multiple transcripts, including a minute proportion of normally spliced RNA, which may explain the milder phenotype.	Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, F-69495 Pierre Benite, France; Lyon Sud Med Sch, INSERM, Unit 189, Oullins, France; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Guys Hosp, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Tottori Univ, Fac Med, Sch Life Sci, Dept Neurobiol, Yonago, Tottori 683, Japan; Charles Univ Prague, Inst Inherited Metabol Disorders, Fac Med 1, Prague, Czech Republic	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Rutgers State University New Brunswick; Rutgers State University Medical Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Tottori University; Charles University Prague	Vanier, MT (corresponding author), Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, Batiment 3B, F-69495 Pierre Benite, France.	vanier@univ-lyon1.fr	MILLAT, Gilles/GWZ-2688-2022	CHIKH, Karim/0000-0002-1217-4193	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54317, R01 DK054317] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker CS, 1993, BIOL REPROD S1, V48, P86; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; Christomanou H, 2000, MOL GENET METAB, V70, P196, DOI 10.1006/mgme.2000.3004; Cruz JC, 2000, J BIOL CHEM, V275, P41309, DOI 10.1074/jbc.M008272200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Elleder M, 2001, VIRCHOWS ARCH, V439, P206, DOI 10.1007/s004280100407; Greer WL, 1998, AM J HUM GENET, V63, P52, DOI 10.1086/301931; Greer WL, 1999, AM J HUM GENET, V65, P1252, DOI 10.1086/302620; HIGGINS CM, 1999, CURRENT TOP VIROL, V1, P1; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; OHNO K, 1988, J BIOL CHEM, V263, P18563; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; PIN I, 1990, ARCH FR PEDIATR, V47, P373; RaveHarel N, 1997, AM J HUM GENET, V60, P87; Ribeiro I, 2001, HUM GENET, V109, P24, DOI 10.1007/s004390100531; Schofer O, 1998, EUR J PEDIATR, V157, P45, DOI 10.1007/s004310050764; Steinberg SJ, 1996, J INHERIT METAB DIS, V19, P769, DOI 10.1007/BF01799171; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; Sun XF, 2001, AM J HUM GENET, V68, P1361, DOI 10.1086/320599; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 1996, AM J HUM GENET, V58, P118; VANIER MT, 1992, AM J HUM GENET, V51, P111; VANIER MT, 1996, HDB CLIN NEUROLOGY, V66, P133; VANIER MT, 2000, NEUROPEDIATRIE, P81; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	41	118	125	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1013	1021		10.1086/324068	http://dx.doi.org/10.1086/324068			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11567215	Bronze, Green Published			2022-12-18	WOS:000171413400009
J	Brown, DT; Samuels, DC; Michael, EM; Turnbull, DM; Chinnery, PF				Brown, DT; Samuels, DC; Michael, EM; Turnbull, DM; Chinnery, PF			Random genetic drift determines the level of mutant mtDNA in human primary oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATIONS; MELAS; SEGREGATION; MERRF; HETEROPLASMY; DYSFUNCTION; CELLS; LOAD	We measured the proportion of mutant mtDNA (mutation load) in 82 primary oocytes from a woman who harbored the A3243G mtDNA mutation. The frequency distribution of mutation load indicates that random drift is the principal mechanism that determines the level of mutant mtDNA within individual oocytes.	Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Dept Math, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Dept Obstet & Gynaecol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617				BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; HOWELL N, 1992, HUM GENET, V90, P117; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Jacobs, 2000, Trends Genet, V16, P487, DOI 10.1016/S0168-9525(00)02147-8; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488; White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	24	118	124	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					533	536		10.1086/318190	http://dx.doi.org/10.1086/318190			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133360	Bronze, Green Published			2022-12-18	WOS:000166524800026
J	Douglas, JA; Boehnke, M; Lange, K				Douglas, JA; Boehnke, M; Lange, K			A multipoint method for detecting genotyping errors and mutations in sibling-pair linkage data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB PAIRS; MARKER; INCOMPATIBILITIES; TRAITS	The identification of genes contributing to complex diseases and quantitative traits requires genetic data of high fidelity, because undetected errors and mutations can profoundly affect linkage information. The recent emphasis on the use of the sibling-pair design eliminates or decreases the likelihood of detection of genotyping errors and marker mutations through apparent Mendelian incompatibilities or close double recombinants. In this article, we describe a hidden Markov method for detecting genotyping errors and mutations in multilocus linkage data. Specifically, we calculate the posterior probability of genotyping error or mutation for each sibling-pair-marker combination, conditional on all marker data and an assumed genotype-error rate. The method is designed for use with sibling-pair data when parental genotypes are unavailable. Through Monte Carlo simulation, we explore the effects of map density, marker-allele frequencies, marker position, and genotype-error rate on the accuracy of our error-detection method. In addition, we examine the impact of genotyping errors and error detection and correction on multipoint linkage information. We illustrate that even moderate error rates can result in substantial loss of linkage information, given efforts to fine-map a putative disease locus. Although simulations suggest that our method detects less than or equal to 50% of genotyping errors, it generally flags those errors that have the largest impact on linkage results. For high-resolution genetic maps, removal of the errors identified by our method restores most or nearly all the lost linkage information and can be accomplished without generating false evidence for linkage by removing incorrectly identified errors.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG00040, T32 HG000040, R01 HG00376, R01 HG000376] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275] Funding Source: Medline; NIMH NIH HHS [R01 MH059490, MH59490, R37 MH059490] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAUM LE, 1972, INEQUALITIES, V3, P11; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; DOUGLAS J, 1998, AM J HUM GENET S, V63, pA1661; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; Ehm Margaret Gelder, 1995, Journal of Biological Systems, V3, P13, DOI 10.1142/S0218339095000034; Ehm MG, 1996, AM J HUM GENET, V58, P225; Feakes R, 1999, GENET EPIDEMIOL, V17, P51, DOI 10.1002/(SICI)1098-2272(1999)17:1<51::AID-GEPI4>3.0.CO;2-V; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LATHROP GM, 1983, AM J HUM GENET, V35, P241; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Stringham HM, 1996, AM J HUM GENET, V59, P946; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	20	118	121	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1287	1297		10.1086/302861	http://dx.doi.org/10.1086/302861			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739757	Green Published, Bronze			2022-12-18	WOS:000088373400012
J	Conley, ME; Mathias, D; Treadaway, J; Minegishi, Y; Rohrer, J				Conley, ME; Mathias, D; Treadaway, J; Minegishi, Y; Rohrer, J			Mutations in Btk in patients with presumed X-linked agammaglobulinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRUTONS TYROSINE KINASE; B-CELL DEVELOPMENT; GENOMIC ORGANIZATION; REPEAT POLYMORPHISM; CARRIER DETECTION; DEFECTIVE GENE; HEMOPHILIA-A; ORIGIN; IDENTIFICATION; DEFICIENCY	In 1993, two groups showed that X-linked agammaglobulinemia (XLA) was due to mutations in a tyrosine kinase now called Btk. Most laboratories have been able to detect mutations in Btk in 80%-90% of males with presumed XLA. The remaining patients may have mutations in Btk that are difficult to identify, or they may have defects that are phenotypically similar to XLA but genotypically different. We analyzed 101 families in which affected males were diagnosed as having XLA. Mutations in Btk were identified in 38 of 40 families with more than one affected family member and in 56 of 61 families with sporadic disease. Excluding the patients in whom the marked decrease in B cell numbers characteristic of XLA could not be confirmed by immunofluorescence studies, mutations in Btk were identified in 43 of 46 patients with presumed sporadic XLA. Two of the three remaining patients had defects in other genes required for normal B cell development, and the third patient was unlikely to have XLA, on the basis of results of extensive Btk analysis. Our techniques were unable to identify a mutation in Btk in one male with both a family history and laboratory findings suggestive of XLA. DNA samples from 41 of 49 of the mothers of males with sporadic disease and proven mutations in Btk were positive for the mutation found in their son. In the other 8 families, the mutation appeared to arise in the maternal germ line. In 20 families, haplotype analysis showed that the new mutation originated in the maternal grandfather or great-grandfather. These studies indicate that 90%-95% of males with presumed XLA have mutations in Btk. The other patients are likely to have defects in other genes.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Tennessee, Dept Pediat, Coll Med, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Conley, ME (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.			Mathias, Derrick/0000-0002-8743-7285	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NIAID NIH HHS [AI25129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI025129, R37AI025129, R01AI025129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN RC, 1992, HUM MOL GENET, V1, P216, DOI 10.1093/hmg/1.3.216; ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1993, HUM MOL GENET, V2, P1508, DOI 10.1093/hmg/2.9.1508-a; Becker J, 1996, AM J HUM GENET, V58, P657; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; CONLEY ME, 1988, J PEDIATR-US, V112, P688, DOI 10.1016/S0022-3476(88)80683-8; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1995, CLIN IMMUNOL IMMUNOP, V76, pS192, DOI 10.1016/S0090-1229(95)90198-1; CONLEY ME, 1985, J IMMUNOL, V134, P3070; CONLEY ME, 1992, J CLIN IMMUNOL, V12, P139, DOI 10.1007/BF00918144; CONLEY ME, 1994, HUM MOL GENET, V3, P1751, DOI 10.1093/hmg/3.10.1751; CONLEY ME, 1994, IMMUNOL REV, V138, P5, DOI 10.1111/j.1600-065X.1994.tb00844.x; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; Farrar JE, 1996, CLIN IMMUNOL IMMUNOP, V81, P271, DOI 10.1006/clin.1996.0188; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; HAGEMANN TL, 1994, HUM MOL GENET, V3, P1743, DOI 10.1093/hmg/3.10.1743; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; HOFFMAN T, 1977, CLIN IMMUNOL IMMUNOP, V7, P364, DOI 10.1016/0090-1229(77)90070-8; JIN H, 1995, HUM MOL GENET, V4, P693, DOI 10.1093/hmg/4.4.693; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KETTERLING RP, 1991, GENOMICS, V10, P1093, DOI 10.1016/0888-7543(91)90207-U; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KNOBLOCH O, 1993, HUM GENET, V92, P40, DOI 10.1007/BF00216143; Kornfeld SJ, 1996, MOL MED, V2, P619, DOI 10.1007/BF03401645; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Ochs HD, 1996, MEDICINE, V75, P287, DOI 10.1097/00005792-199611000-00001; OHTA Y, 1994, P NATL ACAD SCI USA, V91, P9062, DOI 10.1073/pnas.91.19.9062; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PAROLINI O, 1993, GENOMICS, V15, P342, DOI 10.1006/geno.1993.1066; PUCK JM, 1995, J CLIN INVEST, V95, P895, DOI 10.1172/JCI117740; Puck JM, 1997, BLOOD, V89, P1968; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; Rohrer J, 1998, BLOOD, V91, P214, DOI 10.1182/blood.V91.1.214.214_214_221; ROHRER J, 1994, IMMUNOGENETICS, V40, P319, DOI 10.1007/BF01246672; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; SIDERAS P, 1994, J IMMUNOL, V153, P5607; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; STEPHENS K, 1992, HUM GENET, V88, P279; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TUCHMAN M, 1995, AM J MED GENET, V55, P67, DOI 10.1002/ajmg.1320550118; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vihinen M, 1996, NUCLEIC ACIDS RES, V24, P160, DOI 10.1093/nar/24.1.160; VORECHOVSKY I, 1993, LANCET, V341, P1153, DOI 10.1016/0140-6736(93)93172-W; Vorechovsky I, 1997, HUM MUTAT, V9, P418; WICKER LS, 1986, CURR TOP MICROBIOL, V124, P87; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003; ZHU QL, 1994, HUM MOL GENET, V3, P1899, DOI 10.1093/hmg/3.10.1899	56	118	130	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1034	1043		10.1086/301828	http://dx.doi.org/10.1086/301828			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545398	Green Published, Bronze			2022-12-18	WOS:000073487000006
J	Travis, GH				Travis, GH			Mechanisms of cell death in the inherited retinal degenerations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; NITRIC-OXIDE SYNTHASE; PHOTORECEPTOR DEGENERATION; ALPHA-SUBUNIT; EPITHELIAL-CELLS; OUTER SEGMENTS; MUTANT MICE; RCS RATS; GENE; MUTATIONS		Univ Texas, SW Med Ctr, Mol Neurobiol Lab, Dept Psychiat, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Mol Neurobiol Lab, Program Neurosci, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Travis, GH (corresponding author), Univ Texas, SW Med Ctr, Mol Neurobiol Lab, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	travis@utsw.swmed.edu	Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493				Abler AS, 1996, RES COMMUN MOL PATH, V92, P177; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; BECQUET F, 1994, J CELL PHYSIOL, V159, P256, DOI 10.1002/jcp.1041590209; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; DEKOZAK Y, 1997, RECEPT SIGNAL TRANS, V5, P85; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; FARBER D, 1986, RETINA, V1, P1; FARBER DB, 1977, J NEUROCHEM, V28, P1089, DOI 10.1111/j.1471-4159.1977.tb10673.x; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; GOUREAU O, 1993, NEUROREPORT, V5, P233, DOI 10.1097/00001756-199312000-00012; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; KOCH KW, 1994, EMBO J, V13, P3312, DOI 10.1002/j.1460-2075.1994.tb06633.x; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; LIEPE BA, 1994, J NEUROSCI, V14, P7641; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Liu XR, 1997, J CELL SCI, V110, P2589; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Molthagen M, 1996, J NEUROCYTOL, V25, P243, DOI 10.1007/BF02284800; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Sanyal S, 1989, Prog Clin Biol Res, V314, P233; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Seigel G M, 1997, Mol Vis, V3, P14; Shastry BS, 1997, CELL MOL LIFE SCI, V53, P419, DOI 10.1007/s000180050050; STEINBERG RH, 1987, INVEST OPHTH VIS SCI, V28, P1888; Travis G. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS699; TSO MOM, 1994, INVEST OPHTH VIS SCI, V35, P2693; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175	50	118	130	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					503	508		10.1086/301772	http://dx.doi.org/10.1086/301772			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497269	Green Published, Bronze			2022-12-18	WOS:000072894400001
J	Mountain, JL; CavalliSforza, LL				Mountain, JL; CavalliSforza, LL			Multilocus genotypes, a tree of individuals, and human evolutionary history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; MANDENKA POPULATION; Y-CHROMOSOME; NEW-GUINEA; POLYMORPHISMS; SEQUENCES; GENE; AUSTRALIANS; DIVERGENCE	Our goal is to infer, from human genetic data, general patterns as well as details of human evolutionary history. Here we present the results of an analysis of genetic data at the level of the individual. A tree relating 144 individuals from 12 human groups of Africa, Asia, Europe, and Oceania, inferred from an average of 75 DNA polymorphisms/individual, is remarkable in that most individuals cluster with other members of their regional group. In order to interpret this tree, we consider the factors that influence the tree pattern, including the number of genetic loci examined, the length of population isolation, the sampling process, and the extent of gene flow among groups. Understanding the impact of these factors enables us to infer details of human evolutionary history that might otherwise remain undetected. Our analyses indicate that some recent ancestor(s) of each of a few of the individuals tested may have immigrated. In general, the populations within regional groups appear to have been isolated from one another for <25,000 years. Regional groups may have been isolated for somewhat longer.	STANFORD UNIV,DEPT GENET,STANFORD,CA 94305	Stanford University	Mountain, JL (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720, USA.				NIGMS NIH HHS [GM20467, GM40282] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282, R01GM020467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AQUADRO CF, 1983, GENETICS, V103, P287; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Bowcock A M, 1987, Gene Geogr, V1, P47; Bowcock A M, 1991, Gene Geogr, V5, P151; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1967, HERITAGE MENDEL, P309; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; COCKERHAM CC, 1973, GENETICS, V74, P679; Edwards AWF, 1964, PHENETIC PHYLOGENETI, P67; Goudet J., 2001, CLADISTICS; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; LAWLOR DA, 1988, NATURE, V335, P268, DOI 10.1038/335268a0; LIN AA, 1994, GENE GEOGR, V8, P191; Matullo G, 1994, Gene Geogr, V8, P25; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NEI M, 1974, AM J HUM GENET, V26, P421; Nei M., 1987, MOL EVOLUTIONARY GEN; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; RANNALA B, IN PRESS P NATL ACAD; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Rogers AR, 1996, AM J HUM GENET, V58, P1033; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Shriver MD, 1997, AM J HUM GENET, V60, P957; STONEKING M, 1990, GENETICS, V124, P717; TAKAHATA N, 1989, GENETICS, V122, P957; Thompson E.A., 1975, HUMAN EVOLUTIONARY T; TIERCY JM, 1992, AM J HUM GENET, V51, P592; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407; WIJSMAN EM, 1986, AFRICAN PYGMIES, P347	46	118	126	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					705	718		10.1086/515510	http://dx.doi.org/10.1086/515510			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326336	Bronze, Green Published			2022-12-18	WOS:A1997XY52300028
J	Lee, MP; DeBaun, M; Randhawa, G; Reichard, BA; Elledge, SJ; Feinberg, AP				Lee, MP; DeBaun, M; Randhawa, G; Reichard, BA; Elledge, SJ; Feinberg, AP			Low frequency of p57(KIP2) mutation in Beckwith-Wiedemann syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT KINASE INHIBITOR; WILMS-TUMOR; REDUCED EXPRESSION; GENE P57(KIP2); H19 LOCUS; IGF2; REGION; 11P15; METHYLATION; RELAXATION	Beckwith-Wiedemann syndrome (BWS) is an autosomal dominant disorder of increased prenatal growth and predisposition to embryonal cancers such as Wilms tumor. BWS is thought to involve One or more imprinted genes, since some patients show paternal uniparental disomy, and others show balanced germ-line chromosomal rearrangements involving the maternal chromosome. We previously mapped BWS, by genetic linkage analysis, to 11p15.5, which are and others also found to contain several imprinted genes; these include the gene for insulin-like growth factor II (IGF2) and H19, which show abnormal imprint-specific expression and/???? or methylation in 20% of BWS patients, and p57(KIP2), a cyclin-dependent Kinase inhibitor, which we found showed biallelic expression in one of nine BWS patients studied. In addition, p57(KIP2) was recently reported to show mutations ire two of nine BWS patients. We have now analyzed the entire coding sequence and intronexon boundaries of p57(KIP2) in 40 unrelated BWS patients. Of these patients, only two (5%) showed mutations, both involving frameshifts in the second exon, In one case, the mutation was transmitted to the proband's mother, who was also affected, from the maternal grandfather, suggesting that p57(KIP2) is not: imprinted in at least some affected tissues at a critical stage of development and that haploinsufficiency due to mutation of either parental allele may cause at least some features of BWS. The low frequency of p57(KIP2) mutations, as well as our recent discovery of disruption of the K(v)LQT1 gene in patients with chromosomal rearrangements, suggest that BWS can involve disruption of multiple independent 11p15.5 genes.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205; WASHINGTON UNIV,ST LOUIS,MO; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Baylor College of Medicine			Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [CA54358, R01 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown KW, 1996, HUM MOL GENET, V5, P2027, DOI 10.1093/hmg/5.12.2027; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Mannens M., 1994, European Journal of Human Genetics, V2, P3; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OKANO Y, 1986, JPN J HUM GENET, V31, P365, DOI 10.1007/BF01907937; PING AJ, 1989, AM J HUM GENET, V44, P720; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Thompson JS, 1996, CANCER RES, V56, P5723; Tokino T, 1996, HUM GENET, V97, P625, DOI 10.1007/s004390050106; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807	26	118	123	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					304	309		10.1086/514858	http://dx.doi.org/10.1086/514858			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311734	Green Published, hybrid			2022-12-18	WOS:A1997XX70100007
J	Carlson, C; Papolos, D; Pandita, RK; Faedda, GL; Veit, S; Goldberg, R; Shprintzen, R; Kucherlapati, R; Morrow, B				Carlson, C; Papolos, D; Pandita, RK; Faedda, GL; Veit, S; Goldberg, R; Shprintzen, R; Kucherlapati, R; Morrow, B			Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL CREST; DIGEORGE-SYNDROME; VELOCARDIOFACIAL SYNDROME; CHROMOSOME-22; INTERVIEW; DELETIONS; 22Q11; CHILDREN; REGION	Velo-cardio-facial syndrome (VCFS) is characterized by conotruncal cardiac defects, cleft palate, learning disabilities, and characteristic facial appearance and is associated with hemizygous deletions within 22q11. A newly recognized clinical feature is the presence of psychiatric illness in children and adults with VCFS. To ascertain the relationship between psychiatric illness, VCFS, and chromosome 22 deletions, we evaluated 26 VCFS patients by clinical and molecular biological methods. The VCFS children and adolescents were found to share a set of psychiatric disorders, including bipolar spectrum disorders and attention-deficit disorder with hyperactivity. The adult patients, >18 years of age, were affected with bipolar spectrum disorders. Four of six adult patients had psychotic symptoms manifested as paranoid and grandiose delusions. Loss-of-heterozygosity analysis of all 26 patients revealed that all but 3 had a large 3-Mb common deletion. One patient had a nested distal deletion and two did not have a detectable deletion. Somatic cell hybrids were developed from the two patients who did not have a detectable deletion within 22q11 and were analyzed with a large number of sequence tagged sites. A deletion was not detected among the two patients at a resolution of 21 kb. There was no correlation between the phenotype and the presence of the deletion within 22q11. The remarkably high prevalence of bipolar spectrum disorders, in association with the congenital anomalies of VCFS and its occurrence among nondeleted VCFS patients, suggest a common genetic etiology.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOL GENET, BRONX, NY 10461 USA; YESHIVA UNIV, ALBERT EINSTEIN COLL MED,MONTEFIORE MED CTR, PROGRAM BEHAV GENET,DEPT PSYCHIAT, NEW YORK, NY 10033 USA; YESHIVA UNIV, ALBERT EINSTEIN COLL MED,BRONX CHILDRENS HOSP CTR, DIV CHILD PSYCHIAT,DEPT PSYCHIAT, NEW YORK, NY 10033 USA; MONTEFIORE MED CTR, CTR CRANIOFACIAL DISORDERS, BRONX, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Yeshiva University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine			Faedda, Gianni L/E-6379-2012; Kucherlapati, Raju/ABC-8807-2021	Faedda, Gianni L/0000-0001-6197-0543; Morrow, Bernice/0000-0002-8076-4726	NICHD NIH HHS [R01HD31601] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031601] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; Bockman D E, 1989, Immunol Ser, V45, P451; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BURN J, 1996, EMERY RIMOINS PRINCI, V1, P767; CHOW EWC, 1994, AM J MED GENET, V54, P107, DOI 10.1002/ajmg.1320540205; COLLINS JE, 1995, NATURE, V377, P367; COULY G, 1988, DEVELOPMENT, V103, P101; Daniels JK, 1996, AM J PSYCHIAT, V153, P268; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOLDBERG R, 1985, American Journal of Human Genetics, V37, pA54; GOLDINGKUSHNER KJ, 1985, J CRAN GENET DEV BIO, V5, P259; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HERJANIC B, 1977, J ABNORM CHILD PSYCH, V5, P127, DOI 10.1007/BF00913088; HERJANIC B, 1982, J ABNORM CHILD PSYCH, V10, P307, DOI 10.1007/BF00912324; JEDELE KB, 1992, PEDIATRICS, V89, P915; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; LEDOUARIN NM, 1980, NEURAL CREST; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; MORROW B, 1995, AM J HUM GENET, V56, P1391; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; REICH W, 1985, REVISED VERSION DIAG; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; STEVENS CA, 1990, PEDIATRICS, V85, P526; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; YOUNG D, 1980, AM J CARDIOL, V46, P643, DOI 10.1016/0002-9149(80)90515-9	37	118	118	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					851	859						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WT614	9106531				2022-12-18	WOS:A1997WT61400014
J	Lalioti, MD; Mirotsou, M; Buresi, C; Peitsch, MC; Rossier, C; Ouazzani, R; BaldyMoulinier, M; Bottani, A; Malafosse, A; Antonarakis, SE				Lalioti, MD; Mirotsou, M; Buresi, C; Peitsch, MC; Rossier, C; Ouazzani, R; BaldyMoulinier, M; Bottani, A; Malafosse, A; Antonarakis, SE			Identification of mutations in Cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDITERRANEAN MYOCLONUS; STEFIN-B; PAPAIN; INHIBITORS; 21Q22.3	Progressive myoclonus epilepsy (EPM1) is an autosomal recessive disorder, characterized by severe, stimulus-sensitive myoclonus and tonic-clonic seizures. The EPM1 locus was mapped to within 0.3 cM from PFKL in chromosome 21q22.3. The gene for the proteinase inhibitor cystatin B was recently localized in the EPM1 critical region, and mutations were identified in two EPM1 families. We have identified six nucleotide changes in the cystatin B gene of non-Finnish EPM1 families from northern Africa and Europe. The 426G-->C change in exon 1 results in a Gly4Arg substitution and is the first missense mutation described that is associated with EPM1. Molecular modeling predicts that this substitution severely affects the contact of cystatin B with papain. Mutations in the invariant AG dinucleotides of the acceptor sites of introns 1 and 2 probably result in abnormal splicing. A deletion of two nucleotides in exon 3 produces a frameshift and truncates the protein. Therefore, these four mutations are all predicted to impair the production of functional protein. These mutations were found in 7 of the 29 unrelated EPM1 patients analyzed, in homozygosity in 1, and in heterozygosity in the others. The remaining two sequence changes, 431G-->T and 2575A-->G, probably represent polymorphic variants. In addition, a tandem repeat in the 5' UTR (CCCCGCCCCGCG) is present two or three times in normal alleles. It is peculiar that in the majority of patients no mutations exist within the exons and splice sites of the cystatin B gene.	UNIV GENEVA,SCH MED,LAB HUMAN MOL GENET,DEPT GENET & MICROBIOL,CH-1211 GENEVA,SWITZERLAND; HOP BELLE IDEE,DIV NEUROPSYCHIAT,GENEVA,SWITZERLAND; UNIV HOSP GENEVA,GLAXO INST MOL BIOL,GENEVA,SWITZERLAND; UNIV HOSP GENEVA,DIV MED GENET,GENEVA,SWITZERLAND; HOP SPECIAL,SERV NEUROL,RABAT,MOROCCO; HOP SPECIAL,CLIN NEUROPHYSIOL,RABAT,MOROCCO; CNRS,INSERM U249,EXPT MED LAB,UPR 9008,MONTPELLIER,FRANCE	University of Geneva; University of Geneva; GlaxoSmithKline; University of Geneva; University of Geneva; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			Antonarakis, Stylianos E/N-8866-2014; Peitsch, Manuel/J-7416-2017	Antonarakis, Stylianos E/0000-0001-8907-5823; Peitsch, Manuel/0000-0001-5324-359X				ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COCHIUS JI, 1993, ANN NEUROL, V34, P739, DOI 10.1002/ana.410340519; GENTON P, 1990, ACTA NEUROL SCAND, V81, P8; Henskens YMC, 1996, BIOL CHEM H-S, V377, P71; LAFRENIERE RG, 1995, GENOMICS, V29, P288, DOI 10.1006/geno.1995.1248; Lalioti MD, 1996, GENOMICS, V35, P321, DOI 10.1006/geno.1996.0363; LALIOTI MD, 1995, MED GENET, V2, pA249; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEHESJOKI AE, 1993, NEUROLOGY, V43, P2384, DOI 10.1212/WNL.43.11.2384; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; MALAFOSSE A, 1992, LANCET, V339, P1080, DOI 10.1016/0140-6736(92)90667-R; McNamara JO, 1996, NATURE, V381, P26, DOI 10.1038/381026a0; NORIO R, 1979, CLIN GENET, V15, P382; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Stone NE, 1996, GENOME RES, V6, P218, DOI 10.1101/gr.6.3.218; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; THIELE U, 1990, BIOL CHEM H-S, V371, P125; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Virtaneva K, 1996, AM J HUM GENET, V58, P1247; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709	22	118	122	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					342	351						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012407				2022-12-18	WOS:A1997WE93100013
J	Michie, S; Bron, F; Bobrow, M; Marteau, TM				Michie, S; Bron, F; Bobrow, M; Marteau, TM			Nondirectiveness in genetic counseling: An empirical study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLLOW-UP; SATISFACTION; INTERVIEWS; CARE	Nondirectiveness is considered an essential part of genetic counseling, yet there is no generally accepted definition nor data documenting its impact on counselees. This study is an empirical investigation of directiveness, using ratings Aom transcripts of consultations and comparing these with counselor-reported and counselee-reported directiveness, Rated directiveness was defined as advice, expressed views about or selective reinforcement of counselees' behavior, thoughts, or emotions (advice, evaluation, and reinforcement). Analysis of 131 transcripts revealed a mean of 5.8 advice statements per consultation, 5.8 evaluative statements, and 1.7 reinforcing statements. When asked to describe their counseling style, none of the 11 counselors rated It as ''not at all'' directive. Half the counselees who fated a decision felt steered by the counselor. Items of rated directiveness showed satisfactory interrater reliability (kappa = .63). Factor analysis revealed that they formed one factor (eigenvalue 1.72). There were no associations either between counselor-reported, counselee-reported, and rated directiveness or between these measures and counselee anxiety and concern, satisfaction with information, or the meeting of counselees' expectations. Rated directiveness was the only measure to be associated with other process measures of the consultation, being associated with longer consultations, more blocks of speech, more social and emotional issues being raised, and fewer concerns being followed up, advice was more likely to be given to counselees of lower socioeconomic status and to counselees judged by counselors to be highly concerned, Evaluative statements were more likely to be made by counselors who had received counseling training. These results show that genetic counseling was Plod characterized-by counselors, counselees, of a standardized rating scale-as uniformly nondirective.	ADDENBROOKES HOSP, DEPT MED GENET, CAMBRIDGE, ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Michie, S (corresponding author), UNITED MED & DENT SCH, PSYCHOL & GENET RES GRP, GROUND FLOOR, LONDON SE1 9RT, ENGLAND.		; Michie, Susan/A-1745-2010	Marteau, Theresa/0000-0003-3025-1129; Michie, Susan/0000-0003-0063-6378	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bernstein T, 1994, RADON RENTAL HOUSING; CARTER CO, 1971, LANCET, V1, P281, DOI 10.1016/S0140-6736(71)91016-6; CLARKE A, 1990, LANCET, V335, P1145, DOI 10.1016/0140-6736(90)91139-2; CLARKE A, 1991, LANCET, V338, P998, DOI 10.1016/0140-6736(91)91849-P; CZEIZEL A, 1981, J MED GENET, V18, P91, DOI 10.1136/jmg.18.2.91; Eiser R, 1986, SOCIAL PSYCHOL ATTIT; ELLIOTT R, 1985, J COUNS PSYCHOL, V32, P307, DOI 10.1037/0022-0167.32.3.307; EMERY AEH, 1979, BMJ-BRIT MED J, V1, P1253, DOI 10.1136/bmj.1.6173.1253; GOLDBERG DP, 1984, BRIT J PSYCHIAT, V144, P567, DOI 10.1192/bjp.144.6.567; GUTTMAN N, 1993, BETWEEN COMMUNICATIO, V4, P293; HARPER PS, 1988, PRACTICAL GENETIC CO; *HER MAJ STAT OFF, 1990, STAND OCC CLASS; HILL C, 1993, MANUAL HILL COUNSELL; HILL CE, 1978, J COUNS PSYCHOL, V25, P461, DOI 10.1037/0022-0167.25.5.461; *HLTH COUNC NETH, 1994, GEN SCREEN; Kessler Seymour, 1992, J Genet Couns, V1, P9, DOI 10.1007/BF00960080; KLEIN D, 1977, J GENET HUM, V25, P47; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIPPMAN A, 1991, AM J LAW MED, V17, P15; LIPPMANHAND A, 1979, AM J MED GENET, V3, P113, DOI 10.1002/ajmg.1320030202; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Michie S, 1996, PSYCHOL HEALTH, V11, P797, DOI 10.1080/08870449608400276; Muller-Hill B., 1988, MURDEROUS SCI; Nuffield Council on Bioethics, 1993, GEN SCREEN ETH ISS; PRESS NA, 1993, FETAL DIAGN THER, V8, P97, DOI 10.1159/000263878; ROBERTS JAF, 1959, INTRO HUMAN GENETICS; *ROYAL COLL PHYS, 1989, PREN DIAGN GEN SCREE; SAVAGE R, 1990, BRIT MED J, V301, P968, DOI 10.1136/bmj.301.6758.968; SHILOH S, 1989, PSYCHOL HEALTH, V3, P45, DOI DOI 10.1080/08870448908400365; Stewart M, 1995, PATIENT CTR MED TRAN; STILES WB, 1979, J MED EDUC, V54, P81; WAITZKIN H, 1985, J HEALTH SOC BEHAV, V26, P81, DOI 10.2307/2136599; WERTZ DC, 1988, AM J HUM GENET, V42, P592; WERTZ DC, 1986, CLIN GENET, V30, P494; WILLIAMS S, 1995, FAM PRACT, V12, P193, DOI 10.1093/fampra/12.2.193; WOLFSON PS, 1995, J ENVIRON PERMITTING, V4, P3	36	118	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					40	47						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WA818	8981945				2022-12-18	WOS:A1997WA81800008
J	DeFranchis, R; Mancini, FP; DAngelo, A; Sebastio, G; Fermo, I; DeStefano, V; Margaglione, M; Mazzola, G; DiMinno, G; Andria, G				DeFranchis, R; Mancini, FP; DAngelo, A; Sebastio, G; Fermo, I; DeStefano, V; Margaglione, M; Mazzola, G; DiMinno, G; Andria, G			Elevated total plasma homocysteine and 677C->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HYPERHOMOCYSTEINEMIA		UNIV NAPLES FEDERICO II,DEPT PEDIAT,I-80131 NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT BIOCHIM & BIOTECNOL,NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT CLIN MED,NAPLES,ITALY; IRCCS,OSPED SAN RAFFAELE,IST SCI,DIPARTIMENTO MED LAB,MILAN,ITALY; IRCCS,LAB TROMBOSI & ATEROSCLEROSI,SAN GIOVANNI ROTO,ITALY	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Casa Sollievo Della Sofferenza			fermo, isabella/AAN-3999-2020; Melis, Daniela/AAD-3623-2019; andria, generoso/V-7172-2019	fermo, isabella/0000-0003-2947-1933; Melis, Daniela/0000-0002-9458-3926; Di Minno, Giovanni/0000-0003-4235-7166; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; d'angelo, armando/0000-0002-9857-4509				ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FERMO I, 1995, ANN INTERN MED, V123, P747, DOI 10.7326/0003-4819-123-10-199511150-00002; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Motulsky AG, 1996, AM J HUM GENET, V58, P17	5	118	119	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					262	264						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659535				2022-12-18	WOS:A1996VL45500037
J	Soodyall, H; Vigilant, L; Hill, AV; Stoneking, M; Jenkins, T				Soodyall, H; Vigilant, L; Hill, AV; Stoneking, M; Jenkins, T			mtDNA control-region sequence variation suggests multiple independent origins of an ''Asian-specific'' 9-bp deletion in sub-Saharan Africans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; LENGTH MUTATIONS; POPULATIONS; POLYMORPHISMS; MIGRATIONS; EVOLUTION; LINEAGES; AMERICA	The intergenic COII/tRNA(Lys) 9-bp deletion in human mtDNA, which is found at varying frequencies in Asia, Southeast Asia, Polynesia, and the New World, was also found in 81 of 919 sub-Saharan Africans. Using mtDNA control-region sequence data from a subset of 41 individuals with the deletion, we identified 22 unique mtDNA types associated with the deletion in Africa. A comparison of the unique mtDNA types from sub-Saharan Africans and Asians with the 9-bp deletion revealed that subSaharan Africans and Asians have sequence profiles that differ in the locations and frequencies of variant sites. Both phylogenetic and mismatch-distribution analysis suggest that the 9-bp deletion arose independently in sub-Saharan Africa and Asia and that the deletion has arisen more than once in Africa. Within Africa, the deletion was not found among Khoisan peoples and was rare to absent in western and southwestern African populations, but it did occur in Pygmy and Negroid populations from central Africa and in Malawi and southern African Bantu-speakers. The distribution of the 9-bp deletion in Africa suggests that the deletion could have arisen in central Africa and was then introduced to southern Africa via the recent ''Bantu expansion.''	S AFRICAN INST MED RES, DEPT HUMAN GENET, JOHANNESBURG 2000, SOUTH AFRICA; UNIV WITWATERSRAND, JOHANNESBURG, SOUTH AFRICA; JOHN RADCLIFFE HOSP, INST MOLEC MED, MOLEC IMMUNOL GRP, OXFORD OX3 9DU, ENGLAND	University of Witwatersrand; University of Oxford	Soodyall, H (corresponding author), PENN STATE UNIV, DEPT ANTHROPOL, 511 CARPENTER BLDG, UNIVERSITY PK, PA 16802 USA.		HILL, Adrian V>S>/C-1306-2008					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; BALLINGER SW, 1992, GENETICS, V130, P139; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P159; CHEN YS, 1995, AM J HUM GENET, V57, P133; CLARK DJ, 1959, PREHISTORY SO AFRICA; Coon CS, 1965, LIVING RACES MAN; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GREENBERG JH, 1963, LANGUAGES AFRICA; Grimes BF, 1992, ETHNOLOGUE LANGUAGES; GUTHRIE M, 1962, J AFR HIST, V3, P273, DOI 10.1017/S002185370000311X; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAGELBERG E, 1994, NATURE, V369, P25, DOI 10.1038/369025a0; HARIHARA S, 1992, HUM BIOL, V64, P161; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Hiernaux J., 1975, PEOPLE AFRICA; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1987, HUM GENET, P177; HUFFMAN TN, 1980, AFR STUD, V39, P123, DOI 10.1080/00020188008707556; LORENZ JG, 1994, HUM BIOL, V66, P777; LUM JK, 1994, HUM BIOL, V66, P567; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether D. A., 1994, American Journal of Human Genetics, V55, pA158; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Nei M., 1987, MOL EVOLUTIONARY GEN; Nurse G T, 1987, Gene Geogr, V1, P65; NURST GT, 1985, PEOPLES SO AFRICA TH; PARKER SP, 1994, WORLD GEOGRAPHICAL E, V1; PASSARINO G, 1993, AM J HUM GENET, V53, P609; Phillipson D. W., 1985, AFRICAN ARCHAEOLOGY; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHERRY ST, 1994, HUM BIOL, V66, P761; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; SOODYALL H, 1993, THESIS U WITWATERSRA; STONEKING M, 1989, COLONIZATION PACIFIC, P215; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1995, AM J HUM GENET, V57, P507; TORRONI A, 1992, GENETICS, V130, P153; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALFORNIA B; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	54	118	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					595	608						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644719				2022-12-18	WOS:A1996TV56400018
J	PEGORARO, E; SCHIMKE, RN; ARAHATA, K; HAYASHI, Y; STERN, H; MARKS, H; GLASBERG, MR; CARROLL, JE; TABER, JW; WESSEL, HB; BAUSERMAN, SC; MARKS, WA; TORIELLO, HV; HIGGINS, JV; APPLETON, S; SCHWARTZ, L; GARCIA, CA; HOFFMAN, EP				PEGORARO, E; SCHIMKE, RN; ARAHATA, K; HAYASHI, Y; STERN, H; MARKS, H; GLASBERG, MR; CARROLL, JE; TABER, JW; WESSEL, HB; BAUSERMAN, SC; MARKS, WA; TORIELLO, HV; HIGGINS, JV; APPLETON, S; SCHWARTZ, L; GARCIA, CA; HOFFMAN, EP			DETECTION OF NEW PATERNAL DYSTROPHIN GENE-MUTATIONS IN ISOLATED CASES OF DYSTROPHINOPATHY IN FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; X-CHROMOSOME INACTIVATION; SEVERE COMBINED IMMUNODEFICIENCY; MANIFESTING CARRIERS; AUTOSOME TRANSLOCATIONS; MOSAIC EXPRESSION; DIAGNOSIS; PROTEIN; REPEAT; ABNORMALITIES	Duchenne muscular dystrophy is one of the most common lethal monogenic disorders and is caused by dystrophin deficiency. The disease is transmitted as an X-linked recessive trait; however, recent biochemical and clinical studies have shown that many girls and women with a primary myopathy have an underlying dystrophinopathy, despite a negative family history for Duchenne dystrophy. These isolated female dystrophinopathy patients carried ambiguous diagnoses with presumed autosomal recessive inheritance (limb-girdle muscular dystrophy) prior to biochemical detection of dystrophin abnormalities in their muscle biopsy. It has been assumed that these female dystrophinopathy patients are heterozygous carriers who show preferential inactivation of the X chromosome harboring the normal dystrophin gene, although this has been shown for only a few X:autosome translocations and for two cases of discordant monozygotic twin female carriers. Here we study X-inactivation patterns of 13 female dystrophinopathy patients-10 isolated cases and 3 cases with a positive family history for Duchenne dystrophy in males. We show that all cases have skewed X-inactivation patterns in peripheral blood DNA. Of the nine isolated cases informative in our assay, eight showed inheritance of the dystrophin gene mutation from the paternal germ line. Only a single case showed maternal inheritance. The 10-fold higher incidence of paternal transmission of dystrophin gene mutations in these cases is at 30-fold variance with Bayesian predictions and gene mutation rates. Thus, our results suggest some mechanistic interaction between new dystrophin gene mutations, paternal inheritance, and skewed X inactivation. Our results provide both empirical risk data and a molecular diagnostic test method, which permit genetic counseling and prenatal diagnosis of this new category of patients.	UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,DEPT HUMAN GENET,PITTSBURGH,PA; UNIV PITTSBURGH,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15261; UNIV PITTSBURGH,CHILDRENS HOSP PITTSBURGH,SCH MED,PITTSBURGH,PA 15260; UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103; NATL INST NEUROSCI,NATL CTR NEUROL & PSYCHIAT,TOKYO,JAPAN; CHILDRENS NATL MED CTR,DEPT LAB MED,WASHINGTON,DC 20010; CHILDRENS NATL MED CTR,DEPT MED GENET,WASHINGTON,DC; ALFRED I DUPONT INST,DEPT NEUROL,WILMINGTON,DE; HENRY FORD HOSP,DIV NEUROMUSCULAR DIS,DETROIT,MI; MED COLL GEORGIA,PEDIAT NEUROL SECT,AUGUSTA,GA; SCOTT & WHITE MEM HOSP & CLIN,DIV ANAT PATHOL,TEMPLE,TX; COOK FT WORTH CHILDRENS MED CTR,FT WORTH,TX; BUTTERWORTH GENET SERV,GRAND RAPIDS,MI; LOUISIANA STATE UNIV,MED CTR,SCH MED,NEW ORLEANS,LA 70112; RICHLAND MEM HOSP,MUSCULAR DYSTROPHY CLIN,COLUMBIA,MD; GREENVILLE HOSP SYST,DEPT INTERNAL MED,GREENEVILLE,NC	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; National Center for Neurology & Psychiatry - Japan; Children's National Health System; Children's National Health System; Nemours Alfred I. duPont Hospital for Children; Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University; Scott & White Medical Center; Cook Children's Medical Center; Louisiana State University System				Schwartz, Lisa/0000-0003-4981-4948	NINDS NIH HHS [NS28403] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1989, NEW ENGL J MED, V320, P138, DOI 10.1056/NEJM198901193200302; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; ARIKAWA E, 1991, NEUROLOGY, V41, P1491, DOI 10.1212/WNL.41.9.1491; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BARKHAUS PE, 1989, ARCH NEUROL-CHICAGO, V46, P673, DOI 10.1001/archneur.1989.00520420093029; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; BONILLA E, 1990, NEUROLOGY, V40, P1267, DOI 10.1212/WNL.40.8.1267; BONILLA E, 1988, AM J PATHOL, V133, P440; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; BROWN RM, 1993, J MED GENET, V30, P177, DOI 10.1136/jmg.30.3.177; BUSHBY KMD, 1993, NEUROMUSCULAR DISORD, V3, P57, DOI 10.1016/0960-8966(93)90042-I; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; CLERK A, 1991, J NEUROL SCI, V102, P197, DOI 10.1016/0022-510X(91)90069-J; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; COOPER BJ, 1990, LAB INVEST, V62, P171; EMERY AEH, 1993, DUCHENNE MUSCULAR DY, P25; EMERY AEH, 1967, EXPLORATORY CONCEPTS, P271; FEENER CA, 1991, AM J HUM GENET, V48, P621; GOODSHIP J, 1988, LANCET, V1, P729; GOODSHIP J, 1991, BLOOD, V77, P2677; GRUEMER HD, 1985, AM J CLIN PATHOL, V84, P655, DOI 10.1093/ajcp/84.5.655; HARRIS A, 1992, J MED GENET, V29, P608, DOI 10.1136/jmg.29.9.608; HIGUCHI R, 1989, AMPLIFICATIONS FORUM; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1992, NEUROLOGY, V42, P967, DOI 10.1212/WNL.42.5.967; HOFFMAN EP, 1993, MOL CELL BIOL MUSCUL, P12; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MINETTI C, 1991, NEUROLOGY, V41, P1288, DOI 10.1212/WNL.41.8.1288; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MOSER H, 1974, CLIN GENET, V5, P271; NICHOLSON LVB, 1993, J MED GENET, V30, P737, DOI 10.1136/jmg.30.9.737; Oliveira A S, 1992, Arq Neuropsiquiatr, V50, P478; PUCK JM, 1992, AM J HUM GENET, V50, P742; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; SCHWARTZ LS, 1992, AM J HUM GENET, V51, P721; SEWRY CA, 1993, NEUROMUSCULAR DISORD, V3, P141, DOI 10.1016/0960-8966(93)90006-6; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013; WENGER SL, 1992, AM J MED GENET, V43, P1012, DOI 10.1002/ajmg.1320430619; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YOSHIOKA M, 1981, CLIN GENET, V20, P6; ZNEIMER SM, 1993, AM J MED GENET, V45, P601, DOI 10.1002/ajmg.1320450517	57	118	119	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					989	1003						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198142				2022-12-18	WOS:A1994NP05300007
J	VERLANDER, PC; LIN, JD; UDONO, MU; ZHANG, Q; GIBSON, RA; MATHEW, CG; AUERBACH, AD				VERLANDER, PC; LIN, JD; UDONO, MU; ZHANG, Q; GIBSON, RA; MATHEW, CG; AUERBACH, AD			MUTATION ANALYSIS OF THE FANCONI-ANEMIA GENE FACC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; REGISTRY	Fanconi anemia (FA) is a genetically heterogeneous autosomal recessive disorder characterized by a unique hypersensitivity of cells to DNA cross-linking agents; a gene for complementation group C (FACC) has recently been cloned. We have amplified FACC exons with their nanking intron sequences from genomic DNA from 174 racially and ethnically diverse families in the International Fanconi Anemia Registry and have screened for mutations by using SSCP analysis. We identified eight different variants in 32 families; three were detected in exon 1, one in exon 4, one in intron 4, two in exon 6, and one in exon 14. Two of the eight variants, in seven families, did not segregate with the disease allele in multiplex families, suggesting that these variants represented benign polymorphisms. Disease-associated mutations in FACC were detected in a total of 25 (14.4%) of 174 families screened. The most frequent mutations were IVS4 +4 A-->T (intron 4; 12 families) and 322delG (exon 1; 9 families). Other, less common mutations include Q13X in exon 1, R185X and D195V in exon 6, and L554P in exon 14. The polymorphisms were S26F in exon 1 and G139E in exon 4. All patients in our study with 322delG, Q13X, R185X, and D195V are of northern or eastern European or southern Italian ancestry, and 18 of 19 have a mild form of the disease, while the 2 patients with L554P, both from the same family, have a severe phenotype. All 19 patients with IVS4 +4 A-->T have Jewish ancestry and have a severe phenotype.	UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DIV MED & MOLEC GENET,LONDON,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	VERLANDER, PC (corresponding author), ROCKEFELLER UNIV,INVEST DERMATOL LAB,1230 YORK AVE,BOX H30,NEW YORK,NY 10021, USA.		Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Gibson, Rachel/0000-0002-1338-1290; Auerbach, Arleen/0000-0002-6911-8379	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032987] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL32987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler-Brecher B., 1992, American Journal of Human Genetics, V51, pA251; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; AUERBACH AD, 1981, PEDIATRICS, V67, P128; AUERBACH AD, 1985, PEDIATRICS, V76, P794; AUERBACH AD, 1986, HUM GENET, V73, P86, DOI 10.1007/BF00292671; AUERBACH AD, 1989, BLOOD, V73, P391; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BUCHWALD M, 1989, FANCONI ANEMIA CLIN, P226; CLAEKSON R, 1991, POLYM CHAIN REACTION, P187; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GIBSON RA, 1993, HUM MOL GENET, V2, P35, DOI 10.1093/hmg/2.1.35; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; McPherson M.J., 1991, PCR PRACTICAL APPROA, P171; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Verlander P. C., 1992, American Journal of Human Genetics, V51, pA204; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202	19	118	119	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					595	601						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128956				2022-12-18	WOS:A1994NC83600003
J	KUO, WL; TENJIN, H; SEGRAVES, R; PINKEL, D; GOLBUS, MS; GRAY, J				KUO, WL; TENJIN, H; SEGRAVES, R; PINKEL, D; GOLBUS, MS; GRAY, J			DETECTION OF ANEUPLOIDY INVOLVING CHROMOSOME-13, CHROMOSOME-18, OR CHROMOSOME-21, BY FLUORESCENCE INSITU HYBRIDIZATION (FISH) TO INTERPHASE AND METAPHASE AMNIOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-SPECIFIC RATES; DNA LIBRARIES; ABERRATIONS; ABNORMALITIES; SEQUENCES; PROBES; AMNIOCENTESIS; CELLS	Fluorescence in situ hybridization (FISH) with chromosome-specific proves has been applied to detection of numerical aberrations involving chromosomes 13, 18, and 21 in metaphase and interphase amniocytes. High-complexity, composite probes for chromosomes 13, 18, and 21 were used as hybridization probes for this study. These probes were constructed as chromosome-specific libraries in Bluescribe plasmids and are designated pBS-13, pBS-18, and pBS-21. Elements of these probes bind at numerous sites along the target chromosome and, when detected fluorescently, stain essentially the entire long arm of the target chromosome. The target chromosome number (i.e., the number of chromosomes of the type for which the probe was specific) was correctly determined in 20 of 20 samples in which metaphase spreads were analyzed and in 43 of 43 samples in which interphase nuclei were analyzed; all of these studies were conducted in blind fashion. These results suggest the utility of FISH with composite probes for rapid detection of numerical aberrations in metaphase and interphase amniotic cells.	UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550; NIPPON MED COLL,DEPT GYNECOL,TOKYO 113,JAPAN; UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; Nippon Medical School; University of California System; University of California San Francisco			Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723	NICHD NIH HHS [HD 17665] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAIRD PA, 1988, AM J MED GENET, V29, P917, DOI 10.1002/ajmg.1320290424; CHOO KH, 1988, HUM GENET, V81, P49, DOI 10.1007/BF00283728; COLLINS C, UNPUB CONSTRUCTION C; CREMER T, 1986, HUM GENET, V74, P346, DOI 10.1007/BF00280484; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; DEVILEE P, 1988, CANCER RES, V48, P5825; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; DORAN TA, 1986, AM J OBSTET GYNECOL, V154, P277, DOI 10.1016/0002-9378(86)90655-1; EASTMOND DA, 1989, MECHANISMS CHROMOSOM, P277; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; FUSCOE JC, 1989, GENOMICS, V5, P100, DOI 10.1016/0888-7543(89)90092-X; HOOK EB, 1988, AM J HUM GENET, V42, P797; HOOK EB, 1987, ANN HUM GENET, V51, P27; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; LANDEGENT JE, 1984, EXP CELL RES, V153, P61, DOI 10.1016/0014-4827(84)90448-8; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; MANUELIDIS L, 1985, HUM GENET, V71, P288, DOI 10.1007/BF00388453; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; VANDILLA MA, 1986, BIO-TECHNOL, V4, P537, DOI 10.1038/nbt0686-537; WEIER HU, UNPUB DEGENERATE ALP	26	118	131	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					112	119						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063863				2022-12-18	WOS:A1991FW51100014
J	HELMUTH, R; FILDES, N; BLAKE, E; LUCE, MC; CHIMERA, J; MADEJ, R; GORODEZKY, C; STONEKING, M; SCHMILL, N; KLITZ, W; HIGUCHI, R; ERLICH, HA				HELMUTH, R; FILDES, N; BLAKE, E; LUCE, MC; CHIMERA, J; MADEJ, R; GORODEZKY, C; STONEKING, M; SCHMILL, N; KLITZ, W; HIGUCHI, R; ERLICH, HA			HLA-DQ-ALPHA ALLELE AND GENOTYPE FREQUENCIES IN VARIOUS HUMAN-POPULATIONS, DETERMINED BY USING ENZYMATIC AMPLIFICATION AND OLIGONUCLEOTIDE PROBES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CETUS CORP,DEPT HUMAN GENET,1400 53RD ST,EMERYVILLE,CA 94608; RDS W,EMERYVILLE,CA; FORENS SCI ASSOCIATES,RICHMOND,CA; ROCHE BIOMED LABS,DEPT MOLEC BIOL,RES TRIANGLE PK,NC; INST SALUBRIDAD & ENFERMADADES TROP,MEXICO CITY,DF,MEXICO; ALBERTA CHILDRENS PROV GEN HOSP,ALBERTA HEREDITARY DIS PROGRAM,CALGARY T2T 5C7,ALBERTA,CANADA; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720	Alberta Childrens Hospital; University of Calgary; University of California System; University of California Berkeley			Gorodezky, Clara/AAB-7332-2020		NIGMS NIH HHS [GM35326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1984, HISTOCOMPATIBILITY T; BALAZS I, 1989, AM J HUM GENET, V44, P182; BODMER JG, 1990, TISSUE ANTIGENS, V35, P1, DOI 10.1111/j.1399-0039.1990.tb01749.x; BUGAWAN TL, 1988, BIO-TECHNOL, V6, P943, DOI 10.1038/nbt0888-943; ERLICH HA, 1989, PCR TECHNOLOGY PRINC, P193; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; Garber R.A., 1983, INCLUSION PROBABILIT, P277; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KELLOGG DE, 1990, PCR PROTOCOLS GUIDE, P337; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LEE CL, 1983, INCLUSION PROBABILIT, P507; LEE CL, 1983, INCLUSION PROBABILIT, P525; Maniatis T., 1982, MOL CLONING; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUELLER L, IN PRESS GENETICS FO; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEI M, 1974, GENETICS, V76, P379; PECK S, 1989, J INT FED CLIN CHEM, V1, P150; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; Sokal R.R., 1981, BIOMETRY PRINCIPLES; STONEKING M, 1990, GENETICS, V124, P717; TROWSDALE J, 1985, IMMUNOL REV, V85, P5, DOI 10.1111/j.1600-065X.1985.tb01129.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x	33	118	132	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					515	523						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393024				2022-12-18	WOS:A1990DX22300016
J	LATHAM, T; GRABOWSKI, GA; THEOPHILUS, BDM; SMITH, FI				LATHAM, T; GRABOWSKI, GA; THEOPHILUS, BDM; SMITH, FI			COMPLEX ALLELES OF THE ACID BETA-GLUCOSIDASE GENE IN GAUCHER DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DEPT MICROBIOL,DIV MED & MOLEC GENET,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [DK36729, DK38381] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038381, R01DK038381, R01DK036729] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGMANN JE, 1989, AM J HUM GENET, V44, P741; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DAHL N, 1988, GENOMICS, V3, P296, DOI 10.1016/0888-7543(88)90118-8; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; FABBRO D, 1987, AM J HUM GENET, V40, P15; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; FRIED K, 1973, ISRAEL J MED SCI, V9, P1396; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRACE M E, 1989, American Journal of Human Genetics, V45, pA190; GRAVES PN, 1986, AM J HUM GENET, V39, P763; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Institute of Gaucher Disease, 2020, EP GAUCH DIS; ISELIUS L, 1989, ACTA PAEDIATR SCAND, V78, P592, DOI 10.1111/j.1651-2227.1989.tb17942.x; Maniatis T., 1982, MOL CLONING; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Svennerholm L, 1982, Prog Clin Biol Res, V95, P67; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10933, DOI 10.1093/nar/16.22.10933; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	30	118	120	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					79	86						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349952				2022-12-18	WOS:A1990DK48200011
J	OWEN, F; POULTER, M; COLLINGE, J; CROW, TJ				OWEN, F; POULTER, M; COLLINGE, J; CROW, TJ			CODON-129 CHANGES IN THE PRION PROTEIN GENE IN CAUCASIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											OWEN, F (corresponding author), CLIN RES CTR,DIV PSYCHIAT,HARROW HA1 3UJ,MIDDX,ENGLAND.							COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GOLDFARB L G, 1989, American Journal of Human Genetics, V45, pA189; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; OWEN F, 1989, LANCET, V1, P51; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	8	118	119	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1215	1216						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2378641				2022-12-18	WOS:A1990DF20200024
J	HOOK, EB; TOPOL, BB; CROSS, PK				HOOK, EB; TOPOL, BB; CROSS, PK			THE NATURAL-HISTORY OF CYTOGENETICALLY ABNORMAL FETUSES DETECTED AT MIDTRIMESTER AMNIOCENTESIS WHICH ARE NOT TERMINATED ELECTIVELY - NEW DATA AND ESTIMATES OF THE EXCESS AND RELATIVE RISK OF LATE FETAL DEATH ASSOCIATED WITH 47,+21 AND SOME OTHER ABNORMAL KARYOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY,DEPT BIOMED & ENVIRONM HLTH SCI,PROGRAM BIOSTAT,BERKELEY,CA 94720; NEW YORK STATE DEPT HLTH,BUR ENVIRONM EPIDEMIOL,ALBANY,NY 12201	University of California System; University of California Berkeley; State University of New York (SUNY) System	HOOK, EB (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720, USA.							HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOOK EB, 1987, ANN HUM GENET, V51, P27; LOWE CU, 1978, US DHEW NIH78190 PUB	4	118	120	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					855	861						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589318				2022-12-18	WOS:A1989CF40300004
J	HOOK, EB; LINDSJO, A				HOOK, EB; LINDSJO, A			DOWN SYNDROME IN LIVE BIRTHS BY SINGLE YEAR MATERNAL AGE INTERVAL IN A SWEDISH STUDY - COMPARISON WITH RESULTS FROM A NEW-YORK STATE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV,ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	Albany Medical College; Union College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,INST BIRTH DEFECTS,DIV LABS & RES,EPIDEMIOL & HUMAN ECOL SECT,ALBANY,NY 12237, USA.							DIEM K, 1962, DOCUMENTA GEIGY SCI, P85; DRAPER NR, 1966, APPLIED REGRESSION A, P77; ERICKSON JD, ANN HUM GENET; HARLAP S, 1974, AM J EPIDEMIOL, V99, P210, DOI 10.1093/oxfordjournals.aje.a121604; Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HOOK EB, 1977, POPULATION CYTOGENET, P353; LANGENBECK U, 1976, HUM GENET, V33, P89; LINDSJO A, 1974, ACTA PAEDIATR SCAND, V63, P571, DOI 10.1111/j.1651-2227.1974.tb04849.x; MORRIS R, 1971, New Zealand Medical Journal, V73, P195; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x	10	118	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					19	27						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	146429				2022-12-18	WOS:A1978EL57500003
J	RAO, DC; MORTON, NE; YEE, S				RAO, DC; MORTON, NE; YEE, S			RESOLUTION OF CULTURAL AND BIOLOGICAL INHERITANCE BY PATH-ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; FREIREMAIA A, 1974, BEHAV GENET, V4, P269, DOI 10.1007/BF01074159; Jencks C, 1972, INEQUALITY REASSESSM; JENSEN AR, 1974, EDUCABILITY GROUP DI; Kamin L. J., 1974, SCI POLITICS IQ; LEWONTIN RC, 1974, AM J HUM GENET, V26, P400; Mather K, 1971, BIOMETRICAL GENETICS; NANCE WE, TO BE PUBLISHED; RAO DB, IN PRESS; RAO DC, 1974, AM J HUM GENET, V26, P767; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1975, AM J HUM GENET, V27, P509; Wright S, 1931, J AM STAT ASSOC, V26, P155	15	118	118	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					228	242						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	BS306	944529				2022-12-18	WOS:A1976BS30600004
J	SARTO, GE; THERMAN, E; PATAU, K				SARTO, GE; THERMAN, E; PATAU, K			X-INACTIVATION IN MAN - WOMAN WITH T(XQ- - 12Q+)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN,DEPT GYNECOL & OBSTET,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								ALLDERDICE PW, 1971, EXCERPTA MEDICA  233, P14; BUCKTON KE, 1971, ANN HUM GENET, V35, P171, DOI 10.1111/j.1469-1809.1956.tb01390.x; CASPERSSON T, 1970, SCIENCE, V170, P762, DOI 10.1126/science.170.3959.762; COHEN MM, 1967, ANN HUM GENET, V30, P313, DOI 10.1111/j.1469-1809.1967.tb00032.x; COHEN MM, 1966, 3 INT C HUM GEN, P19; De MARS ROBERT, 1964, WE3TAR INST SYMP MONOGR, V1, P35; DOYLE CT, 1972, THESIS U WISCONSIN; ENGEL W, 1971, CYTOGENETICS, V10, P87, DOI 10.1159/000130131; GERALD PS, 1970, HUMAN POPULATION CYT, V5; GRZESCHIK KH, 1972, P NATL ACAD SCI USA, V69, P69, DOI 10.1073/pnas.69.1.69; GUSTAVSSON I, 1968, NATURE, V218, P183, DOI 10.1038/218183a0; Hamerton JL, 1971, HUMAN CYTOGENETICS, V1; HAMERTON JL, 1971, HUMAN CYTOGENETICS, V2; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; KALLIO H, IN PRESS; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; MANN JD, 1965, AM J HUM GENET, V17, P377; Ohno S., 1967, SEX CHROMOSOMES SEX; RUSSELL LB, 1970, GENETICS, V64, P281; SARTO GE, 1971, THESIS U WISCONSIN; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SINHA AK, 1969, ANN HUM GENET, V33, P117, DOI 10.1111/j.1469-1809.1969.tb01638.x; THELEN TH, 1971, AM J HUM GENET, V23, P410; THORBURN M J, 1970, Journal of Medical Genetics, V7, P402, DOI 10.1136/jmg.7.4.402; TURNER JH, 1970, HUMAN POPULATION CYT, V5	25	118	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					262	270						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704858				2022-12-18	WOS:A1973P918200005
J	Neveling, K; Martinez-Carrera, LA; Holker, I; Heister, A; Verrips, A; Hosseini-Barkooie, SM; Gilissen, C; Vermeer, S; Pennings, M; Meijer, R; te Riele, M; Frijns, CJM; Suchowersky, O; MacLaren, L; Rudnik-Schoneborn, S; Sinke, RJ; Zerres, K; Lowry, RB; Lemmink, HH; Garbes, L; Veltman, JA; Schelhaas, HJ; Scheffer, H; Wirth, B				Neveling, Kornelia; Martinez-Carrera, Lilian A.; Hoelker, Irmgard; Heister, Angelien; Verrips, Aad; Hosseini-Barkooie, Seyyed Mohsen; Gilissen, Christian; Vermeer, Sascha; Pennings, Maartje; Meijer, Rowdy; te Riele, Margot; Frijns, Catharina J. M.; Suchowersky, Oksana; MacLaren, Linda; Rudnik-Schoeneborn, Sabine; Sinke, Richard J.; Zerres, Klaus; Lowry, R. Brian; Lemmink, Henny H.; Garbes, Lutz; Veltman, Joris A.; Schelhaas, Helenius J.; Scheffer, Hans; Wirth, Brunhilde			Mutations in BICD2, which Encodes a Golgin and Important Motor Adaptor, Cause Congenital Autosomal-Dominant Spinal Muscular Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MARIE-TOOTH-DISEASE; BICAUDAL-D; MISSENSE MUTATIONS; HEAVY-CHAIN; NEUROPATHY; DYNACTIN; GENE; TRANSPORT; PROTEIN	Spinal muscular atrophy (SMA) is a heterogeneous group of neuromuscular disorders caused by degeneration of lower motor neurons. Although functional loss of SMN1 is associated with autosomal-recessive childhood SMA, the genetic cause for most families affected by dominantly inherited SMA is unknown. Here, we identified pathogenic variants in bicaudal D homolog 2 (Drosophila) (BICD2) in three families afflicted with autosomal-dominant SMA. Affected individuals displayed congenital slowly progressive muscle weakness mainly of the lower limbs and congenital contractures. In a large Dutch family, linkage analysis identified a 9q22.3 locus in which exome sequencing uncovered c.320C>T (p.Ser107Leu) in BICD2. Sequencing of 23 additional families affected by dominant SMA led to the identification of pathogenic variants in one family from Canada (c.2108C>T [p.Thr703Met]) and one from the Netherlands (c.563A>C [p.Asn188Thr]). BICD2 is a golgin and motor-adaptor protein involved in Golgi dynamics and vesicular and mRNA transport. Transient transfection of He La cells with all three mutant BICD2 cDNAs caused massive Golgi fragmentation. This observation was even more prominent in primary fibroblasts from an individual harboring c.2108C>T (p.Thr703Met) (affecting the C-terminal coiled-coil domain) and slightly less evident in individuals with c.563A>C (p.Asn188Thr) (affecting the N-terminal coiled-coil domain). Furthermore, BICD2 levels were reduced in affected individuals and trapped within the fragmented Golgi. Previous studies have shown that Drosophila mutant BicD causes reduced larvae locomotion by impaired clathrin-mediated synaptic endocytosis in neuromuscular junctions. These data emphasize the relevance of BICD2 in synaptic-vesicle recycling and support the conclusion that BICD2 mutations cause congenital slowly progressive dominant SMA.	[Neveling, Kornelia; Heister, Angelien; Gilissen, Christian; Vermeer, Sascha; Pennings, Maartje; Meijer, Rowdy; Veltman, Joris A.; Scheffer, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Neveling, Kornelia; Gilissen, Christian; Vermeer, Sascha; Veltman, Joris A.; Scheffer, Hans] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Martinez-Carrera, Lilian A.; Hoelker, Irmgard; Hosseini-Barkooie, Seyyed Mohsen; Garbes, Lutz; Wirth, Brunhilde] Univ Cologne, Inst Genet, Inst Human Genet, D-50931 Cologne, Germany; [Martinez-Carrera, Lilian A.; Hoelker, Irmgard; Hosseini-Barkooie, Seyyed Mohsen; Garbes, Lutz; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Verrips, Aad] Canisius Wilhelmina Hosp, Dept Pediat Neurol, NL-6532 SZ Nijmegen, Netherlands; [Gilissen, Christian; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gilissen, Christian] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [te Riele, Margot; Schelhaas, Helenius J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 GA Nijmegen, Netherlands; [Frijns, Catharina J. M.] Univ Med Ctr Utrecht, Dept Neurol, NL-3508 GA Utrecht, Netherlands; [Suchowersky, Oksana] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2B7, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2B7, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2B7, Canada; [MacLaren, Linda; Lowry, R. Brian] Univ Calgary, Dept Med Genet, Alberta Childrens Hosp, Calgary, AB T2N 4N1, Canada; [MacLaren, Linda; Lowry, R. Brian] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 4N1, Canada; [Rudnik-Schoeneborn, Sabine; Zerres, Klaus] Univ Aachen, Inst Human Genet, D-52057 Aachen, Germany; [Sinke, Richard J.; Lemmink, Henny H.] Univ Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands; [Sinke, Richard J.; Lemmink, Henny H.] Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; University of Cologne; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; University of Bergen; Haukeland University Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Alberta; University of Alberta; University of Alberta; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; RWTH Aachen University; University of Groningen; University of Groningen	Wirth, B (corresponding author), Univ Cologne, Inst Genet, Inst Human Genet, D-50931 Cologne, Germany.	h.scheffer@gen.umcn.nl; brunhilde.wirth@uk-koeln.de	Rudnik-Schöneborn, Sabine/F-8473-2015; Scheffer, Hans/E-4644-2012; Wirth, Brunhilde/H-3192-2019; Gilissen, Christian/E-5246-2012; Heister, Angelien/ABC-3651-2020; Neveling, K./L-4544-2015; Veltman, Joris A/F-5128-2010	Scheffer, Hans/0000-0002-2986-0915; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; Wirth, Brunhilde/0000-0003-4051-5191; Vermeer, Sascha/0000-0001-7625-1912; Hosseini-Barkooie, Seyyedmohsen/0000-0001-6121-8562	European Community [223143, 2012-305121]	European Community(European Commission)	We are very grateful to all participating affected families and their relatives. We would like to particularly thank Markus Storbeck for computational support and Karin Boss for critical reading of the manuscript. The research leading to these results received funding from the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement 223143 (project acronym TECHGENE) to H.S. and J.V. and under grant agreement 2012-305121 (project acronym NeurOmics) to B.W.	Adams C, 1998, NEUROMUSCULAR DISORD, V8, P405, DOI 10.1016/S0960-8966(98)00042-X; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Baets J, 2011, BRAIN, V134, P2664, DOI 10.1093/brain/awr184; Barwick KES, 2012, AM J HUM GENET, V91, P1103, DOI 10.1016/j.ajhg.2012.09.019; Beetz C, 2012, AM J HUM GENET, V91, P139, DOI 10.1016/j.ajhg.2012.05.007; Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; De Jonghe P, 2002, BRAIN, V125, P1320, DOI 10.1093/brain/awf127; Dienstbier M, 2009, BIOCHEM SOC T, V37, P1066, DOI 10.1042/BST0371066; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FRIJNS CJM, 1994, MUSCLE NERVE, V17, P192, DOI 10.1002/mus.880170210; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Karle K.N., 2012, NEUROGENETICS, V13, P169; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kolb SJ, 2010, NEUROLOGY, V74, P502, DOI 10.1212/WNL.0b013e3181cef84a; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Ting CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051826; Torres-Benito L, 2012, DEV NEUROBIOL, V72, P126, DOI 10.1002/dneu.20912; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Walker AK, 2011, IUBMB LIFE, V63, P754, DOI 10.1002/iub.520; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	45	117	118	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					946	954		10.1016/j.ajhg.2013.04.011	http://dx.doi.org/10.1016/j.ajhg.2013.04.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23664116	Green Published, Bronze			2022-12-18	WOS:000320415300011
J	Metspalu, M; Romero, IG; Yunusbayev, B; Chaubey, G; Mallick, CB; Hudjashov, G; Nelis, M; Magi, R; Metspalu, E; Remm, M; Pitchappan, R; Singh, L; Thangaraj, K; Villems, R; Kivisild, T				Metspalu, Mait; Romero, Irene Gallego; Yunusbayev, Bayazit; Chaubey, Gyaneshwer; Mallick, Chandana Basu; Hudjashov, Georgi; Nelis, Mari; Maegi, Reedik; Metspalu, Ene; Remm, Maido; Pitchappan, Ramasamy; Singh, Lalji; Thangaraj, Kumarasamy; Villems, Richard; Kivisild, Toomas			Shared and Unique Components of Human Population Structure and Genome-Wide Signals of Positive Selection in South Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; GENETIC DIVERSITY; INDIAN CASTE; FAT; PREVALENCE; LANDSCAPE; MYOSTATIN; INFERENCE; SEQUENCE	South Asia harbors one of the highest levels genetic diversity in Eurasia, which could be interpreted as a result of its long-term large effective population size and of admixture during its complex demographic history. In contrast to Pakistani populations, populations of Indian origin have been underrepresented in previous genomic scans of positive selection and population structure. Here we report data for more than 600,000 SNP markers genotyped in 142 samples from 30 ethnic groups in India. Combining our results with other available genome-wide data, we show that Indian populations are characterized by two major ancestry components, one of which is spread at comparable frequency and haplotype diversity in populations of South and West Asia and the Caucasus. The second component is more restricted to South Asia and accounts for more than 50% of the ancestry in Indian populations. Haplotype diversity associated with these South Asian ancestry components is significantly higher than that of the components dominating the West Eurasian ancestry palette. Modeling of the observed haplotype diversities suggests that both Indian ancestry components are older than the purported Indo-Aryan invasion 3,500 YBP. Consistent with the results of pairwise genetic distances among world regions, Indians share more ancestry signals with West than with East Eurasians. However, compared to Pakistani populations, a higher proportion of their genes show regionally specific signals of high haplotype homozygosity. Among such candidates of positive selection in India are MSTN and DOK5, both of which have potential implications in lipid metabolism and the etiology of type 2 diabetes.	[Metspalu, Mait; Yunusbayev, Bayazit; Chaubey, Gyaneshwer; Mallick, Chandana Basu; Hudjashov, Georgi; Villems, Richard; Kivisild, Toomas] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Metspalu, Mait; Mallick, Chandana Basu; Hudjashov, Georgi; Metspalu, Ene; Villems, Richard; Kivisild, Toomas] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Romero, Irene Gallego; Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 1QH, England; [Yunusbayev, Bayazit] Russian Acad Sci, Inst Biochem & Genet, Ufa Res Ctr, Ufa 450054, Russia; [Yunusbayev, Bayazit] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450054, Russia; [Nelis, Mari] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-51010 Tartu, Estonia; [Nelis, Mari] Estonian Bioctr, EE-51010 Tartu, Estonia; [Nelis, Mari] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Maegi, Reedik; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, EE-51010 Tartu, Estonia; [Maegi, Reedik] Univ Oxford, Genet & Genom Epidemiol Unit, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pitchappan, Ramasamy] Chettinad Hlth City, Chettinad Acad Res & Educ, Chennai 603103, Tamil Nadu, India; [Singh, Lalji; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Estonian Biocentre; University of Tartu; University of Cambridge; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; University of Tartu; Estonian Biocentre; University of Geneva; University of Tartu; University of Oxford; Wellcome Centre for Human Genetics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Banaras Hindu University (BHU); Estonian Academy of Sciences	Metspalu, M (corresponding author), Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia.	mait@ebc.ee	Remm, Maido/L-9072-2019; Yunusbaev, Bayazit/T-5444-2019; Kivisild, Toomas/P-5889-2017; Chaubey, Gyaneshwer/H-2753-2012; Hudjashov, Georgi/H-1254-2015; Metspalu, Mait/G-8671-2015; Mägi, Reedik/AAJ-9679-2021; Chaubey, Gyaneshwer/AAC-6409-2019; Nelis, Mari/ABG-7775-2020	Remm, Maido/0000-0003-3966-8422; Kivisild, Toomas/0000-0002-6297-7808; Chaubey, Gyaneshwer/0000-0003-2899-3852; Hudjashov, Georgi/0000-0002-7536-9086; Metspalu, Mait/0000-0003-3099-9161; Chaubey, Gyaneshwer/0000-0003-2899-3852; Nelis, Mari/0000-0001-9748-1020; Magi, Reedik/0000-0002-2964-6011; Thangaraj, Kumarasamy/0000-0002-0075-0106; Gallego Romero, Irene/0000-0003-1613-8998; Yunusbayev, Bayazit/0000-0002-6035-8763	European Union; University of Tartu; Estonian Basic Research [SF0270177As08, SF0180026s09]; Tartu University [PBGMR06901]; Estonian Science Foundation [7858, 8973]; Estonian Ministry of Education and Research [0180142s08]; European Commission [245536, 205419]; Council of Scientific and Industrial Research, Government of India	European Union(European Commission); University of Tartu; Estonian Basic Research; Tartu University; Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Commission(European CommissionEuropean Commission Joint Research Centre); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	We thank A. Migliano, S. Raj, and P. Underhill for discussion; J. Pickrell and J. Barna for help calculating iHS and XP-EHH scores; A. Aasa, I. Hilpus, T. Reisberg, V. Soo, and L. Anton for technical assistance. R.V., M.M., G.C. and C.B.M. thank the European Union European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre, and University of Tartu. This research was supported by Estonian Basic Research grant SF0270177As08 to R.V. and SF0180026s09 to M.R. and R.M.; Tartu University grant (PBGMR06901) to T.K.; Estonian Science Foundation grants (7858) to EM. and (8973) to M.M.; Estonian Ministry of Education and Research (0180142s08) and European Commission grant 245536 (OPENGENE) to M.N.; European Commission grant (ECOGENE 205419) to MM., I.G.R., B.Y., G.H, R.M., and R.V.; and Council of Scientific and Industrial Research, Government of India to L.S. and K.T. Calculations were carried out in the High Performance Computing Center, University of Tartu and with University of Cambridge Bioinformatics and Computational Biology services.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bass J, 1999, DOMEST ANIM ENDOCRIN, V17, P191, DOI 10.1016/S0739-7240(99)00036-3; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Brahmachari SK, 2008, J GENET, V87, P3; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Cann HM, 2002, SCIENCE, V296, P261; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Deraniyagala S.U., 1992, AD CHILDR ORD 1941 A; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2010, EUR J HUM GENET, V18, P364, DOI 10.1038/ejhg.2009.176; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Mitchell MD, 2006, J CLIN ENDOCR METAB, V91, P1434, DOI 10.1210/jc.2005-2361; Mukherjee N, 2000, J GENET, V79, P41, DOI 10.1007/BF02728944; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Petraglia MD, 2011, NATURE, V470, P50, DOI 10.1038/470050a; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prentice AM, 2005, P NUTR SOC, V64, P153, DOI 10.1079/PNS2005421; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Saunders MA, 2006, AM J HUM GENET, V79, P1089, DOI 10.1086/509707; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sharma S, 2009, J HUM GENET, V54, P47, DOI 10.1038/jhg.2008.2; Snehalatha C, 2009, DIABETOLOGIA, V52, P596, DOI 10.1007/s00125-009-1279-x; Tabassum R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-35; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weiss KM, 2009, GENOME RES, V19, P703, DOI 10.1101/gr.076539.108; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	90	117	117	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					731	744		10.1016/j.ajhg.2011.11.010	http://dx.doi.org/10.1016/j.ajhg.2011.11.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152676	Green Published, Bronze			2022-12-18	WOS:000298208700004
J	Zuchner, S; Dallman, J; Wen, R; Beecham, G; Naj, A; Farooq, A; Kohli, MA; Whitehead, PL; Hulme, W; Konidari, I; Edwards, YJK; Cai, GQ; Peter, I; Seo, D; Buxbaum, JD; Haines, JL; Blanton, S; Young, JA; Alfonso, E; Vance, JM; Lam, BL; Pericak-Vance, MA				Zuechner, Stephan; Dallman, Julia; Wen, Rong; Beecham, Gary; Naj, Adam; Farooq, Amjad; Kohli, Martin A.; Whitehead, Patrice L.; Hulme, William; Konidari, Ioanna; Edwards, Yvonne J. K.; Cai, Guiqing; Peter, Inga; Seo, David; Buxbaum, Joseph D.; Haines, Jonathan L.; Blanton, Susan; Young, Juan; Alfonso, Eduardo; Vance, Jeffery M.; Lam, Byron L.; Pericak-Vance, Margaret A.			Whole-Exome Sequencing Links a Variant in DHDDS to Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNTHASE	Increasingly, mutations in genes causing Mendelian disease will be supported by individual and small families only; however, exome sequencing studies have thus far focused on syndromic phenotypes characterized by low locus heterogeneity. In contrast, retinitis pigmentosa (RP) is caused by >50 known genes, which still explain only half of the clinical cases. In a single, one-generation, nonsyndromic RP family, we have identified a gene, dehydrodolichol diphosphate synthase (DHDDS), demonstrating the power of combining whole-exome sequencing with rapid in vivo studies. DHDDS is a highly conserved essential enzyme for dolichol synthesis, permitting global N-linked glycosylation. Zebrafish studies showed virtually identical photoreceptor defects as observed with N-linked glycosylation-interfering mutations in the light-sensing protein rhodopsin. The identified Lys42Glu variant likely arose from an ancestral founder, because eight of the nine identified alleles in 27,174 control chromosomes were of confirmed Ashkenazi Jewish ethnicity. These findings demonstrate the power of exome sequencing linked to functional studies when faced with challenging study designs and, importantly, link RP to the pathways of N-linked glycosylation, which promise new avenues for therapeutic interventions.	[Wen, Rong; Alfonso, Eduardo; Lam, Byron L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Zuechner, Stephan; Beecham, Gary; Naj, Adam; Kohli, Martin A.; Whitehead, Patrice L.; Hulme, William; Konidari, Ioanna; Edwards, Yvonne J. K.; Seo, David; Blanton, Susan; Young, Juan; Vance, Jeffery M.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Zuechner, Stephan; Beecham, Gary; Naj, Adam; Kohli, Martin A.; Whitehead, Patrice L.; Hulme, William; Konidari, Ioanna; Edwards, Yvonne J. K.; Seo, David; Blanton, Susan; Young, Juan; Vance, Jeffery M.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Farooq, Amjad] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Farooq, Amjad] Univ Miami, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, Miami, FL 33146 USA; [Dallman, Julia] Univ Miami, Dept Biol, Miami, FL 33146 USA; [Cai, Guiqing; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Peter, Inga; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Sch Med, Nashville, TN 37232 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Vanderbilt University	Lam, BL (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	blam@med.miami.edu; mpericak@med.miami.edu	Haines, Jonathan/C-3374-2012; Buxbaum, Joseph D/G-6001-2010; Dallman, Julia/AGG-3507-2022; Farooq, Amjad/B-5084-2012; Dallman, Julia/I-1414-2019; Blanton, Susan Halloran/ABF-1323-2021	Haines, Jonathan/0000-0002-4351-4728; Dallman, Julia/0000-0002-5839-807X; Vance, Jeffery/0000-0003-3815-8199; Edwards, Yvonne/0000-0001-8505-3168; Buxbaum, Joseph/0000-0001-8898-8313	Department of Defense [W81XWH-09-1-0674]; National Institutes of Health [P30-EY14801, R01-EY018586, R01-EY012118, R01-GM083897, U54-NS065712]; Hope for Vision; Research to Prevent Blindness; Florida Office of Tourism, Trade and Economic Development; NATIONAL EYE INSTITUTE [P30EY014801, R01EY012118, R01EY018586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Florida Office of Tourism, Trade and Economic Development; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are thankful to the family members studied and to their support for our research. We also thank Olaf Bodamer for helpful discussions and Yiwen Li, Deqiang Huang, and Zhengying Wang for technical assistance on the development of this manuscript. This study was supported by grants from the Department of Defense (W81XWH-09-1-0674), National Institutes of Health (P30-EY14801 core grant, R01-EY018586 to R.W., R01-EY012118 to MAP-V., R01-GM083897 to A.F., and U54-NS065712 to S.Z.), Hope for Vision, an unrestricted grant from Research to Prevent Blindness, and a grant from the Florida Office of Tourism, Trade and Economic Development.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Balgobind B, 2005, J INHERIT METAB DIS, V28, P1143, DOI 10.1007/s10545-005-0178-7; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Endo S, 2003, BBA-GENE STRUCT EXPR, V1625, P291, DOI 10.1016/S0167-4781(02)00628-0; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Goodwin P, 2008, CURR OPIN OPHTHALMOL, V19, P255, DOI 10.1097/ICU.0b013e3282fc27fc; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	18	117	123	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					201	206		10.1016/j.ajhg.2011.01.001	http://dx.doi.org/10.1016/j.ajhg.2011.01.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21295283	Green Published, Bronze			2022-12-18	WOS:000287684100008
J	Kim, HG; Ahn, JW; Kurth, I; Ullmann, R; Kim, HT; Kulharya, A; Ha, KS; Itokawa, Y; Meliciani, I; Wenzel, W; Lee, D; Rosenberger, G; Ozata, M; Bick, DP; Sherins, RJ; Nagase, T; Tekin, M; Kim, SH; Kim, CH; Ropers, HH; Gusella, JF; Kalscheuer, V; Choi, CY; Layman, LC				Kim, Hyung-Goo; Ahn, Jang-Won; Kurth, Ingo; Ullmann, Reinhard; Kim, Hyun-Taek; Kulharya, Anita; Ha, Kyung-Soo; Itokawa, Yasuhide; Meliciani, Irene; Wenzel, Wolfgang; Lee, Deresa; Rosenberger, Georg; Ozata, Metin; Bick, David P.; Sherins, Richard J.; Nagase, Takahiro; Tekin, Mustafa; Kim, Soo-Hyun; Kim, Cheol-Hee; Ropers, Hans-Hilger; Gusella, James F.; Kalscheuer, Vera; Choi, Cheol Yong; Layman, Lawrence C.			WDR11, a WD Protein that Interacts with Transcription Factor EMX1, Is Mutated in Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GONADOTROPIN-RELEASING-HORMONE; METASTASIS SUPPRESSOR GENE; TERMINAL DELETION; EMPTY-SPIRACLES; MUTATIONS; TRANSLOCATION; EXPRESSION; RECEPTOR; IDENTIFICATION; HYBRIDIZATION	By defining the chromosomal breakpoint of a balanced 1(10,12) translocation from a subject with Kallmann syndrome and scanning genes in its vicinity in unrelated hypogonadal subjects, we have identified WDR11 as a gene involved in human puberty We found six patients with a total of five different heterozygous WDR11 missense mutations, including three alterations (A435T, R448Q and H690Q) in WD domains important for beta propeller formation and protein-protein interaction In addition, we discovered that WDR11 interacts with EMX1, a homeodomain transcription factor involved in the development of olfactory neurons, and that missense alterations reduce or abolish this interaction. Our findings suggest that impaired pubertal development in these patients results from a deficiency of productive WDR11 protein interaction	[Kim, Hyung-Goo; Layman, Lawrence C.] Med Coll Georgia, Sect Reprod Endocrinol Infertil & Genet, Reprod Med & Dev Neurobiol Programs, Dept Obstet & Gynecol,Inst Mol Med & Genet, Augusta, GA 30912 USA; [Kim, Hyung-Goo; Layman, Lawrence C.] Med Coll Georgia, Neurosci Program, Augusta, GA 30912 USA; [Ahn, Jang-Won; Lee, Deresa; Choi, Cheol Yong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Kurth, Ingo; Rosenberger, Georg] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Kim, Hyung-Goo; Ullmann, Reinhard; Ropers, Hans-Hilger; Kalscheuer, Vera] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Kim, Hyun-Taek; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Kim, Hyun-Taek; Kim, Cheol-Hee] Chungnam Natl Univ, Grad Sch Analyt Sci & Technolgy, Taejon 305764, South Korea; [Kulharya, Anita] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Kulharya, Anita] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Ha, Kyung-Soo] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA; [Itokawa, Yasuhide; Nagase, Takahiro] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba 2920818, Japan; [Meliciani, Irene; Wenzel, Wolfgang] Forschungszentrum Karlsruhe, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Ozata, Metin] Gulhane Mil Med Acad, Haydarpasa Training Hosp, Dept Endocrinol, TR-34660 Istanbul, Turkey; [Bick, David P.] Med Coll Wisconsin, Div Med Genet, Dept Pediat, Milwaukee, WI 53226 USA; [Bick, David P.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Sherins, Richard J.] Columbia Fertil Associates, Washington, DC 20037 USA; [Tekin, Mustafa] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miller Sch Med, Miami, FL 33156 USA; [Kim, Soo-Hyun] Univ London, Div Basic Med Sci, St Georges Med Sch, London SW17 0RE, England; [Kim, Hyung-Goo; Gusella, James F.] Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kim, Hyung-Goo; Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Kurth, Ingo] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06610 Ankara, Turkey	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Sungkyunkwan University (SKKU); University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Chungnam National University; Chungnam National University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Kazusa DNA Research Institute; Helmholtz Association; Karlsruhe Institute of Technology; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Medical College of Wisconsin; Medical College of Wisconsin; University of Miami; St Georges University London; University of London; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Friedrich Schiller University of Jena; Ankara University	Kim, HG (corresponding author), Med Coll Georgia, Sect Reprod Endocrinol Infertil & Genet, Reprod Med & Dev Neurobiol Programs, Dept Obstet & Gynecol,Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.		Kim, Soo Hyun/ABG-8773-2020; Kim, Cheol-Hee/F-6278-2013; Wenzel, Wolfgang/B-3207-2009; Tekin, Mustafa/ABG-7627-2020	Kim, Soo Hyun/0000-0002-9394-1437; Wenzel, Wolfgang/0000-0001-9487-4689; Tekin, Mustafa/0000-0002-3525-7960; Kim, Cheol-Hee/0000-0002-3019-0699; Kalscheuer, Vera/0000-0001-6898-3259; Kurth, Ingo/0000-0002-5642-8378	Landesstiftung Baden-Wurtemberg; Deutsche Akademische Austauschdienst (German Academic Exchange Service; government of the Republic of Korea [2009-00983]; National Institutes of Health [GM061354, HD33004, HD040287]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033004] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD033004, K24HD040287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Landesstiftung Baden-Wurtemberg; Deutsche Akademische Austauschdienst (German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); government of the Republic of Korea(Korean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is dedicated to the 80<SUP>th</SUP> birthday of Paul G. McDonough We thank all families for their kind participation in this study. We are indebted to the following colleagues for this study. Stefanie Meien, Milton David Stuart, Karen Norris, Ihn-Sik Seong, Jae Ho Lee, Gabriela Alexandru, Wei Chen, Ines Muller, Fer Lan, Hans-Jurgen Kreienkamp, Enno Gossling, Duygu Duman, Lynn Chorich, Sandra Tho, Jill Mokry, Lisa Halvorson, and Temple Smith. We acknowledge support by the Landesstiftung Baden-Wurtemberg, the Deutsche Akademische Austauschdienst (German Academic Exchange Service) and the volunteers of POEM@HOME. This study was supported in part by a Korea Science and Engineering Foundation (KOSEF) grant funded by the government of the Republic of Korea (The Ubiquitome Research Program, 2009-00983 to C Y.C) J.F.G was supported by National Institutes of Health grant GM061354 for the Developmental Genome Anatomy Protect We also acknowledge support to L CL from National Institutes of Health grants HD33004 and HD040287.	Baccetti B, 2003, HUM REPROD, V18, P2302, DOI 10.1093/humrep/deg460; Bhagavath B, 2006, FERTIL STERIL, V85, P706, DOI 10.1016/j.fertnstert.2005.08.044; Bhagavath B, 2005, FERTIL STERIL, V84, P951, DOI 10.1016/j.fertnstert.2005.04.029; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; BOFINGER MK, 1991, AM J MED GENET, V38, P1, DOI 10.1002/ajmg.1320380102; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Chernova OB, 2001, ONCOGENE, V20, P5378, DOI 10.1038/sj.onc.1204694; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Franke WW, 2004, NAT CELL BIOL, V6, P1013, DOI 10.1038/ncb1104-1013; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hu YL, 2009, J BIOL CHEM, V284, P29905, DOI 10.1074/jbc.M109.049155; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Kim HT, 2008, DEV DYNAM, V237, P3921, DOI 10.1002/dvdy.21806; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Kim HG, 2008, NEUROSIGNALS, V16, P165, DOI 10.1159/000111561; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.3.CO;2-T; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; Leonard NJ, 1999, AM J MED GENET, V86, P115, DOI 10.1002/(SICI)1096-8628(19990910)86:2<115::AID-AJMG5>3.3.CO;2-P; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210; Lukusa T, 2000, GENET COUNSEL, V11, P119; Miura K, 2004, J HUM GENET, V49, P265, DOI 10.1007/s10038-004-0137-4; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Mutoh A, 1999, SCAND J UROL NEPHROL, V33, P77; Ogata T, 2000, KIDNEY INT, V58, P2281, DOI 10.1046/j.1523-1755.2000.00412.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Ojeda SR, 2010, MOL CELL ENDOCRINOL, V324, P3, DOI 10.1016/j.mce.2009.12.003; Parent AS, 2008, HORM RES, V69, P114, DOI 10.1159/000111815; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; SCHINZEL A, 1995, J MED GENET, V32, P957, DOI 10.1136/jmg.32.12.957; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Suzuki Y, 1998, UROL INT, V61, P186, DOI 10.1159/000030321; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Tzschach A, 2010, EUR J HUM GENET, V18, P291, DOI 10.1038/ejhg.2009.163; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200	57	117	127	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					465	479		10.1016/j.ajhg.2010.08.018	http://dx.doi.org/10.1016/j.ajhg.2010.08.018			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20887964	Green Published, Bronze			2022-12-18	WOS:000283037600003
J	Renbaum, P; Kellerman, E; Jaron, R; Geiger, D; Segel, R; Lee, M; King, MC; Levy-Lahad, E				Renbaum, Paul; Kellerman, Efrat; Jaron, Ranit; Geiger, Dan; Segel, Reeval; Lee, Ming; King, Mary Claire; Levy-Lahad, Ephrat			Spinal Muscular Atrophy with Pontocerebellar Hypoplasia Is Caused by a Mutation in the VRK1 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CYCLE PROGRESSION; KINASE; IDENTIFICATION; DROSOPHILA; FAMILY; CREB; VACCINIA-RELATED-KINASE-1; EXPRESSION; PHENOTYPE; DISEASE	The spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of disorders characterized by degeneration and loss of anterior horn cells in the spinal cord, leading to muscle weakness and atrophy. Spinal muscular atrophy with pontocerebellar hypoplasia (SMA-PCH, also known as pontocerebellar hypoplasia type 1 [PCH1]) is one of the rare infantile SMA variants that include additional clinical manifestations, and its genetic basis is unknown. We used a homozygosity mapping and positional cloning approach in a consanguineous family of Ashkenazi Jewish origin and identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH. VRK1, one of three members of the mammalian VRK family, is a serine/threonme kinase that phosphorylates p53 and CREB and is essential for nuclear envelope formation. Its identification as a gene involved in SMA-PCH implies new roles for the VRK proteins in neuronal development and maintenance and suggests the VRK genes as candidates for related phenotypes.	[Renbaum, Paul; Kellerman, Efrat; Jaron, Ranit; Segel, Reeval; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Kellerman, Efrat; Segel, Reeval; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, IL-91120 Jerusalem, Israel; [Jaron, Ranit; Segel, Reeval] Shaare Zedek Med Ctr, Dept Pediat, IL-91031 Jerusalem, Israel; [Geiger, Dan] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Lee, Ming; King, Mary Claire] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Lee, Ming; King, Mary Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Technion Israel Institute of Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Levy-Lahad, E (corresponding author), Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel.	lahad@szmc.org.il	Segel, Reeval/AAT-1498-2020; Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1872/2008, 1174/2007]	Legacy Heritage Bio-Medical Program of the Israel Science Foundation	We thank Tom D. Bird of the Departments of Medicine and Neurology at the University of Washington, Seattle, WA, for reviewing the clinical information on the patients described in the study. Shirley Horn-Saban, Head of the Microarray Facility at the Weizmann Institute of Science, Rehovot, Israel, performed SNP genotyping. We thank Anna Tzemach for assistance with the genome-wide linkage analysis. We thank Hadassah Hartman for excellent secretarial assistance, and we thank all family members for their participation in this study. This research was supported by the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant no. 1872/2008 to RR. and E.L.L.), by the Israel Science Foundation (grant no. 1174/2007 to D.G.), and by a generous gift from Rabbi and Mrs. David Fuld to Shaare Zedek Medical Center.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; BARTH PG, 1993, BRAIN DEV-JPN, V15, P411, DOI 10.1016/0387-7604(93)90080-R; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fishelson M, 2005, HUM HERED, V59, P41, DOI 10.1159/000084736; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Jacobs WB, 2006, J NEUROCHEM, V97, P1571, DOI 10.1111/j.1471-4159.2006.03980.x; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Majumder S, 2004, J BIOL CHEM, V279, P14803, DOI 10.1074/jbc.M308225200; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Rudnik-Schoneborn S, 2003, AM J MED GENET A, V117A, P10, DOI 10.1002/ajmg.a.10863; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Tsai MS, 2006, EUR J HUM GENET, V14, P372, DOI 10.1038/sj.ejhg.5201556; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.3.CO;2-0; Young PJ, 2002, J BIOL CHEM, V277, P2852, DOI 10.1074/jbc.M108769200; ZERRES K, 2006, PRINCIPLES PRACTICE, P3001	29	117	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					281	289		10.1016/j.ajhg.2009.07.006	http://dx.doi.org/10.1016/j.ajhg.2009.07.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19646678	Green Published, Bronze			2022-12-18	WOS:000269332900017
J	Clapp, J; Mitchell, LM; Bolland, DJ; Fantes, J; Corcoran, AE; Scoffing, PJ; Armour, JAL; Hewitt, JE				Clapp, Jannine; Mitchell, Laura M.; Bolland, Daniel J.; Fantes, Judy; Corcoran, Anne E.; Scoffing, Paul J.; Armour, John A. L.; Hewitt, Jane E.			Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FSHD; GENE; REGION; LOCUS; HYPOMETHYLATION; REARRANGEMENTS; EXPRESSION; FAMILY; TRANSCRIPTION	Facioscapulohumeral muscular dystrophy (FSHD) is caused by deletions within the polymorphic DNA tandem array D4Z4. Each D4Z4 repeat unit has an open reading frame (ORF), termed "DUX4," containing two homeobox sequences. Because there has been no evidence of a transcript from the array, these deletions are thought to cause FSHD by a position effect on other genes. Here, we identify D4Z4 homologues in the genomes of rodents, Afrotheria (superorder of elephants and related species), and other species and show that the DUX4 ORF is conserved. Phylogenetic analysis suggests that primate and Afrotherian D4Z4 arrays are orthologous and originated from a retrotransposed copy of an intron-containing DUX gene, DUXC. Reverse-transcriptase polymerase chain reaction and RNA fluorescence and tissue in situ hybridization data indicate transcription of the mouse array. Together with the conservation of the DUX4 ORF for >100 million years, this strongly supports a coding function for D4Z4 and necessitates re-examination of current models of the FSHD disease mechanism.	Univ Nottingham, Queens Med Ctr, Sch Biol, Genet Inst, Nottingham NG7 2UH, England; Babraham Inst, Lab Chromtin & Gene Express, Cambridge, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Edinburgh	Hewitt, JE (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biol, Genet Inst, Nottingham NG7 2UH, England.	jane.hewitt@nottingham.ac.uk	Bolland, Daniel/AAE-5185-2020	Bolland, Daniel/0000-0003-3674-9913; Armour, John/0000-0002-8558-8506	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163] Funding Source: Medline; Wellcome Trust [066536/z/01/z] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Baird DM, 1997, HUM MOL GENET, V6, P2291, DOI 10.1093/hmg/6.13.2291; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Booth HAF, 2007, GENE, V387, P7, DOI 10.1016/j.gene.2006.07.034; Burglin Thomas R., 1994, P25; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Goudet J., 2001, CLADISTICS; Graves JAM, 1998, CYTOGENET CELL GENET, V80, P94, DOI 10.1159/000014963; Grewal PK, 1998, MAMM GENOME, V9, P603, DOI 10.1007/s003359900829; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Lee CJ, 2002, MOL BRAIN RES, V106, P151, DOI 10.1016/S0169-328X(02)00439-4; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ostlund C, 2005, BIOCHEMISTRY-US, V44, P2378, DOI 10.1021/bi047992w; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Padberg GW, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P41; Rex Maria, 1999, V97, P645; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Saitoh Y, 2000, GENOMICS, V67, P291, DOI 10.1006/geno.2000.6261; Sambrook J., 1989, MOLECULAR CLONING LA; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Vogel T, 1998, CYTOGENET CELL GENET, V80, P209, DOI 10.1159/000014982; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Yang F, 2004, CHROMOSOMA, V112, P350, DOI 10.1007/s00412-004-0280-x; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	52	117	121	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					264	279		10.1086/519311	http://dx.doi.org/10.1086/519311			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668377	Green Published, Bronze			2022-12-18	WOS:000248540400007
J	Delague, V; Jacquier, A; Hamadouche, T; Poitelon, Y; Baudot, C; Boccaccio, I; Chouery, E; Chaouch, M; Kassouri, N; Jabbour, R; Grid, D; Megarbane, A; Haase, G; Levy, N				Delague, Valerie; Jacquier, Arnaud; Hamadouche, Tarik; Poitelon, Yannick; Baudot, Cecile; Boccaccio, Irene; Chouery, Eliane; Chaouch, Malika; Kassouri, Nora; Jabbour, Rosette; Grid, Djamel; Megarbane, Andre; Haase, Georg; Levy, Nicolas			Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIATION-ASSOCIATED PROTEIN-1; N-TERMINAL KINASE; DEJERINE-SOTTAS; MICROSPIKE FORMATION; DEMYELINATING NEUROPATHY; MYOTUBULARIN FAMILY; MISSENSE MUTATION; PERIPHERAL-NERVES; HEREDITARY MOTOR; HOMOLOGY DOMAIN	Charcot-Marie-Tooth (CMT) disorders are a clinically and genetically heterogeneous group of hereditary motor and sensory neuropathies characterized by muscle weakness and wasting, foot and hand deformities, and electrophysiological changes. The CMT4H subtype is an autosomal recessive demyelinating form of CMT that was recently mapped to a 15.8-Mb region at chromosome 12p11.21-q13.11, in two consanguineous families of Mediterranean origin, by homozygosity mapping. We report here the identification of mutations in FGD4, encoding FGD4 or FRABIN (FGD1-related F-actin binding protein), in both families. FRABIN is a GDP/GTP nucleotide exchange factor (GEF), specific to Cdc42, a member of the Rho family of small guanosine triphosphate (GTP)-binding proteins (Rho GTPases). Rho GTPases play a key role in regulating signal-transduction pathways in eukaryotes. In particular, they have a pivotal role in mediating actin cytoskeleton changes during cell migration, morphogenesis, polarization, and division. Consistent with these reported functions, expression of truncated FRABIN mutants in rat primary motoneurons and rat Schwann cells induced significantly fewer microspikes than expression of wild-type FRABIN. To our knowledge, this is the first report of mutations in a Rho GEF protein being involved in CMT.	Fac Med Marseille, INSERM U491, F-13385 Marseille, France; Univ Mediterranee, INSERM, Inst Neurobiol Mediterranee, Equipe AVENIR, F-13385 Marseille, France; Hop Enfants La Timone, AP HP, Dept Genet Med, F-13385 Marseille, France; Genethon III, Evry, France; CHU Ben Aknoun, Inst Pasteur, Lab Biol Mol, Algiers, Algeria; CHU Ben Aknoun, Neurol Serv, Algiers, Algeria; Amer Univ Beirut, Med Ctr, Beirut, Lebanon; Univ St Joseph, Unite Genet Med, Beirut, Lebanon	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; American University of Beirut; Saint Joseph University Beirut	Delague, V (corresponding author), Fac Med Marseille, INSERM U491, 27 Blvd Jean Moulin, F-13385 Marseille, France.	valerie.delague@medecine.univ-mrs.fr	Chouery, Eliane/AAC-5957-2021; LEVY, Nicolas/J-1632-2014; Megarbane, Andre/ABD-5574-2021; delague, valerie/K-5837-2013	LEVY, Nicolas/0000-0001-5171-6365; Jabbour, Rosette/0000-0002-0491-0306; Poitelon, Yannick/0000-0001-9868-1569; Jacquier, Arnaud/0000-0002-2883-9620; delague, valerie/0000-0003-2652-362X				Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Berciano J, 2003, CURR OPIN NEUROL, V16, P613, DOI 10.1097/00019052-200310000-00008; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Sandre-Giovannoli A, 2005, J MED GENET, V42, P260, DOI 10.1136/jmg.2004.024364; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; Dyck P.J, 1993, PNP, P1094; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eymard-Pierre E, 2006, ANN NEUROL, V59, P976, DOI 10.1002/ana.20879; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; Ikeda W, 2001, ONCOGENE, V20, P3457, DOI 10.1038/sj.onc.1204463; Ikeda W, 2001, BIOCHEM BIOPH RES CO, V286, P1066, DOI 10.1006/bbrc.2001.5481; Ikegami T, 1996, BIOCHEM BIOPH RES CO, V222, P107, DOI 10.1006/bbrc.1996.0705; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Kortenjann M, 1995, CRIT REV ONCOGENESIS, V6, P99; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 2001, TRENDS GENET, V17, P221, DOI 10.1016/S0168-9525(01)02245-4; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; PASTERIS NG, 1994, CELL, V79, P669; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shy ME, 2004, CURR OPIN NEUROL, V17, P579, DOI 10.1097/00019052-200410000-00008; SKRE H, 1974, CLIN GENET, V6, P98; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yasuda T, 2000, GENES CELLS, V5, P583, DOI 10.1046/j.1365-2443.2000.00349.x; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	62	117	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					1	16		10.1086/518428	http://dx.doi.org/10.1086/518428			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564959	Green Published, Bronze			2022-12-18	WOS:000247039700001
J	Balaci, L; Spada, MC; Olla, N; Sole, G; Loddo, L; Anedda, F; Naitza, S; Zuncheddu, MA; Maschio, A; Altea, D; Uda, M; Pilia, S; Sanna, S; Masala, M; Crisponi, L; Fattori, M; Devoto, M; Doratiotto, S; Rassu, S; Mereu, S; Giua, E; Cadeddu, NG; Atzeni, R; Pelosi, U; Corrias, A; Perra, R; Torrazza, PL; Pirina, P; Ginesu, F; Marcias, S; Schintu, MG; Del Giacco, GS; Manconi, PE; Malerba, G; Bisognin, A; Trabetti, E; Boner, A; Pescollderungg, L; Pignatti, PF; Schlessinger, D; Cao, A; Pilia, G				Balaci, Lenuta; Spada, Maria Cristina; Olla, Nazario; Sole, Gabriella; Loddo, Laura; Anedda, Francesca; Naitza, Silvia; Zuncheddu, Maria Antonietta; Maschio, Andrea; Altea, Daniele; Uda, Manuela; Pilia, Sabrina; Sanna, Serena; Masala, Marco; Crisponi, Laura; Fattori, Matilde; Devoto, Marcella; Doratiotto, Silvia; Rassu, Stefania; Mereu, Simonetta; Giua, Enrico; Cadeddu, Natalina Graziella; Atzeni, Roberto; Pelosi, Umberto; Corrias, Adriano; Perra, Roberto; Torrazza, Pier Luigi; Pirina, Pietro; Ginesu, Francesco; Marcias, Silvano; Schintu, Maria Grazia; Del Giacco, Gennaro Sergio; Manconi, Paolo Emilio; Malerba, Giovanni; Bisognin, Andrea; Trabetti, Elisabetta; Boner, Attilio; Pescollderungg, Lydia; Pignatti, Pier Franco; Schlessinger, David; Cao, Antonio; Pilia, Giuseppe			IRAK-M is involved in the pathogenesis of early-onset persistent asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOLL-LIKE RECEPTORS; SARDINIAN POPULATION; NEGATIVE REGULATOR; LINKAGE ANALYSIS; IMMUNE-RESPONSE; ACTIVATION; DISEASE; ASSOCIATION; HAPLOTYPES; PHENOTYPES	Asthma is a multifactorial disease influenced by genetic and environmental factors. In the past decade, several loci and 1100 genes have been found to be associated with the disease in at least one population. Among these loci, region 12q13-24 has been implicated in asthma etiology in multiple populations, suggesting that it harbors one or more asthma susceptibility genes. We performed linkage and association analyses by transmission/ disequilibrium test and case-control analysis in the candidate region 12q13-24, using the Sardinian founder population, in which limited heterogeneity of pathogenetic alleles for monogenic and complex disorders as well as of environmental conditions should facilitate the study of multifactorial traits. We analyzed our cohort, using a cutoff age of 13 years at asthma onset, and detected significant linkage to a portion of 12q13-24. We identified IRAK-M as the gene contributing to the linkage and showed that it is associated with early-onset persistent asthma. We defined protective and predisposing SNP haplotypes and replicated associations in an outbred Italian population. Sequence analysis in patients found mutations, including inactivating lesions, in the IRAK-M coding region. Immunohistochemistry of lung biopsies showed that IRAK-M is highly expressed in epithelial cells. We report that IRAK-M is involved in the pathogenesis of early-onset persistent asthma. IRAK-M, a negative regulator of the Toll-like receptor/IL-1R pathways, is a master regulator of NF-kappa B and inflammation. Our data suggest a mechanistic link between hyperactivation of the innate immune system and chronic airway inflammation and indicate IRAK-M as a potential target for therapeutic intervention against asthma.	CNR, Ist Neurogenet & Neurofarmacol, Div Pneumol 2, Osped Binaghi, I-09042 Monserrato, CA, Italy; Univ Cagliari, Dipartimento Sci & Tecnol Biomed, Sez Patol Sperimentale, Div Pneumol 2,Osped Binaghi, Cagliari, Italy; Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Div Pneumol 2, Osped Binaghi, Cagliari, Italy; Univ Cagliari, Dipartimento Sci Pediat Allergol Pediat, Clin Pediat 1, Div Pneumol 2,Osped Binaghi, Cagliari, Italy; Osped Macciotta, Dipartimento Chirurg Materno Infantile Sci & Imma, Sez Pediat, Cagliari, Italy; Policlin Univ Cagliari, Ist Naz Riposo & Cura Anziani, Cagliari, Italy; Policlin Univ Cagliari, Allergol & Immunol Clin, Cagliari, Italy; Presidio Pneumotisiol, Oristano, Italy; Clin Pneumotisiol, Sassari, Italy; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Osped Cesare Zonchello, Unita Operat Allergol, Nuoro, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy; Univ Verona, Dipartimento Materno Infantile & Biol Genet, Sez Biol & Genet, I-37100 Verona, Italy; Univ Verona, Pediat Clin, I-37100 Verona, Italy; Osped Bolzano, Dipartimento Pediat, Bolzano, Italy; NIA, Genet Lab, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sapienza University Rome; University of Verona; University of Verona; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cao, A (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, Div Pneumol 2, Osped Binaghi, Cittadella Univ Cagliari, I-09042 Monserrato, CA, Italy.	acao@mcweb.unica.it	Malerba, Giovanni/T-3278-2019; Maschio, Andrea/AAX-8185-2020; sanna, serena/H-3009-2019; Uda, Manuela/AAC-2645-2019; NAITZA, SILVIA/AAB-8775-2022; Naitza, Silvia/D-5620-2017; Devoto, Marcella/AAP-7595-2021; Masala, Marco/Q-2748-2018; Crisponi, Laura/AAC-2642-2019; Sole, Gabriella/I-4820-2013; Bisognin, Andrea/J-3619-2013	sanna, serena/0000-0002-3768-1749; Uda, Manuela/0000-0002-4890-6456; NAITZA, SILVIA/0000-0002-0108-757X; Masala, Marco/0000-0001-5556-9964; Crisponi, Laura/0000-0001-9128-8537; Sole, Gabriella/0000-0001-5292-5038; Del Giacco, G. Sergio/0000-0001-9169-9440; Malerba, Giovanni/0000-0001-8705-8560; DEVOTO, MARCELLA/0000-0002-4431-5114; maschio, andrea/0000-0002-4238-9144; Bisognin, Andrea/0000-0002-9114-1508	Intramural NIH HHS Funding Source: Medline; Telethon [E.0867] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000672] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; CAO A, 1989, BRIT J HAEMATOL, V71, P309; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; El Biaze M, 2003, ALLERGY, V58, P844, DOI 10.1034/j.1398-9995.2003.00282.x; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Gangloff SC, 2004, CLIN REV ALLERG IMMU, V26, P115, DOI 10.1385/CRIAI:26:2:115; Glidden DV, 2003, GENET EPIDEMIOL, V24, P107, DOI 10.1002/gepi.10215; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laitinen T, 2002, CURR OPIN ALLERGY CL, V2, P379, DOI 10.1097/00130832-200210000-00002; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Malerba G, 2000, AM J RESP CRIT CARE, V162, P1587, DOI 10.1164/ajrccm.162.4.9909031; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Nakashima K, 2006, J HUM GENET, V51, P284, DOI 10.1007/s10038-005-0358-1; *NAT I HLTH NAT HE, 1995, NAT I HLTH PUBL; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Pritchard JK, 2000, GENETICS, V155, P945; Raby BA, 2003, HUM MOL GENET, V12, P1973, DOI 10.1093/hmg/ddg208; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb	42	117	124	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1103	1114		10.1086/518259	http://dx.doi.org/10.1086/518259			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503328	Bronze, Green Published			2022-12-18	WOS:000246553800009
J	Cantor, RM; Kono, N; Duvall, JA; Alvarez-Retuerto, A; Stone, JL; Alarcon, M; Nelson, SF; Geschwind, DH				Cantor, RM; Kono, N; Duvall, JA; Alvarez-Retuerto, A; Stone, JL; Alarcon, M; Nelson, SF; Geschwind, DH			Replication of autism linkage: Fine-mapping peak at 17q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC RESOURCE EXCHANGE; GENOMIC SCREEN; GENOMEWIDE SCREEN; BLOOD-PRESSURE; ASSOCIATION; DISORDERS; LOCUS	Autism is a heritable but genetically complex disorder characterized by deficits in language and in reciprocal social interactions, combined with repetitive and stereotypic behaviors. As with many genetically complex disorders, numerous genome scans reveal inconsistent results. A genome scan of 345 families from the Autism Genetic Resource Exchange (AGRE) (AGRE_1), gave the strongest evidence of linkage at 17q11-17q21 in families with no affected females. Here, we report a full-genome scan of an independent sample of 91 AGRE families with 109 affected sibling pairs (AGRE_2) that also shows the strongest evidence of linkage to 17q11-17q21 in families with no affected females. Taken together, these samples provide a replication of linkage to this chromosome region that is, to our knowledge, the first such replication in autism. Fine mapping at 2-centimorgan (cM) intervals in the combined sample of families with no affected females reveals a linkage peak at 66.85 cM, which places this locus at 17q21.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Inst Neuropsychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cantor, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	rcantor@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114	NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIMH NIH HHS [R01 MH064547, MH64547] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Bartlett CW, 2005, AM J HUM GENET, V76, P688, DOI 10.1086/429345; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Kanner L, 1943, NERV CHILD, V2, P217; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Sajid M, 2002, ARTERIOSCL THROM VAS, V22, P1984, DOI 10.1161/01.ATV.0000043664.48689.7F; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; SMALLEY SL, IN PRESS AM J MED GE; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; World Health Organization, 2010, ICD 10 INT STAT CLAS; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	32	117	125	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1050	1056		10.1086/430278	http://dx.doi.org/10.1086/430278			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877280	Green Published, Bronze			2022-12-18	WOS:000229047900010
J	Molinari, F; Raas-Rothschild, A; Rio, M; Fiermonte, G; Encha-Razavi, F; Palmieri, L; Palmieri, F; Ben-Neriah, Z; Kadhom, N; Vekemans, M; Attie-Bitach, T; Munnich, A; Rustin, P; Colleaux, L				Molinari, F; Raas-Rothschild, A; Rio, M; Fiermonte, G; Encha-Razavi, F; Palmieri, L; Palmieri, F; Ben-Neriah, Z; Kadhom, N; Vekemans, M; Attie-Bitach, T; Munnich, A; Rustin, P; Colleaux, L			Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIVARY-DENTATE DYSPLASIA; BACTERIAL EXPRESSION; RECONSTITUTION; ENCEPHALOPATHY; SEIZURES; MUTATION; CORTEX; SYSTEM; RAT	Severe neonatal epilepsies with suppression-burst pattern are epileptic syndromes with either neonatal onset or onset during the first months of life. These disorders are characterized by a typical electroencephalogram pattern namely, suppression burst, in which higher-voltage bursts of slow waves mixed with multifocal spikes alternate with isoelectric suppression phases. Here, we report the genetic mapping of an autosomal recessive form of this condition to chromosome 11p15.5 and the identification of a missense mutation (p.Pro206Leu) in the gene encoding one of the two mitochondrial glutamate/H+ symporters (SLC25A22, also known as "GC1"). The mutation co-segregated with the disease and altered a highly conserved amino acid. Functional analyses showed that glutamate oxidation in cultured skin fibroblasts from patients was strongly defective. Further studies in reconstituted proteoliposomes showed defective [C-14]glutamate uniport and [C-14]glutamate/glutamate exchange by mutant protein. Moreover, expression studies showed that, during human development, SLC25A22 is specifically expressed in the brain, within territories proposed to contribute to the genesis and control of myoclonic seizures. These findings provide the first direct molecular link between glutamate mitochondrial metabolism and myoclonic epilepsy and suggest potential insights into the pathophysiological bases of severe neonatal epilepsies with suppression-burst pattern.	Hop Necker Enfants Malad, INSERM, U393, F-75015 Paris, France; Hadassah Hebrew Univ Med Ctr, Dept Human Genet, Jerusalem, Israel; Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, Bari, Italy; CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Colleaux, L (corresponding author), Hop Necker Enfants Malad, INSERM, U393, 149 Rue Sevres, F-75015 Paris, France.	colleaux@necker.fr	COLLEAUX, LAURENCE/AAA-8144-2022; Molinari, Florence/M-7683-2016; COLLEAUX, Laurence/H-6455-2017; Fiermonte, Giuseppe/D-3680-2018; ATTIE-BITACH, Tania/K-1453-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Molinari, Florence/0000-0001-5111-7215; Fiermonte, Giuseppe/0000-0002-6764-9395; Rio, Marlene/0000-0003-2049-5058; ATTIE-BITACH, Tania/0000-0002-1155-3626				AICARDI J, 1978, REV EEG NEUROPHYSIOL, V8, P99, DOI 10.1016/S0370-4475(78)80124-5; Aicardi Jean, 1992, P13; CLEMENTS JR, 1987, BRAIN RES, V421, P343, DOI 10.1016/0006-8993(87)91304-7; Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; Deransart C, 2001, NEUROSCIENCE, V105, P203, DOI 10.1016/S0306-4522(01)00165-8; DURING MJ, 1993, LANCET, V341, P1607; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; HARDING BN, 1991, J NEUROL SCI, V104, P157, DOI 10.1016/0022-510X(91)90305-Q; OHTSUKA Y, 1993, EPILEPSIA, V34, P627, DOI 10.1111/j.1528-1157.1993.tb00439.x; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; ROBAIN O, 1992, NEUROPEDIATRICS, V23, P162, DOI 10.1055/s-2008-1071334; Trinka E, 2001, EPILEPSIA, V42, P950, DOI 10.1046/j.1528-1157.2001.042007950.x; Vigevano F, 2002, J CHILD NEUROL, V17, pS9; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; ZHANG N, 1990, NEUROSCIENCE, V38, P61, DOI 10.1016/0306-4522(90)90374-D	21	117	122	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					334	339		10.1086/427564	http://dx.doi.org/10.1086/427564			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15592994	Green Published, Bronze			2022-12-18	WOS:000226215100018
J	Mulcare, CA; Weale, ME; Jones, AL; Connell, B; Zeitlyn, D; Tarekegn, A; Swallow, DM; Bradman, N; Thomas, MG				Mulcare, CA; Weale, ME; Jones, AL; Connell, B; Zeitlyn, D; Tarekegn, A; Swallow, DM; Bradman, N; Thomas, MG			The T allele of a single-nucleotide polymorphism 13.9 kb upstream of the lactase gene (LCT) (C-13.9kbT) does not predict or cause the lactase-persistence phenotype in Africans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT-TYPE HYPOLACTASIA; HUMAN Y-CHROMOSOME; NIGERIAN ETHNIC GROUPS; LACTOSE-INTOLERANCE; PHLORHIZIN HYDROLASE; POPULATION; DEFICIENCY; ABSORPTION; DIGESTION; MICROSATELLITE	The ability to digest the milk sugar lactose as an adult (lactase persistence) is a variable genetic trait in human populations. The lactase-persistence phenotype is found at low frequencies in the majority of populations in sub-Saharan Africa that have been tested, but, in some populations, particularly pastoral groups, it is significantly more frequent. Recently, a CT polymorphism located 13.9 kb upstream of exon 1 of the lactase gene (LCT) was shown in a Finnish population to be closely associated with the lactase-persistence phenotype (Enattah et al. 2002). We typed this polymorphism in 1,671 individuals from 20 distinct cultural groups in seven African countries. It was possible to match seven of the groups tested with groups from the literature for whom phenotypic information is available. In five of these groups, the published frequencies of lactase persistence are greater than or equal to25%. We found the T allele to be so rare that it cannot explain the frequency of the lactase-persistence phenotype throughout Africa. By use of a statistical procedure to take phenotyping and sampling errors into account, the T-allele frequency was shown to be significantly different from that predicted in five of the African groups. Only the Fulbe and Hausa from Cameroon possessed the T allele at a level consistent with phenotypic observations (as well as an Irish sample used for comparison). We conclude that the C-13.9kbT polymorphism is not a predictor of lactase persistence in sub-Saharan Africans. We also present Y-chromosome data that are consistent with previously reported evidence for a back-migration event into Cameroon, and we comment on the implications for the introgression of the -13.9kb*T allele.	UCL, Dept Biol, Galton Lab, London NW1 2HE, England; UCL, Ctr Genet Anthropol, London, England; York Univ, Dept Languages Literatures & Linguist, Toronto, ON M3J 2R7, Canada; Univ Kent, Dept Anthropol, Ctr Social Anthropol & Comp, Canterbury, Kent, England	University of London; University College London; University of London; University College London; York University - Canada; University of Kent	Swallow, DM (corresponding author), UCL, Dept Biol, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	dswallow@hgmp.mrc.ac.uk	Zeitlyn, David/F-5961-2013; Thomas, Mark G/A-2219-2012; Weale, Michael E/F-2587-2010	Zeitlyn, David/0000-0001-5853-7351; Thomas, Mark G/0000-0002-2452-981X; Weale, Michael E/0000-0003-4593-1186				ARNOLD J, 1980, CR SOC BIOL, V174, P983; AROLA H, 1988, SCAND J GASTROENTERO, V23, P351, DOI 10.3109/00365528809093878; BAYOUMI RAL, 1982, AM J PHYS ANTHROPOL, V58, P173, DOI 10.1002/ajpa.1330580208; BAYOUMI RAL, 1981, HUM GENET, V57, P279, DOI 10.1007/BF00278944; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blench R., 1999, PASTORALISTS PRESSUR; BOLL W, 1991, AM J HUM GENET, V48, P889; Buning C, 2003, GASTROENTEROLOGY, V124, pA144; COOK GC, 1966, LANCET, V1, P725, DOI 10.1016/S0140-6736(66)90888-9; COOK GC, 1967, GUT, V8, P622, DOI 10.1136/gut.8.6.622; COOK GC, 1973, BRIT J NUTR, V30, P519, DOI 10.1079/BJN19730058; COX JA, 1974, AM J DIG DIS, V19, P714, DOI 10.1007/BF01844941; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Ellis N, 2002, GENOME RES, V12, P339; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; FIELDING JF, 1981, IRISH J MED SCI, V150, P276, DOI 10.1007/BF02938254; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hoegenauer C, 2003, GASTROENTEROLOGY, V124, pA64, DOI 10.1016/S0016-5085(03)80315-3; Holden C, 1997, HUM BIOL, V69, P605; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HOWELL JN, 1981, HUM GENET, V57, P276, DOI 10.1007/BF00278943; Kayser M, 1997, ELECTROPHORESIS, V18, P1602, DOI 10.1002/elps.1150180920; KRETCHME.N, 1971, LANCET, V2, P392; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Kurt I, 2003, TURK J MED SCI, V33, P103; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWCOMER AD, 1975, NEW ENGL J MED, V293, P1232, DOI 10.1056/NEJM197512112932405; Newman JL., 1995, PEOPLING AFRICA GEOG; NURSE GT, 1974, BRIT MED J, V2, P728, DOI 10.1136/bmj.2.5921.728-a; OKEEFE SJD, 1983, S AFR MED J, V63, P778; OKEEFE SJD, 1984, GUT, V25, P942, DOI 10.1136/gut.25.9.942; OLATUNBOSUN DA, 1971, AM J DIG DIS, V16, P909, DOI 10.1007/BF02238172; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; PUEHKURI K, 2000, THESIS HAKAPAINO HEL; RANSOMEK.O, 1972, PEDIATR RES, V6, P359; RANSOMEKUTI O, 1975, GASTROENTEROLOGY, V68, P431; SAHI T, 1974, SCAND J GASTROENTE S, P1; SEGAL I, 1983, AM J CLIN NUTR, V38, P901, DOI 10.1093/ajcn/38.6.901; SWALLOW DM, 2000, METABOLIC MOL BASIS; SWALLOW DM, 1993, DYN NUTR RES, V3, P1; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; [No title captured]	47	117	124	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1102	1110		10.1086/421050	http://dx.doi.org/10.1086/421050			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15106124	Bronze, Green Published			2022-12-18	WOS:000221651900003
J	Abecasis, GR; Yashar, BM; Zhao, Y; Ghiasvand, NM; Zareparsi, S; Branham, KEH; Reddick, AC; Trager, EH; Yoshida, S; Bahling, J; Filippova, E; Elner, S; Johnson, MW; Vine, AK; Sieving, PA; Jacobson, SG; Richards, JE; Swaroop, A				Abecasis, GR; Yashar, BM; Zhao, Y; Ghiasvand, NM; Zareparsi, S; Branham, KEH; Reddick, AC; Trager, EH; Yoshida, S; Bahling, J; Filippova, E; Elner, S; Johnson, MW; Vine, AK; Sieving, PA; Jacobson, SG; Richards, JE; Swaroop, A			Age-related macular degeneration: A high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BEAVER DAM EYE; NONPARAMETRIC LINKAGE ANALYSIS; RISK-FACTORS; FAMILIAL AGGREGATION; MACULOPATHY; DRUSEN; STRATEGIES; PREVALENCE; DEPOSITS; GENETICS	Age-related macular degeneration (AMD) is a complex multifactorial disease that affects the central region of the retina. AMD is clinically heterogeneous, leading to geographic atrophy (GA) and/or choroidal neovascularization (CNV) at advanced stages. Considerable data exists in support of a genetic predisposition for AMD. Recent linkage studies have provided evidence in favor of several AMD susceptibility loci. We have performed a high-resolution (5-cM) genome scan of 412 affected relative pairs that were enriched for late-stage disease ( GA and/or CNV). Nonparametric linkage analysis was performed using two different diagnostic criteria and also by dividing the affected individuals according to GA or CNV phenotype. Our results demonstrate evidence of linkage in regions that were suggested in at least one previous study at chromosomes 1q ( 236 - 240 cM in the Marshfield genetic map), 5p ( 40 - 50 cM), and 9q ( 111 cM). Multipoint analysis of affected relatives with CNV provided evidence of additional susceptibility loci on chromosomes 2p ( 10 cM) and 22q ( 25 cM). A recently identified Gln5345Arg change in HEMICENTIN-1 on chromosome 1q25 was not detected in 274 affected members in the restricted group with AMD, 346 additional patients with AMD, and 237 unaffected controls. Our results consolidate the chromosomal locations of several AMD susceptibility loci and, together with previous reports, should facilitate the search for disease-associated sequence variants.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48105 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Abecasis, Goncalo R/B-7840-2010	Branham, Kari/0000-0002-2492-254X; Yashar, Beverly M./0000-0003-0807-3258; Swaroop, Anand/0000-0002-1975-1141; Johnson, Mark W/0000-0001-9720-8761; Jacobson, Samuel/0000-0003-2122-169X; Yoshida, Shigeo/0000-0003-1049-8909; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [F32EY014085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000065, Z01DC000065] Funding Source: NIH RePORTER; NEI NIH HHS [F32-EY014085, F32 EY014085] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DeWan AT, 2002, AM J HUM GENET, V70, P101, DOI 10.1086/324774; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Gorin MB, 1999, MOL VIS, V5, pU31; Green W R, 1999, Mol Vis, V5, P27; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Hirvela H, 1996, OPHTHALMOLOGY, V103, P871, DOI 10.1016/S0161-6420(96)30593-9; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; *NAT ADV EYE COUNC, 1998, PUBL NAT ADV EYE COU; Prevent Blindness America National Eye Institute, 2002, VIS PROBL US PREV AD; RISCH N, 1990, AM J HUM GENET, V46, P229; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Sengul H, 2001, AM J HUM GENET, V69, P179, DOI 10.1086/321264; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; Sullivan PF, 2003, AM J MED GENET B, V121B, P89, DOI 10.1002/ajmg.b.20069; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; Weir BS, 1990, GENETIC DATA ANAL; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yoshida S, 2002, INVEST OPHTH VIS SCI, V43, P2554	47	117	125	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					482	494		10.1086/382786	http://dx.doi.org/10.1086/382786			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14968411	Green Published, Bronze			2022-12-18	WOS:000220118500015
J	Huang, QY; Xu, FH; Shen, H; Deng, HY; Liu, YJ; Liu, YZ; Li, JL; Recker, RR; Deng, HW				Huang, QY; Xu, FH; Shen, H; Deng, HY; Liu, YJ; Liu, YZ; Li, JL; Recker, RR; Deng, HW			Mutation patterns at dinucleotide microsatellite loci in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; DROSOPHILA-MELANOGASTER; ALLELE FREQUENCIES; DIRECTIONAL EVOLUTION; GERMLINE MUTATIONS; RECOMBINATION RATE; GENETIC DISTANCES; PROVIDES EVIDENCE; SLIPPAGE EVENTS; POINT MUTATIONS	Microsatellites are a major type of molecular markers in genetics studies. Their mutational dynamics are not clear. We investigated the patterns and characteristics of 97 mutation events unambiguously identified, from 53 multi-generational pedigrees with 630 subjects, at 362 autosomal dinucleotide microsatellite loci. A size-dependent mutation bias (in which long alleles are biased toward contraction, whereas short alleles are biased toward expansion) is observed. There is a statistically significant negative relationship between the magnitude (repeat numbers changed during mutation) and direction (contraction or expansion) of mutations and standardized allele size. Contrasting with earlier findings in humans, most mutation events (63%) in our study are multistep events that involve changes of more than one repeat unit. There was no correlation between mutation rate and recombination rate. Our data indicate that mutational dynamics at microsatellite loci are more complicated than the generalized stepwise mutation models.	Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA; Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	Creighton University; Creighton University; Hunan Normal University	Deng, HY (corresponding author), Creighton Univ, Osteoporosis Res Ctr, 601 N 30th St,Suite 6787, Omaha, NE 68131 USA.		Xu, Fuhua/B-8937-2014; Liu, Yaozhong/ABD-5544-2020	XU, FUHUA/0000-0002-8318-1825; Deng, Hong-Wen/0000-0002-0387-8818	NIAMS NIH HHS [K01 AR002170, R01 AR45349-01, K01 AR02170-01] Funding Source: Medline; NIDCD NIH HHS [P01 DC01813-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM060402, R0 GM60402-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002170, R01AR045349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Amos W, 1996, NAT GENET, V12, P13, DOI 10.1038/ng0196-13; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Colson I, 1999, GENETICS, V152, P617; Cooper G, 1999, P NATL ACAD SCI USA, V96, P11916, DOI 10.1073/pnas.96.21.11916; Deng HW, 2001, J CLIN ENDOCR METAB, V86, P3735, DOI 10.1210/jc.86.8.3735; Di Rienzo A, 1998, GENETICS, V148, P1269; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Falush D, 1999, MOL BIOL EVOL, V16, P960, DOI 10.1093/oxfordjournals.molbev.a026185; Farrall M, 1998, AM J HUM GENET, V62, P1260, DOI 10.1086/301829; Feldman MW, 1997, GENETICS, V145, P207; Fitzsimmons NN, 1998, MOL ECOL, V7, P575, DOI 10.1046/j.1365-294x.1998.00355.x; Gardner MG, 2000, J EVOLUTION BIOL, V13, P551; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; Goldstein D, 1999, MICROSATELLITES EVOL; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gonser R, 2000, GENETICS, V154, P1793; Harr B, 2000, GENETICS, V155, P1213; Harr B, 1998, MOL BIOL EVOL, V15, P176, DOI 10.1093/oxfordjournals.molbev.a025913; Henke J, 1999, AM J HUM GENET, V64, P1473, DOI 10.1086/302373; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; Jones AG, 1999, GENETICS, V152, P1057; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kimmel M, 1996, GENETICS, V143, P549; Kruglyak S, 2000, MOL BIOL EVOL, V17, P1210, DOI 10.1093/oxfordjournals.molbev.a026404; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li JL, 2001, GENOME RES, V11, P1304, DOI 10.1101/gr.159701; Michalakis Y, 1996, GENETICS, V143, P1713; Nielsen R, 1999, MOL PHYLOGENET EVOL, V11, P477, DOI 10.1006/mpev.1998.0597; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Palsboll PJ, 1999, GENETICS, V151, P285; Payseur BA, 2000, GENETICS, V156, P1285; Primmer CR, 1998, MOL BIOL EVOL, V15, P1047, DOI 10.1093/oxfordjournals.molbev.a026003; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rubinsztein DC, 1999, PHILOS T R SOC B, V354, P1095, DOI 10.1098/rstb.1999.0465; Sajantila A, 1999, EUR J HUM GENET, V7, P263, DOI 10.1038/sj.ejhg.5200257; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schlotterer C, 1998, MOL BIOL EVOL, V15, P1269, DOI 10.1093/oxfordjournals.molbev.a025855; Schug MD, 1998, GENETICA, V102-3, P359, DOI 10.1023/A:1017083025154; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; SLATKIN M, 1995, GENETICS, V139, P457; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wierdl M, 1997, GENETICS, V146, P769; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Zhivotovsky LA, 1997, MOL BIOL EVOL, V14, P926, DOI 10.1093/oxfordjournals.molbev.a025835	59	117	126	0	19	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					625	634		10.1086/338997	http://dx.doi.org/10.1086/338997			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11793300	Bronze, Green Published			2022-12-18	WOS:000173880000007
J	Wessman, M; Kallela, M; Kaunisto, MA; Marttila, P; Sobel, E; Hartiala, J; Oswell, G; Leal, SM; Papp, JC; Hamalainen, E; Broas, P; Joslyn, G; Hovatta, I; Hiekkalinna, T; Kaprio, J; Ott, J; Cantor, RM; Zwart, JA; Ilmavirta, M; Havanka, H; Farkkila, M; Peltonen, L; Palotie, A				Wessman, M; Kallela, M; Kaunisto, MA; Marttila, P; Sobel, E; Hartiala, J; Oswell, G; Leal, SM; Papp, JC; Hamalainen, E; Broas, P; Joslyn, G; Hovatta, I; Hiekkalinna, T; Kaprio, J; Ott, J; Cantor, RM; Zwart, JA; Ilmavirta, M; Havanka, H; Farkkila, M; Peltonen, L; Palotie, A			A susceptibility locus for migraine with aura, on chromosome 4q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; EPISODIC ATAXIA TYPE-2; CA2+ CHANNEL GENE; GENOME-WIDE SCAN; LINKAGE ANALYSIS; TYPICAL MIGRAINE; UNITED-STATES; CACNA1A GENE; POPULATION; PREVALENCE	Migraine is a complex neurovascular disorder with substantial evidence supporting a genetic contribution. Prior attempts to localize susceptibility loci for common forms of migraine have not produced conclusive evidence of linkage or association. To date, no genomewide screen for migraine has been published. We report results from a genomewide screen of 50 multigenerational, clinically well-defined Finnish families showing intergenerational transmission of migraine with aura (MA). The families were screened using 350 polymorphic microsatellite markers, with an average intermarker distance of 11 cM. Significant evidence of linkage was found between the MA phenotype and marker D4S1647 on 4q24. Using parametric two-point linkage analysis and assuming a dominant mode of inheritance, we found for this marker a maximum LOD score of 4.20 under locus homogeneity (P = .000006) or locus heterogeneity (P = .000011). Multipoint parametric (HLOD = 4.45; P = .0000058) and nonparametric (NPLall = 3.43; P = .0007) analyses support linkage in this region. Statistically significant linkage was not observed in any other chromosomal region.	Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth, Helsinki, Finland; Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; Univ Helsinki, Dept Biosci, Helsinki, Finland; Univ Helsinki, Dept Neurol, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Oulu, Dept Publ Hlth & Gen Practice, Oulu, Finland; Norwegian Univ Sci & Technol, Fac Med, Dept Clin Neurosci, N-7034 Trondheim, Norway; Cent Hosp Cent Finland, Dept Neurol, Jyvaskyla, Finland; Lansi Pohja Cent Hosp, Dept Neurol, Kemi, Finland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Rockefeller University; University of Oulu; Norwegian University of Science & Technology (NTNU); Central Finland Central Hospital	Palotie, A (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol, 695 Charles E Young Dr S,Box 95-7088, Los Angeles, CA 90095 USA.	apalotie@mednet.ucla.edu	Kaprio, Jaakko/A-1820-2008; Hovatta, Iiris/D-6871-2012	Kaprio, Jaakko/0000-0002-3716-2455; Hovatta, Iiris/0000-0002-5990-7892; Kaunisto, Mari/0000-0002-6946-9195; Sobel, Eric/0000-0002-1718-0031; Palotie, Aarno/0000-0002-2527-5874; Hiekkalinna, Tero/0000-0002-3345-2981	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037675] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG00008, R01 HG000008] Funding Source: Medline; NINDS NIH HHS [R01 NS37675-02, R01 NS037675] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; CHIANO MN, 1995, ANN HUM GENET, V59, P83, DOI 10.1111/j.1469-1809.1995.tb01607.x; Del Zompo M, 1998, NEUROLOGY, V51, P781, DOI 10.1212/WNL.51.3.781; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; FARKKILA M, 1992, CEPHALALGIA, V12, P383, DOI 10.1111/j.1468-2982.1992.00383.x; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Gervil M, 1999, ANN NEUROL, V46, P606, DOI 10.1002/1531-8249(199910)46:4<606::AID-ANA8>3.0.CO;2-O; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hagen K, 2000, CEPHALALGIA, V20, P900, DOI 10.1046/j.1468-2982.2000.00145.x; Hasselblatt M, 1999, NEUROREPORT, V10, P423, DOI 10.1097/00001756-199902050-00039; HENRY P, 1992, CEPHALALGIA, V12, P229, DOI 10.1046/j.1468-2982.1992.1204229.x; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; HOVATTA I, 1994, GENOMICS, V23, P707, DOI 10.1006/geno.1994.1563; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kallela M, 2001, EUR J NEUROL, V8, P61, DOI 10.1046/j.1468-1331.2001.00165.x; Kallela M, 1998, CEPHALALGIA, V18, P329, DOI 10.1046/j.1468-2982.1998.1806329.x; Kowa H, 2000, AM J MED GENET, V96, P762, DOI 10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lea RA, 2000, NEUROGENETICS, V3, P35; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; LIPTON RB, 1994, HEADACHE, V34, P319, DOI 10.1111/j.1526-4610.1994.hed3406319.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MAY A, 1995, HUM GENET, V96, P604, DOI 10.1007/BF00197420; MOCHI M, 1993, CEPHALALGIA, V13, P389, DOI 10.1046/j.1468-2982.1993.1306389.x; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, NEUROLOGY, V50, P1428, DOI 10.1212/WNL.50.5.1428; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OBRIEN B, 1994, INT J EPIDEMIOL, V23, P1020, DOI 10.1093/ije/23.5.1020; Ogilvie A, 1998, CEPHALALGIA, V18, P23, DOI 10.1046/j.1468-2982.1998.1801023.x; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ophoff RA, 1997, HEADACHE, V37, P479, DOI 10.1046/j.1526-4610.1997.3708479.x; OTERINO A, 2001, CEPHALALGIA, V21, P346; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; PARDO J, 1995, CEPHALALGIA, V15, P200, DOI 10.1046/j.1468-2982.1995.015003200.x; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peroutka SJ, 1997, NEUROLOGY, V49, P201, DOI 10.1212/WNL.49.1.201; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; RUSSELL MB, 1995, HUM GENET, V96, P726, DOI 10.1007/BF00210307; RUSSELL MB, 2001, CEPHALALGIA, V21, P346; Sobel E, 1996, AM J HUM GENET, V58, P1323; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Terwindt GM, 2001, NEUROLOGY, V56, P1028, DOI 10.1212/WNL.56.8.1028; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Ulrich V, 1999, HEADACHE, V39, P173, DOI 10.1046/j.1526-4610.1999.3903173.x; WHITE NJ, 2001, CEPHALALGIA, V21, P280; WIESER T, 2001, CEPHALALGIA, V21, P280; Ziegler DK, 1998, HEADACHE, V38, P417, DOI 10.1046/j.1526-4610.1998.3806417.x	72	117	121	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					652	662		10.1086/339078	http://dx.doi.org/10.1086/339078			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836652	Bronze, Green Published			2022-12-18	WOS:000173880000009
J	Gray-McGuire, C; Moser, KL; Gaffney, PM; Kelly, J; Yu, H; Olson, JM; Jedrey, CM; Jacobs, KB; Kimberly, RP; Neas, BR; Rich, SS; Behrens, TW; Harley, JB				Gray-McGuire, C; Moser, KL; Gaffney, PM; Kelly, J; Yu, H; Olson, JM; Jedrey, CM; Jacobs, KB; Kimberly, RP; Neas, BR; Rich, SS; Behrens, TW; Harley, JB			Genome scan of human systemic lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16-15.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENES; REVISED CRITERIA; COMPLEX TRAITS; CLASSIFICATION; AUTOIMMUNITY; FAMILIES	Systemic lupus erythematosus (SLE) is a complex autoimmune disorder involving at least hormonal, environmental, and genetic factors. Familial aggregation, a 2%-3% sibling recurrence rate, monozygotic twin concordance >20%, association with several candidate genes, as well as the results of five genome scans support a genetic component. We present here the results of a genome scan of 126 pedigrees multiplex for SLE, including 469 sibling pairs (affected and unaffected) and 175 affected relative pairs. Using the revised multipoint Haseman-Elston regression technique for concordant and discordant sibling pairs and a conditional logistic regression technique for affected relative pairs, we identify a novel linkage to chromosome 4p16-15.2 (P = .0003 and LOD = 3.84) and present evidence of an epistatic interaction between chromosome 4p16-15.2 and chromosome 5p15 in our European American families. We confirm the evidence of linkage to chromosome 4p16-15.2 in European American families using data from an independent pedigree collection. In addition, our data support the published results of three independent studies for nine purportedly linked regions and agree with the previously published results from a subset of these data for three regions. In summary, results from two new analytical techniques establish and confirm linkage with SLE at 4p16-15.2, indicate epistasis between 4p16-15.2 and 5p15, and confirm other linkage effects with SLE that have been reported elsewhere.	Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center	Harley, JB (corresponding author), Oklahoma Med Res Fdn, Arthrit & Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.		Stein, Catherine/P-9498-2019	Stein, Catherine/0000-0002-9763-5023; Kelly, Jennifer/0000-0002-3203-2467; Gaffney, Patrick/0000-0002-1580-869X; Rich, Stephen/0000-0003-3872-7793; Kimberly, Robert/0000-0002-5330-3086; Jacobs, Kevin/0000-0002-4657-6473	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001577, R29HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031584, R37AI024717, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P50AR045231] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655] Funding Source: Medline; NHGRI NIH HHS [R01 HG001577, R29 HG001577] Funding Source: Medline; NIAID NIH HHS [AI24717, R01 AI024717, R01 AI031584, R37 AI024717] Funding Source: Medline; NIAMS NIH HHS [AR42460, R01 AR042460, AR45231] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; Brand A, 1999, J AUTOIMMUN, V13, P149, DOI 10.1006/jaut.1999.0307; Cooper GS, 1998, ARTHRITIS RHEUM, V41, P1714, DOI 10.1002/1529-0131(199810)41:10<1714::AID-ART3>3.3.CO;2-L; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Friday RP, 1999, DIABETES NUTR METAB, V12, P3; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; KASLOW RA, 1978, ARTHRITIS RHEUM-US, V21, P473, DOI 10.1002/art.1780210412; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Mehrian R, 1998, ARTHRITIS RHEUM, V41, P596, DOI 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Moser KL, 1999, ARTHRITIS RHEUM, V42, P1902, DOI 10.1002/1529-0131(199909)42:9<1902::AID-ANR16>3.0.CO;2-G; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Petri M, 1998, J Am Med Womens Assoc (1972), V53, P9; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; REICHLIN M, 1992, ARTHRITIS RHEUM, V35, P457, DOI 10.1002/art.1780350416; RISCH N, 1990, AM J HUM GENET, V46, P229; *SAGE, 1993, STAT AN GEN EP REL 4; SCHUR PH, 1982, CLIN IMMUNOL IMMUNOP, V24, P263, DOI 10.1016/0090-1229(82)90237-9; Sestak AL, 1999, J RHEUMATOL, V26, P1495; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan Filemon K., 1998, Current Opinion in Rheumatology, V10, P399, DOI 10.1097/00002281-199809000-00002; Tsao BP, 1999, J CLIN INVEST, V103, P1135, DOI 10.1172/JCI5967; Tsuang MT, 1999, HARVARD REV PSYCHIAT, V7, P185, DOI 10.1093/hrp/7.4.185; Xu JF, 1999, GENET EPIDEMIOL, V17, pS773	34	117	125	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1460	1469		10.1086/316891	http://dx.doi.org/10.1086/316891			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078476	Green Published, Bronze			2022-12-18	WOS:000165607600011
J	Touraine, RL; Attie-Bitach, T; Manceau, E; Korsch, E; Sarda, P; Pingault, V; Encha-Razavi, F; Pelet, A; Auge, J; Nivelon-Chevallier, A; Holschneider, AM; Munnes, M; Doerfler, W; Goossens, M; Munnich, A; Vekemans, M; Lyonnet, S				Touraine, RL; Attie-Bitach, T; Manceau, E; Korsch, E; Sarda, P; Pingault, V; Encha-Razavi, F; Pelet, A; Auge, J; Nivelon-Chevallier, A; Holschneider, AM; Munnes, M; Doerfler, W; Goossens, M; Munnich, A; Vekemans, M; Lyonnet, S			Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIRSCHSPRUNG-DISEASE; ENDOTHELIN-3 GENE; RET LIGAND; CELLS	Waardenburg syndrome type 4 (WS4), also called Shah-Waardenburg syndrome, is a rare neurocristopathy that results from the absence of melanocytes and intrinsic ganglion cells of the terminal hindgut. WS4 is inherited as an autosomal recessive trait attributable to EDN3 or EDNRB mutations. It is inherited as an autosomal dominant condition when SOX10 mutations are involved. We report on three unrelated WS4 patients with growth retardation and an as-yet-unreported neurological phenotype with impairment of both the central and autonomous nervous systems and occasionally neonatal hypotonia and arthrogryposis. Each of the three patients was heterozygous for a SOX10 truncating mutation (Y313X in two patients and S351X in one patient). The extended spectrum of the WS4 phenotype is relevant to the brain expression of SOX10 during human embryonic and fetal development. Indeed, the expression of SOX10 in human embryo was not restricted to neural-crest-derived cells but also involved fetal brain cells, most likely of glial origin. These data emphasize the important role of SOX10 in early development of both neural-crest-derived tissues, namely melanocytes, autonomic and enteric nervous systems, and glial cells of the central nervous system.	Hop Necker Enfants Malad, Dept Genet, INSERM U393, F-75743 Paris, France; Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM U393, F-75743 Paris, France; Hop Enfants, Ctr Genet, Dijon, France; Kliniken Stadt Koln, Kinderkrankenhaus, Cologne, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany; Hop Arnaud de Villeneuve, Unite Genet Med & Foetopathol, Montpellier, France; Hop Henri Mondor, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; University of Cologne; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, Dept Genet, INSERM U393, F-75743 Paris, France.		Touraine, Renaud/AAV-1605-2020; Lyonnet, Stanislas/H-5483-2017; ATTIE-BITACH, Tania/K-1453-2017	Lyonnet, Stanislas/0000-0001-5426-9417; ATTIE-BITACH, Tania/0000-0002-1155-3626; Pingault, Veronique/0000-0001-7064-0765; PELET, Anastella/0000-0002-8353-1725				ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Bidaud C, 1997, EUR J HUM GENET, V5, P247, DOI 10.1159/000484771; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Bondurand N, 1998, FEBS LETT, V432, P168, DOI 10.1016/S0014-5793(98)00843-6; BRANSKI D, 1979, PEDIATRICS, V63, P803; CANTANI A, 1989, Paediatrie und Paedologie, V24, P137; Delaney CL, 1996, J NEUROSCI, V16, P6908; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; KAWABATA E, 1987, OPHTHALMIC PAED GEN, V8, P165, DOI 10.3109/13816818709031463; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; MAQUAT LE, 1995, RNA, V1, P453; MCKUSICK VA, 1973, NEW ENGL J MED, V288, P691; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; SCHUFFLER MD, 1978, GASTROENTEROLOGY, V75, P889; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Southard-Smith EM, 1999, GENOME RES, V9, P215; WILKINSON DG, 1992, PRACTICAL APPROACH S, V109	27	117	129	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1496	1503		10.1086/302895	http://dx.doi.org/10.1086/302895			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762540	Green Published, Bronze			2022-12-18	WOS:000088373700003
J	Yashin, AI; De Benedictis, G; Vaupel, JW; Tan, Q; Andreev, KF; Iachine, IA; Bonafe, M; DeLuca, M; Valensin, S; Carotenuto, L; Franceschi, C				Yashin, AI; De Benedictis, G; Vaupel, JW; Tan, Q; Andreev, KF; Iachine, IA; Bonafe, M; DeLuca, M; Valensin, S; Carotenuto, L; Franceschi, C			Genes, demography, and life span: The contribution of demographic data in genetic studies on aging and longevity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORTALITY; MODEL; HETEROGENEITY; DYNAMICS; AGE; HLA	In population studies on aging, the data on genetic markers are often collected for individuals from different age groups. The purpose of such studies is to identify, by comparison of the frequencies of selected genotypes, "longevity" or "frailty" genes in the oldest and in younger groups of individuals. To address questions about more-complicated aspects of genetic influence on longevity, additional information must be used. In this article, we show that the use of demographic information, together with data on genetic markers, allows us to calculate hazard rates, relative risks, and survival functions for respective genes or genotypes. New methods of combining genetic and demographic information are discussed. These methods are tested on simulated data and then are applied to the analysis of data on genetic markers for two haplogroups of human mtDNA. The approaches suggested in this article provide a powerful tool for analyzing the influence of candidate genes on longevity and survival. We also show how factors such as changes in the initial frequencies of candidate genes in subsequent cohorts, or secular trends in cohort mortality, may influence the results of an analysis.	Max Planck Inst Demog Res, D-18057 Rostock, Germany; Duke Univ, Ctr Demog Studies, Durham, NC 27706 USA; Duke Univ, Sanford Inst, Durham, NC 27706 USA; Univ Calabria, Dept Syst Sci, Calabria, Italy; Univ Calabria, Dept Cell Biol, Calabria, Italy; Ist Nazl Riposa & Cura Anziani, Ancona, Italy; Univ Bologna, Dept Biomed Sci, Bologna, Italy; Odense Univ, Dept Stat & Demog, Odense, Denmark	Max Planck Society; Duke University; Duke University; University of Calabria; University of Calabria; IRCCS INRCA; University of Bologna; University of Southern Denmark	Yashin, AI (corresponding author), Max Planck Inst Demog Res, Doberaner Str 114, D-18057 Rostock, Germany.	yashin@demogr.mpg.de	Tan, Qihua/F-1349-2015; Franceschi, Claudio/L-4484-2017; Tan, Qihua/AAG-2582-2019	Tan, Qihua/0000-0003-3194-0030; Franceschi, Claudio/0000-0001-9841-6386; Tan, Qihua/0000-0003-3194-0030; Vaupel, James/0000-0003-0783-3905				Anderson P.K., 1992, STAT MODELS BASED CO; *APT SYST, 1996, GAUSS MATH STAT SYST, V1; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CLAYTON D, 1985, J R STAT SOC A STAT, V148, P82, DOI 10.2307/2981943; Cox D.R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; De Benedictis G, 1998, EUR J HUM GENET, V6, P534, DOI 10.1038/sj.ejhg.5200222; De Benedictis G, 1998, ANN HUM GENET, V62, P115, DOI 10.1017/S0003480098006757; DeBenedictis G, 1997, HUM GENET, V99, P312; Fisher R.A., 1930, GENETIC THEORY NATUR; HANSELMAN DC, 1998, MASTERING MATLAB VER; Ivanova R, 1998, HUM MOL GENET, V7, P187, DOI 10.1093/hmg/7.2.187; KIMURA MOTOO, 1958, HEREDITY, V12, P145, DOI 10.1038/hdy.1958.21; PROUST J, 1982, TISSUE ANTIGENS, V19, P168, DOI 10.1111/j.1399-0039.1982.tb01436.x; Rettaroli R., 1994, INTRO DEMOGRAFIA STO; SCHACHTER F, 1993, HUM GENET, V91, P519; TAKATA H, 1987, LANCET, V2, P824; THATCHER AR, 1998, ODENSE MONOGRAPH POP, V5; Toupance B, 1998, AM J HUM GENET, V62, P1525, DOI 10.1086/301865; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Weir B., 1996, GENETIC DATA ANAL; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; YAKOVLEV AY, 1995, BIOMETRICAL J, V37, P435, DOI 10.1002/bimj.4710370405; YASHIN AI, 1994, MECH AGEING DEV, V74, P1, DOI 10.1016/0047-6374(94)90094-9; YASHIN AI, 1998, J EPIDEMIOL BIOSTAT, V3, P289	26	117	122	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1178	1193		10.1086/302572	http://dx.doi.org/10.1086/302572			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486337	Green Published, Bronze			2022-12-18	WOS:000082910000027
J	Mikami, M; Yasuda, T; Terao, A; Nakamura, M; Ueno, S; Tanabe, H; Tanaka, T; Onuma, T; Goto, Y; Kaneko, S; Sano, A				Mikami, M; Yasuda, T; Terao, A; Nakamura, M; Ueno, S; Tanabe, H; Tanaka, T; Onuma, T; Goto, Y; Kaneko, S; Sano, A			Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTAL-LOBE EPILEPSY; CORTICAL REFLEX MYOCLONUS; POTASSIUM CHANNEL GENE; GENERALIZED EPILEPSY; FEBRILE CONVULSIONS; LINKAGE ANALYSIS; MUTATION; SEIZURES; SUBUNIT; LOCUS	Benign adult familial myoclonic epilepsy is an autosomal dominant idiopathic epileptic syndrome characterized by adult-onset tremulous finger movement, myoclonus, epileptic seizures, and nonprogressive course. It was recently recognized in Japanese families. In this study, we report that the gene locus is assigned to the distal long arm of chromosome 8, by linkage analysis in a large Japanese kindred with a maximum two-point LOD score of 4.31 for D8S555 at recombination fraction of 0 (maximum multipoint LOD score of 5.42 for the interval between D8S555 and D8S1779). Analyses of recombinations place the locus within an 8-cM interval, between D8S1784 and D8S1694, in which three markers, D8S1830, D8S555, and D8S1779, show no recombination with the phenotypes. Although three other epilepsy-related loci on chromosome 8q have been recognized-one on chromosome 8q13-21 (familial febrile convulsion) and two others on chromosome 8q24 (KCNQ3 and childhood absence epilepsy)-the locus assigned here is distinct from these three epilepsy-related loci. This study establishes the presence of a new epilepsy-related locus on 8q23.3-q24.11.	Ehime Univ, Sch Med, Dept Neuropsychiat, Shigenobu, Ehime 7910295, Japan; Kawasaki Med Sch, Dept Neurol, Okayama, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Natl Ctr Neurol & Psychiat, Tokyo, Japan; Natl Saigata Hosp, Dept Psychiat, Saigata, Japan; Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan	Ehime University; Kawasaki Medical School; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Hirosaki University	Sano, A (corresponding author), Ehime Univ, Sch Med, Dept Neuropsychiat, Shigenobu, Ehime 7910295, Japan.	sano@m.ehime-u.ac.jp		Sano, Akira/0000-0001-5843-9786				Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; HASHIMOTO O, 1993, JPN J PSYCHIAT NEUR, V47, P275; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; IKEDA A, 1990, NEUROLOGY, V40, P1561, DOI 10.1212/WNL.40.10.1561; Inazuki G, 1990, Seishin Shinkeigaku Zasshi, V92, P1; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; KOYAMA K, 1994, GENOMICS, V21, P460, DOI 10.1006/geno.1994.1300; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuwano A, 1996, J MED GENET, V33, P80, DOI 10.1136/jmg.33.1.80; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Lewis TB, 1996, GENOMICS, V32, P131, DOI 10.1006/geno.1996.0088; LEWIS TB, 1993, AM J HUM GENET, V53, P670; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; Okino S, 1997, J NEUROL SCI, V145, P113, DOI 10.1016/S0022-510X(96)00245-6; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Terada K, 1997, MOVEMENT DISORD, V12, P370, DOI 10.1002/mds.870120316; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; WOOD S, 1995, SOMAT CELL MOLEC GEN, V21, P147, DOI 10.1007/BF02255790; YASUDA T, 1991, Kawasaki Medical Journal, V17, P1; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	34	117	126	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					745	751		10.1086/302535	http://dx.doi.org/10.1086/302535			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441581	Bronze, Green Published			2022-12-18	WOS:000082426400019
J	OKeefe, D; Dao, D; Zhao, L; Sanderson, R; Warburton, D; Weiss, L; AnyaneYeboa, K; Tycko, B				OKeefe, D; Dao, D; Zhao, L; Sanderson, R; Warburton, D; Weiss, L; AnyaneYeboa, K; Tycko, B			Coding mutations in p57(KIP2) are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT-KINASE INHIBITOR; GROWTH-FACTOR-II; REDUCED EXPRESSION; GENE; H19; 11P15.5; REGION; LOCUS; POLYMORPHISMS; DISRUPTION	The Beckwith-Wiedemann syndrome (BWS) is marked by fetal organ overgrowth and conveys a predisposition to certain childhood tumors, including Wilms tumor (WT). The genetics of BWS have implicated a gene that maps to chromosome 11p15 and is paternally imprinted, and the gene encoding the cyclin-cdk inhibitor p57(KIP2) has been a strong candidate. By complete sequencing of the coding exons and intron/exon junctions, we found a maternally transmitted coding mutation in the cdk-inhibitor domain of the KIP2 gene in one of five cases of BWS. The BWS mutation was an in-frame three-amino-acid deletion that significantly reduced but did not fully abrogate growth-suppressive activity in a transfection assay. In contrast, no somatic coding mutations in KIP2 were found in a set of 12 primary WTs enriched for cases that expressed KIP2 mRNA, including cases with and without 11p15.5 loss of heterozygosity. Two other 11p15.5 loci, the linked and oppositely imprinted H19 and IGF2 genes, have been previously implicated in WT pathogenesis, and several of the tumors with persistent KIP2 mRNA expression and absence of KIP2 coding mutations showed full inactivation of H19. These data suggest that KIP2 is a BWS gene but that it is not uniquely equivalent to the 11p15.5 ''WT2'' tumor-suppressor locus.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,DIV CLIN GENET,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; OVERLOOK HOSP,DEPT OBSTET & GYNECOL,SUMMIT,NJ; CITY HOPE NATL MED CTR,DEPT PATHOL,DUARTE,CA 91010	Columbia University; Columbia University; Columbia University; Columbia University; Atlantic Health System; City of Hope			O'Keefe, Denise/A-6273-2010	Anyane-Yeboa, Kwame/0000-0002-4977-9719	NATIONAL CANCER INSTITUTE [R01CA060765] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA60765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Hatada I, 1996, HUM MOL GENET, V5, P783, DOI 10.1093/hmg/5.6.783; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; Kondo M, 1996, ONCOGENE, V12, P1365; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Mannens M., 1994, European Journal of Human Genetics, V2, P3; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Moulton T, 1996, MED PEDIATR ONCOL, V27, P476; Orlow I, 1996, CANCER RES, V56, P1219; Overall ML, 1996, GENE CHROMOSOME CANC, V17, P56, DOI 10.1002/(SICI)1098-2264(199609)17:1<56::AID-GCC8>3.0.CO;2-1; PING AJ, 1989, AM J HUM GENET, V44, P720; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Tokino T, 1996, HUM GENET, V97, P625, DOI 10.1007/s004390050106; Tycko B, 1996, HUM GENET, V98, P430, DOI 10.1007/s004390050234; Weksberg R, 1996, MED PEDIATR ONCOL, V27, P462, DOI 10.1002/(SICI)1096-911X(199611)27:5<462::AID-MPO13>3.0.CO;2-C; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143	30	117	118	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					295	303		10.1086/514854	http://dx.doi.org/10.1086/514854			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311733	Green Published, hybrid			2022-12-18	WOS:A1997XX70100006
J	Greer, WL; Riddell, DC; Byers, DM; Welch, JP; Girouard, GS; Sparrow, SM; Gillan, TL; Neumann, PE				Greer, WL; Riddell, DC; Byers, DM; Welch, JP; Girouard, GS; Sparrow, SM; Gillan, TL; Neumann, PE			Linkage of Niemann-Pick disease type D to the same region of human chromosome 18 as Niemann-Pick disease type C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D FIBROBLASTS; CHOLESTEROL; ESTERIFICATION	Niemann-Pick type II disease is a severe disorder characterized by accumulation of tissue cholesterol and sphingomyelin and by progressive degeneration of the nervous system. This disease has two clinically similar subtypes, type C (NPC) and type D (NPD). NPC is clinically variable and has been identified in many ethnic groups. NPD, on the other hand, has been reported only in descendants of an Acadian couple who lived in Nova Scotia in the early 18th century and has a more homogeneous expression resembling that of less severely affected NPC patients. Despite biochemical differences, it has not been established whether NPC and NPD are allelic variants of the same disease. We report here that NPD is tightly linked (recombination fraction .00; maximum LOD score 4.50) to a microsatellite marker, D18S480, from the centromeric region of chromosome 18q, Carstea et al. have reported that the NPC gene maps to this same site; therefore we suggest that NPC acid NPD likely result from mutations in the same gene.	DALHOUSIE UNIV, FAC MED, DEPT PATHOL, DIV MOL PATHOL & MOL GENET, HALIFAX, NS, CANADA; DALHOUSIE UNIV, FAC MED, DEPT BIOCHEM, HALIFAX, NS, CANADA; DALHOUSIE UNIV, FAC MED, DEPT PEDIAT, HALIFAX, NS B3H 3J5, CANADA; DALHOUSIE UNIV, FAC MED, DEPT ANAT & NEUROBIOL, HALIFAX, NS, CANADA	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University				Neumann, Paul/0000-0002-8480-4799				BYERS DM, 1989, BIOCHEM J, V262, P713, DOI 10.1042/bj2620713; Carstea E. D., 1994, American Journal of Human Genetics, V55, pA182; CARSTEA ED, 1993, P NATL ACAD SCI USA, V90, P2002, DOI 10.1073/pnas.90.5.2002; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; CROCKER AC, 1961, J NEUROCHEM, V7, P69, DOI 10.1111/j.1471-4159.1961.tb13499.x; HIGGINS JJ, 1992, NEUROLOGY, V42, P2286, DOI 10.1212/WNL.42.12.2286; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1986, J BIOL CHEM, V261, P6775; SIDHU HS, 1993, BIOCHEM CELL BIOL, V71, P467, DOI 10.1139/o93-069; SPENCE MW, 1989, METABOLIC BASIS INHE, P1655; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 1996, AM J HUM GENET, V58, P118; VETHAMANY VG, 1972, ARCH PATHOL, V93, P537; WINSOR EJT, 1978, AM J HUM GENET, V30, P530	19	117	119	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					139	142		10.1086/513899	http://dx.doi.org/10.1086/513899			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245994	Green Published, Bronze			2022-12-18	WOS:A1997XM72800021
J	Hahnen, E; Schonling, J; RudnikSchoneborn, S; Zerres, K; Wirth, B				Hahnen, E; Schonling, J; RudnikSchoneborn, S; Zerres, K; Wirth, B			Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: New insights into molecular mechanisms responsible for the disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETIONS; 5Q13; RECOMBINATION; CONVERSION; SEQUENCE; REGION; DNA; INDIVIDUALS; MARKER; LOCUS	Spinal muscular atrophy (SMA) is a frequent autosomal recessive neurodegenerative disorder leading to weakness and atrophy of voluntary muscles. The survival motor-neuron gene (SMN), a strong candidate for SMA, is present in two highly homologous copies (telSMN and cenSMN) within the SMA region. Only five nucleotide differences within the region between intron 6 and exon 8 distinguish these homologues. Independent of the severity of the disease, 90%-98% of all SMA patients carry homozygous deletions in telSMN, affecting either exon 7 or both exons 7 and 8. We present the molecular analysis of 42 SMA patients who carry homozygous deletions of telSMN exon 7 but not of exon 8. The question arises whether in these cases the telSMN is truncated upstream of exon 8 or whether hybrid SMN genes exist that are composed of centromeric and telomeric sequences. By a simple PCR-based assay we demonstrate that in each case the remaining telSMN exon 8 is part of a hybrid SMN gene. Sequencing of cloned hybrid SMN genes from seven patients, as well as direct sequencing and single-strand conformation analysis of all patients, revealed the same composition in all but two patients: the base-pair differences in introns 6 and 7 and exon 7 are of centromeric origin whereas exon 8 is of telomeric origin. Nonetheless, haplotype analysis with polymorphic multicopy markers, Ag1-CA and C212, localized at the 5' end of the SMN genes suggests different mechanisms of occurrence, unequal rearrangements, and gene conversion involving both copies of the SMN genes. In approximately half of all patients, we identified a consensus haplotype, suggesting a common origin. Interestingly, we identified a putative recombination hot spot represented by recombination-stimulating elements (TGGGG and TGAGGT) in exon 8 that is homologous to the human deletion-hot spot consensus sequence in the immunoglobulin switch region, the alpha-globin cluster, and the polymerase alpha arrest sites. This may explain why independent hybrid SMN genes show identical sequences.	UNIV BONN,INST HUMAN GENET,D-53111 BONN,GERMANY	University of Bonn			Wirth, Brunhilde/H-3192-2019; Rudnik-Schöneborn, Sabine/F-8473-2015	Wirth, Brunhilde/0000-0003-4051-5191				BRAHE C, 1994, HUM GENET, V93, P494, DOI 10.1007/BF00202811; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANG JG, 1995, AM J HUM GENET, V57, P1503; COBBEN JM, 1995, AM J HUM GENET, V57, P805; DIBONATO CJ, 1994, AM J HUM GENET, V55, P1218; GRITZMACHER CA, 1989, CRIT REV IMMUNOL, V9, P173; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen ET, 1996, HUM GENET, V98, P122, DOI 10.1007/s004390050172; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; KONRAD M, 1996, HUM MOL GENET, V3, P367; KRAWCZAK M, 1991, HUM GENET, V86, P425; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; REYNIERS E, 1995, GENOMICS, V29, P323, DOI 10.1006/geno.1995.9998; Rodrigues NR, 1996, J MED GENET, V33, P93, DOI 10.1136/jmg.33.2.93; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Sambrook J, 1989, MOL CLONING LAB MANU; STEEN VM, 1995, HUM MOL GENET, V4, P2251, DOI 10.1093/hmg/4.12.2251; THEODOSIOU AM, 1994, AM J HUM GENET, V55, P1209; URABE K, 1990, AM J HUM GENET, V46, P1178; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; WIRTH B, 1995, EUR J HUM GENET, V3, P56; 1992, NEUROMUSCULAR DISORD, V2, P423	35	117	125	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1057	1065						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900234				2022-12-18	WOS:A1996VN90000013
J	KRAJINOVIC, M; PINAMONTI, B; SINAGRA, G; VATTA, M; SEVERINI, GM; MILASIN, J; FALASCHI, A; CAMERINI, F; GIACCA, M; MESTRONI, L; DILENARDA, A; LARDIERI, G; MORGERA, T; SILVESTRI, F; BUSSANI, R; DAVANZO, M; MERINGOLO, G				KRAJINOVIC, M; PINAMONTI, B; SINAGRA, G; VATTA, M; SEVERINI, GM; MILASIN, J; FALASCHI, A; CAMERINI, F; GIACCA, M; MESTRONI, L; DILENARDA, A; LARDIERI, G; MORGERA, T; SILVESTRI, F; BUSSANI, R; DAVANZO, M; MERINGOLO, G			LINKAGE OF FAMILIAL DILATED CARDIOMYOPATHY TO CHROMOSOME-9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORES; POLYMORPHISMS; ATAXIA; MAP	Idiopathic dilated cardiomyopathy is a heart muscle disease of unknown etiology, characterized by impaired myocardial contractility and ventricular dilatation. The disorder is an important cause of morbidity and mortality and represents the chief indication for heart transplantation. Familial transmission is often recognized (familial dilated cardiomyopathy, or FDC), mostly with autosomal dominant inheritance. In order to understand the molecular generic basis of the disease, a large six-generation kindred with autosomal dominant FDC was studied for linkage analysis. A genome-wide search was undertaken after a large series of candidate genes were excluded and was then extended to two other families with autosomal dominant pattern of transmission and identical clinical features. Coinheritance of the disease gene was excluded for >95% of the genome, after 251 polymorphic markers were analyzed. Linkage was found for chromosome 9q13-q22, with a maximum multipoint lod score of 4.2. There was no evidence of heterogeneity. The FDC locus was placed in the interval between loci D9S153 and D9S152. Several candidate genes for causing dilated cardiomyopathy map in this region.	INT CTR GENET ENGN & BIOTECHNOL,I-34012 TRIESTE,ITALY; OSPED MAGGIORE TRIESTE,DEPT CARDIOL,TRIESTE,ITALY; UNIV TRIESTE,TRIESTE,ITALY	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste			Di Lenarda, Andrea/AAC-2377-2022; sinagra, gianfranco gs/P-7643-2014; Milasin, Jelena/J-1247-2019; Giacca, Mauro/J-9287-2016; Sinagra, Gianfranco/AAE-3943-2020	Di Lenarda, Andrea/0000-0001-8482-4872; Milasin, Jelena/0000-0002-6225-7210; Giacca, Mauro/0000-0003-2927-7225; Mestroni, Luisa/0000-0003-1116-2286; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Bussani, Rossana/0000-0001-8241-9726	Fondazione Telethon Funding Source: Custom	Fondazione Telethon(Fondazione Telethon)		ATTWOOD J, 1994, GENOMICS, V19, P203, DOI 10.1006/geno.1994.1049; BRANDENBURG RO, 1981, CIRCULATION, V64, pA437; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; FUJITA R, 1991, GENOMICS, V10, P915, DOI 10.1016/0888-7543(91)90179-I; GRAW SL, 1993, HUM MOL GENET, V2, P614, DOI 10.1093/hmg/2.5.614-a; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KEELING PJ, 1994, HERZ, V19, P91; KELLY DP, 1994, NEW ENGL J MED, V330, P913; KRAJINOVIC M, 1994, J MED GENET, V31, P766, DOI 10.1136/jmg.31.10.766; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MESTRONI L, 1990, AM J CARDIOL, V65, P1449, DOI 10.1016/0002-9149(90)91353-8; MESTRONI L, 1994, BRIT HEART J, V72, P35; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MICHELS VV, 1985, AM J CARDIOL, V55, P1232, DOI 10.1016/0002-9149(85)90675-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Ott J., 1991, ANAL HUMAN GENETIC L; PERLOFF JK, 1988, HEART DISEASE, P1782; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; SUNG LA, 1991, CYTOGENET CELL GENET, V58, P1944; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; 1994, SCIENCE, V265, P2049; 1989, J AM SOC ECHOCARDIOG, V2, P358	33	117	119	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					846	852						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573045				2022-12-18	WOS:A1995RV79300015
J	OLIVOSGLANDER, IM; JANNE, PA; NUSSBAUM, RL				OLIVOSGLANDER, IM; JANNE, PA; NUSSBAUM, RL			THE OCULOCEREBRORENAL SYNDROME GENE-PRODUCT IS A 105-KD PROTEIN LOCALIZED TO THE GOLGI-COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING-PROTEIN; BETA-COP; INOSITOL POLYPHOSPHATE-5-PHOSPHATASE; PHOSPHOLIPASE-D; MEMBRANES; LOWE; ARF	The oculocerebrorenal syndrome of Lowe (OCRL) is a multisystem disorder affecting the lens, kidney, and CNS. The predicted amino acid sequence of the OCRL gene, OCRL-1, was used to develop antibodies against the OCRL-1 protein. Western blot analysis using affinity-purified serum against the amino terminus of the OCRL-1 gene product (ocrl-1) demonstrates a single protein of 105 kD in fibroblasts of a normal individual that is absent in fibroblasts of an OCRL patient who lacks OCRL-1 transcript. A single protein with the same electrophoretic mobility is found by western analysis in various human cultured cell lines, and approximately the same size protein is also found in all mouse tissues tested. Northern analysis of various human and mouse tissues demonstrate that OCRL-1 transcript is expressed in nearly all tissues examined. By immunofluorescence, the ocrl-1 antibody stains a juxtanuclear region in normal fibroblast cells, while no specific staining is evident in the OCRL patient who produces no transcript. Colocalization of the ocrl-1 protein to the Golgi complex was demonstrated using a known monoclonal antibody against a Golgi-specific coat protein, beta-COP (beta coatomer protein).	NIH,NCHGR,LGDR,BETHESDA,MD 20892; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD23245] Funding Source: Medline; NIGMS NIH HHS [T32GM07170] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P3094; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Harlow E, 1988, ANTIBODIES LABORATOR, P471; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KENWORTHY L, 1993, AM J MED GENET, V46, P297, DOI 10.1002/ajmg.1320460312; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LEAHEY AM, 1993, HUM MOL GENET, V2, P461, DOI 10.1093/hmg/2.4.461; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATZARIS M, 1994, J BIOL CHEM, V269, P3397; PLUSKAL MG, 1986, BIOTECHNIQUES, V4, P272; ROSS TS, 1991, J BIOL CHEM, V266, P20283; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TANG WJY, 1993, METHOD CELL BIOL, V37, P99; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	23	117	120	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					817	823						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573041				2022-12-18	WOS:A1995RV79300011
J	DAS, S; LEVINSON, B; VULPE, C; WHITNEY, S; GITSCHIER, J; PACKMAN, S				DAS, S; LEVINSON, B; VULPE, C; WHITNEY, S; GITSCHIER, J; PACKMAN, S			SIMILAR SPLICING MUTATIONS OF THE MENKES MOTTLED COPPER-TRANSPORTING ATPASE GENE IN OCCIPITAL HORN SYNDROME AND THE BLOTCHY MOUSE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSYL OXIDASE ACTIVITY; KINKY HAIR SYNDROME; LINKED CUTIS LAXA; MENKES DISEASE; MOTTLED MOUSE; CANDIDATE GENE; SKIN FIBROBLASTS; DEFICIENCY; METABOLISM; ENCODES	The connective-tissue disorder occipital horn syndrome (OHS) is hypothesized to be allelic to Menkes disease. The two diseases have different clinical presentations but have a similar abnormality of copper transport. Mice hemizygous for the blotchy allele of the X-linked mottled locus have similar connective-tissue defects as OHS and may represent a mouse model of this disease. We have analyzed the Menkes/mottled copper-transporting ATPase in these two potentially homologous disorders and have identified similar splicing mutations in both. Some expression of normal mRNA was detectable by reverse transcription-PCR in the mutant tissues. These findings contrast with the more debilitating mutations observed in Menkes disease and suggest that low amounts of an otherwise normal protein product could result in the relatively mild phenotype of OHS and of the blotchy mouse.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Vulpe, Chris/AAF-9170-2020	Vulpe, Chris/0000-0001-5134-8929	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047192] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47192] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BYERS PH, 1980, NEW ENGL J MED, V303, P61, DOI 10.1056/NEJM198007103030201; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHRISTODOULOU J, 1994, 6TH INT C INB ERR ME; DANKS DM, 1994, 6TH INT C INB ERR ME; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DAS S, 1994, AM J HUM GENET, V55, P883; GACHERU S, 1993, ARCH BIOCHEM BIOPHYS, V301, P325, DOI 10.1006/abbi.1993.1151; GREEN MC, 1989, GENETIC VARIANTS STR, P241; HAMALAINEN ER, 1991, GENOMICS, V11, P508, DOI 10.1016/0888-7543(91)90057-L; HUNT DM, 1976, LIFE SCI, V19, P1913, DOI 10.1016/0024-3205(76)90124-7; HUNT DM, 1977, COMP BIOCHEM PHYS C, V57, P79, DOI 10.1016/0306-4492(77)90082-X; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; KUIVANIEMI H, 1985, AM J HUM GENET, V37, P798; KUIVANIEMI H, 1982, J CLIN INVEST, V69, P730, DOI 10.1172/JCI110503; Lazoff S G, 1975, Birth Defects Orig Artic Ser, V11, P71; LEVINSON B, 1993, NAT GENET, V3, P6, DOI 10.1038/ng0193-6; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; MANN JR, 1979, BIOCHEM J, V180, P605, DOI 10.1042/bj1800605; MEGURO Y, 1991, BRAIN DEV-JPN, V13, P184, DOI 10.1016/S0387-7604(12)80027-1; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MILLER J, 1990, X LINKED TRAITS CATA, P115; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; PACKMAN S, 1984, J INHERIT METAB DIS, V7, P168, DOI 10.1007/BF01805602; PACKMAN S, 1987, J CLIN INVEST, V79, P1338, DOI 10.1172/JCI112959; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; ROYCE PM, 1982, BIOCHEM J, V202, P369, DOI 10.1042/bj2020369; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; VULPE C, 1993, NAT GENET, V3, P273, DOI 10.1038/ng0393-273a; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; [No title captured]	35	117	118	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					570	576						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887410				2022-12-18	WOS:A1995QK91800003
J	ARASON, A; BARKARDOTTIR, RB; EGILSSON, V				ARASON, A; BARKARDOTTIR, RB; EGILSSON, V			LINKAGE ANALYSIS OF CHROMOSOME-17Q MARKERS AND BREAST-OVARIAN CANCER IN ICELANDIC FAMILIES, AND POSSIBLE RELATIONSHIP TO PROSTATIC-CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISM; LOCUS	Seven families, selected for breast cancer segregation, have been analyzed for chromosome 17q12-q23 linkage to breast and ovarian cancer. In two of them, linkage is seen with most markers tested, increasing toward the most proximal region, but without informative recombinations above NM23. In the remaining families, no linkage is observed. Families with 17q linkage are not easily distinguished by clinical characteristics such as early onset (mean age at diagnosis less-than-or-equal-to 45 years) or organs involved. In fact, the family with the highest lod scores (greater-than-or-equal-to 2.3) belongs to the ''later onset'' (>45 years) category of families. Interestingly, prostatic cancer is the most frequent malignancy, after breast cancer, in the families that we studied (13 cases total, all metastasizing) and is especially prevalent in males presumed to carry the trait. Of 16 paternal carriers, 7 (44%) had developed prostatic cancer. Haplotype analysis in families with 17q linkage reveals two further prostatic cases as potential carriers. We propose that breast cancer genes may predispose to prostatic cancer in male carriers.	UNIV HOSP ICELAND,DEPT PATHOL,CELL BIOL LAB,LANDSPITALINN 101,REYKJAVIK,ICELAND	Landspitali National University Hospital								BARKARDOTTIR RB, 1989, INT J CANCER, V44, P251, DOI 10.1002/ijc.2910440211; EASTON DF, 1993, AM J HUM GENET, V52, P678; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JACKSON DP, 1990, J CLIN PATHOL, V43, P499, DOI 10.1136/jcp.43.6.499; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NAROD SA, 1991, LANCET, V338, P82; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P686, DOI 10.1159/000133177; THIESSEN EU, 1974, CANCER, V34, P1102, DOI 10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	12	117	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					711	717						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460636				2022-12-18	WOS:A1993KY05900007
J	BIEGEL, JA; WHITE, PS; MARSHALL, HN; FUJIMORI, M; ZACKAI, EH; SCHER, CD; BRODEUR, GM; EMANUEL, BS				BIEGEL, JA; WHITE, PS; MARSHALL, HN; FUJIMORI, M; ZACKAI, EH; SCHER, CD; BRODEUR, GM; EMANUEL, BS			CONSTITUTIONAL IP36 DELETION IN A CHILD WITH NEUROBLASTOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVE NA+/H+ ANTIPORTER; WILMS TUMOR; HUMAN RETINOBLASTOMA; NEURO-BLASTOMA; FAMILIAL PREDISPOSITION; HUMAN CHROMOSOME-1; OSTEO-SARCOMA; LINKAGE MAP; GENE LOCUS; SHORT ARM	We describe a child with dysmorphic features, as well as developmental and growth delay, who developed neuroblastoma at 5 mo of age. Cytogenetic analysis of blood lymphocytes revealed an interstitial deletion of 1p36.1-->1p36.2, which was apparent only with high-resolution banding. Molecular analysis with a collection of polymorphic DNA probes for 1p confirmed an interstitial deletion involving subbands of 1p36. Deletions of this region are a common finding in neuroblastoma cells from patients with advanced stages of disease. Therefore, these results (a) suggest that constitutional deletion of this region predisposed the patient to the development of neuroblastoma and (b) support the localization of a neuroblastoma tumor-suppressor locus to 1p36.	CHILDRENS HOSP PHILADELPHIA,DIV ONCOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Washington University (WUSTL)	BIEGEL, JA (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET,WOOD BLDG,34TH ST & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039771, P01CA047983] Funding Source: NIH RePORTER; NCI NIH HHS [CA-39771, CA-47983] Funding Source: Medline; NICHD NIH HHS [HD-26979] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1981, CANCER RES, V41, P4678; BRODEUR GM, 1990, CANCER SURV, V9, P673; BRODEUR GM, 1989, CANCER GENET CYTOGEN, V41, P153, DOI 10.1016/0165-4608(89)90243-4; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; BRODEUR GM, 1991, BIOCH MOL ASPECTS SE, P251; BUROKER N, 1987, HUM GENET, V77, P175, DOI 10.1007/BF00272388; CAVENEE WK, 1986, NEW ENGL J MED, V314, P1201, DOI 10.1056/NEJM198605083141901; DARBY JK, 1986, NUCLEIC ACIDS RES, V14, P9543, DOI 10.1093/nar/14.23.9543; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI N C, 1988, Genomics, V3, P124, DOI 10.1016/0888-7543(88)90142-5; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FONG CT, 1992, CANCER RES, V52, P1780; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P9223, DOI 10.1093/nar/14.22.9223; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GILBERT F, 1984, CANCER RES, V44, P5444; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HOWARD PJ, 1990, CLIN GENET, V87, P127; HUFF V, 1988, NATURE, V336, P366; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KOUFOS A, 1989, AM J HUM GENET, V44, P711; KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7; LAMB J, 1988, CYTOGENET CELL GENET, V49, P1029; LAUREYS G, 1990, GENE CHROMOSOME CANC, V2, P252, DOI 10.1002/gcc.2870020315; LEACH RJ, 1990, CELL GROWTH DIFFER, V1, P401; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; MATTEI MG, 1988, CYTOGENET CELL GENET, V48, P6, DOI 10.1159/000132575; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9365, DOI 10.1093/nar/16.19.9365; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; SUZUKI T, 1989, CANCER RES, V49, P1095; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; WEISS MJ, 1987, NUCLEIC ACIDS RES, V15, P860, DOI 10.1093/nar/15.2.860; WEITH A, 1989, GENE CHROMOSOME CANC, V1, P159, DOI 10.1002/gcc.2870010209; YOUNG J L JR, 1986, Cancer, V58, P598, DOI 10.1002/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	48	117	117	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					176	182						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434586				2022-12-18	WOS:A1993KK90800020
J	KLEIN, CJ; COOVERT, DD; BULMAN, DE; RAY, PN; MENDELL, JR; BURGHES, AHM				KLEIN, CJ; COOVERT, DD; BULMAN, DE; RAY, PN; MENDELL, JR; BURGHES, AHM			SOMATIC REVERSION SUPPRESSION IN DUCHENNE MUSCULAR-DYSTROPHY (DMD) - EVIDENCE SUPPORTING A FRAME-RESTORING MECHANISM IN RARE DYSTROPHIN-POSITIVE FIBERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; GENE COLIAI; SKELETAL-MUSCLE; MOLECULAR-BASIS; POINT MUTATION; I COLLAGEN; MDX; MOSAICISM; DELETION; MOUSE	Many Duchenne muscular dystrophy (DMD) patients are known to have rare staining dystrophin-positive fibers, termed "revertants." The precise etiology of these rare fibers is unknown. The most likely explanation, however, is somatic mosaicism or somatic reversion/suppression. Immunocytochemistry was performed on serial sections from deleted and nondeleted patients, with a panel of antibodies-9219, 1377, 9218, and Dys-2-that span dystrophin. Both familial and nonfamilial patients possessed revertants. Either the same clusters or individual revertant fibers stained with amino- and carboxyl-terminal antibodies in all 14 DMD patients. In patients with deletions, revertants did not stain with antibodies raised to polypeptide sequences within the deletion. These results indicate that positively staining fibers are not the result of somatic mosaicism in deleted patients. Five of 10 patients without deletions had revertant fibers. In two of these patients, the revertant fibers did not stain with antibody 9218, which was generated against amino acids 2305-2554 and which corresponds to exons 48-52. The remaining antibodies from the panel stained the same fibers on separate serial sections in these two patients. The most likely mechanism giving rise to these positively staining fibers is a second site in-frame deletion. Antibodies generated to polypeptide sequences within deletions can be used to control for the natural occurrence of revertant fibers in myoblast transfer studies and may be useful in the detection of point mutations.	OHIO STATE UNIV, COLL MED, DEPT NEUROSURG, 1654 UPHAM DR, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL BIOL SCI, DEPT MOLEC GENET, COLUMBUS, OH 43210 USA; HOSP SICK CHILDREN, DEPT SHOWA KU, TORONTO M5G 1X8, ONTARIO, CANADA; OHIO STATE UNIV, COLL MED, DEPT PATHOL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL MED, DEPT MED CHEM, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University				Burghes, Arthur/0000-0001-9031-1555; Klein, Christopher/0000-0002-4012-8856	NIAMS NIH HHS [R29-AR40015-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040015] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURROW K, 1991, NEUROLOGY, V41, P662; CARPENTER S, 1990, MUSCLE NERVE, V13, P376, DOI 10.1002/mus.880130503; COHN DH, 1990, AM J HUM GENET, V46, P591; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GREENSPAN JA, 1988, MOL CELL BIOL, V8, P4185, DOI 10.1128/MCB.8.10.4185; HATLEN L, 1971, J MOL BIOL, V56, P535, DOI 10.1016/0022-2836(71)90400-1; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KLEIN CJ, UNPUB CORRELATION CL; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; ROTH JR, 1974, ANNU REV GENET, V8, P319, DOI 10.1146/annurev.ge.08.120174.001535; SHIMIZU T, 1988, P JPN ACAD B-PHYS, V64, P205, DOI 10.2183/pjab.64.205; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	38	117	119	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					950	959						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570844				2022-12-18	WOS:A1992HR47300008
J	NEEL, JV; SATOH, C; GORIKI, K; ASAKAWA, J; FUJITA, M; TAKAHASHI, N; KAGEOKA, T; HAZAMA, R				NEEL, JV; SATOH, C; GORIKI, K; ASAKAWA, J; FUJITA, M; TAKAHASHI, N; KAGEOKA, T; HAZAMA, R			SEARCH FOR MUTATIONS ALTERING PROTEIN CHARGE AND-OR FUNCTION IN CHILDREN OF ATOMIC-BOMB SURVIVORS - FINAL REPORT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RADIAT EFFECTS RES FDN,HIROSHIMA,JAPAN; RADIAT EFFECTS RES FDN,NAGASAKI,JAPAN	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	NEEL, JV (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,4708 MED SCI 2,ANN ARBOR,MI 48109, USA.							ALBERTINI RJ, 1985, NATURE, V316, P369, DOI 10.1038/316369a0; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; ASHMAN CR, 1987, P NATL ACAD SCI USA, V84, P3354, DOI 10.1073/pnas.84.10.3354; AUXIER J A, 1975, Journal of Radiation Research, V16, P1, DOI 10.1269/jrr.16.SUPPLEMENT_1; CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; DELEHANTY J, 1986, MUTAT RES, V167, P215, DOI 10.1016/0165-1110(86)90031-X; FERRELL RE, 1977, ANN HUM GENET, V40, P407, DOI 10.1111/j.1469-1809.1977.tb02028.x; GARRIOTT ML, 1982, MUTAT RES, V105, P157, DOI 10.1016/0165-7992(82)90005-7; GIBBS RA, 1987, SCIENCE, V236, P303, DOI 10.1126/science.3563511; GILBERT ES, 1984, RADIAT RES, V98, P591, DOI 10.2307/3576491; GRAHN D, 1983, RADIAT RES, V95, P566, DOI 10.2307/3576101; GRAHN D, 1984, MUTAT RES, V129, P215, DOI 10.1016/0027-5107(84)90154-4; GROSOVSKY AJ, 1988, P NATL ACAD SCI USA, V85, P185, DOI 10.1073/pnas.85.1.185; GROSOVSKY AJ, 1986, GENETICS, V113, P405; HASHIZUME T, 1975, Journal of Radiation Research, V16, P12, DOI 10.1269/jrr.16.SUPPLEMENT_12; ITO H, 1985, JPN J HUM GENET, V30, P261, DOI 10.1007/BF01907963; JABLON S, 1971, 2371 AT BOMB CAS COM, P41; Kato H., 1966, AM J HUM GENET, V16, P214; KERR GD, 1981, 4TH S NEUTR DOS COMM, P501; LEWIS SE, 1986, GENETIC TOXICOLOGY B, P359; LIBER HL, 1987, MUTAT RES, V178, P143, DOI 10.1016/0027-5107(87)90096-0; LIBER HL, 1986, MUTAT RES, V163, P91, DOI 10.1016/0027-5107(86)90062-X; Lindahl T., 1977, DNA REPAIR PROCESS, P225; MALLING HV, 1973, RADIAT RES, V53, P77, DOI 10.2307/3573449; MALLING HV, 1977, ARCH TOXICOL, V38, P45; MILTON RC, 1968, ABCC168 TECH REP; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; NEEL IV, 1978, AM J HUM GENET, V41, P429; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NEEL JV, 1974, GENETICS, V76, P311; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NEEL JV, IN PRESS MUTAT RES; NEEL JV, 1983, UTILIZATION MAMMALIA, P71; NEEL JV, 1984, 2 DIMENSIONAL GEL EL, P259; NEEL JV, 1956, PUBL NATIONAL ACADEM, V461; RINCHIK EM, 1986, GENETICS, V112, P321; ROESCH WC, 1987, HIROSHIMA RAD EFFECT, P434; RUSSELL LB, 1976, P NATL ACAD SCI USA, V73, P2843, DOI 10.1073/pnas.73.8.2843; RUSSELL LB, 1986, GENETIC TOXICOLOGY E, P437; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024; SATOH C, 1984, JPN J HUM GENET, V29, P89, DOI 10.1007/BF01873529; SATOH C, 1983, AM J HUM GENET, V35, P656; SATOH C, 1977, ANN HUM GENET, V41, P169, DOI 10.1111/j.1469-1809.1977.tb01912.x; SATOH C, 1982, HUMAN GENETICS A, P267; SCHULL WJ, 1981, SCIENCE, V213, P1220, DOI 10.1126/science.7268429; SCHULL WJ, 1982, ENV MUTAGENS CARCINO, P687; SINCLAIR WK, 1985, RADIAT PROT DOSIM, V13, P319; SKOLNICK MM, 1986, ADV HUM GENET, V15, P55; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; TANIS RJ, 1978, ANN HUM GENET, V41, P419, DOI 10.1111/j.1469-1809.1978.tb00912.x; TURNER DR, 1985, NATURE, V315, P343, DOI 10.1038/315343a0; UEDA N, 1977, ANN HUM GENET, V41, P43, DOI 10.1111/j.1469-1809.1977.tb01960.x; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WILSON JM, 1986, J CLIN INVEST, V77, P188, DOI 10.1172/JCI112275; YANDELL DW, 1986, SOMAT CELL MOLEC GEN, V12, P255, DOI 10.1007/BF01570784; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772; 1986, INT COMMISSION RAD U, V40, P1; 1986, OTAH298 US C OFF TEC	59	117	124	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					663	676						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358419				2022-12-18	WOS:A1988N143800002
J	Luo, R; Sanders, SJ; Tian, Y; Voineagu, I; Huang, N; Chu, SH; Klei, L; Cai, CC; Ou, J; Lowe, JK; Hurles, ME; Devlin, B; State, MW; Geschwind, DH				Luo, Rui; Sanders, Stephan J.; Tian, Yuan; Voineagu, Irina; Huang, Ni; Chu, Su H.; Klei, Lambertus; Cai, Chaochao; Ou, Jing; Lowe, Jennifer K.; Hurles, Matthew E.; Devlin, Bernie; State, Matthew W.; Geschwind, Daniel H.			Genome-wide Transcriptome Profiling Reveals the Functional Impact of Rare De Novo and Recurrent CNVs in Autism Spectrum Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; CANDIDATE-GENE; BEHAVIORAL CHARACTERIZATION; PSYCHIATRIC-DISORDERS; HUMAN BRAIN; 16P11.2; ASSOCIATION; DELETION; MUTATIONS	Copy-number variants (CNVs) are a major contributor to the pathophysiology of autism spectrum disorders (ASDs), but the functional impact of CNVs remains largely unexplored. Because brain tissue is not available from most samples, we interrogated gene expression in lymphoblasts from 244 families with discordant siblings in the Simons Simplex Collection in order to identify potentially pathogenic variation. Our results reveal that the overall frequency of significantly misexpressed genes (which we refer to here as outliers) identified in probands and unaffected siblings does not differ. However, in probands, but not their unaffected siblings, the group of outlier genes is significantly enriched in neural-related pathways, including neuropeptide signaling, synaptogenesis, and cell adhesion. We demonstrate that outlier genes cluster within the most pathogenic CNVs (rare de novo CNVs) and can be used for the prioritization of rare CNVs of potentially unknown significance. Several nonrecurrent CNVs with significant gene-expression alterations are identified (these include deletions in chromosomal regions 3q27, 3p13, and 3p26 and duplications at 2p15), suggesting that these are potential candidate ASD loci. In addition, we identify distinct expression changes in 16p11.2 microdeletions, 16p11.2 microduplications, and 7q11.23 duplications, and we show that specific genes within the 16p CNV interval correlate with differences in head circumference, an ASD-relevant phenotype. This study provides evidence that pathogenic structural variants have a functional impact via transcriptome alterations in ASDs at a genome-wide level and demonstrates the utility of integrating gene expression with mutation data for the prioritization of genes disrupted by potentially pathogenic mutations.	[Luo, Rui; Cai, Chaochao; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Luo, Rui; Tian, Yuan; Voineagu, Irina; Ou, Jing; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, Program Neurogenet, New Haven, CT 06520 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, Program Human Genet & Genom, New Haven, CT 06520 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Tian, Yuan] Univ Calif Los Angeles, Interdept PhD Program Bioinformat, Los Angeles, CA 90095 USA; [Voineagu, Irina; Ou, Jing; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA; [Huang, Ni; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Chu, Su H.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Cai, Chaochao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Wellcome Trust Sanger Institute; Carnegie Mellon University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@ucla.edu	State, Matthew/W-2256-2019; Sanders, Stephan/S-8645-2019	State, Matthew/0000-0003-1624-8302; Voineagu, Irina/0000-0003-4162-3872; Chu, Su/0000-0002-6345-008X; Sanders, Stephan/0000-0001-9112-5148	Simons Foundation [R08741 M09R10124, 20104829]; Autism Center of Excellence Network [5R01 MH081754-04]; National Institute of Mental Health; Wellcome Trust [077014/Z/05/Z]; Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754] Funding Source: NIH RePORTER	Simons Foundation; Autism Center of Excellence Network; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge the resources provided by Simons genetic consortium and Simons investigators, and we sincerely thank the families who have participated in the Simons Simplex study. This work is supported by grant R08741 M09R10124 (to D.H.G., M.S., and B.D.) and Pilot Grant 20104829 (to D.H.G.) from the Simons Foundation, the Autism Center of Excellence Network grant 5R01 MH081754-04 (to D.H.G. [principal investigator] and M.S.) from the National Institute of Mental Health, Wellcome Trust grant 077014/Z/05/Z (to M.H.), and the Dennis Weatherstone predoctoral fellowship from Autism Speaks (to R.L). We are also grateful to Neelroop Parikshak, Jamee Bomar, and Jeremy Miller for critical reading of the manuscript and to Lauren Kawaguchi for her help as a laboratory manager.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benderska N, 2010, BBA-GENE REGUL MECH, V1799, P448, DOI 10.1016/j.bbagrm.2010.01.003; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; Bonferroni CE, 1936, PUBBL R 1 SUPER SCI, V8, P3, DOI DOI 10.4135/9781412961288.N455; Bourgeron T, 2009, B ACAD NAT MED PARIS, V193, P299, DOI 10.1016/S0001-4079(19)32583-X; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gold DL, 2005, AM J PHARMACOGENOMIC, V5, P271, DOI 10.2165/00129785-200505040-00007; Hanson E, 2010, J DEV BEHAV PEDIATR, V31, P649, DOI 10.1097/DBP.0b013e3181ea50ed; Hehir-Kwa JY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000752; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kumar RA, 2010, J MED GENET, V47, P81, DOI 10.1136/jmg.2008.065821; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McClellan J, 2010, JAMA-J AM MED ASSOC, V303, P2523, DOI 10.1001/jama.2010.869; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Miller DT, 1993, GENEREVIEWS; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newbury DF, 2009, AM J MED GENET A, V149A, P588, DOI 10.1002/ajmg.a.32704; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Novak MJU, 2010, MOVEMENT DISORD, V25, P2176, DOI 10.1002/mds.23223; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Okamoto S, 2002, MOL BRAIN RES, V107, P89, DOI 10.1016/S0169-328X(02)00440-0; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pellerin L, 2010, DIABETES METAB, V36, pS59, DOI 10.1016/S1262-3636(10)70469-9; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ploeger A, 2010, BIOL PSYCHIAT, V67, P602, DOI 10.1016/j.biopsych.2009.10.010; Pobbe RLH, 2012, PHYSIOL BEHAV, V107, P641, DOI 10.1016/j.physbeh.2012.02.024; ROCHE AF, 1987, PEDIATRICS, V79, P706; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schorge S, 2010, TRENDS NEUROSCI, V33, P211, DOI 10.1016/j.tins.2010.02.005; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Settembre C, 2007, P NATL ACAD SCI USA, V104, P4506, DOI 10.1073/pnas.0700382104; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Treadwell-Deering DE, 2010, J DEV BEHAV PEDIATR, V31, P137, DOI 10.1097/DBP.0b013e3181cda67e; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Voineagu I, 2012, MOL PSYCHIATR, V17, P4, DOI 10.1038/mp.2011.95; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wagner B, 2010, METHODS MOL BIOL, V661, P481, DOI 10.1007/978-1-60761-795-2_30; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	82	116	118	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					38	55		10.1016/j.ajhg.2012.05.011	http://dx.doi.org/10.1016/j.ajhg.2012.05.011			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22726847	Green Published, Bronze			2022-12-18	WOS:000306445000004
J	Riazuddin, SA; Parker, DS; McGlumphy, EJ; Oh, EC; Iliff, BW; Schmedt, T; Jurkunas, U; Schleif, R; Katsanis, N; Gottsch, JD				Riazuddin, S. Amer; Parker, David S.; McGlumphy, Elyse J.; Oh, Edwin C.; Iliff, Benjamin W.; Schmedt, Thore; Jurkunas, Ula; Schleif, Robert; Katsanis, Nicholas; Gottsch, John D.			Mutations in LOXHD1, a Recessive-Deafness Locus, Cause Dominant Late-Onset Fuchs Corneal Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOTHELIAL DYSTROPHY; MISSENSE MUTATIONS; PROTEIN; COL8A2; GENE; COLLAGEN; LINKAGE	Fuchs corneal dystrophy (FCD) is a genetic disorder of the corneal endothelium and is the most common cause of corneal transplantation in the United States. Previously, we mapped a late-onset FCD locus, FCD2, on chromosome 18q. Here, we present next-generation sequencing of all coding exons in the FCD2 critical interval in a multigenerational pedigree in which FCD segregates as an autosomal-dominant trait. We identified a missense change in LOXHD1, a gene causing progressive hearing loss in humans, as the sole variant capable of explaining the phenotype in this pedigree. We observed LOXHD1 mRNA in cultured human corneal endothelial cells, whereas antibody staining of both human and mouse corneas showed staining in the corneal epithelium and endothelium. Corneal sections of the original proband were stained for LOXHD1 and demonstrated a distinct increase in antibody punctate staining in the endothelium and Descemet membrane; punctate staining was absent from both normal corneas and FCD corneas negative for causal LOXHDI mutations. Subsequent interrogation of a cohort of >200 sporadic affected individuals identified another 15 heterozygous missense mutations that were absent from >800 control chromosomes. Furthermore, in silico analyses predicted that these mutations reside on the surface of the protein and are likely to affect the protein's interface and protein-protein interactions. Finally, expression of the familial LOXHD1 mutant allele as well as two sporadic mutations in cells revealed prominent cytoplasmic aggregates reminiscent of the corneal phenotype. All together, our data implicate rare alleles in LOXHD1 in the pathogenesis of FCD and highlight how different mutations in the same locus can potentially produce diverse phenotypes.	[Riazuddin, S. Amer; McGlumphy, Elyse J.; Iliff, Benjamin W.; Gottsch, John D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Parker, David S.; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Cell Biol, Durham, NC 27710 USA; [Schmedt, Thore; Jurkunas, Ula] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Schleif, Robert] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Duke University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Johns Hopkins University	Gottsch, JD (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	igottsch@jhmi.edu	Katsanis, Nicholas/E-1837-2012	Schleif, Robert/0000-0002-4430-7085; Jurkunas, Ula/0000-0002-5059-608X; Katsanis, Nicholas/0000-0002-2480-0171	National Eye Institute [R01 EY016835]; Kwok Research Fund; NATIONAL EYE INSTITUTE [R01EY016835, R01EY020581] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Kwok Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank all family members for their enthusiastic participation in this study. None of the contributing authors have any financial interest related to this work. We are thankful to Ulrich Mueller for providing the Loxhd1 construct. This study was supported in part by the National Eye Institute grant R01 EY016835 (J.D.G.) and the Kwok Research Fund (J.D.G.). J.D.G. is a distinguished Margaret C. Mosher Professor of Ophthalmology. N.K. is a distinguished Brumley Professor.	Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Edvardson S, 2011, AM J MED GENET A, V155A, P1170, DOI 10.1002/ajmg.a.33972; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Goar E L, 1933, Trans Am Ophthalmol Soc, V31, P48; Gottsch JD, 2006, CORNEA, V25, P485, DOI 10.1097/01.ico.0000178726.11693.14; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Mannis MJ, 2006, CORNEA, V25, P164; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Stehouwer M, 2011, CLIN OPHTHALMOL, V5, P1297, DOI 10.2147/OPTH.S23091; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; WILSON SE, 1988, CORNEA, V7, P2; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617	27	116	119	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					533	539		10.1016/j.ajhg.2012.01.013	http://dx.doi.org/10.1016/j.ajhg.2012.01.013			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341973	Green Published, Bronze			2022-12-18	WOS:000301762800020
J	Belostotsky, R; Ben-Shalom, E; Rinat, C; Becker-Cohen, R; Feinstein, S; Zeligson, S; Segel, R; Elpeleg, O; Nassar, S; Frishberg, Y				Belostotsky, Ruth; Ben-Shalom, Efrat; Rinat, Choni; Becker-Cohen, Rachel; Feinstein, Sofia; Zeligson, Sharon; Segel, Reeval; Elpeleg, Orly; Nassar, Suheir; Frishberg, Yaacov			Mutations in the Mitochondrial Seryl-tRNA Synthetase Cause Hyperuricemia, Pulmonary Hypertension, Renal Failure in Infancy and Alkalosis, HUPRA Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUAL-MODE RECOGNITION; AMINOACYLATION; DEFICIENCY; TRNAS(SER); DISORDERS; MYOPATHY; GENE	An uncharacterized multisystemic mitochondrial cytopathy was diagnosed in two infants from consanguineous Palestinian kindred living in a single village. The most significant clinical findings were tubulopathy (hyperuricemia, metabolic alkalosis), pulmonary hypertension, and progressive renal failure in infancy (HUPRA syndrome). Analysis of the consanguineous pedigree suggested that the. causative mutation is in the nuclear DNA. By using genome-wide SNP homozygosity analysis, we identified a homozygous identity-by-descent region on chromosome 19 and detected the pathogenic mutation c.1169A>G (p.Asp390Gly) in SARS2, encoding the mitochondrial seryl-tRNA synthetase. The same homozygous mutation was later identified in a third infant with HUPRA syndrome. The carrier rate of this mutation among inhabitants of this Palestinian isolate was found to be 1:15. The mature enzyme catalyzes the ligation of serine to two mitochondrial tRNA isoacceptors: tRNA(AGY)(Ser) and tRNA(UCN)(Ser). Analysis of amino acylation of the two target tRNAs, extracted from immortalized peripheral lymphocytes derived from two patients, revealed that the p.Asp390Gly mutation significantly impacts on the acylation of tRNA(AGY)(Ser) but probably not that of tRNA(UCN)(Ser). Marked decrease in the expression of the nonacylated transcript and the complete absence of the acylated tRNA(AGY)(Ser) suggest that this mutation leads to significant loss of function and that the uncharged transcripts undergo degradation.	[Belostotsky, Ruth; Ben-Shalom, Efrat; Rinat, Choni; Becker-Cohen, Rachel; Feinstein, Sofia; Frishberg, Yaacov] Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel; [Zeligson, Sharon; Segel, Reeval; Frishberg, Yaacov] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Ben-Shalom, Efrat; Rinat, Choni; Becker-Cohen, Rachel; Feinstein, Sofia] Hadassah Hebrew Univ, Sch Med, IL-91120 Jerusalem, Israel; [Elpeleg, Orly] Hadassah Hebrew Univ, Monique & Jacques Roboh Dept Genet Res, Dept Genet & Metab Dis, Med Ctr, IL-91120 Jerusalem, Israel; [Nassar, Suheir] Makassed Hosp, Mol Genet Lab, IL-91194 Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Frishberg, Y (corresponding author), Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel.	yaacovf@ekmd.huji.ac.il	Segel, Reeval/AAT-1498-2020					Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222; Bendayan D, 2003, RESP MED, V97, P130, DOI 10.1053/rmed.2003.1440; Chernyakov I, 2008, METHOD ENZYMOL, V449, P221, DOI 10.1016/S0076-6879(08)02411-7; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x; Gibbons WJ, 2004, BIOCHEM BIOPH RES CO, V317, P774, DOI 10.1016/j.bbrc.2004.03.113; Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Hutchin TP, 2001, EUR J HUM GENET, V9, P385, DOI 10.1038/sj.ejhg.5200640; Papp LV, 2008, NUCLEIC ACIDS RES, V36, P7192, DOI 10.1093/nar/gkn829; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; STEINBERG S, 1994, J MOL BIOL, V236, P982, DOI 10.1016/0022-2836(94)90004-3; Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626; Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024; Yokogawa T, 2000, J BIOL CHEM, V275, P19913, DOI 10.1074/jbc.M908473199; Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021	23	116	121	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					193	200		10.1016/j.ajhg.2010.12.010	http://dx.doi.org/10.1016/j.ajhg.2010.12.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21255763	Green Published, Bronze			2022-12-18	WOS:000287684100007
J	Ji, YL; Zhang, AM; Jia, XY; Zhang, YP; Xiao, XS; Li, SQ; Guo, XM; Bandelt, HJ; Zhang, QJ; Yao, YG				Ji, Yanli; Zhang, A-Mei; Jia, Xiaoyun; Zhang, Ya-Ping; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Bandelt, Hans-Juergen; Zhang, Qingjiong; Yao, Yong-Gang			Mitochondrial DNA Haplogroups M7b1 ' 2 and M8a Affect Clinical Expression of Leber Hereditary Optic Neuropathy in Chinese Families with the m.11778G -> A Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; G11778A MUTATION; SEQUENCE-ANALYSIS; PENETRANCE; LHON; DISEASE; EAST; NEURORETINOPATHY; EPIDEMIOLOGY; HAPLOTYPE	Leber hereditary optic neuropathy (LHON) is the most extensively studied mitochondrial disease, with the majority of the cases being caused by one of three primary mitochondrial DNA (mtDNA) mutations. Incomplete disease penetrance and gender bias are two features of LHON and indicate involvement of additional genetic or environmental factors in the pathogenesis of the disorder. Haplogroups J, K, and H have been shown to influence the clinical expression of LHON in subjects harboring primary mutations in European families. However, whether mtDNA haplogroups would affect the penetrance of LHON in East Asian families has not been evaluated yet. By studying the penetrance of LHON in 1859 individuals from 182 Chinese families (including one from Cambodia) with the m.11778G -> A mutation, we found that haplogroup M7b1'2 significantly increases the risk of visual loss, whereas M8a has a protective effect. Analyses of the complete mtDNA sequences from LHON families with m.11778G -> A narrow the association of disease expression to m.12811T -> C (Y159H) in the NADH dehydrogenase 5 gene (MT-ND5) in haplogroup M7b1'2 and suggest that the specific combination of amino acid changes (A20T-T531) in the ATP synthase 6 protein (MT-ATP6) caused by m.8584G -> A and m.8684C -> T might account for the beneficial background effect of M8a. Protein secondary-structure prediction for the MT-ATP6 with the two M8a-specific amino acid changes further supported our inferences. These findings will assist in further understanding the pathogenesis of LHON and guide future genetic counseling in East Asian patients with m.11778G -> A.	[Zhang, A-Mei; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Ji, Yanli; Jia, Xiaoyun; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Zhang, A-Mei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, D-20146 Hamburg, Germany	Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Hamburg	Yao, YG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China.	ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Zhang, Qingjiong/AAR-6331-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Qingjiong/0000-0001-7508-848X	Chinese Academy of Sciences; National Science Fund for Distinguished Young Scholars	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	The authors thank the patients for donating DNA samples, Jin-Xin Zhang (The Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University) for statistical assistance, and the reviewers for critical comments on the early version of the manuscript. This study was supported by grants from the Chinese Academy of Sciences (Y.-G.Y. and Y.-P.Z.) and the National Science Fund for Distinguished Young Scholars (30725044 to Q.Z.). Y.-G.Y. was supported by the "Century Program" (or Hundreds-Talent Program) of the Chinese Academy of Sciences. Y.J. is a Ph.D. student of Q.Z.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Annunen-Rasila J, 2006, NEUROGENETICS, V7, P185, DOI 10.1007/s10048-006-0049-x; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1994, AM J HUM GENET, V55, P410; Brown MD, 1997, AM J HUM GENET, V60, P381; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fujitake J, 2002, ACTA NEUROL BELG, V102, P82; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339; Ishikawa K, 2005, JPN J OPHTHALMOL, V49, P121, DOI 10.1007/s10384-004-0166-8; Ji YL, 2007, BIOCHEM BIOPH RES CO, V364, P238, DOI 10.1016/j.bbrc.2007.09.111; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; LAMMINEN T, 1995, AM J HUM GENET, V56, P1238; Majander A, 1997, FEBS LETT, V412, P351, DOI 10.1016/S0014-5793(97)00757-6; Man PYW, 2002, NEUROLOGY, V58, P1861, DOI 10.1212/WNL.58.12.1861; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Mather MW, 1998, FEBS LETT, V433, P93, DOI 10.1016/S0014-5793(98)00891-6; Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828; Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Qu J, 2005, BIOCHEM BIOPH RES CO, V328, P1139, DOI 10.1016/j.bbrc.2005.01.062; Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014; Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Torroni A, 1997, AM J HUM GENET, V60, P1107; Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002; Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128	56	116	129	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					760	768		10.1016/j.ajhg.2008.11.002	http://dx.doi.org/10.1016/j.ajhg.2008.11.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19026397	Green Published, Bronze			2022-12-18	WOS:000261822100011
J	Canzonetta, C; Mulligan, C; Deutsch, S; Ruf, S; O'Doherty, A; Lyle, R; Borel, C; Lin-Marq, N; Delom, F; Groet, J; Schnappauf, F; De Vita, S; Averill, S; Priestley, JV; Martin, JE; Shipley, J; Denyer, G; Epstein, CJ; Fillat, C; Estivill, X; Tybulewicz, VLJ; Fisher, EMC; Antonarakis, SE; Nizetic, D				Canzonetta, Claudia; Mulligan, Claire; Deutsch, Samuel; Ruf, Sandra; O'Doherty, Aideen; Lyle, Robert; Borel, Christelle; Lin-Marq, Nathalie; Delom, Frederic; Groet, Juergen; Schnappauf, Felix; De Vita, Serena; Averill, Sharon; Priestley, John V.; Martin, Joanne E.; Shipley, Janet; Denyer, Gareth; Epstein, Charles J.; Fillat, Cristina; Estivill, Xavier; Tybulewicz, Victor L. J.; Fisher, Elizabeth M. C.; Antonarakis, Stylianos E.; Nizetic, Dean			DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESTRICTIVE SILENCER FACTOR; GENE-EXPRESSION VARIATION; REST/NRSF TARGET GENES; PROTEIN-KINASE; MOUSE MODEL; NEURONAL DEVELOPMENT; MENTAL-RETARDATION; IN-VIVO; REST; DYRK1A	Down syndrome (DS) is the most common cause of mental retardation. Many neural phenotypes are shared between DS individuals and DS mouse models; however, the common underlying molecular pathogenetic mechanisms remain unclear. Using a transchromosomic model of DS, we show that a 30%-60% reduced expression of Nrsf/Rest (a key regulator of pluripotency and neuronal differentiation) is an alteration that persists in trisomy 21 from undifferentiated embryonic stem (ES) cells to adult brain and is reproducible across several DS models. Using partially trisomic ES cells, we map this effect to a three-gene segment of HSA21, containing DYRK1A. We independently identify the same locus as the most significant eQTL controlling REST expression in the human genome. We show that specifically silencing the third copy of DYRK1A rescues Rest levels, and we demonstrate altered Rest expression in response to inhibition of DYRK1A expression or kinase activity, and in a transgenic Dyrk1A mouse. We reveal that undifferentiated trisomy 21 ES cells show DYRK1A-dosesensitive reductions in levels of some pluripotency regulators, causing premature expression of transcription factors driving early endodermal and mesodermal differentiation, partially overlapping recently reported downstream effects of Rest +/-. They produce embryoid bodies with elevated levels of the primitive endoderm progenitor marker Gata4 and a strongly reduced neuroectodermal progenitor compartment. Our results suggest that DYRK1A-mediated deregulation of REST is a very early pathological consequence of trisomy 21 with potential to disturb the development of all embryonic lineages, warranting closer research into its contribution to DS pathology and new rationales for therapeutic approaches.	[Canzonetta, Claudia; Mulligan, Claire; Delom, Frederic; Groet, Juergen; Schnappauf, Felix; De Vita, Serena; Averill, Sharon; Priestley, John V.; Martin, Joanne E.; Nizetic, Dean] Univ London, Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; [Deutsch, Samuel; Lyle, Robert; Borel, Christelle; Lin-Marq, Nathalie; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ruf, Sandra; O'Doherty, Aideen; Tybulewicz, Victor L. J.] Natl Inst Med Res, London NW7 1AA, England; [O'Doherty, Aideen; Fisher, Elizabeth M. C.] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Shipley, Janet] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Denyer, Gareth] Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; [Epstein, Charles J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fillat, Cristina; Estivill, Xavier] Ctr Genom Regulat CRG UPF, Genes & Dis Program, Barcelona 08003, Spain; [Fillat, Cristina; Estivill, Xavier] CIBERESP, Barcelona 08003, Spain; [Fillat, Cristina; Estivill, Xavier] CIBERER, Barcelona 08003, Spain	University of London; Queen Mary University London; University of Geneva; MRC National Institute for Medical Research; University of London; University College London; University of London; Institute of Cancer Research - UK; University of Sydney; University of California System; University of California San Francisco; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Nizetic, D (corresponding author), Univ London, Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	d.nizetic@qmul.ac.uk	Nizetic, Dean/F-9509-2015; denyer, gareth/E-3437-2010; Estivill, Xavier/A-3125-2013; Fisher, Elizabeth MC/C-2168-2008; borel, christelle/AAC-9645-2019; Estivill, Xavier/E-2957-2012; Fillat, Cristina/ABH-1674-2020; Antonarakis, Stylianos E/N-8866-2014; Delom, Frederic/J-2782-2014	Estivill, Xavier/0000-0002-0723-2256; Fisher, Elizabeth MC/0000-0003-2850-9936; Antonarakis, Stylianos E/0000-0001-8907-5823; Delom, Frederic/0000-0002-4600-7633; Tybulewicz, Victor/0000-0003-2439-0798; Shipley, Janet/0000-0001-6748-8678; Fillat, Cristina/0000-0002-0801-3338; Nizetic, Dean/0000-0001-5486-5761; Deutsch, Samuel/0000-0001-9456-7101; Canzonetta, Claudia/0000-0002-8928-5537	EU Commission; Leukaemia Research Fund-UK [06003]; Barts and The London Charitable Foundation; Fondation Jerome Lejeune; Swiss National Science Foundation; Center of Excellence "Frontiers in Genetics"; "Childcare" Foundation; National Institute of Child Health and Human Development; Spanish Ministry of Education and Science, Medical Research Council UK; The Wellcome Trust; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [MC_U117527252, G0601056] Funding Source: researchfish	EU Commission(European CommissionEuropean Commission Joint Research Centre); Leukaemia Research Fund-UK; Barts and The London Charitable Foundation; Fondation Jerome Lejeune; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center of Excellence "Frontiers in Genetics"; "Childcare" Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Spanish Ministry of Education and Science, Medical Research Council UK(Spanish Government); The Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the AnEUploidy grant from Framework Programme 6 from the EU Commission and by the Specialist Programme Grant 06003 from the Leukaemia Research Fund-UK. We also thank the following for their support: Barts and The London Charitable Foundation, Fondation Jerome Lejeune, Swiss National Science Foundation and Center of Excellence "Frontiers in Genetics", "Childcare" Foundation, National Institute of Child Health and Human Development, Spanish Ministry of Education and Science, Medical Research Council UK, and The Wellcome Trust. We thank Philip Cohen (University of Dundee) for advice.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; EPSTEIN CJ, 2001, METABOLIC MOL BASES, P1223; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lepagnol-Bestel AM, 2007, NEUROREPORT, V18, P441, DOI 10.1097/WNR.0b013e328011dc81; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Mensah A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-131; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olguin P, 2006, J NEUROSCI, V26, P2820, DOI 10.1523/JNEUROSCI.5037-05.2006; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Rachidi M, 2005, DNA RES, V12, P203, DOI 10.1093/dnares/dsi004; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Sultan M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r91; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yoo JY, 2001, BIOCHEM BIOPH RES CO, V283, P928, DOI 10.1006/bbrc.2001.4857	53	116	119	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					388	400		10.1016/j.ajhg.2008.08.012	http://dx.doi.org/10.1016/j.ajhg.2008.08.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18771760	Green Published, Bronze			2022-12-18	WOS:000259307200009
J	Roessler, E; Ouspenskaia, MV; Karkera, JD; Velez, JI; Kantipong, A; Lacbawan, F; Bowers, P; Belmont, JW; Towbin, JA; Goldmuntz, E; Feldman, B; Muenke, M				Roessler, Erich; Ouspenskaia, Maia V.; Karkera, Jayaprakash D.; Velez, Jorge I.; Kantipong, Amy; Lacbawan, Felicitas; Bowers, Peter; Belmont, John W.; Towbin, Jeffrey A.; Goldmuntz, Elizabeth; Feldman, Benjamin; Muenke, Maximilian			Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMAD INTERACTION MOTIF; OF-FUNCTION MUTATIONS; LATERALITY DEFECTS; DIGEORGE-SYNDROME; NKX2.5 MUTATIONS; DISEASE; MICE; ZIC3; ASYMMETRY; GENETICS	Abnormalities of embryonic patterning are hypothesized to underlie many common congenital malformations in humans including congenital heart defects (CHDs), left-right disturbances (L-R) or laterality, and holoprosencephaly (HPE). Studies in model organisms suggest that Nodal-like factors provide instructions for key aspects of body axis and germ layer patterning; however, the complex genetics of pathogenic gene variant(s) in humans are poorly understood. Here we report our studies of FOXH1, CFC1, and SMAD2 and summarize our mutational analysis of three additional components in the human NODAL-signaling pathway: NODAL, GDF1, and TDGF1. We identify functionally abnormal gene products throughout the pathway that are clearly associated with CHD, laterality, and HPE. Abnormal gene products are most commonly detected in patients within a narrow spectrum of isolated conotruncal heart defects (minimum 5%-10% of subjects), and far less commonly in isolated laterality or HPE patients (similar to 1% for each). The difference in the mutation incidence between these groups is highly significant. We show that apparent gene dosage discrepancies between humans and model organisms can be reconciled by considering a broader combination of sequence variants. Our studies confirm that (1) the genetic vulnerabilities inferred from model organisms with defects in Nodal signaling are indeed analogous to humans; (2) the molecular analysis of an entire signaling pathway is more complete and robust than that of individual genes and presages future studies by whole-genome analysis; and (3) a functional genomics approach is essential to fully appreciate the complex genetic interactions necessary to produce these effects in humans.	[Roessler, Erich; Ouspenskaia, Maia V.; Karkera, Jayaprakash D.; Velez, Jorge I.; Kantipong, Amy; Lacbawan, Felicitas; Feldman, Benjamin; Muenke, Maximilian] NHGRI, NIH, Med Genet Branch, Bethesda, MD 20892 USA; [Bowers, Peter] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Belmont, John W.; Towbin, Jeffrey A.] Baylor Coll Med, Dept Pediat, Div Cardiol, Houston, TX 77030 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yale University; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Muenke, M (corresponding author), NHGRI, NIH, Med Genet Branch, Bethesda, MD 20892 USA.	mmuenke@nhgri.nih.gov	Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; Towbin, Jeffrey A./J-5595-2019	Belmont, John W/0000-0001-7409-3578; Towbin, Jeffrey A./0000-0002-6585-714X; Velez, Jorge/0000-0002-3146-7899; Muenke, Maximilian/0000-0002-7719-6545; Feldman, Benjamin/0000-0003-4838-8641	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091771, P50HL074731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200343, ZIAHG000209, ZIAHG000175] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL091771-01, R01 HL091771, R01 HL091771-02, P50 HL074731, P50 HL74731] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baldini A, 2004, CURR OPIN CARDIOL, V19, P201, DOI 10.1097/00001573-200405000-00002; Baldini A, 2002, HUM MOL GENET, V11, P2363, DOI 10.1093/hmg/11.20.2363; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; de la Cruz JM, 2002, HUM GENET, V110, P422, DOI 10.1007/s00439-002-0709-3; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Germain S, 2000, GENE DEV, V14, P435; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Krauss Robert S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000440; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ozcelik C, 2006, PEDIATR CARDIOL, V27, P695, DOI 10.1007/s00246-006-1082-0; Pei WH, 2007, DEV BIOL, V310, P10, DOI 10.1016/j.ydbio.2007.07.011; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; Roessler E, 2001, BIOESSAYS, V23, P888, DOI 10.1002/bies.1130; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Ware SM, 2004, AM J HUM GENET, V74, P93, DOI 10.1086/380998; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Yamada S, 2004, BIRTH DEFECTS RES A, V70, P495, DOI 10.1002/bdra.20048; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhu LR, 2008, HUM MUTAT, V29, P99, DOI 10.1002/humu.20606; Zhu LR, 2006, EUR J HUM GENET, V14, P17, DOI 10.1038/sj.ejhg.5201506	38	116	121	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					18	29		10.1016/j.ajhg.2008.05.012	http://dx.doi.org/10.1016/j.ajhg.2008.05.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18538293	Bronze, Green Published			2022-12-18	WOS:000257784000004
J	Lautier, C; Goldwurm, S; Durr, A; Giovannone, B; Tsiaras, WG; Pezzoli, G; Brice, A; Smith, RJ				Lautier, Corinne; Goldwurm, Stefano; Durr, Alexandra; Giovannone, Barbara; Tsiaras, William G.; Pezzoli, Gianni; Brice, Alexis; Smith, Robert J.			Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY-ONSET PARKINSONISM; ADAPTER PROTEIN GRB10; CLINICAL-DIAGNOSIS; INSULIN-RECEPTOR; LRRK2 G2019S; GYF DOMAIN; SUSCEPTIBILITY; LOCALIZATION; ASSOCIATION; ACCURACY	The genetic basis for association of the PARK11 region of chromosome 2 with familial Parkinson disease (PD) is unknown. This study examined the GIGYF2 (Grb10-Interacting GYF Protein-2) (TNRC15) gene, which contains the PARK11 microsatellite marker with the highest linkage score (D2S206, LOD 5.14). The 27 coding exons of the GIGYF2 gene were sequenced in 123 Italian and 126 French patients with familial PD, plus 131 Italian and 96 French controls. A total of seven different GIGYF2 missense mutations resulting in single amino acid substitutions were present in 12 unrelated PD index patients (4.8%) and not in controls. Three amino acid insertions or deletions were found in four other index patients and absent in controls. Specific exon sequencing showed that these ten sequence changes were absent from a further 91 controls. In four families with amino acid substitutions in which at least one other PD case was available, the GIGYF2 mutations (Asn56Ser, Thr112Ala, and Asp606Glu) segregated with PD. There were, however, two unaffected carriers in one family, suggesting age-dependent or incomplete penetrance. One index case (PD onset age 33) inherited a GIGYF2 mutation (Ile278Val) from her affected father (PD onset age 66) and a previously described PD-linked mutation in the LRRK2 gene (IIeI371Val) from her affected mother (PD onset age 61). The earlier onset and severe clinical course in the index patient suggest additive effects of the GIGYF2 and LRRK2 mutations. These data strongly support GIGYF2 as a PARK11 gene with a causal role in familial PD.	[Lautier, Corinne; Giovannone, Barbara; Tsiaras, William G.; Smith, Robert J.] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Endocrinol, Providence, RI 02903 USA; [Lautier, Corinne; Durr, Alexandra; Brice, Alexis] INSERM, U679, F-75013 Paris, France; [Lautier, Corinne; Durr, Alexandra; Brice, Alexis] Univ Paris 06, UMR S679, Pitie Salpetriere Hosp, F-75013 Paris, France; [Lautier, Corinne; Durr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Goldwurm, Stefano; Pezzoli, Gianni] Parkinson Inst, Ist Clin Perfezionamento, I-20126 Milan, Italy	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Smith, RJ (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Endocrinol, Providence, RI 02903 USA.	rsmith4@iifespan.org	Goldwurm, Stefano/Q-8978-2016; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Lautier, Corinne/P-2701-2018	Goldwurm, Stefano/0000-0002-1651-567X; brice, alexis/0000-0002-0941-3990; Lautier, Corinne/0000-0002-3229-191X; Pezzoli, Gianni/0000-0003-4665-6710; Tsiaras, William/0000-0002-4080-4762; Giovannone, Barbara/0000-0003-3143-1922	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043038] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043038, DK43038] Funding Source: Medline; Telethon [GTF04007] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon)		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brice A, 2005, BRAIN, V128, P2760, DOI 10.1093/brain/awh676; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Di Fonzo A, 2006, EUR J HUM GENET, V14, P322, DOI 10.1038/sj.ejhg.5201539; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Fahn S., 1987, RECENT DEV PARKINSON, P153; Freund C, 1999, NAT STRUCT BIOL, V6, P656, DOI 10.1038/10712; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Hedrich K, 2001, HUM MOL GENET, V10, P1649, DOI 10.1093/hmg/10.16.1649; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ibanez P, 2003, NEUROLOGY, V61, P1429, DOI 10.1212/01.WNL.0000094121.48373.FD; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; Kofler MM, 2006, FEBS J, V273, P245, DOI 10.1111/j.1742-4658.2005.05078.x; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Langlais P, 2004, MOL ENDOCRINOL, V18, P350, DOI 10.1210/me.2003-0117; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Lesage S, 2008, J MED GENET, V45, P43, DOI 10.1136/jmg.2007.051854; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2005, ANN NEUROL, V58, P784, DOI 10.1002/ana.20636; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Matsumine H, 1997, AM J HUM GENET, V60, P588; Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2005, NEUROLOGY, V65, P696, DOI 10.1212/01.WNL.0000167552.79769.b3; Pankratz N, 2003, HUM MOL GENET, V12, P2599, DOI 10.1093/hmg/ddg270; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383; Pankratz N, 2002, AM J HUM GENET, V71, P124, DOI 10.1086/341282; Payami H, 1998, J GERIATR PSYCH NEUR, V11, P98, DOI 10.1177/089198879801100207; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prestel J, 2005, EUR J HUM GENET, V13, P193, DOI 10.1038/sj.ejhg.5201317; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102	55	116	122	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					822	833		10.1016/j.ajhg.2008.01.015	http://dx.doi.org/10.1016/j.ajhg.2008.01.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18358451	Green Published, Bronze			2022-12-18	WOS:000255103900002
J	Motazacker, MM; Rost, BR; Hucho, T; Garshasbi, M; Kahrizi, K; Ullmann, R; Abedini, SS; Nieh, SE; Amini, SH; Goswami, C; Tzschach, A; Jensen, LR; Schmitz, D; Ropers, HH; Najmabadi, H; Kuss, AW				Motazacker, Mohammad Mahdi; Rost, Benjamin Rainer; Hucho, Tim; Garshasbi, Masoud; Kahrizi, Kimia; Ullmann, Reinhard; Abedini, Seyedeh Sedigheh; Nieh, Sahar Esmaeeli; Amini, Saeid Hosseini; Goswami, Chandan; Tzschach, Andreas; Jensen, Lars Riff; Schmitz, Dietmar; Ropers, Hans Hilger; Najmabadi, Hossein; Kuss, Andreas Walter			A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KAINATE RECEPTORS; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; HIPPOCAMPUS; EXPRESSION; PROFILIN; MUTATION; RELEASE; LINKAGE; AUTISM	Nonsyndromic mental retardation is one of the most important unresolved problems in genetic health care. Autosomal forms are far more common than X-linked forms, but, in contrast to the latter, they are still largely unexplored. Here, we report a complex mutation in the ionotropic glutamate receptor 6 gene (GRIK2, also called "GLUR6") that cosegregates with moderate-to-severe nonsyndromic autosomal recessive mental retardation in a large, consanguineous Iranian family. The predicted gene product lacks the first ligand-binding domain, the adjacent transmembrane domain, and the putative pore loop, suggesting a complete loss of function of the GLU(K6) protein, which is supported by electrophysiological data. This finding provides the first proof that GLU(K6) is indispensable for higher brain functions in humans, and future studies of this and other ionotropic kainate receptors will shed more light on the pathophysiology of mental retardation.	Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; Charite Univ Med Berlin, Ctr Res Neurosci, Berlin, Germany; Univ Social Welf & Rehabil Sci, Ctr Gene Res, Tehran, Iran	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuss, AW (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kuss_a@molgen.mpg.de	Rost, Benjamin/AHD-2242-2022; Hucho, Tim/F-8973-2010; Abedini, Seyedeh Sedigheh/AAG-3694-2021; Hucho, Tim/Q-5218-2018; Kahrizi, Kimia/D-7989-2017; Tzschach, Andreas/I-2648-2019; Najmabadi, Hossein/P-8182-2017	Rost, Benjamin/0000-0003-1906-0081; Hucho, Tim/0000-0002-4147-9308; Tzschach, Andreas/0000-0002-6840-965X; Garshasbi, Masoud/0000-0002-5508-7903; Schmitz, Dietmar/0000-0003-2741-5241; Najmabadi, Hossein/0000-0002-6084-7778; Abedini, Seyedeh Sedigheh/0000-0003-2671-2295; Kuss, Andreas/0000-0002-9401-4627				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; BAHN S, 1994, J NEUROSCI, V14, P5525; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; DINGLEDINE R, 1991, TRENDS PHARMACOL SCI, V12, P360, DOI 10.1016/0165-6147(91)90602-O; Erdogan F, 2006, CYTOGENET GENOME RES, V115, P247, DOI 10.1159/000095921; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lauri SE, 2005, J NEUROSCI, V25, P4473, DOI 10.1523/JNEUROSCI.4050-04.2005; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; OCHMAN H, 1988, GENETICS, V120, P621; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N	31	116	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					792	798		10.1086/521275	http://dx.doi.org/10.1086/521275			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847003	Green Published, Bronze			2022-12-18	WOS:000249307600019
J	Liu, F; Arias-Vasquez, A; Sleegers, K; Aulchenko, YS; Kayser, M; Sanchez-Juan, P; Feng, BJ; Bertoli-Avella, AM; van Swieten, J; Axenovich, TI; Heutink, P; van Broeckhoven, C; Oostra, BA; van Duijn, CM				Liu, Fan; Arias-Vasquez, Alejandro; Sleegers, Kristel; Aulchenko, Yurii S.; Kayser, Manfred; Sanchez-Juan, Pascual; Feng, Bing-Jian; Bertoli-Avella, Aida M.; van Swieten, John; Axenovich, Tatiana I.; Heutink, Peter; van Broeckhoven, Christine; Oostra, Ben A.; van Duijn, Cornelia M.			A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MEMORY PERFORMANCE; MISSENSE MUTATIONS; GENOMIC SCREEN; LOCUS; GENE; ASSOCIATION; RISK; DEMENTIA; SCAN	Alzheimer disease (AD) is the most common cause of dementia. We conducted a genome screen of 103 patients with late-onset AD who were ascertained as part of the Genetic Research in Isolated Populations (GRIP) program that is conducted in a recently isolated population from the southwestern area of The Netherlands. All patients and their 170 closely related relatives were genotyped using 402 microsatellite markers. Extensive genealogy information was collected, which resulted in an extremely large and complex pedigree of 4,645 members. The pedigree was split into 35 subpedigrees, to reduce the computational burden of linkage analysis. Simulations aiming to evaluate the effect of pedigree splitting on false-positive probabilities showed that a LOD score of 3.64 corresponds to 5% genomewide type I error. Multipoint analysis revealed four significant and one suggestive linkage peaks. The strongest evidence of linkage was found for chromosome 1q21 (heterogeneity LOD at marker D1S498). Approximately 30 cM upstream of this locus, [HLOD] p 5.20 we found another peak at 1q25 (at marker D1S218). These two loci are in a previously established linkage HLOD = 4.0 region. We also confirmed the AD locus at 10q22-24 (at marker D10S185). There was significant evidence HLOD = 4.15 of linkage of AD to chromosome 3q22-24 (at marker D3S1569). For chromosome 11q24-25, there was HLOD = 4.44 suggestive evidence of linkage (at marker D11S1320). We next tested for association between cognitive HLOD = 3.29 function and 4,173 single- nucleotide polymorphisms in the linked regions in an independent sample consisting of 197 individuals from the GRIP region. After adjusting for multiple testing, we were able to detect significant associations for cognitive function in four of five AD- linked regions, including the new region on chromosome 3q22- 24 and regions 1q25, 10q22- 24, and 11q25. With use of cognitive function as an endophenotype of AD, our study indicates the that the RGSL2, RALGPS2, and C1orf49 genes are the potential disease- causing genes at 1q25. Our analysis of chromosome 10q22- 24 points to the HTR7, MPHOSPH1, and CYP2C cluster. This is the first genomewide screen that showed significant linkage to chromosome 3q23 markers. For this region, our analysis identified the NMNAT3 and CLSTN2 genes. Our findings confirm linkage to chromosome 11q25. We were unable to confirm SORL1; instead, our analysis points to the OPCML and HNT genes.	Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Dept Forens Mol Biol, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Dept Neurol, NL-3015 GE Rotterdam, Netherlands; Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Novosibirsk, Russia; Vrije Univ Amsterdam, Sect Med Genom, Dept Human Genet, Sect Med Genom, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands; Univ Antwerp VIB, Flanders Interuniv Inst Biotechnol, Dept Mol Genet, B-2610 Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Flanders Institute for Biotechnology (VIB); University of Antwerp	van Duijn, CM (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Unit, Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	c.vanduijn@erasmusmc.nl	Axenovich, Tatiana I/AAD-2595-2022; Feng, Bing-Jian/C-6974-2009; Bertoli-Avella, Aida/AAW-2751-2020; Sanchez-Juan, Pascual/B-9282-2009; Vasquez, Alejandro Arias/E-4762-2012; Aulchenko, Yurii/M-8270-2013; Liu, Fan/B-8833-2013; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017	Axenovich, Tatiana I/0000-0002-4318-4458; Bertoli-Avella, Aida/0000-0001-9544-1877; Sanchez-Juan, Pascual/0000-0002-6081-8037; Vasquez, Alejandro Arias/0000-0002-4786-0169; Aulchenko, Yurii/0000-0002-7899-1575; Liu, Fan/0000-0001-9241-8161; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Duijn, Cornelia/0000-0002-2374-9204; van Swieten, John/0000-0001-6278-6844; Heutink, Peter/0000-0001-5218-1737				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; [Anonymous], 1932, STAT METHODS RES WOR; Ashley-Koch AE, 2005, NEUROSCI LETT, V379, P199, DOI 10.1016/j.neulet.2004.12.065; Aulchenko YS, 2005, ANN HUM GENET, V69, P233, DOI 10.1046/j.1529-8817.2005.00154.x; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Buyske S, 2006, BEHAV GENET, V36, P65, DOI 10.1007/s10519-005-9008-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Curtis D, 2001, ANN HUM GENET, V65, P473, DOI 10.1017/S0003480001008776; Dermaut B, 2002, AM J HUM GENET, V70, P1568, DOI 10.1086/340732; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Escamilla MA, 2001, BIPOLAR DISORD, V3, P299, DOI 10.1034/j.1399-5618.2001.30605.x; Falchi M, 2004, AM J HUM GENET, V75, P1015, DOI 10.1086/426155; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goddard KAB, 2004, NEUROGENETICS, V5, P121, DOI 10.1007/s10048-004-0174-3; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; Holmans P, 2005, AM J MED GENET B, V135B, P24, DOI 10.1002/ajmg.b.30114; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee JH, 2004, NEUROLOGY, V62, P414, DOI 10.1212/01.WNL.0000106461.96637.AC; Lee JH, 2006, ARCH NEUROL-CHICAGO, V63, P1591, DOI 10.1001/archneur.63.11.1591; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Liu F, 2006, ANN HUM GENET, V70, P965, DOI 10.1111/j.1469-1809.2006.00279.x; MACKAY KB, 1994, J NEURAL TRANSM-PARK, V7, P73, DOI 10.1007/BF02252664; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Myers AJ, 2001, CURR OPIN NEUROL, V14, P433, DOI 10.1097/00019052-200108000-00002; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson JM, 2002, AM J HUM GENET, V71, P154, DOI 10.1086/341034; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; ROBEY FA, 1984, J BIOL CHEM, V259, P7311; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sleegers K, 2007, NEUROBIOL AGING, V28, P735, DOI 10.1016/j.neurobiolaging.2006.03.012; Sleegers K, 2004, BRAIN, V127, P1641, DOI 10.1093/brain/awh179; Sleegers K., 2001, Community Genet, V4, P197, DOI 10.1159/000064193; Swan GE, 1999, ARCH NEUROL-CHICAGO, V56, P1127, DOI 10.1001/archneur.56.9.1127; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Yamada H, 1998, ALZ DIS ASSOC DIS, V12, P204, DOI 10.1097/00002093-199809000-00013; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200; Zubenko GS, 1998, GENOMICS, V50, P121, DOI 10.1006/geno.1998.5306	67	116	119	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					17	31		10.1086/518720	http://dx.doi.org/10.1086/518720			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564960	Green Published, Bronze			2022-12-18	WOS:000247039700002
J	Nielsen, KB; Sorensen, S; Cartegni, L; Corydon, TJ; Doktor, TK; Schroeder, LD; Reinert, LS; Elpeleg, O; Krainer, AR; Gregersen, N; Kjems, J; Andresen, BS				Nielsen, Karsten Bork; Sorensen, Suzette; Cartegni, Luca; Corydon, Thomas Juhl; Doktor, Thomas Koed; Schroeder, Lisbeth Dahl; Reinert, Line Sinnathamby; Elpeleg, Orly; Krainer, Adrian R.; Gregersen, Niels; Kjems, Jorgen; Andresen, Brage Storstein			Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: A synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL MOTOR-NEURON; MESSENGER-RNA; REGULATORY ELEMENTS; SINGLE-NUCLEOTIDE; HNRNP A1; PURIFYING SELECTION; MISSENSE MUTATIONS; IDENTIFICATION; NONSENSE	The idea that point mutations in exons may affect splicing is intriguing and adds an additional layer of complexity when evaluating their possible effects. Even in the best-studied examples, the molecular mechanisms are not fully understood. Here, we use patient cells, model minigenes, and in vitro assays to show that a missense mutation in exon 5 of the medium-chain acyl-CoA dehydrogenase (MCAD) gene primarily causes exon skipping by inactivating a crucial exonic splicing enhancer (ESE), thus leading to loss of a functional protein and to MCAD deficiency. This ESE functions by antagonizing a juxtaposed exonic splicing silencer (ESS) and is necessary to define a suboptimal 3' splice site. Remarkably, a synonymous polymorphic variation in MCAD exon 5 inactivates the ESS, and, although this has no effect on splicing by itself, it makes splicing immune to deleterious mutations in the ESE. Furthermore, the region of MCAD exon 5 that harbors these elements is nearly identical to the exon 7 region of the survival of motor neuron (SMN) genes that contains the deleterious silent mutation in SMN2, indicating a very similar and finely tuned interplay between regulatory elements in these two genes. Our findings illustrate a mechanism for dramatic context-dependent effects of single-nucleotide polymorphisms on gene-expression regulation and show that it is essential that potential deleterious effects of mutations on splicing be evaluated in the context of the relevant haplotype.	Skejby Sygehus, Res Univ Mol Med, Fac Hlth Sci, DK-8200 Aarhus N, Denmark; Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Human Genet, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Biol Mol, DK-8000 Aarhus, Denmark; Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, Jerusalem, Israel; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Hebrew University of Jerusalem; Hadassah University Medical Center; Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory	Andresen, BS (corresponding author), Skejby Sygehus, Res Univ Mol Med, Fac Hlth Sci, DK-8200 Aarhus N, Denmark.	brage@ki.au.dk	Andresen, Brage/D-2515-2012; Kjems, Jorgen/I-3490-2016; Doktor, Thomas/AAB-2216-2020; Doktor, Thomas K/G-9923-2014	Andresen, Brage/0000-0001-7488-3035; Kjems, Jorgen/0000-0003-4128-9317; Doktor, Thomas/0000-0002-5315-8325; Doktor, Thomas K/0000-0002-5315-8325; Corydon, Thomas Juhl/0000-0003-3588-6350; Krainer, Adrian/0000-0001-9024-9501; Reinert, Line/0000-0002-8317-0886	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42699, R01 GM042699, R37 GM042699] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Campos Berta, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9176; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gorlov IP, 2004, MUTAT RES-FUND MOL M, V554, P175, DOI 10.1016/j.mrfmmm.2004.04.014; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Korman SH, 2004, MOL GENET METAB, V82, P121, DOI 10.1016/j.ymgme.2004.03.002; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Orban TI, 2001, TRENDS GENET, V17, P252; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Pagani F, 2003, J BIOL CHEM, V278, P26580, DOI 10.1074/jbc.M212813200; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pfarr N, 2005, J IMMUNOL, V174, P4172, DOI 10.4049/jimmunol.174.7.4172; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Pollard AJ, 2002, J BIOL CHEM, V277, P15241, DOI 10.1074/jbc.M109046200; Schaal TD, 1999, MOL CELL BIOL, V19, P261; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Steiner B, 2004, HUM MUTAT, V24, P120, DOI 10.1002/humu.20064; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013; Zhao XM, 2004, J VIROL, V78, P10888, DOI 10.1128/JVI.78.20.10888-10905.2004; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	53	116	118	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					416	432		10.1086/511992	http://dx.doi.org/10.1086/511992			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273963	Bronze, Green Published			2022-12-18	WOS:000244403300003
J	Lenzi, ML; Smith, J; Snowden, T; Kim, M; Fishel, R; Poulos, BK; Cohen, PE				Lenzi, ML; Smith, J; Snowden, T; Kim, M; Fishel, R; Poulos, BK; Cohen, PE			Extreme heterogeneity in the molecular events leading to the establishment of chiasmata during meiosis I in human oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOUBLE-STRAND BREAKS; MISMATCH REPAIR PROTEINS; MEIOTIC CROSSING-OVER; MUTS HOMOLOG; CHROMOSOME SYNAPSIS; SACCHAROMYCES-CEREVISIAE; REDUCED RECOMBINATION; MOUSE SPERMATOCYTES; MAMMALIAN MEIOSIS; BUDDING YEAST	In humans, similar to 50% of conceptuses are chromosomally aneuploid as a consequence of errors in meiosis, and most of these aneuploid conceptuses result in spontaneous miscarriage. Of these aneuploidy events, 70% originate during maternal meiosis, with the majority proposed to arise as a direct result of defective crossing over during meiotic recombination in prophase I. By contrast, <1% - 2% of mouse germ cells exhibit prophase I - related nondisjunction events. This disparity among mammalian species is surprising, given the conservation of genes and events that regulate meiotic progression. To understand the mechanisms that might be responsible for the high error rates seen in human females, we sought to further elucidate the regulation of meiotic prophase I at the molecular cytogenetic level. Given that these events occur during embryonic development in females, samples were obtained during a defined period of gestation ( 17 - 24 weeks). Here, we demonstrate that human oocytes enter meiotic prophase I and progress through early recombination events in a similar temporal framework to mice. However, at pachynema, when chromosomes are fully paired, we find significant heterogeneity in the localization of the MutL homologs, MLH1 and MLH3, among human oocyte populations. MLH1 and MLH3 have been shown to mark late-meiotic nodules that correlate well with - and are thought to give rise to - the sites of reciprocal recombination between homologous chromosomes, which suggests a possible 10-fold variation in the processing of nascent recombination events. If such variability persists through development and into adulthood, these data would suggest that as many as 30% of human oocytes are predisposed to aneuploidy as a result of prophase I defects in MutL homolog - related events.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Kimmel Canc Ctr, Philadelphia, PA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Jefferson University	Cohen, PE (corresponding author), Cornell Univ, Dept Biomed Sci, T3014,Vet Res Tower, Ithaca, NY 14853 USA.	pc242@cornell.edu						Abdullah MFF, 2004, CYTOGENET GENOME RES, V107, P180, DOI 10.1159/000080596; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bocher T, 1999, CANCER RES, V59, P816; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown AS, 2000, HUM MOL GENET, V9, P515, DOI 10.1093/hmg/9.4.515; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Hoffmann ER, 2003, GENETICS, V163, P515; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Judis LA, 2004, FERTIL STERIL, V81, P205, DOI 10.1016/j.fertnstert.2003.05.021; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Marcon E, 2003, GENETICS, V165, P2283; Moens PB, 2002, J CELL SCI, V115, P1611; Novak JE, 2001, GENETICS, V158, P1013; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Plug AW, 1996, P NATL ACAD SCI USA, V93, P5920, DOI 10.1073/pnas.93.12.5920; Plug AW, 1998, J CELL SCI, V111, P413; Roig I, 2004, CHROMOSOMA, V113, P22, DOI 10.1007/s00412-004-0290-8; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Savage AR, 1998, HUM MOL GENET, V7, P1221, DOI 10.1093/hmg/7.8.1221; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; van Veen JE, 2003, CURR BIOL, V13, pR831, DOI 10.1016/j.cub.2003.10.014; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Winand NJ, 1998, GENOMICS, V53, P69, DOI 10.1006/geno.1998.5447; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zalevsky J, 1999, GENETICS, V153, P1271	61	116	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					112	127		10.1086/427268	http://dx.doi.org/10.1086/427268			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15558497	Bronze, Green Published			2022-12-18	WOS:000225643600010
J	Simmonds, MJ; Howson, JMM; Heward, JM; Cordell, HJ; Foxall, H; Carr-Smith, J; Gibson, SM; Walker, N; Tomer, Y; Franklyn, JA; Todd, JA; Gough, SCL				Simmonds, MJ; Howson, JMM; Heward, JM; Cordell, HJ; Foxall, H; Carr-Smith, J; Gibson, SM; Walker, N; Tomer, Y; Franklyn, JA; Todd, JA; Gough, SCL			Regression mapping of association between the human leukocyte antigen region and Graves disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DEPENDENT DIABETES-MELLITUS; AUTOIMMUNE THYROID-DISEASE; CLASS-II ALLELES; GENETIC-HETEROGENEITY; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; HLA; DQB1; DRB1	The human leukocyte antigen class II genes DRB1, DQB1, and DQA1 are associated with Graves disease (GD), but, because of strong linkage disequilibrium within this region, the primary etiological variant(s) remains unknown. In the present study, 871 patients with GD and 621 control subjects were genotyped at the DRB1, DQB1, and DQA1 loci. All three loci were associated with GD (P = 1.45 x 10(-12), P = 3.20 x 10(-5), and P = 9.26 x 10(-12), respectively). Stepwise logistic-regression analysis showed that the association could be explained by either DRB1 or DQA1 but not by DQB1. To extend previous results, the amino acid sequence of the exon 2-encoded peptide-binding domain of DRB1 was predicted for each subject, and, by use of logistic regression, each position was analyzed for association with GD. Of 102 amino acids, 70 were uninformative; of the remaining 32 amino acids, 13 were associated with GD (P values ranged from 2.20 x 10(-4) to 1.2 x 10(-12)). The strongest association was at position beta74. This analysis is consistent with the possibility that position beta74 of exon 2 of the DRB1 molecule may have a specific and central role in autoantigen presentation by DRB1 to T lymphocytes. However, we cannot yet exclude a primary role for DQA1 or for other polymorphisms that affect DRB1 function or expression.	Birmingham Heartlands Hosp, Dept Med, Div Med Sci, Birmingham B9 5SS, W Midlands, England; Univ Birmingham, Div Med Sci, Inst Biomed Res, Birmingham, W Midlands, England; Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge, England; Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA	Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham; University of Cambridge; Icahn School of Medicine at Mount Sinai	Gough, SCL (corresponding author), Birmingham Heartlands Hosp, Dept Med, Div Med Sci, Bordesley Green E, Birmingham B9 5SS, W Midlands, England.	s.c.gough@bham.ac.uk	Todd, John A/A-3542-2010; Tomer, Yaron/GWU-8933-2022	Todd, John A/0000-0003-2740-8148; Howson, Joanna/0000-0001-7618-0050; Simmonds, Matt/0000-0003-3154-3510; Cordell, Heather/0000-0002-1879-5572; Walker, Neil/0000-0001-9796-7688				AWATA T, 1992, DIABETOLOGIA, V35, P419, DOI 10.1007/BF02342437; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; BECH K, 1977, ACTA ENDOCRINOL-COP, V86, P510, DOI 10.1530/acta.0.0860510; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; CAVA RJ, 1993, PROCESSING PROPERTIE, V1, P1; Chelvanayagam G, 1997, HUM IMMUNOL, V58, P61, DOI 10.1016/S0198-8859(97)00185-7; Chen QY, 1999, J CLIN ENDOCR METAB, V84, P3182, DOI 10.1210/jc.84.9.3182; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Doebele RC, 2003, J IMMUNOL, V170, P4683, DOI 10.4049/jimmunol.170.9.4683; Gough SCL, 2000, ENDOCRIN METAB CLIN, V29, P255, DOI 10.1016/S0889-8529(05)70130-4; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; Nepom GT, 1996, EUR J IMMUNOL, V26, P949, DOI 10.1002/eji.1830260435; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Tomer Y, 1999, J CLIN ENDOCR METAB, V84, P4656, DOI 10.1210/jc.84.12.4656; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WEYAND CM, 1995, J CLIN INVEST, V95, P2120, DOI 10.1172/JCI117900; YANAGAWA T, 1993, J CLIN ENDOCR METAB, V76, P1569, DOI 10.1210/jcem.76.6.8501164; Zhao Y, 1996, Chin Med Sci J, V11, P232	24	116	119	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					157	163		10.1086/426947	http://dx.doi.org/10.1086/426947			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15558498	Green Published, Bronze			2022-12-18	WOS:000225643600015
J	Whittock, NV; Sparrow, DB; Wouters, MA; Sillence, D; Ellard, S; Dunwoodie, SL; Turnpenny, PD				Whittock, NV; Sparrow, DB; Wouters, MA; Sillence, D; Ellard, S; Dunwoodie, SL; Turnpenny, PD			Mutated MESP2 causes spondylocostal dysostosis in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AXIAL SKELETAL DEFECTS; DELTA HOMOLOG; GENE; DLL3; SEGMENTATION; MUTATIONS; MESODERM; CELLS	Spondylocostal dysostosis (SCD) is a term given to a heterogeneous group of disorders characterized by abnormal vertebral segmentation (AVS). We have previously identified mutations in the Delta-like 3 (DLL3) gene as a major cause of autosomal recessive spondylocostal dysostosis. DLL3 encodes a ligand for the Notch receptor and, when mutated, defective somitogenesis occurs resulting in a consistent and distinctive pattern of AVS affecting the entire spine. From our study cohort of cases of AVS, we have identified individuals and families with abnormal segmentation of the entire spine but no mutations in DLL3, and, in some of these, linkage to the DLL3 locus at 19q13.1 has been excluded. Within this group, the radiological phenotype differs mildly from that of DLL3 mutation-positive SCD and is variable, suggesting further heterogeneity. Using a genomewide scanning strategy in one consanguineous family with two affected children, we demonstrated linkage to 15q21.3-15q26.1 and furthermore identified a 4-bp duplication mutation in the human MESP2 gene that codes for a basic helix-loop-helix transcription factor. No MESP2 mutations were found in a further 7 patients with related radiological phenotypes in whom abnormal segmentation affected all vertebrae, nor in a further 12 patients with diverse phenotypes.	Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; Victor Chang Cardiac Res Inst, Dev Biol Program, Darlinghurst, NSW, Australia; Victor Chang Cardiac Res Inst, Computat Biol & Bioinformat Program, Darlinghurst, NSW, Australia; Childrens Hosp, Dept Med Genet, Westmead, NSW, Australia; Univ New S Wales, St Vincents Clin Sch, Kensington, NSW, Australia; Univ New S Wales, Dept Biotechnol & Biomol Sci, Kensington, NSW, Australia	University of Exeter; University of Exeter; Victor Chang Cardiac Research Institute; Victor Chang Cardiac Research Institute; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Turnpenny, PD (corresponding author), Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England.	peter.turnpenny@rdehc-tr.swest.nhs.uk	Wouters, Merridee/F-4310-2010; Sparrow, Duncan/B-3994-2008; Wouters, Merridee A/G-2481-2015; Dunwoodie, Sally L/M-4019-2018; Wouters, Merridee/D-2046-2012	Sparrow, Duncan/0000-0002-1141-6613; Wouters, Merridee A/0000-0002-2121-912X; Dunwoodie, Sally L/0000-0002-2069-7349; Ellard, Sian/0000-0002-7620-5526				Bonafe L, 2003, CLIN GENET, V64, P28, DOI 10.1034/j.1399-0004.2003.00085.x; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Haraguchi S, 2001, MECH DEVELOP, V108, P59, DOI 10.1016/S0925-4773(01)00478-6; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1998, MECH DEVELOP, V75, P53, DOI 10.1016/S0925-4773(98)00077-X; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Saga Y, 1996, DEVELOPMENT, V122, P2769; Sparrow DB, 1998, DEVELOPMENT, V125, P2041; Sparrow DB, 2002, INT J DEV BIOL, V46, P365; Takahashi Y, 2003, DEVELOPMENT, V130, P4259, DOI 10.1242/dev.00629; Turnpenny PD, 1999, AM J HUM GENET, V65, P175, DOI 10.1086/302464; Turnpenny PD, 2003, J MED GENET, V40, P333, DOI 10.1136/jmg.40.5.333; Turnpenny Peter D., 2004, P470	18	116	129	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1249	1254		10.1086/421053	http://dx.doi.org/10.1086/421053			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15122512	Green Published, Bronze			2022-12-18	WOS:000221651900017
J	Brzustowicz, LM; Simone, J; Mohseni, P; Hayter, JE; Hodgkinson, KA; Chow, EWC; Bassett, AS				Brzustowicz, LM; Simone, J; Mohseni, P; Hayter, JE; Hodgkinson, KA; Chow, EWC; Bassett, AS			Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; GENETIC INSIGHTS; LOCUS; ANTICIPATION; ASSOCIATION; EXPRESSION; PEDIGREES; PROTEINS; LOCATION; RECEPTOR	Previously, we have reported linkage of markers from chromosome 1q22 to schizophrenia, a finding supported by several independent studies. We have now examined the region of strongest linkage for evidence of linkage disequilibrium (LD) in a sample of 24 Canadian familial-schizophrenia pedigrees. Analysis of 14 microsatellites and 15 single-nucleotide polymorphisms (SNPs) from the 5.4-Mb region between D1S1653 and D1S1677 produced significant evidence (nominal P < .05) of LD between schizophrenia and 2 microsatellites and 6 SNPs. All of the markers exhibiting significant LD to schizophrenia fall within the genomic extent of the gene for carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (CAPON), making it a prime positional candidate for the schizophrenia-susceptibility locus on 1q22, although initial mutation analysis of this gene has not identified any schizophrenia-associated changes within exons. Consistent with several recently identified candidate genes for schizophrenia, CAPON is involved in signal transduction in the NMDA receptor system, highlighting the potential importance of this pathway in the etiology of schizophrenia.	Rutgers State Univ, Dept Genet, Nelson Biol Labs, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ Toronto, Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Brzustowicz, LM (corresponding author), Rutgers State Univ, Dept Genet, Nelson Biol Labs, Room B314,604 Allison Rd, Piscataway, NJ 08854 USA.	brzustowicz@biology.rutgers.edu			NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIMH NIH HHS [R01 MH062440, R01 MH62440] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062440] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Bassett AS, 1997, AM J HUM GENET, V60, P630; Bassett AS, 2001, CAN J PSYCHIAT, V46, P131, DOI 10.1177/070674370104600203; Bassett AS, 2001, SCHIZOPHRENIA BULL, V27, P417, DOI 10.1093/oxfordjournals.schbul.a006884; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 2003, AM J HUM GENET, V73, P183; Brzustowicz LM, 2002, HUM HERED, V54, P199, DOI 10.1159/000070665; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hata Y, 1999, CELL MOL LIFE SCI, V56, P461, DOI 10.1007/s000180050445; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Jaffrey SR, 2002, CHEM BIOL, V9, P1329, DOI 10.1016/S1074-5521(02)00293-4; Jaffrey SR, 2002, P NATL ACAD SCI USA, V99, P3199, DOI 10.1073/pnas.261705799; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Margolis RL, 1999, ARCH GEN PSYCHIAT, V56, P1019, DOI 10.1001/archpsyc.56.11.1019; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rosa A, 2002, AM J MED GENET, V114, P516, DOI 10.1002/ajmg.10526; Sawa A, 2003, MOL MED, V9, P3, DOI 10.1007/BF03402101; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Zornberg GL, 2000, AM J PSYCHIAT, V157, P196, DOI 10.1176/appi.ajp.157.2.196	39	116	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1057	1063		10.1086/420774	http://dx.doi.org/10.1086/420774			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15065015	Bronze, Green Published			2022-12-18	WOS:000220926100024
J	Myers, JS; Vincent, BJ; Udall, H; Watkins, WS; Morrish, TA; Kilroy, GE; Swergold, GD; Henke, J; Henke, L; Moran, JV; Jorde, LB; Batzer, MA				Myers, JS; Vincent, BJ; Udall, H; Watkins, WS; Morrish, TA; Kilroy, GE; Swergold, GD; Henke, J; Henke, L; Moran, JV; Jorde, LB; Batzer, MA			A comprehensive analysis of recently integrated human Ta L1 elements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOMIC DIVERSITY; ALU INSERTION POLYMORPHISMS; GENE CONVERSION; REPETITIVE ELEMENTS; Y-CHROMOSOME; LINE-1 RETROTRANSPOSITION; LINKAGE DISEQUILIBRIUM; TRANSPOSABLE ELEMENT; HUMAN-POPULATION; MOBILE ELEMENTS	The Ta ((t) under bar ranscribed, subset (a) under bar) subfamily of L1 LINEs ((l) under bar ong (i) under bar nterspersed (e) under bar lements) is characterized by a 3-bp ACA sequence in the 3 untranslated region and contains similar to520 members in the human genome. Here, we have extracted 468 Ta L1Hs ((L1) under bar (h) under bar uman (s) under bar pecific) elements from the draft human genomic sequence and screened individual elements using polymerase-chain-reaction (PCR) assays to determine their phylogenetic origin and levels of human genomic diversity. One hundred twenty-four of the elements amenable to complete sequence analysis were full length (similar to6 kb) and have apparently escaped any 5' truncation. Forty-four of these full-length elements have two intact open reading frames and may be capable of retrotransposition. Sequence analysis of the Ta L1 elements showed a low level of nucleotide divergence with an estimated age of 1.99 million years, suggesting that expansion of the L1 Ta subfamily occurred after the divergence of humans and African apes. A total of 262 Ta L1 elements were screened with PCR-based assays to determine their phylogenetic origin and the level of human genomic variation associated with each element. All of the Ta L1 elements analyzed by PCR were absent from the orthologous positions in nonhuman primate genomes, except for a single element (L1HS72) that was also present in the common (Pan troglodytes) and pygmy (P. paniscus) chimpanzee genomes. Sequence analysis revealed that this single exception is the product of a gene conversion event involving an older preexisting L1 element. One hundred fifteen (45%) of the Ta L1 elements were polymorphic with respect to insertion presence or absence and will serve as identical-by-descent markers for the study of human evolution.	Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA 70803 USA; Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Stanley S Scott Canc Ctr,Dept Pathol, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Stanley S Scott Canc Ctr,Dept Genet, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Stanley S Scott Canc Ctr,Dept Biochem, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Stanley S Scott Canc Ctr,Dept Mol Biol, New Orleans, LA USA; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84132 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Columbia Univ, Dept Med, Div Mol Med, New York, NY USA; Inst Blutgrp Forsch, Cologne, Germany	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University	Batzer, MA (corresponding author), Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu		Morrish, Tammy/0000-0002-6725-0253	NCI NIH HHS [R21 CA 87356-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM060518, R01 GM 60518, R01 GM 59290, R01 GM059290] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA087356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060518, R01GM059290] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; AUSABEL FM, 1987, CURRENT PROTOCOLS MO; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BATZER MA, 1991, NUCLEIC ACIDS RES, V19, P3619, DOI 10.1093/nar/19.13.3619; BATZER MA, 1995, J MOL BIOL, V247, P418, DOI 10.1006/jmbi.1994.0150; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Boeke JD, 1999, NATURE, V398, P108, DOI 10.1038/18118; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brookfield JFY, 2001, CURR BIOL, V11, pR900, DOI 10.1016/S0960-9822(01)00547-4; BURTON FH, 1991, MOL BIOL EVOL, V8, P609; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Cost GJ, 2001, NUCLEIC ACIDS RES, V29, P573, DOI 10.1093/nar/29.2.573; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; ENG B, 1994, J FORENSIC SCI, V39, P1356; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FITCH DHA, 1991, P NATL ACAD SCI USA, V88, P7396, DOI 10.1073/pnas.88.16.7396; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HARDIES SC, 1986, MOL BIOL EVOL, V3, P109; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MAEDA N, 1988, MOL BIOL EVOL, V5, P1; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; PERNA NT, 1992, HUM BIOL, V64, P641; Prak ETL, 2000, NAT REV GENET, V1, P134; Rothbarth K, 2001, BBA-GENE STRUCT EXPR, V1518, P271, DOI 10.1016/S0167-4781(01)00198-1; Roy AM, 1999, GENETICA, V107, P149, DOI 10.1023/A:1003941704138; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Roy-Engel AM, 2002, J MOL BIOL, V316, P1033, DOI 10.1006/jmbi.2001.5380; Roy-Engel AM, 2001, GENETICS, V159, P279; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Tremblay A, 2000, MOL CELL BIOL, V20, P54, DOI 10.1128/MCB.20.1.54-60.2000; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891	70	116	118	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					312	326		10.1086/341718	http://dx.doi.org/10.1086/341718			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12070800	Green Published, Bronze			2022-12-18	WOS:000176977700010
J	Demir, E; Sabatelli, P; Allamand, V; Ferreiro, A; Moghadaszadeh, B; Makrelouf, M; Topaloglu, H; Echenne, B; Merlini, L; Guicheney, P				Demir, E; Sabatelli, P; Allamand, V; Ferreiro, A; Moghadaszadeh, B; Makrelouf, M; Topaloglu, H; Echenne, B; Merlini, L; Guicheney, P			Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN-VI DEFICIENCY; AUTOSOMAL-DOMINANT MYOPATHY; BETHLEM MYOPATHY; ALPHA-3 CHAIN; EXTRACELLULAR-MATRIX; LAMININ ALPHA-2-CHAIN; NONSENSE MUTATION; MISSENSE MUTATION; MOSAIC STRUCTURE; INTIMA COLLAGEN	Ullrich congenital muscular dystrophy (UCMD) is an autosomal recessive disorder characterized by generalized muscular weakness, contractures of multiple joints, and distal hyperextensibility. Homozygous and compound heterozygous mutations of COL6A2 on chromosome 21q22 have recently been shown to cause UCMD. We performed a genomewide screening with microsatellite markers in a consanguineous family with three sibs affected with UCMD. Linkage of the disease to chromosome 2q37 was found in this family and in two others. We analyzed COL6A3, which encodes the a 3 chain of collagen VI, and identified one homozygous mutation per family. In family I, the three sibs carried an A G transition in the splice-donor site of intron 29 (6930+5A-->G), leading to the skipping of exon 29, a partial reduction of collagen VI in muscle biopsy, and an intermediate phenotype. In family II, the patient had an unusual mild phenotype, despite a nonsense mutation, R465X, in exon 5. Analysis of the patient's COL6A3 transcripts showed the presence of various mRNA species-one of which lacked several exons, including the exon containing the nonsense mutation. The deleted splice variant encodes collagen molecules that have a shorter N-terminal domain but that may assemble with other chains and retain a functional role. This could explain the mild phenotype of the patient who was still ambulant at age 18 years and who showed an unusual combination of hyperlaxity and finger contractures. In family III, the patient had a nonsense mutation, R2342X, causing absence of collagen VI in muscle and fibroblasts, and a severe phenotype, as has been described in patients with UCMD. Mutations in COL6A3 are described in UCMD for the first time and illustrate the wide spectrum of phenotypes which can be caused by collagen VI deficiency.	Grp Hosp Pitie Salpetriere, INSERM, U523, Inst Myol, F-75651 Paris 13, France; Ist Ortoped Rizzoli, CNR, Ist Citomorfol Normale & Patol, Bologna, Italy; Ist Ortoped Rizzoli, Neuromuscular Unit, Bologna, Italy; Hacettepe Childrens Hosp Med Ctr, Dept Paediat Neurol, Ankara, Turkey; Hop St Eloi, Serv Neuropediat, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Hacettepe University; Universite de Montpellier; CHU de Montpellier	Guicheney, P (corresponding author), Grp Hosp Pitie Salpetriere, INSERM, U523, Inst Myol, 47 Blvd Lhop, F-75651 Paris 13, France.		Allamand, Valerie/M-4333-2017; Ferreiro, Ana/F-5371-2011; Demir, Ercan/CAA-1553-2022; Allamand, Valérie/AAH-6272-2021; TOPALOGLU, HALUK AYDIN/I-9318-2013; Sabatelli, Patrizia/C-7479-2019; Merlini, Luciano/N-6478-2019; Guicheney, Pascale/D-1034-2017	Ferreiro, Ana/0000-0003-2806-5386; Allamand, Valérie/0000-0001-8997-9742; Sabatelli, Patrizia/0000-0003-2345-5094; Merlini, Luciano/0000-0002-1108-1198; Guicheney, Pascale/0000-0002-7663-2050; Moghadaszadeh, Behzad/0000-0001-9787-0106				Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; BONALDO P, 1989, J BIOL CHEM, V264, P20235; Brockington M, 2000, AM J HUM GENET, V66, P428, DOI 10.1086/302775; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; Corman B, 1999, AM J HUM GENET, V64, P126, DOI 10.1086/302206; DEPAILLETTE L, 1989, J NEUROL, V236, P108; Di Blasi C, 2001, BRAIN, V124, P698, DOI 10.1093/brain/124.4.698; Dubowitz V, 1997, NEUROMUSCULAR DISORD, V7, P539; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Guicheney P, 1998, J MED GENET, V35, P211, DOI 10.1136/jmg.35.3.211; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Higuchi I, 2001, ANN NEUROL, V49, P544, DOI 10.1002/ana.109; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; MERLINI L, 1994, NEUROMUSCULAR DISORD, V4, P503, DOI 10.1016/0960-8966(94)90091-4; Merlini L, 1999, NEUROMUSCULAR DISORD, V9, P326, DOI 10.1016/S0960-8966(99)00022-X; Moghadaszadeh B, 1999, NEUROMUSCULAR DISORD, V9, P376, DOI 10.1016/S0960-8966(99)00051-6; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; ODERMATT E, 1983, BIOCHEM J, V211, P295, DOI 10.1042/bj2110295; Pan TC, 1998, HUM HERED, V48, P235, DOI 10.1159/000022808; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Pepe G, 1999, BIOCHEM BIOPH RES CO, V258, P802, DOI 10.1006/bbrc.1999.0680; Pepe G, 1999, NEUROMUSCULAR DISORD, V9, P264, DOI 10.1016/S0960-8966(99)00014-0; RICCI E, 1988, AM J MED GENET, V31, P933, DOI 10.1002/ajmg.1320310428; Ruhl M, 1999, EXP CELL RES, V250, P548, DOI 10.1006/excr.1999.4540; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; STOKES DG, 1991, J BIOL CHEM, V266, P8626; Tillet E, 1997, J BIOL CHEM, V272, P10769; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Tome FMS, 1999, NEUROPEDIATRICS, V30, P55, DOI 10.1055/s-2007-973461; Ullrich O, 1930, Z GESAMTE NEUROL PSY, V126, P171, DOI 10.1007/BF02864097; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Voit T, 1998, BRAIN DEV-JPN, V20, P65, DOI 10.1016/S0387-7604(97)00094-6; VOIT T, 2001, DISORDERS VOLUNTARY, P503; YAMADA H, 1995, LAB INVEST, V72, P715; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082	52	116	122	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1446	1458		10.1086/340608	http://dx.doi.org/10.1086/340608			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992252	Green Published, Bronze			2022-12-18	WOS:000175445700006
J	Smith, MW; Lautenberger, JA; Shin, HD; Chretien, JP; Shrestha, S; Gilbert, DA; O'Brien, SJ				Smith, MW; Lautenberger, JA; Shin, HD; Chretien, JP; Shrestha, S; Gilbert, DA; O'Brien, SJ			Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; ADMIXED POPULATIONS; SUSCEPTIBILITY LOCUS; ETHNIC-DIFFERENCES; DNA-POLYMERASE; DISEASE RISK; GENES; MICROSATELLITES; PROPORTIONS; SELECTION	Population linkage disequilibrium occurs as a consequence of mutation, selection, genetic drift, and population substructure produced by admixture of genetically distinct ethnic populations. African American and Hispanic ethnic groups have a history of significant gene flow among parent groups, which can be of value in affecting genome scans for disease-gene discovery in the case-control and transmission/disequilibrium test designs. Disease-gene discovery using mapping by admixture linkage disequilibrium (MALD) requires a map of polymorphic markers that differentiate between the founding populations, along with differences in disease-gene allele frequencies. We describe markers appropriate for MALD mapping by assessing allele frequencies of 744 short tandem repeats (STRs) in African Americans, Hispanics, European Americans, and Asians, by choosing STR markers that have large differences in composite delta, log-likelihood ratios, and/or I*(2) for MALD. Additional markers can be added to this MALD map by utilization of the rapidly growing single-nucleotide-polymorphism databases and the literature, to achieve a 3-10-cM scanning scale. The map will be useful for studies of diseases, including prostate and breast cancer, diabetes, hypertension, and end-stage renal disease, that have large differences in incidence between the founding populations of either Hispanics or African Americans.	NCI, Intramural Res Support Program, Sci Applicat Int Corp Frederick, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Welsh Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; Celera Genom, Foster City, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Smith, MW (corresponding author), NCI, Intramural Res Support Program, Sci Applicat Int Corp Frederick, POB B,7th St Extens, Frederick, MD 21702 USA.		Smith, Michael/B-5341-2012; OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRISCOE D, 1994, J HERED, V85, P59; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1991, Ethnicity and Disease, V1, P245; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; DEAN M, 1994, AM J HUM GENET, V55, P788; Destro-Bisol G, 1999, HUM GENET, V104, P149, DOI 10.1007/s004390050928; DIGGLE PJ, 1994, OXFORD STAT SCI SERI, V13; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Huttley GA, 1999, GENETICS, V152, P1711; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; Kristensen VN, 2001, BIOTECHNIQUES, V30, P318, DOI 10.2144/01302tt01; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1991, AM J PHYS ANTHROPOL, V84, P141, DOI 10.1002/ajpa.1330840204; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Marsh DG, 1997, NAT GENET, V15, P389; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; O'Brien SJ, 2000, ANNU REV GENET, V34, P563, DOI 10.1146/annurev.genet.34.1.563; OBRIEN SJ, 2000, MEDSCAPE HIV AIDS AN, P19; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paula D, 1999, AM J HUM GENET, V65, P1428; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; STEPHENS JC, 1999, MICROSATELLITES EVOL, P211; Walder K, 2000, INT J OBESITY, V24, P559, DOI 10.1038/sj.ijo.0801197; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	49	116	120	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1080	1094		10.1086/323922	http://dx.doi.org/10.1086/323922			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590548	Bronze, Green Published			2022-12-18	WOS:000171413400016
J	Rebbeck, TR; Walker, AH; Zeigler-Johnson, C; Weisburg, S; Martin, AM; Nathanson, KL; Wein, AJ; Malkowicz, SB				Rebbeck, TR; Walker, AH; Zeigler-Johnson, C; Weisburg, S; Martin, AM; Nathanson, KL; Wein, AJ; Malkowicz, SB			Association of HPC2/ELAC2 genotypes and prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; ANDROGEN RECEPTOR; CHROMOSOME; GENE	HPC2/ELAC2 has been identified as a prostate cancer (CaP) susceptibility gene. Two common missense variants in HPC2/ELAC2 have been identified: a Ser-->Leu change at amino acid 217, and an Ala-->Thr change at amino acid 541. Tavtigian et al. reported that these variants were associated with Cap in a sample of men drawn from families with hereditary Cap. To confirm this report in a sample unselected for family history, we studied 359 incident Cap case subjects and 266 male control subjects that were frequency matched for age and race and were identified from a large health-system population. Among control subjects, the Thr541 frequency was 2.9%, and the Leu217 frequency was 31.6%, with no significant differences in frequency across racial groups. Thr541 was only observed in men who also carried Leu217. The probability of having Cap was increased in men who carried the Leu217/Thr541 variants (odds ratio = 2.37; 95% CI 1.06-5.29). This risk did not differ significantly by family history or race. Genotypes at HPC2/ELAC2 were estimated to cause 5% of Cap in the general population of inference. These results suggest that common variants at HPC2/ELAC2 are associated with Cap risk in a sample unselected for family history or other factors associated with Cap risk.	Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Urol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, 904 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	trebbeck@cceb.med.upenn.edu	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900; Zeigler-Johnson, Charnita/0000-0003-2641-7755; Nathanson, Katherine/0000-0002-6740-0901	NATIONAL CANCER INSTITUTE [R01CA085074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER; NCI NIH HHS [CA85074, R01 CA085074] Funding Source: Medline; NIEHS NIH HHS [ES08031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; Jaffe JM, 2000, CANCER RES, V60, P1626; Lillienfeld A. M., 1980, FDN EPIDEMIOLOGY; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Rebbeck TR, 1999, CANCER EPIDEM BIOMAR, V8, P283; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Tavtigian SV, 2000, AM J HUM GENET, V67, P11; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; WALKER AH, 1999, ENV HLTH PERSPECT, V107, P3; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	15	116	128	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1014	1019		10.1086/303096	http://dx.doi.org/10.1086/303096			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986046	Green Published, Bronze			2022-12-18	WOS:000089651100027
J	Unger, MA; Nathanson, KL; Calzone, K; Antin-Ozerkis, D; Shih, HA; Martin, AM; Lenoir, GM; Mazoyer, S; Weber, BL				Unger, MA; Nathanson, KL; Calzone, K; Antin-Ozerkis, D; Shih, HA; Martin, AM; Lenoir, GM; Mazoyer, S; Weber, BL			Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MUTATIONS; GENETIC-HETEROGENEITY; ADENOMATOUS POLYPOSIS; APC GENE; DELETIONS; KB; PENETRANCE; FREQUENCY; REGION	The frequency of genomic rearrangements in BRCA1 was assessed in 42 American families with breast and ovarian cancer who were seeking genetic testing and who were subsequently found to be negative for BRCA1 and BRCA2 coding-region mutations. An affected individual from each family was tested by PCR for the exon 13 duplication (Puget et al. 1999a) and by Southern blot analysis for novel genomic rearrangements. The exon 13 duplication was detected in one family, and four families had other genomic rearrangements. A total of 5 (11.9%) of the 42 families with breast/ovarian cancer who did not have BRCA1 and BRCA2 coding-region mutations had mutations in BRCA1 that were missed by conformation-sensitive gel electrophoresis or sequencing. Four of five families with BRCA1 genomic rearrangements included at least one individual with both breast and ovarian cancer; therefore, 4 (30.8%) of 13 families with a case of multiple primary breast and ovarian cancer had a genomic rearrangement in BRCA1. Families with genomic rearrangements had prior probabilities of having a BRCA1 mutation, ranging from 33% to 97% (mean 70%) (Couch et al. 1997). In contrast, in families without rearrangements, prior probabilities of having a BRCA1 mutation ranged from 7% to 92% (mean 37%). Thus, the prior probability of detecting a BRCA1 mutation may be a useful predictor when considering the use of Southern blot analysis for families with breast/ovarian cancer who do not have detectable coding-region mutations.	Univ Penn, Ctr Canc, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; UCBL, UMR CNRS 5641, Genet Lab, Lyon, France	University of Pennsylvania; University of Pennsylvania; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Weber, BL (corresponding author), Univ Penn, Ctr Canc, Sch Med, Dept Med, 316-A BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Mazoyer, Sylvie/N-7559-2017; Shih, Helen A/O-7653-2017	Shih, Helen A/0000-0003-1550-9726; Nathanson, Katherine/0000-0002-6740-0901; Calzone, Kathleen/0000-0002-2354-6810; Mazoyer, Sylvie/0000-0002-2135-0160	NCI NIH HHS [R01CA76417-03, R01 CA076417] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076417] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown MA, 1996, ONCOGENE, V12, P2507; CHEN SJ, 1989, NUCLEIC ACIDS RES, V17, P7631, DOI 10.1093/nar/17.19.7631; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Giarola M, 1999, HUM MUTAT, V13, P116, DOI 10.1002/(SICI)1098-1004(1999)13:2<116::AID-HUMU3>3.0.CO;2-2; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Mazoyer S, 2000, AM J HUM GENET, V67, P207, DOI 10.1086/302974; Montagna M, 1999, ONCOGENE, V18, P4160, DOI 10.1038/sj.onc.1202754; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; NAROD SA, 1995, AM J HUM GENET, V56, P254; Nordling M, 1998, CANCER RES, V58, P1372; Peelen T, 2000, BRIT J CANCER, V82, P151, DOI 10.1054/bjoc.1999.0892; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Puget N, 1997, CANCER RES, V57, P828; Puget N, 1999, CANCER RES, V59, P455; Rohlfs EM, 2000, GENE CHROMOSOME CANC, V28, P300, DOI 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1; Sambrook J., 1989, MOL CLONING, pA1; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; vanderLuijt RB, 1997, HUM MUTAT, V9, P7, DOI 10.1002/(SICI)1098-1004(1997)9:1<7::AID-HUMU2>3.0.CO;2-8; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659	28	116	118	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					841	850		10.1086/303076	http://dx.doi.org/10.1086/303076			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10978226	Green Published, Bronze			2022-12-18	WOS:000089651100008
J	Abney, M; McPeek, MS; Ober, C				Abney, M; McPeek, MS; Ober, C			Estimation of variance components of quantitative traits in inbred populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; PEDIGREES; HUMANS; MODEL	Use of variance-component estimation for mapping of quantitative-trait loci in humans is a subject of great current interest. When only trait values, not genotypic information, are considered, variance-component estimation can also be used to estimate heritability of a quantitative trait. Inbred pedigrees present special challenges for variance-component estimation. First, there are more variance components to be estimated in the inbred case, even for a relatively simple model including additive, dominance, and environmental effects. Second, more identity coefficients need to be calculated from an inbred pedigree in order to perform the estimation, and these are computationally more difficult to obtain in the inbred than in the outbred case. As a result, inbreeding effects have generally been ignored in practice. We describe here the calculation of identity coefficients and estimation of variance components of quantitative traits in large inbred pedigrees, using the example of HDL in the Hutterites. We use a multivariate normal model for the genetic effects, extending the central-limit theorem of Lange to allow for both inbreeding and dominance under the assumptions of our variance-component model. We use simulated examples to give an indication of under what conditions one has the power to detect the additional variance components and to examine their impact on variance-component estimation. We discuss the implications for mapping and heritability estimation by use of variance components in inbred populations.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Abney, M (corresponding author), Univ Chicago, Dept Human Genet, 924 E 57th St,R-102, Chicago, IL 60637 USA.	abney@genetics.uchicago.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049596, P50HL056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001645, R01HG001645] Funding Source: NIH RePORTER; NHGRI NIH HHS [R29 HG001645, HG01645, R01 HG001645] Funding Source: Medline; NHLBI NIH HHS [P50 HL056399, HL56399, U01 HL049596] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, 2 INT S INF THEOR; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; BARRAI I, 1964, HEREDITY, V19, P651, DOI 10.1038/hdy.1964.76; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Bleibtreu H., 1964, THESIS HARVARD U CAM; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; CORBEIL RR, 1976, BIOMETRICS, V32, P779, DOI 10.2307/2529264; Cotterman C.W., 1940, THESIS OHIO STATE U; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEBOER IJM, 1993, THEOR APPL GENET, V86, P245, DOI 10.1007/BF00222086; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GILLOIS M, 1965, ANN I H POINCARE B, V2, P1; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HARRIS DL, 1964, GENETICS, V50, P1319; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Hofer A, 1998, J ANIM BREED GENET, V115, P247, DOI 10.1111/j.1439-0388.1998.tb00347.x; Hostetler J, 1974, HUTTERITE SOC; Jacquard A., 1974, GENETIC STRUCTURE PO; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KULLBACK S, 1959, INFORMATION THEORY S; LANGE K, 1978, J MATH BIOL, V6, P59, DOI 10.1007/BF02478517; Lange K., 1997, MATH STAT METHODS GE; Lynch M, 1998, GENETICS ANAL QUANTI; MANGE AP, 1964, HUM BIOL, V36, P104; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; MCCULLOCH RE, 1988, AM STAT, V42, P73, DOI 10.2307/2685266; MORTON NE, 1974, AM J HUM GENET, V26, P489; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; OBRIEN E, 1987, MAMMALIAN DISPERSAL, P193; OREY S, 1958, DUKE MATH J, V25, P543, DOI 10.1215/S0012-7094-58-02548-1; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Searle SR, 1992, VARIANCE COMPONENTS; Shaw FH, 1999, GENET SEL EVOL, V31, P43, DOI 10.1051/gse:19990103; Shaw RG, 1998, GENETICS, V150, P1649; Weinberg W., 1908, Z INDUKTIVE ABSTAMMU, V1, P377, DOI [10.1007/BF01990605, DOI 10.1007/BF01990605]; [No title captured]	47	116	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					629	650		10.1086/302759	http://dx.doi.org/10.1086/302759			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677322	Green Published, Bronze			2022-12-18	WOS:000088373100029
J	Jackson, AP; McHale, DP; Campbell, DA; Jafri, H; Rashid, Y; Mannan, J; Karbani, G; Corry, P; Levene, MI; Mueller, RF; Markham, AF; Lench, NJ; Woods, CG				Jackson, AP; McHale, DP; Campbell, DA; Jafri, H; Rashid, Y; Mannan, J; Karbani, G; Corry, P; Levene, MI; Mueller, RF; Markham, AF; Lench, NJ; Woods, CG			Primary autosomal recessive microcephaly (MCPH1) maps to chromosome 8p22-pter	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; DROSOPHILA; TRAITS; GENE	Primary (or "true") microcephaly is inherited as an autosomal recessive trait and is thought to be genetically heterogeneous. Using autozygosity mapping, we have identified a genetic locus (MCPH1) for primary microcephaly, at chromosome 8p22-pter, in two consanguineous families of Pakistani origin. Our results indicate that the gene lies within a 13-cM region between the markers D8S1824 and D8S1825 (maximum multipoint LOD score of 8.1 at D8S277). In addition, we have demonstrated the genetic heterogeneity of this condition by analyzing a total of nine consanguineous families with primary microcephaly.	Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; Gen Infirm, Dept Paediat, Leeds, W Yorkshire, England; Fatima Jinnah Med Coll, Lahore, Pakistan; Rawalpindi Med Coll, Rawalpindi, Pakistan; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; Leeds General Infirmary; National University of Sciences & Technology - Pakistan; Rawalpindi Medical College	Jackson, AP (corresponding author), Univ Leeds, St James Hosp, Mol Med Unit, Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	medapj@leeds.ac.uk	Lench, Nicholas/AAB-1791-2021; woods, christopher g/A-1361-2010; Jackson, Andrew P/D-3442-2009	Jackson, Andrew P/0000-0002-8739-2646; Lench, Nicholas/0000-0002-6108-0759	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXIOU M, 1992, DEVELOPMENT, V114, P185; Baraitser B, 1990, GENETICS NEUROLOGICA, V18, P26; BUNDEY S, 1992, GENETICS NEUROLOGY G, P20; CHERBAS L, 1986, J MOL BIOL, V189, P617, DOI 10.1016/0022-2836(86)90492-4; COWIE V, 1960, J MENT DEFIC RES, V4, P42; FUJII T, 1955, AM J HUM GENET, V7, P72; JAFFE M, 1987, DEV MED CHILD NEUROL, V29, P187; KOMAI T, 1955, AM J HUM GENET, V7, P51; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MINET M, 1990, CURR GENET, V18, P287, DOI 10.1007/BF00318209; QAZI QH, 1973, CLIN GENET, V4, P46; Ross JJ, 1977, HDB CLIN NEUROLOGY, V30, P507; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TOLMIE J, 1996, EMERY RIMOINS PRINCI, V2, P2145; TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311; VANDENBOSCH J, 1958, ANN HUM GENET, V23, P91; WOOD JW, 1967, PEDIATRICS, V39, P385	21	116	119	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					541	546		10.1086/301966	http://dx.doi.org/10.1086/301966			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683597	Green Published, Bronze			2022-12-18	WOS:000075360800030
J	Buiting, K; Dittrich, B; Gross, S; Lich, C; Farber, C; Buchholz, T; Smith, E; Reis, A; Burger, J; Nothen, MM; Barth-Witte, U; Janssen, B; Abeliovich, D; Lerer, I; van den Ouweland, AMW; Halley, DJJ; Schrander-Stumpel, C; Smeets, H; Meinecke, P; Malcolm, S; Gardner, A; Lalande, M; Nicholls, RD; Friend, K; Schulze, A; Matthijs, G; Kokkonen, H; Hilbert, P; Van Maldergem, L; Glover, G; Carbonell, P; Willems, P; Gillessen-Kaesbach, G; Horsthemke, B				Buiting, K; Dittrich, B; Gross, S; Lich, C; Farber, C; Buchholz, T; Smith, E; Reis, A; Burger, J; Nothen, MM; Barth-Witte, U; Janssen, B; Abeliovich, D; Lerer, I; van den Ouweland, AMW; Halley, DJJ; Schrander-Stumpel, C; Smeets, H; Meinecke, P; Malcolm, S; Gardner, A; Lalande, M; Nicholls, RD; Friend, K; Schulze, A; Matthijs, G; Kokkonen, H; Hilbert, P; Van Maldergem, L; Glover, G; Carbonell, P; Willems, P; Gillessen-Kaesbach, G; Horsthemke, B			Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: Implications for imprint-switch models, genetic counseling, and prenatal diagnosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; HUMAN SNRPN GENE; DNA METHYLATION; CHROMOSOME 15Q11-Q13; MOLECULAR DIAGNOSIS; FAMILIAL ANGELMAN; CRITICAL REGION; EXPRESSED GENE; LINKAGE MAP; HUMAN-CHROMOSOME-15	The Prader-Willi syndrome (PWS) and the Angelman syndrome (AS) are caused by the loss of function of imprinted genes in proximal 15q. In similar to 2%-4% of patients, this loss of function is due to an imprinting defect. In some cases, the imprinting defect is the result of a parental imprint-switch failure caused by a microdeletion of the imprinting center (IC). Here we describe the molecular analysis of 13 PWS patients and 17 AS patients who have an imprinting defect but no IC deletion. Heteroduplex and partial sequence analysis did not reveal any point mutations of the known IC elements, either. Interestingly, all of these patients represent sporadic cases, and some share the paternal (PWS) or the maternal (AS) 15q11-q13 haplotype with an unaffected sib. In each of five PWS patients informative for the grandparental origin of the incorrectly imprinted chromosome region and four cases described elsewhere, the maternally imprinted paternal chromosome region was inherited from the paternal grandmother. This suggests that the grandmaternal imprint was not erased in the father's germ line. In seven informative AS patients reported here and in three previously reported patients, the paternally imprinted maternal chromosome region was inherited from either the maternal grandfather or the maternal grandmother. The latter finding is not compatible with an imprint-switch failure, but it suggests that a paternal imprint developed either in the maternal germ line or postzygotically. We conclude (1) that the incorrect imprint in non-IC-deletion cases is the result of a spontaneous prezygotic or postzygotic error, (2) that these cases have a low recurrence risk, and (3) that the paternal imprint may be the default imprint.	Univ Essen Gesamthsch Klinikum, Inst Humangenet, D-45122 Essen, Germany; New Childrens Hosp, Sydney, NSW, Australia; Humboldt Univ, Inst Humangenet, Berlin, Germany; Univ Bonn, Inst Humangenet, D-5300 Bonn, Germany; Inst Humangenet, Heidelberg, Germany; Hadassah Univ Hosp, Dept Genet, IL-91120 Jerusalem, Israel; Erasmus Univ Hosp, Dept Clin Genet, Rotterdam, Netherlands; Maastricht Univ, Dept Mol Genet & Cell Biol, Maastricht, Netherlands; Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; Inst Child Hlth, London, England; Southmead Hosp, Reg Cytogenet Ctr, Bristol, Avon, England; Harvard Univ, Inst Med, Div Genet, Boston, MA 02115 USA; HHMI, Boston, MA USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Womens & Childrens Hosp, Ctr Med Genet, Adelaide, SA, Australia; John F Kennedy Inst, DK-2600 Glostrup, Denmark; Univ Louvain, Ctr Human Genet, Louvain, Belgium; Oulu Univ, Cent Hosp, Dept Clin Genet, SF-90220 Oulu, Finland; Ctr Human Genet, Loverval, Belgium; Ctr Bioquim & Genet Clin, Murcia, Spain; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	University of Duisburg Essen; University of Sydney; Humboldt University of Berlin; University of Bonn; Hebrew University of Jerusalem; Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Southmead Hospital; Harvard University; Howard Hughes Medical Institute; Case Western Reserve University; Womens & Childrens Hospital Australia; University of Oulu; University of Antwerp	Horsthemke, B (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Humangenet, Hufelandstr 55, D-45122 Essen, Germany.		Stöger, Claudia/M-9860-2014; Reis, André/D-2309-2009; Nöthen, Markus/B-2027-2009; Van Maldergem, Lionel/O-3242-2019; Carbonell, Pablo/I-4111-2015; Van Maldergem, Lionel/G-9849-2017	Stöger, Claudia/0000-0001-8361-0274; Reis, André/0000-0002-6301-6363; Nöthen, Markus/0000-0002-8770-2464; Van Maldergem, Lionel/0000-0001-8880-5214; Carbonell, Pablo/0000-0002-3861-9883; Van Maldergem, Lionel/0000-0001-8880-5214; Matthijs, Gert/0000-0001-6710-1912				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; Beuten J, 1996, HUM GENET, V97, P294, DOI 10.1007/BF02185757; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BUITING K, 1994, HUM MOL GENET, V3, P893, DOI 10.1093/hmg/3.6.893; Burger J, 1997, AM J HUM GENET, V61, P88, DOI 10.1086/513900; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DITTRICH B, 1992, HUM GENET, V90, P313; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; FergusonSmith AC, 1996, NAT GENET, V14, P119, DOI 10.1038/ng1096-119; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; Glatt Karen A., 1992, Human Molecular Genetics, V1, P348, DOI 10.1093/hmg/1.5.348; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Glenn CC, 1996, AM J HUM GENET, V58, P335; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kosaki K, 1997, AM J MED GENET, V73, P308; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Kubota T, 1996, J MED GENET, V33, P1011, DOI 10.1136/jmg.33.12.1011; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; LINDEMAN R, 1991, NUCLEIC ACIDS RES, V19, P5449, DOI 10.1093/nar/19.19.5449-a; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Lyko F, 1998, P NATL ACAD SCI USA, V95, P1698, DOI 10.1073/pnas.95.4.1698; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P195, DOI 10.1093/nar/19.1.195; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schuffenhauer S, 1996, HUM MUTAT, V8, P288, DOI 10.1002/(SICI)1098-1004(1996)8:3<288::AID-HUMU18>3.0.CO;2-Z; Schulze A, 1997, ACTA PAEDIATR, V86, P906; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Teshima I, 1996, Am J Med Genet, V62, P217; Trent R. J., 1995, American Journal of Human Genetics, V57, pA272; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Zeschnigk M, 1997, EUR J HUM GENET, V5, P94, DOI 10.1159/000484740	50	116	118	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					170	180		10.1086/301935	http://dx.doi.org/10.1086/301935			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634532	Bronze, Green Published			2022-12-18	WOS:000074761000025
J	Peral, B; SanMillan, JL; Ong, ACM; Gamble, V; Ward, CJ; Strong, C; Harris, PC				Peral, B; SanMillan, JL; Ong, ACM; Gamble, V; Ward, CJ; Strong, C; Harris, PC			Screening the 3' region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATIONS; LOCALIZATION; MARKER; LOCUS; SSCP	Recently, the gene for the most common form of autosomal dominant polycystic kidney disease (ADPKD), PKD1 (polycystic kidney disease 1), has been fully characterized and shown to encode an integral membrane protein, polycystin, involved in cell-cell and/or cell-matrix interactions. Study of the PKD1 gene has been complicated because most of the gene lies in a genomic region reiterated several times elsewhere on the same chromosome, and consequently only seven mutations have been described so far. Here we report a systematic screen covering similar to 80% of the similar to 2.75 kb of translated transcript that is encoded by single-copy DNA. We have identified and characterized six novel mutations that, together with the previously described changes, amount to a detection rate of 10%-15% in the population studied. The newly described mutations are two deletions, an insertion of a T-nucleotide causing a frameshift, two single-base-pair substitutions resulting in premature stop codons, and a G-->C transversion that may be a missense mutation. These results have important implications for genetic diagnosis of PKD1 because they indicate that the majority of mutations lie within the duplicated area, which is difficult to study. The regions of polycystin removed in each mutation so far described are assessed for their functional significance; an area disrupted by two new small in-frame changes is highlighted. PKD1 mutations are contrasted with those in the PKD1/TSC2 contiguous-gene syndrome, and the likely mutational mechanism in PKD1 is considered.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,RENAL UNIT,OXFORD OX3 7LJ,ENGLAND	University of Oxford; University of Oxford			San-Millán, José L./F-9944-2015; Peral, Belén/F-4562-2015; Ong, Albert/AAN-9430-2021	Peral, Belén/0000-0003-4984-4020; Ong, Albert/0000-0002-7211-5400	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1994, CELL, V77, P881; [Anonymous], 1995, CELL, V81, P289; BOGDANOVA N, 1995, HUM GENET, V95, P645; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; DODE C, 1990, BRIT J HAEMATOL, V76, P275, DOI 10.1111/j.1365-2141.1990.tb07884.x; FICK GM, 1993, J AM SOC NEPHROL, V3, P1863; FICK GM, 1994, KIDNEY INT, V45, P1153, DOI 10.1038/ki.1994.153; GABOW PA, 1991, KIDNEY INT, V40, P989, DOI 10.1038/ki.1991.306; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; GAUSSEM P, 1994, THROMB HAEMOSTASIS, V71, P748; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HAUBENWALLNER S, 1993, GENOMICS, V18, P392, DOI 10.1006/geno.1993.1481; HAUGHES J, 1995, NAT GENET, V10, P151; IAKOUBOVA OA, 1995, GENOMICS, V26, P107, DOI 10.1016/0888-7543(95)80088-4; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MILUTINOVIC J, 1992, AM J KIDNEY DIS, V19, P465, DOI 10.1016/S0272-6386(12)80956-5; NELLIST M, 1993, J MED GENET, V30, P224, DOI 10.1136/jmg.30.3.224; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; PERAL B, 1994, AM J HUM GENET, V54, P899; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; RYYNANEN M, 1987, J MED GENET, V24, P462, DOI 10.1136/jmg.24.8.462; SNAREY A, 1994, AM J HUM GENET, V55, P365; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583	36	116	124	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					86	96						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554072				2022-12-18	WOS:A1996TL69700012
J	KREMER, B; ALMQVIST, E; THEILMANN, J; SPENCE, N; TELENIUS, H; GOLDBERG, YP; HAYDEN, MR				KREMER, B; ALMQVIST, E; THEILMANN, J; SPENCE, N; TELENIUS, H; GOLDBERG, YP; HAYDEN, MR			SEX-DEPENDENT MECHANISMS FOR EXPANSIONS AND CONTRACTIONS OF THE CAG REPEAT ON AFFECTED HUNTINGTON DISEASE CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT; MOLECULAR ANALYSIS; (CAG)(N) REPEAT; LENGTH; ONSET; INSTABILITY; AGE	A total of 254 affected parent-child pairs with Huntington disease (HD) and 440 parent-child pairs with CAG size in the normal range were assessed to determine the nature and frequency of intergenerational CAG changes in the HD gene. Intergenerational CAG changes are extremely rare (3/440 [0.68%]) on normal chromosomes. In contrast, on HD chromosomes, changes in CAG size occur in similar to 70% of meioses on HD chromosomes, with expansions accounting for 73% of these changes. These intergenerational CAG changes make a significant but minor contribution to changes in age at onset (r(2) = .19). The size of the CAG repeat influenced larger intergenerational expansions (>7 CAG repeats), but the likelihood of smaller expansions or contractions was not influenced by CAG size, Large expansions (>7 CAG repeats) occur almost exclusively through paternal transmission (0.96%; P < 10(-7)), while offspring of affected mothers are more likely to show no change (P = .01) or contractions in CAG size (P = .002). This study demonstrates that sex of the transmitting parent is the major determinant for CAG intergenerational changes in the HD gene. Similar paternal sex effects are seen in the evolution of new mutations for HD from intermediate alleles and for large expansions on affected chromosomes. Affected mothers almost never transmit a significantly expanded CAG repeat, despite the fact that many have similar large-sized alleles, compared with affected fathers. The sex-dependent effects of major expansion and contractions of the CAG repeat in the HD gene implicate different effects of gametogenesis, in males versus females, on intergenerational CAG repeat stability.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; ACAD HOSP,DEPT NEUROL,NIJMEGEN,NETHERLANDS; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT GERIATR MED,S-14186 HUDDINGE,SWEDEN; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT MOLEC MED,S-14186 HUDDINGE,SWEDEN	University of British Columbia; Karolinska Institutet; Karolinska Institutet			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				ALMQVIST E, 1995, HUM MOL GENET, V4, P207, DOI 10.1093/hmg/4.2.207; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KREMER B, 1993, J MED GENET, V30, P991, DOI 10.1136/jmg.30.12.991; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063; 1993, CELL, V72, P971	22	116	120	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					343	350						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668260				2022-12-18	WOS:A1995RL77100017
J	LIU, AW; DELGADOESCUETA, AV; SERRATOSA, JM; ALONSO, ME; MEDINA, MT; GEE, MN; CORDOVA, S; ZHAO, HZ; SPELLMAN, JM; PEEK, JRR; DONNADIEU, FR; SPARKES, RS				LIU, AW; DELGADOESCUETA, AV; SERRATOSA, JM; ALONSO, ME; MEDINA, MT; GEE, MN; CORDOVA, S; ZHAO, HZ; SPELLMAN, JM; PEEK, JRR; DONNADIEU, FR; SPARKES, RS			JUVENILE MYOCLONIC EPILEPSY LOCUS IN CHROMOSOME 6P21.2-P11 - LINKAGE TO CONVULSIONS AND ELECTROENCEPHALOGRAPHY TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; NORMAL-CHILDREN; HLA REGION; FAMILIES	Despite affecting 4 million Americans and 100-200 million persons worldwide, the precise molecular mechanisms of human epilepsies remain unknown. Juvenile myoclonic epilepsy (JME) is the most frequent and, hence, most important form of hereditary grand mal epilepsy. In this epilepsy, electroencephalographic (EEG) 15-30-Hz multispikes produce myoclonic and tonic-clonic convulsions beginning at 8-20 years of age. Moreover, EEG 3.5-6-Hz multispike wave complexes appear in clinically asymptomatic family members. We first studied 38 members of a four-generation LA-Belize family with classical JME but with no pyknoleptic absences. Five living members had JME; four clinically asymptomatic members had EEG multispike wave complexes. Pairwise analysis tightly linked microsatellites centromeric to HLA, namely D6S272 (peak lod score [Z(max)] = 3.564-3.560 at male-female recombination [theta(m=f)] = 0.001) and D6S257 (Z(max) = 3.672-3.6667 at theta(m=f) = 0.001), spanning 7 cM, to convulsive seizures and EEG multispike wave complexes. A recombination between D6S276 and D6S273 in one affected member placed the JME locus within or below HLA. Pairwise, multipoint, and recombination analyses in this large family independently proved that a JME gene is located in chromosome 6p, centromeric to HLA. We next screened, with the same chromosome 6p21.2-p11 short tandem-repeat polymorphic markers, seven multiplex pedigrees with classic JME, When led scores for small multiplex families are added to led scores of the LA-Belize pedigree, Z(max) values for D6S294 and D6S257 are >7 (theta(m=f) = .000). Our results prove that in chromosome 6p21.2-p11 an epilepsy locus exists whose phenotype consists of classic JME with convulsions and/or EEG rapid multispike wave complexes.	W LOS ANGELES VET AFFAIRS MED CTR,VET AFFAIRS SW REG EPILEPSY CTR,NEUROL SERV,LOS ANGELES,CA 90073; W LOS ANGELES VET AFFAIRS MED CTR,VET AFFAIRS SW REG EPILEPSY CTR,RES SERV,LOS ANGELES,CA 90073; UNIV CALIF LOS ANGELES,DEPT NEUROL,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,CALIF COMPREHENS EPILEPSY PROGRAM,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA; NATL AUTONOMOUS UNIV,TEGUCIGALPA,HONDURAS; NATL INST NEUROL & NEUROSURG,MEXICO CITY,DF,MEXICO	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universidad Nacional Autonoma de Honduras				Medina, Marco Tulio/0000-0003-0469-054X; Serratosa, Jose/0000-0003-2239-8948; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908] Funding Source: NIH RePORTER; NINDS NIH HHS [5P01 NS21908] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CAVAZZUTI GB, 1980, EPILEPSIA, V21, P43, DOI 10.1111/j.1528-1157.1980.tb04043.x; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; DELGADOESCUETA AV, 1983, NEW ENGL J MED, V308, P1508, DOI 10.1056/NEJM198306233082506; DELGADOESCUETA AV, 1994, EPILEPSIA S1, V35, P29; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V2, P375, DOI 10.1055/s-0028-1091791; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GREENBERG DA, 1993, EPILEPSIA, V34, pS12; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUSER WA, 1993, EPILEPSY FREQUENCY C, P1; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LANGE K, 1991, AM J HUM GENET, V49, P1320; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu A. W., 1992, Epilepsia, V33, P73; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PERBAL B, 1988, PRACTICAL GUIDE MOL, P73; REES M, 1992, 1ST INT WORKSH CHROM, V6; RISCH N, 1991, AM J HUM GENET, V48, P1058; TEMKIN O, 1971, FALLING SICKNESS HIS, P4; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WEISSENBACH J, 1992, NATURE, V53, P794; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; Wolf Peter, 1992, P307; ZIVIN L, 1968, BRAIN, V91, P751, DOI 10.1093/brain/91.4.751; 1989, EPILEPSIA, V3, P389; [No title captured]	31	116	118	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					368	381						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668263				2022-12-18	WOS:A1995RL77100020
J	ZHONG, N; YANG, WH; DOBKIN, C; BROWN, WT				ZHONG, N; YANG, WH; DOBKIN, C; BROWN, WT			FRAGILE-X GENE INSTABILITY - ANCHORING AGGS AND LINKED MICROSATELLITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGG-REPEAT; LINKAGE DISEQUILIBRIUM; FOUNDER CHROMOSOMES; CAG REPEAT; DNA; MUTATIONS; IDENTIFICATION; POLYMORPHISM; POPULATIONS; EXPANSION	Interspersed AGGs within the FMR1 gene CGG repeat region may anchor the sequence and prevent slippage during replication. In order to detect the AGG position variations, we developed a method employing partial MnlI restriction analysis and analyzed X chromosomes from 187 males, including 133 normal controls (117 with 20-34 and 16 with 35-52 repeats), plus 54 fragile X premutations with 56-180 repeats. Among controls, the interspersed AGG positions were highly polymorphic, with a heterozygosity of 91%. Among the control samples, 1.5% had no AGG positions, 25% had one, 71% had two, and 3% had three. Among the fragile X premutation samples, 63% had no AGG, while 37% had only one AGG. Analysis of premutation samples within fragile X families showed that variation occurred only within the 3' end of the region. Thus, the instability was polar. Controls with greater than or equal to 15 pure CGG repeats were associated with the longest alleles of two nearby microsatellites, FRAXAC1 with 20-21 repeats and DXS548 with 202-206 bp and with increased microsatellite heterozygosity. The association of long pure CGG regions, as with fragile X chromosomes, with the longer and more heterozygous microsatellite alleles suggests they may be related mechanistically. Further, our results do not support a recent suggestion that the frequency of fragile X alleles may be increasing. Finally, analysis of a set of nonhuman primate samples showed that long pure CGG tracks are variable in size and are located within the 3' region, which suggests that polar instability within FMR1 is evolutionarily quite old.	NEW YORK STATE INST BASIC RES DEV DISABIL,DEPT HUMAN GENET,STATEN ISL,NY 10314	Institute for Basic Research in Developmental Disabilities			Brown, William/GXN-2777-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029407] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29407] Funding Source: Medline; PHS HHS [MCJ360587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brown W T, 1992, Mol Genet Med, V2, P39; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEKA R, 1992, AM J HUM GENET, V51, P1325; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; HORNSTRA IK, 1993, HUM MOL GENET, V1, P571; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Oudet C., 1993, European Journal of Human Genetics, V1, P181; OUDET C, 1993, AM J HUM GENET, V52, P297; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PIERETTI M, 1991, CELL, V66, P1; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; RICHARDS RJ, 1994, AM J MED GENET, V51, P412, DOI 10.1002/ajmg.1320510422; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; SMITS APT, 1993, J MED GENET, V30, P94, DOI 10.1136/jmg.30.2.94; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; VANDENOUWELAND AMW, 1994, HUM MOL GENET, V3, P1823, DOI 10.1093/hmg/3.10.1823; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248; ZHONG N, 1994, AM J MED GENET, V51, P405, DOI 10.1002/ajmg.1320510421; ZHONG N, 1994, AM J MED GENET, V51, P417, DOI 10.1002/ajmg.1320510423; 1993, CELL, V72, P971	51	116	119	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					351	361						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668261				2022-12-18	WOS:A1995RL77100018
J	TAMBOR, ES; BERNHARDT, BA; CHASE, GA; FADEN, RR; GELLER, G; HOFMAN, KJ; HOLTZMAN, NA				TAMBOR, ES; BERNHARDT, BA; CHASE, GA; FADEN, RR; GELLER, G; HOFMAN, KJ; HOLTZMAN, NA			OFFERING CYSTIC-FIBROSIS CARRIER SCREENING TO AN HMO POPULATION - FACTORS ASSOCIATED WITH UTILIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; GENE; ATTITUDES; CARE	We offered cystic fibrosis (CF) carrier testing to reproductive-age enrollees in an HMO, in order to determine factors associated with test utilization in a primarily nonpregnant population. Male and female enrollees either were mailed an invitation to have the test after attending an educational session (N = 2,713) or were approached in waiting rooms at the HMO sites and given the opportunity to have the test without making an additional visit (N = 608). Uptake was considerably higher when testing could be obtained without making an additional visit (23.5%) than when attendance at an educational session was required as a prerequisite for having the test (3.7%). Utilization was higher among respondents who were planning children, Caucasians, and those with higher educational attainment. Among respondents planning to have children, individuals with higher tolerance for test uncertainty, lower fear of stigma, and higher perceived risk of being a carrier were significantly more likely to have the test. Testing decisions were not associated with the perceived burden of a child with CF or with the likelihood of aborting for CF. Although utilization of CF carrier testing is relatively low among nonpregnant individuals, uptake is significantly higher when testing can be obtained with minimal effort. Factors associated with the decision to be tested had more to do with implications of being a carrier per se than with the concerns of having a child with CF.	JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH PUBL HLTH,BALTIMORE,MD	Johns Hopkins University; Johns Hopkins University				HOFMAN, KAREN/0000-0001-9512-7220	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000481] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG00481] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bannerman, 1982, CLIN GENETICS PROBLE, P107; Becker M H, 1975, J Community Health, V1, P3, DOI 10.1007/BF01318939; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; Bernhardt B A, 1993, J Genet Couns, V2, P69, DOI 10.1007/BF00962540; BOTKIN JR, 1992, AM J PUBLIC HEALTH, V82, P723, DOI 10.2105/AJPH.82.5.723; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; EKWO EE, 1987, AM J MED GENET, V28, P955, DOI 10.1002/ajmg.1320280422; GELLER G, 1993, MED CARE, V31, P989, DOI 10.1097/00005650-199311000-00002; GOLDSTEIN MS, 1977, SOC SCI MED, V11, P515, DOI 10.1016/0037-7856(77)90030-0; KABACK MM, 1974, ETHICAL SOCIAL LEGAL, V10, P145; KASS NE, 1992, HASTINGS CENT REP, V22, P6, DOI 10.2307/3562940; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MYERS MF, 1994, AM J HUM GENET, V54, P719; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; VALVERDE K, 1990, AM J HUM GENET S, V47, pA125; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; WILFOND BS, 1992, MILBANK Q, V70, P629, DOI 10.2307/3350214; WILLIAMSON R, 1989, PRENATAL DIAG, V9, P727, DOI 10.1002/pd.1970091008; 1990, NEW ENGL J MED, V323, P70; 1992, CYSTIC FIBROSIS DNA; 1990, AM J HUM GENET, V46, P393; 1992, AM J HUM GENET, V51, P1443	23	116	116	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					626	637						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	PJ027	7942840				2022-12-18	WOS:A1994PJ02700004
J	CHOMYN, A; LAI, ST; SHAKELEY, R; BRESOLIN, N; SCARLATO, G; ATTARDI, G				CHOMYN, A; LAI, ST; SHAKELEY, R; BRESOLIN, N; SCARLATO, G; ATTARDI, G			PLATELET-MEDIATED TRANSFORMATION OF MTDNA-LESS HUMAN-CELLS - ANALYSIS OF PHENOTYPIC VARIABILITY AMONG CLONES FROM NORMAL INDIVIDUALS - AND COMPLEMENTATION BEHAVIOR OF THE TRNA(LYS) MUTATION CAUSING MYOCLONIC EPILEPSY AND RAGGED-RED FIBERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL PROTEIN-SYNTHESIS; PARKINSONS-DISEASE; SKELETAL-MUSCLE; RNALYS MUTATION; HELA-CELLS; DNA; CHAIN; DEFECTS; MERRF; ENCEPHALOMYOPATHY	In the present work, we demonstrate the possibility of using human blood platelets as mitochondrial donors for the repopulation of mtDNA-less (rho(0)) cells. The noninvasive nature of platelet isolation, combined with the prolonged viability of platelet mitochondria and the simplicity and efficiency of the mitochondria-transfer procedure, has substantially increased the applicability of the rho(0) cell transformation approach for mitochondrial genetic analysis and for the study of mtDNA-linked diseases. This approach has been applied to platelets from several normal human individuals and one individual affected by the myoclonic-epilepsy-and-ragged-red-fibers (MERRF) encephalomyopathy. A certain variability in respiratory capacity was observed among the platelet-derived rho(0) cell transformants from a given normal subject, and it was shown to be unrelated to their mtDNA content. The results of sequential transfer of mitochondria from selected transformants into a rho(0) cell line different from the first rho(0) acceptor strongly suggest that this variability reflected, at least in part, differences in nuclear gene content and/or activity among the original recipient cells. A much greater variability in respiratory capacity was observed among the transformants derived from the MERRF patient and was found to be related to the presence and amount of the mitochondrial tRNA(Lys) mutation associated with the MERRF syndrome. An analysis of the relationship between proportion of mtDNA carrying the MERRF mutation and degree of respiratory activity in various transformants derived from the MERRF patient revealed an unusual complementation behavior of the tRNA(Lys) mutation, possibly reflecting the distribution of mutant mtDNA among the platelet mitochondria.	CALTECH,DIV BIOL 15629,PASADENA,CA 91125; UNIV MILAN,INST CLIN NEUROL,MILAN,ITALY	California Institute of Technology; University of Milan				Bresolin, Nereo/0000-0001-6694-3595	NCI NIH HHS [CM 11726] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS ES, 1992, METHOD ENZYMOL, V212, P71; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BENECKE R, 1993, BRAIN, V16, P1451; BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T; BOULET L, 1992, AM J HUM GENET, V51, P1187; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; MASON TL, 1973, J BIOL CHEM, V248, P1346; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9; STORRIE B, 1972, J MOL BIOL, V71, P177, DOI 10.1016/0022-2836(72)90345-2; TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YONEDA M, 1990, BIOCHEM INT, V21, P789; YONEDA M, IN PRESS MOL CELL BI; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619	29	116	126	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					966	974						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198140				2022-12-18	WOS:A1994NP05300005
J	JAZWINSKA, EC; LEE, SC; WEBB, SI; HALLIDAY, JW; POWELL, LW				JAZWINSKA, EC; LEE, SC; WEBB, SI; HALLIDAY, JW; POWELL, LW			LOCALIZATION OF THE HEMOCHROMATOSIS GENE CLOSE TO D6S105	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; HLA-A; LINKAGE; LOCUS; REGION; MICROSATELLITES; PREVALENCE; POPULATION	The hemochromatosis (HC) gene is known to be linked to HLA-A (6p21.3); however, its precise location has been difficult to determine because of a lack of additional highly polymorphic markers for this region. The recent identification of short tandem repeat sequences (microsatellites) has now provided this area with a number of markers with similar polymorphic index to the HLA serological polymorphisms. Using four microsatellites-D6S105, D6S109, D6S89, and F13A-together with the HLA class I loci HLA-A and HLA-B in 13 large pedigrees clearly segregating for HC, we have been able to refine the location of the HC gene. We identified no recombination between HC and HLA-A or D6S105, and two-point analyses placed the HC gene within one centimorgan (cM) of HLA-A and D6S105 (HLA-A maximum of the lod score [Z(max)] of 9.90 at recombination fraction [theta] of 0.0, and D6S105 Z(max) of 8.26 at theta of 0.0). The markers HLA-B, D6S109, D6S89, and F13A were separated from the HC locus by recombination, defining the centromeric and telomeric limits for the HC gene as HLA-B and D6S109, respectively. A multipoint map constructed using HLA-B, HLA-A, and D6S109 indicates that the HC gene is located in a region less than 1 cM proximal to HLA-A and less than 1 cM telomeric of HLA-A. These pedigree data indicate an association between HC and specific alleles at HLA-A and D6S105 (i.e., HLA-A3 and D6S105 allele 8). To determine the significance of these allelic associations, we have analyzed the alleles' frequency in 82 unrelated HC patients and 82 unrelated healthy controls. D6S105 allele 8 was present in 93% of patients and only 21% of controls (chi2 = 86.46; P < .0001). The approximate relative risk for this allele was 48.4. HLA-A3 was present in 62% of patients and 26% of controls (chi2 = 22.28; P < .001). Approximate relative risk for A3 was 4.8. We conclude that the microsatellite marker D6S105 is the closest marker to the HC gene reported to date.			JAZWINSKA, EC (corresponding author), ROYAL BRISBANE HOSP,QUEENSLAND INST MED RES,LIVER UNIT,BRISBANE,QLD 4029,AUSTRALIA.							BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; EDWARDS CQ, 1986, AM J HUM GENET, V38, P805; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; JAZWINSKA EC, 1992, 1ST INT WORKSH CHROM; Jorde L. B., 1992, American Journal of Human Genetics, V51, pA15; JOUANOLLE AM, 1990, HUM GENET, V85, P279, DOI 10.1007/BF00206746; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3343; LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x; LITT M, 1986, AM J HUM GENET, V39, P166; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; Maniatis T., 1982, MOL CLONING; Ott J., 1991, ANAL HUMAN GENETIC L; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; SIMON M, 1987, AM J HUM GENET, V41, P89; SUMMERS KM, 1989, AM J HUM GENET, V45, P41; SUMMERS KM, 1990, HEPATOLOGY, V12, P20, DOI 10.1002/hep.1840120105; TROWSDALE J, 1991, IMMUNOL TODAY, V12, P443, DOI 10.1016/0167-5699(91)90017-N; WALTER MA, 1991, AM J HUM GENET, V49, P917; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968	26	116	123	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					347	352						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328453				2022-12-18	WOS:A1993LN82000007
J	CHANCE, PF; BIRD, TD; OCONNELL, P; LIPE, H; LALOUEL, JM; LEPPERT, M				CHANCE, PF; BIRD, TD; OCONNELL, P; LIPE, H; LALOUEL, JM; LEPPERT, M			GENETIC-LINKAGE AND HETEROGENEITY IN TYPE-I CHARCOT-MARIE-TOOTH DISEASE (HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132; UNIV WASHINGTON,SCH MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DIV NEUROL,SEATTLE,WA 98195; VET ADM MED CTR,SEATTLE,WA 98108	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA)	CHANCE, PF (corresponding author), UNIV UTAH,MED CTR,DIV MED GENET,413 MED RES & EDUC BLDG,50 N MED DR,SALT LAKE CITY,UT 84132, USA.		Chance, Phillip/AAX-5826-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001341] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01341] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1980, AM J HUM GENET, V32, pA99; BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHANCE P, 1988, Neurology, V38, P175; CHANCE PF, 1987, NEUROLOGY, V37, P325, DOI 10.1212/WNL.37.2.325; CHANCE PF, 1989, MOL GENETICS DISEASE, P349; COLLINS FS, 1989, AM J HUM GENET, V44, P1; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; DYCK PJ, 1989, NEUROLOGY, V39, P1302, DOI 10.1212/WNL.39.10.1302; DYCK PJ, 1984, DISEASES PERIPHERAL, P1609; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; GRIFFITHS LR, 1988, AM J HUM GENET, V42, P756; GRUNDY HO, 1989, IMMUNOGENETICS, V29, P331, DOI 10.1007/BF00352843; GUILOFF RJ, 1982, J NEUROL NEUROSUR PS, V45, P669, DOI 10.1136/jnnp.45.8.669; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; IONASESCU V, 1987, J NEUROL SCI, V80, P73, DOI 10.1016/0022-510X(87)90222-X; IONASESCU V, 1988, AM J HUM GENET, V42, P74; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBO R, 1986, MUSCLE NERVE, V9, P235; LEBO R V, 1989, American Journal of Human Genetics, V45, pA148; Maniatis T., 1982, MOL CLONING; MARAZITA ML, 1985, CYTOGENET CELL GENET, V40, P688; MIDDLETONPRICE HR, 1989, GENOMICS, V4, P192, DOI 10.1016/0888-7543(89)90299-1; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; OCONNELL P, 1989, AM J HUM GENET, V44, P51; OTT J, 1985, ANAL HUMAN GENETIC L, P200; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; ROSSI A, 1985, J NEUROL, V232, P91, DOI 10.1007/BF00313907; SKRE H, 1974, CLIN GENET, V6, P98; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; VANASSE M, 1981, MUSCLE NERVE, V4, P26, DOI 10.1002/mus.880040106; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	43	116	117	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					915	925						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	2239969				2022-12-18	WOS:A1990EK40000006
J	SYKES, B; OGILVIE, D; WORDSWORTH, P; WALLIS, G; MATHEW, C; BEIGHTON, P; NICHOLLS, A; POPE, FM; THOMPSON, E; TSIPOURAS, P; SCHWARTZ, R; JENSSON, O; ARNASON, A; BORRESEN, AL; HEIBERG, A; FREY, D; STEINMANN, B				SYKES, B; OGILVIE, D; WORDSWORTH, P; WALLIS, G; MATHEW, C; BEIGHTON, P; NICHOLLS, A; POPE, FM; THOMPSON, E; TSIPOURAS, P; SCHWARTZ, R; JENSSON, O; ARNASON, A; BORRESEN, AL; HEIBERG, A; FREY, D; STEINMANN, B			CONSISTENT LINKAGE OF DOMINANTLY INHERITED OSTEOGENESIS-IMPERFECTA TO THE TYPE-I COLLAGEN LOCI - COLIA1 AND COLIA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MRC, CLIN RES CTR, HARROW HA1 3UJ, MIDDX, ENGLAND; INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND; UNIV CONNECTICUT, CTR HLTH, SCH MED, DEPT PEDIAT, FARMINGTON, CT 06032 USA; UNIV ZURICH, INST MED GENET, CH-8006 ZURICH, SWITZERLAND; UNIV ZURICH, DEPT PAEDIAT, CH-8006 ZURICH, SWITZERLAND; UNIV STELLENBOSCH, SCH MED, MRC, CTR MOLEC & CELLULAR BIOL, TYGERBERG 7505, SOUTH AFRICA; NATL HOSP, BLOOD BANK, DIV GENET, REYKJAVIK, ICELAND; NORWEGIAN RADIUM HOSP, INST CANC RES, DEPT GENET, OSLO, NORWAY; FRAMBU HLTH CTR, SIGGERUD, NORWAY	Medical Research Council Clinical Trials Unit; University of London; University College London; University of Connecticut; University of Zurich; University of Zurich; Stellenbosch University; Landspitali National University Hospital; University of Oslo	SYKES, B (corresponding author), UNIV OXFORD, JOHN RADCLIFFE HOSP, INST MOLEC MED, COLLAGEN GENET GRP, OXFORD OX3 9DU, ENGLAND.		Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001224] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 01224] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		AITCHISON K, 1988, HUM GENET, V78, P233, DOI 10.1007/BF00291667; Borresen A L, 1985, Prog Clin Biol Res, V177, P37; BYERS PH, 1988, AM J HUM GENET, V42, P237; DAW S, 1988, J MED GENET, V25, P275; FALK CT, 1986, AM J HUM GENET, V38, P269; GILCHRIST F, 1987, THESIS U OXFORD OXFO; GROBLERRABIE AF, 1985, J MED GENET, V22, P182, DOI 10.1136/jmg.22.3.182; GROBLERRABIE AF, 1985, EMBO J, V4, P1745, DOI 10.1002/j.1460-2075.1985.tb03845.x; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; McKusick V.A., 1972, CLIN GENET; OGILVIE DJ, 1987, NUCLEIC ACIDS RES, V15, P4699, DOI 10.1093/nar/15.11.4699; OTT J, 1986, AM J HUM GENET, V39, P159; PENTTINEN RP, 1975, P NATL ACAD SCI USA, V72, P586, DOI 10.1073/pnas.72.2.586; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SYKES B, 1977, NEW ENGL J MED, V296, P1200, DOI 10.1056/NEJM197705262962104; SYKES B, 1986, LANCET, V2, P69; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; WALLIS G, 1986, J MED GENET, V23, P411, DOI 10.1136/jmg.23.5.411; WALLIS G, UNPUB OSTEOGENESIS I	20	116	120	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					293	307						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	1967900				2022-12-18	WOS:A1990CM93800010
J	ATKIN, CL; HASSTEDT, SJ; MENLOVE, L; CANNON, L; KIRSCHNER, N; SCHWARTZ, C; NGUYEN, K; SKOLNICK, M				ATKIN, CL; HASSTEDT, SJ; MENLOVE, L; CANNON, L; KIRSCHNER, N; SCHWARTZ, C; NGUYEN, K; SKOLNICK, M			MAPPING OF ALPORT SYNDROME TO THE LONG ARM OF THE X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,DEPT MED & BIOCHEM,SALT LAKE CITY,UT 84132; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah				albright, lisa/0000-0003-2602-3668	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017463, R23HD017463] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA028854] Funding Source: NIH RePORTER; NCI NIH HHS [CA 28854] Funding Source: Medline; NICHD NIH HHS [HD 17463] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALPORT AC, 1927, BRIT MED J, V1, P504; ATKIN CL, IN PRESS STRAUSS WEL, P617; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRUNNER H, 1986, 7TH INT C HUM GEN BE; CASSADY G, 1965, PEDIATRICS, V35, P967; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CHAZAN JA, 1971, AM J MED, V50, P764, DOI 10.1016/0002-9343(71)90184-7; CLARE NM, 1979, AM J CLIN PATHOL, V72, P111; CRAWFURD MD, 1968, Q J MED, V37, P563; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; EVANS SH, 1980, CLIN GENET, V17, P285; FISCHBECK K H, 1986, American Journal of Human Genetics, V39, pA154; GOVAN JAA, 1983, BRIT J OPHTHALMOL, V67, P493, DOI 10.1136/bjo.67.8.493; GRAHAM JB, 1959, AM J HUM GENET, V11, P333; Guthrie LG, 1902, LANCET, V1, P1243; HASSTEDT SJ, 1983, AM J HUM GENET, V35, P1241; HASSTEDT SJ, 1986, AM J HUM GENET, V38, P940; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HEPTINSTALL RH, 1983, PATHOLOGY KIDNEY, P1652; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; McKusick V.A., 1978, MENDELIAN INHERITANC; MCNEILL E, 1973, J MED GENET, V10, P23; MENLOVE L, 1985, CYTOGENET CELL GENET, V40, P697; MENLOVE L, 1984, American Journal of Human Genetics, V36, p146S; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; ONEILL WM, 1980, PATHOL RES PRACT, V168, P146, DOI 10.1016/S0344-0338(80)80214-7; ONEILL WM, 1978, ANN INTERN MED, V88, P176, DOI 10.7326/0003-4819-88-2-176; OTT J, 1987, GENET EPIDEMIOL, V4, P51, DOI 10.1002/gepi.1370040107; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; PREUS M, 1971, Clinical Genetics, V2, P331; PURRIEL P, 1970, American Journal of Medicine, V49, P753, DOI 10.1016/S0002-9343(70)80057-2; SCHNEIDER RG, 1963, NY STATE J MED, V15, P2644; SCHWARTZ CE, 1986, CYTOGENET CELL GENET, V43, P117, DOI 10.1159/000132307; SHAW RF, 1961, AM J HUM GENET, V13, P89; SPEAR GS, 1984, CLIN NEPHROL, V21, P3; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; TISHLER P V, 1974, Birth Defects Original Article Series, V10, P93; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	44	116	122	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					249	255						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3422540				2022-12-18	WOS:A1988M313300005
J	UCHIDA, IA; SMITH, DW; PATAU, K				UCHIDA, IA; SMITH, DW; PATAU, K			DERMAL PATTERNS OF 18 AND D1 TRISOMICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Cummins H, 1939, ANAT REC, V73, P407, DOI 10.1002/ar.1090730404; PATAU K, 1960, LANCET, V1, P790; PATAU K, 1961, HEREDITAS, V47, P239; PATAU K, 1961, CHROMOSOMA, V12, P280, DOI 10.1007/BF00328924; PENROSE LS, 1949, 8 P INT C GEN HER  S, P412; ROWE RD, 1961, AM J MED, V31, P726, DOI 10.1016/0002-9343(61)90157-7; SMITH DW, 1962, J PEDIATR-US, V60, P513, DOI 10.1016/S0022-3476(62)80112-7; SMITH DW, 1961, LANCET, V2, P211; SMITH DW, 1960, J PEDIATR-US, V57, P338, DOI 10.1016/S0022-3476(60)80241-7; SMITH DW, 1962, J PEDIAT; THERMAN E, 1961, AM J HUM GENET, V13, P193; UCHIDA IA, 1962, NEW ENGL J MED, V266, P1198, DOI 10.1056/NEJM196206072662304; WALKER NF, 1957, J PEDIATR-US, V50, P27, DOI 10.1016/S0022-3476(57)80006-7; WALKER NF, 1957, J PEDIATR-US, V50, P19, DOI 10.1016/S0022-3476(57)80005-5	14	116	118	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					345	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13995080				2022-12-18	WOS:A19622965A00009
J	Sanderson, SC; Brothers, KB; Mercaldo, ND; Clayton, EW; Antommaria, AHM; Aufox, SA; Brilliant, MH; Campos, D; Carrell, DS; Connolly, J; Conway, P; Fullerton, SM; Garrison, NA; Horowitz, CR; Jarvik, GP; Kaufman, D; Kitchner, TE; Li, RL; Ludman, EJ; McCarty, CA; McCormick, JB; McManus, VD; Myers, MF; Scro, A; Williams, JL; Shrubsole, MJ; Schildcrout, JS; Smith, ME; Hom, IA				Sanderson, Saskia C.; Brothers, Kyle B.; Mercaldo, Nathaniel D.; Clayton, Ellen Wright; Antommaria, Armand H. Matheny; Aufox, Sharon A.; Brilliant, Murray H.; Campos, Diego; Carrell, David S.; Connolly, John; Conway, Pat; Fullerton, Stephanie M.; Garrison, Nanibaa' A.; Horowitz, Carol R.; Jarvik, Gail P.; Kaufman, David; Kitchner, Terrie E.; Li, Rongling; Ludman, Evette J.; McCarty, Catherine A.; McCormick, Jennifer B.; McManus, Valerie D.; Myers, Melanie F.; Scro, Aaron; Williams, Janet L.; Shrubsole, Martha J.; Schildcrout, Jonathan S.; Smith, Maureen E.; Hom, Ingrid A.			Public Attitudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey in the US	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RESEARCH PARTICIPANTS; BROAD CONSENT; INFORMED-CONSENT; PERSPECTIVES; INFORMATION; NANOTECHNOLOGY; PREFERENCES; POPULATION; TUSKEGEE	Individuals participating in biobanks and other large research projects are increasingly asked to provide broad consent for open-ended research use and widespread sharing of their biosamples and data. We assessed willingness to participate in a biobank using different consent and data sharing models, hypothesizing that willingness would be higher under more restrictive scenarios. Perceived benefits, concerns, and information needs were also assessed. In this experimental survey, individuals from 11 US healthcare systems in the Electronic Medical Records and Genomics (eMERGE) Network were randomly allocated to one of three hypothetical scenarios: tiered consent and controlled data sharing; broad consent and controlled data sharing; or broad consent and open data sharing. Of 82,328 eligible individuals, exactly 13,000 (15.8%) completed the survey. Overall, 66% (95% CI: 63%-69%) of population-weighted respondents stated they would be willing to participate in a biobank; willingness and attitudes did not differ between respondents in the three scenarios. Willingness to participate was associated with self-identified white race, higher educational attainment, lower religiosity, perceiving more research benefits, fewer concerns, and fewer information needs. Most (86%, CI: 84%-87%) participants would want to know what would happen if a researcher misused their health information; fewer (51%, CI: 47%-55%) would worry about their privacy. The concern that the use of broad consent and open data sharing could adversely affect participant recruitment is not supported by these findings. Addressing potential participants' concerns and information needs and building trust and relationships with communities may increase acceptance of broad consent and wide data sharing in biobank research.	[Sanderson, Saskia C.] UCL, Dept Behav Sci & Hlth, London WC1E 6BT, England; [Sanderson, Saskia C.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Sanderson, Saskia C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Brothers, Kyle B.] Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; [Mercaldo, Nathaniel D.; Schildcrout, Jonathan S.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37203 USA; [Clayton, Ellen Wright] Vanderbilt Univ, Ctr Biomed Eth & Soc, Nashville, TN 37203 USA; [Antommaria, Armand H. Matheny] Cincinnati Childrens Hosp Med Ctr, Eth Ctr, Cincinnati, OH 45229 USA; [Aufox, Sharon A.; Smith, Maureen E.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Brilliant, Murray H.; Kitchner, Terrie E.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Campos, Diego] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Carrell, David S.; Ludman, Evette J.; Scro, Aaron] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Connolly, John] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Conway, Pat; McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN 55805 USA; [Fullerton, Stephanie M.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Garrison, Nanibaa' A.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Horowitz, Carol R.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kaufman, David] NHGRI, Div Genom & Soc, Bethesda, MD 20892 USA; [Li, Rongling] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [McCormick, Jennifer B.] Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA; [McManus, Valerie D.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA; [Myers, Melanie F.] Cincinnati Childrens Hosp Med Ctr, Genet Counseling Grad Program, Cincinnati, OH 45229 USA; [Myers, Melanie F.] Univ Cincinnati, Cincinnati, OH 45229 USA; [Williams, Janet L.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Shrubsole, Martha J.] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Hom, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Hom, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Garrison, Nanibaa' A.] Univ Washington, Div Bioeth, Dept Pediat, Seattle, WA 98101 USA	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Icahn School of Medicine at Mount Sinai; University of Louisville; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; Northwestern University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Geisinger Health System; Vanderbilt University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle	Sanderson, SC (corresponding author), UCL, Dept Behav Sci & Hlth, London WC1E 6BT, England.; Sanderson, SC (corresponding author), Great Ormond St Hosp Sick Children, London WC1N 3JH, England.; Sanderson, SC (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Brothers, KB (corresponding author), Univ Louisville, Dept Pediat, Louisville, KY 40202 USA.	saskia.sanderson@ucl.ac.uk; kyle.brothers@louisville.edu	Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048; Sanderson, Saskia/0000-0001-8427-724X; McCarty, Catherine/0000-0003-1089-0142; Holm, Ingrid/0000-0003-4712-8821; Mercaldo, Nathaniel/0000-0003-1658-6598; Myers, Melanie/0000-0002-6845-5226; Connolly, John/0000-0003-4396-1226	NHGRI; NIH Office of the Director [U01HG006828, U01HG006830, UOIHG006389, U01HG006382, U01HG006375, 3U01HG006379, U01HG006380, 3U01-HG006388, U01HG006378, 3U01HG0006385]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008673, U01HG006380, U01HG007278, U01HG006388, U01HG006385, U01HG006382, U01HG006379, U01HG008657, U01HG006830, U01HG008701, U01HG006378, U01HG006375] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The CERC Survey project within the eMERGE Network was initiated and funded by NHGRI with additional funding by the NIH Office of the Director through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital), U01HG006830 (Children's Hospital of Philadelphia), UOIHG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation, and Pennsylvania State University), U01HG006382 (Geisinger Clinic), U01HG006375 (Group Health Cooperative/University of Washington), 3U01HG006379 (Mayo Clinic), U01HG006380 (Icahn School of Medicine at Mount Sinai), 3U01-HG006388 (Northwestern University), U01HG006378 (Vanderbilt University Medical Center), and 3U01HG0006385 (Vanderbilt University Medical Center serving as the Coordinating Center).	American Association for Public Opinion Research, 2011, STAND DEF FIN DISP C; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Bates BR, 2004, J NATL MED ASSOC, V96, P1051; Brossard D, 2009, PUBLIC UNDERST SCI, V18, P546, DOI 10.1177/0963662507087304; Brothers KB, 2011, AM J MED GENET A, V155A, P2982, DOI 10.1002/ajmg.a.34304; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chen DT, 2005, ARCH INTERN MED, V165, P652, DOI 10.1001/archinte.165.6.652; Chen H, 2012, BIOMETRICS, V68, P1278, DOI 10.1111/j.1541-0420.2012.01761.x; Chowdhury S., 2007, P SURV RES METH SECT, P2651; Collins FS, 2007, NATURE, V445, P259, DOI 10.1038/445259a; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; De Vries RG, 2016, LIFE SCI SOC POLICY, V12, DOI 10.1186/s40504-016-0036-4; Department of Health and Human Services, 2016, FED REGISTER, V81, P4036; Department of Homeland Security, 2015, FED REGISTER, V80, P53942; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Fullerton SM, 2011, ACHIEVING JUSTICE GE, P40; Garrison NA, 2016, GENET MED, V18, P663, DOI 10.1038/gim.2015.138; Gaskell G, 2011, NAT BIOTECHNOL, V29, P113, DOI 10.1038/nbt.1771; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hall MA, 2006, MED CARE, V44, P1048, DOI 10.1097/01.mlr.0000228023.37087.cb; Hamilton CM, 2011, AM J EPIDEMIOL, V174, P253, DOI 10.1093/aje/kwr193; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartzler A, 2013, GENET MED, V15, P792, DOI 10.1038/gim.2013.127; Helft PR, 2007, J EMPIR RES HUM RES, V2, P15, DOI 10.1525/jer.2007.2.3.15; Ho SS, 2013, PUBLIC UNDERST SCI, V22, P606, DOI 10.1177/0963662511417936; Hudson K, 2015, PRECISION MED INITIA; Johnson DR, 2015, SOCIOL SCI, V2, P106, DOI 10.15195/v2.a7; Kaufman D, 2009, GENET MED, V11, P329, DOI 10.1097/GIM.0b013e31819994f8; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Kaye J, 2012, ANNU REV GENOM HUM G, V13, P415, DOI 10.1146/annurev-genom-082410-101454; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; McGuire AL, 2008, GENET MED, V10, P46, DOI 10.1097/GIM.0b013e31815f1e00; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Platt J, 2014, GENET MED, V16, P11, DOI 10.1038/gim.2013.59; Potter F., 1988, P SURV RES METH SECT, P2651; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rubin D. B., 2004, MULTIPLE IMPUTATION; Scheufele DA, 2009, NAT NANOTECHNOL, V4, P91, DOI 10.1038/NNANO.2008.361; Shabani M, 2014, EXPERT REV MOL DIAGN, V14, P1053, DOI 10.1586/14737159.2014.961917; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Shea JA, 2008, J GEN INTERN MED, V23, P727, DOI 10.1007/s11606-008-0575-3; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Smith ME, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0263-7; Steinsbekk KS, 2013, EUR J HUM GENET, V21, P897, DOI 10.1038/ejhg.2012.282; Terry AL, 2008, HEALTH POLICY, V85, P293, DOI 10.1016/j.healthpol.2007.08.002; Trinidad SB, 2011, SCIENCE, V331, P287, DOI 10.1126/science.1199000; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wheeland DG, 2014, FED REGISTER, V79, P51345	53	115	115	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					414	427		10.1016/j.ajhg.2017.01.021	http://dx.doi.org/10.1016/j.ajhg.2017.01.021			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EN2PH	28190457	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000395851900009
J	Thiel, C; Kessler, K; Giessl, A; Dimmler, A; Shalev, SA; von der Haar, S; Zenker, M; Zahnleiter, D; Stoss, H; Beinder, E; Abou Jamra, R; Ekici, AB; Schroder-Kress, N; Aigner, T; Kirchner, T; Reis, A; Brandstatter, JH; Rauch, A				Thiel, Christian; Kessler, Kristin; Giessl, Andreas; Dimmler, Arno; Shalev, Stavit A.; von der Haar, Sigrun; Zenker, Martin; Zahnleiter, Diana; Stoess, Hartmut; Beinder, Ernst; Abou Jamra, Rami; Ekici, Arif B.; Schroeder-Kress, Nadja; Aigner, Thomas; Kirchner, Thomas; Reis, Andre; Brandstaetter, Johann H.; Rauch, Anita			NEK1 Mutations Cause Short-Rib Polydactyly Syndrome Type Majewski	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CILIUM; GENE PRIORITIZATION; ALLEGRO; LINKAGE; KINASE; IDENTIFICATION; INHERITANCE; DISORDERS; DEFECTS; DISEASE	Defects of ciliogenesis have been implicated in a wide range of human phenotypes and play a crucial role in signal transduction and cell-cycle coordination. We used homozygosity mapping in two families with autosomal-recessive short-rib polydactyly syndrome Majewski type to identify mutations in NEK1 as an underlying cause of this lethal osteochondrodysplasia. NEK1 encodes a serine/threonine kinase with proposed function in DNA double-strand repair, neuronal development, and coordination of cell-cycle-associated ciliogenesis. We found that absence of functional full-length NEK1 severely reduces cilia number and alters ciliar morphology in vivo. We further substantiate a proposed digenic diallelic inheritance of ciliopathies by the identification of heterozygous mutations in NEK1 and DYNC2H1 in an additional family. Notably, these findings not only increase the broad spectrum of ciliar disorders, but suggest a correlation between the degree of defective microtubule or centriole elongation and organization and the severity of the resulting phenotype.	[Thiel, Christian; Kessler, Kristin; Zahnleiter, Diana; Abou Jamra, Rami; Ekici, Arif B.; Reis, Andre] Friedrich Alexander Univ Erlangen Nuremberg, Inst Human Genet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Giessl, Andreas; Schroeder-Kress, Nadja; Brandstaetter, Johann H.] Friedrich Alexander Univ Erlangen Nuremberg, D-91058 Erlangen, Germany; [Dimmler, Arno] St Vincentius Hosp, Inst Pathol, D-76137 Karlsruhe, Germany; [Shalev, Stavit A.] Emek Med Ctr, Genet Inst, IL-18101 Afula, Israel; [Shalev, Stavit A.] Technion Israel Inst Technol, Rappaport Fac Med, IL-31906 Haifa, Israel; [von der Haar, Sigrun] Private Clin Kossakiewicz, D-90402 Nurnberg, Germany; [Zenker, Martin] Otto VonGuericke Univ Magdegurg, Inst Human Genet, D-39120 Magdeburg, Germany; [Stoess, Hartmut] Inst Pathol, D-33098 Paderborn, Germany; [Beinder, Ernst] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland; [Aigner, Thomas] Univ Leipzig, Inst Pathol, D-04103 Leipzig, Germany; [Kirchner, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Otto von Guericke University; University of Zurich; University Zurich Hospital; Leipzig University; University of Munich; University of Zurich	Thiel, C (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Inst Human Genet, Univ Hosp Erlangen, D-91054 Erlangen, Germany.	christian.thiel@uk-erlangen.de	Jamra, Rami Abou/I-4805-2015; Rauch, Anita/C-5568-2014; Jamra, Rami Abou/I-2350-2012; Ekici, Arif B/C-3971-2013; Abou Jamra, Rami/AAC-8192-2019; Thiel, Christian T/H-8964-2012; Reis, André/D-2309-2009	Jamra, Rami Abou/0000-0002-1542-1399; Rauch, Anita/0000-0003-2930-3163; Jamra, Rami Abou/0000-0002-1542-1399; Ekici, Arif B/0000-0001-6099-7066; Abou Jamra, Rami/0000-0002-1542-1399; Thiel, Christian T/0000-0003-3817-7277; Reis, André/0000-0002-6301-6363; Giessl, Andreas/0000-0002-9768-2049	Bundesministerium fur Bildung und Forschung (BMBF) [SKELNET GFGM01141901]; DFG [TH896/4-1]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	We thank Frank Majewski for helpful discussion of the phenotype, the families for giving their consent for this study, and J. Adam for technical assistance. This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) network grant SKELNET GFGM01141901 to A. Rauch and A. Reis and the DFG grant TH896/4-1 to C.T.T. The study was approved by the ethical review board of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; D'Angelo Anna, 2009, Pathogenetics, V2, P3, DOI 10.1186/1755-8417-2-3; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elcioglu NH, 2002, AM J MED GENET, V111, P392, DOI 10.1002/ajmg.10562; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Fauser S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e104; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hilton LK, 2009, BIOCHEM BIOPH RES CO, V389, P52, DOI 10.1016/j.bbrc.2009.08.086; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Janaswami PM, 1997, GENOMICS, V40, P101, DOI 10.1006/geno.1996.4567; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Lanza DCF, 2010, MOL CELL BIOCHEM, V338, P35, DOI 10.1007/s11010-009-0317-9; MAJEWSKI F, 1971, Z KINDERHEILKD, V111, P118, DOI 10.1007/BF00446428; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Moser JJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-448; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Rampersaud E, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032029; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tompson SWJ, 2007, HUM GENET, V120, P663, DOI 10.1007/s00439-006-0237-7; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Vogler C, 1999, J AM SOC NEPHROL, V10, P2534; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29	41	115	120	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					106	114		10.1016/j.ajhg.2010.12.004	http://dx.doi.org/10.1016/j.ajhg.2010.12.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21211617	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000286501500011
J	Woods, CG; Stricker, S; Seemann, P; Stern, R; Cox, J; Sherridan, E; Roberts, E; Springell, K; Scott, S; Karbani, G; Sharif, SM; Toomes, C; Bond, J; Kumar, D; Al-Gazali, L; Mundlos, S				Woods, C. G.; Stricker, S.; Seemann, P.; Stern, R.; Cox, J.; Sherridan, E.; Roberts, E.; Springell, K.; Scott, S.; Karbani, G.; Sharif, S. M.; Toomes, C.; Bond, J.; Kumar, D.; Al-Gazali, L.; Mundlos, S.			Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPLICATION-COMPETENT RETROVIRUSES; VERTEBRATE LIMB; IN-VITRO; GENE; EXPRESSION; POLARITY; PATTERN; WNT-7A; LMX1; SHH	Fuhrmann syndrome and the Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome are considered to be distinct limb-malformation disorders characterized by various degrees of limb aplasia/hypoplasia and joint dysplasia in humans. In families with these syndromes, we found homozygous missense mutations in the dorsoventral- patterning geneWNT7A and confirmed their functional significance in retroviral-mediated transfection of chicken mesenchyme cell cultures and developing limbs. The results suggest that a partial loss of WNT7A function causes Fuhrmann syndrome (and a phenotype similar to mouse Wnt7a knockout), whereas the more-severe limb truncation phenotypes observed in Al-Awadi/RaasRothschild/Schinzel phocomelia syndrome result from null mutations (and cause a phenotype similar to mouse Shh knockout). These findings illustrate the specific and conserved importance of WNT7A in multiple aspects of vertebrate limb development.	Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; Max Planck Inst Mol Genet, Berlin, Germany; Inst Med Genet, Berlin, Germany; St Jamess Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; St Jamess Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds, W Yorkshire, England; Sheffield Childrens Hosp, Ctr Human Genet, Sheffield, S Yorkshire, England; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates	University of Cambridge; Max Planck Society; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; United Arab Emirates University	Woods, CG (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 2XY, England.	cw347@cam.ac.uk	woods, christopher g/A-1361-2010; Seemann, Petra/G-3606-2011; Cox, James/R-1910-2016; Mundlos, Stefan/ABH-9585-2020; Stricker, Sigmar/B-9169-2009	Seemann, Petra/0000-0002-6056-6669; Stricker, Sigmar/0000-0002-7174-5363; Toomes, Carmel/0000-0001-8373-9545; Mundlos, Stefan/0000-0002-9788-3166	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kornak U, 2003, AM J HUM GENET, V73, P447, DOI 10.1086/377110; Kumar D, 1997, AM J MED GENET, V70, P107, DOI 10.1002/(SICI)1096-8628(19970516)70:2<107::AID-AJMG1>3.0.CO;2-V; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Parr BA, 1998, DEV BIOL, V202, P228, DOI 10.1006/dbio.1998.9007; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Stott NS, 1999, J CELL PHYSIOL, V180, P314, DOI 10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.3.CO;2-P; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; Tufan AC, 2001, FASEB J, V15, P1436, DOI 10.1096/fj.00-0784fje; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; YANG YZ, 1995, CELL, V80, P939, DOI 10.1016/0092-8674(95)90297-X	22	115	155	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					402	408		10.1086/506332	http://dx.doi.org/10.1086/506332			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826533	Green Published, Bronze			2022-12-18	WOS:000239040400024
J	Kudo, M; Brem, MS; Canfield, WM				Kudo, M; Brem, MS; Canfield, WM			Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha/beta-subunits precursor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UDP-N-ACETYLGLUCOSAMINE; LYSOSOMAL-ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PARTIAL-PURIFICATION; MOLECULAR-BASIS; ACETYLGLUCOSAMINYLPHOSPHOTRANSFERASE; FIBROBLASTS; GLCNAC-1-PHOSPHOTRANSFERASE; PHOSPHODIESTERASE; PHOSPHORYLATION; IDENTIFICATION	Mucolipidosis II (MLII; I-cell disease) and mucolipidosis IIIA (MLIIIA; classical pseudo-Hurler polydystrophy) are diseases in which the activity of the uridine diphosphate (UDP)-N-acetylglucosamine: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc-phosphotransferase) is absent or reduced, respectively. In the absence of mannose phosphorylation, trafficking of lysosomal hydrolases to the lysosome is impaired. In these diseases, mistargeted lysosomal hydrolases are secreted into the blood, resulting in lysosomal deficiency of many hydrolases and a storage-disease phenotype. To determine whether these diseases are caused by mutations in the GlcNAc-phosphotransferase alpha/beta-subunits precursor gene (GNPTAB), we sequenced GNPTAB exons and flanking intronic sequences and measured GlcNAc-phosphotransferase activity in patient fibroblasts. We identified 15 different mutations in GNPTAB from 18 pedigrees with MLII or MLIIIA and demonstrated that these two diseases are allelic. Mutations in both alleles were identified in each case, which demonstrated that GNPTAB mutations are the cause of both diseases. Some pedigrees had identical mutations. One frameshift mutation (truncation at amino acid 1171) predominated and was found in both MLII and MLIIIA. This mutation was found in combination with severe mutations (i. e., mutations preventing the generation of active enzyme) in MLII and with mild mutations (i. e., mutations allowing the generation of active enzyme) in MLIIIA. Some cases of MLII and MLIIIA were the result of mutations that cause aberrant splicing. Substitutions were inside the invariant splice-site sequence in MLII and were outside it in MLIIIA. When the mutations were analyzed along with GlcNAc-phosphotransferase activity, it was possible to confidently distinguish these two clinically related but distinct diseases. We propose criteria for distinguishing these two disorders by a combination of mutation detection and GlcNAc-phosphotransferase activity determination.	Genzyme Corp, Oklahoma City, OK 73104 USA	Sanofi-Aventis; Genzyme Corporation	Canfield, WM (corresponding author), Genzyme Corp, 800 Res Pkway,Suite 200, Oklahoma City, OK 73104 USA.	William.Canfield@genzyme.com						Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Canfield WM, 1998, AM J HUM GENET, V63, pA15; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; GARROD AE, 1902, LANCET, V2, P1611; HASILIK A, 1981, BIOCHEM BIOPH RES CO, V98, P761, DOI 10.1016/0006-291X(81)91177-3; HONEY NK, 1982, P NATL ACAD SCI-BIOL, V79, P7420, DOI 10.1073/pnas.79.23.7420; KORNFELD S, 2001, METABOLIC MOL BASES, V3, P3469; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Kudo M, 2004, GLYCOBIOLOGY, V14, P1057; LITTLE LE, 1986, J BIOL CHEM, V261, P733; MUELLER OT, 1985, CLIN CHIM ACTA, V150, P175, DOI 10.1016/0009-8981(85)90242-6; MUELLER OT, 1983, J CLIN INVEST, V72, P1016, DOI 10.1172/JCI111025; Raas-Rothschild A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015222; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; REITMAN ML, 1984, METHOD ENZYMOL, V107, P163; SHOWS TB, 1982, AM J MED GENET, V12, P343, DOI 10.1002/ajmg.1320120312; Steet RA, 2005, AM J MED GENET A, V132A, P369, DOI 10.1002/ajmg.a.30498; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; VARKI A, 1981, J BIOL CHEM, V256, P9937; VARKI A, 1982, AM J HUM GENET, V34, P717; VARKI AP, 1981, P NATL ACAD SCI-BIOL, V78, P7773, DOI 10.1073/pnas.78.12.7773; WAHEED A, 1982, BIOCHEM BIOPH RES CO, V105, P1052, DOI 10.1016/0006-291X(82)91076-2; WAHEED A, 1982, J BIOL CHEM, V257, P2322; WAHEED A, 1981, J BIOL CHEM, V256, P5717	30	115	121	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					451	463		10.1086/500849	http://dx.doi.org/10.1086/500849			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465621	Bronze, Green Published			2022-12-18	WOS:000236747500012
J	Evans, DM; Cardon, LR				Evans, DM; Cardon, LR			Guidelines for genotyping in genomewide linkage studies: Single-nucleotide-polymorphism maps versus microsatellite maps	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC MAPS; DENSITY; MARKERS; POWER; IMPACT; ASSAY	Genomewide linkage scans have traditionally employed panels of microsatellite markers spaced at intervals of similar to10 cM across the genome. However, there is a growing realization that a map of closely spaced single-nucleotide polymorphisms (SNPs) may offer equal or superior power to detect linkage, compared with low-density microsatellite maps. We performed a series of simulations to calculate the information content associated with microsatellite and SNP maps across a range of different marker densities and heterozygosities for sib pairs (with and without parental genotypes), sib trios, and sib quads. In the case of microsatellite markers, we varied density across 11 levels (1 marker every 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 cM) and marker heterozygosity across 6 levels (2, 3, 4, 5, 10, or 20 equally frequent alleles), whereas, in the case of SNPs, we varied marker density across 4 levels (1 marker every 0.1, 0.2, 0.5, or 1 cM) and minor-allele frequency across 7 levels (0.5, 0.4, 0.3, 0.2, 0.1, 0.05, and 0.01). When parental genotypes were available, a map consisting of microsatellites spaced every 2 cM or a relatively sparse map of SNPs (i.e., at least 1 SNP/cM) was sufficient to extract most of the inheritance information from the map (>95% in most cases). However, when parental genotypes were unavailable, it was important to use as dense a map of markers as possible to extract the greatest amount of inheritance information. It is important to note that the information content associated with a traditional map of microsatellite markers (i.e., 1 marker every similar to10 cM) was significantly lower than the information content associated with a dense map of SNPs or microsatellites. These results strongly suggest that previous linkage studies that employed sparse microsatellite maps could benefit substantially from reanalysis by use of a denser map of markers.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Evans, DM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	davide@well.ox.ac.uk	Evans, David M/H-6325-2013	Evans, David M/0000-0003-0663-4621	NEI NIH HHS [EY-126562] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dolan CV, 1999, BEHAV GENET, V29, P163, DOI 10.1023/A:1021687817609; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Goddard KAB, 2002, GENET EPIDEMIOL, V22, P205, DOI 10.1002/gepi.0177; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KOSTANJE R, 2002, NAT GENET, V31, P235; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Oliphant A, 2002, BIOTECHNIQUES, P56; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Wilson AF, 2000, AM J HUM GENET, V66, P1610, DOI 10.1086/302889	26	115	118	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					687	692		10.1086/424696	http://dx.doi.org/10.1086/424696			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15311375	Green Published, Bronze			2022-12-18	WOS:000223634100015
J	van der Knaap, MS; van Berkel, CGM; Herms, J; van Coster, R; Baethmann, M; Naidu, S; Boltshauser, E; Willemsen, MAAP; Plecko, B; Hoffmann, GF; Proud, CG; Scheper, GC; Pronk, JC				van der Knaap, MS; van Berkel, CGM; Herms, J; van Coster, R; Baethmann, M; Naidu, S; Boltshauser, E; Willemsen, MAAP; Plecko, B; Hoffmann, GF; Proud, CG; Scheper, GC; Pronk, JC			eIF2B-related disorders: Antenatal onset and involvement of multiple organs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VANISHING WHITE-MATTER; INITIATION-FACTOR EIF2B; CHILDHOOD ATAXIA; PROTEIN-SYNTHESIS; LEUKOENCEPHALOPATHY; TRANSLATION; DISEASE; STRESS; PHOSPHORYLATION; SUBUNITS	Leukoencephalopathy with vanishing white matter, also called "childhood ataxia with central nervous system hypomyelination," is the first human disease related to mutations in any of the five genes encoding subunits of eukaryotic initiation factor eIF2B or any translation factor at all. eIF2B is essential in all cells of the body for protein synthesis and the regulation of this protein synthesis under different stress conditions. It is surprising that mutations in the eIF2B genes have been reported to lead to abnormalities of the white matter of the brain only, although it has been shown recently that ovarian failure may accompany the leukoencephalopathy. Another surprising observation is that the onset of the disease varies from early childhood to adulthood, with the exception of Cree leukoencephalopathy, a disease related to a particular mutation in one of the eIF2B genes, which invariably has its onset within the first year of life. We analyzed the eIF2B genes of nine patients with an antenatal- or early-infantile-onset encephalopathy and an early demise and found mutations in eight of the patients. In addition to signs of a serious encephalopathy, we found oligohydramnios, intrauterine growth retardation, cataracts, pancreatitis, hepatosplenomegaly, hypoplasia of the kidneys, and ovarian dysgenesis. Until now, no evidence had been found for a genotype-phenotype correlation, but the consistently severe phenotype in affected siblings among our patients and in Cree encephalopathy patients suggests an influence of the genotype on the phenotype.	Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Clin & Human Genet, Amsterdam, Netherlands; Univ Munich, Inst Neuropathol, D-8000 Munich, Germany; Childrens Hosp Dritter Orden, Dept Pediat, Munich, Germany; Univ Ziekenhuis C Hooft, Dept Pediat Neurol, Ghent, Belgium; Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; Univ Childrens Hosp, Dept Neuropediat, Zurich, Switzerland; Univ Med Ctr Nijmegen, Dept Pediat Neurol, Nijmegen, Netherlands; Univ Childrens Hosp, Dept Pediat, Graz, Austria; Univ Childrens Hosp, Dept Pediat, Heidelberg, Germany; Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee, Scotland	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Munich; Kennedy Krieger Institute; University Children's Hospital Zurich; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Dundee	van der Knaap, MS (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Child Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	ms.vanderknaap@vumc.nl	Herms, Jochen/D-3518-2011; Scheper, Gert C/D-7001-2014; Willemsen, Michel A.A.P./H-8119-2014	Plecko, Barbara/0000-0002-3203-1325; Proud, Christopher/0000-0003-0704-6442				BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Bin-Abbas B, 2002, AM J MED GENET, V111, P187, DOI 10.1002/ajmg.10495; BLACK DN, 1988, ANN NEUROL, V24, P490, DOI 10.1002/ana.410240403; Boltshauser E, 2002, NEUROPEDIATRICS, V33, P57, DOI 10.1055/s-2002-32363; Bruck W, 2001, ANN NEUROL, V50, P532, DOI 10.1002/ana.1227; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; OLDFIELD S, 1994, EUR J BIOCHEM, V221, P399, DOI 10.1111/j.1432-1033.1994.tb18752.x; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schneider RJ, 2000, COLD SPRING HARBOR M, V39, P581; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; VANDERKNAAP MS, 1990, NEURORADIOLOGY, V31, P459, DOI 10.1007/BF00340123; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234	33	115	117	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1199	1207		10.1086/379524	http://dx.doi.org/10.1086/379524			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14566705	Bronze, Green Published			2022-12-18	WOS:000186493400021
J	Liede, A; Malik, IA; Aziz, Z; de los Rios, P; Kwan, E; Narod, SA				Liede, A; Malik, IA; Aziz, Z; de los Rios, P; Kwan, E; Narod, SA			Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONSANGUINEOUS MARRIAGE; PREVALENCE; MORTALITY; FAMILIES; GENE	The population of Pakistan has been reported to have the highest rate of breast cancer of any Asian population (excluding Jews in Israel) and one of the highest rates of ovarian cancer worldwide. To explore the contribution that genetic factors make to these high rates, we have conducted a case-control study of 341 case subjects with breast cancer, 120 case subjects with ovarian cancer, and 200 female control subjects from two major cities of Pakistan (Karachi and Lahore). The prevalence of BRCA1 or BRCA2 mutations among case subjects with breast cancer was 6.7% (95% confidence interval [CI] 4.1%- 9.4%), and that among case subjects with ovarian cancer was 15.8% (95% CI 9.2%-22.4%). Mutations of the BRCA1 gene accounted for 84% of the mutations among case subjects with ovarian cancer and 65% of mutations among case subjects with breast cancer. The majority of detected mutations are unique to Pakistan. Five BRCA1 mutations (2080insA, 3889delAG, 4184del4, 4284delAG, and IVS14-1A-->G) and one BRCA2 mutation (3337C-->T) were found in multiple case subjects and represent candidate founder mutations. The penetrance of deleterious mutations in BRCA1 and BRCA2 is comparable to that of Western populations. The cumulative risk of cancer to age 85 years in female first-degree relatives of BRCA1-mutation-positive case subjects was 48% and was 37% for first-degree relatives of the BRCA2-mutation-positive case subjects. A higher proportion of case subjects with breast cancer than of control subjects were the progeny of first-cousin marriages (odds ratio [OR] 2.1; 95% CI 1.4-3. 3; P = .001). The effects of consanguinity were significant for case subjects with early-onset breast cancer (age <40 years) (OR = 2.7; 95% CI 1.5-4.9; P = .0008) and case subjects with ovarian cancer (OR = 2.4; 95% CI 1.4-4.2; P = .002). These results suggest that recessively inherited genes may contribute to breast and ovarian cancer risk in Pakistan.	Univ Toronto, Sunnybrook & Womens Coll, Ctr Hlth Sci, Toronto, ON, Canada; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Natl Canc Inst, Karachi, Pakistan; Loma Linda Univ, Med Ctr, Loma Linda, CA USA; Jinnah Hosp, Lahore, Pakistan	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cedars Sinai Medical Center; Loma Linda University	Narod, SA (corresponding author), Ctr Res Womens Hlth, 790 Bay St,Suite 750A, Toronto, ON M5G 1N8, Canada.	steven.narod@swchsc.on.ca	Narod, Steven A/AAA-6112-2022					Ahmed Rashida, 1997, JPMA (Journal of the Pakistan Medical Association), V47, P114; Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; Bhurgri Y, 2000, INT J CANCER, V85, P325, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;325::AID-IJC5&gt;3.0.CO;2-J; BITTLES AH, 1993, INT J EPIDEMIOL, V22, P463, DOI 10.1093/ije/22.3.463; Breslow NE, 1987, DESIGN ANAL COHORT S, VII; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; Denic S, 2001, BRIT J CANCER, V85, P1675, DOI 10.1054/bjoc.2001.2131; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; Hashmi M. A., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P75; Hussain R, 1999, J BIOSOC SCI, V31, P121, DOI 10.1017/S0021932099001212; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Khoo U S, 2000, Hum Mutat, V16, P88, DOI 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G; Khoo Ui-Soon, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9015; LIEDE A, IN PRESS HUM MUTAT; Malik Iftikhar Ahmad, 1992, Journal of Environmental Pathology Toxicology and Oncology, V11, P353; Moslehi R, 1998, AM J MED GENET, V78, P386; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; POWELL JE, 1995, BRIT J CANCER, V72, P1563, DOI 10.1038/bjc.1995.549; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; SHAMI SA, 1989, J MED GENET, V26, P267, DOI 10.1136/jmg.26.4.267; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Usmani Khalida, 1996, Journal of Environmental Pathology Toxicology and Oncology, V15, P251; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A; YAQOOB M, 1993, ACTA PAEDIATR, V82, P17, DOI 10.1111/j.1651-2227.1993.tb12903.x; 1991, LANCET, V338, P85	27	115	118	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					595	606		10.1086/342506	http://dx.doi.org/10.1086/342506			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12181777	Bronze, Green Published			2022-12-18	WOS:000177489600013
J	Lindgren, CM; Mahtani, MM; Widen, E; McCarthy, MI; Daly, MJ; Kirby, A; Reeve, MP; Kruglyak, L; Parker, A; Meyer, J; Almgren, P; Lehto, M; Kanninen, T; Tuomi, T; Groop, LC; Lander, ES				Lindgren, CM; Mahtani, MM; Widen, E; McCarthy, MI; Daly, MJ; Kirby, A; Reeve, MP; Kruglyak, L; Parker, A; Meyer, J; Almgren, P; Lehto, M; Kanninen, T; Tuomi, T; Groop, LC; Lander, ES			Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: The Botnia study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL GENOMIC SCAN; PIMA-INDIANS; MEXICAN-AMERICANS; LINKAGE ANALYSIS; CHROMOSOME 12Q; COMPLEX TRAITS; MAPPING GENES; WIDE SEARCH; ONSET; NIDDM	Type 2 diabetes mellitus is a heterogeneous inherited disorder characterized by chronic hyperglycemia resulting from pancreatic beta-cell dysfunction and insulin resistance. Although the pathogenic mechanisms are not fully understood, manifestation of the disease most likely requires interaction between both environmental and genetic factors. In the search for such susceptibility genes, we have performed a genomewide scan in 58 multiplex families (comprising 440 individuals, 229 of whom were affected) from the Botnia region in Finland. Initially, linkage between chromosome 12q24 and impaired insulin secretion had been reported, by Mahtani et al., in a subsample of 26 families. In the present study, we extend the initial genomewide scan to include 32 additional families, update the affectation status, and fine map regions of interest, and we try to replicate the initial stratification analysis. In our analysis of all 58 families, we identified suggestive linkage to one region, chromosome 9p13-q21 (nonparametric linkage [NPL] score 3.9; P < .0002). Regions with nominal P values <.05 include chromosomes 2p11 (NPL score 2.0 [P<.03]), 3p24-p22 (NPL score 2.2 [P<.02]), 4q32-q33 (NPL score 2.5 [P<.01]), 12q24 (NPL score [P<.03]), 16p12-11 (NPL score 1.7 [P<.05]), and 17p12-p11 (NPL score 1.9 [P<.03]). When chromosome 12q24 was analyzed in only the 32 additional families, a nominal P value <.04 was observed. Together with data from other published genomewide scans, these findings lend support to the hypothesis that regions on chromosome 9p13-q21 and 12q24 may harbor susceptibility genes for type 2 diabetes.	MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Malmo Univ Hosp, Dept Endocrinol, Wallenberg Lab, Malmo, Sweden; Millennium Pharmaceut, Cambridge, MA USA; Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Internal Med, Helsinki, Finland; Imperial Coll Sch Med, Complex Traits Anal Grp, London, England; Hammersmith Hosp, MRC, Ctr Clin Sci, London, England; Walter & Eliza Hall Inst Med Res, Dept Genet & Bioinformat, Melbourne, Vic 3050, Australia; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Lund University; Skane University Hospital; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Imperial College London; Imperial College London; Walter & Eliza Hall Institute; Fred Hutchinson Cancer Center	Lander, ES (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017; McCarthy, Mark/M-3763-2015	Daly, Mark J/0000-0002-0949-8752; McCarthy, Mark/0000-0002-4393-0510; Tuomi, Tiinamaija/0000-0002-8306-6202; Lindgren, Cecilia/0000-0002-4903-9374	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERTI KGMM, 1988, DIABETIC MED, V5, P275, DOI 10.1111/j.1464-5491.1988.tb00984.x; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Bektas A, 1999, DIABETES, V48, P2246, DOI 10.2337/diabetes.48.11.2246; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; CHARLES MA, 1991, DIABETES, V40, P796, DOI 10.2337/diabetes.40.7.796; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Groop LC, 1997, ANN MED, V29, P37, DOI 10.3109/07853899708998742; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Klos KL, 2001, ARTERIOSCL THROM VAS, V21, P971, DOI 10.1161/01.ATV.21.6.971; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luo TH, 2001, DIABETOLOGIA, V44, P501, DOI 10.1007/s001250051649; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MITCHELL BD, 1995, DIABETES, V44, P1046, DOI 10.2337/diabetes.44.9.1046; Mitchell BD, 2000, DIABETES, V49, P513, DOI 10.2337/diabetes.49.3.513; Norman RA, 1997, AM J HUM GENET, V60, P166; Parker A, 2001, DIABETES, V50, P675, DOI 10.2337/diabetes.50.3.675; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shaw JTE, 1998, DIABETES, V47, P1793, DOI 10.2337/diabetes.47.11.1793; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Yamada T, 1996, POLYM REACT ENG, V4, P1; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	45	115	121	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					509	516		10.1086/338629	http://dx.doi.org/10.1086/338629			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791216	Green Published, Bronze			2022-12-18	WOS:000173254300021
J	Abney, M; McPeek, MS; Ober, C				Abney, M; McPeek, MS; Ober, C			Broad and narrow heritabilities of quantitative traits in a founder population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS; HERITAGE FAMILY; BLOOD-PRESSURE; MEXICAN-AMERICANS; RISK-FACTORS; PEDIGREES; RESEMBLANCE; LINKAGE; DISEASE; PLASMA	Estimation of the components of variance for a quantitative trait allows one to evaluate both the degree to which genetics influences the trait and the trait's underlying genetic architecture. For particular traits, the estimates also may have implications for discriminating between potential models of selection and for choosing an appropriate model for linkage analysis. Using a recently developed method, we estimate the additive and dominance components of variance-or, equivalently, the narrow and broad sense heritabilities-of several traits in the Hutterites, a founder population with extensive genealogical records. As a result of inbreeding and because Hutterite individuals are typically related through multiple lines of descent, we expect that power to detect dominance variance will be increased relative to that in outbred studies. Furthermore, the communal lifestyle of the Hutterites allows us to evaluate the genetic influences in a relatively homogeneous environment. Four phenotypes had a significant dominance variance, resulting in a relatively high broad heritability. We estimated the narrow and broad heritabilities as being, respectively, .36 and .96 for LDL, .51 and 1.0 for serotonin levels, and .45 and .76 for fat free mass (FFM). There was no significant additive component for systolic blood pressure (SBP), resulting in a narrow heritability of 0 and a broad heritability of .45. There were several traits for which we found no significant dominance component, resulting in equal broad and narrow heritability estimates. These traits and their heritabilities are as follows: HDL, .63; triglycerides, .37; diastolic blood pressure, .21; immunoglobulin E,.63; lipoprotein( a), .77; and body-mass index, .54. The large difference between broad and narrow heritabilities for LDL, serotonin, FFM, and SBP are indicative of strong dominance effects in these phenotypes. To our knowledge, this is the first study to report an estimate of heritability for serotonin and to detect a dominance variance for LDL, FFM, and SBP.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Abney, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01645, R29 HG001645, R01 HG001645] Funding Source: Medline; NHLBI NIH HHS [U01 HL049596] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; An P, 1999, AM J HYPERTENS, V12, P264, DOI 10.1016/S0895-7061(98)00261-1; BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3; Blangero J, 2000, HUM BIOL, V72, P35; Bleibtreu H., 1964, THESIS HARVARD U CAM; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BRENN T, 1994, ANN HUM GENET, V58, P369, DOI 10.1111/j.1469-1809.1994.tb00733.x; Charlesworth B, 2000, EVOL GENET, P369; Cheng LSC, 1998, HUM BIOL, V70, P59; Cloninger CR, 1998, AM J MED GENET, V81, P313, DOI 10.1002/(SICI)1096-8628(19980710)81:4<313::AID-AJMG7>3.0.CO;2-U; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; CRNOKRAK P, 1995, HEREDITY, V75, P530, DOI 10.1038/hdy.1995.169; Edwards KL, 1999, ARTERIOSCL THROM VAS, V19, P2456, DOI 10.1161/01.ATV.19.10.2456; Fisher R., 2005, TEACHING CHILDREN TH; HARRIS DL, 1964, GENETICS, V50, P1319; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V73, P265, DOI 10.1016/S0091-6749(84)80018-4; HOPP RJ, 1990, GENETIC ENV FACTORS; Hostetler J, 1974, HUTTERITE SOC; Jacquard A., 1974, GENETIC STRUCTURE PO; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MANGE AP, 1964, HUM BIOL, V36, P104; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Rainwater DL, 1997, ATHEROSCLEROSIS, V128, P223, DOI 10.1016/S0021-9150(96)05993-X; Rice T, 1997, OBES RES, V5, P557; Rotimi CN, 1999, HYPERTENSION, V33, P874, DOI 10.1161/01.HYP.33.3.874; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SPENCE MA, 1977, ANN HUM GENET, V41, P111, DOI 10.1111/j.1469-1809.1977.tb01968.x	32	115	116	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1302	1307		10.1086/320112	http://dx.doi.org/10.1086/320112			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309690	Green Published, Bronze			2022-12-18	WOS:000168171200026
J	Broman, KW; Weber, JL				Broman, KW; Weber, JL			Characterization of human crossover interference	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE MAP; SIZE-DEPENDENT CONTROL; MEIOTIC RECOMBINATION; MULTILOCUS RECOMBINATION; CHIASMA INTERFERENCE; HUMAN GENOME; RELATIVE EFFICIENCIES; POSITIVE INTERFERENCE; SYNAPTONEMAL COMPLEX; HUMAN CHROMOSOME-21	We present an analysis of crossover interference over the entire human genome, on the basis of genotype data from more than 8,000 polymorphisms in eight CEPH families. Overwhelming evidence was found for strong positive crossover interference, with average strength lying between the levels of interference implied by the Kosambi and Carter-Falconer map functions. Five mathematical models of interference were evaluated: the gamma model and four versions of the count-location model. The gamma model fit the data far better than did any of the other four models. Analysis of intercrossover distances was greatly superior to the analysis of crossover counts, in both demonstrating interference and distinguishing between the five models. In contrast to earlier suggestions, interference was found to continue uninterrupted across the centromeres. No convincing differences in the levels of interference were found between the sexes or among chromosomes; however, we did detect possible individual variation in interference among the eight mothers. Finally, we present an equation that provides the probability of the occurrence of a double crossover between two nonrecombinant, informative polymorphisms.	Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA	Johns Hopkins University	Broman, KW (corresponding author), Johns Hopkins Univ, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	kbroman@jhsph.edu		Broman, Karl/0000-0002-4914-6671	NHGRI NIH HHS [F32-HG000198] Funding Source: Medline; NHLBI NIH HHS [N01-HV48141] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000198] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; ATTWOOD J, 1994, GENOMICS, V19, P203, DOI 10.1006/geno.1994.1049; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P107, DOI 10.1002/gepi.1370050206; BLANK RD, 1988, GENETICS, V120, P1073; Brent R.P., 1973, ALGORITHMS MINIMIZAT; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Bugge M, 1998, HUM MOL GENET, V7, P661, DOI 10.1093/hmg/7.4.661; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COLLINS A, 1992, P NATL ACAD SCI USA, V89, P4598, DOI 10.1073/pnas.89.10.4598; COLLINS A, 1995, ANN HUM GENET, V59, P393, DOI 10.1111/j.1469-1809.1995.tb00758.x; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; Cox DR., 1962, RENEWAL THEORY; COX S, 1995, ANN HUM GENET, V59, P413, DOI 10.1111/j.1469-1809.1995.tb00760.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EGEL R, 1995, TRENDS GENET, V11, P206, DOI 10.1016/S0168-9525(00)89046-0; FISHER RA, 1947, HEREDITY, V1, P355, DOI 10.1038/hdy.1947.23; FORABOSCO P, 1995, ANN HUM GENET, V59, P291, DOI 10.1111/j.1469-1809.1995.tb00749.x; FOSS E, 1993, GENETICS, V133, P681; FOSS EJ, 1995, GENETICS, V139, P1201; GOLDGAR DE, 1988, AM J HUM GENET, V43, P38; GOLDGAR DE, 1989, GENOMICS, V5, P283, DOI 10.1016/0888-7543(89)90059-1; GOLDSTEIN DR, 1995, GENOMICS, V27, P265, DOI 10.1006/geno.1995.1041; Haines J L, 1993, Prog Clin Biol Res, V384, P51; Haldane JBS, 1919, J GENET, V8, P299; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; HULTEN M, 1974, HEREDITAS, V76, P55; HULTEN M, 1990, AM J MED GENET, P148; Kaback DB, 1996, NAT GENET, V13, P20, DOI 10.1038/ng0596-20; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kaback DB, 1999, GENETICS, V152, P1475; KARLIN S, 1994, THEOR POPUL BIOL, V46, P198, DOI 10.1006/tpbi.1994.1025; KARLIN S, 1978, P NATL ACAD SCI USA, V75, P6332, DOI 10.1073/pnas.75.12.6332; KARLIN S, 1979, ADV APPL PROBAB, V11, P479, DOI 10.2307/1426950; KINGSLEY DM, 1989, GENETICS, V123, P165; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LAWRENCE S, 1993, P NATL ACAD SCI USA, V90, P7210, DOI 10.1073/pnas.90.15.7210; Lin S, 1999, ANN HUM GENET, V63, P81, DOI 10.1046/j.1469-1809.1999.6310081.x; Lin SL, 1996, HUM HERED, V46, P315, DOI 10.1159/000154371; Manly B. F., 1997, RANDOMIZATION BOOTST; Mather K, 1938, BIOL REV CAMB PHILOS, V13, P252, DOI 10.1111/j.1469-185X.1938.tb00516.x; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MCPEEK MS, 1995, GENETICS, V139, P1031; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; MUNZ P, 1994, GENETICS, V137, P701; OTT J, 1996, GENETIC MAPPING DNA, V81, P49; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RISCH N, 1979, ANN HUM GENET, V43, P61, DOI 10.1111/j.1469-1809.1979.tb01549.x; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; SCHMITT K, 1994, AM J HUM GENET, V55, P423; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; SILVERMAN BW, 1996, DENSITY ESTIMATION S; SPEED TP, 1996, GENETIC MAPPING DNA, V81, P65; STURT E, 1976, ANN HUM GENET, V40, P147, DOI 10.1111/j.1469-1809.1976.tb00175.x; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Sunden SLF, 1996, GENOMICS, V32, P15, DOI 10.1006/geno.1996.0071; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; TANZI RE, 1992, AM J HUM GENET, V50, P551; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEEKS DE, 1994, GENETICS, V136, P1217; Weinstein A, 1936, GENETICS, V21, P155; Yu J, 1996, AM J HUM GENET, V59, P1186; YU K, 1998, AM J HUM GENET S, V63, pA225; ZAHN LM, 1995, GENOMICS, V28, P140, DOI 10.1006/geno.1995.1124; Zhao HY, 1996, GENETICS, V142, P1369; ZHAO HY, 1995, GENETICS, V139, P1057; ZHAO HY, 1995, GENETICS, V139, P1045	82	115	118	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1911	1926		10.1086/302923	http://dx.doi.org/10.1086/302923			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10801387	Bronze, Green Published			2022-12-18	WOS:000088373800019
J	Glaser, RL; Jiang, W; Boyadjiev, SA; Tran, AK; Zachary, AA; Van Maldergem, L; Johnson, M; Walsh, S; Oldridge, M; Wall, SA; Wilkie, AOM; Jabs, EW				Glaser, RL; Jiang, W; Boyadjiev, SA; Tran, AK; Zachary, AA; Van Maldergem, L; Johnson, M; Walsh, S; Oldridge, M; Wall, SA; Wilkie, AOM; Jabs, EW			Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	49th Annual Meeting of the American-Society-of-Human-Genetics	OCT 19-23, 1999	SAN FRANCISCO, CALIFORNIA	Amer Soc Human Genet			APERT-SYNDROME; GENE; ACHONDROPLASIA; IDENTIFICATION; INSERTIONS; AGE	Crouzon syndrome and Pfeiffer syndrome are both autosomal dominant craniosynostotic disorders that can be caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene. To determine the parental origin of these FGFR2 mutations, the amplification refractory mutation system (ARMS) was used, ARMS IS PCR primers were developed to recognize polymorphisms that could distinguish maternal and paternal alleles, A total of 4,374 bases between introns IIIa and 11 of the FGFR2 gene were sequenced and were assayed by heteroduplex analysis, to identify polymorphisms. Two polymorphisms (1333TA/TATA and 2710 C/T) were found and were used with two previously described polymorphisms, to screen a total of 41 families, Twenty-two of these families were shown to be informative (11 for Crouzon syndrome and 11 for Pfeiffer syndrome), Eleven different mutations in the 22 families mere detected by either restriction digest or allele-specific oligonucleotide hybridization of ARMS PCR products. We molecularly proved the origin of these different mutations to be paternal for all informative cases analyzed (P = 2.4 x 10(-7); 95% confidence limits 87%-100%). Advanced paternal age was noted for the fathers of patients with Crouzon syndrome or Pfeiffer syndrome, compared with the fathers of control individuals (34.50 +/- 7.65 years vs. 30.45 +/- 1.28 years, P < .01), Our data on advanced paternal age corroborates and extends previous clinical evidence based on statistical analyses as well as additional reports of advanced paternal age associated with paternal origin of three sporadic mutations causing Apert syndrome (FGFR2) and achondroplasia (FGFR3). Our results suggest that older men either have accumulated or are more susceptible to a variety of germline mutations.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Ctr Craniofacial Dev & Disorders, Dept Pediat, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Ctr Craniofacial Dev & Disorders, Dept Plast Surg, Baltimore, MD USA; Univ Maryland, Baltimore Coll Dent Surg, Dept Orthodont, Baltimore, MD 21201 USA; Ctr Genet Med, Inst Pathol & Genet, Loverval, Belgium; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Radcliffe Infirm, Oxford Craniofacial Unit, Oxford OX2 6HE, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Oxford; Radcliffe Infirmary	Jabs, EW (corresponding author), Johns Hopkins Sch Med, Inst Med Genet, Childrens Med & Surg Ctr 1004, 600 N Wolfe St, Baltimore, MD 21287 USA.		Wilkie, Andrew/AAC-3820-2020; jiang, wen/GYI-9662-2022; Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019; Jiang, Wen G./AAF-1876-2020	Wilkie, Andrew/0000-0002-2972-5481; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Jiang, Wen G./0000-0002-3283-1111; Jiang, Wen/0000-0002-3916-8826; Jabs, Ethylin/0000-0001-8983-5466	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007471] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 00052, M01 RR000052] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814, T32 GM07814, T32 GM7471, T32 GM007471] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AlQattan MM, 1997, J CRANIOFAC SURG, V8, P11, DOI 10.1097/00001665-199701000-00006; BELLUS GA, 1995, AM J HUM GENET, V56, P368; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; COHEN MM, 1992, CLIN GENET, V41, P12; COHEN MM, 1993, AM J MED GENET, V45, P300, DOI 10.1002/ajmg.1320450305; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; HELLER CG, 1963, SCIENCE, V140, P184, DOI 10.1126/science.140.3563.184; Jones K. L., 1997, SMITHS RECOGNIZABLE; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; Meyers GA, 1996, AM J HUM GENET, V58, P491; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; *OFF POP CENS SURV, 1960, REG GEN STAT REV E 2; *OFF POP CENS SURV, 1974, BIRTH STAT FM1; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; PENROSE LS, 1955, LANCET, V2, P312; PRYZLEPA KA, 1998, J CRANIOFAC GENET DE, V18, P6; Riccardi V M, 1988, Neurofibromatosis, V1, P93; RISCH N, 1987, AM J HUM GENET, V41, P218; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; URQUHART A, 1995, BIOTECHNIQUES, V18, P116; *US DEP HHS, 1967, VIT STAT US, V1; *US DEP HHS, 1994, VIT STAT US 1990, V1; *US DEP HHS, 1999, VIT STAT US 1993, V2; *US DEP HHS, 1988, VIT STAT US 1984, V1; *US DEP HHS, 1990, VIT STAT US 1988, V1; *US DEP HHS, 1993, VIT STAT US 1989, V1; *US DEP HHS, 1974, VIT STAT US 1969, V1; *US DEP HHS, 1989, VIT STAT US 1987, V1; *US DEP HHS, 1988, VIT STAT US 1986, V1; *US DEP HHS, 1995, VIT STAT US 1991, V1; *US DEP HHS, 1995, VIT STAT US 1992, V1; VOGEL F, 1975, ADV HUM GENET, V5, P223; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; ZACHARY AA, 1997, MANUAL CLIN LAB IMMU, P1141	41	115	124	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					768	777		10.1086/302831	http://dx.doi.org/10.1086/302831			10	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712195	Green Published, Bronze			2022-12-18	WOS:000088373200003
J	Xu, JF				Xu, JF		Int Consortium Prostate Cancer Gen	Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium For Prostate Cancer Genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; CHROMOSOME 1Q; HISTORY; INHERITANCE; HPC1; RISK	A previous linkage study provided evidence for a prostate cancer-susceptibility locus at 1q24-25. Subsequent reports in additional collections of families have yielded conflicting results. In addition, evidence for locus heterogeneity has been provided by the identification of other putative hereditary prostate cancer loci on Xq27-28, 1q42-43, and 1p36. The present study describes a combined analysis for six markers in the 1q24-25 region in 772 families affected by hereditary prostate cancer and ascertained by the members of the International Consortium for Prostate Cancer Genetics (ICPCG) from North America, Australia, Finland, Norway, Sweden, and the United Kingdom. Overall, there was some evidence for linkage, with a peak parametric multipoint LOD score assuming heterogeneity (HLOD) of 1.40 (P = .01) at D1S212. The estimated proportion of families (a) linked to the locus was .06 (1-LOD support interval .01-.12). This evidence was not observed by a nonparametric approach, presumably because of the extensive heterogeneity. Further parametric analysis revealed a significant effect of the presence of male-to-male disease transmission within the families. In the subset of 491 such families, the peak HLOD was 2.56 (P = .0006) and alpha =.11 (1-LOD support interval .04-.19), compared with HLODs of 0 in the remaining 281 families. Within the families with male-to-male disease transmission, a increased with the early mean age at diagnosis (<65 years, alpha = .19, with 1-LOD support interval .06-.34) and the number of affected family members (five or more family members, alpha =.15, with 1-LOD support interval .04-.28). The highest value of alpha was observed for the 48 families that met all three criteria (peak HLOD = 2.25, P = .001, alpha =.29, with 1-LOD support interval .08-.53). These results support the finding of a prostate cancer-susceptibility gene linked to 1q24-25, albeit in a defined subset of prostate cancer families. Although HPC1 accounts for only a small proportion of all families affected by hereditary prostate cancer, it appears to play a more prominent role in the subset of families with several members affected at an early age and with male-to-male disease transmission.	Univ Maryland, Sch Med, Program Human Genet, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Xu, JF (corresponding author), Univ Maryland, Sch Med, Program Human Genet, 100 N Greene Str,Suite 211, Baltimore, MD 21201 USA.		Smith, Jeff/C-3484-2012	Simard, Jacques/0000-0001-6906-3390; Smith, Jeffrey/0000-0001-8424-910X; Schleutker, Johanna/0000-0002-1863-0305	NATIONAL CANCER INSTITUTE [P50CA069568, R01CA072818, R01CA056678, P50CA058236] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA069568, R01 CA056678, R01 CA072818, P50 CA058236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Ott J., 1991, ANAL HUMAN GENETIC L; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; SKOLNICK M, 1979, SOCIOL SOC RES, V63, P506; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	26	115	116	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					945	957		10.1086/302807	http://dx.doi.org/10.1086/302807			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712209	Green Published, Bronze			2022-12-18	WOS:000088373200017
J	Rioux, JD; Stone, VA; Daly, MJ; Cargill, M; Green, T; Nguyen, H; Nutman, T; Zimmerman, PA; Tucker, MA; Hudson, T; Goldstein, AM; Lander, E; Lin, AY				Rioux, JD; Stone, VA; Daly, MJ; Cargill, M; Green, T; Nguyen, H; Nutman, T; Zimmerman, PA; Tucker, MA; Hudson, T; Goldstein, AM; Lander, E; Lin, AY			Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLONY-STIMULATING FACTOR; HUMAN INTERLEUKIN-5 GENE; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; MULTILOCUS LINKAGE ANALYSIS; CORE-BINDING-FACTOR; MESSENGER-RNA; 3T3 FIBROBLASTS; HUMAN GENOME; EXPRESSION; PROMOTER	Familial eosinophilia (FE) is an autosomal dominant disorder characterized by peripheral hypereosinophilia of unidentifiable cause with or without other organ involvement. To localize the gene for FE, we performed a genomewide search in a large U.S. kindred, using 312 different polymorphic markers. Seventeen affected subjects, 28 unaffected bloodline relatives, and 8 spouses were genotyped. The initial linkage results from the genome scan provided evidence for linkage on chromosome 5q31-q33. Additional genotyping of genetic markers located in this specific region demonstrated significant evidence that the FE locus is situated between the chromosome 5q markers D5S642 and D5S816 (multipoint LOD score of 6.49). Notably, this region contains the cytokine gene cluster, which includes three genes-namely, those for interleukin (IL)-3, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF)-whose products play important roles in the development and proliferation of eosinophils. These three cytokine genes were screened for potential disease-specific mutations by resequencing of a subgroup of individuals from the present kindred. No functional sequence polymorphisms were found within the promoter, the exons, or the introns of any of these genes or within the IL-3/CM-CSF enhancer, suggesting that the primary defect in FE is not caused by a mutation in any one of these genes but, rather, is caused by another gene in the area.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rioux, JD (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rioux@genome.wi.mit.edu	Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015; Tucker, Margaret A/B-4297-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; 				BARANGER L, 1994, BRIT J HAEMATOL, V88, P343, DOI 10.1111/j.1365-2141.1994.tb05029.x; BAUMGARTEN E, 1989, ACTA HAEMATOL-BASEL, V82, P85; BERKOWICZ M, 1991, CANCER GENET CYTOGEN, V51, P277, DOI 10.1016/0165-4608(91)90142-H; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; CHIHARA J, 1990, J EXP MED, V172, P1347, DOI 10.1084/jem.172.5.1347; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COUSINS DJ, 1994, AM J RESP CRIT CARE, V150, pS50, DOI 10.1164/ajrccm/150.5_Pt_2.S50; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; DESREUMAUX P, 1993, BLOOD, V82, P1553; DESREUMAUX P, 1992, J EXP MED, V175, P293, DOI 10.1084/jem.175.1.293; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; ENGELAND K, 1995, J BIOL CHEM, V270, P24572, DOI 10.1074/jbc.270.41.24572; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; FERMAND JP, 1993, BRIT J HAEMATOL, V83, P359, DOI 10.1111/j.1365-2141.1993.tb04657.x; Gaugain M., 1909, SEMIN MED, V29, P329; GOH KO, 1985, CANCER, V55, P2395, DOI 10.1002/1097-0142(19850515)55:10<2395::AID-CNCR2820551016>3.0.CO;2-U; GRUARTGOUILLEUX V, 1995, EUR J IMMUNOL, V25, P1431, DOI 10.1002/eji.1830250544; HARDY WR, 1968, ANN INTERN MED, V68, P1220, DOI 10.7326/0003-4819-68-6-1220; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; HOGAN TF, 1987, J CLIN ONCOL, V5, P382, DOI 10.1200/JCO.1987.5.3.382; JANI K, 1994, BRIT J HAEMATOL, V87, P57, DOI 10.1111/j.1365-2141.1994.tb04870.x; Karlen S, 1996, BLOOD, V88, P211; Karlen S, 1996, IMMUNOL CELL BIOL, V74, P218, DOI 10.1038/icb.1996.31; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee NA, 1997, J IMMUNOL, V158, P1332; Lin AY, 1998, AM J MED GENET, V76, P229, DOI 10.1002/(SICI)1096-8628(19980319)76:3<229::AID-AJMG6>3.0.CO;2-L; LOPEZ AF, 1989, P NATL ACAD SCI USA, V86, P7022, DOI 10.1073/pnas.86.18.7022; MATSUSHIMA T, 1994, LEUKEMIA LYMPHOMA, V15, P491, DOI 10.3109/10428199409049753; MIYATAKE S, 1985, EMBO J, V4, P2561, DOI 10.1002/j.1460-2075.1985.tb03971.x; MOQBEL R, 1991, J EXP MED, V174, P749, DOI 10.1084/jem.174.3.749; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAIMAN JL, 1964, AM J HUM GENET, V16, P195; Nimer S, 1996, BLOOD, V88, P66, DOI 10.1182/blood.V88.1.66.bloodjournal88166; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; PARRILLO JE, 1978, ANN INTERN MED, V89, P167, DOI 10.7326/0003-4819-89-2-167; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SCHREZENMEIER H, 1993, EXP HEMATOL, V21, P358; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STAYNOV DZ, 1995, P NATL ACAD SCI USA, V92, P3606, DOI 10.1073/pnas.92.8.3606; Stranick KS, 1997, J BIOL CHEM, V272, P16453, DOI 10.1074/jbc.272.26.16453; Taylor DS, 1996, J BIOL CHEM, V271, P14020, DOI 10.1074/jbc.271.24.14020; VAUX DL, 1990, INT IMMUNOL, V2, P965, DOI 10.1093/intimm/2.10.965; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; WELLER PF, 1991, NEW ENGL J MED, V324, P1110; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; YATES P, 1991, CLIN LAB HAEMATOL, V13, P211	55	115	120	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1086	1094		10.1086/302053	http://dx.doi.org/10.1086/302053			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758611	Green Published, Bronze			2022-12-18	WOS:000076577800022
J	Telatar, M; Teraoka, S; Wang, ZJ; Chun, HH; Liang, T; Castellvi-Bel, S; Udar, N; Borresen-Dale, AL; Chessa, L; Bernatowska-Matuszkiewicz, E; Porras, O; Watanabe, M; Junker, A; Concannon, P; Gatti, RA				Telatar, M; Teraoka, S; Wang, ZJ; Chun, HH; Liang, T; Castellvi-Bel, S; Udar, N; Borresen-Dale, AL; Chessa, L; Bernatowska-Matuszkiewicz, E; Porras, O; Watanabe, M; Junker, A; Concannon, P; Gatti, RA			Ataxia-telangiectasia: Identification and detection of founder-effect mutations in the ATM gene in ethnic populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIES; CANCER; FREQUENCY; BREAST; LOCUS	To facilitate the evaluation of ATM heterozygotes for susceptibility to other diseases, such as breast cancer, we have attempted to define the most common mutations and their frequencies in ataxia-telangiectasia (A-T) homozygotes from 10 ethnic populations. Both genomic mutations and their effects on cDNA were characterized. Protein-truncation testing of the entire ATM cDNA detected 92 (66%) truncating mutations in 140 mutant alleles screened. The haplotyping of patients with identical mutations indicates that almost all of these represent common ancestry and that very few spontaneously recurring ATM mutations exist. Assays requiring minimal amounts of genomic DNA were designed to allow rapid screening for common ethnic mutations. These rapid assays detected mutations in 76% of Costa Rican patients (3), 50% of Norwegian patients (1), 25% of Polish patients (4), and 14% of Italian patients (1), as well as in patients of Amish/Mennonite and Irish English backgrounds. Additional mutations were observed in Japanese, Utah Mormon, and African American patients. These assays should facilitate screening for A-T heterozygotes in the populations studied.	Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Univ Washington, Sch Med, Virginia Mason Res Ctr, Seattle, WA USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; Norwegian Radium Hosp, Dept Genet, Oslo, Norway; Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; Childrens Mem Hosp, Warsaw, Poland; Natl Childrens Hosp, Dept Immunol, San Jose, Costa Rica; Gunma Univ, Dept Neurol, Gunma, Japan; British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Oslo; Sapienza University Rome; Children's Memorial Health Institute; Gunma University; BC Childrens Hospital; University of British Columbia	Gatti, RA (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.	rgatti@pathology.medsch.ucla.edu		Castellvi-Bel, Sergi/0000-0003-1217-5097; Udar, Nitin/0000-0001-8533-9190; Concannon, Patrick/0000-0002-5801-1859; Bernatowska, Ewa/0000-0002-0125-266X	NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER; NCI NIH HHS [CA57569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; Beaudet AL, 1996, HUM MUTAT, V8, P197; BODER E, 1958, PEDIATRICS, V21, P526; BODER E, 1985, ATAXIA TELANGIECTASI, P1; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; BUNDEY S, 1994, INT J RADIAT BIOL, V66, pS23; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; CURRY CJR, 1989, AM J HUM GENET, V45, P270; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1994, INT J RADIAT BIOL, V66, pS57, DOI 10.1080/09553009414551861; GATTI RA, 1997, METABOLIC MOL BASIS; Gilad S, 1996, HUM MOL GENET, V5, P2033, DOI 10.1093/hmg/5.12.2033; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Hostetler John A., 1983, MENNONITE LIFE; HUE YK, 1994, CANCER RES, V54, P2544; Lakin ND, 1996, ONCOGENE, V13, P2707; LANGE E, 1995, AM J HUM GENET, V57, P112; LANGE E, 1993, ATAXIA TELANGIECTASI, P37; LIU Q, 1995, BIOTECHNIQUES, V18, P470; McConville CM, 1996, AM J HUM GENET, V59, P320; PIPPARD EC, 1988, CANCER RES, V48, P2929; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; POHL KRE, 1992, J PEDIATR-US, V121, P405, DOI 10.1016/S0022-3476(05)81795-0; RASIO D, 1995, CANCER RES, V55, P6053; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1994, INT J RADIAT BIOL, V66, pS35, DOI 10.1080/09553009414551841; Telatar M, 1996, AM J HUM GENET, V59, P40; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; VANAGAITE L, 1995, HUM GENET, V95, P451; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, EUR J HUM GENET, V4, P352; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; WOODS CG, 1992, Q J MED, V82, P169; Wright J, 1996, AM J HUM GENET, V59, P839	44	115	123	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					86	97		10.1086/301673	http://dx.doi.org/10.1086/301673			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443866	Green Published, Bronze			2022-12-18	WOS:000072127900014
J	Lohmann, DR; Gerick, M; Brandt, B; Oelschlager, U; Lorenz, B; Passarge, E; Horsthemke, B				Lohmann, DR; Gerick, M; Brandt, B; Oelschlager, U; Lorenz, B; Passarge, E; Horsthemke, B			Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENIC POINT MUTATIONS; TUMOR-SUPPRESSOR GENE; RNA SPLICE JUNCTIONS; GERM-LINE MUTATIONS; RB1 GENE; HEREDITARY RETINOBLASTOMA; SOMATIC MOSAICISM; GEL-ELECTROPHORESIS; CPG ISLAND; DNA	In most patients with isolated unilateral retinoblastoma, tumor development is initiated by somatic inactivation of both alleles of the RB1 gene. However, some of these Patients can transmit retinoblastoma predisposition to their offspring. To determine the frequency and nature of constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma, we analyzed DNA from peripheral blood and from tumor tissue, The analysis of tumors from 54 (71%) of 76 informative patients showed loss of constitutional heterozygosity (LOH) at intragenic loci,Three of 13 uninformative patients had constitutional deletions. For 39 randomly selected tumors, SSCP, heteroduplex analysis, sequencing, and Southern blot analysis were used to identify mutations. Mutations were detected in 21 (91%) of 23 tumors with LOH, In 6 (38%) of 16 tumors without LOH, one mutation was detected, and in 9 (56%) of the tumors without LOH, both mutations were found. Thus, a Petal of 45 mutations were identified in tumors of 36 patients. Thirty-nine of the mutations-including 33 small mutations, 2 large structural alterations, and hypermethylation in 3 tumors-were not detected in the corresponding peripheral blood DNA. En 6 (17%) of the 36 patients, a mutation was detected in constitutional DNA, and 1 of these mutations is known to be associated with reduced expressivity. The presence of a constitutional mutation was not associated with an early age at treatment. In 1 patient, somatic mosaicism was demonstrated by molecular analysis of DNA and RNA from peripheral blood. In 2 patients without a detectable mutation in peripheral blood, mosaicism was suggested because 1 of the patients showed multifocal tumors and the other later developed bilateral retinoblastoma, In conclusion, our results emphasize that the manifestation and;1 transmissibility of retinoblastoma depend on the nature of the first mutation, its time in development, and the number and types of cells that are affected.	UNIV ESSEN GESAMTHSCH KLINIKUM,ZENTRUM AUGENHEILKUNDE,D-45122 ESSEN,GERMANY; UNIV REGENSBURG,ABT KINDEROPHTHALMOL STRABISMOL & OPHTHALMOGENET,D-8400 REGENSBURG,GERMANY	University of Duisburg Essen; University of Regensburg	Lohmann, DR (corresponding author), UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMANGENET,HUFELANDSTR 55,D-45122 ESSEN,GERMANY.		Lohmann, Dietmar R/B-4041-2013; Lohmann, Dietmar R./X-4895-2019	Lohmann, Dietmar R/0000-0002-2624-9889; Lohmann, Dietmar R./0000-0002-2624-9889				ABRAMSON DH, 1994, BRIT J OPHTHALMOL, V78, P698, DOI 10.1136/bjo.78.9.698; *AD HOC COMM MUT N, 1996, HUM MUTAT, V8, P197; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; BLANQUET V, 1993, HUM MOL GENET, V2, P975, DOI 10.1093/hmg/2.7.975; BOURN D, 1994, AM J HUM GENET, V55, P69; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRANDT B, 1992, AM J HUM GENET, V51, P1450; BRIARDGUILLEMOT ML, 1974, HUMANGENETIK, V24, P271, DOI 10.1007/BF00297591; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; BROWN S, 1995, AM J HUM GENET, V57, P859; BUNIN GR, 1989, J NATL CANCER I, V81, P370, DOI 10.1093/jnci/81.5.370; CARLSON EA, 1979, AM J MED GENET, V4, P365, DOI 10.1002/ajmg.1320040408; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colman SD, 1996, AM J HUM GENET, V58, P484; Cowell JK, 1996, ONCOGENE, V12, P431; Cowell JK, 1996, EUR J CANCER, V32A, P1749, DOI 10.1016/0959-8049(96)00201-8; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; EJIMA Y, 1988, HUM GENET, V79, P118, DOI 10.1007/BF00280548; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GREGER V, 1994, HUM GENET, V94, P491; GREGER V, 1988, J MED GENET, V25, P217, DOI 10.1136/jmg.25.4.217; GREGER V, 1990, AM J HUM GENET, V46, P1187; HALL JG, 1988, AM J HUM GENET, V43, P355; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herrmann J, 1976, Birth Defects Orig Artic Ser, V12, P79; HOGG A, 1992, ONCOGENE, V7, P1445; HOGG A, 1993, P NATL ACAD SCI USA, V90, P7351, DOI 10.1073/pnas.90.15.7351; Kato MV, 1996, AM J HUM GENET, V59, P1084; KATO MV, 1995, INT J CANCER, V64, P3, DOI 10.1002/ijc.2910640103; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Lohmann DR, 1996, AM J HUM GENET, V58, P940; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; LOHMANN DR, 1994, HUM GENET, V94, P491; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MATSUNAGA E, 1976, HUM GENET, V33, P1, DOI 10.1007/BF00447281; MATSUNAGA E, 1980, HUM GENET, V56, P53; MUNIER FL, 1994, OPHTHALMIC GENET, V15, P101, DOI 10.3109/13816819409057835; Musarella M A, 1987, J Pediatr Ophthalmol Strabismus, V24, P124; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Noorani HZ, 1996, AM J HUM GENET, V59, P301; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; RIBEIRO MCM, 1988, CANCER GENET CYTOGEN, V32, P169, DOI 10.1016/0165-4608(88)90279-8; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; SAKAI T, 1991, AM J HUM GENET, V48, P880; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMIZU T, 1994, AM J HUM GENET, V54, P793; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; TOGUCHIDA J, 1993, GENOMICS, V17, P535, DOI 10.1006/geno.1993.1368; VOGEL F, 1979, HUM GENET, V52, P1; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153; YANDELL DW, 1989, AM J HUM GENET, V45, P547; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; YANDELL DW, 1991, AM J HUM GENET S, V49, pA45; ZHU X, 1992, CYTOGENET CELL GENET, V59, P248, DOI 10.1159/000133261	69	115	119	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					282	294		10.1086/514845	http://dx.doi.org/10.1086/514845			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311732	Green Published, Bronze			2022-12-18	WOS:A1997XX70100005
J	ELLIS, NA; LENNON, DJ; PROYTCHEVA, M; ALHADEFF, B; HENDERSON, EE; GERMAN, J				ELLIS, NA; LENNON, DJ; PROYTCHEVA, M; ALHADEFF, B; HENDERSON, EE; GERMAN, J			SOMATIC INTRAGENIC RECOMBINATION WITHIN THE MUTATED LOCUS BLM CAN CORRECT THE HIGH SISTER-CHROMATID EXCHANGE PHENOTYPE OF BLOOM-SYNDROME CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPSTEIN-BARR; LYMPHOCYTES; INVIVO	Cells from persons with Bloom syndrome feature an elevated rate of sister-chromatid exchange (SCE). However, in some affected persons a minority of blood lymphocytes have a normal SCE rate. Persons who inherit the Bloom syndrome gene BLM identical by descent from a common ancestor very rarely exhibit this high-SCE/low-SCE mosaicism; conversely, mosaicism arises predominantly in persons who do not share a common ancestor. These population data suggested that most persons with Bloom syndrome in whom the exceptional low-SCE cells arise are not homozygous for a mutation at BLM but instead are compound heterozygotes. Following this clue, we carried out a genotype analysis of loci syntenic with BLM in 11 persons who exhibited mosaicism. In five of them, polymorphic loci distal to BLM that were heterozygous in their high-SCE cells had become homozygous in their low-SCE cells, whereas heterozygous loci proximal to BLM remained heterozygous. These observations are interpreted to mean that intragenic recombination between paternally derived and maternally derived mutated sites within BLM can generate a functionally wild-type gene and that low-SCE lymphocytes are progeny of a somatic cell in which such intragenic recombination had occurred.	TEMPLE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19122	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	ELLIS, NA (corresponding author), NEW YORK BLOOD CTR,HUMAN GENET LAB,310 E 67TH ST,NEW YORK,NY 10021, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004134] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050897] Funding Source: NIH RePORTER; NCI NIH HHS [CA50897] Funding Source: Medline; NICHD NIH HHS [HD04134] Funding Source: Medline; NIGMS NIH HHS [GM1116802] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BRYANT EM, 1979, NATURE, V279, P795, DOI 10.1038/279795a0; BUBLEY G, 1986, P AM ASSOC CANC RES, V27, P101; CAVANEE WK, 1985, SCIENCE, V228, P501; ELLIS NA, 1994, AM J HUM GENET, V55, P453; GERMAN J, 1989, CLIN GENET, V35, P57; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1977, AM J HUM GENET, V29, P248; German J., 1994, American Journal of Human Genetics, V55, pA152; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GERMAN J, 1994, CURRENT PROTOCOLS HU; GERMAN J, IN PRESS CLIN GENET; GERMAN J, 1980, GENETIC ENV FACTORS, P175; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; GUPTA RS, 1980, MUTAT RES, V73, P331, DOI 10.1016/0027-5107(80)90198-0; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; HENDERSON E, 1978, J SUPRAMOL STRUCT S, V2, P83; KUHN EM, 1985, HUM GENET, V70, P1, DOI 10.1007/BF00389448; KUSUNOKI Y, 1994, JPN J CANCER RES, V85, P610, DOI 10.1111/j.1349-7006.1994.tb02403.x; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; PONTECORVO G, 1958, ADV GENET, V9, P71, DOI 10.1016/S0065-2660(08)60160-1; RAY JH, 1983, CHROMOSOME MUTATION, P135; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; SHIRAISHI Y, 1983, CANCER RES, V43, P3836; Stern C, 1936, GENETICS, V21, P625; VIJAYALAXMI H J E, 1983, Science (Washington D C), V221, P851; WARREN ST, 1981, P NATL ACAD SCI-BIOL, V78, P3133, DOI 10.1073/pnas.78.5.3133; WEKSBERG R, 1988, AM J HUM GENET, V42, P816	30	115	118	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1019	1027						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485150				2022-12-18	WOS:A1995TA44900006
J	CRADDOCK, N; KHODEL, V; VANEERDEWEGH, P; REICH, T				CRADDOCK, N; KHODEL, V; VANEERDEWEGH, P; REICH, T			MATHEMATICAL LIMITS OF MULTILOCUS MODELS - THE GENETIC TRANSMISSION OF BIPOLAR DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; FAMILIAL TRANSMISSION; LINKAGE STRATEGIES; COMPLEX TRAITS; RELIABILITY; SEGREGATION; DIAGNOSIS; RELATIVES; UNIPOLAR; PROBANDS	We describe a simple, graphical method for determining plausible modes of inheritance for complex traits and apply this to bipolar disorder. The constraints that allele frequencies and penetrances lie in the interval 0-1 impose limits on recurrence risks, K-R, in relatives of an affected proband for a given population prevalence, K-p. We have investigated these limits for K-R in three classes of relatives (MZ co-twin, sibling, and parent/offspring) for the general single-locus model and for two types of multilocus models: heterogeneity and multiplicative. In our models we have assumed Hardy-Weinberg equilibrium, an all-or-none trait, absence of nongenetic resemblance between relatives, and negligible mutation at the disease loci. Although the true values of K-p and the K-R'S are only approximately known, observed population and family data for bipolar disorder are inconsistent with a single-locus model or with any heterogeneity model. In contrast, multiplicative models involving three or more loci are consistent with observed data and, thus, represent plausible models for the inheritance of bipolar disorder. Studies to determine the genetic basis of most bipolar disorder should use methods capable of detecting interacting oligogenes.	UNIV WASHINGTON,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO	Washington University (WUSTL)					NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401, U10AA008403] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA08403, AA08401] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1981, ARCH GEN PSYCHIAT, V38, P400; ASHERSON P, 1994, AM J HUM GENET, V54, P386; BUCHER KD, 1981, J PSYCHIAT RES, V16, P65, DOI 10.1016/0022-3956(81)90014-5; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CRADDOCK N, 1993, ANN MED, V25, P317, DOI 10.3109/07853899309147291; CRADDOCK N, 1995, THESIS U WALES COLLE; CROWE RR, 1977, J PSYCHIATR RES, V13, P273, DOI 10.1016/0022-3956(77)90015-2; DEFRISEGUSSENHO.E, 1962, ACTA GENET STAT MED, V12, P65; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GILLIGAN SB, 1989, GENET EPIDEMIOL, V6, P241, DOI 10.1002/gepi.1370060142; Giuffra L. A., 1992, American Journal of Human Genetics, V51, pA150; GOLDIN LR, 1983, AM J HUM GENET, V35, P274; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P699; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MCGUFFIN P, 1986, BIOL DEPRESSION, P26; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1990, AM J HUM GENET, V46, P219; PAULS DL, 1992, ARCH GEN PSYCHIAT, V49, P703; REICH T, 1987, J PSYCHIAT RES, V21, P613, DOI 10.1016/0022-3956(87)90112-9; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; RICE JP, 1986, PSYCHIAT RES, V19, P285, DOI 10.1016/0165-1781(86)90121-6; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; SHAM PC, 1991, PSYCHIAT GENET, V2, P175, DOI DOI 10.1097/00041444-199203000-00002; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; SUAREZ BK, 1976, ANN HUM GENET, V40, P321; VANEERDEWEGH P, 1993, PSYCHIATR GENET, V3, P188	32	115	115	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					690	702						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668299				2022-12-18	WOS:A1995RR60500020
J	NATHANS, J; MAUMENEE, IH; ZRENNER, E; SADOWSKI, B; SHARPE, LT; LEWIS, RA; HANSEN, E; ROSENBERG, T; SCHWARTZ, M; HECKENLIVELY, JR; TRABOULSI, E; KLINGAMAN, R; BECHHANSEN, NT; LAROCHE, GR; PAGON, RA; MURPHEY, WH; WELEBER, RG				NATHANS, J; MAUMENEE, IH; ZRENNER, E; SADOWSKI, B; SHARPE, LT; LEWIS, RA; HANSEN, E; ROSENBERG, T; SCHWARTZ, M; HECKENLIVELY, JR; TRABOULSI, E; KLINGAMAN, R; BECHHANSEN, NT; LAROCHE, GR; PAGON, RA; MURPHEY, WH; WELEBER, RG			GENETIC-HETEROGENEITY AMONG BLUE-CONE MONOCHROMATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; HUMAN COLOR-VISION; MOLECULAR-GENETICS; CYSTEINE RESIDUE-110; HUMAN RED; GREEN; ACHROMATOPSIA; RHODOPSIN; DELETION; EXPRESSION	Thirty-three unrelated subjects with blue-cone monochromacy or closely related variants of blue-cone monochromacy were examined for rearrangements in the tandem array of genes encoding the red- and green-cone pigments. In 24 subjects, eight genotypes were found that would be predicted to eliminate the function of all of the genes within the array. As observed in an earlier study, the rearrangements involve either deletion of a locus control region adjacent to the gene array or loss of function via homologous recombination and point mutation. One inactivating mutation, Cys203-to-Arg, was found in 15 probands who carry single genes and in both visual pigment genes in one subject whose array has two genes. This mutation was also found in at least one of the visual pigment genes in 1 subject whose array has multiple genes and in 2 of 321 control subjects, suggesting that preexisting Cys203-to-Arg mutations constitute a reservoir of chromosomes that are predisposed to generate blue-cone-monochromat genotypes by unequal homologous recombination and/or gene conversion. Two other point mutations were identified: (a) Arg247-to-Ter in one subject with a single red-pigment gene and (b) Pro307-to-Leu in one subject with a single 5' red-3' green hybrid gene. The observed heterogeneity of genotypes points to the existence of multiple one- and two-step mutational pathways to blue-cone monochromacy.	JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT GENET NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, WILMER EYE INST, BALTIMORE, MD 21205 USA; UNIV EYE HOSP, TUBINGEN, GERMANY; UNIV FREIBURG, NEUROL KLIN, W-7800 FREIBURG, GERMANY; BAYLOR COLL MED, CULLEN EYE INST, HOUSTON, TX 77030 USA; UNIV OSLO, NATL HOSP, DEPT OPHTHALMOL, OSLO 3, NORWAY; ALBERTA CHILDRENS PROV GEN HOSP, CALGARY T2T 5C7, ALBERTA, CANADA; IZAAK WALTON KILLAM HOSP CHILDREN, HALIFAX B3J 3G9, NS, CANADA; UNIV CALIF LOS ANGELES, SCH MED, JULES STEIN EYE INST, LOS ANGELES, CA USA; NATL EYE CLIN, HELLERUP, DENMARK; UNIV COPENHAGEN HOSP, DEPT PEDIAT, DK-2100 COPENHAGEN, DENMARK; SO COLL OPT, MEMPHIS, TN USA; UNIV WASHINGTON, SCH MED, DEPT PEDIAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA; OREGON HLTH SCI UNIV, DEPT OPHTHALMOL, PORTLAND, OR 97201 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; Baylor College of Medicine; University of Oslo; National Hospital Norway; Alberta Childrens Hospital; University of Calgary; Dalhousie University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	NATHANS, J (corresponding author), JOHNS HOPKINS UNIV, SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC BIOL, PCTB 805, 725 N WOLFE ST, BALTIMORE, MD 21205 USA.		Traboulsi, Elias/AAY-7443-2020	Nathans, Jeremy/0000-0001-8106-5460				ALPERN M, 1974, INVEST OPHTH VISUAL, V13, P648; ANDREASSON S, 1991, ACTA OPHTHALMOL, V69, P711; BLACKWELL HR, 1961, VISION RES, V1, P62, DOI 10.1016/0042-6989(61)90022-0; Boynton R. M., 1979, HUMAN COLOR VISION; CURTIN P, 1985, J CLIN INVEST, V76, P1554, DOI 10.1172/JCI112136; DEEB SS, 1992, AM J HUM GENET, V51, P687; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; FLEISCHMAN JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P468, DOI 10.1001/archopht.1981.03930010470016; HANSEN E, 1979, ACTA OPHTHALMOL, V57, P211; HESS RF, 1989, J PHYSIOL-LONDON, V417, P123, DOI 10.1113/jphysiol.1989.sp017794; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; MURRAY NE, 1977, MOL GEN GENET, V150, P53, DOI 10.1007/BF02425325; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PAGON RA, 1987, OPHTHALMIC PAEDIATR, V9, P43; POKORNY J., 1979, CONGENITAL ACQUIRED; REITNER A, 1991, NATURE, V352, P798, DOI 10.1038/352798a0; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TARAMELLI R, 1986, NUCLEIC ACIDS RES, V14, P7017, DOI 10.1093/nar/14.17.7017; VANDERPLOEG LHT, 1980, NATURE, V283, P637, DOI 10.1038/283637a0; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251; WINDERICKX J, 1992, P NATL ACAD SCI USA, V89, P9710, DOI 10.1073/pnas.89.20.9710	28	115	117	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					987	1000						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213841				2022-12-18	WOS:A1993MC33300002
J	BODNAR, AG; COOPER, JM; HOLT, IJ; LEONARD, JV; SCHAPIRA, AHV				BODNAR, AG; COOPER, JM; HOLT, IJ; LEONARD, JV; SCHAPIRA, AHV			NUCLEAR COMPLEMENTATION RESTORES MTDNA LEVELS IN CULTURED-CELLS FROM A PATIENT WITH MTDNA DEPLETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY; ANIMAL MITOCHONDRIAL-DNA; PARKINSONS-DISEASE; REPLICATION; RNA	We have studied cultured skin fibroblasts from a patient with a fatal mitochondrial disease manifesting soon after birth. These fibroblasts were found to grow only in the presence of pyruvate and uridine, a characteristic of cells lacking mtDNA (rho0 cells). Southern blot and PCR analyses confirmed that the patient's fibroblasts contained less than 2% of control levels of mtDNA. Biochemical analyses indicated that the activities of all the respiratory-chain enzymes were severely decreased in mitochondria isolated from these fibroblasts. In order to elucidate the underlying molecular defect, cell fusions were performed between enucleated fibroblasts from this patient and a human-derived rho0 cell line (rho0A549.B2). The resulting cybrids were plated in medium lacking pyruvate and uridine, to select for the restoration of respiratory-chain function. Complementation was observed between the nuclear genome of the rh0A549.B2 cells and the mtDNA of the patient's cells, restoring mtDNA levels and respiratory-chain function in the cybrid cells. These results indicate that mtDNA depletion in our patient is under the control of the nuclear genome.	ROYAL FREE HOSP,SCH MED,DEPT NEUROL SCI,ROWLAND HILL ST,LONDON NW3 2PF,ENGLAND; UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,LONDON,ENGLAND; INST CHILD HLTH,MED UNIT,LONDON WC1N 1EH,ENGLAND; UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT BIOCHEM MED,DUNDEE DD1 9SY,SCOTLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; University of Dundee			Schapira, Anthony H V/A-1245-2010; Cooper, J Mark/D-5826-2013	Schapira, Anthony H V/0000-0002-3018-3966; Cooper, J Mark/0000-0002-3007-3054; holt, ian/0000-0001-5468-0193	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CLAYTON PT, 1986, EUR J PEDIATR, V145, P46, DOI 10.1007/BF00441851; COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; DESJARDINS P, 1986, SOMAT CELL MOLEC GEN, V12, P133, DOI 10.1007/BF01560660; FORD N, 1989, MOL CLONING LABORATO; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HARDING AE, 1991, BRIT MED J, V303, P377, DOI 10.1136/bmj.303.6799.377; HAUSWIRTH WW, 1987, MITOCHONDRIA, P171; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; King T. E., 1967, METHODS ENZYMOLOGY, V10, P216; KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; LEONARD JV, 1991, EUR J PEDIATR, V150, P198, DOI 10.1007/BF01963566; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN GM, 1973, TISSUE CULTURE METHO, P39; MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X; MORAES CT, 1991, AM J HUM GENET, V48, P492; Norwood T. H., 1982, TECHNIQUES SOMATIC C, P35; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; SMITH CAD, 1992, LANCET, V339, P1375, DOI 10.1016/0140-6736(92)91196-F; TOPPER JN, 1992, CELL, V70, P16, DOI 10.1016/0092-8674(92)90529-L; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; VEOMETT GE, 1982, TECHNIQUES SOMATIC C, P67; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WELTER C, 1989, GENE, V83, P169, DOI 10.1016/0378-1119(89)90415-0; Wharton DC., 1967, METHOD ENZYMOL, P245	29	115	117	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					663	669						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8394647				2022-12-18	WOS:A1993LU55900010
J	HANSON, B; MCGUE, M; ROITMANJOHNSON, B; SEGAL, NL; BOUCHARD, TJ; BLUMENTHAL, MN				HANSON, B; MCGUE, M; ROITMANJOHNSON, B; SEGAL, NL; BOUCHARD, TJ; BLUMENTHAL, MN			ATOPIC DISEASE AND IMMUNOGLOBULIN-E IN TWINS REARED APART AND TOGETHER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM IGE LEVELS; MINNESOTA; CHILDREN; SEX	Both genetic and environmental influences have been implicated in the etiology of atopic disease and in the determination of serum IgE levels. To quantify the relative contribution of these influences, we studied the prevalence of asthma and seasonal rhinitis, skin-test response, total serum IgE levels, and specific IgE, as measured by RAST, in a sample of MZ and DZ twins reared apart or together. Concordance rates for asthma, rhinitis, positive skin tests, and RAST were calculated. MZ twins, whether reared apart or together, showed a greater concordance than dizygotic twins reared apart or together. Maximum-likelihood tests of genetic and environmental components of the variation of total IgE levels revealed a substantial genetic component and a negligible contribution from common familial environmental effects.	UNIV MINNESOTA HOSP & CLIN,BOX 434,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital								BAHNA SL, 1983, J ALLERGY CLIN IMMUN, V71, P100, DOI 10.1016/0091-6749(83)90170-7; BLUMENTHAL MN, 1981, AM J MED GENET, V10, P219, DOI 10.1002/ajmg.1320100304; BLUMENTHAL MN, 1987, CHEST, V91, pS176, DOI 10.1378/chest.91.6.176S; BLUMENTHAL MN, 1990, GENETIC ENV FACTORS, P132; BLUMENTHAL MN, 1983, ALLERGY PRINCIPLES P, P11; BONINI S, 1983, J ALLERGY CLIN IMMUN, V71, P100, DOI 10.1016/0091-6749(83)90169-0; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; DAVIS JB, 1976, CLIN ALLERGY, V6, P329, DOI 10.1111/j.1365-2222.1976.tb01913.x; EAVES LJ, 1979, BR J MATH STAT PSYCH, V30, P1; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; KING TP, 1972, BIOCHEMISTRY-US, V11, P367, DOI 10.1021/bi00753a010; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; KOHLER PF, 1985, J CLIN INVEST, V75, P883, DOI 10.1172/JCI111787; LAPKOFF CB, 1974, INT ARCH ALLER A IMM, V46, P215, DOI 10.1159/000231125; LYKKEN DT, 1990, ACTA GENET MED GEMEL, V39, P35, DOI 10.1017/S0001566000005572; LYKKEN DT, 1978, BEHAV GENET, V8, P437, DOI 10.1007/BF01067939; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; NORMAN PS, 1983, ALLERGY PRINCIPLES P, P295; SISTONEN P, 1980, HUM HERED, V30, P155, DOI 10.1159/000153120; SMITH JM, 1988, ALLERGY PRINCIPLES P, P891; TELLEGEN A, 1988, J PERS SOC PSYCHOL, V54, P1036; UNDERDOWN BJ, 1969, BIOCHEMISTRY-US, V8, P980, DOI 10.1021/bi00831a031; WUTRICH B, 1983, HUM HERED, V30, P147	24	115	117	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					873	879						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018039				2022-12-18	WOS:A1991FK89700006
J	LATHROP, GM; LALOUEL, JM				LATHROP, GM; LALOUEL, JM			EFFICIENT COMPUTATIONS IN MULTILOCUS LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah	LATHROP, GM (corresponding author), UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132, USA.							BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CLAYTON J, 1986, HUM GENET, V73, P68, DOI 10.1007/BF00292667; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; LALOUEL JM, 1986, COLD SPRING HARB SYM, V51, P39, DOI 10.1101/SQB.1986.051.01.006; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P38; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1986, AM J HUM GENET, V39, P425; MORTON NE, 1986, AM J HUM GENET, V38, P868; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1974, AM J HUM GENET, V26, P588; Thomas J.M., 1984, 8TH P INT C CAT BERL, V1, P31; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	23	115	118	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					498	505						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	3162348				2022-12-18	WOS:A1988M620600013
J	YANGFENG, TL; FLOYDSMITH, G; NEMER, M; DROUIN, J; FRANCKE, U				YANGFENG, TL; FLOYDSMITH, G; NEMER, M; DROUIN, J; FRANCKE, U			THE PRONATRIODILATIN GENE IS LOCATED ON THE DISTAL SHORT ARM OF HUMAN CHROMOSOME-1 AND ON MOUSE CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CLIN RES INST MONTREAL, MOLEC BIOL LAB, MONTREAL H2W 1R7, QUEBEC, CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	YANGFENG, TL (corresponding author), YALE UNIV, SCH MED, DEPT HUMAN GENET, POB 3333, NEW HAVEN, CT 06510 USA.			Drouin, Jacques/0000-0001-8226-5691	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGENTIN S, 1985, J BIOL CHEM, V260, P4568; ATLAS SA, 1984, NATURE, V309, P717, DOI 10.1038/309717a0; BASS F, 1984, HUM GENET, V67, P301; CANTIN M, 1985, ENDOCR REV; CARRITT B, 1982, ANN HUM GENET, V46, P329, DOI 10.1111/j.1469-1809.1982.tb01583.x; CHIMOSKEY JE, 1984, SCIENCE, V223, P820, DOI 10.1126/science.6538050; CURRIE MG, 1984, SCIENCE, V223, P67, DOI 10.1126/science.6419347; CURRIE MG, 1983, SCIENCE, V221, P71, DOI 10.1126/science.6857267; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLYNN TG, 1983, BIOCHEM BIOPH RES CO, V117, P859, DOI 10.1016/0006-291X(83)91675-3; FRANCKE U, 1981, SOMAT CELL GENET, V7, P171; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P5776; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P57, DOI 10.1159/000130799; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; FRANCKE U, 1979, P NATL ACAD SCI USA, V76, P5230, DOI 10.1073/pnas.76.10.5230; GIBLETT E R, 1974, Birth Defects Original Article Series, V10, P91; GREENBERG BD, 1984, NATURE, V312, P656, DOI 10.1038/312656a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KANGAWA K, 1984, BIOCHEM BIOPH RES CO, V119, P933, DOI 10.1016/0006-291X(84)90863-5; KANGAWA K, 1984, BIOCHEM BIOPH RES CO, V118, P131, DOI 10.1016/0006-291X(84)91077-5; LAZURE C, 1984, FEBS LETT, V172, P80, DOI 10.1016/0014-5793(84)80878-9; LUND E, 1984, J BIOL CHEM, V259, P2013; MAKI M, 1984, NATURE, V309, P722, DOI 10.1038/309722a0; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V119, P524, DOI 10.1016/S0006-291X(84)80279-X; NAYLOR SL, 1984, SOMAT CELL MOLEC GEN, V10, P307, DOI 10.1007/BF01535252; NEMER M, 1984, NATURE, V312, P654, DOI 10.1038/312654a0; OIKAWA S, 1984, NATURE, V309, P724, DOI 10.1038/309724a0; SEIDAH NG, 1984, P NATL ACAD SCI-BIOL, V81, P2640, DOI 10.1073/pnas.81.9.2640; SEIDMAN CE, 1984, SCIENCE, V225, P324, DOI 10.1126/science.6234658; SEIDMAN CE, 1984, SCIENCE, V226, P1206, DOI 10.1126/science.6542248; SONNENBERG H, 1983, HYPERTENSION, V5, P672, DOI 10.1161/01.HYP.5.5.672; Southern E, 1979, Methods Enzymol, V68, P152; THIBAULT G, 1984, FEBS LETT, V167, P352, DOI 10.1016/0014-5793(84)80155-6; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; WEITKAMP LR, 1970, AM J HUM GENET, V22, P216; YAMANAKA M, 1984, NATURE, V309, P719, DOI 10.1038/309719a0; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; ZIVIN RA, 1984, P NATL ACAD SCI-BIOL, V81, P6325, DOI 10.1073/pnas.81.20.6325; 1981, CYTOGENET CELL GENET, V31, P1; 1984, CYTOGENET CELL GENET, V37, P312	43	115	118	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1117	1128						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	2934979				2022-12-18	WOS:A1985AXE3600008
J	KEMPTHORNE, O; OSBORNE, RH				KEMPTHORNE, O; OSBORNE, RH			INTERPRETATION OF TWIN DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Osborne, Richard H/A-9447-2010	Osborne, Richard H/0000-0002-9081-2699				ALLEN C, 1955, AM J HUMAN GENET, V7, P15; ALLEN G, 1955, Acta Genet Med Gemellol (Roma), V4, P143; CLARK PJ, 1956, AM J HUM GENET, V8, P49; COCKERHAM CC, 1956, GENETICS, V41, P138; COCKERHAM CC, 1954, GENETICS, V39, P859; Cornfield J, 1944, J AM STAT ASSOC, V39, P236, DOI 10.2307/2279953; DOBZHANSKY T, 1954, AM J HUM GENET, V6, P199; Dobzhansky T., 1955, EVOLUTION GENETICS M, VFirst; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; HANCOCK J, 1952, NEW ZEAL J SCI TECH, V34A, P131; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; KEMPTHORNE O, 1954, PROC R SOC SER B-BIO, V143, P103, DOI 10.1098/rspb.1954.0056; LILIENFELD AM, 1955, AM J HUM GENET, V7, P204; Mather K., 1949, BIOMETRICAL GENETICS; MATHER K, 1953, CG; Newman HH., 1937, TWINS STUDY HEREDITY; OSBORNE RH, 1959, AM NAT, V93, P140, DOI 10.1086/282068; OSBORNE RH, 1958, SCIENCE, V127, P1294, DOI 10.1126/science.127.3309.1294; Osborne RH, 1959, GENETIC BASIS MORPHO; PROCE B, 1950, AM J HUMAN GENET, V2, P293; REEVE ECR, 1955, BIOMETRICS, V11, P357, DOI 10.2307/3001774; ROBERTSON A, 1960, BIOMETRICAL GENETICS; SNYDER LH, 1954, AM J HUM GENET, V6, P108; SNYDER LH, 1955, AM SCI, V43, P391; STORMONT C, 1954, STATISTICS MATHEMATI; TALLIS GM, 1959, AUST J STAT, V1, P35, DOI 10.1111/j.1467-842X.1959.tb00271.x; VERSCHUER OV, 1939, P ROY SOC          B, V128, P62; WILK MB, 1956, ANN MATH STAT, V27, P950, DOI 10.1214/aoms/1177728068; WRIGHT S, 1954, STATISTICS MATHEMATI; [No title captured]	30	115	115	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	3					320	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2961A	13752449				2022-12-18	WOS:A19612961A00001
J	Faundes, V; Newman, WG; Bernardini, L; Canham, N; Clayton-Smith, J; Dallapiccola, B; Davies, SJ; Demos, MK; Goldman, A; Gill, H; Horton, R; Kerr, B; Kumar, D; Lehman, A; McKee, S; Morton, J; Parker, MJ; Rankin, J; Robertson, L; Temple, IK; Banka, S				Faundes, Victor; Newman, William G.; Bernardini, Laura; Canham, Natalie; Clayton-Smith, Jill; Dallapiccola, Bruno; Davies, Sally J.; Demos, Michelle K.; Goldman, Amy; Gill, Harinder; Horton, Rachel; Kerr, Bronwyn; Kumar, Dhavendra; Lehman, Anna; McKee, Shane; Morton, Jenny; Parker, Michael J.; Rankin, Julia; Robertson, Lisa; Temple, I. Karen; Banka, Siddharth		Clin Assessment Utility Sequencin; Deciphering Dev Disorders DD	Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; LOSS-OF-FUNCTION; GENES; AUTISM; MLL2; VARIANTS; DISEASE; HAPLOINSUFFICIENCY; DELETIONS; SEQUENCE	Histone lysine methyltransferases (KMTs) and demethylases (KDMs) underpin gene regulation. Here we demonstrate that variants causing haploinsufficiency of KMTs and KDMs are frequently encountered in individuals with developmental disorders. Using a combination of human variation databases and existing animal models, we determine 22 KMTs and KDMs as additional candidates for dominantly inherited developmental disorders. We show that KMTs and KDMs that are associated with, or are candidates for, dominant developmental disorders tend to have a higher level of transcription, longer canonical transcripts, more interactors, and a higher number and more types of post-translational modifications than other KMT and KDMs. We provide evidence to firmly associate KMT2C, ASH1L, and KMT5B haploinsufficiency with dominant developmental disorders. Whereas KMT2C or ASH1L haploinsufficiency results in a predominantly neurodevelopmental phenotype with occasional physical anomalies, KMT5B mutations cause an overgrowth syndrome with intellectual disability. We further expand the phenotypic spectrumof KMT2B-related disorders and show that some individuals can have severe developmental delay without dystonia at least until mid-childhood. Additionally, we describe a recessive histone lysine-methylation defect caused by homozygous or compound heterozygous KDM5B variants and resulting in a recognizable syndrome with developmental delay, facial dysmorphism, and camptodactyly. Collectively, these results emphasize the significance of histone lysine methylation in normal human development and the importance of this process in human developmental disorders. Our results demonstrate that systematic clinically oriented pathway-based analysis of genomic data can accelerate the discovery of rare genetic disorders.	[Faundes, Victor; Newman, William G.; Clayton-Smith, Jill; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Manchester Ctr Genom Med, Sch Biol Sci,Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England; [Faundes, Victor] Univ Chile, Inst Nutr & Tecnol Alimentos, Lab Genet & Enfermedades Metab, Santiago 7830490, Chile; [Newman, William G.; Clayton-Smith, Jill; Goldman, Amy; Banka, Siddharth] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Hlth Innovat Manchester, Manchester M13 9WL, Lancs, England; [Bernardini, Laura] Casa Sollievo Sofferenza Hosp, Cytogenet Unit, I-71013 San Giovanni Rotondo, FG, Italy; [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Watford Rd, Harrow HA1 3UJ, Middx, England; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, IRCCS, I-00146 Rome, Italy; [Davies, Sally J.; Kumar, Dhavendra] Univ Hosp Wales, Inst Med Genet, Heath Pk, Cardiff CF14 4XW, S Glam, Wales; [Demos, Michelle K.] Univ British Columbia, Dept Pediat, Div Pediat Neurol, Vancouver, BC V6H 3V4, Canada; [Gill, Harinder; Lehman, Anna; Clin Assessment Utility Sequencin] Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Horton, Rachel; Temple, I. Karen] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Horton, Rachel; Temple, I. Karen] Princess Anne Hosp, Div Human Genet, Southampton SO16 5YA, Hants, England; [McKee, Shane] Belfast City Hosp, Belfast HSC Trust, Northern Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Morton, Jenny] Birmingham Womens & Childrens Hosp NHS Fdn Trust, West Midlands Reg Clin Genet Serv, Birmingham B15 2TG, W Midlands, England; [Morton, Jenny] Birmingham Womens & Childrens Hosp NHS Fdn Trust, Birmingham Hlth Partners, Birmingham B15 2TG, W Midlands, England; [Parker, Michael J.] Sheffield Childrens Hosp NHS Fdn Trust, Sheffield Clin Genet Serv, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Rankin, Julia] Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Robertson, Lisa] NHS Grampian, North Scotland Reg Genet Serv, Med Sch, Dept Med Genet, Aberdeen AB25 2ZD, Scotland; [Deciphering Dev Disorders DD] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England	University of Manchester; Universidad de Chile; University of Manchester; IRCCS Casa Sollievo Della Sofferenza; Imperial College London; IRCCS Bambino Gesu; Cardiff University; University of British Columbia; BC Women's Hospital & Health Centre; University of Southampton; Belfast City Hospital; Birmingham Women's Hospital; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Aberdeen; Wellcome Trust Sanger Institute	Banka, S (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester Ctr Genom Med, Sch Biol Sci,Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England.; Banka, S (corresponding author), Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Hlth Innovat Manchester, Manchester M13 9WL, Lancs, England.	siddharth.banka@manchester.ac.uk	Sifrim, Alejandro/AAY-2019-2021; Houge, Sofia Douzgou/I-2049-2019; Balasubramanian, Meena/AGB-4083-2022; Tischkowitz, Marc/O-4452-2018; Faundes, Víctor/A-2125-2011; Bernardini, Laura/H-5360-2016; KRISHNAPPA, NETRAVATHI/AAD-9576-2021; LACHLAN, KATHERINE/ABH-6991-2020; Dallapiccola, Bruno/K-8692-2016	Sifrim, Alejandro/0000-0001-8247-4020; Houge, Sofia Douzgou/0000-0001-8890-7544; Balasubramanian, Meena/0000-0003-1488-3695; Tischkowitz, Marc/0000-0002-7880-0628; Faundes, Víctor/0000-0002-6746-0103; Bernardini, Laura/0000-0002-3554-2817; Lynch, Sally Ann/0000-0003-3540-1333; McKee, Shane/0000-0002-1772-0106; Wright, Caroline/0000-0003-2958-5076; Newman, William/0000-0002-6382-4678; Horton, Rachel/0000-0001-6080-6354; de Vries, Dylan/0000-0002-0953-0257; LACHLAN, KATHERINE/0000-0002-3816-7346; Dallapiccola, Bruno/0000-0002-5031-1013; Temple, Isabel Karen/0000-0002-6045-1781; Straub, Volker/0000-0001-9046-3540; Banka, Siddharth/0000-0002-8527-2210; Adam, Shelin/0000-0002-4401-6157; Murphy, Helen/0000-0002-5489-0614	CONICYT, Chile's National Commission for Scientific and Technological Research [72160007]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Mining for Miracles (British Columbia Children's Hospital Foundation); Genome British Columbia; British Columbia Provincial Health Services Authority; British Columbia Women's Hospital	CONICYT, Chile's National Commission for Scientific and Technological Research; Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Mining for Miracles (British Columbia Children's Hospital Foundation); Genome British Columbia; British Columbia Provincial Health Services Authority; British Columbia Women's Hospital	We are thankful to all the individuals and their families for taking part in the study. We are thankful to Matthew Hurles for his critical review of the manuscript. Victor Faundes acknowledges CONICYT, Chile's National Commission for Scientific and Technological Research, for its scholarship support (grant number 72160007). We are thankful to the Deciphering Developmental Disorders (DDD) study for the invaluable collaboration. The DDD Study (Cambridge South REC approval 10/H0305/83 and the Republic of Ireland REC GEN/284/12) presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The CAUSES study (seeWeb Resources) (University of British Columbia protocol H-1500092) is funded by the Mining for Miracles (British Columbia Children's Hospital Foundation) and Genome British Columbia, with support from the British Columbia Provincial Health Services Authority and British Columbia Women's Hospital.	Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banka S, 2015, CLIN GENET, V87, P252, DOI 10.1111/cge.12363; Banka S, 2013, CLIN GENET, V83, P467, DOI 10.1111/j.1399-0004.2012.01955.x; Banka S, 2015, ANN RHEUM DIS, V74, P1249, DOI 10.1136/annrheumdis-2013-204309; Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Benjamin JS, 2017, P NATL ACAD SCI USA, V114, P125, DOI 10.1073/pnas.1611431114; Binda O, 2013, EPIGENETICS-US, V8, P457, DOI 10.4161/epi.24451; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Bogershausen N, 2015, J CLIN INVEST, V125, P3585, DOI 10.1172/JCI80102; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Breuza L, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav120; Brinkmeier ML, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131516; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Chong JX, 2016, GENET MED, V18, P788, DOI 10.1038/gim.2015.161; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Goede C, 2016, EUR J PAEDIATR NEURO, V20, P286, DOI 10.1016/j.ejpn.2015.11.012; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Eram MS, 2015, BBA-GEN SUBJECTS, V1850, P1842, DOI 10.1016/j.bbagen.2015.05.013; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Goldsworthy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061870; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; He RS, 2017, NUCLEIC ACIDS RES, V45, P6427, DOI 10.1093/nar/gkx251; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; HUGO Gene Nomenclature Committee, 2016, GEN FAM CHROM MOD EN; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kasher PR, 2016, AM J HUM GENET, V98, P363, DOI 10.1016/j.ajhg.2015.12.014; Kataoka M, 2016, MOL PSYCHIATR, V21, P885, DOI 10.1038/mp.2016.69; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Labonne JDJ, 2016, HUM GENET, V135, P757, DOI 10.1007/s00439-016-1668-4; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Luscan A, 2014, J MED GENET, V51, P512, DOI 10.1136/jmedgenet-2014-102402; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Meyer E, 2017, NAT GENET, V49, P223, DOI 10.1038/ng.3740; Micale L, 2014, HUM MUTAT, V35, P841, DOI 10.1002/humu.22547; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miyazaki H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003897; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep18209; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zech M, 2016, AM J HUM GENET, V99, P1377, DOI 10.1016/j.ajhg.2016.10.010	73	114	116	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					175	187		10.1016/j.ajhg.2017.11.013	http://dx.doi.org/10.1016/j.ajhg.2017.11.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29276005	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-18	WOS:000419305500013
J	Carvill, GL; McMahon, JM; Schneider, A; Zemel, M; Myers, CT; Saykally, J; Nguyen, J; Robbiano, A; Zara, F; Specchio, N; Mecarelli, O; Smith, RL; Leventer, RJ; Moller, RS; Nikanorova, M; Dimova, P; Jordanova, A; Petrou, S; Helbig, I; Striano, P; Weckhuysen, S; Berkovic, SF; Scheffer, IE; Mefford, HC				Carvill, Gemma L.; McMahon, Jacinta M.; Schneider, Amy; Zemel, Matthew; Myers, Candace T.; Saykally, Julia; Nguyen, John; Robbiano, Angela; Zara, Federico; Specchio, Nicola; Mecarelli, Oriano; Smith, Robert L.; Leventer, Richard J.; Moller, Rikke S.; Nikanorova, Marina; Dimova, Petia; Jordanova, Albena; Petrou, Steven; Helbig, Ingo; Striano, Pasquale; Weckhuysen, Sarah; Berkovic, Samuel F.; Scheffer, Ingrid E.; Mefford, Heather C.		EuroEPINOMICS Rare Epilepsy Syndro	Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; PLASMA-MEMBRANE TRANSPORTER; FEBRILE SEIZURES; GENERALIZED EPILEPSY; ASTATIC EPILEPSY; INTELLECTUAL DISABILITY; ABSENCE EPILEPSY; CEREBRAL-CORTEX; SCN1A MUTATION; PLUS	GAT-1, encoded by SLC6A1, is one of the major gamma-aminobutyric acid (GABA) transporters in the brain and is responsible for re-uptake of GABA from the synapse. In this study, targeted resequencing of 644 individuals with epileptic encephalopathies led to the identification of six SLC6A1 mutations in seven individuals, all of whom have epilepsy with myoclonic-atonic seizures (MAE). We describe two truncations and four missense alterations, all of which most likely lead to loss of function of GAT-1 and thus reduced GABA re-uptake from the synapse. These individuals share many of the electrophysiological properties of Gat1-deficient mice, including spontaneous spike-wave discharges. Overall, pathogenic mutations occurred in 6/160 individuals with MAE, accounting for similar to 4% of unsolved MAE cases.	[Carvill, Gemma L.; Zemel, Matthew; Myers, Candace T.; Saykally, Julia; Nguyen, John; Mefford, Heather C.] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98195 USA; [McMahon, Jacinta M.; Schneider, Amy; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Robbiano, Angela; Zara, Federico] Ist Giannina Gaslini, Dept Neurosci, Neurogenet Lab, I-16148 Genoa, Italy; [Specchio, Nicola] Bambino Gesu Childrens Hosp IRCCS, Dept Neurosci, Div Neurol, I-00165 Rome, Italy; [Mecarelli, Oriano] Univ Roma La Sapienza, Dept Neurol & Psychiat, I-00185 Rome, Lazio, Italy; [Smith, Robert L.] John Hunter Childrens Hosp, Dept Neurol, Newcastle, NSW 2305, Australia; [Smith, Robert L.] Univ Newcastle, Fac Hlth, Newcastle, NSW 2305, Australia; [Leventer, Richard J.; Scheffer, Ingrid E.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Leventer, Richard J.; Scheffer, Ingrid E.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Moller, Rikke S.; Nikanorova, Marina] Danish Epilepsy Ctr, DK-4293 Dianalund, Denmark; [Moller, Rikke S.] Univ Southern Denmark, Inst Reg Hlth Serv, DK-5230 Odense, Denmark; [Dimova, Petia] St Ivan Rilski Univ Hosp, Epilepsy Ctr, Sofia 1431, Bulgaria; [Jordanova, Albena; Weckhuysen, Sarah] Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [Jordanova, Albena; Weckhuysen, Sarah] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Jordanova, Albena] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia 1431, Bulgaria; [Petrou, Steven; Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3084, Australia; [Helbig, Ingo] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Helbig, Ingo] Univ Med Ctr Schleswig Holstein, Dept Neuropediat, D-24118 Kiel, Germany; [Helbig, Ingo] Univ Kiel, D-24118 Kiel, Germany; [Striano, Pasquale] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16148 Genoa, Italy; [Striano, Pasquale] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Weckhuysen, Sarah] Sorbonne Univ, Univ Paris 06, CNRS, INSERM,U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, F-75013 Paris, France	University of Washington; University of Washington Seattle; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu; Sapienza University Rome; University of Newcastle; University of Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Southern Denmark; Medical University Sofia; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Medical University Sofia; Florey Institute of Neuroscience & Mental Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Scheffer, IE (corresponding author), Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia.	scheffer@unimelb.edu.au; hmefford@uw.edu	Muhle, Hiltrud/F-5715-2010; Weckhuysen, Sarah/HGB-9957-2022; Craiu, Dana/ABE-4886-2020; Scheffer, Ingrid E/G-1668-2013; Helbig, Ingo/G-8467-2018; Specchio, Nicola/K-9461-2016; Striano, Pasquale/F-9117-2014; Jordanova, Albena/H-8323-2015; Zara, Federico/U-3477-2017; jiang, yu/HGU-0029-2022	Weckhuysen, Sarah/0000-0003-2878-1147; Scheffer, Ingrid E/0000-0002-2311-2174; Helbig, Ingo/0000-0001-8486-0558; Striano, Pasquale/0000-0002-6065-1476; Jordanova, Albena/0000-0002-3833-3754; Zara, Federico/0000-0001-9744-5222; SPECCHIO, NICOLA/0000-0002-8120-0287; Guerrini, Renzo/0000-0002-7272-7079; Berkovic, Samuel/0000-0003-4580-841X; Selmer, Kaja Kristine/0000-0003-4871-112X; Moller, Rikke S./0000-0002-9664-1448; Suls, Arvid/0000-0003-0328-198X; Petrou, Steven/0000-0002-4960-6375	NIH [NINDS 1R01NS069605, 1K99NS089858]; American Epilepsy Society; Lennox and Lombroso Fund; National Health and Medical Research Council of Australia; Bulgarian Ministry of Education and Science National Science Fund [DTK02/67]; University of Antwerp [TOP-BOF-29069]; University of Kiel; German Research Foundation [HE5415/5-1, HE5415/6-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, K99NS089858] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; Lennox and Lombroso Fund; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bulgarian Ministry of Education and Science National Science Fund; University of Antwerp; University of Kiel; German Research Foundation(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	G.L.C. and I.H. are members of the scientific advisory board of Ambry Genetics. We are grateful to Angelika Ackerhans and Kerstin Wuhlbrandt (Department of Neuropediatrics, University of Kiel) for database and sample management. We appreciate access to phenotypic data on SFARI Base, and we are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators. This research was supported by the NIH (NINDS 1R01NS069605 to H.C.M.; 1K99NS089858 to G.L.C.), the American Epilepsy Society and the Lennox and Lombroso Fund (G.L.C.), the National Health and Medical Research Council of Australia (S.F.B. and I.E.S.), the Bulgarian Ministry of Education and Science National Science Fund (grant DTK02/67), the Research Fund of the University of Antwerp (grant TOP-BOF-29069 to A.J.). Intramural funds from the University of Kiel and the German Research Foundation (HE5415/5-1 and HE5415/6-1) further supported I.H. Additional funding sources are listed in the Supplemental Data.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1998, J COMP NEUROL, V396, P51, DOI 10.1002/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Dikow N, 2014, AM J MED GENET A, V164, P3061, DOI 10.1002/ajmg.a.36761; Dimova PS, 2010, PEDIATR NEUROL, V42, P137, DOI 10.1016/j.pediatrneurol.2009.09.007; DOOSE H, 1987, EUR J PEDIATR, V146, P550, DOI 10.1007/BF02467351; DOOSE H, 1970, Neuropaediatrie, V2, P59, DOI 10.1055/s-0028-1091841; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Kaminska A, 1999, EPILEPSY RES, V36, P15, DOI 10.1016/S0920-1211(99)00021-2; Kilaru S, 2007, EPILEPSIA, V48, P1703, DOI 10.1111/j.1528-1167.2007.01186.x; Koepp MJ, 2005, EPILEPSIA, V46, P1625, DOI 10.1111/j.1528-1167.2005.00263.x; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Minelli A, 1996, J NEUROSCI, V16, P6255, DOI 10.1523/jneurosci.16-19-06255.1996; Mullen SA, 2011, ARCH NEUROL-CHICAGO, V68, P1152, DOI 10.1001/archneurol.2011.102; Nabbout R, 2003, EPILEPSY RES, V56, P127, DOI 10.1016/j.eplepsyres.2003.08.007; Oguni H, 2001, BRAIN DEV-JPN, V23, P757, DOI 10.1016/S0387-7604(01)00281-9; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schousboe A, 2014, NEUROCHEM RES, V39, P1980, DOI 10.1007/s11064-014-1263-9; Scimemi A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00161; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wein T, 2010, J MOL MODEL, V16, P155, DOI 10.1007/s00894-009-0520-3; Yordanova I, 2011, NEUROSCI LETT, V494, P180, DOI 10.1016/j.neulet.2011.03.008	36	114	126	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					808	815		10.1016/j.ajhg.2015.02.016	http://dx.doi.org/10.1016/j.ajhg.2015.02.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25865495	Green Published, Bronze			2022-12-18	WOS:000354189300011
J	Zhu, ZH; Bakshi, A; Vinkhuyzen, AAE; Hemani, G; Lee, SH; Nolte, IM; van Vliet-Ostaptchouk, JV; Snieder, H; Esko, T; Milani, L; Magi, R; Metspalu, A; Hill, WG; Weir, BS; Goddard, ME; Visscher, PM; Yang, J				Zhu, Zhihong; Bakshi, Andrew; Vinkhuyzen, Anna A. E.; Hemani, Gibran; Lee, Sang Hong; Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold; Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres; Hill, William G.; Weir, Bruce S.; Goddard, Michael E.; Visscher, Peter M.; Yang, Jian		LifeLines Cohort Study	Dominance Genetic Variation Contributes Little to the Missing Heritability for Human Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; COMMON	For human complex traits, non-additive genetic variation has been invoked to explain "missing heritability,'' but its discovery is often neglected in genome-wide association studies. Here we propose a method of using SNP data to partition and estimate the proportion of phenotypic variance attributed to additive and dominance genetic variation at all SNPs (h(SNP)(2) and delta(2)(SNP)) in unrelated individuals based on an orthogonal model where the estimate of h(SNP)(2) is independent of that of delta(2)(SNP). With this method, we analyzed 79 quantitative traits in 6,715 unrelated European Americans. The estimate of delta(2)(SNP) averaged across all the 79 quantitative traits was 0.03, approximately a fifth of that for additive variation (average h(SNP)(2) = 0.15). There were a few traits that showed substantial estimates of delta(2)(SNP), none of which were replicated in a larger sample of 11,965 individuals. We further performed genome-wide association analyses of the 79 quantitative traits and detected SNPs with genome-wide significant dominance effects only at the ABO locus for factor VIII and von Willebrand factor. All these results suggest that dominance variation at common SNPs explains only a small fraction of phenotypic variation for human complex traits and contributes little to the missing narrow-sense heritability problem.	[Zhu, Zhihong; Bakshi, Andrew; Vinkhuyzen, Anna A. E.; Hemani, Gibran; Lee, Sang Hong; Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Hemani, Gibran] Univ Bristol, Sch Social & Community Med, IEU, MRC, Bristol BS8 1TH, Avon, England; [Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [LifeLines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51006 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA 02141 USA; [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02242 USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Hill, William G.] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic 3083, Australia; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia	University of Queensland; University of Bristol; University of Groningen; University of Groningen; University of Groningen; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Tartu; University of Edinburgh; University of Washington; University of Washington Seattle; University of Melbourne; University of Queensland	Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	jian.yang@uq.edu.au	Visscher, Peter/ABB-6151-2020; Lee, Sang Hong/A-2569-2011; Zhu, Zhihong/F-8720-2015; Mägi, Reedik/AAJ-9679-2021; Weir, Bruce S/A-2894-2013; Yang, Jian/A-5852-2010; Milani, Lili/N-1097-2019; Vinkhuyzen, Anna/N-8691-2013	Visscher, Peter/0000-0002-2143-8760; Lee, Sang Hong/0000-0001-9701-2718; Zhu, Zhihong/0000-0002-6783-3037; Yang, Jian/0000-0003-2001-2474; Milani, Lili/0000-0002-5323-3102; Magi, Reedik/0000-0002-2964-6011; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Hemani, Gibran/0000-0003-0920-1055; Vinkhuyzen, Anna/0000-0003-3352-0603; Esko, Tonu/0000-0003-1982-6569; Goddard, Michael/0000-0001-9917-7946; Bakshi, Andrew/0000-0001-5650-7036	Australian Research Council [130102666]; Australian National Health and Medical Research Council [1052684, 613601, 1048853]; USA NIH [GM057091, GM099568, MH100141]; Sylvia & Charles Viertel Charitable Foundation; UQ Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM075091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); USA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sylvia & Charles Viertel Charitable Foundation; UQ Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Australian Research Council (130102666), the Australian National Health and Medical Research Council (1052684, 613601, 1048853), the USA NIH (GM057091, GM099568, MH100141), the Sylvia & Charles Viertel Charitable Foundation, and the UQ Foundation. This study makes use of data from the database of Genotypes and Phenotypes (dbGaP) under accession phs000090, the Lifelines study, and the EGCUT study (see the Supplemental Acknowledgments for the full set of acknowledgments for these data).	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R., 1930, GENETICAL THEORY NAT; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/BF02185763; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; KACSER H, 1981, GENETICS, V97, P639; Leitsalu L., 2014, INT J EPIDE IN PRESS, DOI 10. 1093/ije/dyt268; Lynch M, 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maki-Tanila A, 2014, GENETICS, V198, P355, DOI 10.1534/genetics.114.165282; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Speed D, 2013, AM J HUM GENET, V93, P1155, DOI 10.1016/j.ajhg.2013.10.016; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; TRELOAR SA, 1990, AM J HUM GENET, V47, P137; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	35	114	115	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					377	385		10.1016/j.ajhg.2015.01.001	http://dx.doi.org/10.1016/j.ajhg.2015.01.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683123	Green Published, Bronze			2022-12-18	WOS:000350747800010
J	Stittrich, AB; Lehman, A; Bodian, DL; Ashworth, J; Zong, ZY; Li, H; Lam, P; Khromykh, A; Iyer, RK; Vockley, JG; Baveja, R; Silva, ES; Dixon, J; Leon, EL; Solomon, BD; Glusman, G; Niederhuber, JE; Roach, JC; Patel, MS				Stittrich, Anna-Barbara; Lehman, Anna; Bodian, Dale L.; Ashworth, Justin; Zong, Zheyuan; Li, Hong; Lam, Patricia; Khromykh, Alina; Iyer, Ramaswamy K.; Vockley, Joseph G.; Baveja, Rajiv; Silva, Ermelinda Santos; Dixon, Joanne; Leon, Eyby L.; Solomon, Benjamin D.; Glusman, Gustavo; Niederhuber, John E.; Roach, Jared C.; Patel, Milian S.			Mutations in NOTCH1 Cause Adams-Oliver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APLASIA-CUTIS-CONGENITA; CARDIOVASCULAR MALFORMATIONS; VASCULAR MORPHOGENESIS; LIMB DEFECTS; ABNORMALITIES; HYPERTENSION; ASSOCIATION; SPECIFICITY; INHIBITION; COMPLEXES	Notch signaling determines and reinforces cell fate in bilaterally symmetric multicellular eukaryotes. Despite the involvement of Notch in many key developmental systems, human mutations in Notch signaling components have mainly been described in disorders with vascular and bone effects. Here, we report five heterozygous NOTCH1 variants in unrelated individuals with Adams-Oliver syndrome (AOS), a rare disease with major features of aplasia cutis of the scalp and terminal transverse limb defects. Using whole-genome sequencing in a cohort of 11 families lacking mutations in the four genes with known roles in AOS pathology (ARHGAP31, RBPJ, DOCK6, and EOGT), we found a heterozygous de novo 85 kb deletion spanning the NOTCH1 5' region and three coding variants (c.1285T>C [p.Cys429Arg], c.4487G>A [p.Cys1496Tyr], and c.5965G>A [p.Asp1989Asn]), two of which are de novo, in four unrelated probands. In a fifth family, we identified a heterozygous canonical splice-site variant (c.743-1 G>T) in an affected father and daughter. These variants were not present in 5,077 in-house control genomes or in public databases. In keeping with the prominent developmental role described for Notch1 in mouse vasculature, we observed cardiac and multiple vascular defects in four of the five families. We propose that the limb and scalp defects might also be due to a vasculopathy in NOTCH1-related AOS. Our results suggest that mutations in NOTCH1 are the most common cause of AOS and add to a growing list of human diseases that have a vascular and/or bony component and are caused by alterations in the Notch signaling pathway.	[Stittrich, Anna-Barbara; Ashworth, Justin; Li, Hong; Glusman, Gustavo; Roach, Jared C.] Inst Syst Biol, Seattle, WA 98109 USA; [Lehman, Anna; Zong, Zheyuan; Lam, Patricia; Patel, Milian S.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Bodian, Dale L.; Khromykh, Alina; Iyer, Ramaswamy K.; Vockley, Joseph G.; Solomon, Benjamin D.; Niederhuber, John E.] Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA 22042 USA; [Baveja, Rajiv] Inova Hlth Syst, Fairfax Neonatal Associates, Falls Church, VA 22042 USA; [Silva, Ermelinda Santos] Ctr Hosp Porto, Pediat Gastroenterol Serv, P-4050111 Oporto, Portugal; [Dixon, Joanne] Wellington Hosp, Genet Serv, Capital & Coast Dist Hlth Board, Wellington 6242, New Zealand; [Leon, Eyby L.] Childrens Natl Med Ctr, Div Genet & Metab, Washington, DC 20010 USA; [Solomon, Benjamin D.] Inova Hlth Syst, Inova Childrens Hosp, Dept Pediat, Falls Church, VA 22042 USA	Institute for Systems Biology (ISB); University of British Columbia; Inova Health System; Inova Health System; Children's National Health System; Inova Fairfax Hospital; Inova Health System	Niederhuber, JE (corresponding author), Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA 22042 USA.	john.niederhuber@inova.org; mpatel@cw.bc.ca	Lehman, Anna/R-6706-2017; Leon, Eyby/Z-5317-2019; Silva, Ermelinda Santos/T-2673-2018	Lehman, Anna/0000-0003-0636-123X; Leon, Eyby/0000-0002-1852-2849; Silva, Ermelinda Santos/0000-0002-0987-341X; Ashworth, Justin/0000-0003-4835-6551; Lam, Patricia/0000-0002-7673-0371; /0000-0001-7061-6837; Glusman, Gustavo/0000-0001-8060-5955	Rare Disease Foundation; BC Children's Hospital Foundation; University of Luxembourg Institute for Systems Biology Program; Center for Systems Biology [2P50GM075647]; Inova Health System; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst); German Research Foundation (Deutsche Forschungsgemeinschaf)	Rare Disease Foundation; BC Children's Hospital Foundation; University of Luxembourg Institute for Systems Biology Program; Center for Systems Biology; Inova Health System; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (Deutsche Forschungsgemeinschaf)	We are very grateful to the families who took part in this study and the Adams-Oliver syndrome Facebook support group. This work was funded in part by the Rare Disease Foundation, the BC Children's Hospital Foundation, the University of Luxembourg Institute for Systems Biology Program, the Center for Systems Biology (2P50GM075647), the Inova Health System, and a gift from the Odeen family. A.B.S. was supported by the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst) and the German Research Foundation (Deutsche Forschungsgemeinschaf). J.A. is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. We thank Edward Greenberg and John H. Lee for help with radiologic interpretation for the proband from family 4.	ADAMS FH, 1945, J HERED, V36, P2; Algaze C, 2013, AM J MED GENET A, V161A, P1386, DOI 10.1002/ajmg.a.35864; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chang L, 2012, P NATL ACAD SCI USA, V109, P6993, DOI 10.1073/pnas.1118512109; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Digilio MC, 2008, AM J MED GENET A, V146A, P2842, DOI 10.1002/ajmg.a.32526; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; HOYME HE, 1982, J PEDIATR-US, V101, P839, DOI 10.1016/S0022-3476(82)80343-0; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2010, GENESIS, V48, P146, DOI 10.1002/dvg.20599; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085437; Lin AE, 1998, CLIN DYSMORPHOL, V7, P235, DOI 10.1097/00019605-199810000-00001; Maniscalco M, 2005, AM J MED GENET A, V136A, P269, DOI 10.1002/ajmg.a.30828; Martinez-Frias M L, 1996, An Esp Pediatr, V45, P57; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Patel MS, 2004, AM J MED GENET A, V129A, P294, DOI 10.1002/ajmg.a.30221; Pereira-da-Silva L, 2000, AM J MED GENET, V94, P75, DOI 10.1002/1096-8628(20000904)94:1<75::AID-AJMG15>3.0.CO;2-3; Petrovic J, 2014, DEVELOPMENT, V141, P2313, DOI 10.1242/dev.108100; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Silva G, 2012, AM J MED GENET A, V158A, P648, DOI 10.1002/ajmg.a.34435; Snape KMG, 2009, AM J MED GENET A, V149A, P1860, DOI 10.1002/ajmg.a.32708; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Swartz EN, 1999, AM J MED GENET, V82, P49, DOI 10.1002/(SICI)1096-8628(19990101)82:1<49::AID-AJMG10>3.0.CO;2-M; TORIELLO HV, 1988, AM J MED GENET, V29, P269, DOI 10.1002/ajmg.1320290204; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Vandersteen AM, 2011, CLIN DYSMORPHOL, V20, P210, DOI 10.1097/MCD.0b013e32834964d1; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	50	114	117	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					275	284		10.1016/j.ajhg.2014.07.011	http://dx.doi.org/10.1016/j.ajhg.2014.07.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25132448	Green Published, Bronze			2022-12-18	WOS:000341404100003
J	Poultney, CS; Goldberg, AP; Drapeau, E; Kou, Y; Harony-Nicolas, H; Kajiwara, Y; De Rubeis, S; Durand, S; Stevens, C; Rehnstrom, K; Palotie, A; Daly, MJ; Ma'ayan, A; Fromer, M; Buxbaum, JD				Poultney, Christopher S.; Goldberg, Arthur P.; Drapeau, Elodie; Kou, Yan; Harony-Nicolas, Hala; Kajiwara, Yuji; De Rubeis, Silvia; Durand, Simon; Stevens, Christine; Rehnstroem, Karola; Palotie, Aarno; Daly, Mark J.; Ma'ayan, Avi; Fromer, Menachem; Buxbaum, Joseph D.			Identification of Small Exonic CNV from Whole-Exome Sequence Data and Application to Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; GENE; REVEALS; HAPLOINSUFFICIENCY; DISCOVERY; NETWORK; SHANK3; TOOL	Copy number variation (CNV) is an important determinant of human diversity and plays important roles in susceptibility to disease. Most studies of CNV carried out to date have made use of chromosome microarray and have had a lower size limit for detection of about 30 kilobases (kb). With the emergence of whole-exome sequencing studies, we asked whether such data could be used to reliably call rare exonic CNV in the size range of 1-30 kilobases (kb), making use of the eXome Hidden Markov Model (XHMM) program. By using both transmission information and validation by molecular methods, we confirmed that small CNV encompassing as few as three exons can be reliably called from whole-exome data. We applied this approach to an autism case-control sample (n = 811, mean per-target read depth = 161) and observed a significant increase in the burden of rare (MAF <= 1%) 1-30 kb CNV, 1-30 kb deletions, and 1-10 kb deletions in ASD. CNV in the 1-30 kb range frequently hit just a single gene, and we were therefore able to carry out enrichment and pathway analyses, where we observed enrichment for disruption of genes in cytoskeletal and autophagy pathways in ASD. In summary, our results showed that XHMM provided an effective means to assess small exonic CNV from whole-exome data, indicated that rare 1-30 kb exonic deletions could contribute to risk in up to 7% of individuals with ASD, and implicated a candidate pathway in developmental delay syndromes.	[Poultney, Christopher S.; Goldberg, Arthur P.; Drapeau, Elodie; Kou, Yan; Harony-Nicolas, Hala; Kajiwara, Yuji; De Rubeis, Silvia; Durand, Simon; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Poultney, Christopher S.; Goldberg, Arthur P.; Drapeau, Elodie; Harony-Nicolas, Hala; Kajiwara, Yuji; De Rubeis, Silvia; Durand, Simon; Fromer, Menachem; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Goldberg, Arthur P.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Kou, Yan; Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Kou, Yan; Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Syst Biol Ctr New York, New York, NY 10029 USA; [Stevens, Christine; Palotie, Aarno; Daly, Mark J.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Rehnstroem, Karola; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Rehnstroem, Karola] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Fromer, Menachem; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fromer, Menachem; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Buxbaum, JD (corresponding author), Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.	joseph.buxbaum@mssm.edu	De Rubeis, Silvia/E-9852-2013; Ma'ayan, Avi/AAG-3131-2019; Daly, Mark J/B-2453-2017; Buxbaum, Joseph D/G-6001-2010	De Rubeis, Silvia/0000-0001-9383-6883; Ma'ayan, Avi/0000-0002-6904-1017; Daly, Mark J/0000-0002-0949-8752; Durand, Simon/0000-0003-1748-7655; Palotie, Aarno/0000-0002-2527-5874; Stevens, Christine/0000-0002-2621-2234; kajiwara, yuji/0000-0002-9307-8215; Buxbaum, Joseph/0000-0001-8898-8313	National Institute of Mental Health, National Institutes of Health [MH089025, MH097849, MH100233]; Seaver Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097849, R56MH097849, U01MH100233, R01MH089025] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Seaver Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health, National Institutes of Health (grants MH089025, MH097849, and MH100233 to J.D.B.) and the Seaver Foundation. C.S.P. is a Seaver Fellow and A.P.G. is a Seaver Fellow.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aoki K.F., 2005, USING KEGG DATABASE; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Betancur C, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-17; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fernandez JJ, 2012, GENET MOL RES, V11, P467, DOI 10.4238/2012.March.1.4; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Handrigan GR, 2013, J MED GENET, V50, P163, DOI 10.1136/jmedgenet-2012-101288; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Komoike Y, 2010, J HUM GENET, V55, P155, DOI 10.1038/jhg.2010.1; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krepischi-Santos ACV, 2009, CYTOGENET GENOME RES, V125, P1, DOI 10.1159/000218743; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Le Grand JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063133; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Melom JE, 2011, CURR OPIN GENET DEV, V21, P256, DOI 10.1016/j.gde.2011.01.002; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen W, 2010, AUTOPHAGY, V6, P168, DOI 10.4161/auto.6.1.10625; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	47	114	119	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					607	619		10.1016/j.ajhg.2013.09.001	http://dx.doi.org/10.1016/j.ajhg.2013.09.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094742	Bronze, Green Published			2022-12-18	WOS:000326305600003
J	Martignetti, JA; Tian, LF; Li, D; Ramirez, MCM; Camacho-Vanegas, O; Camacho, SC; Guo, YR; Zand, DJ; Bernstein, AM; Masur, SK; Kim, CE; Otieno, FG; Hou, CP; Abdel-Magid, N; Tweddale, B; Metry, D; Fournet, JC; Papp, E; McPherson, EW; Zabel, C; Vaksmann, G; Morisot, C; Keating, B; Sleiman, PM; Cleveland, JA; Everman, DB; Zackai, E; Hakonarson, H				Martignetti, John A.; Tian, Lifeng; Li, Dong; Ramirez, Maria Celeste M.; Camacho-Vanegas, Olga; Camacho, Sandra Catalina; Guo, Yiran; Zand, Dina J.; Bernstein, Audrey M.; Masur, Sandra K.; Kim, Cecilia E.; Otieno, Frederick G.; Hou, Cuiping; Abdel-Magid, Nada; Tweddale, Ben; Metry, Denise; Fournet, Jean-Christophe; Papp, Eniko; McPherson, Elizabeth W.; Zabel, Carrie; Vaksmann, Guy; Morisot, Cyril; Keating, Brendan; Sleiman, Patrick M.; Cleveland, Jeffrey A.; Everman, David B.; Zackai, Elaine; Hakonarson, Hakon			Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCING DATA; INHERITANCE; DISEASE; VARIANTS; DATABASE; GENOME; FAMILY; GROWTH; GENE; SNPS	Infantile myofibromatosis (IM) is a disorder of mesenchymal proliferation characterized by the development of nonrnetastasizing tumors in the skin, muscle, bone, and viscera. Occurrence within families across multiple generations is suggestive of an autosomal-dominant (AD) inheritance pattern, but autosomal-recessive (AR) modes of inheritance have also been proposed. We performed whole-exome sequencing (WES) in members of nine unrelated families clinically diagnosed with AD IM to identify the genetic origin of the disorder. In eight of the families, we identified one of two disease-causing mutations, c.1978C>A (p.Pro660Thr) and c.1681C>T (p.Arg561Cys), in PDGFRB. Intriguingly, one family did not have either of these PDGFRB mutations but all affected individuals had a c.4556T>C (p.Leu1519Pro) mutation in NOTCH3. Our studies suggest that mutations in PDGFRB are a cause of IM and highlight NOTCH3 as a candidate gene. Further studies of the crosstalk between PDGFRB and NOTCH pathways may offer new opportunities to identify mutations in other genes that result in IM and is a necessary first step toward understanding the mechanisms of both tumor growth and regression and its targeted treatment.	[Martignetti, John A.; Ramirez, Maria Celeste M.; Camacho-Vanegas, Olga; Camacho, Sandra Catalina] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Tian, Lifeng; Li, Dong; Guo, Yiran; Kim, Cecilia E.; Otieno, Frederick G.; Hou, Cuiping; Abdel-Magid, Nada; Tweddale, Ben; Keating, Brendan; Sleiman, Patrick M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Zand, Dina J.] Childrens Natl Med Ctr, Div Genet & Metab, Washington, DC 20010 USA; [Bernstein, Audrey M.; Masur, Sandra K.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA; [Metry, Denise] Baylor Coll Med, Texas Childrens Hosp, Dept Dermatol, Houston, TX 77030 USA; [Fournet, Jean-Christophe] Hop Necker Enfants Malad, F-75743 Paris 15, France; [Papp, Eniko] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [McPherson, Elizabeth W.; Zabel, Carrie] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Vaksmann, Guy; Morisot, Cyril] Hop Cardiol, Dept Pediat Cardiol, F-59037 Lille, France; [Keating, Brendan; Sleiman, Patrick M.; Zackai, Elaine; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Keating, Brendan; Sleiman, Patrick M.; Zackai, Elaine; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cleveland, Jeffrey A.] Carolinas HealthCare Syst, Matthews, NC 28105 USA; [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Marshfield Clinic; Universite de Lille - ISITE; CHU Lille; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Carolinas HealthCare System; Greenwood Genetic Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu; hakonarson@email.chop.edu	Guo, Yiran/H-4120-2011	Bernstein, Audrey/0000-0002-2537-2594	Children's Hospital of Philadelphia; Levitt Family Foundation; NATIONAL EYE INSTITUTE [R01EY009414] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; Levitt Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank all the families that participated in this study. This work was supported by an Institutional Development Award to the Center for Applied Genomics from The Children's Hospital of Philadelphia, a donation from Adele and Daniel Kubert (to H.H.), and the Levitt Family Foundation (to J.A.M.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Auriti C, 2008, J PEDIAT HEMATOL ONC, V30, P179, DOI 10.1097/MPH.0b013e31815e62bb; BAIRD PA, 1976, CLIN GENET, V9, P488; BARTLETT RC, 1961, CANCER, V14, P913, DOI 10.1002/1097-0142(196109/10)14:5<913::AID-CNCR2820140503>3.0.CO;2-G; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; CHUNG EB, 1981, CANCER, V48, P1807, DOI 10.1002/1097-0142(19811015)48:8<1807::AID-CNCR2820480818>3.0.CO;2-G; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Montpreville VT, 2004, VIRCHOWS ARCH, V444, P300, DOI 10.1007/s00428-003-0938-4; Demoulin JB, 2012, AM J BLOOD RES, V2, P44; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; ENZINGER FM, 1965, CANCER, V18, P241, DOI 10.1002/1097-0142(196502)18:2<241::AID-CNCR2820180216>3.0.CO;2-C; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Ikediobi NI, 2003, J AM ACAD DERMATOL, V49, pS148, DOI 10.1067/mjd.2003.333; JENNINGS TA, 1984, AM J SURG PATHOL, V8, P529, DOI 10.1097/00000478-198407000-00005; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KAUFFMAN SL, 1965, CANCER, V18, P460, DOI 10.1002/1097-0142(196504)18:4<460::AID-CNCR2820180410>3.0.CO;2-B; Kulkarni K, 2012, J PEDIATR SURG, V47, P2312, DOI 10.1016/j.jpedsurg.2012.09.046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leaute-Labreze C, 2001, PEDIATR DERMATOL, V18, P305, DOI 10.1046/j.1525-1470.2001.01933.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Narchi H, 2001, CLIN GENET, V59, P134, DOI 10.1034/j.1399-0004.2001.590213.x; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; PFLUGER H, 1976, WIEN KLIN WOCHENSCHR, V88, P92; SALAMAH MM, 1988, J PEDIATR SURG, V23, P975, DOI 10.1016/S0022-3468(88)80398-1; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Smith A, 2011, AUSTRALAS J DERMATOL, V52, P214, DOI 10.1111/j.1440-0960.2011.00730.x; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; STOUT AP, 1954, CANCER, V7, P953, DOI 10.1002/1097-0142(195409)7:5<953::AID-CNCR2820070520>3.0.CO;2-W; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033915; WILLIAMS JO, 1951, AMA ARCH PATHOL, V51, P548; WISWELL TE, 1988, J PEDIATR SURG, V23, P314, DOI 10.1016/S0022-3468(88)80196-9; Zand DJ, 2004, AM J MED GENET A, V126A, P261, DOI 10.1002/ajmg.a.20598	39	114	121	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					1001	1007		10.1016/j.ajhg.2013.04.024	http://dx.doi.org/10.1016/j.ajhg.2013.04.024			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731542	Green Published, Bronze			2022-12-18	WOS:000320415300018
J	Polvi, A; Linnankivi, T; Kivela, T; Herva, R; Keating, JP; Makitie, O; Pareyson, D; Vainionpaa, L; Lahtinen, J; Hovatta, I; Pihko, H; Lehesjoki, AE				Polvi, Anne; Linnankivi, Tarja; Kivela, Tero; Herva, Riitta; Keating, James P.; Makitie, Outi; Pareyson, Davide; Vainionpaa, Leena; Lahtinen, Jenni; Hovatta, Iris; Pihko, Helena; Lehesjoki, Anna-Elina			Mutations in CTC1, Encoding the CTS Telomere Maintenance Complex Component 1, Cause Cerebroretinal Microangiopathy with Calcifications and Cysts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-STRANDED-DNA; DYSKERATOSIS-CONGENITA; INTRACRANIAL CALCIFICATION; FAMILIAL SYNDROME; PROTEIN COMPLEX; LEUKOENCEPHALOPATHY; DISEASE; SHELTERIN; DEFECTS	Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is a rare multisystem disorder characterized by extensive intracranial calcifications and cysts, leukoencephalopathy, and retinal vascular abnormalities. Additional features include poor growth, skeletal and hematological abnormalities, and recurrent gastrointestinal bleedings. Autosomal-recessive inheritance has been postulated. The pathogenesis of CRMCC is unknown, but its phenotype has key similarities with Revesz syndrome, which is caused by mutations in TINF2, a gene encoding a member of the telomere protecting shelterin complex. After a whole-exome sequencing approach in four unrelated individuals with CRMCC, we observed four recessively inherited compound heterozygous mutations in CTC1, which encodes the CTS telomere maintenance complex component 1. Sanger sequencing revealed seven more compound heterozygous mutations in eight more unrelated affected individuals. Two individuals who displayed late-onset cerebral findings, a normal fundus appearance, and no systemic findings did not have CTC1 mutations, implying that systemic findings are an important indication for CTC1 sequencing. Of the 11 mutations identified, four were missense, one was nonsense, two resulted in in-frame amino acid deletions, and four were short frameshift-creating deletions. All but two affected individuals were compound heterozygous for a missense mutation and a frameshift or nonsense mutation. No individuals with two frameshift or nonsense mutations were identified, which implies that severe disturbance of CTC1 function from both alleles might not be compatible with survival. Our preliminary functional experiments did not show evidence of severely affected telomere integrity in the affected individuals. Therefore, determining the underlying pathomechanisms associated with deficient CTC1 function will require further studies.	[Polvi, Anne; Makitie, Outi; Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki 00290, Finland; [Polvi, Anne; Lehesjoki, Anna-Elina] Univ Helsinki, Mol Med Res Program, Res Programs Unit, Haartman Inst, FIN-00290 Helsinki, Finland; [Polvi, Anne; Lahtinen, Jenni; Hovatta, Iris; Lehesjoki, Anna-Elina] Univ Helsinki, Dept Med Genet, Haartman Inst, FIN-00290 Helsinki, Finland; [Polvi, Anne; Lehesjoki, Anna-Elina] Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland; [Linnankivi, Tarja; Pihko, Helena] Univ Helsinki, Cent Hosp, Dept Pediat Neurol, FIN-00290 Helsinki, Finland; [Kivela, Tero] Univ Helsinki, Cent Hosp, Dept Ophthalmol, FIN-00290 Helsinki, Finland; [Herva, Riitta] Oulu Univ Hosp, Dept Pathol, Oulu 90029, Finland; [Keating, James P.] Washington Univ, Sch Med, Dept Pediat, St Louis Childrens Hosp, St Louis, MO 63110 USA; [Makitie, Outi] Univ Helsinki, Childrens Hosp, FIN-00290 Helsinki, Finland; [Pareyson, Davide] Fdn Inst Ricovero & Cura Carattere Sci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Dept Clin Neurosci, C Besta Neurol Inst, I-20133 Milan, Italy; [Vainionpaa, Leena] Oulu Univ Hosp, Dept Pediat, Oulu 90029, Finland; [Lahtinen, Jenni; Hovatta, Iris] Univ Helsinki, Mol Neurol Res Program, Res Programs Unit, Haartman Inst, FIN-00290 Helsinki, Finland; [Hovatta, Iris] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki 00271, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; St. Louis Children's Hospital; Washington University (WUSTL); University of Helsinki; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare	Lehesjoki, AE (corresponding author), Folkhalsan Inst Genet, Helsinki 00290, Finland.	anna-elina.lehesjoki@helsinki.fi	Kivelä, Tero/C-9241-2009; Hovatta, Iiris/D-6871-2012; Pareyson, Davide/K-5890-2016	Kivelä, Tero/0000-0003-1198-4394; Hovatta, Iiris/0000-0002-5990-7892; Pareyson, Davide/0000-0001-6854-765X; Makitie, Outi/0000-0002-4547-001X; Linnankivi, Tarja/0000-0001-9190-2218; Lahtinen, Jenni/0000-0003-4867-4090	Wellcome Trust [098051]; Folkhalsan Research Foundation; Academy of Finland Center of Excellence of Complex Disease Genetics [213506]; Foundation for Pediatric Research in Finland	Wellcome Trust(Wellcome TrustEuropean Commission); Folkhalsan Research Foundation; Academy of Finland Center of Excellence of Complex Disease Genetics(Academy of Finland); Foundation for Pediatric Research in Finland	The authors warmly thank all individuals with cerebroretinal microangiopathy with calcifications and cysts and the families who participated in the study. We also thank several colleagues who helped gather the clinical data and samples, namely Anneli Beilmann, Federico de Gonda, Aki Mustonen, Pekka Nokelainen, Mario Savoiardo, Paivi Lindahl, and Anna Majander. We thank Sinikka Lindh for her help with genealogical analysis and Hanna Hellgren and Paula Hakala for expert technical assistance. The next-generation sequencing and variant calling were performed at the Institute for Molecular Medicine Finland Technology Centre at the University of Helsinki. The authors would like to thank Aarno Palotie and Karola Rehnstrom for providing the unpublished variant-frequency data from exome sequences of Finnish individuals (Wellcome Trust grant no 098051 to A.P.). The authors would also like to thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and the following ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). Our work was funded by the Folkhalsan Research Foundation and Academy of Finland Center of Excellence of Complex Disease Genetics (grant 213506) and by the Foundation for Pediatric Research in Finland.	Alter B.P., 2011, HAEMATOLOGICA; Briggs TA, 2008, AM J MED GENET A, V146A, P182, DOI 10.1002/ajmg.a.32080; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Crow YJ, 2004, NEUROPEDIATRICS, V35, P10, DOI 10.1055/s-2003-43552; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Labrune P, 1996, NEUROLOGY, V46, P1297, DOI 10.1212/WNL.46.5.1297; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Linnankivi T, 2006, NEUROLOGY, V67, P1437, DOI 10.1212/01.wnl.0000236999.63933.b0; Marelli C, 2008, J NEUROL NEUROSUR PS, V79, P1303, DOI 10.1136/jnnp.2008.148429; Mason M, 2011, CURR OPIN STRUC BIOL, V21, P92, DOI 10.1016/j.sbi.2010.11.005; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nagae-Poetscher LM, 2004, NEUROLOGY, V62, P1206, DOI 10.1212/01.WNL.0000119341.59445.CF; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; Norio R, 2003, HUM GENET, V112, P470, DOI 10.1007/s00439-002-0877-1; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349; SASA G, 2011, CLIN GENET, DOI DOI 10.1111/J.1399-0004.2011.01658.X; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sazgar M, 2002, PEDIATR NEUROL, V26, P324, DOI 10.1016/S0887-8994(01)00398-8; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Toiviainen-Salo S, 2011, AM J MED GENET A, V155A, P1322, DOI 10.1002/ajmg.a.33994; TOLMIE JL, 1988, EYE, V2, P297, DOI 10.1038/eye.1988.56; Tsilou ET, 2010, OPHTHALMOLOGY, V117, P615, DOI 10.1016/j.ophtha.2009.08.023; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	34	114	117	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					540	549		10.1016/j.ajhg.2012.02.002	http://dx.doi.org/10.1016/j.ajhg.2012.02.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22387016	Bronze, Green Published			2022-12-18	WOS:000301762800021
J	Hood, RL; Lines, MA; Nikkel, SM; Schwartzentruber, J; Beaulieu, C; Nowaczyk, MJM; Allanson, J; Kim, CA; Wieczorek, D; Moilanen, JS; Lacombe, D; Gillessen-Kaesbach, G; Whiteford, ML; Quaio, CRDC; Gomy, I; Bertola, DR; Albrecht, B; Platzer, K; McGillivray, G; Zou, RB; McLeod, DR; Chudley, AE; Chodirker, BN; Marcadier, J; Majewski, J; Bulman, DE; White, SM; Boycott, KM				Hood, Rebecca L.; Lines, Matthew A.; Nikkel, Sarah M.; Schwartzentruber, Jeremy; Beaulieu, Chandree; Nowaczyk, Malgorzata J. M.; Allanson, Judith; Kim, Chong Ae; Wieczorek, Dagmar; Moilanen, Jukka S.; Lacombe, Didier; Gillessen-Kaesbach, Gabriele; Whiteford, Margo L.; Quaio, Caio Robledo D. C.; Gomy, Israel; Bertola, Debora R.; Albrecht, Beate; Platzer, Konrad; McGillivray, George; Zou, Ruobing; McLeod, D. Ross; Chudley, Albert E.; Chodirker, Bernard N.; Marcadier, Janet; Majewski, Jacek; Bulman, Dennis E.; White, Susan M.; Boycott, Kym M.		FORGE Canada Consortium	Mutations in SRCAP, Encoding SNF2-Related CREBBP Activator Protein, Cause Floating-Harbor Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RUBINSTEIN-TAYBI-SYNDROME; HISTONE VARIANT H2A.Z; MEDIATED TRANSCRIPTION; BINDING PROTEIN; CBP; COACTIVATOR; CHROMATIN	Floating-Harbor syndrome (FHS) is a rare condition characterized by short stature, delayed osseous maturation, expressive-language deficits, and a distinctive facial appearance. Occurrence is generally sporadic, although parent-to-child transmission has been reported on occasion. Employing whole-exome sequencing, we identified heterozygous truncating mutations in SRCAP in five unrelated individuals with sporadic MS. Sanger sequencing identified mutations in SRCAP in eight more affected persons. Mutations were de novo in all six instances in which parental DNA was available. SRCAP is an SNF2-related chromatin-remodeling factor that serves as a coactivator for CREB-binding protein (CREBBP, better known as CBP, the major cause of Rubinstein-Taybi syndrome [RTS]). Five SRCAP mutations, two of which are recurrent, were identified; all are tightly clustered within a small (111 codon) region of the final exon. These mutations are predicted to abolish three C-terminal AT-hook DNA-binding motifs while leaving the CBP-binding and ATPase domains intact. Our findings show that SRCAP mutations are the major cause of FHS and offer an explanation for the clinical overlap between FHS and RTS.	[Lines, Matthew A.; Nikkel, Sarah M.; Allanson, Judith; Boycott, Kym M.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Hood, Rebecca L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Hood, Rebecca L.; Zou, Ruobing; Bulman, Dennis E.] Ottawa Hosp, Res Inst, Ottawa, ON K1Y 4E9, Canada; [Nikkel, Sarah M.; Boycott, Kym M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Beaulieu, Chandree; Marcadier, Janet; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Med Ctr, Hamilton, ON L8S 4J9, Canada; [Kim, Chong Ae; Quaio, Caio Robledo D. C.; Gomy, Israel; Bertola, Debora R.] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Crianca,Unidad Genet, BR-05403000 Sao Paulo, Brazil; [Wieczorek, Dagmar; Albrecht, Beate] Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Moilanen, Jukka S.] Oulu Univ Hosp, Dept Clin Genet, FI-90029 Oulu, Finland; [Moilanen, Jukka S.] Univ Oulu, FI-90029 Oulu, Finland; [Lacombe, Didier] Univ Bordeaux, Ctr Hosp Univ Bordeaux, Lab Malad Rares Genet & Metab, Serv Genet Med,EA 4576, F-33076 Bordeaux, France; [Gillessen-Kaesbach, Gabriele] Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany; [Whiteford, Margo L.] Yorkhill Hosp, Ferguson Smith Ctr Clin Gentet, Glasgow G3 0SJ, Lanark, Scotland; [McGillivray, George; White, Susan M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic 3052, Australia; [McLeod, D. Ross] Univ Calgary, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Chudley, Albert E.; Chodirker, Bernard N.] Univ Manitoba, Dept Paediat & Child Hlth, Winnipeg, MB R3E 0J9, Canada; [Chudley, Albert E.; Chodirker, Bernard N.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [White, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; McMaster University; Universidade de Sao Paulo; University of Duisburg Essen; University of Oulu; University of Oulu; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Lubeck; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Calgary; University of Manitoba; University of Manitoba; McGill University; University of Melbourne	Boycott, KM (corresponding author), Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada.	dbulman@ohri.ca; kboycott@cheo.on.ca	Quaio, CR/H-3784-2013; Wieczorek, Dagmar/AAU-6008-2021; Scherer, Stephen W./B-3785-2013; Bertola, Débora/I-5120-2016; McGillivray, George/AAN-9793-2020; Quaio, Caio/GQQ-6180-2022; Gomy, Israel/J-2358-2016; lacombe, didier/K-7967-2014; Lines, Matthew/M-4540-2018; Moilanen, Jukka S/G-2604-2012	Quaio, CR/0000-0003-2873-2820; Wieczorek, Dagmar/0000-0003-2812-6492; Scherer, Stephen W./0000-0002-8326-1999; Bertola, Débora/0000-0002-4701-6777; Gomy, Israel/0000-0002-7926-8477; Moilanen, Jukka S/0000-0002-8041-3205; Schwartzentruber, Jeremy/0000-0002-6183-2092; Platzer, Konrad/0000-0001-6127-6308; Kim, Chong/0000-0002-1754-1300; Lacombe, Didier/0000-0002-8956-2207	government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics	government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR))	The authors would first like to thank the study participants and their families, without whose participation and cooperation this work would not have been possible. This work was funded by the government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. K.M.B. is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. This work was selected for study by the FORGE Canada Steering Committee, consisting of K. Boycott (University of Ottawa), J. Friedman (University of British Columbia), J. Michaud (University of Montreal), E Bernier (University of Calgary), M. Brudno (University of Toronto), B. Fernandez (Memorial University), B. Knoppers (McGill University), M. Samuels (Universite de Montreal), and S. Scherer (University of Toronto).	Arpin S, 2012, CLIN DYSMORPHOL, V21, P11, DOI 10.1097/MCD.0b013e32834af5a7; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; LACOMBE D, 1995, EUR J PEDIATR, V154, P658, DOI 10.1007/s004310050367; Leisti J, 1975, Birth Defects Orig Artic Ser, V11, P305; Monroy MA, 2003, MOL ENDOCRINOL, V17, P2519, DOI 10.1210/me.2003-0208; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Pelletier G., 1973, SYNDR IDENTIF, V1, P8; Penaloza JM, 2003, GENET COUNSEL, V14, P31; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; ROBINSON PL, 1988, J PEDIATR-US, V113, P703, DOI 10.1016/S0022-3476(88)80384-6; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Stevens C.A., 2002, GENEREVIEWS; White SM, 2010, AM J MED GENET A, V152A, P821, DOI 10.1002/ajmg.a.33294; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200	16	114	120	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					308	313		10.1016/j.ajhg.2011.12.001	http://dx.doi.org/10.1016/j.ajhg.2011.12.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22265015	Green Published, Bronze			2022-12-18	WOS:000300742200012
J	Zhang, ZL; Xia, WB; He, JW; Zhang, Z; Ke, YH; Yue, H; Wang, C; Zhang, H; Gu, JM; Hu, WW; Fu, WZ; Hu, YQ; Li, M; Liu, YJ				Zhang, Zhenlin; Xia, Weibo; He, Jinwei; Zhang, Zeng; Ke, Yaohua; Yue, Hua; Wang, Chun; Zhang, Hao; Gu, Jiemei; Hu, Weiwei; Fu, Wenzhen; Hu, Yunqiu; Li, Miao; Liu, Yujuan			Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROSTAGLANDIN TRANSPORTER; HPGD MUTATIONS; SWISS-MODEL; DEHYDROGENASE; GENE; EXPRESSION	By using whole-exome sequencing, we identified a homozygous guanine-to-adenine transition at the invariant -1 position of the acceptor site of intron 1 (c.97-1G>A) in solute carrier organic anion transporter family member 2A1 (SLCO2A1), which encodes a prostaglandin transporter protein, as the causative mutation in a single individual with primary hypertrophic osteoarthropathy (PHO) from a consanguineous family. In two other affected individuals with PHO from two unrelated nonconsanguineous families, we identified two different compound heterozygous mutations by using Sanger sequencing. These findings confirm that SLCO2A1 mutations inactivate prostaglandin E(2) (PGE(2)) transport, and they indicate that mutations in SLCO2A1 are the pathogenic cause of PHO. Moreover, this study might also help to explain the cause of secondary hypertrophic osteoarthropathy.	[Zhang, Zhenlin; He, Jinwei; Zhang, Zeng; Ke, Yaohua; Yue, Hua; Wang, Chun; Zhang, Hao; Gu, Jiemei; Hu, Weiwei; Fu, Wenzhen; Hu, Yunqiu; Li, Miao; Liu, Yujuan] Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai 200233, Peoples R China; [Zhang, Zhenlin; He, Jinwei; Zhang, Zeng; Ke, Yaohua; Yue, Hua; Wang, Chun; Zhang, Hao; Gu, Jiemei; Hu, Weiwei; Fu, Wenzhen; Hu, Yunqiu; Li, Miao; Liu, Yujuan] Shanghai Sixth Peoples Hosp, Shanghai 200233, Peoples R China; [Xia, Weibo] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Minist Hlth, Key Lab Endocrinol,Dept Endocrinol, Beijing 100730, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, ZL (corresponding author), Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai 200233, Peoples R China.	zhangzhenlin2011@gmail.com			National Natural Science Foundation of China [81170803, 81070692, 81000360, 30771019, 30800387]; Program of Shanghai Subject Chief Scientist [08XD1403000]; Science and Technology Commission of Shanghai Municipality [10D21950100, 08411963100]; Shanghai Rising-Star Program [11QA1404900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Rising-Star Program	We are grateful to our patients and their families for participating in this study. We acknowledge technical assistance from Shanghai Genesky Bio-Teck Co., Ltd. This study was supported by the National Natural Science Foundation of China (81170803, 81070692, 81000360, 30771019, and 30800387), the Program of Shanghai Subject Chief Scientist (08XD1403000), the Science and Technology Commission of Shanghai Municipality (10D21950100 and 08411963100), and the Shanghai Rising-Star Program (11QA1404900). We wish to thank two anonymous reviewers for their helpful comments, which improved the manuscript and aided our further research.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergmann C, 2011, EXP DERMATOL, V20, P532, DOI 10.1111/j.1600-0625.2011.01248.x; Castori M, 2005, CLIN GENET, V68, P477, DOI 10.1111/j.1399-0004.2005.00533.x; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Chi YL, 2006, J PHARMACOL EXP THER, V316, P1346, DOI 10.1124/jpet.105.091975; Coggins KG, 2008, NAT GENET, V40, P691, DOI 10.1038/ng0608-691; de Greef JC, 2011, AM J HUM GENET, V88, P796, DOI 10.1016/j.ajhg.2011.04.018; Diggle CP, 2010, RHEUMATOLOGY, V49, P1056, DOI 10.1093/rheumatology/keq048; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grosdidier A, 2007, PROTEINS, V67, P1010, DOI 10.1002/prot.21367; Harifi G, 2011, JOINT BONE SPINE, V78, P218, DOI 10.1016/j.jbspin.2010.08.012; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Konuk EBY, 2006, EUR J ENDOCRINOL, V155, P681, DOI 10.1530/eje.1.02280; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Schuster VL, 2002, PROSTAG OTH LIPID M, V68-9, P633, DOI 10.1016/S0090-6980(02)00061-8; Schuster VL, 1998, ANNU REV PHYSIOL, V60, P221, DOI 10.1146/annurev.physiol.60.1.221; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seifert W, 2009, EUR J HUM GENET, V17, P1570, DOI 10.1038/ejhg.2009.104; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Sinibaldi L, 2010, CLIN EXP RHEUMATOL, V28, P153; Tariq M, 2009, J MED GENET, V46, P14, DOI 10.1136/jmg.2008.061234; Uppal S, 2008, NAT GENET, V40, P789, DOI 10.1038/ng.153; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yuksel-Konuk B, 2009, RHEUMATOL INT, V30, P39, DOI 10.1007/s00296-009-0895-6; ZIFRONI A, 1983, GUT, V24, P659, DOI 10.1136/gut.24.7.659	35	114	129	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					125	132		10.1016/j.ajhg.2011.11.019	http://dx.doi.org/10.1016/j.ajhg.2011.11.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22197487	Green Published, Bronze			2022-12-18	WOS:000299409100013
J	O'Sullivan, J; Bitu, CC; Daly, SB; Urquhart, JE; Barron, MJ; Bhaskar, SS; Martelli, H; Neto, PED; Mansilla, MA; Murray, JC; Coletta, RD; Black, GCM; Dixon, MJ				O'Sullivan, James; Bitu, Carolina C.; Daly, Sarah B.; Urquhart, Jill E.; Barron, Martin J.; Bhaskar, Sanjeev S.; Martelli-Junior, Hercilio; dos Santos Neto, Pedro Eleuterio; Mansilla, Maria A.; Murray, Jeffrey C.; Coletta, Ricardo D.; Black, Graeme C. M.; Dixon, Michael J.			Whole-Exome Sequencing Identifies FAM20A Mutations as a Cause of Amelogenesis Imperfecta and Gingival Hyperplasia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONE-ROD DYSTROPHY; PROTEIN; FAMILY	Amelogenesis imperfecta (AI) describes a clinically and genetically heterogeneous group of disorders of biomineralization resulting from failure of normal enamel formation. AI is found as an isolated entity or as part of a syndrome, and an autosomal-recessive syndrome associating AI and gingival hyperplasia was recently reported. Using whole-exome sequencing, we identified a homozygous nonsense mutation in exon 2 of FAM20A that was not present in the Single Nucleotide Polymorphism database (dbSNP), the 1000 Genomes database, or the Centre d'Etude du Polymorphisme Humain (CEPH) Diversity Panel. Expression analyses indicated that Fam20a is expressed in ameloblasts and gingivae, providing biological plausibility for mutations in FAM20A underlying the pathogenesis of this syndrome.	[O'Sullivan, James; Daly, Sarah B.; Urquhart, Jill E.; Barron, Martin J.; Black, Graeme C. M.; Dixon, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [O'Sullivan, James; Daly, Sarah B.; Urquhart, Jill E.; Bhaskar, Sanjeev S.; Black, Graeme C. M.] St Marys Hosp, Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Bitu, Carolina C.; Coletta, Ricardo D.] Univ Estadual Campinas, Sch Dent, Dept Oral Diag, BR-13414018 Sao Paulo, Brazil; [Martelli-Junior, Hercilio; dos Santos Neto, Pedro Eleuterio] Univ Montes Claros, Sch Dent, Stomatol Clin, BR-39401089 Montes Claros, MG, Brazil; [Mansilla, Maria A.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Manchester; University of Manchester; Universidade Estadual de Campinas; University of Iowa	Black, GCM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	graeme.black@manchester.ac.uk; mike.dixon@manchester.ac.uk	Urquhart, Jill/G-2282-2015; Coletta, Ricardo D./B-4909-2015; Martelli Júnior, Hercílio/K-7246-2012; Barron, Martin/E-9649-2015; Black, Graeme/K-7374-2015	Urquhart, Jill/0000-0002-5788-5511; Coletta, Ricardo D./0000-0001-5285-3046; Barron, Martin/0000-0002-2047-3513; Black, Graeme/0000-0001-8727-6592	Wellcome Trust [075945, 093113]; National Institute for Health Research Manchester Biomedical Research Centre; State Minas Gerais Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); Brazil National Council for Scientific and Technological Development (CNPq); Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); State Minas Gerais Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazil National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We express our gratitude to the family members for participating in the study and to Aline Petrin, University of Iowa, for collection of the control DNA samples from Brazilian individuals. We gratefully acknowledge financial support from the Wellcome Trust (075945, 093113), the National Institute for Health Research Manchester Biomedical Research Centre, the State Minas Gerais Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), and the Brazil National Council for Scientific and Technological Development (CNPq). C.C.B. was supported by grants from Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil.	An Chunying, 2010, Kobe J Med Sci, V55, pE82; BACKMAN B, 1986, COMMUNITY DENT ORAL, V14, P43, DOI 10.1111/j.1600-0528.1986.tb01493.x; Coffield KD, 2005, J AM DENT ASSOC, V136, P620, DOI 10.14219/jada.archive.2005.0233; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Funari VA, 2010, AM J HUM GENET, V87, P532, DOI 10.1016/j.ajhg.2010.08.015; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Martelli H, 2008, J PERIODONTOL, V79, P1287, DOI [10.1902/jop.2008.070520, 10.1902/jop.2008.070520 ]; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Stephanopoulos G, 2005, J DENT RES, V84, P1117, DOI 10.1177/154405910508401206; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010	23	114	120	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					616	620		10.1016/j.ajhg.2011.04.005	http://dx.doi.org/10.1016/j.ajhg.2011.04.005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549343	Green Published, Bronze			2022-12-18	WOS:000290832100009
J	Sambuughin, N; Yau, KS; Olive, M; Duff, RM; Bayarsaikhan, M; Lu, SJ; Gonzalez-Mera, L; Sivadorai, P; Nowak, KJ; Ravenscroft, G; Mastaglia, FL; North, KN; Ilkovski, B; Kremer, H; Lammens, M; van Engelen, BGM; Fabian, V; Lamont, P; Davis, MR; Laing, NG; Goldfarb, LG				Sambuughin, Nyamkhishig; Yau, Kyle S.; Olive, Montse; Duff, Rachael M.; Bayarsaikhan, Munkhuu; Lu, Shajia; Gonzalez-Mera, Laura; Sivadorai, Padma; Nowak, Kristen J.; Ravenscroft, Gianina; Mastaglia, Frank L.; North, Kathryn N.; Ilkovski, Biljana; Kremer, Hannie; Lammens, Martin; van Engelen, Baziel G. M.; Fabian, Vicki; Lamont, Phillipa; Davis, Mark R.; Laing, Nigel G.; Goldfarb, Lev G.			Dominant Mutations in KBTBD13, a Member of the BTB/Kelch Family, Cause Nemaline Myopathy with Cores	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-TROPOMYOSIN; CONGENITAL MYOPATHY; RYANODINE RECEPTOR; UBIQUITIN LIGASES; PROTEIN; CARDIOMYOPATHY; GIGAXONIN; DISEASE; RODS	We identified a member of the BTB/Kelch protein family that is mutated in nemaline myopathy type 6 (NEM6), an autosomal-dominant neuromuscular disorder characterized by the presence of nemaline rods and core lesions in the skeletal myofibers. Analysis of affected families allowed narrowing of the candidate region on chromosome 15q22.31, and mutation screening led to the identification of a previously uncharacterized gene, KBTBD13, coding for a hypothetical protein and containing missense mutations that perfectly cose-gregate with nemaline myopathy in the studied families. KBTBD13 contains a BTB/POZ domain and five Kelch repeats and is expressed primarily in skeletal and cardiac muscle. The identified disease-associated mutations, C.742C>A (p.Arg248Ser), c.1170G>C (p.Lys390Asn), and c.1222C>T (p.Arg408Cys), located in conserved domains of Kelch repeats, are predicted to disrupt the molecule's beta-propeller blades. Previously identified BTB/POZ/Kelch-domain-containing proteins have been implicated in a broad variety of biological processes, including cytoskeleton modulation, regulation of gene transcription, ubiquitination, and myofibril assembly. The functional role of KBTBD13 in skeletal muscle and the pathogenesis of NEM6 are subjects for further studies.	[Sambuughin, Nyamkhishig; Bayarsaikhan, Munkhuu] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA; [Yau, Kyle S.; Duff, Rachael M.; Nowak, Kristen J.; Ravenscroft, Gianina; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, QEII Med Ctr, Western Australia Inst Med Res, Nedlands, WA 6009, Australia; [Olive, Montse; Gonzalez-Mera, Laura] IDIBELL Hosp Bellvitge, Inst Neuropatol, Dept Pathol, Barcelona 08907, Spain; [Olive, Montse; Gonzalez-Mera, Laura] IDIBELL Hosp Bellvitge, Dept Neurol, Neuromuscular Unit, Barcelona 08907, Spain; [Olive, Montse; Gonzalez-Mera, Laura] CIBERNED, Barcelona 08907, Spain; [Lu, Shajia] NIAMSD, NIH, Bethesda, MD 20892 USA; [Sivadorai, Padma; Fabian, Vicki; Davis, Mark R.] Royal Perth Hosp, Dept Anat Pathol, Perth, WA 6000, Australia; [Mastaglia, Frank L.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [North, Kathryn N.; Ilkovski, Biljana] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW 2145, Australia; [Kremer, Hannie; Lammens, Martin; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 Nijmegen, Netherlands; [Lamont, Phillipa] Royal Perth Hosp, Div Neurosci, Perth, WA 6000, Australia; [Goldfarb, Lev G.] NINDS, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; University of Western Australia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBERNED; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Sydney; Radboud University Nijmegen; Royal Perth Hospital; University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sambuughin, N (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA.	nsambuughin@usuhs.mil	North, Kathryn N/K-6476-2012; Ravenscroft, Gina/H-5695-2014; Lammens, Martin/AAI-9343-2021; Lammens, Martin/H-1503-2011; Kremer, Hannie/F-5126-2010; Olivé, Montse/AAI-6150-2021; van Engelen, Baziel/H-8027-2014	North, Kathryn N/0000-0003-0841-8009; Ravenscroft, Gina/0000-0003-3634-211X; Lammens, Martin/0000-0002-3881-6692; Kremer, Hannie/0000-0002-0841-8693; Olivé, Montse/0000-0001-5727-0165; van Engelen, Baziel/0000-0001-9867-9047; Laing, Nigel/0000-0001-5111-3732; Gonzalez-Mera, Laura/0000-0001-5691-0343	USU [R080CD]; Instituto Carlos III, Ministry of Education and Research, Spain [PI08-574]; Australian National Health and Medical Research Council (NHMRC) [403904, 403941]; National Institute of Neurological Disorders and Stroke, NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002973] Funding Source: NIH RePORTER	USU; Instituto Carlos III, Ministry of Education and Research, Spain; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the members of the affected families for their participation in the study. We thank O. Mungunsukh, USU, for technical advice and for providing RNA from mice tissues. We are grateful to R. Horowits, NIH, for critical comments on the manuscript. The authors thank the Biomedical Instrumentation Center of USU for oligo synthesis, DNA sequencing, and assistance with confocal microscopy. This research was supported by a USU R080CD grant to N.S. M.O. is supported by FIS grant PI08-574 from the Instituto Carlos III, Ministry of Education and Research, Spain. N.G.L. is supported by an Australian National Health and Medical Research Council (NHMRC) fellowship grant, 403904. K.J.N., G.R., and B.I. are supported by NHMRC project grant 403941. This work was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, NIH.	Abou-Elhamd A, 2009, MECH DEVELOP, V126, P852, DOI 10.1016/j.mod.2009.07.006; Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; [Anonymous], NCBI NUCL DAT; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], 2010, NCBI PROT DAT; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gommans IMP, 2003, BRAIN, V126, P1545, DOI 10.1093/brain/awg162; Greenberg CC, 2008, EXP CELL RES, V314, P1177, DOI 10.1016/j.yexcr.2007.12.009; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Laing Nigel G, 2009, Neuromuscul Disord, V19, P300, DOI 10.1016/j.nmd.2009.02.002; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599; *NCBI, NCBI BUILD 37 1; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; OLIVE M, 2010, MUSCLE NERV IN PRESS; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; Pauw-Gommans IMP, 2006, NEUROMUSCULAR DISORD, V16, P477, DOI 10.1016/j.nmd.2006.05.003; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Prag S, 2007, INT J BIOCHEM CELL B, V39, P366, DOI 10.1016/j.biocel.2006.09.003; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X	29	114	120	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					842	847		10.1016/j.ajhg.2010.10.020	http://dx.doi.org/10.1016/j.ajhg.2010.10.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109227	Bronze, Green Published			2022-12-18	WOS:000285564600011
J	Hudson, K; Javitt, G; Burke, W; Byers, P				Hudson, Kathy; Javitt, Gail; Burke, Wylie; Byers, Peter		ASHG Social Issues	ASHG statement* on direct-to-consumer genetic testing in the United States	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material														Byers, Peter H./0000-0001-7786-7030				Australian Law Reform Commission and the Australian Health Ethics Committee of the National Health and Medical Research Council, 2003, ESS YOURS PROT HUM G; *FED TRAD COMM, 2006, AT HOM GEN TESTS HLT; Food and Drug Administration, 2006, DRAFT GUID IND CLIN; *GEN PUBL POL CTR, 2007, SURV DIR TO CONS TES; *GOV ACC OFF, 2006, NUTR TEST TEST PURCH; Hudson KL, 2006, NAT BIOTECHNOL, V24, P1083, DOI 10.1038/nbt0906-1083; *HUM GEN COMM, 2003, GEN DIR ENS EFF OV G; Javitt Gail H, 2004, Oklahoma Law Rev, V57, P251; Ontario Ministry of Health and Long-Term Care, 2002, GEN TEST GEN PAT CHA	9	114	117	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					635	637		10.1086/521634	http://dx.doi.org/10.1086/521634			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX		Bronze, Green Published			2022-12-18	WOS:000249128200022
J	Tang, H; Choudhry, S; Mei, R; Morgan, M; Rodriguez-Cintron, W; Burchard, EG; Risch, NJ				Tang, Hua; Choudhry, Shweta; Mei, Rui; Morgan, Martin; Rodriguez-Cintron, William; Burchard, Esteban Gonzalez; Risch, Neil J.			Recent genetic selection in the ancestral admixture of Puerto Ricans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; POPULATION; AMERICANS; LOCI	Recent studies have used dense markers to examine the human genome in ancestrally homogeneous populations for hallmarks of selection. No genomewide studies have focused on recently admixed groups - populations that have experienced admixing among continentally divided ancestral populations within the past 200-500 years. New World admixed populations are unique in that they represent the sudden confluence of geographically diverged genomes with novel environmental challenges. Here, we present a novel approach for studying selection by examining the genomewide distribution of ancestry in the genetically admixed Puerto Ricans. We find strong statistical evidence of recent selection in three chromosomal regions, including the human leukocyte antigen region on chromosome 6p, chromosome 8q, and chromosome 11q. Two of these regions harbor genes for olfactory receptors. Interestingly, all three regions exhibit deficiencies in the European-ancestry proportion.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci & Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA USA; Vet Caribbean Hlth Care Syst, San Juan, PR USA; Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; Kaiser Permanente Med Ctr, Div Res, Oakland, CA USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Kaiser Permanente	Risch, NJ (corresponding author), Univ Calif San Francisco, Inst Human Genet, 513 Parnassus Ave,S965, San Francisco, CA 94143 USA.	RischN@humgen.ucsf.edu			NHLBI NIH HHS [HL078885, R01 HL078885] Funding Source: Medline; NIGMS NIH HHS [R01 GM073059, GM073059] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Carrion A Morales, 1984, PUERTO RICO POLITICA; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; KIMURA M, 2003, NEURAL THEORY MOL EV; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; LONG JC, 1991, GENETICS, V127, P417; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Santiago-Delpin EA, 2002, TRANSPLANT P, V34, P3075, DOI 10.1016/S0041-1345(02)03594-7; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; Zuniga J, 2006, FORENSIC SCI INT, V164, P266, DOI 10.1016/j.forsciint.2005.11.022	24	114	116	1	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					626	633		10.1086/520769	http://dx.doi.org/10.1086/520769			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701908	Bronze, Green Published			2022-12-18	WOS:000249128200019
J	Zou, YX; Liu, QJ; Chen, BX; Zhang, XY; Guo, CH; Zhou, HB; Li, JX; Gao, GM; Guo, YS; Yan, CZ; Wei, JJ; Shao, CS; Gong, YQ				Zou, Yongxin; Liu, Qiji; Chen, Bingxi; Zhang, Xiyu; Guo, Chenhong; Zhou, Haibin; Li, Jiangxia; Gao, Guimin; Guo, Yishou; Yan, Chuanzhu; Wei, Jianjun; Shao, Changshun; Gong, Yaoqin			Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINEMAN-MYERS-SYNDROME; GENE; FAMILY	We reevaluated a previously reported family with an X-linked mental retardation syndrome and attempted to identify the underlying genetic defect. Screening of candidate genes in a 10-Mb region on Xq25 implicated CUL4B as the causative gene. CUL4B encodes a scaffold protein that organizes a cullin-RING ( really interesting new gene) ubiquitin ligase (E3) complex in ubiquitylation. A base substitution, c.1564C -> T, converted a codon for arginine into a premature termination codon, p.R388X, and rendered the truncated peptide completely devoid of the C-terminal catalytic domain. The nonsense mutation also results in nonsense-mediated mRNA decay in patients. In peripheral leukocytes of obligate carriers, a strong selection against cells expressing the mutant allele results in an extremely skewed X-chromosome inactivation pattern. Our findings point to the functional significance of CUL4B in cognition and in other aspects of human development.	Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Shandong 250012, Peoples R China; Shandong Univ, Sch Med, Inst Med Genet, Shandong 250012, Peoples R China; Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Shandong University; Shandong University; Shandong University; Rutgers State University New Brunswick	Gong, YQ (corresponding author), Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Shandong 250012, Peoples R China.	yxg8@sdu.edu.cn	WEI, JJ/AAN-2638-2020; Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Gong Y, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P277; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Liu Qi-ji, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P198; Liu Qiji, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P22; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Villard L, 2000, AM J MED GENET, V91, P83, DOI 10.1002/(SICI)1096-8628(20000306)91:1<83::AID-AJMG15>3.3.CO;2-E; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; WEI JJ, 1993, AM J MED GENET, V47, P307, DOI 10.1002/ajmg.1320470302	21	114	121	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					561	566		10.1086/512489	http://dx.doi.org/10.1086/512489			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273978	Green Published, Bronze			2022-12-18	WOS:000244403300018
J	Mills, RE; Bennett, EA; Iskow, RC; Luttig, CT; Tsui, C; Pittard, WS; Devine, SE				Mills, RE; Bennett, EA; Iskow, RC; Luttig, CT; Tsui, C; Pittard, WS; Devine, SE			Recently mobilized Transposons in the human and chimpanzee Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETROTRANSPOSITION; ELEMENTS; INSERTION; MECHANISM; SEQUENCES; LINEAGE; CELLS; GENE	Transposable genetic elements are abundant in the genomes of most organisms, including humans. These endogenous mutagens can alter genes, promote genomic rearrangements, and may help to drive the speciation of organisms. In this study, we identified almost 11,000 transposon copies that are differentially present in the human and chimpanzee genomes. Most of these transposon copies were mobilized after the existence of a common ancestor of humans and chimpanzees, similar to 6 million years ago. Alu, L1, and SVA insertions accounted for > 95% of the insertions in both species. Our data indicate that humans have supported higher levels of transposition than have chimpanzees during the past several million years and have amplified different transposon subfamilies. In both species, similar to 34% of the insertions were located within known genes. These insertions represent a form of species-specific genetic variation that may have contributed to the differential evolution of humans and chimpanzees. In addition to providing an initial overview of recently mobilized elements, our collections will be useful for assessing the impact of these insertions on their hosts and for studying the transposition mechanisms of these elements.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Ctr Bioinformat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, BimCore, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Devine, SE (corresponding author), Emory Univ, Sch Med, Dept Biochem, 4133 Rollins Res Ctr,1510 Clifton Rd NE, Atlanta, GA 30322 USA.	sedevin@emory.edu	Mills, Ryan/F-4225-2010	Mills, Ryan/0000-0003-3425-6998	NHGRI NIH HHS [1R01HG002898, R01 HG002898, R01 HG002898-02] Funding Source: Medline; NIGMS NIH HHS [2T32GM00849, T32 GM008490] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; *CHIMP SEQ AN CONS, 2005, NATURE; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Ivics Z, 1997, BIOTECHNIQUES, V22, P254, DOI 10.2144/97222bm12; Johanning K, 2003, J MOL EVOL, V56, P658, DOI 10.1007/s00239-002-2433-y; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2003, J VIROL, V77, P7459, DOI 10.1128/JVI.77.13.7459-7466.2003; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; SHEN LM, 1994, J BIOL CHEM, V269, P8466; van de Lagemaat LN, 2005, GENOME RES, V15, P1243, DOI 10.1101/gr.3910705; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	28	114	120	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					671	679		10.1086/501028	http://dx.doi.org/10.1086/501028			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532396	Green Published, Bronze			2022-12-18	WOS:000236755900012
J	Savkur, RS; Philips, AV; Cooper, TA; Dalton, JC; Moseley, ML; Ranum, LPW; Day, JW				Savkur, RS; Philips, AV; Cooper, TA; Dalton, JC; Moseley, ML; Ranum, LPW; Day, JW			Insulin receptor splicing alteration in myotonic dystrophy type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; RESISTANCE; MUSCLE; MODEL	Myotonic dystrophy (DM) is caused by either an untranslated CTG expansion in the 3' untranslated region of the DMPK gene on chromosome 19 (dystrophia myotonica type 1 [DM1]), or an untranslated CCTG tetranucleotide repeat expansion in intron 1 of the ZNF9 gene on chromosome 3 (dystrophia myotonica type 2 [DM2]). RNA-binding proteins adhere to transcripts of the repeat expansions that accumulate in the nucleus, and a trans-dominant dysregulation of pre-mRNA alternative splicing has been demonstrated for several genes. In muscle from patients with DM1, altered insulin-receptor splicing to the nonmuscle isoform corresponds to the insulin insensitivity and diabetes that are part of the DM phenotype; because of insulin-receptor species differences, this effect is not seen in mouse models of the disease. We now demonstrate that comparable splicing abnormalities occur in DM2 muscle prior to the development of muscle histopathology, thus demonstrating an early pathogenic effect of RNA expansions.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Baylor Univ, Dept Pathol, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor University	Day, JW (corresponding author), Univ Minnesota, Inst Human Genet, MMC 206,420 Delaware St, Minneapolis, MN 55455 USA.	johnday@umn.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00400, M01 RR000400] Funding Source: Medline; NIAMS NIH HHS [R01AR45653, R01 AR045653] Funding Source: Medline; NINDS NIH HHS [R01 NS035870, R01NS35870] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROOK, 1992, CELL, V69, P385; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Furling D, 2001, HUM MOL GENET, V10, P2079, DOI 10.1093/hmg/10.19.2079; HARPER PS, 2001, MYOTONIC DYSTROPHY, V37; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1980, NEUROLOGY, V30, P1077, DOI 10.1212/WNL.30.10.1077; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X	18	114	117	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1309	1313		10.1086/421528	http://dx.doi.org/10.1086/421528			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15114529	Bronze, Green Published			2022-12-18	WOS:000221651900026
J	Tanaka, T; Ikari, K; Furushima, K; Okada, A; Tanaka, H; Furukawa, KI; Yoshida, K; Ikeda, T; Ikegawa, S; Hunt, SC; Takeda, J; Toh, S; Harata, S; Nakajima, T; Inoue, I				Tanaka, T; Ikari, K; Furushima, K; Okada, A; Tanaka, H; Furukawa, KI; Yoshida, K; Ikeda, T; Ikegawa, S; Hunt, SC; Takeda, J; Toh, S; Harata, S; Nakajima, T; Inoue, I			Genomewide linkage and linkage disequilibrium analyses identify COL6A1, on chromosome 21, as the locus for ossification of the posterior longitudinal ligament of the spine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETHLEM MYOPATHY; GENE; ASSOCIATION; MUTATIONS; NPPS; DISH	Ossification of the posterior longitudinal ligament (OPLL) of the spine is a subset of "bone-forming" diseases, characterized by ectopic ossification in the spinal ligaments. OPLL is a common disorder among elderly populations in eastern Asia and is the leading cause of spinal myelopathy in Japan. We performed a genomewide linkage study with 142 affected sib pairs, to identify genetic loci related to OPLL. In multipoint linkage analysis using GENE-HUNTER-PLUS, evidence of linkage to OPLL was detected on chromosomes 1p, 6p, 11q, 14q, 16q, and 21q. The best evidence of linkage was detected near D21S1903 on chromosome 21q22.3 (maximum Z(lr) = 3.97); there fore, the linkage region was extensively investigated for linkage disequilibrium with single-nucleotide polymorphisms (SNPs) covering 20 Mb. One hundred fifty positional candidate genes lie in the region, and 600 gene-based SNPs were genotyped. There were positive allelic associations with seven genes (P < .01) in 280 patients and 210 controls, and four of the seven genes were clustered within a region of 750 kb, similar to 1.2 Mb telomeric to D21S1903. Extensive linkage disequilibrium and association studies of the four genes indicated that SNPs in the collagen 6A1 gene (COL6A1) were strongly associated with OPLL (P = .000003 for the SNP in intron 32 [-29]). Haplotype analysis with three SNPs in COL6A1 gave a single-point P value of .0000007. Identification of the locus of susceptibility to OPLL by genomewide linkage and linkage disequilibrium studies permits us to investigate the pathogenesis of the disease, which may lead to the development of novel therapeutic tools.	Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Inst Rheumatol, Dept Orthoped Surg, Tokyo, Japan; Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo, Japan; Hirosaki Univ, Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori 036, Japan; Hirosaki Univ, Sch Med, Dept Pharmacol, Hirosaki, Aomori 036, Japan; Yamaguchi Univ, Sch Med, Dept Orthopaed Surg, Ube, Yamaguchi 755, Japan; Univ Utah, Salt Lake City, UT USA; Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Regulat, Maebashi, Gumma 371, Japan	University of Tokyo; Tokyo Women's Medical University; RIKEN; Hirosaki University; Hirosaki University; Yamaguchi University; Utah System of Higher Education; University of Utah; Gunma University	Inoue, I (corresponding author), Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ituro@ims.u-tokyo.ac.jp	Furukawa, Ken-Ichi/N-9244-2014; Toh, Satoshi/K-5737-2013; Ikegawa, Shiro/N-6895-2015	Furukawa, Ken-Ichi/0000-0002-5680-007X; Ikegawa, Shiro/0000-0003-0316-2147				BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Furushima K, 2002, J BONE MINER RES, V17, P128, DOI 10.1359/jbmr.2002.17.1.128; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ikari K, 2001, J HUM GENET, V46, P207, DOI 10.1007/s100380170090; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Koga H, 1998, AM J HUM GENET, V62, P1460, DOI 10.1086/301868; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEWONTIN RC, 1964, GENETICS, V49, P49; Maeda S, 2001, J BONE MINER RES, V16, P948, DOI 10.1359/jbmr.2001.16.5.948; Matsunaga S., 1997, OSSIFICATION POSTERI, P11; MOHIRE MD, 1988, NEUROLOGY, V38, P573, DOI 10.1212/WNL.38.4.573; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Onda H, 2001, AM J HUM GENET, V69, P804, DOI 10.1086/323614; PAPE G, 1999, BIOCHEM BIOPH RES CO, V258, P802; RESNICK D, 1978, AM J ROENTGENOL, V131, P1049, DOI 10.2214/ajr.131.6.1049; Saito M, 2002, J HUM GENET, V47, P377, DOI 10.1007/s100380200054; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TROJAN DA, 1992, AM J MED, V92, P296, DOI 10.1016/0002-9343(92)90080-U; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222, DOI 10.1007/s002560050225; Yamauchi T, 1999, J BONE MINER METAB, V17, P296, DOI 10.1007/s007740050098; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	33	114	127	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					812	822		10.1086/378593	http://dx.doi.org/10.1086/378593			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12958705	Green Published, Bronze			2022-12-18	WOS:000185676100009
J	Richards, M; Macaulay, V; Torroni, A; Bandelt, HJ				Richards, M; Macaulay, V; Torroni, A; Bandelt, HJ			In search of geographical patterns in European mitochondrial DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-GENE-FREQUENCIES; Y-CHROMOSOME; CONTROL-REGION; DEMIC DIFFUSION; MTDNA; DIVERSITY; POOL; LINEAGES; ORIGINS	Previous studies of mitochondrial DNA (mtDNA) in Europe and the Near East have suggested that, in contrast with classical markers and the Y chromosome, mtDNA does not exhibit significant geographical structuring. Here, we show that, with a sufficiently large sample size and a better resolved mtDNA tree, clades of mtDNA do indeed exhibit gradients similar to those of other marker systems. However, the more detailed analyses afforded by molecular sequence data suggest that the explanations for these gradients are likely to be much more complex than those proposed for classical markers.	Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Hamburg, Fachbereich Math, Hamburg, Germany	University of Huddersfield; University of Oxford; University of Pavia; University of Hamburg	Richards, M (corresponding author), Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.		Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; RICHARDS, MARTIN/0000-0003-3118-0967				Ammerman A.J., 1984, NEOLITHIC TRANSITION; BARBUJANI G, 2000, ARCHAEOGENETICS DNA, P119; Bogucki P., 2000, EUROPES 1 FARMERS, P197, DOI DOI 10.1017/CBO9780511607851.009; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CLARK GA, 2000, CURR ANTHROPOL, V41, P372; Ellis N, 2002, GENOME RES, V12, P339; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Gamble C.S., 1999, PALAEOLITHIC SOC EUR; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Price T.D., 2000, EUROPES 1 FARMERS; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; RICHARDS M, 2000, ARCHAEOGENETICS DNA, P139; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 1996, AM J HUM GENET, V59, P964; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; ZilhAo J, 2000, EUROPES 1 FARMERS, P144, DOI DOI 10.1017/CBO9780511607851.007	33	114	117	1	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1168	1174		10.1086/342930	http://dx.doi.org/10.1086/342930			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12355353	Green Published, Bronze			2022-12-18	WOS:000178884300014
J	Pei, Y; Paterson, AD; Wang, KR; He, N; Hefferton, D; Watnick, T; Germino, GG; Parfrey, P; Somlo, S; St George-Hyslop, P				Pei, Y; Paterson, AD; Wang, KR; He, N; Hefferton, D; Watnick, T; Germino, GG; Parfrey, P; Somlo, S; St George-Hyslop, P			Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MODEL; PKD2 GENE; MOLECULAR-BASIS; RENAL CYST; MUTATIONS; TYPE-2; FAMILY; REGION; LOCUS; IDENTIFICATION	In searching for a putative third gene for autosomal dominant polycystic kidney disease (ADPKD), we studied the genetic inheritance of a large family (NFL10) previously excluded from linkage to both the PKD1 locus and the PKD2 locus. We screened 48 members of the NFL10 pedigree, by ultrasonography, and genotyped them, with informative markers, at both the PKD1 locus and the PKD2 locus. Twenty-eight of 48 individuals assessed were affected with ADPKD. Inspection of the haplotypes of these individuals suggested the possibility of bilineal disease from independently segregating PKD1 and PKD2 mutations. Using single-stranded conformational analysis, we screened for and found a PKD2 mutation (i.e., 2152delA; L736X) in 12 affected pedigree members. Additionally, when the disease status of these individuals was coded as "unknown" in linkage analysis, we also found, with markers at the PKD1 locus, significant LOD scores (i.e., >3.0). These findings strongly support the presence of a PKD1 mutation in 15 other affected pedigree members, who lack the PKD2 mutation. Two additional affected individuals had trans-heterozygous mutations involving both genes, and they had renal disease that was more severe than that in affected individuals who had either mutation alone. This is the first documentation of bilineal disease in ADPKD. In humans, trans-heterozygous mutations involving both PKD1 and PKD2 are not necessarily embryonically lethal. However, the disease associated with the presence of both mutations appears to be more severe than the disease associated with either mutation alone. The presence of bilineal disease as a confounder needs to be considered seriously in the search for the elusive PKD3 locus.	Univ Hlth Network, Dept Med, Div Genom Med, Toronto, ON, Canada; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Mem Univ Newfoundland, Div Nephrol, St Johns, NF, Canada; Johns Hopkins Univ, Div Nephrol, Baltimore, MD USA; Yale Univ, Sch Med, Div Nephrol, New Haven, CT USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Memorial University Newfoundland; Johns Hopkins University; Yale University	Pei, Y (corresponding author), 13 EN-228,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	york.pei@uhn.on.ca	Paterson, Andrew D/A-4088-2011	Paterson, Andrew D/0000-0002-9169-118X; Germino, Gregory/0000-0002-3609-5588; St George-Hyslop, Peter/0000-0003-0796-7209	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328] Funding Source: NIH RePORTER; NIDDK NIH HHS [P50 DK057328] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ariza M, 1997, J MED GENET, V34, P587, DOI 10.1136/jmg.34.7.587; BOGDANOVA N, 1995, HUM GENET, V95, P645; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Chauveau D, 1997, Adv Nephrol Necker Hosp, V26, P265; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; FICK GM, 1994, KIDNEY INT, V46, P951, DOI 10.1038/ki.1994.354; Floeth M, 1999, AM J HUM GENET, V65, P1530, DOI 10.1086/302672; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Hateboer N, 1999, KIDNEY INT, V56, P34, DOI 10.1046/j.1523-1755.1999.00541.x; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Koptides M, 2000, HUM MOL GENET, V9, P447, DOI 10.1093/hmg/9.3.447; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAUCKS SP, 1981, BRIT J RADIOL, V54, P12, DOI 10.1259/0007-1285-54-637-12; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Paterson AD, 1998, KIDNEY INT, V54, P1759, DOI 10.1046/j.1523-1755.1998.00166.x; Paterson AD, 1999, NEPHROL DIAL TRANSPL, V14, P2965, DOI 10.1093/ndt/14.12.2965; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pei Y, 1998, J AM SOC NEPHROL, V9, P1853; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; SANMILLAN JL, 1995, AM J HUM GENET, V56, P248; Sobel E, 1996, AM J HUM GENET, V58, P1323; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Turco AE, 1996, AM J KIDNEY DIS, V28, P759, DOI 10.1016/S0272-6386(96)90261-9; Watnick T, 1999, AM J HUM GENET, V65, P1561, DOI 10.1086/302657; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	44	114	117	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					355	363		10.1086/318188	http://dx.doi.org/10.1086/318188			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11156533	Bronze, Green Published			2022-12-18	WOS:000166524800006
J	Bellus, GA; Spector, EB; Speiser, PW; Weaver, CA; Garber, AT; Bryke, CR; Israel, J; Rosengren, SS; Webster, MK; Donoghue, DJ; Francomano, CA				Bellus, GA; Spector, EB; Speiser, PW; Weaver, CA; Garber, AT; Bryke, CR; Israel, J; Rosengren, SS; Webster, MK; Donoghue, DJ; Francomano, CA			Distinct missense mutations of the FCFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; THANATOPHORIC DYSPLASIA; ACANTHOSIS NIGRICANS; GENETIC-HETEROGENEITY; DEVELOPMENTAL DELAY; HYPOCHONDROPLASIA; ACHONDROPLASIA; TRANSMEMBRANE; DOMAIN; FGFR3	The fibroblast growth factor-receptor 3 (FGFR3) Lys650 codon is located within a critical region of the tyrosine kinase-domain activation loop, Two missense mutations in this codon are known to result in strong constitutive activation of the FGFR3 tyrosine kinase and cause three different skeletal dysplasia syndromes-thanatophoric dysplasia type II (TD2) (A1948G [Lys650Glu]) and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) syndrome and thanatophoric dysplasia type I (TD1) (both due to A1949T [Lys650Met]). Other mutations within the FGFR3 tyrosine kinase domain (e.g., C1620A or C1620G [both resulting in Asn540Lys]) are known to cause hypochondroplasia, a relatively common but milder skeletal dysplasia. In 90 individuals with suspected clinical diagnoses of hypochondroplasia who do not have Asn540Lys mutations, we screened for mutations, in FGFR3 exon 15, that would disrupt a unique BbsI restriction site that includes the Lys650 codon. We report here the discovery of three novel mutations (G1950T and G1950C [both resulting in Lys650Asn] and A1948C [Lys650Gln]) occurring in six individuals from five families. Several physical and radiological features of these individuals were significantly milder than those in individuals with the Asn540Lys mutations. The Lys650Asn/Gln mutations result in constitutive activation of the FGFR3 tyrosine kinase but to a lesser degree than that observed with the Lys540Glu and Lys650Met mutations. These results demonstrate that different amino acid substitutions at the FGFR3 Lys650 codon can result in several different skeletal dysplasia phenotypes.	Univ Colorado, Sch Med, Dept Dermatol, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA; Univ Colorado, Sch Med, Ctr Med Genet, Denver, CO 80262 USA; N Shore Univ Hosp, Dept Pediat, NYU, Sch Med, Manhasset, NY 11030 USA; Carle Clin Assoc, Div Med Genet, Dept Pediat, Urbana, IL USA; Comprehens Genet Serv, Milwaukee, WI USA; Univ Connecticut, Sch Med, Dept Pediat, Farmington, CT 06032 USA; Univ Calif San Diego, Ctr Mol Genet, Dept Chem & Biochem, La Jolla, CA 92093 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; New York University; Northwell Health; North Shore University Hospital; University of Connecticut; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bellus, GA (corresponding author), Univ Colorado, Sch Med, Dept Dermatol, B-153,4200 E 9th Ave, Denver, CO 80262 USA.	gary.bellus@uchsc.edu		Bellus, Gary/0000-0001-7492-3324	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012581] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08 AR002075, 1K08AR002075] Funding Source: Medline; NIDCR NIH HHS [R01-DE12581] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Baker KM, 1997, AM J MED GENET, V70, P427, DOI 10.1002/(SICI)1096-8628(19970627)70:4<427::AID-AJMG18>3.0.CO;2-J; BEALS RK, 1969, J BONE JOINT SURG AM, VA 51, P728, DOI 10.2106/00004623-196951040-00011; Bellus GA, 1996, ANN NY ACAD SCI, V785, P182, DOI 10.1111/j.1749-6632.1996.tb56257.x; Bellus GA, 1999, AM J MED GENET, V85, P53, DOI 10.1002/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.3.CO;2-6; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Deutz-Terlouw PP, 1998, HUM MUTAT, pS62; Glantz S.A., 1997, PRIMER BIOSTATISTICS, P65; Grigelioniene G, 2000, ACTA PAEDIATR, V89, P1072, DOI 10.1080/713794579; Grigelioniene G, 1998, HUM MUTAT, V11, P333, DOI 10.1002/(SICI)1098-1004(1998)11:4<333::AID-HUMU17>3.3.CO;2-A; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; HO KL, 1984, ACTA NEUROPATHOL, V63, P218, DOI 10.1007/BF00685248; Kitoh Hiroshi, 1998, Human Mutation, V12, P362; KOZLOWSKI K, 1965, POL REV RADIOL NUCL, V29, P450; MAROTEAUX P, 1988, ARCH FR PEDIATR, V45, P105; MAROTEAUX P, 1960, CHONDRODYSTROPHIES G, P26; Matsui Y, 1998, J BONE JOINT SURG BR, V80B, P1052, DOI 10.1302/0301-620X.80B6.9277; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Mortier G, 2000, J MED GENET, V37, P220, DOI 10.1136/jmg.37.3.220; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; POZNANSKI AK, 1984, HAND RADIOLOGIC DIAG, V1, P31; PRINOS P, 1995, HUM MOL GENET, V4, P2097, DOI 10.1093/hmg/4.11.2097; Prinster C, 1998, AM J MED GENET, V75, P109, DOI 10.1002/(SICI)1096-8628(19980106)75:1<109::AID-AJMG22>3.0.CO;2-P; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; Ramaswami U, 1998, J PEDIATR-US, V133, P99, DOI 10.1016/S0022-3476(98)70186-6; RAVENNA F, 1913, N ICONOG SALPERTRIER, V26, P157; Rousseau F, 1996, J MED GENET, V33, P749, DOI 10.1136/jmg.33.9.749; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STOILOV I, 1995, J MED GENET, V32, P492, DOI 10.1136/jmg.32.6.492-a; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WALKER BA, 1971, AM J DIS CHILD, V122, P95, DOI 10.1001/archpedi.1971.02110020029001; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Winterpacht A, 2000, PHYSIOL GENOMICS, V2, P9, DOI 10.1152/physiolgenomics.2000.2.1.9; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674	41	114	124	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1411	1421		10.1086/316892	http://dx.doi.org/10.1086/316892			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11055896	Green Published, Bronze			2022-12-18	WOS:000165607600006
J	Wren, JD; Forgacs, E; Fondon, JW; Pertsemlidis, A; Cheng, SY; Gallardo, T; Williams, RS; Shohet, RV; Minna, JD; Garner, HR				Wren, JD; Forgacs, E; Fondon, JW; Pertsemlidis, A; Cheng, SY; Gallardo, T; Williams, RS; Shohet, RV; Minna, JD; Garner, HR			Repeat polymorphisms within gene regions: Phenotypic and evolutionary implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X SYNDROME; APO(A) GENE; DNA; EXPANSION; SEQUENCES; DISEASE; SPERM; IDENTIFICATION; MICROSATELLITE; FREQUENCY	We have developed an algorithm that predicted 11,265 potentially polymorphic tandem repeats within transcribed sequences. We estimate that 22% (2,207/9,717) of the annotated clusters within UniGene contain at least one potentially polymorphic locus. Our predictions were tested by allelotyping a panel of similar to 30 individuals for 5% of these regions, confirming polymorphism for more than half the loci tested. Our study indicates that tandem-repeat polymorphisms in genes are more common than is generally believed. Approximately 8% of these loci are within coding sequences and, if polymorphic, would result in frameshifts. Our catalogue of putative polymorphic repeats within transcribed sequences comprises a large set of potentially phenotypic or disease-causing loci. In addition, from the anomalous character of the repetitive sequences within unannotated clusters, we also conclude that the UniGene cluster count substantially overestimates the number of genes in the human genome. We hypothesize that polymorphisms in repeated sequences occur with some baseline distribution, on the basis of repeat homogeneity, size, and sequence composition, and that deviations from that distribution are indicative of the nature of selection pressure at that locus. We find evidence of selective maintenance of the ability of some genes to respond very rapidly, perhaps even on intragenerational timescales, to fluctuating selective pressures.	Univ Texas, SW Med Ctr, SW Grad Sch Biomed Sci, Program Genet & Dev, Dallas, TX USA; Univ Texas, SW Med Ctr, SW Grad Sch Biomed Sci, Program Mol Biophys, Dallas, TX USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; Univ Texas, SW Med Ctr, Ctr Biomed Invent, Dallas, TX USA; Univ Texas, SW Med Ctr, Ryburn Cardiac Ctr, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garner, HR (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Shohet, ralph V/A-1731-2011; Wren, Jonathan D/E-5611-2011; Pertsemlidis, Alexander/Q-7899-2017	Wren, Jonathan D/0000-0003-2776-3545; Pertsemlidis, Alexander/0000-0003-1624-9372	NCI NIH HHS [P50 CA070907, P50CA70907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alba MM, 1999, J MOL EVOL, V49, P789, DOI 10.1007/PL00006601; Alba MM, 1999, MOL BIOL EVOL, V16, P1641, DOI 10.1093/oxfordjournals.molbev.a026077; BEATON S, 1995, MOL REPROD DEV, V40, P242, DOI 10.1002/mrd.1080400214; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Fondon JW, 1998, P NATL ACAD SCI USA, V95, P7514, DOI 10.1073/pnas.95.13.7514; Gay E, 2000, BIOCHEM BIOPH RES CO, V267, P509, DOI 10.1006/bbrc.1999.2000; Hancock JM, 1998, EMBO J, V17, P5521, DOI 10.1093/emboj/17.19.5521; Jakupciak JP, 1999, J BIOL CHEM, V274, P23468, DOI 10.1074/jbc.274.33.23468; JANSEN G, 1994, AM J HUM GENET, V54, P575; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Karthikeyan G, 1999, NUCLEIC ACIDS RES, V27, P3851, DOI 10.1093/nar/27.19.3851; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kunst CB, 1997, J MED GENET, V34, P627, DOI 10.1136/jmg.34.8.627; Leeflang EP, 1999, HUM MOL GENET, V8, P173, DOI 10.1093/hmg/8.2.173; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; MOOSER V, 1995, HUM MOL GENET, V4, P173, DOI 10.1093/hmg/4.2.173; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OHNO S, 1984, J MOL EVOL, V20, P313, DOI 10.1007/BF02104737; Rayner S, 1998, GENOME RES, V8, P741, DOI 10.1101/gr.8.7.741; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; Schmid KJ, 1999, GENETICS, V153, P1717; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; SMITS APT, 1993, J MED GENET, V30, P94, DOI 10.1136/jmg.30.2.94; STALLINGS RL, 1994, GENOMICS, V21, P116, DOI 10.1006/geno.1994.1232; Sumiyama K, 1996, J MOL EVOL, V43, P170, DOI 10.1007/PL00006075; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Valenti K, 1999, ATHEROSCLEROSIS, V147, P17, DOI 10.1016/S0021-9150(99)00137-9; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; ZULIANI G, 1990, AM J HUM GENET, V46, P963	34	114	125	1	13	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					345	356		10.1086/303013	http://dx.doi.org/10.1086/303013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10889045	Green Published, Bronze			2022-12-18	WOS:000089357800011
J	Forster, P; Rohl, A; Lunnemann, P; Brinkmann, C; Zerjal, T; Tyler-Smith, C; Brinkmann, B				Forster, P; Rohl, A; Lunnemann, P; Brinkmann, C; Zerjal, T; Tyler-Smith, C; Brinkmann, B			A short tandem repeat-based phylogeny for the human Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION-RATES; AFRICAN POPULATIONS; DNA VARIATION; HAPLOTYPES; EVOLUTION; ORIGIN; MICROSATELLITES; MINISATELLITE; POLYMORPHISMS; RESOLUTION	Human Y-chromosomal short tandem repeat (STR) data provide a potential model system for the understanding of autosomal STR mutations in humans and other species. Yet, the reconstruction of STR evolution is rarely attempted, because of the absence of an appropriate methodology We here develop and validate a phylogenetic network approach. We have typed 256 Y chromosomes of indigenous descent from Africa, Asia, Europe, Australia, and highland Papua Near Guinea, for the STR loci DYS19, DXYS156Y, DYS389, DYS390, DYS392, and DYS393, as well as for five ancient biallelic mutation events: two poly (A) length variants associated with the YAP insertion, two independent SRY-1532 mutations, and the 92R7 mutation. We have used our previously published pedigree data from 11,000 paternity-tested autosomal STR-allele transfers to produce a two-class weighting system for the Y-STR loci that is based on locus lengths and motif lengths. Reduced-median-network analysis yields a phylogeny that is independently supported by the five biallelic mutations, with an error of 6%. We find the earliest branch in our African San (Bushmen) sample. Assuming an age of 20,000 years for the Native American DYS199 T mutation, we estimate a mutation rate of 2.6 x 10(-4) mutations/20 years for slowly mutating Y STRs, similar to 10-fold slower than the published average pedigree rate.	Univ Munster, Inst Rechtsmed, D-48149 Munster, Germany; Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Munster; University of Cambridge; University of Oxford	Brinkmann, B (corresponding author), Univ Munster, Inst Rechtsmed, Von Esmarch Str 62, D-48149 Munster, Germany.		zerjal, tatiana/AAO-9473-2020					Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Forster P, 1996, AM J HUM GENET, V59, P935; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Jobling MA, 1999, HUM MOL GENET, V8, P2117, DOI 10.1093/hmg/8.11.2117; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Jobling MA, 1998, HUM MOL GENET, V7, P643, DOI 10.1093/hmg/7.4.643; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; KAYSER M, 1997, INT J LEGAL MED, V110, P141; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; Macaulay VA, 1997, AM J HUM GENET, V61, P983; MORELL V, 1990, SCIENCE, V241, P439; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nata M, 1999, INT J LEGAL MED, V112, P406; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; Richards M, 1996, AM J HUM GENET, V59, P185; Rolf B, 1999, GENOMIC DIVERSITY, P75; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Saunders NJ, 1998, NATURE, V392, P145, DOI 10.1038/32337; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Seielstad M, 1999, GENOME RES, V9, P558; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WIEGAND P, 1993, INT J LEGAL MED, V106, P81, DOI 10.1007/BF01225045	44	114	117	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					182	196		10.1086/302953	http://dx.doi.org/10.1086/302953			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10827105	Green Published, Bronze			2022-12-18	WOS:000088926900020
J	Kruse, S; Mao, XQ; Heinzmann, A; Blattmann, S; Roberts, MH; Braun, S; Gao, PS; Forster, J; Kuehr, J; Hopkin, JM; Shirakawa, T; Deichmann, KA				Kruse, S; Mao, XQ; Heinzmann, A; Blattmann, S; Roberts, MH; Braun, S; Gao, PS; Forster, J; Kuehr, J; Hopkin, JM; Shirakawa, T; Deichmann, KA			The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLATELET-ACTIVATING-FACTOR; GENOME-WIDE SEARCH; MISSENSE MUTATION; CHROMOSOME 11Q13; RISK FACTOR; DEFICIENCY; GENE; PHOSPHOLIPASE; CHILDREN; LIPOPROTEIN	The platelet-activating factor (PAF) represents a phospholipid with complex biological functions, including involvement in inflammatory processes. The degrading enzyme PAF acetylhydrolase (PAFAH) represents a candidate for asthma and other atopic diseases. Two loss-of-function mutations of PAFAH are associated with severe asthma in Japanese individuals. Our aim was to look for further PAFAH variants in white populations, their possible association with atopic and asthmatic phenotypes, and their functional importance. We picked up three common variants in the PAFAH gene: Arg92His (exon 4), Ile198Thr (exon 7), and Ala379Val (exon 11). The known loss-of-function mutations were not seen. The variant allele Thr198 was found to be highly associated with total IgE concentrations in an atopic population (P = .009) and with "atopic asthma" in an asthmatic population (P = .008). The variant allele Val379 was found to be highly associated with "specific sensitization" in the atopic population (P = .002) and with "asthma" in the asthmatic population (P = .003). By use of recombinant PAFAH enzymes, the variant Val379 showed increased (14 mu M) and Thr198 markedly increased (42 mu M) K-M values compared to the wild type (7 mu M); furthermore, Vmax of Val379 was highly increased (132%). Thr198 and Val379 influence plasmatic PAFAH toward lower substrate affinities and therefore are very likely to prolong the activities of PAF At the same time, they are associated with an increased risk to develop asthma and atopy. Thus, two PAFAH variants seem to play a key role in atopic and asthmatic processes in Caucasian populations.	Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Univ Coll Swansea, Expt Med Unit, Swansea, W Glam, Wales	University of Freiburg; Swansea University	Deichmann, KA (corresponding author), Univ Freiburg, Childrens Hosp, Mathildenstr 1, D-79106 Freiburg, Germany.	deichman@kk1200.ukl.uni-freiburg.de						Adra CN, 1999, CLIN GENET, V55, P431, DOI 10.1034/j.1399-0004.1999.550606.x; AVERILL FJ, 1992, AM REV RESPIR DIS, V145, P571, DOI 10.1164/ajrccm/145.3.571; Bartemes KR, 1999, J IMMUNOL, V162, P2982; Bell R, 1997, BIOCHEM BIOPH RES CO, V241, P630, DOI 10.1006/bbrc.1997.7741; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Gao PS, 1998, HUM GENET, V103, P57, DOI 10.1007/s004390050783; HIORT O, 1994, HUM MOL GENET, V3, P1163, DOI 10.1093/hmg/3.7.1163; Hiramoto M, 1997, STROKE, V28, P2417, DOI 10.1161/01.STR.28.12.2417; HSIEH KH, 1993, J ALLERGY CLIN IMMUN, V91, P650, DOI 10.1016/0091-6749(93)90271-G; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; KLEINETEBBE J, 1992, CLIN EXP ALLERGY, V22, P475, DOI 10.1111/j.1365-2222.1992.tb00150.x; Kruse S, 1999, IMMUNOLOGY, V96, P365; MITTAL KK, 1976, VOX SANG, V31, P161, DOI 10.1111/j.1423-0410.1976.tb02206.x; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; SIMON HU, 1994, J IMMUNOL, V153, P364; STAFFORINI DM, 1990, METHOD ENZYMOL, V187, P344; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; Suzuki I, 1999, IMMUNOGENETICS, V49, P738, DOI 10.1007/s002510050677; TETTA C, 1990, INT ARCH ALLER A IMM, V91, P244, DOI 10.1159/000235124; Tew DG, 1996, ARTERIOSCL THROM VAS, V16, P591, DOI 10.1161/01.ATV.16.4.591; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Toledano BJ, 1999, CELL IMMUNOL, V191, P60, DOI 10.1006/cimm.1998.1410; Tsukioka K, 1993, Arerugi, V42, P167; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Yamada Y, 1997, BIOCHEM BIOPH RES CO, V236, P772, DOI 10.1006/bbrc.1997.7047; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	114	135	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1522	1530		10.1086/302901	http://dx.doi.org/10.1086/302901			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10733466	Green Published, Bronze			2022-12-18	WOS:000088373700006
J	Lomax, B; Tang, S; Separovic, E; Phillips, D; Hillard, E; Thomson, T; Kalousek, DK				Lomax, B; Tang, S; Separovic, E; Phillips, D; Hillard, E; Thomson, T; Kalousek, DK			Comparative genomic hybridization in combination with flow cytometry improves results of cytogenetic analysis of spontaneous abortions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOLID TUMORS; DNA; MOSAICISM	More than 50% of spontaneous abortions (SAs) have abnormal chromosomes; the most common abnormalities are trisomy, sex chromosome monosomy, and polyploidy. Conventional cytogenetic analysis of SAs depends on tissue culturing and is associated with a significant tissue culture failure rate and contamination by maternally derived cells. Comparative genomic hybridization (CCH), in combination with flow cytometry (FCM), can detect numerical and unbalanced structural chromosomal abnormalities associated with SAs while avoiding the technical problems associated with tissue culture. Routine cytogenetic and CGH analysis was performed independently on tissue from 301 SAs. Samples shown to be chromosomally balanced by CGH were analyzed by FCM to determine ploidy. Of 253 samples successfully analyzed by both approaches, there was an absolute correlation of results in 235 (92.8%). Of the 18 cases with discrepancies between cytogenetic and CGH/FCM results, an explanation could be found in 17. Twelve samples produced a 46,XX karyotype by cytogenetics, whereas CGH/FCM demonstrated aneuploidy/polyploidy or a male genome, indicating maternal contamination of the tissue cultures. In two cases, where tetraploidy was demonstrated by cytogenetics and diploidy by FCM, tissue culture artifact is implied. In three cases, CCH demonstrated an aneuploidy, and cytogenetics demonstrated hypertriploidy. In one unexplainable case, aneuploidy demonstrated by CGH could not be detected by repeat CGH analysis, conventional cytogenetic, or FISH analysis. These results demonstrate that CGH supplemented with FCM can readily identify chromosomal abnormalities associated with SAs and, by avoiding maternal contamination and tissue culture artifacts, can do so with a lower failure rate and more accuracy than conventional cytogenetic analysis.	Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; British Columbia Canc Agcy, Dept Lab Med, Analyt Cytol Dept, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Kalousek, DK (corresponding author), British Columbia Childrens & Womens Hosp, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.							ATKINS D, 1997, PEDIATR PATHOL LAB M, V17, P707; Bell KA, 1999, FERTIL STERIL, V71, P334, DOI 10.1016/S0015-0282(98)00445-2; BEREZOWSKY J, 1995, MODERN PATHOL, V8, P775; BOUIE J, 1976, TERATOLOGY, V14, P3, DOI 10.1002/tera.1420140103; BRYNDORF T, 1995, AM J HUM GENET, V57, P1211; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; Daniely M, 1998, HUM REPROD, V13, P805, DOI 10.1093/humrep/13.4.805; HASSOLD TJ, 1986, TRENDS GENET, V2, P105, DOI 10.1016/0168-9525(86)90194-0; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Henderson KG, 1996, HUM GENET, V97, P650; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; Kalousek D K, 1993, Birth Defects Orig Artic Ser, V29, P53; KOHN G, 1970, LANCET, V2, P778; Lestou VS, 1999, TERATOLOGY, V59, P325, DOI 10.1002/(SICI)1096-9926(199905)59:5<325::AID-TERA3>3.0.CO;2-N; Levy B, 1998, GENET MED, V1, P4; Lomax BL, 1998, PRENATAL DIAG, V18, P752, DOI 10.1002/(SICI)1097-0223(199807)18:7<752::AID-PD313>3.0.CO;2-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ROONEY DE, 1997, ESSENTIAL TECHNIQUES, P1	20	114	134	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1516	1521		10.1086/302878	http://dx.doi.org/10.1086/302878			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10741955	Green Published, Bronze			2022-12-18	WOS:000088373700005
J	Taylor, MD; Gokgoz, N; Andrulis, IL; Mainprize, TG; Drake, JM; Rutka, JT				Taylor, MD; Gokgoz, N; Andrulis, IL; Mainprize, TG; Drake, JM; Rutka, JT			Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL-NERVOUS-SYSTEM; PRIMITIVE NEUROECTODERMAL TUMOR; RHABDOID TUMOR; KIDNEY; INTERACTS; REGION	We have identified a family afflicted over multiple generations with posterior fossa tumors of infancy, including central nervous system (CNS) malignant rhabdoid tumor (a subset of primitive neuroectodermal tumors, or PNET) and choroid plexus carcinoma. Various hereditary tumor syndromes, including Li-Fraumeni syndrome, Gorlin syndrome, and Turcot syndrome, have been linked to increased risk of developing CNS PNETs and choroid plexus tumors. Malignant rhabdoid tumors of the CNS and kidney show loss of heterozygosity at chromosome 22q11. The hSNF5 gene on chromosome 22q11 has recently been identified as a candidate tumor-suppressor gene in sporadic CNS and renal malignant rhabdoid tumors. We describe a family in which both affected and some unaffected family members were found to have a germline splice-site mutation of the hSNF5 gene, leading to exclusion of exon 7 from the mature cDNA and a subsequent frameshift. Tumor tissue shows loss of the wildtype hSNF5 allele, in keeping with a tumor-suppressor gene. These findings suggest that germline mutations in hSNF5 are associated with a novel autosomal dominant syndrome with incomplete penetrance that predisposes to malignant posterior fossa brain tumors in infancy.	Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Div Neurosurg, Toronto, ON M4N 1X8, Canada; Univ Toronto, Div Neurosurg, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Rutka, JT (corresponding author), Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Div Neurosurg, 3008b McMaster Bldg,88 Elm St, Toronto, ON M4N 1X8, Canada.		Andrulis, Irene L./E-7267-2013	Taylor, Michael/0000-0001-7009-3466				BIEGEL JA, 1990, J NEUROSURG, V73, P710, DOI 10.3171/jns.1990.73.5.0710; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Biegel JA, 1999, CANCER RES, V59, P74; BIGNER SH, 1990, CANCER RES, V50, P2347; BONNIN JM, 1984, CANCER-AM CANCER SOC, V54, P2137, DOI 10.1002/1097-0142(19841115)54:10<2137::AID-CNCR2820541014>3.0.CO;2-D; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; FORT DW, 1994, GENE CHROMOSOME CANC, V11, P146, DOI 10.1002/gcc.2870110303; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; LI FP, 1969, J NATL CANCER I, V43, P1365; LYNCH HT, 1983, CANCER-AM CANCER SOC, V52, P290, DOI 10.1002/1097-0142(19830715)52:2<290::AID-CNCR2820520216>3.0.CO;2-L; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Parellada JA, 1998, EUR J RADIOL, V28, P219, DOI 10.1016/S0720-048X(98)00123-5; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212	16	114	115	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1403	1406		10.1086/302833	http://dx.doi.org/10.1086/302833			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739763	Green Published, Bronze			2022-12-18	WOS:000088373400021
J	Giulian, D				Giulian, D			Microglia and the immune pathology of Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYLOID-BETA-PROTEIN; SCAVENGER RECEPTOR; SENILE PLAQUES; BRAIN; CELLS; RELEASE		Baylor Coll Med, Dept Neurol, Alzheimers Dis Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Giulian, D (corresponding author), Baylor Coll Med, Dept Neurol, Alzheimers Dis Res Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012548] Funding Source: NIH RePORTER; NIA NIH HHS [AG12548] Funding Source: Medline; NINDS NIH HHS [NS35972, NS3400] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BOLSI DINO, 1927, RIV PAT NERV E MENT, V32, P65; BREITNER JCS, 1990, NEUROLOGY, V44, P227; Christie RH, 1996, AM J PATHOL, V148, P399; EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4; ElKhoury J, 1996, NATURE, V382, P716; Giulian D, 1998, ALZ DIS ASSOC DIS, V12, pS7; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Giulian D, 1996, J NEUROSCI, V16, P6021; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; Giulian D, 1998, J BIOL CHEM, V273, P29719, DOI 10.1074/jbc.273.45.29719; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; GIULIAN D, 1995, NEUROCHEM INT, V27, P119, DOI 10.1016/0197-0186(95)00067-I; GIULIAN D, 1988, NEUROLOGY NEUROBIOLO, V48, P281; Giulian D., 1992, CURR TOP NEUROL, V12, P23; Growdon JH, 1999, ARCH NEUROL-CHICAGO, V56, P281, DOI 10.1001/archneur.56.3.281; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Kovacs DM, 1998, CELL MOL LIFE SCI, V54, P902, DOI 10.1007/s000180050219; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Sisodia SS, 1999, AM J HUM GENET, V65, P7, DOI 10.1086/302475; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; THERY C, 1993, CLIN NEUROPATHOL, V12, P288	32	114	123	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					13	18		10.1086/302477	http://dx.doi.org/10.1086/302477			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364511	Bronze, Green Published			2022-12-18	WOS:000081224300003
J	Ducros, A; Denier, C; Joutel, A; Vahedi, K; Michel, A; Darcel, F; Madigand, M; Guerouaou, D; Tison, F; Julien, J; Hirsch, E; Chedru, F; Bisgard, C; Lucotte, G; Despres, P; Billard, C; Barthez, MA; Ponsot, G; Bousser, MG; Tournier-Lasserve, E				Ducros, A; Denier, C; Joutel, A; Vahedi, K; Michel, A; Darcel, F; Madigand, M; Guerouaou, D; Tison, F; Julien, J; Hirsch, E; Chedru, F; Bisgard, C; Lucotte, G; Despres, P; Billard, C; Barthez, MA; Ponsot, G; Bousser, MG; Tournier-Lasserve, E			Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P-TYPE; SUBCELLULAR-DISTRIBUTION; SYNAPTIC TRANSMISSION; ALPHA(1A) SUBUNITS; CA2+ CHANNELS; ION CHANNELS; HETEROGENEITY; MAPS; SCA6; DNA	Familial hemiplegic migraine (HM) is an autosomal dominant migraine with aura. In 20% of HM families, HM is associated with a mild permanent cerebellar ataxia (PCA). The CACNA1A gene encoding the alpha 1A subunit of P/Q-type voltage-gated calcium channels is involved in 50% of unselected HM families and in all families with HM/PCA. Four CACNA1A missense mutations have been identified in HM: two in pure HM and two in HM/PCA. Different CACNA1A mutations have been identified in other autosomal dominant conditions: mutations leading to a truncated protein in episodic ataxia type 2 (EA2), small expansions of a CAG trinucleotide in spinocerebellar ataxia type 6 and also in three families with EA2 features, and, finally, a missense mutation in a single family suffering from episodic ataxia and severe progressive PCA. We screened 16 families and 3 nonfamilial case patients affected by HM/PCA for specific CACNA1A mutations and found nine families and one nonfamilial case with the same T666M mutation, one new mutation (D715E) in one family and no CAG repeat expansion. Both T666M and D715E substitutions were absent in 12 probands belonging to pure HM families whose disease appears to be linked to CACNA1A. Finally, haplotyping with neighboring markers suggested that T666M arose through recurrent mutational events. These data could indicate that the PCA observed in 20% of HM families results from specific pathophysiologic mechanisms.	Fac Med Necker, INSERM U25, F-75730 Paris 15, France; Hop Lariboisiere, Serv Neurol, F-75475 Paris, France; Hop Lariboisiere, Cytogenet Serv, F-75475 Paris, France; Hop St Vincent de Paul, F-75674 Paris, France; CHU Rennes, Rennes, France; Hop St Brieuc, St Brieuc, France; CHU Lille, F-59037 Lille, France; CHU Bordeaux, Bordeaux, France; Hop Haut Leveque, Pessac, France; CHU Strasbourg, F-67000 Strasbourg, France; Ctr Hosp Meaux, Meaux, France; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; CHU Reims, Dept Genet, Reims, France; CH Rambouillet, Serv Pediat, Rambouillet, France; CHU Tours, Serv Neuropediat, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Lille - ISITE; CHU Lille; CHU Bordeaux; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Aarhus University; CHU de Reims; CHU Tours	Tournier-Lasserve, E (corresponding author), Fac Med Necker, INSERM U25, 156 Rue Vaugirad, F-75730 Paris 15, France.		Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017; DUCROS, Anne/D-1899-2010	Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; DUCROS, Anne/0000-0001-5560-5013				BLAU JN, 1955, LANCET, V2, P1115; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Elliott MA, 1996, ANN NEUROL, V39, P100, DOI 10.1002/ana.410390115; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Geschwind DH, 1997, NEUROLOGY, V49, P1247, DOI 10.1212/WNL.49.5.1247; Gurnett CA, 1996, J BIOL CHEM, V271, P27975, DOI 10.1074/jbc.271.45.27975; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Headache Classification Committee of the International Headache Society, 1998, CEPHALALGIA S7, V8, P19; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; JOUTEL A, 1994, AM J HUM GENET, V55, P1166; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; Moreno H, 1997, P NATL ACAD SCI USA, V94, P14042, DOI 10.1073/pnas.94.25.14042; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Terwindt GM, 1998, NEUROLOGY, V50, P1105, DOI 10.1212/WNL.50.4.1105; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Wheeler DB, 1995, PROG BRAIN RES, V105, P65; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; YOUNG GF, 1970, ARCH NEUROL-CHICAGO, V23, P201, DOI 10.1001/archneur.1970.00480270011002; Yue Q, 1998, AM J MED GENET, V77, P298, DOI 10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319	33	114	126	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					89	98		10.1086/302192	http://dx.doi.org/10.1086/302192			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915947	Green Published, Bronze			2022-12-18	WOS:000078477400013
J	Passarino, G; Semino, O; Quintana-Murci, L; Excoffier, L; Hammer, M; Santachiara-Benerecetti, AS				Passarino, G; Semino, O; Quintana-Murci, L; Excoffier, L; Hammer, M; Santachiara-Benerecetti, AS			Different genetic components in the Ethiopian population, identified by mtDNA and Y-chromosome polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; SOUTHERN AFRICAN POPULATIONS; CONTROL-REGION SEQUENCE; JEWISH COMMUNITIES; HUMAN-EVOLUTION; 9-BP DELETION; AFFINITIES; MARKERS; ORIGINS; HAPLOTYPES	Seventy-seven Ethiopians were investigated for mtDNA and Y chromosome-specific variations, in order to (1) define the different maternal and paternal components of the Ethiopian gene pool, (2) infer the origins of these maternal and paternal lineages and estimate their relative contributions, and (3) obtain information about ancient populations living in Ethiopia. The mtDNA was studied for the RFLPs relative to the six classical enzymes (HpaI, BamHI, HaeII, MspI, AvaII, and HincII) that identify the African haplogroup L and the Caucasoid haplogroups I and T. The sample was also examined at restriction sites that define the other Caucasoid haplogroups (H, U, V, W, X, J, and K) and for the simultaneous presence of the DdeI(10394) and AluI(10397) sites, which defines the Asian haplogroup M, Four polymorphic systems were examined on the Y chromosome: the TaqI/12f2 and the 49a,f RFLPs, the Y Alu polymorphic element (DYS287), and the sY81-A/G (DYS271) polymorphism. For comparison, the last two Y polymorphisms were also examined in 87 Senegalese previously classified for the two TaqI RFLPs. Results from these markers led to the hypothesis that the Ethiopian population (1) experienced Caucasoid gene flow mainly through males, (2) contains African components ascribable to Bantu migrations and to an in situ differentiation process from an ancestral African gene pool, and (3) exhibits some Y-chromosome affinities with the Tsumkwe San (a very ancient African group). Our finding of a high (20%) frequency of the "Asian" DdeI(10394)AluI(10394), (++) mtDNA haplotype in Ethiopia is discussed in terms of the "out of Africa" model.	Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, I-27100 Pavia, Italy; Univ Calabria, Dipartimento Biol Cellulare, I-87036 Cosenza, Italy; Univ Geneva, Dept Anthropol & Ecol, Carouge, Switzerland; Univ Arizona, Lab Mol Systemat & Evolut, Tucson, AZ USA	University of Pavia; University of Calabria; University of Geneva; University of Arizona	Santachiara-Benerecetti, AS (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, Via Abbiategrasso 207, I-27100 Pavia, Italy.	santa@ipvgen.unipv.it	Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494; Quintana-Murci, Lluis/0000-0003-2429-6320; SEMINO, Ornella/0000-0002-9675-9403				Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; ASTRINIDIS A, 1994, HUM BIOL, V66, P601; BALLINGER SW, 1992, GENETICS, V130, P139; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BENTON W, 1964, ENCY BRITANNICA; Brega A, 1994, Gene Geogr, V8, P45; Brega A, 1987, Gene Geogr, V1, P201; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRPAHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CHEN YS, 1995, AM J HUM GENET, V57, P133; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; EXCOFFIER L, 1996, GENOME DIG, V3, P15; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GREENBERG JH, 1963, LANGUAGES AFRICA; Guglielmino CR, 1996, ANN HUM GENET, V60, P221, DOI 10.1111/j.1469-1809.1996.tb00425.x; GUGLIELMINO CR, 1987, ATTI ASSOC GENET IT, V33, P177; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hiernaux J., 1975, PEOPLE AFRICA; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Levine D.N, 1974, GREATER ETHIOPIA; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; Lucotte G, 1996, HUM BIOL, V68, P467; NGO KY, 1986, AM J HUM GENET, V38, P407; Nurse GT., 1985, PEOPLES SO AFRICA TH; Passarino G, 1996, AM J HUM GENET, V59, P927; PASSARINO G, 1993, AM J HUM GENET, V53, P609; Passarino G, 1996, ANN HUM BIOL, V23, P121, DOI 10.1080/03014469600004342; PASSARINO G, 1996, GEN OR HUNG POP MIT; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; RITTE U, 1993, HUM BIOL, V65, P359; RITTE U, 1993, J MOL EVOL, V37, P435; Salem AH, 1996, AM J HUM GENET, V59, P741; SANTACHIARABENE.AS, 1992, GENETIC DIVERSITY JE, P45; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SEMINO O, 1992, 2 EUR HUGO C HUM GEN; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; Soodyall H, 1996, AM J HUM GENET, V58, P595; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1990, ANN HUM GENET, V54, P287; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; Watson E, 1996, AM J HUM GENET, V59, P437; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZOOSSMANNDISKIN A, 1991, ISRAEL J MED SCI, V27, P245; [No title captured]	67	114	114	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					420	434		10.1086/301702	http://dx.doi.org/10.1086/301702			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463310	Green Published, Bronze			2022-12-18	WOS:000072416000026
J	DePaepe, A; Nuytinck, L; Hausser, I; AntonLamprecht, I; Naeyaert, JM				DePaepe, A; Nuytinck, L; Hausser, I; AntonLamprecht, I; Naeyaert, JM			Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							V COLLAGEN; OSTEOGENESIS IMPERFECTA; MOLECULAR HETEROGENEITY; TERMINAL PROPEPTIDE; CHAIN; FIBRILLOGENESIS; ASSOCIATION; PROCOLLAGEN; EXCLUSION; DOMAIN	The Ehlers-Danlos syndrome (EDS) is a heterogeneous connective-tissue disorder of which at least nine subtypes are recognized. Considerable clinical overlap exists between the EDS I and II subtypes, suggesting that both are allelic disorders. Recent evidence based on linkage and transgenic mice studies suggest that collagen V is causally involved in human EDS. Collagen V forms heterotypic fibrils with collagen I in many tissues and plays an important role in collagen I fibrillogenesis. We have identified a mutation in COL5A1, the gene encoding the proal(V) collagen chain, segregating with EDS I in a four-generation family. The mutation causes the substitution of the most 5' cysteine residue by a serine within a highly conserved sequence of the proal(V) C-propeptide domain and causes reduction of collagen V by preventing incorporation of the mutant proal(V) chains in the collagen V trimers. In addition, we have detected splicing defects in the COL5A1 gene in a patient with EDS I and in a family with EDS II. These findings confirm the causal role of collagen V in at least a subgroup of EDS I, prove that EDS I and II are allelic conditions, and represent a, so far, unique example of a human collagen disorder caused by substitution of a highly conserved cysteine residue in the C-propeptide domain of a fibrillar collagen.	STATE UNIV GHENT HOSP,DEPT DERMATOL,B-9000 GHENT,BELGIUM; UNIV HEIDELBERG,HAUTKLIN,INST ULTRASTRUKTURFORSCH HAUT,D-6900 HEIDELBERG,GERMANY	Ghent University; Ghent University Hospital; Ruprecht Karls University Heidelberg	DePaepe, A (corresponding author), STATE UNIV GHENT HOSP,DEPT MED GENET,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.			Nuytinck, Lieve/0000-0002-5165-6937				ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; BEIGHTON P, 1969, ANN RHEUM DIS, V28, P228, DOI 10.1136/ard.28.3.228; BIRK DE, 1990, J CELL SCI, V95, P649; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; GREENSPAN DS, 1994, HUM MOL GENET, V3, P385, DOI 10.1093/hmg/3.2.385-a; GREENSPAN DS, 1995, GENOMICS, V25, P737, DOI 10.1016/0888-7543(95)80021-D; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; GREENSPAN DS, 1992, GENOMICS, V12, P836, DOI 10.1016/0888-7543(92)90320-R; HASHIMOTO Y, 1988, J INVEST DERMATOL, V91, P238, DOI 10.1111/1523-1747.ep12470365; HAUSSER I, 1994, HUM GENET, V3, P394; Holbrook K. A, 1982, J INVEST DERMATOL, V79, P7; LAEMMLI VK, 1975, NATURE, V227, P680; LEES JF, 1994, J BIOL CHEM, V269, P24354; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LOUGHLIN J, 1995, HUM MOL GENET, V4, P1649, DOI 10.1093/hmg/4.9.1649; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MCINTOSH I, 1995, HUM MUTAT, V5, P121, DOI 10.1002/humu.1380050204; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; NIYIBIZI C, 1994, BIOCHEM BIOPH RES CO, V202, P328, DOI 10.1006/bbrc.1994.1931; NIYIBIZI C, 1984, J BIOL CHEM, V259, P4170; Nuytinck L, 1996, HUM GENET, V97, P324, DOI 10.1007/BF02185764; SOKOLOV BP, 1991, HUM GENET, V88, P125; Steinmann Beat, 1993, P351; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WILLING MC, 1994, AM J HUM GENET, V55, P638; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P173; WORDSWORTH P, 1985, ANN RHEUM DIS, V44, P431, DOI 10.1136/ard.44.7.431	30	114	118	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					547	554						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042913				2022-12-18	WOS:A1997WK40300010
J	Watson, E; Bauer, K; Aman, R; Weiss, G; vonHaeseler, A; Paabo, S				Watson, E; Bauer, K; Aman, R; Weiss, G; vonHaeseler, A; Paabo, S			mtDNA sequence diversity in Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA SEQUENCES; PAIRWISE COMPARISONS; HUMAN-EVOLUTION; HUMAN ORIGINS; POPULATIONS; AFFINITIES; AMERINDS; HISTORY; GENOME; PANAMA	mtDNA sequences were determined from 241 individuals from nine ethnic groups in Africa. When they were compared with published data from other groups, it was found that the !Kung, Mbuti, and Biaka show on the order of 10 times more sequence differences between the three groups, as well as between those and the other groups (the Fulbe, Hausa, Tuareg, Songhai, Kanuri, Yoruba, Mandenka, Somali, Tukana, and Kikuyu), than these other groups do between one other. Furthermore, the pairwise sequence distributions, patterns of coalescence events, and numbers of variable positions relative to the mean sequence difference indicate that the former three groups have been of constant size over time, whereas the latter have expanded in size. We suggest that this reflects subsistence patterns in that the populations that have expanded in size are food producers whereas those that have not are hunters and gatherers.	UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY; NATL MUSEUMS KENYA,DEPT MOL GENET,NAIROBI,KENYA	University of Munich			von Haeseler, Arndt/HCI-9958-2022	von Haeseler, Arndt/0000-0002-3366-4458				Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; CABOT EL, 1993, ESEE EYEBALL SEQUENC; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; FELSENSTEIN J, 1990, PHYLIP VERSION 3 5P; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; KOLMAN CJ, 1995, GENETICS, V140, P275; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; MARJORAM P, 1994, GENETICS, V136, P673; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Murdock G.P., 1959, AFRICA ITS PEOPLES T; NEE S, 1995, PHILOS T ROY SOC B, V349, P25, DOI 10.1098/rstb.1995.0087; Nei M., 1987, MOL EVOLUTIONARY GEN; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SANTOS M, 1994, HUM BIOL, V66, P963; SHERRY ST, 1994, HUM BIOL, V66, P761; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1989, GENETICS, V123, P597; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Weiss G, 1996, SCIENCE, V272, P1359, DOI 10.1126/science.272.5266.1359; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	40	114	115	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					437	444						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755932				2022-12-18	WOS:A1996VM28800021
J	VARESCO, L; GISMONDI, V; JAMES, R; ROBERTSON, M; GRAMMATICO, P; GRODEN, J; CASARINO, L; DEBENEDETTI, L; BAFICO, A; BERTARIO, L; SALA, P; SASSATELLI, R; DELEON, MP; BIASCO, G; ALLEGRETTI, A; ASTE, H; DESANCTIS, S; ROSSETTI, C; ILLENI, MT; SCIARRA, A; DELPORTO, G; WHITE, R; FERRARA, GB				VARESCO, L; GISMONDI, V; JAMES, R; ROBERTSON, M; GRAMMATICO, P; GRODEN, J; CASARINO, L; DEBENEDETTI, L; BAFICO, A; BERTARIO, L; SALA, P; SASSATELLI, R; DELEON, MP; BIASCO, G; ALLEGRETTI, A; ASTE, H; DESANCTIS, S; ROSSETTI, C; ILLENI, MT; SCIARRA, A; DELPORTO, G; WHITE, R; FERRARA, GB			IDENTIFICATION OF APC GENE-MUTATIONS IN ITALIAN ADENOMATOUS POLYPOSIS-COLI PATIENTS BY PCR-SSCP ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS	The APC gene is a putative human tumor-suppressor gene responsible for adenomatous polyposis coli (APC), an inherited, autosomal dominant predisposition to colon cancer. It is also implicated in the development of sporadic colorectal tumors. The characterization of APC gene mutations in APC patients is clinically important because DNA-based tests can be applied for presymptomatic diagnosis once a specific mutation has been identified in a family. Moreover, the identification of the spectrum of APC gene mutations in patients is of great interest in the study of the biological properties of the APC gene product. We analyzed the entire coding region of the APC gene by the PCR-single-strand conformation polymorphism method in 42 unrelated Italian APC patients. Mutations were found in 12 cases. These consist of small (5-14 bp) base-pair deletions leading to frameshifts; all are localized within exon 15. Two of these deletions, a 5-bp deletion at position 3183-3187 and a 5-bp deletion at position 3926-3930, are present in 3/42 and 7/42 cases of our series, respectively, indicating the presence of mutational hot spots at these two sites.	IST NAZL RIC CANC,IMMUNOGENET LAB,VIALE BENEDETTO XV 10,I-16132 GENOA,ITALY; UNIV UTAH,HOWARD HUGHES MED INST,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV ROME LA SAPIENZA,CATTEDRA GENET MED,I-00185 ROME,ITALY; IST NAZL TUMORI,I-20133 MILAN,ITALY; UNIV MODENA,IST PATOL MED,I-41100 MODENA,ITALY; UNIV BOLOGNA,IST CLIN MED,I-40126 BOLOGNA,ITALY; UNIV NAPLES,CATTEDRA GENET UMANA,I-80134 NAPLES,ITALY	University of Genoa; IRCCS AOU San Martino IST; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Sapienza University Rome; Fondazione IRCCS Istituto Nazionale Tumori Milan; Universita di Modena e Reggio Emilia; University of Bologna; University of Naples Federico II			Sassatelli, Romano/AAC-2934-2020; de Leon, Maurizio Ponz/A-9356-2015; Varesco, Liliana/AAF-6521-2019	de Leon, Maurizio Ponz/0000-0003-4465-1043; Varesco, Liliana/0000-0003-4871-6668; Bertario, Lucio/0000-0001-5653-1431; Gismondi, Viviana/0000-0002-1115-0325				BURT RW, 1992, TXB GASTROENTEROLOGY, P1614; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; GRODEN J, 1993, AM J HUM GENET, V52, P263; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hayashi K, 1991, PCR Methods Appl, V1, P34; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Sambrook J., 1989, MOL CLONING LAB MANU; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; ZEUTHEN J, 1983, J CANCER RES CLIN, V106, P1, DOI 10.1007/BF00399890	17	114	115	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					280	285						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8381581				2022-12-18	WOS:A1993KN27500005
J	LUSTBADER, ED; WILLIAMS, WR; BONDY, ML; STROM, S; STRONG, LC				LUSTBADER, ED; WILLIAMS, WR; BONDY, ML; STROM, S; STRONG, LC			SEGREGATION ANALYSIS OF CANCER IN FAMILIES OF CHILDHOOD SOFT-TISSUE-SARCOMA PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; SBLA SYNDROME; CHILDREN; CARCINOMA	This paper presents the analysis of familial cancer data collected in a hospital-based study of 159 childhood soft-tissue-sarcoma patients. Two different statistical models detected excess aggregation of cancer, which could be explained by a rare dominant gene. For each kindred, we estimated the probability of the observed cancer distribution under the dominant-gene model and identified 12 families that are the most likely to be segregating the gene. Two of those families have confirmed germ-line mutations in the p53 tumor-suppressor gene. The relative risk of affection for children who are gene carriers was estimated to be 100 times the background rate. Females were found to have a slightly higher age-specific penetrance, but maternal and paternal lineages made equal contributions to the evidence in favor of the dominant gene. The proband's histology, ethnicity, and age at diagnosis were evaluated to determine whether any of these altered the probability of affection in family members. Only embryonal rhabdomyosarcoma was found to be a significant covariate under the dominant-gene model. While molecular genetic studies of familial cancer will eventually provide answers to the questions of genetic heterogeneity, age- and site-specific penetrance, mutation rates, and gene frequency, information from statistical models is useful for setting priorities and defining hypotheses.	UNIV TEXAS, MD ANDERSON CANC CTR, HOUSTON, TX 77025 USA	University of Texas System; UTMD Anderson Cancer Center	LUSTBADER, ED (corresponding author), FOX CHASE CANC INST, 7701 BURHOLME AVE, PHILADELPHIA, PA 19111 USA.				NCI NIH HHS [CA-22780, CA-34936, CA-38929] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038929, P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRCH JM, 1990, J CLIN ONCOL, V8, P583, DOI 10.1200/JCO.1990.8.4.583; BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BOTTOMLEY RH, 1971, CANCER-AM CANCER SOC, V28, P519, DOI 10.1002/1097-0142(197108)28:2<519::AID-CNCR2820280234>3.0.CO;2-G; Bussey H, 1975, FAMILIAL POLYPOSIS C; HARTLEY AL, 1989, CANCER GENET CYTOGEN, V42, P221, DOI 10.1016/0165-4608(89)90090-3; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1980, POINTER COMPUTER PRO; LAW JC, 1991, CANCER RES, V51, P6385; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1969, J NATL CANCER I, V43, P1365; LYNCH HT, 1990, ONCOLOGY-BASEL, V47, P75; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; ORJUELA M, 1990, BRIT J CANCER, V61, P341, DOI 10.1038/bjc.1990.70; PASTORE G, 1985, FAM CANCER, P146; PEARSON ADJ, 1982, J MED GENET, V19, P362, DOI 10.1136/jmg.19.5.362; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SORANT AJM, 1989, SEGREGATION ANAL DIS; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; THOMPSON EN, 1988, BRIT J CANCER, V57, P127, DOI 10.1038/bjc.1988.25; TOMLINSON MJ, 1987, BRIT J RADIOL, V60, P89, DOI 10.1259/0007-1285-60-709-89; TSUNEMATSU Y, 1990, BRIT J CANCER, V57, P127; VOGEL F, 1979, HUM GENET, V52, P1; 1989, MATH LIBRARY, pCH8	26	114	114	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					344	356						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642235				2022-12-18	WOS:A1992JF77600014
J	PARK, VM; GUSTASHAW, KM; WATHEN, TM				PARK, VM; GUSTASHAW, KM; WATHEN, TM			THE PRESENCE OF INTERSTITIAL TELOMERIC SEQUENCES IN CONSTITUTIONAL CHROMOSOME-ABNORMALITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERMINAL TRANSFERASE; (TTAGGG)N; RIBONUCLEOPROTEIN; TRANSLOCATIONS; TETRAHYMENA; ENZYME	We describe a novel chromosome structure in which telomeric sequences are present interstitially, at the apparent breakpoint junctions of structurally abnormal chromosomes. In the linear chromosomes with interstitial telomeric sequences, there were three sites of hybridization of the telomere consensus sequence within each derived chromosome: one at each terminus and one at the breakpoint junction. Telomeric sequences also were observed within a ring chromosome. The rearrangements examined were constitutional chromosome abnormalities with a breakpoint assigned to a terminal band. In each case (with the exception of the ring chromosome), an acentric segment of one chromosome was joined to the terminus of an apparently intact recipient chromosome. One case exhibited apparent instability of the chromosome rearrangement, resulting in somatic mosaicism. The rearrangements described here differ from the telomeric associations observed in certain tumors, which appear to represent end-to-end fusion of two or more intact chromosomes. The observed interstitial telomeric sequences appear to represent nonfunctional chromosomal elements, analogous to the inactivated centromeres observed in dicentric chromosomes.	CASE WESTERN RESERVE UNIV,CTR GENET,DEPT PEDIAT,11001 CEDAR AVE,SUITE 510,CLEVELAND,OH 44106	Case Western Reserve University								BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; CORNFORTH MN, 1989, RADIAT RES, V120, P205, DOI 10.2307/3577708; DRAKE V J, 1985, American Journal of Human Genetics, V37, pA91; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; HOLMQUIST GP, 1979, P NATL ACAD SCI USA, V76, P4566, DOI 10.1073/pnas.76.9.4566; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; JEDELE K B, 1989, American Journal of Human Genetics, V45, pA102; LIN SP, 1991, AM J HUM GENET, V49, P298; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MITELMAN F, 1988, CATALOG CHROMOSOME A; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER HJ, 1939, COLLECTING NET WOODS, V13, P181; PARK VM, 1991, AM J HUM GENET, V49, P305; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RIVERA H, 1990, AM J MED GENET, V37, P311, DOI 10.1002/ajmg.1320370304; Schwartz H S, 1990, Appl Cytogenet, V16, P133; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	21	114	116	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					914	923						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570843				2022-12-18	WOS:A1992HR47300005
J	KEATING, M; DUNN, C; ATKINSON, D; TIMOTHY, K; VINCENT, GM; LEPPERT, M				KEATING, M; DUNN, C; ATKINSON, D; TIMOTHY, K; VINCENT, GM; LEPPERT, M			CONSISTENT LINKAGE OF THE LONG-QT SYNDROME TO THE HARVEY RAS-1 LOCUS ON CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER-PATIENTS; FRAGMENTS; DNA	The long-QT syndrome (LQT; Ward-Romano syndrome) is a cardiac disorder that is inherited as an autosomal dominant trait. Affected family members suffer from recurrent syncope and sudden death due to ventricular arrhythmias. Recently, we identified a DNA marker on the short arm of chromosome 11 (the Harvey ras-1 locus [H-ras-1]) that was completely linked to the LQT locus in one large family. In the study presented here, we performed linkage investigations on six new and unrelated families with LQT. The LQT locus was again completely linked to the H-ras-1 locus in all families examined, with a combined lod score of 5.25 at a recombination fraction of 0. This work confirms our previous assignment of the LQT locus to chromosome 11p and supports the hypothesis that LQT is genetically homogeneous. As no obligate recombinants were identified in either this or our previous study, the H-ras-1 protooncogene remains a candidate for the LQT disease gene. Identification of LQT families with locus homogeneity is an important step in the development of a refined genetic map of this locus and will help determine whether the H-ras-1 marker would be of general use for presymptomatic diagnosis of this potentially fatal, but treatable, disorder.	UNIV UTAH,HLTH SCI CTR,DIV CARDIOL,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,ECCLES PROGRAM HUMAN MOLEC BIOL & GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; LATTER DAY ST HOSP,DEPT MED,SALT LAKE CITY,UT 84143	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	KEATING, M (corresponding author), ECCLES INST HUMAN GENET,ROME 2100,10 N 2030 EAST ST,SALT LAKE CITY,UT 84112, USA.							Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; DAVIDENKO JM, 1989, CIRCULATION, V79, P674, DOI 10.1161/01.CIR.79.3.674; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIDEREAU R, 1986, JNCI-J NATL CANCER I, V77, P697, DOI 10.1093/jnci/77.3.697; MCKUSICK VA, 1989, MENDELIAN INHERITANC; MITSUTAKE A, 1981, CIRCULATION, V63, P1029, DOI 10.1161/01.CIR.63.5.1029; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; ROMANO C, 1965, LANCET, V1, P658; SCHWARTZ P J, 1989, Journal of the American College of Cardiology, V13, p20A; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VINCENT G M, 1974, Progress in Cardiovascular Diseases, V16, P523; WARD O C, 1964, J Ir Med Assoc, V54, P103; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J	18	114	119	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1335	1339						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746560				2022-12-18	WOS:A1991GU67200020
J	OTTMAN, R; ANNEGERS, JF; HAUSER, WA; KURLAND, LT				OTTMAN, R; ANNEGERS, JF; HAUSER, WA; KURLAND, LT			HIGHER RISK OF SEIZURES IN OFFSPRING OF MOTHERS THAN OF FATHERS WITH EPILEPSY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10032; UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225; MAYO CLIN & MAYO FDN,CLIN EPIDEMIOL SECT,ROCHESTER,MN 55905	Columbia University; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic	OTTMAN, R (corresponding author), COLUMBIA UNIV,GH SERGIEVSKY CTR,100 HAVEN AVE,TOWER III,APARTMENT 2G,NEW YORK,NY 10032, USA.		Hauser, W Allen/AAB-5277-2020; Ottman, Ruth/O-2371-2013	Ottman, Ruth/0000-0001-7074-242X	NINDS NIH HHS [NS22050, NS16308, NS20656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS022050, P50NS016308, R01NS020656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANNEGERS JF, 1976, EPILEPSIA, V17, P1, DOI 10.1111/j.1528-1157.1976.tb03375.x; ANNEGERS JF, 1978, INT J EPIDEMIOL, V7, P241, DOI 10.1093/ije/7.3.241; BEAUSSART M, 1969, EPILEPSIA, V10, P55, DOI 10.1111/j.1528-1157.1969.tb03828.x; BECKMANNAGETTA G, 1986, SEP GEN EP WORKSH W; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; DANSKY LV, 1980, EPILEPSIA, V21, P261, DOI 10.1111/j.1528-1157.1980.tb04072.x; DIMAURO S, 1986, AM J MED GENET, V25, P635, DOI 10.1002/ajmg.1320250406; DIXON WJ, 1985, BMDP STATISTICAL SOF; DOOSE H, 1987, NEUROPEDIATRICS, V18, P1, DOI 10.1055/s-2008-1052489; EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304; FINE PEM, 1977, J MED GENET, V14, P399, DOI 10.1136/jmg.14.6.399; Fleiss JL, 1981, STAT METHODS RATES P; GERKEN H, 1977, NEUROPADIATRIE, V8, P3, DOI 10.1055/s-0028-1091499; HARVALD B, 1951, ACTA PSYCH NEUROL, V26, P339, DOI 10.1111/j.1600-0447.1951.tb09678.x; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; LENNOX WG, 1947, AM J PSYCHIAT, V103, P457, DOI 10.1176/ajp.103.4.457; METRAKOS K, 1961, NEUROLOGY, V11, P464; NELSON KB, 1982, NEUROLOGY, V32, P1247, DOI 10.1212/WNL.32.11.1247; OTTMAN R, 1987, J CHRON DIS, V40, P165, DOI 10.1016/0021-9681(87)90068-3; OTTMAN R, 1985, AM J EPIDEMIOL, V122, P923, DOI 10.1093/oxfordjournals.aje.a114197; Ounsted C, 1955, EUGEN REV, V47, P33; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SUSSER M, 1985, NIH851149 PUBL, P359; Teramo K, 1982, EPILEPSY PREGNANCY C, P53; THOMPSON JS, 1986, GENETICS MED, P58; TSUBOI T, 1977, HUM GENET, V36, P173, DOI 10.1007/BF00273256; WEBBER MP, 1986, EPILEPSIA, V27, P746, DOI 10.1111/j.1528-1157.1986.tb03605.x	27	114	115	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					257	264						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3414683				2022-12-18	WOS:A1988P884100005
J	CHUNG, CS; BIXLER, D; WATANABE, T; KOGUCHI, H; FOGHANDERSEN, P				CHUNG, CS; BIXLER, D; WATANABE, T; KOGUCHI, H; FOGHANDERSEN, P			SEGREGATION ANALYSIS OF CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE - A COMPARISON OF DANISH AND JAPANESE DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,PACIFIC BIOMED RES CTR,HONOLULU,HI 96822; INDIANA UNIV,SCH DENT,DEPT ORAL FACIAL GENET,INDIANAPOLIS,IN 46202; DEACONESS HOSP,DEPT PLAST & RECONSTRUCT SURG,COPENHAGEN,DENMARK; KYUSHU UNIV DENT,DEPT ORAL SURG,FUKUOKA,JAPAN	University of Hawaii System; Indiana University System; Indiana University-Purdue University Indianapolis; Kyushu University	CHUNG, CS (corresponding author), UNIV HAWAII,DEPT PUBL HLTH SCI,HONOLULU,HI 96822, USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE006069] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-06069] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BIXLER D, 1971, CLIN GENET, V6, P83; CHUNG CS, 1985, J CRAN GENET DEV BIO, V5, P341; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CHUNG CS, 1980, ETIOLOGY CLEFT LIP C, P325; DEMENAIS F, 1984, J MED GENET, V21, P436, DOI 10.1136/jmg.21.6.436; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1970, AM J HUM GENET, V22, P336; KOGUCHI H, 1975, JPN J HUM GENET, V20, P207; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MELNICK M, 1976, LANCET, V1, P176; MELNICK M, 1986, AM J MED GENET; MELNICK M, 1980, ETIOLOGY CLEFT LIP C, P225; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEEL JV, 1958, AM J HUM GENET, V10, P398; TANAKA K, 1969, JPN J HUM GENET, V14, P1; TANAKA K, 1967, Japanese Journal of Human Genetics, V12, P141	24	114	115	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1986	39	5					603	611						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3032	3788974				2022-12-18	WOS:A1986F303200005
J	WOOLF, CM				WOOLF, CM			GENETIC STUDY OF CARCINOMA OF THE LARGE INTESTINE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DUKES CE, 1952, ANN EUGENIC, V17, P1; HESTON WE, 1952, AM J HUM GENET, V4, P314; Jacobsen O., 1946, HEREDITY BREAST CANC; LAHEY F H, 1952, Lahey Clin Bull, V7, P226; PENROSE LS, 1948, ANN EUGENIC, V14, P234; REED TE, 1955, AM J HUM GENET, V7, P236; RICHARDS R C, 1956, Am Surg, V22, P287; RIDER JA, 1954, AM J MED, V16, P555, DOI 10.1016/0002-9343(54)90372-1; SWINTON NW, 1954, JAMA-J AM MED ASSOC, V154, P658, DOI 10.1001/jama.1954.02940420020006; VIDEBAEK A, 1954, ACTA MED SCAND, V149, P137; WOOLF CHARLES M., 1955, UNIV CALIFORNIA PUBL PUBLIC HEALTH, V2, P265; WOOLF CM, 1956, AM J HUM GENET, V8, P102; WOOLF CM, 1955, CANCER, V8, P403, DOI 10.1002/1097-0142(1955)8:2<403::AID-CNCR2820080220>3.0.CO;2-E	13	114	114	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	1					42	47						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA218	13520697				2022-12-18	WOS:A1958WA21800004
J	Tanaka, AJ; Cho, MT; Millan, F; Juusola, J; Retterer, K; Joshi, C; Niyazov, D; Garnica, A; Gratz, E; Deardorff, M; Wilkins, A; Ortiz-Gonzalez, X; Mathews, K; Panzer, K; Brilstra, E; van Gassen, KLI; Volker-Touw, CML; van Binsbergen, E; Sobreira, N; Hamosh, A; McKnight, D; Monaghan, KG; Chung, WK				Tanaka, Akemi J.; Cho, Megan T.; Millan, Francisca; Juusola, Jane; Retterer, Kyle; Joshi, Charuta; Niyazov, Dmitriy; Garnica, Adolfo; Gratz, Edward; Deardorff, Matthew; Wilkins, Alisha; Ortiz-Gonzalez, Xilma; Mathews, Katherine; Panzer, Karin; Brilstra, Eva; van Gassen, Koen L. I.; Volker-Touw, Catharina M. L.; van Binsbergen, Ellen; Sobreira, Nara; Hamosh, Ada; McKnight, Dianalee; Monaghan, Kristin G.; Chung, Wendy K.			Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPASTIC PARAPLEGIA; PROTEIN; MITOCHONDRIA; GENE	Using whole-exome sequencing, we have identified in ten families 14 individuals with microcephaly, developmental delay, intellectual disability, hypotonia, spasticity, seizures, sensorineural hearing loss, cortical visual impairment, and rare autosomal-recessive predicted pathogenic variants in spermatogenesis-associated protein 5 (SPATA5). SPATA5 encodes a ubiquitously expressed member of the ATPase associated with diverse activities (AAA) protein family and is involved in mitochondrial morphogenesis during early spermatogenesis. It might also play a role in post-translational modification during cell differentiation in neuronal development. Mutations in SPATA5 might affect brain development and function, resulting in microcephaly, developmental delay, and intellectual disability.	[Tanaka, Akemi J.; Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Cho, Megan T.; Millan, Francisca; Juusola, Jane; Retterer, Kyle; McKnight, Dianalee; Monaghan, Kristin G.] GeneDx, Gaithersburg, MD 20877 USA; [Joshi, Charuta; Mathews, Katherine] Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA 52242 USA; [Joshi, Charuta; Mathews, Katherine] Univ Iowa, Childrens Hosp, Dept Neurol, Iowa City, IA 52242 USA; [Niyazov, Dmitriy] Ochsner Hlth Syst, Dept Pediat, Div Med Genet, New Orleans, LA 70121 USA; [Garnica, Adolfo] Arkansas Childrens Hosp, Little Rock, AR 72202 USA; [Gratz, Edward] Gratz & Shafrir MD, Child Neurol, Baltimore, MD 21215 USA; [Deardorff, Matthew; Wilkins, Alisha] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Panzer, Karin] Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA 52242 USA; [Brilstra, Eva; van Gassen, Koen L. I.; Volker-Touw, Catharina M. L.; van Binsbergen, Ellen] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 Utrecht, Netherlands; [Sobreira, Nara; Hamosh, Ada] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; University of Iowa; University of Iowa; Ochsner Health System; Arkansas Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Columbia University	Chung, WK (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.	wkc15@columbia.edu	Brilstra, Eva/AAT-3092-2021; Ortiz-Gonzalez, Xilma/AAD-2211-2021	Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; mathews, katherine/0000-0003-4160-0435; van Gassen, Koen/0000-0001-7934-0662; McKnight, Dianalee/0000-0002-7462-6300	Simons Foundation; National Human Genome Research Institute [1U54HG006542]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER	Simons Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We gratefully acknowledge the input of the individuals and their families for their generous contributions. This work was supported in part by a grant from the Simons Foundation. A grant from the National Human Genome Research Institute (1U54HG006542) provided support for the work performed in the Baylor-Hopkins Center for Mendelian Genomics. F.M., M.T.C., J.J., K.R., D.M., and K.G.M. are employees of GeneDx. W.K.C. is a consultant for BioReference Laboratories.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heallen TR, 2008, DEV CELL, V15, P603, DOI 10.1016/j.devcel.2008.08.005; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YG, 2000, ONCOGENE, V19, P1579, DOI 10.1038/sj.onc.1203442; Loibl M, 2014, J BIOL CHEM, V289, P3913, DOI 10.1074/jbc.M113.536110; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Ren RJ, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-23; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Stes E, 2014, J PROTEOME RES, V13, P3107, DOI 10.1021/pr4012443; Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003; van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224; Volgyi K, 2015, J PROTEOMICS, V120, P142, DOI 10.1016/j.jprot.2015.03.005; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	27	113	114	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					457	464		10.1016/j.ajhg.2015.07.014	http://dx.doi.org/10.1016/j.ajhg.2015.07.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26299366	Bronze, Green Published			2022-12-18	WOS:000361084700008
J	Onoufriadis, A; Paff, T; Antony, D; Shoemark, A; Micha, D; Kuyt, B; Schmidts, M; Petridi, S; Dankert-Roelse, JE; Haarman, EG; Daniels, JMA; Emes, RD; Wilson, R; Hogg, C; Scambler, PJ; Chung, EMK; Pals, G; Mitchison, HM				Onoufriadis, Alexandros; Paff, Tamara; Antony, Dinu; Shoemark, Amelia; Micha, Dimitra; Kuyt, Bertus; Schmidts, Miriam; Petridi, Stavroula; Dankert-Roelse, Jeanette E.; Haarman, Eric G.; Daniels, Johannes M. A.; Emes, Richard D.; Wilson, Robert; Hogg, Claire; Scambler, Peter J.; Chung, Eddie M. K.; Pals, Gerard; Mitchison, Hannah M.		UK10K	Splice-Site Mutations in the Axonemal Outer Dynein Arm Docking Complex Gene CCDC114 Cause Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; CONGENITAL HEART-DISEASE; CHLAMYDOMONAS-REINHARDTII; ELECTRON-MICROSCOPY; DIAGNOSIS; DEFECTS; INNER; BEAT; RANDOMIZATION; ASYMMETRY	Defects in motile cilia and sperm flagella cause primary ciliary dyskinesia (PCD), characterized by chronic airway disease, infertility, and left-right laterality disturbances, usually as a result of loss of the outer dynein arms (ODAs) that power cilia/flagella beating. Here, we identify loss-of-function mutations in CCDC114 causing PCD with laterality malformations involving complex heart defects. CCDC114 is homologous to DCC2, an ODA microtubule-docking complex component of the biflagellate alga Chlamydomonas. We show that CCDC114 localizes along the entire length of human cilia and that its deficiency causes a complete absence of ciliary ODAs, resulting in immotile cilia. Thus, CCDC114 is an essential ciliary protein required for microtubular attachment of ODAs in the axoneme. Fertility is apparently not greatly affected by CCDC114 deficiency, and qPCR shows that this may explained by low transcript expression in testis compared to ciliated respiratory epithelium. One CCDC114 mutation, c.742G>A, dating back to at least the 1400s, presents an important diagnostic and therapeutic target in the isolated Dutch Volendam population.	[Onoufriadis, Alexandros; Antony, Dinu; Schmidts, Miriam; Petridi, Stavroula; Scambler, Peter J.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Onoufriadis, Alexandros; Antony, Dinu; Schmidts, Miriam; Petridi, Stavroula; Scambler, Peter J.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Birth Defects Res Ctr, London WC1N 1EH, England; [Paff, Tamara; Micha, Dimitra; Kuyt, Bertus; Pals, Gerard] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1077 MC Amsterdam, Netherlands; [Paff, Tamara; Haarman, Eric G.] Vrije Univ Amsterdam Med Ctr, Dept Padiatr Pulmonol, NL-1077 MC Amsterdam, Netherlands; [Paff, Tamara; Daniels, Johannes M. A.] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, NL-1077 MC Amsterdam, Netherlands; [Shoemark, Amelia; Hogg, Claire] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Dankert-Roelse, Jeanette E.] Atrium Med Ctr, Dept Pediat, NL-6401 CX Heerlen, Netherlands; [Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Wilson, Robert] Royal Brompton & Harefield NHS Trust, Host Def Unit, London SW3 6NP, England; [Chung, Eddie M. K.] UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London WC1E 6DE, England	University of London; University College London; University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Atrium Medical Center; University of Nottingham; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of London; University College London	Pals, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, POB 7057, NL-1077 MC Amsterdam, Netherlands.	g.pals@vumc.nl; h.mitchison@ucl.ac.uk	Schmidts, Miriam/A-3777-2012; Daniels, Johannes/N-9525-2016; Emes, Richard D/C-5341-2008; Micha, Dimitra/U-4979-2019; Shoemark, Amelia/I-4068-2019; Scambler, Peter/AAZ-6026-2020	Schmidts, Miriam/0000-0002-1714-6749; Daniels, Johannes/0000-0001-8976-9120; Emes, Richard D/0000-0001-6855-5481; Micha, Dimitra/0000-0001-7890-4411; Shoemark, Amelia/0000-0001-7360-6060; Scambler, Peter/0000-0002-1487-4628; Mitchison, Hannah/0000-0002-3163-6293; Pals, Gerard/0000-0003-4091-7115	Wellcome Trust [WT091310]; Dutch patient organization PCD Belangengroep; "It Krystteam" (Friesland); British Heart Foundation; Action Medical Research UK Clinical Training Fellowship; Milena Carvajal Pro-Kartagener Foundation; Action Medical Research UK; Henry Smith Charity; New life Foundation for Disabled Children UK; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Action Medical Research [1773] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Dutch patient organization PCD Belangengroep; "It Krystteam" (Friesland); British Heart Foundation(British Heart Foundation); Action Medical Research UK Clinical Training Fellowship; Milena Carvajal Pro-Kartagener Foundation; Action Medical Research UK; Henry Smith Charity; New life Foundation for Disabled Children UK; National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research; Great Ormond Street Hospital Childrens Charity	We would like to thank all the PCD families for their participation in the study, Fiona Copeland, and the U.K. PCD Family Support Group. We thank Maggie Meeks and R. Mark Gardiner for patient recruitment and their past involvement in the project. We thank Paul Griffin for electron microscopy processing. We thank all the participants of the UK10K RARE group, as listed in the Supplemental Data file, which is part of the UK10K Consortium, in particular Matthew Hurles, Saeed Al Turki, and Philip Beales. The UK10K project is funded by the Wellcome Trust (award WT091310). T.P., D.M., B.K., and G.P. were supported by the Dutch patient organization PCD Belangengroep, funded by "It Krystteam" (Friesland). P.J.S. is supported by the Wellcome Trust and British Heart Foundation. M.S. is supported by an Action Medical Research UK Clinical Training Fellowship. A.O., D.A., M.S., S.P., E.M.K.C., and H.M.M. are supported by the Milena Carvajal Pro-Kartagener Foundation, Action Medical Research UK, the Henry Smith Charity, and New life Foundation for Disabled Children UK.	Afzelius BA, 1998, THORAX, V53, P894, DOI 10.1136/thx.53.10.894; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Jeganathan D, 2004, J MED GENET, V41, P233, DOI 10.1136/jmg.2003.014084; Jorissen M, 2000, ACTA OTO-LARYNGOL, V120, P291; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; KAMIYA R, 1985, J CELL SCI, V74, P181; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; MADAN K, 1990, HUM GENET, V85, P15, DOI 10.1007/BF00276319; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Meerman GJT, 1997, GENET EPIDEMIOL, V14, P1125; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Nakhleh N, 2012, CIRCULATION, V125, P2232, DOI 10.1161/CIRCULATIONAHA.111.079780; O'Callaghan C, 2010, ARCH DIS CHILD, V95, P51, DOI 10.1136/adc.2009.158493; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Wakabayashi K, 2001, CELL MOTIL CYTOSKEL, V48, P277, DOI 10.1002/cm.1015; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820	48	113	121	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					88	98		10.1016/j.ajhg.2012.11.002	http://dx.doi.org/10.1016/j.ajhg.2012.11.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23261303	hybrid, Green Published			2022-12-18	WOS:000313759000009
J	Horani, A; Druley, TE; Zariwala, MA; Pate, AC; Levinson, BT; Van Arendonk, LG; Thornton, KC; Giacalone, JC; Albee, AJ; Wilson, KS; Turner, EH; Nickerson, DA; Shendure, J; Bayly, PV; Leigh, MW; Knowles, MR; Brody, SL; Dutcher, SK; Ferkol, TW				Horani, Amjad; Druley, Todd E.; Zariwala, Maimoona A.; Pate, Anand C.; Levinson, Benjamin T.; Van Arendonk, Laura G.; Thornton, Katherine C.; Giacalone, Joe C.; Albee, Alison J.; Wilson, Kate S.; Turner, Emily H.; Nickerson, Deborah A.; Shendure, Jay; Bayly, Philip V.; Leigh, Margaret W.; Knowles, Michael R.; Brody, Steven L.; Dutcher, Susan K.; Ferkol, Thomas W.			Whole-Exome Capture and Sequencing Identifies HEATR2 Mutation as a Cause of Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHLAMYDOMONAS-REINHARDTII; PROTEOMIC ANALYSIS; GENE; REPEATS; DISEASE; PROTEIN; CELLS; CILIOPATHIES; POPULATION; PREDICTION	Motile cilia are essential components of the mucociliary escalator and are central to respiratory-tract host defenses. Abnormalities in these evolutionarily conserved organelles cause primary ciliary dyskinesia (PCD). Despite recent strides characterizing the ciliome and sensory ciliopathies through exploration of the phenotype-genotype associations in model organisms, the genetic bases of most cases of PCD remain elusive. We identified nine related subjects with PCD from geographically dispersed Amish communities and performed exome sequencing of two affected individuals and their unaffected parents. A single autosomal-recessive nonsynonymous missense mutation was identified in HEATR2, an uncharacterized gene that belongs to a family not previously associated with ciliary assembly or function. Airway epithelial cells isolated from PCD-affected individuals had markedly reduced HEATR2 levels, absent dynein arms, and loss of ciliary beating. MicroRNA-mediated silencing of the orthologous gene in Chlamydomonas reinhardtii resulted in absent outer dynein arms, reduced flagellar beat frequency, and decreased cell velocity. These findings were recapitulated by small hairpin RNA-mediated knockdown of HEATR2 in airway epithelial cells from unaffected donors. Moreover, immunohistochemistry studies in human airway epithelial cells showed that HEATR2 was localized to the cytoplasm and not in cilia, which suggests a role in either dynein arm transport or assembly. The identification of HEATR2 contributes to the growing number of genes associated with PCD identified in both individuals and model organisms and shows that exome sequencing in family studies facilitates the discovery of novel disease-causing gene mutations.	[Horani, Amjad; Druley, Todd E.; Pate, Anand C.; Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Druley, Todd E.; Levinson, Benjamin T.; Van Arendonk, Laura G.; Thornton, Katherine C.; Giacalone, Joe C.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27599 USA; [Pate, Anand C.; Brody, Steven L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Albee, Alison J.; Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wilson, Kate S.; Turner, Emily H.; Bayly, Philip V.] Washington Univ, Sch Med, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Leigh, Margaret W.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Knowles, Michael R.] Univ N Carolina, Sch Med, Dept Internal Med, Chapel Hill, NC 27599 USA; [Dutcher, Susan K.; Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL)	Ferkol, TW (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	ferkol_t@kids.wustl.edu	Shendure, Jay/AAU-3684-2021; Patel, Anand/B-1441-2009	Turner, Emily/0000-0001-9040-9229; Druley, Todd/0000-0002-3245-7561; Shendure, Jay/0000-0002-1516-1865; Giacalone, Joseph/0000-0003-4404-9749; Bayly, Philip/0000-0003-4303-0704; Patel, Anand/0000-0002-6570-8582	Children's Discovery Institute; National Institutes of Health (NIH) [HL082657, HL056244, GM32843, HL071798, HL094976, HG005608, HL083095]; Ruth L. Kirschstein National Research Service Awards fellowship [F32GM093598]; NATIONAL CANCER INSTITUTE [K08CA140720] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056244, R01HL071798, K08HL083095, U54HL096458, R01HL082657, R29HL056244, R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093598, R01GM032843] Funding Source: NIH RePORTER	Children's Discovery Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Awards fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were funded by the Children's Discovery Institute (T.E.D., P.V.B., S.L.B., S.K.D., and T.W.F.), the National Institutes of Health (NIH) awards HL082657 (T.W.F.), HL056244 (S.L.B.), GM32843 (S.K.D.), HL071798 (M.R.K., M.A.Z.), HL094976 (D.A.N., J.S.), HG005608 (D.A.N., J.S.), and HL083095 (A.C.P.), and the Ruth L. Kirschstein National Research Service Awards fellowship F32GM093598 (A.J.A.). In addition, this work was advanced by the Genetic Disorders of Mucociliary Clearance Consortium, HL096458 (M.A.Z., M.W.L., M.R.K., S.L.B., and T.W.F.), part of the NIH Rare Diseases Clinical Research Network, with programmatic support from the National Heart, Lung, and Blood Institute and the NIH Office of Rare Diseases Research. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Al-Rawi MM, 1998, LARYNGOSCOPE, V108, P1816, DOI 10.1097/00005537-199812000-00010; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; Bayly PV, 2010, CYTOSKELETON, V67, P56, DOI 10.1002/cm.20424; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lie H, 2010, J PEDIATR-US, V156, P1023, DOI 10.1016/j.jpeds.2010.01.054; Lin HW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001105; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Morton DH, 2003, AM J MED GENET C, V121C, P5, DOI 10.1002/ajmg.c.20002; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ostrowski LE, 2010, AM J RESP CELL MOL, V43, P55, DOI 10.1165/rcmb.2009-0118OC; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pannain S, 1999, J CLIN ENDOCR METAB, V84, P1061, DOI 10.1210/jc.84.3.1061; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; SALISBURY JL, 1988, J CELL BIOL, V107, P635, DOI 10.1083/jcb.107.2.635; Seelow D, 2012, NUCLEIC ACIDS RES, V40, pW516, DOI 10.1093/nar/gks487; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Teng SL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S2-S5; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	44	113	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					685	693		10.1016/j.ajhg.2012.08.022	http://dx.doi.org/10.1016/j.ajhg.2012.08.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040496	Green Published, Bronze			2022-12-18	WOS:000309568500010
J	Blaydon, DC; Etheridge, SL; Risk, JM; Hennies, HC; Gay, LJ; Carroll, R; Plagnol, V; McRonald, FE; Stevens, HP; Spurr, NK; Bishop, DT; Ellis, A; Jankowski, J; Field, JK; Leigh, IM; South, AP; Kelsell, DP				Blaydon, Diana C.; Etheridge, Sarah L.; Risk, Janet M.; Hennies, Hans-Christian; Gay, Laura J.; Carroll, Rebecca; Plagnol, Vincent; McRonald, Fiona E.; Stevens, Howard P.; Spurr, Nigel K.; Bishop, D. Timothy; Ellis, Anthony; Jankowski, Janusz; Field, John K.; Leigh, Irene M.; South, Andrew P.; Kelsell, David P.			RHBDF2 Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SQUAMOUS-CELL CARCINOMA; PALMOPLANTAR KERATODERMA; CHROMOSOME 17Q; TOC LOCUS; REGION; GENE; HETEROZYGOSITY; DROSOPHILA; MAPS; KB	Tylosis esophageal cancer (TOC) is an autosomal-dominant syndrome characterized by palmoplantar keratoderma, oral precursor lesions, and a high lifetime risk of esophageal cancer. We have previously localized the TOC locus to a small genomic interval within chromosomal region 17q25. Using a targeted capture array and next-generation sequencing, we have now identified missense mutations (c.557T>C [p.Ile186Thr] and c.566C>T [p.Pro189Leu] in RHBDF2, which encodes the inactive rhomboid protease RHBDF2 (also known as iRhom2), as the underlying cause of TOC. We show that the distribution of RHBDF2 in tylotic skin is altered in comparison with that in normal skin, and immortalized tylotic keratinocytes have decreased levels of total epidermal growth factor receptor (EGFR) and display an increased proliferative and migratory potential relative to normal cells, even when normal cells are stimulated with exogenous epidermal growth factor. It would thus appear that EGFR signaling is dysregulated in tylotic cells. Furthermore, we also show an altered localization of RHBDF2 in both tylotic and sporadic squamous esophageal tumors. The elucidation of a role of RHBDF2 in growth-factor signaling in esophageal cancer will help to determine whether targeting this pathway in chemotherapy for this and other squamous cell carcinomas will be effective.	[Blaydon, Diana C.; Etheridge, Sarah L.; Gay, Laura J.; Jankowski, Janusz; Kelsell, David P.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 4AT, England; [Risk, Janet M.; McRonald, Fiona E.] Univ Liverpool, Sch Dent, Liverpool L3 5PS, Merseyside, England; [Hennies, Hans-Christian] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, D-50931 Cologne, Germany; [Carroll, Rebecca] Queen Mary Univ London, Barts & London Sch Med & Dent, Core Pathol Dept, London E1 4AT, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Stevens, Howard P.] Barnet Hosp, Barnet EN5 3DJ, England; [Spurr, Nigel K.] Roche Pharmaceut, Welwyn Garden City AL7 1TW, Herts, England; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Ellis, Anthony] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool L7 8XP, Merseyside, England; [Field, John K.] Univ Liverpool, Roy Castle Lung Canc Res Programme, Dept Mol & Clin Canc Med, Inst Translat Med,Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Leigh, Irene M.; South, Andrew P.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Mol Med, Div Med Sci, Dundee DD1 9SY, Scotland; [Jankowski, Janusz] Univ Oxford, Dept Oncol, Oxford OX3 9DQ, England; [Jankowski, Janusz] Univ Hosp Leicester, Ctr Digest Dis, Leicester LE1 5WW, Leics, England	University of London; Queen Mary University London; University of Liverpool; University of Cologne; University of London; Queen Mary University London; University of London; University College London; Roche Holding; Saint James's University Hospital; University of Leeds; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Liverpool; University of Dundee; University of Oxford; University Hospitals of Leicester NHS Trust; University of Leicester	Kelsell, DP (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 4AT, England.	d.p.kelsell@qmul.ac.uk	Jankowski, Janusz/H-2706-2012; Hennies, Hans C/G-9424-2014; Kelsell, David P/F-8767-2011; Field, John K./AAD-5674-2020; Plagnol, Vincent/A-5667-2011	Jankowski, Janusz/0000-0003-2130-9181; Hennies, Hans C/0000-0001-7210-2389; Field, John K./0000-0003-3951-6365; Risk, Janet/0000-0002-8770-7783; Plagnol, Vincent/0000-0002-5597-9215; Blaydon, Diana/0000-0002-9998-2563; McRonald, Fiona/0000-0001-7226-9461; Bishop, Tim/0000-0002-8752-8785; Kelsell, David/0000-0002-9910-7144	Queen Mary Innovation Fund; Cancer Research UK [C7738/A10476, C5314/A6695]; Cancer Research UK [13044, 10589] Funding Source: researchfish	Queen Mary Innovation Fund; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by the Queen Mary Innovation Fund (to D.P.K.) and, in part, by Cancer Research UK (to J.M.R. [C7738/A10476] and I.M.L. [C5314/A6695]). We thank the Barts and the London Genome Centre and the Blizard Advanced Light Microscopy core facilities. We also thank Rebecca Harrison for helpful comments.	Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; ELLIS A, 1994, ORAL ONCOL, V30B, P102; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Field EA, 1997, ORAL ONCOL, V33B, P55, DOI 10.1016/S0964-1955(96)00052-8; FREEMAN M, 1992, DEVELOPMENT, V116, P335; HENNIES HC, 1995, GENOMICS, V29, P537, DOI 10.1006/geno.1995.9971; Iwaya T, 1998, GASTROENTEROLOGY, V114, P1206, DOI 10.1016/S0016-5085(98)70426-3; Kelsell DP, 1996, HUM MOL GENET, V5, P857, DOI 10.1093/hmg/5.6.857; Langan JE, 2004, HUM GENET, V114, P534, DOI 10.1007/s00439-004-1100-3; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; MORLEY SN, 1995, J CELL SCI, V108, P3463; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RISK JM, 1994, NAT GENET, V8, P319, DOI 10.1038/ng1294-319; Risk JM, 1999, GENOMICS, V59, P234, DOI 10.1006/geno.1999.5857; Risk JM, 2002, ONCOGENE, V21, P6395, DOI 10.1038/sj.onc.1205768; Rumiato E, 2011, CANCER LETT, V310, P84, DOI 10.1016/j.canlet.2011.06.017; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shahabi M, 2004, INT J ONCOL, V25, P389; Stevens HP, 1996, ARCH DERMATOL, V132, P640, DOI 10.1001/archderm.132.6.640; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; von Brevern M, 1998, ONCOGENE, V17, P2101, DOI 10.1038/sj.onc.1202139; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	27	113	117	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					340	346		10.1016/j.ajhg.2011.12.008	http://dx.doi.org/10.1016/j.ajhg.2011.12.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22265016	Green Published, Bronze			2022-12-18	WOS:000300742200016
J	Degn, SE; Jensenius, JC; Thiel, S				Degn, Soren E.; Jensenius, Jens C.; Thiel, Steffen			Disease-Causing Mutations in Genes of the Complement System	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MANNAN-BINDING LECTIN; TRANSLATIONAL MINIREVIEW SERIES; PATTERN-RECOGNITION MOLECULES; LEUKOCYTE ADHESION DEFICIENCY; HEMOLYTIC-UREMIC SYNDROME; X-RAY-STRUCTURE; C6 DEFICIENCY; FACTOR-H; INHERITED DEFICIENCY; CATALYTIC REGION		[Degn, Soren E.; Jensenius, Jens C.; Thiel, Steffen] Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	Aarhus University	Degn, SE (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Wilhelm Meyers Alle 4, DK-8000 Aarhus, Denmark.	sdegn@microbiology.au.dk; st@microbiology.au.dk	Degn, Søren E/G-7936-2017	Degn, Søren E/0000-0001-5409-045X; Thiel, Steffen/0000-0002-4817-155X	Danish Council for Independent Research, Medical Sciences	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF))	Financial support was provided by The Danish Council for Independent Research, Medical Sciences.	Aguilar-Ramirez P, 2009, MOL IMMUNOL, V46, P2116, DOI 10.1016/j.molimm.2008.10.035; Alugupalli KR, 2005, IMMUNITY, V23, P1, DOI 10.1016/j.immuni.2005.07.001; Arnold DF, 2009, J CLIN IMMUNOL, V29, P691, DOI 10.1007/s10875-009-9295-7; Bally I, 2005, J IMMUNOL, V175, P4536, DOI 10.4049/jimmunol.175.7.4536; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barroso S, 2010, SCAND J IMMUNOL, V72, P38, DOI 10.1111/j.1365-3083.2010.02403.x; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Busby WH, 2000, J BIOL CHEM, V275, P37638, DOI 10.1074/jbc.M006107200; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Carroll MC, 2004, NAT REV IMMUNOL, V4, P825, DOI 10.1038/nri1456; Carroll M, 2006, NATURE, V444, P159, DOI 10.1038/nature05307; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cher THB, 2011, BIOCHEM BIOPH RES CO, V404, P1099, DOI 10.1016/j.bbrc.2010.12.124; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; CROUCH EC, 1995, AM J RESP CELL MOL, V12, P410, DOI 10.1165/ajrcmb.12.4.7695920; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Rooij BJF, 2010, HEPATOLOGY, V52, P1100, DOI 10.1002/hep.23782; DEGN SE, 2010, CURRENT OPIN ORGAN T; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Endo Y, 1998, J IMMUNOL, V161, P4924; Endo Y, 1996, INT IMMUNOL, V8, P1355, DOI 10.1093/intimm/8.9.1355; Etzioni A, 2010, CLIN REV ALLERG IMMU, V38, P54, DOI 10.1007/s12016-009-8132-3; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Firszt R, 2010, AM J CLIN DERMATOL, V11, P383, DOI 10.2165/11537030-000000000-00000; Frank MM, 2010, J ALLERGY CLIN IMMUN, V125, pS262, DOI 10.1016/j.jaci.2009.10.063; Fremeaux-Bacchi V, 2005, J MED GENET, V42, P852, DOI 10.1136/jmg.2005.030783; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Garcia-Laorden MI, 2008, J ALLERGY CLIN IMMUN, V122, P368, DOI 10.1016/j.jaci.2008.05.037; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Gibson TLB, 1999, GROWTH HORM IGF RES, V9, P241, DOI 10.1054/ghir.1999.0115; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Hirt-Minkowski P, 2010, NEPHRON CLIN PRACT, V114, pC219, DOI 10.1159/000276545; Israels J, 2010, ARCH DIS CHILD-FETAL, V95, pF452, DOI 10.1136/adc.2009.172122; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Iwanaga Sadaaki, 1998, Frontiers in Bioscience, V3, pD973; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; JENNINGS C, 1994, NATURE, V372, P498, DOI 10.1038/372498a0; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Khajoee V, 2003, HUM GENET, V112, P244, DOI 10.1007/s00439-002-0870-8; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Krem MM, 2000, TRENDS CARDIOVAS MED, V10, P171, DOI 10.1016/S1050-1738(00)00068-2; Krem MM, 1999, J BIOL CHEM, V274, P28063, DOI 10.1074/jbc.274.40.28063; Lachmann PJ, 2010, J IMMUNOL METHODS, V352, P195, DOI 10.1016/j.jim.2009.11.003; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lipsker D, 2010, LUPUS, V19, P1096, DOI 10.1177/0961203310373370; Lopez-Lera A, 2009, MOL IMMUNOL, V46, P2340, DOI 10.1016/j.molimm.2009.03.026; Lynch NJ, 2005, J IMMUNOL, V174, P4998, DOI 10.4049/jimmunol.174.8.4998; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; Mayilyan KR, 2006, NEUROSCI LETT, V404, P336, DOI 10.1016/j.neulet.2006.06.051; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Moller--Kristensen M, 2009, ANIMAL LECTINS FUNCT, P303; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Nita IM, 2011, MOL IMMUNOL, V48, P1068, DOI 10.1016/j.molimm.2011.01.012; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Nonaka M, 2002, GENOME BIOL, V3; Olesen HV, 2006, CLIN IMMUNOL, V121, P324, DOI 10.1016/j.clim.2006.08.014; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; Parham KL, 2007, MOL IMMUNOL, V44, P2756, DOI 10.1016/j.molimm.2006.11.022; Patthy L, 1990, Blood Coagul Fibrinolysis, V1, P153; PETTIGREW, 2009, ANN NY ACAD SCI, V1173, P108; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Pickering M C, 2000, Adv Immunol, V76, P227; Rachidi S, 2010, EUR J INTERN MED, V21, P260, DOI 10.1016/j.ejim.2010.04.002; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Rameix-Welti MA, 2007, EUR J IMMUNOL, V37, P1377, DOI 10.1002/eji.200636812; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Roos D, 2002, EXP HEMATOL, V30, P252, DOI 10.1016/S0301-472X(01)00782-2; Rossi V, 2005, J BIOL CHEM, V280, P41811, DOI 10.1074/jbc.M503813200; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; Ryu E, 2010, MOL VIS, V16, P2811; SALVESEN G, 1991, BIOMED BIOCHIM ACTA, V50, P665; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Schagat TL, 2003, AM J PHYSIOL-LUNG C, V284, pL140, DOI 10.1152/ajplung.00125.2002; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; Servais A, 2011, HUM PATHOL, V42, P1305, DOI 10.1016/j.humpath.2010.11.023; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Sjoholm AG, 2006, MOL IMMUNOL, V43, P78, DOI 10.1016/j.molimm.2005.06.025; SPRINGER TA, 1984, J EXP MED, V160, P1901, DOI 10.1084/jem.160.6.1901; SPRINGER TA, 1986, J IMMUNOL, V136, P240; Sprong T, 2006, BLOOD, V107, P4865, DOI 10.1182/blood-2005-07-2820; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SUPER M, 1989, LANCET, V2, P1236; TAKADA F, 1995, GENOMICS, V25, P757, DOI 10.1016/0888-7543(95)80027-J; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Titomanlio L, 2005, AM J MED GENET A, V137A, P332, DOI 10.1002/ajmg.a.30878; van den Bogaard R, 2000, EUR J HUM GENET, V8, P513, DOI 10.1038/sj.ejhg.5200496; Vekemans M, 2007, CLIN INFECT DIS, V44, P1593, DOI 10.1086/518171; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; Wurzner R, 2003, CLIN EXP IMMUNOL, V133, P156, DOI 10.1046/j.1365-2249.2003.02230.x; Yanamadala V, 2010, TRENDS MOL MED, V16, P69, DOI 10.1016/j.molmed.2009.12.001; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zheng B, 1998, ENDOCRINOLOGY, V139, P1708, DOI 10.1210/endo.139.4.5945; Zhu ZB, 2000, CLIN EXP IMMUNOL, V119, P305; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	128	113	115	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					689	705		10.1016/j.ajhg.2011.05.011	http://dx.doi.org/10.1016/j.ajhg.2011.05.011			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21664996	Green Published, Bronze			2022-12-18	WOS:000291768500002
J	Li, Y; Pawlik, B; Elcioglu, N; Aglan, M; Kayserili, H; Yigit, G; Percin, F; Goodman, F; Nurnberg, G; Cenani, A; Urquhart, J; Chung, BD; Ismail, S; Amr, K; Aslanger, AD; Becker, C; Netzer, C; Scambler, P; Eyaid, W; Hamamy, H; Clayton-Smith, J; Hennekam, R; Nurnberg, P; Herz, J; Temtamy, SA; Wollnik, B				Li, Yun; Pawlik, Barbara; Elcioglu, Nursel; Aglan, Mona; Kayserili, Huelya; Yigit, Goekhan; Percin, Ferda; Goodman, Frances; Nuernberg, Gudrun; Cenani, Asim; Urquhart, Jill; Chung, Boi-Dinh; Ismail, Samira; Amr, Khalda; Aslanger, Ayca D.; Becker, Christian; Netzer, Christian; Scambler, Pete; Eyaid, Wafaa; Hamamy, Hanan; Clayton-Smith, Jill; Hennekam, Raoul; Nuernberg, Peter; Herz, Joachim; Temtamy, Samia A.; Wollnik, Bernd			LRP4 Mutations Alter Wnt/beta-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIAL DYSMORPHISM; RENAL HYPOPLASIA; LINKAGE ANALYSIS; RECEPTOR; PATHWAYS; COMPLEX; MODELS; FAMILY; TOOL	Cenani-Lenz syndrome (CLS) is an autosomal-recessive congenital disorder affecting distal limb development. It is characterized mainly by syndactyly and/or oligodactyly and is now shown to be commonly associated with kidney anomalies. We used a homozygosity-mapping approach to map the CLS1 locus to chromosome 11p11.2-q13.1. By sequencing candidate genes, we identified recessive LRP4 mutations in 12 families with CLS. LRP4 belongs to the low-density lipoprotein (LDL) receptor-related proteins (LRPs), which are essential for various developmental processes. LRP4 is known to antagonize LRP6-mediated activation of canonical Wnt signaling, a function that is lost by the identified mutations. Our findings increase the spectrum of congenital anomalies associated with abnormal lipoprotein receptor-dependent signaling.	[Li, Yun; Pawlik, Barbara; Yigit, Goekhan; Nuernberg, Gudrun; Netzer, Christian; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Li, Yun; Pawlik, Barbara; Yigit, Goekhan; Chung, Boi-Dinh; Netzer, Christian; Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Elcioglu, Nursel] Marmara Univ Hosp, Dept Pediat Genet, TR-34668 Istanbul, Turkey; [Aglan, Mona; Ismail, Samira; Amr, Khalda; Temtamy, Samia A.] Natl Res Ctr, Div Human Genet & Genome Res, Dept Clin, Cairo 12311, Egypt; [Aglan, Mona; Ismail, Samira; Amr, Khalda; Temtamy, Samia A.] Natl Res Ctr, Div Human Genet & Genome Res, Dept Mol Genet, Cairo 12311, Egypt; [Kayserili, Huelya; Aslanger, Ayca D.] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34094 Istanbul, Turkey; [Percin, Ferda] Gazi Univ, Fac Med, Dept Med Genet, TR-06500 Ankara, Turkey; [Goodman, Frances; Hennekam, Raoul] UCL, Great Ormond St Hosp Children, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 3JH, England; [Nuernberg, Gudrun; Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Chung, Boi-Dinh; Becker, Christian; Netzer, Christian; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Cenani, Asim] Istanbul Univ, Cerrahpasa Med Sch, GETAM, TR-34452 Istanbul, Turkey; [Urquhart, Jill; Clayton-Smith, Jill] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 0JH, Lancs, England; [Scambler, Pete] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Eyaid, Wafaa] King Abdul Aziz Med City, King Fahad Natl Guard Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; [Hamamy, Hanan] Univ Hosp Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Hennekam, Raoul] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Cologne; University of Cologne; Marmara University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Istanbul University; Gazi University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Cologne; University of Cologne; Istanbul University; Istanbul University - Cerrahpasa; University of Manchester; University of London; University College London; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of Geneva; University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wollnik, B (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de	Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008; Urquhart, Jill/G-2282-2015; Percin, Ferda E/H-6850-2016; Wollnik, Bernd/GRY-6062-2022	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Urquhart, Jill/0000-0002-5788-5511; Percin, Ferda E/0000-0001-9317-8155; Wollnik, Bernd/0000-0003-2589-0364; temtamy, samia/0000-0002-6452-823X; aglan, mona/0000-0002-0908-0639; Amr, Khalda/0000-0001-8472-5911	German Federal Ministry of Education and Research (BMBF) [01GM0880, 01GM0801]; National Institutes of Health; American Health Assistance Foundation; Perot Family Foundation; Alexander-von-Humboldt Foundation; German Research Foundation (DFG) [NE826/3-2]; Medical Research Council [G9901217] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; MRC [G9901217] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Perot Family Foundation; Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are thankful to all family members that participated in this study, to Bernhard Zabel for referral of patients, to Esther Milz for excellent technical assistance, and to Christian Kubisch, Brunhilde Wirth, and Karin Boss for critical reading of the manuscript. This work was supported by the German Federal Ministry of Education and Research (BMBF) by grant numbers 01GM0880 (SKELNET) and 01GM0801 (E-RARE network CRANIRARE) to B.W. J.H. is supported by grants from the National Institutes of Health, the American Health Assistance Foundation, the Perot Family Foundation, and the Wolfgang-Paul Program of the Alexander-von-Humboldt Foundation. C.N. was supported by the German Research Foundation (DFG), grant NE826/3-2.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bacchelli C, 2001, CLIN GENET, V59, P203, DOI 10.1034/j.1399-0004.2001.590312.x; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; CENANI A, 1967, Z KINDERHEILKD, V101, P181, DOI 10.1007/BF00438491; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Elcioglu N, 1997, AM J MED GENET, V70, P341, DOI 10.1002/(SICI)1096-8628(19970627)70:4<341::AID-AJMG1>3.0.CO;2-W; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Huze C, 2009, AM J HUM GENET, V85, P155, DOI 10.1016/j.ajhg.2009.06.015; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Jarbhou H, 2008, CLIN DYSMORPHOL, V17, P269, DOI 10.1097/MCD.0b013e328306a6ed; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Percin EF, 2003, GENET COUNSEL, V14, P313; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Seven M, 2000, GENET COUNSEL, V11, P41; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Temtamy SA, 2003, CLIN DYSMORPHOL, V12, P77, DOI 10.1097/00019605-200304000-00001; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488	30	113	117	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					696	706		10.1016/j.ajhg.2010.03.004	http://dx.doi.org/10.1016/j.ajhg.2010.03.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20381006	Green Published, Bronze			2022-12-18	WOS:000278045300006
J	Demeo, DL; Mariani, T; Bhattacharya, S; Srisuma, S; Lange, C; Litonjua, A; Bueno, R; Pillai, SG; Lomas, DA; Sparrow, D; Shapiro, SD; Criner, GJ; Kim, HP; Chen, ZH; Choi, AMK; Reilly, J; Silverman, EK				DeMeo, Dawn L.; Mariani, Thomas; Bhattacharya, Soumyaroop; Srisuma, Sorachai; Lange, Christoph; Litonjua, Augusto; Bueno, Raphael; Pillai, Sreekumar G.; Lomas, David A.; Sparrow, David; Shapiro, Steven D.; Criner, Gerard J.; Kim, Hong P.; Chen, Zhihua; Choi, Augustine M. K.; Reilly, John; Silverman, Edwin K.			Integration of Genomic and Genetic Approaches Implicates IREB2 as a COPD Susceptibility Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IRON-REGULATORY PROTEIN-2; LUNG-CANCER; CIGARETTE-SMOKE; SERPINE2 GENE; ASSOCIATION; LOCUS; EPIDEMIOLOGY; HOMEOSTASIS; METABOLISM	Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is influenced by both genetic determinants and smoking. We identified genomic regions from 56 lung-tissue gene-expression microarrays and used them to select 889 SNPs to be tested for association with COPD. We genotyped SNPs in 389 severe COPD cases from the National Emphysema Treatment Trial and 424 cigarette-smoking controls from the Normative Aging Study. A total of 71 autosomal SNPs demonstrated at least nominal significance with COPI) susceptibility (p = 3.4 x 10(-6) to 0.05). These 71 SNPs were evaluated in a farnily-based study of 127 probands with severe, early-onset COPI) and 822 of their family members in the Boston Early-Onset COPI) Study. We combined p values from the case-control and family-based analyses, setting p = 5.60 x 10(-5) as a conservative threshold for significance. Three SNPs in the iron regulatory protein 2 (IREB2) gene met this stringent threshold for significance, and four other IREB2 SNPs demonstrated combined p < 0.02. We demonstrated replication of association for these seven IREB2 SNPs (all p values :5: 0.02) in a farnily-based study of 3117 subjects from the International COPD Genetics Network; combined p values across all cohorts for the main phenotype of interest ranged from 1.6 x 10(-7) to 6.4 x 10(-4). IREB2 protein and mRNA were increased in lung-tissue samples from COPI) subjects in comparison to controls. In summary gene-expression and genetic-association results have implicated IREB2 as a COPI) susceptibility gene.	[DeMeo, Dawn L.; Litonjua, Augusto; Silverman, Edwin K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [DeMeo, Dawn L.; Litonjua, Augusto; Kim, Hong P.; Chen, Zhihua; Choi, Augustine M. K.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Bueno, Raphael] Harvard Univ, Div Thorac Surg, Boston, MA 02115 USA; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [DeMeo, Dawn L.; Lange, Christoph; Litonjua, Augusto; Bueno, Raphael; Kim, Hong P.; Chen, Zhihua; Choi, Augustine M. K.; Silverman, Edwin K.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Mariani, Thomas; Bhattacharya, Soumyaroop] Univ Rochester, Div Neonatol, Rochester, NY 14642 USA; [Mariani, Thomas; Bhattacharya, Soumyaroop] Univ Rochester, Ctr Pediat Biomed Res, Rochester, NY 14642 USA; [Srisuma, Sorachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Physiol, Bangkok 10700, Thailand; [Pillai, Sreekumar G.] Glaxo SmithKline Res & Dev, Div Genet, Res Triangle Pk, NC 27709 USA; [Lomas, David A.] Cambridge Inst Med Res, Cambridge CB2 2XY, England; [Sparrow, David] Boston Vet Affairs Med Ctr, Boston, MA 02130 USA; [Sparrow, David] Boston Univ, Med Ctr, Ctr Pulm, Boston, MA 02130 USA; [Shapiro, Steven D.; Reilly, John] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Criner, Gerard J.] Temple Univ, Sch Med, Temple Lung Ctr, Philadelphia, PA 19140 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Rochester; University of Rochester; Mahidol University; GlaxoSmithKline; University of Cambridge; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Demeo, DL (corresponding author), Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	dawn.demeo@channing.harvard.edu	Reilly, John/H-8755-2012; Bhattacharya, Soumyaroop/E-7669-2010	Bhattacharya, Soumyaroop/0000-0003-1140-7845; Litonjua, Augusto/0000-0003-0422-5875	National Institutes of Health (NIH) [HL072918, HL71885, HL72303]; NIH [HL07S478, HL084323, HL083069]; National Heart, Lung and Blood Institute [N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110, N01HR76111, N01HR76112, N01HR76113, N01HR7611.4, N01HR76115, N01HR76116, N01HR761.18, N01HR76119]; Cooperative Studies Program/Epiderniology Research and Information Center of the U.S. Department of Veterans Affairs; Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA, USA; GlaxoSmithKline; Pennsylvania Department of Health [PA-DOH 02-70-02]; MRC [G0500306] Funding Source: UKRI; DIVISION OF LUNG DISEASES [N01HR076106, N01HR076108, N01HR076113, N01HR076118, N01HR076110, N01HR076102, N01HR076119, N01HR076101, N01HR076107, N01HR076105, N01HR076115, N01HR076112, N01HR076103, N01HR076104, N01HR076111, N01HR076114, N01HR076116, N01HR076109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071885, P01HL083069, F32HL076108, R01HL075478, R01HL076114, R01HL072303, T32HL076116, R01HL076101, T32HL076118, R01HL076113, R01HL084323, K08HL072918] Funding Source: NIH RePORTER; Medical Research Council [G0500306] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cooperative Studies Program/Epiderniology Research and Information Center of the U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA, USA; GlaxoSmithKline(GlaxoSmithKline); Pennsylvania Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the NETT Genetics Ancillary Study co-investigator group, including Joshua Benditt, Gerard Criner, Malcolm DeCamp, Philip Diaz, Mark Ginsburg, Larry Kaiser, Marcia Katz, Mark Krasna, Neil Maclntyre, Barry Make, Rob McKenna, Fernando Martinez, Zab Mosenifar, Andrew Ries, Paul Scanlon, Frank Sciurba, and James Utz. We acknowledge the contribution of the International COPD Genetics Network (ICGN) investigators for the development of the ICGN cohort. In addition to E.S, and D.L. (co-authors), the ICGN investigators include A. Agusti, P. M.A. Calverley, C.F. Donner, R.D. Levy, B. J. Make, P.D. Pare, J. Vestbo, S.I. Rennard, and E. F.M. Wouters. Support for this projectwas provided by National Institutes of Health (NIH) grants HL072918, HL71885, and HL72303 and by a Doris Duke Clinical Scientist Award (D.L.D.). The NETT-NAS and BEOCOPD studies were supported by NIH grants HL07S478, HL084323, and HL083069 (E.K.S.). Additionally the NETT was supported by the National Heart, Lung and Blood Institute (grants N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, NOIHR76110, N01HR76111, N01HR76112, N01HR76113, NOIHR7611.4, NOIHR76115, N01HR76116, N01HR761.18, N01HR76119), the Centers for Medicare and Medicaid Services, and the Agency for Healthcare Research and Quality. The Normative Aging study is supported by the Cooperative Studies Program/Epiderniology Research and Information Center of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA, USA. The development of the ICGN cohort was funded by GlaxoSmithKline. The collection Of lung tissue at Temple Lung Center was supported by the Pennsylvania Department of Health (PA-DOH 02-70-02).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BELL B, 1966, GERONTOLOGIST, V6, P179, DOI 10.1093/geront/6.4.179; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Coon KD, 2006, J ALZHEIMERS DIS, V9, P225; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; DEMEO DL, 2007, ANN M AM SOC HUM GEN; Falvella FS, 2009, CLIN CANCER RES, V15, P1837, DOI 10.1158/1078-0432.CCR-08-2107; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Ghio AJ, 1997, J LAB CLIN MED, V129, P53, DOI 10.1016/S0022-2143(97)90161-X; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4; MORENO JJ, 1992, CHEM RES TOXICOL, V5, P116, DOI 10.1021/tx00025a020; Nelson ME, 1996, AM J RESP CRIT CARE, V153, P1353, DOI 10.1164/ajrccm.153.4.8616566; O'Brien-Ladner AR, 2000, AM J RESP CELL MOL, V23, P112, DOI 10.1165/ajrcmb.23.1.3736; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; THOMPSON AB, 1991, J LAB CLIN MED, V117, P493; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC; J THORAC CARDIOVASC, V118, P518	28	113	116	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					493	502		10.1016/j.ajhg.2009.09.004	http://dx.doi.org/10.1016/j.ajhg.2009.09.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19800047	Green Published, Bronze			2022-12-18	WOS:000270836000006
J	Garshasbi, M; Hadavi, V; Habibi, H; Kahrizi, K; Kariminejad, R; Behjati, F; Tzschach, A; Najmabadi, H; Ropers, HH; Kuss, AW				Garshasbi, Masoud; Hadavi, Valeh; Habibi, Haleh; Kahrizi, Kimia; Kariminejad, Roxana; Behjati, Farkhondeh; Tzschach, Andreas; Najmabadi, Hossein; Ropers, Hans Hilger; Kuss, Andreas Walter			A defect in the TUSC3 gene is associated with autosomal recessive mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMAN GENOME; COPY NUMBER; PROTEIN PHOSPHATASE-1; OLIGOSACCHARYLTRANSFERASE; DELETION; POLYMORPHISM; MUTATION; PROGRAM; FAMILY	Recent studies have shown that autosomal recessive mental retardation (ARMR) is extremely heterogeneous, and there is reason to believe that the number of underlying gene defects goes into the thousands. To date, however, only four genes have been implicated in nonsyndromic ARMR (NS-ARMR): PRSS12 (neurotrypsin), CRBN (cereblon), CC2D1A, and GRIK2. As part of an ongoing systematic study aiming to identify ARMR genes, we investigated a large consanguineous family comprising seven patients with nonsyndromic ARMR in four sibships. Genome-wide SNP typing enabled us to map the relevant genetic defect to a 4.6 Mbp interval on chromosome 8. Haplotype analyses and copy-number studies led to the identification of a homozygous deletion partly removing TUSC3 (N33) in all patients. All obligate carriers of this family were heterozygous, but none of 192 unrelated healthy individuals from the same population carried this deletion. We excluded other disease-causing mutations in the coding regions of all genes within the linkage interval by sequencing; moreover, we verified the complete absence of a functional TUSC3 transcript in all patients through RT-PCR. TUSC3 is thought to encode a subunit of the endoplasmic reticulum-bound oligosaccharyltransferase complex that catalyzes a pivotal step in the protein N-glycosylation process. Our data suggest that in contrast to other genetic defects of glycosylation, inactivation of TUSC3 causes nonsyndromic MR, a conclusion that is supported by a separate report in this issue of AJHG. TUSC3 is only the fifth gene implicated in NS-ARMR and the first for which mutations have been reported in more than one family.	[Garshasbi, Masoud; Tzschach, Andreas; Ropers, Hans Hilger; Kuss, Andreas Walter] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Garshasbi, Masoud; Kahrizi, Kimia; Behjati, Farkhondeh; Najmabadi, Hossein] Univ Social Welfare & Rehabil Sci, Genet Res Ctr, Tehran 19834, Iran; [Hadavi, Valeh; Kariminejad, Roxana; Najmabadi, Hossein] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Habibi, Haleh] Hamedan Welfare Org, Med Genet Counselling Ctr, Hamadan 6516815353, Iran	Max Planck Society	Kuss, AW (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kuss_a@molgen.mpg.de	Kahrizi, Kimia/D-7989-2017; Tzschach, Andreas/I-2648-2019; Najmabadi, Hossein/P-8182-2017; Behjati, Farkhondeh/D-8497-2017	Tzschach, Andreas/0000-0002-6840-965X; Behjati, Farkhondeh/0000-0001-6343-0452; Najmabadi, Hossein/0000-0002-6084-7778; Garshasbi, Masoud/0000-0002-5508-7903; Kuss, Andreas/0000-0002-9401-4627				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bova GS, 1996, GENOMICS, V35, P46, DOI 10.1006/geno.1996.0321; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; KELLEHER DJ, 1994, J BIOL CHEM, V269, P12908; MacGrogan D, 1996, GENOMICS, V35, P55, DOI 10.1006/geno.1996.0322; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	27	113	124	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1158	1164		10.1016/j.ajhg.2008.03.018	http://dx.doi.org/10.1016/j.ajhg.2008.03.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18452889	Bronze, Green Published			2022-12-18	WOS:000255923600015
J	Molinari, F; Foulquier, F; Tarpey, PS; Morelle, W; Boissel, S; Teague, J; Edkins, S; Futreal, PA; Stratton, MR; Turner, G; Matthijs, G; Gecz, J; Munnich, A; Colleaux, L				Molinari, Florence; Foulquier, Francois; Tarpey, Patrick S.; Morelle, Willy; Boissel, Sarah; Teague, Jon; Edkins, Sarah; Futreal, P. Andrew; Stratton, Michael R.; Turner, Gillian; Matthijs, Gert; Gecz, Jozef; Munnich, Arnold; Colleaux, Laurence			Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; POLYSIALIC ACID; PSA-NCAM; GENE; PLASTICITY; COMPLEXES; MEMORY; YEAST; GLYCOSYLATION	Mental retardation (MR) is the most frequent handicap among children and young adults. Although a large proportion of X-linked MR genes have been identified, only four genes responsible for autosomal-recessive nonsyndromic MR (AR-NSMR) have been described so far. Here, we report on two genes involved in autosomal-recessive and X-linked NSMR. First, autozygosity mapping in two sibs born to first-cousin French parents led to the identification of a region on 8p22-p23.1. This interval encompasses the gene N33/TUSC3 encoding one subunit of the oligosaccharyltransferase (OTase) complex, which catalyzes the transfer of an oligosaccharide chain on nascent proteins, the key step of N-glycosylation. Sequencing N33/TUSC3 identified a I bp insertion, c. 787_788insC, resulting in a premature stop codon, p.N263fsX300, and leading to mRNA decay. Surprisingly, glycosylation analyses of patient fibroblasts showed normal N-glycan synthesis and transfer, suggesting that normal N-glycosylation observed in patient fibroblasts may be due to functional compensation. Subsequently, screening of the X-linked N33/TUSC3 paralog, the IAP gene, identified a missense mutation (c.932T -> G, p.V311G) in a family with X-linked NSMR. Recent studies of fucosylation and polysialic-acid modification of neuronal cell-adhesion glycoproteins have shown the critical role of glycosylation in synaptic plasticity. However, our data provide the first demonstration that a defect in N-glycosylation can result in NSMR. Together, our results demonstrate that fine regulation of OTase activity is essential for normal cognitive-function development, providing therefore further insights to understand the pathophysiological bases of MR.	[Molinari, Florence; Boissel, Sarah; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Neurosensorielles & Dev INSERM U 781, Lab Genet & Epigenet Malad Metab, F-75015 Paris, France; [Foulquier, Francois; Matthijs, Gert] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Foulquier, Francois; Morelle, Willy] USTL, CNRS, Unite Mixte Rech 8576, IFR 147, F-59655 Villeneuve Dascq, France; [Tarpey, Patrick S.; Teague, Jon; Edkins, Sarah; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Turner, Gillian] Univ Newcastle, Newcastle, NSW 2308, Australia; [Turner, Gillian] Univ Newcastle, Gold Serv Hunter Genet, Newcastle, NSW 2308, Australia; [Gecz, Jozef] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5005, Australia; [Gecz, Jozef] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Gecz, Jozef] Univ Adelaide, Dept Pediat, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; KU Leuven; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of Cambridge; Wellcome Trust Sanger Institute; University of Newcastle; University of Newcastle; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide	Colleaux, L (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Neurosensorielles & Dev INSERM U 781, Lab Genet & Epigenet Malad Metab, F-75015 Paris, France.	colleaux@necker.fr	FOULQUIER, FRANCOIS/AAI-1182-2021; Molinari, Florence/M-7683-2016; COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017; foulquier, francois/ABE-5886-2020; Gecz, Jozef/X-3469-2019	Molinari, Florence/0000-0001-5111-7215; COLLEAUX, LAURENCE/0000-0002-0987-7648; foulquier, francois/0000-0002-6551-3240; Gecz, Jozef/0000-0002-7884-6861; Matthijs, Gert/0000-0001-6710-1912; Foulquier, Francois/0000-0001-5084-4015				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Eklund Erik A, 2006, NeuroRx, V3, P254; Faid V, 2007, PROTEOMICS, V7, P1800, DOI 10.1002/pmic.200600977; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Matthies H, 1999, NEUROSCIENCE, V91, P175, DOI 10.1016/S0306-4522(98)00628-9; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Weller S, 2001, HUM MUTAT, V18, P1, DOI 10.1002/humu.1144; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026	27	113	116	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1150	1157		10.1016/j.ajhg.2008.03.021	http://dx.doi.org/10.1016/j.ajhg.2008.03.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18455129	Green Published, Bronze			2022-12-18	WOS:000255923600014
J	Huang, QQ; Shete, S; Amos, CI				Huang, QQ; Shete, S; Amos, CI			Ignoring linkage disequilibrium among tightly linked markers induces false-positive evidence of linkage for affected sib pair analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE FREQUENCIES; COMPUTER-PROGRAM; HETEROGENEITY; GENOME; TESTS	Most multipoint linkage programs assume linkage equilibrium among the markers being studied. The assumption is appropriate for the study of sparsely spaced markers with intermarker distances exceeding a few centimorgans, because linkage equilibrium is expected over these intervals for almost all populations. However, with recent advancements in high-throughput genotyping technology, much denser markers are available, and linkage disequilibrium (LD) may exist among the markers. Applying linkage analyses that assume linkage equilibrium to dense markers may lead to bias. Here, we demonstrated that, when some or all of the parental genotypes are missing, assuming linkage equilibrium among tightly linked markers where strong LD exists can cause apparent oversharing of multipoint identity by descent (IBD) between sib pairs and false-positive evidence for multipoint model-free linkage analysis of affected sib pair data. LD can also mimic linkage between a disease locus and multiple tightly linked markers, thus causing false-positive evidence of linkage using parametric models, particularly when heterogeneity LOD score approaches are applied. Bias can be eliminated by inclusion of parental genotype data and can be reduced when additional unaffected siblings are included in the analysis.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Amos, CI (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	camos@mdanderson.org			NCI NIH HHS [P30CA16672, P01CA34936, P01 CA034936, P30 CA016672, R01CA76293, U01 CA076293] Funding Source: Medline; NHGRI NIH HHS [R01HG02275, R01 HG002275] Funding Source: Medline; NIAMS NIH HHS [AR44422, R01 AR044422, N01AR82232] Funding Source: Medline; NIEHS NIH HHS [R01ES09912, R01 ES009912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA076293, P01CA034936, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; KNAPP M, 1993, GENET EPIDEMIOL, V10, P413, DOI 10.1002/gepi.1370100614; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1999, ANAL HUMAN GENETIC L, P251; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WILLIAMSON JA, 1995, GENET EPIDEMIOL, V12, P163, DOI 10.1002/gepi.1370120205	18	113	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1106	1112		10.1086/426000	http://dx.doi.org/10.1086/426000			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15492927	Green Published, Bronze			2022-12-18	WOS:000224866400014
J	Schaid, DJ; Guenther, JC; Christensen, GB; Hebbring, S; Rosenow, C; Hilker, CA; McDonnell, SK; Cunningham, JM; Slager, SL; Blute, ML; Thibodeau, SN				Schaid, DJ; Guenther, JC; Christensen, GB; Hebbring, S; Rosenow, C; Hilker, CA; McDonnell, SK; Cunningham, JM; Slager, SL; Blute, ML; Thibodeau, SN			Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MUTATIONS; GENOTYPING ERRORS; PAIR LINKAGE; FAMILIES; CHROMOSOME; GENE; SCAN; MAPS; CONSORTIUM	Prostate cancer is one of the most common cancers among men and has long been recognized to occur in familial clusters. Brothers and sons of affected men have a 2-3-fold increased risk of developing prostate cancer. However, identification of genetic susceptibility loci for prostate cancer has been extremely difficult. Although the suggestion of linkage has been reported for many chromosomes, the most promising regions have been difficult to replicate. In this study, we compare genome linkage scans using microsatellites with those using single-nucleotide polymorphisms (SNPs), performed in 467 men with prostate cancer from 167 families. For the microsatellites, the ABI Prism Linkage Mapping Set version 2, with 402 microsatellite markers, was used, and, for the SNPs, the Early Access Affymetrix Mapping 10K array was used. Our results show that the presence of linkage disequilibrium (LD) among SNPs can lead to inflated LOD scores, and this seems to be an artifact due to the assumption of linkage equilibrium that is required by the current genetic-linkage software. After excluding SNPs with high LD, we found a number of new LOD-score peaks with values of at least 2.0 that were not found by the microsatellite markers: chromosome 8, with a maximum model-free LOD score of 2.2; chromosome 2, with a LOD score of 2.1; chromosome 6, with a LOD score of 4.2; and chromosome 12, with a LOD score of 3.9. The LOD scores for chromosomes 6 and 12 are difficult to interpret, because they occurred only at the extreme ends of the chromosomes. The greatest gain provided by the SNP markers was a large increase in the linkage information content, with an average information content of 61% for the SNPs, versus an average of 41% for the microsatellite markers. The strengths and weaknesses of microsatellite versus SNP markers are illustrated by the results of our genome linkage scans.	Mayo Clin & Mayo Fdn, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Urol, Rochester, MN 55905 USA; Affymetrix, Santa Clara, CA USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Affymetrix	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Hlth Sci Res, Harwick 7,200 1st St SW, Rochester, MN 55905 USA.	schaid@mayo.edu	Slager, Susan L./B-6756-2009	McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [CA94919, CA72818, P30 CA015083, K07 CA094919, R01 CA072818, CA89600, P50 CA091956, N01 CA015083, U01 CA089600, CA91956] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA094919, R01CA072818, P30CA015083, P50CA091956, U01CA089600] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cunningham JM, 2003, PROSTATE, V57, P335, DOI 10.1002/pros.10308; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Easton DF, 2003, PROSTATE, V57, P261, DOI 10.1002/pros.10300; Edwards S, 2003, PROSTATE, V57, P270, DOI 10.1002/pros.10301; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hsieh CL, 2001, AM J HUM GENET, V69, P148, DOI 10.1086/321281; Janer M, 2003, PROSTATE, V57, P309, DOI 10.1002/pros.10305; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Xu J, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, PROSTATE, V57, P320, DOI 10.1002/pros.10306	34	113	120	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					948	965		10.1086/425870	http://dx.doi.org/10.1086/425870			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15514889	Bronze, Green Published			2022-12-18	WOS:000224866400002
J	Stambolian, D; Ibay, G; Reider, L; Dana, D; Moy, C; Schlifka, M; Holmes, T; Ciner, E; Bailey-Wilson, JE				Stambolian, D; Ibay, G; Reider, L; Dana, D; Moy, C; Schlifka, M; Holmes, T; Ciner, E; Bailey-Wilson, JE			Genomewide linkage scan for myopia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 22q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FULL-LENGTH HUMAN; GENETIC-LINKAGE; SIB-PAIR; OCULAR REFRACTION; HEME OXYGENASE-1; RISK-FACTORS; ADULT-ONSET; I ERROR; MAPS; ASSOCIATION	Mild/moderate (common) myopia is a very common disorder, with both genetic and environmental influences. The environmental factors are related to near work and can be measured. There are no known genetic loci for common myopia. Our goal is to find evidence for a myopia susceptibility gene causing common myopia. Cycloplegic and manifest refraction were performed on 44 large American families of Ashkenazi Jewish descent, each with at least two affected siblings. Individuals with at least -1.00 diopter or lower in each meridian of both eyes were classified as myopic. Microsatellite genotyping with 387 markers was performed by the Center for Inherited Disease Research. Linkage analyses were conducted with parametric and nonparametric methods by use of 12 different penetrance models. The family-based association test was used for an association scan. A maximum multipoint parametric heterogeneity LOD (HLOD) score of 3.54 was observed at marker D22S685, and nonparametric linkage analyses gave consistent results, with a P value of .0002 at this marker. The parametric multipoint HLOD scores exceeded 3.0 for a 4-cM interval, and significant evidence of genetic heterogeneity was observed. This genomewide scan is the first step toward identifying a gene on chromosome 22 with an influence on common myopia. At present, we are following up our linkage results on chromosome 22 with a dense map of >1,500 single-nucleotide-polymorphism markers for fine mapping and association analyses. Identification of a susceptibility locus in this region may eventually lead to a better understanding of gene-environment interactions in the causation of this complex trait.	Univ Penn, Stellar Chance Labs, Dept Ophthalmol, Philadelphia, PA 19104 USA; Penn Coll Optometry, Philadelphia, PA 19141 USA; NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA)	Stambolian, D (corresponding author), Univ Penn, Stellar Chance Labs, Dept Ophthalmol, Room 313,422 Curie Blvd, Philadelphia, PA 19104 USA.	stamboli@mail.med.upenn.edu		Bailey-Wilson, Joan/0000-0002-9153-2920	NEI NIH HHS [EY12226, R01 EY012226, U10 EY012226] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000178] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abreu PC, 2002, GENET EPIDEMIOL, V22, P156, DOI 10.1002/gepi.0155; BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P516; BEAR JC, 1981, CLIN GENET, V19, P462; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Chen C J, 1985, Ophthalmic Paediatr Genet, V6, P353; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; DAVID R, 1985, ARCH OPHTHALMOL-CHIC, V103, P1812; Duffy DL, 1997, AM J HUM GENET, V61, pA197; DURNER M, 1992, AM J HUM GENET, V51, P859; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; *GAS, 1995, GAS VERS 2 0; Gasperoni TL, 2003, AM J MED GENET B, V116B, P8, DOI 10.1002/ajmg.b.10757; GOSS DA, 1983, AM J OPTOM PHYS OPT, V60, P651; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; HARDING JJ, 1989, ACTA OPHTHALMOL, V67, P510; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HUI J, 1995, VISION RES, V35, P1353, DOI 10.1016/0042-6989(94)00224-A; IBAY G, IN PRESS BMC MED GEN; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; KELLER JT, 1973, AM J OPTOM PHYS OPT, V50, P206; Krause U H, 1993, Arctic Med Res, V52, P161; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUTTY RK, 1994, GENOMICS, V20, P513, DOI 10.1006/geno.1994.1213; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Mutti DO, 1996, INVEST OPHTH VIS SCI, V37, P952; Naiglin L, 1999, ANN GENET-PARIS, V42, P140; Naiglin L, 2002, J MED GENET, V39, P118, DOI 10.1136/jmg.39.2.118; Norris JD, 2002, MOL ENDOCRINOL, V16, P459, DOI 10.1210/me.16.3.459; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Paluru P, 2003, INVEST OPHTH VIS SCI, V44, P1830, DOI 10.1167/iovs.02-0697; Paul R, 1996, CYTOGENET CELL GENET, V73, P317, DOI 10.1159/000134366; Pericak-Vance Margaret A., 1998, P323; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SIMENSEN B, 1994, ACTA OPHTHALMOL, V72, P469; SORSBY A, 1966, Journal of Medical Genetics, V3, P269, DOI 10.1136/jmg.3.4.269; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TEIKARI JM, 1988, GENET EPIDEMIOL, V5, P171, DOI 10.1002/gepi.1370050304; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Tokoro T, 1988, Acta Ophthalmol Suppl, V185, P172; Tsuruga H, 1997, BIOCHEM BIOPH RES CO, V236, P118, DOI 10.1006/bbrc.1997.6865; Vieland VJ, 2002, HUM HERED, V53, P23, DOI 10.1159/000048601; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; WEALE R, 1980, BRIT J OPHTHALMOL, V64, P311, DOI 10.1136/bjo.64.5.311; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186; XU X, 2000, FBAT FAMILY BASED AS; YAP M, 1993, OPHTHAL PHYSL OPT, V13, P316, DOI 10.1111/j.1475-1313.1993.tb00479.x; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; ZYLBERMANN R, 1993, J PEDIATR OPHTHALMOL, V30, P319	75	113	117	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					448	459		10.1086/423789	http://dx.doi.org/10.1086/423789			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15273935	Green Published, Bronze			2022-12-18	WOS:000223272200009
J	Willour, VL; Shugart, YY; Samuels, J; Grados, M; Cullen, B; Bienvenu, OJ; Wang, Y; Liang, KY; Valle, D; Hoehn-Saric, R; Riddle, M; Nestadt, G				Willour, VL; Shugart, YY; Samuels, J; Grados, M; Cullen, B; Bienvenu, OJ; Wang, Y; Liang, KY; Valle, D; Hoehn-Saric, R; Riddle, M; Nestadt, G			Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; HUMAN GENOME; RECOMBINATION; GENETICS	Obsessive-compulsive disorder (OCD) is a severe psychiatric illness that is characterized by intrusive and senseless thoughts and impulses (obsessions) and by repetitive behaviors (compulsions). Family, twin, and segregation studies support the presence of both genetic and environmental susceptibility factors, and the only published genome scan for OCD identified a candidate region on 9p24 at marker D9S288 that met criteria for suggestive significance (Hanna et al. 2002). In an attempt to replicate this finding, we genotyped 50 pedigrees with OCD, using microsatellite markers spanning the 9p24 candidate region, and analyzed the data, using parametric and nonparametric linkage analyses under both a narrow phenotype model (DSM-IV OCD definite; 41 affected sib pairs) and a broad phenotype model (DSM-IV OCD definite and probable; 50 affected sib pairs). Similar to what was described by Hanna et al. (2002), our strongest findings came with the dominant parameters and the narrow phenotype model: the parametric signal peaked at marker D9S1792 with an HLOD of 2.26 (alpha=0.59), and the nonparametric linkage signal (NPL) peaked at marker D9S1813 with an NPL of 2.52 (P=.006). These findings are striking in that D9S1813 and D9S1792 lie within 0.5 cM (<350 kb) of the original 9p24 linkage signal at D9S288; furthermore, pedigree-based association analyses also implicated the 9p24 candidate region by identifying two markers (D9S288 and GATA62F03) with modest evidence (P=.046 and .02, respectively) for association.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21287 USA; Kennedy Krieger Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute	Willour, VL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Meyer Bldg Room 4-132,600 N Wolfe St, Baltimore, MD 21287 USA.	willour@jhmi.edu	Liang, Kung-Yee/F-8299-2011	Willour, Virginia/0000-0002-6639-487X; YAO, YIN/0000-0003-3053-8429; Samuels, Jack/0000-0002-6715-7905; Bienvenu, Joe/0000-0002-8466-102X; Grados, Marco/0000-0002-6189-6264	NCRR NIH HHS [M01 RR000052, RR00052] Funding Source: Medline; NIMH NIH HHS [R01 MH50214, R01 MH050214] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050214] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cooper J, 1970, Psychol Med, V1, P48; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grados MA, 2003, BRAIN DEV-JPN, V25, pS55, DOI 10.1016/S0387-7604(03)90010-6; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MANNUZZA S, 1986, J PSYCHIAT RES, V20, P317, DOI 10.1016/0022-3956(86)90034-8; Mannuzza S, 1985, FAMILY INFORMANT SCH; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pato M T, 2001, Curr Psychiatry Rep, V3, P163, DOI 10.1007/s11920-001-0015-0; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Samuels J, 1997, INT REV PSYCHIATR, V9, P61; Veenstra-VanderWeele J, 2001, MOL PSYCHIATR, V6, P160, DOI 10.1038/sj.mp.4000806; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073	24	113	120	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					508	513		10.1086/423899	http://dx.doi.org/10.1086/423899			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15272418	Green Published, Bronze			2022-12-18	WOS:000223272200016
J	van der Walt, JM; Noureddine, MA; Kittappa, R; Hauser, MA; Scott, WK; McKay, R; Zhang, FY; Stajich, JM; Fujiwara, K; Scott, BL; Pericak-Vance, MA; Vance, JM; Martin, ER				van der Walt, JM; Noureddine, MA; Kittappa, R; Hauser, MA; Scott, WK; McKay, R; Zhang, FY; Stajich, JM; Fujiwara, K; Scott, BL; Pericak-Vance, MA; Vance, JM; Martin, ER			Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; PEDIGREE DISEQUILIBRIUM TEST; FIBROBLAST-GROWTH-FACTOR; NEUROTROPHIC FACTOR; GENERAL PEDIGREES; LINKAGE; ASSOCIATION; FGF-20	The pathogenic process responsible for the loss of dopaminergic neurons within the substantia nigra of patients with Parkinson disease (PD) is poorly understood. Current research supports the involvement of fibroblast growth factor (FGF20) in the survival of dopaminergic cells. FGF20 is a neurotrophic factor that is preferentially expressed within the substantia nigra of rat brain. The human homologue has been mapped to 8p21.3-8p22, which is within an area of PD linkage revealed through our published genomic screen. To test whether FGF20 influences risk of PD, we genotyped five single-nucleotide polymorphisms (SNPs) lying within the FGF20 gene, in a large family study. We analyzed our sample (644 families) through use of the pedigree disequilibrium test (PDT), the genotype PDT, the multilocus-genotype PDT, and the family-based association test to assess association between risk of PD and alleles, genotypes, multilocus genotypes, and haplotypes. We discovered a highly significant association of PD with one intronic SNP, rs1989754 (P=.0006), and two SNPs, rs1721100 (P=.02) and ss20399075 (P=.0008), located in the 3' regulatory region in our overall sample. Furthermore, we detected a haplotype (A-G-C-C-T) that is positively associated with risk of PD (P=.0003), whereas a second haplotype (A-G-G-G-C) was found to be negatively associated with risk of PD (P=.0009). Our results strongly support FGF20 as a risk factor for PD.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; NINDS, NIH, Bethesda, MD 20892 USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Martin, ER (corresponding author), Duke Univ, Med Ctr, Dept Med, 595 LaSalle St,Box 3468, Durham, NC 27710 USA.	eden.martin@duke.edu	Zhang, Fengyu/M-1396-2019; Scott, William/A-7593-2009	Zhang, Fengyu/0000-0001-8504-0770; Scott, William/0000-0001-9336-6404; Vance, Jeffery/0000-0003-3815-8199; Fujiwara, Kenichiro/0000-0002-9677-0637	NIA NIH HHS [R01 AG020135] Funding Source: Medline; NINDS NIH HHS [P01 NS26630, 2 P50 NS39764-03, P01 NS026630, P50 NS039764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, ZIANS002981, Z01NS002981, Z01NS002881, P50NS039764, ZIANS002881] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Fahn S., 1987, RECENT DEV PARKINSON, P153; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jeffers M, 2001, CANCER RES, V61, P3131; Kirikoshi H, 2000, BIOCHEM BIOPH RES CO, V274, P337, DOI 10.1006/bbrc.2000.3142; Lenhard T, 2002, MOL CELL NEUROSCI, V20, P181, DOI 10.1006/mcne.2002.1134; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Nicholas KB., 1997, EMBNET NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Ohmachi S, 2003, J NEUROSCI RES, V72, P436, DOI 10.1002/jnr.10592; Pankratz N, 2003, HUM MOL GENET, V12, P2599, DOI 10.1093/hmg/ddg270; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239	23	113	120	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1121	1127		10.1086/421052	http://dx.doi.org/10.1086/421052			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15122513	Bronze, Green Published			2022-12-18	WOS:000221651900005
J	Kornak, U; Mundlos, S				Kornak, U; Mundlos, S			Genetic disorders of the skeleton: A developmental approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							AUTOSOMAL-DOMINANT OSTEOPETROSIS; MULTIPLE EPIPHYSEAL DYSPLASIA; RECEPTOR TYROSINE KINASE; DOMAIN-SPECIFIC MUTATIONS; ALBERS-SCHONBERG-DISEASE; GROWTH-FACTOR RECEPTOR-3; TRANSPORTER DTDST GENE; BRACHYDACTYLY TYPE-B; HIGH-BONE-MASS; SULFATE TRANSPORTER	Although disorders of the skeleton are individually rare, they are of clinical relevance because of their overall frequency. Many attempts have been made in the past to identify disease groups in order to facilitate diagnosis and to draw conclusions about possible underlying pathomechanisms. Traditionally, skeletal disorders have been subdivided into dysostoses, defined as malformations of individual bones or groups of bones, and osteochondrodysplasias, defined as developmental disorders of chondro- osseous tissue. In light of the recent advances in molecular genetics, however, many phenotypically similar skeletal diseases comprising the classical categories turned out not to be based on defects in common genes or physiological pathways. In this article, we present a classification based on a combination of molecular pathology and embryology, taking into account the importance of development for the understanding of bone diseases.	Charite, Inst Med Genet, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mundlos, S (corresponding author), Charite, Inst Med Genet, Campus Virchow,Augustenburger Pl 1, D-13353 Berlin, Germany.	mundlos@molgen.mpg.de	Mundlos, Stefan/ABH-9585-2020	Mundlos, Stefan/0000-0002-9788-3166				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BARON R, 1990, J CELL SCI, V97, P439; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; Benichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bilezikian JP, 1998, NEW ENGL J MED, V339, P599, DOI 10.1056/NEJM199808273390905; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Brunner HG, 2002, AM J MED GENET, V112, P284, DOI 10.1002/ajmg.10778; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; BYERS H, 2002, CONNECTIVE TISSUE IT, P385; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; COLE WG, 2002, CLIN ORTHOP RELAT R, V401, P6; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Davis AP, 1996, DEVELOPMENT, V122, P1175; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Dreyer SD, 2000, HUM MOL GENET, V9, P1067, DOI 10.1093/hmg/9.7.1067; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Faiyaz-Ul-Haque M, 2002, CLIN GENET, V61, P454, DOI 10.1034/j.1399-0004.2002.610610.x; FELIX R, 1990, J BONE MINER RES, V5, P781; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; GERRITSEN EJA, 1994, PEDIATRICS, V93, P247; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1999, AM J HUM GENET, V64, P570, DOI 10.1086/302249; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hermanns P, 2001, AM J MED GENET, V106, P258, DOI 10.1002/ajmg.10231; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Horikoshi T, 2003, J BONE MINER METAB, V21, P1, DOI 10.1007/s007740300000; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Janssens K, 2002, HUM MOL GENET, V11, P2385, DOI 10.1093/hmg/11.20.2385; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Karaplis A C, 2000, Rev Endocr Metab Disord, V1, P331, DOI 10.1023/A:1026526703898; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Ludecke HJ, 2001, AM J HUM GENET, V68, P81, DOI 10.1086/316926; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Massague J, 2000, GENE DEV, V14, P627; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Morava E, 2002, EUR J PEDIATR, V161, P619, DOI 10.1007/s00431-002-0977-x; Morello R, 2001, NAT GENET, V27, P205, DOI 10.1038/84853; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mundlos S, 1996, AM J MED GENET, V63, P129; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Mundlos S, 1997, FASEB J, V11, P125, DOI 10.1096/fasebj.11.2.9039954; MUNDLOS S, 2002, CONNECTIVE TISSUE IT, V2, P993; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/88236; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pederson L, 1999, P NATL ACAD SCI USA, V96, P505, DOI 10.1073/pnas.96.2.505; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Quack I, 1999, AM J HUM GENET, V65, P1268, DOI 10.1086/302622; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Reddy S V, 2001, Rev Endocr Metab Disord, V2, P195; Rickard DJ, 1999, J CELL BIOCHEM, P123; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Robinson JA, 1996, ENDOCRINOLOGY, V137, P615, DOI 10.1210/en.137.2.615; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; SPRANGER J, 1994, PEDIATR RADIOL, V24, P431, DOI 10.1007/BF02011911; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Stuppia L, 1999, J MED GENET, V36, P711; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Thompson AA, 2000, NAT GENET, V26, P397, DOI 10.1038/82511; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tumpel S, 2002, DEV BIOL, V250, P251, DOI 10.1006/dbio.2002.0762; Unger S, 2002, EUR J PEDIATR, V161, P623, DOI 10.1007/s00431-002-0978-9; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; Vaananen HK, 2000, J CELL SCI, V113, P377; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Van Hul E, 2002, J BONE MINER RES, V17, P1111, DOI 10.1359/jbmr.2002.17.6.1111; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; WINTERPACHT A, 1993, NAT GENET, V3, P323, DOI 10.1038/ng0493-323; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	187	113	121	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					447	474		10.1086/377110	http://dx.doi.org/10.1086/377110			28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900795	Bronze, Green Published			2022-12-18	WOS:000185134000001
J	Pan, TC; Zhang, RZ; Sudano, DG; Marie, SK; Bonnemann, CG; Chu, ML				Pan, TC; Zhang, RZ; Sudano, DG; Marie, SK; Bonnemann, CG; Chu, ML			New molecular mechanism for Ullrich congenital muscular dystrophy: A heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN TYPE-VI; BETHLEM-MYOPATHY; ALPHA-3 CHAIN; MUTATIONS; DISEASE; DOMAIN; FAMILY; MINISATELLITE; CONTRACTURES; EXPRESSION	Recessive mutations in two of the three collagen VI genes, COL6A2 and COL6A3, have recently been shown to cause Ullrich congenital muscular dystrophy (UCMD), a frequently severe disorder characterized by congenital muscle weakness with joint contractures and coexisting distal joint hyperlaxity. Dominant mutations in all three collagen VI genes had previously been associated with the considerably milder Bethlem myopathy. Here we report that a de novo heterozygous deletion of the COL6A1 gene can also result in a severe phenotype of classical UCMD precluding ambulation. The internal gene deletion occurs near a minisatellite DNA sequence in intron 8 that removes 1.1 kb of genomic DNA encompassing exons 9 and 10. The resulting mutant chain contains a 33 - amino acid deletion near the amino-terminus of the triple-helical domain but preserves a unique cysteine in the triple-helical domain important for dimer formation prior to secretion. Thus, dimer formation and secretion of abnormal tetramers can occur and exert a strong dominant negative effect on microfibrillar assembly, leading to a loss of normal localization of collagen VI in the basement membrane surrounding muscle fibers. Consistent with this mechanism was our analysis of a patient with a much milder phenotype, in whom we identified a previously described Bethlem myopathy heterozygous in-frame deletion of 18 amino acids somewhat downstream in the triple-helical domain, a result of exon 14 skipping in the COL6A1 gene. This deletion removes the crucial cysteine, so that dimer formation cannot occur and the abnormal molecule is not secreted, preventing the strong dominant negative effect. Our studies provide a biochemical insight into genotype-phenotype correlations in this group of disorders and establish that UCMD can be caused by dominantly acting mutations.	Thomas Jefferson Univ, Jefferson Inst Mol Med, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Sao Paulo, Dept Med, BR-05508 Sao Paulo, Brazil	Jefferson University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Universidade de Sao Paulo	Chu, ML (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.		Marie, Suely Kazue Nagahashi/D-1870-2012	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038912] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38912, R01 AR038912] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BACHINGER HP, 1981, J BIOL CHEM, V256, P3193; Bertini Enrico, 2002, Eur J Paediatr Neurol, V6, P193, DOI 10.1053/ejpn.2002.0593; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P193; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; DEPAILLETTE L, 1989, J NEUROL, V236, P108; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; HEISKANEN M, 1995, GENOMICS, V29, P801, DOI 10.1006/geno.1995.9008; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Muntoni F, 2002, Neuromuscul Disord, V12, P889, DOI 10.1016/S0960-8966(02)00068-8; Muntoni F, 2002, LANCET, V360, P1419, DOI 10.1016/S0140-6736(02)11397-3; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Pepe G, 1999, BIOCHEM BIOPH RES CO, V258, P802, DOI 10.1006/bbrc.1999.0680; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R., 1987, STRUCTURE FUNCTION C, P105, DOI [10.1016/B978--0--12--481280-2.50008---8, DOI 10.1016/B978--0--12--481280-2.50008---8]; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Tubridy N, 2001, CURR OPIN NEUROL, V14, P575, DOI 10.1097/00019052-200110000-00005; TURRI MG, 1995, NUCLEIC ACIDS RES, V23, P1854, DOI 10.1093/nar/23.11.1854; Ullrich O, 1930, MONATSSCHR KINDERH, V47, P502; Vanegas OC, 2002, MUSCLE NERVE, V25, P513, DOI 10.1002/mus.10100; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Voit T, 1998, BRAIN DEV-JPN, V20, P65, DOI 10.1016/S0387-7604(97)00094-6; WEIL D, 1988, AM J HUM GENET, V42, P435; Weis MA, 1998, J BIOL CHEM, V273, P4761, DOI 10.1074/jbc.273.8.4761; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	43	113	117	1	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					355	369		10.1086/377107	http://dx.doi.org/10.1086/377107			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12840783	Bronze, Green Published			2022-12-18	WOS:000184223900011
J	Hande, MP; Azizova, TV; Geard, CR; Burak, LE; Mitchell, CR; Khokhryakov, VF; Vasilenko, EK; Brenner, DJ				Hande, MP; Azizova, TV; Geard, CR; Burak, LE; Mitchell, CR; Khokhryakov, VF; Vasilenko, EK; Brenner, DJ			Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAYAK-PRODUCTION-ASSOCIATION; NUCLEAR WORKERS; HUMAN-LYMPHOCYTES; HUMAN-CHROMOSOMES; PLUTONIUM; FISH; ABERRATIONS; MODEL; INTRACHANGES; DOSIMETRY	Speculation has long surrounded the question of whether past exposure to ionizing radiation leaves a unique permanent signature in the genome. Intrachromosomal rearrangements or deletions are produced much more efficiently by densely ionizing radiation than by chemical mutagens, x-rays, or endogenous aging processes. Until recently, such stable intrachromosomal aberrations have been very hard to detect, but a new chromosome band painting technique has made their detection practical. We report the detection and quantification of stable intrachromosomal aberrations in lymphocytes of healthy former nuclear-weapons workers who were exposed to plutonium many years ago. Even many years after occupational exposure, more than half the blood cells of the healthy plutonium workers contain large (>6 Mb) intrachromosomal rearrangements. The yield of these aberrations was highly correlated with plutonium dose to the bone marrow. The control groups contained very few such intrachromosomal aberrations. Quantification of this large-scale chromosomal damage in human populations exposed many years earlier will lead to new insights into the mechanisms and risks of cytogenetic damage.	Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; So Urals Biophys Inst, Ozyorsk, Russia; Mayak Prod Assoc, Ozyorsk, Russia	Columbia University; Southern Urals Biophysics Institute	Brenner, DJ (corresponding author), Columbia Univ, Ctr Radiol Res, 630 W 168th St, New York, NY 10032 USA.		Azizova, Tamara V./R-5295-2019; Hande, M. Prakash/B-1645-2008; Vasilenko, Evgenii K./ABI-2737-2020	Azizova, Tamara V./0000-0001-6954-2674; Hande, M. Prakash/0000-0002-4511-6256; Vasilenko, Evgenii K./0000-0003-4965-6839; Mitchell, Catherine/0000-0002-3983-7719	NCI NIH HHS [P01 CA049062, CA-49062] Funding Source: Medline; NCRR NIH HHS [RR-11623] Funding Source: Medline; NIEHS NIH HHS [ES-07361] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007361] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alavanja MCR, 2002, ONCOGENE, V21, P7365, DOI 10.1038/sj.onc.1205798; [Anonymous], 2000, SOURCES EFFECTS IONI; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; Bauchinger M, 1998, INT J RADIAT BIOL, V74, P17, DOI 10.1080/095530098141681; Blettner M, 1998, RADIAT ENVIRON BIOPH, V37, P75, DOI 10.1007/s004110050097; Boei JJWA, 2002, MUTAT RES-FUND MOL M, V504, P47, DOI 10.1016/S0027-5107(02)00078-7; BRENNER DJ, 1994, RADIAT RES, V140, P134, DOI 10.2307/3578579; Burak LE, 2001, INT J RADIAT BIOL, V77, P901, DOI 10.1080/09553000110063386; Chudoba I, 1999, CYTOGENET CELL GENET, V84, P156, DOI 10.1159/000015245; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Durante M, 2002, RADIAT ENVIRON BIOPH, V41, P125, DOI 10.1007/s00411-002-0156-5; Gilbert ES, 2000, RADIAT RES, V154, P246, DOI 10.1667/0033-7587(2000)154[0246:LCIMW]2.0.CO;2; Greulich KM, 2000, MUTAT RES-FUND MOL M, V452, P73, DOI 10.1016/S0027-5107(00)00057-9; *INT AT EN AG, 2001, 405 INT AT EN AG; Karhu R, 2001, GENE CHROMOSOME CANC, V30, P105, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1068>3.0.CO;2-9; Khokhryakov V, 2000, HEALTH PHYS, V79, P72, DOI 10.1097/00004032-200007000-00012; Khokhryakov VF, 1998, J RADIOANAL NUCL CH, V234, P209, DOI 10.1007/BF02389773; Khokhryakov VF, 1998, J RADIOANAL NUCL CH, V234, P293, DOI 10.1007/BF02389788; KHOKHRYAKOV VF, 1994, RADIAT PROT DOSIM, V53, P235; Khokhryakov VF, 2002, HEALTH PHYS, V82, P425, DOI 10.1097/00004032-200204000-00001; Koshurnikova NA, 2000, RADIAT RES, V154, P237, DOI 10.1667/0033-7587(2000)154[0237:BCIMW]2.0.CO;2; Krahenbuhl MP, 2002, HEALTH PHYS, V82, P445, DOI 10.1097/00004032-200204000-00003; Kreisheimer M, 2000, RADIAT RES, V154, P3, DOI 10.1667/0033-7587(2000)154[0003:LCMAMN]2.0.CO;2; LUBIN JH, 1995, RADIAT RES, V144, P329, DOI 10.2307/3578953; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; RAMALHO AT, 1995, MUTAT RES-FUND MOL M, V331, P47, DOI 10.1016/0027-5107(95)00049-O; Romanov SA, 2002, RADIAT ENVIRON BIOPH, V41, P23, DOI 10.1007/s00411-001-0134-3; Romanyukha AA, 2000, HEALTH PHYS, V78, P15, DOI 10.1097/00004032-200001000-00004; Sachs RK, 1997, RADIAT RES, V148, P330, DOI 10.2307/3579518; SANKARANARAYANAN K, 1973, Current Topics in Radiation Research Quarterly, V9, P72; Savage JRK, 1998, MUTAT RES-FUND MOL M, V404, P139, DOI 10.1016/S0027-5107(98)00107-9; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STRAUME T, 1993, INT J RADIAT BIOL, V64, P185, DOI 10.1080/09553009314551281; Suslova KG, 2002, HEALTH PHYS, V82, P432, DOI 10.1097/00004032-200204000-00002; Tucker JD, 2001, RADIAT PROT DOSIM, V97, P55, DOI 10.1093/oxfordjournals.rpd.a006638; TUCKER JD, 1994, MUTAT RES-ENVIR MUTA, V313, P193, DOI 10.1016/0165-1161(94)90049-3; VASILENKO EK, 2000, RAD SAF PROBL, V3, P42; Wolber G, 1996, Bull Cancer Radiother, V83 Suppl, p19s	38	113	123	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1162	1170		10.1086/375041	http://dx.doi.org/10.1086/375041			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12679897	Green Published, Bronze			2022-12-18	WOS:000182474400009
J	Douglas, JA; Skol, AD; Boehnke, M				Douglas, JA; Skol, AD; Boehnke, M			Probability of detection of genotyping errors and mutations as inheritance inconsistencies in nuclear-family data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; PAIR LINKAGE; INCOMPATIBILITIES; IDENTIFICATION; INFERENCE	Gene-mapping studies routinely rely on checking for Mendelian transmission of marker alleles in a pedigree, as a means of screening for genotyping errors and mutations, with the implicit assumption that, if a pedigree is consistent with Mendel's laws of inheritance, then there are no genotyping errors. However, the occurrence of inheritance inconsistencies alone is an inadequate measure of the number of genotyping errors, since the rate of occurrence depends on the number and relationships of genotyped pedigree members, the type of errors, and the distribution of marker-allele frequencies. In this article, we calculate the expected probability of detection of a genotyping error or mutation as an inheritance inconsistency in nuclear-family data, as a function of both the number of genotyped parents and offspring and the marker-allele frequency distribution. Through computer simulation, we explore the sensitivity of our analytic calculations to the underlying error model. Under a random-allele-error model, we find that detection rates are 51%-77% for multiallelic markers and 13%-75% for biallelic markers; detection rates are generally lower when the error occurs in a parent than in an offspring, unless a large number of offspring are genotyped. Errors are especially difficult to detect for biallelic markers with equally frequent alleles, even when both parents are genotyped; in this case, the maximum detection rate is 34% for four-person nuclear families. Error detection in families in which parents are not genotyped is limited, even with multiallelic markers. Given these results, we recommend that additional error checking (e. g., on the basis of multipoint analysis) be performed, beyond routine checking for Mendelian consistency. Furthermore, our results permit assessment of the plausibility of an observed number of inheritance inconsistencies for a family, allowing the detection of likely pedigree-rather than genotyping-errors in the early stages of a genome scan. Such early assessments are valuable in either the targeting of families for resampling or discontinued genotyping.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Douglas, JA (corresponding author), Univ Michigan, Dept Human Genet, Buhl Bldg,Room 5912, Ann Arbor, MI 48109 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, T32HG000040] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000040, R01 HG00376, T32 HG00040, R01 HG000376] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Ehm Margaret Gelder, 1995, Journal of Biological Systems, V3, P13, DOI 10.1142/S0218339095000034; Ehm MG, 1996, AM J HUM GENET, V58, P225; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gordon D, 2000, Pac Symp Biocomput, P663; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stringham HM, 1996, AM J HUM GENET, V59, P946; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	15	113	119	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					487	495		10.1086/338919	http://dx.doi.org/10.1086/338919			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791214	Green Published, Bronze			2022-12-18	WOS:000173254300019
J	Capelli, C; Wilson, JF; Richards, M; Stumpf, MPH; Gratrix, F; Oppenheimer, S; Underhill, P; Pascali, VL; Ko, TM; Goldstein, DB				Capelli, C; Wilson, JF; Richards, M; Stumpf, MPH; Gratrix, F; Oppenheimer, S; Underhill, P; Pascali, VL; Ko, TM; Goldstein, DB			A predominantly indigenous paternal heritage for the Austronesian-speaking peoples of insular Southeast Asia and Oceania	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; GENETIC-RELATIONSHIPS; MICROSATELLITE LOCI; POLYNESIAN ORIGINS; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; MTDNA; POLYMORPHISMS; AFFINITIES; PACIFIC	Modern humans reached Southeast Asia and Oceania in one of the first dispersals out of Africa. The resulting temporal overlap of modern and archaic humans-and the apparent morphological continuity between them-has led to claims of gene flow between Homo sapiens and H. erectus. Much more recently, an agricultural technology from mainland Asia spread into the region, possibly in association with Austronesian languages. Using detailed genealogical study of Y chromosome variation, we show that the majority of current Austronesian speakers trace their paternal heritage to Pleistocene settlers in the region, as opposed to more-recent agricultural immigrants. A fraction of the paternal heritage, however, appears to be associated with more-recent immigrants from northern populations. We also show that the northern Neolithic component is very unevenly dispersed through the region, with a higher contribution in Southeast Asia and a nearly complete absence in Melanesia. Contrary to claims of gene flow (under regional continuity) between H. erectus and H. sapiens, we found no ancestral Y chromosome lineages in a set of 1,209 samples. The finding excludes the possibility that early hominids contributed significantly to the paternal heritage of the region.	UCL, Galton Lab, Dept Biol, London NW1 2HE, England; Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Green Coll, Oxford, England; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan	University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; University of Oxford; Stanford University; National Taiwan University	Goldstein, DB (corresponding author), UCL, Galton Lab, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020; pascali, vincenzo lorenzo/AAC-8436-2022; Wilson, James F/A-5704-2009	Wilson, James F/0000-0001-5751-9178; Capelli, Cristian/0000-0001-9348-9084; RICHARDS, MARTIN/0000-0003-3118-0967				Bellwood P., 1997, PREHISTORY INDO MALA, VRevised; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P60; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; DYEN I, 1962, LANGUAGE, V38, P38, DOI 10.2307/411187; DYEN I, 1965, INT J AM LING MEMOIR, V19; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GOLDSTEIN DB, IN PRESS GENETICS; Goodenough Ward H., 1996, PREHISTORIC SETTLEME, P11; Hagelberg E, 1999, PHILOS T R SOC B, V354, P141, DOI 10.1098/rstb.1999.0367; HILL AVS, 1987, AM J HUM GENET, V40, P453; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MELTON T, 1995, AM J HUM GENET, V57, P403; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; Merriwether DA, 1999, AM J PHYS ANTHROPOL, V110, P243, DOI 10.1002/(SICI)1096-8644(199911)110:3<243::AID-AJPA1>3.0.CO;2-M; Oppenheimer S., 1998, EDEN E DROWNED CONTI; PAVLIDES C, 1994, ANTIQUITY, V68, P604, DOI 10.1017/S0003598X00047104; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; ROSS MD, 1994, COMP AUSTRONESIAN DI, P69; RUHLEN M, 1991, GUIDE WORLDS LANGUAG, V1, P172; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; SLATKIN M, 1995, GENETICS, V139, P457; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; SYKES B, 1995, AM J HUM GENET, V57, P1463; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31; Zerjal T, 1997, AM J HUM GENET, V60, P1174	44	113	113	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					432	443		10.1086/318205	http://dx.doi.org/10.1086/318205			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	394LD	11170891	Green Published, Bronze			2022-12-18	WOS:000166524800013
J	Hurles, ME; Veitia, R; Arroyo, E; Armenteros, M; Bertranpetit, J; Perez-Lezaun, A; Bosch, E; Shlumukova, M; Cambon-Thomsen, A; McElreavey, K; de Munain, AL; Rohl, A; Wilson, IJ; Singh, LJ; Pandya, A; Santos, FR; Tyler-Smith, C; Jobling, MA				Hurles, ME; Veitia, R; Arroyo, E; Armenteros, M; Bertranpetit, J; Perez-Lezaun, A; Bosch, E; Shlumukova, M; Cambon-Thomsen, A; McElreavey, K; de Munain, AL; Rohl, A; Wilson, IJ; Singh, LJ; Pandya, A; Santos, FR; Tyler-Smith, C; Jobling, MA			Recent male-mediated gene flow over a linguistic barrier in Iberia, suggested by analysis of a Y-chromosomal DNA polymorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; POPULATION; HAPLOTYPES; ORIGIN; FREQUENCIES; BASQUES; HISTORY; EUROPEANS; LANGUAGES; PENINSULA	We have examined the worldwide distribution of a Y-chromosomal base-substitution polymorphism, the T/C transition at SRY-2627, where the T allele defines haplogroup 22; sequencing of primate homologues shows that the ancestral state cannot be determined unambiguously but is probably the C allele. Of 1,191 human Y chromosomes analyzed, 33 belong to haplogroup 22. Twenty-nine come from Iberia, and the highest frequencies are in Basques (11%; n = 117) and Catalans (22%; n = 32). Microsatellite and minisatellite (MSY1) diversity analysis shows that non-Iberian haplogroup-22 chromosomes are not significantly different from Iberian ones. The simplest interpretation of these data is that haplogroup 22 arose in Iberia and that non-Iberian cases reflect Iberian emigrants. Several different methods were used to date the origin of the polymorphism: microsatellite data gave ages of 1,650, 2,700, 3,100, or 3,450 years, and MSY1 gave ages of 1,000, 2,300, or 2,650 years, although 95% confidence intervals on all of these figures are wide. The age of the split between Basque and Catalan haplogroup-22 chromosomes was calculated as only 20% of the age of the lineage as a whole. This study thus provides evidence for direct or indirect gene flow over the substantial linguistic barrier between the Indo-European and non-Indo-European-speaking populations of the Catalans and the Basques, during the past few thousand years.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Inst Pasteur, Unite Immunogenet Humaine, Paris, France; Univ Complutense Madrid, Fac Med, Madrid, Spain; Guardia Civil, Policia Judicial, Lab ADN, Ctr Invest & Criminalist, Madrid, Spain; Univ Barcelona, Dept Biol Anim, Unitat Anthropol, Barcelona, Spain; Fac Med Toulouse, INSERM, U518, F-31073 Toulouse, France; Arantzazuko Amaren Ospitalea, Neurol Serv, San Sebastian, Spain; Univ Hamburg, Math Seminar, D-2000 Hamburg, Germany; Univ London Queen Mary & Westfield Coll, Sch Biol Sci, London E1 4NS, England; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; Univ Oxford, Dept Biochem, CRC, Chromosome Mol Biol Grp, Oxford OX1 3QU, England	University of Leicester; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Complutense University of Madrid; University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Hamburg; University of London; Queen Mary University London; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Oxford	Jobling, MA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Pardo, Eduardo Arroyo/L-2240-2014; Bosch, Elena/D-8681-2014; Bosch, Elena/N-7603-2019; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Santos, Fabrício Rodrigues/H-2370-2011; Bertranpetit, Jaume/F-8550-2012	Pardo, Eduardo Arroyo/0000-0003-1851-0589; Bosch, Elena/0000-0003-2848-103X; Bosch, Elena/0000-0003-2848-103X; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Bertranpetit, Jaume/0000-0003-0100-0590; /0000-0002-9509-4032; Wilson, Ian/0000-0001-6893-2873; Jobling, Mark/0000-0002-8061-1308	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGORRETA MJP, 1986, VASCONES POBLAMIENTO, P63; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; BARBUJANI G, 1991, TRENDS ECOL EVOL, V6, P151, DOI 10.1016/0169-5347(91)90056-4; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BERTRANPETIT J, 1996, VARIATION HUMAN GENO, P97; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; CALAFELL F, 1994, HUM BIOL, V66, P823; Collins R., 1986, BASQUES; Comas D, 1997, HUM GENET, V99, P443, DOI 10.1007/s004390050386; Comas D, 1998, TISSUE ANTIGENS, V51, P30, DOI 10.1111/j.1399-0039.1998.tb02944.x; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hassall W. O., 1967, HIST SURNAMES; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Jobling MA, 1998, HUM MOL GENET, V7, P643, DOI 10.1093/hmg/7.4.643; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; LAFON R, 1972, BEDI KARTLISA, V27, P7; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Lucotte G, 1996, J MOL EVOL, V42, P472; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MINCH E, 1997, MICROSAT 1 5D; Mitchell RJ, 1996, CURR OPIN GENET DEV, V6, P737, DOI 10.1016/S0959-437X(96)80029-3; MOURANT AE, 1947, NATURE, V160, P505, DOI 10.1038/160505b0; MOURANT AE, 1983, BLOOD RELATIONS; NGO KY, 1986, AM J HUM GENET, V38, P407; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; Santos FR, 1996, BRAZ J GENET, V19, P665, DOI 10.1590/S0100-84551996000400025; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SLATKIN M, 1995, GENETICS, V139, P457; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Urtasun M, 1998, BRAIN, V121, P1735, DOI 10.1093/brain/121.9.1735; Veitia R, 1997, HUM GENET, V99, P648, DOI 10.1007/s004390050422; Wilson IJ, 1998, GENETICS, V150, P499; Zerjal T, 1997, AM J HUM GENET, V60, P1174; [No title captured], P271	50	113	114	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1437	1448		10.1086/302617	http://dx.doi.org/10.1086/302617			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ	10521311	Green Published, Bronze			2022-12-18	WOS:000083531000027
J	Mallery, DL; Tanganelli, B; Colella, S; Steingrimsdottir, H; van Gool, AJ; Troelstra, C; Stefanini, M; Lehmann, AR				Mallery, DL; Tanganelli, B; Colella, S; Steingrimsdottir, H; van Gool, AJ; Troelstra, C; Stefanini, M; Lehmann, AR			Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGING AGENTS; ATR-X SYNDROME; ACTIVE GENES; CELLULAR-SENSITIVITY; UV IRRADIATION; SYNDROME CELLS; RNA-SYNTHESIS; TRANSCRIPTION; MECHANISM	Cockayne syndrome is a multisystem sun-sensitive genetic disorder associated with a specific defect in the ability to perform transcription-coupled repair of active genes after UV irradiation. Two complementation groups (CS-A and CS-B) have been identified, and 80% of patients have been assigned to the CS-B complementation group. We have analyzed the sites of the mutations in the CSB gene in 16 patients, to determine the spectrum of mutations in this gene and to see whether the nature of the mutation correlates with the type and severity of the clinical symptoms. In nine of the patients, the mutations resulted in truncated products in both alleles, whereas, in the other seven, at least one allele contained a single amino acid change. The latter mutations were confined to the C-terminal two-thirds of the protein and were shown to be inactivating by their failure to restore UV-irradiation resistance to hamster UV61 cells, which are known to be defective in the CSB gene. Neither the site nor the nature of the mutation correlated with the severity of the clinical features. Severe truncations were found in different patients with either classical or early-onset forms of the disease.	Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	University of Sussex; Consiglio Nazionale delle Ricerche (CNR); Erasmus University Rotterdam	Lehmann, AR (corresponding author), Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England.	a.r.lehmann@sussex.ac.uk	Colella, Stefano/A-7040-2008; van Gool, Alain J./L-4328-2015; van Gool, Alain J/G-3806-2010	Colella, Stefano/0000-0003-3139-6055; van Gool, Alain/0000-0003-0010-5286; Mallery, Donna/0000-0003-2713-5215	Telethon [E.0550] Funding Source: Medline	Telethon(Fondazione Telethon)		ARLETT CF, 1978, J INVEST DERMATOL, V70, P173, DOI 10.1111/1523-1747.ep12541290; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BRUMBACK RA, 1978, ARCH NEUROL-CHICAGO, V35, P337, DOI 10.1001/archneur.1978.00500300011002; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; Friedberg EC, 1996, BIOESSAYS, V18, P731, DOI 10.1002/bies.950180908; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEHMANN AR, 1993, J MED GENET, V30, P679, DOI 10.1136/jmg.30.8.679; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1995, TRENDS BIOCHEM SCI, V20, P402, DOI 10.1016/S0968-0004(00)89088-X; LEHMANN AR, 1994, MUTAT RES, V315, P41, DOI 10.1016/0921-8777(94)90026-4; LOWRY RB, 1982, AM J MED GENET, V13, P209, DOI 10.1002/ajmg.1320130211; MAYNE LV, 1982, CANCER RES, V42, P1473; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Stefanini M, 1996, HUM GENET, V97, P418; STEINGRIMSDOTTIR H, 1993, MUTAT RES, V294, P29, DOI 10.1016/0921-8777(93)90055-L; SUGITA K, 1991, BRAIN DEV-JPN, V13, P163, DOI 10.1016/S0387-7604(12)80023-4; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TROELSTRA C, 1990, MOL CELL BIOL, V10, P5806, DOI 10.1128/MCB.10.11.5806; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; WADE MH, 1979, MUTAT RES, V59, P49, DOI 10.1016/0027-5107(79)90194-5	36	113	115	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					77	85		10.1086/301686	http://dx.doi.org/10.1086/301686			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443879	Bronze, Green Published			2022-12-18	WOS:000072127900013
J	Ishikawa, K; Tanaka, H; Saito, M; Ohkoshi, N; Fujita, T; Yoshizawa, K; Ikeuchi, T; Watanabe, M; Hayashi, A; Takiyama, Y; Nishizawa, M; Nakano, I; Matsubayashi, K; Miwa, M; Shoji, S; Kanazawa, I; Tsuji, S; Mizusawa, H				Ishikawa, K; Tanaka, H; Saito, M; Ohkoshi, N; Fujita, T; Yoshizawa, K; Ikeuchi, T; Watanabe, M; Hayashi, A; Takiyama, Y; Nishizawa, M; Nakano, I; Matsubayashi, K; Miwa, M; Shoji, S; Kanazawa, I; Tsuji, S; Mizusawa, H			Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACHADO-JOSEPH DISEASE; TRINUCLEOTIDE REPEAT LENGTH; BULBAR MUSCULAR-ATROPHY; CLINICAL-FEATURES; LARGE KINDREDS; LOCUS; INSTABILITY; ONSET; LOCALIZATION; DEGENERATION	Autosomal dominant cerebellar ataxia is a group of clinically and genetically heterogeneous disorders, We carried out genomewide linkage analysis in 15 families with autosomal dominant pure cerebellar ataxia (ADPCA). Evidence for linkage to chromosome 19p markers was found in nine families, and combined multipoint analysis refined the candidate region to a 13.3-cM interval in 19p13.1-p13.2. The remaining six families were excluded for this region. Analysis of GAG-repeat expansion in the alpha1A-voltage-dependent calcium channel (CACNL1A4) gene lying in 19p13.1, recently identified among 8 small American kindreds with ADPCA (spino-cerebellar ataxia type 6 [SCA6]), revealed that 8 of the 15 families studied had similar, very small expansion in this gene: all affected individuals had larger alleles (range of CAG repeats 21-25), compared with alleles observed in neurologically normal. Japanese (range 5-20 repeats). Inverse correlation between the GAG-repeat number and the age at onset was found in affected individuals with expansion. The number of CAG repeats in expanded chromosomes was completely stable within each family, which was consistent with the fact that anticipation was not statistically proved in the SCA6 families that we studied, We conclude that more than half of Japanese cases of ADPCA map to 19p13.1-p13.2 and are strongly associated with the mild CAG expansion in the SCAG/CACNL1A4 gene.	TOKYO MED & DENT UNIV,DEPT NEUROL,FAC MED,INST BRAIN RES,BUNKYO KU,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,DEPT NEUROL,TOKYO 113,JAPAN; KOCHI MED SCH,DEPT GERONTOL,KOCHI,JAPAN; JICHI MED SCH,DEPT NEUROL,YAKUSHIJI,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; UNIV TSUKUBA,INST BASIC MED SCI,DEPT BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kochi University; Jichi Medical University; Niigata University; University of Tsukuba; University of Tsukuba								BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; David G, 1996, AM J HUM GENET, V59, P1328; Diriong S, 1995, GENOMICS, V30, P605, DOI 10.1006/geno.1995.1284; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EADIE MJ, 1991, HDB CLIN NEUROLOGY, V16, P569; Flanigan K, 1996, AM J HUM GENET, V59, P392; FRONTALI M, 1992, BRAIN, V115, P1647, DOI 10.1093/brain/115.6.1647; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOFFMAN PM, 1971, NEUROLOGY, V21, P771, DOI 10.1212/WNL.21.8.771; *HUNT DIS COLL RES, 1993, CELL, V72, P971; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Ishikawa K, 1996, BRAIN, V119, P1173, DOI 10.1093/brain/119.4.1173; JODICE C, 1994, AM J HUM GENET, V54, P959; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACIEL P, 1995, AM J HUM GENET, V57, P54; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; YAKURA H, 1974, NEW ENGL J MED, V291, P154; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	41	113	118	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					336	346		10.1086/514867	http://dx.doi.org/10.1086/514867			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311738	Green Published, Bronze			2022-12-18	WOS:A1997XX70100011
J	Hodge, SE; Abreu, PC; Greenberg, DA				Hodge, SE; Abreu, PC; Greenberg, DA			Magnitude of type I error when single-locus linkage analysis is maximized over models: A simulation study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE ANALYSIS; RECOMBINATION FRACTION; REDUCED PENETRANCE; OLIGOGENIC TRAITS; INFERRING MODE; INHERITANCE; DISEASES; APPROXIMATIONS; HETEROGENEITY; ADEQUACY	It is well known that maximizing the maximum LOD score over multiple parameter values or models (i.e., the method of mod scores, or MMLS), will inflate type I error, compared with assuming only one parameter value/model in the linkage analysis. On the other hand, a mod score often has greater power to detect linkage than does a LOD score (Z) calculated under a wrong genetic model. Therefore, it is of interest to determine the actual magnitude of type I error in realistic genetic situations. Simulated data sets with no linkage were generated under three dominant and three recessive single-locus models, with reduced penetrance (f = .8, .5, and .2). Data sets were analyzed for linkage by (1) maximizing over penetrance only, (2) maximizing over ''dominance model'' (i.e., dominant versus recessive), and (3) maximizing over both penetrance and dominance model simultaneously. In (1), the resultant significance levels were approximately doubled, compared with baseline values if one had not maximized over penetrances (i.e., compared with a one-sided chi(1)(2)). In (2), significance levels were increased somewhat less, and, in (3), they were increased by approximately two to three times (but not more than four times) over those of the one-sided chi(1)(2). This means that, for a given size of test alpha, an investigator would need to increase the Z used as a test criterion, by similar to 0.30 LOD units for analyses as in (1) or (2) and by 0.60 Z units for analyses as in (3). These guidelines, which are valid up to approximate to Z = 3.0, are conservative for (1) and are very conservative for (2) and (3). By quantifying the increase in significance level (or, correspondingly, the increase in Z), our findings will enable users to rationally assess the advantages versus the disadvantages of mod scores.	COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY; COLUMBIA UNIV,SCH PUBL HLTH,DIV BIOSTAT,NEW YORK,NY 10032; MT SINAI SCH MED,DEPT PSYCHIAT,NEW YORK,NY	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Hodge, SE (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP,CLIN GENET EPIDEMIOL UNIT,UNIT 14,722 W 168TH ST,NEW YORK,NY 10032, USA.				NIMH NIH HHS [MH-48858, MH-28274, MH-36197] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036197, R37MH028274, R01MH028274, R01MH048858] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DAVIES RB, 1977, BIOMETRIKA, V64, P246; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; Greenberg DA, 1996, AM J HUM GENET, V58, P892; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HODGE SE, 1993, AM J HUM GENET, V53, P775; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; MACLEAN CJ, 1993, AM J HUM GENET, V52, P354; OTT J, 1974, AM J HUM GENET, V26, P588; RISCH N, 1991, AM J HUM GENET, V48, P1058; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502	23	113	113	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					217	227						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981965				2022-12-18	WOS:A1997WA81800028
J	Horwitz, M; Goode, EL; Jarvik, GP				Horwitz, M; Goode, EL; Jarvik, GP			Anticipation in familial leukemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; TRINUCLEOTIDE REPEAT; GENETIC INSTABILITY; MYOTONIC-DYSTROPHY; DISORDER; DISEASE; MONOSOMY-7; ACTIVATION; MUTATIONS; ANEMIA	Anticipation refers to worsening severity or earlier age at onset with each generation for an inherited disease and primarily has been described for neurodegenerative illnesses resulting from expansion of trinucleotide repeats. We have tested for evidence of anticipation in familial leukemia. Of 49 affected individuals in nine families transmitting autosomal dominant acute myelogenous leukemia (AML), the mean age at onset is 57 years in the grandparental generation, 32 years in the parental generation, and 13 years in the youngest generation (P < .001). Of 21 parent-child pairs with AML, 19 show younger ages at onset in the child and demonstrate a mean decline in age at onset of 28 years (P <.001). Of 18 affected individuals from seven pedigrees with autosomal dominant chronic lymphocytic leukemia (CLL), the mean age at onset in the parental generation is 66 years versus 51 years in the youngest generation (P = .008). Of nine parent-child pairs with CLL, eight show younger ages at onset in the child and reveal a mean decline in age at onset of 21 years (P = .001). Inspection of rare pedigrees transmitting acute lymphocytic leukemia, chronic myelogenous leukemia, multiple types of leukemia, and lymphoma is also compatible with anticipation. Sampling bias is unlikely to explain these findings. This suggests that dynamic mutation of unstable DNA sequence repeats could be a common mechanism of inherited hematopoietic malignancy with implications for the role of somatic mutation in the more frequent sporadic cases. We speculate on three possible candidate genes for familial leukemia with anticipation: a locus on 21q22.1-22.2, CBL2 on 11q23.3, and CBFB or a nearby gene on 16q22.	UNIV WASHINGTON, SCH PUBL HLTH & COMMUNITY MED, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	Horwitz, M (corresponding author), UNIV WASHINGTON, SCH MED,DEPT MED,DIV MED GENET,MARKEY MOL MED CTR, BOX 357720, SEATTLE, WA 98195 USA.		Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; Horwitz, Marshall/0000-0002-1683-1680	NICHD NIH HHS [HD0108-03] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BANFI S, 1994, BAILLIERE CLIN NEUR, V3, P281; BLEYL S, 1995, AM J HUM GENET, V56, P408; BRANDA RF, 1978, AM J MED, V64, P508, DOI 10.1016/0002-9343(78)90238-3; BRIDGES JM, 1961, ACTA HAEMATOL-BASEL, V26, P246, DOI 10.1159/000206658; CARREROVALENZUELA R, 1995, NEUROLOGY, V45, P1760, DOI 10.1212/WNL.45.9.1760; CHAMPLIN R, 1991, HARRISONS PRINCIPLES, P1552; CHITAMBAR CR, 1983, AM J MED, V75, P756, DOI 10.1016/0002-9343(83)90404-7; DOWTON SB, 1985, BLOOD, V65, P557; FELIX CA, 1992, J CLIN INVEST, V90, P653, DOI 10.1172/JCI115907; FERRO MT, 1994, CANCER GENET CYTOGEN, V78, P160, DOI 10.1016/0165-4608(94)90084-1; FRAUMENI JF, 1975, AM J MED, V59, P145, DOI 10.1016/0002-9343(75)90333-2; FURBETTA D, 1961, P 2 INT C HUM GEN RO, P1078; Gartenhaus R, 1996, BLOOD, V87, P38; German J., 1983, CHROMOSOME MUTATION, P97; GERRARD JM, 1991, BRIT J HAEMATOL, V79, P246, DOI 10.1111/j.1365-2141.1991.tb04529.x; GILBERT HS, 1995, POLYCYTHEMIA VERA MY, P222; GORDON RD, 1963, AUSTRALAS ANN MED, V12, P202, DOI 10.1111/imj.1963.12.3.202; GUNZ F, 1957, JAMA-J AM MED ASSOC, V164, P1323, DOI 10.1001/jama.1957.62980120001007; GUNZ FW, 1978, J NATL CANCER I, V60, P1243, DOI 10.1093/jnci/60.6.1243; HAJRA A, 1995, GENOMICS, V26, P571, DOI 10.1016/0888-7543(95)80177-N; HARPER PS, 1992, AM J HUM GENET, V51, P10; HEATH CW, 1965, NEW ENGL J MED, V272, P882, DOI 10.1056/NEJM196504292721703; Ho CY, 1996, BLOOD, V87, P5218, DOI 10.1182/blood.V87.12.5218.bloodjournal87125218; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; Horwitz M, 1996, AM J HEMATOL, V52, P295, DOI 10.1002/(SICI)1096-8652(199608)52:4<295::AID-AJH9>3.0.CO;2-N; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; INDRACCOLO S, 1995, LEUKEMIA, V9, P1517; JACOBSEN P, 1973, HUM HERED, V23, P568, DOI 10.1159/000152624; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; KJELLSTROM T, 1979, SCAND J HAEMATOL, V23, P272; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; LI FP, 1979, AM J HEMATOL, V6, P61, DOI 10.1002/ajh.2830060109; LI FP, 1981, CANCER GENET CYTOGEN, V4, P189, DOI 10.1016/0165-4608(81)90013-3; LIU PP, 1995, BLOOD, V85, P2289, DOI 10.1182/blood.V85.9.2289.bloodjournal8592289; LIZHEN H, 1994, CANCER GENET CYTOGEN, V76, P65; MARSDEN K, 1995, AM J HEMATOL, V49, P153, DOI 10.1002/ajh.2830490210; MCPHEDRAN P, 1969, CANCER-AM CANCER SOC, V24, P403, DOI 10.1002/1097-0142(196908)24:2<403::AID-CNCR2820240224>3.0.CO;2-L; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; NEULAND CY, 1983, JNCI-J NATL CANCER I, V71, P1143; Olopade OI, 1996, LEUKEMIA, V10, P669; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; PENROSE LS, 1948, ANN EUGENIC, V14, P125; RANEN NG, 1995, AM J HUM GENET, V57, P593; RAZIS DV, 1959, ANN INTERN MED, V51, P933, DOI 10.7326/0003-4819-51-5-933; RIGBY PG, 1968, ARCH INTERN MED, V121, P67, DOI 10.1001/archinte.121.1.67; ROBLEDO M, 1995, LEUKEMIA, V9, P960; Sasaki T, 1996, HUM GENET, V97, P244, DOI 10.1007/BF02265274; SEIPEL K, 1994, MOL REPROD DEV, V39, P215, DOI 10.1002/mrd.1080390215; SHEN QC, 1994, GENOMICS, V23, P292, DOI 10.1006/geno.1994.1499; SNYDER AL, 1970, LANCET, V1, P586; *SPSS, 1991, SPSS STAT ALG; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; VIDEBAEK A, 1947, OPERA EX DOMO BIOL H, V13; WISNIEWSKI D, 1966, BLUT, V12, P241, DOI 10.1007/BF01632449; YOUNG BD, 1992, BAILLIERE CLIN HAEM, V5, P881, DOI 10.1016/S0950-3536(11)80050-8	55	113	118	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					990	998						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900225				2022-12-18	WOS:A1996VN90000004
J	Kaukonen, JA; Amati, P; Suomalainen, A; Rotig, A; Piscaglia, MG; Salvi, F; Weissenbach, J; Fratta, G; Comi, G; Peltonen, L; Zeviani, M				Kaukonen, JA; Amati, P; Suomalainen, A; Rotig, A; Piscaglia, MG; Salvi, F; Weissenbach, J; Fratta, G; Comi, G; Peltonen, L; Zeviani, M			An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETION; EXTERNAL OPHTHALMOPLEGIA; LINKAGE ANALYSIS; TISSUES; HUMANS	Autosomal dominant progressive external ophthalmoplegia (adPEO) is a disorder characterized by ptosis, progressive weakness of the external eye muscles, and general muscle weakness. The patients have multiple deletions of mtDNA on Southern blots or in PCR analysis of muscle DNA and a mild deficiency of one or more respiratory-chain enzymes carrying mtDNA-encoded subunits. The pattern of inheritance indicates a nuclear gene defect predisposing to secondary mtDNA deletions. Recently, in one Finnish family, we assigned an adPEO locus to chromosome 10q 23.3-24.3 but also excluded linkage to this same locus in two Italian adPEO families with a phenotype closely resembling the Finnish one. We applied a random mapping approach to informative non-10q-linked Italian families to assign the second locus for adPEO and found strong evidence for linkage on chromosome 3p 14.1-21.2 in three Italian families, with a maximum two-point lod score of 4.62 at a recombination fraction of .0. However, in three additional families, linkage to the same chromosomal region was clearly absent, indicating further genetic complexity of the adPEO trait.	NATL NEUROL INST CARLO BESTA,DIV BIOCHEM & GENET,I-20133 MILAN,ITALY; NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,HELSINKI,FINLAND; UNIV MILAN,INST CLIN NEUROL,I-20122 MILAN,ITALY; HOP NECKER ENFANTS MALAD,INSERM U393,PARIS,FRANCE; PUBL HOSP,DIV NEUROL,RIMINI,ITALY; HOSP BELLARIA,DIV NEUROL,BOLOGNA,ITALY; GENETHON,EVRY,FRANCE; IRCCS,CSS,SAN GIOVANNI ROTO,FOGGIA,ITALY; PEDIAT HOSP BAMBINO GESU,MOLEC MED LAB,ROME,ITALY	IRCCS Istituto Neurologico Besta; Finland National Institute for Health & Welfare; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; IRCCS Casa Sollievo Della Sofferenza; IRCCS Bambino Gesu			Zeviani, Massimo/K-2891-2014; Rötig, Agnès/G-9592-2017; Zeviani, Massimo/AAU-2632-2021; Comi, Giacomo P/K-5702-2016	Rötig, Agnès/0000-0003-0589-0703; Zeviani, Massimo/0000-0002-9067-5508; Comi, Giacomo P/0000-0002-1383-5248; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Telethon [767] Funding Source: Medline	Telethon(Fondazione Telethon)		Battey, 1986, BASIC METHODS MOL BI; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MORAES CT, 1991, AM J HUM GENET, V48, P492; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	19	113	113	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					763	769						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644740				2022-12-18	WOS:A1996UA38000014
J	RANUM, LPW; LUNDGREN, JK; SCHUT, LJ; AHRENS, MJ; PERLMAN, S; AITA, J; BIRD, TD; GOMEZ, C; ORR, HT				RANUM, LPW; LUNDGREN, JK; SCHUT, LJ; AHRENS, MJ; PERLMAN, S; AITA, J; BIRD, TD; GOMEZ, C; ORR, HT			SPINOCEREBELLAR ATAXIA TYPE-I AND MACHADO-JOSEPH DISEASE - INCIDENCE OF CAG EXPANSIONS AMONG ADULT-ONSET ATAXIA PATIENTS FROM 311 FAMILIES WITH DOMINANT, RECESSIVE, OR SPORADIC ATAXIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR-ATAXIA; LINKAGE	The ataxias are a complex group of diseases with both environmental and genetic causes. Among the autosomal dominant forms of ataxia the genes for two, spinocerebellar ataxia type 1 (SCA1) and Machado-Joseph disease (MJD), have been isolated. In both of these disorders the molecular basis of disease is the expansion of an unstable CAG trinucleotide repeat. To assess the frequency of the SCA1 and MJD trinucleotide repeat expansions among individuals diagnosed with ataxia we have collected DNA from individuals representing 311 families with adult-onset ataxia of unknown etiology and screened these samples for trinucleotide repeat expansions within the SCA1 and MJD genes. Within this group there are 149 families with dominantly inherited ataxia. Of these, 3% had SCA1 trinucleotide repeat expansions, whereas 21% were positive for the MJD trinucleotide expansion. Thus, together SCA1 and MJD represent 24% of the autosomal dominant ataxias in our group, and the frequency of MJD is substantially greater than that of SCA1. For the 57 patients with MJD trinucleotide repeat expansions, a strong inverse correlation between CAG repeat size and age at onset was observed (r = -.838). Among the MJD patients, the normal and affected ranges of CAG repeat size are 14-40 and 68-82 repeats, respectively. For SCA1 the normal and affected ranges are much closer, containing 19-38 and 40-81 CAG repeats, respectively.	UNIV MINNESOTA,DEPT MED GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT BIOCHEM,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV CALIF LOS ANGELES,REED NEUROL INST,LOS ANGELES,CA; NEBRASKA METHODIST HOSP,OMAHA,NE; DEPT VET AFFAIRS MED CTR,SEATTLE,WA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles	RANUM, LPW (corresponding author), UNIV MINNESOTA,DEPT NEUROL,BOX 295 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455, USA.			Orr, Harry/0000-0001-6118-741X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS033718] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33718-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AITA JF, 1978, ARCH NEUROL-CHICAGO, V35, P55, DOI 10.1001/archneur.1978.00500250059016; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DOUBOURG O, 1995, ANN NEUROL, V37, P176; ETO K, 1990, ARCH NEUROL-CHICAGO, V47, P968, DOI 10.1001/archneur.1990.00530090038011; GARDNER K, 1994, NEUROLOGY, V44, pA361; GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GIUNTI P, 1994, BRAIN, V117, P645, DOI 10.1093/brain/117.4.645; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Jackson J F, 1978, Adv Neurol, V21, P315; JODICE C, 1994, AM J HUM GENET, V54, P959; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kramer P. L., 1994, American Journal of Human Genetics, V55, pA191; ORR HT, 1993, NAT GENET, V4, P211; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; RANUM LPW, 1992, NEUROLOGY, V43, P344; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; Zoghbi HY, 1991, CURR NEUROL, V11, P121	30	113	117	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					603	608						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668288				2022-12-18	WOS:A1995RR60500009
J	PRAMATAROVA, A; FIGLEWICZ, DA; KRIZUS, A; HAN, FY; CEBALLOSPICOT, I; NICOLE, A; DIB, M; MEININGER, V; BROWN, RH; ROULEAU, GA				PRAMATAROVA, A; FIGLEWICZ, DA; KRIZUS, A; HAN, FY; CEBALLOSPICOT, I; NICOLE, A; DIB, M; MEININGER, V; BROWN, RH; ROULEAU, GA			IDENTIFICATION OF NEW MUTATIONS IN THE CU/ZN SUPEROXIDE-DISMUTASE GENE OF PATIENTS WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-21; POLYMERASE; LOCUS; DNA	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting motor neurons. Although most cases of ALS are sporadic, similar to 10% are inherited as an autosomal dominant trait. Mutations in the Cu/Zn superoxide dismutase gene (SOD 1) are responsible for a fraction of familial ALS (FALS). Screening our FALS kindreds by SSCP, we have identified mutations in 15 families, of which 9 have not been previously reported. Two of the new mutations alter amino acids that have never been implicated in FALS. One of them affects a highly conserved amino acid involved in dimer contact, and the other one affects the active-site loop of the enzyme. These two mutations reduce significantly SOD 1 enzyme activity in lymphoblasts. Our results suggest that SOD 1 mutations are responsible for greater than or equal to 13% of FALS cases.	MONTREAL GEN HOSP, RES INST, DEPT NEUROL, MONTREAL, PQ H3G 1A4, CANADA; MCGILL UNIV, CTR RES NEUROSCI, MONTREAL, PQ H3A 2T5, CANADA; UNIV ROCHESTER, MED CTR, DEPT NEUROL, ROCHESTER, NY 14642 USA; HOP NECKER ENFANTS MALAD, DEPT BIOCHIM MED B, PARIS, FRANCE; HOP HOTEL DIEU, CTR DIAGNOST, CTR SLA, PARIS, FRANCE; MASSACHUSETTS GEN HOSP E, DAY NEUROMUSCULAR RES LAB, BOSTON, MA USA	McGill University; McGill University; University of Rochester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite								BANNISTER WH, 1991, FREE RADICAL RES COM, V12-3, P349, DOI 10.3109/10715769109145804; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; ELSHAFEY A, 1994, HUM MOL GENET, V3, P363, DOI 10.1093/hmg/3.2.363; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRAMATAROVA A, 1994, HUM MOL GENET, V3, P2061; RAINERO I, 1994, NEUROLOGY, V44, P347, DOI 10.1212/WNL.44.2.347; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302	16	113	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					592	596						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887412				2022-12-18	WOS:A1995QK91800006
J	ASHIZAWA, T; ANVRET, M; BAIGET, M; BARCELO, JM; BRUNNER, H; COBO, AM; DALLAPICCOLA, B; FENWICK, RG; GRANDELL, U; HARLEY, H; JUNIEN, C; KOCH, MC; KORNELUK, RG; LAVEDAN, C; MIKI, T; MULLEY, JC; DEMUNAIN, AL; NOVELLI, G; ROSES, AD; SELTZER, WK; SHAW, DJ; SMEETS, H; SUTHERLAND, GR; YAMAGATA, H; HARPER, PS				ASHIZAWA, T; ANVRET, M; BAIGET, M; BARCELO, JM; BRUNNER, H; COBO, AM; DALLAPICCOLA, B; FENWICK, RG; GRANDELL, U; HARLEY, H; JUNIEN, C; KOCH, MC; KORNELUK, RG; LAVEDAN, C; MIKI, T; MULLEY, JC; DEMUNAIN, AL; NOVELLI, G; ROSES, AD; SELTZER, WK; SHAW, DJ; SMEETS, H; SUTHERLAND, GR; YAMAGATA, H; HARPER, PS			CHARACTERISTICS OF INTERGENERATIONAL CONTRACTIONS OF THE CTG REPEAT IN MYOTONIC-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNSTABLE DNA; ANTICIPATION; REGION; EXPANSION; GENE	In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation. However, there have also been cases with an intergenerational contraction of the repeat. We examined 1,489 DM parent-offspring pairs, of which 95 (6.4%) showed such contractions in peripheral blood leukocytes (PBL). In 56 of the 95 pairs, clinical data allowed an analysis of their anticipation status. It is surprising that anticipation occurred in 27 (48%) of these 56 pairs, while none clearly showed a later onset of DM in the symptomatic offspring. The contraction occurred in 76 (10%) of 753 paternal transmissions and in 19 (3%) of 736 maternal transmissions. Anticipation was observed more frequently in maternal (85%) than in paternal (37%) transmissions (P < .001). The parental repeat size correlated with the size of intergenerational contraction (r(2) =.50, P much less than .001), and the slope of linear regression was steeper in paternal (-.62) than in maternal (-.30) transmissions (P much less than .001). Sixteen DM parents had multiple DM offspring with the CTG repeat contractions. This frequency was higher than the frequency expected from the probability of the repeat contractions (6.4%) and the size of DM sib population (1.54 DM offspring per DM parent, in 968 DM parents). We conclude that (1) intergenerational contraction of the CTG repeat in leukocyte DNA frequently accompanies apparent anticipation, especially when DM is maternally transmitted, and (2) the paternal origin of the repeat and the presence of the repeat contraction in a sibling increase the probability of the CTG repeat contraction.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; HOSP SANTA CRUZ & SAN PABLO,MOLEC GENET UNIT,BARCELONA,SPAIN; CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ON,CANADA; UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA,ON,CANADA; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; UNIV ROMA TOR VERGATA,ROME,ITALY; CATHOLIC UNIV ROME,ROME,ITALY; CSS HOSP,ROME,ITALY; UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; INSERM,U73,PARIS,FRANCE; HOP AMBROISE PARE,BOULOGNE,FRANCE; UNIV MARBURG,MED ZENTRUM HUMANGENET,MARBURG,GERMANY; OSAKA UNIV,SCH MED,DEPT GERIATR MED,OSAKA 553,JAPAN; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA,AUSTRALIA; HOSP NUESTRA SRA ARANZAU,DEPT NEUROL,SAN SEBASTIAN,SPAIN; DUKE UNIV,MED CTR,DIV NEUROL,DURHAM,NC 27710; UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,DENVER,CO 80262	Baylor College of Medicine; Karolinska Institutet; Karolinska University Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Radboud University Nijmegen; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Philipps University Marburg; Osaka University; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	ASHIZAWA, T (corresponding author), BAYLOR COLL MED,DEPT NEUROL,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Novelli, Giuseppe/GQB-3329-2022; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Sutherland, Grant Robert/D-2606-2012; Brunner, Han/C-9928-2013; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Dallapiccola, Bruno/0000-0002-5031-1013	Telethon [511, 1] Funding Source: Medline	Telethon(Fondazione Telethon)		ABELIOVICH D, 1993, AM J HUM GENET, V52, P1175; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1992, J MED GENET, V29, P780, DOI 10.1136/jmg.29.11.780; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; COBO AM, 1993, LANCET, V341, P1159, DOI 10.1016/0140-6736(93)93186-5; FISCHBECK KH, 1993, AM J HUM GENET, V53, P1157; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; HUNTER AGW, 1993, AM J MED GENET, V45, P401, DOI 10.1002/ajmg.1320450330; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; KOCH MC, 1991, AM J HUM GENET, V48, P1084; KRAHE R, 1993, AM J HUM GENET, V53, P1186; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; NAKAGAWA M, IN PRESS J MED GENET; NOVELLI G, 1993, BIOCHEM MOL BIOL INT, V29, P291; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; OHOY KL, 1993, SCIENCE, V259, P809, DOI 10.1126/science.8094260; PENROSE LS, 1948, ANN EUGENIC, V14, P125; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SHAW DJ, 1993, J MED GENET, V30, P189, DOI 10.1136/jmg.30.3.189; SHELBOURNE P, 1993, NEW ENGL J MED, V328, P471, DOI 10.1056/NEJM199302183280704; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192	43	113	114	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					414	423						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116611				2022-12-18	WOS:A1994MZ15800003
J	CANNONALBRIGHT, LA; GOLDGAR, DE; WRIGHT, EC; TURCO, A; JOST, M; MEYER, LJ; PIEPKORN, M; ZONE, JJ; SKOLNICK, MH				CANNONALBRIGHT, LA; GOLDGAR, DE; WRIGHT, EC; TURCO, A; JOST, M; MEYER, LJ; PIEPKORN, M; ZONE, JJ; SKOLNICK, MH			EVIDENCE AGAINST THE REPORTED LINKAGE OF THE CUTANEOUS MELANOMA DYSPLASTIC NEVUS SYNDROME LOCUS TO CHROMOSOME IP36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,DEPT INTERNAL MED,DIV HEMATOL ONCOL,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DEPT INTERNAL MED,DIV DERMATOL,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112; VET ADM MED CTR,DEPT MED,SALT LAKE CITY,UT 84148	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)				albright, lisa/0000-0003-2602-3668	NATIONAL CANCER INSTITUTE [R01CA028854, P01CA048711] Funding Source: NIH RePORTER; NCI NIH HHS [CA 28854, CA 48711] Funding Source: Medline; NCRR NIH HHS [RR 64] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARDESHIR F, 1983, MOL CELL BIOL, V3, P2076, DOI 10.1128/MCB.3.11.2076; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BARKER D, 1984, AM J HUM GENET, V36, P1159; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; COOKE KR, 1989, CANCER, V63, P1240, DOI 10.1002/1097-0142(19890315)63:6<1240::AID-CNCR2820630635>3.0.CO;2-9; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ELDER DE, 1980, CANCER, V46, P1787, DOI 10.1002/1097-0142(19801015)46:8<1787::AID-CNCR2820460816>3.0.CO;2-S; ELDER DE, 1982, AM J DERMATOPATH, V4, P455, DOI 10.1097/00000372-198210000-00014; Elder DE, 1981, PATHOLOGY MALIGNANT, P185; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; GREENE MH, 1983, P NATL ACAD SCI-BIOL, V80, P6071, DOI 10.1073/pnas.80.19.6071; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; LYNCH HT, 1978, J MED GENET, V15, P352, DOI 10.1136/jmg.15.5.352; MEYER LJ, 1988, PIGMENT CELL RES S1, V1, P144; NEMER M, 1986, NUCLEIC ACIDS RES, V14, P8696, DOI 10.1093/nar/14.21.8696; NEMER M, 1984, NATURE, V312, P654, DOI 10.1038/312654a0; PIEPKORN M, 1989, J AM ACAD DERMATOL, V20, P407, DOI 10.1016/S0190-9622(89)70050-5; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STCLAIR D, 1989, NATURE, V339, P305; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117; 1989, J AM ACAD DERMATOL, V10, P683	30	113	115	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					912	918						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339690				2022-12-18	WOS:A1990DD89600008
J	HALL, JG; FRIEDMAN, JM; KENNA, BA; POPKIN, J; JAWANDA, M; ARNOLD, W				HALL, JG; FRIEDMAN, JM; KENNA, BA; POPKIN, J; JAWANDA, M; ARNOLD, W			CLINICAL, GENETIC, AND EPIDEMIOLOGICAL FACTORS IN NEURAL-TUBE DEFECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,226-6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA; BRITISH COLUMBIA CHILDRENS HOSP,MENINGOMYELOCELE CLIN,VANCOUVER,BC,CANADA; VICTORIA SPINA BIFIDA CLIN,VICTORIA,BC,CANADA	University of British Columbia; BC Childrens Hospital; University of British Columbia				Hall, Judith G./0000-0001-5062-491X; Friedman, Jan/0000-0002-7482-9570				BAIRD PA, 1983, AM J MED GENET, V16, P49, DOI 10.1002/ajmg.1320160109; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; CARTER CO, 1974, DEV MED CHILD NEUROL, V16, P3; COHEN MM, 1982, TERATOLOGY, V25, P161, DOI 10.1002/tera.1420250206; CZEIZEL A, 1981, AM J MED GENET, V10, P25, DOI 10.1002/ajmg.1320100105; EVANS DR, 1979, BRIT MED J, V1, P975, DOI 10.1136/bmj.1.6169.975; FRASER FC, 1982, LANCET, V2, P144; GRANROTH G, 1978, TERATOLOGY, V17, P213, DOI 10.1002/tera.1420170302; HOLMES LB, 1976, NEW ENGL J MED, V294, P365, DOI 10.1056/NEJM197602122940704; HUNTER AGW, 1984, AM J MED GENET, V19, P45, DOI 10.1002/ajmg.1320190108; KHOURY MJ, 1982, AM J HUM GENET, V34, P980; LEMIRE RJ, 1988, JAMA-J AM MED ASSOC, V259, P558, DOI 10.1001/jama.259.4.558; LEMIRE RJ, 1978, ANENCEPHALY, P11; LIPPMAN A, 1984, CLIN GENET, V26, P563; MARTIN RA, 1983, AM J MED GENET, V16, P519, DOI 10.1002/ajmg.1320160410; MCBRIDE ML, 1979, AM J MED GENET, V3, P377, DOI 10.1002/ajmg.1320030409; MULLER F, 1988, ANAT EMBRYOL, V177, P203, DOI 10.1007/BF00321132; MULLER F, 1987, ANAT EMBRYOL, V176, P413, DOI 10.1007/BF00310083; SADOVNICK AD, 1985, TERATOLOGY, V32, P355, DOI 10.1002/tera.1420320305; SADOVNICK AD, 1967, AM J MED GENET, V26, P811; SEARLE AG, 1959, ANN HUM GENET, V23, P279, DOI 10.1111/j.1469-1809.1959.tb01471.x; SELLER MJ, 1987, AM J MED GENET, V26, P699, DOI 10.1002/ajmg.1320260325; SHURTLEFF D, 1986, EMBRYOLOGY ETIOLOGY, P39; STEVENSON AC, 1966, B WHO              S, V34, P25; TORIELLO HV, 1985, AM J MED GENET, V21, P13, DOI 10.1002/ajmg.1320210103; TRIMBLE BK, 1978, TERATOLOGY, V17, P43, DOI 10.1002/tera.1420170111; VERMA IC, 1978, LANCET, V1, P879; WARKANY J, 1981, MENTAL RETARDATION C, P158; WARREN J, 1979, J MED GENET, V16, P338, DOI 10.1136/jmg.16.5.338	29	113	115	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					827	837						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3195584				2022-12-18	WOS:A1988R344900004
J	GOODFELLOW, P; PYM, B; MOHANDAS, T; SHAPIRO, LJ				GOODFELLOW, P; PYM, B; MOHANDAS, T; SHAPIRO, LJ			THE CELL-SURFACE ANTIGEN LOCUS, MIC2X, ESCAPES X-INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,MED CTR,DIV MED GENET,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	GOODFELLOW, P (corresponding author), IMPERIAL CANC RES FUND,HUMAN MOLEC GENET LAB,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015193, R01HD012178] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-15193, HD-12178] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CATTANACH BM, 1982, NATURE, V300, P445, DOI 10.1038/300445a0; CHANCE PF, 1983, AM J HUM GENET, V35, P234; DAIGER SP, 1982, NATURE, V298, P682, DOI 10.1038/298682a0; EPSTEIN EH, 1981, J CLIN INVEST, V67, P1257, DOI 10.1172/JCI110153; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P273; FERGUSONSMITH MA, 1965, J MED GENET, V2, P145; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GOODFELLOW P, 1980, SOMAT CELL GENET, V6, P777, DOI 10.1007/BF01538976; GOODFELLOW PN, 1981, NATURE, V289, P404, DOI 10.1038/289404a0; IMMKEN L, 1984, AM J HUM GENET; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; MCLAREN A, 1982, NATURE, V300, P446, DOI 10.1038/300446a0; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MOHANDAS T, 1984, HUM GENET; MULLER CR, 1980, HUM GENET, V54, P197, DOI 10.1007/BF00278971; Ohno S., 1967, SEX CHROMOSOMES SEX; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PEARSON PL, 1970, NATURE, V226, P959, DOI 10.1038/226959a0; PEARSON PL, 1978, CYTOGENET CELL GENET, V22, P534, DOI 10.1159/000131018; POLANI PE, 1970, NATURE, V227, P613, DOI 10.1038/227613a0; Race RR., 1975, BLOOD GROUPS MAN; ROPERS HH, 1981, HUM GENET, V57, P354, DOI 10.1007/BF00281683; SANGER R, 1977, J MED GENET, V14, P210, DOI 10.1136/jmg.14.3.210; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SINGH L, 1982, CELL, V28, P205, DOI 10.1016/0092-8674(82)90338-5; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352	32	113	113	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	4					777	782						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TJ077	6540985				2022-12-18	WOS:A1984TJ07700006
J	Shringarpure, SS; Bustamante, CD				Shringarpure, Suyash S.; Bustamante, Carlos D.			Privacy Risks from Genomic Data-Sharing Beacons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREDICTION; DISEASE	The human genetics community needs robust protocols that enable secure sharing of genomic data from participants in genetic research. Beacons are web servers that answer allele-presence queries such as "Do you have a genome that has a specific nucleotide (e.g., A) at a specific genomic position (e.g., position 11,272 on chromosome 1)?"-with either "yes" or "no." Here, we show that individuals in a beacon are susceptible to re-identification even if the only data shared include presence or absence information about alleles in a beacon. Specifically, we propose a likelihood-ratio test of whether a given individual is present in a given genetic beacon. Our test is not dependent on allele frequencies and is the most powerful test for a specified false-positive rate. Through simulations, we showed that in a beacon with 1,000 individuals, re-identification is possible with just 5,000 queries. Relatives can also be identified in the beacon. Re-identification is possible even in the presence of sequencing errors and variant-calling differences. In a beacon constructed with 65 European individuals from the 1000 Genomes Project, we demonstrated that it is possible to detect membership in the beacon with just 250 SNPs. With just 1,000 SNP queries, we were able to detect the presence of an individual genome from the Personal Genome Project in an existing beacon. Our results show that beacons can disclose membership and implied phenotypic information about participants and do not protect privacy a priori. We discuss risk mitigation through policies and standards such as not allowing anonymous pings of genetic beacons and requiring minimum beacon sizes.	[Shringarpure, Suyash S.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Shringarpure, SS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	suyashs@stanford.edu; cdbustam@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920	NIH [U01HG007436]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge Snehit Prabhu, Christopher Gignoux, and Katie Kanagawa for helpful comments on the manuscript and the Stanford Genetics Bioinformatics Service Center for computing resources. This research was partially supported by the NIH under award number U01HG007436. C.D.B is on the scientific advisory boards (SABs) of Ancestry.com, Personalis, Liberty Biosecurity, and Etalon DX. He is also a founder and chair of the SAB of IdentifyGenomics. None of these entities played a role in the design, interpretation, or presentation of these results.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Clayton D, 2010, BIOSTATISTICS, V11, P661, DOI 10.1093/biostatistics/kxq035; Erlich Y, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001983; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Goldstein BA, 2015, GENET EPIDEMIOL, V39, P439, DOI 10.1002/gepi.21912; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Rothstein MA, 2008, GENET MED, V10, P655, DOI 10.1097GIM.0b013e31818337bd; Sankararaman S, 2009, NAT GENET, V41, P965, DOI 10.1038/ng.436; Schrodi SJ, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00162, 10.3389/fmicb.2014.00144]; Visscher PM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000628; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Zerhouni EA, 2008, SCIENCE, V322, P44, DOI 10.1126/science.1165490	18	112	113	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					631	646		10.1016/j.ajhg.2015.09.010	http://dx.doi.org/10.1016/j.ajhg.2015.09.010			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26522470	Green Published, hybrid			2022-12-18	WOS:000364803000001
J	Saruhan-Direskeneli, G; Hughes, T; Aksu, K; Keser, G; Coit, P; Aydin, SZ; Alibaz-Oner, F; Kamali, S; Inanc, M; Carette, S; Hoffman, GS; Akar, S; Onen, F; Akkoc, N; Khalidi, NA; Koening, C; Karadag, O; Kiraz, S; Langford, CA; McAlear, CA; Ozbalkan, Z; Ates, A; Karaaslan, Y; Maksimowicz-McKinnon, K; Monach, PA; Ozer, HT; Seyahi, E; Fresko, I; Cefle, A; Seo, P; Warrington, KJ; Ozturk, MA; Ytterberg, SR; Cobankara, V; Onat, AM; Guthridge, JM; James, JA; Tunc, E; Duzgun, N; Bicakcigil, M; Yentur, SP; Merkel, PA; Direskeneli, H; Sawalha, AH				Saruhan-Direskeneli, Guher; Hughes, Travis; Aksu, Kenan; Keser, Gokhan; Coit, Patrick; Aydin, Sibel Z.; Alibaz-Oner, Fatma; Kamali, Sevil; Inanc, Murat; Carette, Simon; Hoffman, Gary S.; Akar, Servet; Onen, Fatos; Akkoc, Nurullah; Khalidi, Nader A.; Koening, Curry; Karadag, Omer; Kiraz, Sedat; Langford, Carol A.; McAlear, Carol A.; Ozbalkan, Zeynep; Ates, Askin; Karaaslan, Yasar; Maksimowicz-McKinnon, Kathleen; Monach, Paul A.; Ozer, Huseyin T.; Seyahi, Emire; Fresko, Izzet; Cefle, Ayse; Seo, Philip; Warrington, Kenneth J.; Ozturk, Mehmet A.; Ytterberg, Steven R.; Cobankara, Veli; Onat, A. Mesut; Guthridge, Joel M.; James, Judith A.; Tunc, Ercan; Duzgun, Nursen; Bicakcigil, Muge; Yentur, Sibel P.; Merkel, Peter A.; Direskeneli, Haner; Sawalha, Amr H.			Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GIANT-CELL ARTERITIS; ULCERATIVE-COLITIS; MYCOBACTERIUM-TUBERCULOSIS; HLA ALLELES; POPULATION; DISEASE; TURKEY; VISUALIZATION; HAPLOTYPES	Takayasu arteritis is a rare inflammatory disease of large arteries. The etiology of Takayasu arteritis remains poorly understood, but genetic contribution to the disease pathogenesis is supported by the genetic association with HLA-B*52. We genotyped similar to 200,000 genetic variants in two ethnically divergent Takayasu arteritis cohorts from Turkey and North America by using a custom-designed genotyping platform (Immunochip). Additional genetic variants and the classical HLA alleles were imputed and analyzed. We identified and confirmed two independent susceptibility loci within the HLA region (r(2) < 0.2): HLA-B/MICA (rs12524487, OR = 3.29, p = 5.57 x 10(-16)) and HLA-DQB1/HLA-DRB1 (rs113452171, OR = 2.34, p = 3.74 x 10(-9); and rs189754752, OR = 2.47, p = 4.22 x 10(-9)). In addition, we identified and confirmed a genetic association between Takayasu arteritis and the FCGR2A/FCGR3A locus on chromosome 1 (rs10919543, OR = 1.81, p = 5.89 x 10(-12)). The risk allele in this locus results in increased mRNA expression of FCGR2A. We also established the genetic association between IL12B and Takayasu arteritis (rs56167332, OR = 1.54, p = 2.18 x 10(-8)).	[Saruhan-Direskeneli, Guher; Yentur, Sibel P.] Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34093 Istanbul, Turkey; [Hughes, Travis; Coit, Patrick; Sawalha, Amr H.] Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA; [Aksu, Kenan; Keser, Gokhan] Ege Univ, Fac Med, Dept Rheumatol, TR-35100 Izmir, Turkey; [Aydin, Sibel Z.; Alibaz-Oner, Fatma; Direskeneli, Haner] Marmara Univ, Fac Med, Dept Rheumatol, TR-34890 Istanbul, Turkey; [Aydin, Sibel Z.] Medeniyet Univ, Goztepe Training & Res Hosp, Rheumatol Unit, TR-34730 Istanbul, Turkey; [Kamali, Sevil; Inanc, Murat] Istanbul Univ, Istanbul Fac Med, Dept Rheumatol, TR-34093 Istanbul, Turkey; [Carette, Simon] Mt Sinai Hosp, Div Rheumatol, Toronto, ON M5L 3L9, Canada; [Hoffman, Gary S.; Langford, Carol A.] Cleveland Clin, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA; [Akar, Servet; Onen, Fatos; Akkoc, Nurullah] Dokuz Eylul Univ, Fac Med, Dept Rheumatol, TR-35340 Izmir, Turkey; [Khalidi, Nader A.] McMaster Univ, St Josephs Healthcare, Div Rheumatol, Hamilton, ON L8N 1Y2, Canada; [Koening, Curry] Univ Utah, Div Rheumatol, Salt Lake City, UT 84132 USA; [Karadag, Omer; Kiraz, Sedat] Hacettepe Univ, Fac Med, Dept Rheumatol, TR-06100 Ankara, Turkey; [McAlear, Carol A.; Merkel, Peter A.] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA; [Ozbalkan, Zeynep; Ates, Askin; Karaaslan, Yasar] Ankara Numune Training & Res Hosp, Dept Rheumatol, TR-06100 Ankara, Turkey; [Ates, Askin] Ankara Univ, Fac Med, Dept Rheumatol, TR-06100 Ankara, Turkey; [Karaaslan, Yasar] Hitit Univ, Fac Med, Dept Rheumatol, TR-19200 Corum, Turkey; [Maksimowicz-McKinnon, Kathleen] Univ Pittsburgh, Div Rheumatol, Pittsburgh, PA 15261 USA; [Maksimowicz-McKinnon, Kathleen] Henry Ford Hlth Syst, Div Rheumatol, Detroit, MI 48202 USA; [Monach, Paul A.] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Ozer, Huseyin T.] Cukurova Univ, Fac Med, Dept Rheumatol, TR-01330 Adana, Turkey; [Seyahi, Emire; Fresko, Izzet] Istanbul Univ, Cerrahpasa Fac Med, Dept Rheumatol, TR-34098 Istanbul, Turkey; [Cefle, Ayse] Kocaeli Univ, Fac Med, Dept Rheumatol, TR-41380 Kocaeli, Turkey; [Seo, Philip] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD 21224 USA; [Warrington, Kenneth J.; Ytterberg, Steven R.] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA; [Ozturk, Mehmet A.] Gazi Univ, Fac Med, Dept Rheumatol, TR-06500 Ankara, Turkey; [Cobankara, Veli] Pamukkale Univ, Fac Med, Dept Rheumatol, TR-20160 Denizli, Turkey; [Onat, A. Mesut] Gaziantep Univ, Fac Med, Dept Rheumatol, TR-27310 Gaziantep, Turkey; [Guthridge, Joel M.; James, Judith A.] Oklahoma Med Res Fdn, Arthritis & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Tunc, Ercan] Suleyman Demirel Univ, Fac Med, Dept Rheumatol, TR-32260 Isparta, Turkey; [Bicakcigil, Muge] Yeditepe Univ, Fac Med, Dept Rheumatol, TR-34752 Istanbul, Turkey	Istanbul University; University of Michigan System; University of Michigan; Ege University; Marmara University; Istanbul Goztepe Training and Research Hospital; Istanbul Medeniyet University; Istanbul University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cleveland Clinic Foundation; Dokuz Eylul University; McMaster University; Utah System of Higher Education; University of Utah; Hacettepe University; University of Pennsylvania; Ankara Numune Training & Research Hospital; Ankara University; Hitit University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Henry Ford Health System; Henry Ford Hospital; Boston University; Cukurova University; Istanbul University; Istanbul University - Cerrahpasa; Kocaeli University; Johns Hopkins University; Mayo Clinic; Gazi University; Pamukkale University; Gaziantep University; Oklahoma Medical Research Foundation; Suleyman Demirel University; Yeditepe University	Sawalha, AH (corresponding author), Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA.	asawalha@umich.edu	Onen, Fatos/AAA-8970-2021; Seyahi, Emire/AAD-1769-2021; Ates, Askin/AAG-7996-2020; Akkoc, Nurullah/D-9870-2011; Fresko, Izzet/AAD-1755-2021; Keser, Gokhan/I-4282-2019; Akar, Servet/G-2339-2012; ALIBAZ-ONER, FATMA/AAR-2072-2020; Karadag, Omer/AAD-5448-2019; Direskeneli, Haner/AAS-5508-2020; inanç, murat/I-3444-2012; Cefle, Ayse/AAT-3653-2020; SEYAHI, EMIRE/AAB-3576-2020; Karadag, Omer/AAR-4219-2020; Karadag, Omer/I-9042-2013; Warrington, Kenneth/CAG-1626-2022	Ates, Askin/0000-0003-1966-3333; Akkoc, Nurullah/0000-0002-3718-171X; ALIBAZ-ONER, FATMA/0000-0002-6653-1758; inanç, murat/0000-0002-6376-5583; Karadag, Omer/0000-0002-3443-3117; Karadag, Omer/0000-0002-3443-3117; aksu, kenan/0000-0001-8889-2688; Guthridge, Joel/0000-0002-9308-237X; Seo, Philip/0000-0003-3435-6737; Fresko, Izzet/0000-0002-8914-9690; Onen, Fatos/0000-0002-6341-2622; Warrington, Kenneth/0000-0001-7708-2487; Coit, Patrick/0000-0003-0660-764X	University of Michigan; Vasculitis Foundation; National Institutes of Health [GM103510, AR053483, AI08714, AI101914]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319, U01 AR51874 04]; National Center for Research Resources [U54 RR019497]; Office of Rare Diseases Research of the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483, U01AR051874, U54AR057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); Vasculitis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Rare Diseases Research of the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the University of Michigan and the Vasculitis Foundation. Procurement and genotyping of the European-American control samples was supported by the National Institutes of Health grants GM103510, AR053483, AI08714, and AI101914. The Vasculitis Clinical Research Consortium has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319 and U01 AR51874 04), the National Center for Research Resources (U54 RR019497), and the Office of Rare Diseases Research of the National Center for Advancing Translational Sciences.	Aggarwal A, 1996, INT J CARDIOL, V55, P49, DOI 10.1016/0167-5273(96)02660-5; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Charoenwongse P, 1998, INT J CARDIOL, V66, pS117, DOI 10.1016/S0167-5273(98)00158-2; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Soto ME, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-194; Grayson PC, 2012, ANN RHEUM DIS, V71, P1329, DOI 10.1136/annrheumdis-2011-200795; HALL S, 1985, MEDICINE, V64, P89, DOI 10.1097/00005792-198503000-00002; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Johnston SL, 2002, J CLIN PATHOL, V55, P481, DOI 10.1136/jcp.55.7.481; Kasuya K, 1992, Heart Vessels Suppl, V7, P116, DOI 10.1007/BF01744556; Kitamura H, 1998, INT J CARDIOL, V66, pS121, DOI 10.1016/S0167-5273(98)00159-4; Kobayashi Y, 2002, INTERNAL MED, V41, P44, DOI 10.2169/internalmedicine.41.44; Lee SW, 2007, CLIN EXP RHEUMATOL, V25, pS18; Maksimowicz-McKinnon K, 2009, MEDICINE, V88, P221, DOI 10.1097/MD.0b013e3181af70c1; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mehra NK, 1998, INT J CARDIOL, V66, pS127, DOI 10.1016/S0167-5273(98)00160-0; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1996; Numano F, 1992, Heart Vessels Suppl, V7, P68, DOI 10.1007/BF01744547; Ohta Y, 2003, ANGIOLOGY, V54, P339, DOI 10.1177/000331970305400310; Phillip R, 2008, CLIN EXP RHEUMATOL, V26, pS94; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reny JL, 2003, ANN MED INTERNE, V154, P85; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sahin Z, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3730; Saruhan-Direskeneli G, 2006, HUM IMMUNOL, V67, P735, DOI 10.1016/j.humimm.2006.06.003; Uyar FA, 2004, TISSUE ANTIGENS, V64, P180, DOI 10.1111/j.1399-0039.2004.00258.x; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	33	112	118	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					298	305		10.1016/j.ajhg.2013.05.026	http://dx.doi.org/10.1016/j.ajhg.2013.05.026			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23830517	Bronze, Green Published			2022-12-18	WOS:000323186200009
J	Zeng, J; Konopka, G; Hunt, BG; Preuss, TM; Geschwind, D; Yi, SV				Zeng, Jia; Konopka, Genevieve; Hunt, Brendan G.; Preuss, Todd M.; Geschwind, Dan; Yi, Soojin V.			Divergent Whole-Genome Methylation Maps of Human and Chimpanzee Brains Reveal Epigenetic Basis of Human Regulatory Evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROMOTER DNA METHYLATION; GENE-EXPRESSION LEVELS; INSIGHTS; ALIGNMENT; PATTERNS; MUTATION	DNA methylation is a pervasive epigenetic DNA modification that strongly affects chromatin regulation and gene expression. To date, it remains largely unknown how patterns of DNA methylation differ between closely related species and whether such differences contribute to species-specific phenotypes. To investigate these questions, we generated nucleotide-resolution whole-genome methylation maps of the prefrontal cortex of multiple humans and chimpanzees. Levels and patterns of DNA methylation vary across individuals within species according to the age and the sex of the individuals. We also found extensive species-level divergence in patterns of DNA methylation and that hundreds of genes exhibit significantly lower levels of promoter methylation in the human brain than in the chimpanzee brain. Furthermore, we investigated the functional consequences of methylation differences in humans and chimpanzees by integrating data on gene expression generated with next-generation sequencing methods, and we found a strong relationship between differential methylation and gene expression. Finally, we found that differentially methylated genes are strikingly enriched with loci associated with neurological disorders, psychological disorders, and cancers. Our results demonstrate that differential DNA methylation might be an important molecular mechanism driving gene-expression divergence between human and chimpanzee brains and might potentially contribute to the evolution of disease vulnerabilities. Thus, comparative studies of humans and chimpanzees stand to identify key epigenomic modifications underlying the evolution of human-specific traits.	[Zeng, Jia; Hunt, Brendan G.; Yi, Soojin V.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Konopka, Genevieve; Geschwind, Dan] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Semel Inst, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Geschwind, Dan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Dept Neurol, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Geschwind, Dan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Konopka, Genevieve] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Preuss, Todd M.] Emory Univ, Div Neuropharmacol & Neurol Dis, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30329 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Emory University; Emory University	Yi, SV (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	soojinyi@gatech.edu	Preuss, Todd/GSI-6571-2022; Hunt, Brendan G/B-9816-2009	Hunt, Brendan G/0000-0002-0030-9302; Konopka, Genevieve/0000-0002-3363-7302	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland [N01-HD-4-3368, N01-HD-4-3383]; Yerkes National Primate Research Center; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs [OD P51OD11132]; NIH/NIA [5P01 AG026423-03]; James S. McDonnell Foundation's 21st Century Science Initiative [JSMF 21002093]; National Institute of Mental Health [MH060233:05, MH094714-01]; Georgia Tech Fund for Innovation in Research and Education (GT-FIRE); National Science Foundation [MCB-0950896, BCS-0751481]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, R01MH094714, R00MH090238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026423] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland; Yerkes National Primate Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); James S. McDonnell Foundation's 21st Century Science Initiative; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Georgia Tech Fund for Innovation in Research and Education (GT-FIRE); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Georgia Tech Office of Information and Technology and the Emory Genome Core for technical assistance. Human tissue was obtained from the National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland (NICHD contract numbers N01-HD-4-3368 and N01-HD-4-3383). The role of the NICHD Brain and Tissue Bank is to distribute tissue, and it therefore cannot endorse the studies performed or the interpretation of results. This study was supported by the Yerkes National Primate Research Center funded by the National Center for Research Resources P51RR165, and it is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132, by NIH/NIA (5P01 AG026423-03), by the James S. McDonnell Foundation's 21st Century Science Initiative (JSMF 21002093) to T.P. and D.H.G., by National Institute of Mental Health grants MH060233:05 and MH094714-01 to D.H.G., and by the Georgia Tech Fund for Innovation in Research and Education (GT-FIRE) and National Science Foundation grants (MCB-0950896 and BCS-0751481) to S.V.Y.	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Benjamini Y, 2001, ANN STAT, V29, P1165; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elango N, 2008, MOL BIOL EVOL, V25, P1602, DOI 10.1093/molbev/msn110; Enard W, 2004, CURR BIOL, V14, pR148, DOI 10.1016/j.cub.2004.01.042; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Han L, 2007, CANCER BIOL THER, V6, P1284; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SF, 2003, ANN NY ACAD SCI, V983, P161, DOI 10.1111/j.1749-6632.2003.tb05971.x; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sarda S, 2012, MOL BIOL EVOL, V29, P1907, DOI 10.1093/molbev/mss062; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	59	112	115	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					455	465		10.1016/j.ajhg.2012.07.024	http://dx.doi.org/10.1016/j.ajhg.2012.07.024			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22922032	Green Published, Bronze			2022-12-18	WOS:000308683100006
J	Chen, JJ; Ma, ZW; Jiao, XD; Fariss, R; Kantorow, WL; Kantorow, M; Pras, E; Frydman, M; Pras, E; Riazuddin, S; Riazuddin, SA; Hejtmancik, JF				Chen, Jianjun; Ma, Zhiwei; Jiao, Xiaodong; Fariss, Robert; Kantorow, Wanda Lee; Kantorow, Marc; Pras, Eran; Frydman, Moshe; Pras, Elon; Riazuddin, Sheikh; Riazuddin, S. Amer; Hejtmancik, J. Fielding			Mutations in FYCO1 Cause Autosomal-Recessive Congenital Cataracts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON ELIMINATED REGION-1; NONSENSE MUTATION; MISSENSE MUTATION; GENE; AUTOPHAGY; DISEASE; FAMILY; CELLS; RAB7; PATHWAY	Congenital cataracts (CCs), responsible for about one-third of blindness in infants, are a major cause of vision loss in children worldwide. Autosomal-recessive congenital cataracts (arCC) form a clinically diverse and genetically heterogeneous group of disorders of the crystalline lens. To identify the genetic cause of arCC in consanguineous Pakistani families, we performed genome-wide linkage analysis and fine mapping and identified linkage to 3p21-p22 with a summed LOD score of 33.42. Mutations in the gene encoding FYVE and coiled-coil domain containing 1 (FTCO1), a PI(3) P-binding protein family member that is associated with the exterior of autophagosomes and mediates microtubule plus-end-directed vesicle transport, were identified in 12 Pakistani families and one Arab Israeli family in which arCC had previously been mapped to the overlapping CATC2 region. Nine different mutations were identified, including c.3755 delC (p.Ala1252AspfsX71), c.3858_3862dupGGAAT (p.Leu1288TrpfsX37), c.1045 C > T (p.Gln349X), c.2206C > T (p.Gln736X), c.2761C > T (p.Arg921X), c.2830C > T (p.Arg944X), c.3150+1 G > T, c.4127T > C (p.Leu1376Pro), and c.1546C > T (p.Gln516X). Fyco1 is expressed in the mouse embryonic and adult lens and peaks at P12d. Expressed mutant proteins p.Leu1288TrpfsX37 and p.Gln736X are truncated on immunoblots. Wild-type and p.L1376P FYCO1, the only missense mutant identified, migrate at the expected molecular mass. Both wild-type and p. Leu1376Pro FYCO1 proteins expressed in human lens epithelial cells partially colocalize to microtubules and are found adjacent to Golgi, but they primarily colocalize to autophagosomes. Thus, FYCO1 is involved in lens development and transparency in humans, and mutations in this gene are one of the most common causes of arCC in the Pakistani population.	[Chen, Jianjun; Ma, Zhiwei; Jiao, Xiaodong; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Kantorow, Wanda Lee; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Pras, Eran] Assaf Harofeh Med Ctr, Dept Ophthalmol, IL-70300 Zerifin, Israel; [Pras, Eran; Frydman, Moshe; Pras, Elon] Tel Aviv Univ, Sackler Sch Med, Danek Gertner Inst Human Genet, IL-69978 Tel Aviv, Israel; [Riazuddin, Sheikh; Riazuddin, S. Amer] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Riazuddin, Sheikh] Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); State University System of Florida; Florida Atlantic University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Johns Hopkins University; Johns Hopkins Medicine	Hejtmancik, JF (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov	Fariss, Robert/ABI-1771-2020; chen, jianjun/AAG-7572-2019	Fariss, Robert/0000-0003-3227-7170	Higher Education Commission and Ministry of Science and Technology, Islamabad, Pakistan; NIH [ey13022]; National Academy of Sciences; U.S. Department of State, Washington, DC, USA; NATIONAL EYE INSTITUTE [R01EY013022, ZICEY000459] Funding Source: NIH RePORTER	Higher Education Commission and Ministry of Science and Technology, Islamabad, Pakistan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Academy of Sciences; U.S. Department of State, Washington, DC, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are thankful to all the family members for their participation in this study and to James Friedman for advice and assistance with the fluorescent localization studies. This study was supported in part by the Higher Education Commission and Ministry of Science and Technology, Islamabad, Pakistan. This work was also supported by the NIH grant ey13022, National Academy of Sciences, and the U.S. Department of State, Washington, DC, USA (Note: All findings and conclusions are those of the authors and do not necessarily reflect the views of the National Academy of Sciences or the U.S. Department of State).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Foster A, 1999, EYE, V13, P449, DOI 10.1038/eye.1999.120; FRANCOIS J, 1982, OPHTHALMOLOGICA, V184, P61, DOI 10.1159/000309186; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kaul H, 2010, MOL VIS, V16, P511; Kiss H, 2002, MAMM GENOME, V13, P646, DOI 10.1007/s00335-002-3037-y; Kiss H, 2002, EUR J HUM GENET, V10, P52, DOI 10.1038/sj.ejhg.5200758; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Merin S., 1991, INHERITED EYE DIS, P86; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Pankiv S, 2010, AUTOPHAGY, V6, P550, DOI 10.4161/auto.6.4.11670; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Ponnam SPG, 2008, MOL VIS, V14, P1204; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66; Shiels A, 2010, MOL VIS, V16, P2007; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Wormstone IM, 2000, INVEST OPHTH VIS SCI, V41, P4216	38	112	119	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					827	838		10.1016/j.ajhg.2011.05.008	http://dx.doi.org/10.1016/j.ajhg.2011.05.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21636066	Green Published, Bronze			2022-12-18	WOS:000291768500015
J	Pearlman, A; Loke, J; Le Caignec, C; White, S; Chin, L; Friedman, A; Warr, N; Willan, J; Brauer, D; Farmer, C; Brooks, E; Oddoux, C; Riley, B; Shajahan, S; Camerino, G; Homfray, T; Crosby, AH; Couper, J; David, A; Greenfield, A; Sinclair, A; Ostrer, H				Pearlman, Alexander; Loke, Johnny; Le Caignec, Cedric; White, Stefan; Chin, Lisa; Friedman, Andrew; Warr, Nicholas; Willan, John; Brauer, David; Farmer, Charles; Brooks, Eric; Oddoux, Carole; Riley, Bridget; Shajahan, Shahin; Camerino, Giovanna; Homfray, Tessa; Crosby, Andrew H.; Couper, Jenny; David, Albert; Greenfield, Andy; Sinclair, Andrew; Ostrer, Harry			Mutations in MAP3K1 Cause 46,XY Disorders of Sex Development and Implicate a Common Signal Transduction Pathway in Human Testis Determination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GONADAL-DYSGENESIS; UP-REGULATION; BETA-CATENIN; GENE; REVERSAL; KINASE; SOX9; EXPRESSION; INTERACTS; PROTEIN	Investigations of humans with disorders of sex development (DSDs) resulted in the discovery of many of the now-known mammalian sex-determining genes, including SRY, RSPO1, SOX9, NR5A1, WT1, NROB1, and WNT4. Here, the locus for an autosomal sex-determining gene was mapped via linkage analysis in two families with 46,XY DSD to the long arm of chromosome 5 with a combined, multipoint parametric LOD score of 6.21. A splice-acceptor mutation (c.634-8T>A) in MAP3K1 segregated with the phenotype in the first family and disrupted RNA splicing. Mutations were demonstrated in the second family (p.Gly616Arg) and in two of 11 sporadic cases (p.Leu189Pro, p.Leu189Arg)-18% prevalence in this cohort of sporadic cases. In cultured primary lymphoblastoid cells from family 1 and the two sporadic cases, these mutations altered the phosphorylation of the downstream targets, p38 and ERK1/2, and enhanced binding of RHOA to the MAP3K1 complex. Map3k1 within the syntenic region was expressed in the embryonic mouse gonad prior to, and after, sex determination. Thus, mutations in MAP3K1 that result in 46,XY DSD with partial or complete gonadal dysgenesis implicate this pathway in normal human sex determination.	[Pearlman, Alexander; Loke, Johnny; Chin, Lisa; Friedman, Andrew; Brauer, David; Farmer, Charles; Brooks, Eric; Oddoux, Carole; Riley, Bridget; Shajahan, Shahin; Ostrer, Harry] NYU, Sch Med, Human Genet Program, New York, NY 10016 USA; [Le Caignec, Cedric; David, Albert] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Le Caignec, Cedric] Inst Thorax, INSERM, UMR915, F-44007 Nantes, France; [White, Stefan; Sinclair, Andrew] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [White, Stefan; Sinclair, Andrew] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Warr, Nicholas; Willan, John; Greenfield, Andy] MRC Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; [Camerino, Giovanna] Univ Pavia, Dipartimento Patol Umana & Ereditaria, I-27100 Pavia, Italy; [Homfray, Tessa; Crosby, Andrew H.] St George Hosp, Sch Med, London SW17 0RE, England; [Couper, Jenny] Womens & Childrens Hosp, Dept Endocrinol & Diabet, Adelaide, SA 5006, Australia	New York University; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; MRC Harwell; University of Pavia; St Georges University London; Womens & Childrens Hospital Australia	Ostrer, H (corresponding author), NYU, Sch Med, Human Genet Program, New York, NY 10016 USA.	harry.ostrer@nyumc.org	willan, john/ABD-8708-2020; Willan, John/AAP-7309-2020; Crosby, Andrew H/E-2218-2015; Sinclair, Andrew H/A-3598-2010; Le Caignec, Cedric/K-8467-2015; Greenfield, Andy/F-5099-2017	Willan, John/0000-0001-8700-2073; Crosby, Andrew H/0000-0003-3667-9054; Sinclair, Andrew H/0000-0003-2741-7992; Le Caignec, Cedric/0000-0002-0598-653X; Warr, Nick/0000-0003-0767-1360; Couper, Jennifer/0000-0003-4448-8629; Greenfield, Andy/0000-0002-1477-1776; Brauer, David/0000-0002-0251-4350; Pearlman, Alexander/0000-0002-0465-5886	US National Institutes of Health; Medical Research Council of the United Kingdom; National Health and Medical Research Council of Australia; MRC [MC_U142684167] Funding Source: UKRI; Medical Research Council [MC_U142684167] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported in part by the US National Institutes of Health, the Medical Research Council of the United Kingdom, and the National Health and Medical Research Council of Australia.	*1000 GEN, 1000 GEN PROJ; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], POLYPHEN; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; BOCZKOWSKI K, 1973, OBSTET GYNECOL, V41, P310; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Cool J, 2009, SEMIN REPROD MED, V27, P5, DOI 10.1055/s-0028-1108005; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; ESPINER EA, 1970, NEW ENGL J MED, V283, P6, DOI 10.1056/NEJM197007022830102; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; GERMAN J, 1978, SCIENCE, V202, P53, DOI 10.1126/science.567843; Hastie Nicholas D., 1992, Human Molecular Genetics, V1, P293; Jawaheer D, 2003, CLIN GENET, V63, P530, DOI 10.1034/j.1399-0004.2003.00082.x; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Jost A., 1973, Recent Progress Hormone Res, V29, P1; Juriloff DM, 2005, GENOMICS, V85, P139, DOI 10.1016/j.ygeno.2004.10.002; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Le Caignec C, 2003, AM J MED GENET A, V116A, P37, DOI 10.1002/ajmg.a.10820; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; NG RC, 2003, NUCLEIC ACIDS RES, V31, P3812; Ng SS, 2010, BIOL CHEM, V391, P171, DOI [10.1515/BC.2010.028, 10.1515/bc.2010.028]; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; OSTRER H, 2008, GENEREVIEWS GENETEST; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200	37	112	116	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					898	904		10.1016/j.ajhg.2010.11.003	http://dx.doi.org/10.1016/j.ajhg.2010.11.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129722	Green Published, Bronze			2022-12-18	WOS:000285564600018
J	Thornton, T; McPeek, MS				Thornton, Timothy; McPeek, Mary Sara			ROADTRIPS: Case-Control Association Testing with Partially or Completely Unknown Population and Pedigree Structure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; CANDIDATE GENES; STRATIFICATION; POWER; COGA	Genome-wide association studies are routinely conducted to identify genetic variants that influence complex disorders. It is well known that failure to properly account for population or pedigree structure can lead to spurious association as well as reduced power. We propose a method, ROADTRIPS, for case-control association testing in samples with partially or completely unknown population and pedigree structure. ROADTRIPS uses a covariance matrix estimated from genome-screen data to correct for unknown population and pedigree structure while maintaining high power by taking advantage of known pedigree information when it is available. ROADTRIPS can incorporate data on arbitrary combinations of related and unrelated individuals and is computationally feasible for the analysis of genetic studies with millions of markers. In simulations with related individuals and population structure, including admixture, we demonstrate that ROADTRIPS provides a substantial improvement over existing methods in terms of power and type 1 error. The ROADTRIPS method can be used across a variety of study designs, ranging from studies that have a combination of unrelated individuals and small pedigrees to studies of isolated founder populations with partially known or completely unknown pedigrees. We apply the method to analyze two data sets: a study of rheumatoid arthritis in small UK pedigrees, from Genetic Analysis Workshop 15, and data from the Collaborative Study of the Genetics of Alcoholism on alcohol dependence in a sample of moderate-size pedigrees of European descent, from Genetic Analysis Workshop 14. We detect genome-wide significant association, after Bonferroni correction, in both studies.	[McPeek, Mary Sara] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [McPeek, Mary Sara] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Thornton, Timothy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle	McPeek, MS (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.	mcpeck@galton.uchicago.edu			University of California; Lamond Family Foundation; National Institutes of Health [R01 HG001645]; NATIONAL CANCER INSTITUTE [K01CA148958] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER	University of California(University of California System); Lamond Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This Study was supported in part by the University of California President's Postdoctoral Fellowship and the Lamond Family Foundation Postdoctoral Fellowship (to T.T.) and by National Institutes of Health grant R01 HG001645 (to M.S.M.). Data on alcohol dependence were provided by the Collaborative Study on the Genetics of Alcoholism (U10AA008401) through the Genetics Analysis Workshop (R01GM031575). Data on RA were provided by a UK group led by Jane Worthington and Sally John through the Genetics Analysis Workshop (R01GM031575).	Amos Christopher I, 2007, BMC Proc, V1 Suppl 1, pS3; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edenberg HJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S2; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kimmel G, 2007, AM J HUM GENET, V81, P895, DOI 10.1086/521372; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lange K., 2002, MATH STAT METHODS GE; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; McPeek MS, 2004, BIOMETRICS, V60, P359; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rakovski CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005825; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schott J. R, 1996, MATRIX ANAL STAT; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Wang ZH, 2009, J AM STAT ASSOC, V104, P1251, DOI 10.1198/jasa.2009.tm08507; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007928; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhu XF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S128; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	33	112	118	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					172	184		10.1016/j.ajhg.2010.01.001	http://dx.doi.org/10.1016/j.ajhg.2010.01.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137780	Bronze, Green Published			2022-12-18	WOS:000274637200007
J	Zhao, C; Bellur, DL; Lu, SS; Zhao, F; Grassi, MA; Bowne, SJ; Sullivan, LS; Daiger, SP; Chen, LJ; Pang, CP; Zhao, KX; Staley, JP; Larsson, C				Zhao, Chen; Bellur, Deepti L.; Lu, Shasha; Zhao, Feng; Grassi, Michael A.; Bowne, Sara J.; Sullivan, Lori S.; Daiger, Stephen P.; Chen, Li Jia; Pang, Chi Pui; Zhao, Kanxing; Staley, Jonathan P.; Larsson, Catharina			Autosomal-Dominant Retinitis Pigmentosa Caused by a Mutation in SNRNP200, a Gene Required for Unwinding of U4/U6 snRNAs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; DEXD/H-BOX ATPASE; SPLICING FACTOR; TRI-SNRNP; SACCHAROMYCES-CEREVISIAE; DESIGN PRINCIPLES; ASSEMBLY PATHWAY; 19Q13.4 RP11; RP9 FORM; YEAST	Mutations in genes associated with the U4/U6-U5 small nuclear ribonucleoprotein (snRNP) complex of the spliceosome are implicated in autosomal-dominant retinitis pigmentosa (adRP), a group of progressive retinal degenerative disorders leading to visual impairment, loss of visual field, and even blindness. We recently assigned a locus (RP33) for adRP to 2cen-q12.1, a region that harbors the SNRNP200 gene encoding hBrr2, another U4/U6-U5 snRNP component that is required for unwinding of U4/U6 snRNAs during spliceosome activation and for disassembly of the spliceosome. Here, we report the identification of a missense mutation, c.3260C>T (p.S1087L), in exon 25 of the SNRNP200 gene in an RP33-linked family. The c.3260C>T substitution showed complete cosegregation with the retinitis pigmentosa (RP) phenotype over four generations, but was absent in a panel of 400 controls. The p.S1087L mutation and p.R1090L, another adRP-associated allele, reside in the "ratchet" helix of the first of two Sec63 domains implicated in the directionality and processivity of nucleic acid unwinding. Indeed, marked defects in U4/U6 unwinding, but not U4/U6-U5 snRNP assembly, were observed in budding yeast for the analogous mutations (N1104L and R1107L) of the corresponding Brr2p residues. The linkage of hBrr2 to adRP suggests that the mechanism of pathogenesis for splicing-factor-related RP may fundamentally derive from a defect in hBrr2-dependent RNA unwinding and a consequent defect in spliceosome activation.	[Zhao, Chen; Lu, Shasha; Zhao, Kanxing] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin 300040, Peoples R China; [Zhao, Chen; Lu, Shasha; Larsson, Catharina] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, CMM L8 01, SE-17176 Stockholm, Sweden; [Bellur, Deepti L.; Staley, Jonathan P.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Zhao, Feng] Tianjin Med Univ, Tianjin Chest & Heart Hosp, Tianjin 300200, Peoples R China; [Grassi, Michael A.] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA; [Bowne, Sara J.; Sullivan, Lori S.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Chen, Li Jia; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China	Tianjin Medical University; Karolinska Institutet; Karolinska University Hospital; University of Chicago; Tianjin Medical University; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Chinese University of Hong Kong	Zhao, KX (corresponding author), Tianjin Med Univ, Tianjin Eye Hosp, 4 Gansu Rd, Tianjin 300040, Peoples R China.	zhaokanxing@yahoo.com.cn	Pang, Chi P/I-5388-2014; Chen, Li Jia/I-5078-2014	Chen, Li Jia/0000-0003-3500-5840	Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council; Stockholm County Council; Chinese National Natural Science Foundation; National Institutes of Health [GM62264]; American Heart Association; NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062264] Funding Source: NIH RePORTER	Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was financially supported by The Goran Gustavsson Foundation for Research in Natural Sciences and Medicine, The Swedish Research Council, and the Stockholm County Council (to C.L.); by the Chinese National Natural Science Foundation Awards (to KZ); by a grant from the National Institutes of Health (no. GM62264 to J.P.S.); and by a fellowship from the American Heart Association (to D.L.B.).	AlMaghtheh M, 1996, AM J HUM GENET, V59, P864; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Chan WM, 2001, BRIT J OPHTHALMOL, V85, P1046, DOI 10.1136/bjo.85.9.1046; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Chiang SWY, 2006, EYE, V20, P602, DOI 10.1038/sj.eye.6701944; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; LI N, 2009, INVEST OPHT IN PRESS; Lin J, 1996, RNA, V2, P835; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Maita H, 2005, EXP CELL RES, V302, P61, DOI 10.1016/j.yexcr.2004.08.022; Maita H, 2004, EXP CELL RES, V300, P283, DOI 10.1016/j.yexcr.2004.07.029; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Mefford MA, 2009, RNA, V15, P1386, DOI 10.1261/rna.1582609; Mordes D, 2006, MOL VIS, V12, P1259; NEWMAN AJ, 1985, CELL, V42, P335, DOI 10.1016/S0092-8674(85)80129-X; Noble SM, 1996, GENETICS, V143, P67; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P4579, DOI 10.1167/iovs.06-0440; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Valadkhan S, 2009, P NATL ACAD SCI USA, V106, P11901, DOI 10.1073/pnas.0902020106; van Lith-Verhoeven J J C, 2002, Ophthalmic Genet, V23, P1, DOI 10.1076/opge.23.1.1.2206; van Nues RW, 2001, GENETICS, V157, P1451; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Xu DM, 1996, NATURE, V381, P709, DOI 10.1038/381709a0; Xu SY, 1996, HUM MOL GENET, V5, P1193, DOI 10.1093/hmg/5.8.1193; Xu YZ, 2007, MOL CELL, V28, P838, DOI 10.1016/j.molcel.2007.09.022; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3	54	112	126	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					617	627		10.1016/j.ajhg.2009.09.020	http://dx.doi.org/10.1016/j.ajhg.2009.09.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19878916	Green Published, Bronze			2022-12-18	WOS:000271916500009
J	Pasutto, F; Matsumoto, T; Mardin, CY; Sticht, H; Brandstatter, JH; Michels-Rautenstrauss, K; Weisschuh, N; Gramer, E; Ramdas, WD; van Koolwijk, LME; Klaver, CCW; Vingerling, JR; Weber, BHF; Kruse, FE; Rautenstrauss, B; Barde, YA; Reis, A				Pasutto, Francesca; Matsumoto, Tomoya; Mardin, Christian Y.; Sticht, Heinrich; Brandstaetter, Johann H.; Michels-Rautenstrauss, Karin; Weisschuh, Nicole; Gramer, Eugen; Ramdas, Wishal D.; van Koolwijk, Leonieke M. E.; Klaver, Caroline C. W.; Vingerling, Johannes R.; Weber, Bernhard H. F.; Kruse, Friedrich E.; Rautenstrauss, Bernd; Barde, Yves-Alain; Reis, Andre			Heterozygous NTF4 Mutations Impairing Neurotrophin-4 Signaling in Patients with Primary Open-Angle Glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL GANGLION-CELLS; IN-VIVO; CYP1B1 MUTATIONS; GERMAN PATIENTS; NEURONAL DEATH; GENE; EXPRESSION; SURVIVAL; TRKB; POPULATION	Glaucoma, a main cause of blindness in the developed world, is characterized by progressive degeneration of retinal ganglion cells (RGCs), resulting in irreversible loss of vision. Although members of the neurotrophin gene family in various species are known to support the survival of numerous neuronal populations, including RGCs, it is less clear whether they are also required for survival and maintenance of adult neurons in humans. Here, we report seven different heterozygous mutations in the Neurotrophin-4 (NTF4) gene accounting for about 1.7% of primary open-angle glaucoma patients of European origin. Molecular modeling predicted a decreased affinity of neurotrophin 4 protein (NIT-4) mutants with its specific tyrosine kinase receptor B (TrkB). Expression of recombinant NT-4 carrying the most frequent mutation was demonstrated to lead to decreased activation of TrkB. These findings suggest a pathway in the pathophysiology of glaucoma through loss of neurotrophic function and may eventually open the possibility of using ligands activating TrkB to prevent the progression of the disease.	[Pasutto, Francesca; Michels-Rautenstrauss, Karin; Rautenstrauss, Bernd; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Mardin, Christian Y.; Kruse, Friedrich E.] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Matsumoto, Tomoya; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Weisschuh, Nicole] Univ Eye Hosp, Mol Genet Lab, D-72076 Tubingen, Germany; [Gramer, Eugen] Univ Eye Hosp, D-97080 Wurzburg, Germany; [Ramdas, Wishal D.; van Koolwijk, Leonieke M. E.; Klaver, Caroline C. W.; Vingerling, Johannes R.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ramdas, Wishal D.; Klaver, Caroline C. W.; Vingerling, Johannes R.] Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; [Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Regensburg	Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	reis@humgenet.uni-erlangen.de	Reis, André/D-2309-2009; Barde, Yves/F-6019-2011; Klaver, Caroline C.W./A-2013-2016; Ramdas, Wishal D/H-5062-2018	Reis, André/0000-0002-6301-6363; Ramdas, Wishal D/0000-0002-1780-5281; Sticht, Heinrich/0000-0001-5644-045X; Weber, Bernhard H.F./0000-0002-8808-7723; Rautenstrauss, Bernd/0000-0001-5099-7476; Barde, Yves/0000-0002-7627-461X; Klaver, Caroline/0000-0002-2355-5258	Deutsche Forschungsgerneinschaft (DFG);  [SFB539]	Deutsche Forschungsgerneinschaft (DFG)(German Research Foundation (DFG)); 	We thank all of the patients and control individuals for their participation, Claudia Preller and Freya Boggasch for technical assistance, and Juliane Niedzella for patient recruitment support. This work was supported by grants from the SFB539 to A.R., C.Y.M., B.R., F.E.K., and J.H.B. and by an individual grant to B.H.F.W., both funded by the Deutsche Forschungsgerneinschaft (DFG).	Acharya M, 2006, MOL VIS, V12, P399; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Banfield MJ, 2001, STRUCTURE, V9, P1191, DOI 10.1016/S0969-2126(01)00681-5; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blesch A, 2006, BRAIN PATHOL, V16, P295, DOI 10.1111/j.1750-3639.2006.00036.x; Chakrabarti S, 2007, INVEST OPHTH VIS SCI, V48, P5439, DOI 10.1167/iovs.07-0629; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6; COHEN A, 1994, J NEUROBIOL, V25, P953, DOI 10.1002/neu.480250805; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Ghazi-Nouri SMS, 2008, EXP EYE RES, V86, P819, DOI 10.1016/j.exer.2008.02.010; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; GOTZ R, 1994, COMP BIOCHEM PHYS C, V108, P1, DOI 10.1016/1367-8280(94)90082-5; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; Harada C, 2005, INVEST OPHTH VIS SCI, V46, P669, DOI 10.1167/iovs.04-0826; Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P522, DOI 10.1007/BF02169199; JONAS JB, 1995, OPHTHALMOLOGY, V102, P1102; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEYDHECKER W, 1960, GLAUKOM HDB; Lutjen-Drecoll E, 2007, OPHTHALMOLOGE, V104, P167, DOI 10.1007/s00347-007-1481-5; Medeiros FA, 2002, DRUGS TODAY, V38, P563, DOI 10.1358/dot.2002.38.8.704676; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Murphy JA, 2006, MED HYPOTHESES, V67, P1208, DOI 10.1016/j.mehy.2006.04.049; Nickells RW, 1996, J GLAUCOMA, V5, P345; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; PASUTTO F, 2009, INVEST OPHTHALMOL VI; Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P270, DOI 10.1167/iovs.07-0500; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Robinson RC, 1999, PROTEIN SCI, V8, P2589; Rohrer B, 2001, EXP NEUROL, V172, P81, DOI 10.1006/exnr.2001.7795; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Sawai H, 1996, J NEUROSCI, V16, P3887; Schlotzer-Schrehardt U, 2008, AM J PATHOL, V173, P1724, DOI 10.2353/ajpath.2008.080535; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Taylor S, 2003, MOL BRAIN RES, V111, P189, DOI 10.1016/S0169-328X(03)00030-5; Tuck MW, 2003, OPHTHAL PHYSL OPT, V23, P175, DOI 10.1046/j.1475-1313.2003.00104.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weber YG, 2008, DEV MED CHILD NEUROL, V50, P648, DOI 10.1111/j.1469-8749.2008.03058.x; Weisschuh N, 2007, MOL VIS, V13, P724; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Wilkins MR, 1999, METH MOL B, V112, P531; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309	56	112	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					447	456		10.1016/j.ajhg.2009.08.016	http://dx.doi.org/10.1016/j.ajhg.2009.08.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19765683	Bronze, Green Published			2022-12-18	WOS:000270836000002
J	Arlt, MF; Mulle, JG; Schaibley, VM; Ragland, RL; Durkin, SG; Warren, ST; Glover, TW				Arlt, Martin F.; Mulle, Jennifer G.; Schaibley, Valerie M.; Ragland, Ryan L.; Durkin, Sandra G.; Warren, Stephen T.; Glover, Thomas W.			Replication Stress Induces Genome-wide Copy Number Changes in Human Cells that Resemble Polymorphic and Pathogenic Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; COMMON FRAGILE SITE; H-CADHERIN CDH13; MOLECULAR CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; HOMOZYGOUS DELETIONS; STRUCTURAL VARIATION; REARRANGEMENTS; GENE; DUPLICATIONS	Copy number variants (CNVs) are an important component of genomic variation in humans and other mammals. Similar de novo deletions and duplications, or copy number changes (CNCs), are now known to be a major cause of genetic and developmental disorders and to arise somatically in many cancers. A major mechanism leading to both CNVs and disease-associated CNCs is meiotic unequal crossing over, or nonallelic homologous recombination (NAHR), mediated by flanking repeated sequences or segmental duplications. Others appear to involve nonhomologous end joining (NHEJ) or aberrant replication suggesting a mitotic cell origin. Here we show that aphidicolin-induced replication stress in normal human cells leads to a high frequency of CNCs of tens to thousands of kilobases across the human genome that closely resemble CNVs and disease-associated CNCs. Most deletion and duplication breakpoint junctions were characterized by short (<6 bp) microhomologies, consistent with the hypothesis that these rearrangements were formed by NHEJ or a replication-coupled process, such as template switching. This is a previously unrecognized consequence of replication stress and Suggests that replication fork stalling and subsequent error-prone repair are important mechanisms in the formation of CNVs and pathogenic CNCs in humans.	[Arlt, Martin F.; Schaibley, Valerie M.; Ragland, Ryan L.; Durkin, Sandra G.; Glover, Thomas W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Mulle, Jennifer G.; Warren, Stephen T.] Emory Clin, Dept Human Genet, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Emory University	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	glover@umich.edu	Warren, Stephen T/A-2498-2012		NIH [CA43222]; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Matthew Butler and Beth Helgeson for their assistance in the sequencing of deletion breakpoints. This work was supported by NIH grant CA43222 to T.W.G.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Brunetti-Pierri N, 2007, CLIN GENET, V72, P411, DOI 10.1111/j.1399-0004.2007.00896.x; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Fiorenza MT, 2001, DEV BIOL, V233, P214, DOI 10.1006/dbio.2001.0199; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; HU XY, 1990, AM J HUM GENET, V46, P682; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Katsura Y, 2007, DNA REPAIR, V6, P639, DOI 10.1016/j.dnarep.2006.12.002; Kawakami M, 1999, INT J ONCOL, V15, P715; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kuhfittig-Kulle S, 2007, MUTAGENESIS, V22, P217, DOI 10.1093/mutage/gem007; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Natrajan R, 2008, J CLIN PATHOL, V61, P95, DOI 10.1136/jcp.2007.047159; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2006, CYTOGENET GENOME RES, V115, P303, DOI 10.1159/000095928; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stankiewicz P, 2003, COLD SPRING HARB SYM, V68, P445, DOI 10.1101/sqb.2003.68.445; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; White SJ, 2006, HUM MUTAT, V27, P938, DOI 10.1002/humu.20367; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027	49	112	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					339	350		10.1016/j.ajhg.2009.01.024	http://dx.doi.org/10.1016/j.ajhg.2009.01.024			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19232554	Green Published, Bronze			2022-12-18	WOS:000264304200005
J	Wycisk, KA; Zeitz, C; Feil, S; Wittmer, M; Forster, U; Neidhardt, J; Wissinger, B; Zrenner, E; Wilke, R; Kohl, S; Berger, W				Wycisk, Katharina Agnes; Zeitz, Christina; Feil, Silke; Wittmer, Mariana; Forster, Ursula; Neidhardt, John; Wissinger, Bernd; Zrenner, Eberhart; Wilke, Robert; Kohl, Susanne; Berger, Wolfgang			Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessive cone dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STATIONARY NIGHT BLINDNESS; ALPHA(2)DELTA SUBUNIT; CA2+ CHANNELS; MOUSE RETINA; GENE; BINDING	Retinal signal transmission depends on the activity of high voltage-gated L-type calcium channels in photoreceptor ribbon synapses. We recently identified a truncating frameshift mutation in the Cacna2d4 gene in a spontaneous mouse mutant with profound loss of retinal signaling and an abnormal morphology of ribbon synapses in rods and cones. The Cacna2d4 gene encodes an L-type calcium-channel auxiliary subunit of the alpha(2)delta type. Mutations in its human orthologue, CACNA2D4, were not yet known to be associated with a disease. We performed mutation analyses of 34 patients who received an initial diagnosis of night blindness, and, in two affected siblings, we detected a homozygous nucleotide substitution (c.2406C -> A) in CACNA2D4. The mutation introduces a premature stop codon that truncates one-third of the corresponding open reading frame. Both patients share symptoms of slowly progressing cone dystrophy. These findings represent the first report of a mutation in the human CACNA2D4 gene and define a novel gene defect that causes autosomal recessive cone dystrophy.	Univ Zurich, Div Med Mol Genet & Gene Diagnost, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; Univ Tubingen, Genet Mol Lab, Univ Eye Hosp Tubingen, Tubingen, Germany; Univ Tubingen, Dept Pathophysiol Vis & Neuroophthalmol, Univ Eye Hosp Tubingen, Tubingen, Germany	University of Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Berger, W (corresponding author), Univ Zurich, Div Med Mol Genet & Gene Diagnost, Inst Med Genet, Schorenstr 16, CH-8603 Schwerzenbach, Switzerland.	berger@medgen.unizh.ch	Neidhardt, John/J-4310-2017; Zeitz, Christina/F-2757-2017	Zeitz, Christina/0000-0002-3510-1712; Kohl, Susanne/0000-0002-6438-6331; Neidhardt, John/0000-0002-9205-8394				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Brown JP, 1998, J BIOL CHEM, V273, P25458, DOI 10.1074/jbc.273.39.25458; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Felix R, 1997, J NEUROSCI, V17, P6884; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; HILDEBRANDT G, 1984, EINFACHE METHODE ROU, P191; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Marmor MF, 1999, DOC OPHTHALMOL, V97, P143; MIYAKE Y, 1987, INVEST OPHTH VIS SCI, V28, P1816; Miyake Yozo, 2002, Nippon Ganka Gakkai Zasshi, V106, P737; Sipos I, 2000, PFLUG ARCH EUR J PHY, V439, P691, DOI 10.1007/s004240050994; Song HT, 2003, J NEUROPHYSIOL, V89, P1143, DOI 10.1152/jn.00482.2002; VINGRYS AJ, 1993, COLOUR VISION DEFICI, V11, P267; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	23	112	116	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					973	977		10.1086/508944	http://dx.doi.org/10.1086/508944			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033974	Green Published, Bronze			2022-12-18	WOS:000241667400019
J	Klaassens, M; van Dooren, M; Eussen, HJ; Douben, H; den Dekker, AT; Lee, C; Donahoe, PK; Galjaard, RJ; Goemaere, N; de Krijger, RR; Wouters, C; Wauters, J; Oostra, BA; Tibboel, D; de Klein, A				Klaassens, M; van Dooren, M; Eussen, HJ; Douben, H; den Dekker, AT; Lee, C; Donahoe, PK; Galjaard, RJ; Goemaere, N; de Krijger, RR; Wouters, C; Wauters, J; Oostra, BA; Tibboel, D; de Klein, A			Congenital Diaphragmatic hernia and chromosome 15q26: Determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-LANGE-SYNDROME; NIPPED-B; MALFORMATIONS; MUTATIONS; ANOMALIES; MOLECULE; DEFECTS; HOMOLOG; NIPBL	Congenital diaphragmatic hernia (CDH) has an incidence of 1 in 3,000 births and a high mortality rate (33%-58%). Multifactorial inheritance, teratogenic agents, and genetic abnormalities have all been suggested as possible etiologic factors. To define candidate regions for CDH, we analyzed cytogenetic data collected on 200 CDH cases, of which 7% and 5% showed numerical and structural abnormalities, respectively. This study focused on the most frequent structural anomaly found: a deletion on chromosome 15q. We analyzed material from three of our patients and from four previously published patients with CDH and a 15q deletion. By using array-based comparative genomic hybridization and fluorescent in situ hybridization to determine the boundaries of the deletions and by including data from two individuals with terminal 15q deletions but without CDH, we were able to exclude a substantial portion of the telomeric region from the genetic etiology of this disorder. Moreover, one patient with CDH harbored a small interstitial deletion. Together, these findings allowed us to define a minimal deletion region of similar to 5 Mb at chromosome 15q26.1-26.2. The region contains four known genes, of which two-NR2F2 and CHD2-are particularly intriguing gene candidates for CDH.	Erasmus MC, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Paediat Surg, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Pathol, Josephine Nefkens Inst, NL-3000 DR Rotterdam, Netherlands; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Pediat Surg Res Lab, Boston, MA 02114 USA; Univ Hosp Antwerpen, Dept Cytogenet, Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Antwerp	de Klein, A (corresponding author), Erasmus MC, Dept Clin Genet, Postbus 1738, NL-3000 DR Rotterdam, Netherlands.	a.deklein@erasmusmc.nl		den Dekker, Alexander/0000-0002-3353-8101; Wouters, Carine/0000-0002-6426-8845	NICHD NIH HHS [P01 HD039942, HD39942] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039942] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Beresford MW, 2000, PEDIATR PULM, V30, P249; Biggio JR, 2004, AM J MED GENET A, V126A, P183, DOI 10.1002/ajmg.a.20464; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; BUTLER MG, 1988, AM J MED GENET, V29, P149, DOI 10.1002/ajmg.1320290119; Chen CP, 1998, PRENATAL DIAG, V18, P1289, DOI 10.1002/(SICI)1097-0223(199812)18:12<1289::AID-PD432>3.0.CO;2-Y; DEJONG G, 1989, J MED GENET, V26, P469, DOI 10.1136/jmg.26.7.469; Enns GM, 1998, AM J MED GENET, V79, P215, DOI 10.1002/(SICI)1096-8628(19980923)79:3<215::AID-AJMG13>3.0.CO;2-K; FRYNS JP, 1979, HUM GENET, V50, P65, DOI 10.1007/BF00295591; Greer JJ, 2003, PEDIATR RES, V53, P726, DOI 10.1203/01.PDR.0000062660.12769.E6; Hengstschlager M, 2004, FETAL DIAGN THER, V19, P510, DOI 10.1159/000080164; Kimura Y, 2002, CLIN SCI, V103, P613, DOI 10.1042/cs1030613; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lurie IW, 2003, GENET COUNSEL, V14, P75; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Rogan PK, 1996, AM J MED GENET, V62, P10, DOI 10.1002/(SICI)1096-8628(19960301)62:1<10::AID-AJMG3>3.3.CO;2-5; ROSENBERG C, 1992, AM J HUM GENET, V50, P700; Schlembach D, 2001, PRENATAL DIAG, V21, P289, DOI 10.1002/pd.50; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tonks A, 2004, PRENATAL DIAG, V24, P596, DOI 10.1002/pd.908; TORFS CP, 1992, TERATOLOGY, V46, P555, DOI 10.1002/tera.1420460605; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407	22	112	114	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					877	882		10.1086/429842	http://dx.doi.org/10.1086/429842			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15750894	Green Published, Bronze			2022-12-18	WOS:000228198300014
J	Sun, F; Oliver-Bonet, M; Liehr, T; Starke, H; Ko, E; Rademaker, A; Navarro, J; Benet, J; Martin, RH				Sun, F; Oliver-Bonet, M; Liehr, T; Starke, H; Ko, E; Rademaker, A; Navarro, J; Benet, J; Martin, RH			Human male recombination maps for individual chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHIASMA DISTRIBUTION; CROSSING-OVER; SYNAPTONEMAL COMPLEXES; MEIOTIC RECOMBINATION; CENM-FISH; SPERM; SPERMATOCYTES; INTERFERENCE; REGION; MLH1	Meiotic recombination is essential for the segregation of chromosomes and the formation of normal haploid gametes, yet we know very little about the meiotic process in humans. We present the first ( to our knowledge) recombination maps for every autosome in the human male obtained by new immunofluorescence techniques followed by centromere-specific multicolor fluorescence in situ hybridization in human spermatocytes. The mean frequency of autosomal recombination foci was, corresponding to a genetic length of 2,490 cM. All autosomal 49.8 +/- 4.3 bivalents had at least one recombination focus. In contrast, the XY bivalent had a recombination focus in 73% of nuclei, suggesting that a relatively large proportion of spermatocytes may be at risk for nondisjunction of the XY bivalent or elimination by meiotic arrest. There was a very strong correlation between mean length of the synaptonemal complex (SC) and the number of recombination foci per SC. Each bivalent presented a distinct distribution of recombination foci, but in general, foci were near the distal parts of the chromosome, with repression of foci near the centromere. The position of recombination foci demonstrated positive interference, but, in rare instances, foci were very close to one another.	Alberta Childrens Prov Gen Hosp, Dept Genet, Calgary, AB T2T 5C7, Canada; Univ Calgary, Dept Med Genet, Calgary, AB, Canada; Inst Human Genet & Anthropol, Jena, Germany; Northwestern Univ, Sch Med, Ctr Canc, Biometry Sect, Chicago, IL 60611 USA; Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol, Bellaterra, Spain	Alberta Childrens Hospital; University of Calgary; University of Calgary; Northwestern University; Autonomous University of Barcelona	Martin, RH (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Genet, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	rhmartin@ucalgary.ca	Benet, Jordi/I-1690-2017; Liehr, Thomas/H-2852-2019; Sun, Fei/N-2850-2013	Benet, Jordi/0000-0001-6185-2555; Liehr, Thomas/0000-0003-1672-3054; Navarro, Joaquima/0000-0002-9245-2260; Oliver-Bonet, Maria/0000-0001-5635-6741				Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; HALE DW, 1994, CYTOGENET CELL GENET, V65, P278, DOI 10.1159/000133648; HARNDEN DG, 1985, BIRTH DEFECTS-ORIG, V21, P115; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Heng HHQ, 2001, GENOME, V44, P293, DOI 10.1139/gen-44-2-293; HULTEN M, 1974, HEREDITAS, V76, P55; HULTEN M, 1973, ADV HUM GENET, P327; HULTEN M, 2003, NATURE ENCY HUMAN GE, V2, P876; Ko E, 2001, CYTOGENET CELL GENET, V95, P143, DOI 10.1159/000059336; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Marcon E, 2003, GENETICS, V165, P2283; Martin RH, 1996, BIOL REPROD, V54, P394, DOI 10.1095/biolreprod54.2.394; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Nietzel A, 2001, HUM GENET, V108, P199, DOI 10.1007/s004390100459; Oliver-Bonet M, 2003, EUR J HUM GENET, V11, P879, DOI 10.1038/sj.ejhg.5201067; Pigozzi MI, 1999, GENOME, V42, P308, DOI 10.1139/gen-42-2-308; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; Tapper WJ, 2002, ANN HUM GENET, V66, P75, DOI 10.1017/S0003480001008946; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Wintle RF, 1997, GENOMICS, V40, P409, DOI 10.1006/geno.1996.4572	28	112	119	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					521	531		10.1086/382138	http://dx.doi.org/10.1086/382138			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973780	Bronze, Green Published			2022-12-18	WOS:000220118500018
J	Licht, CL; Stevnsner, T; Bohr, VA				Licht, CL; Stevnsner, T; Bohr, VA			Cockayne syndrome group B cellular and biochemical functions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; LIGHT-INDUCED APOPTOSIS; PCNA COMPLEX-FORMATION; PROTEIN FAMILY-MEMBER; INDUCED DNA-DAMAGE; CSB GENE-PRODUCT; XERODERMA-PIGMENTOSUM; HUMAN-FIBROBLASTS	The devastating genetic disorder Cockayne syndrome (CS) arises from mutations in the CSA and CSB genes. CS is characterized by progressive multisystem degeneration and is classified as a segmental premature-aging syndrome. The CS complementation group B (CSB) protein is at the interface of transcription and DNA repair and is involved in transcription-coupled and global genome-DNA repair, as well as in general transcription. Recent structure-function studies indicate a process-dependent variation in the molecular mechanism employed by CSB and provide a starting ground for a description of the mechanisms and their interplay.	NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; Aarhus Univ, Dept Mol Biol, Lab DNA Repair, DK-8000 Aarhus, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Aarhus University	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Licht, Cecilie Löe/AAR-3625-2020; Bohr, Vilhelm/AAP-5931-2020	Stevnsner, Tinna/0000-0003-1007-0427; Licht, Cecilie Loe/0000-0003-2220-2722	NATIONAL INSTITUTE ON AGING [Z01AG000731] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auble DT, 1999, MOL CELL BIOL, V19, P412; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Balajee AS, 1998, MUTAT RES-DNA REPAIR, V409, P135, DOI 10.1016/S0921-8777(98)00051-2; Balajee AS, 1999, NUCLEIC ACIDS RES, V27, P4476, DOI 10.1093/nar/27.22.4476; Balajee AS, 2000, ONCOGENE, V19, P477, DOI 10.1038/sj.onc.1203372; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Brosh RM, 1999, MOL BIOL CELL, V10, P3583, DOI 10.1091/mbc.10.11.3583; Christiansen M, 2003, NUCLEIC ACIDS RES, V31, P963, DOI 10.1093/nar/gkg164; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Cockayne E A, 1936, Arch Dis Child, V11, P1; Colella S, 1999, HUM MOL GENET, V8, P935, DOI 10.1093/hmg/8.5.935; Colella S, 2000, HUM MOL GENET, V9, P1171, DOI 10.1093/hmg/9.8.1171; Conconi A, 2002, P NATL ACAD SCI USA, V99, P649, DOI 10.1073/pnas.022373099; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; De Santis LP, 2002, DNA REPAIR, V1, P209, DOI 10.1016/S1568-7864(01)00017-9; De Santis LP, 2001, MUTAT RES-DNA REPAIR, V485, P121, DOI 10.1016/S0921-8777(00)00065-3; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Dollfus H, 2003, SURV OPHTHALMOL, V48, P107, DOI 10.1016/S0039-6257(02)00400-9; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Gowen LC, 2003, SCIENCE, V300, P1657; Gregory SM, 2001, NUCLEIC ACIDS RES, V29, P3080, DOI 10.1093/nar/29.14.3080; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hara R, 1999, J BIOL CHEM, V274, P24779, DOI 10.1074/jbc.274.35.24779; Hayashi M, 2001, J NEUROPATH EXP NEUR, V60, P350, DOI 10.1093/jnen/60.4.350; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Itoh M, 1999, BRAIN DEV-JPN, V21, P326, DOI 10.1016/S0387-7604(99)00033-9; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jensen A, 2003, J BIOL CHEM, V278, P19541, DOI 10.1074/jbc.M301504200; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Kyng KJ, 2003, ONCOGENE, V22, P1135, DOI 10.1038/sj.onc.1206187; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Leadon SA, 2003, CANCER RES, V63, P3846; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lindenbaum Y, 2001, Eur J Paediatr Neurol, V5, P225, DOI 10.1053/ejpn.2001.0523; Ljungman M, 1996, ONCOGENE, V13, P823; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Mahmoud AAH, 2002, AM J MED GENET, V111, P81, DOI 10.1002/ajmg.10492; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; MAYNE LV, 1984, MUTAT RES, V131, P187, DOI 10.1016/0167-8817(84)90023-3; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; McKay BC, 2001, MUTAT RES-DNA REPAIR, V485, P93, DOI 10.1016/S0921-8777(00)00064-1; Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Muftuoglu M, 2002, GENE, V283, P27, DOI 10.1016/S0378-1119(01)00870-8; MULLENDERS LHF, 1988, NUCLEIC ACIDS RES, V16, P10607, DOI 10.1093/nar/16.22.10607; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; Orren DK, 1996, NUCLEIC ACIDS RES, V24, P3317, DOI 10.1093/nar/24.17.3317; Osterod M, 2002, ONCOGENE, V21, P8232, DOI 10.1038/sj.onc.1206027; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Pickart CM, 2002, NATURE, V419, P120, DOI 10.1038/419120a; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Selzer RR, 2002, NUCLEIC ACIDS RES, V30, P782, DOI 10.1093/nar/30.3.782; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SNYDERWINE EG, 1992, CANCER RES, V52, P4183; Spivak G., 2003, DNA Repair, V2, P235, DOI 10.1016/S1568-7864(02)00197-0; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Sunesen M, 2002, ONCOGENE, V21, P3571, DOI 10.1038/sj.onc.1205443; Sunesen M, 2000, NUCLEIC ACIDS RES, V28, P3151, DOI 10.1093/nar/28.16.3151; Surralles J, 2002, P NATL ACAD SCI USA, V99, P10571, DOI 10.1073/pnas.162278199; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; TANG MS, 1989, J BIOL CHEM, V264, P14455; Tantin D, 1998, J BIOL CHEM, V273, P27794, DOI 10.1074/jbc.273.43.27794; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4; Travers A, 1999, CELL, V96, P311, DOI 10.1016/S0092-8674(00)80543-7; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Trzcinska AM, 2002, MOL BIOL REP, V29, P347, DOI 10.1023/A:1021237021338; Tu YQ, 1997, J BIOL CHEM, V272, P20747, DOI 10.1074/jbc.272.33.20747; Tuo J, 2001, J BIOL CHEM, V276, P45772, DOI 10.1074/jbc.M107888200; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; van Oosterwijk MF, 1998, J BIOL CHEM, V273, P13599, DOI 10.1074/jbc.273.22.13599; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; WADE MH, 1979, MUTAT RES, V59, P49, DOI 10.1016/0027-5107(79)90194-5; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	108	112	115	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1217	1239		10.1086/380399	http://dx.doi.org/10.1086/380399			23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14639525	Green Published, Bronze			2022-12-18	WOS:000187491100001
J	Glaser, RL; Broman, KW; Schulman, RL; Eskenazi, B; Wyrobek, AJ; Jabs, EW				Glaser, RL; Broman, KW; Schulman, RL; Eskenazi, B; Wyrobek, AJ; Jabs, EW			The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CROUZON-SYNDROME; FGFR2 MUTATIONS; PARENTAL AGE; ORIGIN; PREVALENCE; REPAIR	A paternal-age effect and the exclusive paternal origin of mutations have been reported in Apert syndrome (AS). As the incidence of sporadic AS births increases exponentially with paternal age, we hypothesized that the frequency of AS mutations in sperm would also increase. To determine the frequency of two common FGFR2 mutations in AS, we developed allele-specific peptide nucleic acid-PCR assays. Analyzing sperm DNA from 148 men, age 21-80 years, we showed that the number of sperm with mutations increased in the oldest age groups among men who did not have a child with AS. These older men were also more likely to have both mutations in their sperm. However, this age-related increase in mutation frequency was not sufficient to explain the AS-birth frequency. In contrast, the mutation frequency observed in men who were younger and had children with AS was significantly greater. In addition, our data suggest selection for sperm with specific mutations. Therefore, contributing factors to the paternal-age effect may include selection and a higher number of mutant sperm in a subset of men ascertained because they had a child with AS. No age-related increase in the frequency of these mutations was observed in leukocytes. Selection and/or quality-control mechanisms, including DNA repair and apoptosis, may contribute to the cell-type differences in mutation frequency.	Johns Hopkins Univ, Sch Med, Dept Pediat,CMSC 1004, Ctr Craniofacial Dev & Disorders,Inst Genet Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21287 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Jabs, EW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat,CMSC 1004, Ctr Craniofacial Dev & Disorders,Inst Genet Med, 600 N Wolfe St, Baltimore, MD 21287 USA.			Jabs, Ethylin/0000-0001-8983-5466; Wyrobek, Andrew/0000-0002-5921-5298; Broman, Karl/0000-0002-4914-6671	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NIDCR NIH HHS [P60 DE013078, P60 DE13078, R01 DE1441] Funding Source: Medline; NIEHS NIH HHS [P42 ES004705, P42 ES04705] Funding Source: Medline; NIGMS NIH HHS [T32 GM07814, T32 GM007814] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLANK CE, 1960, ANN HUM GENET, V24, P151; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Hurst LD, 2002, NATURE, V420, P365, DOI 10.1038/420365a; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Intano GW, 2002, MOL CELL BIOL, V22, P2410, DOI 10.1128/MCB.22.7.2410-2418.2002; Manly B. F., 1997, RANDOMIZATION BOOTST; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; PARK WJ, 1995, AM J HUM GENET, V57, P321; PENROSE LS, 1955, LANCET, V2, P312; RISCH N, 1987, AM J HUM GENET, V41, P218; Schuffenecker I, 1997, AM J HUM GENET, V60, P233; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Vani RG, 1997, GENE, V185, P19; VOGEL F, 1975, ADV HUM GENET, V5, P223; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	24	112	118	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					939	947		10.1086/378419	http://dx.doi.org/10.1086/378419			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12900791	Green Published, Bronze			2022-12-18	WOS:000185676100019
J	Feitosa, MF; Borecki, IB; Rich, SS; Arnett, DK; Sholinsky, P; Myers, RH; Leppert, M; Province, MA				Feitosa, MF; Borecki, IB; Rich, SS; Arnett, DK; Sholinsky, P; Myers, RH; Leppert, M; Province, MA			Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: The National Heart, Lung, and Blood Institute Family Heart Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR GENE POLYMORPHISM; AUTOSOMAL GENOMIC SCAN; RESTING METABOLIC-RATE; SIB-PAIR ANALYSIS; HUMAN OB GENE; QUEBEC FAMILY; LINKAGE ANALYSIS; EXTREME OBESITY; RESPIRATORY QUOTIENT; SUSCEPTIBILITY LOCUS	Obesity is a risk factor for many chronic diseases, including glucose intolerance, lipid disorders, hypertension, and coronary heart disease. Even though the body-mass index (BMI) is a heterogeneous phenotype reflecting the amount of fat, lean mass, and body build, several studies have provided evidence of one or two major loci contributing to the variation in this complex trait. We sought to identify loci with potential influence on BMI in the data obtained from National Heart, Lung, and Blood Institute Family Heart Study. Two complementary samples were studied: (a) 1, 184 subjects in 317 sibships, with 243 markers typed by the Utah Molecular Genetics Laboratory (UMGL) and (b) 3,027 subjects distributed among 401 three-generation families, with 404 markers typed by the Mammalian Genotyping Service (MGS). A genome scan using a variance-components-based linkage approach was performed for each sample, as well as for the combined sample, in which the markers from each analysis were placed on a common genetic map. There was strong evidence for linkage on chromosome 7q32.3 in each sample: the maximum multipoint LOD scores were 4.7 (P<10(-3)) at marker GATA43C11 and 3.2 (P = .00007) at marker D7S1804, for the MGS and UMGL samples, respectively. The linkage result is replicated by the consistent evidence from these two complementary subsets. Furthermore, the evidence for linkage was maintained in the combined sample, with a LOD score of 4.9 (P<10(-5)) for both markers, which map to the same location. This signal is very near the published location for the leptin gene, which is the most prominent candidate gene in this region. For the combined-sample analysis, evidence of linkage was also found on chromosome 13q14, with D13S257 (LOD score 3.2, P = .00006), and other, weaker signals (LOD scores 1.5-1. 9) were found on chromosomes 1, 2, 3, 5, 6, 14, and 15.	Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; NHLBI, Epidemiol & Biometry Program, NIH, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA	Washington University (WUSTL); Washington University (WUSTL); Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Utah System of Higher Education; University of Utah	Feitosa, MF (corresponding author), Washington Univ, Sch Med, Div Biostat, Campus Box 8067,660 S Euclid, St Louis, MO 63110 USA.		Feitosa, Mary F/K-8044-2012	Feitosa, Mary F/0000-0002-0933-2410; Rich, Stephen/0000-0003-3872-7793; Myers, Richard/0000-0002-8365-2674	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL056567, U01HL056565, U01HL056564, U01HL056569, U01HL056568, U01HL056563, U01HL056566] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL56563, U01 HL056567, U01 HL56565, U01 HL56564, U01 HL56568, U01 HL56567, U01 HL56566, U01 HL56569] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; Allison DB, 1998, GENETICS, V148, P859; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Atwood LD, 2001, GENET EPIDEMIOL, V20, P373, DOI 10.1002/gepi.7; Aubert R, 2000, INT J OBESITY, V24, P920, DOI 10.1038/sj.ijo.0801253; Borecki I B, 1994, Obes Res, V2, P213; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BORECKI IB, 1991, INT J OBESITY, V15, P763; Borecki IB, 1998, AM J HUM GENET, V63, P831, DOI 10.1086/302006; BORECKI IB, 1993, AM J HUM GENET, V53, P676; Borecki IB, 1999, GENET EPIDEMIOL, V17, pS73; BORECKI IB, 1999, GENET EPIDEMIOL, V17, P212; Bouchard C., 1998, HDB OBESITY, P157; Bray MS, 1999, GENET EPIDEMIOL, V16, P397; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cheng LSC, 2000, HYPERTENSION, V36, P718; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Clement K, 1999, DIABETES, V48, P398, DOI 10.2337/diabetes.48.2.398; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; de Andrade M, 2000, GENET EPIDEMIOL, V19, P333, DOI 10.1002/1098-2272(200012)19:4<333::AID-GEPI5>3.3.CO;2-R; DERIAZ O, 1994, J CLIN INVEST, V93, P838, DOI 10.1172/JCI117038; Duggirala R, 1996, AM J HUM GENET, V59, P694; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hasstedt SJ, 1997, AM J HUM GENET, V61, P668, DOI 10.1086/515509; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; HINDS D, 1998, ASPEX PACKAGE AFFECT; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Ishihara K, 1999, INT J NEUROPSYCHOP, V2, P101, DOI 10.1017/S1461145799001467; Katzmarzyk PT, 1999, J CLIN ENDOCR METAB, V84, P2093, DOI 10.1210/jc.84.6.2093; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Knoblauch H, 2000, AM J HUM GENET, V66, P157, DOI 10.1086/302704; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kumanyika SK, 2001, ANNU REV PUBL HEALTH, V22, P293, DOI 10.1146/annurev.publhealth.22.1.293; Lapsys NM, 1997, OBES RES, V5, P430; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; LEIBOWITZ SF, 1990, DRUGS, V39, P33, DOI 10.2165/00003495-199000393-00005; Lorentzon M, 1999, J CLIN ENDOCR METAB, V84, P4597, DOI 10.1210/jc.84.12.4597; Mandal DM, 2000, HUM HERED, V50, P126, DOI 10.1159/000022900; Meirhaeghe A, 1999, LANCET, V353, P896, DOI 10.1016/S0140-6736(99)00251-2; Mitchell BD, 1999, DIABETES, V48, P1863, DOI 10.2337/diabetes.48.9.1863; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; PRICE RA, 1990, HUM BIOL, V62, P747; PROVINCE MA, 1990, AM J HUM GENET S, V47, pA143; PROVINCE MA, IN PRESS GENET EPIDE; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; Rice T, 1999, GENET EPIDEMIOL, V16, P316; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Roth H, 1997, EXP CLIN ENDOCR DIAB, V105, P341, DOI 10.1055/s-0029-1211776; VANITALLIE TB, 1985, RECENT ADV OBESITY R, V4; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Yamada K, 1999, J CLIN ENDOCR METAB, V84, P1754, DOI 10.1210/jc.84.5.1754	65	112	119	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					72	82		10.1086/338144	http://dx.doi.org/10.1086/338144			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11713718	Bronze, Green Published			2022-12-18	WOS:000172571900008
J	Pratt, SC; Daly, MJ; Kruglyak, L				Pratt, SC; Daly, MJ; Kruglyak, L			Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; SIB-PAIR; EXTENSIONS	Methods based on variance components are powerful tools for linkage analysis of quantitative traits, because they allow simultaneous consideration of all pedigree members. The central idea is to identify loci making a significant contribution to the population variance of a trait, by use of allele-sharing probabilities derived from genotyped marker loci. The technique is only as powerful as the methods used to infer these probabilities, but, to date, no implementation has made full use of the inheritance information in mapping data. Here we present a new implementation that uses an exact multipoint algorithm to extract the full probability distribution of allele sharing at every point in a mapped region. At each locus in the region, the program fits a model that partitions total phenotypic variance into components due to environmental factors, a major gene at the locus, and other unlinked genes. Numerical methods are used to derive maximum-likelihood estimates of the variance components, under the assumption of multivariate normality A likelihood-ratio test is then applied to detect any significant effect of the hypothesized major gene. Simulations show the method to have greater power than does traditional sib-pair analysis. The method is freely available in a new release of the software package GENEHUNTER.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Fred Hutchinson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute	Kruglyak, L (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D4-100, Seattle, WA 98109 USA.		Daly, Mark J/B-2453-2017; Pratt, Stephen/C-5418-2011	Daly, Mark J/0000-0002-0949-8752; 				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; JENNRICH RI, 1976, TECHNOMETRICS, V18, P11, DOI 10.2307/1267911; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F	18	112	116	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1153	1157		10.1086/302830	http://dx.doi.org/10.1086/302830			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712227	Bronze, Green Published			2022-12-18	WOS:000088373200035
J	Umbach, DH; Weinberg, CR				Umbach, DH; Weinberg, CR			The use of case-parent triads to study joint meets of genotype and exposure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENES; ASSOCIATION; DISEASE; TESTS	Most noninfectious disease is caused by low-penetrance alleles interacting with other genes and environmental factors. Consider the simple setting where a diallelic autosomal candidate gene and a binary exposure together affect disease susceptibility. Suppose that one has genotyped affected probands and their parents and has determined each proband's exposure status. One proposed method for assessment of etiologic interaction of genotype and exposure, an extension of the transmission/disequilibrium test, tests for differences in transmission of the variant allele from heterozygous parents to exposed versus unexposed probands. We show that this test is not generally valid. An alternative approach compares the conditional genotype distribution of unexposed cases, given parental genotypes, versus that of exposed cases. This approach provides maximum-likelihood estimators for genetic relative-risk parameters and genotype-exposure-interaction parameters, as well as a likelihood-ratio test (LRT) of the no-interaction null hypothesis. We show how to apply this approach, using log-linear models. When a genotype-exposure association arises solely through incomplete mixing of subpopulations that differ in both exposure prevalence and allele frequency, the LRT remains valid. The LRT becomes invalid, however, if offspring genotypes do not follow Mendelian proportions in each parental mating type-for example, because of genotypic differences in survival-or if a genotype-exposure association reflects an influence of genotype on propensity for exposure-for example, through behavioral mechanisms. Because the needed assumptions likely hold in many situations, the likelihood-based approach should be broadly applicable for diseases in which probands commonly have living parents.	NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Umbach, DH (corresponding author), NIEHS, Biostat Branch, NIH, MD A3-03,POB 12233, Res Triangle Pk, NC 27709 USA.			Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES045002, ZIAES045002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Chen WJ, 1998, ALCOHOL CLIN EXP RES, V22, P1048, DOI 10.1111/j.1530-0277.1998.tb03697.x; ENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141, DOI 10.1111/j.1530-0277.1991.tb00532.x; Flanders WD, 1996, AM J EPIDEMIOL, V144, P696; Harley JB, 1995, GENET EPIDEMIOL, V12, P607, DOI 10.1002/gepi.1370120614; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KHOURY MJ, 1994, AM J HUM GENET, V55, P414; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, Vsecond, P329; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P261, DOI 10.1002/(SICI)1098-2272(1999)16:3<261::AID-GEPI3>3.0.CO;2-M; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Sherman SL, 1997, EPIDEMIOL REV, V19, P44, DOI 10.1093/oxfordjournals.epirev.a017945; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tsai AF, 1998, J REPROD IMMUNOL, V40, P147, DOI 10.1016/S0165-0378(98)00073-4; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Witte JS, 1999, AM J EPIDEMIOL, V149, P693	22	112	117	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					251	261		10.1086/302707	http://dx.doi.org/10.1086/302707			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631155	Bronze, Green Published			2022-12-18	WOS:000085033600026
J	Saar, K; Al-Gazali, L; Sztriha, L; Rueschendorf, F; Nur-E-Kamal, M; Reis, A; Bayoumi, R				Saar, K; Al-Gazali, L; Sztriha, L; Rueschendorf, F; Nur-E-Kamal, M; Reis, A; Bayoumi, R			Homozygosity mapping in families with Joubert syndrome identifies a locus on chromosome 9q34.3 and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; EXPRESSION; CHILDREN; MAP	Joubert syndrome is a rare developmental defect of the cerebellar vermis, with autosomal recessive inheritance, The phenotype is highly variable and may include episodic hyperpnea, abnormal eye movements, hypotonia, ataxia, developmental delay, and mental retardation. Even within sibships the phenotype may vary, making it difficult to establish the exact clinical diagnostic boundaries of Joubert syndrome, To genetically localize the gene region, we have performed a whole-genome scan in two consanguineous families of Arabian/Iranian origins, with multiple affected probands. In one family we detected linkage to the telomeric region of chromosome 9q, close to the marker D9S158, with a multipoint LOD score of Z = +3.7. The second family did not show linkage to this region, giving a first indication of genetic heterogeneity underlying Joubert syndrome. These findings were supported by subsequent analysis of two smaller families-one compatible with linkage to 9q; the other, unlinked. We conclude that Joubert syndrome is clinically and genetically heterogeneous and that one locus maps to chromosome 9q.	Sultan Qaboos Univ, Coll Med, Dept Biochem, Muscat 123, Oman; Max Delbruck Ctr Mol Med, Mikrosatellitenzentrum, Berlin, Germany; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	Sultan Qaboos University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United Arab Emirates University; United Arab Emirates University	Bayoumi, R (corresponding author), Sultan Qaboos Univ, Coll Med, Dept Biochem, POB 35, Muscat 123, Oman.	bayoumi@omantel.net.om	Bayoumi, Riad/ABH-2732-2020; Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Bayoumi, Riad/0000-0001-8177-8129; Saar, Kathrin/0000-0002-4483-1557				BOLTSHAUSER E, 1977, NEUROPADIATRIE, V8, P57, DOI 10.1055/s-0028-1091505; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Matsumoto K, 1996, NEUROSCI LETT, V211, P147, DOI 10.1016/0304-3940(96)12749-X; OTT J, 1986, GENET EPIDEMIOL, P251; PARR BA, 1993, DEVELOPMENT, V119, P247; Pellegrino JE, 1997, AM J MED GENET, V72, P59, DOI 10.1002/(SICI)1096-8628(19971003)72:1<59::AID-AJMG12>3.0.CO;2-T; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sidman R, 1982, HISTOL HISTOPATHOL, P94; Steinlin M, 1997, NEUROPEDIATRICS, V28, P204, DOI 10.1055/s-2007-973701; Sztriha L, 1999, PEDIATR NEUROL, V20, P274, DOI 10.1016/S0887-8994(98)00154-4; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Wu HK, 1996, ONCOGENE, V12, P1205; ZHADANOV AB, 1995, GENOMICS, V27, P27, DOI 10.1006/geno.1995.1004	21	112	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1666	1671		10.1086/302655	http://dx.doi.org/10.1086/302655			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577920	Green Published, Bronze			2022-12-18	WOS:000084282500021
J	Seppala, R; Lehto, VP; Gahl, WA				Seppala, R; Lehto, VP; Gahl, WA			Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID STORAGE DISEASE; FREE SIALIC-ACID; FIRST 2 STEPS; ACETYLNEURAMINIC ACID; SALLA DISEASE; RAT-LIVER; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; FIBROBLASTS; METABOLISM; DISORDER	Sialuria is a rare inborn error of metabolism characterized by cytoplasmic accumulation and increased urinary excretion of free N-acetylneuraminic acid (NeuAc, sialic acid). Overproduction of NeuAc is believed to result from loss of feedback inhibition of uridinediphosphate-N-acetylglucosamine 2-epimerase (UDP-GlcNAc 2-epimerase) by cytidine monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac). We report the cloning and characterization of human UDP-GlcNAc 2-epimerase cDNA, with mutation analysis of three patients with sialuria. Their heterozygote mutations, R266W; R266Q, and R263L, indicate that the allosteric site of the epimerase resides in the region of codons 263-266. The heterozygous nature of the mutant allele in all three patients reveals a dominant mechanism of inheritance for sialuria.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Oulu Univ, Dept Pathol, SF-90220 Oulu, Finland	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oulu	Gahl, WA (corresponding author), NICHD, NIH, 10 Ctr Dr,MSC 1830,Bldg 10,Room 9S-241, Bethesda, MD 20892 USA.				NIDDK NIH HHS [DK48796] Funding Source: Medline; PHS HHS [M01-00064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048796] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AULA P, 1979, ARCH NEUROL-CHICAGO, V36, P88, DOI 10.1001/archneur.1979.00500380058006; BAUDET AL, 1995, METABOLIC MOL BASES, P2529; BLOM HJ, 1990, BIOCHEM J, V268, P621, DOI 10.1042/bj2680621; DON NA, 1991, J INHERIT METAB DIS, V14, P942, DOI 10.1007/BF01800480; GAHL WA, 1996, HDB CLIN NEUROLOGY, V22, P353; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; KRASNEWICH DM, 1993, BIOCHEM MED METAB B, V49, P90, DOI 10.1006/bmmb.1993.1010; MANCINI GMS, 1986, HUM GENET, V73, P214, DOI 10.1007/BF00401229; MONTREUI.J, 1968, CLIN CHIM ACTA, V21, P61, DOI 10.1016/0009-8981(68)90011-9; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; RENLUND M, 1983, NEUROLOGY, V33, P57, DOI 10.1212/WNL.33.1.57; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; SEPPALA R, 1991, J BIOL CHEM, V266, P7456; SEPPALA R, 1990, LAB INVEST, V63, P197; SOMMAR KM, 1972, BIOCHIM BIOPHYS ACTA, V268, P581, DOI 10.1016/0005-2744(72)90355-5; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; STEVENSON RE, 1983, PEDIATRICS, V72, P441; THOMAS GH, 1985, PEDIATR RES, V19, P451, DOI 10.1203/00006450-198505000-00009; TIETZE F, 1989, J BIOL CHEM, V264, P15316; TONDEUR M, 1982, EUR J PEDIATR, V139, P142, DOI 10.1007/BF00441499; WEISS P, 1989, J BIOL CHEM, V264, P17635; WILCKEN B, 1987, J INHERIT METAB DIS, V10, P97, DOI 10.1007/BF01800030	27	112	122	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1563	1569		10.1086/302411	http://dx.doi.org/10.1086/302411			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330343	Green Published, Bronze			2022-12-18	WOS:000080696200008
J	Tavormina, PL; Bellus, GA; Webster, MK; Bamshad, MJ; Fraley, AE; McIntosh, I; Szabo, J; Jiang, W; Jabs, EW; Wilcox, WR; Wasmuth, JJ; Donoghue, DJ; Thompson, LM; Francomano, CA				Tavormina, PL; Bellus, GA; Webster, MK; Bamshad, MJ; Fraley, AE; McIntosh, I; Szabo, J; Jiang, W; Jabs, EW; Wilcox, WR; Wasmuth, JJ; Donoghue, DJ; Thompson, LM; Francomano, CA			A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINE KINASE DOMAIN; THANATOPHORIC DYSPLASIA; TRANSMEMBRANE DOMAIN; FGFR3 MUTATIONS; POINT MUTATION; ACHONDROPLASIA; ACTIVATION; HYPOCHONDROPLASIA; DWARFISM; SUBSTITUTION	We have identified a novel fibroblast growth factor receptor 3 (FGFR3) missense mutation in four unrelated individuals with skeletal dysplasia that approaches the severity observed in thanatophoric dysplasia type I (TD1), However, three of the four individuals developed extensive areas of acanthosis nigricans beginning in early childhood, suffer from severe neurological impairments, and have survived past infancy without prolonged life-support measures. The FGFR3 mutation (A1949T: Lys650Met) occurs at the nucleotide adjacent to the TD type II (TD2) mutation (A1948G: Lys650Glu) and results in a different amino acid substitution at a highly conserved codon in the kinase domain activation loop. Transient transfection studies with FGFR3 mutant constructs show that the Lys650Met mutation causes a dramatic increase in constitutive receptor kinase activity, approximately three times greater than that observed with the Lys650Glu mutation, We refer to the phenotype caused by the Lys650Met mutation as "severe achondroplasia with developmental delay and acanthosis nigricans" (SADDAN) because it differs significantly from the phenotypes of other known FGFR3 mutations.	Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; Univ Calif San Diego, Ctr Mol Genet, San Diego, CA 92103 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT USA; Johns Hopkins Univ, Sch Med, Ctr Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Craniofacial Dev, Baltimore, MD 21205 USA; Burns & Allen Cedars Sinai Res Inst, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Francomano, CA (corresponding author), Natl Human Genome Res Inst, Med Genet Branch, NIH, Rm 10C-101,MSC 1852,10 Ctr Dr, Bethesda, MD 20892 USA.	clairf@nhgri.nih.gov	Jiang, Wen G./AAF-1876-2020; jiang, wen/GYI-9662-2022	Jiang, Wen G./0000-0002-3283-1111; Bellus, Gary/0000-0001-7492-3324; Jabs, Ethylin/0000-0001-8983-5466; Jiang, Wen/0000-0002-3916-8826	NCI NIH HHS [CA40573] Funding Source: Medline; NIDCR NIH HHS [DE12581, DE11441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012581, R01DE011441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Baker KM, 1997, AM J MED GENET, V70, P427, DOI 10.1002/(SICI)1096-8628(19970627)70:4<427::AID-AJMG18>3.0.CO;2-J; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Bellus GA, 1996, ANN NY ACAD SCI, V785, P182, DOI 10.1111/j.1749-6632.1996.tb56257.x; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bellus GA, 1997, AM J HUM GENET, V61, pA326; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; HALL J G, 1969, Birth Defects Original Article Series, V5, P24; HO KL, 1984, ACTA NEUROPATHOL, V63, P218, DOI 10.1007/BF00685248; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Langer L O Jr, 1987, Am J Med Genet Suppl, V3, P167; MACDONALD IM, 1989, AM J MED GENET, V33, P508, DOI 10.1002/ajmg.1320330420; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Muenke M, 1997, AM J HUM GENET, V60, P555; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; NISHIMURA G, 1995, AM J MED GENET, V59, P393, DOI 10.1002/ajmg.1320590325; Norman A M, 1992, Clin Dysmorphol, V1, P115; PRINOS P, 1995, HUM MOL GENET, V4, P2097, DOI 10.1093/hmg/4.11.2097; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SHIGEMATSU H, 1985, BRAIN DEV-JPN, V7, P628, DOI 10.1016/S0387-7604(85)80013-9; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; SUPERTIFURGA A, 1995, EUR J PEDIATR, V154, P215, DOI 10.1007/BF01954274; TAVORMINA PL, 1995, HUM MOL GENET, V4, P2175, DOI 10.1093/hmg/4.11.2175; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WALKER BA, 1971, AM J DIS CHILD, V122, P95, DOI 10.1001/archpedi.1971.02110020029001; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1996, MOL CELL BIOL, V16, P4081; WONGMONGKOLRIT T, 1983, ARCH PATHOL LAB MED, V107, P132	39	112	124	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					722	731		10.1086/302275	http://dx.doi.org/10.1086/302275			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053006	Bronze, Green Published			2022-12-18	WOS:000079204700009
J	Semino, O; Passarino, G; Brega, A; Fellous, M; SantachiaraBenerecetti, AS				Semino, O; Passarino, G; Brega, A; Fellous, M; SantachiaraBenerecetti, AS			A view of the neolithic demic diffusion in Europe through two Y chromosome-specific markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							POLYMORPHISMS; POPULATIONS; HAPLOTYPES; PROBE; JEWS		UNIV PAVIA, DIPARTIMENTO GENET & MICROBIOL, I-27100 PAVIA, ITALY; UNIV CALABRIA, DIPARTIMENTO BIOL CELLULARE, I-87036 COSENZA, ITALY; UNIV MILAN, DIPARTIMENTO BIOL & GENET SCI MED, MILAN, ITALY; INST PASTEUR, PARIS, FRANCE	University of Pavia; University of Calabria; University of Milan; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				SEMINO, Ornella/0000-0002-9675-9403				Ammerman A.J., 1984, NEOLITHIC TRANSITION; ARANZADI T, 1889, PUEBLO EUSKALDUNA DI; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; BOSCHGIMPERA A, 1943, EUSKO JAKINTZA, V3, P39; Brega A, 1987, Gene Geogr, V1, P201; BREUIL S, 1987, ANN GENET-PARIS, V30, P209; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; EXCOFFIER L, IN PRESS MOL BIOL HU; LIU A, 1994, 26 ANN M EUR SOC HUM; Lucotte G, 1990, Gene Geogr, V4, P21; LUCOTTE G, 1993, HUM BIOL, V65, P835; LUCOTTE G, 1992, HUM BIOL, V64, P757; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MITCHELL RJ, 1993, HUM BIOL, V65, P387; NGO KY, 1986, AM J HUM GENET, V38, P407; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Piazza A, 1988, MUNIBE S, V6, P169; RENFREW C, 1989, CAMB ARCHAEOL J, V1, P3; SANTACHIARABENE.AS, 1994, AM J HUM GENET S, V55, pA164; SFORZA LLC, 1988, MUNIBE S, V6, P129; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; TORRONI A, 1990, ANN HUM GENET, V54, P287; TORRONI A, 1994, AM J HUM GENET, V54, P303	26	112	113	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					964	968						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808616				2022-12-18	WOS:A1996VL28300030
J	DeteraWadleigh, SD; Badner, JA; Goldin, LR; Berrettini, WH; Sanders, AR; Rollins, DY; Turner, G; Moses, T; Haerian, H; Muniec, D; Nurnberger, JI; Gershon, ES				DeteraWadleigh, SD; Badner, JA; Goldin, LR; Berrettini, WH; Sanders, AR; Rollins, DY; Turner, G; Moses, T; Haerian, H; Muniec, D; Nurnberger, JI; Gershon, ES			Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; X-CHROMOSOME MARKERS; LINKAGE ANALYSIS; PEDIGREES; GENE; DISEASE	In 22 multiplex pedigrees screened for linkage to bipolar disorder, by use of 18 markers on chromosome 21q, single-locus affected-sib-pair (ASP) analysis detected a high proportion (57%-62%) of alleles shared identical by descent (IBD), with P values of .049-.0008 on nine marker loci. Multilocus ASP analyses revealed locus trios in the distal region between D21S270 and D21S171, with excess allele sharing (nominal P values <.01) under two affection-status models, ASM I (bipolars and schizoaffectives) and ASM II (ASM I plus recurrent unipolars). In addition, under ASM I, the proximal interval spanned by D21S1436 and D21S65 showed locus trios with excess allele sharing (nominal P values of .03-.0003). These findings support prior evidence that a susceptibility locus for bipolar disorder is on 21q.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PSYCHIAT & HUMAN BEHAV,PHILADELPHIA,PA 19107; INDIANA UNIV,INST PSYCHIAT RES,DEPT PSYCHIAT,INDIANAPOLIS,IN	Jefferson University; Indiana University System; Indiana University-Purdue University Indianapolis	DeteraWadleigh, SD (corresponding author), NIMH,UNIT GENE MAPPING & EXPRESS,CLIN NEUROGENET BRANCH,NIH,BLDG 10,ROOM 3N218,BETHESDA,MD 20892, USA.			Nurnberger, John/0000-0002-7674-1767				BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; Berrettini Wade H., 1991, Psychiatric Genetics, V2, P125, DOI 10.1097/00041444-199124000-00002; BERRETTINI WH, 1990, ARCH GEN PSYCHIAT, V47, P366; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BERRETTINI WH, IN PRESS ARCH GEN PS; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BYERLEY W, 1995, AM J MED GENET, V60, P231, DOI 10.1002/ajmg.1320600312; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; DETERAWADLEIGH SD, 1994, AM J MED GENET, V54, P206, DOI 10.1002/ajmg.1320540307; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DETERAWADLEIGH SD, 1992, NEUROPSYCHOPHARMACOL, V6, P219; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GEJMAN PV, 1990, GENOMICS, V8, P648, DOI 10.1016/0888-7543(90)90251-O; GERSHON ES, IN PRESS AM J MED GE; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDGAR DE, 1993, GENET EPIDEMIOL, V10, P383, DOI 10.1002/gepi.1370100609; GOLDGAR DE, 1992, AM J HUM GENET, V50, P598; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREGOR P, 1993, P NATL ACAD SCI USA, V90, P3053, DOI 10.1073/pnas.90.7.3053; GURLING H, 1995, NAT GENET, V10, P8, DOI 10.1038/ng0595-8b; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; *LA STAT U MED CTR, 1992, STAT AN GEN EP REL 2; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LAWRENCE S, 1993, P NATL ACAD SCI USA, V90, P7210, DOI 10.1073/pnas.90.15.7210; Ott J., 1991, ANAL HUMAN GENETIC L; PEKKARINEN P, 1995, GENOME RES, V5, P105, DOI 10.1101/gr.5.2.105; RISCH N, 1987, AM J HUM GENET, V40, P1; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; WEEKS DE, 1988, AM J HUM GENET, V42, P315; 1994, SCIENCE, V265, P2049	38	112	114	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1279	1285						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651306				2022-12-18	WOS:A1996UM27100022
